PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Biel, M				Biel, Martin			Cyclic Nucleotide-regulated Cation Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CGMP-GATED CHANNEL; HYPERPOLARIZATION-ACTIVATED CHANNEL; RECESSIVE RETINITIS-PIGMENTOSA; HCN PACEMAKER CHANNELS; I-H; MICE LACKING; PHYSIOLOGICAL-FUNCTION; TOTAL COLOURBLINDNESS; ROD PHOTORECEPTORS; SINUS BRADYCARDIA	Cyclic nucleotide-regulated cation channels are ion channels whose activation is regulated by the direct binding of cAMP or cGMP to the channel protein. Two structurally related families of channels regulated by cyclic nucleotides have been identified, the cyclic nucleotide-gated channels and the hyperpolarization-activated cyclic nucleotide-gated channels. Cyclic nucleotide-gated channels play a key role in visual and olfactory transduction. Hyperpolarization-activated cyclic nucleotide-gated channels are present in the conduction system of the heart and are involved in the control of cardiac automaticity. Moreover, these channels are widely expressed in central and peripheral neurons, where they control a variety of fundamental processes.	[Biel, Martin] Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Biel, Martin] Univ Munich, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany	University of Munich; University of Munich	Biel, M (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Butenandtstr 5-13, D-81377 Munich, Germany.	mbiel@cup.uni-muenchen.de	Biel, Martin/G-1175-2014	Biel, Martin/0000-0002-9974-3052	Deutsche Forschungsgemeinschaft; European Union Research Project NORMACOR within the Sixth Framework Programme of the European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union Research Project NORMACOR within the Sixth Framework Programme of the European Union(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft and by European Union Research Project NORMACOR within the Sixth Framework Programme of the European Union. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Biel M, 2007, MOL NEUROBIOL, V35, P266, DOI 10.1007/s12035-007-0025-y; Boccaccio A, 2006, J GEN PHYSIOL, V128, P171, DOI 10.1085/jgp.200609555; Bonigk W, 1999, J NEUROSCI, V19, P5332; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Bucchi A, 2007, CURR OPIN PHARMACOL, V7, P208, DOI 10.1016/j.coph.2006.09.005; Budde T, 2008, PFLUG ARCH EUR J PHY, V456, P1061, DOI 10.1007/s00424-008-0482-9; Cacheaux LP, 2005, J PHARMACOL EXP THER, V315, P517, DOI 10.1124/jpet.105.091801; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; DIFRANCESCO D, 1986, NATURE, V324, P470, DOI 10.1038/324470a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Herrmann S, 2007, EMBO J, V26, P4423, DOI 10.1038/sj.emboj.7601868; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hofmann F, 2005, PHARMACOL REV, V57, P455, DOI 10.1124/pr.57.4.8; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Ishii TM, 2001, J PHYSIOL-LONDON, V537, P93, DOI 10.1111/j.1469-7793.2001.0093k.x; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kitayama M, 2003, EPILEPSIA, V44, P20, DOI 10.1046/j.1528-1157.2003.22702.x; Knaus A, 2007, CIRCULATION, V115, P872, DOI 10.1161/CIRCULATIONAHA.106.667675; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Michalakis S, 2006, J BIOL CHEM, V281, P35156, DOI 10.1074/jbc.M606409200; Michels G, 2005, CIRCULATION, V111, P399, DOI 10.1161/01.CIR.0000153799.65783.3A; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; MOLDAY RS, 1991, J BIOL CHEM, V266, P21917; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Nof E, 2007, CIRCULATION, V116, P463, DOI 10.1161/CIRCULATIONAHA.107.706887; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Peng CH, 2004, NEURON, V42, P401, DOI 10.1016/S0896-6273(04)00225-9; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 1997, P NATL ACAD SCI USA, V94, P14815, DOI 10.1073/pnas.94.26.14815; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Song Y, 2008, NEURON, V58, P374, DOI 10.1016/j.neuron.2008.02.029; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Stieber J, 2003, J BIOL CHEM, V278, P33672, DOI 10.1074/jbc.M305318200; Sulfi S, 2006, INT J CLIN PRACT, V60, P222, DOI 10.1111/j.1742-1241.2006.00817.x; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Vasilyev DV, 2007, J NEUROPHYSIOL, V97, P3713, DOI 10.1152/jn.00841.2006; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; WOHLFART P, 1989, J BIOL CHEM, V264, P20934; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zong XG, 1998, EMBO J, V17, P353, DOI 10.1093/emboj/17.2.353	74	71	73	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9017	9021		10.1074/jbc.R800075200	http://dx.doi.org/10.1074/jbc.R800075200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19054768	Green Published, hybrid			2022-12-27	WOS:000264669100003
J	Mack, PJ; Zhang, Y; Chung, S; Vickerman, V; Kamm, RD; Garcia-Cardena, G				Mack, Peter J.; Zhang, Yuzhi; Chung, Seok; Vickerman, Vernella; Kamm, Roger D.; Garcia-Cardena, Guillermo			Biomechanical Regulation of Endothelium-dependent Events Critical for Adaptive Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE GROWTH-FACTOR; FLUID SHEAR-STRESS; MUSCLE-CELL DIFFERENTIATION; CORONARY-ARTERY-DISEASE; GENE-EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSCRIPTION FACTOR; MOLECULAR REGULATION; VESSEL MATURATION; NITRIC-OXIDE	Alterations in hemodynamic shear stress acting on the vascular endothelium are critical for adaptive arterial remodeling. The molecular mechanisms regulating this process, however, remain largely uncharacterized. Here, we sought to define the responses evoked in endothelial cells exposed to shear stress waveforms characteristic of coronary collateral vessels and the subsequent paracrine effects on smooth muscle cells. A lumped parameter model of the human coronary collateral circulation was used to simulate normal and adaptive remodeling coronary collateral shear stress waveforms. These wave forms were then applied to cultured human endothelial cells ( EC), and the resulting differences in EC gene expression were assessed by genome-wide transcriptional profiling to identify genes distinctly regulated by collateral flow. Analysis of these transcriptional programs identified several genes to be differentially regulated by collateral flow, including genes important for endothelium-smooth muscle interactions. In particular, the transcription factor KLF2 was up- regulated by the adaptive remodeling coronary collateral waveform, and several of its downstream targets displayed the expected modulation, including the down-regulation of connective tissue growth factor. To assess the effect of endothelial KLF2 expression on smooth muscle cell migration, a three-dimensional microfluidic assay was developed. Using this three-dimensional system, we showed that KLF2-expressing EC co-cultured with SMC significantly reduce SMC migration compared with control EC and that this reduction can be rescued by the addition of exogenous connective tissue growth factor. Collectively, these results demonstrate that collateral flow evokes distinct EC gene expression profiles and functional phenotypes that subsequently influence vascular events important for adaptive remodeling.	[Chung, Seok; Garcia-Cardena, Guillermo] MIT, Dept Biol, Cambridge, MA 02139 USA; [Vickerman, Vernella] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Mack, Peter J.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Garcia-Cardena, Guillermo] Harvard Univ, Sch Med, Dept Pathol, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Garcia-Cardena, Guillermo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kamm, RD (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave,NE47-320, Cambridge, MA 02139 USA.	rdkamm@mit.edu; guillermo_garcia-cardena@hms.harvard.edu	Garcia-Cardena, Guillermo/Q-6649-2019; Kamm, Roger D/I-7630-2012; Chung, Seok/B-1501-2015	/0000-0002-7232-304X	National Institutes of Health; NHLB [RO1-HL7066686, P50-HL56985]; NIBIB [BRP-EB003805]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006348, R01EB003805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLB; NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health, NHLB, Grants RO1-HL7066686 and P50-HL56985 (to G. G.- C.) and National Institutes of Health, NIBIB, Grant BRP-EB003805 (to R. D. K.).	Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; CHAITMAN BR, 1981, CIRCULATION, V64, P360, DOI 10.1161/01.CIR.64.2.360; Chatzizisis YS, 2007, CURR OPIN CARDIOL, V22, P552, DOI 10.1097/HCO.0b013e3282f07548; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Chiu JJ, 2005, ARTERIOSCL THROM VAS, V25, P963, DOI 10.1161/01.ATV.0000159703.43374.19; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; Comander J, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-17; Corriere MA, 2008, J SURG RES, V145, P142, DOI 10.1016/j.jss.2007.03.077; Crean JK, 2004, FASEB J, V18, P1541, DOI 10.1096/fj.04-1546fje; Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Garcia-Cardena G, 2006, Handb Exp Pharmacol, P79; Hastings NE, 2007, AM J PHYSIOL-CELL PH, V293, pC1824, DOI 10.1152/ajpcell.00385.2007; Heil M, 2004, CORONARY ARTERY DIS, V15, P373, DOI 10.1097/00019501-200411000-00002; Heldt T, 2002, J APPL PHYSIOL, V92, P1239, DOI 10.1152/japplphysiol.00241.2001; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Huddleson JP, 2005, J BIOL CHEM, V280, P23371, DOI 10.1074/jbc.M413839200; Huddleson JP, 2004, BIOL CHEM, V385, P723, DOI 10.1515/BC.2004.088; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jones N, 2000, CANCER METAST REV, V19, P13, DOI 10.1023/A:1026555121511; Korshunov VA, 2007, ARTERIOSCL THROM VAS, V27, P1722, DOI 10.1161/ATVBAHA.106.129254; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904; LEE E, 1995, ARTERIOSCL THROM VAS, V15, P2284, DOI 10.1161/01.ATV.15.12.2284; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Limbourg A, 2007, CIRC RES, V100, P363, DOI 10.1161/01.RES.0000258174.77370.2c; Lindahl P, 1998, CURR OPIN LIPIDOL, V9, P407, DOI 10.1097/00041433-199810000-00004; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393; Mees B, 2007, ARTERIOSCL THROM VAS, V27, P1926, DOI 10.1161/ATVBAHA.107.145375; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Oemar BS, 1997, ARTERIOSCL THROM VAS, V17, P1483, DOI 10.1161/01.ATV.17.8.1483; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Reiss Y, 2007, CIRC RES, V101, P88, DOI 10.1161/CIRCRESAHA.106.143594; Rockstroh J, 2002, CIRCULATION, V105, P168, DOI 10.1161/hc0202.102120; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Sakamoto N, 2006, ANN BIOMED ENG, V34, P408, DOI 10.1007/s10439-005-9043-y; Schaper W, 2003, ARTERIOSCL THROM VAS, V23, P1143, DOI 10.1161/01.ATV.0000069625.11230.96; SCHREINER W, 1990, J BIOMED ENG, V12, P429, DOI 10.1016/0141-5425(90)90029-M; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Song RH, 2000, ARTERIOSCL THROM VAS, V20, P923, DOI 10.1161/01.ATV.20.4.923; Sullivan CC, 2003, P NATL ACAD SCI USA, V100, P12331, DOI 10.1073/pnas.1933740100; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f; Vita JA, 2008, CIRCULATION, V117, P3126, DOI 10.1161/CIRCULATIONAHA.108.778472; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Watts KL, 2004, AM J PHYSIOL-LUNG C, V287, pL1323, DOI 10.1152/ajplung.00447.2003; Wolf C, 1998, J MOL CELL CARDIOL, V30, P2291, DOI 10.1006/jmcc.1998.0790; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Zhao XM, 1997, J MATER CHEM, V7, P1069, DOI 10.1039/a700145b	55	38	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8412	8420		10.1074/jbc.M804524200	http://dx.doi.org/10.1074/jbc.M804524200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19047056	hybrid, Green Published			2022-12-27	WOS:000264397800025
J	Pedram, A; Razandi, M; Kim, JK; O'Mahony, F; Lee, EYHP; Luderer, U; Levin, ER				Pedram, Ali; Razandi, Mahnaz; Kim, Jin K.; O'Mahony, Fiona; Lee, Eva Y. H. P.; Luderer, Ulrike; Levin, Ellis R.			Developmental Phenotype of a Membrane Only Estrogen Receptor alpha(MOER) Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATION PROVIDES EVIDENCE; ALPHA KNOCKOUT MICE; PLASMA-MEMBRANE; ADIPOSE-TISSUE; IN-VIVO; DIFFERENTIATION; EXPRESSION; INDUCTION; BINDING; GLAND	Estrogen receptors (ERs) alpha and beta exist as nuclear, cytoplasmic, and membrane cellular pools in a wide variety of organs. The relative contributions of each ER alpha pool to in vivo phenotypes resulting from estrogen signaling have not been determined. To address this, we generated a transgenic mouse expressing only a functional E domain of ER alpha at the plasma membrane (MOER). Cells isolated from many organs showed membrane only localized E domain of ER alpha and no other receptor pools. Liver cells from MOER and wild type mice responded to 17-beta-estradiol (E2) with comparable activation of ERK and phosphatidylinositol 3-kinase, not seen in cells from ER alpha KO mice. Mating the MOER female mice with proven male wild type breeders produced no pregnancies because the uterus and vagina of the MOER female mice were extremely atrophic. Ovaries of MOER and homozygous Strasbourg ER alpha KO mice showed multiple hemorrhagic cysts and no corpus luteum, and the mammary gland development in both MOER and ER alpha KO mice was rudimentary. Despite elevated serum E2 levels, serum LH was not suppressed, and prolactin levels were low in MOER mice. MOER and Strasbourg female mice showed plentiful abdominal visceral and other depots of fat and increased body weight compared to wild type mice despite comparable food consumption. These results provide strong evidence that the normal development and adult functions of important organs in female mice requires nuclear ER alpha and is not rescued by membrane ER alpha domain expression alone.	[Levin, Ellis R.] UC Irvine, Vet Affairs Med Ctr, Div Endocrinol, Med Serv I 111, Long Beach, CA 90822 USA; [Pedram, Ali; Razandi, Mahnaz; Kim, Jin K.; O'Mahony, Fiona; Luderer, Ulrike; Levin, Ellis R.] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Lee, Eva Y. H. P.; Levin, Ellis R.] Univ Calif Irvine, Dept Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine	Levin, ER (corresponding author), UC Irvine, Vet Affairs Med Ctr, Div Endocrinol, Med Serv I 111, 5901 E 7th St, Long Beach, CA 90822 USA.	ellis.levin@med.va.gov	Levin, Ellis/J-5402-2013		National Institutes of Health Grants [CA-100366, K08HL089066]; Research Service of the Department of Veteran's Affairs; National Biophotonics and Imaging Platform of Ireland; NATIONAL CANCER INSTITUTE [P30CA062203, R01CA100366] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089066] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Service of the Department of Veteran's Affairs(US Department of Veterans Affairs); National Biophotonics and Imaging Platform of Ireland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-100366(to E. R. L.) and K08HL089066(to J.K.K.). This work was also supported by grants from the Research Service of the Department of Veteran's Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a post-doctoral fellowship grant from the National Biophotonics and Imaging Platform of Ireland.	Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Dupont S, 2000, DEVELOPMENT, V127, P4277; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kousteni S, 2007, MOL CELL BIOL, V27, P1516, DOI 10.1128/MCB.01550-06; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; O'Brien JE, 2006, J BIOL CHEM, V281, P26683, DOI 10.1074/jbc.M601522200; Pedersen SB, 2001, MOL CELL ENDOCRINOL, V182, P27, DOI 10.1016/S0303-7207(01)00557-3; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Quyyumi AA, 2006, J AM COLL CARDIOL, V47, p66S, DOI 10.1016/j.jacc.2004.11.075; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Scully KM, 1997, MOL ENDOCRINOL, V11, P674, DOI 10.1210/me.11.6.674; Simpson ER, 2004, SEMIN REPROD MED, V22, P25; Sinkevicius KW, 2008, ENDOCRINOLOGY, V149, P2970, DOI 10.1210/en.2007-1526; Vasudevan N, 2001, P NATL ACAD SCI USA, V98, P12267, DOI 10.1073/pnas.221449798	21	107	110	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3488	3495		10.1074/jbc.M806249200	http://dx.doi.org/10.1074/jbc.M806249200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19054762	Green Published, hybrid			2022-12-27	WOS:000262872500015
J	Avenson, TJ; Ahn, TK; Niyogi, KK; Ballottari, M; Bassi, R; Fleming, GR				Avenson, Thomas J.; Ahn, Tae Kyu; Niyogi, Krishna K.; Ballottari, Matteo; Bassi, Roberto; Fleming, Graham R.			Lutein Can Act as a Switchable Charge Transfer Quencher in the CP26 Light-harvesting Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL-CATION FORMATION; HIGHER-PLANTS; CHLOROPHYLL FLUORESCENCE; ENERGY-DISSIPATION; LHCA PROTEINS; ANTENNA; MECHANISM; ZEAXANTHIN; ELECTRON; PHOTOPROTECTION	Energy-dependent quenching of excitons in photosystem II of plants, or qE, has been positively correlated with the transient production of carotenoid radical cation species. Zeaxanthin was shown to be the donor species in the CP29 antenna complex. We report transient absorbance analyses of CP24 and CP26 complexes that bind lutein and zeaxanthin in the L1 and L2 domains, respectively. For CP24 complexes, the transient absorbance difference profiles give a reconstructed transient absorbance spectrum with a single peak centered at similar to 980 nm, consistent with zeaxanthin radical cation formation. In contrast, CP26 gives constants for the decay components probed at 940 and 980 nm of 144 and 194 ps, a transient absorbance spectrum that has a main peak at 980 nm, and a substantial shoulder at 940 nm. This suggests the presence of two charge transfer quenching sites in CP26 involving zeaxanthin radical cation and lutein radical cation species. Wealso show that lutein radical cation formation in CP26 is dependent on binding of zeaxanthin to the L2 domain, implying that zeaxanthin acts as an allosteric effector of charge transfer quenching involving lutein in the L1 domain.	[Avenson, Thomas J.; Ahn, Tae Kyu; Niyogi, Krishna K.; Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Avenson, Thomas J.; Ahn, Tae Kyu; Niyogi, Krishna K.; Fleming, Graham R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Avenson, Thomas J.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Ballottari, Matteo; Bassi, Roberto] Univ Verona, Dept Sci & Technol, I-37134 Verona, Italy	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Verona	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	GRFleming@lbl.gov	Ahn, Tae Kyu/A-5838-2013; Ballottari, Matteo/N-1916-2019	Ahn, Tae Kyu/0000-0002-7474-6513; Ballottari, Matteo/0000-0001-8410-3397; bassi, roberto/0000-0002-4140-8446	Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy [DE-AC02-05CH11231]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U. S. Department of Energy [DE-AC03-76SF000098]; Korea Research Foundation [KRF-2006-214-C00037]; Korean Government (MOEHRD); National Research Initiative Competitive [2006-03279]	Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy(United States Department of Energy (DOE)); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U. S. Department of Energy(United States Department of Energy (DOE)); Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); National Research Initiative Competitive(United States Department of Agriculture (USDA))	This work was supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U. S. Department of Energy under Contract DE-AC02-05CH11231 and by the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, U. S. Department of Energy under Contract DE-AC03-76SF000098 (to G. R. F. and K. K. N.), by the Korea Research Foundation Grant KRF-2006-214-C00037 funded by the Korean Government (MOEHRD) (to T. K. A.), and by the National Research Initiative Competitive Grant 2006-03279 (to T. J. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 These authors contributed equally to this work.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Carbonera D, 2005, BIOCHEMISTRY-US, V44, P8337, DOI 10.1021/bi050260z; Cheng YC, 2008, J PHYS CHEM B, V112, P13418, DOI 10.1021/jp802730c; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2007, J BIOL CHEM, V282, P35056, DOI 10.1074/jbc.M704729200; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Dreuw A, 2005, BIOCHEM SOC T, V33, P858, DOI 10.1042/BST0330858; Dreuw A, 2003, PHYS CHEM CHEM PHYS, V5, P3247, DOI 10.1039/b304944b; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Galinato MGI, 2007, PHOTOSYNTH RES, V94, P67, DOI 10.1007/s11120-007-9218-5; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Han RM, 2006, PHOTOCHEM PHOTOBIOL, V82, P538, DOI 10.1562/2005-09-30-RA-705; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ihalainen JA, 2005, J PHYS CHEM B, V109, P21150, DOI 10.1021/jp0519316; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Mortensen A, 1997, J AGR FOOD CHEM, V45, P2970, DOI 10.1021/jf970010s; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; Novoderezhkin VI, 2005, J PHYS CHEM B, V109, P10493, DOI 10.1021/jp044082f; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Polivka T, 2002, BIOCHEMISTRY-US, V41, P439, DOI 10.1021/bi011589x; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2006, J BIOL CHEM, V281, P14981, DOI 10.1074/jbc.M511415200; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c	44	63	63	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2830	2835		10.1074/jbc.M807192200	http://dx.doi.org/10.1074/jbc.M807192200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	18990705	hybrid			2022-12-27	WOS:000262700900026
J	Matyash, A; Singh, N; Hanes, SD; Urlaub, H; Jackle, H				Matyash, Alexey; Singh, Navjot; Hanes, Steven D.; Urlaub, Henning; Jaeckle, Herbert			SAP18 Promotes Kruppel-dependent Transcriptional Repression by Enhancer-specific Histone Deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTBP-INDEPENDENT REPRESSION; TRITHORAX GROUP GENES; DROSOPHILA EMBRYO; GAGA FACTOR; POSTERIOR REGION; MODIFIER SCREEN; BINDING-SITE; DNA-BINDING; IN-VIVO; POLYCOMB	Body pattern formation during early embryogenesis of Drosophila melanogaster relies on a zygotic cascade of spatially restricted transcription factor activities. The gap gene Kruppel ranks at the top level of this cascade. It encodes a C2H2 zinc finger protein that interacts directly with cis-acting stripe enhancer elements of pair rule genes, such as even skipped and hairy, at the next level of the gene hierarchy. Kruppel mediates their transcriptional repression by direct association with the corepressor Drosophila C terminus-binding protein (dCtBP). However, for some Kruppel target genes, deletion of the dCtBP-binding sites does not abolish repression, implying a dCtBP-independent mode of repression. We identified Kruppel-binding proteins by mass spectrometry and found that SAP18 can both associate with Kruppel and support Kruppel-dependent repression. Genetic interaction studies combined with pharmacological and biochemical approaches suggest a site-specific mechanism of Kruppel-dependent gene silencing. The results suggest that Kruppel tethers the SAP18 bound histone deacetylase complex 1 at distinct enhancer elements, which causes repression via histone H3 deacetylation.	[Matyash, Alexey; Jaeckle, Herbert] Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, D-37077 Gottingen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Singh, Navjot; Hanes, Steven D.] SUNY Albany, Wadsworth Ctr, New York State Dept Hlth, Albany, NY 12208 USA; [Singh, Navjot; Hanes, Steven D.] SUNY Albany, Dept Biomed Sci, Albany, NY 12208 USA	Max Planck Society; Max Planck Society; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Jackle, H (corresponding author), Fassberg 11, D-37077 Gottingen, Germany.	hjaeckl@gwdg.de			Max-Planck-Gesellschaft; American Cancer Society [RSG-9508506-DDC, 1-FY07-527]	Max-Planck-Gesellschaft(Max Planck Society); American Cancer Society(American Cancer Society)	This work was supported by funds from the Max-Planck-Gesellschaft (to H.J., H.U., and A.M.) and by American Cancer Society Grant RSG-9508506-DDC and March of Dimes Grant 1-FY07-527 (to V.N.S. and S. D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.. S The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables S1 and S2 and Figs. S1 and S2.	Abrell S, 2000, CHROMOSOMA, V109, P334, DOI 10.1007/s004120000092; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Canudas S, 2005, NUCLEIC ACIDS RES, V33, P4857, DOI 10.1093/nar/gki776; Carrera P, 1998, P NATL ACAD SCI USA, V95, P10779, DOI 10.1073/pnas.95.18.10779; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; CHOU TB, 1992, GENETICS, V131, P643; Chou TB, 1996, GENETICS, V144, P1673; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Espinas ML, 2000, EMBO REP, V1, P253, DOI 10.1093/embo-reports/kvd046; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Faucheux M, 2003, MOL CELL BIOL, V23, P1181, DOI 10.1128/MCB.23.4.1181-1195.2003; Foglietti C, 2006, J BIOL CHEM, V281, P17968, DOI 10.1074/jbc.M511945200; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Gaul U, 1990, Adv Genet, V27, P239; Gildea JJ, 2000, GENETICS, V156, P645; Hartmann C, 1997, EMBO J, V16, P5299, DOI 10.1093/emboj/16.17.5299; HOCH M, 1991, EMBO J, V10, P2267, DOI 10.1002/j.1460-2075.1991.tb07763.x; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; Hoch M, 1998, EMBO J, V17, P5766, DOI 10.1093/emboj/17.19.5766; Huang XJ, 2001, J BIOL CHEM, V276, P12497, DOI 10.1074/jbc.C100034200; JACKLE H, 1992, J CELL SCI, P39; La Rosee-Borggreve A, 1999, MECH DEVELOP, V89, P133, DOI 10.1016/S0925-4773(99)00219-1; LaRosee A, 1997, EMBO J, V16, P4403, DOI 10.1093/emboj/16.14.4403; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Matyash A, 2004, J BIOL CHEM, V279, P30689, DOI 10.1074/jbc.M403345200; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mottus R, 2000, GENETICS, V154, P657; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Ng J, 2000, MOL CELL BIOL, V20, P3069, DOI 10.1128/MCB.20.9.3069-3078.2000; Nibu Y, 2003, MOL CELL BIOL, V23, P3990, DOI 10.1128/MCB.23.11.3990-3999.2003; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; PANKRATZ MJ, 1990, TRENDS GENET, V6, P287, DOI 10.1016/0168-9525(90)90234-W; PANKRATZ MJ, 1989, NATURE, V341, P337, DOI 10.1038/341337a0; PANKRATZ MJ, 1990, CELL, V61, P309, DOI 10.1016/0092-8674(90)90811-R; Phippen TM, 2000, J BIOL CHEM, V275, P37628, DOI 10.1074/jbc.M004234200; ROSENBERG UB, 1985, NATURE, V313, P703, DOI 10.1038/313703a0; Ryu JR, 2003, NUCLEIC ACIDS RES, V31, P4654, DOI 10.1093/nar/gkg491; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; SAUER F, 1995, NATURE, V375, P162, DOI 10.1038/375162a0; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh N, 2005, DEV BIOL, V278, P242, DOI 10.1016/j.ydbio.2004.11.011; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Song CP, 2006, PLANT MOL BIOL, V60, P241, DOI 10.1007/s11103-005-3880-9; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; STRECKER TR, 1994, BIOTECH HISTOCHEM, V69, P25, DOI 10.3109/10520299409106257; Struffi P, 2005, J BIOL CHEM, V280, P40757, DOI 10.1074/jbc.M506819200; Struffi P, 2004, DEVELOPMENT, V131, P2419, DOI 10.1242/dev.01075; Subramanian T, 2003, FEBS LETT, V540, P255, DOI 10.1016/S0014-5793(03)00275-8; Tie F, 2001, DEVELOPMENT, V128, P275; Tillib S, 1999, MOL CELL BIOL, V19, P5189; Wang L, 2002, GENE, V285, P119, DOI 10.1016/S0378-1119(02)00418-3; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhu WC, 2000, GENE, V245, P329, DOI 10.1016/S0378-1119(00)00048-2; Zhu WC, 2001, DEV GENES EVOL, V211, P109, DOI 10.1007/s004270100135	66	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3012	3020		10.1074/jbc.M806163200	http://dx.doi.org/10.1074/jbc.M806163200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049982	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000262700900045
J	Takahata, M; Inoue, Y; Tsuda, H; Imoto, I; Koinuma, D; Hayashi, M; Ichikura, T; Yamori, T; Nagasaki, K; Yoshida, M; Matsuoka, M; Morishita, K; Yuki, K; Hanyu, A; Miyazawa, K; Inazawa, J; Miyazono, K; Imamura, T				Takahata, Mami; Inoue, Yasumichi; Tsuda, Hitoshi; Imoto, Issei; Koinuma, Daizo; Hayashi, Makoto; Ichikura, Takashi; Yamori, Takao; Nagasaki, Koichi; Yoshida, Mika; Matsuoka, Masao; Morishita, Kazuhiro; Yuki, Keiko; Hanyu, Aki; Miyazawa, Keiji; Inazawa, Johji; Miyazono, Kohei; Imamura, Takeshi			SKI and MEL1 Cooperate to Inhibit Transforming Growth Factor-beta Signal in Gastric Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; C-SKI; SMAD PROTEINS; GENE-EXPRESSION; LEUKEMIA-CELLS; ONCOPROTEIN; BINDING; LINES; SNO; DIFFERENTIATION	Chromosomal amplification occurs frequently in solid tumors and is associated with poor prognosis. Several reports demonstrated the cooperative effects of oncogenic factors in the same amplicon during cancer development. However, the functional correlation between the factors remains unclear. Transforming growth factor (TGF)-beta signaling plays important roles in cytostasis and normal epithelium differentiation, and alterations in TGF-beta signaling have been identified in many malignancies. Here, we demonstrated that transcriptional co-repressors of TGF-beta signaling, SKI and MDS1/EVI1-like gene 1 (MEL1), were aberrantly expressed in MKN28 gastric cancer cells by chromosomal co-amplification of 1p36.32. SKI and MEL1 knockdown synergistically restored TGF-beta responsiveness in MKN28 cells and reduced tumor growth in vivo. MEL1 interacted with SKI and inhibited TGF-beta signaling by stabilizing the inactive Smad3-SKI complex on the promoter of TGF-beta target genes. These findings reveal a novel mechanism where distinct transcriptional co-repressors are co-amplified and functionally interact, and provide molecular targets for gastric cancer treatment.	[Takahata, Mami; Inoue, Yasumichi; Koinuma, Daizo; Hayashi, Makoto; Hanyu, Aki; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Div Biochem, Koto Ku, Tokyo 1358550, Japan; [Yamori, Takao] Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Koto Ku, Tokyo 1358550, Japan; [Nagasaki, Koichi] Japanese Fdn Canc Res, Genome Ctr, Koto Ku, Tokyo 1358550, Japan; [Takahata, Mami; Yuki, Keiko; Miyazawa, Keiji; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Tsuda, Hitoshi] Natl Def Med Coll, Dept Basic Pathol, Tokorozawa, Saitama 3598513, Japan; [Ichikura, Takashi] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan; [Imoto, Issei; Inazawa, Johji] Tokyo Med & Dent Univ, Dept Mol Cytogenet, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Imoto, Issei; Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Yoshida, Mika; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Lab Virus Immunol, Sakyo Ku, Kyoto 6068507, Japan; [Morishita, Kazuhiro] Miyazaki Med Coll, Dept Biochem, Kiyotake, Miyazaki 8891692, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; University of Tokyo; National Defense Medical College - Japan; National Defense Medical College - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University; University of Miyazaki	Imamura, T (corresponding author), Japanese Fdn Canc Res, Inst Canc, Div Biochem, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp	imoto, Issei/D-8065-2012; Imoto, Issei/AAD-5799-2020; Koinuma, Daizo/Y-8716-2018; MIYAZAWA, KEIJI/I-9713-2014	Koinuma, Daizo/0000-0001-5611-2122; Matsuoka, Masao/0000-0002-0473-754X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Vehicle Racing Commemorative Foundation, Naito Foundation,; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation, Naito Foundation,; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by KAKENHI grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the Vehicle Racing Commemorative Foundation, Naito Foundation, and Takeda Science Foundation.	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Alliston T, 2005, J BIOL CHEM, V280, P24227, DOI 10.1074/jbc.M414305200; ARIYAMA T, 1995, CANCER GENET CYTOGEN, V81, P20, DOI 10.1016/0165-4608(94)00197-9; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Collins C, 2001, GENOME RES, V11, P1034, DOI 10.1101/gr.GR1743R; Dan S, 2002, CANCER RES, V62, P1139; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Ebisawa T, 1999, J CELL SCI, V112, P3519; Fukuchi M, 2004, INT J CANCER, V108, P818, DOI 10.1002/ijc.11651; FUMAGALLI S, 1993, MELANOMA RES, V3, P23, DOI 10.1097/00008390-199304000-00004; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Korchynskyi O, 1999, INT J CANCER, V82, P197, DOI 10.1002/(SICI)1097-0215(19990719)82:2<197::AID-IJC8>3.0.CO;2-V; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; MORISHITA K, 1992, P NATL ACAD SCI USA, V89, P3937, DOI 10.1073/pnas.89.9.3937; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Nagata M, 2006, GENES CELLS, V11, P1267, DOI 10.1111/j.1365-2443.2006.01018.x; Nishihara A, 1999, J BIOL CHEM, V274, P28716, DOI 10.1074/jbc.274.40.28716; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; PEARSONWHITE S, 1993, NUCLEIC ACIDS RES, V21, P4632, DOI 10.1093/nar/21.19.4632; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Reed JA, 2001, CANCER RES, V61, P8074; Sakakura C, 1999, GENE CHROMOSOME CANC, V24, P299, DOI 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; STAVNEZER E, 1989, MOL CELL BIOL, V9, P4038, DOI 10.1128/MCB.9.9.4038; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Takada H, 2005, CANCER SCI, V96, P100, DOI 10.1111/j.1349-7006.2005.00016.x; Warner DR, 2007, BBA-MOL CELL RES, V1773, P814, DOI 10.1016/j.bbamcr.2007.03.016; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Xiangming C, 2001, CLIN CANCER RES, V7, P277; Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05; Yoshida M, 2004, BLOOD, V103, P2753, DOI 10.1182/blood-2003-07-2482; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	46	63	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3334	3344		10.1074/jbc.M808989200	http://dx.doi.org/10.1074/jbc.M808989200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049980	hybrid			2022-12-27	WOS:000262700900076
J	Vararattanavech, A; Lin, X; Torres, J; Tan, SM				Vararattanavech, Ardcharaporn; Lin, Xin; Torres, Jaume; Tan, Suet-Mien			Disruption of the Integrin alpha L beta 2 Transmembrane Domain Interface by beta 2 Thr-686 Mutation Activates alpha L beta 2 and Promotes Micro-clustering of the alpha L Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR-ADHESION MOLECULE-3; RECEPTOR LATERAL MOBILITY; RESONANCE ENERGY-TRANSFER; EXTENDED CONFORMATIONS; MONOCLONAL-ANTIBODIES; CYTOPLASMIC DOMAINS; SIGNAL-TRANSDUCTION; BETA(2) SUBUNIT; CELL-ADHESION; LFA-1	Integrins are type I heterodimeric cell adhesion molecules that mediate a wide array of biological processes. Integrin bidirectional signaling allows communication between the cell interior with its microenvironment. The integrin transmembrane domains (TMs) are the transducers of activation signal that is relayed from the cytoplasmic domains to the distal ligand binding site located in the ectodomain of the integrin and vice versa. In this study, we showed that the disruption of the alpha L beta 2 TMs by mutation of a key interface residue Thr-686 in the beta 2 TM promoted alpha L beta 2 activation with ICAMs binding properties that are reminiscent of an intermediate affinity receptor. The activated alpha L beta 2 TM mutants, however, showed minimal reactivity with the reporter mAb KIM127 that recognizes a highly extended alpha L beta 2. Two models of alpha L beta 2 TM interaction were proposed previously. One with GXXXG-type interaction, and another that is based on TM cysteine-scanning analyses. Our data are consistent with a GXXXG-type interaction of the alpha L beta 2 TMs. Finally, we observed by FRET analyses that perturbation of the alpha L beta 2 TMs by beta 2 Thr-686 mutation facilitated alpha L microcluster formation. This was diminished by linking the alpha L beta 2 TMs with a disulfide bond, which served to clasp the TMs. These data suggest that disruption of the TM interface changes alpha L beta 2 ligand binding affinity, and it may contribute to alpha L micro-cluster formation.	[Vararattanavech, Ardcharaporn; Lin, Xin; Torres, Jaume; Tan, Suet-Mien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	smtan@ntu.edu.sg	Torres, Jaume/AAJ-4510-2020; Tan, Suet/A-2224-2011; Torres, Jaume/A-2179-2011	Torres, Jaume/0000-0002-1282-9727; Tan, Suet-Mien/0000-0003-2371-8739	Singapore Agency for Science, Technology, and Research (A*STAR) [04/1/22/19/358, 03/1/22/19/238]	Singapore Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by Singapore Agency for Science, Technology, and Research (A*STAR) BMRC Grant 04/1/22/19/358. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by A*STAR BMRC Grant 03/1/22/19/238.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Al-Shamkhani A, 1998, EUR J IMMUNOL, V28, P3291, DOI 10.1002/(SICI)1521-4141(199810)28:10<3291::AID-IMMU3291>3.0.CO;2-E; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Cairo CW, 2008, BIOPOLYMERS, V89, P409, DOI 10.1002/bip.20898; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fu G, 2006, BIOCHEM BIOPH RES CO, V351, P847, DOI 10.1016/j.bbrc.2006.10.127; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; HILDRETH JEK, 1985, J IMMUNOL, V134, P3272; Huang CC, 1997, P NATL ACAD SCI USA, V94, P3162, DOI 10.1073/pnas.94.7.3162; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Li YF, 2007, J BIOL CHEM, V282, P24310, DOI 10.1074/jbc.M701860200; Lin X, 2006, PROTEINS, V65, P274, DOI 10.1002/prot.21072; Liu SC, 2000, J CELL SCI, V113, P3563; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Nurmi SM, 2007, J BIOL CHEM, V282, P968, DOI 10.1074/jbc.M608524200; Parthasarathy K, 2008, PROTEIN SCI, V17, P930, DOI 10.1110/ps.073234208; Poloni F, 2001, EUR J IMMUNOL, V31, P57, DOI 10.1002/1521-4141(200101)31:1<57::AID-IMMU57>3.0.CO;2-9; Reichardt P, 2007, IMMUNOL REV, V218, P165, DOI 10.1111/j.1600-065X.2007.00526.x; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Stephens P, 1995, CELL ADHES COMMUN, V3, P375, DOI 10.3109/15419069509081292; Suzuki J, 2007, BLOOD, V109, P168, DOI 10.1182/blood-2005-12-020164; Tan SM, 2000, J IMMUNOL, V165, P2574, DOI 10.4049/jimmunol.165.5.2574; Tang ML, 2006, BIOCHEM BIOPH RES CO, V348, P1184, DOI 10.1016/j.bbrc.2006.07.179; Tang RH, 2005, J BIOL CHEM, V280, P29208, DOI 10.1074/jbc.M503239200; Tang XY, 2008, J IMMUNOL, V180, P4793, DOI 10.4049/jimmunol.180.7.4793; Vararattanavech A, 2008, BIOCHEM J, V410, P495, DOI 10.1042/BJ20071218; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; Xu Y, 2002, MOL BIOL CELL, V13, P3493, DOI 10.1091/mbc.E02-01-0004; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	61	14	14	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3239	3249		10.1074/jbc.M802782200	http://dx.doi.org/10.1074/jbc.M802782200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029120	hybrid			2022-12-27	WOS:000262700900067
J	Ludwig, M; Schubert, T; Zebger, I; Wisitruangsakul, N; Saggu, M; Strack, A; Lenz, O; Hildebrandt, P; Friedrich, B				Ludwig, Marcus; Schubert, Torsten; Zebger, Ingo; Wisitruangsakul, Nattawadee; Saggu, Miguel; Strack, Angelika; Lenz, Oliver; Hildebrandt, Peter; Friedrich, Baerbel			Concerted Action of Two Novel Auxiliary Proteins in Assembly of the Active Site in a Membrane-bound [NiFe] Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RALSTONIA-EUTROPHA H16; IRON-SULFUR CLUSTERS; HYP GENE-PRODUCTS; ALCALIGENES-EUTROPHUS; ESCHERICHIA-COLI; CARBON-MONOXIDE; FE HYDROGENASE; THIOCAPSA-ROSEOPERSICINA; RHIZOBIUM-LEGUMINOSARUM; BINDING PROTEIN	[NiFe] hydrogenases catalyze the reversible conversion of H-2 into protons and electrons. The reaction takes place at the active site, which is composed of a nickel and an iron atom and three diatomic ligands, two cyanides and one carbon monoxide, bound to the iron. The NiFe(CN-)(2)CO cofactor is synthesized by an intricate posttranslational maturation process, which is mediated by a set of six conserved Hyp proteins. Depending on the cellular location and the physiological function, additional auxiliary proteins are involved in hydrogenase biosynthesis. Here we present evidence that the auxiliary proteins HoxL and HoxV assist in assembly of the Fe(CN-)(2)CO moiety. This unit was identified as a cofactor intermediate of the oxygen-tolerant membrane-bound [NiFe] hydrogenase (MBH) in the beta-proteobacterium Ralstonia eutropha H16. Both HoxL and HoxV proved to be essential for H-2-oxidizing activity and MBH-driven growth on H-2. Copurification studies revealed that HoxL and HoxV directly interact with the hydrogenase apoprotein. HoxV forms complexes with HoxL and HypC, a HoxL paralogue that is essential for cofactor assembly. These observations suggest that HoxL acts as a specific chaperone assisting the transfer of the Fe(CN-)(2)CO cofactor intermediate from the Hyp machinery to the MBH. This shuttle also involves the scaffold protein HoxV. Indeed, infrared spectroscopy and metal analysis identified for the first time a non-redox-active Fe(CN-)(2)CO intermediate coordinated to HoxV.	[Ludwig, Marcus; Schubert, Torsten; Strack, Angelika; Lenz, Oliver; Friedrich, Baerbel] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany; [Zebger, Ingo; Wisitruangsakul, Nattawadee; Saggu, Miguel; Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany	Humboldt University of Berlin; Technical University of Berlin	Friedrich, B (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Chausseestr 117, D-10115 Berlin, Germany.	baerbel.friedrich@cms.hu-berlin.de	Lenz, Oliver/N-5130-2019; Hildebrandt, Peter/J-5658-2014; Lenz, Oliver/C-1582-2019; Saggu, Miguel/B-1224-2009; Schubert, Torsten/ABG-5468-2020; Schubert, Torsten/N-2457-2016	Lenz, Oliver/0000-0003-4550-5128; Hildebrandt, Peter/0000-0003-1030-5900; Lenz, Oliver/0000-0003-4550-5128; Schubert, Torsten/0000-0002-6569-1194; Schubert, Torsten/0000-0002-6569-1194	Deutsche Forschungsgemeinschaft [Sfb498]; Cluster of Excellence; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant Sfb498 and the Cluster of Excellence "Unifying Concepts in Catalysis" and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; Blokesch M, 2001, J BACTERIOL, V183, P2817, DOI 10.1128/JB.183.9.2817-2822.2001; Blokesch M, 2002, J MOL BIOL, V324, P287, DOI 10.1016/S0022-2836(02)01070-7; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buhrke T, 2005, J BIOL CHEM, V280, P19488, DOI 10.1074/jbc.M500601200; Buhrke T, 2001, J BACTERIOL, V183, P7087, DOI 10.1128/JB.183.24.7087-7093.2001; Cammack R., 2001, HYDROGEN FUEL LEARNI; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; DeLacey AL, 2003, J BIOL INORG CHEM, V8, P129, DOI 10.1007/s00775-002-0397-4; Dernedde J, 1996, EUR J BIOCHEM, V235, P351, DOI 10.1111/j.1432-1033.1996.00351.x; Fichtner C, 2006, BIOCHEMISTRY-US, V45, P9706, DOI 10.1021/bi0602462; Fodor BD, 2004, APPL ENVIRON MICROB, V70, P712, DOI 10.1128/AEM.70.2.712-721.2004; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; FRIEDRICH B, 1993, ANNU REV MICROBIOL, V47, P351, DOI 10.1146/annurev.mi.47.100193.002031; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; HENNESSY DJ, 1984, CAN J CHEM, V62, P721, DOI 10.1139/v84-121; IMPERIAL J, 1993, MOL MICROBIOL, V9, P1305, DOI 10.1111/j.1365-2958.1993.tb01260.x; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Kennedy DC, 2007, J AM CHEM SOC, V129, P16, DOI 10.1021/ja066958x; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kleihues L, 2000, J BACTERIOL, V182, P2716, DOI 10.1128/JB.182.10.2716-2724.2000; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; KORTLUKE C, 1992, J BACTERIOL, V174, P6277; Kovacs AT, 2005, J BACTERIOL, V187, P2618, DOI 10.1128/JB.187.8.2618-2627.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leach MR, 2007, CURR OPIN CHEM BIOL, V11, P159, DOI 10.1016/j.cbpa.2007.01.011; Lenz O, 2002, J MOL MICROB BIOTECH, V4, P255; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Liaw WF, 2002, J AM CHEM SOC, V124, P1680, DOI 10.1021/ja011504f; Loscher S, 2005, FEBS LETT, V579, P4287, DOI 10.1016/j.febslet.2005.06.063; Magalon A, 2000, J BIOL CHEM, V275, P21114, DOI 10.1074/jbc.M000987200; Maier T, 1996, BIOCHEMISTRY-US, V35, P10089, DOI 10.1021/bi960567l; Maroti G, 2003, EUR J BIOCHEM, V270, P2218, DOI 10.1046/j.1432-1033.2003.03589.x; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; Miller J.H., 1972, EXPT MOL GENETICS; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; REY L, 1994, J BACTERIOL, V176, P6066, DOI 10.1128/jb.176.19.6066-6073.1994; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Soboh B, 2006, J BIOL CHEM, V281, P36701, DOI 10.1074/jbc.M606820200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Winter G, 2004, ARCH MICROBIOL, V182, P138, DOI 10.1007/s00203-004-0680-6; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	68	43	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2159	2168		10.1074/jbc.M808488200	http://dx.doi.org/10.1074/jbc.M808488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017638	hybrid			2022-12-27	WOS:000262545600025
J	Rhode, S; Grurl, R; Brameshuber, M; Hermetter, A; Schutz, GJ				Rhode, Sebastian; Grurl, Reinhard; Brameshuber, Mario; Hermetter, Albin; Schuetz, Gerhard J.			Plasma Membrane Fluidity Affects Transient Immobilization of Oxidized Phospholipids in Endocytotic Sites for Subsequent Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR CLASS-B; SCAVENGER RECEPTOR; SR-BI; SELECTIVE UPTAKE; LIPID-BILAYERS; CELLS; CHOLESTEROL; IDENTIFICATION; LIPOPROTEINS; ACTIVATION	Oxidized phospholipids in serum initiate severe pathophysiological responses during the process of atherogenesis. On the cellular level it is known that these lipids induce apoptosis; however, the uptake mechanism remains enigmatic. We investigated here the behavior of the fluorescent oxidized phospholipid 1-palmitoyl-2-glutaroyl-sn-glycero-3-phospho-N-Alexa647-ethanolamine (PGPE-Alexa647) in the plasma membrane of various cell lines. The probe was taken up by the cells unspecifically via caveolae or clathrin-coated pits. Interestingly, we found the uptake to be facilitated by the overexpression of the scavenger receptor class B type I. Ultra-sensitive microscopy allowed us to follow the uptake process at the single molecule level; we observed rapid diffusion of PGPE-Alexa647 in the plasma membrane, interrupted by transient halts with duration of similar to 0.9 s at endocytotic sites. Scavenger receptor class B type I overexpression yielded a pronounced increase in the single molecule mobility, and in consequence an increased frequency of immobilization. Alternatively, the plasma membrane fluidity could also be increased by treating cells with high levels of the unlabeled oxidized phospholipid 1- palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine; also in this case, the immobilization frequency of PGPE-Alexa647 was concomitantly increased. The data demonstrate the relevance of plasma membrane properties for uptake of oxidized phospholipids, and indicate a novel indirect mechanism for the control of endocytosis.	[Rhode, Sebastian; Grurl, Reinhard; Brameshuber, Mario; Schuetz, Gerhard J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Hermetter, Albin] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Johannes Kepler University Linz; Graz University of Technology	Schutz, GJ (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	gerhard.schuetz@jku.at	Schuetz, Gerhard/B-1243-2008	Schuetz, Gerhard/0000-0003-1542-1089; Brameshuber, Mario/0000-0001-8672-2255	Austrian Research Funds [P15053, Y250-B10, P14714-PHA, F30-B05]; Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF) [F 3006, Y 250] Funding Source: researchfish	Austrian Research Funds(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Research Funds Project Numbers P15053, Y250-B10, P14714-PHA, and F30-B05 (SFB-Lipotox) and by the GEN-AU Project of the Austrian Federal Ministry for Science and Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Burns AR, 2005, BIOPHYS J, V89, P1081, DOI 10.1529/biophysj.105.060327; Calvo D, 1998, J LIPID RES, V39, P777; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; Deigner HP, 2008, CURR OPIN LIPIDOL, V19, P289, DOI 10.1097/MOL.0b013e3282fe1d0e; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Frank PG, 2002, BIOCHEMISTRY-US, V41, P11931, DOI 10.1021/bi0257078; Fureder-Kitzmuller E, 2005, CHEM PHYS LETT, V404, P13, DOI 10.1016/j.cplett.2005.01.053; GALLA HJ, 1979, J MEMBRANE BIOL, V48, P215, DOI 10.1007/BF01872892; Ghosh PK, 2002, NAT CELL BIOL, V4, P894, DOI 10.1038/ncb873; Graf GA, 1999, J BIOL CHEM, V274, P12043, DOI 10.1074/jbc.274.17.12043; Graf GA, 1999, TRENDS CARDIOVAS MED, V9, P221, DOI 10.1016/S1050-1738(00)00031-1; Grunfelder CG, 2003, MOL BIOL CELL, V14, P2029, DOI 10.1091/mbc.E02-10-0640; Hazen SL, 2002, P NATL ACAD SCI USA, V99, P12515, DOI 10.1073/pnas.212532799; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kogure K, 2003, CHEM PHYS LIPIDS, V126, P29, DOI 10.1016/S0009-3084(03)00091-4; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Krieger M, 1998, P NATL ACAD SCI USA, V95, P4077, DOI 10.1073/pnas.95.8.4077; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Liu CH, 1997, BIOPHYS J, V73, P2580, DOI 10.1016/S0006-3495(97)78287-0; Loidl A, 2004, BBA-MOL BASIS DIS, V1690, P150, DOI 10.1016/j.bbadis.2004.06.003; Loidl A, 2003, J BIOL CHEM, V278, P32921, DOI 10.1074/jbc.M306088200; Matveev S, 1999, J LIPID RES, V40, P1647; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mortelmaier M, 2002, SINGLE MOL, V3, P225, DOI 10.1002/1438-5171(200208)3:4<225::AID-SIMO225>3.0.CO;2-K; Moumtzi A, 2007, J LIPID RES, V48, P565, DOI 10.1194/jlr.M600394-JLR200; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Parathath S, 2004, J BIOL CHEM, V279, P41310, DOI 10.1074/jbc.M404952200; Sampaio JL, 2005, BIOPHYS J, V88, P4064, DOI 10.1529/biophysj.104.054007; Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stangl H, 1999, J BIOL CHEM, V274, P32692, DOI 10.1074/jbc.274.46.32692; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 2000, FREE RADICAL BIO MED, V28, P1751, DOI 10.1016/S0891-5849(00)00233-1; Swarnakar S, 1999, J BIOL CHEM, V274, P29733, DOI 10.1074/jbc.274.42.29733; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; WATSON AD, 1995, J CLIN INVEST, V95, P774, DOI 10.1172/JCI117726; Williams DL, 2002, J LIPID RES, V43, P544	44	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2258	2265		10.1074/jbc.M807591200	http://dx.doi.org/10.1074/jbc.M807591200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19043088	hybrid			2022-12-27	WOS:000262545600035
J	Li, YJ; Lu, J; Prochownik, EV				Li, Youjun; Lu, Jie; Prochownik, Edward V.			Modularity of the Oncoprotein-like Properties of Platelet Glycoprotein Ib alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; VON-WILLEBRAND-FACTOR; IX-V COMPLEX; C-MYC TARGET; GENOMIC INSTABILITY; PLASMA-MEMBRANE; GPIB-ALPHA; EXPRESSION; PROLIFERATION; FILAMIN	Glycoprotein Ib alpha(GpIb alpha), a trans-membrane glycoprotein, is expressed on the surface of megakaryocytes and platelets, where, in association with glycoprotein Ib beta, glycoprotein V, and glycoprotein IX, it normally forms the von Willebrand factor receptor (vWFR). A fully functional vWFR is necessary for platelet attachment, aggregation, and activation and has also been shown to regulate megakaryocyte ploidy. We have recently shown that the gene encoding GpIb alpha is a transcriptional target for the c-Myc oncoprotein and is more widely expressed than previously thought, with particularly high levels occurring in transformed cells. Indeed, GpIb alpha can substitute for c-Myc in promoting growth, transformation, and genomic instability. In the current work, we have demonstrated that, despite the promiscuous expression of GpIb alpha, other vWFR subunits remain largely restricted to megakaryocytes. We have characterized a panel of GpIb alpha mutants and shown that some regions of the protein essential for vWFR activity are not necessary for c-Myc-like functions. Specifically, the six C-terminal amino acids of the cytoplasmic domain, which mediate vWFR signaling, are entirely dispensible for the c-Myc-like functions of GpIb alpha. Instead, these require a more membrane-proximal filamin-binding domain. Also important is the GpIb alpha signal peptide, which, in the absence of other vWFR subunits, directs GpIb alpha to the endoplasmic reticulum rather than the membrane. Together, these results provide strong evidence that the domains of GpIb alpha mediating c-Myc-like functions are modular, genetically distinct, and independent of those involved in vWFR signaling.	[Prochownik, Edward V.] Childrens Hosp Pittsburgh, Hematol Oncol Sect, Rangos Res Ctr, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Childrens Hosp Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Prochownik, Edward V.] Univ Pittsburgh, Med Ctr, Ctr Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Prochownik, EV (corresponding author), Childrens Hosp Pittsburgh, Hematol Oncol Sect, Rangos Res Ctr, Rm 8125,3460 5th Ave, Pittsburgh, PA 15213 USA.	procev@chp.edu			National Institutes of Health [CA105033, CA078259]; Children's Hospital of Pittsburgh Research Advisory Committee; NATIONAL CANCER INSTITUTE [R01CA078259, R01CA105033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh Research Advisory Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105033 and CA078259 (to E.V.P.). This work was also supported by a postdoctoral fellowship award from the Children's Hospital of Pittsburgh Research Advisory Committee (to Y.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beckman RA, 2005, SEMIN CANCER BIOL, V15, P423, DOI 10.1016/j.semcancer.2005.06.007; Berndt MC, 2001, THROMB HAEMOSTASIS, V86, P178; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Canobbio H, 2004, CELL SIGNAL, V16, P1329, DOI 10.1016/j.cellsig.2004.05.008; Dai KS, 2005, BLOOD, V106, P1975, DOI 10.1182/blood-2005-01-0440; Dong JF, 1998, J BIOL CHEM, V273, P31449, DOI 10.1074/jbc.273.47.31449; Feng S, 1999, BLOOD, V93, P4256, DOI 10.1182/blood.V93.12.4256.412k33_4256_4263; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Geddis AE, 2001, J BIOL CHEM, V276, P34473, DOI 10.1074/jbc.M105178200; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; HUNZIKER W, 1992, FEBS LETT, V307, P93, DOI 10.1016/0014-5793(92)80908-Y; Kanaji T, 2004, BLOOD, V104, P3161, DOI 10.1182/blood-2004-03-0893; KONKLE BA, 1990, J BIOL CHEM, V265, P19833; Li Y, 2008, ONCOGENE, V27, P1599, DOI 10.1038/sj.onc.1210794; Li YJ, 2007, P NATL ACAD SCI USA, V104, P3490, DOI 10.1073/pnas.0610163104; LOPEZ JA, 1992, J BIOL CHEM, V267, P12851; LOPEZ JA, 1994, BLOOD COAGUL FIBRIN, V5, P97; LOPEZ JA, 1992, J BIOL CHEM, V267, P10055; Luo SZ, 2007, BLOOD, V109, P603, DOI 10.1182/blood-2006-05-024091; Miyazawa KEISUKE, 2000, Hematology, V5, P233; Mo X, 2006, J BIOL CHEM, V281, P23050, DOI 10.1074/jbc.M600924200; Monteiro MR, 1999, J INVEST DERMATOL, V113, P272, DOI 10.1046/j.1523-1747.1999.00665.x; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Oleksowicz L, 1997, EXP CELL RES, V237, P110, DOI 10.1006/excr.1997.3784; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Rogulski KR, 2005, P NATL ACAD SCI USA, V102, P18968, DOI 10.1073/pnas.0507902102; Rothermund K, 2005, CANCER RES, V65, P2097, DOI 10.1158/0008-5472.CAN-04-2928; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Strassel C, 2003, BIOCHEMISTRY-US, V42, P4452, DOI 10.1021/bi026213d; Ulsemer P, 2001, BIOCHEM J, V358, P295, DOI 10.1042/0264-6021:3580295; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wu Y, 2003, BLOOD, V101, P3469, DOI 10.1182/blood-2002-03-0806; Yin H, 2008, BLOOD, V111, P658, DOI 10.1182/blood-2007-04-085514; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Yin XY, 2002, J BIOL CHEM, V277, P19998, DOI 10.1074/jbc.M200860200; Yin XY, 2001, CANCER RES, V61, P6487; Yin XY, 2001, ONCOGENE, V20, P4650, DOI 10.1038/sj.onc.1204606	44	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1410	1418		10.1074/jbc.M806222200	http://dx.doi.org/10.1074/jbc.M806222200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017648	Green Published, hybrid			2022-12-27	WOS:000262330100008
J	Schottkowski, M; Gkalympoudis, S; Tzekova, N; Stelljes, C; Schunemann, D; Ankele, E; Nickelsen, J				Schottkowski, Marco; Gkalympoudis, Stephanie; Tzekova, Nevena; Stelljes, Christian; Schuenemann, Danja; Ankele, Elisabeth; Nickelsen, Joerg			Interaction of the Periplasmic PratA Factor and the PsbA (D1) Protein during Biogenesis of Photosystem II in Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; TERMINAL EXTENSION; CRYSTAL-STRUCTURE; MEMBRANE; COMPLEXES; PRECURSOR; REPAIR; ACCUMULATION; PCC-6803; HOMOLOG	The biogenesis of photosynthetic complexes is assisted by a growing number of trans-acting factors in both chloroplasts and cyanobacteria. We have previously shown that the periplasmic PratA factor from Synechocystis sp. PCC 6803 (Synechocystis 6803) is required for adequate C-terminal processing of the PsbA (D1) subunit of photosystem II (PSII) supporting the idea that the early steps of PSII assembly occur at the plasma membrane. Here we report on the molecular analysis of the interaction between PratA and the D1 protein. Both yeast two-hybrid and glutathione S-transferase pull-down assays revealed that PratA binds to the soluble forms of both mature and precursor D1 C-terminal regions. In agreement with that finding, the binding region was mapped to amino acid positions 314-328 of D1 by applying a peptide-scanning approach. Approximately 10-20% of the soluble PratA factor was found to be associated with membranes in a D1-dependent manner. Sucrose density gradient centrifugations allowed the identification of a specific membrane subfraction that contains both PratA and D1 and which might represent a transfer and/or connecting region between plasma and thylakoid membrane. Imaging data obtained with enhanced cyan fluorescent protein-labeled D1 protein in wild-type and pratA mutant backgrounds further supported this notion.	[Schottkowski, Marco; Gkalympoudis, Stephanie; Tzekova, Nevena; Stelljes, Christian; Ankele, Elisabeth; Nickelsen, Joerg] Biozentrum LMU Munchen, D-82152 Planegg Martinsried, Germany; [Schuenemann, Danja] Ruhr Univ Bochum, LS Allgemeine & Mol Bot, D-44780 Bochum, Germany	University of Munich; Ruhr University Bochum	Nickelsen, J (corresponding author), Biozentrum LMU Munchen, Univ Str 150, D-82152 Planegg Martinsried, Germany.	joerg.nickelsen@lrz.uni-muenchen.de	Nickelsen, Jörg/J-8896-2014	Schuenemann, Danja/0000-0001-8894-7685; Nickelsen, Joerg/0000-0003-4184-4560				Bergantino E, 2003, J BIOL CHEM, V278, P41820, DOI 10.1074/jbc.M303096200; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; Duhring U, 2006, BBA-BIOENERGETICS, V1757, P3, DOI 10.1016/j.bbabio.2005.11.001; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Inagaki N, 2001, FEBS LETT, V509, P197, DOI 10.1016/S0014-5793(01)03180-5; Ivleva NB, 2000, PLANT PHYSIOL, V124, P1403, DOI 10.1104/pp.124.3.1403; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Keren N, 2005, PLANT CELL, V17, P2768, DOI 10.1105/tpc.105.035048; Keren N, 2005, J BIOL CHEM, V280, P6548, DOI 10.1074/jbc.M410218200; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Komenda J, 2005, PLANT CELL PHYSIOL, V46, P1477, DOI 10.1093/pcp/pci159; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Komenda J, 2007, BBA-BIOENERGETICS, V1767, P829, DOI 10.1016/j.bbabio.2007.01.005; Kuvikova S, 2005, PHOTOCH PHOTOBIO SCI, V4, P1044, DOI 10.1039/b506059a; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Nickelsen Jorg, 2007, V68, P57, DOI 10.1007/978-3-540-36832-8_3; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10589; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Ossenbuhl F, 2006, PLANT CELL, V18, P2236, DOI 10.1105/tpc.106.043646; Pasch JC, 2005, APPL MICROBIOL BIOT, V69, P440, DOI 10.1007/s00253-005-0029-3; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; Reineke U, 1999, CURR TOP MICROBIOL, V243, P23; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Srivastava R, 2006, ARCH MICROBIOL, V185, P238, DOI 10.1007/s00203-006-0086-8; Uniacke J, 2007, PLANT CELL, V19, P3640, DOI 10.1105/tpc.107.054882; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zinchenko VV, 1999, RUSS J GENET+, V35, P228; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	36	55	58	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1813	1819		10.1074/jbc.M806116200	http://dx.doi.org/10.1074/jbc.M806116200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017636	hybrid			2022-12-27	WOS:000262330100052
J	Schredelseker, J; Dayal, A; Schwerte, T; Franzini-Armstrong, C; Grabner, M				Schredelseker, Johann; Dayal, Anamika; Schwerte, Thorsten; Franzini-Armstrong, Clara; Grabner, Manfred			Proper Restoration of Excitation-Contraction Coupling in the Dihydropyridine Receptor beta(1)-null Zebrafish Relaxed Is an Exclusive Function of the beta(1a) Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II-III-LOOP; DYSGENIC SKELETAL-MUSCLE; CALCIUM-CHANNEL; CA2+ CURRENT; CHARGE MOVEMENTS; BETA-1A SUBUNIT; ALPHA(1S); EXPRESSION; ABSENCE; TRANSIENTS	The paralyzed zebrafish strain relaxed carries a null mutation for the skeletal muscle dihydropyridine receptor (DHPR) beta(1a) subunit. Lack of beta(1a) results in (i) reduced membrane expression of the pore forming DHPR alpha(1S) subunit, (ii) elimination of alpha(1S) charge movement, and (iii) impediment of arrangement of the DHPRs in groups of four (tetrads) opposing the ryanodine receptor (RyR1), a structural prerequisite for skeletal muscle-type excitation-contraction (EC) coupling. In this study we used relaxed larvae and isolated myotubes as expression systems to discriminate specific functions of beta(1a) from rather general functions of beta isoforms. Zebrafish and mammalian beta 1a subunits quantitatively restored alpha(1S) triad targeting and charge movement as well as intracellular Ca2+ release, allowed arrangement of DHPRs in tetrads, and most strikingly recovered a fully motile phenotype in relaxed larvae. Interestingly, the cardiac/neuronal beta(2a) as the phylogenetically closest, and the ancestral housefly beta(M) as the most distant isoform to beta(1a) also completely recovered alpha(1S) triad expression and charge movement. However, both revealed drastically impaired intracellular Ca2+ transients and very limited tetrad formation compared with beta(1a). Consequently, larval motility was either only partially restored (beta(2a)-injected larvae) or not restored at all (beta(M)). Thus, our results indicate that triad expression and facilitation of 1,4-dihydropyridine receptor (DHPR) charge movement are common features of all tested beta subunits, whereas the efficient arrangement of DHPRs in tetrads and thus intact DHPR-RyR1 coupling is only promoted by the beta(1a) isoform. Consequently, we postulate a model that presents beta(1a) as an allosteric modifier of alpha(1S) conformation enabling skeletal muscle-type EC coupling.	[Schredelseker, Johann; Dayal, Anamika; Grabner, Manfred] Innsbruck Med Univ, Div Biochem Pharmacol, Dept Med Genet Clin & Mol Pharmacol, A-6020 Innsbruck, Austria; [Schwerte, Thorsten] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Medical University of Innsbruck; University of Innsbruck; University of Pennsylvania	Grabner, M (corresponding author), Innsbruck Med Univ, Div Biochem Pharmacol, Dept Med Genet Clin & Mol Pharmacol, A-6020 Innsbruck, Austria.	manfred.grabner@i-med.ac.at	Schwerte, Thorsten/K-6549-2019; Schwerte, Thorsten/A-6088-2009; Tuluc, Petronel/C-2527-2011	Schwerte, Thorsten/0000-0002-6330-8817; Schredelseker, Johann/0000-0002-6657-0466; Dayal, Anamika/0000-0001-8075-8812	National Institutes of Health [HL-48093]; Austrian Fonds zur Forderung der wissenschaftlichen Forschung Research [FWF-16098-B04]; Medizinische Forschungsforderung Innsbruck [MFI-6180]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048093, R37HL048093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Fonds zur Forderung der wissenschaftlichen Forschung Research(Austrian Science Fund (FWF)); Medizinische Forschungsforderung Innsbruck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-48093 (to C.F.-A.). This work was also supported by Austrian Fonds zur Forderung der wissenschaftlichen Forschung Research Grant FWF-16098-B04 (to M.G.) and Medizinische Forschungsforderung Innsbruck Grant MFI-6180 (to J.S.).	ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Ahern CA, 2003, BIOPHYS J, V84, P942, DOI 10.1016/S0006-3495(03)74911-X; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; Beurg M, 1999, BIOPHYS J, V76, P1744, DOI 10.1016/S0006-3495(99)77336-4; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; Beurg M, 1999, BIOPHYS J, V77, P2953, DOI 10.1016/S0006-3495(99)77128-6; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Cheng HP, 2002, FRONT BIOSCI, V7, pD1867, DOI 10.2741/cheng; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Coronado R, 2004, BIOL RES, V37, P565; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; FLUCHER BE, 1993, J CELL BIOL, V123, P1161, DOI 10.1083/jcb.123.5.1161; FLUCHER BE, 1994, MOL BIOL CELL, V5, P1105, DOI 10.1091/mbc.5.10.1105; Freise D, 2000, J BIOL CHEM, V275, P14476, DOI 10.1074/jbc.275.19.14476; Gach MP, 2008, BIOPHYS J, V94, P3023, DOI 10.1529/biophysj.107.118893; GARCIA J, 1994, J GEN PHYSIOL, V103, P125, DOI 10.1085/jgp.103.1.125; Garcia K, 2008, J PHYSIOL-LONDON, V586, P727, DOI 10.1113/jphysiol.2007.147959; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; GRABNER M, 1994, J BIOL CHEM, V269, P23668; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Granato M, 1996, DEVELOPMENT, V123, P399; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Haffter P, 1996, DEVELOPMENT, V123, P1; Hirata H, 2004, DEVELOPMENT, V131, P5457, DOI 10.1242/dev.01410; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; Kugler G, 2004, ARCH BIOCHEM BIOPHYS, V427, P91, DOI 10.1016/j.abb.2004.04.007; Kugler G, 2004, J BIOL CHEM, V279, P4721, DOI 10.1074/jbc.M307538200; Leong P, 1998, J BIOL CHEM, V273, P29958, DOI 10.1074/jbc.273.45.29958; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; MORTON ME, 1987, J BIOL CHEM, V262, P11904; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Neuhuber B, 1998, J BIOL CHEM, V273, P9110, DOI 10.1074/jbc.273.15.9110; Neuhuber B, 1998, P NATL ACAD SCI USA, V95, P5015, DOI 10.1073/pnas.95.9.5015; Nusslein-Volhard C, 2002, ZEBRAFISH; Obermair GJ, 2005, J BIOL CHEM, V280, P2229, DOI 10.1074/jbc.M411501200; Ono F, 2001, J NEUROSCI, V21, P5439, DOI 10.1523/JNEUROSCI.21-15-05439.2001; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Rios E, 1997, ANNU REV BIOPH BIOM, V26, P47, DOI 10.1146/annurev.biophys.26.1.47; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Schwerte T, 2006, J EXP BIOL, V209, P1093, DOI 10.1242/jeb.02117; Schwerte T, 2000, J EXP BIOL, V203, P1659; Sheridan DC, 2003, BIOPHYS J, V85, P3739, DOI 10.1016/S0006-3495(03)74790-0; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; Slavik KJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1475, DOI 10.1152/ajpcell.1997.272.5.C1475; Strube C, 1998, BIOPHYS J, V75, P207, DOI 10.1016/S0006-3495(98)77507-1; Strube C, 1996, BIOPHYS J, V71, P2531, DOI 10.1016/S0006-3495(96)79446-8; SUN XH, 1995, J CELL BIOL, V129, P659, DOI 10.1083/jcb.129.3.659; Takekura H, 2004, MOL BIOL CELL, V15, P5408, DOI 10.1091/mbc.E04-05-0414; TANABE T, 1990, NATURE, V344, P451, DOI 10.1038/344451a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Ursu D, 2001, J PHYSIOL-LONDON, V533, P367, DOI 10.1111/j.1469-7793.2001.0367a.x; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wilkens CM, 2001, P NATL ACAD SCI USA, V98, P5892, DOI 10.1073/pnas.101618098; Zhou WB, 2006, CELL CALCIUM, V39, P227, DOI 10.1016/j.ceca.2005.10.015	63	57	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1242	1251		10.1074/jbc.M807767200	http://dx.doi.org/10.1074/jbc.M807767200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008220	Green Published, hybrid			2022-12-27	WOS:000262122900060
J	Schroder, R; Merten, N; Mathiesen, JM; Martini, L; Kruljac-Letunic, A; Krop, F; Blaukat, A; Fang, Y; Tran, E; Ulven, T; Drewke, C; Whistler, J; Pardo, L; Gomeza, J; Kostenis, E				Schroeder, Ralf; Merten, Nicole; Mathiesen, Jesper Mosolff; Martini, Lene; Kruljac-Letunic, Anamarija; Krop, Friederike; Blaukat, Andree; Fang, Ye; Tran, Elizabeth; Ulven, Trond; Drewke, Christel; Whistler, Jennifer; Pardo, Leonardo; Gomeza, Jesus; Kostenis, Evi			The C-terminal Tail of CRTH2 Is a Key Molecular Determinant That Constrains G alpha(i) and Downstream Signaling Cascade Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; PROSTAGLANDIN D-2; ALLERGIC INFLAMMATION; AIRWAY INFLAMMATION; CRYSTAL-STRUCTURE; BETA-ARRESTINS; BETA(1)-ADRENERGIC RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; BRADYKININ RECEPTOR	Prostaglandin D-2 activation of the seven-transmembrane receptor CRTH2 regulates numerous cell functions that are important in inflammatory diseases, such as asthma. Despite its disease implication, no studies to date aimed at identifying receptor domains governing signaling and surface expression of human CRTH2. We tested the hypothesis that CRTH2 may take advantage of its C-tail to silence its own signaling and that this mechanism may explain the poor functional responses observed with CRTH2 in heterologous expression systems. Although the C terminus is a critical determinant for retention of CRTH2 at the plasma membrane, the presence of this domain confers a signaling-compromised conformation onto the receptor. Indeed, a mutant receptor lacking the major portion of its C-terminal tail displays paradoxically enhanced G alpha(i) and ERK1/2 activation despite enhanced constitutive and agonist-mediated internalization. Enhanced activation of G alpha(i) proteins and downstream signaling cascades is probably due to the inability of the tail-truncated receptor to recruit beta-arrestin2 and undergo homologous desensitization. Unexpectedly, CRTH2 is not phosphorylated upon agonist-stimulation, a primary mechanism by which GPCR activity is regulated. Dynamic mass redistribution assays, which allow label-free monitoring of all major G protein pathways in real time, confirm that the C terminus inhibits G alpha(i) signaling of CRTH2 but does not encode G protein specificity determinants. We propose that intrinsic CRTH2 inhibition by its C terminus may represent a rather unappreciated strategy employed by a GPCR to specify the extent of G protein activation and that this mechanism may compensate for the absence of the classical phosphorylation-dependent signal attenuation.	[Kostenis, Evi] Univ Bonn, Dept Mol Cellular & Pharmacobiol, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Mathiesen, Jesper Mosolff] Zealand Pharma AS, Dept Mol Pharmacol, DK-2600 Glostrup, Denmark; [Martini, Lene; Whistler, Jennifer] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Kruljac-Letunic, Anamarija; Krop, Friederike; Blaukat, Andree] Merck KGaA, Merck Serono Res, TA Oncol, D-64293 Darmstadt, Germany; [Fang, Ye; Tran, Elizabeth] Corning Inc, Div Sci & Technol, Biochem Technol, New York, NY 14831 USA; [Schroeder, Ralf; Merten, Nicole; Ulven, Trond] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense, Denmark; [Pardo, Leonardo] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain	University of Bonn; Zealand Pharma A/S; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Merck KGaA; EMD Serono Inc.; Corning Inc; State University of New York (SUNY) System; SUNY Community College; University of Southern Denmark; Autonomous University of Barcelona	Kostenis, E (corresponding author), Univ Bonn, Dept Mol Cellular & Pharmacobiol, Inst Pharmaceut Biol, Nussallee 6, D-53115 Bonn, Germany.	kostenis@uni-bonn.de	/B-1341-2009; Ulven, Trond/H-5500-2015	Ulven, Trond/0000-0002-8135-1755; Fang, Ye/0000-0002-1322-7365; Pardo, Leonardo/0000-0003-1778-7420; Mathiesen, Jesper Mosolff/0000-0003-4251-4416				Almishri W, 2005, J PHARMACOL EXP THER, V313, P64, DOI 10.1124/jpet.104.079079; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blaukat A, 1996, J BIOL CHEM, V271, P32366, DOI 10.1074/jbc.271.50.32366; Blaukat A, 2001, J BIOL CHEM, V276, P40431, DOI 10.1074/jbc.M107024200; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Bohm E, 2004, J BIOL CHEM, V279, P7663, DOI 10.1074/jbc.M310270200; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Budd DC, 2003, J BIOL CHEM, V278, P19565, DOI 10.1074/jbc.M211670200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Estall JL, 2005, J BIOL CHEM, V280, P22124, DOI 10.1074/jbc.M500078200; Fang Y, 2005, ANAL CHEM, V77, P5720, DOI 10.1021/ac050887n; Fang Y, 2008, COMB CHEM HIGH T SCR, V11, P357, DOI 10.2174/138620708784534789; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Hata AN, 2005, J BIOL CHEM, V280, P32442, DOI 10.1074/jbc.M502563200; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hirai K, 2001, CURR TOP MICROBIOL, V255, P261; Hoare S, 1999, J BIOL CHEM, V274, P28682, DOI 10.1074/jbc.274.40.28682; Hosoi T, 2002, J BIOL CHEM, V277, P31459, DOI 10.1074/jbc.M203194200; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Kang DS, 2002, MOL PHARMACOL, V62, P281, DOI 10.1124/mol.62.2.281; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kostenis E, 2005, J PHARMACOL EXP THER, V313, P78, DOI 10.1124/jpet.104.080424; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Lee CJ, 2008, J THROMB HAEMOST, V6, P83; Lee KB, 2000, J BIOL CHEM, V275, P9284, DOI 10.1074/jbc.275.13.9284; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Lukacs NW, 2008, AM J PHYSIOL-LUNG C, V295, pL767, DOI 10.1152/ajplung.90351.2008; Mathiesen JM, 2006, MOL PHARMACOL, V69, P1441, DOI 10.1124/mol.105.017681; Mathiesen JM, 2005, MOL PHARMACOL, V68, P393, DOI 10.1124/mol.104.010520; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Monneret G, 2003, J PHARMACOL EXP THER, V304, P349, DOI 10.1124/jpet.102.042937; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Royer JF, 2007, ALLERGY, V62, P1401, DOI 10.1111/j.1398-9995.2007.01452.x; Sano T, 1997, J BIOL CHEM, V272, P23631, DOI 10.1074/jbc.272.38.23631; Satoh T, 2006, J IMMUNOL, V177, P2621, DOI 10.4049/jimmunol.177.4.2621; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Shichijo M, 2003, J PHARMACOL EXP THER, V307, P518, DOI 10.1124/jpet.103.055442; Shiraishi Y, 2008, J IMMUNOL, V180, P541, DOI 10.4049/jimmunol.180.1.541; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Takeshita K, 2004, INT IMMUNOL, V16, P947, DOI 10.1093/intimm/dxh096; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Uller L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-16; Ulven T, 2007, BIOORG MED CHEM LETT, V17, P5924, DOI 10.1016/j.bmcl.2007.07.080; Verzijl D, 2006, J BIOL CHEM, V281, P35327, DOI 10.1074/jbc.M606877200; WANG J, 2008, MOL BIOL RE IN PRESS; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; WESS J, 1990, MOL PHARMACOL, V38, P872; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamamoto M, 2009, INT ARCH ALLERGY IMM, V148, P127, DOI 10.1159/000155743; Yoshimura-Uchiyama C, 2004, CLIN EXP ALLERGY, V34, P1283, DOI 10.1111/j.1365-2222.2004.02027.x	78	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1324	1336		10.1074/jbc.M806867200	http://dx.doi.org/10.1074/jbc.M806867200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010788	hybrid			2022-12-27	WOS:000262122900067
J	Haimerl, F; Erhardt, A; Sass, G; Tiegs, G				Haimerl, Florian; Erhardt, Annette; Sass, Gabriele; Tiegs, Gisa			Down-regulation of the De-ubiquitinating Enzyme Ubiquitin-specific Protease 2 Contributes to Tumor Necrosis Factor-alpha-induced Hepatocyte Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; TNF-ALPHA; DEUBIQUITINATING ENZYMES; JNK ACTIVATION; C-FLIP; PROSTATE-CANCER; RAT HEPATOCYTES; TERMINAL KINASE; D-GALACTOSAMINE	Tumor necrosis factor-alpha(TNF alpha) stimulation of hepatocytes induces either cell survival or apoptosis, which seems to be regulated by the ubiquitin-proteasome system. Here we investigated the role of TNF alpha-induced down-modulation of the deubiquitinating enzyme USP2 for hepatocyte survival. Inhibition of hepatocyte apoptosis by pre-treatment with TNF alpha (TNF alpha tolerance) was analyzed in the mouse model of galactosamine/TNF alpha-induced liver injury and in actinomycin D/TNF alpha-treated primary mouse hepatocytes. The role of USP2 for TNF alpha-induced hepatocyte survival was studied using small interference RNA or an expression clone. Injection of mice or preincubation of hepatocytes with TNF alpha caused a rapid down-regulation of hepatic USP2-41kD, the predominant USP2 isoform in the liver. In vitro an artificial knockdown of USP2 inhibited actinomycin D/TNF alpha-induced hepatocyte apoptosis, which was associated with elevated levels of the anti-apoptotic protein c-Flip(L/S) and a concomitant decrease of cellular levels of the ubiquitin-ligase Itch, a negative regulator of c-Flip. USP2-41kD overexpression abrogated TNF alpha tolerance in vitro, prevented accumulation of c-Flip(L/S) and resulted in elevated levels of Itch. Accordingly, c-Flip(L/S) protein levels were elevated in livers of TNF alpha-tolerant mice, which correlated to a switch from JNK and ERK to p38 signaling after galactosamine/TNF re-challenge. Our results indicate that TNF alpha-induced USP2 down-regulation is an effective cytoprotective mechanism in hepatocytes. Hence, USP2 could be a novel pharmacological target, and specific USP2 inhibitors might be potential candidates for the treatment of inflammation-related apoptotic liver damage.	[Haimerl, Florian; Tiegs, Gisa] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Erhardt, Annette; Sass, Gabriele; Tiegs, Gisa] Univ Med Ctr Hamburg Eppendorf, Div Expt Immunol & Hepatol, D-20246 Hamburg, Germany	University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Tiegs, G (corresponding author), Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany.	g.tiegs@uke.de	Erhardt, Annette/AAS-5350-2021		Deutsche Forschungsgemeinschaft [TI 169/7-3,4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grant TI 169/7-3,4). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Arvelo MB, 2002, HEPATOLOGY, V35, P535, DOI 10.1053/jhep.2002.31309; Baek SH, 1997, J BIOL CHEM, V272, P25560, DOI 10.1074/jbc.272.41.25560; Bradham CA, 1998, AM J PHYSIOL-GASTR L, V275, pG387, DOI 10.1152/ajpgi.1998.275.3.G387; Chaisson ML, 2002, J CLIN INVEST, V110, P193, DOI 10.1172/JCI200215295; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Ciechanover A, 2003, BIOCHEM SOC T, V31, P474, DOI 10.1042/BST0310474; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; DECKER K, 1974, REV PHYSIOL BIOCH P, V71, P77, DOI 10.1007/BFb0027661; Furusu A, 2007, J CELL PHYSIOL, V210, P703, DOI 10.1002/jcp.20881; Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033; Gewies A, 2003, CANCER RES, V63, P682; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kim Dong-Joon, 2008, J Mol Signal, V3, P2, DOI 10.1186/1750-2187-3-2; Layfield R, 2001, NEUROPATH APPL NEURO, V27, P171, DOI 10.1046/j.1365-2990.2001.00335.x; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; LEIST M, 1995, AM J PATHOL, V146, P1220; Li HZ, 2007, J BIOL CHEM, V282, P4943, DOI 10.1074/jbc.M609494200; Lim SJ, 2006, ONCOL REP, V16, P1131; Marderstein EL, 2003, SURGERY, V134, P280, DOI 10.1067/msy.2003.237; Mathew R, 2006, CLIN CANCER RES, V12, P3648, DOI 10.1158/1078-0432.CCR-06-0620; Meiners S, 2008, MED RES REV, V28, P309, DOI 10.1002/med.20111; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; Perez D, 2003, J VIROL, V77, P2651, DOI 10.1128/JVI.77.4.2651-2662.2003; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; RIJCKEN WRP, 1995, GLYCOBIOLOGY, V5, P495, DOI 10.1093/glycob/5.5.495; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Sass G, 2005, BIOCHEM J, V385, P537, DOI 10.1042/BJ20040279; Sass G, 2002, INFLAMM RES, V51, P229, DOI 10.1007/PL00000298; Sass G, 2007, J IMMUNOL, V179, P7042, DOI 10.4049/jimmunol.179.10.7042; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Sohn D, 2006, MOL CELL BIOL, V26, P1967, DOI 10.1128/MCB.26.5.1967-1978.2006; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Takai S, 2007, LAB INVEST, V87, P572, DOI 10.1038/labinvest.3700544; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Wilkinson KD, 1999, J NUTR, V129, P1933, DOI 10.1093/jn/129.11.1933; Wullaert A, 2007, ENDOCR REV, V28, P365, DOI 10.1210/er.2006-0031; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Zang GQ, 2000, WORLD J GASTROENTERO, V6, P688; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	56	48	50	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					495	504		10.1074/jbc.M803533200	http://dx.doi.org/10.1074/jbc.M803533200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001362	hybrid			2022-12-27	WOS:000261974800054
J	Neidt, EM; Scott, BJ; Kovar, DR				Neidt, Erin M.; Scott, Bonnie J.; Kovar, David R.			Formin Differentially Utilizes Profilin Isoforms to Rapidly Assemble Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; CAPPING PROTEIN; CAENORHABDITIS-ELEGANS; ADP-ACTIN; C-ELEGANS; CYTOKINESIS; DOMAIN; POLYMERIZATION; ELONGATION; MONOMERS	Cells contain multiple formin isoforms that drive the assembly of profilin-actin for diverse processes. Given that many organisms also contain several profilin isoforms, specific formin/profilin pairs might be matched to optimally stimulate actin polymerization. We utilized a combination of bulk actin polymerization and single filament total internal reflection fluorescence microscopy assays to measure the effect of different profilin isoforms on the actin assembly properties of the cytokinesis formins from fission yeast (Cdc12p) and the nematode worm (CYK-1). We discovered that Cdc12p only effectively utilizes the single fission yeast profilin isoform SpPRF. Conversely, CYK-1 prefers the essential worm cytokinesis profilin CePFN-1 to the two non-essential worm profilin isoforms (SpPRF = CePFN-1 > CePFN-2 > CePFN-3). Chimeras containing the profilin-binding formin homology 1 (FH1) domain from one formin and the barbed-end associated FH2 domain from the other formin, revealed that both the FH1 and FH2 domains help confer profilin isoform specialization. Although the Cdc12p and CYK-1 FH1 domains cannot differentiate between profilin isoforms in the absence of actin, formin FH1 domains appear to preferentially select specific isoforms of profilin-actin. Surprisingly, analysis of profilin point mutants revealed that differences in highly conserved residues in both the poly-L-proline and actin binding regions of profilin do not explain their differential utilization by formin. Therefore, rapid formin-mediated elongation of profilin-actin depends upon favorable interactions of profilin-actin with the FH1 domain as well as the barbed-end associated FH2 domain. Specific formin FH1FH2 domains are tailored to optimally utilize actin bound to particular profilin isoforms.	[Neidt, Erin M.; Scott, Bonnie J.; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kovar, DR (corresponding author), 920 East 58th St,Suite 915 E, Chicago, IL 60637 USA.	drkovar@uchicago.edu						Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Ono S, 1999, CELL MOTIL CYTOSKEL, V43, P128, DOI 10.1002/(SICI)1097-0169(1999)43:2&lt;128::AID-CM4&gt;3.0.CO;2-C; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Polet D, 2006, CELL MOTIL CYTOSKEL, V63, P14, DOI 10.1002/cm.20102; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Swan KA, 1998, J CELL SCI, V111, P2017; Takaine M, 2007, J BIOL CHEM, V282, P21683, DOI 10.1074/jbc.M611371200; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3	34	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					673	684		10.1074/jbc.M804201200	http://dx.doi.org/10.1074/jbc.M804201200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18978356	hybrid			2022-12-27	WOS:000261974800072
J	Sebag, JA; Hinkle, PM				Sebag, Julien A.; Hinkle, Patricia M.			Regions of Melanocortin 2 (MC2) Receptor Accessory Protein Necessary for Dual Topology and MC2 Receptor Trafficking and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL GLUCOCORTICOID DEFICIENCY; POSITIVELY CHARGED RESIDUES; ACTIVITY-MODIFYING PROTEINS; FLUORESCENCE COMPLEMENTATION; TRANSMEMBRANE ORIENTATION; RESISTANCE SYNDROMES; MEMBRANE; VISUALIZATION; MRAP; RAMPS	MRAP, melanocortin 2 (MC2) receptor accessory protein, is required for trafficking by the MC2 (ACTH) receptor. MRAP is a single transmembrane protein that forms highly unusual antiparallel homodimers. We used molecular complementation to ask where MRAP achieves dual topology. Fragments of yellow fluorescent protein (YFP) were fused to the NH2 or COOH terminus of MRAP such that YFP fluorescence could occur only in antiparallel homodimers; fluorescence was present in the endoplasmic reticulum. MRAP retained dual topology after deletion of most of the amino terminus. In contrast, deletion of residues 31-37, just NH2-terminal to the transmembrane domain, forced MRAP into a single N-exo/C-cyt orientation and blocked its ability to promote MC2 receptor trafficking and homodimerize. When the transmembrane domain of MRAP was replaced with the corresponding region from RAMP3, dual topology was retained but MRAP was inactive. Insertion of MRAP residues 29-37 conferred dual topology to RAMP3, normally in an N-exo/C-cyt orientation. When expressed with MRAP Delta 1-30, MRAP Delta 10-20, or MRAP Delta 21-30, MC2 receptor was localized on the plasma membrane but unable to respond to ACTH. Residues 18-21 of MRAP were critical; MC2 receptor expressed with MRAP(18-21A) localized to the plasma membrane but did not bind I-125-ACTH or increase cAMP in response to ACTH. A newly identified MRAP homolog, MRAP2, lacks amino acids (LDYI21)-L-18 of MRAP and, like MRAP(18-21A), allows MC2 receptor trafficking but not signaling. MRAP2 with an LDYI insertion functions like MRAP. These results demonstrate that MRAP not only facilitates MC2 receptor trafficking but also allows properly localized receptor to bind ACTH and consequently signal.	[Sebag, Julien A.; Hinkle, Patricia M.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Hinkle, PM (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA.	Patricia_Hinkle@urmc.rochester.edu	sebag, julien/AAU-2142-2020	sebag, julien/0000-0002-8366-312X	National Institutes of Health [DK19974]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK19974 ( to P. M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BELTZER JP, 1991, J BIOL CHEM, V266, P973; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; Bouschet T, 2005, J CELL SCI, V118, P4709, DOI 10.1242/jcs.02598; Chan LF, 2008, HORM RES, V69, P75, DOI 10.1159/000111810; CHAN LF, 2008, END SOC ANN M SAN FR; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Cooray SN, 2008, ENDOCRINOLOGY, V149, P1935, DOI 10.1210/en.2007-1463; Cooray Sadani N., 2008, V13, P99, DOI 10.1159/000134828; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kuwasako K, 2000, J BIOL CHEM, V275, P29602, DOI 10.1074/jbc.M004534200; Kuwasako K, 2003, J BIOL CHEM, V278, P22623, DOI 10.1074/jbc.M302571200; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Metherell LA, 2006, BEST PRACT RES CL EN, V20, P547, DOI 10.1016/j.beem.2006.09.002; Modan-Moses D, 2006, J CLIN ENDOCR METAB, V91, P3713, DOI 10.1210/jc.2006-0687; Parameswaran N, 2006, TRENDS BIOCHEM SCI, V31, P631, DOI 10.1016/j.tibs.2006.09.006; Roy S, 2007, MOL ENDOCRINOL, V21, P1656, DOI 10.1210/me.2007-0041; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Sexton PM, 2006, ANN NY ACAD SCI, V1070, P90, DOI 10.1196/annals.1317.076; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0	29	94	95	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					610	618		10.1074/jbc.M804413200	http://dx.doi.org/10.1074/jbc.M804413200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18981183	Green Published, hybrid			2022-12-27	WOS:000261974800066
J	Beyer, S; Kristensen, MM; Jensen, KS; Johansen, JV; Staller, P				Beyer, Sophie; Kristensen, Malene Maag; Jensen, Kim Steen; Johansen, Jens Vilstrup; Staller, Peter			The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HUMAN NEUROBLASTOMA-CELLS; TISSUE OXYGEN DISTRIBUTION; GENE-EXPRESSION; FACTOR-I; CHROMATIN MODIFICATIONS; FACTOR 1-ALPHA; H3 LYSINE-9; PHD FINGER; CANCER	Posttranslational histone modifications serve to store epigenetic information and control both nucleosome assembly and recruitment of non-histone proteins. Histone methylation occurs on arginine and lysine residues and is involved in the regulation of gene transcription. A dynamic control of these modifications is exerted by histone methyltransferases and the recently discovered histone demethylases. Here we show that the hypoxia-inducible factor HIF-1 alpha binds to specific recognition sites in the genes encoding the jumonji family histone demethylases JMJD1A and JMJD2B and induces their expression. Accordingly, hypoxic cells express elevated levels of JMJD1A and JMJD2B mRNA and protein. Furthermore, we find increased expression of JMJD1A and JMJD2B in renal cancer cells that have lost the von Hippel Lindau tumor suppressor protein VHL and therefore display a deregulated expression of hypoxia-inducible factor. Studies on ectopically expressed JMJD1A and JMJD2B indicate that both proteins retain their histone lysine demethylase activity in hypoxia and thereby might impact the hypoxic gene expression program.	[Beyer, Sophie; Kristensen, Malene Maag; Jensen, Kim Steen; Johansen, Jens Vilstrup; Staller, Peter] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Johansen, Jens Vilstrup] Univ Copenhagen, Bioinformat Ctr, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Staller, P (corresponding author), Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	peter.staller@bric.ku.dk		Hjorth-Jensen, Kim/0000-0001-5415-9525; Vilstrup Johansen, Jens/0000-0001-7094-6801	Biotech Research and Innovation Centre; Danish Cancer Society; Danish Cancer Research Foundation; Lykfeldts Legat; Novo Nordisk Foundation	Biotech Research and Innovation Centre; Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; Lykfeldts Legat; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by the Biotech Research and Innovation Centre, the Danish Cancer Society, the Danish Cancer Research Foundation, Lykfeldts Legat, and the Novo Nordisk Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This rticle must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adam MF, 1999, HEAD NECK-J SCI SPEC, V21, P146, DOI 10.1002/(SICI)1097-0347(199903)21:2<146::AID-HED8>3.0.CO;2-U; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Birner P, 2000, CANCER RES, V60, P4693; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brahimi-Horn MC, 2007, ESSAYS BIOCHEM, V43, P165, DOI 10.1042/bse0430165; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jogi A, 2004, EXP CELL RES, V295, P469, DOI 10.1016/j.yexcr.2004.01.013; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Kaelin WG, 2005, COLD SH Q B, V70, P159, DOI 10.1101/sqb.2005.70.001; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Knebel J, 2006, J CELL BIOCHEM, V99, P319, DOI 10.1002/jcb.20945; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Lockman K, 2007, CIRC RES, V101, pE115, DOI 10.1161/CIRCRESAHA.107.164178; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maina EN, 2005, ONCOGENE, V24, P4549, DOI 10.1038/sj.onc.1208649; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Murata H, 2002, CANCER RES, V62, P7004; Nilsson H, 2005, EXP CELL RES, V303, P447, DOI 10.1016/j.yexcr.2004.10.003; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; POLLARD PJ, 2008, J BIOCH IN PRESS; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Seigneuric R, 2007, RADIOTHER ONCOL, V83, P374, DOI 10.1016/j.radonc.2007.05.002; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Semenza GL, 2006, EXP PHYSIOL, V91, P803, DOI 10.1113/expphysiol.2006.033498; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Stratmann R, 1997, J NEUROPATH EXP NEUR, V56, P1242, DOI 10.1097/00005072-199711000-00009; Tacconelli A, 2004, CANCER CELL, V6, P347, DOI 10.1016/j.ccr.2004.09.011; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; VAUPEL P, 1991, CANCER RES, V51, P3316; Vengellur A, 2005, PHYSIOL GENOMICS, V22, P308, DOI 10.1152/physiolgenomics.00045.2004; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang ZQ, 2000, CANCER RES, V60, P4735	83	247	254	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36542	36552		10.1074/jbc.M804578200	http://dx.doi.org/10.1074/jbc.M804578200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984585	hybrid, Green Published			2022-12-27	WOS:000261840500052
J	Robakis, T; Bak, B; Lin, SH; Bernard, DJ; Scheiffele, P				Robakis, Thalia; Bak, Beata; Lin, Shu-huei; Bernard, Daniel J.; Scheiffele, Peter			An Internal Signal Sequence Directs Intramembrane Proteolysis of a Cellular Immunoglobulin Domain Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; INHIBIN-BINDING-PROTEIN; VIRUS CORE PROTEIN; PEPTIDE PEPTIDASE; ASPARTIC PROTEASES; TNF-ALPHA; CLEAVAGE; PRESENILIN; GENE; IDENTIFICATION	Precursor proteolysis is a crucial mechanism for regulating protein structure and function. Signal peptidase (SP) is an enzyme with a well defined role in cleaving N-terminal signal sequences but no demonstrated function in the proteolysis of cellular precursor proteins. We provide evidence that SP mediates intraprotein cleavage of IgSF1, a large cellular Ig domain protein that is processed into two separate Ig domain proteins. In addition, our results suggest the involvement of signal peptide peptidase (SPP), an intramembrane protease, which acts on substrates that have been previously cleaved by SP. We show that IgSF1 is processed through sequential proteolysis by SP and SPP. Cleavage is directed by an internal signal sequence and generates two separate Ig domain proteins from a polytopic precursor. Our findings suggest that SP and SPP function are not restricted to N-terminal signal sequence cleavage but also contribute to the processing of cellular transmembrane proteins.	[Robakis, Thalia; Lin, Shu-huei; Scheiffele, Peter] Columbia Univ, Dept Physiol & Cellular Biophys, Dept Neurosci, New York, NY 10032 USA; [Bak, Beata; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada	Columbia University; McGill University	Scheiffele, P (corresponding author), Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	peter.scheiffele@unibas.ch	Robakis, Thalia/AAQ-5277-2020	Robakis, Thalia/0000-0003-2919-2555; Bernard, Daniel/0000-0001-5365-5586	Natural Sciences and Engineering Research Council of Canada Discovery; Joseph and Esther Klingenstein Fund; Alfred P. Sloan Foundation; Searle Scholar Program; Irma T. Hirschl Trust; John Merck Fund; Medical Scientist Training Program training program at Columbia University; Natural Sciences and Engineering Research Council of Canada M.Sc. fellowship	Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Joseph and Esther Klingenstein Fund(Klingenstein Philanthropies); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Searle Scholar Program; Irma T. Hirschl Trust; John Merck Fund; Medical Scientist Training Program training program at Columbia University; Natural Sciences and Engineering Research Council of Canada M.Sc. fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant ( to D.J.B.) and funds from the Joseph and Esther Klingenstein Fund, The Alfred P. Sloan Foundation, The Searle Scholar Program, The Irma T. Hirschl Trust, and The John Merck Fund( to P. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the Medical Scientist Training Program training program at Columbia University.; Supported by a Natural Sciences and Engineering Research Council of Canada M.Sc. fellowship.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernard DJ, 2003, MOL CELL BIOL, V23, P4882, DOI 10.1128/MCB.23.14.4882-4891.2003; Bernard DJ, 2001, MOL ENDOCRINOL, V15, P654, DOI 10.1210/me.15.4.654; Blobel G, 1979, Symp Soc Exp Biol, V33, P9; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Chapman SC, 2001, MOL ENDOCRINOL, V15, P668, DOI 10.1210/me.15.4.668; Chong HR, 2000, ENDOCRINOLOGY, V141, P2600, DOI 10.1210/en.141.7.2600; Crawshaw SG, 2004, BIOCHEM J, V384, P9, DOI 10.1042/BJ20041216; DE SB, 1999, NATURE, V398, P518; Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Frattini A, 1998, GENE, V214, P1, DOI 10.1016/S0378-1119(98)00253-4; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; HAEUPTLE MT, 1989, J CELL BIOL, V108, P1227, DOI 10.1083/jcb.108.4.1227; Hegde RS, 1999, TRENDS CELL BIOL, V9, P132, DOI 10.1016/S0962-8924(99)01504-4; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; LILJESTROM P, 1991, J VIROL, V65, P147; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; Mazzarella R, 1998, GENOMICS, V48, P157, DOI 10.1006/geno.1997.5156; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Pekosz A, 1998, P NATL ACAD SCI USA, V95, P13233, DOI 10.1073/pnas.95.22.13233; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; STOCKS CE, 1995, J VIROL, V69, P8123, DOI 10.1128/JVI.69.12.8123-8126.1995; Targett-Adams P, 2006, J BIOL CHEM, V281, P29221, DOI 10.1074/jbc.M605373200; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	44	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36369	36376		10.1074/jbc.M807527200	http://dx.doi.org/10.1074/jbc.M807527200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981173	Green Published, hybrid			2022-12-27	WOS:000261840500034
J	Song, HP; Luo, J; Luo, WJ; Weng, JS; Wang, ZQ; Li, BX; Li, DL; Liu, MY				Song, Huiping; Luo, Jian; Luo, Weijia; Weng, Jinsheng; Wang, Zhiqiang; Li, Baoxing; Li, Dali; Liu, Mingyao			Inactivation of G-protein-coupled Receptor 48 (Gpr48/Lgr4) Impairs Definitive Erythropoiesis at Midgestation through Down-regulation of the ATF4 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; ACTIVATING TRANSCRIPTION FACTOR-4; STAT5A(-/-)5B(-/-) MICE; POSTNATAL-DEVELOPMENT; TARGETED DISRUPTION; CELL-PROLIFERATION; TYROSINE RESIDUES; FETAL ANEMIA; YOLK-SAC; STAT5	G-protein-coupled receptors (GPCRs), one of the most versatile groups of cell surface receptors, can recognize specific ligands from neural, hormonal, and paracrine organs and regulate cell growth, proliferation, and differentiation. Gpr48/LGR4 is a recently identified orphan GPCR with unknown functions. To reveal the functions of Gpr48 in vivo, we generated Gpr48(-/-) mice and found that Gpr48(-/-) fetuses displayed transient anemia during midgestation and abnormal definitive erythropoiesis. The dramatic decrease of definitive erythroid precursors (Ter119(pos) population) in Gpr48(-/-) fetal liver at E13.5 was confirmed by histological analysis and blood smear assays. Real-time PCR analyses showed that in Gpr48(-/-) mice both adult hemoglobin alpha and beta chains were decreased while embryonic hemoglobin chains (zeta, beta H1, and epsilon y) were increased, providing another evidence for the impairment of definitive erythropoiesis. Furthermore, proliferation was suppressed in Gpr48(-/-) fetal liver with decreased c-Myc and cyclin D1 expression, whereas apoptosis was unaffected. ATF4, a key transcription factor in erythropoiesis, was down-regulated in Gpr48(-/-) fetal livers during midgestation stage through the cAMP-PKA-CREB pathway, suggesting that Gpr48 regulated definitive erythropoiesis	[Song, Huiping; Luo, Weijia; Weng, Jinsheng; Liu, Mingyao] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Song, Huiping; Luo, Weijia; Weng, Jinsheng; Liu, Mingyao] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX 77030 USA; [Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Song, Huiping; Wang, Zhiqiang] N China Coal Med Univ, Tangshan 063000, Peoples R China; [Song, Huiping; Li, Baoxing] So Med Univ, Shanxi Prov Tissue Bank, Taiyuan 030006, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; East China Normal University; East China Normal University; North China University of Science & Technology; Southern Medical University - China	Liu, MY (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mliu@ibt.tamhsc.edu	Luo, Jian/H-3362-2016	Luo, Jian/0000-0003-3583-0154; Liu, Mingyao/0000-0001-7339-5048	National Institutes of Health [5R01HL064792, 1R01CA106479]; NATIONAL CANCER INSTITUTE [R01CA106479] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01HL064792 and 1R01CA106479 (to M.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Boer AK, 2003, EXP HEMATOL, V31, P512, DOI 10.1016/S0301-472X(03)00075-4; Boer AK, 2002, BLOOD, V100, P467, DOI 10.1182/blood.V100.2.467; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cui KY, 2000, J BIOL CHEM, V275, P7591, DOI 10.1074/jbc.275.11.7591; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; Dumitriu B, 2006, BLOOD, V108, P1198, DOI 10.1182/blood-2006-02-004184; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Fischer C, 2004, BIOL REPROD, V70, P371, DOI 10.1095/biolreprod.103.021600; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao Y, 2006, HOKKAIDO IGAKU ZASSH, V81, P109; Gao Y, 2006, HOKKAIDO IGAKU ZASSH, V81, P107; Gao Yun, 2006, Hokkaido Igaku Zasshi, V81, P101; Gobert S, 1996, EMBO J, V15, P2434, DOI 10.1002/j.1460-2075.1996.tb00601.x; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Klingmuller U, 1996, P NATL ACAD SCI USA, V93, P8324, DOI 10.1073/pnas.93.16.8324; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Loh ED, 2000, CYTOGENET CELL GENET, V89, P2, DOI 10.1159/000015576; Loh ED, 2001, BIOCHEM BIOPH RES CO, V282, P757, DOI 10.1006/bbrc.2001.4625; Marchese A, 1999, TRENDS PHARMACOL SCI, V20, P370, DOI 10.1016/S0165-6147(99)01366-8; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; McGrath KE, 2005, EXP HEMATOL, V33, P1021, DOI 10.1016/j.exphem.2005.06.012; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mitchell DC, 2006, J BIOL CHEM, V281, P51, DOI 10.1074/jbc.M506245200; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Osuga Y, 1997, MOL ENDOCRINOL, V11, P1659, DOI 10.1210/me.11.11.1659; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palis J, 1999, DEVELOPMENT, V126, P5073; Perry C, 2002, EUR J BIOCHEM, V269, P3607, DOI 10.1046/j.1432-1033.2002.02999.x; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; Samakoglu S, 2001, BLOOD, V97, P2213, DOI 10.1182/blood.V97.8.2213; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	61	48	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36687	36697		10.1074/jbc.M800721200	http://dx.doi.org/10.1074/jbc.M800721200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18955481	hybrid, Green Published			2022-12-27	WOS:000261840500067
J	Wells, RD				Wells, Robert D.			Discovery of the Role of Non-B DNA Structures in Mutagenesis and Human Genomic Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							REPEATING NUCLEOTIDE SEQUENCES; SINGLE-STRANDED-DNA; DOUBLE-HELICAL DNA; RESTRICTION ENDONUCLEASE; SUPERCOILED PLASMIDS; INVERTED REPEAT; KINETOPLAST DNA; NUCLEIC-ACIDS; BENT DNA; CONFORMATIONS		Texas Med Ctr, Texas A&M Syst Hlth Sci Ctr, Inst Biosci & Technol, Ctr Genome Res, Houston, TX 77030 USA	Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wells, RD (corresponding author), Texas Med Ctr, Texas A&M Syst Hlth Sci Ctr, Inst Biosci & Technol, Ctr Genome Res, Houston, TX 77030 USA.	rwells@ibt.tamhsc.edu			NIEHS NIH HHS [R01 ES011347, ES11347] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011347] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bacolla A, 2008, GENOME RES, V18, P1545, DOI 10.1101/gr.078303.108; Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; Bacolla A, 2006, NUCLEIC ACIDS RES, V34, P2663, DOI 10.1093/nar/gkl354; Bacolla A, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P89, DOI 10.1007/978-1-59745-039-3_6; BLAHO JA, 1988, J BIOL CHEM, V263, P14446; BLAHO JA, 1989, PROG NUCLEIC ACID RE, V37, P107; BLAKESLEY RW, 1975, NATURE, V257, P421, DOI 10.1038/257421a0; BLAKESLEY RW, 1977, J BIOL CHEM, V252, P7300; Bowater RP, 2001, PROG NUCLEIC ACID RE, V66, P159; CHAMBERLIN MJ, 1965, FED PROC, V24, P1446; DREW H, 1980, NATURE, V286, P567, DOI 10.1038/286567a0; FELSENFE.G, 1967, ANNU REV BIOCHEM, V36, P407, DOI 10.1146/annurev.bi.36.070167.002203; GRANT RC, 1972, BIOCHEMISTRY-US, V11, P805, DOI 10.1021/bi00755a020; GRIFFITH JD, 1988, J BIOMOL STRUCT DYN, V3, P25; Halvorson HO, 2007, BIOL CELL, V99, P717, DOI 10.1042/BC20070061; HANVEY JC, 1988, J BIOL CHEM, V263, P7386; HANVEY JC, 1988, P NATL ACAD SCI USA, V85, P6292, DOI 10.1073/pnas.85.17.6292; HEBERT A, 1996, J BIOL CHEM, V271, P11595; HORIUCHI K, 1975, P NATL ACAD SCI USA, V72, P2555, DOI 10.1073/pnas.72.7.2555; Jakupciak JP, 2000, IUBMB LIFE, V50, P355, DOI 10.1080/152165400300089358; JAWORSKI A, 1987, SCIENCE, V238, P773, DOI 10.1126/science.3313728; KHORANA HG, 1966, COLD SPRING HARB SYM, V31, P39, DOI 10.1101/SQB.1966.031.01.010; KITCHIN PA, 1986, J BIOL CHEM, V261, P1302; LILLEY DMJ, 1980, P NATL ACAD SCI-BIOL, V77, P6468, DOI 10.1073/pnas.77.11.6468; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; MCLEAN MJ, 1987, NUCLEIC ACIDS RES, V15, P6917, DOI 10.1093/nar/15.17.6917; MCLEAN MJ, 1988, J BIOL CHEM, V263, P7370; MITSUI Y, 1970, NATURE, V228, P1166, DOI 10.1038/2281166a0; MORGAN AR, 1968, J MOL BIOL, V37, P63, DOI 10.1016/0022-2836(68)90073-9; PANAYOTATOS N, 1981, NATURE, V289, P466, DOI 10.1038/289466a0; POHL FM, 1972, J MOL BIOL, V67, P375, DOI 10.1016/0022-2836(72)90457-3; SELSING E, 1979, J BIOL CHEM, V254, P5417; SELSING E, 1978, NATURE, V275, P249, DOI 10.1038/275249a0; SELSING E, 1979, J BIOL CHEM, V254, P5410; SHIMIZU M, 1989, J BIOL CHEM, V264, P5944; SINGLETON CK, 1983, J BIOL CHEM, V258, P7661; SINGLETON CK, 1982, J BIOL CHEM, V257, P6292; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Tissier A, 1996, GENOMICS, V38, P238, DOI 10.1006/geno.1996.0623; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Wells R D, 1980, Prog Nucleic Acid Res Mol Biol, V24, P167; Wells R.D., 2006, GENETIC INSTABILITIE; WELLS RD, 1967, J MOL BIOL, V27, P273, DOI 10.1016/0022-2836(67)90020-4; WELLS RD, 1988, J BIOL CHEM, V263, P1095; WELLS RD, 1977, CRC CR REV BIOCH MOL, V4, P305, DOI 10.3109/10409237709102561; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 2002, IUBMB LIFE, V53, P137, DOI 10.1080/15216540211475; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; WELLS RD, 1982, COLD SPRING HARB SYM, V47, P77; WELLS RD, 1969, SCIENCE, V165, P75, DOI 10.1126/science.165.3888.75; WELLS RD, 1990, ICN UCLA S MOL CELL, V127, P79; WELLS RD, 2002, MOL CELL PROTEOMICS, V1, P1; Wells RD, 1974, BIOCH NUCL ACIDS, V6, P41; WELLS RD, 1990, ORG BACTERIAL CHROMO, P187; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Wells RD, 2006, SCIENCE, V314, P1081; WOHLRAB F, 1989, J BIOL CHEM, V264, P8207; WOHLRAB F, 1991, P NATL ACAD SCI USA, V88, P6432, DOI 10.1073/pnas.88.15.6432; Wojciechowska M, 2006, J BIOL CHEM, V281, P24531, DOI 10.1074/jbc.M603888200	63	24	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					8997	9009		10.1074/jbc.X800010200	http://dx.doi.org/10.1074/jbc.X800010200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19054760	Green Published, hybrid			2022-12-27	WOS:000264669100001
J	Tutter, AV; Kowalski, MP; Baltus, GA; Iourgenko, V; Labow, M; Li, E; Kadam, S				Tutter, Antonin V.; Kowalski, Michael P.; Baltus, Gretchen A.; Iourgenko, Vadim; Labow, Mark; Li, En; Kadam, Shilpa			Role for Med12 in Regulation of Nanog and Nanog Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; MEDIATOR COMPLEX; SELF-RENEWAL; TRANSCRIPTION; PLURIPOTENCY; DIFFERENTIATION; NETWORK; SUBUNITS; MUTATION	Nanog, Oct4, and Sox2 form the core of a transcription factor network that maintains embryonic stem cells in the pluripotent state in both humans and mice. These critical factors have been implicated as both positive and negative regulators of transcription, varying by promoter and differentiation state of the cell. The Mediator complex, a ubiquitous conserved complex of similar to 30 subunits, facilitates transcription by coordinating RNA polymerase II binding to target promoters via gene-specific activators and can be divided into several functional subcomplexes. Med12 is part of a subcomplex of four proteins associated with the core Mediator complex and has been found to function both in repressing and activating transcription when recruited to target promoters. We identified an interaction between Med12 and Nanog and present evidence of involvement of Med12 in regulation of Nanog function. Gene expression analysis of embryonic stem cells knocked down for Med12 showed a similarity to Nanog knockdown, with increased expression of Nanog-repressed targets and decreased expression of Nanog-activated targets. Using chromatin immunoprecipitation, we found that Med12 and Nanog co-occupied Nanog target promoters in embryonic stem cells and that Med12 dissociated from target promoters upon differentiation with kinetics similar to Nanog. Our results indicate that Nanog and Med12 function in concert to regulate Nanog target genes and	[Tutter, Antonin V.; Baltus, Gretchen A.; Li, En; Kadam, Shilpa] Novartis Inst Biomed Res, Epigenet, Cambridge, MA 02139 USA; [Kowalski, Michael P.; Iourgenko, Vadim; Labow, Mark] Novartis Inst Biomed Res, Dev & Mol Pathways, Cambridge, MA 02139 USA	Novartis; Novartis	Kadam, S (corresponding author), Novartis Inst Biomed Res, Epigenet, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	shilpa.kadam@novartis.com						Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Kamachi Y, 1999, MOL CELL BIOL, V19, P107; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li J, 2007, EMBO J, V26, P2284, DOI 10.1038/sj.emboj.7601667; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Pan GJ, 2003, CELL RES, V13, P499, DOI 10.1038/sj.cr.7290193; Philiber RA, 2007, PHARMACOGENOMICS, V8, P909, DOI 10.2217/14622416.8.8.909; Rau MJ, 2006, DEV BIOL, V296, P83, DOI 10.1016/j.ydbio.2006.04.437; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Rohwedel J, 1999, CELLS TISSUES ORGANS, V165, P190, DOI 10.1159/000016699; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Shin CH, 2008, DEV BIOL, V317, P467, DOI 10.1016/j.ydbio.2008.02.031; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yoda A, 2005, DEVELOPMENT, V132, P1885, DOI 10.1242/dev.01776; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	31	50	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3709	3718		10.1074/jbc.M805677200	http://dx.doi.org/10.1074/jbc.M805677200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19036726	hybrid			2022-12-27	WOS:000262872500039
J	Hou, ZJ; Matherly, LH				Hou, Zhanjun; Matherly, Larry H.			Oligomeric Structure of the Human Reduced Folate Carrier IDENTIFICATION OF HOMO-OLIGOMERS AND DOMINANT-NEGATIVE EFFECTS ON CARRIER EXPRESSION AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; ESCHERICHIA-COLI; TRANSMEMBRANE DOMAINS; METHOTREXATE SENSITIVITY; SEROTONIN TRANSPORTER; QUATERNARY STRUCTURE; CROSS-LINKING; CELLS; MEMBRANE; LOCALIZATION	The ubiquitously expressed reduced folate carrier (RFC) is the major transport system for folate cofactors in mammalian cells and tissues. Previous considerations of RFC structure and mechanism were based on the notion that RFC monomers were sufficient to mediate transport of folate and antifolate substrates. The present study examines the possibility that human RFC (hRFC) exists as higher order homo-oligomers. By chemical cross-linking, transiently expressed hRFC in hRFC-null HeLa (R5) cells with the homobifunctional cross-linker 1,3-propanediyl bis-methanethiosulfonate and Western blotting, hRFC species with molecular masses of hRFC homo-oligomers were identified. Hemagglutinin- and Myc epitope-tagged hRFC proteins expressed in R5 cells were co-immunoprecipitated from both membrane particulate and surface-enriched membrane fractions, indicating that oligomeric hRFC is expressed at the cell surface. By co-expression of wild type and inactive mutant S138C hRFCs, combined with surface biotinylation and confocal microscopy, a dominant-negative phenotype was demonstrated involving greatly decreased cell surface expression of both mutant and wild type carrier caused by impaired intracellular trafficking. For another hRFC mutant (R373A), expression of oligomeric wild type-mutant hRFC was accompanied by a significant and disproportionate loss of wild type activity unrelated to the level of surface carrier. Collectively, our results demonstrate the existence of hRFC homo-oligomers. They also establish the likely importance of these higher order hRFC structures to intracellular trafficking and carrier function.	[Hou, Zhanjun; Matherly, Larry H.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dev Therapeut Program, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Canc Biol Grad Program, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University	Matherly, LH (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	matherly@kci.wayne.edu	/S-1117-2019		National Institutes of Health [CA53535]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant CA53535. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; AMBUDKAR SV, 1990, J BIOL CHEM, V265, P12287; Balamurugan K, 2006, AM J PHYSIOL-CELL PH, V291, pC189, DOI 10.1152/ajpcell.00594.2005; Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; Dahl NK, 2003, J BIOL CHEM, V278, P44949, DOI 10.1074/jbc.M308660200; Deng YJ, 2008, MOL PHARMACOL, V73, P1274, DOI 10.1124/mol.107.043190; DIXON KH, 1994, J BIOL CHEM, V269, P17; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; FRY DW, 1982, J BIOL CHEM, V257, P1890; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; HICKMAN RK, 1988, J BACTERIOL, V170, P1715, DOI 10.1128/jb.170.4.1715-1720.1988; Horschitz S, 2008, NEUROCHEM INT, V52, P770, DOI 10.1016/j.neuint.2007.09.005; Hou ZJ, 2006, J BIOL CHEM, V281, P33588, DOI 10.1074/jbc.M607049200; Hou ZJ, 2005, J BIOL CHEM, V280, P36206, DOI 10.1074/jbc.M507295200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Kneuer C, 2005, CELL TISSUE RES, V320, P517, DOI 10.1007/s00441-005-1092-x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matherly LH, 2008, VITAM HORM, V79, P145, DOI 10.1016/S0083-6729(08)00405-6; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; Matherly Larry H., 2004, Current Pharmacogenomics, V2, P287, DOI 10.2174/1570160043377547; MATHERLY LH, 1991, CANCER RES, V51, P3420; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Payton SG, 2007, BBA-GENE STRUCT EXPR, V1769, P131, DOI 10.1016/j.bbaexp.2006.12.006; Regeer RR, 2007, INT J BIOCHEM CELL B, V39, P2240, DOI 10.1016/j.biocel.2007.06.015; Sadlish H, 2002, J BIOL CHEM, V277, P42105, DOI 10.1074/jbc.M206459200; Sharina IG, 2001, MOL PHARMACOL, V59, P1022, DOI 10.1124/mol.59.5.1022; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Sitte HH, 2003, EUR J PHARMACOL, V479, P229, DOI 10.1016/j.ejphar.2003.08.072; Spector R, 2006, PHARM RES-DORDR, V23, P2515, DOI 10.1007/s11095-006-9091-5; Stokstad ELR, 1990, FOLIC ACID METABOLIS, P1; SWEIRY JH, 1985, BIOCHIM BIOPHYS ACTA, V821, P497, DOI 10.1016/0005-2736(85)90055-0; Taylor AM, 2001, BIOCHEM J, V359, P661, DOI 10.1042/0264-6021:3590661; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Witt TL, 2004, J BIOL CHEM, V279, P46755, DOI 10.1074/jbc.M408696200; WONG SC, 1995, J BIOL CHEM, V270, P17468, DOI 10.1074/jbc.270.29.17468; Wong SC, 1998, BBA-BIOMEMBRANES, V1375, P6, DOI 10.1016/S0005-2736(98)00118-7; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044; Yin CC, 2000, MOL MICROBIOL, V38, P482, DOI 10.1046/j.1365-2958.2000.02149.x; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2003, ONCOGENE, V22, P7431, DOI 10.1038/sj.onc.1206946; Zhao RB, 2007, CANCER METAST REV, V26, P129, DOI 10.1007/s10555-007-9047-1; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	48	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3285	3293		10.1074/jbc.M807206200	http://dx.doi.org/10.1074/jbc.M807206200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19019821	Green Published, hybrid			2022-12-27	WOS:000262700900071
J	Ramakrishnan, NA; Drescher, MJ; Barretto, RL; Beisel, KW; Hatfield, JS; Drescher, DG				Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Barretto, Roberto L.; Beisel, Kirk W.; Hatfield, James S.; Drescher, Dennis G.			Calcium-dependent Binding of HCN1 Channel Protein to Hair Cell Stereociliary Tip Link Protein Protocadherin 15 CD3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNEL; INWARDLY RECTIFYING CURRENTS; PACEMAKER CHANNELS; INNER-EAR; CATION CHANNELS; MOLECULAR CHARACTERIZATION; INSTANTANEOUS CURRENT; IONIC COMPOSITION; SUPPORTING CELLS; RAT COCHLEA	The cytoplasmic amino terminus of HCN1, the primary full-length HCN isoform expressed in trout saccular hair cells, was found by yeast two-hybrid protocols to bind the cytoplasmic carboxyl-terminal domain of a protocadherin 15a-like protein. HCN1 was immunolocalized to discrete sites on saccular hair cell stereocilia, consistent with gradated distribution expected for tip link sites of protocadherin 15a. HCN1 message was also detected in cDNA libraries of rat cochlear inner and outer hair cells, and HCN1 protein was immunolocalized to cochlear hair cell stereocilia. As predicted by the trout hair cell model, the amino terminus of rat organ of Corti HCN1 was found by yeast two-hybrid analysis to bind the carboxyl terminus of protocadherin 15 CD3, a tip link protein implicated in mechanosensory transduction. Specific binding between HCN1 and protocadherin 15 CD3 was confirmed with pull-down assays and surface plasmon resonance analysis, both predicting dependence on Ca2+. In the presence of calcium chelators, binding between HCN1 and protocadherin 15 CD3 was characterized by a K-D = 2.39 x 10(-7) M. Ca2+ at 26.5-68.0 mu M promoted binding, with K-D = 5.26 x 10(-8) M (at 61 mu M Ca2+). Binding by deletion mutants of protocadherin 15 CD3 pointed to amino acids 158-179 (GenBank (TM) accession number XP_238200), with homology to the comparable region in trout hair cell protocadherin 15a-like protein, as necessary for binding to HCN1. Amino terminus binding of HCN1 to HCN1, hypothesized to underlie HCN1 channel formation, was also found to be Ca2+-dependent, although the binding was skewed toward a lower effective maximum [Ca2+] than for the HCN1 interaction with protocadherin 15 CD3. Competition may therefore exist in vivo between the two binding sites for HCN1, with binding of HCN1 to protocadherin 15 CD3 favored between 26.5 and 68 mu M Ca2+. Taken together, the evidence supports a role for HCN1 in mechanosensory transduction of inner ear hair cells.	[Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Barretto, Roberto L.; Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Otolaryngol, Detroit, MI 48201 USA; [Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Beisel, Kirk W.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Hatfield, James S.] Vet Affairs Med Ctr, Electron Microscopy Lab, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Creighton University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Drescher, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol, 261 Lande Med Res Bldg,540 E Canfield Ave, Detroit, MI 48201 USA.	mdresche@med.wayne.edu			National Institutes of Health [DC04076, DC000156]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004076, R01DC000156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC04076 and DC000156. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.. S The on-line version of this article ( available	Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Azene EM, 2005, CARDIOVASC RES, V67, P263, DOI 10.1016/j.cardiores.2005.03.006; Barritt LC, 1999, MOL BRAIN RES, V68, P42, DOI 10.1016/S0169-328X(99)00078-9; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; Cho WJ, 2003, NEUROSCIENCE, V118, P525, DOI 10.1016/S0306-4522(02)00913-2; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; de Brouwer APM, 2003, HUM GENET, V112, P156, DOI 10.1007/s00439-002-0833-0; Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Drescher DG, 2004, NEUROSCIENCE, V127, P737, DOI 10.1016/j.neuroscience.2004.05.037; DRESCHER DG, 1989, BRAIN RES, V485, P225, DOI 10.1016/0006-8993(89)90565-9; Drescher MJ, 2006, NEUROSCIENCE, V142, P139, DOI 10.1016/j.neuroscience.2006.05.065; Drescher MJ, 1997, MOL BRAIN RES, V45, P325, DOI 10.1016/S0169-328X(97)00007-7; DRESCHER MJ, 1991, J NEUROCHEM, V56, P658, DOI 10.1111/j.1471-4159.1991.tb08200.x; ENGER PS, 1964, COMP BIOCHEM PHYSIOL, V11, P131, DOI 10.1016/0010-406X(64)90100-8; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Ghanem TA, 2008, BIOL BULL-US, V214, P83, DOI 10.2307/25066662; HARASZTOSI C, 2008, ASS RES OT ABSTR, V31, P654; HOLT JR, 1995, J NEUROPHYSIOL, V73, P1484, DOI 10.1152/jn.1995.73.4.1484; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jagger DJ, 1999, PFLUG ARCH EUR J PHY, V438, P8, DOI 10.1007/s004240050873; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Khan KM, 2002, NEUROSCIENCE, V111, P291, DOI 10.1016/S0306-4522(02)00020-9; Lin W, 2007, BIOPHYS J, V92, P1559, DOI 10.1529/biophysj.106.092478; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; Martin P, 2003, J NEUROSCI, V23, P4533; Masetto S, 1997, J NEUROPHYSIOL, V78, P1913, DOI 10.1152/jn.1997.78.4.1913; Mistrik P, 2006, PFLUG ARCH EUR J PHY, V452, P718, DOI 10.1007/s00424-006-0095-0; NAM JH, 2008, ASS RES OT ABSTR, V31, P658; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; RAMAKRISHNAN NA, 2007, ASS RES OT ABSTR, V30, P31; Ricci AJ, 2006, J MEMBRANE BIOL, V209, P71, DOI 10.1007/s00232-005-0834-8; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rusch A, 1998, J NEUROSCI, V18, P7487; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Seiler C, 2005, DEVELOPMENT, V132, P615, DOI 10.1242/dev.01591; SEWELL WF, 1993, HEARING RES, V70, P131, DOI 10.1016/0378-5955(93)90150-Y; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; SRINIVASAN A, 2008, ASS RES OT ABSTR, V31, P655; STERKERS O, 1984, AM J PHYSIOL, V247, pF602, DOI 10.1152/ajprenal.1984.247.4.F602; Sugihara I, 1996, J PHYSIOL-LONDON, V495, P665, DOI 10.1113/jphysiol.1996.sp021624; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005	50	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3227	3238		10.1074/jbc.M806177200	http://dx.doi.org/10.1074/jbc.M806177200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19008224	hybrid, Green Published			2022-12-27	WOS:000262700900066
J	Zhang, Z; Xing, JP; Ma, L; Gong, RJ; Chin, YE; Zhuang, SG				Zhang, Zhu; Xing, Jingping; Ma, Li; Gong, Rujun; Chin, Y. Eugene; Zhuang, Shougang			Transglutaminase-1 Regulates Renal Epithelial Cell Proliferation through Activation of Stat-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; KINASE-ACTIVITY; GROWTH; PHOSPHORYLATION; EXPRESSION; STRESS; CANCER; INHIBITION; SUBSTRATE; PATHWAY	Transglutaminase-1 (TGase-1) is a Ca2+-dependent enzyme capable of cross-linking a variety of proteins and promoting wound healing in the skin. In this study, we examined the role of TGase-1 in proliferation of renal proximal tubular cells (RPTC). TGase-1, but not TGase-2, -5, and -7, was expressed in RPTC. Treatment with monodansylcadarevine (MDC), a selective TGase inhibitor or down-regulation of TGase-1 with small interfering RNA (siRNA) decreased RPTC proliferation. Proliferation of RPTC was accompanied by activation of Akt and Stat-3 (signal transducer and activator of transcription-3). Treatment with MDC or TGase-1 siRNA decreased Stat-3 but not Akt phosphorylation. Further studies showed that the Janus-activated kinase 2 (JAK2) mediates phosphorylation of Stat-3, and knockdown of either JAK2 or Stat-3 by siRNA decreased RPTC proliferation. However, inhibition of TGase-1 decreased phosphorylation of Stat-3 but not JAK2. Overexpression of Stat-3, JAK2, and/or TGase-1 in RPTC revealed that JAK2 is indispensable for TGase-1 to induce Stat-3 phosphorylation and TGase-1 potentiates JAK2-induced Stat-3 phosphorylation. Consistent with these observations, we found that inhibition of TGase-1 and the JAK2-Stat-3 signaling pathway decreased the transcriptional activity of Stat-3 and expression of the Stat-3-targeted genes, cyclin D1 and cyclin E. Conversely, overexpresssion of TGase-1 enhanced the JAK2-dependent transcriptional activity of Stat-3. Finally, TGase-1 was found to interact with JAK2, and this interaction was inhibited by MDC. These results demonstrate that TGase-1 plays an important role in regulation of renal epithelial cell proliferation through the JAK2-Stat-3 signaling pathway.	[Zhang, Zhu; Xing, Jingping; Gong, Rujun; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Med, Providence, RI 02903 USA; [Ma, Li; Chin, Y. Eugene] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Zhuang, SG (corresponding author), Brown Univ, Rhode Isl Hosp, Sch Med, Dept Med, Middle House 301,593 Eddy St, Providence, RI 02903 USA.	szhuang@lifespan.org	Zhang, Zhu/A-2575-2012		National Institutes of Health [DK-071997]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-071997. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arany I, 2006, KIDNEY INT, V70, P669, DOI 10.1038/sj.ki.5001604; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Colman H, 2006, AM J SURG PATHOL, V30, P657, DOI 10.1097/01.pas.0000202048.28203.25; ERNEST S, 1995, AM J PHYSIOL-CELL PH, V269, pC323, DOI 10.1152/ajpcell.1995.269.2.C323; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Hiiragi T, 1999, J BIOL CHEM, V274, P34148, DOI 10.1074/jbc.274.48.34148; Ientile R, 2007, AMINO ACIDS, V33, P385, DOI 10.1007/s00726-007-0517-0; Inada R, 2000, AM J PATHOL, V157, P1875, DOI 10.1016/S0002-9440(10)64826-2; Kijima T, 2002, CELL GROWTH DIFFER, V13, P355; KIM SY, 1995, J BIOL CHEM, V270, P18026, DOI 10.1074/jbc.270.30.18026; Klampfer L, 2008, FRONT BIOSCI-LANDMRK, V13, P2888, DOI 10.2741/2893; Kwon DS, 2006, EUR J CELL BIOL, V85, P1189, DOI 10.1016/j.ejcb.2006.06.001; Lee YM, 2006, CELL CYCLE, V5, P2110, DOI 10.4161/cc.5.18.3218; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Martinet N, 2003, AM J RESP CELL MOL, V28, P428, DOI 10.1165/rcmb.2002-0114OC; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mishra S, 2006, J BIOL CHEM, V281, P5532, DOI 10.1074/jbc.M506864200; Mishra S, 2006, BIOCHEM BIOPH RES CO, V339, P726, DOI 10.1016/j.bbrc.2005.11.071; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Nony PA, 2003, J PHARMACOL EXP THER, V304, P905, DOI 10.1124/jpet.102.035022; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Odajima J, 2000, J BIOL CHEM, V275, P24096, DOI 10.1074/jbc.M001606200; PERRY MJM, 1995, NEUROSCIENCE, V65, P1063, DOI 10.1016/0306-4522(94)00556-K; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shetty S, 2006, AM J PHYSIOL-LUNG C, V291, pL772, DOI 10.1152/ajplung.00476.2005; Shin DM, 2004, J BIOL CHEM, V279, P15032, DOI 10.1074/jbc.M308734200; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Stephanou A, 2005, GROWTH FACTORS, V23, P177, DOI 10.1080/08977190500178745; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Xing JP, 2008, AM J PHYSIOL-RENAL, V295, pF145, DOI 10.1152/ajprenal.00092.2008; Zhuang SG, 2004, AM J PHYSIOL-RENAL, V287, pF365, DOI 10.1152/ajprenal.00035.2004; Zhuang S, 2008, AM J PHYSIOL-RENAL, V294, pF459, DOI 10.1152/ajprenal.00473.2007	43	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3345	3353		10.1074/jbc.M808396200	http://dx.doi.org/10.1074/jbc.M808396200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049964	hybrid, Green Published			2022-12-27	WOS:000262700900077
J	Bakker, H; Oka, T; Ashikov, A; Yadav, A; Berger, M; Rana, NA; Bai, XM; Jigami, Y; Haltiwanger, RS; Esko, JD; Gerardy-Schahn, R				Bakker, Hans; Oka, Takuji; Ashikov, Angel; Yadav, Ajit; Berger, Monika; Rana, Nadia A.; Bai, Xiaomei; Jigami, Yoshifumi; Haltiwanger, Robert S.; Esko, Jeffrey D.; Gerardy-Schahn, Rita			Functional UDP-xylose Transport across the Endoplasmic Reticulum/Golgi Membrane in a Chinese Hamster Ovary Cell Mutant Defective in UDP-xylose Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-LIKE; GLUCURONIC ACID DECARBOXYLASE; NUCLEOTIDE-SUGAR TRANSPORTER; FUNGUS CRYPTOCOCCUS-NEOFORMANS; HEPARAN-SULFATE BIOSYNTHESIS; PROTEOGLYCAN CORE PROTEIN; SUBSTRATE-SPECIFICITY; XT-II; N-ACETYLGLUCOSAMINYLTRANSFERASE; SUBCELLULAR-LOCALIZATION	In mammals, xylose is found as the first sugar residue of the tetrasaccharide GlcA beta 1-3Gal beta 1-3Gal beta 1-4Xyl beta 1-O-Ser, initiating the formation of the glycosaminoglycans heparin/heparan sulfate and chondroitin/dermatan sulfate. It is also found in the trisaccharide Xyl alpha 1-3Xyl alpha 1-3Glc beta 1-O-Ser on epidermal growth factor repeats of proteins, such as Notch. UDP-xylose synthase (UXS), which catalyzes the formation of the UDP-xylose substrate for the different xylosyltransferases through decarboxylation of UDP-glucuronic acid, resides in the endoplasmic reticulum and/or Golgi lumen. Since xylosylation takes place in these organelles, no obvious requirement exists for membrane transport of UDP-xylose. However, UDP-xylose transport across isolated Golgi membranes has been documented, and we recently succeeded with the cloning of a human UDP-xylose transporter (SLC25B4). Here we provide new evidence for a functional role of UDP-xylose transport by characterization of a new Chinese hamster ovary cell mutant, designated pgsI-208, that lacks UXS activity. The mutant fails to initiate glycosaminoglycan synthesis and is not capable of xylosylating Notch. Complementation was achieved by expression of a cytoplasmic variant of UXS, which proves the existence of a functional Golgi UDP-xylose transporter. A similar to 200 fold increase of UDP-glucuronic acid occurred in pgsI-208 cells, demonstrating a lack of UDP-xylose-mediated control of the cytoplasmically localized UDP-glucose dehydrogenase in the mutant. The data presented in this study suggest the bidirectional transport of UDP-xylose across endoplasmic reticulum/Golgi membranes and its role in controlling homeostasis of UDP-glucuronic acid and UDP-xylose production.	[Bakker, Hans; Ashikov, Angel; Yadav, Ajit; Berger, Monika; Gerardy-Schahn, Rita] Hannover Med Sch, Zentrum Biochem, D-30625 Hannover, Germany; [Oka, Takuji; Jigami, Yoshifumi] Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan; [Rana, Nadia A.; Haltiwanger, Robert S.] SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Bai, Xiaomei; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Hannover Medical School; National Institute of Advanced Industrial Science & Technology (AIST); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego	Bakker, H (corresponding author), Hannover Med Sch, Zentrum Biochem, Zellulare Chem OE 4330,Carl Neuberg Str 1, D-30625 Hannover, Germany.	bakker.hans@mh-hannover.de	Bakker, Hans/A-1787-2017; Ashikov, Angel/N-7714-2015; Bakker, Hans/AAA-1623-2020	Bakker, Hans/0000-0002-1364-9154; Ashikov, Angel/0000-0001-9679-7955; Bakker, Hans/0000-0002-1364-9154; Oka, Takuji/0000-0002-5691-654X	National Institutes of Health [GM33063, GM61126]; Deutsche Forschungsgemeinschaft (DFG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063, R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM33063 (to J. D. E.) and GM61126 (to R. S. H.). This work was also supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) for the Junior Research Group "Glycomics" established under the roof of REBIRTH, a DFG cluster of Excellence (to R. G.- S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Bai XM, 1999, J BIOL CHEM, V274, P13017, DOI 10.1074/jbc.274.19.13017; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; Bakker H, 1999, BIOCHEM BIOPH RES CO, V261, P829, DOI 10.1006/bbrc.1999.1117; BAME KJ, 1989, J BIOL CHEM, V264, P8059; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Bossuyt X, 2001, J HEPATOL, V34, P210, DOI 10.1016/S0168-8278(00)00083-0; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; ELBEIN AD, 2003, Patent No. 20030166012; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1992, ADV EXP MED BIOL, V313, P97; ESKO JD, 1989, METHOD CELL BIOL, V32, P387; FAYE L, 1993, ANAL BIOCHEM, V209, P104, DOI 10.1006/abio.1993.1088; GEETHAHABIB M, 1984, J BIOL CHEM, V259, P7300; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Ishimizu T, 2007, J BIOCHEM, V141, P593, DOI 10.1093/jb/mvm064; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; KEARNS AE, 1993, J BIOL CHEM, V268, P11097; Kobayashi M, 2002, PLANT CELL PHYSIOL, V43, P1259, DOI 10.1093/pcp/pcf157; Kotake T, 2004, J BIOL CHEM, V279, P45728, DOI 10.1074/jbc.M408716200; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Minamida S, 1996, J BIOCHEM-TOKYO, V120, P1002; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moriarity JL, 2002, J BIOL CHEM, V277, P16968, DOI 10.1074/jbc.M109316200; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; NEUFELD EF, 1965, BIOCHEM BIOPH RES CO, V19, P456, DOI 10.1016/0006-291X(65)90146-4; Nita-Lazar A, 2006, METHOD ENZYMOL, V417, P93, DOI 10.1016/S0076-6879(06)17008-1; NUWAYHID N, 1986, J BIOL CHEM, V261, P2936; Oka T, 2006, FEBS J, V273, P2645, DOI 10.1111/j.1742-4658.2006.05281.x; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Omichi K, 1997, EUR J BIOCHEM, V245, P143, DOI 10.1111/j.1432-1033.1997.00143.x; Ponighaus C, 2007, J BIOL CHEM, V282, P5201, DOI 10.1074/jbc.M611665200; RODEN L, 1966, J BIOL CHEM, V241, P65; Schon S, 2006, J BIOL CHEM, V281, P14224, DOI 10.1074/jbc.M510690200; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; SIMINOVITCH L, 1976, CELL, V7, P1, DOI 10.1016/0092-8674(76)90249-X; Strasser R, 2000, FEBS LETT, V472, P105, DOI 10.1016/S0014-5793(00)01443-5; ten Dam GB, 2003, J HISTOCHEM CYTOCHEM, V51, P727; Voglmeir J, 2007, J BIOL CHEM, V282, P5984, DOI 10.1074/jbc.M608087200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Zhang LJ, 2001, J BIOL CHEM, V276, P42311, DOI 10.1074/jbc.M101441200	52	42	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2576	2583		10.1074/jbc.M804394200	http://dx.doi.org/10.1074/jbc.M804394200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028698	Green Published, hybrid			2022-12-27	WOS:000262545600062
J	Blanco-Garcia, N; Asensio-Juan, E; de la Cruz, X; Martinez-Balbas, MA				Blanco-Garcia, Noemi; Asensio-Juan, Elena; de la Cruz, Xavier; Martinez-Balbas, Marian A.			Autoacetylation Regulates P/CAF Nuclear Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; FUNCTION IN-VIVO; DNA-DAMAGE; PCAF CONTROLS; ACETYLATION; P53; APOPTOSIS; TRANSCRIPTION; PHOSPHORYLATION; P300	Acetylation is a posttranslational modification that alters the biological activities of proteins by affecting their association with other proteins or DNA, their catalytic activities, or their subcellular distribution. The acetyltransferase P/CAF is autoacetylated and acetylated by p300 in vivo. P/CAF autoacetylation is an intramolecular or intermolecular event. Intramolecular acetylation targets five lysines within the nuclear localization signal at the P/CAF C terminus. We analyzed how the subcellular distribution of P/CAF is regulated by intramolecular autoacetylation and found that a P/CAF mutant lacking histone acetyltransferase activity accumulated primarily in the cytoplasm. This cytoplasmic fraction of P/CAF is enriched for nonautoacetylated P/CAF. In addition, P/CAF deacetylation by HDAC3 and in a minor degree by HDAC1, HDAC2, or HDAC4 leads to cytoplasmic accumulation of P/CAF. Importantly, our data show that P/CAF accumulates in the cytoplasm during apoptosis. These results reveal the molecular mechanism of autoacetylation control of P/CAF nuclear translocation and suggest a novel pathway by which P/CAF activity is controlled in vivo.	[Blanco-Garcia, Noemi; Asensio-Juan, Elena; Martinez-Balbas, Marian A.] CSIC, Inst Mol Biol, E-08028 Barcelona, Spain; [de la Cruz, Xavier] Inst Catala Recerca & Estudis Avancats, E-08018 Barcelona, Spain; [de la Cruz, Xavier] IRB, Inst Mol Biol, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Martinez-Balbas, MA (corresponding author), CSIC, Inst Mol Biol, Baldiri & Reixac 15-21,Parc Cient Barcelona, E-08028 Barcelona, Spain.	mmbbmc@ibmb.csic.es		Martinez-Balbas, Marian/0000-0003-0173-0964; De la Cruz Montserrat, Fco. Xavier/0000-0002-9738-8472	Spanish Ministry of Education and Science [Gen2003-20642, SAF2005-01285, BFU2006-01493, CSD2006-00049, BIO2006-15557]	Spanish Ministry of Education and Science(Spanish Government)	This work was supported by Spanish Ministry of Education and Science Grants Gen2003-20642, SAF2005-01285, BFU2006-01493, CSD2006-00049,and BIO2006-15557. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Boix-Chornet M, 2006, J BIOL CHEM, V281, P13540, DOI 10.1074/jbc.M601136200; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Candau R, 1997, EMBO J, V16, P555, DOI 10.1093/emboj/16.3.555; Chan HM, 2001, J CELL SCI, V114, P2363; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; Chen CJ, 2001, MOL CELL BIOL, V21, P476, DOI 10.1128/MCB.21.2.476-487.2001; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; di Bari MG, 2006, EMBO REP, V7, P727, DOI 10.1038/sj.embor.7400700; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gay F, 2003, GENE DEV, V17, P717, DOI 10.1101/gad.1042403; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Kratzmeier M, 2000, J BIOL CHEM, V275, P30478, DOI 10.1074/jbc.M003956200; Linares LK, 2007, NAT CELL BIOL, V9, P331, DOI 10.1038/ncb1545; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; McLaughlin F, 2004, BIOCHEM PHARMACOL, V68, P1139, DOI 10.1016/j.bcp.2004.05.034; Mimnaugh EG, 2001, CELL DEATH DIFFER, V8, P1182, DOI 10.1038/sj.cdd.4400924; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Reid JL, 1998, EMBO J, V17, P4469, DOI 10.1093/emboj/17.15.4469; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Spilianakis C, 2000, MOL CELL BIOL, V20, P8489, DOI 10.1128/MCB.20.22.8489-8498.2000; Thevenet L, 2004, EMBO J, V23, P3336, DOI 10.1038/sj.emboj.7600352; Valls E, 2005, J BIOL CHEM, V280, P42592, DOI 10.1074/jbc.M507407200; Valls E, 2003, NUCLEIC ACIDS RES, V31, P3114, DOI 10.1093/nar/gkg418; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; Wong DS, 2004, J BIOL CHEM, V279, P55667, DOI 10.1074/jbc.M408174200; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamagoe S, 2003, MOL CELL BIOL, V23, P1025, DOI 10.1128/MCB.23.3.1025-1033.2003; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yuan LW, 2002, BBA-MOL CELL RES, V1592, P205, DOI 10.1016/S0167-4889(02)00327-0; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200; Zhao LY, 2003, ONCOGENE, V22, P8316, DOI 10.1038/sj.onc.1206916	59	53	54	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1343	1352		10.1074/jbc.M806075200	http://dx.doi.org/10.1074/jbc.M806075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015268	hybrid, Green Submitted			2022-12-27	WOS:000262330100002
J	Watanabe, T; Kubota, N; Ohsugi, M; Kubota, T; Takamoto, I; Iwabu, M; Awazawa, M; Katsuyama, H; Hasegawa, C; Tokuyama, K; Moroi, M; Sugi, K; Yamauchi, T; Noda, T; Nagai, R; Terauchi, Y; Tobe, K; Ueki, K; Kadowaki, T				Watanabe, Taku; Kubota, Naoto; Ohsugi, Mitsuru; Kubota, Tetsuya; Takamoto, Iseki; Iwabu, Masato; Awazawa, Motoharu; Katsuyama, Hisayuki; Hasegawa, Chiaki; Tokuyama, Kumpei; Moroi, Masao; Sugi, Kaoru; Yamauchi, Toshimasa; Noda, Tetsuo; Nagai, Ryozo; Terauchi, Yasuo; Tobe, Kazuyuki; Ueki, Kohjiro; Kadowaki, Takashi			Rimonabant Ameliorates Insulin Resistance via both Adiponectin-dependent and Adiponectin-independent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CB1 RECEPTOR ANTAGONIST; ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; ENDOGENOUS CANNABINOID SYSTEM; NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; RISK-FACTORS; OVERWEIGHT PATIENTS; HEPATIC STEATOSIS; WEIGHT-LOSS	Rimonabant has been shown to not only decrease the food intake and body weight but also to increase serum adiponectin levels. This increase of the serum adiponectin levels has been hypothesized to be related to the rimonabant-induced amelioration of insulin resistance linked to obesity, although experimental evidence to support this hypothesis is lacking. To test this hypothesis experimentally, we generated adiponectin knock-out (adipo(-/-)) ob/ob mice. After 21 days of 30 mg/kg rimonabant, the body weight and food intake decreased to similar degrees in the ob/ob and adipo(-/-)ob/ob mice. Significant improvement of insulin resistance was observed in the ob/ob mice following rimonabant treatment, associated with significant up-regulation of the plasma adiponectin levels, in particular, of high molecular weight adiponectin. Amelioration of insulin resistance in the ob/ob mice was attributed to the decrease of glucose production and activation of AMP-activated protein kinase (AMPK) in the liver induced by rimonabant but not to increased glucose uptake by the skeletal muscle. Interestingly, the rimonabant-treated adipo(-/-) ob/ob mice also exhibited significant amelioration of insulin resistance, although the degree of improvement was significantly lower as compared with that in the ob/ob mice. The effects of rimonabant on the liver metabolism, namely decrease of glucose production and activation of AMPK, were also less pronounced in the adipo(-/-)ob/ob mice. Thus, it was concluded that rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways.	[Kadowaki, Takashi] Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; [Nagai, Ryozo] Univ Tokyo, Dept Cardiovasc Dis, Grad Sch Med, Tokyo 1138655, Japan; [Watanabe, Taku] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 0608648, Japan; [Kubota, Naoto; Awazawa, Motoharu; Katsuyama, Hisayuki; Kadowaki, Takashi] Natl Inst Hlth & Nutr, Div Appl Nutr, Tokyo 1628636, Japan; [Kubota, Tetsuya; Moroi, Masao; Sugi, Kaoru] Toho Univ, Ohashi Hosp, Div Cardiovasc Med, Tokyo 1538515, Japan; [Hasegawa, Chiaki; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3050006, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 1358550, Japan; [Terauchi, Yasuo] Yokohama City Univ, Sch Med, Dept Diabet & Endocrinol, Kanagawa 2360004, Japan; [Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Fac Med, Toyama 9300194, Japan	University of Tokyo; University of Tokyo; Hokkaido University; National Institute of Health & Nutrition - Japan; Toho University; University of Tsukuba; Japanese Foundation for Cancer Research; Yokohama City University; University of Toyama	Kadowaki, T (corresponding author), Univ Tokyo, Dept Diabet & Metab Dis, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kadowaki-3im@h.u-tokyo.ac.jp	Noda, Tetsuo/B-1667-2016; Terauchi, Yasuo/AAO-4347-2020; Kubota, Naoto/N-7892-2015; Watanabe, Taku/H-2083-2012	Watanabe, Taku/0000-0002-3195-2413	Ministry of Education, Culture, Sports, Science and Technology of Japan [16209030, 18209033]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan ( for the Translational Systems Biology and Medicine Initiative), Grant-in-Aid for Scientific Research in Priority Areas (A) 16209030 and (A) 18209033 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Addy C, 2008, CELL METAB, V7, P68, DOI 10.1016/j.cmet.2007.11.012; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Chin ML, 2008, ANESTH ANALG, V107, P4, DOI 10.1213/ane.0b013e3181788ca3; Costa B, 2007, BRIT J PHARMACOL, V150, P535, DOI 10.1038/sj.bjp.0707139; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cota D, 2003, INT J OBESITY, V27, P289, DOI 10.1038/sj.ijo.0802250; Croci T, 2003, BRIT J PHARMACOL, V140, P115, DOI 10.1038/sj.bjp.0705412; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gary-Bobo M, 2006, MOL PHARMACOL, V69, P471, DOI 10.1124/mol.105.015040; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Hada Y, 2007, BIOCHEM BIOPH RES CO, V356, P487, DOI 10.1016/j.bbrc.2007.03.004; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hosking RD, 2008, BRIT J ANAESTH, V101, P59, DOI 10.1093/bja/aen119; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Hurley RW, 2008, ANESTH ANALG, V107, P309, DOI 10.1213/01.ane.0b013e31816ba437; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Schafers M, 2003, EUR J NEUROSCI, V17, P791, DOI 10.1046/j.1460-9568.2003.02504.x; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Xie S, 2007, J CLIN PHARM THER, V32, P209, DOI 10.1111/j.1365-2710.2007.00817.x; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	52	40	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1803	1812		10.1074/jbc.M807120200	http://dx.doi.org/10.1074/jbc.M807120200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19008231	hybrid			2022-12-27	WOS:000262330100051
J	Pattanaik, P; Bethel, CR; Hujer, AM; Hujer, KM; Distler, AM; Taracila, M; Anderson, VE; Fritsche, TR; Jones, RN; Pagadala, SRR; van den Akker, F; Buynak, JD; Bonomo, RA				Pattanaik, Priyaranjan; Bethel, Christopher R.; Hujer, Andrea M.; Hujer, Kristine M.; Distler, Anne M.; Taracila, Magdalena; Anderson, Vernon E.; Fritsche, Thomas R.; Jones, Ronald N.; Pagadala, Sundar Ram Reddy; van den Akker, Focco; Buynak, John D.; Bonomo, Robert A.			Strategic Design of an Effective beta-Lactamase Inhibitor LN-1-255, A 6-ALKYLIDENE-2 '-SUBSTITUTED PENICILLIN SULFONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE BACTEREMIA; ESCHERICHIA-COLI; CLAVULANIC ACID; CLASS-A; RESISTANCE; SHV-1; INACTIVATION; TAZOBACTAM; COMMUNITY; CRYSTALLOGRAPHY	In an effort to devise strategies for overcoming bacterial beta-lactamases, we studied LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone inhibitor. By possessing a catecholic functionality that resembles a natural bacterial siderophore, LN-1-255 is unique among beta-lactamase inhibitors. LN-1-255 combined with piperacillin was more potent against Escherichia coli DH10B strains bearing bla(SHV) extended-spectrum and inhibitor-resistant beta-lactamases than an equivalent amount of tazobactam and piperacillin. In addition, LN-1-255 significantly enhanced the activity of ceftazidime and cefpirome against extended-spectrum cephalosporin and Sme-1 containing carbapenem-resistant clinical strains. LN-1-255 inhibited SHV-1 and SHV-2 beta-lactamases with nM affinity (K-I = 110 +/- 10 and 100 +/- 10 nM, respectively). When LN-1-255 inactivated SHV beta-lactamases, a single intermediate was detected by mass spectrometry. The crystal structure of LN-1-255 in complex with SHV-1 was determined at 1.55 angstrom resolution. Interestingly, this novel inhibitor forms a bicyclic aromatic intermediate with its carbonyl oxygen pointing out of the oxyanion hole and forming hydrogen bonds with Lys-234 and Ser-130 in the active site. Electron density for the "tail" of LN-1-255 is less ordered and modeled in two conformations. Both conformations have the LN-1-255 carboxyl group interacting with Arg-244, yet the remaining tails of the two conformations diverge. The observed presence of the bicyclic aromatic intermediate with its carbonyl oxygen positioned outside of the oxyanion hole provides a rationale for the stability of this inhibitory intermediate. The 2 '-substituted penicillin sulfone, LN-1-255, is proving to be an important lead compound for novel beta-lactamase inhibitor design.	[Pattanaik, Priyaranjan; Anderson, Vernon E.; van den Akker, Focco] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Distler, Anne M.; Bonomo, Robert A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Bethel, Christopher R.; Hujer, Andrea M.; Hujer, Kristine M.; Taracila, Magdalena; Bonomo, Robert A.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Res Serv, Cleveland, OH 44106 USA; [Pagadala, Sundar Ram Reddy; Buynak, John D.] So Methodist Univ, Dept Chem, Dallas, TX 75275 USA; [Fritsche, Thomas R.; Jones, Ronald N.] JMI Labs, N Liberty, IA 52317 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Southern Methodist University; JMI Laboratories	van den Akker, F (corresponding author), Case Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	fxv5@case.edu; robert.bonomo@med.va.gov	Anderson, Vernon/W-2673-2019	Anderson, Vernon Emmett/0000-0002-1699-7621	National Institutes of Health [R01 AI062968, RO1 AI063517-01]; Robert A. Welch Foundation [N-0871]; Geriatric Research Education and Clinical Care; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062968, R01AI063517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Geriatric Research Education and Clinical Care; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI062968 (to F. V. D. A.), RO1 AI063517-01 (to R. A. B.), and the Robert A. Welch Foundation (J. D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; supported by Grant N-0871 from the Robert A. Welch Foundation.; Supported by a grant from the Veterans Affairs Merit Review Program, Geriatric Research Education and Clinical Care.	Beharry Z, 2004, BIOCHEM BIOPH RES CO, V313, P541, DOI 10.1016/j.bbrc.2003.11.158; Bethel CR, 2006, ANTIMICROB AGENTS CH, V50, P4124, DOI 10.1128/AAC.00848-06; Bonomo RA, 2001, BBA-PROTEIN STRUCT M, V1547, P196, DOI 10.1016/S0167-4838(01)00175-3; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSH K, 1993, ANTIMICROB AGENTS CH, V37, P851, DOI 10.1128/AAC.37.4.851; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Buynak JD, 2000, BIOORG MED CHEM LETT, V10, P853, DOI 10.1016/S0960-894X(00)00098-6; Buynak JD, 2004, CURR MED CHEM, V11, P1951, DOI 10.2174/0929867043364847; Buynak JD, 1999, BIOORG MED CHEM LETT, V9, P1997, DOI 10.1016/S0960-894X(99)00325-X; Buynak JD, 2000, BIOORG MED CHEM LETT, V10, P847, DOI 10.1016/S0960-894X(00)00094-9; Calbo E, 2006, J ANTIMICROB CHEMOTH, V57, P780, DOI 10.1093/jac/dkl035; Chakraborty R, 2007, BIOMETALS, V20, P263, DOI 10.1007/s10534-006-9060-9; CHARNAS RL, 1978, BIOCHEMISTRY-US, V17, P2185, DOI 10.1021/bi00604a025; CHEN YL, 1986, TETRAHEDRON LETT, V27, P3449, DOI 10.1016/S0040-4039(00)84819-4; Crichlow GV, 2001, BIOCHEMISTRY-US, V40, P6233, DOI 10.1021/bi010131s; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOULDS CD, 1985, J CHEM SOC P1, P964; Helfand MS, 2006, CLIN INFECT DIS, V43, P1415, DOI 10.1086/508891; Helfand MS, 2003, J BIOL CHEM, V278, P52724, DOI 10.1074/jbc.M306059200; Hujer AM, 2002, ANTIMICROB AGENTS CH, V46, P3971, DOI 10.1128/AAC.46.12.3971-3977.2002; Hujer AM, 2001, BBA-PROTEIN STRUCT M, V1547, P37, DOI 10.1016/S0167-4838(01)00164-9; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Kalp M, 2007, J BIOL CHEM, V282, P21588, DOI 10.1074/jbc.C700080200; Kotapati S, 2005, J INFECTION, V51, P211, DOI 10.1016/j.jinf.2005.01.005; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padayatti PS, 2006, J AM CHEM SOC, V128, P13235, DOI 10.1021/ja063715w; Pagan-Rodriguez D, 2004, J BIOL CHEM, V279, P19494, DOI 10.1074/jbc.M311669200; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Paterson DL, 2004, CLIN INFECT DIS, V39, P31, DOI 10.1086/420816; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pitout JDD, 2005, J CLIN MICROBIOL, V43, P2844, DOI 10.1128/JCM.43.6.2844-2849.2005; Rice LB, 2000, ANTIMICROB AGENTS CH, V44, P362, DOI 10.1128/AAC.44.2.362-367.2000; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P104, DOI 10.1111/j.1469-0691.2007.01866.x; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Swaren P, 1999, BIOCHEMISTRY-US, V38, P9570, DOI 10.1021/bi990758z; Thomson JM, 2007, BIOCHEMISTRY-US, V46, P11361, DOI 10.1021/bi700792a; Thomson JM, 2006, J BIOL CHEM, V281, P26734, DOI 10.1074/jbc.M603222200	43	39	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					945	953		10.1074/jbc.M806833200	http://dx.doi.org/10.1074/jbc.M806833200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18955486	Green Published, hybrid			2022-12-27	WOS:000262122900030
J	Pu, YM; Garfield, SH; Kedei, N; Blumberg, PM				Pu, Yongmei; Garfield, Susan H.; Kedei, Noemi; Blumberg, Peter M.			Characterization of the Differential Roles of the Twin C1a and C1b Domains of Protein Kinase C delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; 12-MYRISTATE 13-ACETATE; INDUCED TRANSLOCATION; THERAPEUTIC TARGET; DOWN-REGULATION; NIH 3T3-CELLS; DIACYLGLYCEROL; ACTIVATION; LIGANDS; PKC	Classic and novel protein kinase C (PKC) isozymes contain two zinc finger motifs, designated "C1a" and "C1b" domains, which constitute the recognition modules for the second messenger diacylglycerol (DAG) or the phorbol esters. However, the individual contributions of these tandem C1 domains to PKC function and, reciprocally, the influence of protein context on their function remain uncertain. In the present study, we prepared PKC delta constructs in which the individual C1a and C1b domains were deleted, swapped, or substituted for one another to explore these issues. As isolated fragments, both the delta C1a and delta C1b domains potently bound phorbol esters, but the binding of [H-3] phorbol 12,13-dibutyrate ([H-3]PDBu) by the delta C1a domain depended much more on the presence of phosphatidylserine than did that of the delta C1b domain. In intact PKC delta, the delta C1b domain played the dominant role in [H-3]PDBu binding, membrane translocation, and down-regulation. A contribution from the delta C1a domain was nonetheless evident, as shown by retention of [H-3]PDBu binding at reduced affinity, by increased [H-3]PDBu affinity upon expression of a second delta C1a domain substituting for the delta C1b domain, and by loss of persistent plasma membrane translocation for PKC delta expressing only the delta C1b domain, but its contribution was less than predicted from the activity of the isolated domain. Switching the position of the delta C1b domain to the normal position of the delta C1a domain (or vice versa) had no apparent effect on the response to phorbol esters, suggesting that the specific position of the C1 domain within PKC delta was not the primary determinant of its activity.	[Garfield, Susan H.; Blumberg, Peter M.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Pu, Yongmei; Kedei, Noemi; Blumberg, Peter M.] Lab Canc Biol & Genet, Mol Mech Tumor Promot Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Blumberg, PM (corresponding author), NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bldg 37,Rm 4048,37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.	blumberp@dc37a.nci.nih.gov			National Institutes of Health; NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [Z01BC005270, ZICBC010858, ZIABC005270, Z01BC010858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research.	AHMED S, 1993, J BIOL CHEM, V268, P10709; Anderson PW, 2007, CURR OPIN NEPHROL HY, V16, P397, DOI 10.1097/MNH.0b013e3281ead025; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Bogi K, 1999, FEBS LETT, V456, P27, DOI 10.1016/S0014-5793(99)00927-8; Bogi K, 1998, CANCER RES, V58, P1423; Braun DC, 2005, MOL CANCER THER, V4, P141; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; BURNS DJ, 1991, J BIOL CHEM, V266, P18330; Chen D, 2007, J BIOL CHEM, V282, P33776, DOI 10.1074/jbc.M703320200; Choi SH, 2008, J BIOL CHEM, V283, P10543, DOI 10.1074/jbc.M707463200; Choi SH, 2006, CANCER RES, V66, P7261, DOI 10.1158/0008-5472.CAN-05-4177; Choi Y, 2007, J MED CHEM, V50, P3465, DOI 10.1021/jm0702579; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Fields Alan P, 2003, Methods Mol Biol, V233, P519; Giorgione J, 2003, BIOCHEMISTRY-US, V42, P11194, DOI 10.1021/bi0350046; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HANNUN YA, 1986, J BIOL CHEM, V261, P9341; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; IKKAWA U, 1983, J BIOL CHEM, V258, P11442; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Mach UR, 2006, CHEMMEDCHEM, V1, P307, DOI 10.1002/cmdc.200500068; Marquez VE, 2003, ACCOUNTS CHEM RES, V36, P434, DOI 10.1021/ar020124b; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; Mosior M, 1996, BIOCHEMISTRY-US, V35, P1612, DOI 10.1021/bi952031q; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Nowak I, 2007, CURR TOP MED CHEM, V7, P355, DOI 10.2174/156802607779941260; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; Pellecchia M, 2004, CURR PHARM DESIGN, V10, P1371, DOI 10.2174/1381612043384907; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Rozengurt E, 1997, BIOCHEM SOC T, V25, P565, DOI 10.1042/bst0250565; SHIEH HL, 1995, MOL CARCINOGEN, V12, P166, DOI 10.1002/mc.2940120308; SLATER SJ, 1994, J BIOL CHEM, V269, P17160; Slater SJ, 1996, J BIOL CHEM, V271, P4627; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; SZALLASI Z, 1994, J BIOL CHEM, V269, P2118; SZALLASI Z, 1994, MOL PHARMACOL, V46, P840; Szallasi Z, 1996, J BIOL CHEM, V271, P18299, DOI 10.1074/jbc.271.31.18299; Teicher BA, 2006, CLIN CANCER RES, V12, P5336, DOI 10.1158/1078-0432.CCR-06-0945; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	46	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1302	1312		10.1074/jbc.M804796200	http://dx.doi.org/10.1074/jbc.M804796200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001377	hybrid, Green Published			2022-12-27	WOS:000262122900065
J	Wang, JH; Bian, CJ; Li, J; Couch, FJ; Wu, KJ; Zhao, RC				Wang, Jinhua; Bian, Chunjing; Li, Jing; Couch, Fergus J.; Wu, Kangjian; Zhao, Robert Chunhua			Poly(ADP-ribose) Polymerase-1 Down-regulates BRCA2 Expression through the BRCA2 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSCEPTIBILITY GENE BRCA2; BREAST-CANCER; OVARIAN CANCERS; DNA-DAMAGE; KAPPA-B; BINDING; PROTEIN; TRANSCRIPTION; COACTIVATOR; MUTATIONS	Expression of the BRCA2 tumor suppressor gene is tightly linked to its roles in DNA damage repair and maintenance of chromosomal stability and genomic integrity. Three transcription factors that activate (USF, NF-kappa B, and Elf1) and a single factor that represses (SLUG) BRCA2 promoter activity have been reported. In addition, a 67-bp region (-582 to -516) associated with inhibition of promoter activity has been identified. However, it remains unclear how the 67-bp region contributes to regulation of BRCA2 expression. Here, we describe the affinity purification of a 120-kDa protein that binds to a silencer-binding region within the 67-bp repression region of the BRCA2 promoter. Mass spectrometry revealed the identity of the protein as poly-(ADP-ribose) polymerase-1 (Parp-1). Gel shift, antibody super-shift, and chromatin immunoprecipitation (ChIP) assays demonstrated that Parp-1 is associated with the BRCA2 promoter both in vitro and in vivo. Furthermore, Parp-1 inhibitors (either 3-AB or NU1025) and Parp-1 gene specific siRNA resulted in increased levels of endogenous BRCA2 expression. Inhibition of Parp-1 activity (by 3-AB) reduced histone 3 lysine 9 acetylation and blocked Parp-1 binding to the BRCA2 promoter. These results indicate that Parp-1 down-regulates BRCA2 expression through an interaction with a repression region of the BRCA2 promoter.	[Wang, Jinhua; Bian, Chunjing; Li, Jing; Zhao, Robert Chunhua] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Wang, Jinhua; Bian, Chunjing; Li, Jing; Zhao, Robert Chunhua] Chinese Acad Med Sci, Sch Basic Med, Ctr Excellence Tissue Engn, Beijing 100730, Peoples R China; [Couch, Fergus J.; Wu, Kangjian] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Wang, Jinhua; Bian, Chunjing; Li, Jing; Zhao, Robert Chunhua] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Mayo Clinic; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, KJ (corresponding author), Room 258-14 Bldg,180 Wyeth Res 401 N Middletown R, Pearl River, NY 10965 USA.	wuk@wyeth.com; chunhuaz@public.tpt.tj.cn			National Institutes of Health [R01CA116167]; NCI; Ruth L. Kirschstein National Research Training Award; Ministry of Science and Technology of PR China [2006AA02A109]; NATIONAL CANCER INSTITUTE [R01CA116167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth L. Kirschstein National Research Training Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of PR China(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health R01 Grant CA116167 and NCI Sponsored Program in Research Excellence (SPORE) in Breast Cancer to the Mayo Clinic (to F.J.C.) and a Ruth L. Kirschstein National Research Training Award (to K.W.). This work was also supported from the "863 Projects" of Ministry of Science and Technology of PR China Grant No. 2006AA02A109 (to R.C.Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambrose HE, 2007, ONCOGENE, V26, P6244, DOI 10.1038/sj.onc.1210434; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Amiri KI, 2006, ONCOGENE, V25, P7714, DOI 10.1038/sj.onc.1209751; Anderson MG, 2000, J VIROL, V74, P2169, DOI 10.1128/JVI.74.5.2169-2177.2000; Bertwistle D, 1997, CANCER RES, V57, P5485; BONGGUN JU, 2006, SCIENCE, V312, P1798; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Collins N, 1997, BRIT J CANCER, V76, P1150, DOI 10.1038/bjc.1997.526; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davis PL, 1999, ONCOGENE, V18, P6000, DOI 10.1038/sj.onc.1202990; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Easton D, 1997, NAT GENET, V16, P210, DOI 10.1038/ng0797-210; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Soldatenkov VA, 2002, J BIOL CHEM, V277, P665, DOI 10.1074/jbc.M108551200; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teng DHF, 1996, NAT GENET, V13, P241, DOI 10.1038/ng0696-241; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wu K, 2000, J BIOL CHEM, V275, P35548, DOI 10.1074/jbc.M004390200; Wu KJ, 2003, J BIOL CHEM, V278, P15652, DOI 10.1074/jbc.M211297200; Zhang Z, 2002, VIROLOGY, V296, P107, DOI 10.1006/viro.2002.1385	33	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36249	36256		10.1074/jbc.M803693200	http://dx.doi.org/10.1074/jbc.M803693200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990703	Green Published, hybrid			2022-12-27	WOS:000261840500020
J	Chou, CJ; Herman, D; Gottesfeld, JM				Chou, C. James; Herman, David; Gottesfeld, Joel M.			Pimelic Diphenylamide 106 Is a Slow, Tight-binding Inhibitor of Class I Histone Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; CATALYTIC-ACTIVITY; FRIEDREICH ATAXIA; HDAC INHIBITORS; FAMILY; CANCER; ASSAY; SUPPRESSES; ACETYLASES; CHROMATIN	Histone deacetylase (HDAC) inhibitors, including various benzamides and hydroxamates, are currently in clinical development for a broad range of human diseases, including cancer and neurodegenerative diseases. We recently reported the identification of a family of benzamide-type HDAC inhibitors that are relatively non-toxic compared with the hydroxamates. Members of this class of compounds have shown efficacy in cell-based and mouse models for the neurodegenerative diseases Friedreich ataxia and Huntington disease. Considerable differences in IC50 values for the various HDAC enzymes have been reported for many of the HDAC inhibitors, leading to confusion as to the HDAC isotype specificities of these compounds. Here we show that a benzamide HDAC inhibitor, a pimelic diphenylamide (106), is a class I HDAC inhibitor, demonstrating no activity against class II HDACs. 106 is a slow, tight-binding inhibitor of HDACs 1, 2, and 3, although inhibition for these enzymes occurs through different mechanisms. Inhibitor 106 also has preference toward HDAC3 with K-i of similar to 14 nM, 15 times lower than the Ki for HDAC1. In comparison, the hydroxamate suberoylanilide hydroxamic acid does not discriminate between these enzymes and exhibits a fast-on/fast-off inhibitory mechanism. These observations may explain a paradox involving the relative activities of pimelic diphenylamides versus hydroxamates as gene activators.	[Chou, C. James; Herman, David; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Gottesfeld, JM (corresponding author), 10550 N Torrey Pines Rd,MB 27, La Jolla, CA 92037 USA.	joelg@scripps.edu	Chou, C. James/I-6563-2012	Gottesfeld, Joel/0000-0002-4643-5777	National Institutes of Health [R21-NS055781]; Repligen Corporation, Waltham, MA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Repligen Corporation, Waltham, MA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-NS055781. This work was also supported by Repligen Corporation, Waltham, MA. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beckers T, 2007, INT J CANCER, V121, P1138, DOI 10.1002/ijc.22751; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bonfils C, 2008, CLIN CANCER RES, V14, P3441, DOI 10.1158/1078-0432.CCR-07-4427; Butler LM, 2000, CANCER RES, V60, P5165; CORNISHBOWDEN A, 1975, BIOCHEM J, V149, P305, DOI 10.1042/bj1490305; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DUGGLEBY RG, 1982, BIOCHEMISTRY-US, V21, P3364, DOI 10.1021/bi00257a018; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hu ED, 2003, J PHARMACOL EXP THER, V307, P720, DOI 10.1124/jpet.103.055541; Itoh Y, 2008, CURR PHARM DESIGN, V14, P529; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones P, 2008, BIOORG MED CHEM LETT, V18, P3456, DOI 10.1016/j.bmcl.2008.02.026; Jones P, 2008, BIOORG MED CHEM LETT, V18, P1814, DOI 10.1016/j.bmcl.2008.02.025; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Koh CY, 2007, J BIOL CHEM, V282, P29101, DOI 10.1074/jbc.M705600200; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Marmorstein R, 2001, NAT REV MOL CELL BIO, V2, P422, DOI 10.1038/35073047; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Siliphaivanh P, 2007, BIOORG MED CHEM LETT, V17, P4619, DOI 10.1016/j.bmcl.2007.05.080; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thiel G, 2004, EUR J BIOCHEM, V271, P2855, DOI 10.1111/j.1432-1033.2004.04174.x; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; TORNHEIM K, 1994, ANAL BIOCHEM, V221, P53, DOI 10.1006/abio.1994.1377; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Wegener D, 2003, ANAL BIOCHEM, V321, P202, DOI 10.1016/S0003-2697(03)00426-3; Wegener D, 2003, CHEM BIOL, V10, P61, DOI 10.1016/S1074-5521(02)00305-8; Wong JC, 2003, J AM CHEM SOC, V125, P5586, DOI 10.1021/ja0341440	37	156	167	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35402	35409		10.1074/jbc.M807045200	http://dx.doi.org/10.1074/jbc.M807045200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18953021	hybrid, Green Published			2022-12-27	WOS:000261687900011
J	Blouse, GE; Botkjaer, KA; Deryugina, E; Byszuk, AA; Jensen, JM; Mortensen, KK; Quigley, JP; Andreasen, PA				Blouse, Grant E.; Botkjaer, Kenneth A.; Deryugina, Elena; Byszuk, Aleksandra A.; Jensen, Janni M.; Mortensen, Kim K.; Quigley, James P.; Andreasen, Peter A.			A Novel Mode of Intervention with Serine Protease Activity TARGETING ZYMOGEN ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR; IN-VIVO; UROKINASE RECEPTOR; MONOCLONAL-ANTIBODIES; FIBROSARCOMA CELLS; ALLOSTERIC SITE; DOWN-REGULATION; INHIBITORS; SUBSTRATE; PROUROKINASE	Serine proteases are secreted from cells as single-chain zymogens, typically having activities orders of magnitude lower than those of the mature two-chain enzymes. Activation occurs by a conformational change initiated by cleavage of a specific peptide bond. We have derived a monoclonal antibody (mAb-112) which binds with subnanomolar affinity to pro-uPA, the zymogen form of urokinase-type plasminogen activator (uPA). We mapped the epitope of the antibody to the autolysis loop, one of the structural elements known to change conformation during zymogen activation. A mechanistic evaluation with biophysical methods elucidated a novel bifunctional inhibitory mechanism whereby mAb-112 not only delays the proteolytic conversion of single-chain pro-uPA into the two-chain form but also subsequently averts the conformational transition to a mature protease by sequestering the two-chain form in a zymogen-like, noncatalytic state. Functional studies employing two variants of human HT-1080 cells, exhibiting high and low levels of dissemination in a chorioallantoic membrane assay, demonstrate that mAb-112 is an effective inhibitor of tumor cell intravasation. These findings show that pharmacological interference with zymogen activation is a plausible and robust means to regulate uPA activity and the downstream effects of plasminogen activation in the spread of cancer and other processes of pathological tissue remodeling. A strategy that targets regions related to pro-enzyme activation likely provide a unique inhibitor-protease interaction surface and is, thus, expected to enhance the chances of engineering high inhibitor specificity. Our results provide new information about the structural flexibility underlying the equilibrium between active and inactive forms of serine proteases.	[Blouse, Grant E.; Botkjaer, Kenneth A.; Byszuk, Aleksandra A.; Jensen, Janni M.; Mortensen, Kim K.; Andreasen, Peter A.] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Deryugina, Elena; Quigley, James P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Aarhus University; Scripps Research Institute	Andreasen, PA (corresponding author), Univ Aarhus, Dept Mol Biol, 10C Gustav Wieds Vej, DK-8000 Aarhus C, Denmark.	pa@mb.au.dk			National Institutes of Health [CA55852, CA105412]; Danish Cancer Society; Danish Cancer Research Foundation; Danish Research Agency; Carlsberg Foundation; Novo-Nordisk Foundation; European Union FP6 [LSHC-CT-2003 h503297]; Danish Heart Association; NATIONAL CANCER INSTITUTE [R01CA105412, R01CA055852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; Danish Research Agency; Carlsberg Foundation(Carlsberg Foundation); Novo-Nordisk Foundation(Novo Nordisk Foundation); European Union FP6(European Commission); Danish Heart Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA55852 and CA105412 (to J.P.Q.). This work was also supported by grants from the Danish Cancer Society, the Danish Cancer Research Foundation, the Danish Research Agency, the Carlsberg Foundation, the Novo-Nordisk Foundation, European Union FP6 Contract LSHC-CT-2003 h503297 (the Cancer Degradome) (to P. A. A.), and the Danish Heart Association (to G. E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAMOWITZ N, 1967, BIOCHEM BIOPH RES CO, V29, P862, DOI 10.1016/0006-291X(67)90299-9; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Behrendt N, 2003, BIOCHEM J, V371, P277, DOI 10.1042/BJ20021508; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Creighton T. E., 1993, PROTEINS STRUCTURES, P419; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Egelund R, 2001, EUR J BIOCHEM, V268, P673, DOI 10.1046/j.1432-1327.2001.01921.x; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; JESPERSEN MH, 1993, SCAND J CLIN LAB INV, V53, P639; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Knoop A, 1998, BRIT J CANCER, V77, P932, DOI 10.1038/bjc.1998.154; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; List K, 2000, BIOCHEMISTRY-US, V39, P508, DOI 10.1021/bi991701f; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lund IK, 2008, J BIOL CHEM, V283, P32506, DOI 10.1074/jbc.M801924200; LUND LR, 1988, MOL CELL ENDOCRINOL, V60, P43, DOI 10.1016/0303-7207(88)90118-9; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Madsen MA, 2006, J BIOL CHEM, V281, P15997, DOI 10.1074/jbc.M601223200; Moran P, 2006, J BIOL CHEM, V281, P30439, DOI 10.1074/jbc.M605440200; NIELSEN LS, 1986, THROMB HAEMOSTASIS, V55, P206; OSSOWSKI L, 1980, CANCER RES, V40, P2300; OSSOWSKI L, 1988, J CELL BIOL, V107, P2437, DOI 10.1083/jcb.107.6.2437; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; Panizzi P, 2006, J BIOL CHEM, V281, P1169, DOI 10.1074/jbc.M507955200; Pasternak A, 1998, BIOCHEMISTRY-US, V37, P16201, DOI 10.1021/bi980951d; Petersen HH, 2001, EUR J BIOCHEM, V268, P4430, DOI 10.1046/j.1432-1327.2001.02365.x; PICONE R, 1989, J CELL BIOL, V108, P693, DOI 10.1083/jcb.108.2.693; Rockway TW, 2002, CURR PHARM DESIGN, V8, P2541, DOI 10.2174/1381612023392676; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9; Stoppelli M. Patrizia, 2008, P721, DOI 10.1007/978-0-387-69057-5_35	37	34	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4647	4657		10.1074/jbc.M804922200	http://dx.doi.org/10.1074/jbc.M804922200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19047064	Green Published, hybrid			2022-12-27	WOS:000263134400064
J	Taleux, N; Guigas, B; Dubouchaud, H; Moreno, M; Weitzel, JM; Goglia, F; Favier, R; Leverve, XM				Taleux, Nellie; Guigas, Bruno; Dubouchaud, Herve; Moreno, Maria; Weitzel, Joachim M.; Goglia, Fernando; Favier, Roland; Leverve, Xavier M.			High Expression of Thyroid Hormone Receptors and Mitochondrial Glycerol-3-phosphate Dehydrogenase in the Liver Is Linked to Enhanced Fatty Acid Oxidation in Lou/C, a Rat Strain Resistant to Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL-PHOSPHATE DEHYDROGENASE; AGE-RELATED-CHANGES; MACRONUTRIENT INTAKE; PARENCHYMAL-CELLS; GENE-EXPRESSION; WISTAR RATS; METABOLISM; EXERCISE; MODEL; GLUCONEOGENESIS	Besides its well recognized role in lipid and carbohydrate metabolisms, glycerol is involved in the regulation of cellular energy homeostasis via glycerol-3-phosphate, a key metabolite in the translocation of reducing power across the mitochondrial inner membrane with mitochondrial glycerol-3-phosphate dehydrogenase. Here, we report a high rate of gluconeogenesis from glycerol and fatty acid oxidation in hepatocytes from Lou/C, a peculiar rat strain derived from Wistar, which is resistant to age- and diet-related obesity. This feature, associated with elevated cellular respiration and cytosolic ATP/ADP and NAD(+)/NADH ratios, was linked to a high expression and activity of mitochondrial glycerol-3-phosphate dehydrogenase. Interestingly, this strain exhibited high expression and protein content of thyroid hormone receptor, whereas circulating thyroid hormone levels were slightly decreased and hepatic thyroid hormone carrier MCT-8 mRNA levels were not modified. We propose that an enhanced liver thyroid hormone receptor in Lou/C may explain its unique resistance to obesity by increasing fatty acid oxidation and lowering liver oxidative phosphorylation stoichiometry at the translocation of reducing power into mitochondria.	[Taleux, Nellie; Dubouchaud, Herve; Favier, Roland; Leverve, Xavier M.] Univ Grenoble 1, INSERM, Bioenerget Fondamentale & Appl U884, F-38041 Grenoble 9, France; [Guigas, Bruno] Univ Catholique Louvain, Hormone & Metab Res Unit, B-1200 Brussels, Belgium; [Moreno, Maria; Goglia, Fernando] Univ Sannio, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy; [Weitzel, Joachim M.] Charite Univ Med Berlin, Inst Expt Endocrinol, D-10117 Berlin, Germany; [Guigas, Bruno] Inst Cellular Pathol, B-1200 Brussels, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Catholique Louvain; University of Sannio; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Leverve, XM (corresponding author), Univ Grenoble 1, INSERM, Bioenerget Fondamentale & Appl U884, BP 53X, F-38041 Grenoble 9, France.	xavier.leverve@ujf-grenoble.fr	Guigas, Bruno/M-2515-2015	Guigas, Bruno/0000-0002-8856-5799; Weitzel, Joachim/0000-0002-4073-6691; MORENO, Maria/0000-0002-6218-5501; GOGLIA, Fernando/0000-0003-0468-9645	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by a grant from INSERM. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alliot J, 2002, J GERONTOL A-BIOL, V57, pB312, DOI 10.1093/gerona/57.8.B312; BAZIN H, 1990, RAT HYBRIDOMAS RAT M, P43; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN; BERRY MN, 1973, EUR J BIOCHEM, V33, P407, DOI 10.1111/j.1432-1033.1973.tb02697.x; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Boghossian S, 2000, PHYSIOL BEHAV, V69, P231, DOI 10.1016/S0031-9384(99)00233-4; Brown LJ, 2002, J BIOL CHEM, V277, P32899, DOI 10.1074/jbc.M202409200; Couturier K, 2004, INT J OBESITY, V28, P972, DOI 10.1038/sj.ijo.0802717; Couturier K, 2002, OBES RES, V10, P188, DOI 10.1038/oby.2002.29; DEBEER LJ, 1974, EUR J BIOCHEM, V47, P591, DOI 10.1111/j.1432-1033.1974.tb03730.x; ESTABROOK RW, 1958, J BIOL CHEM, V233, P1014; Garait B, 2005, FREE RADICAL BIO MED, V39, P1249, DOI 10.1016/j.freeradbiomed.2005.06.026; GROEN AK, 1983, J BIOL CHEM, V258, P4346; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; KLINGENBERG M, 1970, EUR J BIOCHEM, V13, P247, DOI 10.1111/j.1432-1033.1970.tb00924.x; KLINGENBERG M, 1959, BIOCHEM Z, V331, P486; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Kuriyama H, 2002, DIABETES, V51, P2915, DOI 10.2337/diabetes.51.10.2915; Lacraz G, 2008, INT J OBESITY, V32, P629, DOI 10.1038/sj.ijo.0803779; LEE YP, 1965, J BIOL CHEM, V240, P1427; LEVERVE XM, 1986, EUR J BIOCHEM, V155, P551, DOI 10.1111/j.1432-1033.1986.tb09523.x; Leverve XM, 2001, IUBMB LIFE, V52, P221; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mitchell SE, 2006, J ENDOCRINOL, V190, P571, DOI 10.1677/joe.1.06576; NEWBY FD, 1990, AM J PHYSIOL, V259, pR1117, DOI 10.1152/ajpregu.1990.259.6.R1117; Nguyen NHT, 2003, J NEUROCHEM, V85, P831, DOI 10.1046/j.1471-4159.2003.01762.x; Nogueira V, 2001, J BIOL CHEM, V276, P46104, DOI 10.1074/jbc.M107425200; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Rauchova H, 2003, ACTA BIOCHIM POL, V50, P405; ROBBINS BL, 1991, LIFE SCI, V48, P1075, DOI 10.1016/0024-3205(91)90509-A; RUTTER GA, 1992, BIOCHIM BIOPHYS ACTA, V1175, P107, DOI 10.1016/0167-4889(92)90016-5; Servais S, 2003, FREE RADICAL BIO MED, V35, P24, DOI 10.1016/S0891-5849(03)00177-1; Sibille B, 2001, BIOCHEM J, V355, P231, DOI 10.1042/0264-6021:3550231; SIBILLE B, 1995, EUR J BIOCHEM, V231, P498, DOI 10.1111/j.1432-1033.1995.tb20724.x; STIRLING JL, 1968, NATURE, V220, P801, DOI 10.1038/220801a0; STOCK MJ, 1978, J APPL PHYSIOL, V45, P350, DOI 10.1152/jappl.1978.45.3.350; TALEUX N, 2007, INT J OBES LOND, V32, P639; VANDERMEER R, 1976, FEBS LETT, V67, P36, DOI 10.1016/0014-5793(76)80865-4; Veyrat-Durebex C, 1998, MECH AGEING DEV, V103, P223, DOI 10.1016/S0047-6374(98)00013-X; Veyrat-Durebex C, 1997, PHYSIOL BEHAV, V62, P1273, DOI 10.1016/S0031-9384(97)00304-1; Weitzel JM, 2001, EUR J BIOCHEM, V268, P4095, DOI 10.1046/j.1432-1327.2001.02332.x; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Zuurendonk P F, 1979, Methods Enzymol, V56, P207	44	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4308	4316		10.1074/jbc.M806187200	http://dx.doi.org/10.1074/jbc.M806187200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19049970	hybrid			2022-12-27	WOS:000263134400029
J	Inglis, KJ; Chereau, D; Brigham, EF; Chiou, SS; Schobel, S; Frigon, NL; Yu, M; Caccavello, RJ; Nelson, S; Motter, R; Wright, S; Chian, D; Santiago, P; Soriano, F; Ramos, C; Powell, K; Goldstein, JM; Babcock, M; Yednock, T; Bard, F; Basi, GS; Sham, H; Chilcote, TJ; McConlogue, L; Griswold-Prenner, I; Anderson, JP				Inglis, Kelly J.; Chereau, David; Brigham, Elizabeth F.; Chiou, San-San; Schoebel, Susanne; Frigon, Normand L.; Yu, Mei; Caccavello, Russell J.; Nelson, Seth; Motter, Ruth; Wright, Sarah; Chian, David; Santiago, Pamela; Soriano, Ferdie; Ramos, Carla; Powell, Kyle; Goldstein, Jason M.; Babcock, Michael; Yednock, Ted; Bard, Frederique; Basi, Guriqbal S.; Sham, Hing; Chilcote, Tamie J.; McConlogue, Lisa; Griswold-Prenner, Irene; Anderson, John P.			Polo-like Kinase 2 (PLK2) Phosphorylates alpha-Synuclein at Serine 129 in Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; LEWY BODIES; SYNAPTIC PLASTICITY; PROTEIN-KINASE; DEMENTIA; MUTATION; SER-129; IDENTIFICATION; NEUROTOXICITY; DUPLICATION	Several neurological diseases, including Parkinson disease and dementia with Lewy bodies, are characterized by the accumulation of alpha-synuclein phosphorylated at Ser-129 (p-Ser-129). The kinase or kinases responsible for this phosphorylation have been the subject of intense investigation. Here we submit evidence that polo-like kinase 2 (PLK2, also known as serum-inducible kinase or SNK) is a principle contributor to alpha-synuclein phosphorylation at Ser-129 in neurons. PLK2 directly phosphorylates alpha-synuclein at Ser-129 in an in vitro biochemical assay. Inhibitors of PLK kinases inhibited alpha-synuclein phosphorylation both in primary cortical cell cultures and in mouse brain in vivo. Finally, specific knockdown of PLK2 expression by transduction with short hairpin RNA constructs or by knock-out of the plk2 gene reduced p-Ser-129 levels. These results indicate that PLK2 plays a critical role in alpha-synuclein phosphorylation in central nervous system.	[Inglis, Kelly J.; Chereau, David; Brigham, Elizabeth F.; Chiou, San-San; Schoebel, Susanne; Frigon, Normand L.; Yu, Mei; Caccavello, Russell J.; Nelson, Seth; Motter, Ruth; Wright, Sarah; Chian, David; Santiago, Pamela; Soriano, Ferdie; Ramos, Carla; Powell, Kyle; Goldstein, Jason M.; Babcock, Michael; Yednock, Ted; Bard, Frederique; Basi, Guriqbal S.; Sham, Hing; Chilcote, Tamie J.; McConlogue, Lisa; Griswold-Prenner, Irene; Anderson, John P.] Elan Pharmaceut Inc, San Francisco, CA 94080 USA		Anderson, JP (corresponding author), Elan Pharmaceut Inc, 800 Gateway Blvd, San Francisco, CA 94080 USA.	john.p.anderson@elan.com		Goldstein, Jason/0000-0003-1558-1832; Wright, Sarah/0000-0002-3156-3792				Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Baba M, 1998, AM J PATHOL, V152, P879; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; CHILCOTE TJ, 2007, Patent No. 2007089862; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Mirzaei H, 2006, ANAL CHEM, V78, P2422, DOI 10.1021/ac051978n; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	33	166	172	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2598	2602		10.1074/jbc.C800206200	http://dx.doi.org/10.1074/jbc.C800206200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19004816	Green Published, hybrid			2022-12-27	WOS:000262700900002
J	Kos, V; Cuthbertson, L; Whitfield, C				Kos, Veronica; Cuthbertson, Leslie; Whitfield, Chris			The Klebsiella pneumoniae O2a Antigen Defines a Second Mechanism for O Antigen ATP-binding Cassette Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; O1K2 NCTC-5055 LIPOPOLYSACCHARIDE; GRAM-NEGATIVE BACTERIA; VIBRIO-CHOLERAE O1; RFB GENE-CLUSTER; D-GALACTAN-I; OUTER-MEMBRANE; POLYSIALIC ACID; POLYSACCHARIDE EXPORT; CAMPYLOBACTER-JEJUNI	An ATP-binding cassette (ABC) transporter-dependent mechanism is responsible for the biosynthesis of polysaccharide O antigens in the lipopolysaccharides of many Gram-negative bacteria. In the Escherichia coli O9a prototype, addition of a non-reducing terminal modification regulates chain length. The terminal residue is an export signal recognized by the nucleotide-binding domain component of the cognate ABC transporter. The Klebsiella pneumoniae O2a antigen lacks a capping residue, and the corresponding nucleotide-binding protein does not contain a separate substrate-binding domain. Unlike the O9a transporter, the O2a transporter can export heterologous O antigens. Export of the O2a antigen is obligatorily coupled to chain elongation, and the O2a transporter is essential for establishing O antigen chain length. The E. coli O9a transporter operates after chain length has been determined. Furthermore biosynthesis and export can be uncoupled. O antigen chain length is a critical element in the ability of lipopolysaccharides to confer resistance to complement-mediated killing. This study establishes that two distinctly different approaches are available for the regulation of O antigen chain length and export via an ABC transporter.	[Kos, Veronica; Cuthbertson, Leslie; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research (CIHR) (to C. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Bliss JM, 1996, MOL MICROBIOL, V21, P221, DOI 10.1046/j.1365-2958.1996.6461357.x; Bliss JM, 1996, GLYCOBIOLOGY, V6, P445, DOI 10.1093/glycob/6.4.445; BRONNER D, 1994, MOL MICROBIOL, V14, P505, DOI 10.1111/j.1365-2958.1994.tb02185.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CLARKE BR, 1995, J BACTERIOL, V177, P5411, DOI 10.1128/jb.177.19.5411-5418.1995; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; FITZGERA.DK, 1971, EUR J BIOCHEM, V24, P222, DOI 10.1111/j.1432-1033.1971.tb19674.x; Guan S, 2001, J BACTERIOL, V183, P3318, DOI 10.1128/JB.183.11.3318-3327.2001; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hisatsune K, 1996, MICROBIOL IMMUNOL, V40, P621, DOI 10.1111/j.1348-0421.1996.tb01119.x; HISATSUNE K, 1993, BIOCHEM BIOPH RES CO, V190, P302, DOI 10.1006/bbrc.1993.1046; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; KELLY RF, 1993, MOL MICROBIOL, V10, P615, DOI 10.1111/j.1365-2958.1993.tb00933.x; Kelly RF, 1996, J BACTERIOL, V178, P5205, DOI 10.1128/jb.178.17.5205-5214.1996; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; KOL O, 1992, CARBOHYD RES, V236, P339, DOI 10.1016/0008-6215(92)85028-X; KOL O, 1991, CARBOHYD RES, V217, P117, DOI 10.1016/0008-6215(91)84122-U; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; Lo RYC, 2001, INFECT IMMUN, V69, P4458, DOI 10.1128/IAI.69.7.4458-4464.2001; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; MEIERDIETER U, 1992, J BIOL CHEM, V267, P746; Miller J. H., 1972, EXPT MOL GENETICS, P431; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rick P, 1996, ESCHERICHIA COLI SAL, P104; RICK PD, 1994, J BACTERIOL, V176, P2877, DOI 10.1128/JB.176.10.2877-2884.1994; Rocchetta HL, 1997, J BACTERIOL, V179, P4713, DOI 10.1128/jb.179.15.4713-4724.1997; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Sambrook J., 1989, MOL CLONING LAB MANU; SCHNAITMAN CA, 1990, J BACTERIOL, V172, P5511, DOI 10.1128/jb.172.9.5511-5513.1990; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Steenbergen SM, 2008, MOL MICROBIOL, V68, P1252, DOI 10.1111/j.1365-2958.2008.06231.x; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; STORM DR, 1973, J BIOL CHEM, V248, P3940; STROEHER UH, 1992, P NATL ACAD SCI USA, V89, P2566, DOI 10.1073/pnas.89.7.2566; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Whitfield C, 1997, MOL MICROBIOL, V23, P629, DOI 10.1046/j.1365-2958.1997.2571614.x; WHITFIELD C, 1991, J BACTERIOL, V173, P1420, DOI 10.1128/jb.173.4.1420-1431.1991; WHITFIELD C, 1992, J BACTERIOL, V174, P4913, DOI 10.1128/JB.174.15.4913-4919.1992; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WHTIFIELD C, 1989, J GEN MICROBIOL, V135, P2589; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; ZHANG LJ, 1993, MOL MICROBIOL, V9, P309, DOI 10.1111/j.1365-2958.1993.tb01692.x	59	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2947	2956		10.1074/jbc.M807213200	http://dx.doi.org/10.1074/jbc.M807213200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19036729	hybrid			2022-12-27	WOS:000262700900039
J	Placanica, L; Tarassishin, L; Yang, G; Peethumnongsin, E; Kim, SH; Zheng, H; Sisodia, SS; Li, YM				Placanica, Lisa; Tarassishin, Leonid; Yang, Guangli; Peethumnongsin, Erica; Kim, Seong-Hun; Zheng, Hui; Sisodia, Sangram S.; Li, Yue-Ming			Pen2 and Presenilin-1 Modulate the Dynamic Equilibrium of Presenilin-1 and Presenilin-2 gamma-Secretase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; AMYLOID PATHOLOGY; TALKING POINT; IN-VITRO; APH-1; NICASTRIN; MUTATIONS; INHIBITORS; SUBSTRATE; STATE	gamma-Secretase is known to play a pivotal role in the pathogenesis of Alzheimer disease through production of amyloidogenic A beta 42 peptides. Early onset familial Alzheimer disease mutations in presenilin (PS), the catalytic core of gamma-secretase, invariably increase the A beta 42:A beta 40 ratio. However, the mechanism by which these mutations affect gamma-secretase complex formation and cleavage specificity is poorly understood. We show that our in vitro assay system recapitulates the effect of PS1 mutations on the A beta 42:A beta 40 ratio observed in cell and animal models. We have developed a series of small molecule affinity probes that allow us to characterize active gamma-secretase complexes. Furthermore we reveal that the equilibrium of PS1- and PS2-containing active complexes is dynamic and altered by overexpression of Pen2 or PS1 mutants and that formation of PS2 complexes is positively correlated with increased A beta 42:A beta 40 ratios. These data suggest that perturbations to gamma-secretase complex equilibrium can have a profound effect on enzyme activity and that increased PS2 complexes along with mutated PS1 complexes contribute to an increased A beta 42:A beta 40 ratio.	[Placanica, Lisa; Tarassishin, Leonid; Yang, Guangli; Li, Yue-Ming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Placanica, Lisa; Li, Yue-Ming] Cornell Univ, Sch Med Sci, Weill Grad Sch, Dept Pharmacol, New York, NY 10065 USA; [Peethumnongsin, Erica; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Huffington Ctr Aging, Houston, TX 77030 USA; [Kim, Seong-Hun; Sisodia, Sangram S.] Univ Chicago, Ctr Mol Neurobiol, Chicago, IL 60637 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Baylor College of Medicine; University of Chicago	Li, YM (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10065 USA.	liy2@mskcc.org	LI, Yue/GRS-8071-2022	Tarassishin, Leonid/0000-0002-2649-5465	National Institutes of Health [R01-AG026660, R01-AG20670]; Institutional Training [T32 GM073546-01A1]; Ruth L. Kirschstein National Research Service [T32 CA062948-11A1]; William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; William Randolph Hearst Fund in Experimental Therapeutics; American Health Assistance Foundation; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020670, R01AG026660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Training; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; William Randolph Hearst Fund in Experimental Therapeutics; American Health Assistance Foundation(BrightFocus Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG026660 (to Y.M.L.) and R01-AG20670 (to H.Z.), Institutional Training Grant T32 GM073546-01A1 (to L. P.), and Ruth L. Kirschstein National Research Service Award T32 CA062948-11A1 (to L. P.). This work was also supported by William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research, the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center, the William Randolph Hearst Fund in Experimental Therapeutics, and the American Health Assistance Foundation (to Y. M. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Nadin A, 2001, TETRAHEDRON, V57, P1861, DOI 10.1016/S0040-4020(00)01167-4; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Vetrivel KS, 2008, J BIOL CHEM, V283, P19489, DOI 10.1074/jbc.M801037200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; YANG G, 2009, BIOORG MED IN PRESS; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	44	47	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2967	2977		10.1074/jbc.M807269200	http://dx.doi.org/10.1074/jbc.M807269200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19036728	hybrid, Green Published			2022-12-27	WOS:000262700900041
J	Barroso-Gonzalez, J; Machado, JD; Garcia-Exposito, L; Valenzuela-Fernandez, A				Barroso-Gonzalez, Jonathan; Machado, Jose-David; Garcia-Exposito, Laura; Valenzuela-Fernandez, Agustin			Moesin Regulates the Trafficking of Nascent Clathrin-coated Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTIN-INTERACTING PROTEIN-1; AGONIST-INDUCED ENDOCYTOSIS; ACTIN CYTOSKELETON; N-WASP; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEDIATED ENDOCYTOSIS; HIP1-RELATED PROTEIN; CHEMOKINE RECEPTORS; IMAGING ACTIN; ERM PROTEINS	Clathrin-coated vesicles are responsible for the trafficking of several internalized biological cargos. We have observed that the endogenous F-actin-linker moesin co-distributes with constitutive components of clathrin-coated structures. Total internal reflection fluorescence microscopy studies have shown that short interference RNA of moesin enhances the lateral movement of clathrin-coated structures and provokes their abnormal clustering. The aggregation of clathrin-coated structures has also been observed in cells overexpressing N-moesin, a dominant-negative construct unable to bind to F-actin. Only overexpressed moesin constructs with an intact phosphatidylinositol 4,5-bisphosphate-binding domain co-distribute with clathrin-coated structures. Hence, this N-terminal domain is mostly responsible for moesin/clathrin-coated structure association. Biochemical endosome fractioning together with total internal reflection fluorescence microscopy comparative studies, between intact cells and plasma-membrane sheets, indicate that moesin knockdown provokes the accumulation of endocytic rab5-clathrin-coated vesicles carrying the transferrin receptor. The altered trafficking of these endocytic rab5-clathrin- coated vesicles accounts for a transferrin receptor recycling defect that reduces cell-surface expression of the transferrin receptor and increases the amount of sequestered transferrin ligand. Therefore, we propose that moesin is a clathrin-coated vesicle linker that drives cargo trafficking and acts on nascent rab5clathrin-coated vesicles by simultaneously binding to clathrin-coated vesicle-associated phosphatidylinositol 4,5-bisphosphate and actin cytoskeleton. Hence, functional alterations of moesin may be involved in pathological disorders associated with clathrin-mediated internalization or receptor recycling.	[Barroso-Gonzalez, Jonathan; Garcia-Exposito, Laura; Valenzuela-Fernandez, Agustin] Univ La Laguna, Lab Inmunol Celular & Viral, Fac Med, Inst Tecnol Biomed,Dept Med Fis & Farmacol, Tenerife 38071, Spain; [Machado, Jose-David] Univ La Laguna, Lab Neurosecrec, Fac Med, Inst Tecnol Biomed,Dept Med Fis & Farmacol, Tenerife 38071, Spain; [Barroso-Gonzalez, Jonathan; Machado, Jose-David; Garcia-Exposito, Laura; Valenzuela-Fernandez, Agustin] Univ La Laguna, Unidad Farmacol, Fac Med, Inst Tecnol Biomed,Dept Med Fis & Farmacol, Tenerife 38071, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna	Valenzuela-Fernandez, A (corresponding author), Univ La Laguna, Lab Inmunol Celular & Viral, Fac Med, Inst Tecnol Biomed,Dept Med Fis & Farmacol, Campus Ofra S-N, Tenerife 38071, Spain.	avalenzu@ull.es	Barroso, Jonathan/T-9295-2017; Machado, José David/N-5210-2014; Valenzuela-Fernández, Agustín/B-6219-2014; Valenzuela-Fernández, Agustín/P-1638-2019	Barroso, Jonathan/0000-0001-9167-6660; Machado, José David/0000-0003-3531-7051; Valenzuela-Fernández, Agustín/0000-0002-2585-8703; Valenzuela-Fernández, Agustín/0000-0002-2585-8703; Garcia Exposito, Laura/0000-0002-8172-7986	Instituto de Salud Carlos III; Ministeriode Sanidad y Consumo, Spain [FIS-PI050995]; Fundacion para la Investigacion y Prevencio n del SIDA en Espana [FIPSE-24508/05, FIPSE-24661/07]; Consejeria de Industria; Comercio y Nuevas Tecnologias del Gobierno Auto nomo de Canarias, Spain [IDT-TF-06/066]; Universidad de La Laguna, Tenerife, Spain [ULL-06-1500]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministeriode Sanidad y Consumo, Spain; Fundacion para la Investigacion y Prevencio n del SIDA en Espana; Consejeria de Industria; Comercio y Nuevas Tecnologias del Gobierno Auto nomo de Canarias, Spain; Universidad de La Laguna, Tenerife, Spain	This work was supported in part by the Instituto de Salud Carlos III, Ministeriode Sanidad y Consumo, Spain (Grant FIS-PI050995), by the Fundacion para la Investigacion y Prevencio n del SIDA en Espana (Grants FIPSE-24508/05 and FIPSE-24661/07), by the Consejeria de Industria, Comercio y Nuevas Tecnologias del Gobierno Auto nomo de Canarias, Spain (Grant IDT-TF-06/066), and by the Universidad de La Laguna, Tenerife, Spain(Grant ULL-06-1500). The authors declare that they have no competing financial interests. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; Amieva MR, 1999, J CELL SCI, V112, P111; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Burns Alan R., 2008, V440, P235, DOI 10.1007/978-1-59745-178-9_18; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chen CY, 2005, J BIOL CHEM, V280, P6109, DOI 10.1074/jbc.M408454200; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Connor JR, 2004, NEUROLOGY, V62, P1563, DOI 10.1212/01.WNL.0000123251.60485.AC; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; FRANCK Z, 1993, J CELL SCI, V105, P219; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Haffner C, 1997, FEBS LETT, V419, P175, DOI 10.1016/S0014-5793(97)01451-8; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Hirasawa A, 1998, BRIT J PHARMACOL, V124, P55, DOI 10.1038/sj.bjp.0701795; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 2002, CELL, V109, P413, DOI 10.1016/S0092-8674(02)00751-1; Knuehl C, 2006, TRAFFIC, V7, P1688, DOI 10.1111/j.1600-0854.2006.00499.x; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Laroche G, 2005, J BIOL CHEM, V280, P23215, DOI 10.1074/jbc.M414071200; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Clainche C, 2007, EMBO J, V26, P1199, DOI 10.1038/sj.emboj.7601576; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Lindsay AJ, 2004, J CELL SCI, V117, P4365, DOI 10.1242/jcs.01280; Lunn JA, 2000, AM J PHYSIOL-CELL PH, V279, pC2019, DOI 10.1152/ajpcell.2000.279.6.C2019; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Marin-Vicente C, 2005, MOL BIOL CELL, V16, P2848, DOI 10.1091/mbc.E05-01-0067; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; McPherson PS, 2002, TRENDS CELL BIOL, V12, P312, DOI 10.1016/S0962-8924(02)02309-7; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Rappoport JZ, 2005, TRAFFIC, V6, P539, DOI 10.1111/j.1600-0854.2005.00280.x; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Scott MGH, 2002, J BIOL CHEM, V277, P3552, DOI 10.1074/jbc.M106586200; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wallace DME, 2002, BIOCHEM BIOPH RES CO, V299, P770, DOI 10.1016/S0006-291X(02)02720-1; Wilbur JD, 2008, J BIOL CHEM, V283, P32870, DOI 10.1074/jbc.M802863200; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708; Zaslaver A, 2001, J IMMUNOL, V166, P1272, DOI 10.4049/jimmunol.166.2.1272; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	92	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2419	2434		10.1074/jbc.M805311200	http://dx.doi.org/10.1074/jbc.M805311200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047065	hybrid			2022-12-27	WOS:000262545600050
J	Ko, MH; Puglielli, L				Ko, Mi Hee; Puglielli, Luigi			Two Endoplasmic Reticulum (ER)/ER Golgi Intermediate Compartment-based Lysine Acetyltransferases Post-translationally Regulate BACE1 Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-CLEAVING ENZYME-1; ALZHEIMERS-DISEASE; QUALITY-CONTROL; ACETYLATION; CERAMIDE; IDENTIFICATION; PURIFICATION; METABOLISM; GENERATION; DOMAIN	We have recently identified a novel form of post-translational regulation of BACE1(beta-site amyloid precursor protein-cleaving enzyme 1), a membrane protein that acts as the rate-limiting enzyme in the generation of the Alzheimer disease amyloid beta-peptide. Specifically, nascent BACE1 is transiently acetylated in seven lysine residues clustered in a highly disordered region of the protein that faces the lumen of the endoplasmic reticulum (ER)/ER Golgi intermediate compartment (ER/ERGIC). The acetylation protects the nascent protein from degradation by PCSK9/NARC-1 in the ERGIC and allows it to reach the Golgi apparatus. Here we report the identification of two ER/ERGIC-based acetyltransferases, ATase1 and ATase2. Both proteins display acetyl-CoA: lysine acetyltransferase activity, can interact with and acetylate BACE1, and display an ER/ERGIC localization with the catalytic site facing the lumen of the organelle. Both ATase1 and ATase2 regulate the steady-state levels of BACE1 and the rate of amyloid beta-peptide generation. Finally, their transcripts are up-regulated by ceramide treatment. In conclusion, our studies have identified two new enzymes that may be involved in the pathogenesis of late-onset Alzheimer disease. The biochemical characterization of the above events could lead to the identification of novel pharmacological strategies for the prevention of this form of dementia.	[Ko, Mi Hee; Puglielli, Luigi] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Puglielli, Luigi] Vet Affairs Med Ctr, Ctr Geriatr Res Educ Clin, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Puglielli, L (corresponding author), Univ Wisconsin, Dept Med, VAH GRECC 11G,2500 Overlook Terrace, Madison, WI 53705 USA.	lp1@medicine.wisc.edu			National Institutes of Health; NATIONAL INSTITUTE ON AGING [R01AG028569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by a National Institutes of Health grant (to L. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; CAREY DJ, 1981, J BIOL CHEM, V256, P989; Costantini C, 2005, BIOCHEM J, V391, P59, DOI 10.1042/BJ20050700; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Costantini C, 2006, EMBO J, V25, P1997, DOI 10.1038/sj.emboj.7601062; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dempski RE, 2002, CURR OPIN CHEM BIOL, V6, P844, DOI 10.1016/S1367-5931(02)00390-3; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Ko MH, 2007, J BIOL CHEM, V282, P19742, DOI 10.1074/jbc.M611426200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Popsueva AE, 2001, DEV BIOL, V234, P483, DOI 10.1006/dbio.2001.0261; Puglielli L, 1999, J BIOL CHEM, V274, P12665, DOI 10.1074/jbc.274.18.12665; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tissenbaum HA, 2002, DEV CELL, V2, P9, DOI 10.1016/S1534-5807(01)00098-3; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Yang XJ, 2007, EMBO REP, V8, P556, DOI 10.1038/sj.embor.7400977; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	37	88	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2482	2492		10.1074/jbc.M804901200	http://dx.doi.org/10.1074/jbc.M804901200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19011241	Green Published, hybrid			2022-12-27	WOS:000262545600055
J	Watanabe, N; Sekine, T; Takagi, M; Iwasaki, J; Imamoto, N; Kawasaki, H; Osada, H				Watanabe, Nobumoto; Sekine, Tomomi; Takagi, Masatoshi; Iwasaki, Jun-ichi; Imamoto, Naoko; Kawasaki, Hisashi; Osada, Hiroyuki			Deficiency in Chromosome Congression by the Inhibition of Plk1 Polo Box Domain-dependent Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-CHECKPOINT PROTEINS; SMALL-MOLECULE INHIBITOR; SOMATIC WEE1; CENP-E; KINASE; PHOSPHORYLATION; KINETOCHORE; METAPHASE; BINDING; ROLES	Polo-like kinase 1 (Plk1) is one of the key regulators of mitotic cell division. In addition to an N-terminal protein kinase catalytic domain, Plk1 possesses a phosphopeptide binding domain named polo box domain (PBD) at its C terminus. PBD is postulated to be essential for Plk1 localization and substrate targeting. Here, we developed a high-throughput screening system to identify inhibitors of PBD-dependent binding and screened a chemical library. Weisolated a benzotropolone-containing natural compound derived from nutgalls (purpurogallin (PPG)) that inhibited PBD-dependent binding in vitro and in vivo. PPG not only delayed the onset of mitosis but also prolonged the progression of mitosis in HeLa cells. Although apparently normal bipolar spindles were formed even in the presence of PPG, the perturbation of chromosome alignment at metaphase plates activated the spindle assembly checkpoint pathway. These results demonstrate the predominant role of PBD-dependent binding on smooth chromosome congression at metaphase.	[Watanabe, Nobumoto; Osada, Hiroyuki] RIKEN, Dept Biol Chem, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Watanabe, Nobumoto; Sekine, Tomomi; Iwasaki, Jun-ichi; Osada, Hiroyuki] RIKEN, Antibiot Lab, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Takagi, Masatoshi; Imamoto, Naoko] RIKEN, Cellular Dynam Lab, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Sekine, Tomomi; Kawasaki, Hisashi] Tokyo Denki Univ, Dept Environm Mat Sci, Chiyoda Ku, Tokyo 1018457, Japan	RIKEN; RIKEN; RIKEN; Tokyo Denki University	Watanabe, N (corresponding author), RIKEN, Dept Biol Chem, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nwatanab@riken.jp	Osada, Hiroyuki/N-4305-2014; Imamoto, Naoko/A-7458-2015; Osada, Hiroyuki/AAY-6254-2020; Watanabe, Nobumoto/N-6959-2015; 川崎, 寿/AAY-1352-2021	Imamoto, Naoko/0000-0002-2886-3022; Watanabe, Nobumoto/0000-0002-2130-1334; Kawasaki, Hisashi/0000-0001-6662-9301	Ministry of Education, Science, Technology, Sports, and Culture of Japan	Ministry of Education, Science, Technology, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science, Technology, Sports, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abou-Karam M, 1999, PHYTOTHER RES, V13, P337, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;337::AID-PTR451&gt;3.0.CO;2-J; Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Farnet CM, 1998, ANTIMICROB AGENTS CH, V42, P2245, DOI 10.1128/AAC.42.9.2245; Fung KP, 1996, CHEMOTHERAPY, V42, P199, DOI 10.1159/000239442; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Inamori Y, 1997, BIOSCI BIOTECH BIOCH, V61, P890, DOI 10.1271/bbb.61.890; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Ma S, 2003, MOL CANCER RES, V1, P376; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nishino M, 2006, CURR BIOL, V16, P1414, DOI 10.1016/j.cub.2006.05.052; Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tomiki T, 2006, J COMPUT AIDED CHEM, V7, P157; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Wong OK, 2007, J CELL BIOL, V179, P611, DOI 10.1083/jcb.200708044; Wong OK, 2005, J CELL BIOL, V170, P709, DOI 10.1083/jcb.200502163; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	52	96	100	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2344	2353		10.1074/jbc.M805308200	http://dx.doi.org/10.1074/jbc.M805308200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19033445	hybrid			2022-12-27	WOS:000262545600043
J	Mukherjee, S; Shields, D				Mukherjee, Shaeri; Shields, Dennis			Nuclear Import Is Required for the Pro-apoptotic Function of the Golgi Protein p115	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-MEDIATED CLEAVAGE; VESICLE-TETHERING PROTEIN; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; SECRETORY PATHWAY; TRANSPORT; FRAGMENTATION; APPARATUS; COMPLEX; GM130	During apoptosis the Golgi apparatus undergoes irreversible fragmentation. In part, this results from caspase-mediated cleavage of several high molecular weight coiled-coil proteins, termed golgins. These include GM130, golgin 160, and the Golgi vesicle tethering protein p115, whose caspase cleavage generates a C-terminal fragment (CTF) of 205 residues. Here we demonstrate that early during apoptosis, following the rapid cleavage of p115, endogenous CTF translocated to the cell nucleus and its nuclear import was required to enhance the apoptotic response. Expression of a series of deletion constructs identified a putative alpha-helical region of 26 amino acids, whose expression alone was sufficient to induce apoptosis; deletion of these 26 residues from the CTF diminished its proapoptotic activity. This region contains several potential SUMOylation sites and co-expression of SUMO together with the SUMO ligase, UBC9, resulted in SUMOylation of the p115 CTF. Significantly, when cells were treated with drugs that induce apoptosis, SUMOylation enhanced the efficiency of p115 cleavage and the kinetics of apoptosis. A construct in which a nuclear export signal was fused to the N terminus of p115 CTF accumulated in the cytoplasm and surprisingly, its expression did not induce apoptosis. In contrast, treatment of cells expressing this chimera with the antibiotic leptomycin induced its translocation into the nucleus and resulted in the concomitant induction of apoptosis. These results demonstrate that nuclear import of the p115 CTF is required for it to stimulate the apoptotic response and suggest that its mode of action is confined to the nucleus.	[Mukherjee, Shaeri; Shields, Dennis] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Shields, Dennis] Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Mukherjee, S (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, 333 Cedar St, New Haven, CT 06536 USA.	smukherj@aecom.yu.edu			National Institutes of Health [DK21860]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021860, R37DK021860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK21860 (to D. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Alvarez C, 1999, J CELL BIOL, V147, P1205, DOI 10.1083/jcb.147.6.1205; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Besnault-Mascard L, 2005, ONCOGENE, V24, P3268, DOI 10.1038/sj.onc.1208448; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866; Haga N, 2003, ONCOGENE, V22, P5579, DOI 10.1038/sj.onc.1206576; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lowe M, 2004, J CELL SCI, V117, P1139, DOI 10.1242/jcs.00950; Maag RS, 2005, MOL BIOL CELL, V16, P3019, DOI 10.1091/mbc.E04-11-0971; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Sesso A, 1999, TISSUE CELL, V31, P357, DOI 10.1054/tice.1999.0042; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sohda M, 2005, BIOCHEM BIOPH RES CO, V338, P1268, DOI 10.1016/j.bbrc.2005.10.084; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Walker A, 2004, BIOCHEM BIOPH RES CO, V316, P6, DOI 10.1016/j.bbrc.2004.02.015; Warren G, 1998, CURR OPIN CELL BIOL, V10, P493, DOI 10.1016/S0955-0674(98)80064-1	38	25	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1709	1717		10.1074/jbc.M807263200	http://dx.doi.org/10.1074/jbc.M807263200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028683	Green Published, hybrid			2022-12-27	WOS:000262330100040
J	Bailey, LK; Campbell, LJ; Evetts, KA; Littlefield, K; Rajendra, E; Nietlispach, D; Owen, D; Mott, HR				Bailey, Laura K.; Campbell, Louise J.; Evetts, Katrina A.; Littlefield, Keily; Rajendra, Eeson; Nietlispach, Daniel; Owen, Darerca; Mott, Helen R.			The Structure of Binder of Arl2 (BART) Reveals a Novel G Protein Binding Domain IMPLICATIONS FOR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; ARF-LIKE; COFACTOR-D; ROTATIONAL DIFFUSION; EFFECTOR PROTEINS; NMR-SPECTROSCOPY; PDE-DELTA; COMPLEX; GTPASES	The ADP-ribosylation factor-like (Arl) family of small G proteins are involved in the regulation of diverse cellular processes. Arl2 does not appear to be membrane localized and has been implicated as a regulator of microtubule dynamics. The downstream effector for Arl2, Binder of Arl 2 (BART) has no known function but, together with Arl2, can enter mitochondria and bind the adenine nucleotide transporter. We have solved the solution structure of BART and show that it forms a novel fold composed of six alpha-helices that form three interlocking "L" shapes. Analysis of the backbone dynamics reveals that the protein is highly anisotropic and that the loops between the central helices are dynamic. The regions involved in the binding of Arl2 were mapped onto the surface of BART and are found to localize to these loop regions. BART has faces of differing charge and structural elements, which may explain how it can interact with other proteins.	[Bailey, Laura K.; Campbell, Louise J.; Evetts, Katrina A.; Littlefield, Keily; Rajendra, Eeson; Nietlispach, Daniel; Owen, Darerca; Mott, Helen R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do@bioc.cam.ac.uk; hrm28@bioc.cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Rajendra, Eeson/0000-0002-5301-054X; Nietlispach, Daniel/0000-0003-4364-9291	Medical Research Council [G120/608]; Biotechnology and Biological Sciences Research Council [BB/E013228/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Medical Research Council Grant G120/608. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be here by marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Bagshaw RD, 2006, BIOCHEM BIOPH RES CO, V344, P1186, DOI 10.1016/j.bbrc.2006.03.221; Behin A, 2007, EXP CELL RES, V313, P473, DOI 10.1016/j.yexcr.2006.10.024; Belzacq AS, 2002, BIOCHIMIE, V84, P167, DOI 10.1016/S0300-9084(02)01366-4; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; CASEY PJ, 1994, CURR OPIN CELL BIOL, V6, P219, DOI 10.1016/0955-0674(94)90139-2; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Effros R M, 1986, J Thorac Imaging, V1, P54, DOI 10.1097/00005382-198603000-00007; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Hanzal-Bayer M, 2005, J MOL BIOL, V350, P1074, DOI 10.1016/j.jmb.2005.05.036; Hillig RC, 2000, STRUCTURE, V8, P1239, DOI 10.1016/S0969-2126(00)00531-1; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Houben K, 2004, J MOL BIOL, V344, P513, DOI 10.1016/j.jmb.2004.09.054; Hubbard S. J., 1993, NACCESS; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Kawasaki M, 2005, CURR OPIN STRUC BIOL, V15, P681, DOI 10.1016/j.sbi.2005.10.015; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Muromoto R, 2008, INT IMMUNOL, V20, P395, DOI 10.1093/intimm/dxm154; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Nietlispach D, 2002, J AM CHEM SOC, V124, P11199, DOI 10.1021/ja025865m; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Sharer JD, 1999, J BIOL CHEM, V274, P27553, DOI 10.1074/jbc.274.39.27553; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; Shultz T, 2008, FASEB J, V22, P168, DOI 10.1096/fj.06-7786com; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Veltel S, 2008, FEBS LETT, V582, P2501, DOI 10.1016/j.febslet.2008.05.053; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	47	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					992	999		10.1074/jbc.M806167200	http://dx.doi.org/10.1074/jbc.M806167200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18981177	hybrid			2022-12-27	WOS:000262122900035
J	Sirpio, S; Allahverdiyeva, Y; Holmstrom, M; Khrouchtchova, A; Haldrup, A; Battchikova, N; Aro, EM				Sirpioe, Sari; Allahverdiyeva, Yagut; Holmstrom, Maija; Khrouchtchova, Anastassia; Haldrup, Anna; Battchikova, Natalia; Aro, Eva-Mari			Novel Nuclear-encoded Subunits of the Chloroplast NAD(P)H Dehydrogenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ELECTRON FLOW; PHOTOSYSTEM-II; NDH-1 COMPLEXES; THERMOSYNECHOCOCCUS-ELONGATUS; PHOTOSYNTHETIC MEMBRANES; EXTINCTION COEFFICIENTS; ARABIDOPSIS-THALIANA; THYLAKOID MEMBRANES; CHLOROPHYLL-A; PROTEINS	The NAD(P) H dehydrogenase (NDH) complex functions in photosystem I cyclic electron transfer in higher plant chloroplasts and is crucial for plant responses to environmental stress. Chloroplast NDH complex is a close relative to cyanobacterial NDH-1L complex, and all fifteen subunits so far identified in NDH-1L have homologs in the chloroplast NDH complex. Here we report on the identification of two nuclear-encoded proteins NDH48 and NDH45 in higher plant chloroplasts and show their intimate association with the NDH complex. These two membrane proteins are shown to interact with each other and with the NDH complex enriched in stroma thylakoids. Moreover, the deficiency of either the NDH45 protein or the NDH48 protein in respective mutant plants leads to severe defects in both the accumulation and the function of the NDH complex. The NDH48 and NDH45 proteins are not components of the hydrophilic connecting domain of the NDH complex but are strongly attached to the hydrophobic membrane domain. We conclude that NDH48 and NDH45 are novel nuclear-encoded subunits of the chloroplast NDH complex and crucial both for the stable structure and function of the NDH complex.	[Sirpioe, Sari; Allahverdiyeva, Yagut; Holmstrom, Maija; Battchikova, Natalia; Aro, Eva-Mari] Univ Turku, Dept Biol Plant Physiol & Mol Biol, FI-20014 Turku, Finland; [Khrouchtchova, Anastassia; Haldrup, Anna] Univ Copenhagen, Fac Life Sci, Dept Plant Biol & Biotechnol, VKR Res Ctr Proact Plants, DK-1871 Frederiksberg C, Denmark	University of Turku; University of Copenhagen	Aro, EM (corresponding author), Univ Turku, Dept Biol Plant Physiol & Mol Biol, FI-20014 Turku, Finland.	evaaro@utu.fi	Allahverdiyeva, Yagut/I-5652-2013; Aro, Eva-Mari/Q-8664-2017	Allahverdiyeva, Yagut/0000-0002-9262-1757; Aro, Eva-Mari/0000-0002-2922-1435; Haldrup, Anna/0000-0002-2348-7072	Academy of Finland and Biological Interactions Graduate School	Academy of Finland and Biological Interactions Graduate School(Academy of Finland)	This work was supported by the Academy of Finland and Biological Interactions Graduate School. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allahverdiyeva Y, 2005, BBA-BIOENERGETICS, V1709, P69, DOI 10.1016/j.bbabio.2005.06.004; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; ASADA K, 1993, PLANT CELL PHYSIOL, V34, P39; Battchikova N, 2007, PHYSIOL PLANTARUM, V131, P22, DOI 10.1111/j.1399-3054.2007.00929.x; Carlberg I, 2003, P NATL ACAD SCI USA, V100, P757, DOI 10.1073/pnas.0235452100; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Diaz M, 2007, PLANT CELL ENVIRON, V30, P1578, DOI 10.1111/j.1365-3040.2007.01735.x; Folea IM, 2008, FEBS LETT, V582, P249, DOI 10.1016/j.febslet.2007.12.012; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Ishihara S, 2007, PLANT PHYSIOL, V145, P668, DOI 10.1104/pp.107.105866; Kofer W, 1998, MOL GEN GENET, V258, P166, DOI 10.1007/s004380050719; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Majeran W, 2008, MOL CELL PROTEOMICS, V7, P1609, DOI 10.1074/mcp.M800016-MCP200; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munshi MK, 2006, PLANT PHYSIOL, V141, P737, DOI 10.1104/pp.106.080267; Muraoka R, 2006, PLANT PHYSIOL, V142, P1683, DOI 10.1104/pp.106.088682; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; OGAWA T, 1992, PLANT PHYSIOL, V99, P1604, DOI 10.1104/pp.99.4.1604; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Peng LW, 2008, J BIOL CHEM, V283, P34873, DOI 10.1074/jbc.M803207200; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Rintamaki E, 1996, J BIOL CHEM, V271, P14870, DOI 10.1074/jbc.271.25.14870; Rokka A, 2000, PLANT PHYSIOL, V123, P1525, DOI 10.1104/pp.123.4.1525; Romano PGN, 2004, PLANT PHYSIOL, V134, P1244, DOI 10.1104/pp.104.041186; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimizu H, 2008, PLANT CELL PHYSIOL, V49, P835, DOI 10.1093/pcp/pcn058; Shimizu H, 2007, PLANT J, V52, P539, DOI 10.1111/j.1365-313X.2007.03256.x; Sirpio S, 2007, BIOCHEM J, V406, P415, DOI 10.1042/BJ20070460; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	40	48	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					905	912		10.1074/jbc.M805404200	http://dx.doi.org/10.1074/jbc.M805404200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18974055	hybrid			2022-12-27	WOS:000262122900025
J	Valtcheva, N; Nestorov, P; Beck, A; Russwurm, M; Hillenbrand, M; Weinmeister, P; Feil, R				Valtcheva, Nadejda; Nestorov, Peter; Beck, Alexander; Russwurm, Michael; Hillenbrand, Matthias; Weinmeister, Pascal; Feil, Robert			The Commonly Used cGMP-dependent Protein Kinase Type I (cGKI) Inhibitor Rp-8-Br-PET-cGMPS Can Activate cGKI in Vitro and in Intact Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CYCLIC-NUCLEOTIDE ANALOGS; HUMAN PLATELETS; ALPHA; GMP; NO; HYPERTENSION; MECHANISMS; ISOFORMS; ISOZYME	Small-molecule modulators of cGMP signaling are of interest to basic and clinical research. The cGMP-dependent protein kinase type I (cGKI) is presumably a major mediator of cGMP effects, and the cGMP analogue Rp-8-Br-PET-cGMPS (Rp-PET) (chemical name: beta-phenyl-1,N-2-etheno-8-bromoguanosine-3', 5'-cyclic monophosphorothioate, Rp-isomer) is currently considered one of the most permeable, selective, and potent cGKI inhibitors available for intact cell studies. Here, we have evaluated the properties of Rp-PET using cGKI-expressing and cGKI-deficient primary vascular smooth muscle cells (VSMCs), purified cGKI isozymes, and an engineered cGMP sensor protein. cGKI activity in intact VSMCs was monitored by cGMP/cGKI-stimulated cell growth and phosphorylation of vasodilator-stimulated phosphoprotein. Unexpectedly, Rp-PET (100 mu M) did not efficiently antagonize activation of cGKI by the agonist 8-Br-cGMP (100 mu M) in intact VSMCs. Moreover, in the absence of 8-Br-cGMP, Rp-PET (100 mu M) stimulated cell growth in a cGKI alpha-dependent manner. Kinase assays with purified cGKI isozymes confirmed the previously reported inhibition of the cGMP-stimulated enzyme by Rp-PET in vitro. However, in the absence of the agonist cGMP, Rp-PET partially activated the cGKI alpha isoform. Experiments with a fluorescence resonance energy transfer-based construct harboring the cGMP binding sites of cGKI suggested that binding of Rp-PET induces a conformational change similar to the agonist cGMP. Together, these findings indicate that Rp-PET is a partial cGKI alpha agonist that under certain conditions stimulates rather than inhibits cGKI activity in vitro and in intact cells. Data obtained with Rp-PET as cGKI inhibitor should be interpreted with caution and not be used as sole evidence to dissect the role of cGKI in signaling processes.	[Valtcheva, Nadejda; Nestorov, Peter; Hillenbrand, Matthias; Feil, Robert] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany; [Beck, Alexander] Zentrum Klin Massenspektrometrie GmbH, D-74076 Heilbronn, Germany; [Russwurm, Michael] Ruhr Univ Bochum, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany; [Weinmeister, Pascal] Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany	Eberhard Karls University of Tubingen; Ruhr University Bochum; Technical University of Munich	Feil, R (corresponding author), Univ Tubingen, Interfak Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	robert.feil@uni-tuebingen.de	Feil, Robert/B-8918-2014	Feil, Robert/0000-0002-7335-4841	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Burkhardt M, 2000, J BIOL CHEM, V275, P33536, DOI 10.1074/jbc.M005670200; Butt E, 1995, BRIT J PHARMACOL, V116, P3110, DOI 10.1111/j.1476-5381.1995.tb15112.x; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; BUTT E, 1990, FEBS LETT, V263, P47, DOI 10.1016/0014-5793(90)80702-K; Chu DM, 1997, J BIOL CHEM, V272, P31922, DOI 10.1074/jbc.272.50.31922; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Feil R, 2005, TRENDS MOL MED, V11, P71, DOI 10.1016/j.molmed.2004.12.001; Feil R, 2002, CIRC RES, V90, P1080, DOI 10.1161/01.RES.0000019586.95768.40; FEIL R, 1995, BIOCHEMISTRY-US, V34, P13152, DOI 10.1021/bi00040a029; Foller M, 2008, P NATL ACAD SCI USA, V105, P6771, DOI 10.1073/pnas.0708940105; Gambaryan S, 2004, BLOOD, V103, P2593, DOI 10.1182/blood-2003-09-3349; Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Kemp-Harper B, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.19pe12; Kramer RH, 1996, J NEUROSCI, V16, P1285; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Lincoln TM, 2006, FRONT BIOSCI-LANDMRK, V11, P356, DOI 10.2741/1803; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; Marshall SJ, 2004, BLOOD, V103, P2601, DOI 10.1182/blood-2003-09-3319; Mendelsohn ME, 2005, J CLIN INVEST, V115, P840, DOI 10.1172/JCI200524806; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Russwurm M, 2007, BIOCHEM J, V407, P69, DOI 10.1042/BJ20070348; Ruth P, 1997, J BIOL CHEM, V272, P10522; RUTH P, 1991, EUR J BIOCHEM, V202, P1339, DOI 10.1111/j.1432-1033.1991.tb16509.x; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; SEKHAR KR, 1992, MOL PHARMACOL, V42, P103; Taylor MS, 2004, MOL PHARMACOL, V65, P1111, DOI 10.1124/mol.65.5.1111; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Weber S, 2007, CIRC RES, V101, P1096, DOI 10.1161/CIRCRESAHA.107.154351; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Weinmeister P, 2008, MOL BIOL CELL, V19, P4434, DOI 10.1091/mbc.E08-04-0370; Wolfsgruber W, 2003, P NATL ACAD SCI USA, V100, P13519, DOI 10.1073/pnas.1936024100; WYATT TA, 1991, RES COMMUN CHEM PATH, V74, P3	41	34	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					556	562		10.1074/jbc.M806161200	http://dx.doi.org/10.1074/jbc.M806161200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19008225	hybrid			2022-12-27	WOS:000261974800061
J	Cabart, P; Lee, J; Willis, IM				Cabart, Pavel; Lee, JaeHoon; Willis, Ian M.			Facilitated Recycling Protects Human RNA Polymerase III from Repression by Maf1 in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION REINITIATION; SACCHAROMYCES-CEREVISIAE; ACCURATE TRANSCRIPTION; TERMINATION; COMPLEX; INITIATION; TFIIIB; DEPHOSPHORYLATION; PROMOTE; EXTRACT	Yeast cells synthesize similar to 3-6 million molecules of tRNA every cell cycle at a rate of similar to 2-4 transcripts/gene/s. This high rate of transcription is achieved through many rounds of reinitiation by RNA polymerase (pol) III on stable DNA-bound complexes of the initiation factor TFIIIB. Studies in yeast have shown that the rate of reinitiation is increased by facilitated recycling, a process that involves the repeated reloading of the polymerase on the same transcription unit. However, when nutrients become limiting or stress conditions are encountered, RNA pol III transcription is rapidly repressed through the action of the conserved Maf1 protein. Here we examine the relationship between Maf1-mediated repression and facilitated recycling in a human RNA pol III in vitro system. Using an immobilized template transcription assay, we demonstrate that facilitated recycling is conserved from yeast to humans. We assessed the ability of recombinant human Maf1 to inhibit different steps in transcription before and after preinitiation complex assembly. We show that recombinant Maf1 can inhibit the recruitment of TFIIIB and RNA pol III to immobilized templates. However, RNA pol III bound to preinitiation complexes or in elongation complexes is protected from repression by Maf1 and can undergo several rounds of initiation. This indicates that recombinant Maf1 is unable to inhibit facilitated recycling. The data suggest that additional biochemical steps may be necessary for rapid Maf1-dependent repression of RNA pol III transcription.	[Cabart, Pavel; Lee, JaeHoon; Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Willis, IM (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	willis@aecom.yu.edu		Willis, Ian/0000-0001-6599-2395; Cabart, Pavel/0000-0003-0065-367X	National Institutes of Health [GM42728]; Albert Einstein College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42728. This work was also supported by funds from the Albert Einstein College of Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Boguta M, 1997, GENE, V185, P291, DOI 10.1016/S0378-1119(96)00669-5; DEAN N, 1988, MOL CELL BIOL, V8, P3017, DOI 10.1128/MCB.8.8.3017; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ferrari R, 2004, P NATL ACAD SCI USA, V101, P13442, DOI 10.1073/pnas.0403851101; Ferrari R, 2008, CELL MOL BIOL LETT, V13, P112, DOI 10.2478/s11658-007-0041-y; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Gomez-Roman N, 2006, BIOCHEM SOC SYMP, V73, P141, DOI 10.1042/bss0730141; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; HUIBREGTSE JM, 1989, MOL CELL BIOL, V9, P3244, DOI 10.1128/MCB.9.8.3244; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KOVELMAN R, 1990, GENE DEV, V4, P646, DOI 10.1101/gad.4.4.646; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Liao YL, 2006, MOL CELL BIOL, V26, P5946, DOI 10.1128/MCB.00689-06; MARAIA RJ, 1994, MOL CELL BIOL, V14, P2147, DOI 10.1128/MCB.14.3.2147; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Phizicky EM, 2005, P NATL ACAD SCI USA, V102, P11127, DOI 10.1073/pnas.0504843102; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SEGALL J, 1980, J BIOL CHEM, V255, P1986; STANDRING DN, 1981, P NATL ACAD SCI-BIOL, V78, P5963, DOI 10.1073/pnas.78.10.5963; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Wang ZX, 1998, MOL CELL, V1, P749, DOI 10.1016/S1097-2765(00)80074-X; Wang ZX, 2000, EMBO J, V19, P6823, DOI 10.1093/emboj/19.24.6823; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; WHITE RJ, 1995, MOL CELL BIOL, V15, P1983; Woiwode A, 2008, MOL CELL BIOL, V28, P4204, DOI 10.1128/MCB.01912-07; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005	35	42	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36108	36117		10.1074/jbc.M807538200	http://dx.doi.org/10.1074/jbc.M807538200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974046	hybrid, Green Published			2022-12-27	WOS:000261840500006
J	Chandor-Proust, A; Berteau, O; Douki, T; Gasparutto, D; Ollagnier-De-Choudens, S; Fontecave, M; Atta, M				Chandor-Proust, Alexia; Berteau, Olivier; Douki, Thierry; Gasparutto, Didier; Ollagnier-de-Choudens, Sandrine; Fontecave, Marc; Atta, Mohamed			DNA Repair and Free Radicals, New Insights into the Mechanism of Spore Photoproduct Lyase Revealed by Single Amino Acid Substitution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; ENZYME; ADENOSYLMETHIONINE; SUPERFAMILY; PROTEIN; IRON; 5-THYMINYL-5,6-DIHYDROTHYMINE; SULFUR; DIMERS; LESION	The major DNA photoproduct in UV-irradiated Bacillus subtilis spores is the thymine dimer named spore photoproduct (SP, 5-(alpha-thyminyl)-5,6-dihydrothymine). The SP lesion has been found to be efficiently repaired by SP lyase (SPL) a very specific enzyme that reverses the SP to two intact thymines, at the origin of the great resistance of the spores to UV irradiation. SPL belongs to a superfamily of [4Fe-4S] iron-sulfur enzymes, called "Radical-SAM." Here, we show that the single substitution of cysteine 141 into alanine, a residue fully conserved in Bacillus species and previously shown to be essential for spore DNA repair in vivo, has a major impact on the outcome of the SPL-dependent repair reaction in vitro. Indeed the modified enzyme catalyzes the almost quantitative conversion of the SP lesion into one thymine and one thymine sulfinic acid derivative. This compound results from the trapping of the allyl-type radical intermediate by dithionite, used as reducing agent in the reaction mixture. Implications of the data reported here regarding the repair mechanism and the role of Cys-141 are discussed.	[Chandor-Proust, Alexia; Berteau, Olivier; Ollagnier-de-Choudens, Sandrine; Fontecave, Marc; Atta, Mohamed] CEA, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, F-38054 Grenoble, France; [Chandor-Proust, Alexia; Berteau, Olivier; Ollagnier-de-Choudens, Sandrine; Fontecave, Marc; Atta, Mohamed] CNRS, UMR5249, Grenoble, France; [Berteau, Olivier; Ollagnier-de-Choudens, Sandrine; Fontecave, Marc; Atta, Mohamed] Univ Grenoble 1, F-38081 Grenoble, France; [Douki, Thierry; Gasparutto, Didier] Univ Grenoble 1, CEA, Lab Les Acides Nucle,Direct Sci Mat,UMR E3, Serv Chim Inorgan & Biol,Inst Nanosci & Cryogen, F-38054 Grenoble 9, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fontecave, M (corresponding author), CEA, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, F-38054 Grenoble, France.	marc.fontecave@cea.fr; mohamed.atta@cea.fr	Thierry, Douki/H-2108-2018; Berteau, Olivier/AAF-9080-2019; Chandor-Proust, Alexia/C-1109-2013	Thierry, Douki/0000-0002-5022-071X; Berteau, Olivier/0000-0002-3434-5168; Chandor-Proust, Alexia/0000-0002-4827-3281; Ollagnier de Choudens, Sandrine/0000-0002-0080-6659				BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buis JM, 2006, J BIOL CHEM, V281, P25994, DOI 10.1074/jbc.M603931200; Chandor A, 2006, J BIOL CHEM, V281, P26922, DOI 10.1074/jbc.M602297200; Cheek J, 2002, J AM CHEM SOC, V124, P2860, DOI 10.1021/ja017784g; DONNELLAN JE, 1965, SCIENCE, V149, P308, DOI 10.1126/science.149.3681.308; Fajardo-Cavazos P, 2005, CURR MICROBIOL, V51, P331, DOI 10.1007/s00284-005-0052-8; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fontecave M, 2001, CURR OPIN CHEM BIOL, V5, P506, DOI 10.1016/S1367-5931(00)00237-4; Frey PA, 2006, CHEM REV, V106, P3302, DOI 10.1021/cr050292s; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Halliwell B., 2007, FREE RADICALS BIOL M; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Mehl RA, 1999, ORG LETT, V1, P1065, DOI 10.1021/ol9908676; Ni JS, 1996, ANAL CHEM, V68, P1989, DOI 10.1021/ac960270t; Pieck JC, 2006, J BIOL CHEM, V281, P36317, DOI 10.1074/jbc.M607053200; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Rebeil R, 2001, P NATL ACAD SCI USA, V98, P9038, DOI 10.1073/pnas.161278998; Rebeil R, 1998, J BACTERIOL, V180, P4879, DOI 10.1128/JB.180.18.4879-4885.1998; Romieu A, 2000, ORG LETT, V2, P1085, DOI 10.1021/ol005643y; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; Slieman TA, 2000, J BACTERIOL, V182, P6412, DOI 10.1128/JB.182.22.6412-6417.2000; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; VARGHESE AJ, 1970, BIOCHEM BIOPH RES CO, V38, P484, DOI 10.1016/0006-291X(70)90739-4	25	55	56	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36361	36368		10.1074/jbc.M806503200	http://dx.doi.org/10.1074/jbc.M806503200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957420	hybrid, Green Published			2022-12-27	WOS:000261840500033
J	Martin, S; Bouschet, T; Jenkins, EL; Nishimune, A; Henley, JM				Martin, Stephane; Bouschet, Tristan; Jenkins, Emma L.; Nishimune, Atsushi; Henley, Jeremy M.			Bidirectional Regulation of Kainate Receptor Surface Expression in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED SYNAPTIC-TRANSMISSION; AMPA RECEPTORS; TRAFFICKING; PROTEINS; SUMOYLATION; MOTILITY; SUBUNITS; ROLES; GREEN	Kainate receptors (KARs) are crucial for the regulation of both excitatory and inhibitory neurotransmission, but little is known regarding the mechanisms controlling KAR surface expression. We used super ecliptic pHluorin (SEP)-tagged KAR subunit GluR6a to investigate real-time changes in KAR surface expression in hippocampal neurons. Sindbis virus-expressed SEP-GluR6 subunits efficiently co-assembled with native KAR subunits to form heteromeric receptors. Diffuse surface-expressed dendritic SEP-GluR6 is rapidly internalized following either N-methyl-D-aspartate or kainate application. Sustained kainate or transient N-methyl-D-aspartate application resulted in a slow decrease of base-line surface KAR levels. Surprisingly, however, following the initial loss of surface receptors, a short kainate application caused a long lasting increase in surface-expressed KARs to levels significantly greater than those prior to the agonist challenge. These data suggest that after initial endocytosis, transient agonist activation evokes increased KAR exocytosis and reveal that KAR surface expression is bidirectionally regulated. This process may provide a mechanism for hippocampal neurons to differentially adapt their physiological responses to changes in synaptic activation and extrasynaptic glutamate concentration.	[Martin, Stephane; Bouschet, Tristan; Jenkins, Emma L.; Nishimune, Atsushi; Henley, Jeremy M.] Univ Bristol, Sch Med Sci, MRC, Ctr Synapt Plast,Dept Anat, Bristol BS8 1TD, Avon, England	University of Bristol	Henley, JM (corresponding author), Univ Bristol, Sch Med Sci, MRC, Ctr Synapt Plast,Dept Anat, Univ Walk, Bristol BS8 1TD, Avon, England.	j.m.henley@bristol.ac.uk	Bouschet, Tristan/C-8265-2019; Martin, Stéphane/G-5954-2012; Henley, Jeremy M/A-2776-2009	Bouschet, Tristan/0000-0002-7858-6115; Martin, Stéphane/0000-0001-6771-7645; Henley, Jeremy/0000-0003-3589-8335	Wellcome Trust; Medical Research Council; Biotechnology and Biological Sciences Research Council; European Union (GRIPPANT); MRC [G0601810] Funding Source: UKRI; Medical Research Council [G0601810] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (GRIPPANT)(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Wellcome Trust, the Medical Research Council, the Biotechnology and Biological Sciences Research Council and the European Union (GRIPPANT). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Coussen F, 2006, BIOCHEM SOC T, V34, P927, DOI 10.1042/BST0340927; Fleck MW, 2003, J NEUROSCI, V23, P1219; Ibarretxe G, 2007, J NEUROSCI, V27, P7684, DOI 10.1523/JNEUROSCI.1070-07.2007; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Rivera R, 2007, EMBO J, V26, P4359, DOI 10.1038/sj.emboj.7601865; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X	20	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36435	36440		10.1074/jbc.M806447200	http://dx.doi.org/10.1074/jbc.M806447200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18955488	hybrid, Green Published			2022-12-27	WOS:000261840500041
J	Ramalingam, JK; Hunke, C; Gao, XH; Grurber, G; Preiser, PR				Ramalingam, Jeya Kumar; Hunke, Cornelia; Gao, Xiaohong; Gruerber, Gerhard; Preiser, Peter Rainer			ATP/ADP Binding to a Novel Nucleotide Binding Domain of the Reticulocyte-binding Protein Py235 of Plasmodium yoelii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; METHANOSARCINA-MAZEI GO1; HOST-CELL SELECTION; SECONDARY STRUCTURE; RHOPTRY-PROTEIN; RODENT MALARIA; CIRCUMSPOROZOITE PROTEIN; PHENOTYPIC VARIATION; MEROZOITE PROTEINS; HUMAN ERYTHROCYTES	The mechanism by which a malaria merozoite recognizes a suitable host cell is mediated by a cascade of receptor-ligand interactions. In addition to the availability of the appropriate receptors, intracellular ATP plays an important role in determining whether erythrocytes are suitable for merozoite invasion. Recent work has shown that ATP secreted from erythrocytes signals a number of cellular processes. To determine whether ATP signaling might be involved in merozoite invasion, we investigated whether known plasmodium invasion proteins contain nucleotide binding motifs. Domain mapping identified a putative nucleotide binding region within all members of the reticulocyte-binding protein homologue (RBL) family analyzed. A representative domain, termed here nucleotide binding domain 94 (NBD94), was expressed and demonstrated to specifically bind to ATP. Nucleotide affinities of NBD94 were determined by fluorescence correlation spectroscopy, where an increase in the binding of ATP is observed compared with ADP analogues. ATP binding was reduced by the known F1F0-ATP synthase inhibitor 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole. Fluorescence quenching and circular dichroism spectroscopy of NBD94 after binding of different nucleotides provide evidence for structural changes in this protein. Our data suggest that different structural changes induced by ATP/ADP binding to RBL could play an important role during the invasion process.	[Hunke, Cornelia; Gruerber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, Singapore 637551, Singapore; [Ramalingam, Jeya Kumar; Gao, Xiaohong; Preiser, Peter Rainer] Nanyang Technol Univ, Sch Biol Sci, Div Genom & Genet, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Grurber, G (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct & Computat Biol, 60 Nanyang Dr, Singapore 637551, Singapore.	ggrueber@ntu.edu.sg; PRPreiser@ntu.edu.sg	Preiser, Peter R/A-2201-2011	Gao, Xiaohong Annie/0000-0002-7270-2576; , Peter/0000-0003-4331-7000	Agency for Science, Technology and Research (A*STAR) Biomedical Research Council [06/1/22/19/456]; Academic Research Council [MLC03/03]	Agency for Science, Technology and Research (A*STAR) Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Academic Research Council	This work was supported by Agency for Science, Technology and Research (A*STAR) Biomedical Research Council Grant 06/1/22/19/456 and Academic Research Council Grant MLC03/03. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Armbruster A, 2005, FEBS LETT, V579, P1961, DOI 10.1016/j.febslet.2005.02.042; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; Coskun U, 2002, J BIOL CHEM, V277, P17327, DOI 10.1074/jbc.M110407200; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DLUZEWSKI AR, 1983, PARASITOLOGY, V87, P429, DOI 10.1017/S0031182000082950; DLUZEWSKI AR, 1983, MOL BIOCHEM PARASIT, V9, P145, DOI 10.1016/0166-6851(83)90106-8; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Ellsworth ML, 2004, MED SCI SPORT EXER, V36, P35, DOI 10.1249/01.MSS.0000106284.80300.B2; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; FREEMAN RR, 1980, NATURE, V284, P366, DOI 10.1038/284366a0; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; GAO X, 2008, R PLOS PATHOG, V4; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; GOLENDA CF, 1990, J HISTOCHEM CYTOCHEM, V38, P475, DOI 10.1177/38.4.2181019; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Gruner AC, 2004, MICROBES INFECT, V6, P864, DOI 10.1016/j.micinf.2004.04.004; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807; Hunke C, 2007, PROTEIN EXPRES PURIF, V53, P378, DOI 10.1016/j.pep.2007.01.009; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Iyer JK, 2007, MOL MICROBIOL, V65, P333, DOI 10.1111/j.1365-2958.2007.05786.x; JARRA W, 1989, PARASITE IMMUNOL, V11, P1, DOI 10.1111/j.1365-3024.1989.tb00644.x; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MEIS JFGM, 1992, ACTA TROP, V50, P227, DOI 10.1016/0001-706X(92)90079-D; MEIS JFGM, 1992, PARASITOL RES, V78, P165, DOI 10.1007/BF00931660; Ogun SA, 2006, MOL BIOCHEM PARASIT, V147, P140, DOI 10.1016/j.molbiopara.2006.02.001; Ogun SA, 1996, MOL BIOCHEM PARASIT, V76, P321, DOI 10.1016/0166-6851(95)02540-5; OGUN SA, 1994, EXP PARASITOL, V79, P270, DOI 10.1006/expr.1994.1090; Ogun SA, 2000, EXP PARASITOL, V95, P187, DOI 10.1006/expr.2000.4535; OLSON JA, 1982, J CELL BIOL, V95, P757, DOI 10.1083/jcb.95.3.757; Orriss GL, 1998, STRUCT FOLD DES, V6, P831, DOI 10.1016/S0969-2126(98)00085-9; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; Preiser P, 2000, MICROBES INFECT, V2, P1461, DOI 10.1016/S1286-4579(00)01301-0; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; RANGACHARI K, 1986, NATURE, V324, P364, DOI 10.1038/324364a0; RANGACHARI K, 1989, MOL BIOCHEM PARASIT, V34, P63, DOI 10.1016/0166-6851(89)90020-0; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Roos M, 1998, J BIOL CHEM, V273, P924, DOI 10.1074/jbc.273.2.924; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schafer HJ, 2001, BIOCHEM BIOPH RES CO, V286, P1218, DOI 10.1006/bbrc.2001.5502; Schafer IB, 2006, J MOL BIOL, V358, P725, DOI 10.1016/j.jmb.2006.02.057; Schafer I, 2006, J BIOENERG BIOMEMBR, V38, P83, DOI 10.1007/s10863-006-9015-4; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Snounou G, 2000, PARASITOL TODAY, V16, P28, DOI 10.1016/S0169-4758(99)01546-X; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Svergun DI, 1998, BIOPHYS J, V75, P2212, DOI 10.1016/S0006-3495(98)77665-9; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEBER J, 1994, J BIOL CHEM, V269, P20462; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; WISE JG, 1983, BIOCHEM J, V215, P343, DOI 10.1042/bj2150343	71	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36386	36396		10.1074/jbc.M803102200	http://dx.doi.org/10.1074/jbc.M803102200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957411	Green Published, Green Accepted			2022-12-27	WOS:000261840500036
J	Cheng, Q; Sandalova, T; Lindqvist, Y; Arner, ESJ				Cheng, Qing; Sandalova, Tatyana; Lindqvist, Ylva; Arner, Elias S. J.			Crystal Structure and Catalysis of the Selenoprotein Thioredoxin Reductase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN; GLUTATHIONE-REDUCTASE; ACTIVE-SITE; RECOMBINANT PROTEINS; ESCHERICHIA-COLI; HUMAN PLACENTA; CELL-DEATH; SELENOCYSTEINE; SELENIUM; MECHANISM	Selenoproteins contain a highly reactive 21st amino acid selenocysteine (Sec) encoded by recoding of a predefined UGA codon. Because of a lack of selenoprotein supply, high chemical reactivity of Sec, and intricate translation machineries, selenoprotein crystal structures are difficult to obtain. Structural prerequisites for Sec involvement in enzyme catalysis are therefore sparsely known. Here we present the crystal structure of catalytically active rat thioredoxin reductase 1 (TrxR1), revealing surprises at the C-terminal Sec-containing active site in view of previous literature. The oxidized enzyme presents a selenenyl-sulfide motif in trans-configuration, with the selenium atom of Sec-498 positioned beneath the side chain of Tyr-116, thereby located far from the redox active moieties proposed to be involved in electron transport to the Sec-containing active site. Upon reduction to a selenolthiol motif, the Sec residue moved toward solvent exposure, consistent with its presumed role in reduction of TrxR1 substrates or as target of electrophilic agents inhibiting the enzyme. A Y116I mutation lowered catalytic efficiency in reduction of thioredoxin, but surprisingly increased turnover using 5-hydroxy-1,4-naphthoquinone (juglone) as substrate. The same mutation also decreased sensitivity to inhibition by cisplatin. The results suggest that Tyr-116 plays an important role for catalysis of TrxR1 by interacting with the selenenylsulfide of oxidized TrxR1, thereby facilitating its reduction in the reductive half reaction of the enzyme. The interaction of a selenenylsulfide with the phenyl ring of a tyrosine, affecting turnover, switch of substrate specificity, and modulation of sensitivity to electrophilic agents, gives important clues into the mechanism of TrxR1, which is a selenoprotein that plays a major role for mammalian cell fate and function. The results also demonstrate that a recombinant selenoprotein TrxR can be produced in high amount and sufficient purity to enable crystal structure determination, which suggests that additional structural studies of these types of proteins are feasible.	[Cheng, Qing; Arner, Elias S. J.] Karolinska Inst, Med Nobel Inst Biochem, Div Biochem, SE-17177 Stockholm, Sweden; [Sandalova, Tatyana; Lindqvist, Ylva] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Struct Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Arner, ESJ (corresponding author), Karolinska Inst, Med Nobel Inst Biochem, Div Biochem, SE-17177 Stockholm, Sweden.	Elias.Arner@ki.se	Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019; Lindqvist, Ylva/F-9009-2010	Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114; Cheng, Qing/0000-0002-3170-9333; Sandalova, Tatyana/0000-0002-7694-6420; Lindqvist, Ylva/0000-0003-3162-8661	Karolinska Institutet; The Swedish Research Council (Medicine); The Swedish Cancer Society, Hedlunds Stiftelse; Knutoch Alice Wallenbergs Stiftelse	Karolinska Institutet(Karolinska Institutet); The Swedish Research Council (Medicine)(Swedish Research Council); The Swedish Cancer Society, Hedlunds Stiftelse(Swedish Cancer Society); Knutoch Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation)	This work was supported by the Karolinska Institutet, The Swedish Research Council (Medicine), The Swedish Cancer Society, Hedlunds Stiftelse, and Knutoch Alice Wallenbergs Stiftelse. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Allamand V, 2006, EMBO REP, V7, P450, DOI 10.1038/sj.embor.7400648; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; ARNE RESJ, 2000, CURRENT PROTOCOLS TO; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 2001, FREE RADICAL BIO MED, V31, P1170, DOI 10.1016/S0891-5849(01)00698-0; Arscott LD, 1997, P NATL ACAD SCI USA, V94, P3621, DOI 10.1073/pnas.94.8.3621; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biterova EI, 2005, P NATL ACAD SCI USA, V102, P15018, DOI 10.1073/pnas.0504218102; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Brandt W, 2005, CHEMBIOCHEM, V6, P386, DOI 10.1002/cbic.200400276; Cenas N, 2006, J BIOL CHEM, V281, P5593, DOI 10.1074/jbc.M511972200; Cenas N, 2004, J BIOL CHEM, V279, P2583, DOI 10.1074/jbc.M310292200; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; Cheng Q, 2006, CHEMBIOCHEM, V7, P1976, DOI 10.1002/cbic.200600326; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; DeLano W.L, PYMOL MOL GRAPHICS S; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Eckenroth B, 2006, BIOCHEMISTRY-US, V45, P5158, DOI 10.1021/bi0517887; Eckenroth BE, 2007, BIOCHEMISTRY-US, V46, P9472, DOI 10.1021/bi7004812; Eckenroth BE, 2007, BIOCHEMISTRY-US, V46, P4694, DOI 10.1021/bi602394p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; Flohe L, 2000, IUBMB LIFE, V49, P411; Fritz-Wolf K, 2007, J MOL BIOL, V370, P116, DOI 10.1016/j.jmb.2007.04.044; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Gromer S, 2003, P NATL ACAD SCI USA, V100, P12618, DOI 10.1073/pnas.2134510100; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Gromer S, 2006, CHEMBIOCHEM, V7, P1649, DOI 10.1002/cbic.200600080; Grundner-Culemann E, 2001, J MOL BIOL, V310, P699, DOI 10.1006/jmbi.2001.4809; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Huttenhofer A, 1998, COLD SPRING HARBOR M, P603; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Johansson L, 2006, FREE RADICAL BIO MED, V41, P649, DOI 10.1016/j.freeradbiomed.2006.05.005; Krauth-Siegel RL, 1998, BIOCHEMISTRY-US, V37, P13968, DOI 10.1021/bi980637j; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Moroder L, 2005, J PEPT SCI, V11, P187, DOI 10.1002/psc.654; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145; PAI EF, 1983, J BIOL CHEM, V258, P1752; Ren B, 1997, J MOL BIOL, V268, P869, DOI 10.1006/jmbi.1997.1005; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; Tormay P, 1997, J BACTERIOL, V179, P576, DOI 10.1128/jb.179.3.576-582.1997; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wessjohann LA, 2007, BIOL CHEM, V388, P997, DOI 10.1515/BC.2007.138; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Witte AB, 2005, FREE RADICAL BIO MED, V39, P696, DOI 10.1016/j.freeradbiomed.2005.04.025; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Zhang JX, 1997, PROTEIN SCI, V6, P1549, DOI 10.1002/pro.5560060719; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000095; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	70	149	152	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3998	4008		10.1074/jbc.M807068200	http://dx.doi.org/10.1074/jbc.M807068200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19054767	hybrid			2022-12-27	WOS:000262872500068
J	Halbach, A; Rucktaschel, R; Rottensteiner, H; Erdmann, R				Halbach, Andre; Rucktaeschel, Robert; Rottensteiner, Hanspeter; Erdmann, Ralf			The N-domain of Pex22p Can Functionally Replace the Pex3p N-domain in Targeting and Peroxisome Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORT RECEPTOR PEX5P; MEMBRANE-PROTEINS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; BIOGENESIS; YEAST; PEX19P; UBIQUITINATION; IDENTIFICATION; ASSOCIATION	Pex3p is a central component of the import machinery for peroxisomal membrane proteins (PMPs) that can reach peroxisomes via the endoplasmic reticulum (ER) and even trigger de novo peroxisome formation from the ER. Pex19p is the import receptor for type I PMPs, whereas targeting of type II PMPs, of which Pex3p so far represents the only species, does not require Pex19p. Pex3p possesses two domains with distinct function: a short N-terminal domain, which harbors the information for peroxisomal (and ER) targeting, and a C-terminal domain, which faces the cytosol and serves as a docking site for Pex19p, thereby delivering newly synthesized PMPs to the peroxisome. Here we show that the N-terminal domain of Pex3p can be functionally replaced by the N-terminal peroxisomal membrane targeting signal (mPTS) of Pex22p, a supposedly unrelated component of the import machinery for peroxisomal matrix proteins. An exchange of the mPTS of Pex22p by that of Pex3p likewise fully preserved the function of Pex22p. Neither of the two mPTS interacted with Pex19p, and in the absence of Pex19p, colocalization of Pex3p and Pex22p was observed, indicating that also Pex22p is targeted to peroxisomes by a type II mPTS. When a type I mPTS was hooked to the C-terminal domains of Pex22p and Pex3p, function was retained in the case of Pex22p and in part even for Pex3p. The C-terminal domain of Pex3p thus contains the relevant information required for de novo peroxisome formation, thereby challenging the concept of the N terminus of Pex3p being key in that process.	[Halbach, Andre; Rucktaeschel, Robert; Rottensteiner, Hanspeter; Erdmann, Ralf] Ruhr Univ Bochum, Abt Syst Biochem, Inst Physiol Chem, D-44780 Bochum, Germany	Ruhr University Bochum	Rottensteiner, H (corresponding author), Ruhr Univ Bochum, Abt Syst Biochem, Inst Physiol Chem, D-44780 Bochum, Germany.	Hanspeter.Rottensteiner@rub.de			Deutsche Forschungsgemeinschaft [178/2-4]; FP6 European Union Project Peroxisome [LHSG-CT-2004-512018]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FP6 European Union Project Peroxisome(European Commission); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant 178/2-4, by FP6 European Union Project Peroxisome Grant LHSG-CT-2004-512018, and by the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Bascom RA, 2003, MOL BIOL CELL, V14, P939, DOI 10.1091/mbc.E02-10-0633; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; DECKERS M, 2007, THESIS RUHR U BOCHUM; Eckert JH, 2003, REV PHYSIOL BIOCH P, V147, P75, DOI 10.1007/s10254-003-0007-z; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Faber KN, 2002, J BIOL CHEM, V277, P11026, DOI 10.1074/jbc.M112347200; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Haan GJ, 2006, FEMS YEAST RES, V6, P186, DOI 10.1111/j.1567-1364.2006.00037.x; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; HOHFELD J, 1991, J CELL BIOL, V114, P1167, DOI 10.1083/jcb.114.6.1167; Honsho M, 2002, J BIOL CHEM, V277, P44513, DOI 10.1074/jbc.M206139200; Hunt JE, 2004, BIOCHEM BIOPH RES CO, V314, P586, DOI 10.1016/j.bbrc.2003.12.123; James P, 1996, GENETICS, V144, P1425; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Pause B, 1997, FEBS LETT, V414, P95, DOI 10.1016/S0014-5793(97)00975-7; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Soukupova M, 1999, EUR J CELL BIOL, V78, P357, DOI 10.1016/S0171-9335(99)80078-8; South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345; South ST, 1999, J CELL BIOL, V144, P255, DOI 10.1083/jcb.144.2.255; South ST, 2001, P NATL ACAD SCI USA, V98, P12027, DOI 10.1073/pnas.221289498; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; Tabak HF, 2006, BBA-MOL CELL RES, V1763, P1647, DOI 10.1016/j.bbamcr.2006.08.045; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	48	32	33	5	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3906	3916		10.1074/jbc.M806950200	http://dx.doi.org/10.1074/jbc.M806950200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19017643	hybrid			2022-12-27	WOS:000262872500059
J	Al Sorkhy, M; Craig, R; Market, B; Ard, R; Porter, LA				Al Sorkhy, Mohammad; Craig, Ryan; Market, Brenna; Ard, Ryan; Porter, Lisa A.			The Cyclin-dependent Kinase Activator, Spy1A, Is Targeted for Degradation by the Ubiquitin Ligase NEDD4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL DIVERSITY; THERAPEUTIC TARGET; PROTEIN LIGASES; BREAST-CANCER; DNA-DAMAGE; EXPRESSION; FAMILY; GROWTH; CELLS; PHOSPHORYLATION	Spy1A is a cyclin-like protein required for progression through the G(1)/S phase of the cell cycle. Elevated Spy1A protein levels have been implicated in tumorigenesis and are attributed to overriding the DNA damage response and enhancing cell proliferation. Understanding how Spy1A is produced and degraded is essential in resolving how it contributes to normal and abnormal growth processes. Herein, we demonstrate that Spy1A is degraded in a cell cycle-dependent manner during mitosis via the ubiquitin-proteasome system. We have resolved the E3 ligase and essential phosphorylation sites mediating Spy1A degradation. Furthermore, we have determined that non-degradable forms of Spy1A do not trigger cell cycle arrest but, rather, contribute to uncontrolled cell growth. Further investigation into the regulation of Spy1A may reveal novel strategies for understanding the etiology and progression of specific growth disorders.	[Al Sorkhy, Mohammad; Craig, Ryan; Ard, Ryan; Porter, Lisa A.] Univ Windsor, Windsor, ON N9B 3P4, Canada; [Market, Brenna] Univ Western Ontario, London, ON N6A 5C1, Canada	University of Windsor; Western University (University of Western Ontario)	Porter, LA (corresponding author), 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lporter@uwindsor.ca	, Lisa/AAA-3185-2020	, Lisa/0000-0002-9234-1712; Ard, Ryan/0000-0002-9070-9747; , Brenna/0000-0001-8266-4203	Canadian Institutes of Health Research and the Canadian Breast Cancer Research Alliance [151092]; University of Windsor; Ontario Graduate Scholarship in Science and Technology; Natural Science and Engineering Research Council PGD2; Natural Science and Engineering Research Council Canada Graduate Scholarship-Masters; Canadian Institutes of Health Research New Investigator Program	Canadian Institutes of Health Research and the Canadian Breast Cancer Research Alliance(Canadian Institutes of Health Research (CIHR)); University of Windsor; Ontario Graduate Scholarship in Science and Technology; Natural Science and Engineering Research Council PGD2(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science and Engineering Research Council Canada Graduate Scholarship-Masters(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research New Investigator Program(Canadian Institutes of Health Research (CIHR))	This work was supported by operating funds from a partnership between the Canadian Institutes of Health Research and the Canadian Breast Cancer Research Alliance Grant 151092. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; 1 Supported by the University of Windsor, the Ontario Graduate Scholarship in Science and Technology, and a Natural Science and Engineering Research Council PGD2.; 2 Supported by a Natural Science and Engineering Research Council Canada Graduate Scholarship-Masters.; 3 Supported by the Canadian Institutes of Health Research New Investigator Program.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Barnes EA, 2003, CANCER RES, V63, P3701; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chen C, 2006, MOL CANCER RES, V4, P695, DOI 10.1158/1541-7786.MCR-06-0182; Cheng A, 2005, CELL CYCLE, V4, P155, DOI 10.4161/cc.4.1.1347; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; Gastwirt RF, 2006, J BIOL CHEM, V281, P35425, DOI 10.1074/jbc.M604720200; Giatromanolaki A, 2007, EUR J CLIN INVEST, V37, P878, DOI 10.1111/j.1365-2362.2007.01866.x; Golipour A, 2008, CANCER RES, V68, P3591, DOI 10.1158/0008-5472.CAN-07-6453; Gutierrez GJ, 2006, NAT CELL BIOL, V8, P1084, DOI 10.1038/ncb1472; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Karaiskou A, 2001, J BIOL CHEM, V276, P36028, DOI 10.1074/jbc.M104722200; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; McAndrew CW, 2007, CELL CYCLE, V6, P1937, DOI 10.4161/cc.6.15.4520; Miller BS, 2005, CANCER RES, V65, P10123, DOI 10.1158/0008-5472.CAN-05-2752; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Murillas R, 2002, J BIOL CHEM, V277, P2897, DOI 10.1074/jbc.M110047200; Nurse PM, 2002, BIOSCIENCE REP, V22, P487, DOI 10.1023/A:1022017701871; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Porter LA, 2003, MOL BIOL CELL, V14, P3664, DOI 10.1091/mbc.E02-12-0820; Porter LA, 2002, J CELL BIOL, V157, P357, DOI 10.1083/jcb.200109045; Puputti M, 2006, MOL CANCER RES, V4, P927, DOI 10.1158/1541-7786.MCR-06-0085; Robinson PA, 2004, J CELL SCI, V117, P5191, DOI 10.1242/jcs.01539; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Ryden L, 2003, BREAST CANCER RES TR, V82, P147, DOI 10.1023/B:BREA.0000004357.92232.cb; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	33	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2617	2627		10.1074/jbc.M804847200	http://dx.doi.org/10.1074/jbc.M804847200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054764	Green Submitted, hybrid			2022-12-27	WOS:000262700900004
J	Cordier, F; Grubisha, O; Traincard, F; Veron, M; Delepierre, M; Agou, F				Cordier, Florence; Grubisha, Olivera; Traincard, Francois; Veron, Michel; Delepierre, Muriel; Agou, Fabrice			The Zinc Finger of NEMO Is a Functional Ubiquitin-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANHIDROTIC ECTODERMAL DYSPLASIA; GAMMA IKK-GAMMA; GENOTOXIC STRESS; COMPLEX ACTIVITY; POINT MUTATION; ACTIVATION; KINASE; PROTEIN; SITE	NEMO (NF-kappa B essential modulator) is a regulatory protein essential to the canonical NF-kappa B signaling pathway, notably involved in immune and inflammatory responses, apoptosis, and oncogenesis. Here, we report that the zinc finger (ZF) motif, located in the regulatory C-terminal half of NEMO, forms a specific complex with ubiquitin. We have investigated the NEMO ZF-ubiquitin interaction and proposed a structural model of the complex based on NMR, fluorescence, and mutagenesis data and on the sequence homology with the polymerase eta ubiquitin-binding zinc finger involved in DNA repair. Functional complementation assays and in vivo pull-down experiments further show that ZF residues involved in ubiquitin binding are functionally important and required for NF-kappa B signaling in response to tumor necrosis factor-alpha. Thus, our findings indicate that NEMO ZF is a bona fide ubiquitin-binding domain of the ubiquitin-binding zinc finger type.	[Cordier, Florence; Delepierre, Muriel] CNRS, URA 2185, Unite Resonance Magnet Nucl Biomol, F-75015 Paris, France; [Grubisha, Olivera; Traincard, Francois; Veron, Michel; Agou, Fabrice] CNRS, URA 2185, Unite Biochim Struct & Cellulaire, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Grubisha, O (corresponding author), CNRS, URA 2185, Unite Resonance Magnet Nucl Biomol, 25-28 Rue Dr Roux, F-75015 Paris, France.	fcordier@pasteur.fr; fagou@pasteur.fr	, AGOU/GXA-2760-2022	Cordier, Florence/0000-0002-5963-7773; Grubisha, Olivera/0000-0003-1067-1230	Canceropole Ile-de-France; Banque Nationale de Paris Paribas Foundation; Pasteur Foundation	Canceropole Ile-de-France(Region Ile-de-France); Banque Nationale de Paris Paribas Foundation; Pasteur Foundation	This work was supported by grants from the Canceropole Ile-de-France, the Banque Nationale de Paris Paribas Foundation, and the Pasteur Foundation. The costs of publication of this article were defrayed in part by the payment of pagecharges. This article must there fore be hereby marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; DevilleBonne D, 1996, BIOCHEMISTRY-US, V35, P14643, DOI 10.1021/bi960945m; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fontan E, 2007, FEBS J, V274, P2540, DOI 10.1111/j.1742-4658.2007.05788.x; Fusco F, 2008, HUM MUTAT, V29, P595, DOI 10.1002/humu.20739; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; NENCI A, 2006, NF KAPPAB 20 YEARS R, P84; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Smahi A, 2000, NATURE, V405, P466; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Temmerman ST, 2006, BLOOD, V108, P2324, DOI 10.1182/blood-2006-04-017210; Vinolo E, 2006, J BIOL CHEM, V281, P6334, DOI 10.1074/jbc.M510118200; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu ZH, 2007, J MOL MED, V85, P1187, DOI 10.1007/s00109-007-0227-9; Yang F, 2004, J IMMUNOL, V172, P2446, DOI 10.4049/jimmunol.172.4.2446; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	31	64	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2902	2907		10.1074/jbc.M806655200	http://dx.doi.org/10.1074/jbc.M806655200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19033441	Green Accepted, hybrid			2022-12-27	WOS:000262700900034
J	Lee, AY; Chiang, CM				Lee, A-Young; Chiang, Cheng-Ming			Chromatin Adaptor Brd4 Modulates E2 Transcription Activity and Protein Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PAPILLOMAVIRUS E2; P-TEFB; MITOTIC CHROMOSOMES; E6 PROMOTER; BINDING; ACTIVATION; DNA; DEGRADATION; COMPLEX	Brd4 is a chromatin adaptor containing tandem bromodomains binding to acetylated histone H3 and H4. Although Brd4 has been implicated in the transcriptional control of papilloma-virus-encoded E2 protein, it is unclear how Brd4 regulates E2 function and whether the involvement of Brd4 in transactivation and transrepression is common to different types of E2 proteins. Using DNase I footprinting performed with in vitro reconstituted human papillomavirus (HPV) chromatin and nucleosome-free DNA templates, we found that Brd4 facilitates E2 binding to its cognate sequences in chromatin depending on bromodomains and the E2-interacting region of Brd4. Moreover, the coactivator and corepressor function of Brd4 requires at least one intact bromodomain and is mediated by its direct association with E2 proteins encoded by cancer-inducing high risk HPV-16 and HPV-18, wart-causing low risk HPV-11, and bovine papillomavirus type 1, in part through enhancing the protein stability of E2 that is normally degraded via the ubiquitin dependent proteasome pathway. Our findings indicate that a chromatin adaptor can bridge and enhance the binding of a sequence-specific transcription factor to chromatin and further promote the stability of a labile transcription factor via direct protein-protein interaction.	[Lee, A-Young; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chiang, CM (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Bldg ND2-210H,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	cheng-ming.chiang@utsouthwestern.edu			National Institutes of Health [CA103867, CA124760]; University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center [CSCN 041]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA103867 and CA124760. This work is report CSCN 041 from the University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Bellanger S, 2001, J VIROL, V75, P7244, DOI 10.1128/JVI.75.16.7244-7251.2001; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; CHIANG CM, 1993, EMBO J, V12, P2749, DOI 10.1002/j.1460-2075.1993.tb05936.x; CHIANG CM, 1993, PEPTIDE RES, V6, P62; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Dao LD, 2006, J VIROL, V80, P4792, DOI 10.1128/JVI.80.10.4792-4800.2006; Demeret C, 1997, J VIROL, V71, P9343, DOI 10.1128/JVI.71.12.9343-9349.1997; DONG G, 1994, J VIROL, V68, P1115, DOI 10.1128/JVI.68.2.1115-1127.1994; DOSTATNI N, 1991, GENE DEV, V5, P1657, DOI 10.1101/gad.5.9.1657; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; HIROCHIKA H, 1988, GENE DEV, V2, P54, DOI 10.1101/gad.2.1.54; Hou SY, 2002, J BIOL CHEM, V277, P45619, DOI 10.1074/jbc.M206829200; Hou SY, 2000, MOL CELL BIOL, V20, P113, DOI 10.1128/MCB.20.1.113-125.2000; Ilves I, 2006, J VIROL, V80, P3660, DOI 10.1128/JVI.80.7.3660-3665.2006; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kovelman R, 1996, J VIROL, V70, P7549, DOI 10.1128/JVI.70.11.7549-7560.1996; LI R, 1989, GENE DEV, V3, P510, DOI 10.1101/gad.3.4.510; McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Parish JL, 2006, MOL CELL, V24, P867, DOI 10.1016/j.molcel.2006.11.005; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; Schweiger MR, 2006, J VIROL, V80, P4276, DOI 10.1128/JVI.80.9.4276-4285.2006; Senechal H, 2007, VIROLOGY, V358, P10, DOI 10.1016/j.virol.2006.08.035; TAN SH, 1994, J VIROL, V68, P6411, DOI 10.1128/JVI.68.10.6411-6420.1994; THIERRY F, 1990, MOL CELL BIOL, V10, P4431, DOI 10.1128/MCB.10.8.4431; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Wang WM, 2008, PROTEIN EXPRES PURIF, V59, P144, DOI 10.1016/j.pep.2008.01.016; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu SY, 1999, J BIOL CHEM, V274, P23480, DOI 10.1074/jbc.274.33.23480; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7	35	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2778	2786		10.1074/jbc.M805835200	http://dx.doi.org/10.1074/jbc.M805835200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19038968	hybrid, Green Published			2022-12-27	WOS:000262700900020
J	Schnizler, MK; Schnizler, K; Zha, XM; Hall, DD; Wemmie, JA; Hell, JW; Welsh, MJ				Schnizler, Mikael K.; Schnizler, Katrin; Zha, Xiang-Ming; Hall, Duane D.; Wemmie, John A.; Hell, Johannes W.; Welsh, Michael J.			The Cytoskeletal Protein alpha-Actinin Regulates Acid-sensing Ion Channel 1a through a C-terminal Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ CHANNEL; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; ACTIVATED CURRENTS; SODIUM-CHANNEL; NMDA RECEPTOR; KINASE-II; SUBUNIT; CALCIUM; EXPRESSION	The acid-sensing ion channel 1a (ASIC1a) is widely expressed in central and peripheral neurons where it generates transient cation currents when extracellular pH falls. ASIC1a confers pH-dependent modulation on postsynaptic dendritic spines and has critical effects in neurological diseases associated with a reduced pH. However, knowledge of the proteins that interact with ASIC1a and influence its function is limited. Here, we show that alpha-actinin, which links membrane proteins to the actin cytoskeleton, associates with ASIC1a in brain and in cultured cells. The interaction depended on an alpha-actinin-binding site in the ASIC1a C terminus that was specific for ASIC1a versus other ASICs and for alpha-actinin-1 and -4. Co-expressing alpha-actinin-4 altered ASIC1a current density, pH sensitivity, desensitization rate, and recovery from desensitization. Moreover, reducing alpha-actinin expression altered acid-activated currents in hippocampal neurons. These findings suggest that alpha-actinins may link ASIC1a to a macromolecular complex in the postsynaptic membrane where it regulates ASIC1a activity.	[Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, EMRB 500, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Schnizler, Mikael K.; Zha, Xiang-Ming; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Schnizler, Katrin; Hall, Duane D.; Hell, Johannes W.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Wemmie, John A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Wemmie, John A.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Welsh, MJ (corresponding author), Univ Iowa, Howard Hughes Med Inst, EMRB 500, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Hall, Duane/ACD-6815-2022; Hell, Johannes W./P-5085-2019	Hall, Duane/0000-0003-2228-0966; Wemmie, John/0000-0001-7531-9065; Welsh, Michael/0000-0002-1646-6206; Zha, Xiangming/0000-0001-9490-2731	National Institutes of Health [AG017502]; Deutsche Forschungsgemeinschaft DFG Forschungsstipendium Schn [740/2-1]; American Heart Association [0535235N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL061234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG017502, R01AG017502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft DFG Forschungsstipendium Schn(German Research Foundation (DFG)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG017502 (to J. W. H.). This work was also supported in part by Deutsche Forschungsgemeinschaft DFG Forschungsstipendium Schn 740/2-1 (to M. K. S.) and American Heart Association Grant 0535235N (to D. D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allison DW, 1998, J NEUROSCI, V18, P2423; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bhatt A, 2002, J CELL SCI, V115, P3415; Celli L, 2006, J IMMUNOL, V177, P4113, DOI 10.4049/jimmunol.177.6.4113; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Duggan A, 2002, J BIOL CHEM, V277, P5203, DOI 10.1074/jbc.M104748200; FLOOD G, 1995, J MOL BIOL, V252, P227, DOI 10.1006/jmbi.1995.0490; Fraley TS, 2005, J BIOL CHEM, V280, P15479, DOI 10.1074/jbc.M500631200; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Hruska-Hageman AM, 2002, BIOCHEM J, V361, P443, DOI 10.1042/0264-6021:3610443; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Li Q, 2007, J NEUROCHEM, V103, P2391, DOI 10.1111/j.1471-4159.2007.04940.x; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Maruoka ND, 2000, FEBS LETT, V473, P188, DOI 10.1016/S0014-5793(00)01521-0; Mazzochi C, 2006, AM J PHYSIOL-RENAL, V291, pF1113, DOI 10.1152/ajprenal.00195.2006; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakagawa T, 2004, NEUROPHARMACOLOGY, V47, P734, DOI 10.1016/j.neuropharm.2004.07.022; Nuriya M, 2005, J NEUROCHEM, V95, P544, DOI 10.1111/j.1471-4159.2005.03410.x; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Rao A, 1998, J NEUROSCI, V18, P1217; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sadeghi A, 2002, AM J PHYSIOL-CELL PH, V282, pC1502, DOI 10.1152/ajpcell.00435.2001; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zuckerman JB, 1999, J BIOL CHEM, V274, P23286, DOI 10.1074/jbc.274.33.23286	63	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2697	2705		10.1074/jbc.M805110200	http://dx.doi.org/10.1074/jbc.M805110200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19028690	Green Published, hybrid			2022-12-27	WOS:000262700900012
J	Elias, BC; Suzuki, T; Seth, A; Giorgianni, F; Kale, G; Shen, L; Turner, JR; Naren, A; Desiderio, DM; Rao, R				Elias, Bertha C.; Suzuki, Takuya; Seth, Ankur; Giorgianni, Francesco; Kale, Gautam; Shen, Le; Turner, Jerrold R.; Naren, Anjaparavanda; Desiderio, Dominic M.; Rao, Radhakrishna			Phosphorylation of Tyr-398 and Tyr-402 in Occludin Prevents Its Interaction with ZO-1 and Destabilizes Its Assembly at the Tight Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; INTESTINAL EPITHELIAL BARRIER; STRESS-INDUCED DISRUPTION; POSSIBLE INVOLVEMENT; BINDING; EXPRESSION; LOCALIZATION; COMPLEXES; CALCIUM; DOMAIN	Occludin is phosphorylated on tyrosine residues during the oxidative stress-induced disruption of tight junction, and in vitro phosphorylation of occludin by c-Src attenuates its binding to ZO-1. In the present study mass spectrometric analyses of C-terminal domain of occludin identified Tyr-379 and Tyr-383 in chicken occludin as the phosphorylation sites, which are located in a highly conserved sequence of occludin, YETDYTT; Tyr-398 and Tyr-402 are the corresponding residues in human occludin. Deletion of YETDYTT motif abolished the c-Src-mediated phosphorylation of occludin and the regulation of ZO-1 binding. Y398A and Y402A mutations in human occludin also abolished the c-Src-mediated phosphorylation and regulation of ZO-1 binding. Y398D/Y402D mutation resulted in a dramatic reduction in ZO-1 binding even in the absence of c-Src. Similar to wild type occludin, its Y398A/Y402A mutant was localized at the plasma membrane and cell-cell contact sites in Rat-1 cells. However, Y398D/Y402D mutants of occludin failed to localize at the cell-cell contacts. Calcium-induced reassembly of Y398D/Y402D mutant occludin in Madin-Darby canine kidney cells was significantly delayed compared with that of wild type occludin or its T398A/T402A mutant. Furthermore, expression of Y398D/Y402D mutant of occludin sensitized MDCK cells for hydrogen peroxide-induced barrier disruption. This study reveals a unique motif in the occludin sequence that is involved in the regulation of ZO-1 binding by reversible phosphorylation of specific Tyr residues.	[Elias, Bertha C.; Suzuki, Takuya; Seth, Ankur; Kale, Gautam; Naren, Anjaparavanda; Rao, Radhakrishna] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Giorgianni, Francesco; Desiderio, Dominic M.] Univ Tennessee, Hlth Sci Ctr, Charles B Stout Neurosci Mass Spectrometry Lab, Memphis, TN 38163 USA; [Shen, Le; Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago	Rao, R (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rkrao@physio1.utmem.edu	Shen, Le/E-7866-2010; Turner, Jerrold R/A-6895-2009; Seth, Ankur/AAE-1800-2020; Suzuki, Takuya/H-3750-2019; Turner, Jerrold/H-1502-2019	Turner, Jerrold R/0000-0003-0627-9455; Suzuki, Takuya/0000-0003-3709-543X; Seth, Ankur/0000-0003-0140-4691	National Institutes of Health [R01-DK55532, R01-AA12307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK55532 and R01-AA12307. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AndoAkatsuka Y, 1996, J CELL BIOL, V133, P43, DOI 10.1083/jcb.133.1.43; Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280, DOI 10.1152/ajpgi.2001.280.6.G1280; Balkovetz DF, 2006, AM J PHYSIOL-RENAL, V290, pF572, DOI 10.1152/ajprenal.00135.2005; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Coyne CB, 2002, MOL BIOL CELL, V13, P3218, DOI 10.1091/mbc.E02-03-0134; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Itoh M, 1999, J BIOL CHEM, V274, P5981, DOI 10.1074/jbc.274.9.5981; Kale G, 2003, BIOCHEM BIOPH RES CO, V302, P324, DOI 10.1016/S0006-291X(03)00167-0; Keon BH, 1996, J CELL BIOL, V134, P1003, DOI 10.1083/jcb.134.4.1003; Laukoetter MG, 2006, CURR OPIN GASTROEN, V22, P85, DOI 10.1097/01.mog.0000203864.48255.4f; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Nusrat A, 2000, J BIOL CHEM, V275, P29816, DOI 10.1074/jbc.M002450200; Rao R, 1999, BIOCHEM PHARMACOL, V57, P685, DOI 10.1016/S0006-2952(98)00333-5; Rao R, 2008, FRONT BIOSCI-LANDMRK, V13, P7210, DOI 10.2741/3223; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Sheth P, 2003, J BIOL CHEM, V278, P49239, DOI 10.1074/jbc.M305654200; STEVENS C, 1992, DIGEST DIS SCI, V37, P818, DOI 10.1007/BF01300378; STUART RO, 1994, J CELL PHYSIOL, V159, P423, DOI 10.1002/jcp.1041590306; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; ZHONG Y, 1993, J CELL BIOL, V120, P477, DOI 10.1083/jcb.120.2.477	40	142	151	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1559	1569		10.1074/jbc.M804783200	http://dx.doi.org/10.1074/jbc.M804783200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017651	Green Published, hybrid			2022-12-27	WOS:000262330100024
J	Mene-Saffrane, L; Dubugnon, L; Chetelat, A; Stolz, S; Gouhier-Darimont, C; Farmer, EE				Mene-Saffrane, Laurent; Dubugnon, Lucie; Chetelat, Aurore; Stolz, Stephanie; Gouhier-Darimont, Caroline; Farmer, Edward E.			Nonenzymatic Oxidation of Trienoic Fatty Acids Contributes to Reactive Oxygen Species Management in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; SIGNAL-TRANSDUCTION; SALICYLIC-ACID; DEFENSE; MUTANT; PATHWAYS; RESISTANCE; JASMONATE; STRESS; EXPRESSION	In higher plants such as Arabidopsis thaliana, omega-3 trienoic fatty acids (TFAs), represented mainly by alpha-linolenic acid, serve as precursors of jasmonic acid (JA), a potent lipid signal molecule essential for defense. The JA-independent roles of TFAs were investigated by comparing the TFA- and JA-deficient fatty acid desaturase triple mutant (fad3-2 fad7-2 fad8 (fad3 fad7 fad8)) with the aos (allene oxide synthase) mutant that contains TFAs but is JA-deficient. When challenged with the fungus Botrytis, resistance of the fad3 fad7 fad8 mutant was reduced when compared with the aos mutant, suggesting that TFAs play a role in cell survival independently of being the precursors of JA. An independent genetic approach using the lesion mimic mutant accelerated cell death2 (acd2-2) confirmed the importance of TFAs in containing lesion spread, which was increased in the lines in which the fad3 fad7 fad8 and acd2-2 mutations were combined when compared with the aos acd2-2 lines. Malondialdehyde, found to result from oxidative TFA fragmentation during lesion formation, was measured by gas chromatography-mass spectrometry. Its levels correlated with the survival of the tissue. Furthermore, plants lacking TFAs overproduced salicylic acid (SA), hydrogen peroxide, and transcripts encoding several SA-regulated and SA biosynthetic proteins. The data suggest a physiological role for TFAs as sinks for reactive oxygen species.	[Mene-Saffrane, Laurent; Dubugnon, Lucie; Chetelat, Aurore; Stolz, Stephanie; Gouhier-Darimont, Caroline; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Mène-Saffrané, Laurent/A-7440-2013; Farmer, Edward E/H-1635-2011	Mène-Saffrané, Laurent/0000-0002-1763-7871; 	Swiss National Science Foundation (NSF); University of Lausanne genomics; Swiss NSF [3100A0101711]	Swiss National Science Foundation (NSF)(Swiss National Science Foundation (SNSF)); University of Lausanne genomics; Swiss NSF(Swiss National Science Foundation (SNSF))	This work was supported by a grant from the Swiss National Science Foundation (NSF) (National Center of Competence in Research "Plant Survival"), a University of Lausanne genomics grant, and Swiss NSF Grant 3100A0101711. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P15; BLOCK MA, 1983, J BIOL CHEM, V258, P3281; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Frankel E. N., 2005, OILY PRESS LIPID LIB, V18; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; HARWOOD JL, 1987, METHOD ENZYMOL, V148, P475; HARWOOD JL, 1982, BIOCH PLANTS COMPREH, V4; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Kachroo A, 2003, PLANT CELL, V15, P2952, DOI 10.1105/tpc.017301; Kachroo P, 2001, P NATL ACAD SCI USA, V98, P9448, DOI 10.1073/pnas.151258398; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Mene-Saffrane L, 2007, J BIOL CHEM, V282, P35749, DOI 10.1074/jbc.M706838200; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Mueller MJ, 2006, PLANT J, V45, P472, DOI 10.1111/j.1365-313X.2005.02614.x; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; Poulson ME, 2002, PHOTOSYNTH RES, V72, P55, DOI 10.1023/A:1016054027464; Rao MV, 1999, PLANT J, V17, P603, DOI 10.1046/j.1365-313X.1999.00400.x; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Routaboul JM, 2000, PLANT PHYSIOL, V124, P1697, DOI 10.1104/pp.124.4.1697; Rozhon W, 2005, ANAL BIOANAL CHEM, V382, P1620, DOI 10.1007/s00216-005-3326-x; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Sasaki-Sekimoto Y, 2005, PLANT J, V44, P653, DOI 10.1111/j.1365-313X.2005.02560.x; Shah J, 2001, PLANT J, V25, P563, DOI 10.1046/j.1365-313x.2001.00992.x; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Vijayan P, 2002, PLANT PHYSIOL, V129, P876, DOI 10.1104/pp.004341; Vollenweider S, 2000, PLANT J, V24, P467, DOI 10.1046/j.1365-313x.2000.00897.x; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Weber H, 2004, PLANT J, V37, P877, DOI 10.1111/j.1365-313X.2003.02013.x; Yaeno T, 2004, PLANT J, V40, P931, DOI 10.1111/j.1365-313X.2004.02260.x; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Yeo HC, 1999, METHOD ENZYMOL, V300, P70	40	79	82	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1702	1708		10.1074/jbc.M807114200	http://dx.doi.org/10.1074/jbc.M807114200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18996838	hybrid			2022-12-27	WOS:000262330100039
J	Tapryal, N; Mukhopadhyay, C; Das, D; Fox, PL; Mukhopadhyay, CK				Tapryal, Nisha; Mukhopadhyay, Chaitali; Das, Dola; Fox, Paul L.; Mukhopadhyay, Chinmay K.			Reactive Oxygen Species Regulate Ceruloplasmin by a Novel mRNA Decay Mechanism Involving Its 3 '-Untranslated Region IMPLICATIONS IN NEURODEGENERATIVE DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; OXIDATIVE STRESS; FERROXIDASE ACTIVITY; IRON UPTAKE; GENE-EXPRESSION; DOWN-REGULATION; CELLS; ACTIVATION; HYPOXIA; COPPER	Ceruloplasmin (Cp), a copper-containing protein, plays a significant role in body iron homeostasis as aceruloplasminemia patients and Cp knock-out mice exhibit iron overload in several tissues including liver and brain. Several other functions as oxidant, as antioxidant, and in nitric oxide metabolism are also attributed to Cp. Despite its role in iron oxidation and other biological oxidation reactions the regulation of Cp by reactive oxygen species (ROS) remains unexplored. Cp is synthesized in liver as a secretory protein and predominantly as a glycosylphosphatidylinositol-anchored membrane-bound form in astroglia. In this study we demonstrated that Cp expression is decreased by an mRNA decay mechanism in response to extracellular (H2O2) or intracellular oxidative stress (by mitochondrial chain blockers rotenone or antimycin A) in both hepatic and astroglial cells. The promotion of Cp mRNA decay is conferred by its 3'- untranslated region (UTR). When chloramphenicol acetyltransferase (CAT) gene was transfected as a chimera with Cp 3'- UTR in hepatic or astroglial cells, in response to either H2O2, rotenone, or antimycin A, the expression of CAT transcript was decreased, whereas expression of a 3'-UTR-less CAT transcript remained unaffected. RNA gel shift assay showed significant reduction in 3'-UTR-binding protein complex by ROS in both cell types that was reversed by the antioxidant N-acetylcysteine suggesting that ROS affects RNA-protein complex formation to promote Cp mRNA decay. Our finding is not only the first demonstration of regulation of Cp by ROS by a novel post-transcriptional mechanism but also provides a mechanism of iron deposition in neurodegenerative diseases.	[Tapryal, Nisha; Mukhopadhyay, Chaitali; Das, Dola; Mukhopadhyay, Chinmay K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India; [Fox, Paul L.] Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Jawaharlal Nehru University, New Delhi; Cleveland Clinic Foundation	Mukhopadhyay, CK (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	ckm2300@mail.jnu.ac.in	Das, Dola/I-1802-2014		Department of Biotechnology and Council of Scientific and Industrial Research, India; Council of Scientific and Industrial Research, India	Department of Biotechnology and Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported in part by research grants from the Department of Biotechnology and Council of Scientific and Industrial Research, India ( to C. K. M.), and by a fellowship from the Council of Scientific and Industrial Research, India ( to N.T. and D. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Attieh ZK, 1999, J BIOL CHEM, V274, P1116, DOI 10.1074/jbc.274.2.1116; Biswas S, 2007, AM J PHYSIOL-HEART C, V292, pH758, DOI 10.1152/ajpheart.00718.2006; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Caltagirone A, 2001, J BIOL CHEM, V276, P19738, DOI 10.1074/jbc.M100245200; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Das D, 2007, BIOCHEM J, V402, P135, DOI 10.1042/BJ20060963; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; FLEMING RE, 1991, AM J PHYSIOL, V260, pL68, DOI 10.1152/ajplung.1991.260.2.L68; Fox PL, 2000, FREE RADICAL BIO MED, V28, P1735, DOI 10.1016/S0891-5849(00)00231-8; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GITLIN JD, 1988, J BIOL CHEM, V263, P6281; GOLDSTEIN IM, 1979, J BIOL CHEM, V254, P4040; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; Harris ZL, 2004, BLOOD, V103, P4672, DOI 10.1182/blood-2003-11-4060; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; He Y, 2003, FREE RADICAL BIO MED, V35, P540, DOI 10.1016/S0891-5849(03)00385-X; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Jones RJ, 2000, J HEPATOL, V32, P703, DOI 10.1016/S0168-8278(00)80234-2; Kaneko K, 2008, NEUROSCI LETT, V446, P56, DOI 10.1016/j.neulet.2008.08.089; Ke Y, 2006, J CELL BIOCHEM, V98, P912, DOI 10.1002/jcb.20740; Klomp LWJ, 1996, HUM MOL GENET, V5, P1989, DOI 10.1093/hmg/5.12.1989; Kohgo Y, 2007, WORLD J GASTROENTERO, V13, P4699, DOI 10.3748/wjg.v13.i35.4699; KOSCHINSKY ML, 1986, P NATL ACAD SCI USA, V83, P5086, DOI 10.1073/pnas.83.14.5086; Kowdley KV, 2004, GASTROENTEROLOGY, V127, pS79, DOI 10.1016/j.gastro.2004.09.019; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; MIYAJIMA H, 1987, NEUROLOGY, V37, P761, DOI 10.1212/WNL.37.5.761; Morel Y, 1998, J BIOL CHEM, V273, P26969, DOI 10.1074/jbc.273.41.26969; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; Mukhopadhyay CK, 1998, SCIENCE, V279, P714, DOI 10.1126/science.279.5351.714; Mukhopadhyay CK, 1996, J BIOL CHEM, V271, P14773, DOI 10.1074/jbc.271.25.14773; Mukhopadhyay CK, 1997, P NATL ACAD SCI USA, V94, P11546, DOI 10.1073/pnas.94.21.11546; OSAKI S, 1969, J BIOL CHEM, V244, P5757; OSAKI S, 1966, J BIOL CHEM, V241, P5053; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Patel BN, 2002, J NEUROSCI, V22, P6578; RAGAN HA, 1969, AM J PHYSIOL, V217, P1320, DOI 10.1152/ajplegacy.1969.217.5.1320; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Sen P, 2005, FEBS LETT, V579, P4402, DOI 10.1016/j.febslet.2005.06.081; Seshadri V, 2002, J BIOL CHEM, V277, P27903, DOI 10.1074/jbc.M203610200; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; TAETLE R, 1987, BLOOD, V70, P852; Vassiliev V, 2005, BRAIN RES REV, V49, P633, DOI 10.1016/j.brainresrev.2005.03.003; Xie JX, 2002, MOL BRAIN RES, V99, P12, DOI 10.1016/S0169-328X(01)00336-9	54	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1873	1883		10.1074/jbc.M804079200	http://dx.doi.org/10.1074/jbc.M804079200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19019832	hybrid			2022-12-27	WOS:000262330100058
J	Ju, PC; Pages, G; Riek, RP; Chen, PC; Torres, AM; Bansal, PS; Kuyucak, S; Kuchel, PW; Vandenberg, JI				Ju, Pengchu; Pages, Guilhem; Riek, R. Peter; Chen, Po-chia; Torres, Allan M.; Bansal, Paramjit S.; Kuyucak, Serdar; Kuchel, Philip W.; Vandenberg, Jamie I.			The Pore Domain Outer Helix Contributes to Both Activation and Inactivation of the hERG K+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM-CHANNEL; MOLECULAR-DYNAMICS; BIOLOGICAL MACROMOLECULES; CARDIAC-ARRHYTHMIA; NMR-SPECTROSCOPY; ALPHA-HELIX; PROTEINS; IDENTIFICATION; RECTIFICATION; SENSITIVITY	Ion flow in many voltage-gated K+ channels (VGK), including the (human ether-a-go-go-related gene) hERG channel, is regulated by reversible collapse of the selectivity filter. hERG channels, however, exhibit low sequence homology to other VGKs, particularly in the outer pore helix (S5) domain, and we hypothesize that this contributes to the unique activation and inactivation kinetics in hERG K+ channels that are so important for cardiac electrical activity. The S5 domain in hERG identified by NMR spectroscopy closely corresponded to the segment predicted by bioinformatics analysis of 676 members of the VGK superfamily. Mutations to approximately every third residue, from Phe(551) to Trp(563), affected steady state activation, whereas mutations to approximately every third residue on an adjacent face and spanning the entire S5 segment perturbed inactivation, suggesting that the whole span of S5 experiences a rearrangement associated with inactivation. We refined a homology model of the hERG pore domain using constraints from the mutagenesis data with residues affecting inactivation pointing in toward S6. In this model the three residues with maximum impact on activation (W563A, F559A, and F551A) face out toward the voltage sensor. In addition, the residues that when mutated to alanine, or from alanine to valine, that did not express (Ala(561), His(562), Ala(565), Trp(568), and Ile(571)), all point toward the pore helix and contribute to close hydrophobic packing in this region of the channel.	[Ju, Pengchu; Riek, R. Peter; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Program Cardiac Electroph, Div Mol Cardiol & Biophys, Darlinghurst, NSW 2010, Australia; [Ju, Pengchu; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW 2010, Australia; [Pages, Guilhem; Kuchel, Philip W.; Vandenberg, Jamie I.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Chen, Po-chia; Kuyucak, Serdar] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Torres, Allan M.] Univ Western Sydney, Sch Biomed & Hlth Sci, Penrith, NSW 1797, Australia; [Bansal, Paramjit S.] Australian Nucl Sci & Technol Org, Menai, NSW 2234, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of Sydney; University of Sydney; Western Sydney University; Australian Nuclear Science & Technology Organisation	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Res Program Cardiac Electroph, Div Mol Cardiol & Biophys, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	j.vandenberg@victorchang.edu.au	Torres, Allan/GSN-4624-2022; Chen, Po-chia/J-4521-2019; Kuyucak, Serdar/AAH-8417-2021; Vandenberg, Jamie I/B-6608-2013; Pages, Guilhem/B-5422-2010	Chen, Po-chia/0000-0003-2272-2082; Vandenberg, Jamie I/0000-0002-3859-3716; Pages, Guilhem/0000-0001-9368-5237; Kuchel, Philip/0000-0003-4100-7332; Kuyucak, Serdar/0000-0003-4315-9532	National Health and Medical Research Council [459002]; Australian Research Council [DP0450808]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by Project Grant 459002 from the National Health and Medical Research Council (to J. I. V. and S. K.) and Project Grant DP0450808 from the Australian Research Council (to P. W. K. and J. I. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASHCROFT FM, 2001, ION CHANNELS DIS; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Chakrapani S, 2008, STRUCTURE, V16, P398, DOI 10.1016/j.str.2007.12.015; Chen J, 2002, P NATL ACAD SCI USA, V99, P12461, DOI 10.1073/pnas.192367299; Clarke CE, 2006, J PHYSIOL-LONDON, V573, P291, DOI 10.1113/jphysiol.2006.108332; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Gao LZ, 2005, P NATL ACAD SCI USA, V102, P17630, DOI 10.1073/pnas.0505158102; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Mitrovic AD, 1998, J BIOL CHEM, V273, P14698, DOI 10.1074/jbc.273.24.14698; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Perry M, 2007, P NATL ACAD SCI USA, V104, P13827, DOI 10.1073/pnas.0703934104; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; RIEK RP, 1995, J THEOR BIOL, V172, P245; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schneider R, 2008, J AM CHEM SOC, V130, P7427, DOI 10.1021/ja800190c; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Stansfeld PJ, 2007, PROTEINS, V68, P568, DOI 10.1002/prot.21400; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Torres AM, 2003, J BIOL CHEM, V278, P42136, DOI 10.1074/jbc.M212824200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Vandenberg JI, 2004, EUR BIOPHYS J BIOPHY, V33, P89, DOI 10.1007/s00249-003-0338-3; Vandenberg JI, 2001, TRENDS PHARMACOL SCI, V22, P240, DOI 10.1016/S0165-6147(00)01662-X; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zangger K, 2008, TOXICON, V52, P246, DOI 10.1016/j.toxicon.2008.05.011	51	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1000	1008		10.1074/jbc.M806400200	http://dx.doi.org/10.1074/jbc.M806400200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18996846	Green Published, hybrid			2022-12-27	WOS:000262122900036
J	Stevens, C; Lin, Y; Harrison, B; Burch, L; Ridgway, RA; Sansom, O; Hupp, T				Stevens, Craig; Lin, Yao; Harrison, Ben; Burch, Lindsay; Ridgway, Rachel A.; Sansom, Owen; Hupp, Ted			Peptide Combinatorial Libraries Identify TSC2 as a Death-associated Protein Kinase (DAPK) Death Domain-binding Protein and Reveal a Stimulatory Role for DAPK in mTORC1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS; INDUCED APOPTOSIS; GENE-PRODUCTS; CELL-DEATH; PHOSPHORYLATION; AUTOPHAGY; SURVIVAL; ERK; S6; IDENTIFICATION	Death-associated protein kinase (DAPK) is a multidomain enzyme that plays a central role in autophagic and apoptotic signaling, although the protein-protein interactions regulating DAPK functions are not well defined. Peptide aptamer libraries were used to identify the tumor suppressor protein tuberin (TSC2) as a novel DAPK death domain-binding protein, and we evaluated whether DAPK is a positive or negative effector of the TSC2-regulated mammalian target of rapamycin (mTORC1) signaling pathway. Binding studies using death domain miniproteins invitro and deletion analysis in vivo determined that the death domain of DAPK is the major site for the interaction with TSC2. Recombinant DAPK phosphorylates TSC2 in vitro, and DAPK kinase activity is stimulated by growth factor signaling. Transfection of DAPK promotes phosphorylation of TSC2 in vivo, whereas short interfering RNA-mediated attenuation of DAPK reduces growth factor-stimulated phosphorylation of TSC2. DAPK-dependent phosphorylation leads to TSC1-TSC2 complex dissociation, and consequently manipulation of DAPK by transfection or short interfering RNA demonstrated that DAPK is a positive regulator of mTORC1 in response to growth factor activation. Epistatic studies suggest that DAPK functions downstream from the RAS-MEK-ERK and phosphatidylinositol 3-kinase-AKT growth factor signaling pathways. DAPK(+/-) mouse embryo fibroblasts have attenuated mTORC1 signaling compared with DAPK(+/+) counterparts, and overexpression of DAPK in DAPK(+/-) MEFs stimulates mTORC1 activity. These data uncover a novel interaction between DAPK and TSC2 proteins that has revealed a positive link between growth factor stimulation of DAPK and mTORC1 signaling that may ultimately affect autophagy, cell survival, or apoptosis.	[Stevens, Craig; Lin, Yao; Harrison, Ben; Burch, Lindsay; Hupp, Ted] Univ Edinburgh, Inst Genet & Mol Med, CRUK Signal Transduct Labs P53, Edinburgh EH4 2XR, Midlothian, Scotland; [Ridgway, Rachel A.; Sansom, Owen] CRUK Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of Edinburgh; Beatson Institute	Hupp, T (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, CRUK Signal Transduct Labs P53, Edinburgh EH4 2XR, Midlothian, Scotland.	ted.hupp@ed.ac.uk		, yao/0000-0002-0493-0155; Sansom, Owen J./0000-0001-9540-3010; Harrison, Benjamin/0000-0002-6078-5060	Cancer Research UK and the Biotechnology and Biological Sciences Research Council RASOR Proteomics consortium	Cancer Research UK and the Biotechnology and Biological Sciences Research Council RASOR Proteomics consortium(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Cancer Research UK and the Biotechnology and Biological Sciences Research Council RASOR Proteomics consortium. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bialik S, 2004, CELL DEATH DIFFER, V11, P631, DOI 10.1038/sj.cdd.4401386; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Chen CH, 2005, EMBO J, V24, P294, DOI 10.1038/sj.emboj.7600510; Cohen O, 1999, J CELL BIOL, V146, P141; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Gozuacik D, 2006, AUTOPHAGY, V2, P74, DOI 10.4161/auto.2.2.2459; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harrison B, 2008, J BIOL CHEM, V283, P9999, DOI 10.1074/jbc.M706040200; Henshall DC, 2003, J NEUROCHEM, V86, P1260, DOI 10.1046/j.1471-4159.2003.01934.x; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Jin YJ, 2006, J BIOL CHEM, V281, P39033, DOI 10.1074/jbc.M605097200; Jin YJ, 2003, J BIOL CHEM, V278, P51587, DOI 10.1074/jbc.M309165200; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kuo JC, 2003, J CELL SCI, V116, P4777, DOI 10.1242/jcs.00794; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lin Y, 2007, J BIOL CHEM, V282, P16792, DOI 10.1074/jbc.M611559200; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Raveh T, 2000, P NATL ACAD SCI USA, V97, P1572, DOI 10.1073/pnas.020519497; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schumacher AM, 2006, BIOCHEMISTRY-US, V45, P13614, DOI 10.1021/bi060413y; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shohat G, 2001, J BIOL CHEM, V276, P47460, DOI 10.1074/jbc.M105133200; Stevens C, 2007, J BIOL CHEM, V282, P13791, DOI 10.1074/jbc.M605649200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wang WJ, 2002, J CELL BIOL, V159, P169, DOI 10.1083/jcb.200204050; Wang WJ, 2007, MOL CELL, V27, P701, DOI 10.1016/j.molcel.2007.06.037	43	66	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					334	344		10.1074/jbc.M805165200	http://dx.doi.org/10.1074/jbc.M805165200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18974095	hybrid			2022-12-27	WOS:000261974800038
J	Dhawan, P; Weider, R; Christakos, S				Dhawan, Puneet; Weider, Robert; Christakos, Sylvia			CCAAT Enhancer-binding Protein alpha Is a Molecular Target of 1,25-Dihydroxyvitamin D-3 in MCF-7 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; C/EBP-ALPHA; D ANALOG; IN-VIVO; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; DOWN-REGULATION; REGULATORY ROLE; ONCOGENIC RAS; PROLIFERATION	Numerous studies have shown that the active form of vitamin D, 1,25(OH)(2)D-3, can exert growth inhibitory effects on human breast cancer cells and mammary tumor growth. However, the molecular mechanisms remain to be fully delineated. This study demonstrates for the first time that CCAAT enhancer-binding protein alpha(C/EBP alpha), a member of the C/EBP family of transcription factors, is induced by 1,25(OH)(2)D-3 and is a potent enhancer of VDR transcription in MCF-7 breast cancer cells. 1,25(OH)(2)D-3 was found to induce C/EBP alpha as well as VDR expression in MCF-7 cells. C/EBP alpha was not detected in MDA-MB-231 cells that are poorly responsive to 1,25(OH)(2)D-3. Antiproliferative effects of 1,25(OH)(2)D-3 and induction of VDR were observed in MDA-MB-231 cells transfected with C/EBP alpha, and knockdown of C/EBP alpha suppressed VDR and antiproliferative effects of 1,25(OH)(2)D-3 in MCF-7 cells. Transfection of C/EBP alpha in MCF-7 cells resulted in a dose-dependent enhancement of hVDR transcription. Our studies show that C/EBP alpha can bind to Brahma (Brm), an ATPase that is a component of the SWI/SNF complex, and cooperate with Brm in the regulation of hVDR transcription in MCF-7 cells. Because the levels of VDR in MCF-7 breast cancer cells correlate with the antiproliferative effects of 1,25(OH)(2)D-3 and because C/EBP alpha has been suggested as a potential tumor suppressor in breast cancer, these findings provide important mechanisms whereby 1,25(OH)(2)D-3 may act to inhibit growth of breast cancer cells. These findings also identify C/EBP alpha as a 1,25(OH)(2)D-3 target in breast cancer cells and provide evidence for C/EBP alpha as a candidate for breast cancer treatment.	[Dhawan, Puneet; Christakos, Sylvia] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Weider, Robert] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Christakos, S (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.	christak@umdnj.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038961] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 38961, R01 DK038961-22, R01 DK038961] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABE J, 1991, ENDOCRINOLOGY, V129, P832, DOI 10.1210/endo-129-2-832; ANZANO MA, 1994, CANCER RES, V54, P1653; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng JW, 2007, J BIOL CHEM, V282, P30535, DOI 10.1074/jbc.M704829200; CHOUVET C, 1986, J STEROID BIOCHEM, V24, P373, DOI 10.1016/0022-4731(86)90085-3; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; COLSTON KW, 1992, BIOCHEM PHARMACOL, V44, P2273, DOI 10.1016/0006-2952(92)90669-A; COLSTON KW, 1989, LANCET, V1, P188; COLSTON KW, 1992, BIOCHEM PHARMACOL, V44, P693, DOI 10.1016/0006-2952(92)90405-8; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Dhawan P, 2005, MOL CELL BIOL, V25, P472, DOI 10.1128/MCB.25.1.472-487.2005; ELSTNER E, 1995, CANCER RES, V55, P2822; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Gery S, 2005, CLIN CANCER RES, V11, P3184, DOI 10.1158/1078-0432.CCR-04-2625; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Halmos B, 2002, CANCER RES, V62, P528; Hanson RW, 1998, J BIOL CHEM, V273, P28543, DOI 10.1074/jbc.273.44.28543; Huening M, 2002, MOL ENDOCRINOL, V16, P2052, DOI 10.1210/me.2001-0260; JACOBSON EA, 1989, CANCER RES, V49, P6300; JAMES SY, 1994, J ENDOCRINOL, V141, P555, DOI 10.1677/joe.0.1410555; Janowsky EC, 1999, PUBLIC HEALTH NUTR, V2, P283, DOI 10.1017/S1368980099000385; Kim JW, 2007, BIOCHEM BIOPH RES CO, V354, P517, DOI 10.1016/j.bbrc.2007.01.008; Lee TH, 2001, PHYSIOL GENOMICS, V7, P187, DOI 10.1152/physiolgenomics.00046.2001; Liu Y, 2005, J BONE MINER RES, V20, P1680, DOI 10.1359/JBMR.050410; Maurer U, 2001, J BIOL CHEM, V276, P3727, DOI 10.1074/jbc.M005292200; Mawer EB, 1997, J CLIN ENDOCR METAB, V82, P118, DOI 10.1210/jc.82.1.118; Mehta R, 2000, JNCI-J NATL CANCER I, V92, P1836, DOI 10.1093/jnci/92.22.1836; Menendez-Hurtado A, 2000, ENDOCRINOLOGY, V141, P4164, DOI 10.1210/en.141.11.4164; Miyamoto K, 1997, MOL ENDOCRINOL, V11, P1165, DOI 10.1210/me.11.8.1165; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Ramos RA, 1996, MOL CELL BIOL, V16, P5288; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Salma N, 2004, MOL CELL BIOL, V24, P4651, DOI 10.1128/MCB.24.11.4651-4663.2004; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Shim M, 2005, CANCER RES, V65, P861; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Stoica A, 1999, J CELL BIOCHEM, V75, P640, DOI 10.1002/(SICI)1097-4644(19991215)75:4<640::AID-JCB10>3.3.CO;2-#; Swami S, 2003, BREAST CANCER RES TR, V80, P49, DOI 10.1023/A:1024487118457; Swami S, 2000, CLIN CANCER RES, V6, P3371; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wang Q, 2000, CANCER RES, V60, P2040; Wang Q, 2001, BREAST CANCER RES TR, V67, P157, DOI 10.1023/A:1010643323268; Welsh JE, 2003, J NUTR, V133, p2425S, DOI 10.1093/jn/133.7.2425S; Wietzke JA, 2005, MOL CELL ENDOCRINOL, V230, P59, DOI 10.1016/j.mce.2004.11.001; Wilson HL, 2002, MOL CELL ENDOCRINOL, V188, P15, DOI 10.1016/S0303-7207(01)00754-7; Xu L, 2001, CANCER RES, V61, P3176; Zella LA, 2007, J STEROID BIOCHEM, V103, P435, DOI 10.1016/j.jsbmb.2006.12.019; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhong Y, 2006, J BONE MINER RES, V21, pS120; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zierold C, 2007, ARCH BIOCHEM BIOPHYS, V460, P233, DOI 10.1016/j.abb.2006.11.028; Zinser GM, 2005, J STEROID BIOCHEM, V97, P153, DOI 10.1016/j.jsbmb.2005.06.024; Zinser GM, 2003, MOL CELL ENDOCRINOL, V200, P67, DOI 10.1016/S0303-7207(02)00416-1	65	29	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3086	3095		10.1074/jbc.M803602200	http://dx.doi.org/10.1074/jbc.M803602200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054766	hybrid, Green Published			2022-12-27	WOS:000262700900053
J	Gimenez-Cassina, A; Lim, F; Cerrato, T; Palomo, GM; Diaz-Nido, J				Gimenez-Cassina, Alfredo; Lim, Filip; Cerrato, Toni; Palomo, Gloria M.; Diaz-Nido, Javier			Mitochondrial Hexokinase II Promotes Neuronal Survival and Acts Downstream of Glycogen Synthase Kinase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; APOPTOTIC CELL-DEATH; PARKINSONS-DISEASE; ENERGY-METABOLISM; GLUCOSE-METABOLISM; ROTENONE MODELS; MELANOMA-CELLS; GENE-TRANSFER; COMPLEX-I; LITHIUM	Mitochondrial alterations are detected in most neurodegenerative disorders and may contribute to the dysfunction and demise of neuronal cells. Because glycogen synthase kinase-3 (GSK-3) is considered to be a critical factor in regulating neuronal cell survival and death, we studied the effects of modulating GSK-3 activity in cultured neurons treated with the mitochondrial inhibitor, rotenone. Interestingly, chronic inhibition of GSK-3 protects against rotenone-induced apoptosis in cultured neuronal cells. In an attempt to elucidate the molecular mechanisms underlying this neuroprotection, we demonstrated that chronic inhibition of GSK-3 reprograms the metabolism of neuronal cells, leading to an enhancement of glycolysis. This effect was accompanied by the induction and accumulation of hexokinase II (HKII) in the mitochondria. Interfering with either the mitochondrial binding of HKII or HKII expression significantly diminished the neuroprotection evoked by GSK-3 inhibition, and importantly, HKII overexpression is sufficient to protect against rotenone-induced cell death. Thus, mitochondrial HKII is a promoter of neuronal survival under the regulation of GSK-3. Furthermore, the neuroprotective effect of HKII may be relevant to neurodegenerative diseases in which glucose hypometabolism and mitochondrial dysfunction are prominent features.	[Gimenez-Cassina, Alfredo; Lim, Filip; Cerrato, Toni; Palomo, Gloria M.; Diaz-Nido, Javier] Univ Autonoma Madrid, CSIC, Dept Biol Mol, E-28049 Madrid, Spain; [Gimenez-Cassina, Alfredo; Lim, Filip; Cerrato, Toni; Palomo, Gloria M.; Diaz-Nido, Javier] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Diaz-Nido, J (corresponding author), Univ Autonoma Madrid, CSIC, Dept Biol Mol, Campus Cantoblanco, E-28049 Madrid, Spain.	javier.diaznido@uam.es	Gimenez-Cassina, Alfredo/AAA-6550-2019; Lim, Filip/C-7412-2011; Avila, Jesus/I-2610-2015; Diaz-Nido, Javier/L-2371-2013	Lim, Filip/0000-0001-6570-1017; Avila, Jesus/0000-0002-6288-0571; Diaz-Nido, Javier/0000-0002-0927-7925; Gimenez-Cassina, Alfredo/0000-0002-2768-2350	Spanish Ministry of Education and Science [SAF 2003-06782, SAF2006-12782-C03-02]; Autonomous Government of Madrid (Comunidad Autonoma de Madrid, CAM) [S-SAL-0202-2006]; Instituto de Salud Carlos III	Spanish Ministry of Education and Science(Spanish Government); Autonomous Government of Madrid (Comunidad Autonoma de Madrid, CAM)(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported in part by the Spanish Ministry of Education and Science (Grants SAF 2003-06782 and SAF2006-12782-C03-02) and the Autonomous Government of Madrid (Comunidad Autonoma de Madrid, CAM) through the NEURODEGMODELS project S-SAL-0202-2006. The Centre for Biomedical Research on Rare Diseases (Centro de Investigacion Biomedica en Red sobre Enfermedades Raras) is an initiative supported by the Instituto de Salud Carlos III. The authors declare no conflicts of interest. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; ADAMS V, 1988, BIOCHIM BIOPHYS ACTA, V932, P195, DOI 10.1016/0005-2728(88)90156-9; Alvarez G, 1999, FEBS LETT, V453, P260, DOI 10.1016/S0014-5793(99)00685-7; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Basselin M, 2006, PSYCHOPHARMACOLOGY, V187, P303, DOI 10.1007/s00213-006-0425-0; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; BLASS JP, 1988, REV NEUROL, V144, P543; Bovia F, 2003, BLOOD, V101, P1727, DOI 10.1182/blood-2001-12-0249; BUTTERFIELD PG, 1993, NEUROLOGY, V43, P1150, DOI 10.1212/WNL.43.6.1150; CHI MMY, 1987, ANAL BIOCHEM, V161, P508, DOI 10.1016/0003-2697(87)90481-7; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Facci L, 2003, NEUROREPORT, V14, P1467, DOI 10.1097/00001756-200308060-00012; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GELLER AI, 1988, SCIENCE, V241, P1667, DOI 10.1126/science.2843986; Giasson BI, 2000, NAT NEUROSCI, V3, P1227, DOI 10.1038/81737; Gimenez-Cassina A, 2007, NEUROCHEM INT, V50, P181, DOI 10.1016/j.neuint.2006.08.003; Gimenez-Cassina A, 2006, J NEUROSCI RES, V84, P755, DOI 10.1002/jnr.20976; GolshaniHebroni SG, 1997, J BIOENERG BIOMEMBR, V29, P331, DOI 10.1023/A:1022442629543; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; IWANGOFF P, 1980, MECH AGEING DEV, V14, P203, DOI 10.1016/0047-6374(80)90120-7; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; King TD, 2005, NEUROREPORT, V16, P597, DOI 10.1097/00001756-200504250-00016; Kivell BM, 2000, DEV BRAIN RES, V120, P199, DOI 10.1016/S0165-3806(00)00010-9; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Li J, 2005, J NEUROCHEM, V92, P462, DOI 10.1111/j.1471-4159.2004.02872.x; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; LIGURI G, 1990, NEUROSCI LETT, V112, P338, DOI 10.1016/0304-3940(90)90227-Z; Lim F, 1996, BIOTECHNIQUES, V20, P460; Lim F, 1997, Methods Mol Biol, V62, P223; Lim F, 2007, MOL THER, V15, P1072, DOI 10.1038/sj.mt.6300143; LINDAHL PE, 1961, EXP CELL RES, V23, P228, DOI 10.1016/0014-4827(61)90033-7; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Merlo-Pich M, 2004, EXP GERONTOL, V39, P277, DOI 10.1016/j.exger.2003.11.014; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Penso J, 2003, MOL GENET METAB, V78, P74, DOI 10.1016/S1096-7192(02)00203-2; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Perez M, 2003, BIOCHEM J, V372, P129, DOI 10.1042/BJ20021596; PLENGE P, 1976, INT PHARMACOPSYCHIAT, V11, P84, DOI 10.1159/000468216; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Sanchez S, 2001, J NEUROCHEM, V78, P468, DOI 10.1046/j.1471-4159.2001.00453.x; Saravanan KS, 2005, BRAIN RES, V1049, P147, DOI 10.1016/j.brainres.2005.04.051; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; ZHAN QM, 1994, ONCOGENE, V9, P3743; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	70	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3001	3011		10.1074/jbc.M808698200	http://dx.doi.org/10.1074/jbc.M808698200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19033437	hybrid			2022-12-27	WOS:000262700900044
J	Xu, LS; Komatsu, M				Xu, Lusheng; Komatsu, Masanobu			Promoter Cloning and Characterization of the Anti-vascular Proliferation Gene, R-ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETS TRANSCRIPTION FACTOR; GA-BINDING PROTEIN; ZINC-FINGER GENE; GROWTH-FACTOR; INTEGRIN ACTIVATION; SP1; EXPRESSION; ANGIOGENESIS; FAMILY; CELLS	The R-ras gene encodes a small GTPase of the ras family that is closely related to H-ras and K-ras. Unlike the prototypic ras genes, the disruption of the R-ras gene in mice results in enhanced angiogenesis in tumor implants and sustained neointimal hyperplasia in response to arterial injury, indicating the in vivo role of R-ras as a negative regulator of vascular proliferation. R-ras is abundantly expressed in normal mature blood vessels but significantly down-regulated in pathologically regenerating vasculature. In this study, we investigated the roles of cis-acting elements in the transcription of the human R-ras gene, as well as the transcription factors that interact with these sequences in cultured endothelial cells and arterial smooth muscle cells. The findings from vascular cells were then compared with findings from epithelial tumor cells that aberrantly express R-ras. Deletion analyses on 5 kb of 5'-flanking DNA of the human R-ras gene revealed the functional importance of the region between -727/-476, which contains two Ets and one Sp1 consensus binding motifs. Mutation analyses of various consensus binding motifs within this region suggest both cell type-dependent and -independent regulatory mechanisms for the R-ras gene transcription. Electrophoretic mobility shift and antibody disruption assays demonstrated that an Ets transcription factor family protein, GA-binding protein (GABP), binds to the R-ras-derived sequence. Chromatin immunoprecipitation analyses determined the association of endogenous GABP as well as Sp3 proteins with the -727/-476 region of the R-ras promoter in intact cells grown in culture. Forced expression of GABP significantly enhanced R-ras mRNA expression level in endothelial cells. These results map the functional elements in the R-ras promoter sequence and suggest that the GABP may be critical for transcription of R-ras and for maintenance of normal blood vessel functions through the regulation of this gene.	[Xu, Lusheng; Komatsu, Masanobu] Univ Alabama Birmingham, Div Mol & Cellular Pathol, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Komatsu, M (corresponding author), Burnham Inst Med Res Lake Nona, 8669 Commod Circle, Orlando, FL 32819 USA.	mkomatsu@burnham.org	Komatsu, Masanobu/AAV-3013-2020	Komatsu, Masanobu/0000-0001-7548-137X	American Heart Association [0665251B]; Department of Pathology, University of Alabama	American Heart Association(American Heart Association); Department of Pathology, University of Alabama	This work was supported by American Heart Association Grant 0665251B and departmental start-up funds provided by the Department of Pathology, University of Alabama at Birmingham. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; BOTTINGER EP, 1994, MOL CELL BIOL, V14, P2604; Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000; Chen ZQ, 1997, CANCER RES, V57, P2013; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; DENNIG J, 1995, J BIOL CHEM, V270, P12737, DOI 10.1074/jbc.270.21.12737; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Fromm L, 1998, J PHYSIOLOGY-PARIS, V92, P173, DOI 10.1016/S0928-4257(98)80005-3; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; Gyrd-Hansen M, 2002, J NEUROL SCI, V197, P27, DOI 10.1016/S0022-510X(02)00038-2; Hashiya N, 2004, CIRCULATION, V109, P3035, DOI 10.1161/01.CIR.0000130643.41587.DB; Hata Y, 1998, J BIOL CHEM, V273, P19294, DOI 10.1074/jbc.273.30.19294; HROMAS R, 1991, J BIOL CHEM, V266, P14183; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Iwasaka C, 1996, J CELL PHYSIOL, V169, P522, DOI 10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.3.CO;2-Q; Jiang P, 2002, J BIOL CHEM, V277, P8989, DOI 10.1074/jbc.M105682200; Juven-Gershon T, 2006, BIOCHEM SOC T, V34, P1047, DOI 10.1042/BST0341047; Kappel A, 2000, BLOOD, V96, P3078; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; Kappert K, 2001, BASIC RES CARDIOL, V96, P42, DOI 10.1007/s003950170076; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; LIU XW, 1993, NUCLEIC ACIDS RES, V21, P4954, DOI 10.1093/nar/21.21.4954; LOWE DG, 1987, CELL, V48, P137, DOI 10.1016/0092-8674(87)90364-3; LOWE DG, 1987, MOL CELL BIOL, V7, P2845, DOI 10.1128/MCB.7.8.2845; MORRIS JF, 1995, BLOOD, V86, P3640; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nickel J, 1995, NUCLEIC ACIDS RES, V23, P4785, DOI 10.1093/nar/23.23.4785; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Nuchprayoon I, 1997, BLOOD, V89, P4546, DOI 10.1182/blood.V89.12.4546; Oertli B, 2000, ONCOGENE, V19, P4961, DOI 10.1038/sj.onc.1203876; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Rao MK, 2002, J BIOL CHEM, V277, P26036, DOI 10.1074/jbc.M203374200; ROSEN GD, 1994, J BIOL CHEM, V269, P15652; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; ROSMARIN AG, 1995, J BIOL CHEM, V270, P23627, DOI 10.1074/jbc.270.40.23627; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; SADASIVAN E, 1994, J BIOL CHEM, V269, P4725; Sassa Y, 2004, DIABETES, V53, P1222, DOI 10.2337/diabetes.53.5.1222; Sato Y, 2001, ANN NY ACAD SCI, V947, P117; Sawa C, 1996, NUCLEIC ACIDS RES, V24, P4954, DOI 10.1093/nar/24.24.4954; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Sethi T, 1999, MOL BIOL CELL, V10, P1799, DOI 10.1091/mbc.10.6.1799; Sjottem E, 1996, J VIROL, V70, P188; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suzuki J, 1998, FEBS LETT, V437, P112, DOI 10.1016/S0014-5793(98)01213-7; Suzuki J, 2000, ONCOGENE, V19, P1138, DOI 10.1038/sj.onc.1203402; Tomita N, 2003, CIRCULATION, V107, P1411, DOI 10.1161/01.CIR.0000055331.41937.AA; WERNERT N, 1992, AM J PATHOL, V140, P119; Yasuda M, 1998, LIFE SCI, V64, P249, DOI 10.1016/S0024-3205(98)00560-8; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	55	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2706	2718		10.1074/jbc.M808184200	http://dx.doi.org/10.1074/jbc.M808184200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19011236	hybrid			2022-12-27	WOS:000262700900013
J	Davydova, EK; Kaganman, I; Kazmierczak, KM; Rothman-Denes, LB				Davydova, Elena K.; Kaganman, Irene; Kazmierczak, Krystyna M.; Rothman-Denes, Lucia B.			Identification of Bacteriophage N4 Virion RNA Polymerase-Nucleic Acid Interactions in Transcription Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; PROMOTER RECOGNITION; ELONGATION COMPLEX; STRUCTURAL BASIS; INITIATION; HAIRPIN; PROCESSIVITY; DOMAIN	Bacteriophage N4 mini-virion RNA polymerase (mini-vRNAP), the 1106-amino acid transcriptionally active domain of vRNAP, recognizes single-stranded DNA template-containing promoters composed of conserved sequences and a 3-base loop-5-base pair stem hairpin structure. The major promoter recognition determinants are a purine located at the center of the hairpin loop (-11G) and a base at the hairpin stem (-8G). Mini-vRNAP is an evolutionarily highly diverged member of the T7 family of RNAPs. A two-plasmid system was developed to measure the in vivo activity of mutant mini-vRNAP enzymes. Five mini-vRNAP derivatives, each containing a pair of cysteine residues separated by similar to 100 amino acids and single cysteine-containing enzymes, were generated. These reagents were used to determine the smallest catalytically active polypeptide and to map promoter, substrate, and RNA-DNA hybrid contact sites to single amino acid residues in the enzyme by using end-labeled 5-iododeoxyuridine- and azidophenacyl-substituted oligonucleotides, cross-linkable derivatives of the initiating nucleotide, and RNA products with 5-iodouridine incorporated at specific positions. Localization of functionally important amino acid residues in the recently determined crystal structures of apo-mini-vRNAP and the mini-vRNAP-promoter complex and comparison with the crystal structures of the T7 RNAP initiation and elongation complexes allowed us to predict major rearrangements in mini-vRNAP in the transition from transcription initiation to elongation similar to those observed in T7 RNAP, a task otherwise precluded by the lack of sequence homology between N4 mini-vRNAP and T7 RNAP.	[Davydova, Elena K.; Kaganman, Irene; Kazmierczak, Krystyna M.; Rothman-Denes, Lucia B.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago	Rothman-Denes, LB (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St,CLSC 613, Chicago, IL 60637 USA.	lbrd@uchicago.edu			National Institutes of Health [AI12575]; United States Public Health Service [T32 GM07197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI012575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI12575 ( to L. B. R.-D.). This work was also supported in part by United States Public Health Service Grant T32 GM07197 ( to K. M. K.).	Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Choi KH, 2008, J MOL BIOL, V378, P726, DOI 10.1016/j.jmb.2008.02.059; Davydova EK, 2003, METHOD ENZYMOL, V370, P83; Davydova EK, 2003, P NATL ACAD SCI USA, V100, P9250, DOI 10.1073/pnas.1133325100; Davydova EK, 2007, P NATL ACAD SCI USA, V104, P7033, DOI 10.1073/pnas.0610627104; Gardner LP, 1997, BIOCHEMISTRY-US, V36, P2908, DOI 10.1021/bi962397i; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; GLUCKSMANN MA, 1992, CELL, V70, P491, DOI 10.1016/0092-8674(92)90173-A; GlucksmannKuis MA, 1996, CELL, V84, P147, DOI 10.1016/S0092-8674(00)81001-6; HAYNES LL, 1985, CELL, V41, P597, DOI 10.1016/S0092-8674(85)80032-5; Imburgio D, 2002, J MOL BIOL, V319, P37, DOI 10.1016/S0022-2836(02)00261-9; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kazmierczak KM, 2002, EMBO J, V21, P5815, DOI 10.1093/emboj/cdf584; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; MAKSIMOVA TG, 1991, EUR J BIOCHEM, V195, P841, DOI 10.1111/j.1432-1033.1991.tb15773.x; MARKIEWICZ P, 1992, GENE DEV, V6, P2010, DOI 10.1101/gad.6.10.2010; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; MAYER AN, 1995, GENE, V153, P1, DOI 10.1016/0378-1119(94)00752-E; MOOKHTIAR KA, 1991, BIOCHEMISTRY-US, V30, P6305, DOI 10.1021/bi00239a032; Murakami KS, 2008, P NATL ACAD SCI USA, V105, P5046, DOI 10.1073/pnas.0712325105; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	23	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1962	1970		10.1074/jbc.M807785200	http://dx.doi.org/10.1074/jbc.M807785200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19015264	Green Published, hybrid			2022-12-27	WOS:000262545600003
J	Martin, B; Brenneman, R; Golden, E; Walent, T; Becker, KG; Prabhu, VV; Wood, W; Ladenheim, B; Cadet, JL; Maudsley, S				Martin, Bronwen; Brenneman, Randall; Golden, Erin; Walent, Tom; Becker, Kevin G.; Prabhu, Vinayakumar V.; Wood, William, III; Ladenheim, Bruce; Cadet, Jean-Lud; Maudsley, Stuart			Growth Factor Signals in Neural Cells COHERENT PATTERNS OF INTERACTION CONTROL MULTIPLE LEVELS OF MOLECULAR AND PHENOTYPIC RESPONSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE SET ENRICHMENT; ALPHA-B-CRYSTALLIN; PHEOCHROMOCYTOMA CELLS; KINASE; ACTIVATION; EXPRESSION; SHC; SCAFFOLD; DIFFERENTIATION; PROTEINS	Individual neurons express receptors for several different growth factors that influence the survival, growth, neurotransmitter phenotype, and other properties of the cell. Although there has been considerable progress in elucidating the molecular signal transduction pathways and physiological responses of neurons and other cells to individual growth factors, little is known about if and how signals from different growth factors are integrated within a neuron. In this study, we determined the interactive effects of nerve growth factor, insulin-like growth factor 1, and epidermal growth factor on the activation status of downstream kinase cascades and transcription factors, cell survival, and neurotransmitter production in neural cells that express receptors for all three growth factors. We document considerable differences in the quality and quantity of intracellular signaling and eventual phenotypic responses that are dependent on whether cells are exposed to a single or multiple growth factors. Dual stimulations that generated the greatest antagonistic or synergistic actions, compared with a theoretically neutral summation of their two activities, yielded the largest eventual change of neuronal phenotype indicated by the ability of the cell to produce norepinephrine or resist oxidative stress. Combined activation of insulin-like growth factor 1 and epidermal growth factor receptors was particularly notable for antagonistic interactions at some levels of signal transduction and norepinephrine production, but potentiation at other levels of signaling and cytoprotection. Our findings suggest that in true physiological settings where multiple growth factors are present, activation of one receptor type may result in molecular and phenotypic responses that are different from that observed in typical experimental paradigms in which cells are exposed to only a single growth factor at a time.	[Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Neurosci Lab, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Ladenheim, Bruce; Cadet, Jean-Lud] Natl Inst Drug Abuse, Mol Psychiat Branch, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Maudsley, S (corresponding author), NIA, Receptor Pharmacol Unit, Neurosci Lab, Intramural Res Program,NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	maudsleyst@mail.nih.gov	Maudsley, Stuart/Q-4782-2019; Maudsley, Stuart/AAV-9929-2021	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925; Becker, Kevin/0000-0002-6794-6656	National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000325, ZIAAG000318, ZIAAG000917, ZICAG000616, Z01AG000318, ZIAAG000916, Z01AG000616, Z01AG000325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000494, ZIADA000494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health (Intramural Research Program of the NIA). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blanquet PR, 1998, NEUROSCIENCE, V86, P739, DOI 10.1016/S0306-4522(98)00087-6; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Chao CC, 2006, NEUROBIOL AGING, V27, P105, DOI 10.1016/j.neurobiolaging.2005.01.009; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Che Y, 2001, J NEUROSCI RES, V65, P425, DOI 10.1002/jnr.1170; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Diviani D, 2006, EUR J CELL BIOL, V85, P603, DOI 10.1016/j.ejcb.2006.01.001; Freeman RS, 2004, PROG BRAIN RES, V146, P111, DOI 10.1016/S0079-6123(03)46008-1; GARBER SS, 1989, J NEUROSCI, V9, P3976; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Groot M, 2000, EUR J CELL BIOL, V79, P924, DOI 10.1078/0171-9335-00126; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kim SA, 2008, FEBS LETT, V582, P734, DOI 10.1016/j.febslet.2008.01.053; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; KRASNOVA IN, 1999, KLIN LAB DIAGN, V7, P11; Lee JH, 2004, J PHARMACOL EXP THER, V308, P896, DOI 10.1124/jpet.103.061853; LIU XQ, 1994, RECENT PROG HORM RES, V49, P149; Masilamoni JG, 2005, BRAIN RES BULL, V67, P235, DOI 10.1016/j.brainresbull.2005.07.002; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Maudsley S, 2007, MOL ENDOCRINOL, V21, P1216, DOI 10.1210/me.2006-0053; Maudsley S, 2007, CURR ALZHEIMER RES, V4, P3, DOI 10.2174/156720507779939850; Maudsley S, 2006, NEUROENDOCRINOLOGY, V84, P285, DOI 10.1159/000098402; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Park SY, 2000, J BIOL CHEM, V275, P19768, DOI 10.1074/jbc.M909932199; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1355, DOI 10.1210/en.138.3.1355; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pelicci G, 1996, ONCOGENE, V13, P633; PELICCI G, 1995, ONCOGENE, V11, P899; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; Qureshi FG, 1997, J SURG RES, V69, P354, DOI 10.1006/jsre.1997.5080; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SAMPATH D, 1994, J NEUROCHEM, V62, P2476; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shinoda S, 2003, EUR J NEUROSCI, V17, P2065, DOI 10.1046/j.1460-9568.2003.02655.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung U, 2003, J NEUROSCI, V23, P1697; Tapon N, 1998, EMBO J, V17, P1395, DOI 10.1093/emboj/17.5.1395; TISCHLER AS, 1983, CELL TISSUE RES, V228, P641; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Whitney LW, 1999, ANN NEUROL, V46, P425; Willoughby EA, 2005, J BIOL CHEM, V280, P25651, DOI 10.1074/jbc.M501926200; Xiong WC, 2003, FRONT BIOSCI, V8, pS676, DOI 10.2741/1116; Yamada M, 1997, PROG NEUROBIOL, V51, P19, DOI 10.1016/S0301-0082(96)00046-9; Ying X, 2008, J MOL NEUROSCI, V35, P253, DOI 10.1007/s12031-007-9010-1; YING Z, 1993, J CEREBR BLOOD F MET, V13, P378, DOI 10.1038/jcbfm.1993.51	58	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2493	2511		10.1074/jbc.M804545200	http://dx.doi.org/10.1074/jbc.M804545200			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19038969	Green Published, hybrid			2022-12-27	WOS:000262545600056
J	Lito, P; Mets, BD; Appledorn, DM; Maher, VM; McCormick, JJ				Lito, Piro; Mets, Bryan D.; Appledorn, Daniel M.; Maher, Veronica M.; McCormick, J. Justin			Sprouty 2 Regulates DNA Damage-induced Apoptosis in Ras-transformed Human Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; ACTIVATION; GROWTH; PATHWAY; MDM2; P53; DIFFERENTIATION; EXPRESSION; MODULATION; INHIBITION	We have reported that expression of Sprouty 2 (Spry2) is necessary for tumor formation by HRas(V12)-transformed fibroblasts. We now report on the role of Spry2 in the inhibition of UV254 nm radiation-induced apoptosis in HRas(V12)- transformed human fibroblasts. Silencing Spry2 in this context resulted in increased apoptosis, associated with decreased Akt activation and decreased phosphorylation of HDM2 at Ser-166, which has been shown to stabilize HDM2. As a consequence, when cells with silenced Spry2 were UV-irradiated, they exhibited diminished levels of HDM2 and elevated levels of p53. In agreement with these findings, overexpression of Spry2 in the parental non-transformed fibroblasts led to increased Akt activation and to the stabilization of HDM2. It also led to diminished expression of p53 and decreased apoptosis following UV irradiation. Silencing Spry2 in HRas-transformed cells decreased Rac1 activation, but independent expression of Spry2 in the non-transformed parental cells had no effect on Rac1, suggesting a specific involvement in the activation of Rac1 by Ras. Silencing Spry2 in HRas(V12)- transformed cells resulted in diminished interaction between HRas and Tiam1, a Rac1-specific nucleotide exchange factor. Expression of constitutively active Rac1 in cells with silenced Spry2 partly reversed the effect of Spry2 down-regulation. Furthermore, loss of Spry2 expression in HRas(V12)- transformed cells augmented the cytotoxicity of the DNA-damaging, chemotherapeutic agent cisplatin, a process that was also reversed by active Rac1. Together, these data show that Spry2 inhibits apoptosis in response to DNA damage by regulating Akt, HDM2, and p53, by a process mediated partly by Rac1.	[McCormick, J. Justin] Michigan State Univ, Carcinogenesis Lab, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	McCormick, JJ (corresponding author), Michigan State Univ, Carcinogenesis Lab, Dept Microbiol & Mol Genet, Food Safety & Toxicolo Bldg, E Lansing, MI 48824 USA.	mccormi1@msu.edu			National Institutes of Health [CA098305]; Department of Health and Human Services; Michigan State University; College of Human Medicine; NATIONAL CANCER INSTITUTE [R01CA098305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Michigan State University; College of Human Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA098305 from the Department of Health and Human Services ( to J. J. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a Research Assistantship from the Michigan State University, College of Human Medicine.	Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chandramouli S, 2008, J BIOL CHEM, V283, P1679, DOI 10.1074/jbc.M705457200; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Eom YW, 2001, BIOCHEM BIOPH RES CO, V285, P825, DOI 10.1006/bbrc.2001.5233; Gemma A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-174; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Han QW, 2002, J BIOL CHEM, V277, P48379, DOI 10.1074/jbc.M209542200; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; HURLIN PJ, 1989, P NATL ACAD SCI USA, V86, P187, DOI 10.1073/pnas.86.1.187; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; KONDO S, 1995, ONCOGENE, V10, P2001; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lee M, 2006, BIOCHEM BIOPH RES CO, V350, P450, DOI 10.1016/j.bbrc.2006.09.067; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Lito P, 2008, J BIOL CHEM, V283, P2002, DOI 10.1074/jbc.M709046200; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; Messina S, 2004, BIOCHEM BIOPH RES CO, V320, P493, DOI 10.1016/j.bbrc.2004.06.003; MORGAN TL, 1991, EXP CELL RES, V197, P125, DOI 10.1016/0014-4827(91)90489-H; Okkenhaug K, 2001, Sci STKE, V2001, ppe1; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Saniger ML, 2006, J CELL BIOCHEM, V98, P650, DOI 10.1002/jcb.20801; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200; Wang JH, 2006, PROSTATE, V66, P613, DOI 10.1002/pros.20353; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yip HT, 2006, ARCH OTOLARYNGOL, V132, P317, DOI 10.1001/archotol.132.3.317; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	50	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					848	854		10.1074/jbc.M808045200	http://dx.doi.org/10.1074/jbc.M808045200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008219	Green Published, hybrid			2022-12-27	WOS:000262122900019
J	Kosugi, S; Hasebe, M; Matsumura, N; Takashima, H; Miyamoto-Sato, E; Tomita, M; Yanagawa, H				Kosugi, Shunichi; Hasebe, Masako; Matsumura, Nobutaka; Takashima, Hideaki; Miyamoto-Sato, Etsuko; Tomita, Masaru; Yanagawa, Hiroshi			Six Classes of Nuclear Localization Signals Specific to Different Binding Grooves of Importin alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DISPLAY; IN-VITRO SELECTION; KARYOPHERIN-ALPHA; NUCLEOCYTOPLASMIC TRANSPORT; CRYSTALLOGRAPHIC ANALYSIS; STRUCTURAL BASIS; PROTEIN; RECOGNITION; SEQUENCES; VIRUS	The importin alpha/beta pathway mediates nuclear import of proteins containing the classical nuclear localization signals (NLSs). Although the consensus sequences of the classical NLSs have been defined, there are still many NLSs that do not match the consensus rule and many nonfunctional sequences that match the consensus. We report here six different NLS classes that specifically bind to distinct binding pockets of importin alpha. By screening of random peptide libraries using an mRNA display, we selected peptides bound by importin alpha and identified six classes of NLSs, including three novel classes. Two noncanonical classes (class 3 and class 4) specifically bound the minor binding pocket of importin alpha, whereas the classical monopartite NLSs (class 1 and class 2) bound to the major binding pocket. Using a newly developed universal green fluorescent protein expression system, we found that these NLS classes, including plant-specific class 5 NLSs and bipartite NLSs, fundamentally require the regions outside the core basic residues for their activity and have specific residues or patterns that confer the activities differently between yeast, plants, and mammals. Furthermore, amino acid replacement analyses revealed that the consensus basic patterns of the classical NLSs are not essential for activity, thereby generating more unconventional patterns, including redox-sensitive NLSs. These results explain the causes of the NLS diversity. The defined consensus patterns and properties of importin alpha-dependent NLSs provide useful information for identifying NLSs.	[Kosugi, Shunichi; Hasebe, Masako; Tomita, Masaru; Yanagawa, Hiroshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan; [Kosugi, Shunichi; Matsumura, Nobutaka; Takashima, Hideaki; Miyamoto-Sato, Etsuko; Yanagawa, Hiroshi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 2238522, Japan	Keio University; Keio University	Yanagawa, H (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan.	hyana@bio.keio.ac.jp		Kosugi, Shunichi/0000-0002-5882-9255	Ministry of Agriculture, Forestry, and Fisheries of Japan [SY-1114]; Yamagata prefectural government and Tsuruoka City	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Yamagata prefectural government and Tsuruoka City	This work was supported by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan ( Rice Genome Project SY-1114) and from the Yamagata prefectural government and Tsuruoka City. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Horisawa K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh167; Ide Y, 1996, GENE, V182, P203, DOI 10.1016/S0378-1119(96)00555-0; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kim BJ, 2007, J BIOL CHEM, V282, P30029, DOI 10.1074/jbc.M703705200; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kosugi S, 2002, PLANT PHYSIOL, V128, P833, DOI 10.1104/pp.010642; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Nadler SG, 1997, J BIOL CHEM, V272, P4310, DOI 10.1074/jbc.272.7.4310; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Oishi T, 2006, BIOCHEM BIOPH RES CO, V340, P125, DOI 10.1016/j.bbrc.2005.11.161; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Shoji K, 1998, GENE, V212, P279, DOI 10.1016/S0378-1119(98)00175-9; Shoya Y, 1998, J VIROL, V72, P9755, DOI 10.1128/JVI.72.12.9755-9762.1998; Velichkova M, 2005, MOL CELL BIOL, V25, P4501, DOI 10.1128/MCB.25.11.4501-4513.2005; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521	40	388	422	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					478	485		10.1074/jbc.M807017200	http://dx.doi.org/10.1074/jbc.M807017200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001369	hybrid			2022-12-27	WOS:000261974800052
J	Motiwala, T; Majumder, S; Ghoshal, K; Kutay, H; Datta, J; Roy, S; Lucas, DM; Jacob, ST				Motiwala, Tasneem; Majumder, Sarmila; Ghoshal, Kalpana; Kutay, Huban; Datta, Jharna; Roy, Satavisha; Lucas, David M.; Jacob, Samson T.			RETRACTED: PTPROt Inactivates the Oncogenic Fusion Protein BCR/ABL and Suppresses Transformation of K562 Cells (Retracted article. See vol. 293, pg. 3589, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							RECEPTOR-TYPE-O; CHRONIC MYELOGENOUS LEUKEMIA; ABL TYROSINE KINASE; BCR-ABL; TUMOR-SUPPRESSOR; PHOSPHATASE; DIFFERENTIATION; IMATINIB; MECHANISMS; GROWTH	Chronic myelogenous leukemia is typified by constitutive activation of the c-abl kinase as a result of its fusion to the breakpoint cluster region (BCR). Because the truncated isoform of proteintyrosine phosphatase receptor-type O (PTPROt) is specifically expressed in hematopoietic cells, we tested the possibility that it could potentially dephosphorylate and inactivate the fusion protein bcr/abl. Ectopic expression of PTPROt in the chronic myelogenous leukemia cell line K562 indeed resulted in hypophosphorylation of bcr/abl and reduced phosphorylation of its downstream targets CrkL and Stat5, confirming that PTPROt could inactivate the function of bcr/abl. Furthermore, the expression of catalytically active PTPROt in K562 cells caused reduced proliferation, delayed transition from G(0)/G(1) to S phase, loss of anchorage independent growth, inhibition of ex vivo tumor growth, and increased their susceptibility to apoptosis, affirming that this tyrosine phosphatase can revert the transformation potential of bcr/abl. Additionally, the catalytically inactive PTPROt acted as a trapping mutant that was also able to inhibit anchorage independence and facilitate apoptosis of K562 cells. The inhibitory action of PTPROt on bcr/abl was also confirmed in a murine myeloid cell line overexpressing bcr/abl. PTPROt expression was suppressed in K562 cells and was relieved upon treatment of the cells with 5-azacytidine, aninhibitor of DNA methyltransferase, with concomitant hypomethylation of the PTPRO CpG island. These data demonstrate that suppression of PTPROt by promoter methylation could contribute to the augmented phosphorylation and constitutive activity of its substrate bcr/abl and provide a potentially significant molecular therapeutic target for bcr/abl-positive leukemia.	[Motiwala, Tasneem; Majumder, Sarmila; Ghoshal, Kalpana; Kutay, Huban; Datta, Jharna; Roy, Satavisha; Jacob, Samson T.] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Lucas, David M.] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol Oncol, Columbus, OH 43210 USA; [Jacob, Samson T.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Jacob, ST (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, 646B Tzagournis Med Res Facil,420 W 12th Ave, Columbus, OH 43210 USA.	Samson.Jacob@osumc.edu	Jacob, Samson/H-3135-2011; Motiwala, Tasneem/AAB-9067-2021		National Institutes of Health [CA122695, CA101956, CA086978]; NATIONAL CANCER INSTITUTE [P01CA101956, R01CA086978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA122695, CA101956, and CA086978. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguiar RCT, 1999, BLOOD, V94, P2403, DOI 10.1182/blood.V94.7.2403.419k39_2403_2413; Amin HM, 2007, J PATHOL, V212, P402, DOI 10.1002/path.2178; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Chen LF, 2006, BLOOD, V108, P3428, DOI 10.1182/blood-2006-03-013821; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Di Bacco A, 2000, Oncologist, V5, P405, DOI 10.1634/theoncologist.5-5-405; Donato NJ, 2000, CLIN CANCER RES, V6, P2965; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Gorre ME, 2002, CURR OPIN HEMATOL, V9, P303, DOI 10.1097/00062752-200207000-00007; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Jacob ST, 2005, CANCER GENE THER, V12, P665, DOI 10.1038/sj.cgt.7700828; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; Ju DS, 2007, CANCER LETT, V252, P75, DOI 10.1016/j.canlet.2006.12.013; Kardinal C, 2000, FASEB J, V14, P1529, DOI 10.1096/fj.14.11.1529; Koschmieder S, 2007, BLOOD, V110, P3695, DOI 10.1182/blood-2006-11-058941; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; LaMontagne KR, 1998, MOL CELL BIOL, V18, P2965, DOI 10.1128/MCB.18.5.2965; LaMontagne KR, 1998, P NATL ACAD SCI USA, V95, P14094, DOI 10.1073/pnas.95.24.14094; Liedtke M, 1998, ONCOGENE, V17, P1889, DOI 10.1038/sj.onc.1202117; Lim YM, 2000, P NATL ACAD SCI USA, V97, P12233, DOI 10.1073/pnas.210253497; Lowenberg B, 2003, NEW ENGL J MED, V349, P1399, DOI 10.1056/NEJMp038130; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Motiwala T, 2003, ONCOGENE, V22, P6319, DOI 10.1038/sj.onc.1206750; Motiwala T, 2007, CLIN CANCER RES, V13, P3174, DOI 10.1158/1078-0432.CCR-06-1720; Motiwala T, 2006, PROG NUCLEIC ACID RE, V81, P297, DOI 10.1016/S0079-6603(06)81008-1; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Nieborowska-Skorska M, 2002, BLOOD, V99, P4531, DOI 10.1182/blood.V99.12.4531; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; RENSHAW MW, 1995, MOL CELL BIOL, V15, P1286; Rhodes J, 2000, EXP HEMATOL, V28, P305, DOI 10.1016/S0301-472X(99)00148-4; Saglio G, 2004, CELL MOL LIFE SCI, V61, P2897, DOI 10.1007/s00018-004-4271-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; SEIMIYA H, 1995, ONCOGENE, V10, P1731; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sillaber C, 2000, BLOOD, V95, P2118, DOI 10.1182/blood.V95.6.2118; Smith KM, 2003, MOL CELL, V12, P27, DOI 10.1016/S1097-2765(03)00274-0; Sonoyama J, 2002, J BIOL CHEM, V277, P8076, DOI 10.1074/jbc.M111501200; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Van Etten RA, 2004, LEUKEMIA RES, V28, pS21, DOI 10.1016/j.leukres.2003.10.005	48	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					455	464		10.1074/jbc.M802840200	http://dx.doi.org/10.1074/jbc.M802840200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18997174	Green Published, hybrid			2022-12-27	WOS:000261974800050
J	Townsend, DM; Manevich, Y; He, L; Hutchens, S; Pazoles, CJ; Tew, KD				Townsend, Danyelle M.; Manevich, Yefim; He, Lin; Hutchens, Steven; Pazoles, Christopher J.; Tew, Kenneth D.			Novel Role for Glutathione S-Transferase pi REGULATOR OF PROTEIN S-GLUTATHIONYLATION FOLLOWING OXIDATIVE AND NITROSATIVE STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX; PEROXIREDOXIN; GLUTAREDOXIN; ACTIVATION; SITE; GST	Glutathione S-transferase Pi (GST pi) is a marker protein in many cancers and high levels are linked to drug resistance, even when the selecting drug is not a substrate. S-Glutathionylation of proteins is critical to cellular stress response, but characteristics of the forward reaction are not known. Our results show that GST pi potentiates S-glutathionylation reactions following oxidative and nitrosative stress in vitro and in vivo. Mutational analysis indicated that the catalytic activity of GST is required. GST pi is itself redox-regulated. S-Glutathionylation on Cys(47) and Cys(101) autoregulates GST pi, breaks ligand binding interactions with c-Jun NH2-terminal kinase (JNK), and causes GST pi multimer formation, all critical to stress response. Catalysis of S-glutathionylation at low pK cysteines in proteins is a novel property for GST pi and may be a cause for its abundance in tumors and cells resistant to a range of mechanistically unrelated anticancer drugs.	[Townsend, Danyelle M.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Manevich, Yefim; He, Lin; Hutchens, Steven; Tew, Kenneth D.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Pazoles, Christopher J.] Novelos Inc, Newton, MA 02458 USA	Medical University of South Carolina; Medical University of South Carolina	Tew, KD (corresponding author), 96 Johnathan Lucas St, Charleston, SC 29425 USA.	tewk@musc.edu			National Institutes of Health [CA08660, CA117259]; South Carolina Centers of Excellence program; NATIONAL CANCER INSTITUTE [R41CA117259] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Centers of Excellence program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA08660 and CA117259. This work was also supported by the South Carolina Centers of Excellence program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; BOYLAND E, 1967, BIOCHEM J, V104, P95, DOI 10.1042/bj1040095; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Findlay VJ, 2004, MOL PHARMACOL, V65, P1070, DOI 10.1124/mol.65.5.1070; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Henderson CJ, 1998, P NATL ACAD SCI USA, V95, P5275, DOI 10.1073/pnas.95.9.5275; Ji XH, 1997, BIOCHEMISTRY-US, V36, P9690, DOI 10.1021/bi970805s; Keefer LK, 2003, ANNU REV PHARMACOL, V43, P585, DOI 10.1146/annurev.pharmtox.43.100901.135831; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Lo HW, 2008, MOL CANCER RES, V6, P843, DOI 10.1158/1541-7786.MCR-07-2105; Mack JT, 2007, MOL CELL BIOL, V27, P44, DOI 10.1128/MCB.01824-06; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Ralat LA, 2006, BIOCHEMISTRY-US, V45, P360, DOI 10.1021/bi0520737; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rosario LA, 2000, MOL PHARMACOL, V58, P167, DOI 10.1124/mol.58.1.167; Ruscoe JE, 2001, J PHARMACOL EXP THER, V298, P339; Saavedra JE, 2006, J MED CHEM, V49, P1157, DOI 10.1021/jm050700k; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Tanaka T, 1997, CANCER RES, V57, P3644; TEW KD, 1994, CANCER RES, V54, P4313; Tew KD, 2007, BIOCHEM PHARMACOL, V73, P1257, DOI 10.1016/j.bcp.2006.09.027; Townsend DM, 2008, CANCER RES, V68, P2870, DOI 10.1158/0008-5472.CAN-07-5957; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Townsend DM, 2006, MOL PHARMACOL, V69, P501, DOI 10.1124/mol.105.018523; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200	30	225	235	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					436	445		10.1074/jbc.M805586200	http://dx.doi.org/10.1074/jbc.M805586200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990698	hybrid, Green Published			2022-12-27	WOS:000261974800048
J	Mackenzie, PI; Rogers, A; Treloar, J; Jorgensen, BR; Miners, JO; Meech, R				Mackenzie, Peter I.; Rogers, Anne; Treloar, Joanna; Jorgensen, Bo R.; Miners, John O.; Meech, Robyn			Identification of UDP Glycosyltransferase 3A1 as a UDP N- Acetylglucosaminyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LIVER-MICROSOMES; BILE-ACIDS; IN-VITRO; GLUCURONOSYLTRANSFERASE 2B7; SUBSTRATE-SPECIFICITY; DRUG GLUCURONIDATION; NOMENCLATURE UPDATE; GENE SUPERFAMILY; HUMAN BILIRUBIN; ASPARTIC-ACID	The UDP glycosyltransferases (UGT) attach sugar residues to small lipophilic chemicals to alter their biological properties and enhance elimination. Of the four families present in mammals, two families, UGT1 and UGT2, use UDP glucuronic acid to glucuronidate bilirubin, steroids, bile acids, drugs, and many other endogenous chemicals and xenobiotics. UGT8, in contrast, uses UDP galactose to galactosidate ceramide, an important step in the synthesis of glycosphingolipids and cerebrosides. The function of the fourth family, UGT3, is unknown. Here we report the cloning, expression, and functional characterization of UGT3A1. This enzyme catalyzes the transfer of N-acetylglucosamine from UDP N-acetylglucosamine to ursodeoxycholic acid (3 alpha, 7 beta-dihydroxy-5 beta-cholanoic acid). The enzyme uses ursodeoxycholic acid and UDP N-acetylglucosamine in preference to other primary and secondary bile acids, and other UDP sugars such as UDP glucose, UDP glucuronic acid, UDP galactose, and UDP xylose. In addition to ursodeoxycholic acid, UGT3A1 has activity toward 17 alpha-estradiol, 17 beta-estradiol, and the prototypic substrates of the UGT1 and UGT2 forms, 4-nitrophenol and 1-naphthol. A polymorphic UGT3A1 variant containing a C121G substitution was catalytically inactive. UGT3A1 is found in the liver and kidney, and to a lesser, in the gastrointestinal tract. These data describe the first characterization of a member of the UGT3 family. Its activity and distribution suggest that UGT3A1 may have an important role in the metabolism and elimination of ursodeoxycholic acid in therapies for ameliorating the symptoms of cholestasis or for dissolving gallstones.	[Mackenzie, Peter I.; Rogers, Anne; Treloar, Joanna; Jorgensen, Bo R.; Miners, John O.; Meech, Robyn] Flinders Univ S Australia, Sch Med, Flinders Med Ctr, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia	Flinders Medical Centre; Flinders University South Australia	Mackenzie, PI (corresponding author), Flinders Univ S Australia, Sch Med, Flinders Med Ctr, Dept Clin Pharmacol, Bedford Pk, Bedford Pk, SA 5042, Australia.	Peter.Mackenzie@flinders.edu.au		Mackenzie, Peter/0000-0002-0697-6878; miners, john/0000-0001-9555-9453; Meech, Robyn/0000-0002-6831-0801				Bosio A, 1996, GENOMICS, V34, P69, DOI 10.1006/geno.1996.0242; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dykens JA, 2005, ANN NY ACAD SCI, V1052, P116, DOI 10.1196/annals.1347.008; GALL WE, 1999, BIOCH MOL BIOL, V70, P101; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Ikegawa S, 1999, ANAL SCI, V15, P625, DOI 10.2116/analsci.15.625; Itaaho K, 2008, DRUG METAB DISPOS, V36, P2307, DOI 10.1124/dmd.108.022731; JIN CJ, 1993, CARCINOGENESIS, V14, P2637, DOI 10.1093/carcin/14.12.2637; Kubota T, 2007, MOL PHARMACOL, V72, P1054, DOI 10.1124/mol.107.037952; Li D, 2007, J BIOL CHEM, V282, P36514, DOI 10.1074/jbc.M703107200; Mackenzie P, 2003, BIOCHEM PHARMACOL, V65, P417, DOI 10.1016/S0006-2952(02)01522-8; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; MACKENZIE PI, 1995, REV BIOCHEM TOXICOL, V11, P29; MARSCHALL HU, 1992, J CLIN INVEST, V89, P1981, DOI 10.1172/JCI115806; MARSCHALL HU, 1994, J LIPID RES, V35, P1599; MARSCHALL HU, 1994, HEPATOLOGY, V20, P845, DOI 10.1002/hep.1840200412; MATERN H, 1990, FEBS LETT, V270, P11, DOI 10.1016/0014-5793(90)81223-B; MATERN S, 1984, J CLIN INVEST, V74, P402, DOI 10.1172/JCI111435; McClean J, 2008, EXP NEUROL, V210, P41, DOI 10.1016/j.expneurol.2007.09.027; Meech R, 1997, CLIN EXP PHARMACOL P, V24, P907, DOI 10.1111/j.1440-1681.1997.tb02718.x; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; Miners JO, 2004, ANNU REV PHARMACOL, V44, P1, DOI 10.1146/annurev.pharmtox.44.101802.121546; MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T; Nakagomi M, 1999, STEROIDS, V64, P301, DOI 10.1016/S0039-128X(99)00007-0; Patana AS, 2007, MOL PHARMACOL, V72, P604, DOI 10.1124/mol.107.036871; PAUMGARTNER G, 1994, SCAND J GASTROENTERO, V29, P27, DOI 10.3109/00365529409103622; Paumgartner Gustav, 2004, Clin Liver Dis, V8, P67, DOI 10.1016/S1089-3261(03)00135-1; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; RITTER JK, 1992, J BIOL CHEM, V267, P3257; Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200; SENAFI SB, 1994, BIOCHEM J, V303, P233, DOI 10.1042/bj3030233; Senay C, 2002, BBA-PROTEIN STRUCT M, V1597, P90, DOI 10.1016/S0167-4838(02)00266-2; Tang CY, 2003, DRUG METAB DISPOS, V31, P37, DOI 10.1124/dmd.31.1.37; Toran-Allerand CD, 2005, ENDOCRINOLOGY, V146, P3843, DOI 10.1210/en.2004-1616; Trottier J, 2006, HEPATOLOGY, V44, P1158, DOI 10.1002/hep.21362; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Udomuksorn W, 2007, PHARMACOGENET GENOM, V17, P1017, DOI 10.1097/FPC.0b013e328256b1b6; Williams JA, 2002, DRUG METAB DISPOS, V30, P1266, DOI 10.1124/dmd.30.11.1266; Xiong Y, 2008, DRUG METAB DISPOS, V36, P517, DOI 10.1124/dmd.107.016469	41	64	64	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36205	36210		10.1074/jbc.M807961200	http://dx.doi.org/10.1074/jbc.M807961200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981171	Green Published, hybrid			2022-12-27	WOS:000261840500015
J	Zauner, S; Zahringer, U; Lindner, B; Warnecke, D; Sperling, P				Zaeuner, Simone; Zaehringer, Ulrich; Lindner, Buko; Warnecke, Dirk; Sperling, Petra			Identification and Functional Characterization of the 2-Hydroxy Fatty N-Acyl-Delta 3(E)-desaturase from Fusarium graminearum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B(5) FUSION PROTEIN; SEED OIL; ACYL (E)-DELTA(3)-UNSATURATION; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; HIGHER-PLANTS; ACIDS PRESENT; CEREBROSIDES; FUNGI; SPHINGOLIPIDS	Delta 3( E)-Unsaturated fatty acids are characteristic components of glycosylceramides from some fungi, including also human-and plant-pathogenic species. The function and genetic basis for this unsaturation is unknown. For Fusarium graminearum, which is pathogenic to grasses and cereals, we could show that the level of Delta 3-unsaturation of glucosylceramide (GlcCer) was highest at low temperatures and decreased when the fungus was grown above 28 degrees C. With a bioinformatics approach, we identified a new family of polypeptides carrying the histidine box motifs characteristic for membrane-bound desaturases. One of the corresponding genes was functionally characterized as a sphingolipid-Delta 3(E)-desaturase. Deletion of the candidate gene in F. graminearum resulted in loss of the Delta 3(E)-double bond in the fatty acyl moiety of GlcCer. Heterologous expression of the corresponding cDNA from F. graminearum in the yeast Pichia pastoris led to the formation of Delta 3(E)-unsaturated GlcCer.	[Zaeuner, Simone; Warnecke, Dirk; Sperling, Petra] Univ Hamburg, Bioctr Klein Flottbek, D-22609 Hamburg, Germany; [Zaeuner, Simone; Warnecke, Dirk; Sperling, Petra] Univ Hamburg, Bot Gardens, D-22609 Hamburg, Germany; [Zaehringer, Ulrich; Lindner, Buko] Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany	University of Hamburg; University of Hamburg; Forschungszentrum Borstel	Warnecke, D (corresponding author), Univ Hamburg, Bioctr Klein Flottbek, Ohnhorststr 18, D-22609 Hamburg, Germany.	warnecke@botanik.uni-hamburg.de	Lindner, Buko/G-9731-2014		Deutsche Forschungsgemeinschaft [SP 967/1-1, Li 448/1-4, SFB470]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SP 967/1-1 (to S.Z.), Grant Li 448/1-4 (to B.L. and U.Z.), and Grant SFB470. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; BAGBY MO, 1965, J AM OIL CHEM SOC, V42, P50, DOI 10.1007/BF02558255; BARTON PG, 1975, J BIOL CHEM, V250, P4470; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; BROWSE J, 1985, SCIENCE, V227, P763, DOI 10.1126/science.227.4688.763; Duarte RS, 1998, BBA-LIPID LIPID MET, V1390, P186, DOI 10.1016/S0005-2760(97)00179-3; Dunn TM, 1998, YEAST, V14, P311, DOI 10.1002/(SICI)1097-0061(19980315)14:4<311::AID-YEA220>3.0.CO;2-B; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Kawahara K, 2000, EUR J BIOCHEM, V267, P1837, DOI 10.1046/j.1432-1327.2000.01189.x; KENRICK JR, 1986, PLANT PHYSIOL, V81, P946, DOI 10.1104/pp.81.4.946; KLEIMAN R, 1966, LIPIDS, V1, P301, DOI 10.1007/BF02532670; KLEIMAN R, 1971, LIPIDS, V6, P617, DOI 10.1007/BF02531145; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laloi M, 2007, PLANT PHYSIOL, V143, P461, DOI 10.1104/pp.106.091496; LEACH J, 1982, J GEN MICROBIOL, V128, P1719; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Maier FJ, 2005, FEMS YEAST RES, V5, P653, DOI 10.1016/j.femsyr.2004.12.008; Miedaner T, 2000, Z PFLANZENK PFLANZEN, V107, P124; Mitchell AG, 1997, J BIOL CHEM, V272, P28281, DOI 10.1074/jbc.272.45.28281; MURATA N, 1983, PLANT CELL PHYSIOL, V24, P81, DOI 10.1093/oxfordjournals.pcp.a076516; NIRENBERG HI, 1981, CAN J BOT, V59, P1599, DOI 10.1139/b81-217; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x; RIETSCHEL ET, 1976, EUR J BIOCHEM, V64, P423, DOI 10.1111/j.1432-1033.1976.tb10318.x; Sakaki T, 2001, YEAST, V18, P679, DOI 10.1002/yea.720; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sperling P, 2005, PLANT PHYSIOL BIOCH, V43, P1031, DOI 10.1016/j.plaphy.2005.10.004; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Sperling P, 2001, ARCH BIOCHEM BIOPHYS, V388, P293, DOI 10.1006/abbi.2001.2308; Sperling P, 2001, FEBS LETT, V494, P90, DOI 10.1016/S0014-5793(01)02332-8; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; SUUTARI M, 1995, ARCH MICROBIOL, V164, P212, DOI 10.1007/s002030050256; Ternes P, 2006, J BIOL CHEM, V281, P5582, DOI 10.1074/jbc.M512864200; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toledo MS, 2000, J LIPID RES, V41, P797; Toledo MS, 1999, BIOCHEMISTRY-US, V38, P7294, DOI 10.1021/bi982898z; Toledo MS, 2001, GLYCOBIOLOGY, V11, P113, DOI 10.1093/glycob/11.2.113; Tonon T, 2004, FEBS LETT, V563, P28, DOI 10.1016/S0014-5793(04)00241-8; VILLASBOAS MH, 1994, CHEM PHYS LIPIDS, V70, P11; Wada H, 2007, PHOTOSYNTH RES, V92, P205, DOI 10.1007/s11120-007-9203-z; Warnecke D, 2003, CELL MOL LIFE SCI, V60, P919, DOI 10.1007/s00018-003-2243-4; WOLLENWEBER HW, 1985, ARCH MICROBIOL, V142, P6, DOI 10.1007/BF00409228	45	13	15	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36734	36742		10.1074/jbc.M807264200	http://dx.doi.org/10.1074/jbc.M807264200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981185	Green Published, hybrid			2022-12-27	WOS:000261840500071
J	Hayashida, K; Stahl, PD; Park, PW				Hayashida, Kazutaka; Stahl, Philip D.; Park, Pyong Woo			Syndecan-1 Ectodomain Shedding Is Regulated by the Small GTPase Rab5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; GROWTH-FACTOR; CELL-ADHESION; TYROSINE PHOSPHORYLATION; PSEUDOMONAS-AERUGINOSA; SOLUBLE SYNDECAN-1; EPITHELIAL-CELLS; CYTOPLASMIC DOMAINS; RECEPTOR ACTIVATION; VIRULENCE FACTOR	The ectodomain shedding of syndecan-1, a major cell surface heparan sulfate proteoglycan, modulates molecular and cellular processes central to the pathogenesis of inflammatory diseases. Syndecan-1 shedding is a highly regulated process in which outside-in signaling accelerates the proteolytic cleavage of syndecan-1 ectodomains at the cell surface. Several extracellular agonists that induce syndecan-1 shedding and metalloproteinases that cleave syndecan-1 ectodomains have been identified, but the intracellular mechanisms that regulate syndecan-1 shedding are largely unknown. Here we examined the role of the syndecan-1 cytoplasmic domain in the regulation of agonist-induced syndecan-1 shedding. Our results showed that the syndecan-1 cytoplasmic domain is essential because mutation of invariant cytoplasmic Tyr residues abrogates ectodomain shedding, but not because it is Tyr phosphorylated upon shedding stimulation. Instead, our data showed that the syndecan-1 cytoplasmic domain binds to Rab5, a small GTPase that regulates intracellular trafficking and signaling events, and this interaction controls the onset of syndecan-1 shedding. Syndecan-1 cytoplasmic domain bound specifically to Rab5 and preferentially to inactive GDP-Rab5 over active GTP-Rab5, and shedding stimulation induced the dissociation of Rab5 from the syndecan-1 cytoplasmic domain. Moreover, the expression of dominant-negative Rab5, unable to exchange GDP for GTP, interfered with the agonist-induced dissociation of Rab5 from the syndecan-1 cytoplasmic domain and significantly inhibited syndecan-1 shedding induced by several distinct agonists. Based on these data, we propose that Rab5 is a critical regulator of syndecan-1 shedding that serves as an on-off molecular switch through its alternation between the GDP-bound and GTP-bound forms.	[Hayashida, Kazutaka; Park, Pyong Woo] Harvard Univ, Sch Med, Childrens Hosp, Div Resp Dis, Boston, MA 02115 USA; [Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Washington University (WUSTL)	Park, PW (corresponding author), 320 Longwood Ave,Enders 144, Boston, MA 02115 USA.	Pyong.Park@childrens.harvard.edu	Stahl, Philip/D-6315-2012		National Institutes of Health [HL69050, HL81474]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081474, R01HL069050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL69050 and HL81474. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrian E, 2005, J CELL PHYSIOL, V204, P178, DOI 10.1002/jcp.20287; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Carey DJ, 1997, BIOCHEM J, V327, P1; Charnaux N, 2005, GLYCOBIOLOGY, V15, P119, DOI 10.1093/glycob/cwh148; Chen Y, 2007, J BIOL CHEM, V282, P159, DOI 10.1074/jbc.M608542200; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fears CY, 2006, MATRIX BIOL, V25, P443, DOI 10.1016/j.matbio.2006.07.003; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hayashida K, 2006, J BIOL CHEM, V281, P24365, DOI 10.1074/jbc.M509320200; Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005; Heiz M, 2004, J BIOL CHEM, V279, P31149, DOI 10.1074/jbc.M403587200; Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Joensuu H, 2002, CANCER RES, V62, P5210; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; Kainulainen V, 1996, J BIOL CHEM, V271, P18759, DOI 10.1074/jbc.271.31.18759; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; LI GP, 1993, J BIOL CHEM, V268, P24475; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Oh ES, 1997, J BIOL CHEM, V272, P8133, DOI 10.1074/jbc.272.13.8133; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; Rodman JS, 2000, J CELL SCI, V113, P183; Seidel C, 2003, TRANSPLANTATION, V76, P423, DOI 10.1097/01.TP.0000074316.76104.A5; SLACK BE, 1995, J BIOL CHEM, V270, P8337, DOI 10.1074/jbc.270.14.8337; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Vita F, 1996, EXP CELL RES, V227, P367, DOI 10.1006/excr.1996.0286; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	55	56	56	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35435	35444		10.1074/jbc.M804172200	http://dx.doi.org/10.1074/jbc.M804172200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957427	Green Published, hybrid			2022-12-27	WOS:000261687900015
J	Ito, A; Suganami, T; Yamauchi, A; Degawa-Yamauchi, M; Tanaka, M; Kouyama, R; Kobayashi, Y; Nitta, N; Yasuda, K; Hirata, Y; Kuziel, WA; Takeya, M; Kanegasaki, S; Kamei, Y; Ogawa, Y				Ito, Ayaka; Suganami, Takayoshi; Yamauchi, Akira; Degawa-Yamauchi, Mikako; Tanaka, Miyako; Kouyama, Ryuji; Kobayashi, Yuko; Nitta, Nao; Yasuda, Kazuki; Hirata, Yukio; Kuziel, William A.; Takeya, Motohiro; Kanegasaki, Shiro; Kamei, Yasutomi; Ogawa, Yoshihiro			Role of CC Chemokine Receptor 2 in Bone Marrow Cells in the Recruitment of Macrophages into Obese Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INSULIN-RESISTANCE; PPAR-GAMMA; FATTY-ACIDS; MICE; INFLAMMATION; CHEMOTAXIS; ADIPONECTIN; DIET; INFILTRATION	The MCP-1 (monocyte chemoattractant protein-1)/CCR2 (CC motif chemokine receptor-2) pathway may play a role in macrophage infiltration into obese adipose tissue. Here we investigated the role of CCR2 in the recruitment of bone marrow-derived macrophages into obese adipose tissue in vitro and in vivo. Using the TAXIScan device, which can measure quantitatively the directionality and velocity of cell migration at time lapse intervals in vitro, we demonstrated that bone marrow cells (BMCs) from wild type mice migrate directly toward MCP-1 or culture medium conditioned by adipose tissue explants of genetically obese ob/ob mice, which are efficiently suppressed by pharmacological blockade of CCR2 signaling. The number of F4/80-positive macrophages was reduced in the adipose tissue from high fat diet-fed obese KKA(y) or ob/ob mice treated with a CCR2 antagonist propagermanium relative to vehicle-treated groups. We also found that the number of macrophages is reduced in the adipose tissue from ob/ob mice reconstituted with CR2(-/-) BMCs (ob/ob + CCR2(-/-) BMCs) relative to those with CCR2(+/+) BMCs (ob/ob + CCR2(+/+) BMCs). Expression of mRNAs for CD11c and TLR4 (Toll-like receptor 4) markers of proinflammatory M1 macrophages was also decreased in the adipose tissue from ob/ob + CCR2(-/-) BMCs relative to ob/ob + CCR2(+/+) BMCs, whereas mannose receptor and CD163, markers of anti-inflammatory M2 macrophages, were unchanged. This study provides in vivo and in vitro evidence that CCR2 in bone marrow cells plays an important role in the recruitment of macrophages into obese adipose tissue.	[Ito, Ayaka; Suganami, Takayoshi; Tanaka, Miyako; Kouyama, Ryuji; Kamei, Yasutomi; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Med & Metab, Bunkyo Ku, Tokyo 1138510, Japan; [Kouyama, Ryuji; Hirata, Yukio] Tokyo Med & Dent Univ, Dept Clin & Mol Endocrinol, Bunkyo Ku, Tokyo 1138510, Japan; [Tanaka, Miyako; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Global Ctr Excellence Program Int Res, Ctr Mol Sci Tooth & Bone Dis, Meguro Ku, Tokyo 1138510, Japan; [Yamauchi, Akira; Degawa-Yamauchi, Mikako; Kobayashi, Yuko; Nitta, Nao; Kanegasaki, Shiro] ECI Inc, Cent Lab, Meguro Ku, Tokyo 1530042, Japan; [Yasuda, Kazuki] Int Med Ctr Japan, Res Inst, Dept Metab Disorder, Shinjuku Ku, Tokyo 1628655, Japan; [Kuziel, William A.] Prot Design Labs Inc, Dept Autoimmune & Inflammatory Dis, Fremont, CA 94555 USA; [Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto 8608556, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Center for Global Health & Medicine - Japan; Kumamoto University	Ogawa, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Med & Metab, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	ogawa.mmm@mri.tmd.ac.jp	Tanaka, Miyako/B-2805-2016; Kanegasaki, Shiro/AAM-4921-2021; Yamauchi, Akira/F-2202-2010; Nitta, Nao/J-8231-2019; SUGANAMI, Takayoshi/A-9475-2016	Tanaka, Miyako/0000-0002-5655-5633; Yamauchi, Akira/0000-0001-9205-6922; Nitta, Nao/0000-0002-9093-9016; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan; Takeda Science Foundation; Smoking Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Smoking Research Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Ministry of Health, Labour, and Welfare of Japan and research grants from the Takeda Science Foundation and Smoking Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chen AR, 2005, OBES RES, V13, P1311, DOI 10.1038/oby.2005.159; Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8; CUTLER JE, 1974, P SOC EXP BIOL MED, V147, P471; D'Ambrosio D, 2003, J IMMUNOL METHODS, V273, P3, DOI 10.1016/S0022-1759(02)00414-3; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; JOHN TJ, 1976, LIFE SCI, V18, P177; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Maki W, 2002, J IMMUNOL, V169, P2346, DOI 10.4049/jimmunol.169.5.2346; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; NELSON RD, 1975, J IMMUNOL, V115, P1650; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Toyoda T, 2008, OBESITY, V16, P1199, DOI 10.1038/oby.2008.62; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yokochi S, 2001, J INTERF CYTOK RES, V21, P389, DOI 10.1089/107999001750277862; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	42	122	123	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35715	35723		10.1074/jbc.M804220200	http://dx.doi.org/10.1074/jbc.M804220200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18977759	hybrid			2022-12-27	WOS:000261687900045
J	Mori, J; Pearce, AC; Spalton, JC; Grygielska, B; Eble, JA; Tomlinson, MG; Senis, YA; Watson, SP				Mori, Jun; Pearce, Andrew C.; Spalton, Jennifer C.; Grygielska, Beata; Eble, Johannes A.; Tomlinson, Michael G.; Senis, Yotis A.; Watson, Steve P.			G6b-B Inhibits Constitutive and Agonist-induced Signaling by Glycoprotein VI and CLEC-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA-CHAIN; CELL ADHESION MOLECULE-1; TONIC B-CELL; HUMAN PLATELETS; TYROSINE PHOSPHORYLATION; INTRACYTOPLASMIC DOMAIN; DISTINCT PATHWAYS; GENE-EXPRESSION; COLLAGEN; ACTIVATION	Platelets play an essential role in wound healing by forming thrombi that plug holes in the walls of damaged blood vessels. To achieve this, platelets express a diverse array of cell surface receptors and signaling proteins that induce rapid platelet activation. In this study we show that two platelet glycoprotein receptors that signal via an immunoreceptor tyrosine-based activation motif (ITAM) or an ITAM-like domain, namely the collagen receptor complex glycoprotein VI (GPVI)-FcR gamma-chain and the C-type lectin- like receptor 2 (CLEC-2), respectively, support constitutive (i. e. agonist-independent) signaling in a cell line model using a nuclear factor of activated T-cells (NFAT) transcriptional reporter assay that can detect low level activation of phospholipase C gamma(PLC gamma). Constitutive and agonist signaling by both receptors is dependent on Src and Syk family kinases, and is inhibited by G6b-B, a platelet immunoglobulin receptor that has two immunoreceptor tyrosine-based inhibitory motifs in its cytosolic tail. Mutation of the conserved tyrosines in the two immunoreceptor tyrosine-based inhibitory motifs prevents the inhibitory action of G6b-B. Interestingly, the inhibitory activity of G6b-B is independent of the Src homology 2 (SH2)-domain containing tyrosine phosphatases, SHP1 and SHP2, and the inositol 5'-phosphatase, SHIP. Constitutive signaling via Src and Syk tyrosine kinases is observed in platelets and is associated with tyrosine phosphorylation of GPVI-FcR gamma-chain and CLEC-2. We speculate that inhibition of constitutive signaling through Src and Syk tyrosine kinases by G6b-B may help to prevent unwanted platelet activation.	[Mori, Jun; Pearce, Andrew C.; Spalton, Jennifer C.; Tomlinson, Michael G.; Senis, Yotis A.; Watson, Steve P.] Univ Birmingham, Biomed Res Inst, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Eble, Johannes A.] Frankfurt Univ Hosp, Excellence Cluster Cardio Pulm Syst, Dept Vasc Matrix Biol, Ctr Mol Med, D-60590 Frankfurt, Germany	University of Birmingham; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Watson, SP (corresponding author), Univ Birmingham, Biomed Res Inst, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England.	s.p.watson@bham.ac.uk	Watson, Stephen P/Q-6292-2016; Senis, Yotis/AAD-7183-2021	Watson, Stephen P/0000-0002-7846-7423; Tomlinson, Michael/0000-0002-1189-0091; Senis, Yotis/0000-0002-0947-9957	British Heart Foundation; Deutsche Forschungsgemeinschaft [Eb177/5-1]; Medical Research Council [G0400247] Funding Source: researchfish; MRC [G0400247] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the British Heart Foundation, The Wellcome Trust, and Deutsche Forschungsgemeinschaft Grant Eb177/5-1 (to J.A.E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; BIJSTERBOSCH MK, 1985, J EXP MED, V162, P1825, DOI 10.1084/jem.162.6.1825; BLAKE RA, 1993, BIOCHEM J, V290, P471, DOI 10.1042/bj2900471; Braselmann S, 2006, J PHARMACOL EXP THER, V319, P998, DOI 10.1124/jpet.106.109058; BURKHARDT AL, 1994, J BIOL CHEM, V269, P23642; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Cicmil M, 2002, BLOOD, V99, P137, DOI 10.1182/blood.V99.1.137; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; de Vet ECJM, 2001, J BIOL CHEM, V276, P42070, DOI 10.1074/jbc.M103214200; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dhanjal TS, 2007, PLATELETS, V18, P56, DOI 10.1080/09537100600881396; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Grande SM, 2007, IMMUNOL REV, V218, P214, DOI 10.1111/j.1600-065X.2007.00535.x; INAZU T, 1990, BIOCHEM BIOPH RES CO, V170, P259, DOI 10.1016/0006-291X(90)91268-W; Isnardi I, 2006, IMMUNOL LETT, V104, P156, DOI 10.1016/j.imlet.2005.11.027; Jones KL, 2001, BLOOD, V98, P1456, DOI 10.1182/blood.V98.5.1456; Keren Z, 2004, J BIOL CHEM, V279, P13418, DOI 10.1074/jbc.M311970200; LEREA KM, 1989, BIOCHEMISTRY-US, V28, P9286, DOI 10.1021/bi00450a008; Maeda A, 1998, J EXP MED, V187, P1355, DOI 10.1084/jem.187.8.1355; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Moroi M, 2003, THROMB HAEMOSTASIS, V89, P996; Muraille E, 2000, IMMUNOL LETT, V72, P7, DOI 10.1016/S0165-2478(00)00162-0; Newland SA, 2007, BLOOD, V109, P4806, DOI 10.1182/blood-2006-09-047449; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Patil S, 2001, BLOOD, V97, P1727, DOI 10.1182/blood.V97.6.1727; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 2000, BLOOD, V96, P4246; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Tomlinson MG, 2007, J THROMB HAEMOST, V5, P2274, DOI 10.1111/j.1538-7836.2007.02746.x; van Oers NSC, 1998, J IMMUNOL, V160, P163; Verbrugge A, 2006, EUR J IMMUNOL, V36, P190, DOI 10.1002/eji.200535226; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Washington AV, 2004, BLOOD, V104, P1042, DOI 10.1182/blood-2004-01-0315; Washington AV, 2002, BLOOD, V100, P3822, DOI 10.1182/blood-2002-02-0523; Watson SP, 2001, THROMB HAEMOSTASIS, V86, P276	52	45	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35419	35427		10.1074/jbc.M806895200	http://dx.doi.org/10.1074/jbc.M806895200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955485	Green Published, hybrid			2022-12-27	WOS:000261687900013
J	O'Rourke, JR; Swanson, MS				O'Rourke, Jason R.; Swanson, Maurice S.			Mechanisms of RNA-mediated Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FRAGILE-X-SYNDROME; EXPANDED CUG REPEAT; MYOTONIC-DYSTROPHY; MESSENGER-RNA; DROSOPHILA MODEL; PROTEIN-KINASE; MOUSE MODEL; TREMOR/ATAXIA-SYNDROME; BINDING PROTEIN; RCGG REPEATS	Recent mapping of functional sequence elements in the human genome has led to the realization that transcription is pervasive and that noncoding RNAs compose a significant portion of the transcriptome. Some dominantly inherited neurological disorders are associated with the expansion of microsatellite repeats in noncoding regions that result in the synthesis of pathogenic RNAs. Here, we review RNA gain-of-function mechanisms underlying three of these microsatellite expansion disorders to illustrate how some mutant RNAs cause disease.	[Swanson, Maurice S.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Genet Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Swanson, MS (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	mswanson@ufl.edu		Swanson, Maurice/0000-0001-6245-5367				Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; Entezam A, 2007, GENE, V395, P125, DOI 10.1016/j.gene.2007.02.026; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Handa V, 2003, NUCLEIC ACIDS RES, V31, P6243, DOI 10.1093/nar/gkg818; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Khalil AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001486; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Khateb S, 2007, NUCLEIC ACIDS RES, V35, P5775, DOI 10.1093/nar/gkm636; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Mutsuddi M, 2004, CURR BIOL, V14, P302, DOI 10.1016/j.cub.2004.01.034; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Pascual M, 2006, DIFFERENTIATION, V74, P65, DOI 10.1111/j.1432-0436.2006.00060.x; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Schroeder R, 2002, CURR OPIN STRUC BIOL, V12, P296, DOI 10.1016/S0959-440X(02)00325-1; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zumwalt M, 2007, RNA BIOL, V4, P93, DOI 10.4161/rna.4.2.5039	46	72	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7419	7423		10.1074/jbc.R800025200	http://dx.doi.org/10.1074/jbc.R800025200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	18957432	Green Published, hybrid			2022-12-27	WOS:000264195600004
J	Preveral, S; Gayet, L; Moldes, C; Hoffmann, J; Mounicou, S; Gruet, A; Reynaud, F; Lobinski, R; Verbavatz, JM; Vavasseur, A; Forestier, C				Preveral, Sandra; Gayet, Landry; Moldes, Cristina; Hoffmann, Jonathan; Mounicou, Sandra; Gruet, Antoine; Reynaud, Florie; Lobinski, Ryszard; Verbavatz, Jean-Marc; Vavasseur, Alain; Forestier, Cyrille			A Common Highly Conserved Cadmium Detoxification Mechanism from Bacteria to Humans HEAVY METAL TOLERANCE CONFERRED BY THE ATP-BINDING CASSETTE (ABC) TRANSPORTER SpHMT1 REQUIRES GLUTATHIONE BUT NOT METAL-CHELATING PHYTOCHELATIN PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; SACCHAROMYCES-CEREVISIAE; SYNTHASE; FAMILY; PLANTS; GENES; REDOX	Cadmium poses a significant threat to human health due to its toxicity. In mammals and in bakers' yeast, cadmium is detoxified by ATP-binding cassette transporters after conjugation to glutathione. In fission yeast, phytochelatins constitute the co-substrate with cadmium for the transporter SpHMT1. In plants, a detoxification mechanism similar to the one in fission yeast is supposed, but the molecular nature of the transporter is still lacking. To investigate further the relationship between SpHMT1 and its co-substrate, we overexpressed the transporter in a Schizosaccharomyces pombe strain deleted for the phytochelatin synthase gene and heterologously in Saccharomyces cerevisiae and in Escherichia coli. In all organisms, overexpression of SpHMT1 conferred a markedly enhanced tolerance to cadmium but not to Sb(III), AgNO3, As(III), As(V), CuSO4, or HgCl2. Abolishment of the catalytic activity by expression of SpHMT1(K623M) mutant suppressed the cadmium tolerance phenotype independently of the presence of phytochelatins. Depletion of the glutathione pool inhibited the SpHMT1 activity but not that of AtHMA4, a P-type ATPase, indicating that GSH is necessary for the SpHMT1-mediated cadmium resistance. In E. coli, SpHMT1 was targeted to the periplasmic membrane and led to an increased amount of cadmium in the periplasm. These results demonstrate that SpHMT1 confers cadmium tolerance in the absence of phytochelatins but depending on the presence of GSH and ATP. Our results challenge the dogma of the two separate cadmium detoxification pathways and demonstrate that a common highly conserved mechanism has been selected during the evolution from bacteria to humans.	[Preveral, Sandra; Gayet, Landry; Moldes, Cristina; Hoffmann, Jonathan; Gruet, Antoine; Reynaud, Florie; Vavasseur, Alain; Forestier, Cyrille] Aix Marseille Univ, F-13108 St Paul Les Durance, France; [Mounicou, Sandra; Lobinski, Ryszard] CNRS, UMR 5034, Equipe Chim Analyt Bioinorgan, F-64053 Pau 9, France; [Verbavatz, Jean-Marc] CEA Saclay, DSV, Inst Biol & Technol Saclay, SB2SM, F-91191 Gif Sur Yvette, France; [Preveral, Sandra; Gayet, Landry; Moldes, Cristina; Hoffmann, Jonathan; Gruet, Antoine; Reynaud, Florie; Vavasseur, Alain; Forestier, Cyrille] CEA Cadarache, CNRS,Serv Biol Vegetale & Microbiol Environm, DSV,LEMS, IBEB,UMR Biol Vegetale & Microbiol Environm, F-13108 St Paul Les Durance, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Forestier, C (corresponding author), CEA Aix Marseille II, CNRS, DSV,CEA Cadarache,LEMS, IBEB,UMR 6191, F-13108 St Paul Les Durance, France.	cforestier@cea.fr	FORESTIER, Cyrille/B-9684-2009; Prévéral, sandra/ABE-7177-2021; Gayet, Landry/M-7851-2014; FORESTIER, Cyrille/AAX-8921-2021	FORESTIER, Cyrille/0000-0003-2141-1303; HOFFMANN, JONATHAN/0000-0002-2400-8862; Lobinski, Ryszard/0000-0003-1908-2029; Verbavatz, Jean-Marc/0000-0002-4654-1174; Reynaud, Florie/0000-0002-1653-7377; SANDRA, PREVERAL/0000-0002-0372-6099				AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Clemens S, 2006, J PLANT PHYSIOL, V163, P319, DOI 10.1016/j.jplph.2005.11.010; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Cobbett CS, 1999, TRENDS PLANT SCI, V4, P335, DOI 10.1016/S1360-1385(99)01465-X; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Henkel G, 2004, CHEM REV, V104, P801, DOI 10.1021/cr020620d; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; KONDO N, 1984, TETRAHEDRON LETT, V25, P3869, DOI 10.1016/S0040-4039(01)91190-6; LEBRUN M, 1994, J BACTERIOL, V176, P3040, DOI 10.1128/JB.176.10.3040-3048.1994; Lee SH, 2003, BIOCHEM BIOPH RES CO, V306, P644, DOI 10.1016/S0006-291X(03)01029-5; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Meyer AJ, 2008, J PLANT PHYSIOL, V165, P1390, DOI 10.1016/j.jplph.2007.10.015; MORENO S, 1991, METHOD ENZYMOL, V194, P795; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Preveral S, 2006, BIOCHIMIE, V88, P1651, DOI 10.1016/j.biochi.2006.05.016; Rea PA, 2006, P NATL ACAD SCI USA, V103, P507, DOI 10.1073/pnas.0509971102; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Suga M, 2001, YEAST, V18, P1015, DOI 10.1002/yea.753; Tamas MJ, 2006, TOP CURR GENET, V14, P395; Tommasini R, 1996, P NATL ACAD SCI USA, V93, P6743, DOI 10.1073/pnas.93.13.6743; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Vivares D, 2005, P NATL ACAD SCI USA, V102, P18848, DOI 10.1073/pnas.0505833102; Wunschmann J, 2007, FEBS LETT, V581, P1681, DOI 10.1016/j.febslet.2007.03.039	29	77	81	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4936	4943		10.1074/jbc.M808130200	http://dx.doi.org/10.1074/jbc.M808130200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19054771	hybrid			2022-12-27	WOS:000263416600023
J	Seefeldt, T; Zhao, Y; Chen, W; Raza, AS; Carlson, L; Herman, J; Stoebner, A; Hanson, S; Foll, R; Guan, XM				Seefeldt, Teresa; Zhao, Yong; Chen, Wei; Raza, Ashraf S.; Carlson, Laura; Herman, Jocqueline; Stoebner, Adam; Hanson, Sarah; Foll, Ryan; Guan, Xiangming			Characterization of a Novel Dithiocarbamate Glutathione Reductase Inhibitor and Its Use as a Tool to Modulate Intracellular Glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL REDOX STATE; OXIDATIVE STRESS; IN-VITRO; CRYSTALLOGRAPHIC ANALYSIS; SECONDARY ALCOHOLS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; PROTEIN-THIOLS; ACID; CELL	Thiol redox state (TRS) is an important parameter to reflect intracellular oxidative stress and is associated with various normal and abnormal biochemical processes. Agents that can be used to increase intracellular TRS will be valuable tools in TRS-related research. Glutathione reductase (GR) is a critical enzyme in the homeostasis of TRS. The enzyme catalyzes the reduction of GSSG to GSH to maintain a high GSH: GSSG ratio. Inhibition of the enzyme can be used to increase TRS. Despite the reports of various GR inhibitors, N,N-bis(2-chloroethyl)-N-nitrosourea, an anticancer drug with IC50 = 647 mu M against yeast GR, remains the most commonly used GR inhibitor in the literature. However, the toxicity caused by nonspecific interactions, as well as inhibition of DNA synthesis, complicates the use of N,N-bis(2-chloroethyl)-N-nitrosourea as a GR inhibitor. We report 2-acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylthiocarbonylamino)phenylthio-carbamoylsulfanyl]propionic acid (2-AAPA) as a novel irreversible GR inhibitor. 2-AAPA was prepared by one-step synthesis from commercially available reagents. The K-i and k(inact) of 2-AAPA against yeast GR were determined to be 56 mu M and 0.1 min(-1), respectively. At the concentration that produced >80% yeast GR inhibition, 2-APAA showed no inhibition against glutamylcysteine synthetase, glutathione synthetase, catalase, and superoxide dismutase, but minimal inhibition against glutathione S-transferase and glutathione peroxidase. In CV-1 cells, 2-AAPA (0.1 mM) produced 97% GR inhibition, 25% GSH reduction, and a 5-fold increase in GSSG in 20 min. The compound can be a useful tool in TRS-related research.	[Seefeldt, Teresa; Zhao, Yong; Chen, Wei; Carlson, Laura; Herman, Jocqueline; Stoebner, Adam; Hanson, Sarah; Foll, Ryan; Guan, Xiangming] S Dakota State Univ, Coll Pharm, Dept Pharmaceut Sci, Brookings, SD 57007 USA; [Raza, Ashraf S.] Covance Bioanalyt Serv LLC, Indianapolis, IN 46214 USA	South Dakota State University; Covance	Guan, XM (corresponding author), S Dakota State Univ, Coll Pharm, Dept Pharmaceut Sci, Box 2202C, Brookings, SD 57007 USA.	Xiangming.Guan@sdstate.edu	Raza, Faisal/AAG-4567-2021	Raza, Faisal/0000-0001-5569-3535; Zhao, Yong/0000-0003-3423-2718	National Institutes of Health [CA098810-01, CA120062-01]; American Foundation for Pharmaceutical Education Kappa Epsilon Nellie Wakeman first year graduate mentorship; F. Nelson undergraduate research mentorship awards; NATIONAL CANCER INSTITUTE [R15CA098810, R15CA120062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Pharmaceutical Education Kappa Epsilon Nellie Wakeman first year graduate mentorship; F. Nelson undergraduate research mentorship awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA098810-01 and CA120062-01. This work was also supported by 2005 Governor Rounds' individual research seed grant awards, an American Foundation for Pharmaceutical Education Kappa Epsilon Nellie Wakeman first year graduate mentorship (to T. S.), Joseph F. Nelson undergraduate research mentorship awards (to S. H., L. C., and A. S.), and a South Dakota EPSCoR Rushmore undergraduate research fellowship (to J.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arscott LD, 2000, BIOCHEMISTRY-US, V39, P4711, DOI 10.1021/bi9926431; Asmis R, 2005, FASEB J, V19, P1866, DOI 10.1096/fj.04-2991fje; Bauer H, 2006, J AM CHEM SOC, V128, P10784, DOI 10.1021/ja061155v; BECKER K, 1995, EUR J BIOCHEM, V234, P472, DOI 10.1111/j.1432-1033.1995.472_b.x; BECKER K, 1990, BIOCHEM PHARMACOL, V39, P59, DOI 10.1016/0006-2952(90)90648-5; Biot C, 2004, J MED CHEM, V47, P5972, DOI 10.1021/jm0497545; Bishop GM, 2007, FREE RADICAL BIO MED, V42, P1222, DOI 10.1016/j.freeradbiomed.2007.01.022; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Bizzozero OA, 2006, J NEUROSCI RES, V83, P656, DOI 10.1002/jnr.20771; Boese M, 1997, J BIOL CHEM, V272, P21767, DOI 10.1074/jbc.272.35.21767; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURRELL CJ, 1989, BRIT HEART J, V61, P4; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Cesaratto L, 2005, FREE RADICAL RES, V39, P255, DOI 10.1080/10715760400029603; Davioud-Charvet E, 2001, J MED CHEM, V44, P4268, DOI 10.1021/jm010268g; Deponte M, 2005, J BIOL CHEM, V280, P20628, DOI 10.1074/jbc.M412519200; Dursun E, 2005, J DIABETES COMPLICAT, V19, P142, DOI 10.1016/j.jdiacomp.2004.11.001; Erlemann KR, 2004, J BIOL CHEM, V279, P40376, DOI 10.1074/jbc.M401294200; Farber PM, 1998, FEBS LETT, V422, P311, DOI 10.1016/S0014-5793(98)00031-3; FERRARI R, 1990, CIRCULATION, V81, P201, DOI 10.1161/01.CIR.81.1.201; FITZGERALD GB, 1991, BIOCHEM PHARMACOL, V41, P185, DOI 10.1016/0006-2952(91)90475-K; Gallwitz H, 1999, J MED CHEM, V42, P364, DOI 10.1021/jm980471k; Ghezzi P, 2005, ANTIOXID REDOX SIGN, V7, P964, DOI 10.1089/ars.2005.7.964; Ghezzi P, 2005, BIOCHEM SOC T, V33, P1378, DOI 10.1042/BST0331378; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; Guan XM, 2002, DRUG METAB DISPOS, V30, P331, DOI 10.1124/dmd.30.3.331; Guan XM, 2003, J PHARMACEUT BIOMED, V31, P251, DOI 10.1016/S0731-7085(02)00594-0; Guan XM, 1999, CHEM RES TOXICOL, V12, P1138, DOI 10.1021/tx990086d; Han D, 2006, FREE RADICAL BIO MED, V41, P627, DOI 10.1016/j.freeradbiomed.2006.05.002; HINCHMAN CA, 1990, BIOCHEM PHARMACOL, V40, P1131, DOI 10.1016/0006-2952(90)90503-D; JOCHHEIM CM, 1994, BIOCHEM PHARMACOL, V47, P1197, DOI 10.1016/0006-2952(94)90392-1; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; KANN HE, 1980, CANCER RES, V40, P50; KARPLUS PA, 1988, EUR J BIOCHEM, V171, P193, DOI 10.1111/j.1432-1033.1988.tb13775.x; KASSAHUN K, 1994, BIOCHEM PHARMACOL, V48, P587, DOI 10.1016/0006-2952(94)90290-9; KITZ R, 1962, J BIOL CHEM, V237, P3245; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Linetsky M, 2003, INVEST OPHTH VIS SCI, V44, P3920, DOI 10.1167/iovs.03-0390; NARDI G, 1990, J CHROMATOGR-BIOMED, V530, P122, DOI 10.1016/S0378-4347(00)82310-5; Patsoukis N, 2005, ANAL BIOANAL CHEM, V383, P923, DOI 10.1007/s00216-005-0095-5; Patsoukis N, 2005, NEUROSCI LETT, V376, P24, DOI 10.1016/j.neulet.2004.11.019; Patsoukis N, 2004, ANAL BIOANAL CHEM, V378, P1783, DOI 10.1007/s00216-004-2525-1; Pullela PK, 2006, ANAL BIOCHEM, V352, P265, DOI 10.1016/j.ab.2006.01.047; REGLINSKI J, 1992, J MED CHEM, V35, P2134, DOI 10.1021/jm00089a026; Rigobello MP, 2005, ARCH BIOCHEM BIOPHYS, V441, P112, DOI 10.1016/j.abb.2005.07.007; Savvides SN, 1996, J BIOL CHEM, V271, P8101, DOI 10.1074/jbc.271.14.8101; Schirmer R. H., 1989, GLUTATHIONE CHEM B A, P553; SchonlebenJanas A, 1996, J MED CHEM, V39, P1549, DOI 10.1021/jm950511+; Seefeldt T, 2005, J MED CHEM, V48, P5224, DOI 10.1021/jm050030i; TSUNODA T, 1995, TETRAHEDRON LETT, V36, P2529, DOI 10.1016/0040-4039(95)00299-R; Tsunoda T, 1999, TETRAHEDRON LETT, V40, P7355, DOI 10.1016/S0040-4039(99)01509-9; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wang J, 2007, ARTERIOSCL THROM VAS, V27, P1283, DOI 10.1161/ATVBAHA.107.144659; Yu J, 2007, PROTEINS, V68, P972, DOI 10.1002/prot.21354	54	44	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2729	2737		10.1074/jbc.M802683200	http://dx.doi.org/10.1074/jbc.M802683200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049979	hybrid, Green Published			2022-12-27	WOS:000262700900015
J	Vincke, C; Loris, R; Saerens, D; Martinez-Rodriguez, S; Muyldermans, S; Conrath, K				Vincke, Cecile; Loris, Remy; Saerens, Dirk; Martinez-Rodriguez, Sergio; Muyldermans, Serge; Conrath, Katja			General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-H DOMAIN; HEAVY-CHAIN ANTIBODIES; CRYSTAL-STRUCTURE; ANTIGEN-BINDING; PROTEIN STABILITY; VARIABLE DOMAINS; LIGHT-CHAINS; IN-VITRO; FRAGMENTS; VHH	Nanobodies, single-domain antigen-binding fragments of camelid-specific heavy-chain only antibodies offer special advantages in therapy over classic antibody fragments because of their smaller size, robustness, and preference to target unique epitopes. A Nanobody differs from a human heavy chain variable domain in about ten amino acids spread all over its surface, four hallmark Nanobody-specific amino acids in the framework-2 region ( positions 42, 49, 50, and 52), and a longer third antigen-binding loop (H3) folding over this area. For therapeutic applications the camelid-specific amino acid sequences in the framework have to be mutated to their human heavy chain variable domain equivalent, i.e. humanized. We performed this humanization exercise with Nanobodies of the subfamily that represents close to 80% of all dromedary-derived Nanobodies and investigated the effects on antigen affinity, solubility, expression yield, and stability. It is demonstrated that the humanization of Nanobody-specific residues outside framework-2 are neutral to the Nanobody properties. Surprisingly, the Glu-49 -> Gly and Arg-50 -> Leu humanization of hallmark amino acids generates a single domain that is more stable though probably less soluble. The other framework-2 substitutions, Phe-42 -> Val and Gly/Ala-52 -> Trp, are detrimental for antigen affinity, due to a repositioning of the H3 loop as shown by their crystal structures. These insights were used to identify a soluble, stable, well expressed universal humanized Nanobody scaffold that allows grafts of antigen-binding loops from other Nanobodies with transfer of the antigen specificity and affinity.	[Vincke, Cecile; Saerens, Dirk; Muyldermans, Serge; Conrath, Katja] Vrije Univ Brussel, Cellular & Mol Immunol Lab, B-1050 Brussels, Belgium; [Loris, Remy; Martinez-Rodriguez, Sergio] Vrije Univ Brussel, Ultrastrutture Lab, B-1050 Brussels, Belgium; [Vincke, Cecile; Loris, Remy; Saerens, Dirk; Martinez-Rodriguez, Sergio; Muyldermans, Serge; Conrath, Katja] Vlaams Inst Biotechnol, Dept Mol & Cellular Interact, Brussels, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Muyldermans, S (corresponding author), Vrije Univ Brussel, Cellular & Mol Immunol Lab, Pl Laan 2, B-1050 Brussels, Belgium.	svmuylde@vub.ac.be	Muyldermans, Serge V/C-6418-2016; Saerens, Dirk/B-9162-2008; Muyldermans, Serge/AAC-7374-2019; MARTINEZ-RODRIGUEZ, SERGIO/H-3448-2015; Loris, Remy/GPG-0894-2022; Vincke, Cecile/C-6590-2016	Muyldermans, Serge V/0000-0002-3678-3575; Muyldermans, Serge/0000-0002-3678-3575; MARTINEZ-RODRIGUEZ, SERGIO/0000-0001-6675-1550; Loris, Remy/0000-0002-8862-3338; Saerens, Dirk/0000-0001-8894-8039; Vincke, Cecile/0000-0003-0681-7444				Achour I, 2008, J IMMUNOL, V181, P2001, DOI 10.4049/jimmunol.181.3.2001; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen ZD, 1998, NUCLEIC ACIDS RES, V26, P1126, DOI 10.1093/nar/26.4.1126; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; da Silva FA, 2004, J MOL BIOL, V340, P525, DOI 10.1016/j.jmb.2004.04.062; Davies J, 1996, PROTEIN ENG, V9, P531, DOI 10.1093/protein/9.6.531; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Huang L, 2005, BIOSENS BIOELECTRON, V21, P483, DOI 10.1016/j.bios.2004.11.016; Huang SC, 1996, MOL IMMUNOL, V33, P553, DOI 10.1016/0161-5890(95)00162-X; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; Jung S, 2001, J MOL BIOL, V309, P701, DOI 10.1006/jmbi.2001.4665; KELLIS JT, 1989, BIOCHEMISTRY-US, V28, P4914, DOI 10.1021/bi00437a058; Martin F, 1997, PROTEIN ENG, V10, P607, DOI 10.1093/protein/10.5.607; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Ohlin M, 1996, MOL IMMUNOL, V33, P583, DOI 10.1016/0161-5890(96)00018-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C N, 1986, Methods Enzymol, V131, P266; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; Riechmann L, 1996, J MOL BIOL, V259, P957, DOI 10.1006/jmbi.1996.0373; ROGUSKA MA, 1994, P NATL ACAD SCI USA, V91, P969, DOI 10.1073/pnas.91.3.969; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; ROUSSEL A, 1989, SILICON GRAPHIC GEOM, P71; Royer C A, 1995, Methods Mol Biol, V40, P65; Saerens D, 2005, ANAL CHEM, V77, P7547, DOI 10.1021/ac051092j; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tanha J, 2002, J IMMUNOL METHODS, V263, P97, DOI 10.1016/S0022-1759(02)00027-3; Tanha J, 2001, J BIOL CHEM, V276, P24774, DOI 10.1074/jbc.M100770200; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; Voordijk S, 2000, J MOL BIOL, V300, P963, DOI 10.1006/jmbi.2000.3890; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0	58	308	404	12	138	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3273	3284		10.1074/jbc.M806889200	http://dx.doi.org/10.1074/jbc.M806889200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19010777	hybrid			2022-12-27	WOS:000262700900070
J	Zhang, Y; Hassan, MQ; Xie, RL; Hawse, JR; Spelsberg, TC; Montecino, M; Stein, JL; Lian, JB; van Wijnen, AJ; Stein, GS				Zhang, Ying; Hassan, Mohammad Q.; Xie, Rong-Lin; Hawse, John R.; Spelsberg, Thomas C.; Montecino, Martin; Stein, Janet L.; Lian, Jane B.; van Wijnen, Andre J.; Stein, Gary S.			Co-stimulation of the Bone-related Runx2 P1 Promoter in Mesenchymal Cells by SP1 and ETS Transcription Factors at Polymorphic Purine-rich DNA Sequences (Y-repeats)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; EMBRYONIC-DEVELOPMENT; REGULATED EXPRESSION; GENE-TRANSCRIPTION; CBFA1; DOMAIN; IDENTIFICATION; ACTIVATION	Transcriptional control of Runx2 gene expression through two alternative promoters (P1 and P2) is critical for the execution of its function as an osteogenic cell fate determining factor. In all vertebrates examined to date, the bone related P1 promoter contains a purine-rich region (-303 to -128 bp in the rat) that separates two regulatory domains. The length of this region differs dramatically between species even within the same order. Using deletion analysis, we show that part of this purine-rich region (-200 to -128) containing a duplicated element (Y-repeat) positively regulates Runx2 P1 transcription. Electrophoretic mobility assays and chromatin immunoprecipitations reveal that Y- repeat binds at least two different classes of transcription factors related to GC box binding proteins ( e. g. SP1 and SP7/Osterix) and ETS-like factors ( e. g. ETS1 and ELK1). Forced expression of SP1 increases Runx2 P1 promoter activity through the Y- repeats, and small interfering RNA depletion of SP1 decreases Runx2 expression. Similarly, exogenous expression of wild type ELK1, but not a defective mutant that cannot be phosphorylated, enhances Runx2 gene expression. SP1 is most abundant in proliferating cells, and ELK1 is most abundant in postconfluent cells; during MC3T3-E1 osteoblast differentiation, both proteins are transiently co-expressed when Runx2 expression is enhanced. Taken together, our data suggest that basal Runx2 gene transcription is regulated by dynamic interactions between SP1 and ETS-like factors during progression of osteogenesis.	[Zhang, Ying; Hassan, Mohammad Q.; Xie, Rong-Lin; Stein, Janet L.; Lian, Jane B.; van Wijnen, Andre J.; Stein, Gary S.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Zhang, Ying; Hassan, Mohammad Q.; Xie, Rong-Lin; Stein, Janet L.; Lian, Jane B.; van Wijnen, Andre J.; Stein, Gary S.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Hawse, John R.; Spelsberg, Thomas C.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Montecino, Martin] Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Mayo Clinic; Universidad de Concepcion	Stein, GS (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA.	gary.stein@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019; Hassan, Mohammad/GZA-7507-2022; Zhang, Ying/B-5470-2010	van Wijnen, Andre J./0000-0002-4458-0946; Hassan, Mohammad/0000-0002-1712-0004; 	National Institutes of Health [R01 AR39588]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR39588. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; Bae JS, 2007, J CELL BIOCHEM, V100, P434, DOI 10.1002/jcb.21039; Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Frank RN, 2003, INVEST OPHTH VIS SCI, V44, P1; Fujiwara M, 1999, BBA-GENE STRUCT EXPR, V1446, P265, DOI 10.1016/S0167-4781(99)00113-X; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ghozi MC, 1996, P NATL ACAD SCI USA, V93, P1935, DOI 10.1073/pnas.93.5.1935; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hovhannisyan H, 2004, J BONE MINER RES, V19, pS78; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Kahler RA, 2006, J CELL BIOCHEM, V97, P969, DOI 10.1002/jcb.20702; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; Kim YJ, 2006, GENE, V366, P145, DOI 10.1016/j.gene.2005.08.021; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; LOU Y, 2008, HUM MOL GEN IN PRESS; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Rini D, 2001, GENE, V273, P13, DOI 10.1016/S0378-1119(01)00579-0; Santiago FS, 2004, CIRC RES, V95, P479, DOI 10.1161/01.RES.0000141135.36279.67; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Sears KE, 2007, EVOL DEV, V9, P555, DOI 10.1111/j.1525-142X.2007.00196.x; Stains JP, 2003, J BIOL CHEM, V278, P24377, DOI 10.1074/jbc.M212554200; Stewart M, 1997, P NATL ACAD SCI USA, V94, P8646, DOI 10.1073/pnas.94.16.8646; van Wijnen AJ, 2004, ONCOGENE, V23, P4209, DOI 10.1038/sj.onc.1207758; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Zambotti A, 2002, J BIOL CHEM, V277, P41497, DOI 10.1074/jbc.M204271200; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746	50	63	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3125	3135		10.1074/jbc.M807466200	http://dx.doi.org/10.1074/jbc.M807466200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19017640	Green Published, hybrid			2022-12-27	WOS:000262700900057
J	Carland, JE; Cooper, MA; Sugiharto, S; Jeong, HJ; Lewis, TM; Barry, PH; Peters, JA; Lambert, JJ; Moorhouse, AJ				Carland, Jane E.; Cooper, Michelle A.; Sugiharto, Silas; Jeong, Hyo-Jin; Lewis, Trevor M.; Barry, Peter H.; Peters, John A.; Lambert, Jeremy J.; Moorhouse, Andrew J.			Characterization of the Effects of Charged Residues in the Intracellular Loop on Ion Permeation in alpha 1 Glycine Receptor Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LARGE CYTOPLASMIC LOOP; 5-HT3 RECEPTOR; 5-HYDROXYTRYPTAMINE TYPE-3; ANGSTROM RESOLUTION; GATING MECHANISM; CONDUCTANCE; SUBUNIT; DETERMINANTS; SELECTIVITY	The Cys loop receptor channels mediate fast synaptic transmission in the nervous system. The M2-demarcated transmembrane pore is an important determinant of their ion permeation properties. Portals within the intracellular domain are also part of the permeation pathway in cationic Cys loop receptors, with charged residues in a helical MA stretch partially lining these openings profoundly affecting channel conductance. It is unknown whether analogous portals contribute to the permeation pathway in anionic Cys loop receptors. We therefore investigated the influence of charged residues within the proposed MA stretch on functional properties of the homomeric glycine alpha 1 receptor. Up to eight basic residues in the MA stretch were concurrently mutated to a negatively charged glutamate, and wild-type and mutant subunits were expressed in HEK-293 cells. Mutation of all eight residues produced a non-functional receptor. The greatest reduction in conductance at negative membrane potentials (from 92.2 +/- 2.8 to 60.0 +/- 2.2 picosiemens) was observed with glutamate present at the 377, 378, 385, and 386 positions (the 4E subunit). Inclusion of additional glutamate residues within this subunit did not decrease conductance further. Neutralizing these residues (the 4A subunit) caused a modest decrease in conductance (80.5 +/- 2.3 picosiemens). Outward conductance at positive potentials was not markedly affected. Anion to cation selectivity and concentration-response relationships were unaffected by the 4A or 4E mutations. Our results identify basic residues affecting conductance in the glycine receptor, suggesting that portals are part of the extended permeation pathway but that the M2-demarcated channel pore is the dominant determinant of permeation properties in glycine receptors.	[Carland, Jane E.; Cooper, Michelle A.; Peters, John A.; Lambert, Jeremy J.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Neurosci, Div Mol & Translat Med, Dundee DD1 9SY, Scotland; [Carland, Jane E.; Sugiharto, Silas; Jeong, Hyo-Jin; Lewis, Trevor M.; Barry, Peter H.; Moorhouse, Andrew J.] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia	University of Dundee; University of New South Wales Sydney	Lambert, JJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Ctr Neurosci, Div Mol & Translat Med, Dundee DD1 9SY, Scotland.	j.j.lambert@dundee.ac.uk; moorhouse@unsw.edu.au	Moorhouse, Andrew J/B-8526-2011; Lewis, Trevor/A-2939-2011	Moorhouse, Andrew J/0000-0001-7957-2498; Lewis, Trevor/0000-0003-1864-6806; Carland, Jane/0000-0002-1456-876X	Wellcome Trust, Tenovus Scotland; Anonymous Trust; University of New South Wales (UNSW) Faculty Research	Wellcome Trust, Tenovus Scotland(Wellcome Trust); Anonymous Trust; University of New South Wales (UNSW) Faculty Research	This work was supported by grants from the Wellcome Trust, Tenovus Scotland, and the Anonymous Trust ( to J.A.P. and J.J.L.), and University of New South Wales (UNSW) Faculty Research Grants (A.J.M.).	Barry PH, 2005, IEEE T NANOBIOSCI, V4, P70, DOI 10.1109/TNB.2004.842497; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; FINERMOORE J, 1984, P NATL ACAD SCI-BIOL, V81, P155, DOI 10.1073/pnas.81.1.155; Gee VJ, 2007, BRIT J PHARMACOL, V152, P501, DOI 10.1038/sj.bjp.0707429; GRENNINGLOH G, 1987, NATURE, V330, P25, DOI 10.1038/330025b0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Kuo YP, 2005, J PHARMACOL EXP THER, V314, P455, DOI 10.1124/jpet.105.084954; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Moorhouse AJ, 2002, J GEN PHYSIOL, V119, P411, DOI 10.1085/jgp.20028553; Peters JA, 2006, BIOCHEM SOC T, V34, P882, DOI 10.1042/BST0340882; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; ROBINSON RA, 1965, ACTIVITY COEFFICIENT, P492; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HL, 2000, J GEN PHYSIOL, V116, P449, DOI 10.1085/jgp.116.3.449; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	28	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2023	2030		10.1074/jbc.M806618200	http://dx.doi.org/10.1074/jbc.M806618200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19049967	hybrid			2022-12-27	WOS:000262545600009
J	Gordon, LI; Burke, MA; Singh, ATK; Prachand, S; Lieberman, ED; Sun, L; Naik, TJ; Prasad, SVN; Ardehali, H				Gordon, Leo I.; Burke, Michael A.; Singh, Amareshwar T. K.; Prachand, Sheila; Lieberman, Elliot D.; Sun, Lin; Naik, Tejaswitha Jairaj; Prasad, Sathyamangla V. Naga; Ardehali, Hossein			Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; DILATED CARDIOMYOPATHY; TYROSINE KINASES; ACTIVATION; ONCOGENE; PROTEIN; DYSFUNCTION; INHIBITION; EXPRESSION; ALPHA	Overexpression of the receptor tyrosine kinase erbB2 (Her2 in humans) is correlated with a poor prognosis in breast and ovarian cancers. Treatment with trastuzumab ( a monoclonal antibody against erbB2) improves survival; however, it also causes cardiomyopathy. We hypothesized that blockade of the erbB2 receptor induces cardiomyocyte death through a mitochondrial pathway that is dependent on the production of reactive oxygen species (ROS). We first showed that levels of erbB2 receptor are significantly decreased in an animal model of ischemic heart disease and in human ischemic cardiomyopathy. We treated neonatal rat cardiomyocytes with an inhibitory erbB2 antibody to study the mechanism behind the deleterious effects of erbB2 blockade. These cells displayed a dose-dependent increase in ROS production and cell death compared with control IgG-treated cells; these processes were reversed by the antioxidant, N-acetylcysteine. The effects of erbB2 antibody on both cell death and ROS production were also reversed by cyclosporine A and diazoxide, chemicals that regulate the pro- and anti-apoptotic channels in the mitochondria, respectively. Furthermore, mouse embryonic fibroblasts lacking Bax and Bak ( proteins that mediate cell death through a mitochondrial pathway) were resistant to the deleterious effects of erbB2 antibody. These effects of erbB2 blockade appear to occur through a pathway involving AKT and PKC-alpha. Our results suggest that erbB2 plays a role in cardiomyocyte survival, and that the deleterious effects of trastuzumab on the heart occur through a mitochondrial pathway and is mediated by ROS production. Manipulation of redox signaling may be beneficial in cancer patients receiving trastuzumab.	[Gordon, Leo I.; Singh, Amareshwar T. K.; Prachand, Sheila; Lieberman, Elliot D.; Ardehali, Hossein] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA; [Burke, Michael A.; Sun, Lin; Naik, Tejaswitha Jairaj] Northwestern Univ, Div Cardiol, Dept Med, Chicago, IL 60611 USA; [Gordon, Leo I.; Singh, Amareshwar T. K.; Prachand, Sheila; Ardehali, Hossein] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Prasad, Sathyamangla V. Naga] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Cleveland Clinic Foundation	Ardehali, H (corresponding author), Tarry 12-725,303 E Chicago Ave, Chicago, IL 60611 USA.	h-ardehali@northwestern.edu	Burke, Michael/GSN-3331-2022	Burke, Michael/0000-0003-1491-1131; Gordon, Leo/0000-0003-1666-7064	National Institutes of Health [K08 HL079387, R01 HL087149]; Schweppe Foundation; American Heart Association; American Cancer Society, Illinois; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087149, K08HL079387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schweppe Foundation; American Heart Association(American Heart Association); American Cancer Society, Illinois(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 HL079387 and R01 HL087149. This work was also supported by the Schweppe Foundation, American Heart Association, and a grant from the American Cancer Society, Illinois Chapter ( to H. A.).	Ardehali H, 2005, CIRC RES, V97, P740, DOI 10.1161/01.RES.0000186277.12336.11; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; Di Carlo E, 1999, LAB INVEST, V79, P1261; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Grazette LP, 2004, J AM COLL CARDIOL, V44, P2231, DOI 10.1016/j.jacc.2004.08.066; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Keefe DL, 2002, CANCER-AM CANCER SOC, V95, P1592, DOI 10.1002/cncr.10854; Le XF, 2007, MOL CANCER THER, V6, P2843, DOI 10.1158/1535-7163.MCT-07-0109; Lemke G, 1996, MOL CELL NEUROSCI, V7, P247, DOI 10.1006/mcne.1996.0019; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Timolati F, 2006, J MOL CELL CARDIOL, V41, P845, DOI 10.1016/j.yjmcc.2006.08.002; TOIKKANEN S, 1992, J CLIN ONCOL, V10, P1044, DOI 10.1200/JCO.1992.10.7.1044; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	22	134	140	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2080	2087		10.1074/jbc.M804570200	http://dx.doi.org/10.1074/jbc.M804570200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017630	hybrid, Green Published			2022-12-27	WOS:000262545600016
J	Liu, RH; Lu, PH; Chu, JWK; Sharom, FJ				Liu, Ronghua; Lu, Peihua; Chu, Joseph W. K.; Sharom, Frances J.			Characterization of Fluorescent Sterol Binding to Purified Human NPC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK C1; INTESTINAL CHOLESTEROL ABSORPTION; TRANS-GOLGI NETWORK; SENSING DOMAIN; NUCLEOTIDE-BINDING; PROTEIN-DEFICIENT; C2 DISEASE; MODEL MEMBRANES; LIPID TRANSPORT; P-GLYCOPROTEIN	Mutations in the NPC1 gene cause Niemann-Pick type C disease, which appears to result from a defect in intracellular cholesterol trafficking. NPC1 is a member of the resistance-nodulation-cell division (RND) permease superfamily and contains a sterol-sensing domain, yet its cellular function and the identity of its substrates remain unknown. FLAG-tagged human NPC1 was purified from NPC1-expressing Chinese hamster ovary cells by solubilization in 3-[(3-cholamidopropyl) dimethylammonio]1-propanesulfonic acid (CHAPS), followed by affinity chromatography. Purified NPC1 in detergent solution appeared to be oligomeric as determined by gel filtration fast protein liquid chromatography and was photolabeled by an azido-cholesterol derivative. Fluorescent cholesterol analogs, including dehydroergosterol, cholestatrienol, and 22-(N-(7-nitrobenz-2-oxa-1,3-diazol4-yl)amino)-23,24-bisnor-5- cholen-3 beta-ol (NBD-cholesterol), displayed enhanced fluorescence upon binding to NPC1 and also resulted in saturable, concentration-dependent quenching of NPC1 intrinsic Trp fluorescence. The apparent binding affinity for these three sterols was in the 0.5-6 mu M range. Binding of NBD-cholesterol to NPC1 at low detergent concentration (2 mM CHAPS) was of high apparent affinity(0.5-0.6 mu M) and occurred rapidly (< 1 min). However, binding of a BODIPY-labeled cholesterol derivative was very slow, requiring similar to 3 h to reach equilibrium. The apparent NBD-cholesterol binding affinity was greatly reduced at higher detergent concentration. The stoichiometry of NBD-cholesterol binding to NPC1 was similar to 1. Various sterols, including native cholesterol and 25-hydroxycholesterol, inhibited NBD-cholesterol binding, suggesting that they compete for binding to the protein. Dynamic quenching studies showed that bound NBD-cholesterol was almost completely shielded from the aqueous medium, suggesting that it is buried in a deep hydrophobic pocket in NPC1. The use of fluorescent cholesterol analogs provides novel information on the molecular properties of the sterol-binding site in the full-length NPC1 protein.	[Liu, Ronghua; Lu, Peihua; Chu, Joseph W. K.; Sharom, Frances J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Sharom, FJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex Rm 2255, Guelph, ON N1G 2W1, Canada.	fsharom@uoguelph.ca	Sharom, Frances/A-1613-2010	Sharom, Frances/0000-0002-9521-5367	Ara Parseghian Medical Research Foundation	Ara Parseghian Medical Research Foundation	This work was supported by a research grant from the Ara Parseghian Medical Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Avdulov NA, 1999, BBA-MOL CELL BIOL L, V1437, P37, DOI 10.1016/S0005-2760(98)00178-7; Avdulov NA, 1997, J NEUROCHEM, V69, P1746; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dixit SS, 2007, BIOCHEM J, V408, P1, DOI 10.1042/BJ20071167; Dixon M., 1979, ENZYMES, Vthird; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Gong YP, 2006, J PHARMACOL EXP THER, V316, P242, DOI 10.1124/jpet.105.089482; HABERLAND ME, 1973, P NATL ACAD SCI USA, V70, P2313, DOI 10.1073/pnas.70.8.2313; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P976, DOI 10.1021/bi051978h; Haugland R.P., 2002, HDB FLUORESCENT PROB; Higaki K, 2001, J BIOCHEM-TOKYO, V129, P875, DOI 10.1093/oxfordjournals.jbchem.a002932; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15336, DOI 10.1021/bi981094g; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Ioannou YA, 2005, TRENDS BIOCHEM SCI, V30, P498, DOI 10.1016/j.tibs.2005.07.007; Ioannou YA, 2000, MOL GENET METAB, V71, P175, DOI 10.1006/mgme.2000.3061; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P1; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 1998, CURR OPIN STRUC BIOL, V8, P435, DOI 10.1016/S0959-440X(98)80119-X; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Liou HL, 2006, J BIOL CHEM, V281, P36710, DOI 10.1074/jbc.M608743200; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; LOE DW, 1994, BBA-BIOMEMBRANES, V1190, P72, DOI 10.1016/0005-2736(94)90035-3; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Malathi K, 2004, J CELL BIOL, V164, P547, DOI 10.1083/jcb.200310046; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Mintzer EA, 2002, FEBS LETT, V510, P181, DOI 10.1016/S0014-5793(01)03271-9; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Ory DS, 2000, BBA-MOL CELL BIOL L, V1529, P331, DOI 10.1016/S1388-1981(00)00158-X; Parker C. A., 1968, PHOTOLUMINESCENCE SO, P220; Pentchev PG, 2004, BBA-MOL CELL BIOL L, V1685, P3, DOI 10.1016/j.bbalip.2004.08.005; Petrescu AD, 2001, J BIOL CHEM, V276, P36970, DOI 10.1074/jbc.M101939200; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; Vanier MT, 2004, BBA-MOL CELL BIOL L, V1685, P14, DOI 10.1016/j.bbalip.2004.08.007; Watari H, 1999, J BIOL CHEM, V274, P21861, DOI 10.1074/jbc.274.31.21861; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7	57	51	53	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1840	1852		10.1074/jbc.M803741200	http://dx.doi.org/10.1074/jbc.M803741200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19029290	hybrid			2022-12-27	WOS:000262330100055
J	Nie, J; Sage, EH				Nie, Jing; Sage, E. Helene			SPARC Inhibits Adipogenesis by Its Enhancement of beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; ACTIVATED-RECEPTOR-GAMMA; NULL MICE EXHIBIT; MATRICELLULAR PROTEIN SPARC; IN-VITRO; ADIPOCYTE DIFFERENTIATION; GROWTH-FACTOR; E-CADHERIN; OSTEOCLAST DIFFERENTIATION; GENE-TRANSCRIPTION	SPARC (secreted protein acidic and rich in cysteine) modulates interactions between cells and extracellular matrix and is enriched in white adipose tissue. We have reported that SPARC-null mice accumulate significantly more fat than wild-type mice and maintain relatively high levels of serum leptin. We now show that SPARC inhibits adipogenesis in vitro. Specifically, recombinant SPARC inhibited (a) adipocyte differentiation of stromal-vascular cells isolated from murine white adipose tissue and (b) the expression of adipogenic transcription factors and adipocyte-specific genes. SPARC induced the accumulation and nuclear translocation of beta-catenin and subsequently enhanced the interaction of beta-catenin and T cell/lymphoid enhancer factor 1. The activity of integrin-linked kinase was required for the effect of SPARC on beta-catenin accumulation as well as extracellular matrix remodeling. During adipogenesis, fusiform preadipocytes change into sphere-shaped adipocytes and convert the extracellular matrix from a fibronectin-rich stroma to a laminin-rich basal lamina. SPARC retarded the morphological changes exhibited by preadipocytes during differentiation. In the presence of SPARC, the deposition of fibronectin was enhanced, and that of laminin was inhibited; in parallel, the expression of alpha 5 integrin was enhanced, and that of alpha 6 integrin was inhibited. Lithium chloride, which enhances the accumulation of beta-catenin, also inhibited the expression of alpha 6 integrin. These findings demonstrate a role for SPARC in adipocyte morphogenesis and in signaling processes leading to terminal differentiation.	[Nie, Jing; Sage, E. Helene] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA	Benaroya Research Institute; Virginia Mason Medical Center	Sage, EH (corresponding author), Benaroya Res Inst Virginia Mason, Hope Heart Program, 1201 9th Ave, Seattle, WA 98101 USA.	hsage@benaroyaresearch.org			National Institutes of Health [R01-GM40711]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM40711 (to E.H.S.).	Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Bradshaw Amy D., 2000, Molecular Cell Biology Research Communications, V3, P345, DOI 10.1006/mcbr.2000.0237; Brekken Rolf A., 2001, Matrix Biology, V19, P816; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glass DA, 2006, ANN NY ACAD SCI, V1068, P117, DOI 10.1196/annals.1346.015; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gruber HE, 2005, J HISTOCHEM CYTOCHEM, V53, P1131, DOI 10.1369/jhc.5A6687.2005; Han SW, 2005, AM J RESP CELL MOL, V32, P350, DOI 10.1165/rcmb.2004-0345OC; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Lian J. B., 2003, Current Pharmaceutical Design, V9, P2677, DOI 10.2174/1381612033453659; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Nie J, 2008, STEM CELLS, V26, P2735, DOI 10.1634/stemcells.2008-0212; Niimi T, 1997, MATRIX BIOL, V16, P223, DOI 10.1016/S0945-053X(97)90011-1; Norose K, 2000, EXP EYE RES, V71, P295, DOI 10.1006/exer.2000.0884; Nozaki M, 2006, J CLIN INVEST, V116, P422, DOI 10.1172/JCI26316; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; O'Connor KC, 2003, BIOTECHNOL LETT, V25, P1967, DOI 10.1023/B:BILE.0000004386.08923.ab; Oloumi A, 2004, BBA-MOL CELL RES, V1691, P1, DOI 10.1016/j.bbamcr.2003.12.002; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Sweetwyne MT, 2004, J HISTOCHEM CYTOCHEM, V52, P723, DOI 10.1369/jhc.3A6153.2004; Takahashi M, 2001, OBES RES, V9, P388, DOI 10.1038/oby.2001.50; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tartare-Deckert S, 2001, J BIOL CHEM, V276, P22231, DOI 10.1074/jbc.M010634200; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Weaver MS, 2006, J CELL BIOCHEM, V97, P423, DOI 10.1002/jcb.20654; Yan Q, 2005, INVEST OPHTH VIS SCI, V46, P4652, DOI 10.1167/iovs.05-0460; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11; Zhao L, 2000, J BIOL CHEM, V275, P16845, DOI 10.1074/jbc.275.22.16845	60	113	119	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1279	1290		10.1074/jbc.M808285200	http://dx.doi.org/10.1074/jbc.M808285200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18990699	Green Published, hybrid			2022-12-27	WOS:000262122900063
J	Powell, AJ; Tomberg, J; Deacon, AM; Nicholas, RA; Davies, C				Powell, Ailsa J.; Tomberg, Joshua; Deacon, Ashley M.; Nicholas, Robert A.; Davies, Christopher			Crystal Structures of Penicillin-binding Protein 2 from Penicillin-susceptible and -resistant Strains of Neisseria gonorrhoeae Reveal an Unexpectedly Subtle Mechanism for Antibiotic Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM RESISTANCE; AMINO-ACID SUBSTITUTIONS; MOSAIC-LIKE STRUCTURE; STREPTOCOCCUS-PNEUMONIAE; REDUCED SUSCEPTIBILITY; ESCHERICHIA-COLI; ACTIVE-SITE; PEPTIDOGLYCAN STRUCTURE; ENTEROCOCCUS-FAECIUM; LEVEL RESISTANCE	Penicillin-binding protein 2 (PBP2) from N. gonorrhoeae is the major molecular target for beta-lactam antibiotics used to treat gonococcal infections. PBP2 from penicillin-resistant strains of N. gonorrhoeae harbors an aspartate insertion after position 345 (Asp-345a) and 4-8 additional mutations, but how these alter the architecture of the protein is unknown. We have determined the crystal structure of PBP2 derived from the penicillin-susceptible strain FA19, which shows that the likely effect of Asp-345a is to alter a hydrogen-bonding network involving Asp-346 and the SXN triad at the active site. We have also solved the crystal structure of PBP2 derived from the penicillin-resistant strain FA6140 that contains four mutations near the C terminus of the protein. Although these mutations lower the second order rate of acylation for penicillin by 5-fold relative to wild type, comparison of the two structures shows only minor structural differences, with the positions of the conserved residues in the active site essentially the same in both. Kinetic analyses indicate that two mutations, P551S and F504L, are mainly responsible for the decrease in acylation rate. Melting curves show that the four mutations lower the thermal stability of the enzyme. Overall, these data suggest that the molecular mechanism underlying antibiotic resistance contributed by the four mutations is subtle and involves a small but measurable disordering of residues in the active site region that either restricts the binding of antibiotic or impedes conformational changes that are required for acylation by beta-lactam antibiotics.	[Tomberg, Joshua; Nicholas, Robert A.] SLAC Natl Accelerator Lab, Stanford, CA 94025 USA; [Powell, Ailsa J.; Davies, Christopher] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Deacon, Ashley M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill	Nicholas, RA (corresponding author), SLAC Natl Accelerator Lab, Menlo Pk, Stanford, CA 94025 USA.	nicholas@med.unc.edu; davies@musc.edu		Nicholas, Robert/0000-0003-2507-8974	National Institutes of Health [GM66861, AI36901]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM66861(to C. D.) and AI36901 (to R. A. N.).	Ameyama S, 2002, ANTIMICROB AGENTS CH, V46, P3744, DOI 10.1128/AAC.46.12.3744-3749.2002; [Anonymous], 1992, CHEM B LACTAMS; Antignac A, 2003, J BIOL CHEM, V278, P31529, DOI 10.1074/jbc.M304607200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARBOUR AG, 1981, ANTIMICROB AGENTS CH, V19, P316, DOI 10.1128/AAC.19.2.316; BRANNIGAN JA, 1990, MOL MICROBIOL, V4, P913, DOI 10.1111/j.1365-2958.1990.tb00664.x; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; CANNON JG, 1984, ANNU REV MICROBIOL, V38, P111; Carapito R, 2006, J BIOL CHEM, V281, P1771, DOI 10.1074/jbc.M511506200; Chesnel L, 2003, J BIOL CHEM, V278, P44448, DOI 10.1074/jbc.M305948200; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davies C, 2001, J BIOL CHEM, V276, P616, DOI 10.1074/jbc.M004471200; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200; DOWSON CG, 1989, MOL MICROBIOL, V3, P35, DOI 10.1111/j.1365-2958.1989.tb00101.x; FARUKI H, 1986, ANTIMICROB AGENTS CH, V30, P856, DOI 10.1128/AAC.30.6.856; GARCIABUSTOS J, 1990, P NATL ACAD SCI USA, V87, P5415, DOI 10.1073/pnas.87.14.5415; Ghuysen Jean-Marie, 1994, Trends in Microbiology, V2, P372, DOI 10.1016/0966-842X(94)90614-9; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Gill MJ, 1998, ANTIMICROB AGENTS CH, V42, P2799, DOI 10.1128/AAC.42.11.2799; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Graves-Woodward K, 1998, BIOCHEM J, V332, P755, DOI 10.1042/bj3320755; HAGMAN KE, 1995, MICROBIOL-SGM, V141, P611, DOI 10.1099/13500872-141-3-611; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Ito M, 2005, ANTIMICROB AGENTS CH, V49, P137, DOI 10.1128/AAC.49.1.137-143.2005; Job V, 2008, J BIOL CHEM, V283, P4886, DOI 10.1074/jbc.M706181200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kishida H, 2006, BIOCHEMISTRY-US, V45, P783, DOI 10.1021/bi051533t; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Lindberg R, 2007, ANTIMICROB AGENTS CH, V51, P2117, DOI 10.1128/AAC.01604-06; Macheboeuf P, 2005, P NATL ACAD SCI USA, V102, P577, DOI 10.1073/pnas.0407186102; MANESS MJ, 1973, J INFECT DIS, V128, P321, DOI 10.1093/infdis/128.3.321; Marrec-Fairley M, 2000, MOL MICROBIOL, V37, P1019, DOI 10.1046/j.1365-2958.2000.02054.x; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Morlot C, 2004, MOL MICROBIOL, V51, P1641, DOI 10.1046/j.1365-2958.2003.03953.x; Mouz N, 1998, P NATL ACAD SCI USA, V95, P13403, DOI 10.1073/pnas.95.23.13403; Mouz N, 1999, J BIOL CHEM, V274, P19175, DOI 10.1074/jbc.274.27.19175; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muzammil S, 2003, BIOCHEMISTRY-US, V42, P631, DOI 10.1021/bi027019u; Nicholas RA, 2003, J BIOL CHEM, V278, P52826, DOI 10.1074/jbc.M310177200; Olesky M, 2002, ANTIMICROB AGENTS CH, V46, P2811, DOI 10.1128/AAC.46.9.2811-2820.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Pernot L, 2004, J BIOL CHEM, V279, P16463, DOI 10.1074/jbc.M313492200; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Ropp PA, 2002, ANTIMICROB AGENTS CH, V46, P769, DOI 10.1128/AAC.46.3.769-777.2002; Ropp PA, 1997, J BACTERIOL, V179, P2783, DOI 10.1128/jb.179.8.2783-2787.1997; Rybkine T, 1998, J INFECT DIS, V178, P159, DOI 10.1086/515605; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; Schultz D E, 1991, Protein Expr Purif, V2, P339, DOI 10.1016/1046-5928(91)90092-W; Severin A, 1996, J BACTERIOL, V178, P1788, DOI 10.1128/jb.178.7.1788-1792.1996; SPARLING PF, 1975, J BACTERIOL, V124, P740, DOI 10.1128/JB.124.2.740-749.1975; SPRATT BG, 1988, REV INFECT DIS, V10, P699; SPRATT BG, 1988, NATURE, V332, P173, DOI 10.1038/332173a0; Stefanova ME, 2004, EUR J BIOCHEM, V271, P23, DOI 10.1046/j.1432-1033.2003.03886.x; Stefanova ME, 2003, BIOCHEMISTRY-US, V42, P14614, DOI 10.1021/bi0350607; Takahata S, 2006, ANTIMICROB AGENTS CH, V50, P3638, DOI 10.1128/AAC.00626-06; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; Veal WL, 2002, J BACTERIOL, V184, P5619, DOI 10.1128/JB.184.20.5619-5624.2002; Wang SA, 2003, CLIN INFECT DIS, V37, P849, DOI 10.1086/377500; Whiley DM, 2007, ANTIMICROB AGENTS CH, V51, P3111, DOI 10.1128/AAC.00306-07; Wissel MC, 2004, J BACTERIOL, V186, P490, DOI 10.1128/JB.186.2.490-502.2004; Yamada M, 2008, ANTIMICROB AGENTS CH, V52, P2053, DOI 10.1128/AAC.01456-07; YOCUM RR, 1979, P NATL ACAD SCI USA, V76, P2730, DOI 10.1073/pnas.76.6.2730	74	63	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1202	1212		10.1074/jbc.M805761200	http://dx.doi.org/10.1074/jbc.M805761200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18986991	hybrid, Green Published			2022-12-27	WOS:000262122900056
J	Bhattacharya, A; Muller, FL; Liu, YH; Sabia, M; Liang, HY; Song, W; Jang, YC; Ran, QT; Van Remmen, H				Bhattacharya, Arunabh; Muller, Florian L.; Liu, Yuhong; Sabia, Marian; Liang, Hanyu; Song, Wook; Jang, Youngmok C.; Ran, Qitao; Van Remmen, Holly			Denervation Induces Cytosolic Phospholipase A(2)-mediated Fatty Acid Hydroperoxide Generation by Muscle Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AGING SKELETAL-MUSCLE; GLUTATHIONE-PEROXIDASE; OXIDATIVE STRESS; SELENOORGANIC COMPOUND; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; BIOLOGICAL-SYSTEMS; INDUCED APOPTOSIS; MICE DEFICIENT	Previously, we demonstrated that mitochondria from denervated muscle exhibited dramatically higher Amplex Red dependent fluorescence (thought to be highly specific for hydrogen peroxide) compared with control muscle mitochondria. We now demonstrate that catalase only partially inhibits the Amplex Red signal in mitochondria from denervated muscle. In contrast, ebselen (a glutathione peroxidase mimetic and inhibitor of fatty acid hydroperoxides) significantly inhibits the Amplex Red signal. This suggests that the majority of the Amplex Red signal in mitochondria from denervated muscle is not derived from hydrogen peroxide. Because Amplex Red cannot react with substrates in the lipid environment, we hypothesize that lipid hydroperoxides formed within the mitochondrial lipid bilayer are released as fatty acid hydroperoxides and react with the Amplex Red probe. We also suggest that the release of fatty acid hydroperoxides from denervated muscle mitochondria may be an important determinant of muscle atrophy. In support of this, muscle atrophy and the Amplex Red signal are inhibited in caloric restricted mice and in transgenic mice that overexpress the lipid hydroperoxide-detoxifying enzyme glutathione peroxidase 4. Finally, we propose that cytosolic phospholipase A(2) may be a potential source of these hydroperoxides.	[Bhattacharya, Arunabh; Liu, Yuhong; Liang, Hanyu; Song, Wook; Ran, Qitao; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Bhattacharya, Arunabh; Muller, Florian L.; Liu, Yuhong; Liang, Hanyu; Jang, Youngmok C.; Ran, Qitao; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Sabia, Marian; Ran, Qitao; Van Remmen, Holly] S Texas Vet Hlth Care Syst, San Antonio, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Van Remmen, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Texas Res Pk Campus,15355 Lambda Dr, San Antonio, TX 78245 USA.	vanremmen@uthscsa.edu	Liang, Hanyu/A-1066-2010	Muller, Florian/0000-0001-7568-2948	National Institutes of Health [AG20591]; Muscular Dystrophy Association [MDA 3879]; Veterans Affairs merit grant; NATIONAL INSTITUTE ON AGING [P01AG020591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Veterans Affairs merit grant(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG20591 (to H. V. R.). This work was also supported by Muscular Dystrophy Association Grant MDA 3879 (to H. V. R.) and a Veterans Affairs merit grant (to H. V. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Belikova NA, 2007, INT J RADIAT ONCOL, V69, P176, DOI 10.1016/j.ijrobp.2007.03.043; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brigelius-Flohe R, 2000, ATHEROSCLEROSIS, V152, P307, DOI 10.1016/S0021-9150(99)00486-4; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; BROWN WF, 1972, J NEUROL NEUROSUR PS, V35, P845, DOI 10.1136/jnnp.35.6.845; Brown WF, 1997, MUSCLE NERVE, pS70; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Delbono O, 2003, AGING CELL, V2, P21, DOI 10.1046/j.1474-9728.2003.00011.x; DOHERTY TJ, 1993, J APPL PHYSIOL, V74, P868, DOI 10.1152/jappl.1993.74.2.868; EISENBERG HA, 1994, J APPL PHYSIOL, V76, P859, DOI 10.1152/jappl.1994.76.2.859; Engelbrecht AM, 2007, PROSTAG LEUKOTR ESS, V77, P37, DOI 10.1016/j.plefa.2007.06.002; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flood DG, 1999, AM J PATHOL, V155, P663, DOI 10.1016/S0002-9440(10)65162-0; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Gabryel B, 2007, CELL BIOL INT, V31, P958, DOI 10.1016/j.cellbi.2007.03.005; Girotti AW, 1998, J LIPID RES, V39, P1529; Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3; Guo ZM, 2002, MECH AGEING DEV, V123, P1121, DOI 10.1016/S0047-6374(02)00008-8; Haq S, 2003, NAT MED, V9, P944, DOI 10.1038/nm891; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Kiaei M, 2005, J NEUROCHEM, V93, P403, DOI 10.1111/j.1471-4159.2005.03024.x; Klivenyi P, 1998, J NEUROCHEM, V71, P2634; Kriem B, 2004, FASEB J, V18, P85, DOI 10.1096/fj.04-1807fje; Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0; Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542; MAIORINO M, 1988, BIOCHEM PHARMACOL, V37, P2267, DOI 10.1016/0006-2952(88)90591-6; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Nakamura Y, 2002, J BIOL CHEM, V277, P2687, DOI 10.1074/jbc.M109641200; Nakano M, 1998, CELL MOL NEUROBIOL, V18, P565, DOI 10.1023/A:1020257532357; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Ran QT, 2006, J NEUROSCI RES, V84, P202, DOI 10.1002/jnr.20868; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Stephenson DT, 1996, NEUROBIOL DIS, V3, P51, DOI 10.1006/nbdi.1996.0005; Thomas CK, 2006, MUSCLE NERVE, V33, P21, DOI 10.1002/mus.20400; THOMAS JP, 1990, J BIOL CHEM, V265, P454; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WICKS KL, 1991, AM J PHYSIOL, V260, pC841, DOI 10.1152/ajpcell.1991.260.4.C841; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Yagi K, 1996, BIOCHEM BIOPH RES CO, V219, P486, DOI 10.1006/bbrc.1996.0260; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	54	58	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					46	55		10.1074/jbc.M806311200	http://dx.doi.org/10.1074/jbc.M806311200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001413	Green Published, hybrid			2022-12-27	WOS:000261974800006
J	Ludwig, M; Cracknell, JA; Vincent, KA; Armstrong, FA; Lenz, O				Ludwig, Marcus; Cracknell, James A.; Vincent, Kylie A.; Armstrong, Fraser A.; Lenz, Oliver			Oxygen-tolerant H-2 Oxidation by Membrane-bound [NiFe] Hydrogenases of Ralstonia Species COPING WITH LOW LEVEL H-2 IN AIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCALIGENES-EUTROPHUS H16; ACTIVE-SITE; DESULFOVIBRIO-GIGAS; CARBON-MONOXIDE; ALLOCHROMATIUM-VINOSUM; ATMOSPHERIC HYDROGEN; ACTIVATION; INHIBITION; O-2; MICROORGANISMS	Knallgas bacteria such as certain Ralstonia spp. are able to obtain metabolic energy by oxidizing trace levels of H-2 using O-2 as the terminal electron acceptor. The [NiFe] hydrogenases produced by these organisms are unusual in their ability to oxidize H-2 in the presence of O-2, which is a potent inactivator of most hydrogenases through attack at the active site. To probe the origin of this unusual O-2 tolerance, we conducted a study on the membrane-bound hydrogenase from Ralstonia eutropha H16 and that of the closely related organism Ralstonia metallidurans CH34, which was purified using a new heterologous overproduction system. Direct electrochemical methods were used to determine apparent inhibition constants for O-2 inhibition of H-2 oxidation (K-I(app)(O2)) for each enzyme. These values were at least 2 orders of magnitude higher than those of "standard" [NiFe] hydrogenases. Amino acids close to the active site were exchanged in the membrane-bound hydrogenase of R. eutropha H16 for those from standard hydrogenases to probe the role of individual residues in conferring O-2 sensitivity. Michaelis constants for H-2 (K-M(H2)) were determined, and for some mutants these were increased more than 20-fold relative to the wild type. Mutations resulting in membrane-bound hydrogenase enzymes with increased K-M(H2) or decreased K-I(app)(O2) values were associated with impaired lithoautotrophic growth in the presence of high O-2 concentrations.	[Ludwig, Marcus; Lenz, Oliver] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany; [Cracknell, James A.; Vincent, Kylie A.; Armstrong, Fraser A.] Univ Oxford, Dept Chem, Inorgan Chem Lab, Oxford OX1 3QR, England	Humboldt University of Berlin; University of Oxford	Lenz, O (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Chausseestr 117, D-10115 Berlin, Germany.	oliver.lenz@rz.hu-berlin.de	Vincent, Kylie/H-1224-2011; Lenz, Oliver/N-5130-2019; Lenz, Oliver/C-1582-2019	Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128; Vincent, Kylie/0000-0001-6444-9382	Biotechnology and Biological Sciences Research Council [BB/D52222X/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; Armstrong FA, 2005, PHILOS T ROY SOC A, V363, P937, DOI 10.1098/rsta.2004.1528; Bard A. J., 2001, ELECTROCHEMICAL METH; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; CAMMACK R, 1986, BIOCHIMIE, V68, P85, DOI 10.1016/S0300-9084(86)81072-0; Cammack R., 1997, HYDROGEN FUEL LEARNI; COLBEAU A, 1981, BIOCHIM BIOPHYS ACTA, V662, P271, DOI 10.1016/0005-2744(81)90039-5; CONRAD R, 1988, ADV MICROB ECOL, V10, P231; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; CONRAD R, 1983, FEMS MICROBIOL LETT, V18, P207; Cracknell JA, 2008, J AM CHEM SOC, V130, P424, DOI 10.1021/ja078299+; Duche O, 2005, FEBS J, V272, P3899, DOI 10.1111/j.1742-4658.2005.04806.x; FERNANDEZ VM, 1985, BIOCHIM BIOPHYS ACTA, V832, P69, DOI 10.1016/0167-4838(85)90175-X; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Guo RB, 2008, SOIL BIOL BIOCHEM, V40, P1149, DOI 10.1016/j.soilbio.2007.12.007; Jones AK, 2003, J AM CHEM SOC, V125, P8505, DOI 10.1021/ja035296y; KEEFE RG, 1995, ARCH BIOCHEM BIOPHYS, V317, P449, DOI 10.1006/abbi.1995.1187; Kleihues L, 2000, J BACTERIOL, V182, P2716, DOI 10.1128/JB.182.10.2716-2724.2000; KORTLUKE C, 1992, J BACTERIOL, V174, P6277; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamle SE, 2005, J AM CHEM SOC, V127, P6595, DOI 10.1021/ja0424934; Leger C, 2004, J AM CHEM SOC, V126, P12162, DOI 10.1021/ja046548d; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; LITTLEWOOD D, 1956, BIOCHIM BIOPHYS ACTA, V20, P399, DOI 10.1016/0006-3002(56)90308-0; Miller J.H., 1972, EXPT MOL GENETICS; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; PODZUWEIT HG, 1987, BIOCHIM BIOPHYS ACTA, V905, P435, DOI 10.1016/0005-2736(87)90473-1; Porthun A, 2002, ARCH MICROBIOL, V177, P159, DOI 10.1007/s00203-001-0371-5; Prather MJ, 2003, SCIENCE, V302, P581, DOI 10.1126/science.1091060; Rahn T, 2003, NATURE, V424, P918, DOI 10.1038/nature01917; Rousset M, 1998, J BACTERIOL, V180, P4982, DOI 10.1128/JB.180.18.4982-4986.1998; SCHINK B, 1980, BIOCHEM BIOPH RES CO, V95, P1563, DOI 10.1016/S0006-291X(80)80076-3; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; Shima S, 2007, CHEM REC, V7, P37, DOI 10.1002/tcr.20111; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SURERUS KK, 1994, BIOCHEMISTRY-US, V33, P4980, DOI 10.1021/bi00182a029; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIGNAIS PM, 1982, BIOCHIM BIOPHYS ACTA, V681, P519, DOI 10.1016/0005-2728(82)90195-5; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; Vincent KA, 2006, J AM CHEM SOC, V128, P7448, DOI 10.1021/ja061732f; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; WANG R, 1971, PLANT PHYSIOL, V48, P108, DOI 10.1104/pp.48.1.108; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	58	104	105	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					465	477		10.1074/jbc.M803676200	http://dx.doi.org/10.1074/jbc.M803676200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990688	hybrid			2022-12-27	WOS:000261974800051
J	Cheng, SJ; Sultana, S; Goss, DJ; Gallie, DR				Cheng, Shijun; Sultana, Shemaila; Goss, Dixie J.; Gallie, Daniel R.			Translation Initiation Factor 4B Homodimerization, RNA Binding, and Interaction with Poly(A)-binding Protein Are Enhanced by Zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC TRANSLATION; RECOGNITION MOTIF; PHOSPHORYLATION STATE; HELICASE ACTIVITY; MESSENGER-RNA; WHEAT; EIF4B; AFFINITY; CHROMATOGRAPHY; EIFISO4F	The eukaryotic translation initiation factor (eIF) 4B promotes the RNA-dependent ATP hydrolysis activity and ATP-dependent RNA helicase activity of eIF4A and eIF4F during translation initiation. eIF4B also helps to organize the assembly of the translational machinery through its interactions with eIF4A, eIF4G, eIF3, the (polyA)-binding protein (PABP), and RNA. Although the function of eIF4B is conserved among plants, animals, and yeast, eIF4B is one of the least conserved of initiation factors at the sequence level. Mammalian eIF4B is a constitutive dimer; however, conflicting reports have suggested that plant eIF4B may exist as a monomer or a dimer. In this study, we show that eIF4B from wheat can form a dimer and we identify the region responsible for its dimerization. Zinc stimulated homodimerization of eIF4B and bound eIF4B with a K-d of 19.7 nM. Zinc increased the activity of the eIF4B C-terminal RNA-binding domain specifically. Zinc promoted the interaction between eIF4B and PABP but not the interaction between eIF4B and eIF4A or eIFiso4G, demonstrating that the effect of zinc was highly specific. The interaction between PABP and eIFiso4G was also stimulated by zinc but required significantly higher levels of zinc. Interestingly zinc abolished the ability of eIFiso4G to compete with eIF4B in binding to their overlapping binding sites in PABP by preferentially promoting the interaction between eIF4B and PABP. Our observations suggest that wheat eIF4B can dimerize but requires zinc. Moreover zinc controls the partner protein selection of PABP such that the interaction with eIF4B is preferred over eIFiso4G.	[Cheng, Shijun; Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Sultana, Shemaila; Goss, Dixie J.] CUNY, Grad Ctr, New York, NY 10065 USA; [Sultana, Shemaila; Goss, Dixie J.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA	University of California System; University of California Riverside; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY)	Gallie, DR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu			United States Department of Agriculture [2003-35100-13375]; University of California Agricultural Experiment Station; National Science Foundation [MCB-0814051]	United States Department of Agriculture(United States Department of Agriculture (USDA)); University of California Agricultural Experiment Station(University of California System); National Science Foundation(National Science Foundation (NSF))	This work was supported by United States Department of Agriculture Grant 2003-35100-13375 and the University of California Agricultural Experiment Station (to D. R. G.) and by National Science Foundation Grant MCB-0814051 (to D.J.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARAK P, 1993, DEV PLANT SOIL SCI, V55, P1; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; Cheng S, 2007, J BIOL CHEM, V282, P25247, DOI 10.1074/jbc.M702193200; Cheng SJ, 2006, J BIOL CHEM, V281, P24351, DOI 10.1074/jbc.M605404200; Gallie DR, 1997, J BIOL CHEM, V272, P1046, DOI 10.1074/jbc.272.2.1046; Gallie DR, 2002, PLANT MOL BIOL, V50, P949, DOI 10.1023/A:1021220910664; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Khan MA, 2004, BIOCHEMISTRY-US, V43, P9092, DOI 10.1021/bi049602b; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; LONGNECKER NE, 1993, DEV PLANT SOIL SCI, V55, P79; Methot N, 1996, MOL CELL BIOL, V16, P5328; Methot N, 1996, RNA, V2, P38; Metz AM, 1999, BIOCHEM BIOPH RES CO, V266, P314, DOI 10.1006/bbrc.1999.1814; MILBURN SC, 1990, EMBO J, V9, P2783, DOI 10.1002/j.1460-2075.1990.tb07466.x; PEARSON RG, 1990, COORDIN CHEM REV, V100, P403, DOI 10.1016/0010-8545(90)85016-L; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; PORATH J, 1988, TRAC-TREND ANAL CHEM, V7, P254, DOI 10.1016/0165-9936(88)85074-X; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; TRAKSHEL GM, 1988, BIOCHEM J, V252, P127, DOI 10.1042/bj2520127; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7	26	9	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36140	36153		10.1074/jbc.M807716200	http://dx.doi.org/10.1074/jbc.M807716200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18977752	Green Published, hybrid			2022-12-27	WOS:000261840500009
J	Fiuza, M; Canova, MJ; Patin, D; Letek, M; Zanella-Cleon, I; Becchi, M; Mateos, LM; Mengin-Lecreulx, D; Molle, V; Gil, JA				Fiuza, Maria; Canova, Marc J.; Patin, Delphine; Letek, Michal; Zanella-Cleon, Isabelle; Becchi, Michel; Mateos, Luis M.; Mengin-Lecreulx, Dominique; Molle, Virginie; Gil, Jose A.			The MurC Ligase Essential for Peptidoglycan Biosynthesis Is Regulated by the Serine/Threonine Protein Kinase PknA in Corynebacterium glutamicum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ALANINE LIGASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; CELL-DIVISION; PHOSPHINATE INHIBITORS; PHOSPHORYLATION SITES; CORYNEFORM BACTERIA; AMINO-ACIDS; STEPS; IDENTIFICATION	The Mur ligases play an essential role in the biosynthesis of bacterial cell-wall peptidoglycan and thus represent attractive targets for the design of novel antibacterials. These enzymes catalyze the stepwise formation of the peptide moiety of the peptidoglycan disaccharide peptide monomer unit. MurC is responsible of the addition of the first residue (L-alanine) onto the nucleotide precursor UDP-MurNAc. Phosphorylation of proteins by Ser/Thr protein kinases has recently emerged as a major physiological mechanism of regulation in prokaryotes. Herein, the hypothesis of a phosphorylation-dependent mechanism of regulation of the MurC activity was investigated in Corynebacterium glutamicum. We showed that MurC was phosphorylated in vitro by the PknA protein kinase. An analysis of the phosphoamino acid content indicated that phosphorylation exclusively occurred on threonine residues. Six phosphoacceptor residues were identified by mass spectrometry analysis, and we confirmed that mutagenesis to alanine residues totally abolished PknA-dependent phosphorylation of MurC. In vitro and in vivo ligase activity assays showed that the catalytic activity of MurC was impaired following mutation of these threonine residues. Further in vitro assays revealed that the activity of the MurC-phosphorylated isoform was severely decreased compared with the non-phosphorylated protein. To our knowledge, this is the first demonstration of a MurC ligase phosphorylation in vitro. The finding that phosphorylation is correlated with a decrease in MurC enzymatic activity could have significant consequences in the regulation of peptidoglycan biosynthesis.	[Zanella-Cleon, Isabelle; Becchi, Michel; Molle, Virginie] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR128 BioSci, F-69637 Lyon 07, France; [Fiuza, Maria; Letek, Michal; Mateos, Luis M.; Gil, Jose A.] Univ Leon, Fac Biol, Area Microbiol, Dept Biol Mol, E-24071 Leon, Spain; [Patin, Delphine; Mengin-Lecreulx, Dominique] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, F-91405 Orsay, France; [Mengin-Lecreulx, Dominique] CNRS, Lab Enveloppes Bacteriennes & Antibiot, UMR 8619, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidad de Leon; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Molle, V (corresponding author), Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,IFR128 BioSci, 7 Passage Vercors, F-69637 Lyon 07, France.	vmolle@ibcp.fr; jagils@unileon.es	Letek, Michal/K-3903-2019; Gil, José A./L-1800-2019; Letek, Michal/C-6345-2008; Letek, Michal/AAH-4292-2019; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; MOLLE, Virginie/D-4050-2019; Gil, Jose A./C-3902-2009	Letek, Michal/0000-0002-9509-5174; Gil, José A./0000-0002-5069-2637; Letek, Michal/0000-0002-9509-5174; MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; MOLLE, Virginie/0000-0002-6573-3411; Gil, Jose A./0000-0002-5069-2637; MENGIN-LECREULX, Dominique/0000-0003-3205-0275	Region Rhone-Alpes; CNRS, the University of Lyon (France); National Research Agency [ANR-06-MIME-027-01 t]; Junta de Castilla y Leon [LE040A07]; Ministerio de Ciencia y Tecnologia (Spain) [BIO2008-00519, BIO2005-02723]; CNRS; Universite Paris-Sud XI [8619]	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); CNRS, the University of Lyon (France)(Centre National de la Recherche Scientifique (CNRS)); National Research Agency(French National Research Agency (ANR)); Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Ciencia y Tecnologia (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Sud XI	This work was supported in part by grants from the Region Rhone-Alpes (to M. C.); by the CNRS, the University of Lyon (France), and the National Research Agency (ANR-06-MIME-027-01 to V.M.); by the Junta de Castilla y Leon (Ref. LE040A07 to J.A.G.); by the Ministerio de Ciencia y Tecnologia (Spain) (Grants BIO2008-00519 and BIO2005-02723 to J.A.G. and L.M.M.); and by the CNRS and Universite Paris-Sud XI (Grant UMR 8619 to D.M.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Barbosa MDFS, 2002, ANAL BIOCHEM, V306, P17, DOI 10.1006/abio.2001.5691; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Bendt AK, 2003, PROTEOMICS, V3, P1637, DOI 10.1002/pmic.200300494; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; Bouhss A, 1997, BIOCHEMISTRY-US, V36, P11556, DOI 10.1021/bi970797f; Canova MJ, 2008, PROTEOMICS, V8, P521, DOI 10.1002/pmic.200700442; Cohen-Gonsaud M, 2004, J BIOMOL NMR, V30, P373, DOI 10.1007/s10858-004-3466-x; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deva T, 2006, ACTA CRYSTALLOGR D, V62, P1466, DOI 10.1107/S0907444906038376; Ehmann DE, 2004, BBA-PROTEINS PROTEOM, V1698, P167, DOI 10.1016/j.bbapap.2003.11.006; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hermann T, 2003, J BIOTECHNOL, V104, P155, DOI 10.1016/S0168-1656(03)00149-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kotnik M, 2007, CURR PHARM DESIGN, V13, P2283; Letek M, 2008, ANTON LEEUW INT J G, V94, P99, DOI 10.1007/s10482-008-9224-4; Letek M, 2008, J BACTERIOL, V190, P3283, DOI 10.1128/JB.01934-07; LIGER D, 1995, EUR J BIOCHEM, V230, P80, DOI 10.1111/j.1432-1033.1995.0080i.x; LUGTENBERG EJ, 1972, J BACTERIOL, V110, P35, DOI 10.1128/JB.110.1.35-40.1972; Mateos LM, 1996, J BACTERIOL, V178, P5768, DOI 10.1128/jb.178.19.5768-5775.1996; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2006, PROTEOMICS, V6, P3754, DOI 10.1002/pmic.200500900; Motley ST, 1999, INFECT IMMUN, V67, P5386, DOI 10.1128/IAI.67.10.5386-5394.1999; Peirs P, 1997, EUR J BIOCHEM, V244, P604, DOI 10.1111/j.1432-1033.1997.00604.x; SANTAMARIA RI, 1987, GENE, V56, P199, DOI 10.1016/0378-1119(87)90137-5; SCHAFER A, 1990, J BACTERIOL, V172, P1663, DOI 10.1128/jb.172.3.1663-1666.1990; Strancar K, 2006, BIOORG MED CHEM LETT, V16, P343, DOI 10.1016/j.bmcl.2005.09.086; Strancar K, 2007, ARCH PHARM, V340, P127, DOI 10.1002/ardp.200600191; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; VANHEIJENOORT J, 1996, ESCHERICHIA COLI SAL, P1025; Vicente M, 2006, FEMS MICROBIOL REV, V30, P841, DOI 10.1111/j.1574-6976.2006.00038.x; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Zawadzke LE, 2008, ASSAY DRUG DEV TECHN, V6, P95, DOI 10.1089/adt.2007.114	40	45	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36553	36563		10.1074/jbc.M807175200	http://dx.doi.org/10.1074/jbc.M807175200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974047	Green Published, hybrid			2022-12-27	WOS:000261840500053
J	Upreti, M; Galitovskaya, EN; Chu, R; Tackett, AJ; Terrano, DT; Granell, S; Chambers, TC				Upreti, Meenakshi; Galitovskaya, Elena N.; Chu, Rong; Tackett, Alan J.; Terrano, David T.; Granell, Susana; Chambers, Timothy C.			Identification of the Major Phosphorylation Site in Bcl-xL Induced by Microtubule Inhibitors and Analysis of Its Functional Significance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACLITAXEL-INDUCED APOPTOSIS; PROTEIN-PHOSPHORYLATION; MASS-SPECTROMETRY; DNA-DAMAGE; CELL-DEATH; DEAMIDATION; BCL-X(L); FAMILY; MITOCHONDRIA; SENSITIVITY	Vinblastine and other microtubule inhibitors used as antimitotic cancer drugs characteristically promote the phosphorylation of the key anti-apoptotic protein, Bcl-xL. However, putative sites of phosphorylation have been inferred based on potential recognition by JNK, and no direct biochemical analysis has been performed. In this study we used protein purification and mass spectrometry to identify Ser-62 as a single major site in vivo. Site-directed mutagenesis confirmed Ser-62 to be the site of Bcl-xL phosphorylation induced by several microtubule inhibitors tested. Vinblastine-treated cells overexpressing a Ser-62 -> Ala mutant showed highly significantly reduced apoptosis compared with cells expressing wild-type Bcl-xL. Co-immunoprecipitation revealed that phosphorylation caused wild-type Bcl-xL to release bound Bax, whereas phospho-defective Bcl-xL retained the ability to bind Bax. In contrast, phospho-mimic (Ser-62 -> Asp) Bcl-xL exhibited a reduced capacity to bind Bax. Functional tests were performed by transiently co-transfecting Bax in the context of different Bcl-xL mutants. Co-expression of wild-type or phospho-defective Bcl-xL counteracted the adverse effects of Bax expression on cell viability, whereas phospho-mimic Bcl-xL failed to provide the same level of protection against Bax. These studies suggest that Bcl-xL phosphorylation induced by microtubule inhibitors plays a key pro-apoptotic role at least in part by disabling the ability of Bcl-xL to bind Bax.	[Upreti, Meenakshi; Galitovskaya, Elena N.; Chu, Rong; Tackett, Alan J.; Terrano, David T.; Granell, Susana; Chambers, Timothy C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Chambers, TC (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Mail Slot 516,4301 W Markham St, Little Rock, AR 72205 USA.	ChambersTimothyC@uams.edu	granell, susana/H-2734-2012		National Institutes of Health [CA109821]; NATIONAL CANCER INSTITUTE [R01CA109821] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569, P20RR016460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA109821 (NCI). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amundson SA, 2000, CANCER RES, V60, P6101; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Brichese L, 2002, EXP CELL RES, V278, P101, DOI 10.1006/excr.2002.5563; Chang EJ, 2004, ANAL CHEM, V76, P4472, DOI 10.1021/ac049637h; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; Han J, 2002, ANAL BIOCHEM, V310, P215, DOI 10.1016/S0003-2697(02)00376-7; Ibrado AM, 1997, CANCER RES, V57, P1109; JOHNSON BA, 1989, ARCH BIOCHEM BIOPHYS, V268, P276, DOI 10.1016/0003-9861(89)90589-4; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Ling YH, 1998, J BIOL CHEM, V273, P18984, DOI 10.1074/jbc.273.30.18984; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P12409, DOI 10.1073/pnas.221463198; Rowinsky E. K., 1998, CHEMOTHERAPY SOURCE, P387; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Upreti M, 2006, J BIOL CHEM, V281, P15941, DOI 10.1074/jbc.M512586200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao R, 2007, PLOS BIOL, V5, P39, DOI 10.1371/journal.pbio.0050001	31	70	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35517	35525		10.1074/jbc.M805019200	http://dx.doi.org/10.1074/jbc.M805019200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18974096	hybrid, Green Published			2022-12-27	WOS:000261687900023
J	Guhaniyogi, J; Sohar, I; Das, K; Stock, AM; Lobel, P				Guhaniyogi, Jayita; Sohar, Istvan; Das, Kalyan; Stock, Ann M.; Lobel, Peter			Crystal Structure and Autoactivation Pathway of the Precursor Form of Human Tripeptidyl-peptidase 1, the Enzyme Deficient in Late Infantile Ceroid Lipofuscinosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-CARBOXYL PEPTIDASE; HUMAN CLN2 PROTEIN; I IN-VITRO; X-RAY DATA; KUMAMOLISIN-AS; MOUSE MODEL; MACROMOLECULAR STRUCTURES; CATALYTIC-ACTIVITY; GENE-TRANSFER; ACTIVE-SITE	Late infantile neuronal ceroid lipofuscinosis is a fatal childhood neurological disorder caused by a deficiency in the lysosomal protease tripeptidyl-peptidase 1 (TPP1). TPP1 represents the only known mammalian member of the S53 family of serine proteases, a group characterized by a subtilisin-like fold, a Ser-Glu-Asp catalytic triad, and an acidic pH optimum. TPP1 is synthesized as an inactive proenzyme (pro-TPP1) that is proteolytically processed into the active enzyme after exposure to low pH in vitro or targeting to the lysosome in vivo. In this study, we describe an endoglycosidase H-deglycosylated form of TPP1 containing four Asn-linked N-acetylglucosamines that is indistinguishable from fully glycosylated TPP1 in terms of autocatalytic processing of the proform and enzymatic properties of the mature protease. The crystal structure of deglycosylated pro-TPP1 was determined at 1.85 angstrom resolution. A large 151-residue C-shaped prodomain makes extensive contacts as it wraps around the surface of the catalytic domain with the two domains connected by a 24-residue flexible linker that passes through the substrate-binding groove. The proenzyme structure reveals suboptimal catalytic triad geometry with its propiece linker partially blocking the substrate-binding site, which together serve to prevent premature activation of the protease. Finally, we have identified numerous processing intermediates and propose a structural model that explains the pathway for TPP1 activation in vitro. These data provide new insights into TPP1 function and represent a valuable resource for constructing improved TPP1 variants for treatment of late infantile neuronal ceroid lipofuscinosis.	[Guhaniyogi, Jayita; Sohar, Istvan; Das, Kalyan; Stock, Ann M.; Lobel, Peter] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Guhaniyogi, Jayita; Stock, Ann M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Sohar, Istvan; Lobel, Peter] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Das, Kalyan] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Stock, Ann M.] Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Howard Hughes Medical Institute	Lobel, P (corresponding author), 679 Hoes Lane, Piscataway, NJ 08854 USA.	stock@cabm.rutgers.edu; lobel@cabm.rutgers.edu	Das, Kalyan/O-9224-2019; Das, Kalyan/B-2967-2018	Das, Kalyan/0000-0002-8897-324X; Das, Kalyan/0000-0002-8897-324X; Stock, Ann/0000-0002-0446-8079	National Institutes of Health [NS037918]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017992, S10RR020932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS037918 (to P.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249; Chang M, 2008, MOL THER, V16, P649, DOI 10.1038/mt.2008.9; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Comellas-Bigler M, 2004, STRUCTURE, V12, P1313, DOI 10.1016/j.str.2004.04.013; Comellas-Bigler M, 2002, STRUCTURE, V10, P865, DOI 10.1016/S0969-2126(02)00772-4; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Dauter Z, 2001, ACTA CRYSTALLOGR D, V57, P239, DOI 10.1107/S0907444900015249; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diemand AV, 2004, NUCLEIC ACIDS RES, V32, pW512, DOI 10.1093/nar/gkh403; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezaki J, 2000, BIOCHEM BIOPH RES CO, V268, P904, DOI 10.1006/bbrc.2000.2207; FERSHT A, 1999, STRUCTURE MECH PROTE, P144; Golabek AA, 2005, J BIOL CHEM, V280, P7550, DOI 10.1074/jbc.M412047200; Golabek AA, 2004, J BIOL CHEM, V279, P31058, DOI 10.1074/jbc.M400700200; Golabek AA, 2003, J BIOL CHEM, V278, P7135, DOI 10.1074/jbc.M211872200; Golabek AA, 2008, J BIOL CHEM, V283, P16497, DOI 10.1074/jbc.M800458200; Golabek AA, 2006, BIOL CHEM, V387, P1091, DOI 10.1515/BC.2006.135; Guo HB, 2006, BIOCHEMISTRY-US, V45, P9129, DOI 10.1021/bi060461i; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Junaid MA, 2000, J NEUROCHEM, V74, P287, DOI 10.1046/j.1471-4159.2000.0740287.x; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Khan AR, 1998, PROTEIN SCI, V7, P815; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Lin L, 2001, BIOCHEM J, V357, P49, DOI 10.1042/0264-6021:3570049; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MENARD R, 1992, BIOL CHEM H-S, V373, P393, DOI 10.1515/bchm3.1992.373.2.393; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okubo A, 2006, FEBS J, V273, P2563, DOI 10.1111/j.1742-4658.2006.05266.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAGE AE, 1993, ARCH BIOCHEM BIOPHYS, V306, P354, DOI 10.1006/abbi.1993.1523; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; PAL A, 2009, J BIOL CHEM IN PRESS, V264; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Passini MA, 2006, J NEUROSCI, V26, P1334, DOI 10.1523/JNEUROSCI.2676-05.2006; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rawlings ND, 1999, BBA-PROTEIN STRUCT M, V1429, P496, DOI 10.1016/S0167-4838(98)00238-6; REYNOLDS C, 2008, BIOINFORMATICS OXF; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sleat D E, 2001, Eur J Paediatr Neurol, V5 Suppl A, P57, DOI 10.1053/ejpn.2000.0436; Sleat DE, 1999, AM J HUM GENET, V64, P1511, DOI 10.1086/302427; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sohar I, 2000, CLIN CHEM, V46, P1005; SOHAR I, 2004, HDB PROTEOLYTIC ENZY, P1893; Sondhi D, 2008, EXP NEUROL, V213, P18, DOI 10.1016/j.expneurol.2008.04.022; Sondhi D, 2007, MOL THER, V15, P481, DOI 10.1038/sj.mt.6300049; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tian Y, 2006, J BIOL CHEM, V281, P6559, DOI 10.1074/jbc.M507336200; Tsiakas K, 2004, GLYCOBIOLOGY, V14, p1C, DOI 10.1093/glycob/cwh054; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walus M, 2005, FEBS LETT, V579, P1383, DOI 10.1016/j.febslet.2005.01.035; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Wlodawer A, 2004, J BIOL CHEM, V279, P21500, DOI 10.1074/jbc.M401141200; Wlodawer A, 2004, BIOCHEM BIOPH RES CO, V314, P638, DOI 10.1016/j.bbrc.2003.12.130; Wlodawer A, 2003, ACTA BIOCHIM POL, V50, P81; Wlodawer A, 2001, BIOCHEMISTRY-US, V40, P15602, DOI 10.1021/bi011817n; Wlodawer A, 2001, NAT STRUCT BIOL, V8, P442, DOI 10.1038/87610; Wlodawer Alexander, 2003, BMC Struct Biol, V3, P8, DOI 10.1186/1472-6807-3-8; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200; Xu Q, 2007, BIOCHEMISTRY-US, V46, P3784, DOI 10.1021/bi061737p	81	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3985	3997		10.1074/jbc.M806943200	http://dx.doi.org/10.1074/jbc.M806943200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19038967	Green Published, hybrid			2022-12-27	WOS:000262872500067
J	Bailey, S; Rapson, T; Johnson-Winters, K; Astashkin, AV; Enemark, JH; Kappler, U				Bailey, Susan; Rapson, Trevor; Johnson-Winters, Kayunta; Astashkin, Andrei V.; Enemark, John H.; Kappler, Ulrike			Molecular Basis for Enzymatic Sulfite Oxidation HOW THREE CONSERVED ACTIVE SITE RESIDUES SHAPE ENZYME ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; CYTOCHROME-C OXIDOREDUCTASE; RHODOBACTER-CAPSULATUS; PULSED EPR; OXIDASE; BIOLOGY; EXPRESSION; CATALYSIS; INSIGHTS; COMPLEX	Sulfite dehydrogenases (SDHs) catalyze the oxidation and detoxification of sulfite to sulfate, a reaction critical to all forms of life. Sulfite-oxidizing enzymes contain three conserved active site amino acids (Arg-55, His-57, and Tyr-236) that are crucial for catalytic competency. Here we have studied the kinetic and structural effects of two novel and one previously reported substitution (R55M, H57A, Y236F) in these residues on SDH catalysis. Both Arg-55 and His-57 were found to have key roles in substrate binding. An R55M substitution increased K-m(sulfite)(app) by 2-3 orders of magnitude, whereas His-57 was required for maintaining a high substrate affinity at low pH when the imidazole ring is fully protonated. This effect may be mediated by interactions of His-57 with Arg-55 that stabilize the position of the Arg-55 side chain or, alternatively, may reflect changes in the protonation state of sulfite. Unlike what is seen for SDHWT and SDHY236F, the catalytic turnover rates of SDHR55M and SDHH57A are relatively insensitive to pH (similar to 60 and 200 s(-1), respectively). On the structural level, striking kinetic effects appeared to correlate with disorder (in SDHH57A and SDHY236F) or absence of Arg-55 (SDHR55M), suggesting that Arg-55 and the hydrogen bonding interactions it engages in are crucial for substrate binding and catalysis. The structure of SDHR55M has sulfate bound at the active site, a fact that coincides with a significant increase in the inhibitory effect of sulfate in SDHR55M. Thus, Arg-55 also appears to be involved in enabling discrimination between the substrate and product in SDH.	[Rapson, Trevor; Kappler, Ulrike] Univ Queensland, Sch Mol & Microbial Sci, Ctr Met Biol, Brisbane, Qld 4072, Australia; [Bailey, Susan] Daresbury Lab, Sci & Technol Facil Council, Mol Biophys Grp, Warrington WA4 4AD, Cheshire, England; [Johnson-Winters, Kayunta; Astashkin, Andrei V.; Enemark, John H.] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA	University of Queensland; STFC Daresbury Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); University of Arizona	Kappler, U (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, Ctr Met Biol, Brisbane, Qld 4072, Australia.	u.kappler@uq.edu.au	Enemark, John/AAQ-4395-2020; Kappler, Ulrike/A-9483-2013; Rapson, Trevor/B-3510-2012	Kappler, Ulrike/0000-0002-2642-1319; Rapson, Trevor/0000-0003-1289-0146	National Institutes of Health [GM-37773]; University of Queensland; Science and Technology Facilities Council Daresbury Laboratory; Ruth L. Kirschstein National Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Queensland(University of Queensland); Science and Technology Facilities Council Daresbury Laboratory; Ruth L. Kirschstein National Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-37773 (to J.H.E.). This work was also supported by a grant and fellowship from the University of Queensland (to U. K.), an Endeavor International Postgraduate Research Scholarship from the University of Queensland (to T. D. R.), and by the Science and Technology Facilities Council Daresbury Laboratory (for S. B.). This work was also supported by a Ruth L. Kirschstein National Service Award (to K.J.-W.).	Astashkin AV, 2006, CONCEPT MAGN RESON B, V29B, P125, DOI 10.1002/cmr.b.20064; Astashkin AV, 2002, J AM CHEM SOC, V124, P6109, DOI 10.1021/ja0115417; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; AYLWARD GH, 1971, SI CHEM DATA, P122; Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; Brody MS, 1999, BIOCHEMISTRY-US, V38, P6668, DOI 10.1021/bi9902539; *CCP4, 1994, ACTA CRYSTALLOGR D, V10, P760; Dawson R. M. C., 1991, DATA BIOCH RES, V3rd, P363; DeLano W, 2002, PYMOL 0 99; Enemark JH, 2002, MET IONS BIOL SYST, V39, P621; ENEMARK JH, 2006, J CHEM SOC DA, V29, P3501; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Feng CJ, 2003, J AM CHEM SOC, V125, P14696, DOI 10.1021/ja038197t; Feng CJ, 2002, BIOCHEMISTRY-US, V41, P5816, DOI 10.1021/bi016059f; Garrett RM, 1998, P NATL ACAD SCI USA, V95, P6394, DOI 10.1073/pnas.95.11.6394; Hansch R, 2006, J BIOL CHEM, V281, P6884, DOI 10.1074/jbc.M513054200; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kappler U, 2005, J BIOL CHEM, V280, P24999, DOI 10.1074/jbc.M503237200; Kappler U, 2000, J BIOL CHEM, V275, P13202, DOI 10.1074/jbc.275.18.13202; Kappler U, 2002, FEBS LETT, V529, P208, DOI 10.1016/S0014-5793(02)03344-6; Kappler U, 2001, FEMS MICROBIOL LETT, V203, P1, DOI 10.1016/S0378-1097(01)00304-4; Kappler U, 2008, MICROBIAL SULFUR METABOLISM, P151, DOI 10.1007/978-3-540-72682-1_13; Kappler U, 2006, BIOCHEMISTRY-US, V45, P9696, DOI 10.1021/bi060058b; Karakas E, 2005, J BIOL CHEM, V280, P33506, DOI 10.1074/jbc.M505035200; KARAKAS E, 2005, J CHEM SOC DA, V21, P3459; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; RAJAGOPALAN KV, 1980, MOLYBDENUM MOLYBDENU, P243; Ridge JP, 2002, BIOCHEMISTRY-US, V41, P15762, DOI 10.1021/bi0266582; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; SUZUKI I, 1994, METHOD ENZYMOL, V243, P447; Wilson HL, 2004, J BIOL CHEM, V279, P15105, DOI 10.1074/jbc.M314288200	37	30	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2053	2063		10.1074/jbc.M807718200	http://dx.doi.org/10.1074/jbc.M807718200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19004819	hybrid, Green Published			2022-12-27	WOS:000262545600013
J	Picozzi, P; Wang, FX; Cronk, K; Ryan, K				Picozzi, Paola; Wang, Fengxiang; Cronk, Kevin; Ryan, Kenneth			Eomesodermin Requires Transforming Growth Factor-beta/Activin Signaling and Binds Smad2 to Activate Mesodermal Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-EOMESODERMIN; EXPRESSION; MOUSE; EFFECTOR; SPECIFICATION; INDUCTION; BRACHYURY	The T-box gene Eomesodermin (Eomes) is required for early embryonic mesoderm differentiation in mouse, frog (Xenopus laevis), and zebrafish, is important in late cardiac development in Xenopus, and for CD8(+) T effector cell function in mouse. Eomes can ectopically activate many mesodermal genes. However, the mechanism by which Eomes activates transcription of these genes is poorly understood. We report that Eomes protein interacts with Smad2 and is capable of working in a non-cell autonomous manner via transfer of Eomes protein between adjacent embryonic cells. Blocking of Eomes protein transfer using a farnesylated red fluorescent protein (CherryF) also prevents Eomes nuclear accumulation. Transfer of Eomes protein between cells is mediated by the Eomes carboxyl terminus (456-692). A carbohydrate binding domain within the Eomes carboxyl-terminal region is sufficient for transfer and important for gene activation. We propose a novel mechanism by which Eomes helps effect a cellular response to a morphogen gradient.	Childrens Hosp Philadelphia, Dept Pediat, Div Cardiol, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Ryan, K (corresponding author), 3615 Civ Ctr Blvd,Abramson Res Ctr,Rm 710A, Philadelphia, PA 19104 USA.	ryank@email.chop.edu			National Institutes of Health [HL070168, HL74731]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074731, R01HL070168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070168 and HL74731. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Ataliotis P, 2005, DEV DYNAM, V232, P979, DOI 10.1002/dvdy.20276; Bjornson CRR, 2005, DEV CELL, V9, P523, DOI 10.1016/j.devcel.2005.08.010; Bruce AEE, 2005, DEV DYNAM, V233, P105, DOI 10.1002/dvdy.20305; Bruce AEE, 2003, DEVELOPMENT, V130, P5503, DOI 10.1242/dev.00763; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Derynck R, 1996, CELL, V87, P173, DOI 10.1016/S0092-8674(00)81335-5; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Newfeld SJ, 1996, DEVELOPMENT, V122, P2099; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 2000, MECH DEVELOP, V94, P133, DOI 10.1016/S0925-4773(00)00300-2; Ryan K, 2004, HUM GENE THER, V15, P842, DOI 10.1089/hum.2004.15.842; Ryan K, 1998, MECH DEVELOP, V75, P155, DOI 10.1016/S0925-4773(98)00084-7; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Ryan Kenneth, 2003, Birth Defects Research, V69, P25, DOI 10.1002/bdrc.10001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Spemann H, 2001, INT J DEV BIOL, V45, P13; Standley HJ, 2002, INT J DEV BIOL, V46, P993; Standley HJ, 2002, INT J DEV BIOL, V46, P279; Stennard F, 1999, MECH DEVELOP, V86, P87, DOI 10.1016/S0925-4773(99)00119-7; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tada M, 1997, DEVELOPMENT, V124, P2225; Wilson V, 2002, GENOME BIOL, V3, P30081, DOI [10.1186/gb-2002-3-6-reviews3008, DOI 10.1186/GB-2002-3-6-REVIEWS3008]	43	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2397	2408		10.1074/jbc.M808704200	http://dx.doi.org/10.1074/jbc.M808704200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19036723	Green Published, hybrid			2022-12-27	WOS:000262545600048
J	Yagi, H; Kajiwara, N; Iwabuchi, T; Izumi, K; Yoshida, M; Akutsu, H				Yagi, Hiromasa; Kajiwara, Nobumoto; Iwabuchi, Tomoyuki; Izumi, Kenya; Yoshida, Masasuke; Akutsu, Hideo			Stepwise Propagation of the ATP-induced Conformational Change of the F-1-ATPase beta Subunit Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOPHILIC BACILLUS PS3; ESCHERICHIA-COLI F-1-ATPASE; BOVINE HEART-MITOCHONDRIA; GLYCINE-RICH SEQUENCE; 3 CATALYTIC SITES; H+-ATPASE; NUCLEOTIDE-BINDING; DIPOLAR COUPLINGS; F1-ATPASE; SYNTHASE	The rotation of F1-ATPase (F1) is driven by the open/close bending motion of the beta subunit. The mechanism underlying the bending motion was investigated for the F-1 beta monomer from thermophilic Bacillus PS3 (TF1 beta) in solution, using mutagenesis and NMR. The hydrogen bond networks involving the side chains of Lys-164 (numbering forTF(1)beta; 162 for mitochondrial F-1 beta in parentheses), Thr-165(163), Arg-191(189), Asp-252(256), Asp-311(315), and Arg-333(337) in the catalytic region are significantly different for the ligand-bound and free beta subunits in the crystal structures of mitochondrial F1. The role of each amino acid residue was examined by Ala substitution. beta(K164A) reduced the affinity constant for 5'-adenyl-beta,gamma-imidodiphosphate by 20-fold and abolished the conformational change associated with nucleotide binding and the ATPase activity of alpha(3)beta(K164A)(3)gamma.beta(T165A) and beta(D252A) exhibited no effect on the binding affinity but abolished the conformational change and the ATPase activity. The chemical shift perturbation of backbone amide signals of the segmentally labeled beta(mutant)s indicated stepwise propagation of the open/close conversion on ligand binding. The key action in the conversion is the switching of the hydrogen-bonding partner of Asp-252 from Lys164 to Thr-165. Residual dipolar coupling analysis revealed that the closed conformation of the beta monomer was more closed than that in the crystal structure and was different for MgATP-and MgADP-bound beta subunits. Actually, MgATP induced a conformational change around Tyr-307 (311 for MF1 beta), whereas MgADP did not. The significance of these findings is discussed in connection with the catalytic rotation of F1-ATPase.	[Yagi, Hiromasa; Kajiwara, Nobumoto; Izumi, Kenya; Akutsu, Hideo] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Iwabuchi, Tomoyuki] Yokohama Natl Univ, Fac Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Yoshida, Masasuke] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan	Osaka University; Yokohama National University; Tokyo Institute of Technology	Akutsu, H (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	akutsu@protein.osaka-u.ac.jp	Yagi, Hiromasa/H-9253-2017	Akutsu, Hideo/0000-0001-7236-5285	Scientific research on priority areas; Ministry of Education, Science, Technology, Sport, and Culture of Japan; Japan Science and Technology Agency	Scientific research on priority areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Science, Technology, Sport, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by grants-in-aid for scientific research on priority areas (to H. A.) and grants-in-aid for young scientists (B) (to H. Y.) from the Ministry of Education, Science, Technology, Sport, and Culture of Japan and grants from the Japan Science and Technology Agency (Target Protein Program (to H. A. and M. Y.) and ERATO (to M. Y.)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Aggeler R, 1997, J BIOL CHEM, V272, P19621, DOI 10.1074/jbc.272.31.19621; Ahmad Z, 2004, J BIOL CHEM, V279, P31505, DOI 10.1074/jbc.M404621200; Bandyopadhyay S, 2002, BIOCHEMISTRY-US, V41, P14421, DOI 10.1021/bi026243g; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Dou C, 1998, BIOCHEMISTRY-US, V37, P16757, DOI 10.1021/bi981717q; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; Masaike T, 2002, J BIOL CHEM, V277, P21643, DOI 10.1074/jbc.M110297200; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; MIWA K, 1989, P NATL ACAD SCI USA, V86, P6484, DOI 10.1073/pnas.86.17.6484; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P7670, DOI 10.1021/bi990663x; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; ODAKA M, 1994, J BIOCHEM-TOKYO, V115, P789, DOI 10.1093/oxfordjournals.jbchem.a124410; ODAKA M, 1993, FEBS LETT, V336, P231, DOI 10.1016/0014-5793(93)80809-9; OMOTE H, 1992, J BIOL CHEM, V267, P20571; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PARK MY, 1994, J BIOCHEM-TOKYO, V116, P1139, DOI 10.1093/oxfordjournals.jbchem.a124640; Ren HM, 2000, J BIOL CHEM, V275, P10057, DOI 10.1074/jbc.275.14.10057; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; SENIOR AE, 1993, J BIOL CHEM, V268, P6989; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; TAKEYAMA M, 1990, J BIOL CHEM, V265, P21279; Tolman JR, 1997, NAT STRUCT BIOL, V4, P292, DOI 10.1038/nsb0497-292; TOZAWA K, 1992, J BIOL CHEM, V267, P16484; Tozawa K, 2001, J BIOCHEM, V130, P527, DOI 10.1093/oxfordjournals.jbchem.a003015; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEBER J, 1993, J BIOL CHEM, V268, P20126; Yagi H, 2004, J AM CHEM SOC, V126, P16632, DOI 10.1021/ja045279o; Yagi H, 1999, BIOPHYS J, V77, P2175, DOI 10.1016/S0006-3495(99)77057-8; Yamazaki T, 1998, J AM CHEM SOC, V120, P5591, DOI 10.1021/ja980776o; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; YOHDA M, 1988, BIOCHIM BIOPHYS ACTA, V933, P156, DOI 10.1016/0005-2728(88)90065-5; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; YOSHIDA M, 1990, J BIOL CHEM, V265, P2483	46	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2374	2382		10.1074/jbc.M808212200	http://dx.doi.org/10.1074/jbc.M808212200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028677	hybrid			2022-12-27	WOS:000262545600046
J	Gale, SE; Westover, EJ; Dudley, N; Krishnan, K; Merlin, S; Scherrer, DE; Han, XL; Zhai, XH; Brockman, HL; Brown, RE; Covey, DF; Schaffer, JE; Schlesinger, P; Ory, DS				Gale, Sarah E.; Westover, Emily J.; Dudley, Nicole; Krishnan, Kathiresan; Merlin, Sean; Scherrer, David E.; Han, Xianlin; Zhai, Xiuhong; Brockman, Howard L.; Brown, Rhoderick E.; Covey, Douglas F.; Schaffer, Jean E.; Schlesinger, Paul; Ory, Daniel S.			Side Chain Oxygenated Cholesterol Regulates Cellular Cholesterol Homeostasis through Direct Sterol-Membrane Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM CHOLESTEROL; DENSITY-LIPOPROTEIN CHOLESTEROL; PLASMA-MEMBRANE; SENSING DOMAIN; NPC1 PROTEIN; IN-VITRO; OXYSTEROLS; BINDING; CELLS; SCAP	Side chain oxysterols exert cholesterol homeostatic effects by suppression of sterol regulatory element-binding protein maturation and promoting degradation of hydroxymethylglutaryl-CoA reductase. To examine whether oxysterol-membrane interactions contribute to the regulation of cellular cholesterol homeostasis, we synthesized the enantiomer of 25-hydroxycholesterol. Using this unique oxysterol probe, we provide evidence that oxysterol regulation of cholesterol homeostatic responses is not mediated by enantiospecific oxysterol-protein interactions. We show that side chain oxysterols, but not steroid ringmodified oxysterols, exhibit membrane expansion behavior in phospholipid monolayers and bilayers in vitro. This behavior is non-enantiospecific and is abrogated by increasing the saturation of phospholipid acyl chain constituents. Moreover, we extend these findings into cultured cells by showing that exposure to saturated fatty acids at concentrations that lead to endoplasmic reticulum membrane phospholipid remodeling inhibits oxysterol activity. These studies implicate oxysterol-membrane interactions in acute regulation of sterol homeostatic responses and provide new insights into the mechanism through which oxysterols regulate cellular cholesterol balance.	[Ory, Daniel S.] Washington Univ, Sch Med, Cardiovasc Res Ctr, Dept Med, St Louis, MO 63110 USA; [Westover, Emily J.; Krishnan, Kathiresan; Covey, Douglas F.; Schaffer, Jean E.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Merlin, Sean; Schlesinger, Paul; Ory, Daniel S.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Zhai, Xiuhong; Brockman, Howard L.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Minnesota System	Ory, DS (corresponding author), Washington Univ, Sch Med, Cardiovasc Res Ctr, Dept Med, Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	dory@wustl.edu	Schlesinger, Paul H/C-6049-2012	Brown, Rhoderick/0000-0002-7337-3604	National Institutes of Health [HL67773, HL83762, GM47969, DK54268, HL49180, GM45928, P30 DK56341, 5T32HL007275-29]; Hormel Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275, P50HL083762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK054268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928, P01GM047969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67773 (to D.S.O.and D.F.C.), HL83762 (to D.S.O.), GM47969 (to D.F.C.), DK54268 (to J.E.S.), HL49180 (to H.L.B.), GM45928(to R.E.B.), and P30 DK56341 and by Training Grant 5T32HL007275-29 (to E.J.W.and N.D.).This work was also supported by the Hormel Foundation (to H.L.B. and R.E.B.).The costs of publication of this article were defrayed in part by the payment of page charges.This article must therefore be hereby marked " advertisement" in accordance with 18 U.S.C.Section 1734 solely to indicate this fact.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Aittoniemi J, 2006, J PHYS CHEM B, V110, P25562, DOI 10.1021/jp064931u; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Kauffman JM, 2000, J LIPID RES, V41, P991; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; LANGE Y, 1994, J BIOL CHEM, V269, P3411; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; Lange Y, 1999, J LIPID RES, V40, P2264; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Liu J, 2005, BIOCHEM J, V391, P389, DOI 10.1042/BJ20050428; Massey JB, 2006, BIOCHEMISTRY-US, V45, P10747, DOI 10.1021/bi060540u; Mathai JC, 2008, J GEN PHYSIOL, V131, P69, DOI 10.1085/jgp.200709848; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Phillips JE, 2001, ATHEROSCLEROSIS, V159, P125, DOI 10.1016/S0021-9150(01)00504-4; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rex S, 1998, BIOCHEMISTRY-US, V37, P2336, DOI 10.1021/bi971009p; Smaby JM, 1997, BIOPHYS J, V73, P1492, DOI 10.1016/S0006-3495(97)78181-5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Westover EJ, 2004, J MEMBRANE BIOL, V202, P61, DOI 10.1007/s00232-004-0714-7; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; Westover EJ, 2006, STEROIDS, V71, P484, DOI 10.1016/j.steroids.2006.01.007; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Worgall TS, 2002, J BIOL CHEM, V277, P3878, DOI 10.1074/jbc.M102393200	35	57	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1755	1764		10.1074/jbc.M807210200	http://dx.doi.org/10.1074/jbc.M807210200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18996837	hybrid, Green Published			2022-12-27	WOS:000262330100046
J	Kumar, D; Ray, A; Ray, BK				Kumar, Deepak; Ray, Alpana; Ray, Bimal K.			Transcriptional Synergy Mediated by SAF-1 and AP-1 CRITICAL ROLE OF N-TERMINAL POLYALANINE AND TWO ZINC FINGER DOMAINS OF SAF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-ACTIVATING FACTOR; PROTEIN-KINASE-A; C-FOS/C-JUN; GENE-EXPRESSION; MONOCYTE/MACROPHAGE CELLS; MATRIX METALLOPROTEINASES; FUNCTIONAL COOPERATION; SIGNALING PATHWAY; SYNOVIOCYTE CELLS; DNA ELEMENTS	Previously we determined that inflammation responsive transcription factors AP-1 and SAF-1 synergistically regulate transcriptional induction of the MMP-1 gene. The present study investigated the underlying molecular mechanism of cooperativity between these two different groups of transcription factors. We present evidence that knockdown of SAF-1 by small interfering RNAs inhibits AP-1-mediated increase of human MMP-1 expression. The two key members of the AP-1 family of proteins, c-Fos and c-Jun, and SAF-1 form a ternary protein complex, which has markedly higher DNA binding activity than either a SAF-1 homodimer or a c-Fos/c-Jun heterodimer. The increased DNA binding activity of the ternary complex is translated into a striking enhancement of their transcriptional activity by which synergistic transcriptional induction of MMP-1 expression is achieved. The SAF-1.c-Fos.c-Jun ternary complex efficiently promotes transcription from both SAF-1 and AP-1 sites of human MMP-1 promoter. The physical interaction between SAF-1 and AP-1 was demonstrated both in vitro by Far-Western and antibody pulldown assays with recombinant proteins and in vivo by chromatin immunoprecipitation (ChIP), re-ChIP, and co-immunoprecipitation analyses. Two distinct but adjacent domains in SAF-1 are involved in protein-protein contact with c-Fos and c-Jun; one domain resides within two N-terminal polyalanine tracts, and the other is present within the first two zinc finger motifs. Together these findings delineate the mechanism of synergy and the essential role of SAF-1 and AP-1 in up-regulating human MMP-1 expression under various inflammatory conditions.	[Kumar, Deepak; Ray, Alpana; Ray, Bimal K.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Ray, A (corresponding author), Univ Missouri, Dept Vet Pathobiol, 126 Connaway Hall, Columbia, MO 65211 USA.	rayal@missouri.edu; rayb@missouri.edu						ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; BASSUK AG, 1995, IMMUNITY, V3, P223, DOI 10.1016/1074-7613(95)90092-6; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; Berend KR, 1998, J BONE JOINT SURG AM, V80A, P11, DOI 10.2106/00004623-199801000-00004; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; EHRLICH MG, 1985, J ORTHOP RES, V3, P170, DOI 10.1002/jor.1100030206; Ferguson HA, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.20.e98; Fry CJ, 1999, J BIOL CHEM, V274, P29583, DOI 10.1074/jbc.274.42.29583; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; GUTMAN A, 1991, TRENDS GENET, V7, P49, DOI 10.1016/0168-9525(91)90231-E; Hancock JM, 2005, GENE, V345, P113, DOI 10.1016/j.gene.2004.11.023; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Kampfer S, 1998, EMBO J, V17, P4046, DOI 10.1093/emboj/17.14.4046; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; Ray A, 1999, J BIOL CHEM, V274, P4300, DOI 10.1074/jbc.274.7.4300; Ray A, 2005, BBA-GENE STRUCT EXPR, V1732, P53, DOI 10.1016/j.bbaexp.2005.11.004; RAY A, 1995, J BIOL CHEM, V270, P7365, DOI 10.1074/jbc.270.13.7365; Ray A, 2005, J IMMUNOL, V175, P4039, DOI 10.4049/jimmunol.175.6.4039; Ray A, 1998, MOL CELL BIOL, V18, P7327, DOI 10.1128/MCB.18.12.7327; Ray A, 2003, ARTHRITIS RHEUM, V48, P134, DOI 10.1002/art.10706; Ray A, 2003, J BIOL CHEM, V278, P22586, DOI 10.1074/jbc.M300705200; Ray A, 2002, MOL CELL BIOL, V22, P1027, DOI 10.1128/MCB.22.4.1027-1035.2002; Ray A, 1996, MOL CELL BIOL, V16, P1584; Ray A, 2000, J BIOL CHEM, V275, P39727, DOI 10.1074/jbc.M007907200; Ray BK, 1999, DNA CELL BIOL, V18, P65, DOI 10.1089/104454999315637; Ray BK, 2001, J IMMUNOL, V167, P2343, DOI 10.4049/jimmunol.167.4.2343; Ray BK, 1997, BIOCHEMISTRY-US, V36, P4662, DOI 10.1021/bi9624595; Sambrook J., 2001, MOL CLONING LAB MANU; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; Utsch B, 2002, HUM GENET, V110, P488, DOI 10.1007/s00439-002-0712-8; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	44	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1853	1862		10.1074/jbc.M806289200	http://dx.doi.org/10.1074/jbc.M806289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028685	hybrid			2022-12-27	WOS:000262330100056
J	Bottomley, MJ; Cirillo, A; Orsatti, L; Ruggeri, L; Fisher, TS; Santoro, JC; Cummings, RT; Cubbon, RM; Lo Surdo, P; Calzetta, A; Noto, A; Baysarowich, J; Mattu, M; Talamo, F; De Francesco, R; Sparrow, CP; Sitlani, A; Carfi, A				Bottomley, Matthew J.; Cirillo, Agostino; Orsatti, Laura; Ruggeri, Lionello; Fisher, Timothy S.; Santoro, Joseph C.; Cummings, Richard T.; Cubbon, Rose M.; Lo Surdo, Paola; Calzetta, Alessandra; Noto, Alessia; Baysarowich, Jennifer; Mattu, Marco; Talamo, Fabio; De Francesco, Raffaele; Sparrow, Carl P.; Sitlani, Ayesha; Carfi, Andrea			Structural and Biochemical Characterization of the Wild Type PCSK9-EGF(AB) Complex and Natural Familial Hypercholesterolemia Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTASE SUBTILISIN/KEXIN TYPE-9; DENSITY-LIPOPROTEIN RECEPTORS; PCSK9 GENE; SECRETED PCSK9; MOLECULAR-BASIS; LDL RECEPTORS; MUTATIONS; BINDING; DECREASES; HOMOLOGY	PCSK9 regulates low density lipoprotein receptor (LDLR) levels and consequently is a target for the prevention of atherosclerosis and coronary heart disease. Here we studied the interaction, of LDLR EGF(A/AB) repeats with PCSK9. We show that PCSK9 binds the EGF(AB) repeats in a pH-dependent manner. Although the PCSK9 C-terminal domain is not involved in LDLR binding, PCSK9 autocleavage is required. Moreover, we report the x-ray structure of the PCSK9 Delta C-EGF(AB) complex at neutral pH. Compared with the low pH PCSK9-EGF(A) structure, the new structure revealed rearrangement of the EGF( A) His-306 side chain and disruption of the salt bridge with PCSK9 Asp-374, thus suggesting the basis for enhanced interaction at low pH. In addition, the structure of PCSK9 Delta C bound to EGF(AB)(H306Y), a mutant associated with familial hypercholesterolemia (FH), reveals that the Tyr-306 side chain forms a hydrogen bond with PCSK9 Asp-374, thus mimicking His-306 in the low pH conformation. Consistently, Tyr-306 confers increased affinity for PCSK9. Importantly, we found that although the EGF(AB)(H306Y)-PCSK9 interaction is pH-independent, LDLRH306Y binds PCSK9 50-fold better at low pH, suggesting that factors other than His-306 contribute to the pH dependence of PCSK9-LDLR binding. Further, we determined the structures of EGF(AB) bound to PCSK9 Delta C containing the FH-associated D374Y and D374H mutations, revealing additional interactions with EGF(A) mediated by Tyr-374/His-374 and providing a rationale for their disease phenotypes. Finally, we report the inhibitory properties of EGF repeats in a cellular assay measuring LDL uptake.	[Bottomley, Matthew J.; Cirillo, Agostino; Orsatti, Laura; Ruggeri, Lionello; Lo Surdo, Paola; Calzetta, Alessandra; Noto, Alessia; Mattu, Marco; Talamo, Fabio; De Francesco, Raffaele; Carfi, Andrea] Ist Ric Biol Mol P Angeletti, Dept Biochem, I-00040 Pomezia, Italy; [Fisher, Timothy S.; Santoro, Joseph C.; Cummings, Richard T.; Cubbon, Rose M.; Baysarowich, Jennifer; Sparrow, Carl P.; Sitlani, Ayesha] Merck Res Labs, Div Cardiovasc Dis, Rahway, NJ 07065 USA	Merck & Company; Merck & Company	Bottomley, MJ (corresponding author), Ist Ric Biol Mol P Angeletti, Dept Biochem, Via Pontina Km 30-600, I-00040 Pomezia, Italy.	matthew_bottomley@merck.com; andrea_carfi@merck.com	De Francesco, Raffaele/J-6003-2012; Fisher, Timothy S/D-8517-2011	De Francesco, Raffaele/0000-0001-8754-5123; Fisher, Timothy S/0000-0002-8909-313X				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Bourbon M, 2008, ATHEROSCLEROSIS, V196, P633, DOI 10.1016/j.atherosclerosis.2007.07.019; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Day INM, 1997, HUM MUTAT, V10, P116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Fouchier SW, 2001, HUM GENET, V109, P602, DOI 10.1007/s00439-001-0628-8; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Jeyarajah S, 1998, J AM SOC MASS SPECTR, V9, P157, DOI 10.1016/S1044-0305(97)00247-X; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Malby S, 2001, BIOCHEMISTRY-US, V40, P2555, DOI 10.1021/bi002322l; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Pandit S, 2008, J LIPID RES, V49, P1333, DOI 10.1194/jlr.M800049-JLR200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Saha S, 2001, STRUCTURE, V9, P451, DOI 10.1016/S0969-2126(01)00606-2; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	38	102	119	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1313	1323		10.1074/jbc.M808363200	http://dx.doi.org/10.1074/jbc.M808363200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001363	Green Published, hybrid			2022-12-27	WOS:000262122900066
J	Flamand, N; Luo, M; Peters-Golden, M; Brock, TG				Flamand, Nicolas; Luo, Ming; Peters-Golden, Marc; Brock, Thomas G.			Phosphorylation of Serine 271 on 5-Lipoxygenase and Its Role in Nuclear Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECREASED LEUKOTRIENE-B4 SYNTHESIS; ARACHIDONIC-ACID; ALVEOLAR MACROPHAGES; IN-VITRO; IMPORT; LOCALIZATION; METABOLISM; TRANSLOCATION; ACTIVATION; SEQUENCE	The enzyme 5-lipoxygenase (5-LO) initiates the biosynthesis of leukotrienes, inflammatory mediators involved in immune diseases and defense. The subcellular localization of 5-LO is regulated, with nuclear import commonly leading to increased leukotriene production. We report here that 5-LO is constitutively phosphorylated on Ser-271 in transfected NIH 3T3 cells. This residue is nested in a classical nuclear export sequence, and phosphorylated Ser-271 5-LO was exclusively found in the nucleus by immunofluorescence and by fractionation techniques. Mutation of Ser-271 to Ala allowed nuclear export of 5-LO that was blocked by the specific nuclear export inhibitor leptomycin b, suggesting that phosphorylation of Ser-271 serves to interfere with exportin-1-mediated nuclear export. Consistent with previous reports that purified 5-LO can be phosphorylated on Ser-271 in vitro by MAPK-activated protein kinase 2, the nuclear export of 5-LO was increased by either treatment with the p38 inhibitor SB 203,580 or co-expression of a kinase-deficient p38 MAPK. Nuclear export of 5-LO can also be induced by KN-93, an inhibitor of Ca2+/calmodulin-dependent kinase II, and the effects of SB 203,580 plus KN-93 are additive. Finally, HeLa cells, which lack nuclear 5-LO, also lack constitutive phosphorylation of Ser-271. Taken together, these results indicate that the phosphorylation of Ser-271 serves to inhibit the nuclear export of 5-LO. This action works in concert with nuclear import, which is regulated by phosphorylation on Ser-523, to determine the subcellular distribution of 5-LO, which in turn regulates leukotriene biosynthesis.	[Flamand, Nicolas] Univ Laval, Ctr Rech, Hop Laval, Quebec City, PQ G1V 4G5, Canada; [Flamand, Nicolas; Luo, Ming; Peters-Golden, Marc; Brock, Thomas G.] Univ Michigan Hlth Syst, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	Laval University; University of Michigan System; University of Michigan	Flamand, N (corresponding author), Univ Laval, Ctr Rech, Hop Laval, Off M2653,2725 Chemin St Foy, Quebec City, PQ G1V 4G5, Canada.	Nicolas.Flamand@crhl.ulaval.ca	Flamand, Nicolas/H-5823-2019	Flamand, Nicolas/0000-0001-5944-7200	National Institutes of Health [RO1 AI43955, HL50496, HL078727]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL078727, R01HL050496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants RO1 AI43955, HL50496, and HL078727. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anstead GM, 2003, J LEUKOCYTE BIOL, V74, P982, DOI 10.1189/jlb.0203064; BALTER MS, 1989, J LAB CLIN MED, V114, P662; Beeh KM, 2003, CHEST, V123, P1240, DOI 10.1378/chest.123.4.1240; Biernacki WA, 2003, THORAX, V58, P294, DOI 10.1136/thorax.58.4.294; Brock TG, 1998, BIOCHEM J, V329, P519; Brock TG, 2005, J CELL BIOCHEM, V96, P1203, DOI 10.1002/jcb.20662; Brock TG, 1997, J BIOL CHEM, V272, P8276, DOI 10.1074/jbc.272.13.8276; BROCK TG, 1994, J BIOL CHEM, V269, P22059; Brock TG, 1999, J IMMUNOL, V162, P1669; BROCK TG, 1995, J BIOL CHEM, V270, P21652, DOI 10.1074/jbc.270.37.21652; Cap P, 2005, ALLERGY, V60, P171, DOI 10.1111/j.1398-9995.2005.00675.x; Cederholm T, 2000, J INTERN MED, V247, P715, DOI 10.1046/j.1365-2796.2000.00691.x; CHEN XS, 1995, J BIOL CHEM, V270, P17993, DOI 10.1074/jbc.270.30.17993; Coffey MJ, 1996, J IMMUNOL, V157, P393; Coffey MJ, 2004, PROSTAG LEUKOTR ESS, V71, P185, DOI 10.1016/j.plefa.2004.03.012; COFFEY MJ, 1994, PROSTAG OTH LIPID M, V48, P313, DOI 10.1016/0090-6980(94)90031-0; Covin RB, 1998, AM J PHYSIOL-LUNG C, V275, pL303, DOI 10.1152/ajplung.1998.275.2.L303; Crooks SW, 2000, EUR RESPIR J, V15, P274, DOI 10.1034/j.1399-3003.2000.15b09.x; DEMITSU T, 1989, INT J IMMUNOPHARMACO, V11, P801, DOI 10.1016/0192-0561(89)90134-3; Drazen J M, 1994, Adv Prostaglandin Thromboxane Leukot Res, V22, P251; Flamand N, 2007, CELL MOL LIFE SCI, V64, P2657, DOI 10.1007/s00018-007-7228-2; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Gosselin J, 2005, J IMMUNOL, V174, P1587, DOI 10.4049/jimmunol.174.3.1587; Hanaka H, 2002, BIOCHEM J, V361, P505, DOI 10.1042/0264-6021:3610505; Healy AM, 1999, J BIOL CHEM, V274, P29812, DOI 10.1074/jbc.274.42.29812; Hemak J, 2002, J MOL MODEL, V8, P102, DOI 10.1007/s00894-002-0076-y; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Jones SM, 2003, J BIOL CHEM, V278, P10257, DOI 10.1074/jbc.M211021200; Jones SM, 2002, J BIOL CHEM, V277, P38550, DOI 10.1074/jbc.M206070200; JUBIZ W, 1984, PROSTA LEUKOTR MED, V14, P305, DOI 10.1016/0262-1746(84)90114-8; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; LAVIOLETTE M, 1986, J CLIN INVEST, V77, P54, DOI 10.1172/JCI112301; Luo M, 2005, J BIOL CHEM, V280, P40609, DOI 10.1074/jbc.M507045200; Luo M, 2004, J BIOL CHEM, V279, P41512, DOI 10.1074/jbc.M312568200; Luo M, 2003, P NATL ACAD SCI USA, V100, P12165, DOI 10.1073/pnas.2133253100; Luo M, 2004, TRAFFIC, V5, P847, DOI 10.1111/j.1600-0854.2004.00227.x; Lutteke T, 2003, BIOINFORMATICS, V19, P2482, DOI 10.1093/bioinformatics/btg337; Mancuso P, 2006, AM J RESP CRIT CARE, V173, P212, DOI 10.1164/rccm.200506-909OC; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Mayatepek E, 1999, J INFECT DIS, V179, P714, DOI 10.1086/314619; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Meng WY, 2002, J BIOL CHEM, V277, P37401, DOI 10.1074/jbc.C200418200; MOQBEL R, 1983, CLIN EXP IMMUNOL, V52, P519; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003; Serezani CH, 2006, J IMMUNOL, V177, P3201, DOI 10.4049/jimmunol.177.5.3201; SHINDO K, 1995, EUR RESPIR J, V8, P605; SKERRETT SJ, 1990, J IMMUNOL, V144, P1052; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner CR, 1996, J CLIN INVEST, V97, P381, DOI 10.1172/JCI118426; Vliagoftis H, 2002, J IMMUNOL, V169, P4551, DOI 10.4049/jimmunol.169.8.4551; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; Werz O, 2002, J BIOL CHEM, V277, P14793, DOI 10.1074/jbc.M111945200; WIRTH JJ, 1985, J IMMUNOL, V134, P1989; Zimmerman TL, 2006, J BIOL CHEM, V281, P15434, DOI 10.1074/jbc.M508277200	57	41	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					306	313		10.1074/jbc.M805593200	http://dx.doi.org/10.1074/jbc.M805593200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18978352	Green Published, hybrid			2022-12-27	WOS:000261974800035
J	Su'etsugu, M; Nakamura, K; Keyamura, K; Kudo, Y; Katayama, T				Su'etsugu, Masayuki; Nakamura, Kenta; Keyamura, Kenji; Kudo, Yuka; Katayama, Tsutomu			Hda Monomerization by ADP Binding Promotes Replicase Clamp-mediated DnaA-ATP Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; SLIDING CLAMP; TRANSLATION INITIATION; COUPLED INACTIVATION; BACILLUS-SUBTILIS; GAMMA-COMPLEX; IN-VITRO; PROTEIN; AAA(+); CYCLE	ATP-DnaA is the initiator of chromosomal replication in Escherichia coli, and the activity of DnaA is regulated by the regulatory inactivation of the DnaA (RIDA) system. In this system, the Hda protein promotes DnaA-ATP hydrolysis to produce inactive ADP-DnaA in a mechanism that is mediated by the DNA-loaded form of the replicase sliding clamp. In this study, we first revealed that hda translation uses an unusual initiation codon, CUG, located downstream of the annotated initiation codon. The CUG initiation codon could be used for restricting the Hda level, as this initiation codon has a low translation efficiency, and the cellular Hda level is only similar to 100 molecules per cell. Hda translated using the correct reading frame was purified and found to have a high RIDA activity in vitro. Moreover, we found that Hda has a high affinity for ADP but not for other nucleotides, including ATP. ADP-Hda was active in the RIDA system in vitro and stable in a monomeric state, whereas apo-Hda formed inactive homomultimers. Both ADP-Hda and apo-Hda could form complexes with the DNA-loaded clamp; however, only ADP-Hda-DNA-clamp complexes were highly functional in the following interaction with DnaA. Formation of ADP-Hda was also observed in vivo, and mutant analysis suggested that ADP binding is crucial for cellular Hda activity. Thus, we propose that ADP is a crucial Hda ligand that promotes the activated conformation of the protein. ADP-dependent monomerization might enable the arginine finger of the Hda AAA(+) domain to be accessible to ATP bound to the DnaA AAA(+) domain.	[Su'etsugu, Masayuki; Nakamura, Kenta; Keyamura, Kenji; Kudo, Yuka; Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Katayama, T (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	katayama@phar.kyushu-u.ac.jp		Katayama, Tsutomu/0000-0001-9994-1684; Su'estugu, Masayuki/0000-0001-6695-4032	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arnaud E, 1999, MOL CELL BIOL, V19, P505; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Banack T, 2005, J BACTERIOL, V187, P8507, DOI 10.1128/JB.187.24.8507-8510.2005; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hayashi M, 2005, FEMS MICROBIOL LETT, V247, P73, DOI 10.1016/j.femsle.2005.04.028; Ishida T, 2004, J BIOL CHEM, V279, P45546, DOI 10.1074/jbc.M402762200; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Johnson A, 2003, J BIOL CHEM, V278, P14406, DOI 10.1074/jbc.M212708200; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Katayama T, 2001, MOL MICROBIOL, V41, P9, DOI 10.1046/j.1365-2958.2001.02483.x; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Kawakami H, 2006, J STRUCT BIOL, V156, P220, DOI 10.1016/j.jsb.2006.02.007; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Koh DCY, 2006, VIRUS RES, V122, P35, DOI 10.1016/j.virusres.2006.06.008; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Kurz M, 2004, J BACTERIOL, V186, P3508, DOI 10.1128/JB.186.11.3508-3515.2004; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; NEUHARD J, 1987, ESCHERICHIA COLI SAL, P1579; Neuwald AF, 1999, GENOME RES, V9, P27; Nievera C, 2006, MOL CELL, V24, P581, DOI 10.1016/j.molcel.2006.09.016; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; O'Donnell SM, 2001, J BACTERIOL, V183, P1277, DOI 10.1128/JB.183.4.1277-1283.2001; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Su'etsugu M, 2004, GENES CELLS, V9, P509, DOI 10.1111/j.1356-9597.2004.00741.x; Su'etsugu M, 2001, MOL MICROBIOL, V40, P376, DOI 10.1046/j.1365-2958.2001.02378.x; Sussman JK, 1996, MOL MICROBIOL, V21, P347, DOI 10.1046/j.1365-2958.1996.6371354.x; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x	49	33	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36118	36131		10.1074/jbc.M803158200	http://dx.doi.org/10.1074/jbc.M803158200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18977760	hybrid, Green Published			2022-12-27	WOS:000261840500007
J	Yoshida, R; Takaesu, G; Yoshida, H; Okamoto, F; Yoshioka, T; Choi, Y; Akira, S; Kawai, T; Yoshimura, A; Kobayashi, T				Yoshida, Ryoko; Takaesu, Giichi; Yoshida, Hideyuki; Okamoto, Fuyuki; Yoshioka, Tomoko; Choi, Yongwon; Akira, Shizuo; Kawai, Taro; Yoshimura, Akihiko; Kobayashi, Takashi			TRAF6 and MEKK1 Play a Pivotal Role in the RIG-I-like Helicase Antiviral Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSES; DOUBLE-STRANDED-RNA; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; ADAPTER PROTEIN; VIRAL-INFECTION; GENE INDUCTION; CUTTING EDGE; KINASE TAK1	Type I interferons (IFN-alpha/beta) are essential for immune defense against viruses and induced through the actions of the cytoplasmic helicases, RIG-I and MDA5, and their downstream adaptor molecule IPS-1. TRAF6 and the downstream kinase TAK1 have been shown to be essential for the production of proinflammatory cytokines through the TLR/MyD88/TRIF pathway. Although binding of TRAF6 with IPS-1 has been demonstrated, the role of the TRAF6 pathway in IFN alpha/beta production has not been fully understood. Here, we demonstrate that TRAF6 is critical for IFN-alpha/beta induction in response to viral infection and intracellular double-stranded RNA, poly(I:C). Activation of NF-kappa B, JNK, and p38, but not IRF3, was impaired in TRAF6-deficient mouse embryo fibroblasts in response to vesicular stomatitis virus and poly(I:C). However, TAK1 was not required for IFN-beta induction in this process, since normal IFN-alpha/beta production was observed in TAK1-deficient mouse embryo fibroblasts. Instead, another MAP3K, MEKK1, was important for the activation of the IFN-beta promoter in response to poly(I:C). Forced expression of MEKK1 in combination with IRF3 was sufficient for the induction of IFN-beta, whereas suppression of MEKK1 expression by small interfering RNA inhibited the induction of IFN-beta by poly(I:C). These data suggest that IPS-1 requires TRAF6 and MEKK1 to activate NF-kappa B and mitogen-activated protein kinases that are critical for the optimal induction of type I interferons.	[Kobayashi, Takashi] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan; [Takaesu, Giichi; Kobayashi, Takashi] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo 1608582, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Akira, Shizuo; Kawai, Taro] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Akira, Shizuo] EARTO, Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan; [Yoshimura, Akihiko] CREST, JST, Kawaguchi, Saitama 332001, Japan	Kyushu University; Keio University; Keio University; University of Pennsylvania; Pennsylvania Medicine; Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Kobayashi, T (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takashik@bioreg.kyushu-u.ac.jp	Akira, Shizuo/C-3134-2009; Yoshimura, Akihiko/K-5515-2013	Kawai, Taro/0000-0001-7510-4662; Takaesu, Giichi/0000-0002-1581-1055	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation (NIBIO); Nakatomi Foundation; Takeda Science Foundation; Kato Memorial Trust Foundation for Nanbyo Research; Suzuken Memorial Foundation; Japan Intractable Disease Research Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Research Foundation; Princess Takamatsu Cancer Research	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Nakatomi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Kato Memorial Trust Foundation for Nanbyo Research; Suzuken Memorial Foundation; Japan Intractable Disease Research Foundation; Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Yakult Bioscience Research Foundation; Princess Takamatsu Cancer Research	This study was supported by special grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), the Nakatomi Foundation, the Takeda Science Foundation, the Kato Memorial Trust Foundation for Nanbyo Research, the Suzuken Memorial Foundation, the Japan Intractable Disease Research Foundation, the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Astellas Foundation for Research on Metabolic Disorders, the Yakult Bioscience Research Foundation, and the Princess Takamatsu Cancer Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hirano M, 1996, J BIOL CHEM, V271, P13234, DOI 10.1074/jbc.271.22.13234; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Symons A, 2006, TRENDS IMMUNOL, V27, P40, DOI 10.1016/j.it.2005.11.007; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	38	74	79	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36211	36220		10.1074/jbc.M806576200	http://dx.doi.org/10.1074/jbc.M806576200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984593	hybrid, Green Published			2022-12-27	WOS:000261840500016
J	Marsh, JL; Lukacsovich, T; Thompson, LM				Marsh, J. Lawrence; Lukacsovich, Tamas; Thompson, Leslie Michels			Animal Models of Polyglutamine Diseases and Therapeutic Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CAENORHABDITIS-ELEGANS NEURONS; HUNTINGTONS-DISEASE; TRINUCLEOTIDE REPEAT; PATHOGENESIS; DROSOPHILA; PROTEINS; NEURODEGENERATION; PHOSPHORYLATION; EXPANSION; AUTOPHAGY	The dominant gain-of-function polyglutamine repeat diseases, in which the initiating mutation is known, allow development of models that recapitulate many aspects of human disease. To the extent that pathology is a consequence of disrupted fundamental cellular activities, one can effectively study strategies to ameliorate or protect against these cellular insults. Model organisms allow one to identify pathways that affect disease onset and progression, to test and screen for pharmacological agents that affect pathogenic processes, and to validate potential targets genetically as well as pharmacologically. Here, we describe polyglutamine repeat diseases that have been modeled in a variety of organisms, including worms, flies, mice, and non-human primates, and discuss examples of how they have broadened the therapeutic landscape.	[Marsh, J. Lawrence; Lukacsovich, Tamas] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; [Marsh, J. Lawrence; Lukacsovich, Tamas] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Thompson, Leslie Michels] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Thompson, Leslie Michels] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Thompson, Leslie Michels] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Marsh, J. Lawrence] Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Marsh, JL (corresponding author), Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA.	jlmarsh@uci.edu; lmthomps@uci.edu			National Institutes of Health [NS045283, NS52789]; Hereditary Disease Foundation [HDF-24085]; Huntington's Disease Society of America; High Q Foundation/CHDI, Inc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045283, R01NS052789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; Huntington's Disease Society of America; High Q Foundation/CHDI, Inc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS045283 (to J.L.M.) and NS52789 (to L.M.T.). This work was also supported by Hereditary Disease Foundation Grant HDF-24085, the Huntington's Disease Society of America, and the High Q Foundation/CHDI, Inc.	Adachi H, 2007, NEUROPATH APPL NEURO, V33, P135, DOI 10.1111/j.1365-2990.2007.00830.x; Al-Ramahi I, 2007, PLOS GENET, V3, P2551, DOI 10.1371/journal.pgen.0030234; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Bates GP, 2006, MOL BIOTECHNOL, V32, P147, DOI 10.1385/MB:32:2:147; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Branco J, 2008, HUM MOL GENET, V17, P376, DOI 10.1093/hmg/ddm315; Brignull HR, 2007, ADV EXP MED BIOL, V594, P167; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Burnett BG, 2008, NEUROBIOL DIS, V30, P365, DOI 10.1016/j.nbd.2008.02.007; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Dorval V, 2007, BBA-MOL CELL RES, V1773, P694, DOI 10.1016/j.bbamcr.2007.03.017; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Jia KL, 2007, AUTOPHAGY, V3, P21, DOI 10.4161/auto.3528; Jung J, 2007, SCIENCE, V315, P1857, DOI 10.1126/science.1139517; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Katsuno M, 2004, J MOL MED, V82, P298, DOI 10.1007/s00109-004-0530-7; Katsuno M, 2008, CURR MOL MED, V8, P221, DOI 10.2174/156652408784221298; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Lievens JC, 2008, HUM MOL GENET, V17, P882, DOI 10.1093/hmg/ddm360; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Marsh JL, 2006, NEURON, V52, P169, DOI 10.1016/j.neuron.2006.09.025; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Parker JA, 2007, J NEUROSCI, V27, P11056, DOI 10.1523/JNEUROSCI.1941-07.2007; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Ramaswamy S, 2007, ILAR J, V48, P356, DOI 10.1093/ilar.48.4.356; Riess O, 2008, CEREBELLUM, V7, P125, DOI 10.1007/s12311-008-0013-4; Sang TK, 2005, HUM MOL GENET, V14, P357, DOI 10.1093/hmg/ddi032; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Varma H, 2007, P NATL ACAD SCI USA, V104, P14525, DOI 10.1073/pnas.0704482104; Voisine C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000504; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975	50	25	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7431	7435		10.1074/jbc.R800065200	http://dx.doi.org/10.1074/jbc.R800065200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	18957429	Green Published, hybrid			2022-12-27	WOS:000264195600006
J	Yang, G; Lim, C; Li, C; Xiao, X; Radda, GK; Li, C; Cao, X; Han, W				Yang, Guoqing; Lim, Chun-Yan; Li, Chao; Xiao, Xiaoqiu; Radda, George K.; Li, Cai; Cao, Xinmin; Han, Weiping			FoxO1 Inhibits Leptin Regulation of Pro-opiomelanocortin Promoter Activity by Blocking STAT3 Interaction with Specificity Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; GENE-EXPRESSION; ENERGY HOMEOSTASIS; SIGNAL TRANSDUCER; SKELETAL-MUSCLE; ARCUATE NUCLEUS; MESSENGER-RNA; GROWTH-FACTOR; BODY-WEIGHT; FOOD-INTAKE	Leptin controls food intake and energy expenditure by regulating hypothalamic neuron activities. Leptin exerts its actions through complex signaling pathways including STAT3 phosphorylation, nuclear translocation, and binding to target gene promoter/cofactor complexes. Deficient or defective leptin signaling leads to obesity, which may be caused by insufficient leptin levels and/or resistance to leptin signaling. To understand the molecular mechanisms of leptin resistance, we studied the regulation of pro-opiomelanocortin (POMC) gene expression by leptin. We show that phospho-STAT3 activates POMC promoter in response to leptin signaling through a mechanism that requires an SP1-binding site in the POMC promoter. Furthermore, FoxO1 binds to STAT3 and prevents STAT3 from interacting with the SP1.POMC promoter complex, and consequently, inhibits STAT3-mediated leptin action. Our study suggests that leptin action could be inhibited at a step downstream of STAT3 phosphorylation and nuclear translocation, and provides a potential mechanism of leptin resistance in which an increased FoxO1 antagonizes STAT3-mediated leptin signaling.	[Yang, Guoqing; Lim, Chun-Yan; Li, Chao; Xiao, Xiaoqiu; Radda, George K.; Han, Weiping] ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, Singapore 138667, Singapore; [Li, Cai] Merck Res Labs, Rahway, NJ 07065 USA; [Cao, Xinmin] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Cao, Xinmin; Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Merck & Company; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Han, W (corresponding author), ASTAR, Singapore Bioimaging Consortium, Lab Metab Med, 02-02 Helios,11 Biopolis Way, Singapore 138667, Singapore.	weiping_han@sbic.a-star.edu.sg	Xiao, Xiaoqiu/K-7672-2019	Xiao, Xiaoqiu/0000-0002-4568-8772	Agency for Science, Technology and Research Biomedical Research Council	Agency for Science, Technology and Research Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by an intramural funding from Agency for Science, Technology and Research Biomedical Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Ge HF, 2002, J BIOL CHEM, V277, P45898, DOI 10.1074/jbc.M205825200; Gong L, 2008, ENDOCRINOLOGY, V149, P3346, DOI 10.1210/en.2007-0945; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Huang XF, 2004, DIABETES OBES METAB, V6, P35, DOI 10.1111/j.1463-1326.2004.00312.x; JEANNOTTE L, 1987, MOL CELL BIOL, V7, P4058, DOI 10.1128/MCB.7.11.4058; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Li H, 2007, MOL CELL BIOL, V27, P2676, DOI 10.1128/MCB.01748-06; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Xiao XQ, 2004, ENDOCRINOLOGY, V145, P5344, DOI 10.1210/en.2004-0721; Zhang T, 2000, MOL CELL BIOL, V20, P7132, DOI 10.1128/MCB.20.19.7132-7139.2000; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	34	69	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3719	3727		10.1074/jbc.M804965200	http://dx.doi.org/10.1074/jbc.M804965200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19049975	hybrid			2022-12-27	WOS:000262872500040
J	Wincent, E; Amini, N; Luecke, S; Glatt, H; Bergman, J; Crescenzi, C; Rannug, A; Rannug, U				Wincent, Emma; Amini, Nahid; Luecke, Sandra; Glatt, Hansruedi; Bergman, Jan; Crescenzi, Carlo; Rannug, Agneta; Rannug, Ulf			The Suggested Physiologic Aryl Hydrocarbon Receptor Activator and Cytochrome P4501 Substrate 6-Formylindolo[3,2-b]carbazole Is Present in Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AH RECEPTOR; DIOXIN RECEPTOR; HIGH-AFFINITY; INDUCTION; IDENTIFICATION; TRANSCRIPTION; SULFOTRANSFERASES; SULT1A3; TARGET; GENE	Dioxins and other polycyclic aromatic compounds formed during the combustion of waste and fossil fuels represent a risk to human health, as well as to the well being of our environment. Compounds of this nature exert carcinogenic and endocrine-disrupting effects in experimental animals by binding to the orphan aryl hydrocarbon receptor (AhR). Understanding the mechanism of action of these pollutants, as well as the physiological role(s) of the AhR, requires identification of the endogenous ligand(s) of this receptor. We reported earlier that activation of AhR by ultraviolet radiation is mediated by the chromophoric amino acid tryptophan (Trp), and we suggested that a new class of compounds derived from Trp, in particular 6-formylindolo[3,2-b]carbazole (FICZ), acts as natural high affinity ligands for this receptor. Here we describe seven new FICZ-derived indolo[3,2-b]carbazole-6-carboxylic acid metabolites and two sulfoconjugates, and we demonstrate the following. (i) FICZ is formed efficiently by photolysis of Trp upon exposure to visible light. (ii) FICZ is an exceptionally good substrate for cytochromes P450 (CYP) 1A1, 1A2, and 1B1, and its hydroxylated metabolites are remarkably good substrates for the sulfotransferases (SULTs) 1A1, 1A2, 1B1, and 1E1. Finally, (iii) sulfoconjugates of phenolic metabolites of FICZ are present in human urine. Our findings indicate that formylindolo[3,2-b]carbazols are the most potent naturally occurring activators of the AhR signaling pathway and may be the key substrates of the CYP1 and SULT1 families of enzymes. These conclusions contradict the widespread view that xenobiotic compounds are the major AhR ligands and CYP1 substrates.	[Rannug, Ulf] Stockholm Univ, Arrhenius Labs 16E, Dept Genet Microbiol & Toxicol, SE-10691 Stockholm, Sweden; [Amini, Nahid; Crescenzi, Carlo] Stockholm Univ, Dept Analyt Chem, SE-10691 Stockholm, Sweden; [Luecke, Sandra; Rannug, Agneta] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Glatt, Hansruedi] German Inst Human Nutr Potsdam Rehbrucke, Dept Toxicol, D-14558 Nuthetal, Germany; [Bergman, Jan] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden	Stockholm University; Stockholm University; Karolinska Institutet; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Karolinska Institutet	Rannug, U (corresponding author), Stockholm Univ, Arrhenius Labs 16E, Dept Genet Microbiol & Toxicol, SE-10691 Stockholm, Sweden.	Ulf.Rannug@gmt.su.se	Rannug, Ulf/B-1867-2016; CRESCENZI, CARLO/C-4946-2008; Rannug, Ulf/K-2799-2019	CRESCENZI, CARLO/0000-0001-6950-1506; Rannug, John Ulf/0000-0003-1045-376X; Wincent, Emma/0000-0003-1637-654X; Glatt, Hansruedi/0000-0001-6053-0562; Lucke-Johansson, Sandra/0000-0002-9737-9111	Swedish Research Council ( Formas); Swedish Radiation Safety Authority; Karolinska Institutet; Sven and Lily Lawskis Fund	Swedish Research Council ( Formas)(Swedish Research CouncilSwedish Research Council Formas); Swedish Radiation Safety Authority; Karolinska Institutet(Karolinska Institutet); Sven and Lily Lawskis Fund	This work was supported by Swedish Research Council ( Formas), the Swedish Radiation Safety Authority, Karolinska Institutet, and the Sven and Lily Lawskis Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baba T, 2005, MOL CELL BIOL, V25, P10040, DOI 10.1128/MCB.25.22.10040-10051.2005; Badawi AF, 2001, METABOLISM, V50, P1001, DOI 10.1053/meta.2001.25592; Bergander L, 2004, CHEM-BIOL INTERACT, V149, P151, DOI 10.1016/j.cbi.2004.08.005; BERGHARD A, 1993, MOL CELL BIOL, V13, P677, DOI 10.1128/MCB.13.1.677; Brix LA, 1999, BIOCHEMISTRY-US, V38, P10474, DOI 10.1021/bi990795q; BURKE MD, 1974, DRUG METAB DISPOS, V2, P583; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; Dajani R, 1999, PROTEIN EXPRES PURIF, V16, P11, DOI 10.1006/prep.1999.1030; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Elferink CJ, 2001, MOL PHARMACOL, V59, P664, DOI 10.1124/mol.59.4.664; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fersht A., 1999, STRUCTURE MECH PROTE, P164; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Fujita K, 1999, BIOL PHARM BULL, V22, P446; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Guengerich FP, 1996, METHOD ENZYMOL, V272, P35, DOI 10.1016/S0076-6879(96)72006-2; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; HANKINSON O, 1985, J BIOL CHEM, V260, P1790; Ikuta T, 2006, EXP CELL RES, V312, P3585, DOI 10.1016/j.yexcr.2006.08.002; Katiyar SK, 2000, J INVEST DERMATOL, V114, P328, DOI 10.1046/j.1523-1747.2000.00876.x; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Matsumoto Y, 2007, ENVIRON SCI TECHNOL, V41, P3775, DOI 10.1021/es062793g; Meinl W, 2002, PHARMACOGENETICS, V12, P677, DOI 10.1097/00008571-200212000-00002; Nebert DW, 2008, J BIOL CHEM, V283, P36061, DOI 10.1074/jbc.R800053200; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; OMURA T, 1964, J BIOL CHEM, V239, P2370; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; RANNUG A, 1987, J BIOL CHEM, V262, P15422; Rannug U, 1995, CHEM BIOL, V2, P841, DOI 10.1016/1074-5521(95)90090-X; Shi LZ, 2007, J IMMUNOL, V179, P6952, DOI 10.4049/jimmunol.179.10.6952; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wahlstrom N, 2004, EUR J ORG CHEM, V2004, P2593, DOI 10.1002/ejoc.200400087; Wei YD, 2000, ARCH BIOCHEM BIOPHYS, V383, P99, DOI 10.1006/abbi.2000.2037; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	41	210	218	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2690	2696		10.1074/jbc.M808321200	http://dx.doi.org/10.1074/jbc.M808321200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054769	hybrid			2022-12-27	WOS:000262700900011
J	Colon, E; Shytuhina, A; Cowman, MK; Band, PA; Sanggaard, KW; Enghild, JJ; Wisniewski, HG				Colon, Elisa; Shytuhina, Anastasia; Cowman, Mary K.; Band, Philip A.; Sanggaard, Kristian W.; Enghild, Jan J.; Wisniewski, Hans-Georg			Transfer of Inter-alpha-inhibitor Heavy Chains to Hyaluronan by Surface-linked Hyaluronan-TSG-6 Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-INDUCED ARTHRITIS; T-CELL EXTRAVASATION; TRYPSIN-INHIBITOR; STIMULATED GENE-6; EXTRACELLULAR-MATRIX; BINDING PROTEIN; TSG-6 PROTEIN; RHEUMATOID-ARTHRITIS; FOLLICULAR-FLUID; PRIMARY ADHESION	Inter-alpha-inhibitor, TSG-6, and hyaluronan have important functions in fertility and inflammation. Two subunits of inter-alpha-inhibitor, the heavy chains, form covalent bonds with TSG-6 or hyaluronan in vitro. TSG-6-heavy chain complexes serve as intermediates in the transfer of heavy chains from inter-alpha-inhibitor to hyaluronan. In vivo, in addition to these complexes, stable ternary complexes of hyaluronan with both TSG-6 and heavy chains have been demonstrated in the ovulatory cumulus oophorus. In our ongoing efforts to characterize the multiple interactions between hyaluronan, TSG-6 and inter-alpha-inhibitor, we recently characterized the formation of highly stable complexes of TSG-6 with hyaluronan that had been tethered to a solid surface. Here we show that these hyaluronan-TSG-6 complexes are functionally active and transfer heavy chain subunits from inter-alpha-inhibitor to either free or surfacebound hyaluronan. Transitional hyaluronan-TSG-6-heavy chain complexes do not accumulate in vitro. Our data show the capability for heavy chain transfer by both free TSG-6 and preformed hyaluronan-TSG-6 complexes, suggesting that both might contribute to hyaluronan modification in vivo. Transfer of heavy chains to surface-tethered hyaluronan by either free TSG-6 or surface-tethered hyaluronan-TSG-6 complexes did not affect the CD 44-mediated binding of BW 5147 cells in vitro. We show how TSG-6 and hyaluronan together can deplete inter-alpha-inhibitor and generate bikunin, as has been observed in sepsis, and discuss the role of TSG-6 in the generation of hyaluronan-heavy chain complexes associated with ovulation, arthritis, and sepsis.	[Colon, Elisa; Wisniewski, Hans-Georg] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Band, Philip A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Shytuhina, Anastasia; Cowman, Mary K.] NYU, Polytech Inst, Dept Chem & Biol Sci, Brooklyn, NY 11201 USA; [Sanggaard, Kristian W.; Enghild, Jan J.] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark	New York University; New York University; New York University; New York University Tandon School of Engineering; Aarhus University	Wisniewski, HG (corresponding author), NYU, Sch Med, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA.	hans-georg.wisniewski@med.nyu.edu		Enghild, Jan Johannes/0000-0001-9292-9172	The Vilcek Foundation; Polytechnic Institute of NewYork University	The Vilcek Foundation; Polytechnic Institute of NewYork University	This work was supported by a research grant from The Vilcek Foundation and by the Othmer Institute for Interdisciplinary Studies at the Polytechnic Institute of NewYork University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baek YW, 2003, J PEDIATR-US, V143, P11, DOI 10.1016/S0022-3476(03)00190-2; Balduyck M, 2000, J LAB CLIN MED, V135, P188, DOI 10.1067/mlc.2000.104462; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; BECKER A, 1971, ARTHRITIS RHEUM, V14, P764, DOI 10.1002/art.1780140613; Bonder CS, 2006, BLOOD, V107, P4798, DOI 10.1182/blood-2005-09-3581; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Frost GI, 1997, ANAL BIOCHEM, V251, P263, DOI 10.1006/abio.1997.2262; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; HAYNES BF, 1989, IMMUNOL TODAY, V10, P423, DOI 10.1016/0167-5699(89)90040-6; HUANG L, 1993, J BIOL CHEM, V268, P26725; Jessen TE, 2004, OSTEOARTHR CARTILAGE, V12, P142, DOI 10.1016/j.joca.2003.10.004; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Kida D, 1999, J RHEUMATOL, V26, P1230; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; LESLEY J, 1990, EXP CELL RES, V187, P224, DOI 10.1016/0014-4827(90)90085-O; Lim YP, 2003, J INFECT DIS, V188, P919, DOI 10.1086/377642; Maier R, 1996, ARTHRITIS RHEUM, V39, P552, DOI 10.1002/art.1780390403; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; MIKECZ K, 1995, NAT MED, V1, P558, DOI 10.1038/nm0695-558; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Odum L, 2002, REPRODUCTION, V124, P249, DOI 10.1530/reprod/124.2.249; Opal SM, 2007, CRIT CARE MED, V35, P387, DOI 10.1097/01.CCM.0000253810.08230.83; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; POWERS RW, 1995, AM J PHYSIOL-ENDOC M, V269, pE290, DOI 10.1152/ajpendo.1995.269.2.E290; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Salier JP, 1996, BIOCHEM J, V315, P1, DOI 10.1042/bj3150001; Sandson J, 1965, Trans Assoc Am Physicians, V78, P304; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Shen L, 2006, HEPATOL RES, V34, P178, DOI 10.1016/j.hepres.2005.12.008; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Wisniewski HG, 2005, ANAL BIOCHEM, V347, P42, DOI 10.1016/j.ab.2005.09.038; Wisniewski HG, 2005, J BIOL CHEM, V280, P14476, DOI 10.1074/jbc.M411734200; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; WISNIEWSKI HG, 1994, BIOCHEMISTRY-US, V33, P7423, DOI 10.1021/bi00189a049; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Wu RQ, 2004, CRIT CARE MED, V32, P1747, DOI 10.1097/01.CCM.0000132903.14121.0E; Yang SL, 2002, CRIT CARE MED, V30, P617, DOI 10.1097/00003246-200203000-00021; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	60	19	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2320	2331		10.1074/jbc.M807183200	http://dx.doi.org/10.1074/jbc.M807183200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19033448	hybrid			2022-12-27	WOS:000262545600041
J	Izaguirre, G; Rezaie, AR; Olson, ST				Izaguirre, Gonzalo; Rezaie, Alireza R.; Olson, Steven T.			Engineering Functional Antithrombin Exosites in alpha(1)-Proteinase Inhibitor That Specifically Promote the Inhibition of Factor Xa and Factor IXa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-ACTIVATED ANTITHROMBIN; AUTOLYSIS LOOP; ALPHA-1-PROTEINASE INHIBITOR; COAGULATION PROTEASES; PLASMINOGEN-ACTIVATOR; ALLOSTERIC MECHANISM; SERINE PROTEINASES; RAPID INHIBITION; TERNARY COMPLEX; BASIC RESIDUES	We have previously shown that residues Tyr-253 and Glu-255 in the serpin antithrombin function as exosites to promote the inhibition of factor Xa and factor IXa when the serpin is conformationally activated by heparin. Here we show that functional exosites can be engineered at homologous positions in a P1 Arg variant of the serpin alpha(1)-proteinase inhibitor (alpha 1PI) that does not require heparin for activation. The combined effect of the two exosites increased the association rate constant for the reactions of alpha 1PI with factors Xa and IXa 11-14-fold, comparable with their rate-enhancing effects on the reactions of heparin-activated antithrombin with these proteases. The effects of the engineered exosites were specific, alpha 1PI inhibitor reactions with trypsin and thrombin being unaffected. Mutation of Arg-150 in factor Xa, which interacts with the exosite residues in heparin-activated antithrombin, abrogated the ability of the engineered exosites in alpha 1PI to promote factor Xa inhibition. Binding studies showed that the exosites enhance the Michaelis complex interaction of alpha 1PI with S195A factor Xa as they do with the heparin-activated antithrombin interaction. Replacement of the P4-P2 AIP reactive loop residues in the alpha 1PI exosite variant with a preferred IEG substrate sequence for factor Xa modestly enhanced the reactivity of the exosite mutant inhibitor with factor Xa by similar to 2-fold but greatly increased the selectivity of alpha 1PI for inhibiting factor Xa over thrombin by similar to 1000-fold. Together, these results show that a specific and selective inhibitor of factor Xa can be engineered by incorporating factor Xa exosite and reactive site recognition determinants in a serpin.	[Izaguirre, Gonzalo] Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Rezaie, Alireza R.] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Saint Louis University	Izaguirre, G (corresponding author), Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, 801 S Paulina St,Rm 530C, Chicago, IL 60612 USA.	goniza@uic.edu			National Institutes of Health [HL39888, HL62565]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL39888 (to S.T.O.) and HL62565 (to A.R.R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AKO H, 1972, BIOCHEM BIOPH RES CO, V47, P1402, DOI 10.1016/0006-291X(72)90228-8; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; KWON KS, 1995, BBA-PROTEIN STRUCT M, V1247, P179, DOI 10.1016/0167-4838(94)00224-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langdown J, 2004, J BIOL CHEM, V279, P47288, DOI 10.1074/jbc.M408961200; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; OLSON ST, 1995, J BIOL CHEM, V270, P30007; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P331, DOI 10.1016/S1050-1738(02)00183-4; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PANNELL R, 1974, BIOCHEMISTRY-US, V13, P5439, DOI 10.1021/bi00723a031; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P5324, DOI 10.1021/bi060056r; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; Stratikos E, 1998, J BIOL CHEM, V273, P15582, DOI 10.1074/jbc.273.25.15582; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; TRAVIS J, 1986, BIOL CHEM H-S, V367, P853, DOI 10.1515/bchm3.1986.367.2.853; Yang LK, 2003, J BIOL CHEM, V278, P25032, DOI 10.1074/jbc.M302174200; Yang LK, 2004, BLOOD, V104, P1753, DOI 10.1182/blood-2004-03-1092; YUNG BY, 1975, BIOCHEM BIOPH RES CO, V65, P927, DOI 10.1016/S0006-291X(75)80474-8	38	14	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1550	1558		10.1074/jbc.M807340200	http://dx.doi.org/10.1074/jbc.M807340200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19010776	Green Published, hybrid			2022-12-27	WOS:000262330100023
J	Makharashvili, N; Mi, T; Koroleva, O; Korolev, S				Makharashvili, Nodar; Mi, Tian; Koroleva, Olga; Korolev, Sergey			RecR-mediated Modulation of RecF Dimer Specificity for Single- and Double-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RECF; ARRESTED REPLICATION FORKS; ATP-BINDING; HOMOLOGOUS RECOMBINATION; GENETIC-RECOMBINATION; CRYSTAL-STRUCTURE; ACTIVE-SITE; GAPPED DNA; ABC ATPASE; PROTEIN	RecF pathway proteins play an important role in the restart of stalled replication and DNA repair in prokaryotes. Following DNA damage, RecF, RecR, and RecO initiate homologous recombination ( HR) by loading of the RecA recombinase on single-stranded ( ss) DNA, protected by ssDNA-binding protein. The specific role of RecF in this process is not well understood. Previous studies have proposed that RecF directs the RecOR complex to boundaries of damaged DNA regions by recognizing single-stranded/double-stranded ( ss/ds) DNA junctions. RecF belongs to ABC-type ATPases, which function through an ATP-dependent dimerization. Here, we demonstrate that the RecF of Deinococcus radio-durans interacts with DNA as an ATP-dependent dimer, and that the DNA binding and ATPase activity of RecF depend on both the structure of DNA substrate, and the presence of RecR. We found that RecR interacts as a tetramer with the RecF dimer. RecR increases the RecF affinity to dsDNA without stimulating ATP hydrolysis but destabilizes RecF binding to ssDNA and dimerization, likely due to increasing the ATPase rate. The DNA-dependent binding of RecR to the RecF-DNA complex occurs through specific protein-protein interactions without significant contributions from RecR-DNA interactions. Finally, RecF neither alone nor in complex with RecR preferentially binds to the ss/dsDNA junction. Our data suggest that the specificity of the RecFOR complex toward the boundaries of DNA damaged regions may result from a network of protein-protein and DNA-protein interactions, rather than a simple recognition of the ss/dsDNA junction by RecF.	[Makharashvili, Nodar; Mi, Tian; Koroleva, Olga; Korolev, Sergey] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Korolev, S (corresponding author), DRC 551,1100 S Grand Blvd, St Louis, MO 63104 USA.	korolevs@slu.edu	Korolev, Sergey/ABA-7517-2020	Korolev, Sergey/0000-0001-9313-7126	National Institutes of Health [GM073837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073837. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ASAI T, 1994, J BACTERIOL, V176, P7113, DOI 10.1128/JB.176.22.7113-7114.1994; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bidnenko V, 1999, MOL MICROBIOL, V33, P846, DOI 10.1046/j.1365-2958.1999.01532.x; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Chow KH, 2004, J BIOL CHEM, V279, P3492, DOI 10.1074/jbc.M311012200; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 2001, P NATL ACAD SCI USA, V98, P8196, DOI 10.1073/pnas.121008898; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Harvey SH, 2002, GENOME BIOL, V3; Hegde SP, 1996, P NATL ACAD SCI USA, V93, P14468, DOI 10.1073/pnas.93.25.14468; Hegde SP, 1996, J BACTERIOL, V178, P184, DOI 10.1128/jb.178.1.184-190.1996; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Honda M, 2008, NUCLEIC ACIDS RES, V36, P5013, DOI 10.1093/nar/gkn471; Honda M, 2006, J BIOL CHEM, V281, P18549, DOI 10.1074/jbc.M512658200; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; Ivancic-Bace I, 2003, GENETICS, V163, P485; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; KOLODNER R, 1985, J BACTERIOL, V163, P1060, DOI 10.1128/JB.163.3.1060-1066.1985; Koroleva O, 2007, EMBO J, V26, P867, DOI 10.1038/sj.emboj.7601537; Kowalczykowski SC, 2005, NATURE, V433, P591, DOI 10.1038/433591a; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, GENE DEV, V13, P345, DOI 10.1101/gad.13.3.345; Lee BI, 2004, EMBO J, V23, P2029, DOI 10.1038/sj.emboj.7600222; Liu YH, 1998, J BACTERIOL, V180, P1766, DOI 10.1128/JB.180.7.1766-1770.1998; Lowe J, 2001, J MOL BIOL, V306, P25, DOI 10.1006/jmbi.2000.4379; Lusetti SL, 2006, MOL CELL, V21, P41, DOI 10.1016/j.molcel.2005.11.011; MADIRAJU MVVS, 1992, J BACTERIOL, V174, P7705, DOI 10.1128/JB.174.23.7705-7710.1992; MAHDI AA, 1989, MOL GEN GENET, V216, P503, DOI 10.1007/BF00334397; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mohaghegh P, 2001, HUM MOL GENET, V10, P741, DOI 10.1093/hmg/10.7.741; Moncalian G, 2004, J MOL BIOL, V335, P937, DOI 10.1016/j.jmb.2003.11.026; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; SANDLER SJ, 1994, J BACTERIOL, V176, P3661, DOI 10.1128/JB.176.12.3661-3672.1994; SANDLER SJ, 1992, NUCLEIC ACIDS RES, V20, P839, DOI 10.1093/nar/20.4.839; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; SMITH GR, 1988, MICROBIOL REV, V52, P1; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Timmins J, 2007, EMBO J, V26, P3260, DOI 10.1038/sj.emboj.7601760; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; WANG TCV, 1993, MUTAT RES, V294, P157, DOI 10.1016/0921-8777(93)90024-B; WANG TCV, 1984, J BACTERIOL, V158, P727, DOI 10.1128/JB.158.2.727-729.1984; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Webb BL, 1999, J BIOL CHEM, V274, P15367, DOI 10.1074/jbc.274.22.15367; Webb BL, 1995, J BIOL CHEM, V270, P31397, DOI 10.1074/jbc.270.52.31397; Xu GZ, 2008, J BACTERIOL, V190, P2624, DOI 10.1128/JB.01851-07; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200	61	17	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1425	1434		10.1074/jbc.M806378200	http://dx.doi.org/10.1074/jbc.M806378200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017635	hybrid, Green Published			2022-12-27	WOS:000262330100010
J	Pacheco, B; Maccarana, M; Goodlett, DR; Malmstrom, A; Malmstrom, L				Pacheco, Benny; Maccarana, Marco; Goodlett, David R.; Malmstrom, Anders; Malmstrom, Lars			Identification of the Active Site of DS-epimerase 1 and Requirement of N-Glycosylation for Enzyme Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DERMATAN SULFATE; LINKED OLIGOSACCHARIDES; MODIFYING ENZYMES; MECHANISM; BIOSYNTHESIS; LYASE; ALIGNMENTS; RESOLUTION; SUBSTRATE	Dermatan sulfate is a highly sulfated polysaccharide and has a variety of biological functions in development and disease. Iduronic acid domains in dermatan sulfate, which are formed by the action of two DS-epimerases, have a key role in mediating these functions. We have identified the catalytic site and three putative catalytic residues in DS-epimerase 1, His-205, Tyr-261, and His-450, by tertiary structure modeling and amino acid conservation to heparinase II. These residues were systematically mutated to alanine or more conserved residues, which resulted in complete loss of epimerase activity. Based on these data and the close relationship between lyase and epimerase reactions, we propose a model where His-450 functions as a general base abstracting the C5 proton from glucuronic acid. Subsequent cleavage of the glycosidic linkage by Tyr-261 generates a 4,5-unsaturated hexuronic intermediate, which is protonated at the C5 carbon by His-205 from the side of the sugar plane opposite to the side of previous proton abstraction. Concomitant recreation of the glycosidic linkage ends the reaction, generating iduronic acid. In addition, we show that proper N-glycosylation of DS-epimerase 1 is required for enzyme activity. This study represents the first description of the structural basis for epimerization by a glycosaminoglycan epimerase.	[Pacheco, Benny; Maccarana, Marco; Malmstrom, Anders] Lund Univ, Dept Expt Med Sci, Biomed Ctr D12, SE-22184 Lund, Sweden; [Goodlett, David R.; Malmstrom, Lars] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	Lund University; University of Washington; University of Washington Seattle	Pacheco, B (corresponding author), Lund Univ, Dept Expt Med Sci, Biomed Ctr D12, Tornavagen 10, SE-22184 Lund, Sweden.	benny.pacheco@med.lu.se	Malmström, Lars/R-4991-2019; maccarana, marco/AAB-4764-2021	Malmström, Lars/0000-0001-9885-9312; Maccarana, Marco/0000-0003-3549-8921; Malmstrom, Anders/0000-0002-6691-146X	Swedish Research Council; Greta and Johan Kock Foundation; Osterlund Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock Foundation; Osterlund Foundation	This work was supported by the Swedish Research Council, the Greta and Johan Kock Foundation, and the Osterlund Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; FRANSSON LA, 1982, J BIOL CHEM, V257, P6333; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hannesson HH, 1996, BIOCHEM J, V313, P589, DOI 10.1042/bj3130589; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jaroszewski L, 2000, PROTEIN SCI, V9, P1487, DOI 10.1110/ps.9.8.1487; Jerga A, 2006, BIOCHEMISTRY-US, V45, P9138, DOI 10.1021/bi060748f; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Malmstrom L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-158; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; Misura KMS, 2006, P NATL ACAD SCI USA, V103, P5361, DOI 10.1073/pnas.0509355103; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Shaya D, 2008, GLYCOBIOLOGY, V18, P270, DOI 10.1093/glycob/cwn002; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Tiedemann K, 2005, GLYCOBIOLOGY, V15, P1277, DOI 10.1093/glycob/cwj027; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Wheeler DL, 2004, NUCLEIC ACIDS RES, V32, pD35, DOI 10.1093/nar/gkh073; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Yusa A, 2005, BIOCHEM J, V388, P115, DOI 10.1042/BJ20041573; Yusa A, 2006, J BIOL CHEM, V281, P20393, DOI 10.1074/jbc.M600140200	29	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1741	1747		10.1074/jbc.M805479200	http://dx.doi.org/10.1074/jbc.M805479200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19004833	hybrid			2022-12-27	WOS:000262330100044
J	Virtanen, C; Paris, J; Takahashi, M				Virtanen, Carl; Paris, James; Takahashi, Mark			Identification and Characterization of a Novel Gene, dapr, Involved in Skeletal Muscle Differentiation and Protein Kinase B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLAYS; GSK3; AKT	The phosphatidylinositol 3-kinase (PI3K) signaling pathway has been associated with a variety of cellular functions ranging from cell cycle regulation to tissue development. Although years of research have extensively characterized this signaling pathway, little is known as to how specific cellular events are coordinated by its activation. Here we demonstrate that Dapr (differentiation-associated protein), a novel protein, appears to focus one aspect of this pathway by acting as a putative scaffold protein during skeletal muscle differentiation. We present for the first time a description of this protein using in silico analysis. dapr was discovered through a previous study employing chromatin immunoprecipitation and CpG microarray analysis experiments as being regulated by myocyte-enhancing factor 2, a key transcription factor involved in the differentiation of skeletal muscle tissue. In this study we show that during the course of differentiation, Dapr binds to the PI3K signaling pathway member protein kinase B (PKB). In C2C12 myoblast cells before differentiation Dapr is localized to the cytosol, migrating with PKB to the membrane after initiation of muscle differentiation. Knockdown of Dapr by RNAi resulted in inhibition of myotube formation. Our findings indicate that Dapr is a key component required by myoblasts for orchestrating their differentiation during myogenesis. Furthermore, it appears that Dapr is involved in the PI3K signaling cascade, potentially acting as a scaffold protein for PKB	[Virtanen, Carl; Paris, James; Takahashi, Mark] Univ Hlth Network Microarray Ctr, Toronto, ON M5G 1L7, Canada	University of Toronto; University Health Network Toronto	Takahashi, M (corresponding author), MaRS Ctr, Univ Hlth Microarray Ctr 21, Toronto Med Discovery Tower,101 Coll St 9-301, Toronto, ON M5G 1L7, Canada.	markt@uhnresearch.ca			Genome Canada and the Ontario Research Fund	Genome Canada and the Ontario Research Fund	This work was funded in part by Genome Canada and the Ontario Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Coffer PJ, 1998, BIOCHEM J, V335, P1; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Galvin CD, 2003, MOL CELL ENDOCRINOL, V200, P19, DOI 10.1016/S0303-7207(02)00420-3; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Kaneko S, 2002, J BIOL CHEM, V277, P23230, DOI 10.1074/jbc.M201733200; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Paris J, 2004, PHYSIOL GENOMICS, V20, P143, DOI 10.1152/physiolgenomics.00149.2004; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Tamir Y, 2000, J BIOL CHEM, V275, P34424, DOI 10.1074/jbc.M005815200; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; Vandromme M, 2001, J BIOL CHEM, V276, P8173, DOI 10.1074/jbc.M005587200; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158	27	3	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1636	1643		10.1074/jbc.M807000200	http://dx.doi.org/10.1074/jbc.M807000200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028694	hybrid			2022-12-27	WOS:000262330100032
J	Yu, Q; Kuzmiak, H; Zou, YF; Olsen, L; Defossez, PA; Bi, X				Yu, Qun; Kuzmiak, Holly; Zou, Yanfei; Olsen, Lars; Defossez, Pierre-Antoine; Bi, Xin			Saccharomyces cerevisiae Linker Histone Hho1p Functionally Interacts with Core Histone H4 and Negatively Regulates the Establishment of Transcriptionally Silent Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; TELOMERIC HETEROCHROMATIN; DNA-REPLICATION; GENE ACTIVATION; HOMOLOG HHO1P; YEAST; H1; RECOMBINATION; INHERITANCE; EXPRESSION	Saccharomyces cerevisiae linker histone Hho1p is not essential for cell viability, and very little is known about its function in vivo. We show that deletion of HHO1 (hho1 Delta) suppresses the defect in transcriptional silencing caused by a mutation in the globular domain of histone H4. hho1 Delta also suppresses the reduction in HML silencing by the deletion of SIR1 that is involved in the establishment of silent chromatin at HML. We further show that hho1 Delta suppresses changes in silent chromatin structure caused by the histone H4 mutation and sir1 Delta. These results suggest that HHO1 plays a negative role in transcriptionally silent chromatin. We also provide evidence that Hho1p hinders the de novo establishment of silent chromatin but does not affect the stability of preexistent silent chromatin. Unlike canonical linker histones in higher eukaryotes that have a single conserved globular domain, Hho1p possesses two globular domains. We show that the carboxyl-terminal globular domain of Hho1p is dispensable for its function, suggesting that the mode of Hho1p action is similar to that of canonical linker histones.	[Yu, Qun; Kuzmiak, Holly; Zou, Yanfei; Olsen, Lars; Bi, Xin] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Defossez, Pierre-Antoine] CNRS, UMR218, Inst Curie, Sect Rech, F-75248 Paris, France	University of Rochester; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Bi, X (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	xinbi@mail.rochester.edu		Defossez, Pierre-Antoine/0000-0002-6463-9263	National Institutes of Health [GM62484]; Centre National de la Recherche Scientifique Programme Action Thematique et Incitative sur Programme; Fondation pour la Recherche Medicale; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique Programme Action Thematique et Incitative sur Programme(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62484 ( to X. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by Centre National de la Recherche Scientifique Programme Action Thematique et Incitative sur Programme and by Fondation pour la Recherche Medicale.	Ali T, 2004, J MOL BIOL, V338, P139, DOI 10.1016/j.jmb.2004.02.046; Ali T, 2004, J MOL BIOL, V337, P1123, DOI 10.1016/j.jmb.2004.02.029; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; Chiu YH, 2003, GENETICS, V165, P115; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Escher D, 1997, MOL GEN GENET, V256, P456, DOI 10.1007/s004380050589; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Freidkin I, 2001, NUCLEIC ACIDS RES, V29, P4043, DOI 10.1093/nar/29.19.4043; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1842; HANNON R, 1984, J MOL BIOL, V180, P131, DOI 10.1016/0022-2836(84)90434-0; Harvey AC, 2004, MOL MICROBIOL, V53, P771, DOI 10.1111/j.1365-2958.2004.04195.x; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hellauer K, 2001, J BIOL CHEM, V276, P13587, DOI 10.1074/jbc.M011196200; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Landsman D, 1996, TRENDS BIOCHEM SCI, V21, P287, DOI 10.1016/S0968-0004(96)30030-3; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Li CH, 2008, MOL MICROBIOL, V67, P906, DOI 10.1111/j.1365-2958.2007.06101.x; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Ono K, 2003, NUCLEIC ACIDS RES, V31, P7199, DOI 10.1093/nar/gkg931; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; RODRIGUEZCAMPOS A, 1989, J MOL BIOL, V209, P135, DOI 10.1016/0022-2836(89)90177-0; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SHIMAMURA A, 1989, MOL CELL BIOL, V9, P5573, DOI 10.1128/MCB.9.12.5573; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Ushinsky SC, 1997, YEAST, V13, P151, DOI 10.1002/(SICI)1097-0061(199702)13:2<151::AID-YEA94>3.0.CO;2-5; Van Leeuwen F, 2002, METHOD ENZYMOL, V350, P165, DOI 10.1016/S0076-6879(02)50962-9; Veron M, 2006, GENETICS, V173, P579, DOI 10.1534/genetics.105.050195; VOLKERT FC, 1986, CELL, V46, P541, DOI 10.1016/0092-8674(86)90879-2; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Xu EY, 2005, MOL CELL BIOL, V25, P1846, DOI 10.1128/MCB.25.5.1846-1859.2005; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Zou YF, 2008, NUCLEIC ACIDS RES, V36, P5189, DOI 10.1093/nar/gkn465; Zou YF, 2006, GENETICS, V174, P203, DOI 10.1534/genetics.106.055525	49	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					740	750		10.1074/jbc.M806274200	http://dx.doi.org/10.1074/jbc.M806274200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19017647	Green Published, hybrid			2022-12-27	WOS:000262122900007
J	Garneau, L; Klein, H; Banderali, U; Longpre-Lauzon, A; Parent, L; Sauve, R				Garneau, Line; Klein, Helene; Banderali, Umberto; Longpre-Lauzon, Ariane; Parent, Lucie; Sauve, Remy			Hydrophobic Interactions as Key Determinants to the KCa3.1 Channel Closed Configuration AN ANALYSIS OF KCa3.1 MUTANTS CONSTITUTIVELY ACTIVE IN ZERO Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; NUCLEOTIDE-GATED CHANNELS; POTASSIUM CHANNEL; ACTIVATION GATE; GATING DOMAIN; SMOOTH-MUSCLE; IONIC-RADII; CONDUCTANCE; PORE; CANCER	In this study we present evidence that residue Val(282) in the S6 transmembrane segment of the calcium-activated KCa3.1 channel constitutes a key determinant of channel gating. A Gly scan of the S6 transmembrane segment first revealed that the substitutions A279G and V282G cause the channel to become constitutively active in zero Ca2+. Constitutive activity was not observed when residues extending from Cys(276) to Ala(286), other than Ala(279) and Val(282), were substituted to Gly. The accessibility of Cys engineered at Val(275) deep in the channel cavity was next investigated for the ion-conducting V275C/V282G mutant and closed V275C channel in zero Ca2+ using Ag+ as probe. These experiments demonstrated that internal Ag+ ions have free access to the channel cavity independently of the channel conducting state, arguing against an activation gate located at the S6 segment C-terminal end. Experiments were also conducted where Val(282) was substituted by residues differing in size and/or hydrophobicity. We found a strong correlation between constitutive activity in zero Ca2+ and the hydrophobic energy for side chain burial. Single channel recordings showed finally that constitutive activation in zero Ca2+ is better explained by a model where the channel is locked in a low conducting state with a high open probability rather than resulting from a change in the open/closed energy balance that would favor channel openings to a full conducting state in the absence of Ca2+. We conclude that hydrophobic interactions involving Val(282) constitute key determinants to KCa3.1 gating by modulating the ion conducting state of the selectivity filter through an effect on the S6 transmembrane segment.	[Garneau, Line; Klein, Helene; Banderali, Umberto; Longpre-Lauzon, Ariane; Parent, Lucie; Sauve, Remy] Univ Montreal, Dept Physiol, Grp Etud Prot Membranaires, Fac Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sauve, R (corresponding author), Univ Montreal, Dept Physiol, Grp Etud Prot Membranaires, Fac Med, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	remy.sauve@umontreal.ca	Banderali, Umberto/AAW-2463-2021		Canadian Institutes of Health Research [MOP 7769]; Canadian Cystic Fibrosis Foundation; Canadian Heart & Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cystic Fibrosis Foundation; Canadian Heart & Stroke Foundation(Heart & Stroke Foundation of Canada)	This work was supported by grants from the Canadian Institutes of Health Research (MOP 7769), from the Canadian Cystic Fibrosis Foundation and from the Canadian Heart & Stroke Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Banderali U, 2004, J GEN PHYSIOL, V124, P333, DOI 10.1085/jgp.200409145; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BENZAQUEN LR, 1995, NAT MED, V1, P534, DOI 10.1038/nm0695-534; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Bruening-Wright A, 2002, J NEUROSCI, V22, P6499; Bruening-Wright A, 2007, J GEN PHYSIOL, V130, P601, DOI 10.1085/jgp.200709828; Choe H, 2000, J GEN PHYSIOL, V115, P391, DOI 10.1085/jgp.115.4.391; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Ding SH, 2002, J GEN PHYSIOL, V120, P87, DOI 10.1085/jgp.20028611; Flynn GE, 2003, J GEN PHYSIOL, V121, P563, DOI 10.1085/jgp.200308819; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Klein H, 2007, J GEN PHYSIOL, V129, P299, DOI 10.1085/jgp.200609726; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003; Mauler F, 2004, EUR J NEUROSCI, V20, P1761, DOI 10.1111/j.1460-9568.2004.03615.x; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; SAUVE R, 1986, J MEMBRANE BIOL, V92, P269, DOI 10.1007/BF01869395; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Simoes M, 2002, J GEN PHYSIOL, V120, P99, DOI 10.1085/jgp.20028586; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Wang ZH, 2007, ONCOGENE, V26, P5107, DOI 10.1038/sj.onc.1210308; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zadek B, 2006, J GEN PHYSIOL, V127, P673, DOI 10.1085/jgp.200609534; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	46	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					389	403		10.1074/jbc.M805700200	http://dx.doi.org/10.1074/jbc.M805700200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18996847	hybrid			2022-12-27	WOS:000261974800044
J	Hsu, YH; Johnson, DA; Traugh, JA				Hsu, Yuan-Hao; Johnson, David A.; Traugh, Jolinda A.			Analysis of Conformational Changes during Activation of Protein Kinase Pak2 by Amide Hydrogen/Deuterium Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-PAK; CRYSTAL-STRUCTURES; HYDROGEN-EXCHANGE; CATALYTIC SUBUNIT; ALPHA-PAK; CDC42; PHOSPHORYLATION; AUTOPHOSPHORYLATION; MECHANISM; PAK2/GAMMA-PAK	During apoptotic stress, protein kinase Pak2 is cleaved by caspase 3 to form a heterotetramer that is constitutively activated following autophosphorylation. The active protein kinase migrates slightly slower than the inactive holoenzyme when analyzed by gel filtration, suggesting an expanded conformation. Activation of Pak2 comprises a series of structural changes resulting from caspase cleavage, ATP binding, and autophosphorylation of Pak2. Changes at each step were individually analyzed by amide hydrogen/deuterium exchange coupled with mass spectrometry and compared with inactive Pak2. The auto-inhibited form was shown to bind ATP in the active site, with minor changes in the glycine loop and the autoinhibitory domain (AID). Caspase cleavage produced significant changes in solvent accessibility in the AID and upper lobe of the catalytic domain. Cleavage of ATP-bound Pak2 relaxes the allosteric inhibition, as shown by increased solvent accessibility in the upper and lower lobes, including the G-helix, facilitating the autophosphorylation of two sites required for activation, Ser-141 in the regulatory domain and Thr-402 in the catalytic domain. Autophosphorylation increased the amide hydrogen/deuterium exchange solvent accessibility of the contact region between the AID and the G-helix, the E-F loop, and the N terminus. Thus, activation of Pak2 via caspase cleavage is associated with structural relaxation of Pak2 that allows for complete autophosphorylation, resulting in a more comprehensive solvent-exposed and conformationally dynamic enzyme.	[Hsu, Yuan-Hao; Traugh, Jolinda A.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Johnson, David A.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Traugh, JA (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	jolinda.traugh@ucr.edu	hsu, yuan-hao/B-5744-2009		National Institutes of Health [GM26738]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM26738 (to J. A. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Hoofnagle AN, 2001, P NATL ACAD SCI USA, V98, P956, DOI 10.1073/pnas.98.3.956; Huang ZD, 2004, MOL CELL BIOL, V24, P1582, DOI 10.1128/MCB.24.4.1582-1594.2004; Huang ZD, 2003, J BIOL CHEM, V278, P13101, DOI 10.1074/jbc.M212557200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; Jung JH, 2005, J BIOL CHEM, V280, P40025, DOI 10.1074/jbc.M509075200; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; Miah SMS, 2004, MOL CELL BIOL, V24, P71, DOI 10.1128/MCB.24.1.71-83.2004; OETTING WS, 1986, J BIOL CHEM, V261, P1649; Orton KC, 2004, J BIOL CHEM, V279, P38649, DOI 10.1074/jbc.M407337200; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pirruccello M, 2006, J MOL BIOL, V361, P312, DOI 10.1016/j.jmb.2006.06.017; Roig J, 2000, J BIOL CHEM, V275, P16933, DOI 10.1074/jbc.M001627200; Roig J, 2001, VITAM HORM, V62, P167, DOI 10.1016/S0083-6729(01)62004-1; Roig J, 2000, P NATL ACAD SCI USA, V97, P14346, DOI 10.1073/pnas.97.26.14346; Roig J, 1999, J BIOL CHEM, V274, P31119, DOI 10.1074/jbc.274.44.31119; Tu H, 1999, MOL CELL BIOL, V19, P602; TUAZON PT, 1989, J BIOL CHEM, V264, P2773; Tuazon PT, 1997, BIOCHEMISTRY-US, V36, P16059, DOI 10.1021/bi9717845; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Wu H, 2003, BIOCHEMISTRY-US, V42, P1129, DOI 10.1021/bi026857l; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	35	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36397	36405		10.1074/jbc.M805581200	http://dx.doi.org/10.1074/jbc.M805581200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984590	Green Published, hybrid			2022-12-27	WOS:000261840500037
J	Yamaguchi, M; Terao, Y; Mori, Y; Hamada, S; Kawabata, S				Yamaguchi, Masaya; Terao, Yutaka; Mori, Yuka; Hamada, Shigeyuki; Kawabata, Shigetada			PfbA, a Novel Plasmin- and Fibronectin-binding Protein of Streptococcus pneumoniae, Contributes to Fibronectin-dependent Adhesion and Antiphagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCAL SURFACE PROTEIN; COMMUNITY-ACQUIRED PNEUMONIA; GROUP-A STREPTOCOCCI; EPITHELIAL-CELLS; VIRULENCE FACTORS; FACTOR-H; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BACTERIAL PATHOGENS; PYOGENES CHALLENGE; SEQUENCE-ANALYSIS	Streptococcus pneumoniae is a major causative agent of mortality throughout the world. The initial event in invasive pneumococcal disease is the attachment of pneumococci to epithelial cells in the upper respiratory tract. Several bacterial proteins can bind to host extracellular matrix proteins and function as adhesins and invasins. To identify adhesins or invasins on the pneumococcal cell surface, we searched for several proteins with an LPXTG anchoring motif in the whole-genome sequence of Streptococcus pneumoniae and identified one, which we called PfbA ((p) under bar lasmin- and (f) under bar ibronectin-(b) under bar inding (p) under bar rotein (A) under bar), that bound to human serum proteins. Immunofluorescence microscopy and fluorescence-activated cell sorter analysis revealed that PfbA was expressed on the pneumococcal cell surface. A Delta pfbA mutant strain was only half as competent as the wild-type strain at adhering to and invading lung and laryngeal epithelial cells. In addition, epithelial cells infected with Delta pfbA showed morphological changes, including cell flattening and a loss of microvilli, that did not occur in cells infected with the wild-type strain. The mutant strain also exhibited a weaker antiphagocytotic activity than wild type in human peripheral blood. Moreover, the growth of wild-type bacteria in human whole blood containing anti-PfbA antibodies was reduced by similar to 50% after 3 h compared with its growth without the antibody. These results suggest that PfbA is an important factor in the development of pneumococcal infections.	[Yamaguchi, Masaya; Terao, Yutaka; Mori, Yuka; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka 5650871, Japan; [Hamada, Shigeyuki] Nihon Univ, Adv Res Inst Sci & Humanities, Dept Life Sci, Tokyo 1028251, Japan	Osaka University; Nihon University	Kawabata, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp	Yamaguchi, Masaya/I-8156-2019	Yamaguchi, Masaya/0000-0001-6218-7112; Terao, Yutaka/0000-0002-4450-5583	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science (JSPS); Naito Foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation)	This study was supported in part by a grants-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, grants-in-aid for Scientific Research (B), by the Japan Society for the Promotion of Science (JSPS) Fellows from JSPS, and by grants from the Naito Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; BADDOUR LM, 1994, INFECT IMMUN, V62, P2143, DOI 10.1128/IAI.62.6.2143-2148.1994; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Berry AM, 1996, INFECT IMMUN, V64, P5255, DOI 10.1128/IAI.64.12.5255-5262.1996; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Bumbaca D, 2004, OMICS, V8, P341, DOI 10.1089/omi.2004.8.341; Bumbaca D, 2007, PROTEINS, V66, P547, DOI 10.1002/prot.21205; Butler JC, 1996, J INFECT DIS, V174, P986, DOI 10.1093/infdis/174.5.986; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Dinkla K, 2003, MOL MICROBIOL, V47, P861, DOI 10.1046/j.1365-2958.2003.03352.x; Dintilhac A, 1997, MOL MICROBIOL, V25, P727, DOI 10.1046/j.1365-2958.1997.5111879.x; Duthy TG, 2002, INFECT IMMUN, V70, P5604, DOI 10.1128/IAI.70.10.5604-5611.2002; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Gutierrez F, 2006, J INFECTION, V53, P166, DOI 10.1016/j.jinf.2005.11.006; Guzman CA, 1999, J INFECT DIS, V179, P901, DOI 10.1086/314655; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hammerschmidt S, 1999, INFECT IMMUN, V67, P1683; HASTY DL, 1992, INFECT IMMUN, V60, P2147, DOI 10.1128/IAI.60.6.2147-2152.1992; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hermans PWM, 2006, J BIOL CHEM, V281, P968, DOI 10.1074/jbc.M510014200; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Hyland KA, 2007, INFECT IMMUN, V75, P3188, DOI 10.1128/IAI.01745-06; Iannelli F, 2004, INFECT IMMUN, V72, P3077, DOI 10.1128/IAI.72.5.3077-3080.2004; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jedrzejas MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P891, DOI 10.2741/1299; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Kawabata S, 2001, INFECT IMMUN, V69, P924, DOI 10.1128/IAI.69.2.924-930.2001; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; Molinari G, 2000, CELL MICROBIOL, V2, P145, DOI 10.1046/j.1462-5822.2000.00040.x; Molinari G, 1997, INFECT IMMUN, V65, P1357, DOI 10.1128/IAI.65.4.1357-1363.1997; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; Oishi K, 2006, RESPIROLOGY, V11, P429, DOI 10.1111/j.1440-1843.2006.00867.x; Okada N, 1997, J BIOL CHEM, V272, P26978, DOI 10.1074/jbc.272.43.26978; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pandiripally V, 2003, INFECT IMMUN, V71, P7119, DOI 10.1128/IAI.71.12.7119-7128.2003; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Rigden DJ, 2003, CRIT REV BIOCHEM MOL, V38, P143, DOI 10.1080/713609215; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Schroder A, 2006, MOL BIOL CELL, V17, P5198, DOI 10.1091/mbc.E06-05-0463; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Shaper M, 2004, INFECT IMMUN, V72, P5031, DOI 10.1128/IAI.72.9.5031-5040.2004; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Suzuki N, 2005, J CLIN MICROBIOL, V43, P4528, DOI 10.1128/JCM.43.9.4528-4534.2005; Talay Susanne R., 2005, V12, P90, DOI 10.1159/000081691; Terao Y, 2005, J INFECT DIS, V192, P2081, DOI 10.1086/498162; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; VANDERFLIER M, 1995, INFECT IMMUN, V63, P4317, DOI 10.1128/IAI.63.11.4317-4322.1995; Voyich JM, 2004, MICROBES INFECT, V6, P1117, DOI 10.1016/j.micinf.2004.05.022; Wang BN, 2006, CELL MICROBIOL, V8, P257, DOI 10.1111/j.1462-5822.2005.00618.x; WESSELS MR, 1994, INFECT IMMUN, V62, P433, DOI 10.1128/IAI.62.2.433-441.1994; Yamaguchi M, 2006, MICROBES INFECT, V8, P2791, DOI 10.1016/j.micinf.2006.08.010; YOTHER J, 1992, J BACTERIOL, V174, P601, DOI 10.1128/jb.174.2.601-609.1992; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	64	72	74	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36272	36279		10.1074/jbc.M807087200	http://dx.doi.org/10.1074/jbc.M807087200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974092	Green Published, hybrid			2022-12-27	WOS:000261840500023
J	Liang, D; Nunes-Tavares, N; Xie, HQ; Carvalho, S; Bon, S; Massoulie, J				Liang, Dong; Nunes-Tavares, Nilson; Xie, Heidi Q.; Carvalho, Stephanie; Bon, Suzanne; Massoulie, Jean			Protein CutA Undergoes an Unusual Transfer into the Secretory Pathway and Affects the Folding, Oligomerization, and Secretion of Acetylcholinesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL T-PEPTIDE; BOVINE CAUDATE-NUCLEUS; QUATERNARY ASSOCIATIONS; MEMBRANE ANCHOR; MOLECULAR-FORMS; COLLAGEN TAIL; HELA-CELLS; X-RAY; DEGRADATION; SUBUNIT	The mammalian protein CutA was first discovered in a search for the membrane anchor of mammalian brain acetylcholinesterase (AChE). It was co-purified with AChE, but it is distinct from the real transmembrane anchor protein, PRiMA. CutA is a ubiquitous trimeric protein, homologous to the bacterial CutA1 protein that belongs to an operon involved in resistance to divalent ions ("copper tolerance A"). The function of this protein in plants and animals is unknown, and several hypotheses concerning its subcellular localization have been proposed. We analyzed the expression and the subcellular localization of mouse CutA variants, starting at three in-frame ATG codons, in transfected COS cells. We show that CutA produces 20-kDa (H) and 15-kDa (L) components. The H component is transferred into the secretory pathway and secreted, without cleavage of a signal peptide, whereas the L component is mostly cytosolic. We show that expression of the longer CutA variant reduces the level of AChE, that this effect depends on the AChE C-terminal peptides, and probably results from misfolding. Surprisingly, CutA increased the secretion of a mutant possessing a KDEL motif at its C terminus; it also increased the formation of AChE homotetramers. We found no evidence for a direct interaction between CutA and AChE. The longer CutA variant seems to affect the processing and trafficking of secretory proteins, whereas the shorter one may have a distinct function in the cytoplasm.	[Liang, Dong; Nunes-Tavares, Nilson; Xie, Heidi Q.; Carvalho, Stephanie; Bon, Suzanne; Massoulie, Jean] CNRS, Ecole Normale Super, UMR 8544, Neurobiol Lab, F-75005 Paris, France; [Liang, Dong] E China Normal Univ, Shanghai Inst Brain Funct Genom, Minist Educ & Sci & Technol Commiss Shanghai Muni, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China; [Nunes-Tavares, Nilson] Ctr Univ Zona Oeste UEZO, BR-21941590 Rio De Janeiro, Brazil; [Xie, Heidi Q.] Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); East China Normal University; Centro Universitario Estadual da Zona Oeste; Hong Kong University of Science & Technology	Massoulie, J (corresponding author), CNRS, Ecole Normale Super, UMR 8544, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	jean.massoulie@biologie.ens.fr			CNRS; Ecole Normale Superieure; Association Francais Contre les Myopathies; Direction Generale de l'Armement; Defense Threat Reduction Agency	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure; Association Francais Contre les Myopathies(Association Francaise contre les Myopathies); Direction Generale de l'Armement; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by grants from CNRS, Ecole Normale Superieure, Association Francais Contre les Myopathies, Direction Generale de l'Armement, and Defense Threat Reduction Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arnesano F, 2003, J BIOL CHEM, V278, P45999, DOI 10.1074/jbc.M304398200; Belbeoc'h S, 2004, EUR J BIOCHEM, V271, P1476, DOI 10.1111/j.1432-1033.2004.04052.x; Belbeoc'h S, 2003, EMBO J, V22, P3536, DOI 10.1093/emboj/cdg360; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Falasca C, 2005, J BIOL CHEM, V280, P878, DOI 10.1074/jbc.M409201200; FONG ST, 1995, MOL MICROBIOL, V15, P1127, DOI 10.1111/j.1365-2958.1995.tb02286.x; GENNARI K, 1987, J NEUROCHEM, V49, P12, DOI 10.1111/j.1471-4159.1987.tb03386.x; GRASSI J, 1982, J NEUROCHEM, V38, P457, DOI 10.1111/j.1471-4159.1982.tb08651.x; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; Lin CH, 2006, ACTA CRYSTALLOGR F, V62, P1113, DOI 10.1107/S1744309106039832; Massoulie J, 2008, CHEM-BIOL INTERACT, V175, P30, DOI 10.1016/j.cbi.2008.04.039; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Navaratnam DS, 2000, J NEUROCHEM, V74, P2146, DOI 10.1046/j.1471-4159.2000.0742146.x; Noureddine H, 2008, J BIOL CHEM, V283, P20722, DOI 10.1074/jbc.M801364200; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Savchenko A, 2004, PROTEINS, V54, P162, DOI 10.1002/prot.10585; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; TAKAYUKI N, 1993, Patent No. 1994056895; Tanaka Y, 2004, FEBS LETT, V556, P167, DOI 10.1016/S0014-5793(03)01402-9; Xu YB, 2001, EUR J BIOCHEM, V268, P2028, DOI 10.1046/j.1432-1327.2001.02074.x; Yang JC, 2008, ACTA BIOCHIM POL, V55, P411, DOI 10.18388/abp.2008_3089; Yang JC, 2009, MOL BIOL REP, V36, P63, DOI 10.1007/s11033-007-9152-9	31	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5195	5207		10.1074/jbc.M806260200	http://dx.doi.org/10.1074/jbc.M806260200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19049969	hybrid			2022-12-27	WOS:000263416600050
J	Katona, BW; Anant, S; Covey, DF; Stenson, WF				Katona, Bryson W.; Anant, Shrikant; Covey, Douglas F.; Stenson, William F.			Characterization of Enantiomeric Bile Acid-induced Apoptosis in Colon Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-INDUCED APOPTOSIS; ELECTRON-TRANSPORT CHAIN; DEOXYCHOLIC-ACID; HEPATOCYTE APOPTOSIS; PERMEABILITY TRANSITION; CASPASE-8 ACTIVATION; HEPATIC MITOCHONDRIA; INDUCED CYTOTOXICITY; LIVER-MITOCHONDRIA; OXIDATIVE STRESS	Bile acids are steroid detergents that are toxic to mammalian cells at high concentrations; increased exposure to these steroids is pertinent in the pathogenesis of cholestatic disease and colon cancer. Understanding the mechanisms of bile acid toxicity and apoptosis, which could include nonspecific detergent effects and/or specific receptor activation, has potential therapeutic significance. In this report we investigate the ability of synthetic enantiomers of lithocholic acid (ent-LCA), chenodeoxycholic acid (ent-CDCA), and deoxycholic acid (ent-DCA) to induce toxicity and apoptosis in HT-29 and HCT-116 cells. Natural bile acids were found to induce more apoptotic nuclear morphology, cause increased cellular detachment, and lead to greater capase-3 and -9 cleavage compared with enantiomeric bile acids in both cell lines. In contrast, natural and enantiomeric bile acids showed similar effects on cellular proliferation. These data show that bile acid-induced apoptosisin HT29 and HCT-116 cells is enantiospecific, hence correlated with the absolute configuration of the bile steroid rather than its detergent properties. The mechanism of LCA- and ent-LCA-induced apoptosis was also investigated in HT29 and HCT-116 cells. These bile acids differentially activate initiator caspases-2 and -8 and induce cleavage of full-length Bid. LCA and ent-LCA mediated apoptosis was inhibited by both pan-caspase and selective caspase-8 inhibitors, whereas a selective caspase-2 inhibitor provided no protection. LCA also induced increased CD95 localization to the plasma membrane and generated increased reactive oxygen species compared with ent-LCA. This suggests that LCA/ent-LCA induce apoptosis enantioselectively through CD95 activation, likely because of increased reactive oxygen species generation, with resulting procaspase-8 cleavage.	[Stenson, William F.] Washington Univ, Sch Med, Div Gastroenterol, Dept Med, St Louis, MO 63110 USA; [Katona, Bryson W.; Covey, Douglas F.] Washington Univ, Sch Med, Div Gastroenterol, Dept Dev Biol, St Louis, MO 63110 USA; [Anant, Shrikant] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA	Washington University (WUSTL); Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center	Stenson, WF (corresponding author), Washington Univ, Sch Med, Div Gastroenterol, Dept Med, Campus Box 8124,660 S Euclid Ave, St Louis, MO 63110 USA.	wstenson@im.wustl.edu	Anant, Shrikant/AAF-8020-2020	Katona, Bryson/0000-0001-8186-9119	National Institutes of Health [GM47969, 5-T32-HL07275, CA109269, DK33165]; NATIONAL CANCER INSTITUTE [R01CA109269] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033165, R37DK033165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM47969 ( to D. F. C.), 5-T32-HL07275 ( to B. W. K.), CA109269 ( to S. A.), and DK33165 ( to W. F. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alakoskela JM, 2008, LANGMUIR, V24, P830, DOI 10.1021/la702909q; Alakoskela JM, 2007, BBA-BIOMEMBRANES, V1768, P131, DOI 10.1016/j.bbamem.2006.07.011; Becker S, 2007, BIOL CHEM, V388, P185, DOI 10.1515/BC.2007.021; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Biellmann JF, 2003, CHEM REV, V103, P2019, DOI 10.1021/cr020071b; CHOW SC, 1995, FEBS LETT, V364, P134, DOI 10.1016/0014-5793(95)00370-O; Debruyne PR, 2001, MUTAT RES-FUND MOL M, V480, P359, DOI 10.1016/S0027-5107(01)00195-6; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; FEARNHEAD HO, 1995, FEBS LETT, V375, P283, DOI 10.1016/0014-5793(95)01228-7; Goncalves A, 2000, BIOCHEM PHARMACOL, V60, P1579, DOI 10.1016/S0006-2952(00)00481-0; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Green PS, 2001, ENDOCRINOLOGY, V142, P400, DOI 10.1210/en.142.1.400; Gregoli PA, 1999, J CELL PHYSIOL, V178, P133, DOI 10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X; HAGUE A, 1995, INT J CANCER, V60, P400, DOI 10.1002/ijc.2910600322; Haza AI, 2000, NUTR CANCER, V36, P79, DOI 10.1207/S15327914NC3601_12; HEUMAN DM, 1995, ITAL J GASTROENTEROL, V27, P372; Higuchi H, 2003, AM J PHYSIOL-GASTR L, V284, pG734, DOI 10.1152/ajpgi.00491.2002; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; Iizaka Toru, 2007, Toxicology, V241, P146, DOI 10.1016/j.tox.2007.08.095; Jean-Louis S, 2006, J BIOL CHEM, V281, P14948, DOI 10.1074/jbc.M506710200; Katona BW, 2008, EUR J MED CHEM, V43, P107, DOI 10.1016/j.ejmech.2007.02.017; Katona BW, 2007, J ORG CHEM, V72, P9298, DOI 10.1021/jo701559q; Katona BW, 2007, J MED CHEM, V50, P6048, DOI 10.1021/jm0707931; Khosravi-Far R, 2004, CANCER BIOL THER, V3, P1051, DOI 10.4161/cbt.3.11.1173; KRAHENBUHL S, 1992, HEPATOLOGY, V15, P1160, DOI 10.1002/hep.1840150630; KRAHENBUHL S, 1994, HEPATOLOGY, V19, P471, DOI 10.1016/0270-9139(94)90027-2; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Milovic V, 2002, EUR J CLIN INVEST, V32, P29, DOI 10.1046/j.0014-2972.2001.00938.x; Oh SH, 2003, ARCH TOXICOL, V77, P110, DOI 10.1007/s00204-002-0415-x; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Park SE, 2004, INT J ONCOL, V25, P231; Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139; Payne CM, 2005, CELL BIOL TOXICOL, V21, P215, DOI 10.1007/s10565-005-0166-6; Powell AA, 2001, BIOCHEM J, V356, P481, DOI 10.1042/0264-6021:3560481; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; REDDY BS, 1975, CANCER, V36, P2401, DOI 10.1002/1097-0142(197512)36:6<2401::AID-CNCR2820360619>3.0.CO;2-O; REDDY BS, 1992, LIPIDS, V27, P807, DOI 10.1007/BF02535855; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Reinehr R, 2004, GASTROENTEROLOGY, V127, P1540, DOI 10.1053/j.gastro.2004.08.056; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Richter RK, 2004, BIOORG MED CHEM LETT, V14, P115, DOI 10.1016/j.bmcl.2003.10.018; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rolo AP, 2004, TOXICOL SCI, V79, P196, DOI 10.1093/toxsci/kfh078; Rolo AP, 2003, MITOCHONDRION, V2, P305, DOI 10.1016/S1567-7249(03)00007-2; SAGAWA H, 1993, AM J PHYSIOL, V264, pG835, DOI 10.1152/ajpgi.1993.264.5.G835; Schlottmann K, 2000, CANCER RES, V60, P4270; Scotti E, 2007, CELL MOL LIFE SCI, V64, P2477, DOI 10.1007/s00018-007-7280-y; Shiraki K, 2005, INT J MOL MED, V16, P729; Sodeman T, 2000, AM J PHYSIOL-GASTR L, V278, pG992, DOI 10.1152/ajpgi.2000.278.6.G992; Sokol RJ, 2001, PEDIATR RES, V49, P519, DOI 10.1203/00006450-200104000-00014; Sokol RJ, 2006, J PEDIATR GASTR NUTR, V43, pS4, DOI 10.1097/01.mpg.0000226384.71859.16; Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88; Sola S, 2002, CLIN SCI, V103, P475, DOI 10.1042/CS20020196; Strupp W, 2000, J MEMBRANE BIOL, V175, P181, DOI 10.1007/s002320001066; Takizawa T, 1999, MICROBIOL IMMUNOL, V43, P245, DOI 10.1111/j.1348-0421.1999.tb02400.x; Tan KP, 2007, MOL PHARMACOL, V72, P1380, DOI 10.1124/mol.107.039370; Thomas C, 2008, THYROID, V18, P167, DOI 10.1089/thy.2007.0255; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; Wachs FP, 2005, INT J COLORECTAL DIS, V20, P103, DOI 10.1007/s00384-004-0616-2; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; Yang JI, 2007, BIOCHEM BIOPH RES CO, V361, P156, DOI 10.1016/j.bbrc.2007.07.001; Yi KD, 2008, J PHARMACOL EXP THER, V324, P1188, DOI 10.1124/jpet.107.132308; Yui S, 2005, J BIOCHEM, V138, P151, DOI 10.1093/jb/mvi106	66	52	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3354	3364		10.1074/jbc.M805804200	http://dx.doi.org/10.1074/jbc.M805804200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054763	Green Published, hybrid			2022-12-27	WOS:000262700900078
J	Maity, P; Bindu, S; Dey, S; Goyal, M; Alam, A; Pal, C; Mitra, K; Bandyopadhyay, U				Maity, Pallab; Bindu, Samik; Dey, Sumanta; Goyal, Manish; Alam, Athar; Pal, Chinmay; Mitra, Kalyan; Bandyopadhyay, Uday			Indomethacin, a Non-steroidal Anti-inflammatory Drug, Develops Gastropathy by Inducing Reactive Oxygen Species-mediated Mitochondrial Pathology and Associated Apoptosis in Gastric Mucosa A NOVEL ROLE OF MITOCHONDRIAL ACONITASE OXIDATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; COMPLEX-III; IN-VITRO; INJURY; SUPEROXIDE; STRESS; PROLIFERATION; INVOLVEMENT; ACTIVATION; ISCHEMIA	We have investigated the role of mitochondria on the development of indomethacin (a non-steroidal anti-inflammatory drug)-induced gastric mucosal apoptosis and associated gas-tropathy in rat. Transmission electron microscopic studies indicate that indomethacin damages mitochondrial ultrastructure and causes mitochondrial dysfunction as evident from decreased stage-3 respiration, dehydrogenase activity, and transmembrane potential (Delta psi(m)). Mitochondrial pathology is associated with increased generation of intra-mitochondrial-reactive oxygen species, such as O-2(center dot-), H2O2 and center dot OH, leading to oxidative stress. O-2(center dot-) is the most effective to damage mitochondrial aconitase, leading to the release of iron from its iron-sulfur cluster. The released iron, by interacting with intra-mitochondrial H2O2, forms center dot OH. Immunoprecipitation of mitochondrial aconitase and subsequent Western immunoblotting indicate carbonylation of aconitase along with the loss of activity in vivo after indomethacin treatment. The release of iron has been documented by fluorescence imaging of mucosal cells by using Phen Green SK, a specific probe for chelatable iron. Interestingly, intra-mitochondrial center dot OH generation is crucial for the development of mitochondrial pathology and activation of mitochondrial death pathway by indomethacin. Scavenging of center dot OH by dimethyl sulfoxide or alpha-phenyl-n-tert-butylnitrone, a spin-trap, prevents indomethacin-induced mitochondrial ultrastructural changes, oxidative stress, collapse of Delta psi(m), and mitochondrial dysfunction. The scavengers also restore indomethacin-induced activation of caspase-9 and caspase-3 to block mitochondrial pathway of apoptosis and gastric mucosal damage. This study, thus, reveals the critical role of O-2(center dot-)-mediated mitochondrial aconitase inactivation to release intra-mitochondrial iron, which by generating center dot OH promotes gastric mucosal cell apoptosis and gastropathy during indomethacin treatment.	[Maity, Pallab; Bindu, Samik; Dey, Sumanta; Goyal, Manish; Alam, Athar; Pal, Chinmay; Bandyopadhyay, Uday] Indian Inst Chem Biol, Dept Infect Dis & Immunol, Kolkata 700032, W Bengal, India; [Mitra, Kalyan] Cent Drug Res Inst, Electron Microscopy Unit, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Bandyopadhyay, U (corresponding author), Indian Inst Chem Biol, Dept Infect Dis & Immunol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	ubandyo_1964@yahoo.com	Maity, Pallab/L-3896-2017; Goyal, Manish/O-2183-2015; Alam, Athar/B-3642-2010	Maity, Pallab/0000-0001-9769-3533; Goyal, Manish/0000-0003-2383-5409; Bindu, Samik/0000-0003-1416-2003	Council of Scientific and Industrial Research, New Delhi [SIP 0007]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research, New Delhi for providing funds through Suprainstitutional Project SIP 0007. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggarwal S, 2000, NEOPLASIA, V2, P346, DOI 10.1038/sj.neo.7900097; Andersson U, 1998, BIOCHEM BIOPH RES CO, V249, P512, DOI 10.1006/bbrc.1998.9171; BABBS CF, 1990, METHOD ENZYMOL, V186, P137; Bandyopadhyay U, 2002, LIFE SCI, V71, P2845, DOI 10.1016/S0024-3205(02)02143-4; Biswas K, 2003, J BIOL CHEM, V278, P10993, DOI 10.1074/jbc.M210328200; Cecarini V, 2007, BBA-MOL CELL RES, V1773, P93, DOI 10.1016/j.bbamcr.2006.08.039; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Chan JM, 2006, HEMATOL ONCOL CLIN N, V20, P797, DOI 10.1016/j.hoc.2006.03.002; Chang JK, 2006, TOXICOLOGY, V228, P111, DOI 10.1016/j.tox.2006.08.028; Chattopadhyay I, 2006, FREE RADICAL BIO MED, V40, P1397, DOI 10.1016/j.freeradbiomed.2005.12.016; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102; Chiou SK, 2005, GASTROENTEROLOGY, V128, P63, DOI 10.1053/j.gastro.2004.10.008; *CTR PUBL HLTH PRE, 2005, GRAD STUD EP RESP PR, P6; de Groot DJA, 2005, BRIT J CANCER, V92, P1459, DOI 10.1038/sj.bjc.6602516; Eli Y, 2001, BIOCHEM PHARMACOL, V61, P565, DOI 10.1016/S0006-2952(00)00578-5; Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7; Fujii Y, 2000, P SOC EXP BIOL MED, V224, P102, DOI 10.1046/j.1525-1373.2000.22407.x; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gu Q, 2005, CARCINOGENESIS, V26, P541, DOI 10.1093/carcin/bgh345; Guha M, 2007, J PINEAL RES, V43, P372, DOI 10.1111/j.1600-079X.2007.00488.x; Guha M, 2006, FASEB J, V20, P1224, DOI 10.1096/fj.05-5338fje; Gulbins E, 2003, EXP PHYSIOL, V88, P85, DOI 10.1113/eph8802503; GUTTERIDGE JMC, 1985, FEBS LETT, V185, P19, DOI 10.1016/0014-5793(85)80732-8; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; INSEL PA, 1991, GOODMAN GILMANS PHAR, P638; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; KADIISKA MB, 1995, J CLIN INVEST, V96, P1653, DOI 10.1172/JCI118205; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; LARKAI EN, 1987, AM J GASTROENTEROL, V82, P1153; Maity P, 2008, J BIOL CHEM, V283, P14391, DOI 10.1074/jbc.M800414200; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Naito Y, 2006, REDOX REP, V11, P243, DOI 10.1179/135100006X155021; Ong MMK, 2006, FREE RADICAL BIO MED, V40, P420, DOI 10.1016/j.freeradbiomed.2005.08.038; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; PARKE DV, 1983, VET RES COMMUN, V7, P285, DOI 10.1007/BF02228636; PERRY MA, 1986, GASTROENTEROLOGY, V90, P362, DOI 10.1016/0016-5085(86)90933-9; PORTER DJT, 1987, J BIOL CHEM, V262, P6552; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Redlak MJ, 2005, AM J PHYSIOL-GASTR L, V289, pG731, DOI 10.1152/ajpgi.00150.2005; Regula J, 2006, AM J GASTROENTEROL, V101, P1747, DOI 10.1111/j.1572-0241.2006.00686.x; Ricci C, 2008, AM J PHYSIOL-CELL PH, V294, pC413, DOI 10.1152/ajpcell.00362.2007; Rousou AJ, 2004, AM J PHYSIOL-HEART C, V287, pH1967, DOI 10.1152/ajpheart.00338.2004; Scatena R, 2007, AM J PHYSIOL-CELL PH, V293, pC12, DOI 10.1152/ajpcell.00314.2006; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; SWIFT GL, 1992, DIGESTION, V53, P88, DOI 10.1159/000200975; TAKEUCHI Y, 1991, ARCH BIOCHEM BIOPHYS, V289, P33, DOI 10.1016/0003-9861(91)90438-O; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; TERANO A, 1982, GASTROENTEROLOGY, V83, P1280; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; Wallace JL, 2001, BEST PRACT RES CL GA, V15, P691, DOI 10.1053/bega.2001.0229; YOSHIKAWA T, 1993, GUT, V34, P732, DOI 10.1136/gut.34.6.732; Zhang GS, 2000, LEUKEMIA RES, V24, P385, DOI 10.1016/S0145-2126(99)00198-8; Zheng W, 1998, BRAIN RES, V799, P334, DOI 10.1016/S0006-8993(98)00481-8; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	58	87	89	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3058	3068		10.1074/jbc.M805329200	http://dx.doi.org/10.1074/jbc.M805329200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049974	hybrid			2022-12-27	WOS:000262700900050
J	Pimkina, J; Humbey, O; Zilfou, JT; Jarnik, M; Murphy, ME				Pimkina, Julia; Humbey, Olivier; Zilfou, Jack T.; Jarnik, Michal; Murphy, Maureen E.			ARF Induces Autophagy by Virtue of Interaction with Bcl-xl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P19(ARF) TUMOR-SUPPRESSOR; P53-INDEPENDENT APOPTOSIS; MITOCHONDRIAL P-32; BECLIN-1; P53; PROTEIN; DOMAIN; GENE; TUMORIGENESIS; INHIBITION	The ARF tumor suppressor controls a well-described p53/Mdm2-dependent oncogenic stress checkpoint. In addition, ARF has recently been shown to localize to mitochondria, and to induce autophagy; however, this has never before been demonstrated for endogenous ARF, and the molecular basis for this activity of ARF has not been elucidated. Using an unbiased mass spectrometry-based approach, we show that mitochondrial ARF interacts with the Bcl2 family member Bcl-xl, which normally protects cells from autophagy by inhibiting the Beclin-1/Vps34 complex, which is essential for autophagy. We find that increased expression of ARF decreases Beclin-1/Bcl-xl complexes in cells, thereby providing a basis for ARF-induced autophagy. Our data also indicate that silencing p53 leads to high levels of ARF and increased autophagy, thereby providing a possible basis for the finding by others that p53 inhibits autophagy. The combined data support the premise that ARF induces autophagy in a p53-independent manner in part by virtue of its interaction with Bcl-xl.	[Pimkina, Julia; Humbey, Olivier; Murphy, Maureen E.] Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA; [Pimkina, Julia] Fox Chase Canc Ctr, Smolensk State Med Acad Grad Program, Philadelphia, PA 19111 USA; [Jarnik, Michal] Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA; [Zilfou, Jack T.] Zilfou Therapeut Inc, Allentown, PA 18104 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Murphy, ME (corresponding author), Fox Chase Canc Ctr, Div Med Sci, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Maureen.Murphy@FCCC.edu		Murphy, Maureen/0000-0001-7644-7296	National Institutes of Health [R01 CA080854, R01 CA150002]; Philippe Foundation; NATIONAL CANCER INSTITUTE [R01CA139319, R01CA080854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philippe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health R01 CA080854 (to M. M.) and R01 CA150002 (to M. M.). This work was also supported by the Philippe Foundation (to O. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Criollo A, 2007, AUTOPHAGY, V3, P350, DOI 10.4161/auto.4077; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Humbey O, 2008, CANCER RES, V68, P9608, DOI 10.1158/0008-5472.CAN-08-2263; Itahana K, 2008, CANCER CELL, V13, P542, DOI 10.1016/j.ccr.2008.04.002; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Ku B, 2008, AUTOPHAGY, V4, P519, DOI 10.4161/auto.5846; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Matsuoka M, 2003, BIOCHEM BIOPH RES CO, V301, P1000, DOI 10.1016/S0006-291X(03)00080-9; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Paliwal S, 2006, MOL CELL BIOL, V26, P2360, DOI 10.1128/MCB.26.6.2360-2372.2006; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pietsch EC, 2007, CANCER BIOL THER, V6, P1576, DOI 10.4161/cbt.6.10.4719; Reef S, 2007, ONCOGENE, V26, P6677, DOI 10.1038/sj.onc.1210485; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	35	79	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2803	2810		10.1074/jbc.M804705200	http://dx.doi.org/10.1074/jbc.M804705200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049976	Green Published, hybrid			2022-12-27	WOS:000262700900023
J	Tan, YW; Hanson, JA; Yang, H				Tan, Yan-Wen; Hanson, Jeffrey A.; Yang, Haw			Direct Mg2+ Binding Activates Adenylate Kinase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE MONOPHOSPHATE KINASES; CHRONIC HEMOLYTIC-ANEMIA; CONFORMATIONAL DYNAMICS; SUBSTRATE-INHIBITION; MOLECULAR EVOLUTION; POTASSIUM CHANNELS; CATALYTIC ACTIVITY; CRYSTAL-STRUCTURES; FREE MAGNESIUM; ENERGY-CHARGE	We report evidence that adenylate kinase (AK) from Escherichia coli can be activated by the direct binding of a magnesium ion to the enzyme, in addition to ATP-complexed Mg2+. By systematically varying the concentrations of AMP, ATP, and magnesium in kinetic experiments, we found that the apparent substrate inhibition of AK, formerly attributed to AMP, was suppressed at low magnesium concentrations and enhanced at high magnesium concentrations. This previously unreported magnesium dependence can be accounted for by a modified random bi-bi model in which Mg2+ can bind to AK directly prior to AMP binding. A new kinetic model is proposed to replace the conventional random bi-bi mechanism with substrate inhibition and is able to describe the kinetic data over a physiologically relevant range of magnesium concentrations. According to this model, the magnesium-activated AK exhibits a 23- +/- 3-fold increase in its forward reaction rate compared with the unactivated form. The findings imply that Mg2+ could be an important affecter in the energy signaling network in cells.	[Tan, Yan-Wen; Hanson, Jeffrey A.; Yang, Haw] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Yang, Haw] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Yang, H (corresponding author), Univ Calif Berkeley, Dept Chem, D46 Hildebrand Hall, Berkeley, CA 94720 USA.	hawyang@berkeley.edu	Yang, Haw/AHD-0857-2022; Tan, Yan-Wen/GQZ-0713-2022	Yang, Haw/0000-0003-0268-6352; Tan, Yan-Wen/0000-0002-5522-7996	National Science Foundation; A. P. Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069937] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); A. P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Science Foundation and by the A. P. Sloan Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Aden J, 2007, J AM CHEM SOC, V129, P14003, DOI 10.1021/ja075055g; AINSWORTH S, 1973, BIOCHEM J, V131, P223, DOI 10.1042/bj1310223; ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; BERRY MB, 1994, PROTEINS, V19, P183, DOI 10.1002/prot.340190304; Berry MB, 1998, PROTEINS, V32, P276, DOI 10.1002/(SICI)1097-0134(19980815)32:3<276::AID-PROT3>3.0.CO;2-G; Bianchi P, 1999, BRIT J HAEMATOL, V105, P75, DOI 10.1111/j.1365-2141.1999.01297.x; Bilderback T, 1996, BIOCHEMISTRY-US, V35, P6100, DOI 10.1021/bi951833i; BLAIR JM, 1970, EUR J BIOCHEM, V13, P384, DOI 10.1111/j.1432-1033.1970.tb00940.x; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Chu JW, 2007, BIOPHYS J, V93, P3860, DOI 10.1529/biophysj.107.112060; Corrons JLV, 2003, BLOOD, V102, P353, DOI 10.1182/blood-2002-07-2288; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; Dzeja PP, 2007, J BIOL CHEM, V282, P31366, DOI 10.1074/jbc.M705268200; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Elamrani S, 1996, PROTEINS, V25, P79, DOI 10.1002/(SICI)1097-0134(199605)25:1<79::AID-PROT6>3.3.CO;2-Z; FukamiKobayashi K, 1996, FEBS LETT, V385, P214, DOI 10.1016/0014-5793(96)00367-5; GILLES AM, 1986, P NATL ACAD SCI USA, V83, P5798, DOI 10.1073/pnas.83.16.5798; GILLES AM, 1988, J BIOL CHEM, V263, P8204; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hibino T, 2005, J BIOL CHEM, V280, P30671, DOI 10.1074/jbc.M412601200; HSIEH LS, 1991, J BACTERIOL, V173, P3914, DOI 10.1128/JB.173.12.3914-3917.1991; Huang C Y, 1979, Methods Enzymol, V63, P54; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Igamberdiev AU, 2006, J EXP BOT, V57, P2133, DOI 10.1093/jxb/erl006; Igamberdiev AU, 2001, BIOCHEM J, V360, P225, DOI 10.1042/0264-6021:3600225; JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9; JENSEN PR, 1995, J BACTERIOL, V177, P3420, DOI 10.1128/jb.177.12.3420-3426.1995; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; LACHANT NA, 1991, BLOOD, V77, P2774; Lasko DR, 1996, BIOTECHNOL BIOENG, V52, P364, DOI 10.1002/(SICI)1097-0290(19961105)52:3<364::AID-BIT2>3.0.CO;2-I; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; LIANG P, 1991, PROTEINS, V9, P28, DOI 10.1002/prot.340090105; Lu Q, 2008, J AM CHEM SOC, V130, P4772, DOI 10.1021/ja0780481; Marco-Marin C, 2005, J MOL BIOL, V352, P438, DOI 10.1016/j.jmb.2005.07.045; MATSUURA S, 1989, J BIOL CHEM, V264, P10148; MILNE JA, 1979, BIOCHEMISTRY-US, V18, P3604, DOI 10.1021/bi00583a026; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Munier-Lehmann H, 1999, PROTEINS, V36, P238, DOI 10.1002/(SICI)1097-0134(19990801)36:2<238::AID-PROT9>3.0.CO;2-K; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; Noda L., 1970, ADENYLATE KINASE; Ostermann N, 2000, STRUCTURE, V8, P629, DOI 10.1016/S0969-2126(00)00149-0; PRADET A, 1983, ANNU REV PLANT PHYS, V34, P199, DOI 10.1146/annurev.pp.34.060183.001215; Pucar D, 2000, J BIOL CHEM, V275, P41424, DOI 10.1074/jbc.M007903200; Qualtieri A, 1997, BRIT J HAEMATOL, V99, P770, DOI 10.1046/j.1365-2141.1997.4953299.x; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012; Saks V, 2006, J PHYSIOL-LONDON, V571, P253, DOI 10.1113/jphysiol.2005.101444; SEGEL IH, 1993, ENZYME KINETICS BEHA, P503; Shapiro YE, 2002, BIOCHEMISTRY-US, V41, P6271, DOI 10.1021/bi012132q; Shapiro YE, 2000, BIOCHEMISTRY-US, V39, P6634, DOI 10.1021/bi992076h; Sheng XR, 1999, J BIOL CHEM, V274, P22238, DOI 10.1074/jbc.274.32.22238; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Sinev MA, 1996, BIOCHEMISTRY-US, V35, P6425, DOI 10.1021/bi952687j; Sinev MA, 1996, FEBS LETT, V397, P273, DOI 10.1016/S0014-5793(96)01195-7; Temiz NA, 2004, PROTEINS, V57, P468, DOI 10.1002/prot.20226; THOMAS AP, 1986, BIOCHEM J, V238, P83, DOI 10.1042/bj2380083; Touyz RM, 1996, J BIOL CHEM, V271, P24353, DOI 10.1074/jbc.271.40.24353; vanWorkum M, 1996, MOL MICROBIOL, V20, P351; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; Yde CW, 2005, J MOL BIOL, V347, P399, DOI 10.1016/j.jmb.2005.01.003; YOUNIS HM, 1983, BIOCHEMISTRY-US, V22, P2505, DOI 10.1021/bi00279a030; Zhang WQ, 1997, ANAL BIOCHEM, V251, P246, DOI 10.1006/abio.1997.2238	71	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3306	3313		10.1074/jbc.M803658200	http://dx.doi.org/10.1074/jbc.M803658200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029291	Green Published, hybrid			2022-12-27	WOS:000262700900073
J	Wegierski, T; Lewandrowski, U; Muller, B; Sickmann, A; Walz, G				Wegierski, Tomasz; Lewandrowski, Urs; Mueller, Barbara; Sickmann, Albert; Walz, Gerd			Tyrosine Phosphorylation Modulates the Activity of TRPV4 in Response to Defined Stimuli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION CHANNEL TRPV4; RECEPTOR POTENTIAL VANILLOID-4; HEAT-EVOKED ACTIVATION; MICE LACKING TRPV4; INFLAMMATORY MEDIATORS; ION-CHANNEL; SRC KINASE; CA2+ ENTRY; PROTEIN; EXPRESSION	Src family tyrosine kinases (SFKs) regulate the function of several transient receptor potential (TRP) family members, yet their role in the regulation of the vanilloid subfamily member 4 protein (TRPV4) remains controversial. TRPV4 is a calcium-permeable channel activated by numerous physical and chemical stimuli. Here we show that SFKs mediate tyrosine phosphorylation of TRPV4 in different cell lines. Using mass spectrometric analysis, we identified two novel phosphorylation sites in the cytosolic N- and C-terminal tails of TRPV4. Substitution of either tyrosine with phenylalanine led to a substantial reduction in the overall tyrosine phosphorylation level of TRPV4, suggesting that these two tyrosines constitute major phosphorylation sites. Both mutants efficiently localized to the plasma membrane, indicating that neither tyrosine is required for trafficking of TRPV4 in the secretory pathway. Analysis of the channel function demonstrated a crucial role of the N-terminal tyrosine residue in the activation of TRPV4 by heat, mechanical (shear) stress, hypotonic cell swelling, and phorbol 12-myristate 13-acetate, but not in the activation by synthetic ligand 4 alpha-phorbol 12,13-didecanoate. Furthermore, the response of TRPV4 to phorbol 12-myristate 13-acetate was SFK-dependent. Because the SFK-mediated phosphorylation of the N-terminal tyrosine occurred before TRPV4 activation, tyrosine phosphorylation appears to sensitize rather than activate this channel. Reactive oxygen species, known to mediate inflammatory pain, strongly up-regulated TRPV4 phosphorylation in the presence of SFKs. Our findings indicate that tyrosine phosphorylation of TRPV4 represents an important modulatory mechanism, which may underlie the recently described function of TRPV4 in inflammatory hyperalgesia.	[Wegierski, Tomasz; Mueller, Barbara; Walz, Gerd] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; [Lewandrowski, Urs; Sickmann, Albert] Univ Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany	University of Freiburg; German Research Foundation (DFG); University of Wurzburg	Walz, G (corresponding author), Univ Hosp Freiburg, Div Renal, Hugstetter Str 55, D-79106 Freiburg, Germany.	gerd.walz@uniklinik-freiburg.de	Wegierski, Tomasz/AAG-3284-2020; Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265; Wegierski, Tomasz/0000-0003-2635-8580	Deutsche Forschungsgemeinschaft [FZT-82]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants (to G. W. and to A. S. (FZT-82)). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Chung JM, 2004, MOL INTERV, V4, P248, DOI 10.1124/mi.4.5.3; Cuajungco MP, 2006, J BIOL CHEM, V281, P18753, DOI 10.1074/jbc.M602452200; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; DRAY A, 1995, BRIT J ANAESTH, V75, P125, DOI 10.1093/bja/75.2.125; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guler AD, 2002, J NEUROSCI, V22, P6408; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Jin XC, 2004, AM J PHYSIOL-CELL PH, V287, pC558, DOI 10.1152/ajpcell.00113.2004; Kawasaki BT, 2006, P NATL ACAD SCI USA, V103, P335, DOI 10.1073/pnas.0508030102; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2006, J ENDOCRINOL, V191, P515, DOI 10.1677/joe.1.07000; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Schindler J, 2008, J PROTEOME RES, V7, P432, DOI 10.1021/pr0704736; Sidhaye VK, 2006, P NATL ACAD SCI USA, V103, P4747, DOI 10.1073/pnas.0511211103; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Tian W, 2004, AM J PHYSIOL-RENAL, V287, pF17, DOI 10.1152/ajprenal.00397.2003; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	51	67	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2923	2933		10.1074/jbc.M805357200	http://dx.doi.org/10.1074/jbc.M805357200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19033444	hybrid			2022-12-27	WOS:000262700900037
J	Espinosa, A; Garcia, A; Hartel, S; Hidalgo, C; Jaimovich, E				Espinosa, Alejandra; Garcia, Alejandra; Haertel, Steffen; Hidalgo, Cecilia; Jaimovich, Enrique			NADPH Oxidase and Hydrogen Peroxide Mediate Insulin-induced Calcium Increase in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL GENE-EXPRESSION; PROTEIN-KINASE; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; NAD(P)H OXIDASE; GLUCOSE-UPTAKE; ACTIVATION; DEPOLARIZATION; GENERATION; PHOSPHORYLATION	Skeletal muscle is one of the main physiological targets of insulin, a hormone that triggers a complex signaling cascade and that enhances the production of reactive oxygen species (ROS) in different cell types. ROS, currently considered second messengers, produce redox modifications in proteins such as ion channels that induce changes in their functional properties. In myotubes, insulin also enhances calcium release from intracellular stores. In this work, we studied in myotubes whether insulin stimulated ROS production and investigated the mechanisms underlying the insulin-dependent calcium increase: in particular, whether the late phase of the Ca2+ increase induced by insulin required ROS. We found that insulin stimulated ROS production, as detected with the probe 2', 7'-dichlorofluorescein diacetate (CM-H(2)DCFDA). We used the translocation of p47(phox) from the cytoplasm to the plasma membrane as a marker of the activation of NADPH oxidase. Insulin-stimulated ROS generation was suppressed by the NADPH oxidase inhibitor apocynin and by small interfering RNA against p47(phox), a regulatory NADPH oxidase subunit. Additionally, both protein kinase C and phosphatidylinositol 3-kinase are presumably involved in insulin-induced ROS generation because bisindolylmaleimide, a nonspecific protein kinase C inhibitor, and LY290042, an inhibitor of phosphatidylinositol 3-kinase, inhibited this increase. Bisindolylmaleimide, LY290042, apocynin, small interfering RNA against p47(phox), and two drugs that interfere with inositol 1,4,5-trisphosphate-mediated Ca2+ release, xestospongin C and U73122, inhibited the intracellular Ca2+ increase produced by insulin. These combined results strongly suggest that insulin induces ROS generation trough NADPH activation and that this ROS increase is required for the intracellular Ca2+ rise mediated by inositol 1,4,5-trisphosphate receptors.	[Hidalgo, Cecilia; Jaimovich, Enrique] Univ Chile, Fac Med, ICBM, Programa Biol Mol & Celular, Santiago 7, Chile; [Espinosa, Alejandra] Univ Chile, Fac Med, Escuela Tecnol Med, Santiago 7, Chile; [Garcia, Alejandra; Hidalgo, Cecilia; Jaimovich, Enrique] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago 7, Chile; [Haertel, Steffen] Univ Chile, Fac Med, Inst Ciencias Biomed, Program Anat & Biol Desarrollo, Santiago 7, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Jaimovich, E (corresponding author), Univ Chile, Fac Med, ICBM, Programa Biol Mol & Celular, Casilla 70005, Santiago 7, Chile.	ejaimovi@med.uchile.cl	Härtel, Steffen/AAA-2336-2020; Jaimovich, Enrique/AAY-7632-2020; HIDALGO, Cecilia/H-7107-2013	Härtel, Steffen/0000-0002-8913-1757; 	Fondo Nacional de Investigacion en Areas Prioritarias (FONDAP) [15010006]; Fondecyt [1060890, 1071001]; PBCT [ACT47]	Fondo Nacional de Investigacion en Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PBCT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT)	This work was supported by Fondo Nacional de Investigacion en Areas Prioritarias (FONDAP) Grant 15010006. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by Fondecyt Grants 1060890, 1071001, and PBCT ACT47.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Carrasco MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1438, DOI 10.1152/ajpcell.00117.2002; CHOE CU, 2006, SCI STKE, pRE15; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Espinosa A, 2006, J CELL PHYSIOL, V209, P379, DOI 10.1002/jcp.20745; Feng W, 2000, J BIOL CHEM, V275, P35902, DOI 10.1074/jbc.C000523200; Frey RS, 2006, J BIOL CHEM, V281, P16128, DOI 10.1074/jbc.M508810200; Goldstein BJ, 2005, ANTIOXID REDOX SIGN, V7, P1021, DOI 10.1089/ars.2005.7.1021; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Hutchinson DS, 2007, CELL SIGNAL, V19, P1610, DOI 10.1016/j.cellsig.2007.02.006; Jaimovich E, 2004, BIOL RES, V37, P625; Joseph SK, 2006, BIOCHEM J, V393, P575, DOI 10.1042/BJ20050889; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; KAPLIN AI, 1994, J BIOL CHEM, V269, P28972; Lanner JT, 2006, DIABETES, V55, P2077, DOI 10.2337/db05-1613; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; MANDERS EMM, 1993, J MICROSCOPY    0303, P375; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Powell JA, 2001, J CELL SCI, V114, P3673; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rome S, 2003, J BIOL CHEM, V278, P18063, DOI 10.1074/jbc.M300293200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sanchez G, 2008, CARDIOVASC RES, V77, P380, DOI 10.1093/cvr/cvm011; Talior I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405, DOI 10.1152/ajpendo.00378.2004	29	77	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2568	2575		10.1074/jbc.M804249200	http://dx.doi.org/10.1074/jbc.M804249200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028699	hybrid			2022-12-27	WOS:000262545600061
J	Rybin, VO; Guo, JF; Steinberg, SF				Rybin, Vitalyi O.; Guo, Jianfen; Steinberg, Susan F.			Protein Kinase D1 Autophosphorylation via Distinct Mechanisms at Ser(744)/Ser(748) and Ser(916)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION LOOP PHOSPHORYLATION; ELEMENT-BINDING PROTEIN; D-DEPENDENT ACTIVATION; CARDIAC TROPONIN-I; C-MU; G(Q)-COUPLED RECEPTORS; KAPPA-B; PKC-MU; VIVO; LOCALIZATION	Protein kinase D1 (PKD1) is a physiologically important signaling enzyme that is activated via protein kinase C-dependent trans-phosphorylation of the activation loop at Ser(744) and Ser(748) followed by PKD1 autophosphorylation at Ser(916). Although PKD-Ser(916) autophosphorylation is widely used to track cellular PKD activity, this study exposes conditions leading to increased PKD-Ser(P)(916) immunoreactivity without an associated increase in PKD activity in cardiomyocytes that heterologously overexpress catalytically inactive PKD1 and in cardiomyocytes treated with Go6976 (a PKD inhibitor that competes with ATP). In each case, PKD1 is detected as a Ser(916)-phosphorylated enzyme that lacks kinase activity. In vitro kinase assays reconcile these seemingly discrepant findings by demonstrating that PKD1-Ser(916) autophosphorylation can proceed via either an intermolecular reaction or an intramolecular autophosphorylation that requires only very low ATP concentrations that do not support target substrate phosphorylation. Additional studies show that Ser(744) and Ser(748) are targets for a protein kinase C-independent autocatalytic phosphorylation and that the PKD1-S744A/S748A mutant is a Ser(916)-phosphorylated enzyme that is not active toward heterologous substrates. In contrast, PKD1-S916A is an active kinase that autophosphorylates at Ser(744). However, the S916A substitution leads to a Ser(748) phosphorylation defect and a prolonged cellular PKD1 signaling response. Collectively, these results implicate PKD1-Ser(744) phosphorylation in the phorbol 12-myristate 13-acetate-dependent mechanism that increases PKD1 activity toward physiologically relevant substrates. We show that PKD1-Ser(916) autophosphorylation does not necessarily correlate with PKD1 activity. Rather, autophosphorylation at Ser(916) is required for subsequent autophosphorylation at Ser(748). Finally, this study exposes a novel role for Ser(916) and/or Ser(748) autophosphorylation to terminate the cellular PKD1 signaling response.	[Steinberg, Susan F.] Columbia Univ, Dept Pharmacol, Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Steinberg, SF (corresponding author), Columbia Univ, Dept Pharmacol, Coll Phys & Surg, 630 West,168th St, New York, NY 10032 USA.	sfs1@columbia.edu			National Institutes of Health [77860]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 77860 (USPHS NHLBI). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Feng H, 2007, J BIOL CHEM, V282, P31273, DOI 10.1074/jbc.M701532200; Feng H, 2006, J BIOL CHEM, V281, P17801, DOI 10.1074/jbc.M511899200; Feng H, 2006, J BIOL CHEM, V281, P17815, DOI 10.1074/jbc.M511898200; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Storz P, 2004, MOL PHARMACOL, V66, P870, DOI 10.1124/mol.104.000687; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200	31	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2332	2343		10.1074/jbc.M806381200	http://dx.doi.org/10.1074/jbc.M806381200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19029298	hybrid, Green Published			2022-12-27	WOS:000262545600042
J	Serebrov, V; Beran, RKF; Pyle, AM				Serebrov, Victor; Beran, Rudolf K. F.; Pyle, Anna Marie			Establishing a Mechanistic Basis for the Large Kinetic Steps of the NS3 Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; CRYSTAL-STRUCTURE; RNA HELICASE; UNWINDING ACTIVITY; UVRD HELICASE; DNA HELICASE; IN-VITRO; PROTEIN; TRANSLOCATION; DOMAIN	The NS3 helicase from hepatitis C virus is a prototypical DEx(H/D) RNA helicase. NS3 has been shown to unwind RNA in a discontinuous manner, pausing after long apparent steps of unwinding. We systematically examined the effects of duplex stability and ionic conditions on the periodicity of the NS3 unwinding cycle. The kinetic step size for NS3 unwinding was examined on diverse substrate sequences. The kinetic step size (16 bp/step) was found to be independent of RNA duplex stability and composition, but it exhibited strong dependence on monovalent salt concentration, decreasing to similar to 11 bp/step at low [NaCl]. We addressed this behavior by analyzing the oligomeric state of NS3 at various salt concentrations. Whereas only NS3 oligomers are capable of processive unwinding, we found that monomeric NS3 is an active helicase that unwinds with low processivity. We demonstrate that low salt conditions enhance unwinding by monomeric NS3, which is likely to account for the reduction in apparent step size under low salt conditions. Based on results reported here, as well as available structural and single molecule data, we present an unwinding mechanism that addresses the apparent periodicity of NS3 unwinding, the magnitude of the step size, and that integrates the various stepwise motions observed for NS3. We propose that the large kinetic step size of NS3 unwinding reflects a delayed, periodic release of the separated RNA product strand from a secondary binding site that is located in the NTPase domain (Domain II) of NS3. These findings suggest that the mechanism of product release represents an important and unexplored feature of helicase mechanism.	[Serebrov, Victor; Beran, Rudolf K. F.; Pyle, Anna Marie] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	anna.pyle@yale.edu		Serebrov, Victor/0000-0002-5800-3103	National Institutes of Health [GM60620, 32 GM071120-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060620, F32GM071120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60620 (to A. M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant F32 GM071120-01A1 (Ruth Kirschstein postdoctoral fellowship).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Cho HS, 1998, J BIOL CHEM, V273, P15045, DOI 10.1074/jbc.273.24.15045; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2000, NUCLEIC ACIDS RES, V28, P333, DOI 10.1093/nar/28.1.333; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Jennings TA, 2008, BIOCHEMISTRY-US, V47, P1126, DOI 10.1021/bi701048a; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; Tackett AJ, 2005, J BIOL CHEM, V280, P10797, DOI 10.1074/jbc.M407971200; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	37	40	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2512	2521		10.1074/jbc.M805460200	http://dx.doi.org/10.1074/jbc.M805460200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19010782	Green Published, hybrid			2022-12-27	WOS:000262545600057
J	Yu, JK; Hai, Y; Liu, GD; Fang, TL; Kung, SKP; Xie, JY				Yu, Jiankun; Hai, Yan; Liu, Guodong; Fang, Tielan; Kung, Sam K. P.; Xie, Jiuyong			The Heterogeneous Nuclear Ribonucleoprotein L Is an Essential Component in the Ca2+/Calmodulin-dependent Protein Kinase IV-regulated Alternative Splicing through Cytidine-Adenosine Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACT-BINDING-PROTEIN; HNRNP-L; RNA-BINDING; EXON; GENE; EXPRESSION; PHOSPHORYLATION; RECEPTOR; ELEMENT; DEPOLARIZATION	The regulation of gene expression through alternative pre-mRNA splicing is common in metazoans and is often controlled by intracellular signaling pathways that are important in cell physiology. We have shown that the alternative splicing of a number of genes is controlled by membrane depolarization and Ca2+/calmodulin-dependent protein kinase IV (CaMKIV) through CaMKIV-responsive RNA elements (CaRRE1 and CaRRE2); however, the trans-acting factors remain unknown. Here we show that the heterogeneous nuclear ribonucleoprotein (hnRNP) L is a CaRRE1 binding factor in nuclear extracts. An hnRNP L high affinity CA (cytidine-adenosine) repeat element is sufficient to mediate CaMKIV and hnRNP L repression of splicing in a location (3'-splice site proximity)-dependent way. Depletion of hnRNP L by RNA interference followed by rescue with coexpressed exogenous hnRNP L demonstrates that hnRNP L mediates the CaMKIV-regulated splicing through CA repeats in heterologous contexts. Depletion of hnRNP L also led to increased inclusion of the stress axis-regulated exon and aCA repeat-harboring exon under depolarization or with activated CaMKIV. Moreover, hnRNP L binding to CaRRE1 was increased by CaMKIV and, conversely, was reduced by pretreatments with protein phosphatases. Therefore, hnRNP L is an essential component of CaMKIV-regulated alternative splicing through CA repeats, with its phosphorylation likely playing a critical role.	[Yu, Jiankun; Hai, Yan; Liu, Guodong; Xie, Jiuyong] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB R3E 0J9, Canada	University of Manitoba	Xie, JY (corresponding author), 439 BMSB,745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	xiej@cc.umanitoba.ca	Xie, Jiuyong/D-2899-2013	Xie, Jiuyong/0000-0003-2909-1033; Yu, Jiankun/0000-0001-9916-1012	Canadian Institutes of Health Research [MOP68919]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP68919 (to J.X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	An DS, 2001, J VIROL, V75, P3547, DOI 10.1128/JVI.75.8.3547-3555.2001; An P, 2007, PLOS BIOL, V5, P263, DOI 10.1371/journal.pbio.0050036; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Black DL, 1998, PRACT APPROACH SER, V192, P109; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Forgacs E, 1998, ONCOGENE, V17, P1557, DOI 10.1038/sj.onc.1202070; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Griffith BN, 2006, BBA-GENE STRUCT EXPR, V1759, P552, DOI 10.1016/j.bbaexp.2006.10.001; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Hai Y, 2008, NUCLEIC ACIDS RES, V36, P3320, DOI 10.1093/nar/gkn207; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, RNA, V9, P931, DOI 10.1261/rna.5660803; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; LIU XD, 1995, GENE DEV, V9, P1766, DOI 10.1101/gad.9.14.1766; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mckee AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r159; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Perucho M, 1996, BIOL CHEM, V377, P675; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Radu CG, 2004, P NATL ACAD SCI USA, V101, P245, DOI 10.1073/pnas.2536801100; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Stamm S, 2002, HUM MOL GENET, V11, P2409, DOI 10.1093/hmg/11.20.2409; Stickeler E, 2001, EMBO J, V20, P3821, DOI 10.1093/emboj/20.14.3821; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443	58	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1505	1513		10.1074/jbc.M805113200	http://dx.doi.org/10.1074/jbc.M805113200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017650	Green Accepted, hybrid			2022-12-27	WOS:000262330100018
J	Bellingham, SA; Coleman, LA; Masters, CL; Camakaris, J; Hill, AF				Bellingham, Shayne A.; Coleman, Louise A.; Masters, Colin L.; Camakaris, James; Hill, Andrew F.			Regulation of Prion Gene Expression by Transcription Factors SP1 and Metal Transcription Factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; AMYLOID PRECURSOR PROTEIN; COPPER HOMEOSTASIS; FACTOR MTF-1; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; RESPONSE ELEMENT; MAMMALIAN-CELLS; PLASMA-MEMBRANE; MENKES DISEASE	Prion diseases are associated with the conformational conversion of the host-encoded cellular prion protein into an abnormal pathogenic isoform. Reduction in prion protein levels has potential as a therapeutic approach in treating these diseases. Key targets for this goal are factors that affect the regulation of the prion protein gene. Recent in vivo and in vitro studies have suggested a role for prion protein in copper homeostasis. Copper can also induce prion gene expression in rat neurons. However, the mechanism involved in this regulation remains to be determined. We hypothesized that transcription factors SP1 and metal transcription factor-1(MTF-1) may be involved in copper-mediated regulation of human prion gene. To test the hypothesis, we utilized human fibroblasts that are deleted or overexpressing the Menkes protein (MNK), a major mammalian copper efflux protein. Menkes deletion fibroblasts have high intracellular copper, whereas Menkes overexpressed fibroblasts have severely depleted intracellular copper. We have utilized this system previously to demonstrate copper-dependent regulation of the Alzheimer amyloid precursor protein. Here we demonstrate that copper depletion in MNK overexpressed fibroblasts decreases cellular prion protein and PRNP gene levels. Conversely, expression of transcription factors SP1 and/or MTF-1 significantly increases prion protein levels and up-regulates prion gene expression in copper-replete MNK deletion cells. Furthermore, siRNA "knockdown" of SP1 or MTF-1 in MNK deletion cells decreases prion protein levels and down-regulates prion gene expression. These data support a novel mechanism whereby SP1 and MTF-1 act as copper-sensing transcriptional activators to regulate human prion gene expression and further support a role for the prion protein to function in copper homeostasis. Expression of the prion protein is a vital component for the propagation of prion diseases; thus SP1 and MTF-1 represent new targets in the development of key therapeutics toward modulating the expression of the cellular prion protein and ultimately the prevention of prion disease.	[Bellingham, Shayne A.; Coleman, Louise A.; Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Bellingham, Shayne A.; Coleman, Louise A.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Bellingham, Shayne A.; Coleman, Louise A.; Camakaris, James] Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia; [Bellingham, Shayne A.; Masters, Colin L.; Hill, Andrew F.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Hill, AF (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.	a.hill@unimelb.edu.au	Hill, Andrew F/B-4527-2009; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020; Bellingham, Shayne A/E-5665-2012	Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; 	National Health and Medical Research Council Program; Australian Research Council	National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported in part by a National Health and Medical Research Council Program grant (to A.F.H. and C.L.M.) and an Australian Research Council discovery grant (to S.A.B.). A.F.H. is a shareholder in and consultant to D-Gen Limited, an academic spin-out company working in the field of prion disease diagnosis, therapeutics, and decontamination. D-Gen markets the ICSM18 antibody used in this study.	Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Asante EA, 2004, NEUROSCI LETT, V360, P33, DOI 10.1016/j.neulet.2004.01.049; Balamurugan K, 2004, BIOL CHEM, V385, P597, DOI 10.1515/BC.2004.074; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Barnham KJ, 2006, TRENDS BIOCHEM SCI, V31, P465, DOI 10.1016/j.tibs.2006.06.006; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 2001, BRAIN RES BULL, V55, P165, DOI 10.1016/S0361-9230(01)00453-1; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Burke R, 2008, INT J BIOCHEM CELL B, V40, P1850, DOI 10.1016/j.biocel.2008.01.021; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; CAMAKARIS J, 1980, BIOCHEM GENET, V18, P117, DOI 10.1007/BF00504364; CAMAKARIS J, 1995, HUM MOL GENET, V4, P2117, DOI 10.1093/hmg/4.11.2117; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Cereghetti GM, 2001, BIOPHYS J, V81, P516, DOI 10.1016/S0006-3495(01)75718-9; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; CULOTTA VC, 1989, MOL CELL BIOL, V9, P1376, DOI 10.1128/MCB.9.3.1376; Du T, 2008, PROTEOMICS, V8, P1819, DOI 10.1002/pmic.200700895; DUCHEN LW, 1993, BRAIN, V116, P555, DOI 10.1093/brain/116.3.555; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Hasnain SS, 2001, J MOL BIOL, V311, P467, DOI 10.1006/jmbi.2001.4795; Heicklen-Klein A, 2000, J NEUROCHEM, V75, P1408, DOI 10.1046/j.1471-4159.2000.0751408.x; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; La Fontaine S, 1998, J BIOL CHEM, V273, P31375; LI Y, 2008, MOL CELL BIOL; Mahal SP, 2001, GENE, V268, P105, DOI 10.1016/S0378-1119(01)00424-3; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Martins VR, 2002, FEBS LETT, V512, P25, DOI 10.1016/S0014-5793(02)02291-3; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Miura T, 1999, BIOCHEMISTRY-US, V38, P11560, DOI 10.1021/bi9909389; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Ogra Y, 2001, J BIOL CHEM, V276, P16534, DOI 10.1074/jbc.M100570200; Opazo C, 2003, BIOMETALS, V16, P91, DOI 10.1023/A:1020795422185; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PUCKETT C, 1991, AM J HUM GENET, V49, P320; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; SCHUG J, 1997, TESS TRANSCRIPTIONAL; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Smirnova IV, 2000, J BIOL CHEM, V275, P9377, DOI 10.1074/jbc.275.13.9377; Song IS, 2008, MOL PHARMACOL, V74, P705, DOI 10.1124/mol.108.046771; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Treiber A, 2007, DRUG METAB DISPOS, V35, P1400, DOI 10.1124/dmd.106.013615; Varela-Nallar L, 2006, AM J PHYSIOL-CELL PH, V290, pC271, DOI 10.1152/ajpcell.00160.2005; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; WESTIN G, 1988, EMBO J, V7, P3763, DOI 10.1002/j.1460-2075.1988.tb03260.x; WOLOZIN BL, 1986, SCIENCE, V232, P648, DOI 10.1126/science.3083509	70	53	54	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1291	1301		10.1074/jbc.M804755200	http://dx.doi.org/10.1074/jbc.M804755200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18990686	hybrid			2022-12-27	WOS:000262122900064
J	Chen, SJ; Ko, CY; Yen, CW; Wang, CC				Chen, Shun-Jia; Ko, Chou-Yuan; Yen, Chih-Wei; Wang, Chien-Chia			Translational Efficiency of Redundant ACG Initiator Codons Is Enhanced by a Favorable Sequence Context and Remedial Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; NON-AUG INITIATION; SACCHAROMYCES-CEREVISIAE; STRUCTURAL FEATURES; RIBOSOMAL-SUBUNIT; GENE ENCODES; IN-VIVO; YEAST; MITOCHONDRIAL; PROTEIN	Earlier studies showed that the redundancy of ACG initiation codons enhanced the efficiency of translation initiation by 3- to 6-fold. Evidence presented here shows that this "redundancy effect" can be attributed to a favorable sequence context and, to a lesser extent, remedial initiation. In the case of redundant ACG initiator codons, the second ACG not only acts as a remedial initiation site for scanning ribosomes that skip the first ACG but also enhances the activity of the preceding initiator by providing a preferable "A" at its relative +4 position. Hence, non-successive ACG codons can be as effective as successive ACG codons in initiation, if positioned within a similar context. In contrast, redundant GUG initiation codons (GUG/GUG) bear an unfavorable "G" nucleotide at both the +4 and -3 positions relative to the first and second GUGs, respectively, such that redundant GUG codons act more poorly as translation initiation sites than does a single GUG with a favorable "A" nucleotide in the +4 position (similar to 2.5-fold). Thus, the sequence context plays a much more important role than remedial initiation in modulating the efficiency of translational initiation from redundant non-AUG codons.	[Chen, Shun-Jia; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Jhongli 320, Taiwan; [Ko, Chou-Yuan] Armed Forces Taoyuan Gen Hosp, Lung Tan 325, Taiwan; [Yen, Chih-Wei] Cathay Gen Hosp, Taipei 106, Taiwan	National Central University; Cathay General Hospital	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Jhongli 320, Taiwan.	dukewang@cc.ncu.edu.tw		Chen, Shun-Jia/0000-0002-5489-4930	National Science Council ( Taiwan) [NSC96-2311-B-008-002, NSC96-2311-B-008-003]; CGH-NCU Joint Research Foundation (Taiwan) [CNJRF-96CGH-NCU-B4]; Armed Forces Taoyuan General Hospital (Taiwan)	National Science Council ( Taiwan)(Ministry of Science and Technology, Taiwan); CGH-NCU Joint Research Foundation (Taiwan); Armed Forces Taoyuan General Hospital (Taiwan)	This work was supported by the National Science Council ( Taiwan) ( Grants NSC96-2311-B-008-002 and NSC96-2311-B-008-003 to C.- C. W.), by the CGH-NCU Joint Research Foundation ( Taiwan) (Grant CNJRF-96CGH-NCU-B4 to C.- C. W. and C.- W. Y.), and by a grant from Armed Forces Taoyuan General Hospital ( Taiwan) ( to C.- Y. K. and C.- C. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramczyk D, 2003, YEAST, V20, P1045, DOI 10.1002/yea.1020; ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; BAIM SB, 1988, MOL CELL BIOL, V8, P1591, DOI 10.1128/MCB.8.4.1591; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang KJ, 2006, J BIOL CHEM, V281, P7775, DOI 10.1074/jbc.M511265200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; Chen SP, 2002, ARCH BIOCHEM BIOPHYS, V398, P87, DOI 10.1006/abbi.2001.2675; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; CIGAN AM, 1987, GENE, V59, P1; CIGAN AM, 1988, MOL CELL BIOL, V8, P2964, DOI 10.1128/MCB.8.7.2964; CLEMENTS JM, 1988, MOL CELL BIOL, V8, P4533, DOI 10.1128/MCB.8.10.4533; DIETRICH A, 1992, ANNU REV CELL BIOL, V8, P115, DOI 10.1146/annurev.cb.08.110192.000555; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; HANN SR, 1992, GENE DEV, V6, P1229, DOI 10.1101/gad.6.7.1229; Huang HY, 2006, J BIOL CHEM, V281, P31430, DOI 10.1074/jbc.M601869200; Huang HY, 2006, MOL MICROBIOL, V60, P189, DOI 10.1111/j.1365-2958.2006.05083.x; HUANG S, 1987, BIOCHEMISTRY-US, V26, P8242, DOI 10.1021/bi00399a033; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1991, J BIOL CHEM, V266, P19867; MARTINIS SA, 1996, ESCHERICHIA COLI SAL, P887; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Pelchat M, 1999, BIOCHEM CELL BIOL, V77, P343, DOI 10.1139/bcb-77-4-343; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Riechmann JL, 1999, MOL CELL BIOL, V19, P8505; Sadler R, 1999, J VIROL, V73, P5722, DOI 10.1128/JVI.73.7.5722-5730.1999; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; SHERMAN F, 1980, CELL, V20, P215, DOI 10.1016/0092-8674(80)90249-4; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c; WOLFE CL, 1994, J BIOL CHEM, V269, P13361; YOON H, 1992, MOL MICROBIOL, V6, P1413, DOI 10.1111/j.1365-2958.1992.tb00861.x; ZITOMER RS, 1984, MOL CELL BIOL, V4, P1191, DOI 10.1128/MCB.4.7.1191	44	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					818	827		10.1074/jbc.M804378200	http://dx.doi.org/10.1074/jbc.M804378200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010786	hybrid			2022-12-27	WOS:000262122900016
J	Lewerenz, J; Maher, P				Lewerenz, Jan; Maher, Pamela			Basal Levels of eIF2 alpha Phosphorylation Determine Cellular Antioxidant Status by Regulating ATF4 and xCT Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; EUKARYOTIC INITIATION FACTOR-2-ALPHA; OXIDATIVE GLUTAMATE TOXICITY; AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; TRANSLATIONAL CONTROL; IN-VIVO; NEURONAL DEGENERATION; TRANSCRIPTION FACTOR	eIF2 alpha is part of a multimeric complex that regulates cap-dependent translation. Phosphorylation of eIF2 alpha (phospho-eIF2 alpha) is induced by various forms of cell stress, resulting in changes to the proteome of the cell with two diametrically opposed consequences, adaptation to stress or initiation of programmed cell death. In contrast to the robust eIF2 alpha phosphorylation seen in response to acute insults, less is known about the functional role of basal levels of eIF2 alpha phosphorylation. Here we show that mouse embryonic fibroblasts expressing a nonphosphorylatable eIF2 alpha have enhanced sensitivity to diverse toxic insults, including amyloid beta-(1-42) peptide (A beta), a key factor in the pathogenesis of Alzheimer disease. This correlates with impaired glutathione metabolism because of down-regulation of the light chain, xCT, of the cystine/glutamate antiporter system X-c(-). The mechanistic link between the absence of phospho-eIF2 alpha and xCT expression is nuclear factor ATF4. Consistent with these findings, long term activation of the phospho-eIF2 alpha/ATF4/xCT signaling module by the specific eIF2 alpha phosphatase inhibitor, salubrinal, induces resistance against oxidative glutamate toxicity in the hippocampal cell line HT22 and primary cortical neurons. Furthermore, in PC12 cells selected for resistance against A beta, increased activity of the phospho-eIF2 alpha/ATF4/xCT module contributes to the resistant phenotype. In wild-type PC12 cells, activation of this module by salubrinal ameliorates the response to A beta. Furthermore, in human brains, ATF4 and phospho-eIF2 alpha levels are tightly correlated and upregulated in Alzheimer disease, most probably representing an adaptive response against disease-related cellular stress rather than a correlate of neurodegeneration.	[Lewerenz, Jan; Maher, Pamela] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Maher, P (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pmaher@salk.edu			National Institutes of Health [AG025337]; NATIONAL INSTITUTE ON AGING [R01AG025337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG025337 (to P. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe K, 1996, J NEUROCHEM, V67, P2074; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; BANNAI S, 1986, J BIOL CHEM, V261, P2256; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Burdo J, 2006, J HISTOCHEM CYTOCHEM, V54, P549, DOI 10.1369/jhc.5A6840.2006; Burdo J, 2008, BRAIN RES, V1189, P12, DOI 10.1016/j.brainres.2007.10.077; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x; Cordey M, 2006, J NEUROCHEM, V96, P204, DOI 10.1111/j.1471-4159.2005.03545.x; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; DeGracia DJ, 2002, J CEREBR BLOOD F MET, V22, P127, DOI 10.1097/00004647-200202000-00001; Eriksen JL, 2007, BEHAV GENET, V37, P79, DOI 10.1007/s10519-006-9118-z; Fogal B, 2007, J NEUROSCI, V27, P10094, DOI 10.1523/JNEUROSCI.2459-07.2007; Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717; Grallert B, 2007, CELL CYCLE, V6, P2768, DOI 10.4161/cc.6.22.4933; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; Hussain SG, 2007, BIOCHEM BIOPH RES CO, V355, P365, DOI 10.1016/j.bbrc.2007.01.156; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; KHAN TK, 2008, NEUROBIOL A IN PRESS; Kim HS, 2007, J NEUROSCI RES, V85, P1528, DOI 10.1002/jnr.21267; Kudo T, 2002, ANN NY ACAD SCI, V977, P349, DOI 10.1111/j.1749-6632.2002.tb04837.x; La Bella V, 2007, NEUROCHEM RES, V32, P1081, DOI 10.1007/s11064-006-9277-6; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Leclerc GM, 2000, BIOTECHNIQUES, V29, P590, DOI 10.2144/00293rr02; Lewerenz J, 2003, J NEUROCHEM, V87, P522, DOI 10.1046/j.1471-4159.2003.02019.x; Lewerenz J, 2006, J NEUROCHEM, V98, P916, DOI 10.1111/j.1471-4159.2006.03921.x; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu YB, 1997, J NEUROCHEM, V69, P2285; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005; Maher P, 2008, J NEUROCHEM, V107, P690, DOI 10.1111/j.1471-4159.2008.05620.x; MATSUOKA HC, 2002, BLOOD, V99, P736; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Page G, 2006, NEUROSCIENCE, V139, P1343, DOI 10.1016/j.neuroscience.2006.01.047; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; RAVINDRANATH V, 1990, BIOCHEM BIOPH RES CO, V169, P1075, DOI 10.1016/0006-291X(90)92004-J; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Sagara Y, 1996, J NEUROSCI, V16, P497; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sonnen JA, 2008, FREE RADICAL BIO MED, V45, P219, DOI 10.1016/j.freeradbiomed.2008.04.022; Sontheimer H, 2003, TRENDS NEUROSCI, V26, P543, DOI 10.1016/j.tins.2003.08.007; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Suen KC, 2003, J BIOL CHEM, V278, P49819, DOI 10.1074/jbc.M306503200; Tan S, 2001, J CELL BIOL, V152, P997, DOI 10.1083/jcb.152.5.997; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhu Y, 2008, J NEUROSCI, V28, P2168, DOI 10.1523/JNEUROSCI.5232-07.2008	71	145	152	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1106	1115		10.1074/jbc.M807325200	http://dx.doi.org/10.1074/jbc.M807325200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19017641	Green Published, hybrid			2022-12-27	WOS:000262122900047
J	Pichiorri, F; Okumura, H; Nakamura, T; Garrison, PN; Gasparini, P; Suh, SS; Druck, T; McCorkell, KA; Barnes, LD; Croce, CM; Huebner, K				Pichiorri, Flavia; Okumura, Hiroshi; Nakamura, Tatsuya; Garrison, Preston N.; Gasparini, Pierluigi; Suh, Sung-Suk; Druck, Teresa; McCorkell, Kelly A.; Barnes, Larry D.; Croce, Carlo M.; Huebner, Kay			Correlation of Fragile Histidine Triad (Fhit) Protein Structural Features with Effector Interactions and Biological Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; TUMOR-SUPPRESSOR; COLORECTAL-CANCER; INDUCED APOPTOSIS; TUMORIGENICITY; GENE; LUNG; MODULATION; EXPRESSION; FAMILY	We have previously shown that Fhit tumor suppressor protein interacts with Hsp60 chaperone machinery and ferredoxin reductase (Fdxr) protein. Fhit-effector interactions are associated with a Fhit-dependent increase in Fdxr stability, followed by generation of reactive oxygen species and apoptosis induction under conditions of oxidative stress. To define Fhit structural features that affect interactions, downstream signaling, and biological outcomes, we used cancer cells expressing Fhit mutants with amino acid substitutions that alter enzymatic activity, enzyme substrate binding, or phosphorylation at tyrosine 114. Gastric cancer cell clones stably expressing mutants that do not bind substrate or cannot be phosphorylated showed decreased binding to Hsp60 and Fdxr and reduced mitochondrial localization. Expression of Fhit or mutants that bind interactor proteins results in oxidative damage and accumulation of cells in G(2)/M or sub-G(1) fractions after peroxide treatment; non-interacting mutants are defective in these biological effects. Gastric cancer clones expressing noncomplexing Fhit mutants show reduction of Fhit tumor suppressor activity, confirming that substrate binding, interaction with heat shock proteins, mitochondrial localization, and interaction with Fdxr are important for Fhit tumor suppressor function.	[Pichiorri, Flavia; Okumura, Hiroshi; Nakamura, Tatsuya; Gasparini, Pierluigi; Suh, Sung-Suk; Druck, Teresa; McCorkell, Kelly A.; Croce, Carlo M.; Huebner, Kay] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Garrison, Preston N.; Barnes, Larry D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health San Antonio	Huebner, K (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, BRT Rm 916,460 W 12th Ave, Columbus, OH 43210 USA.	kay.huebner@osumc.edu	Young, Richard A/F-6495-2012; Gasparini, Pierluigi/ABA-2811-2021	Young, Richard A/0000-0001-8855-8647; Gasparini, Pierluigi/0000-0001-8311-8845	National Institutes of Health [CA77738, CA132453, CA115965]; Associazione Italiana Ricerca Cancro; NATIONAL CANCER INSTITUTE [R01CA115965, P01CA077738, R01CA132453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana Ricerca Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77738, CA132453, and CA115965 ( USPHS). This work was also supported by grants from the Associazione Italiana Ricerca Cancro. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both authors contributed equally to this work.	Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; BERNET D, 1991, FEBS LETT, V283, P286, DOI 10.1016/0014-5793(91)80609-7; Bianchi F, 2006, P NATL ACAD SCI USA, V103, P18981, DOI 10.1073/pnas.0605821103; Cantor JP, 2007, INT J CANCER, V120, P24, DOI 10.1002/ijc.22073; Garrison PN, 2005, BIOCHEMISTRY-US, V44, P6286, DOI 10.1021/bi047670s; Guerrette S, 1998, MOL CELL BIOL, V18, P6616, DOI 10.1128/MCB.18.11.6616; Huebner K, 2003, BRIT J CANCER, V88, P1501, DOI 10.1038/sj.bjc.6600937; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Ishii H, 2001, CANCER RES, V61, P1578; Ji L, 1999, CANCER RES, V59, P3333; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Pace HC, 1998, P NATL ACAD SCI USA, V95, P5484, DOI 10.1073/pnas.95.10.5484; Pekarsky Y, 2004, P NATL ACAD SCI USA, V101, P3775, DOI 10.1073/pnas.0400481101; Roz L, 2002, P NATL ACAD SCI USA, V99, P3615, DOI 10.1073/pnas.062030799; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schmutte C, 1998, CANCER RES, V58, P4537; Semba S, 2006, ONCOGENE, V25, P2860, DOI 10.1038/sj.onc.1209323; Siprashvili Z, 1997, P NATL ACAD SCI USA, V94, P13771, DOI 10.1073/pnas.94.25.13771; Trapasso F, 2003, P NATL ACAD SCI USA, V100, P1592, DOI 10.1073/pnas.0437915100; Trapasso F, 2008, J BIOL CHEM, V283, P13736, DOI 10.1074/jbc.M709062200	22	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1040	1049		10.1074/jbc.M806638200	http://dx.doi.org/10.1074/jbc.M806638200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004824	Green Published, hybrid			2022-12-27	WOS:000262122900040
J	Shin, JH; Heo, GY; Kelman, Z				Shin, Jae-Ho; Heo, Gun-Young; Kelman, Zvi			The Methanothermobacter thermautotrophicus MCM Helicase Is Active as a Hexameric Ring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME MAINTENANCE PROTEIN; METHANOBACTERIUM-THERMOAUTOTROPHICUM MCM; COLI DNAB HELICASE; SULFOLOBUS-SOLFATARICUS; ESCHERICHIA-COLI; COMPLEX; MECHANISM; TRANSLOCATION; POLYMORPHISM; REVEALS	The minichromosome maintenance (MCM) complex is thought to function as the replicative helicase in archaea and eukarya. The structure of the single MCM protein homologue from the archaeon Methanothermobacter thermautotrophicus is not yet clear, and hexameric, heptameric, octameric, and dodecameric structures, open rings, and filamentous structures have been reported. Using a combination of biochemical and structural analysis, it is shown here that the M. thermautotrophicus MCM helicase is active as a hexamer.	[Heo, Gun-Young; Kelman, Zvi] Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA; [Shin, Jae-Ho] Kyungpook Natl Univ, Coll Agr & Life Sci, Div Appl Biol & Chem, Taegu 702701, South Korea	University System of Maryland; University of Maryland Baltimore; Kyungpook National University	Kelman, Z (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	kelman@umbi.umd.edu			National Science Foundation [MCB-0815646]	National Science Foundation(National Science Foundation (NSF))	This work was supported by Grant MCB-0815646 from the National Science Foundation ( to Z.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; Chen YJ, 2005, J MOL BIOL, V346, P389, DOI 10.1016/j.jmb.2004.11.076; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2008, EMBO J, V27, P2250, DOI 10.1038/emboj.2008.135; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Costa A, 2006, NUCLEIC ACIDS RES, V34, P5829, DOI 10.1093/nar/gkl708; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; Grainge I, 2003, NUCLEIC ACIDS RES, V31, P4888, DOI 10.1093/nar/gkg662; Haugland GT, 2006, NUCLEIC ACIDS RES, V34, P6337, DOI 10.1093/nar/gkl864; Kasiviswanathan R, 2005, NUCLEIC ACIDS RES, V33, P4940, DOI 10.1093/nar/gki807; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Liu W, 2008, NUCLEIC ACIDS RES, V36, P3235, DOI 10.1093/nar/gkn183; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Poplawski A, 2001, J BIOL CHEM, V276, P49371, DOI 10.1074/jbc.M108519200; Pucci B, 2004, J BIOL CHEM, V279, P49222, DOI 10.1074/jbc.M408967200; SANMARTIN MC, 1995, J STRUCT BIOL, V114, P167, DOI 10.1006/jsbi.1995.1016; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Shin Jae-Ho, 2006, BIOS, V77, P37, DOI 10.1893/0005-3155(2006)77[37:RACAPC]2.0.CO;2; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Tropea Joseph E, 2007, Methods Mol Biol, V363, P1, DOI 10.1007/978-1-59745-209-0_1; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297; Yu X, 2002, EMBO REP, V3, P792, DOI 10.1093/embo-reports/kvf160; ZEIKUS JG, 1972, J BACTERIOL, V109, P707, DOI 10.1128/JB.109.2.707-713.1972	35	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					540	546		10.1074/jbc.M806803200	http://dx.doi.org/10.1074/jbc.M806803200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001412	hybrid			2022-12-27	WOS:000261974800059
J	Khrapunov, S; Cheng, H; Hegde, S; Blanchard, J; Brenowitz, M				Khrapunov, Sergei; Cheng, Huiyong; Hegde, Subray; Blanchard, John; Brenowitz, Michael			Solution Structure and Refolding of the Mycobacterium tuberculosis Pentapeptide Repeat Protein MfpA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE; AGGREGATION; SEGMENTS; MIMICRY; DNA	The pentapeptide repeat is a recently discovered protein fold. Mycobacterium tuberculosis MfpA is a founding member of the pentapeptide repeat protein (PRP) family that confers resistance to the antibiotic fluoroquinolone by binding to DNA gyrase and inhibiting its activity. The size, shape, and surface potential of MfpA mimics duplex DNA. As an initial step in a comprehensive biophysical analysis of the role of PRPs in the regulation of cellular topoisomerase activity and conferring antibiotic resistance, we have explored the solution structure and refolding of MfpA by fluorescence spectroscopy, CD, and analytical centrifugation. A unique CD spectrum for the pentapeptide repeat fold is described. This spectrum reveals a native structure whose beta-strands and turns within the right-handed quadrilateral beta-helix that define the PRP fold differ from canonical secondary structure types. MfpA refolded from urea or guanidium by dialysis or dilution forms stable aggregates of monomers whose secondary and tertiary structure are not native. In contrast, MfpA refolded using a novel "time-dependent renaturation" protocol yields protein with native secondary, tertiary, and quaternary structure. The generality of "time-dependent renaturation" to other proteins and denaturation methods is discussed.	[Khrapunov, Sergei; Cheng, Huiyong; Hegde, Subray; Blanchard, John; Brenowitz, Michael] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Khrapunov, S (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Khrapunov, Sergei/R-8124-2019	Khrapunov, Sergei/0000-0002-6181-9525	National Institutes of Health, NIGMS [R01-GM079618]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079618] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01-GM079618. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baldwin RL, 2002, ADV PROTEIN CHEM, V62, P361; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Cho JH, 2004, J MOL BIOL, V338, P827, DOI 10.1016/j.jmb.2004.02.073; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; Dryden DTF, 2006, TRENDS BIOTECHNOL, V24, P378, DOI 10.1016/j.tibtech.2006.06.004; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hegde SS, 2005, SCIENCE, V308, P1480, DOI 10.1126/science.1110699; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kathir KM, 2005, J BIOL CHEM, V280, P29682, DOI 10.1074/jbc.M504389200; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P452; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li Fusheng, 2002, Methods Mol Biol, V182, P19; MANAVALAN P, 1983, NATURE, V305, P831, DOI 10.1038/305831a0; Matsuo K, 2005, J BIOCHEM, V138, P79, DOI 10.1093/jb/mvi101; Putnam CD, 2005, DNA REPAIR, V4, P1410, DOI 10.1016/j.dnarep.2005.08.007; Schmid F, 2005, PROTEIN FOLDING HANDBOOK, P916, DOI 10.1002/9783527619498.ch25; Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Sreerama N, 2003, PROTEIN SCI, V12, P384, DOI 10.1110/ps.0235003; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; TANFORD C, 1968, ADV PROTEIN CHEM, V23, P12; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Uversky VN, 1999, PROTEIN SCI, V8, P161; VENYAMINOV SY, 1994, ANAL BIOCHEM, V222, P176, DOI 10.1006/abio.1994.1470; Vetting MW, 2006, BIOCHEMISTRY-US, V45, P1, DOI 10.1021/bi052130w; Wallace BA, 2003, PROTEIN SCI, V12, P875, DOI 10.1110/ps.0229603; Wang Y, 1996, PROTEIN SCI, V5, P1898, DOI 10.1002/pro.5560050916	34	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36290	36299		10.1074/jbc.M804702200	http://dx.doi.org/10.1074/jbc.M804702200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18977756	Green Published, hybrid			2022-12-27	WOS:000261840500025
J	Madrid, DC; Ting, LM; Waller, KL; Schramm, VL; Kim, K				Madrid, Dennis C.; Ting, Li-Min; Waller, Karena L.; Schramm, Vern L.; Kim, Kami			Plasmodium falciparum Purine Nucleoside Phosphorylase Is Critical for Viability of Malaria Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMIAUTOMATED MICRODILUTION TECHNIQUE; DEFICIENT ERYTHROCYTE CULTURE; TRANSITION-STATE ANALOG; ADENOSINE-DEAMINASE; SALVAGE PATHWAYS; GENE-EXPRESSION; PLASMA-MEMBRANE; IMMUCILLIN-H; IDENTIFICATION; INHIBITORS	Human malaria infections resulting from Plasmodium falciparum have become increasingly difficult to treat due to the emergence of drug-resistant parasites. The P.falciparum purine salvage enzyme purine nucleoside phosphorylase (PfPNP) is a potential drug target. Previous studies, in which PfPNP was targeted by transition state analogue inhibitors, found that those inhibiting human PNP and PfPNPs killed P. falciparum in vitro. However, many drugs have off-target interactions, and genetic evidence is required to demonstrate single target action for this class of potential drugs. We used targeted gene disruption in P. falciparum strain 3D7 to ablate PNP expression, yielding transgenic 3D7 parasites (Delta pfpnp). Lysates of the Delta pfpnp parasites showed no PNP activity, but activity of another purine salvage enzyme, adenosine deaminase (PfADA), was normal. When compared with wild-type 3D7, the Delta pfpnp parasites showed a greater requirement for exogenous purines and a severe growth defect at physiological concentrations of hypoxanthine. Drug assays using immucillins, specific transition state inhibitors of PNP, were performed on wild-type and Delta pfpnp parasites. The Delta pfpnp parasites were more sensitive to PNP inhibitors that bound hPNP tighter and less sensitive to MT-ImmH, an inhibitor with 100-fold preference for PfPNP over hPNP. The results demonstrate the importance of purine salvage in P.falciparum and validate PfPNP as the target of immucillins.	[Madrid, Dennis C.; Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Ting, Li-Min; Kim, Kami] Albert Einstein Coll Med, Div Infect Dis, Dept Med, Bronx, NY 10461 USA; [Waller, Karena L.] Albert Einstein Coll Med, Div Cardiol, Dept Med, Bronx, NY 10461 USA; [Schramm, Vern L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Kim, K (corresponding author), 1300 Morris Pk Ave,Ullmann 1225, Bronx, NY 10461 USA.	kkim@aecom.yu.edu		Kim, Kami/0000-0003-3384-152X; Waller, Karena/0000-0001-8786-4407	National Institutes of Health [5 F31 AI056665-4, T32-CM007288]; AECOM Medical Science Training Program [R01 AI049512, R21AI052469]; United States Army Research [W81XWH-05-2-0025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI056665, R21AI052469, R01AI049512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AECOM Medical Science Training Program; United States Army Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants NSRA 5 F31 AI056665-4 (to D.C.M.), T32-CM007288 (AECOM Medical Science Training Program), R01 AI049512 (to V.L.S.), and R21AI052469 ( to K. K.). This work was also supported by United States Army Research Grant W81XWH-05-2-0025 (to K.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asahi H, 1996, PARASITOLOGY, V113, P19, DOI 10.1017/S0031182000066233; Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; Berman P A, 1991, Adv Exp Med Biol, V309A, P165; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; Chaudhary K, 2004, J BIOL CHEM, V279, P31221, DOI 10.1074/jbc.M404232200; DADDONA PE, 1984, J BIOL CHEM, V259, P1472; DADDONA PE, 1986, J BIOL CHEM, V261, P1667; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Downie MJ, 2006, MOL MICROBIOL, V60, P738, DOI 10.1111/j.1365-2958.2006.05125.x; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; ELABBADI N, 1992, ANTIMICROB AGENTS CH, V36, P50, DOI 10.1128/AAC.36.1.50; Evans GB, 2001, J ORG CHEM, V66, P5723, DOI 10.1021/jo0155613; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fidock DA, 2000, MOL BIOCHEM PARASIT, V110, P1, DOI 10.1016/S0166-6851(00)00249-8; Gandhi V, 2005, BLOOD, V106, P4253, DOI 10.1182/blood-2005-03-1309; Gandhi V, 2007, SEMIN ONCOL, V34, pS8, DOI 10.1053/j.seminoncol.2007.11.003; Goodyer ID, 1997, EXP PARASITOL, V86, P158, DOI 10.1006/expr.1997.4156; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; Hayward RE, 2000, MOL MICROBIOL, V35, P6, DOI 10.1046/j.1365-2958.2000.01730.x; Kadekoppala M, 2001, MOL BIOCHEM PARASIT, V112, P211, DOI 10.1016/S0166-6851(00)00368-6; Keough DT, 1999, MOL BIOCHEM PARASIT, V98, P29, DOI 10.1016/S0166-6851(98)00139-X; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; Kicska GA, 2002, J BIOL CHEM, V277, P3219, DOI 10.1074/jbc.M105905200; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Quashie NB, 2008, BIOCHEM J, V411, P287, DOI 10.1042/BJ20071460; REYES P, 1982, MOL BIOCHEM PARASIT, V5, P275, DOI 10.1016/0166-6851(82)90035-4; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; Spychala J, 1996, P NATL ACAD SCI USA, V93, P1232, DOI 10.1073/pnas.93.3.1232; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VANDERWEYDEN MB, 1976, J BIOL CHEM, V251, P5448; Wang P, 2002, MOL BIOCHEM PARASIT, V123, P1, DOI 10.1016/S0166-6851(02)00105-6; WELLEMS TE, 1987, CELL, V49, P633, DOI 10.1016/0092-8674(87)90539-3; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	42	55	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35899	35907		10.1074/jbc.M807218200	http://dx.doi.org/10.1074/jbc.M807218200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957439	Green Published, hybrid			2022-12-27	WOS:000261687900065
J	Tanous, C; Soutourina, O; Raynal, B; Hullo, MF; Mervelet, P; Gilles, AM; Noirot, P; Danchin, A; England, P; Martin-Verstraete, I				Tanous, Catherine; Soutourina, Olga; Raynal, Bertrand; Hullo, Marie-Francoise; Mervelet, Peggy; Gilles, Anne-Marie; Noirot, Philippe; Danchin, Antoine; England, Patrick; Martin-Verstraete, Isabelle			The CymR Regulator in Complex with the Enzyme CysK Controls Cysteine Metabolism in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; SERINE ACETYLTRANSFERASE; ESCHERICHIA-COLI; SYNTHASE COMPLEX; PYRIDOXAL 5'-PHOSPHATE; GLUTAMINE-SYNTHETASE; TRANSCRIPTION FACTOR; FUNCTIONAL-ANALYSIS; GLOBAL REGULATOR; GENE-EXPRESSION	Several enzymes have evolved as sensors in signal transduction pathways to control gene expression, thereby allowing bacteria to adapt efficiently to environmental changes. We recently identified the master regulator of cysteine metabolism in Bacillus subtilis, CymR, which belongs to the poorly characterized Rrf2 family of regulators. We now report that the signal transduction mechanism controlling CymR activity in response to cysteine availability involves the formation of a stable complex with CysK, a key enzyme for cysteine biosynthesis. We carried out a comprehensive quantitative characterization of this regulator-enzyme interaction by surface plasmon resonance and analytical ultracentrifugation. We also showed that O-acetylserine plays a dual role as a substrate of CysK and as an effector modulating the CymR-CysK complex formation. The ability of B. subtilis CysK to bind to CymR appears to be correlated to the loss of its capacity to form a cysteine synthase complex with CysE. We propose an original model, supported by the determination of the intracellular concentrations of the different partners, by which CysK positively regulates CymR in sensing the bacterial cysteine pool.	[Raynal, Bertrand; England, Patrick] Inst Pasteur, F-75724 Paris 15, France; [Tanous, Catherine; Soutourina, Olga; Hullo, Marie-Francoise; Gilles, Anne-Marie; Danchin, Antoine; Martin-Verstraete, Isabelle] Inst Pasteur, Unite Genet Genomes Bacteriens, F-75724 Paris 15, France; [Tanous, Catherine; Soutourina, Olga; Hullo, Marie-Francoise; Gilles, Anne-Marie; Danchin, Antoine; Martin-Verstraete, Isabelle] Inst Pasteur, CNRS, URA2171, F-75724 Paris 15, France; [England, Patrick] Inst Pasteur, CNRS, URA2185, F-75724 Paris 15, France; [Mervelet, Peggy; Noirot, Philippe] INRA, Unite Genet Microbienne, F-78352 Jouy En Josas, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; UDICE-French Research Universities; Universite Paris Saclay	England, P (corresponding author), Inst Pasteur, 25 Rue Dr Roux, F-75724 Paris 15, France.	patrick.england@pasteur.fr; isabelle.martin-verstraete@pasteur.fr	Martin-Verstraete, Isabelle/R-7109-2019; Soutourina, Olga/F-2042-2015	Martin-Verstraete, Isabelle/0000-0002-8376-7690; Soutourina, Olga/0000-0001-6439-7228; ENGLAND, Patrick/0000-0001-6410-5918; raynal, Bertrand/0000-0001-5634-0408; Danchin, Antoine/0000-0002-6350-5001	Centre National de la Recherche Scientifique [URA 2171]; Agence National de la Recherche [NT05-2-44860]; Institut Pasteur [PTR256]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); Institut Pasteur(European Commission)	This work was supported by Centre National de la Recherche Scientifique Grant URA 2171, Agence National de la Recherche Grant NT05-2-44860, and Institut Pasteur Grant PTR256. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albanesi D, 2005, J BACTERIOL, V187, P7631, DOI 10.1128/JB.187.22.7631-7638.2005; Auger S, 2005, BIOCHIMIE, V87, P231, DOI 10.1016/j.biochi.2004.09.007; Auger S, 2002, J BACTERIOL, V184, P5179, DOI 10.1128/JB.184.18.5179-5186.2002; Balaji S, 2007, J MOL BIOL, V372, P1108, DOI 10.1016/j.jmb.2007.06.084; Belitsky BR, 2004, J MOL BIOL, V340, P655, DOI 10.1016/j.jmb.2004.05.020; Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Bertoldi M, 2005, BIOCHEM J, V389, P885, DOI 10.1042/BJ20050279; Bettati S, 2000, J BIOL CHEM, V275, P40244, DOI 10.1074/jbc.M007015200; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; Bogdanova N, 1997, PLANT J, V11, P251, DOI 10.1046/j.1365-313X.1997.11020251.x; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Burguiere P, 2005, J BACTERIOL, V187, P6019, DOI 10.1128/JB.187.17.6019-6030.2005; BYRNE CR, 1988, J BACTERIOL, V170, P3150, DOI 10.1128/jb.170.7.3150-3157.1988; Chinthalapudi K, 2008, PROTEINS, V72, P1222, DOI 10.1002/prot.22013; Choi SY, 2006, J BACTERIOL, V188, P5741, DOI 10.1128/JB.00443-06; Clausen T, 2000, EMBO J, V19, P831, DOI 10.1093/emboj/19.5.831; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DENK D, 1987, J GEN MICROBIOL, V133, P515; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; England P, 1997, BIOCHEMISTRY-US, V36, P164, DOI 10.1021/bi961419y; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Fisher SH, 2008, P NATL ACAD SCI USA, V105, P1014, DOI 10.1073/pnas.0709949105; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; GAGNON Y, 1994, J BIOL CHEM, V269, P7473; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Guedon E, 2006, AMINO ACID BIOSYNTHE, P1, DOI [10.1007/7171_2006_060, DOI 10.1007/7171_2006_060]; Holtmann G, 2004, J BACTERIOL, V186, P1683, DOI 10.1128/JB.186.6.1683-1693.2004; Huang B, 2005, J BACTERIOL, V187, P3201, DOI 10.1128/JB.187.9.3201-3205.2005; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; Hullo MF, 2007, J BACTERIOL, V189, P187, DOI 10.1128/JB.01273-06; James P, 1996, GENETICS, V144, P1425; Joly N, 2004, J BIOL CHEM, V279, P33123, DOI 10.1074/jbc.M403615200; KREDICH NM, 1969, J BIOL CHEM, V244, P2428; KREDICH NM, 1996, ESCHERICHIA COLI SAL, V2, P514; Liszewska F, 2007, BBA-PROTEINS PROTEOM, V1774, P450, DOI 10.1016/j.bbapap.2007.02.009; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2001, BIOSCI BIOTECH BIOCH, V65, P865, DOI 10.1271/bbb.65.865; MUNIER H, 1991, EUR J BIOCHEM, V196, P469, DOI 10.1111/j.1432-1033.1991.tb15838.x; Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103; Peres CM, 2006, J BACTERIOL, V188, P8662, DOI 10.1128/JB.01312-06; Schnell R, 2007, J BIOL CHEM, V282, P23473, DOI 10.1074/jbc.M703518200; Schreiber V, 2000, MOL MICROBIOL, V35, P765, DOI 10.1046/j.1365-2958.2000.01747.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; van der Ploeg JR, 2001, FEMS MICROBIOL LETT, V201, P29, DOI 10.1016/S0378-1097(01)00225-7; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Viguier C, 2005, FEMS MICROBIOL LETT, V246, P235, DOI 10.1016/j.femsle.2005.04.012; Wirtz M, 2001, EUR J BIOCHEM, V268, P686, DOI 10.1046/j.1432-1327.2001.01920.x; Wray LV, 2005, J BIOL CHEM, V280, P33298, DOI 10.1074/jbc.M504957200; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200; Zhao CH, 2006, BIOCHEM BIOPH RES CO, V341, P911, DOI 10.1016/j.bbrc.2006.01.054	56	68	71	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35551	35560		10.1074/jbc.M805951200	http://dx.doi.org/10.1074/jbc.M805951200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18974048	Green Published, hybrid			2022-12-27	WOS:000261687900027
J	Wells, RD				Wells, Robert D.			Mutation Spectra in Fragile X Syndrome Induced by Deletions of CGG(.)CCG Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DE-NOVO DELETION; ORIENTATION-DEPENDENT INSTABILITY; MYOTONIC-DYSTROPHY TYPE-1; CGG TRIPLET REPEATS; B DNA CONFORMATIONS; FMR1 GENE; FULL MUTATION; IN-VIVO; TRINUCLEOTIDE REPEATS; INACTIVATION PATTERN		Texas A&M Hlth Sci Ctr, Ctr Genome Res, Inst Biosci & Technol, Texas Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wells, RD (corresponding author), Texas A&M Hlth Sci Ctr, Ctr Genome Res, Inst Biosci & Technol, Texas Med Ctr, Houston, TX 77030 USA.	rwells@ibt.tamhsc.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011347] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES11347] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALBRIGHT SG, 1994, AM J MED GENET, V51, P294, DOI 10.1002/ajmg.1320510403; Bacolla A, 1997, J BIOL CHEM, V272, P16783, DOI 10.1074/jbc.272.27.16783; Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEGRAAFF E, 1995, HUM MOL GENET, V4, P45; deGraaff E, 1996, AM J MED GENET, V64, P302, DOI 10.1002/(SICI)1096-8628(19960809)64:2<302::AID-AJMG14>3.0.CO;2-J; Edamura KN, 2005, HUM GENET, V118, P301, DOI 10.1007/s00439-005-0037-5; Fan HX, 2005, AM J MED GENET A, V136A, P214, DOI 10.1002/ajmg.a.30807; GARCIA AD, 2000, HUM GENET, V106, P366; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; Grasso M, 1999, AM J MED GENET, V85, P311, DOI 10.1002/(SICI)1096-8628(19990730)85:3<311::AID-AJMG24>3.0.CO;2-A; Gronskov K, 1997, AM J HUM GENET, V61, P961, DOI 10.1086/514872; Gronskov K, 1998, HUM GENET, V102, P440, DOI 10.1007/s004390050718; GU YH, 1994, HUM MOL GENET, V3, P1705, DOI 10.1093/hmg/3.9.1705; Hammond LS, 1997, AM J MED GENET, V72, P430; HIRST M, 1995, AM J HUM GENET, V56, P67; Hirst MC, 1998, NUCLEIC ACIDS RES, V26, P2353, DOI 10.1093/nar/26.10.2353; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kosynider B, 2007, DNA REPAIR, V6, P1850, DOI 10.1016/j.dnarep.2007.07.014; Kovtun IV, 2008, CELL RES, V18, P198, DOI 10.1038/cr.2008.5; LUGENBEEL KA, 1995, NAT GENET, V10, P483, DOI 10.1038/ng0895-483; Mannermaa A, 1996, AM J MED GENET, V64, P293, DOI 10.1002/(SICI)1096-8628(19960809)64:2<293::AID-AJMG12>3.0.CO;2-A; MEIJER H, 1994, HUM MOL GENET, V3, P615; Meservy JL, 2003, MOL CELL BIOL, V23, P3152, DOI 10.1128/MCB.23.9.3152-3162.2003; Mila M, 1996, J MED GENET, V33, P338, DOI 10.1136/jmg.33.4.338; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Napierala M, 2005, J BIOL CHEM, V280, P37366, DOI 10.1074/jbc.M508065200; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pelletier R, 2003, MOL CELL BIOL, V23, P1349, DOI 10.1128/MCB.23.4.1349-1357.2003; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Petek E, 1999, AM J MED GENET, V84, P229, DOI 10.1002/(SICI)1096-8628(19990528)84:3<229::AID-AJMG13>3.3.CO;2-K; QUAN F, 1995, HUM MOL GENET, V4, P1681, DOI 10.1093/hmg/4.9.1681; QUAN F, 1995, AM J HUM GENET, V56, P1042; SCHMIDT M, 1994, AM J MED GENET, V51, P451, DOI 10.1002/ajmg.1320510429; Schmucker B, 1996, HUM GENET, V98, P409, DOI 10.1007/s004390050230; Shimizu M, 1996, J MOL BIOL, V258, P614, DOI 10.1006/jmbi.1996.0273; TARLETON J, 1993, HUM MOL GENET, V2, P1973, DOI 10.1093/hmg/2.11.1973; TROTTIER Y, 1994, AM J MED GENET, V51, P454, DOI 10.1002/ajmg.1320510431; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Wang YC, 1997, HUM MUTAT, V10, P393, DOI 10.1002/(SICI)1098-1004(1997)10:5<393::AID-HUMU10>3.3.CO;2-Q; Wang YH, 2007, FRONT BIOSCI-LANDMRK, V12, P4731, DOI 10.2741/2422; Wells R.D., 2006, GENETIC INSTABILITIE; Wells RD, 2005, NUCLEIC ACIDS RES, V33, P3785, DOI 10.1093/nar/gki697; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; WIEGERS AM, 1994, GENET COUNSEL, V5, P377; WOHRLE D, 1992, AM J HUM GENET, V51, P299; Wojciechowska M, 2005, J BIOL CHEM, V280, P941, DOI 10.1074/jbc.M410427200; Wojciechowska M, 2006, J BIOL CHEM, V281, P24531, DOI 10.1074/jbc.M603888200; Wolff DJ, 1997, HUM GENET, V100, P256, DOI 10.1007/s004390050501; Zuhlke CH, 2004, EUR J HUM GENET, V12, P979, DOI 10.1038/sj.ejhg.5201257	50	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7407	7411		10.1074/jbc.R800024200	http://dx.doi.org/10.1074/jbc.R800024200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	18957433	Green Published, hybrid			2022-12-27	WOS:000264195600002
J	Zoghbi, HY; Orr, HT				Zoghbi, Huda Y.; Orr, Harry T.			Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SCA1 TRANSGENIC MICE; BULBAR MUSCULAR-ATROPHY; ALPHA-DEFICIENT MICE; RECEPTOR ROR-ALPHA; MOUSE MODEL; CAG REPEAT; TRINUCLEOTIDE REPEAT; NUCLEAR-LOCALIZATION; MUTANT HUNTINGTIN; AXH DOMAIN	Spinocerebellar ataxia type 1 (SCA1) is one of nine inherited neurodegenerative diseases caused by the expansion of a CAG trinucleotide repeat encoding a polyglutamine tract. SCA1 patients lose motor coordination and develop slurred speech, spasticity, and cognitive impairments. Difficulty with coordinating swallowing and breathing eventually causes death. Genetic evidence indicates that the disease mutation induces a toxic gain of function in the SCA1 encoded protein ATXN1. The discovery that residues in ATXN1 outside of the polyglutamine tract are crucial for pathogenesis hinted that alterations in the normal function of this protein are linked to its toxicity. Biochemical and genetic studies provide evidence that the polyglutamine expansion enhances interactions that are normally regulated by phosphorylation at Ser(776) and a subsequent alteration in its interaction with other cellular proteins. Moreover, the finding that other ATXN1 interactions are decreased in disease suggests that the polyglutamine expansion contributes to disease by both a gain-of-function mechanism and partial loss of function.	[Orr, Harry T.] Univ Minnesota, Inst Human Genet, Dept Biochem, Minneapolis, MN 55455 USA; [Orr, Harry T.] Univ Minnesota, Inst Human Genet, Dept Biophys, Minneapolis, MN 55455 USA; [Orr, Harry T.] Univ Minnesota, Inst Human Genet, Dept Mol Biol, Minneapolis, MN 55455 USA; [Orr, Harry T.] Univ Minnesota, Inst Human Genet, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Howard Hughes Medical Institute	Orr, HT (corresponding author), Univ Minnesota, Inst Human Genet, Dept Biochem, Minneapolis, MN 55455 USA.	orrxx002@umn.edu		Zoghbi, Huda/0000-0002-0700-3349; Orr, Harry/0000-0001-6118-741X	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS27699, NS22920, R01 NS027699, NS45667] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699, R01NS045667, R01NS022920, R37NS022920] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hadj-Sahraoui N, 2001, DEV BRAIN RES, V126, P201, DOI 10.1016/S0165-3806(01)00095-5; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Mitzutani A., 2005, EMBO J, V24, P3339; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Riley BE, 2005, J BIOL CHEM, V280, P21942, DOI 10.1074/jbc.M501677200; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	42	152	155	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7425	7429		10.1074/jbc.R800041200	http://dx.doi.org/10.1074/jbc.R800041200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	18957430	Green Published, hybrid			2022-12-27	WOS:000264195600005
J	Tyagi, R; Shenoy, AR; Visweswariah, SS				Tyagi, Richa; Shenoy, Avinash R.; Visweswariah, Sandhya S.			Characterization of an Evolutionarily Conserved Metallophosphoesterase That Is Expressed in the Fetal Brain and Associated with the WAGR Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; WILMS TUMOR ASSOCIATION; BIOCHEMICAL-CHARACTERIZATION; MYCOBACTERIUM-TUBERCULOSIS; PROTEIN PHOSPHATASES; MUTATIONAL ANALYSIS; HUMAN CHROMOSOME-11; ACID-PHOSPHATASE; ANIRIDIA REGION; PHYSICAL MAP	Among the human diseases that result from chromosomal aberrations, a de novo deletion in chromosome 11p13 is clinically associated with a syndrome characterized by Wilms' tumor, aniridia, genitourinary anomalies, and mental retardation (WAGR). Not all genes in the deleted region have been characterized biochemically or functionally. We have recently identified the first Class III cyclic nucleotide phosphodiesterase, Rv0805, from Mycobacterium tuberculosis, which biochemically and structurally belongs to the superfamily of metallophosphoesterases. We performed a large scale bioinformatic analysis to identify orthologs of the Rv0805 protein and identified many eukaryotic genes that included the human 239FB gene present in the region deleted in the WAGR syndrome. We report here the first detailed biochemical characterization of the rat 239FB protein and show that it possesses metallophosphodiesterase activity. Extensive mutational analysis identified residues that are involved in metal interaction at the binuclear metal center. Generation of a rat 239FB protein with a mutation corresponding to a single nucleotide polymorphism seen in human 239FB led to complete inactivation of the protein. A close ortholog of 239FB is found in adult tissues, and biochemical characterization of the 239AB protein demonstrated significant hydrolytic activity against 2',3'-cAMP, thus representing the first evidence for a Class III cyclic nucleotide phosphodiesterase in mammals. Highly conserved orthologs of the 239FB protein are found in Caenorhabditis elegans and Drosophila and, coupled with available evidence suggesting that 239FB is a tumor suppressor, indicate the important role this protein must play in diverse cellular events.	[Tyagi, Richa; Shenoy, Avinash R.; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019; tyagi, richa/A-7261-2015	Visweswariah, Sandhya/0000-0003-2786-7344; Shenoy, Avinash/0000-0001-6228-9303	Department of Biotechnology and the Council of Scientific and Industrial Research, Government of India	Department of Biotechnology and the Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaDepartment of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology and the Council of Scientific and Industrial Research, Government of India.	BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BEPLER G, 1994, P NATL ACAD SCI USA, V91, P5513, DOI 10.1073/pnas.91.12.5513; BONETTA L, 1990, SCIENCE, V250, P994, DOI 10.1126/science.2173146; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Chen SF, 2004, J BIOL CHEM, V279, P31854, DOI 10.1074/jbc.M401059200; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; COMPTON DA, 1988, CELL, V55, P827, DOI 10.1016/0092-8674(88)90138-9; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Dome JS, 2002, CURR OPIN PEDIATR, V14, P5, DOI 10.1097/00008480-200202000-00002; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EKRYLANDER B, 1991, J BONE MINER RES, V6, P365; FANTES JA, 1995, GENOMICS, V25, P447, DOI 10.1016/0888-7543(95)80045-N; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; GAWIN B, 1995, GENOMICS, V30, P37, DOI 10.1006/geno.1995.0006; GESSLER M, 1989, GENOMICS, V5, P43, DOI 10.1016/0888-7543(89)90084-0; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GESSLER M, 1989, AM J HUM GENET, V44, P486; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; HANSON IM, 1992, GENOMICS, V13, P1331, DOI 10.1016/0888-7543(92)90060-6; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; JUNIEN C, 1980, ANN GENET-PARIS, V23, P165; JUNIEN C, 1989, CYTOGENET CELL GENET, V51, P226, DOI 10.1159/000132793; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P7721, DOI 10.1093/nar/gkm868; Khalid MF, 2005, NUCLEIC ACIDS RES, V33, P6349, DOI 10.1093/nar/gki934; KOONIN EV, 1993, MOL MICROBIOL, V8, P785, DOI 10.1111/j.1365-2958.1993.tb01622.x; Lin YS, 2005, COMP BIOCHEM PHYS B, V141, P71, DOI 10.1016/j.cbpc.2005.01.011; McMillen L, 2003, BIOCHEM J, V372, P625, DOI 10.1042/BJ20021800; Miller DJ, 2007, PROTEIN SCI, V16, P1338, DOI 10.1110/ps.072764907; Newman J, 2004, ACTA CRYSTALLOGR D, V60, P610, DOI 10.1107/S0907444903029640; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; RICCARDI VM, 1978, PEDIATRICS, V61, P604; Schwartz F, 1997, GENE, V194, P57, DOI 10.1016/S0378-1119(97)00149-2; SCHWARTZ F, 1994, HUM GENET, V94, P658; SCHWARTZ F, 1995, GENOMICS, V29, P526, DOI 10.1006/geno.1995.9973; Seitz S, 2006, GENE CHROMOSOME CANC, V45, P612, DOI 10.1002/gcc.20325; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; SHIPMAN R, 1993, HUM GENET, V91, P455; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Uppenberg J, 1999, J MOL BIOL, V290, P201, DOI 10.1006/jmbi.1999.2896; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; ZANKOWALCZEWSKA M, 1987, BIOCHEMISTRY-US, V26, P1194, DOI 10.1021/bi00378a030; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	52	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5217	5228		10.1074/jbc.M805996200	http://dx.doi.org/10.1074/jbc.M805996200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19004815	hybrid			2022-12-27	WOS:000263416600052
J	Yadav, G; Prasad, RLA; Jha, BK; Rai, V; Bhakuni, V; Datta, K				Yadav, Gitanjali; Prasad, Ramachandra L. A.; Jha, Babal Kant; Rai, Vivek; Bhakuni, Vinod; Datta, Kasturi			Evidence for Inhibitory Interaction of Hyaluronan-binding Protein 1 (HABP1/p32/gC1qR) with Streptococcus pneumoniae Hyaluronidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; LYASE; PURIFICATION; ENZYME; CHONDROITINASES; DEGRADATION; COMPLEXES; SUBSTRATE; INVASION; RECEPTOR	Bacterial hyaluronan lyase enzymes are the major virulence factors that enable greater microbial ingress by cleaving hyaluronan (HA) polymers present predominantly in extracellular space of vertebrates. Based on the premise that effective inhibitors may bind to and stabilize HA thereby protecting it from degradation, here we investigated inhibitory activity of human hyaluronan-binding protein 1 (HABP1) on bacterial hyaluronidase because it is highly specific to HA and localized on the cell surface. Biochemical characterization revealed that HABP1 is a competitive inhibitor of Streptococcus pneumoniae hyaluronate lyase (SpnHL) with an IC50 value of 22 mu M. This is thus the first report of an endogenous protein inhibitor that may be used during natural antibacterial defense. Our findings also support a novel multipronged mechanism for the high efficacy of HABP1-mediated inhibition based on structural modeling of enzyme, substrate, and inhibitor. Evidence from docking simulations and contact interface interactions showed that the inherent charge asymmetry of HABP1 plays a key role in the inhibitory activity. This novel role of HABP1 may pave the way for peptide inhibitors as alternatives to synthetic chemicals in antibacterial research.	[Yadav, Gitanjali; Rai, Vivek] Natl Inst Plant Genome Res, Computat Biol Lab, New Delhi 110067, India; [Prasad, Ramachandra L. A.; Jha, Babal Kant; Datta, Kasturi] Jawaharlal Nehru Univ, Sch Environm Sci, Biochem Lab, New Delhi 110067, India; [Bhakuni, Vinod] Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Jawaharlal Nehru University, New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Yadav, G (corresponding author), Natl Inst Plant Genome Res, Computat Biol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	gy@nipgr.res.in; kdatta@mail.jnu.ac.in	RAI, VIVEK/D-5002-2009; jha, babal k/B-1803-2010	jha, babal k/0000-0002-7660-5255; Yadav, Gitanjali/0000-0001-6591-9964	Department of Biotechnology; Department of Science and Technology; Department of Biotechnology, Government of India	Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Supported by the Department of Biotechnology and Department of Science and Technology.; Supported by the Innovative Young Biotechnologist Award by the Department of Biotechnology, Government of India.	Akhtar MS, 2003, J BIOL CHEM, V278, P25509, DOI 10.1074/jbc.M301894200; Asada M, 1997, BIOSCI BIOTECH BIOCH, V61, P1030, DOI 10.1271/bbb.61.1030; Botzki A, 2004, J BIOL CHEM, V279, P45990, DOI 10.1074/jbc.M406146200; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; BRODYAGIN N A, 1970, Byulleten' Eksperimental'noi Biologii i Meditsiny, V70, P52; Chain E, 1939, NATURE, V144, P977, DOI 10.1038/144977b0; Csoka TB, 1997, INVAS METAST, V17, P297; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; DAY TD, 1950, NATURE, V166, P785, DOI 10.1038/166785b0; Deb TB, 1996, J BIOL CHEM, V271, P2206, DOI 10.1074/jbc.271.4.2206; DEB TB, 2001, HYALURONAN, V1, P365; DeLano WL, 2002, PYMOL USERS MANUAL; DORFMAN A, 1948, J BIOL CHEM, V174, P621; FISZERSZAFARZ B, 1968, P SOC EXP BIOL MED, V129, P300; Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x; GUPTA S, 1991, EUR J CELL BIOL, V56, P58; HAAS E, 1946, J BIOL CHEM, V163, P63; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1111/j.1574-6968.2000.tb08958.x; Ito S, 2000, VIROLOGY, V266, P110, DOI 10.1006/viro.1999.0054; IWASAKI Y, 1995, PLANT CELL PHYSIOL, V36, P505, DOI 10.1093/oxfordjournals.pcp.a078786; Jedrzejas MJ, 1998, PROTEIN EXPRES PURIF, V13, P83, DOI 10.1006/prep.1997.0864; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Jha BK, 2003, J BIOL CHEM, V278, P27464, DOI 10.1074/jbc.M206696200; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; KREIL G, 1995, PROTEIN SCI, V4, P1666, DOI 10.1002/pro.5560040902; KUPPUSAMY UR, 1990, BIOCHEM PHARMACOL, V40, P397, DOI 10.1016/0006-2952(90)90709-T; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Li SL, 2001, J BIOL CHEM, V276, P15125, DOI 10.1074/jbc.M011102200; MATHEWS MB, 1955, PHYSIOL REV, V35, P381, DOI 10.1152/physrev.1955.35.2.381; MEYER K, 1951, J BIOL CHEM, V188, P485; Mio K, 2001, Methods Mol Biol, V171, P391; RAPPORT MM, 1951, J BIOL CHEM, V192, P283; Rigden DJ, 2006, GLYCOBIOLOGY, V16, P757, DOI 10.1093/glycob/cwj116; Schaerer MT, 2001, J BIOL CHEM, V276, P26597, DOI 10.1074/jbc.M102534200; Spickenreither M, 2006, BIOORG MED CHEM LETT, V16, P5313, DOI 10.1016/j.bmcl.2006.07.087; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Suzuki K, 2002, J ENZYM INHIB MED CH, V17, P183, DOI 10.1080/14756360290032930; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Udabage L, 2003, GLYCOCONJUGATE J, V20, P461, DOI 10.1023/B:GLYC.0000038292.71098.35; WEISSMANN B, 1954, J BIOL CHEM, V208, P417; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x	48	14	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3897	3905		10.1074/jbc.M804246200	http://dx.doi.org/10.1074/jbc.M804246200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19004836	hybrid			2022-12-27	WOS:000262872500058
J	Chen, J; Lu, YY; Meng, SX; Han, MH; Lin, CY; Wang, XZ				Chen, Jian; Lu, Yanyan; Meng, Shuxia; Han, Meng-Hsuan; Lin, Chengyi; Wang, Xiaozhong			alpha- and gamma-Protocadherins Negatively Regulate PYK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; SRC FAMILY KINASES; GENE-CLUSTER; TYROSINE PHOSPHORYLATION; COMBINATORIAL EXPRESSION; CEREBRAL-ISCHEMIA; CELL-ADHESION; NEURONS; CADHERINS; ORGANIZATION	Genetic studies demonstrate that gamma-protocadherins (PCDH-gamma) are required for the survival and synaptic connectivity in neuronal subpopulations of the central nervous system. However, the intracellular signaling mechanisms for PCDH-gamma are poorly understood. Here, we show that PCDH-gamma binds two tyrosine kinases, PYK2 and focal adhesion kinase (FAK), and interaction with PCDH-gamma inhibits kinase activity. Consistent with this, PYK2 activity is abnormally up-regulated in the Pcdh-gamma-deficient neurons. Overexpression of PYK2 induces apoptosis in the chicken spinal cord. Thus, negative regulation of PYK2 activity by PCDH could contribute to the survival of subsets of neurons. Surprisingly, we found that PCDH-alpha interacts similarly with PYK2 and FAK despite containing a distinct cytoplasmic domain. In neural tissue, PCDH-gamma, together with PCDH-alpha, forms functional complexes with PYK2 and/or FAK. Therefore, the identification of common intracellular effectors for PCDH-gamma and PCDH-alpha suggests that dozens of protocadherins generated by Pcdh-alpha and Pcdh-gamma gene clusters can converge different extracellular signals into common intracellular pathways.	[Chen, Jian; Lu, Yanyan; Meng, Shuxia; Han, Meng-Hsuan; Lin, Chengyi; Wang, Xiaozhong] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Wang, XZ (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	awang@northwestern.edu			National Institutes of Health [5R01NS051253]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01NS051253 (to X. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Bonn S, 2007, MOL CELL BIOL, V27, P4121, DOI 10.1128/MCB.01708-06; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Emond MR, 2008, DEV BIOL, V321, P175, DOI 10.1016/j.ydbio.2008.06.011; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Frank M, 2005, MOL CELL NEUROSCI, V29, P603, DOI 10.1016/j.mcn.2005.05.001; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Murata Y, 2004, J BIOL CHEM, V279, P49508, DOI 10.1074/jbc.M408771200; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; OBATA S, 1995, J CELL SCI, V108, P3765; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Phillips GR, 2003, J NEUROSCI, V23, P5096; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Tian DH, 2000, J NEUROSCI, V20, P6478, DOI 10.1523/JNEUROSCI.20-17-06478.2000; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Yagi T, 2000, GENE DEV, V14, P1169; Zou C, 2007, NEUROSCIENCE, V144, P579, DOI 10.1016/j.neuroscience.2006.10.011	50	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2880	2890		10.1074/jbc.M807417200	http://dx.doi.org/10.1074/jbc.M807417200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047047	Green Published, hybrid			2022-12-27	WOS:000262700900032
J	Kruse, JP; Gu, W				Kruse, Jan-Philipp; Gu, Wei			MSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; NUCLEAR EXPORT; TRANSCRIPTIONAL ACTIVATION; P53-DEPENDENT APOPTOSIS; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; UBIQUITIN LIGASE; TERMINAL DOMAIN; PROTEIN; MDM2	Although it was originally thought of as a passive way to block the nuclear function of p53, accumulating evidence suggests that cytoplasmic localization of p53 plays an active role in p53-mediated functions such as apoptosis and autophagy. Previous studies by us and others demonstrated that Mdm2-mediated p53 ubiquitination induces both degradation and cytoplasmic localization. Here we describe MSL2, a novel E3 ligase for p53 that promotes ubiquitin-dependent cytoplasmic p53 localization. Unlike Mdm2 or most other p53 E3 ligases, MSL2-mediated p53 ubiquitination does not affect the stability of p53. Moreover, the MSL2-mediated effect on p53 is Mdm2-independent. Thus, our study identifies an important ubiquitin-ligase for modulating p53 subcellular localization.	[Kruse, Jan-Philipp; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Kruse, Jan-Philipp; Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu			National Institutes of Health; NCI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants from NCI ( to W. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Brooks CL, 2007, J BIOL CHEM, V282, P22804, DOI 10.1074/jbc.M700961200; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2004, CELL CYCLE, V3, P429; Clegg HV, 2008, CELL CYCLE, V7, P287, DOI 10.4161/cc.7.3.5358; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gilman CP, 2003, NEUROMOL MED, V3, P159, DOI 10.1385/NMM:3:3:159; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Lu WJ, 2006, CELL DEATH DIFFER, V13, P909, DOI 10.1038/sj.cdd.4401922; LUNA RMD, 1995, NATURE, V378, P203; Manfredi JJ, 2003, MOL CELL, V11, P552, DOI 10.1016/S1097-2765(03)00106-0; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Mendjan S, 2007, CHROMOSOMA, V116, P95, DOI 10.1007/s00412-006-0089-x; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Murphy ME, 2004, CELL CYCLE, V3, P836; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175	67	77	81	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3250	3263		10.1074/jbc.M805658200	http://dx.doi.org/10.1074/jbc.M805658200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19033443	Green Published, hybrid			2022-12-27	WOS:000262700900068
J	Wang, H; Lindsey, S; Konieczna, I; Bei, L; Horvath, E; Huang, WQ; Saberwal, G; Eklund, EA				Wang, Hao; Lindsey, Stephan; Konieczna, Iwona; Bei, Ling; Horvath, Elizabeth; Huang, Weiqi; Saberwal, Gurveen; Eklund, Elizabeth A.			Constitutively Active SHP2 Cooperates with HoxA10 Overexpression to Induce Acute Myeloid Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW-CELLS; GENE; EXPRESSION; MUTATIONS; PTPN11; TRANSCRIPTION; PROGENITORS; PHOSPHATASE; ACTIVATION; LINEAGE	The homeodomain transcription factor HoxA10 is maximally expressed in myeloid progenitor cells. Sustained HoxA10 expression during differentiation has been described in poor prognosis human acute myeloid leukemia (AML). Consistent with this, engineered overexpression of HoxA10 in murine bone marrow induces a myeloproliferative disorder that progresses to AML over time. This murine model suggests that HoxA10 overexpression is sufficient for myeloproliferation but that differentiation block, and therefore AML, requires acquisition of additional mutations. In myeloid progenitor cells, HoxA10 represses transcription of genes that encode phagocyte effector proteins such as gp91(PHOX) and p67(PHOX). Tyrosine phosphorylation of HoxA10 during myelopoiesis decreases binding to these target genes. In immature myeloid cells, HoxA10 also activates transcription of the DUSP4 gene that encodes Mkp2, an antiapoptotic protein. HoxA10 binding to the DUSP4 promoter decreases during myelopoiesis. Therefore, both myeloid-specific gene repression and DUSP4 activation by HoxA10 decrease during myelopoiesis. This results in phenotypic differentiation and facilitates apoptosis as differentiation proceeds. HoxA10 is de-phosphorylated by SHP2 protein-tyrosine phosphatase in myeloid progenitors. This mechanism maintains HoxA10 in a nonphosphorylated state in immature, but not differentiating, myeloid cells. Constitutively active SHP2 mutants have been described in human AML, which dephosphorylate HoxA10 throughout myelopoiesis. In this study, we hypothesize that constitutive SHP2 activation synergizes with HoxA10 overexpression to accelerate progression to AML. Because both HoxA10 overexpression and constitutive SHP2 activation are found in poor prognosis human AML, these studies contribute to understanding biochemical aspects of disease progression in myeloid malignancy.	[Wang, Hao; Lindsey, Stephan; Konieczna, Iwona; Bei, Ling; Horvath, Elizabeth; Huang, Weiqi; Saberwal, Gurveen; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Wang, Hao; Lindsey, Stephan; Konieczna, Iwona; Bei, Ling; Horvath, Elizabeth; Huang, Weiqi; Saberwal, Gurveen; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Horvath, Elizabeth; Saberwal, Gurveen; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 710 N Fairbanks Ct,Olson Pavilion Rm 8524, Chicago, IL 60611 USA.	e-eklund@northwestern.edu	Lindsey, Stephan/E-4358-2012	Wang, Hao/0000-0003-2131-0377	National Institutes of Health [HL87717]; Veterans Affairs Merit Review and a Leukemia and Lymphoma Society Translational Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review and a Leukemia and Lymphoma Society Translational Research Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 01 HL87717 (to E. A. E.). This work was also supported by a Veterans Affairs Merit Review and a Leukemia and Lymphoma Society Translational Research Award (to E. A. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Christiansen DH, 2007, GENE CHROMOSOME CANC, V46, P517, DOI 10.1002/gcc.20426; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Eisterer W, 2005, LEUKEMIA, V19, P435, DOI 10.1038/sj.leu.2403649; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Eklund EA, 2000, J BIOL CHEM, V39, P36878; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Ferrando AA, 2003, BLOOD, V102, P262, DOI 10.1182/blood-2002-10-3221; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; KhannaGupta A, 1997, BLOOD, V90, P2784, DOI 10.1182/blood.V90.7.2784.2784_2784_2795; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; LARRICK JW, 1980, J IMMUNOL, V125, P6; LAWRENCE HJ, 1995, EXP HEMATOL, V23, P1160; Lawson ND, 1998, BLOOD, V91, P2517, DOI 10.1182/blood.V91.7.2517.2517_2517_2524; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Lindsey S, 2007, J BIOL CHEM, V282, P2237, DOI 10.1074/jbc.M608642200; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schnabel CA, 2000, ONCOGENE, V19, P608, DOI 10.1038/sj.onc.1203371; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	34	36	43	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2549	2567		10.1074/jbc.M804704200	http://dx.doi.org/10.1074/jbc.M804704200			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19022774	hybrid, Green Published			2022-12-27	WOS:000262545600060
J	Zhang, L; Zhao, H; Qiu, Y; Loh, HH; Law, PY				Zhang, Lei; Zhao, Hui; Qiu, Yu; Loh, Horace H.; Law, Ping-Yee			Src Phosphorylation of mu-Receptor Is Responsible for the Receptor Switching from an Inhibitory to a Stimulatory Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-OPIOID RECEPTOR; ADENYLYL-CYCLASE SUPERACTIVATION; PROTEIN-COUPLED RECEPTORS; NG108-15 HYBRID-CELLS; N-TERMINAL KINASES; TYROSINE KINASE; BETA-ARRESTINS; C-SRC; MUSCARINIC RECEPTORS; MOLECULAR-MECHANISMS	Recent studies have revealed that in Gprotein-coupled receptor signalings switching between G protein-and beta-arrestin (beta Arr)-dependent pathways occurs. In the case of opioid receptors, the signal is switched from the initial inhibition of adenylyl cyclase (AC) to an increase in AC activity (AC activation) during prolonged agonist treatment. The mechanism of such AC activation has been suggested to involve the switching of G proteins activated by the receptor, phosphorylation of signaling molecules, or receptor-dependent recruitment of cellular proteins. Using protein kinase inhibitors, dominant negative mutant studies and mouse embryonic fibroblast cells isolated from Src kinase knock-out mice, we demonstrated that mu-opioid receptor (OPRM1)-mediated AC activation requires direct association and activation of Src kinase by lipid raft-located OPRM1. Such Src activation was independent of beta Arr as indicated by the ability of OPRM1 to activate Src and AC after prolonged agonist treatment in mouse embryonic fibroblast cells lacking both beta Arr-1 and -2. Instead the switching of OPRM1 signals was dependent on the heterotrimeric G protein, specifically G(i2) alpha-subunit. Among the Src kinase substrates, OPRM1 was phosphorylated at Tyr(336) within NPXXY motif by Src during AC activation. Mutation of this Tyr residue, together with mutation of Tyr(166) within the DRY motif to Phe, resulted in the complete blunting of AC activation. Thus, the recruitment and activation of Src kinase by OPRM1 during chronic agonist treatment, which eventually results in the receptor tyrosine phosphorylation, is the key for switching the opioid receptor signals from its initial AC inhibition to subsequent AC activation.	[Zhang, Lei; Zhao, Hui; Qiu, Yu; Loh, Horace H.; Law, Ping-Yee] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Zhao, Hui] Fudan Univ, Dept Chinese & Western Med, Shanghai 200032, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Fudan University	Zhang, L (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	Zhang247@umn.edu		Law, Ping-Yee/0000-0002-5364-1093	National Institutes of Health [DA007339, DA016674, DA000564, DA011806, K05-DA70544, K05-DA00513]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA000564, P50DA011806, K05DA000513, R56DA000564, R01DA007339, R01DA016674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA007339, DA016674, DA000564, DA011806, K05-DA70544 ( to H. H. L.), and K05-DA00513 ( to P.-Y.L.).	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Audet N, 2005, J BIOL CHEM, V280, P7808, DOI 10.1074/jbc.M411695200; AvidorReiss T, 1996, J BIOL CHEM, V271, P21309, DOI 10.1074/jbc.271.35.21309; AvidorReiss T, 1997, J BIOL CHEM, V272, P5040, DOI 10.1074/jbc.272.8.5040; Bahia DS, 1998, BIOCHEMISTRY-US, V37, P11555, DOI 10.1021/bi980284o; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Cavalli A, 2000, J BIOL CHEM, V275, P23693, DOI 10.1074/jbc.M910395199; Chakrabarti S, 1998, MOL PHARMACOL, V54, P949, DOI 10.1124/mol.54.6.949; Chakrabarti S, 2001, P NATL ACAD SCI USA, V98, P4209, DOI 10.1073/pnas.071031798; CHENG HC, 1992, J BIOL CHEM, V267, P9248; Fan GF, 2001, J BIOL CHEM, V276, P13240, DOI 10.1074/jbc.M011578200; Favre N, 2005, BIOCHEMISTRY-US, V44, P9990, DOI 10.1021/bi0509853; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; Fischer JA, 2002, BIOCHEM SOC T, V30, P455, DOI 10.1042/bst0300455; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Garzon J, 2005, NEUROPHARMACOLOGY, V48, P853, DOI 10.1016/j.neuropharm.2005.01.004; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Kam AYF, 2004, J PHARMACOL EXP THER, V310, P301, DOI 10.1124/jpet.104.065078; Kam AYF, 2003, J NEUROCHEM, V84, P503, DOI 10.1046/j.1471-4159.2003.01535.x; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Kramer HK, 2000, MOL BRAIN RES, V79, P55, DOI 10.1016/S0169-328X(00)00097-8; Kramer HK, 2000, BIOCHEM PHARMACOL, V60, P781, DOI 10.1016/S0006-2952(00)00400-7; LAW PY, 1982, MOL PHARMACOL, V22, P1; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; LAW PY, 1983, MOL PHARMACOL, V24, P413; Law PY, 1999, BIOPOLYMERS, V51, P440, DOI 10.1002/(SICI)1097-0282(1999)51:6<440::AID-BIP6>3.0.CO;2-T; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li J, 2001, MOL PHARMACOL, V60, P1064, DOI 10.1124/mol.60.5.1064; Li LY, 1996, MOL PHARMACOL, V50, P599; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Linseman DA, 2001, J BIOL CHEM, V276, P5622, DOI 10.1074/jbc.M006812200; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Narita M, 2006, NEUROREPORT, V17, P115, DOI 10.1097/01.wnr.0000198950.92820.c7; Nguyen QD, 2002, FASEB J, V16, P565, DOI 10.1096/fj.01-0525com; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Pineyro G, 2007, CELL SIGNAL, V19, P8, DOI 10.1016/j.cellsig.2006.05.026; Qiu Y, 2003, J BIOL CHEM, V278, P36733, DOI 10.1074/jbc.M305857200; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Sarnago S, 1999, J BIOL CHEM, V274, P34411, DOI 10.1074/jbc.274.48.34411; Schallmach E, 2006, J MOL NEUROSCI, V29, P115, DOI 10.1385/JMN:29:2:115; Schindelholz B, 1997, J NEUROSCI, V17, P8391; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; SHARMA SK, 1977, P NATL ACAD SCI USA, V74, P3365, DOI 10.1073/pnas.74.8.3365; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Singer CA, 2002, AM J PHYSIOL-GASTR L, V282, pG61, DOI 10.1152/ajpgi.00100.2002; Smith NJ, 2006, HYPERTENSION, V48, P173, DOI 10.1161/01.HYP.0000232641.84521.92; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Szucs M, 2004, J PHARMACOL EXP THER, V310, P256, DOI 10.1124/jpet.104.066837; Varga EV, 2002, EUR J PHARMACOL, V451, P101, DOI 10.1016/S0014-2999(02)02220-3; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Walwyn W, 2007, J NEUROSCI, V27, P5092, DOI 10.1523/JNEUROSCI.1157-07.2007; WONG YH, 1992, SCIENCE, V255, P339, DOI 10.1126/science.1347957; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zhang L, 2006, MOL PHARMACOL, V69, P1810, DOI 10.1124/mol.105.021352; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024	69	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1990	2000		10.1074/jbc.M807971200	http://dx.doi.org/10.1074/jbc.M807971200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19029294	Green Published, hybrid			2022-12-27	WOS:000262545600006
J	Hansen, JL; Hansen, JT; Speerschneider, T; Lyngso, C; Erikstrup, N; Burstein, ES; Weiner, DM; Walther, T; Makita, N; Iiri, T; Merten, N; Kostenis, E; Sheikh, SP				Hansen, Jakob L.; Hansen, Jonas T.; Speerschneider, Tobias; Lyngso, Christina; Erikstrup, Niels; Burstein, Ethan S.; Weiner, David M.; Walther, Thomas; Makita, Noriko; Iiri, Taroh; Merten, Nicole; Kostenis, Evi; Sheikh, Soren P.			Lack of Evidence for AT(1)R/B2R Heterodimerization in COS-7, HEK293, and NIH3T3 Cells HOW COMMON IS THE AT(1)R/B2R HETERODIMER?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II TYPE-1 RECEPTOR; ENERGY-TRANSFER BRET; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; CARDIAC MYOCYTES; WILD-TYPE; ANGIOTENSIN; BRADYKININ; ACTIVATION; OLIGOMERIZATION	It has been suggested previously (AbdAlla, S., Lother, H., and Quitterer, U. (2000) Nature 407, 94-98) that the angiotensin II type 1 receptor (AT(1)R) and the bradykinin B2 receptor (B2R)form constitutive heterodimers. Furthermore they demonstrate that AT(1)R signaling significantly increases in the presence of the B2R. These findings suggest that heterodimerization and potentiation of AT(1)R signaling is a universal phenomenon that occurs as a natural consequence of simultaneous expression of the two receptors. Hence this potential interaction is of great pharmacological and biological interest that adds an additional layer of complexity to the understanding of the cross-talk between the renin-angiotensin and kallikrein-kinin systems. Given the remarkable significance of this finding, scientists from four independent research groups have set out to reproduce and further examine the potential AT(1)R/B2R interaction. We have investigated functional potentiation by the B2R of AT(1)R signaling in three different cell lines using multiple assays including phosphoinositide hydrolysis, ERK activation, beta-arrestin recruitment, and receptor selection and amplification technology, and we have examined dimerization using bioluminescence resonance energy transfer and regulated secretion/aggregation technology. However, although both the AT(1)Rs and B2Rs were functional in our systems and the systems were fine tuned to detect small changes in receptor function, we failed to detect any functional modulation by or physical interaction between the two receptor proteins. In contrast to the previous observations, our data collectively suggest that AT(1)R/B2R heterodimerization does not occur as a natural consequence of their simultaneous expression in the same cell nor does the B2R influence the AT(1)R signaling.	[Hansen, Jakob L.; Hansen, Jonas T.; Speerschneider, Tobias; Lyngso, Christina; Erikstrup, Niels] Univ Copenhagen, Mol Cardiol Lab, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Hansen, Jakob L.; Hansen, Jonas T.; Speerschneider, Tobias; Lyngso, Christina; Erikstrup, Niels] Univ Copenhagen Hosp, Rigshosp, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Mol Cardiol Lab,Heart Ctr, DK-2100 Copenhagen, Denmark; [Burstein, Ethan S.; Weiner, David M.] ACADIA Pharmaceut Inc, San Diego, CA 92121 USA; [Walther, Thomas] Univ Hull, Dept Biomed Sci, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Makita, Noriko; Iiri, Taroh] Univ Tokyo, Sch Med, Dept Endocrinol & Nephrol, Bunkyo Ku, Tokyo 1138655, Japan; [Merten, Nicole; Kostenis, Evi] Univ Bonn, Dept Mol Cellular & Pharmacobiol, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Sheikh, Soren P.] Odense Univ Hosp, Dept Biochem Pharmacol & Genet, DK-5000 Odense, Denmark	Danmarks Grundforskningsfond; University of Copenhagen; Danmarks Grundforskningsfond; Rigshospitalet; University of Copenhagen; University of Hull; University of York - UK; University of Tokyo; University of Bonn; University of Southern Denmark; Odense University Hospital	Hansen, JL (corresponding author), Univ Copenhagen, Mol Cardiol Lab, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Dept Neurosci & Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	jlhansen@sund.ku.dk; sheikh@dadlnet.dk	Makita, Noriko/GQY-8175-2022					Abadir PM, 2006, HYPERTENSION, V48, P316, DOI 10.1161/01.HYP.0000228997.88162.a8; AbdAlla S, 2004, CELL, V119, P343, DOI 10.1016/j.cell.2004.10.006; AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; AbdAlla S, 2005, J MOL NEUROSCI, V26, P185, DOI 10.1385/JMN:26:2-3:185; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P296, DOI 10.1111/j.1742-7843.2007.00064.x; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P289, DOI 10.1111/j.1742-7843.2007.00063.x; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Brauner-Osborne H, 1996, EUR J PHARMACOL, V295, P93, DOI 10.1016/0014-2999(95)00639-7; Burstein ES, 2006, CURR PHARM DESIGN, V12, P1717, DOI 10.2174/138161206776873662; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Hansen JL, 2008, EUR J PHARMACOL, V590, P255, DOI 10.1016/j.ejphar.2008.05.010; Hansen JL, 2000, CIRC RES, V87, P753, DOI 10.1161/01.RES.87.9.753; Hansen JL, 2004, EUR J PHARM SCI, V23, P301, DOI 10.1016/j.ejps.2004.08.004; Hansen JL, 2004, J BIOL CHEM, V279, P24108, DOI 10.1074/jbc.M400092200; Hansen JL, 2004, MOL PHARMACOL, V65, P770, DOI 10.1124/mol.65.3.770; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; Hu K, 1998, CARDIOVASC RES, V39, P401, DOI 10.1016/S0008-6363(98)00090-X; Isbell DC, 2007, AM J PHYSIOL-HEART C, V293, pH3372, DOI 10.1152/ajpheart.00997.2007; Jensen AA, 2002, EUR J BIOCHEM, V269, P5076, DOI 10.1046/j.1432-1033.2002.03218.x; Karip E, 2007, NEUROCHEM INT, V51, P261, DOI 10.1016/j.neuint.2007.05.018; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; LYNGSO C, 2008, MOL CELL EN IN PRESS; MCEACHERN AE, 1991, P NATL ACAD SCI USA, V88, P7724, DOI 10.1073/pnas.88.17.7724; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Milligan G, 2006, DRUG DISCOV TODAY, V11, P541, DOI 10.1016/j.drudis.2006.04.007; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Santos EL, 2007, REGUL PEPTIDES, V141, P159, DOI 10.1016/j.regpep.2006.12.030; Sato M, 2000, CIRCULATION, V102, P346; Shen B, 2007, J AM SOC NEPHROL, V18, P1140, DOI 10.1681/ASN.2006101127; Tan Y, 2004, AM J PHYSIOL-HEART C, V286, pH926, DOI 10.1152/ajpheart.00757.2003; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Weiner DM, 2001, J PHARMACOL EXP THER, V299, P268; YANG HYT, 1970, BIOCHIM BIOPHYS ACTA, V214, P374, DOI 10.1016/0005-2795(70)90017-6; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zeng CY, 2003, HYPERTENSION, V42, P787, DOI 10.1161/01.HYP.0000085334.34963.4E; Zeng CY, 2003, HYPERTENSION, V41, P724, DOI 10.1161/01.HYP.0000047880.78462.0E; Zhu PL, 1999, J CARDIOVASC PHARM, V33, P785, DOI 10.1097/00005344-199905000-00016	44	46	48	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1831	1839		10.1074/jbc.M804607200	http://dx.doi.org/10.1074/jbc.M804607200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017652	hybrid			2022-12-27	WOS:000262330100054
J	Karamysheva, Z; Diaz-Martinez, LA; Crow, SE; Li, B; Yu, HT				Karamysheva, Zemfira; Diaz-Martinez, Laura A.; Crow, Sara E.; Li, Bing; Yu, Hongtao			Multiple Anaphase-promoting Complex/Cyclosome Degrons Mediate the Degradation of Human Sgo1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; PROTEIN PHOSPHATASE 2A; SPINDLE-CHECKPOINT; HUMAN SHUGOSHIN; HUMAN-CELLS; KEN-BOX; CHROMOSOME; MITOSIS; LOCALIZATION; CYTOKINESIS	Shugoshin 1 (Sgo1) protects centromeric sister-chromatid cohesion in early mitosis and, thus, prevents premature sister-chromatid separation. The protein level of Sgo1 is regulated during the cell cycle; it peaks in mitosis and is down-regulated in G(1)/S. Here we show that Sgo1 is degraded during the exit from mitosis, and its degradation depends on the anaphase-promoting complex/cyclosome (APC/C). Overexpression of Cdh1 reduces the protein levels of ectopically expressed Sgo1 in human cells. Sgo1 is ubiquitinated by APC/C bound to Cdh1 (APC/CCdh1) in vitro. We have further identified two functional degradation motifs in Sgo1; that is, aKEN (Lys-Glu-Asn) box and a destruction box (D box). Although removal of either motif is not sufficient to stabilize Sgo1, Sgo1 with both KEN box and D box deleted is stable in cells. Surprisingly, mitosis progresses normally in the presence of non-degradable Sgo1, indicating that degradation of Sgo1 is not required for sister-chromatid separation or mitotic exit. Finally, we show that the spindle checkpoint kinase Bub1 contributes to the maintenance of Sgo1 steady-state protein levels in an APC/C-independent mechanism.	[Karamysheva, Zemfira; Diaz-Martinez, Laura A.; Crow, Sara E.; Li, Bing; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, HT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Howard Hughes Med Inst, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu	Díaz-Martínez, Laura/A-5357-2010	Diaz-Martinez, Laura/0000-0002-7226-7068; Yu, Hongtao/0000-0002-8861-049X	National Institutes of Health [GM76481]; March of Dimes Foundation; Welch Foundation; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Welch Foundation(The Welch Foundation); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM76481. This work was also supported by the March of Dimes Foundation, the Welch Foundation, and the Leukemia and Lymphoma Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fu GS, 2007, BIOCHEM BIOPH RES CO, V357, P672, DOI 10.1016/j.bbrc.2007.03.204; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1561, DOI 10.4161/cc.4.11.2146; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; LOSADA A, 2002, ANNU REV CELL DEV BI, V24, P105; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Qi W, 2007, J BIOL CHEM, V282, P3672, DOI 10.1074/jbc.M609376200; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Suzuki H, 2006, CELL CYCLE, V5, P1094, DOI 10.4161/cc.5.10.2747; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tang Zhanyun, 2004, Methods Mol Biol, V281, P227; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Wang XX, 2006, CELL CYCLE, V5, P635; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zur A, 2001, EMBO J, V20, P792, DOI 10.1093/emboj/20.4.792	30	36	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1772	1780		10.1074/jbc.M807083200	http://dx.doi.org/10.1074/jbc.M807083200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015261	hybrid, Green Published			2022-12-27	WOS:000262330100048
J	Rudolph, V; Schopfer, FJ; Khoo, NKH; Rudolph, TK; Cole, MP; Woodcock, SR; Bonacci, G; Groeger, AL; Golin-Bisello, F; Chen, CS; Baker, PRS; Freeman, BA				Rudolph, Volker; Schopfer, Francisco J.; Khoo, Nicholas K. H.; Rudolph, Tanja K.; Cole, Marsha P.; Woodcock, Steven R.; Bonacci, Gustavo; Groeger, Alison L.; Golin-Bisello, Franca; Chen, Chen-Shan; Baker, Paul R. S.; Freeman, Bruce A.			Nitro-fatty Acid Metabolome: Saturation, Desaturation, beta-Oxidation, and Protein Adduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN OXIDATION; OXIDIZED LIPID DERIVATIVES; HUMAN BLOOD-PLASMA; OLD YELLOW ENZYME; NITROLINOLEIC ACID; METHYL LINOLEATE; OXIDE INHIBITION; POTENTIAL ROLE; CELL-FUNCTION; TRANSDUCTION	Nitrated derivatives of fatty acids (NO2-FA) are pluripotent cell-signaling mediators that display anti-inflammatory properties. Current understanding of NO2-FA signal transduction lacks insight into how or if NO2-FA are modified or metabolized upon formation or administration in vivo. Here the disposition and metabolism of nitro-9-cis- octadecenoic (18:1-NO2) acid was investigated in plasma and liver after intravenous injection in mice. High performance liquid chromatography-tandem mass spectrometry analysis showed that no 18:1-NO2 or metabolites were detected under basal conditions, whereas administered 18:1-NO2 is rapidly adducted to plasma thiol-containing proteins and glutathione. NO2-FA are also metabolized via beta-oxidation, with high performance liquid chromatography-tandem mass spectrometry analysis of liver lipid extracts of treated mice revealing nitro-7-cis-hexadecenoic acid, nitro-5-cis-tetradecenoic acid, and nitro-3-cis-dodecenoic acid and corresponding coenzyme A derivatives of 18:1-NO2 as metabolites. Additionally, a significant proportion of 18:1-NO2 and its metabolites are converted to nitroalkane derivatives by saturation of the double bond, and to a lesser extent are desaturated to diene derivatives. There was no evidence of the formation of nitrohydroxyl or conjugated ketone derivatives in organs of interest, metabolites expected upon 18:1-NO2 hydration or nitric oxide ((NO)-N-center dot) release. Plasma samples from treated mice had significant extents of protein-adducted 18:1-NO2 detected by exchange to added beta-mercaptoethanol. This, coupled with the observation of 18:1-NO2 release from glutathione-18:1-NO2 adducts, supports that reversible and exchangeable NO2-FA-thiol adducts occur under biological conditions. After administration of [H-3] 18:1-NO2, 64% of net radiolabel was recovered 90 min later in plasma (0.2%), liver (18%), kidney (2%), adipose tissue (2%), muscle (31%), urine (6%), and other tissue compartments, and may include metabolites not yet identified. In aggregate, these findings show that electrophilic FA nitroalkene derivatives (a) acquire an extended half-life by undergoing reversible and exchangeable electrophilic reactions with nucleophilic targets and (b) are metabolized predominantly via saturation of the double bond and beta-oxidation reactions that terminate at the site of acyl-chain nitration.	[Rudolph, Volker; Schopfer, Francisco J.; Khoo, Nicholas K. H.; Rudolph, Tanja K.; Cole, Marsha P.; Woodcock, Steven R.; Bonacci, Gustavo; Groeger, Alison L.; Golin-Bisello, Franca; Chen, Chen-Shan; Baker, Paul R. S.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Rudolph, Volker; Rudolph, Tanja K.] Univ Heart Ctr Hamburg, Dept Cardiol, D-20246 Hamburg, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hamburg; University Medical Center Hamburg-Eppendorf	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, E1340 Thomas E Starzl Biomed Sci Tower,200 Lothro, Pittsburgh, PA 15213 USA.	freerad@pitt.edu	Schopfer, Francisco/AAW-6505-2021; Schopfer, Francisco Jose/AAE-8125-2020; Freeman, Bruce A/H-9342-2012; Woodcock, Steven/AAE-9199-2020	Schopfer, Francisco Jose/0000-0001-9526-695X; 	National Institutes of Health [R01 HL58115, R01 HL64937]; American Diabetes Association [7-08-JF-52, 7-06-JF-06]; American Heart Association [0665418U]; Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft; Complexa, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, R01HL064937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Deutsche Herzstiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Complexa, LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL58115 and R01 HL64937. This work was also supported by American Diabetes Association Grants 7-08-JF-52 (to F.J.S.) and 7-06-JF-06 (to P.R.S.B.), American Heart Association Grant 0665418U (to F.J.S.), the Deutsche Herzstiftung (to V.R.), and the Deutsche Forschungsgemeinschaft (to T.R.). B.A.F. acknowledges financial interest in Complexa, LLC.	Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Balazy M, 2001, J PHARMACOL EXP THER, V299, P611; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Calder PC, 1997, ADV ENZYME REGUL, V37, P197, DOI 10.1016/S0065-2571(96)00004-0; CASTUMA JC, 1972, J LIPID RES, V13, P783; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; FINLAYSONPITTS BJ, 1987, TOXICOL APPL PHARM, V89, P438, DOI 10.1016/0041-008X(87)90163-3; Fox JEM, 2003, METABOLISM, V52, P1313, DOI 10.1016/S0026-0495(03)00199-9; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; GALLON AA, 1993, LIPIDS, V28, P125, DOI 10.1007/BF02535776; GALLON AA, 1994, LIPIDS, V29, P171, DOI 10.1007/BF02536725; Hanley PJ, 2005, J PHYSIOL-LONDON, V562, P307, DOI 10.1113/jphysiol.2004.073932; Hastings N, 2001, P NATL ACAD SCI USA, V98, P14304, DOI 10.1073/pnas.251516598; HOGG N, 1993, FEBS LETT, V334, P170, DOI 10.1016/0014-5793(93)81706-6; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; Leonarduzzi G, 2004, FREE RADICAL BIO MED, V37, P1694, DOI 10.1016/j.freeradbiomed.2004.08.027; Lim DG, 2002, P NATL ACAD SCI USA, V99, P15941, DOI 10.1073/pnas.232409599; Lima ES, 2005, FREE RADICAL BIO MED, V39, P532, DOI 10.1016/j.freeradbiomed.2005.04.005; Lima ES, 2003, J LIPID RES, V44, P1660, DOI 10.1194/jlr.M200467-JLR200; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; Magnes C, 2005, ANAL CHEM, V77, P2889, DOI 10.1021/ac048314i; Meah Y, 2000, P NATL ACAD SCI USA, V97, P10733, DOI 10.1073/pnas.190345597; Musiek ES, 2005, BRAIN PATHOL, V15, P149; Napolitano A, 2002, J ORG CHEM, V67, P1125, DOI 10.1021/jo015973b; Napolitano A, 2000, J ORG CHEM, V65, P4853, DOI 10.1021/jo000090q; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; O'Donnell VB, 2001, CIRC RES, V88, P12, DOI 10.1161/01.RES.88.1.12; ODonnell VB, 1997, BIOCHEMISTRY-US, V36, P15216, DOI 10.1021/bi971891z; Riedel MJ, 2005, DIABETES, V54, P2070, DOI 10.2337/diabetes.54.7.2070; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Rubbo H, 1995, ARCH BIOCHEM BIOPHYS, V324, P15, DOI 10.1006/abbi.1995.9935; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6; Trostchansky A, 2008, FREE RADICAL BIO MED, V44, P1887, DOI 10.1016/j.freeradbiomed.2008.03.006; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Wong HL, 2008, CHEM RES TOXICOL, V21, P796, DOI 10.1021/tx700433m; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103	44	96	106	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1461	1473		10.1074/jbc.M802298200	http://dx.doi.org/10.1074/jbc.M802298200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015269	hybrid, Green Published			2022-12-27	WOS:000262330100014
J	Terziyska, N; Grumbt, B; Kozany, C; Hell, K				Terziyska, Nadia; Grumbt, Barbara; Kozany, Christian; Hell, Kai			Structural and Functional Roles of the Conserved Cysteine Residues of the Redox-regulated Import Receptor Mia40 in the Intermembrane Space of Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; SULFHYDRYL OXIDASE; RESPIRATORY-CHAIN; CYTOCHROME-C; PATHWAY; ERV1; TIM10; BIOGENESIS	Oxidative folding drives the import of proteins containing twin CXnC motifs into the intermembrane space of mitochondria. This import pathway employs a disulfide relay system whose key components are the redox-regulated import receptor Mia40 and the thiol oxidase Erv1. Mia40 contains six cysteine residues in a CPC-CX9C-CX9C arrangement in a highly conserved domain. We show that this domain is sufficient for the function of Mia40. By analysis of Mia40 cysteine mutants we demonstrate that the cysteine residues have distinct roles and are not equally important for Mia40 function. The second cysteine residue is essential for viability of yeast cells. It is required for the interaction of Mia40 with Erv1 in a disulfide intermediate and forms a redox-sensitive disulfide bond with the first cysteine residue. Both cysteine residues are required for the oxidation of the substrate, Tim10, in a reconstituted system comprised of Mia40 and Erv1. Mutants with amino acid exchanges in the third and sixth cysteine residues have severe defects in growth and in the import of intermembrane space proteins. These Mia40 variants are not tightly folded. We conclude that the cysteine residues of the twin CX9C motif have a structural role and stabilize Mia40. In particular, the disulfide bond formed by the third and sixth cysteine residues apparently supports a conformation crucial for the function of Mia40. Furthermore, the disulfide bond in the CPC segment mediates the redox reactions with the thiol oxidase Erv1 and substrate proteins in mitochondria.	[Terziyska, Nadia; Grumbt, Barbara; Kozany, Christian; Hell, Kai] Univ Munich, Adolf Butenandt Inst Physiol Chem, D-81377 Munich, Germany	University of Munich	Hell, K (corresponding author), Univ Munich, Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	hell@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [SFB 594, He 2803/2-4]; Elite Netzwerk Bayern	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elite Netzwerk Bayern	This work was supported in part by Grants SFB 594 (B13) and He 2803/2-4, from the Deutsche Forschungsgemeinschaft (to K.H.) and by a predoctoral fellowship from the Elite Netzwerk Bayern (to B.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Allen S, 2003, J BIOL CHEM, V278, P38505, DOI 10.1074/jbc.M306027200; Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chacinska A, 2008, J BIOL CHEM, V283, P29723, DOI 10.1074/jbc.M805356200; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Lu H, 2004, J BIOL CHEM, V279, P18959, DOI 10.1074/jbc.M313046200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Stojanovski D, 2008, BBA-MOL CELL RES, V1783, P610, DOI 10.1016/j.bbamcr.2007.10.004; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010	33	65	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1353	1363		10.1074/jbc.M805035200	http://dx.doi.org/10.1074/jbc.M805035200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19011240	hybrid			2022-12-27	WOS:000262330100003
J	Zhao, YS; Min, CY; Vora, SR; Trackman, PC; Sonenshein, GE; Kirsch, KH				Zhao, Yingshe; Min, Chengyin; Vora, Siddharth R.; Trackman, Philip C.; Sonenshein, Gail E.; Kirsch, Kathrin H.			The Lysyl Oxidase Pro-peptide Attenuates Fibronectin-mediated Activation of Focal Adhesion Kinase and p130(Cas) in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR ACTIVITY; INVASIVE PHENOTYPE; H-RAS; EXPRESSION; GENE; LOX; CARCINOMA; MIGRATION; REVERSION; PRECURSOR	The lysyl oxidase (LOX) gene encodes an enzyme (LOX) critical for extracellular matrix maturation. The LOX gene has also been shown to inhibit the transforming activity of Ras oncogene signaling. In particular, the pro-peptide domain (LOX-PP) released from the secreted precursor protein (Pro-LOX) was found to inhibit the transformed phenotype of breast, lung, and pancreatic cancer cells. However, the mechanisms of action of LOX-PP remained to be determined. Here, the ability of LOX-PP to attenuate the integrin signaling pathway, which leads to phosphorylation of focal adhesion kinase (FAK), and the activation of its downstream target p130(Cas), was determined. In NF639 breast cancer cells driven by Her-2/neu, which signals via Ras, ectopic Pro-LOX and LOX-PP expression inhibited fibronectin-stimulated protein tyrosine phosphorylation. Importantly, phosphorylation of FAK on Tyr-397 and Tyr-576, and p130(Cas) were substantially reduced. The amount of endogenous p130(Cas) in the Triton X-100-insoluble protein fraction, and fibronectin-activated haptotaxis were decreased. Interestingly, expression of mature LOX enzyme enhanced fibronectin-stimulated integrin signaling. Of note, treatment with recombinant LOX-PP selectively reduced fibronectin-mediated haptotaxis of NF639, MDA-MB-231, and Hs578T breast cancer cells. Thus, evidence is provided that one mechanism of action of LOX-PP tumor suppression is to block fibronectin-stimulated signaling and cell migration.	[Zhao, Yingshe; Min, Chengyin; Sonenshein, Gail E.; Kirsch, Kathrin H.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Vora, Siddharth R.; Trackman, Philip C.] Boston Univ, Goldman Sch Dent Med, Div Oral Biol, Boston, MA 02118 USA	Boston University; Boston University	Kirsch, KH (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	kirschk@bu.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Kirsch, Kathrin/0000-0003-1532-1715	National Institute of Health [CA82742, CA106468]; Dept. of the Army [DAMD 05-1-0286, 08-1-0349]; NATIONAL CANCER INSTITUTE [R01CA082742, R01CA106468] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of the Army; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institute of Health Grants CA82742 and CA106468 and by Grants DAMD 05-1-0286 and 08-1-0349 from the Dept. of the Army. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASSOIAN RK, 1989, ANAL BIOCHEM, V177, P95, DOI 10.1016/0003-2697(89)90020-1; AZZOPARI JG, 1974, CANCER, V33, P174, DOI 10.1002/1097-0142(197401)33:1<174::AID-CNCR2820330126>3.0.CO;2-X; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Eto T, 1996, CANCER, V77, P646, DOI 10.1002/(SICI)1097-0142(19960215)77:4<646::AID-CNCR10>3.0.CO;2-0; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; HOWLETT A, 1999, METHODS MOL BIOL, V129; Hsia DA, 2005, MOL CELL BIOL, V25, P9700, DOI 10.1128/MCB.25.21.9700-9712.2005; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; KAGAN HM, 1995, J CELL BIOCHEM, V59, P329, DOI 10.1002/jcb.240590305; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; KRAUS MH, 1984, P NATL ACAD SCI-BIOL, V81, P5384, DOI 10.1073/pnas.81.17.5384; Laczko R, 2007, NEUROPATH APPL NEURO, V33, P631, DOI 10.1111/j.1365-2990.2007.00858.x; Lark AL, 2005, MODERN PATHOL, V18, P1289, DOI 10.1038/modpathol.3800424; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; Peyrol S, 1997, AM J PATHOL, V150, P497; Rodriguez C, 2002, ARTERIOSCL THROM VAS, V22, P1409, DOI 10.1161/01.ATV.0000033818.21748.99; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Seve S, 2002, CONNECT TISSUE RES, V43, P613, DOI 10.1080/03008200290001348; Sibon I, 2005, HEART, V91, DOI 10.1136/hrt.2004.053074; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Watermann DO, 2005, BRIT J CANCER, V93, P694, DOI 10.1038/sj.bjc.6602744; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776	41	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1385	1393		10.1074/jbc.M802612200	http://dx.doi.org/10.1074/jbc.M802612200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19029090	Green Published, hybrid			2022-12-27	WOS:000262330100006
J	Shirato, H; Ogawa, S; Nakajima, K; Inagawa, M; Kojima, M; Tachibana, M; Shinkai, Y; Takeuchi, T				Shirato, Haruki; Ogawa, Satoko; Nakajima, Kuniko; Inagawa, Masayo; Kojima, Mizuyo; Tachibana, Makoto; Shinkai, Yoichi; Takeuchi, Takashi			A Jumonji (Jarid2) Protein Complex Represses cyclin D1 Expression by Methylation of Histone H3-K9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COREPRESSOR; LYSINE METHYLATION; EPIGENETIC CODE; HAIRLESS GENE; G9A; METHYLTRANSFERASE; FAMILY; TRANSCRIPTION; ROLES; JMJC	Covalent modifications of histone tails have critical roles in regulating gene expression. Previously, we identified the jumonji (jmj, Jarid2) gene, the jmjC domain, and a Jmj family. Recently, many Jmj family proteins have been shown to be histone demethylases, and jmjC is the catalytic domain. However, Jmj does not have histone demethylase activity because the jmjC domain lacks conserved residues for binding to cofactors. Independently of these studies, we previously showed that Jmj binds to the cyclin D1 promoter and represses the transcription of cyclin D1. Here, we show the mechanisms by which Jmj represses the transcription of cyclin D1. We found that a protein complex of Jmj had histone methyltransferase activity toward histone H3 lysine 9 (H3-K9). We also found that Jmj bound to the H3-K9 methyltransferases G9a and GLP. Expression of Jmj recruited G9a and GLP to the cyclin D1 promoter and increased H3-K9 methylation. Inactivation of both G9a and GLP, but not of only G9a, inhibited the methylation of H3-K9 in the cyclin D1 promoter and repression of cyclin D1 expression by Jmj. These results suggest that Jmj methylates H3-K9 and represses cyclin D1 expression through G9a and GLP, and that Jmj family proteins can regulate gene expression by not only histone demethylation but also other histone modification.	[Shirato, Haruki; Ogawa, Satoko; Nakajima, Kuniko; Inagawa, Masayo; Kojima, Mizuyo; Takeuchi, Takashi] Kyoto Univ, Mitsubishi Kagaku Inst Life Sci, Kyoto 6068507, Japan; [Tachibana, Makoto; Shinkai, Yoichi] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Takeuchi, Takashi] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan	Kyoto University; Kyoto University; Yokohama National University	Takeuchi, T (corresponding author), 11 Minamiooya, Tokyo 1948511, Japan.	take@mitils.jp	Shinkai, Yoichi/N-3909-2014	Shinkai, Yoichi/0000-0002-6051-2484	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Balciunas D, 2000, TRENDS BIOCHEM SCI, V25, P274, DOI 10.1016/S0968-0004(00)01593-0; CACHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717, DOI 10.1073/pnas.91.16.7717; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Moraitis AN, 2002, MOL CELL BIOL, V22, P6831, DOI 10.1128/MCB.22.19.6831-6841.2002; Motoyama J, 1997, MECH DEVELOP, V66, P27, DOI 10.1016/S0925-4773(97)00082-8; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Potter GB, 2001, GENE DEV, V15, P2687, DOI 10.1101/gad.916701; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Takahashi M, 2007, DEV BIOL, V303, P549, DOI 10.1016/j.ydbio.2006.11.031; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Toyoda M, 2000, BIOCHEM BIOPH RES CO, V274, P332, DOI 10.1006/bbrc.2000.3138; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2	29	59	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					733	739		10.1074/jbc.M804994200	http://dx.doi.org/10.1074/jbc.M804994200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010785	hybrid			2022-12-27	WOS:000262122900006
J	Karbarz, MJ; Six, DA; Raetz, CRH				Karbarz, Mark J.; Six, David A.; Raetz, Christian R. H.			Purification and Characterization of the Lipid A 1-Phosphatase LpxE of Rhizobium leguminosarum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-MANNO-OCTULOSONIC ACID TRANSFERASE; LIPOPOLYSACCHARIDE CORE GLYCOSYLATION; AGROBACTERIUM-TUMEFACIENS C58; ESCHERICHIA-COLI; EXPRESSION CLONING; SALMONELLA-TYPHIMURIUM; PYRIDOXAL-PHOSPHATE; A BIOSYNTHESIS; MUTANT LACKING; GENE	LpxE, a membrane-bound phosphatase found in Rhizobium leguminosarum and some other Gram-negative bacteria, selectively dephosphorylates the 1-position of lipid A on the outer surface of the inner membrane. LpxE belongs to the family of lipid phosphate phosphatases that contain a tripartite active site motif and six predicted transmembrane helices. Here we report the purification and characterization of R. leguminosarum LpxE. A modified lpxE gene, encoding a protein with an N-terminal His(6) tag, was expressed in Escherichia coli. The protein was solubilized with Triton X-100 and purified to near-homogeneity. Gel electrophoresis reveals a molecular weight consistent with the predicted 31 kDa. LpxE activity is dependent upon Triton X-100, optimal near pH6.5, and Mg2+-independent. The H197A and R133A substitutions inactivate LpxE, as does treatment with diethyl pyrocarbonate. In a mixed micelle assay system, the apparent Km for the precursor lipid IVA is 11 mu M. Substrates containing the 3-deoxy-D-manno-oct-2-ulosonic acid disaccharide are dephosphorylated at similar rates to lipid IVA, whereas glycerophospholipids like phosphatidic acid or phosphatidylglycerol phosphate are very poor substrates. However, an LpxE homologue present in Agrobacterium tumefaciens is selective for phosphatidylglycerol phosphate, demonstrating the importance of determining substrate specificity before assigning the functions of LpxE-related proteins. The availability of purified LpxE will facilitate the preparation of novel 1-dephosphorylated lipid A molecules that are not readily accessible by chemical methods.	[Karbarz, Mark J.; Six, David A.; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	raetz@biochem.duke.edu	Six, David A/D-6523-2011	Six, David A/0000-0002-9013-1711	National Institutes of Health [R37-GM-51796]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051796, T32GM008558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-GM-51796 (to C. R. H. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; Babinski KJ, 2002, J BIOL CHEM, V277, P25947, DOI 10.1074/jbc.M204068200; Baldridge JR, 2004, EXPERT OPIN BIOL TH, V4, P1129, DOI 10.1517/14712598.4.7.1129; Basu SS, 1999, J BIOL CHEM, V274, P11139, DOI 10.1074/jbc.274.16.11139; Basu SS, 1999, J BIOL CHEM, V274, P11150, DOI 10.1074/jbc.274.16.11150; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BHAT UR, 1994, J BIOL CHEM, V269, P14402; Bienzle U, 2002, LIVER TRANSPLANT, V8, P562, DOI 10.1053/jlts.2002.33699; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brozek KA, 1996, J BIOL CHEM, V271, P32112, DOI 10.1074/jbc.271.50.32119; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Hoshino K, 1999, J IMMUNOL, V162, P3749; Ishikawa K, 2000, EMBO J, V19, P2412, DOI 10.1093/emboj/19.11.2412; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; Kadrmas JL, 1998, J BIOL CHEM, V273, P26432, DOI 10.1074/jbc.273.41.26432; Kadrmas JL, 1996, J BIOL CHEM, V271, P32119, DOI 10.1074/jbc.271.50.32112; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12865, DOI 10.1074/jbc.M513864200; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12879, DOI 10.1074/jbc.M513865200; Karbarz MJ, 2003, J BIOL CHEM, V278, P39269, DOI 10.1074/jbc.M305830200; Keenleyside WJ, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P331; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; MATSUYAMA T, 1992, J BIOCHEM-TOKYO, V112, P258, DOI 10.1093/oxfordjournals.jbchem.a123887; MATTHEWS KS, 1991, METHOD ENZYMOL, V208, P468; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Miles E W, 1977, Methods Enzymol, V47, P431; Miller J. H., 1972, EXPT MOL GENETICS, P433; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NISHIJIMA M, 1979, J BIOL CHEM, V254, P7837; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Oshiro J, 2003, BBA-MOL CELL BIOL L, V1635, P1, DOI 10.1016/j.bbalip.2003.10.002; Persing DH, 2002, TRENDS MICROBIOL, V10, pS32, DOI 10.1016/S0966-842X(02)02426-5; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PRICE NPJ, 1995, P NATL ACAD SCI USA, V92, P7352, DOI 10.1073/pnas.92.16.7352; PRICE NPJ, 1994, J BACTERIOL, V176, P4646, DOI 10.1128/JB.176.15.4646-4655.1994; Que NLS, 2000, J BIOL CHEM, V275, P28006; Que NLS, 2000, J BIOL CHEM, V275, P28017; Que-Gewirth NLS, 2003, J BIOL CHEM, V278, P12120, DOI 10.1074/jbc.M300379200; Que-Gewirth NLS, 2003, J BIOL CHEM, V278, P12109, DOI 10.1074/jbc.M300378200; QURESHI N, 1982, J BIOL CHEM, V257, P1808; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; RAETZ CRH, 1972, BIOCHEMISTRY-US, V11, P2229, DOI 10.1021/bi00762a004; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Sambrook J., 2001, MOL CLONING LAB MANU; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Stukey J, 1997, PROTEIN SCI, V6, P469; Tran AX, 2004, J BIOL CHEM, V279, P55780, DOI 10.1074/jbc.M406480200; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; Ulrich J T, 1995, Pharm Biotechnol, V6, P495; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Wang XY, 2007, P NATL ACAD SCI USA, V104, P4136, DOI 10.1073/pnas.0611606104; Wang XY, 2006, BIOCHEMISTRY-US, V45, P14427, DOI 10.1021/bi061767s; Wang XY, 2006, J BIOL CHEM, V281, P9321, DOI 10.1074/jbc.M600435200; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93	72	23	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					414	425		10.1074/jbc.M808390200	http://dx.doi.org/10.1074/jbc.M808390200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984595	hybrid, Green Published			2022-12-27	WOS:000261974800046
J	Durkin, SS; Guo, X; Fryrear, KA; Mihaylova, VT; Gupta, SK; Belgnaoui, SM; Haoudi, A; Kupfer, GM; Semmes, OJ				Durkin, Sarah S.; Guo, Xin; Fryrear, Kimberly A.; Mihaylova, Valia T.; Gupta, Saurabh K.; Belgnaoui, S. Mehdi; Haoudi, Abdelali; Kupfer, Gary M.; Semmes, O. John			HTLV-1 Tax Oncoprotein Subverts the Cellular DNA Damage Response via Binding to DNA-dependent Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-VIRUS TYPE-1; DOUBLE-STRAND BREAKS; I TAX; CATALYTIC SUBUNIT; CHROMOSOMAL INSTABILITY; FUNCTIONAL INTERACTION; TELOMERE LENGTH; REPAIR; CELLS; AUTOPHOSPHORYLATION	Human T-cell leukemia virus type-1 is the causative agent for adult T-cell leukemia. Previous research has established that the viral oncoprotein Tax mediates the transformation process by impairing cell cycle control and cellular response to DNA damage. We showed previously that Tax sequesters huChk2 within chromatin and impairs the response to ionizing radiation. Here we demonstrate that DNA-dependent protein kinase (DNA-PK) is a member of the Tax.Chk2 nuclear complex. The catalytic subunit, DNA-PKcs, and the regulatory subunit, Ku70, were present. Tax-containing nuclear extracts showed increased DNA-PK activity, and specific inhibition of DNA-PK prevented Tax-induced activation of Chk2 kinase activity. Expression of Tax induced foci formation and phosphorylation of H2AX. However, Tax-induced constitutive signaling of the DNA-PK pathway impaired cellular response to new damage, as reflected in suppression of ionizing radiation-induced DNA-PK phosphorylation and gamma H2AX stabilization. Tax co-localized with phospho-DNA-PK into nuclear speckles and a nuclear excluded Tax mutant sequestered endogenous phospho-DNA-PK into the cytoplasm, suggesting that Tax interaction with DNA-PK is an initiating event. Wealso describe a novel interaction between DNA-PK and Chk2 that requires Tax. We propose that Tax binds to and stabilizes a protein complex with DNA-PK and Chk2, resulting in a saturation of DNA-PK-mediated damage repair response.	[Durkin, Sarah S.; Guo, Xin; Fryrear, Kimberly A.; Gupta, Saurabh K.; Belgnaoui, S. Mehdi; Haoudi, Abdelali; Semmes, O. John] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Ctr Biomed Prote, Norfolk, VA 23507 USA; [Mihaylova, Valia T.; Kupfer, Gary M.] Yale Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, New Haven, CT 06520 USA	Eastern Virginia Medical School; Yale University	Semmes, OJ (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Ctr Biomed Prote, Lewis Hall,700 W Olney Rd, Norfolk, VA 23507 USA.	semmesoj@evms.edu	Semmes, Oliver/GQA-5179-2022		NCI [CA-76595]; NATIONAL CANCER INSTITUTE [R01CA076595] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Grant CA-76595 from NCI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bailey SM, 2006, NUCLEIC ACIDS RES, V34, P2408, DOI 10.1093/nar/gkl303; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bewersdorf J, 2006, P NATL ACAD SCI USA, V103, P18137, DOI 10.1073/pnas.0608709103; Budman J, 2007, J BIOL CHEM, V282, P11950, DOI 10.1074/jbc.M610058200; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; CUSTER RP, 1985, AM J PATHOL, V120, P464; Derse D, 2004, FRONT BIOSCI-LANDMRK, V9, P2495, DOI 10.2741/1411; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Doherty AJ, 2001, CURR BIOL, V11, pR920, DOI 10.1016/S0960-9822(01)00555-3; Durkin SS, 2006, J BIOL CHEM, V281, P31705, DOI 10.1074/jbc.M607011200; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; FURUKAWA Y, 1992, BLOOD, V80, P1012; Gabet AS, 2003, ONCOGENE, V22, P3734, DOI 10.1038/sj.onc.1206468; GESSAIN A, 1985, LANCET, V2, P407; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Gupta SK, 2007, J BIOL CHEM, V282, P29431, DOI 10.1074/jbc.M704110200; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; Haoudi A, 2003, VIROLOGY, V305, P229, DOI 10.1006/viro.2002.1642; Hosoi Y, 2004, INT J ONCOL, V25, P461; Itoyama A, 2001, BLOOD, V97, P3612, DOI 10.1182/blood.V97.11.3612; JEANG KT, 1990, SCIENCE, V247, P1082, DOI 10.1126/science.2309119; Jhappan C, 1997, NAT GENET, V17, P483, DOI 10.1038/ng1297-483; Kao SY, 1999, J VIROL, V73, P4299, DOI 10.1128/JVI.73.5.4299-4304.1999; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2; Li J, 2005, J BIOL CHEM, V280, P12041, DOI 10.1074/jbc.M412445200; Liu BY, 2003, MOL CELL BIOL, V23, P5269, DOI 10.1128/MCB.23.15.5269-5281.2003; Liu LX, 2003, HEPATO-GASTROENTEROL, V50, P1496; Majone F, 2000, J BIOL CHEM, V275, P32906, DOI 10.1074/jbc.C000538200; MAJONE F, 1993, VIROLOGY, V193, P456, DOI 10.1006/viro.1993.1145; Majone F, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-45; Marriott SJ, 2005, ONCOGENE, V24, P5986, DOI 10.1038/sj.onc.1208976; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Miyake H, 1999, VIROLOGY, V253, P155, DOI 10.1006/viro.1998.9500; Morimoto H, 2005, AM J HEMATOL, V78, P100, DOI 10.1002/ajh.20259; Mortreux F, 2003, LEUKEMIA, V17, P26, DOI 10.1038/sj.leu.2402777; OSAME M, 1986, LANCET, V1, P1031; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Park HU, 2006, ONCOGENE, V25, P438, DOI 10.1038/sj.onc.1209059; Philpott SM, 1999, J NATL CANCER I, V91, P933, DOI 10.1093/jnci/91.11.933; Pise-Masison CA, 2000, MOL CELL BIOL, V20, P3377, DOI 10.1128/MCB.20.10.3377-3386.2000; Pise-Masison CA, 1998, J VIROL, V72, P6348, DOI 10.1128/JVI.72.8.6348-6355.1998; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Rao VA, 2007, MOL CANCER RES, V5, P713, DOI 10.1158/1541-7786.MCR-07-0028; Reddy YVR, 2004, J BIOL CHEM, V279, P39408, DOI 10.1074/jbc.M406432200; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Saggioro D, 1999, EXP CELL RES, V247, P525, DOI 10.1006/excr.1998.4381; Saitou M, 2001, J HUM GENET, V46, P706, DOI 10.1007/s100380170004; Semmes OJ, 1996, J VIROL, V70, P6347, DOI 10.1128/JVI.70.9.6347-6357.1996; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sibon D, 2006, J CLIN INVEST, V116, P974, DOI 10.1172/JCI27198; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Um JH, 2004, J PHARMACOL EXP THER, V311, P1062, DOI 10.1124/jpet.104.070938; Van PL, 2001, J VIROL, V75, P396, DOI 10.1128/JVI.75.1.396-407.2001; Veuger SJ, 2003, CANCER RES, V63, P6008; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	78	62	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36311	36320		10.1074/jbc.M804931200	http://dx.doi.org/10.1074/jbc.M804931200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957425	Green Published, hybrid			2022-12-27	WOS:000261840500027
J	Mortimer, SE; Xu, D; McGrew, D; Hamaguchi, N; Lim, HC; Bowne, SJ; Daiger, SP; Hedstrom, L				Mortimer, Sarah E.; Xu, Dong; McGrew, Dharia; Hamaguchi, Nobuko; Lim, Hoong Chuin; Bowne, Sara J.; Daiger, Stephen P.; Hedstrom, Lizbeth			IMP Dehydrogenase Type 1 Associates with Polyribosomes Translating Rhodopsin mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSINE 5'-MONOPHOSPHATE DEHYDROGENASE; DOMINANT RETINITIS-PIGMENTOSA; MONOPHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; BINDING PROTEINS; IN-VITRO; IDENTIFICATION; MUTATIONS; DOMAIN; COMPLEXES	IMP dehydrogenase (IMPDH) catalyzes the pivotal step in guanine nucleotide biosynthesis. Here we show that both IMPDH type 1 (IMPDH1) and IMPDH type 2 are associated with polyribosomes, suggesting that these housekeeping proteins have an unanticipated role in translation regulation. This interaction is mediated by the subdomain, a region of disputed function that is the site of mutations that cause retinal degeneration. The retinal isoforms of IMPDH1 also associate with polyribosomes. The most common disease-causing mutation, D226N, disrupts the polyribosome association of at least one retinal IMPDH1 isoform. Finally, we find that IMPDH1 is associated with polyribosomes containing rhodopsin mRNA. Because any perturbation of rhodopsin expression can trigger apoptosis in photoreceptor cells, these observations suggest a likely pathological mechanism for IMPDH1-mediated hereditary blindness. We propose that IMPDH coordinates the translation of a set of mRNAs, perhaps by modulating localization or degradation.	[Mortimer, Sarah E.; Xu, Dong; Hamaguchi, Nobuko; Lim, Hoong Chuin; Hedstrom, Lizbeth] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [McGrew, Dharia] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Daiger, Stephen P.] Univ Texas Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA; [Bowne, Sara J.; Daiger, Stephen P.] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA	Brandeis University; Brandeis University; Brandeis University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biochem, MS 009,415 South St, Waltham, MA 02454 USA.	hedstrom@brandeis.edu			National Institutes of Health [GM54403, EY17325, EY014170, GM07956]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY007142, R21EY017325, R01EY014170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54403 and EY17325 (to L. H.) and EY014170 (to S. P. D.), and GM07956 (Macromolecular Structure and Mechanism Training Grant to S. E. M.). This work was also supported by grant from the Foundation Fighting Blindness (to S. P. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P3754, DOI 10.1167/iovs.06-0207; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; CARR SF, 1993, J BIOL CHEM, V268, P27286; Carson JP, 2004, CANCER RES, V64, P2096, DOI 10.1158/0008-5472.CAN-03-2029; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Cornuel JF, 2002, BIOCHIMIE, V84, P279, DOI 10.1016/S0300-9084(02)01400-1; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Gan L, 2002, BIOCHEMISTRY-US, V41, P13309, DOI 10.1021/bi0203785; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Grover S, 2004, OPHTHALMOLOGY, V111, P1910, DOI 10.1016/j.ophtha.2004.03.039; Gunawardena S, 2004, J NEUROBIOL, V58, P258, DOI 10.1002/neu.10319; Gunter JH, 2008, INT J BIOCHEM CELL B, V40, P1716, DOI 10.1016/j.biocel.2007.12.018; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hedstrom L, 1999, CURR MED CHEM, V6, P545; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HOLMES EW, 1974, BIOCHIM BIOPHYS ACTA, V364, P209, DOI 10.1016/0005-2744(74)90006-0; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jain J, 2004, BIOCHEM PHARMACOL, V67, P767, DOI 10.1016/j.bcp.2003.09.043; Jamsen J, 2007, BIOCHEM J, V408, P327, DOI 10.1042/BJ20071017; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kennan A, 2002, HUM MOL GENET, V11, P547, DOI 10.1093/hmg/11.5.547; Kerman A, 2003, ADV EXP MED BIOL, V533, P13; MATSUNO K, 1995, BIOSCI BIOTECH BIOCH, V59, P231, DOI 10.1271/bbb.59.231; McLean JE, 2004, BIOCHEM J, V379, P243, DOI 10.1042/BJ20031585; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Mortimer SE, 2005, BIOCHEM J, V390, P41, DOI 10.1042/BJ20042051; Nimmesgern E, 1999, PROTEIN EXPRES PURIF, V17, P282, DOI 10.1006/prep.1999.1136; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SENDA M, 1994, LIFE SCI, V54, P1917, DOI 10.1016/0024-3205(94)90150-3; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Spellicy CJ, 2007, MOL VIS, V13, P1866; Sung CH, 2000, INT REV CYTOL, V195, P215; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Wada Y, 2005, INVEST OPHTH VIS SCI, V46, P1735, DOI 10.1167/iovs.04-1197; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WEBER G, 1992, ADV ENZYME REGUL, V32, P57; Whitehead JP, 2004, TRAFFIC, V5, P739, DOI 10.1111/j.1600-0854.2004.00217.x; Xu D, 2008, ARCH BIOCHEM BIOPHYS, V472, P100, DOI 10.1016/j.abb.2008.02.012; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v	56	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36354	36360		10.1074/jbc.M806143200	http://dx.doi.org/10.1074/jbc.M806143200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974094	hybrid, Green Published			2022-12-27	WOS:000261840500032
J	Sarg, B; Chwatal, S; Talasz, H; Lindner, HH				Sarg, Bettina; Chwatal, Sabine; Talasz, Heribert; Lindner, Herbert H.			Testis-specific Linker Histone H1t Is Multiply Phosphorylated during Spermatogenesis IDENTIFICATION OF PHOSPHORYLATION SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; AGE-DEPENDENT DEAMIDATION; SPERMATIDAL PROTEIN TP2; CELL-SPECIFIC VARIANT; C-TERMINAL DOMAIN; DNA CONDENSATION; RAT TESTIS; CAPILLARY ELECTROPHORESIS; MAMMALIAN SPERMIOGENESIS; MOUSE SPERMATOGENESIS	During normal spermatogenesis, the testis-specific linker histone H1t appears at pachytene stage becomes phosphorylated in early spermatids and disappears in late spermatids. Using reversed-phase and hydrophilic interaction liquid chromatography, H1t from rat and mouse testes was isolated, subjected to enzymatic digestion, and analyzed by mass spectrometry. We observed different phosphorylated states of H1t (mono-, di-, and triphosphorylated) as well as the unphosphorylated protein. Tandem mass spectrometry and immobilized metal ion affinity chromatography experiments with MS/MS/MS and multistage activation were utilized to identify five phosphorylation sites on H1t from rats. Phosphorylation occurs on both serine and threonine residues, whereas only two of these sites were located on peptides containing the CDK consensus motif (S/T) PXZ. Rat H1t phosphorylation starts first by phosphorylation of the non-consensus motif SPKS in the COOH-terminal domain, namely at Ser-140 and to a smaller degree at a further nonconsensus motif at Ser-186. This is followed by phosphorylation of Ser-177 and Thr-155, both located in CDK consensus motifs. A single phosphorylation site at Ser-8 in the NH2-terminal tail was also found. Mouse H1t lacks Ser-186 and is phosphorylated at up to four sites. In contrast to somatic linker histones, no strict order of increasing phosphorylation could be detected in H1t. Thus, it appears that not the order of up-phosphorylation but the number of the phosphate groups is necessary for regulated chromatin decondensation, thus facilitating the substitution of H1t by transition proteins and protamines.	[Sarg, Bettina; Chwatal, Sabine; Talasz, Heribert; Lindner, Herbert H.] Innsbruck Med Univ, Div Clin Biochem, Bioctr, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Lindner, HH (corresponding author), Innsbruck Med Univ, Div Clin Biochem, Bioctr, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	herbert.lindner@i-med.ac.at			European Science Foundation EUROCORES Programme EuroDYNA; Austrian Science Foundation [I23-B03]	European Science Foundation EUROCORES Programme EuroDYNA(European Science Foundation (ESF)); Austrian Science Foundation(Austrian Science Fund (FWF))	This work, as part of the European Science Foundation EUROCORES Programme EuroDYNA, was supported by funds from Austrian Science Foundation Project I23-B03. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adham IM, 2001, MOL HUM REPROD, V7, P513, DOI 10.1093/molehr/7.6.513; BABA T, 1994, J BIOL CHEM, V269, P10133; CHIRAT F, 1991, EUR J BIOCHEM, V198, P13, DOI 10.1111/j.1432-1033.1991.tb15980.x; CHIRAT F, 1993, BIOCHIM BIOPHYS ACTA, V1203, P109, DOI 10.1016/0167-4838(93)90043-Q; Cobb J, 1999, CHROMOSOMA, V108, P412, DOI 10.1007/s004120050393; COLE KD, 1986, J BIOL CHEM, V261, P7178; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; DELUCIA F, 1994, BIOCHEM BIOPH RES CO, V198, P32, DOI 10.1006/bbrc.1994.1005; Doenecke D, 1997, HISTOCHEM CELL BIOL, V107, P1, DOI 10.1007/s004180050083; Drabent B, 2000, HISTOCHEM CELL BIOL, V113, P433; DRABENT B, 1993, BIOCHIM BIOPHYS ACTA, V1216, P311, DOI 10.1016/0167-4781(93)90162-7; Fantz DA, 2001, BIOL REPROD, V64, P425, DOI 10.1095/biolreprod64.2.425; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; GREEN GR, 1994, MOL REPROD DEV, V37, P255, DOI 10.1002/mrd.1080370303; Hendzel MJ, 2004, J BIOL CHEM, V279, P20028, DOI 10.1074/jbc.M400070200; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Kimmins S, 2005, NATURE, V434, P583, DOI 10.1038/nature03368; KISTLER WS, 1987, ANN NY ACAD SCI, V513, P102, DOI 10.1111/j.1749-6632.1987.tb25001.x; Krishnamoorthy T, 2006, GENE DEV, V20, P2580, DOI 10.1101/gad.1457006; LEBLOND CP, 1952, ANN NY ACAD SCI, V55, P548, DOI 10.1111/j.1749-6632.1952.tb26576.x; LENNOX RW, 1984, DEV BIOL, V103, P80, DOI 10.1016/0012-1606(84)90009-5; Lin QC, 2000, MOL CELL BIOL, V20, P2122, DOI 10.1128/MCB.20.6.2122-2128.2000; LINDNER H, 1986, J CHROMATOGR, V357, P301, DOI 10.1016/S0021-9673(01)95832-7; Lindner H, 1996, J CHROMATOGR A, V743, P137, DOI 10.1016/0021-9673(96)00131-8; LINDNER H, 1992, BIOCHEM J, V283, P467, DOI 10.1042/bj2830467; Lindner H, 1997, J CHROMATOGR A, V782, P55, DOI 10.1016/S0021-9673(97)00468-8; LINDNER H, 1986, ANAL BIOCHEM, V158, P424, DOI 10.1016/0003-2697(86)90570-1; LINDNER H, 1990, CHROMATOGRAPHIA, V30, P518, DOI 10.1007/BF02269797; LINDNER H, 1990, BIOCHEM J, V269, P359, DOI 10.1042/bj2690359; Lindner H, 1999, J CANCER RES CLIN, V125, P182, DOI 10.1007/s004320050261; LINDNER H, 1993, ELECTROPHORESIS, V14, P480, DOI 10.1002/elps.1150140174; Lindner H, 1998, J BIOL CHEM, V273, P13324, DOI 10.1074/jbc.273.21.13324; LINDNER H, 1995, ELECTROPHORESIS, V16, P604, DOI 10.1002/elps.1150160197; Lindner Herbert, 2003, J Capill Electrophor Microchip Technol, V8, P59; Martianov I, 2005, P NATL ACAD SCI USA, V102, P2808, DOI 10.1073/pnas.0406060102; MARUSHIGE Y, 1975, J BIOL CHEM, V250, P39; Meetei AR, 2002, BIOCHEMISTRY-US, V41, P185, DOI 10.1021/bi0117652; MEISTRICH ML, 1992, MOL REPROD DEV, V31, P170, DOI 10.1002/mrd.1080310303; MEISTRICH ML, 1994, BIOL REPROD, V51, P334, DOI 10.1095/biolreprod51.2.334; MEISTRICH ML, 1985, DEV BIOL, V112, P230, DOI 10.1016/0012-1606(85)90137-X; MEISTRICH ML, 1978, FED PROC, V37, P2522; MEISTRICH ML, 1989, HISTONES OTHER BASIC; Nayernia K, 2005, MOL REPROD DEV, V70, P406, DOI 10.1002/mrd.20227; Nayernia K, 2003, CYTOGENET GENOME RES, V103, P314, DOI 10.1159/000076819; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rabini S, 2000, EXP CELL RES, V255, P114, DOI 10.1006/excr.1999.4767; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roque A, 2008, NUCLEIC ACIDS RES, V36, P4719, DOI 10.1093/nar/gkn440; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; Sarg B, 2006, J BIOL CHEM, V281, P6573, DOI 10.1074/jbc.M508957200; Sarg B, 2004, J BIOL CHEM, V279, P53458, DOI 10.1074/jbc.M409099200; Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200; Sarg B, 1999, ARCH BIOCHEM BIOPHYS, V372, P333, DOI 10.1006/abbi.1999.1503; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SHIRES A, 1976, J BIOL CHEM, V251, P4155; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; TROSTLEWEIGE PK, 1982, J BIOL CHEM, V257, P5560; TROSTLEWEIGE PK, 1984, J BIOL CHEM, V259, P8769; Ullas KS, 2003, J BIOL CHEM, V278, P52673, DOI 10.1074/jbc.M308365200; Vila R, 2001, J BIOL CHEM, V276, P46429, DOI 10.1074/jbc.M106952200; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Yan W, 2003, P NATL ACAD SCI USA, V100, P10546, DOI 10.1073/pnas.1837812100; Zhu DH, 1997, DEVELOPMENT, V124, P3007	70	26	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3610	3618		10.1074/jbc.M805925200	http://dx.doi.org/10.1074/jbc.M805925200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19043117	hybrid			2022-12-27	WOS:000262872500029
J	Ter-Avetisyan, G; Tuennemann, G; Nowak, D; Nitschke, M; Herrmann, A; Drab, M; Cardoso, MC				Ter-Avetisyan, Gohar; Tuennemann, Gisela; Nowak, Danny; Nitschke, Matthias; Herrmann, Andreas; Drab, Marek; Cardoso, M. Cristina			Cell Entry of Arginine-rich Peptides Is Independent of Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAT-FUSION PROTEINS; CLATHRIN-DEPENDENT ENDOCYTOSIS; HUMAN IMMUNODEFICIENCY VIRUS; PENETRATING PEPTIDES; IN-VIVO; MAMMALIAN-CELLS; LOW-TEMPERATURE; CARGO DELIVERY; DRUG-DELIVERY; COATED PITS	Arginine-rich peptides are a subclass of cell-penetrating peptides that are taken up by living cells and can be detected freely diffusing inside the cytoplasm and nucleoplasm. This phenomenon has been attributed to either an endocytic mode of uptake and a subsequent release from vesicles or to direct membrane penetration (transduction). To distinguish between both possibilities, we have blocked endocytic pathways suggested to be involved in uptake of cell-penetrating peptides. We have then monitored by confocal microscopy the uptake and distribution of the cell-penetrating transactivator of transcription (TAT) peptide into living mammalian cells over time. To prevent side effects of chemical inhibitors, we used genetically engineered cells as well as different temperature. We found that a knock-down of clathrin-mediated endocytosis and a knock-out of caveolin-mediated endocytosis did not affect the ability of TAT to enter cells. In addition, the TAT peptide showed the same intracellular distribution throughout the cytoplasm and nucleus as in control cells. Even incubation of cells at 4 degrees C did not abrogate TAT uptake nor change its intracellular distribution. We therefore conclude that this distribution results from TAT peptide that directly penetrated (transduced) the plasma membrane. The formation of nonselective pores is unlikely, because simultaneously added fluorophores were not taken up together with the TAT peptide. In summary, although the frequency and kinetics of TAT transduction varied between cell types, it was independent of endocytosis.	[Ter-Avetisyan, Gohar; Tuennemann, Gisela; Nowak, Danny; Cardoso, M. Cristina] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Nitschke, Matthias; Herrmann, Andreas] Humboldt Univ, Dept Biol Biophys, D-10115 Berlin, Germany; [Drab, Marek] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, D-64287 Darmstadt, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Max Planck Society; Technical University of Darmstadt	Cardoso, MC (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.	Cardoso@bio.tu-darmstadt.de	Drab, Marek/J-5196-2013; Cardoso, M. Cristina/F-5215-2011; Drab, Marek/AAQ-1892-2020	Drab, Marek/0000-0002-2771-1692; Ter-Avetisyan, Gohar/0000-0003-2751-1938; Lattig, Gisela/0000-0001-6485-1136	Deutsche Forschungsgemeinschaft; Volkswagen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Volkswagen Foundation (to M. C. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Astriab-Fisher A, 2002, PHARMACEUT RES, V19, P744, DOI 10.1023/A:1016136328329; Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; Dietz Gunnar P. H., 2007, V399, P181, DOI 10.1007/978-1-59745-504-6_13; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Ho A, 2001, CANCER RES, V61, P474; Iversen TG, 2003, P NATL ACAD SCI USA, V100, P5175, DOI 10.1073/pnas.0534231100; Iwasa A, 2006, BBA-BIOMEMBRANES, V1758, P713, DOI 10.1016/j.bbamem.2006.04.015; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kawamura KS, 2006, BIOCHEMISTRY-US, V45, P1116, DOI 10.1021/bi051338e; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARSHAK DR, 1985, BIOCHEMISTRY-US, V24, P144, DOI 10.1021/bi00322a020; Martin-Acebes MA, 2007, VIROLOGY, V369, P105, DOI 10.1016/j.virol.2007.07.021; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Nitschke M, 2008, VIROLOGY, V377, P248, DOI 10.1016/j.virol.2008.04.041; Nori A, 2003, BIOCONJUGATE CHEM, V14, P44, DOI 10.1021/bc0255900; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rothbard JB, 2002, J MED CHEM, V45, P3612, DOI 10.1021/jm0105676; Saalik P, 2004, BIOCONJUGATE CHEM, V15, P1246, DOI 10.1021/bc049938y; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Seeman P, 2002, CAN J PSYCHIAT, V47, P27, DOI 10.1177/070674370204700106; Shibagaki N, 2002, J IMMUNOL, V168, P2393, DOI 10.4049/jimmunol.168.5.2393; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968; Tunnemann G, 2007, J MOL MED-JMM, V85, P1405, DOI 10.1007/s00109-007-0238-6; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	53	176	180	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3370	3378		10.1074/jbc.M805550200	http://dx.doi.org/10.1074/jbc.M805550200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19047062	Green Published, hybrid			2022-12-27	WOS:000262872500002
J	Fischer, A; Baljuls, A; Reinders, J; Nekhoroshkova, E; Sibilski, C; Metz, R; Albert, S; Rajalingam, K; Hekman, M; Rapp, UR				Fischer, Andreas; Baljuls, Angela; Reinders, Joerg; Nekhoroshkova, Elena; Sibilski, Claudia; Metz, Renate; Albert, Stefan; Rajalingam, Krishnaraj; Hekman, Mirko; Rapp, Ulf R.			Regulation of RAF Activity by 14-3-3 Proteins RAF KINASES ASSOCIATE FUNCTIONALLY WITH BOTH HOMO- AND HETERODIMERIC FORMS OF 14-3-3 PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; B-RAF; C-RAF; PHOSPHORYLATION SITES; IN-VIVO; A-RAF; POLYACRYLAMIDE-GELS; BIOLOGICAL-ACTIVITY; BINDING-SITES; CAUSE NOONAN	Mammalian 14-3-3 proteins play a crucial role in the activation process of RAF kinases. However, little is known about the selectivity of the mammalian 14-3-3 isoforms with respect to RAF association and activation. Using mass spectrometry, we analyzed the composition of the 14-3-3 isoforms attached to RAF kinases and found that B-RAF associates in vivo with 14-3-3 at much higher diversity than A- and C-RAF. We also examined in vitro binding of purified mammalian 14-3-3 proteins to RAF kinases using surface plasmon resonance techniques. While B- and C-RAF exhibited binding to all seven 14-3-3 isoforms, A- RAF bound with considerably lower affinities to epsilon, tau, and sigma 14-3-3. These findings indicate that 14-3-3 proteins associate with RAF isoforms in a pronounced isoform-specific manner. Because 14-3-3 proteins appear in dimeric forms, we addressed the question of whether both homo-and heterodimeric forms of 14-3-3 proteins participate in RAF signaling. For that purpose, the budding yeast Saccharomyces cerevisiae, possessing only two 14-3-3 isoforms (BMH1 and BMH2), served as testing system. By deletion of the single BMH2 gene, we found that both homo-and heterodimeric forms of 14-3-3 can participate in RAF activation. Furthermore, we show that A-, B-, and C-RAF activity is differentially regulated by its C-terminal and internal 14-3-3 binding domain. Finally, prohibitin, a scaffold protein that affects C-RAF activation in a stimulatory manner, proved to interfere with the internal 14-3-3 binding site in C-RAF. Together, our results shed more light on the complex mechanism of RAF activation, particularly with respect to activation steps that are mediated by 14-3-3 proteins and prohibitin.	[Fischer, Andreas; Baljuls, Angela; Nekhoroshkova, Elena; Sibilski, Claudia; Metz, Renate; Albert, Stefan; Hekman, Mirko; Rapp, Ulf R.] Univ Wurzburg, Bayer Krebsforschungszentrum, D-97078 Wurzburg, Germany; [Reinders, Joerg] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Rajalingam, Krishnaraj] Univ Frankfurt, Sch Med, Inst Biochem 2, Deutsch Forsch Gemeinschaft,Emmy Noether Grp, D-60596 Frankfurt, Germany	University of Wurzburg; University of Regensburg; Goethe University Frankfurt	Rapp, UR (corresponding author), Univ Wurzburg, Bayer Krebsforschungszentrum, Versbacherstr 5, D-97078 Wurzburg, Germany.	rappur@mail.uni-wuerzburg.de	Rajalingam, krishnaraj/D-3081-2011	Reinders, Joerg/0000-0003-1025-7849	Deutsche Forschungsgemeinschaft [487, C3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487, project C3. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Baljuls A, 2008, J BIOL CHEM, V283, P27239, DOI 10.1074/jbc.M801782200; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; Brummer T, 2006, ONCOGENE, V25, P6262, DOI 10.1038/sj.onc.1209640; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2005, FEBS LETT, V579, P464, DOI 10.1016/j.febslet.2004.11.105; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; LUO ZJ, 1995, J BIOL CHEM, V270, P23681, DOI 10.1074/jbc.270.40.23681; MARTIN H, 1993, FEBS LETT, V331, P296, DOI 10.1016/0014-5793(93)80356-Y; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STEPHENS RM, 1992, MOL CELL BIOL, V12, P3733, DOI 10.1128/MCB.12.9.3733; SUEN KL, 1995, ONCOGENE, V11, P825; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Williams JG, 2000, J BIOL CHEM, V275, P22172, DOI 10.1074/jbc.M000397200; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	55	64	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3183	3194		10.1074/jbc.M804795200	http://dx.doi.org/10.1074/jbc.M804795200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049963	hybrid			2022-12-27	WOS:000262700900062
J	Rust, C; Wild, N; Bernt, C; Vennegeerts, T; Wimmer, R; Beuers, U				Rust, Christian; Wild, Nadine; Bernt, Carina; Vennegeerts, Timo; Wimmer, Ralf; Beuers, Ulrich			Bile Acid-induced Apoptosis in Hepatocytes Is Caspase-6-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED APOPTOSIS; SALT-INDUCED APOPTOSIS; GROWTH-FACTOR RECEPTOR; URSODEOXYCHOLIC ACID; RAT HEPATOCYTES; HEPATOMA-CELLS; FAS; ACTIVATION; LIVER; CD95	Apoptosis induced by hydrophobic bile acids is thought to contribute to liver injury during cholestasis. Caspase-6 is an executioner caspase that also appears to have regulatory functions in hematopoetic cell lines. We aimed to elucidate the role of caspase-6 in bile acid-induced apoptosis. The major human hydrophobic bile acid, glycochenodeoxycholic acid (GCDCA, 75 mu mol/liter), rapidly induced caspase-6 cleavage in HepG2-Ntcp human hepatoma cells. GCDCA-induced, but not tumor necrosis factor alpha-or etoposide-induced activation of effector caspases-3 and -7 was significantly reduced by 50% in caspase-6-deficient HepG2-Ntcp cells as well as in primary rat hepatocytes pretreated with a caspase-6 inhibitor. Inhibition of caspase-9 reduced GCDCA-induced activation of caspase-6, whereas inhibition of caspase-6 reduced activation of caspase-8 placing caspase-6 between caspase-9 and caspase-8. GCDCA also induced apoptosis in Fas-deficient Hep3B-Ntcp and HuH7-Ntcp hepatoma cells. In addition, GCDCA-induced apoptosis was reduced by 50% in FADD-deficient HepG2-Ntcp cells, whereas apoptosis induced by tumor necrosis factor alpha was reduced by 90%. Collectively, these observations suggest that GCDCA can induce hepatocyte apoptosis in the absence of death receptor signaling, presumably by a compensatory mitochondrial pathway. In conclusion, caspase-6 appears to play an important regulatory role in the promotion of bile acid-induced apoptosis as part of a feedback loop.	[Rust, Christian; Wild, Nadine; Bernt, Carina; Vennegeerts, Timo; Wimmer, Ralf] Univ Munich, Dept Med 2, D-81377 Munich, Germany; [Bernt, Carina] Eugenex Biotechnol, CH-8274 Traegerwilen, Switzerland; [Beuers, Ulrich] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 Amsterdam, Netherlands	University of Munich; University of Amsterdam	Beuers, U (corresponding author), Marchioninistr 15, D-81377 Munich, Germany.	christian.rust@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft [Ru 743/3-1, Be 1242/5-5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Ru 743/3-1 (to C. R.) and Be 1242/5-5 (to U. B.). Parts of the data were presented at the Annual Meeting of the European Association for the Study of Liver Disease, Vienna, Austria, 2006 (J. Hepatol. 44, S116) and at the Biannual International Bile Acid Meeting, Freiburg, October 7, 2006. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bajt ML, 2000, TOXICOL SCI, V58, P109, DOI 10.1093/toxsci/58.1.109; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Bernhard D, 2000, CELL DEATH DIFFER, V7, P834, DOI 10.1038/sj.cdd.4400719; Bernt C, 2006, BIOCHEM BIOPH RES CO, V340, P800, DOI 10.1016/j.bbrc.2005.12.081; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Glasova H, 2002, EUR J CLIN INVEST, V32, P437, DOI 10.1046/j.1365-2362.2002.01002.x; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; Hofmann AF, 2002, LIVER, V22, P14, DOI 10.1034/j.1600-0676.2002.00002.x; Jian S, 1999, HEPATOLOGY, V29, P101, DOI 10.1002/hep.510290102; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Loegering DA, 2006, CELL DEATH DIFFER, V13, P346, DOI 10.1038/sj.cdd.4401791; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Reinehr R, 2004, J BIOL CHEM, V279, P23977, DOI 10.1074/jbc.M401519200; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Rodrigues CMP, 1999, CELL DEATH DIFFER, V6, P842, DOI 10.1038/sj.cdd.4400560; Rust C, 2000, J BIOL CHEM, V275, P20210, DOI 10.1074/jbc.M909992199; Rust C, 2006, GUT, V55, P719, DOI 10.1136/gut.2005.077461; Rust C, 2005, CLIN REV ALLERG IMMU, V28, P135, DOI 10.1385/CRIAI:28:2:135; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SCHMUCKER DL, 1990, HEPATOLOGY, V12, P1216, DOI 10.1002/hep.1840120523; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Sokol TJ, 2005, J PEDIATR GASTR NUTR, V41, P235, DOI 10.1097/01.MPG.0000170600.80640.88; Sola S, 2002, CLIN SCI, V103, P475, DOI 10.1042/CS20020196; Sola S, 2007, CURR ISSUES MOL BIOL, V9, P123; Tourneur Lea, 2005, Med Immunol, V4, P1, DOI 10.1186/1476-9433-4-1; Yoon JH, 2002, J HEPATOL, V37, P400, DOI 10.1016/S0168-8278(02)00209-X	34	68	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2908	2916		10.1074/jbc.M804585200	http://dx.doi.org/10.1074/jbc.M804585200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19017654	hybrid			2022-12-27	WOS:000262700900035
J	Zou, J; Chang, SC; Marjanovic, J; Majerus, PW				Zou, Jun; Chang, Shao-Chun; Marjanovic, Jasna; Majerus, Philip W.			MTMR9 Increases MTMR6 Enzyme Activity, Stability, and Role in Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOTUBULARIN-RELATED PROTEIN-2; MARIE-TOOTH-DISEASE; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CAENORHABDITIS-ELEGANS; PHOSPHATASE; FAMILY; GENE; IDENTIFICATION; SPECIFICITY; MYOPATHY	Myotubularin-related protein 6 (MTMR6) is a catalytically active member of the myotubularin (MTM) family, which is composed of 14 proteins. Catalytically active myotubularins possess 3-phosphatase activity dephosphorylating phosphatidylinositol-3-phoshate and phosphatidylinositol-3,5-bisphosphate, and some members have been shown to form homomers or heteromeric complexes with catalytically inactive myotubularins. We demonstrate that human MTMR6 forms a heteromer with an enzymatically inactive member myotubularin-related protein 9 (MTMR9), both in vitro and in cells. MTMR9 increased the binding of MTMR6 to phospholipids without changing the lipid binding profile. MTMR9 increased the 3-phosphatase activity of MTMR6 up to 6-fold. We determined that MTMR6 is activated up to 28-fold in the presence of phosphatidylserine liposomes. Together, MTMR6 activity in the presence of MTMR9 and assayed in phosphatidylserine liposomes increased 84-fold. Moreover, the formation of this heteromer in cells resulted in increased protein levels of both MTMR6 and MTMR9, probably due to the inhibition of degradation of both proteins. Furthermore, co-expression of MTMR6 and MTMR9 decreased etoposide-induced apoptosis, whereas decreasing both MTMR6 and MTMR9 by RNA interference led to increased cell death in response to etoposide treatment when compared with that seen with RNA interference of MTMR6 alone. Thus, MTMR9 greatly enhances the functions of MTMR6.	[Majerus, Philip W.] Washington Univ, Sch Med, Dept Internal Med, Div Hematol, St Louis, MO 63110 USA; [Chang, Shao-Chun] Eli Lilly & Co, Indianapolis, IN 46825 USA	Washington University (WUSTL); Eli Lilly	Majerus, PW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Hematol, 660 S Euclid Ave,Campus Box 8125, St Louis, MO 63110 USA.	phil@dom.wustl.edu			National Institutes of Health [HL 016634]; American Heart Association [0475014N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016634, R37HL016634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 016634( to P. W. M.). This work was also supported by the American Heart Association Grant 0475014N ( to S. C. C.).	Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Berger P, 2006, HUM MOL GENET, V15, P569, DOI 10.1093/hmg/ddi473; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Biro E, 2005, J THROMB HAEMOST, V3, P2754, DOI 10.1111/j.1538-7836.2005.01646.x; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; CALDWELL KK, 1991, J BIOL CHEM, V266, P18378; Choudhury P, 2006, J BIOL CHEM, V281, P31762, DOI 10.1074/jbc.M606344200; Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Laporte J, 1998, HUM MOL GENET, V7, P1703, DOI 10.1093/hmg/7.11.1703; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lorenzo O, 2005, J CELL SCI, V118, P2005, DOI 10.1242/jcs.02325; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Nandurkar HH, 2001, P NATL ACAD SCI USA, V98, P9499, DOI 10.1073/pnas.171306098; Robinson FL, 2005, J BIOL CHEM, V280, P31699, DOI 10.1074/jbc.M505159200; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Srivastava S, 2005, MOL CELL BIOL, V25, P3630, DOI 10.1128/MCB.25.9.3630-3638.2005; Srivastava S, 2006, MOL CELL BIOL, V26, P5595, DOI 10.1128/MCB.00352-06; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Taylor GS, 2003, METHOD ENZYMOL, V366, P43; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Vallat L, 2003, BLOOD, V101, P4598, DOI 10.1182/blood-2002-06-1743; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Verbsky JW, 2005, J BIOL CHEM, V280, P1911, DOI 10.1074/jbc.M411528200; Xue YZ, 2003, J BIOL CHEM, V278, P34380, DOI 10.1074/jbc.M303259200; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zou J, 2007, P NATL ACAD SCI USA, V104, P16834, DOI 10.1073/pnas.0708189104	35	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2064	2071		10.1074/jbc.M804292200	http://dx.doi.org/10.1074/jbc.M804292200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19038970	Green Published, hybrid			2022-12-27	WOS:000262545600014
J	Chen, M; Sinha, M; Luxon, BA; Bresnick, AR; O'Connor, KL				Chen, Min; Sinha, Mala; Luxon, Bruce A.; Bresnick, Anne R.; O'Connor, Kathleen L.			Integrin alpha 6 beta 4 Controls the Expression of Genes Associated with Cell Motility, Invasion, and Metastasis, Including S100A4/Metastasin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; CHEMOTACTIC MIGRATION; LAMELLAE FORMATION; CALCIUM-BINDING; MAMMARY-TUMORS; MTS1 GENE; S100A4; PROGRESSION	The integrin alpha 6 beta 4 is associated with carcinoma progression by contributing to apoptosis resistance, invasion, and metastasis, due in part to the activation of select transcription factors. To identify genes regulated by the alpha 6 beta 4 integrin, we compared gene expression profiles of MDA-MB-435 cells that stably express integrin alpha 6 beta 4 (MDA/beta 4) and vector-only-transfected cells (MDA/mock) using Affymetrix GeneChip (R) analysis. Our results show that integrin alpha 6 beta 4 altered the expression of 538 genes (p < 0.01). Of these genes, 36 are associated with pathways implicated in cell motility and metastasis, including S100A4/metastasin. S100A4 expression correlated well with integrin alpha 6 beta 4 expression in established cell lines. Suppression of S100A4 by small interference RNA resulted in a reduced capacity of alpha 6 beta 4-expressing cells to invade a reconstituted basement membrane in response to lysophosphatidic acid. Using small interference RNA, promoter analysis, and chromatin immuno-precipitation, we demonstrate that S100A4 is regulated by NFAT5, thus identifying the first target of NFAT5 in cancer. In addition, several genes that are known to be regulated by DNA methylation were up-regulated dramatically by integrin alpha 6 beta 4 expression, including S100A4, FST, PDLIM4, CAPG, and Nkx2.2. Notably, inhibition of DNA methyltransferases stimulated expression of these genes in cells lacking the alpha 6 beta 4 integrin, whereas demethylase inhibitors suppressed expression in alpha 6 beta 4 integrin-expressing cells. Alterations in DNA methylation were confirmed by bisulfate sequencing, thus suggesting that integrin alpha 6 beta 4 signaling can lead to the demethylation of select promoters. In summary, our data suggest that integrin alpha 6 beta 4 confers a motile and invasive phenotype to breast carcinoma cells by regulating proinvasive and prometastatic gene expression.	[Chen, Min; O'Connor, Kathleen L.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Sinha, Mala; Luxon, Bruce A.; O'Connor, Kathleen L.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Chen, Min; O'Connor, Kathleen L.] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Bresnick, Anne R.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Yeshiva University; Albert Einstein College of Medicine	O'Connor, KL (corresponding author), Univ Texas Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.	kloconno@utmb.edu	Luxon, Bruce A/C-9140-2012; O'Connor, Kathleen L/H-2569-2013	O'Connor, Kathleen L/0000-0002-1088-9734	National Institutes of Health [R01-CA109136]; University of Texas Medical Branch Gastrointestinal Research Interdisciplinary Research Program; Center for Interdisciplinary Research in Women's Health; Sealy and Smith Foundation; NATIONAL CANCER INSTITUTE [R01CA109136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Medical Branch Gastrointestinal Research Interdisciplinary Research Program; Center for Interdisciplinary Research in Women's Health; Sealy and Smith Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA109136. This work was also supported by the University of Texas Medical Branch Gastrointestinal Research Interdisciplinary Research Program, the Center for Interdisciplinary Research in Women's Health, and the Sealy and Smith Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambartsumian NS, 1996, ONCOGENE, V13, P1621; Bahassi EM, 2004, CLIN EXP METASTAS, V21, P293, DOI 10.1023/B:CLIN.0000046132.46946.dd; Bao X, 2008, VIROLOGY, V374, P114, DOI 10.1016/j.virol.2007.12.024; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Bonaccorsi L, 2000, ENDOCRINOLOGY, V141, P3172, DOI 10.1210/en.141.9.3172; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Chung J, 2004, J BIOL CHEM, V279, P32287, DOI 10.1074/jbc.M403809200; Cruz-Monserrate Z, 2007, MODERN PATHOL, V20, P656, DOI 10.1038/modpathol.3800782; Davies MPA, 1996, ONCOGENE, V13, P1631; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; FRIEDRICHS K, 1995, CANCER RES, V55, P901; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Grigorian M, 1996, INT J CANCER, V67, P831, DOI 10.1002/(SICI)1097-0215(19960917)67:6<831::AID-IJC13>3.0.CO;2-4; Grossman HB, 2000, ONCOL REP, V7, P13; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hernan R, 2003, CANCER RES, V63, P140; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jenkinson SR, 2004, BRIT J CANCER, V90, P253, DOI 10.1038/sj.bjc.6601483; Jones JL, 1997, EXP CELL RES, V235, P325, DOI 10.1006/excr.1997.3662; Kim EJ, 2003, J BIOL CHEM, V278, P30063, DOI 10.1074/jbc.M304909200; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Liang GN, 2000, CANCER RES, V60, P4907; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Lipscomb EA, 2003, CLIN EXP METASTAS, V20, P569, DOI 10.1023/A:1025819521707; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Mercurio AM, 2001, SEMIN CANCER BIOL, V11, P129, DOI 10.1006/scbi.2000.0364; Mukhopadhyay R, 1999, CLIN EXP METASTAS, V17, P325; Nakamura N, 1998, CLIN EXP METASTAS, V16, P471; Noh JH, 2006, MOL CELL BIOCHEM, V288, P91, DOI 10.1007/s11010-006-9124-8; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; PRICE JE, 1990, CANCER RES, V50, P717; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Raymond K, 2007, MOL BIOL CELL, V18, P4210, DOI 10.1091/mbc.E06-08-0720; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Ruse M, 2001, BIOCHEMISTRY-US, V40, P3167, DOI 10.1021/bi0019747; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Tagliabue E, 1998, CLIN CANCER RES, V4, P407; TENNENBAUM T, 1993, CANCER RES, V53, P4803; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; TULCHINSKY E, 1992, P NATL ACAD SCI USA, V89, P9146, DOI 10.1073/pnas.89.19.9146; Vanaja DK, 2006, CLIN CANCER RES, V12, P1128, DOI 10.1158/1078-0432.CCR-05-2072; Wade PA, 2001, ONCOGENE, V20, P3166, DOI 10.1038/sj.onc.1204340; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Xue CS, 2003, CANCER RES, V63, P3386; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Yoon SO, 2006, CANCER RES, V66, P6288, DOI 10.1158/0008-5472.CAN-06-0826; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023	58	122	124	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1484	1494		10.1074/jbc.M803997200	http://dx.doi.org/10.1074/jbc.M803997200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19011242	hybrid, Green Published			2022-12-27	WOS:000262330100016
J	Nicklay, JJ; Shechter, D; Chitta, RK; Garcia, BA; Shabanowitz, J; Allis, CD; Hunt, DF				Nicklay, Joshua J.; Shechter, David; Chitta, Raghu K.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Allis, C. David; Hunt, Donald F.			Analysis of Histones in Xenopus laevis II. MASS SPECTROMETRY REVEALS AN INDEX OF CELL TYPE-SPECIFIC MODIFICATIONS ON H3 AND H4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-CAPTURE DISSOCIATION; POSTTRANSLATIONAL MODIFICATIONS; COMBINATORIAL MODIFICATION; CHROMATIN MODIFICATIONS; SEQUENCE-ANALYSIS; ACETYLATION; METHYLATION; BINDING; PHOSPHORYLATION; TETRAHYMENA	Epigenetic information is hypothesized to be encoded in histone variants and post-translational modifications. Varied cell-and locus-specific combinations of these epigenetic marks are likely contributors to regulation of chromatin-templated transactions, including transcription, replication, recombination, and repair. Therefore, the relative abundance of histone modifications in a given cell type is a potential index of cell fate and specificity. Here, we utilize mass spectrometry techniques to characterize the relative abundance index of cell type-specific modifications on histones H3 and H4 in distinct cell types from the frog Xenopus laevis, including the sperm, the stored predeposition histones in the egg, the early embryo equivalent pronuclei, cultured somatic cells, and erythrocytes. We used collisionally associated dissociation to identify the modifications present on histone H3 in a variety of cell types, resolving 26 distinctly modified H3 peptides. We employed the electron transfer dissociation fragmentation technique in a "middle-down" approach on the H4 N-terminal tail to explore the overlap of post-translational modifications. We observed 66 discrete isoforms of the H4 1-23 fragment in four different cell types. Isolation of the stored, predeposition histone H4 from the frog egg also revealed a more varied pattern of modifications than the previously known diacetylation on Lys(5) and Lys(12). The developmental transitions of modifications on H3 and H4 were strikingly varied, implying a strong correlation of the histone code with cell type and fate. Our results are consistent with a histone code index for each cell type and uncover potential cross-talk between modifications on a single tail.	[Nicklay, Joshua J.; Chitta, Raghu K.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22901 USA; [Shechter, David; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA	University of Virginia; University of Virginia; Rockefeller University	Hunt, DF (corresponding author), McCormick Rd, Charlottesville, VA 22901 USA.	dfh@virgina.edu	Shechter, David/B-4660-2008; Hunt, Donald F/I-6936-2012	Shechter, David/0000-0001-9388-6004; Hunt, Donald F/0000-0003-2815-6368	National Institutes of Health [GM075486, GM37537, GM53512]; Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053512, R01GM037537, F32GM075486, R37GM053512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant National Research Service Award/Kirschstein Fellowship GM075486 (to D. S.), Grant GM37537 (to D. F. H.), and Grant GM53512 (to C. D. A.). This work was also supported by Rockefeller University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyne MT, 2006, J PROTEOME RES, V5, P248, DOI 10.1021/pr050269n; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; Coon JJ, 2005, P NATL ACAD SCI USA, V102, P9463, DOI 10.1073/pnas.0503189102; Garcia BA, 2005, J PROTEOME RES, V4, P2032, DOI 10.1021/pr050188r; Garcia BA, 2008, J PROTEOME RES, V7, P4225, DOI 10.1021/pr800044q; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang L, 2007, J BIOL CHEM, V282, P27923, DOI 10.1074/jbc.M704194200; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; Mackay CL, 2008, ANAL CHEM, V80, P4147, DOI 10.1021/ac702452d; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P872, DOI 10.1074/mcp.M400041-MCP200; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Morris SA, 2005, EUKARYOT CELL, V4, P1446, DOI 10.1128/EC.4.8.1446-1454.2005; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schmitt A, 2002, FEBS LETT, V518, P23, DOI 10.1016/S0014-5793(02)02630-3; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; SOBEL RE, 1994, J BIOL CHEM, V269, P18576; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Zubarev RA, 2000, ANAL CHEM, V72, P563, DOI 10.1021/ac990811p	40	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1075	1085		10.1074/jbc.M807274200	http://dx.doi.org/10.1074/jbc.M807274200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18957437	Green Published, hybrid			2022-12-27	WOS:000262122900044
J	Bruland, N; Wubbeler, JH; Steinbuchel, A				Bruland, Nadine; Wuebbeler, Jan Hendrik; Steinbuechel, Alexander			3-Mercaptopropionate Dioxygenase, a Cysteine Dioxygenase Homologue, Catalyzes the Initial Step of 3-Mercaptopropionate Catabolism in the 3,3-Thiodipropionic Acid-degrading Bacterium Variovorax paradoxus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANOSULFUR COMPOUNDS; IDENTIFICATION; DEGRADATION; CYSTEAMINE; THIOLS; DIMETHYLSULFONIOPROPIONATE; DESULFURIZATION; MECHANISM; PROTEIN	The thioether 3,3-thiodipropionic acid can be used as precursor substrate for biotechnological synthesis of 3-mercaptopropionic acid-containing polythioesters. Therefore, the hitherto unknown catabolism of this compound was elucidated to engineer novel and improved polythioester biosynthesis pathways in the future. Bacteria capable of using 3,3-thiodipropionic acid as the sole source of carbon and energy for growth were enriched from the environment. From eleven isolates, TBEA3, TBEA6, and SFWT were morphologically and physiologically characterized. Their 16 S rDNAs and other features affiliated these isolates to the beta-subgroup of the proteobacteria. Tn5::mob mutagenesis of isolate Variovorax paradoxus TBEA6 yielded ten mutants fully or partially impaired in growth on 3,3-thiodipropionic acid. Genotypic characterization of two 3,3-thiodipropionic acid-negative mutants demonstrated the involvement of a bacterial cysteine dioxygenase (EC 1.13.11.22) homologue in the further catabolism of the 3,3-thiodipropionic acid cleavage product 3-mercaptopropionic acid. Detection of 3-sulfinopropionate in the supernatant of one of these mutants during cultivation on 3,3-thiodipropionic acid as well as in vivo and in vitro enzyme assays using purified protein demonstrated oxygenation of 3-mercaptopropionic acid to 3-sulfinopropionate by this enzyme; cysteine and cysteamine were not used as substrate. Beside cysteine dioxygenase and cysteamine dioxygenase, this 3-mercaptopropionic acid dioxygenase is the third example for a thiol dioxygenase and the first report about the microbial catabolism of 3-mercaptopropionic acid. Insertion of Tn5:: mob in a gene putatively coding for a family III acyl-CoA-transferase resulted in the accumulation of 3-sulfinopropionate during cultivation on 3,3-thiodipropionic acid, indicating that this compound is further metabolized to 3-sulfinopropionyl-CoA and subsequently to propionyl-CoA.	[Bruland, Nadine; Wuebbeler, Jan Hendrik; Steinbuechel, Alexander] Univ Munster, Inst Mol Mikrobiol & Biotechnol, D-48149 Munster, Germany	University of Munster	Steinbuchel, A (corresponding author), Univ Munster, Inst Mol Mikrobiol & Biotechnol, Corrensstr 3, D-48149 Munster, Germany.	steinbu@uni-muenster.de						Aboulmagd E, 2000, ARCH MICROBIOL, V174, P297, DOI 10.1007/s002030000206; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; Antoine R, 2003, J BACTERIOL, V185, P1470, DOI 10.1128/JB.185.4.1470-1474.2003; APPELL RB, 1995, SYNTHETIC COMMUN, V25, P3589, DOI 10.1080/00397919508015494; CAVALLINI D, 1966, J BIOL CHEM, V241, P3189; CAVALLINI D, 1975, FEBS LETT, V56, P348, DOI 10.1016/0014-5793(75)81124-0; Chai SC, 2005, J BIOL CHEM, V280, P9865, DOI 10.1074/jbc.M413733200; Chai SC, 2006, J BIOL CHEM, V281, P15774, DOI 10.1074/jbc.M601269200; DEVEREUX R, 1995, MOL MICROBIAL ECOLOG, P509; Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200; Elbanna K, 2003, INT J SYST EVOL MICR, V53, P1165, DOI 10.1099/ijs.0.02562-0; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FRIEDRICH B, 1981, J BACTERIOL, V147, P198, DOI 10.1128/JB.147.1.198-205.1981; Greene EA, 2000, ARCH MICROBIOL, V174, P111, DOI 10.1007/s002030000184; JOLLESBE.B, 1974, EUR J BIOCHEM, V42, P349, DOI 10.1111/j.1432-1033.1974.tb03346.x; Kamagata Y, 1997, APPL ENVIRON MICROB, V63, P2266, DOI 10.1128/AEM.63.6.2266-2272.1997; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P156, DOI 10.1128/AEM.56.1.156-161.1990; KIENE RP, 1988, APPL ENVIRON MICROB, V54, P2208, DOI 10.1128/AEM.54.9.2208-2212.1988; KIENE RP, 1988, NATURE, V332, P148, DOI 10.1038/332148a0; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Li FL, 2005, APPL ENVIRON MICROB, V71, P276, DOI 10.1128/AEM.71.1.276-281.2005; Liu SJ, 2000, APPL ENVIRON MICROB, V66, P739, DOI 10.1128/AEM.66.2.739-743.2000; Lutke-Eversloh T, 2003, FEMS MICROBIOL LETT, V221, P191, DOI 10.1016/S0378-1097(03)00185-X; Lutke-Eversloh T, 2001, MICROBIOL-UK, V147, P11; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; MCFALL E, 1996, ESCHERICHIA COLI SAL, P358; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mishra RN, 2002, BIOTECHNIQUES, V33, P830, DOI 10.2144/02334st07; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishino SF, 2006, APPL ENVIRON MICROB, V72, P1040, DOI 10.1128/AEM.72.2.1040-1044.2006; OELMULLER U, 1990, J MICROBIOL METH, V11, P73, DOI 10.1016/0167-7012(90)90050-G; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; REYNOLDS RC, 1974, TOXICOL APPL PHARM, V28, P133, DOI 10.1016/0041-008X(74)90138-0; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; Schmalenberger A, 2007, ENVIRON MICROBIOL, V9, P535, DOI 10.1111/j.1462-2920.2006.01172.x; SCOTT G, 1968, CHEM COMMUN, P1572, DOI 10.1039/c19680001572; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; VAIRAVAMURTHY A, 1987, NATURE, V329, P623, DOI 10.1038/329623a0; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; Weber N, 2006, J AGR FOOD CHEM, V54, P2957, DOI 10.1021/jf0530502; Willems A, 2005, BERGEYS MANUALR SYST, P732; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002	53	60	61	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					660	672		10.1074/jbc.M806762200	http://dx.doi.org/10.1074/jbc.M806762200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001372	hybrid			2022-12-27	WOS:000261974800071
J	Kaur, AP; Lansky, IB; Wilks, A				Kaur, Ajinder P.; Lansky, Ila B.; Wilks, Angela			The Role of the Cytoplasmic Heme-binding Protein (PhuS) of Pseudomonas aeruginosa in Intracellular Heme Trafficking and Iron Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; SIGNAL-TRANSDUCTION SYSTEM; GENE-REGULATION; OPPORTUNISTIC PATHOGEN; EXPRESSION ANALYSIS; PYOCYANIN; IDENTIFICATION; ACQUISITION; BIOSYNTHESIS; OXYGENASE	The cytoplasmic heme-binding protein PhuS, encoded within the Fur-regulated Pseudomonas heme utilization (phu) operon, has previously been shown to traffic heme to the iron-regulated heme oxygenase (HO). We further investigate the role of PhuS in heme trafficking to HO on disruption of the phuS and hemO genes in a Pseudomonas aeruginosa siderophore-deficient and wild-type background. Previous studies have shown that deletion of hemO prevents the cells from utilizing heme as the sole source of iron. However, disruption of phuS alone resulted in a slow growth phenotype, consistent with its role as a heme-trafficking protein to HO. Furthermore, in contrast to the hemO and hemO/phuS deletion strains, the phuS knockout prematurely produced pyocyanin in the presence of heme. Western blot analysis of PhuS protein levels in the wild-type strain showed that Fur-regulation of the phu operon could be derepressed in the presence of heme. In addition the premature onset of pyocyanin production requires both heme and a functional HO. Suppression of the phenotype on increasing the external heme concentration suggested that the decreased heme-flux through HO results in premature production of pyocyanin. The premature production of pyocyanin was not due to lower intracellular iron levels as a result of decreased heme flux through HO. However, transcriptional analysis of the phuS mutants indicates that the cells are sensing iron deprivation. The present data suggest that PhuS has a dual function in trafficking heme to HO, and in directly or indirectly sensing and maintaining iron and heme homeostasis.	[Kaur, Ajinder P.; Lansky, Ila B.; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, HSF 2,20 Penn St, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu			National Institutes of Health [AI-55912]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055912, R01AI055912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-55912 (to A. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANKENBAUER RG, 1988, J BACTERIOL, V170, P5364, DOI 10.1128/jb.170.11.5364-5367.1988; Arevalo-Ferro C, 2003, ENVIRON MICROBIOL, V5, P1350, DOI 10.1046/j.1462-2920.2003.00532.x; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; Bibb LA, 2005, INFECT IMMUN, V73, P7406, DOI 10.1128/IAI.73.11.7406-7412.2005; Block DR, 2007, BIOCHEMISTRY-US, V46, P14391, DOI 10.1021/bi701509n; Bollinger N, 2001, J BACTERIOL, V183, P1990, DOI 10.1128/JB.183.6.1990-1996.2001; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britigan BE, 1999, INFECT IMMUN, V67, P1207, DOI 10.1128/IAI.67.3.1207-1212.1999; Cornelis P, 2004, MICROBIOL-SGM, V150, P752, DOI 10.1099/mic.0.27086-0; COX CD, 1986, INFECT IMMUN, V52, P263, DOI 10.1128/IAI.52.1.263-270.1986; COX CD, 1985, INFECT IMMUN, V48, P130, DOI 10.1128/IAI.48.1.130-138.1985; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen V, 2006, J BACTERIOL, V188, P8601, DOI 10.1128/JB.01378-06; Juhas M, 2004, MICROBIOL-SGM, V150, P831, DOI 10.1099/mic.0.26906-0; Juhas M, 2005, FEMS MICROBIOL LETT, V242, P287, DOI 10.1016/j.femsle.2004.11.020; Kaur AP, 2007, BIOCHEMISTRY-US, V46, P2994, DOI 10.1021/bi061722r; Kerr JR, 1999, J CLIN PATHOL, V52, P385, DOI 10.1136/jcp.52.5.385; Kim EJ, 2005, MICROBIOL-SGM, V151, P1127, DOI 10.1099/mic.0.27566-0; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Lazdunski AM, 2004, NAT REV MICROBIOL, V2, P581, DOI 10.1038/nrmicro924; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Miller RA, 1996, INFECT IMMUN, V64, P182, DOI 10.1128/IAI.64.1.182-188.1996; OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palma M, 2003, ARCH MICROBIOL, V180, P374, DOI 10.1007/s00203-003-0602-z; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Poole K, 2003, FRONT BIOSCI-LANDMRK, V8, pD661, DOI 10.2741/1051; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Price-Whelan A, 2007, J BACTERIOL, V189, P6372, DOI 10.1128/JB.00505-07; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmitt MP, 1999, J BACTERIOL, V181, P5330, DOI 10.1128/JB.181.17.5330-5340.1999; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; van Rij ET, 2004, MOL PLANT MICROBE IN, V17, P557, DOI 10.1094/MPMI.2004.17.5.557; Vanderpool CK, 2003, J BACTERIOL, V185, P909, DOI 10.1128/JB.185.3.909-917.2003; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vasil ML, 1999, MOL MICROBIOL, V34, P399, DOI 10.1046/j.1365-2958.1999.01586.x; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; WELLS IC, 1952, J BIOL CHEM, V196, P331; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Zheng P, 2007, J BIOTECHNOL, V132, P342, DOI 10.1016/j.jbiotec.2007.08.013	61	44	45	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					56	66		10.1074/jbc.M806068200	http://dx.doi.org/10.1074/jbc.M806068200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990702	Green Published, hybrid			2022-12-27	WOS:000261974800007
J	Yang, IY; Hashimoto, K; de Wind, N; Blair, IA; Moriya, M				Yang, In-Young; Hashimoto, Keiji; de Wind, Niels; Blair, Ian A.; Moriya, Masaaki			Two Distinct Translesion Synthesis Pathways across a Lipid Peroxidation-derived DNA Adduct in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-ETA; ERROR-PRONE; DEOXYGUANOSINE ADDUCT; OXIDATIVE STRESS; LOW FIDELITY; Y-FAMILY; ZETA; REV1; IOTA; GENE	Translesion DNA synthesis (TLS) of damaged DNA templates is catalyzed by specialized DNA polymerases. To probe the cellular TLS mechanism, a host-vector system consisting of mouse fibroblasts and a replicating plasmid bearing a single DNA adduct was developed. This system was used to explore the TLS mechanism of a heptanone-etheno-dC (H-epsilon dC) adduct, an endogenous lesion produced by lipid peroxidation. In wild-type cells, H-epsilon dC almost exclusively directed incorporation of dT and dA. Whereas knockout of the Y family TLS polymerase genes, Polh, Polk, or Poli, did not qualitatively affect these TLS events, inactivation of the Rev3 gene coding for a subunit of polymerase zeta or of the Rev1 gene abolished TLS associated with dA, but not dT, insertion. The analysis of results of the cellular studies and in vitro TLS studies using purified polymerases has revealed that the insertion of dA and dT was catalyzed by different polymerases in cells. While insertion of dT can be catalyzed by polymerase eta, kappa, and iota, insertion of dA is catalyzed by an unidentified polymerase that cannot catalyze extension from the resulting dA terminus. Therefore, the extension from this terminus requires the activity of polymerase zeta-REV1. These results provide new insight into how cells use different TLS pathways to overcome a synthesis block.	[Yang, In-Young; Hashimoto, Keiji; Moriya, Masaaki] SUNY Stony Brook, Dept Pharmacol Sci, Biol Chem Lab, Stony Brook, NY 11794 USA; [de Wind, Niels] Leiden Univ, Dept Toxicogenet, Med Ctr, NL-2300 RC Leiden, Netherlands; [Blair, Ian A.] Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; [Blair, Ian A.] Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Moriya, M (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Biol Chem Lab, Stony Brook, NY 11794 USA.	maki@pharm.stonybrook.edu			National Institutes of Health [CA76163, CA47995, CA91016, ES11297, ES013508]; EU-IP [FP6-51211]; NATIONAL CANCER INSTITUTE [R56CA076163, R01CA076163, R01CA091016, P01CA047995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, R01ES011297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU-IP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA76163, CA47995, CA91016, ES11297, and ES013508. This work was also supported by Grant EU-IP FP6-51211. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Blair IA, 2008, J BIOL CHEM, V283, P15545, DOI 10.1074/jbc.R700051200; Camenisch G, 1996, NUCLEIC ACIDS RES, V24, P3707, DOI 10.1093/nar/24.19.3707; Davidson JF, 2002, MUTAT RES-FUND MOL M, V509, P17, DOI 10.1016/S0027-5107(02)00228-2; Gibbs PEM, 1998, P NATL ACAD SCI USA, V95, P6876, DOI 10.1073/pnas.95.12.6876; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lawrence CW, 2002, DNA REPAIR, V1, P425, DOI 10.1016/S1568-7864(02)00038-1; Lee SH, 2000, CHEM RES TOXICOL, V13, P565, DOI 10.1021/tx000057z; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Liu X, 2006, BIOCHEMISTRY-US, V45, P12898, DOI 10.1021/bi060792v; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pollack M, 2003, CHEM RES TOXICOL, V16, P893, DOI 10.1021/tx030009p; Pollack M, 2006, CHEM RES TOXICOL, V19, P1074, DOI 10.1021/tx0600503; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Ross AL, 2006, MOL IMMUNOL, V43, P1587, DOI 10.1016/j.molimm.2005.09.017; SCOTT S, 2006, MUTAT RES, V608, P1; Tissier A, 2000, GENE DEV, V14, P1642; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Williams MV, 2006, J BIOL CHEM, V281, P10127, DOI 10.1074/jbc.M600178200; Wittschieben JP, 2006, CANCER RES, V66, P134, DOI 10.1158/0008-5472.CAN-05-2982; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Yang IY, 2003, J BIOL CHEM, V278, P13989, DOI 10.1074/jbc.M212535200; Yang IY, 2002, CHEM RES TOXICOL, V15, P160, DOI 10.1021/tx010123c; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	42	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					191	198		10.1074/jbc.M806414200	http://dx.doi.org/10.1074/jbc.M806414200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18981176	Green Published, hybrid			2022-12-27	WOS:000261974800022
J	Dvir-Ginzberg, M; Gagarina, V; Lee, EJ; Hall, DJ				Dvir-Ginzberg, Mona; Gagarina, Viktoria; Lee, Eun-Jin; Hall, David J.			Regulation of Cartilage-specific Gene Expression in Human Chondrocytes by SirT1 and Nicotinamide Phosphoribosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; TRANSCRIPTIONAL REPRESSION; CELL-SURVIVAL; CHONDROGENESIS; PROTEIN; PGC-1-ALPHA; CHROMATIN; COMPLEX; SOX9; ASSOCIATION	SirT1 is an NAD-dependent histone deacetylase that regulates gene expression, differentiation, development, and organism life span. Here we investigate the function of SirT1 in human chondrocytes derived from osteoarthritic patients. Elevation of SirT1 protein levels or activity in these chondrocytes led to a dramatic increase in cartilage-specific gene expression, whereas a reduction in SirT1 levels or activity significantly lowered cartilage gene expression. SirT1 associated with the cartilage-specific transcription factor Sox9, enhancing transcription from the collagen 2(alpha 1) promoter in a Sox9-dependent fashion. Consistent with this association, SirT1 was targeted to the collagen 2(alpha 1) enhancer and promoter, which in turn recruited the coactivators GCN5, PGC1 alpha, and p300. This led to elevated marks of active chromatin within the promoter; that is, acetylated histone K9/K14 and histone H4K5 as well as trimethylated histone H3K4. Finally, alterations in the NAD salvage pathway enzyme nicotinamide phosphoribosyltransferase led to changes in NAD levels, SirT activity, and cartilage-specific gene expression in human chondrocytes. SirT1, nicotinamide phosphoribosyltransferase, and NAD may, therefore, provide a positive function in human cartilage by elevating expression of genes encoding cartilage extracellular matrix.	[Dvir-Ginzberg, Mona; Gagarina, Viktoria; Lee, Eun-Jin; Hall, David J.] NIAMS, Cartilage Mol Genet Grp, Cartilage Biol & Orthopaed Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Hall, DJ (corresponding author), 50 South Dr,Rm 1524, Bethesda, MD 20892 USA.	halld@mail.nih.gov	Dvir-Ginzberg, Mona/AAZ-9858-2021	Dvir-Ginzberg, Mona/0000-0003-3089-6875; Lee, Eun-Jin/0000-0001-5718-542X	National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041141, ZIAAR041141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by the National Institutes of Health (Intramural Research Program of the NIAMS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chung YL, 2003, MOL THER, V8, P707, DOI 10.1016/S1525-0016(03)00235-1; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Derfoul A, 2007, OSTEOARTHR CARTILAGE, V15, P646, DOI 10.1016/j.joca.2007.01.014; Dharmavaram RM, 1997, J BIOL CHEM, V272, P26918, DOI 10.1074/jbc.272.43.26918; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ghayor C, 2001, J BIOL CHEM, V276, P36881, DOI 10.1074/jbc.M105083200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hasan S, 2002, J MOL MED, V80, P463, DOI 10.1007/s00109-002-0341-7; Hasmann M, 2003, CANCER RES, V63, P7436; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Johnstone RW, 2003, CANCER CELL, V4, P13, DOI 10.1016/S1535-6108(03)00165-X; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kipnes J, 2003, OSTEOARTHR CARTILAGE, V11, P442, DOI 10.1016/S1063-4584(03)00055-4; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; Perkins GL, 2005, DIFFERENTIATION, V73, P199, DOI 10.1111/j.1432-0436.2005.00024.x; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Terkeltaub R, 2002, MITOCHONDRION, V1, P301, DOI 10.1016/S1567-7249(01)00037-X; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Yang HY, 2006, EXP GERONTOL, V41, P718, DOI 10.1016/j.exger.2006.06.003; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Young DA, 2005, ARTHRITIS RES THER, V7, pR503, DOI 10.1186/ar1702; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978	47	149	161	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36300	36310		10.1074/jbc.M803196200	http://dx.doi.org/10.1074/jbc.M803196200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957417	Green Published, hybrid			2022-12-27	WOS:000261840500026
J	Lutzner, N; Kalbacher, H				Luetzner, Nicolas; Kalbacher, Hubert			Quantifying Cathepsin S Activity in Antigen Presenting Cells Using a Novel Specific Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; HUMAN DENDRITIC CELLS; CYSTEINE PROTEASES; INVARIANT CHAIN; IN-VIVO; INDUCED ARTHRITIS; MOLECULES; PEPTIDES; PREDICTION; LYSOSOMES	Cathepsin S (CatS) is a lysosomal cysteine protease belonging to the papain superfamily. Because of the relatively broad substrate specificity of this family, a specific substrate for CatS is not yet known. Based on a detailed study of the CatS endopeptidase specificity, using six series of internally quenched fluorescent peptides, we were able to design a specific substrate for CatS. The peptide series was based on the sequence GRWHTVGL-RWE-Lys(Dnp)-DArg-NH2, which shows only one single cleavage site between Gly and Leu and where every substrate position between P-3 and P-3' was substituted with up to 15 different amino acids. The endopeptidase specificity of CatS was mainly determined by the P-2, P-1', and the P-3' substrate positions. Based on this result, systematically modified substrates were synthesized. Two of these modified substrates, Mca-GRWPP-MGLPWE-Lys(Dnp)-DArg-NH2 and Mca- GRWHPMGAPWE-Lys(Dnp)-DArg-NH2, did not react with the purified cysteine proteases cathepsin B (CatB) and cathepsin L (CatL). Using a specific CatS inhibitor, we could further show that these two peptides were not cleaved by endosomal fractions of antigen presenting cells (APCs), when CatS was inhibited and related cysteine proteases cathepsin B, H, L and X were still active. Although aspartic proteases like cathepsin E and cathepsin D were also present, our substrates were suitable to quantify cathepsin S activity specifically in APCs, including B cells, macrophages, and dendritic cells without the use of any protease inhibitor. We find that CatS activity differs significantly not only between the three types of professional APCs but also between endosomal and lysosomal compartments.	[Kalbacher, Hubert] Univ Tubingen, Med & Nat Sci Res Ctr, D-72074 Tubingen, Germany; [Luetzner, Nicolas; Kalbacher, Hubert] Univ Tubingen, Interfac Inst Biochem, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Kalbacher, H (corresponding author), Univ Tubingen, Med & Nat Sci Res Ctr, Ob Himmelreich 7, D-72074 Tubingen, Germany.	kalbacher@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [SFB 685]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 685. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beck H, 2001, EUR J IMMUNOL, V31, P3726, DOI 10.1002/1521-4141(200112)31:12<3726::AID-IMMU3726>3.0.CO;2-O; Biroc SL, 2001, ARTHRITIS RHEUM, V44, P703, DOI 10.1002/1529-0131(200103)44:3<703::AID-ANR120>3.3.CO;2-U; Brachet V, 1997, J CELL BIOL, V137, P51, DOI 10.1083/jcb.137.1.51; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROMME D, 1994, J BIOL CHEM, V269, P30238; BROMME D, 1989, BIOCHEM J, V264, P475; Cezari MHS, 2002, BIOCHEM J, V368, P365, DOI 10.1042/BJ20020840; Chain BM, 2005, J IMMUNOL, V174, P1791, DOI 10.4049/jimmunol.174.4.1791; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Kramer G, 2007, PROTEIN EXPRES PURIF, V54, P147, DOI 10.1016/j.pep.2007.02.007; Lautwein A, 2004, J LEUKOCYTE BIOL, V75, P844, DOI 10.1189/jlb.0803367; Lautwein A, 2002, EUR J IMMUNOL, V32, P3348, DOI 10.1002/1521-4141(200212)32:12<3348::AID-IMMU3348>3.0.CO;2-S; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P4868, DOI 10.1021/bi982632s; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; Reich M, 2007, J LEUKOCYTE BIOL, V81, P990, DOI 10.1189/jlb.1006600; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Ruckrich T, 2006, BIOL CHEM, V387, P1503, DOI 10.1515/BC.2006.188; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; Schuler Mathias M., 2007, V409, P75; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Sinzger C, 2006, J GEN VIROL, V87, P1853, DOI 10.1099/vir.0.81595-0; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; Villadangos JA, 1999, IMMUNOL REV, V172, P109, DOI 10.1111/j.1600-065X.1999.tb01360.x; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324; Zaidi N, 2007, FEBS J, V274, P3138, DOI 10.1111/j.1742-4658.2007.05846.x	39	49	53	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36185	36194		10.1074/jbc.M806500200	http://dx.doi.org/10.1074/jbc.M806500200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957408	Green Published, hybrid			2022-12-27	WOS:000261840500013
J	Zhao, YX; Coloff, JL; Ferguson, EC; Jacobs, SR; Cui, K; Rathmell, JC				Zhao, Yuxing; Coloff, Jonathan L.; Ferguson, Emily C.; Jacobs, Sarah R.; Cui, Kai; Rathmell, Jeffrey C.			Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-INDEPENDENT SURVIVAL; COLORECTAL-CANCER CELLS; WILD-TYPE P53; HEMATOPOIETIC-CELLS; MEMBRANE PERMEABILIZATION; TRANSPORTER EXPRESSION; APOPTOTIC RESPONSES; SIGNALING PATHWAY; FACTOR WITHDRAWAL; BH3-ONLY PROTEIN	Growth factor stimulation and oncogenic transformation lead to increased glucose metabolism that may provide resistance to cell death. We have previously demonstrated that elevated glucose metabolism characteristic of stimulated or cancerous cells can stabilize the anti-apoptotic Bcl-2 family protein Mcl-1 through inhibition of GSK-3. Here we show that the proapoptotic Bcl-2 family protein, Puma, is also metabolically regulated. Growth factor deprivation led to the loss of glucose uptake and induction of Puma. Maintenance of glucose uptake after growth factor withdrawal by expression of the glucose transporter, Glut1, however, suppressed Puma up-regulation and attenuated growth factor withdrawal-induced activation of Bax, DNA fragmentation, and cell death. Conversely, glucose deprivation led to Puma induction even in the presence of growth factor. This regulation of Puma expression was a central component in cell death as a consequence of growth factor or glucose deprivation because Puma deficiency suppressed both of these cell death pathways. Puma induction in growth factor or glucose withdrawal was dependent on p53 in cell lines and in activated primary T lymphocytes because p53 deficiency suppressed Puma induction and delayed Bax and caspase activation, DNA fragmentation, and loss of clonogenic survival. Importantly, although p53 levels did not change or were slightly reduced, p53 activity was suppressed by elevated glucose metabolism to inhibit Puma induction after growth factor withdrawal. These data show that p53 is metabolically regulated and that glucose metabolism initiates a signaling mechanism to inhibit p53 activation and suppress Puma induction, thus promoting an anti-apoptotic balance to Bcl-2 family protein expression that supports cell survival.	[Zhao, Yuxing; Coloff, Jonathan L.; Ferguson, Emily C.; Jacobs, Sarah R.; Cui, Kai; Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Sarah W Stedman Ctr Nutr & Metab, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Rathmell, JC (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, DUMC 3813, Durham, NC 27710 USA.	jeff.rathmell@duke.edu			National Institutes of Health [RO1 CA123350]; NATIONAL CANCER INSTITUTE [R01CA123350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA123350 (to J.C.R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; BLANDINO G, 1995, ONCOGENE, V10, P731; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brunelle JK, 2007, MOL CELL BIOL, V27, P1222, DOI 10.1128/MCB.01535-06; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chi MMY, 2000, J BIOL CHEM, V275, P40252, DOI 10.1074/jbc.M005508200; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Goetz AW, 2001, CANCER RES, V61, P7635; Gottlieb E, 1996, CELL GROWTH DIFFER, V7, P301; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Grayson JM, 2001, J IMMUNOL, V167, P1333, DOI 10.4049/jimmunol.167.3.1333; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Ohkusu-Tsukada K, 1999, J IMMUNOL, V163, P1966; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Semenza G L, 2001, Novartis Found Symp, V240, P251; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; Vaghefi H, 2004, J BIOL CHEM, V279, P15604, DOI 10.1074/jbc.M311500200; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang P, 2008, ONCOGENE, V27, P1590, DOI 10.1038/sj.onc.1210788; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	51	84	88	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36344	36353		10.1074/jbc.M803580200	http://dx.doi.org/10.1074/jbc.M803580200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990690	Green Published, hybrid			2022-12-27	WOS:000261840500031
J	Deng, WW; Shi, MD; Han, MF; Zhong, J; Li, ZH; Li, WN; Hu, Y; Yan, LC; Wang, J; He, Y; Tang, H; Deubel, V; Luo, XP; Ning, Q; Sun, B				Deng, Weiwen; Shi, Mude; Han, Meifang; Zhong, Jin; Li, Zhenhu; Li, Weina; Hu, Yu; Yan, Lingchen; Wang, Jie; He, Ying; Tang, Hong; Deubel, Vincent; Luo, Xiaoping; Ning, Qin; Sun, Bing			Negative Regulation of Virus-triggered IFN-beta Signaling Pathway by Alternative Splicing of TBK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; TANK-BINDING KINASE-1; EPSTEIN-BARR-VIRUS; RIG-I; ANTIVIRAL RESPONSES; GENE-TRANSCRIPTION; UBIQUITIN LIGASE; VIRAL-INFECTION; ADAPTER PROTEIN	Induction of Type I IFNs is a central event in antiviral responses and must be tightly controlled. The protein kinase TBK1 is critically involved in virus-triggered type I IFN signaling. In this study, we identify an alternatively spliced isoform of TBK1, termed TBK1s, which lacks exons 3-6. Upon Sendai virus (SeV) infection, TBK1s is induced in both human and mouse cells and binds to RIG-1, disrupting the interaction between RIG-I and VISA. Consistent with that result, overexpression of TBK1s inhibits IRF3 nuclear translocation and leads to a shutdown of SeV-triggered IFN-beta production. Taken together, our data indicate that TBK1s plays an inhibitory role in virus-triggered IFN-beta signaling pathways.	[Han, Meifang; Li, Weina; Luo, Xiaoping; Ning, Qin] Huazhong Univ Sci & Technol, Tongji Hosp Tongji, Coll Med, Dept Infect Dis, Wuhan 430030, Peoples R China; [Deng, Weiwen; Shi, Mude; Li, Zhenhu; Hu, Yu; Yan, Lingchen; Wang, Jie; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Zhong, Jin; He, Ying; Deubel, Vincent; Sun, Bing] Chinese Acad Sci, Inst Pasteur, Shanghai 200025, Peoples R China; [Tang, Hong] Chinese Acad Sci, Inst Biophys, Ctr Infect & Immun, Beijing 100101, Peoples R China; [Sun, Bing] Shanghai Univ E Inst, Div Immunol, Shanghai 200041, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Ning, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp Tongji, Coll Med, Dept Infect Dis, Wuhan 430030, Peoples R China.	qning@tjh.tjmu.edu.cn; bsun@sibs.ac.cn	Deng, Weiwen/A-1646-2013; Zhong, Jin/M-6859-2018	Hu, Yu/0000-0002-9511-9383; Han, Meifang/0000-0002-1948-8128; Zhong, Jin/0000-0002-3554-1275	National Natural Science Foundation of China [30325018, 30530700, 30623003, 30421005]; CAS Project [KSCX1-YW-R-43]; National Key Project 973 [2005CB522901, 2006CB504300, 2007CB512404, 2007CB512900]; Technology Commission of Shanghai Municipality [04DZ14902, 04DZ19108, 06DZ22032, 04DZ19112, 07XD14033, 064319034, 07DZ22916]; 863 key projects [2006AA02A247]; Ministry of Health of China [2008ZX10206]; EU [SP5B-CT-2006-044161]; E-institutes of Shanghai Universities, Immunology Division	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Project(Chinese Academy of Sciences); National Key Project 973(National Basic Research Program of China); Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); 863 key projects(National High Technology Research and Development Program of China); Ministry of Health of China; EU(European Commission); E-institutes of Shanghai Universities, Immunology Division	This work was supported in part by Grants 30325018, 30530700, 30623003, and 30421005 from the National Natural Science Foundation of China and CAS Project KSCX1-YW-R-43, Grants 2005CB522901, 2006CB504300, and 2007CB512404, 2007CB512900 of the National Key Project 973, Grants 04DZ14902, 04DZ19108, 06DZ22032, 04DZ19112, 07XD14033, 064319034, and 07DZ22916 of the Technology Commission of Shanghai Municipality, Grant 2006AA02A247 of 863 key projects, Grant 2008ZX10206 from the Ministry of Health of China, EU Project SP5B-CT-2006-044161, and a grant from the E-institutes of Shanghai Universities, Immunology Division. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hou WQ, 2003, J IMMUNOL, V170, P1728, DOI 10.4049/jimmunol.170.4.1728; Huang CJ, 2006, J IMMUNOL, V176, P4173, DOI 10.4049/jimmunol.176.7.4173; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Karpova AY, 2001, MOL CELL BIOL, V21, P4169, DOI 10.1128/MCB.21.13.4169-4176.2001; Karpova AY, 2000, GENE DEV, V14, P2813, DOI 10.1101/gad.813800; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Lee EJ, 2006, BIOCHEM BIOPH RES CO, V347, P882, DOI 10.1016/j.bbrc.2006.06.145; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; Matsui K, 2006, J IMMUNOL, V177, P5785, DOI 10.4049/jimmunol.177.9.5785; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Vilasco M, 2006, HEPATOLOGY, V44, P1635, DOI 10.1002/hep.21432; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748	44	34	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35590	35597		10.1074/jbc.M805775200	http://dx.doi.org/10.1074/jbc.M805775200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18977754	hybrid			2022-12-27	WOS:000261687900031
J	Li, W; Huntington, JA				Li, Wei; Huntington, James A.			The Heparin Binding Site of Protein C Inhibitor Is Protease-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TISSUE DISTRIBUTION; MOLECULAR-CLONING; BASIC RESIDUES; ANTITHROMBIN; COMPLEX; ACTIVATION; MECHANISM; RECOGNITION; THROMBOSIS	Protein C inhibitor (PCI) is a member of the serpin family of protease inhibitors with many biological functions and broad inhibitory specificity. Its major targets in blood are thrombin and activated protein C (APC), and the inhibition of both enzymes can be accelerated by glycosaminoglycans, including heparin. Acceleration of thrombin and APC inhibition by PCI requires that both protease and inhibitor bind to the same heparin chain to form a bridged Michaelis complex. However, the position of the heparin binding site of APC is opposite to that of thrombin, and formation of the bridged complexes must require either radical reorientation of the proteases relative to PCI or alternate heparin binding modes for PCI. In this study, we investigate how heparin bridges thrombin and APC to PCI by determining the effect of mutations in and around the putative heparin binding site of PCI. We found that heparin binds PCI in a linear fashion along helix H to bridge thrombin, consistent with our recent crystal structure (3B9F), but that it must rotate by similar to 60 degrees to engage Arg-229 to bridge APC. To gain insight into the possible modes of heparin binding to PCI, we solved a crystal structure of cleaved PCI bound to an octasaccharide heparin fragment to 1.55 angstrom resolution. The structure reveals a binding mode across the N terminus of helix H to engage Arg-229 and align the heparin binding site of APC. Amolecular model for the heparin-bridged PCI.APC complex was built based on mutagenesis and structural data.	[Li, Wei; Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Huntington, JA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	jah52@cam.ac.uk			Medical Research Council Senior Non-clinical Fellowship; Medical Research Council [G117/444, G0601596] Funding Source: researchfish; MRC [G0601596, G117/444] Funding Source: UKRI	Medical Research Council Senior Non-clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council Senior Non-clinical Fellowship. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carroll VA, 1997, ARTERIOSCL THROM VAS, V17, P114, DOI 10.1161/01.ATV.17.1.114; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; DeLano W.L, PYMOL MOL GRAPHICS S; DRENTH J, 1992, J CRYST GROWTH, V122, P107, DOI 10.1016/0022-0248(92)90233-9; Friedrich U, 2001, J BIOL CHEM, V276, P24122, DOI 10.1074/jbc.M011567200; GARG HG, 2005, CHEM BIOL HEPARIN HE, P367; Geiger M, 1996, IMMUNOPHARMACOLOGY, V32, P53, DOI 10.1016/0162-3109(96)00013-6; Geiger M, 2007, THROMB HAEMOSTASIS, V97, P343, DOI 10.1160/TH06-09-0488; Huntington JA, 2003, STRUCTURE, V11, P205, DOI 10.1016/S0969-2126(02)00944-9; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; Kolbel T, 2006, J VASC SURG, V43, P935, DOI 10.1016/j.jvs.2006.01.019; KUHN LA, 1990, P NATL ACAD SCI USA, V87, P8506, DOI 10.1073/pnas.87.21.8506; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2008, P NATL ACAD SCI USA, V105, P4661, DOI 10.1073/pnas.0711055105; Li W, 2007, J BIOL CHEM, V282, P13759, DOI 10.1074/jbc.M701074200; MARLAR RA, 1980, J CLIN INVEST, V66, P1186, DOI 10.1172/JCI109952; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Meijers JCM, 2002, BRIT J HAEMATOL, V118, P604, DOI 10.1046/j.1365-2141.2002.03652.x; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Neese LL, 1998, ARCH BIOCHEM BIOPHYS, V355, P101, DOI 10.1006/abbi.1998.0716; PRATT CW, 1992, J BIOL CHEM, V267, P8789; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; REZAIE AR, 1995, J BIOL CHEM, V270, P25336, DOI 10.1074/jbc.270.43.25336; SHIRK RA, 1994, J BIOL CHEM, V269, P28690; TOLLEFSEN DM, 1994, ANN NY ACAD SCI, V714, P21, DOI 10.1111/j.1749-6632.1994.tb12027.x; VANDERMEER FJM, 1989, THROMB HAEMOSTASIS, V62, P756; Wakita T, 1998, FEBS LETT, V429, P263, DOI 10.1016/S0014-5793(98)00613-9; Yang LK, 2002, BIOCHEMISTRY-US, V41, P6149, DOI 10.1021/bi015899r; ZechmeisterMachhart M, 1996, IMMUNOPHARMACOLOGY, V32, P96, DOI 10.1016/0162-3109(95)00062-3	35	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					36039	36045		10.1074/jbc.M805974200	http://dx.doi.org/10.1074/jbc.M805974200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18974053	hybrid			2022-12-27	WOS:000261687900078
J	Mohn, WW; van der Geize, R; Stewart, GR; Okamoto, S; Liu, J; Dijkhuizen, L; Eltis, LD				Mohn, William W.; van der Geize, Robert; Stewart, Gordon R.; Okamoto, Sachi; Liu, Jie; Dijkhuizen, Lubbert; Eltis, Lindsay D.			The Actinobacterial mce4 Locus Encodes a Steroid Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELL ENTRY; MYCOBACTERIUM-TUBERCULOSIS; CHOLESTEROL; MACROPHAGES; OPERONS; RHODOCOCCUS; PROTEINS; SURVIVAL; GENE; ATP	Bioinformatic analyses have suggested that Mce proteins in diverse actinobacteria are components of complex ATP-binding cassette transporter systems, comprising more than eight distinct proteins. In Mycobacterium tuberculosis, these proteins are implicated in interactions of this deadly pathogen with its human host. Here, we provide direct evidence that the Mce4 system of Rhodococcus jostii RHA1 is a steroid uptake system. Transcriptional analyses indicate that the system is encoded by an 11-gene operon, up-regulated 4.0-fold during growth on cholesterol versus on pyruvate. Growth of RHA1 on cholesterol and uptake of radiolabeled cholesterol both required expression of genes in the mce4 operon encoding two permeases plus eight additional proteins of unknown function. Cholesterol uptake was ATP-dependent and exhibited Michaelis-Menten kinetics with a K-m of 0.6 +/- 0.1 mu M. This uptake system was also essential for growth of RHA1 on beta-sitosterol, 5-alpha-cholestanol, and 5-alpha-cholestanone. Bioinformatic analysis revealed that all mce4 loci in sequenced genomes are linked to steroid metabolism genes. Thus, we predict that all Mce4 systems are steroid transporters. The transport function of the Mce4 system is consistent with proposed roles of cholesterol and its metabolism in the pathogenesis of M. tuberculosis.	[Mohn, William W.; Stewart, Gordon R.; Okamoto, Sachi; Liu, Jie; Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [van der Geize, Robert; Dijkhuizen, Lubbert] Univ Groningen, Dept Microbiol, NL-9751 NN Haren, Netherlands	University of British Columbia; University of Groningen	Mohn, WW (corresponding author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	wmohn@interchange.ubc.ca	Dijkhuizen, Lubbert/K-3539-2019; Eltis, Lindsay D/J-8272-2015; Dijkhuizen, Lubbert/E-9454-2014	Dijkhuizen, Lubbert/0000-0003-2312-7162; Eltis, Lindsay D/0000-0002-6774-8158; 	Discovery Grants from the Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Discovery Grants from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada( to W. W. M. and L. D. E.) and an Operating Grant from the Canadian Institutes of Health Research ( to W. W. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGARWAL N, 1983, BIOCHIM BIOPHYS ACTA, V723, P150, DOI 10.1016/0005-2728(83)90114-7; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Av-Gay Y, 2000, CAN J MICROBIOL, V46, P826, DOI 10.1139/cjm-46-9-826; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P469; Casali N, 2002, INFECT IMMUN, V70, P6846, DOI 10.1128/IAI.70.12.6846-6852.2002; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Chitale S, 2001, CELL MICROBIOL, V3, P247, DOI 10.1046/j.1462-5822.2001.00110.x; Cole ST, 1998, NATURE, V396, P190, DOI 10.1038/24206; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x; El-Shazly S, 2007, J MED MICROBIOL, V56, P1145, DOI 10.1099/jmm.0.47095-0; Garcia O, 2004, J MOL BIOL, V343, P249, DOI 10.1016/j.jmb.2004.07.093; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Haile Y, 2002, FEMS IMMUNOL MED MIC, V33, P125, DOI 10.1111/j.1574-695X.2002.tb00581.x; Joshi SM, 2006, P NATL ACAD SCI USA, V103, P11760, DOI 10.1073/pnas.0603179103; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kumar A, 2003, INFECT IMMUN, V71, P6083, DOI 10.1128/IAI.71.10.6083-6087.2003; Lu SW, 2006, ANAL BIOCHEM, V353, P7, DOI 10.1016/j.ab.2006.01.044; MATHUR M, 1992, J BIOL CHEM, V267, P19388; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Mitra D, 2005, TUBERCULOSIS, V85, P337, DOI 10.1016/j.tube.2005.08.010; Nakashima N, 2004, BIOTECHNOL BIOENG, V86, P136, DOI 10.1002/bit.20024; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parrish NM, 2004, J ANTIMICROB CHEMOTH, V54, P722, DOI 10.1093/jac/dkh408; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; Rosas-Magallanes V, 2007, INFECT IMMUN, V75, P504, DOI 10.1128/IAI.00058-06; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Senaratne RH, 2008, J MED MICROBIOL, V57, P164, DOI 10.1099/jmm.0.47454-0; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Sutcliffe IC, 1998, ANTON LEEUW INT J G, V74, P49, DOI 10.1023/A:1001747726820; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; van der Geize R, 2001, FEMS MICROBIOL LETT, V205, P197, DOI 10.1016/S0378-1097(01)00464-5; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104	36	147	151	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35368	35374		10.1074/jbc.M805496200	http://dx.doi.org/10.1074/jbc.M805496200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955493	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-27	WOS:000261687900007
J	Shih, MYS; Kane, MA; Zhou, P; Yen, CLE; Streeper, RS; Napoli, JL; Farese, RV				Shih, Michelle Y. S.; Kane, Maureen A.; Zhou, Ping; Yen, C. L. Eric; Streeper, Ryan S.; Napoli, Joseph L.; Farese, Robert V., Jr.			Retinol Esterification by DGAT1 Is Essential for Retinoid Homeostasis in Murine Skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-GLAND; BINDING-PROTEINS; ACYLTRANSFERASE GENE; ACID; HAIR; LECITHIN; MICE; EXPRESSION; ENZYMES; MECHANISMS	Retinoic acid (RA) is a potent signaling molecule that is essential for many biological processes, and its levels are tightly regulated by mechanisms that are only partially understood. The synthesis of RA from its precursor retinol (vitamin A) is an important regulatory mechanism. Therefore, the esterification of retinol with fatty acyl moieties to generate retinyl esters, the main storage form of retinol, may also regulate RA levels. Here we show that the neutral lipid synthesis enzyme acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) functions as the major acyl-CoA: retinol acyltransferase (ARAT) in murine skin. When dietary retinol is abundant, DGAT1 deficiency results in elevated levels of RA in skin and cyclical hair loss; both are prevented by dietary retinol deprivation. Further, DGAT1-deficient skin exhibits enhanced sensitivity to topically administered retinol. Deletion of the enzyme specifically in the epidermis causes alopecia, indicating that the regulation of RA homeostasis by DGAT1 is autonomous in the epidermis. These findings show that DGAT1 functions as an ARAT in the skin, where it acts to maintain retinoid homeostasis and prevent retinoid toxicity. Our findings may have implications for human skin or hair disorders treated with agents that modulate RA signaling.	[Shih, Michelle Y. S.; Zhou, Ping; Yen, C. L. Eric; Streeper, Ryan S.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94158 USA; [Shih, Michelle Y. S.; Farese, Robert V., Jr.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA; [Kane, Maureen A.; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Farese, RV (corresponding author), J David Gladstone Inst, 1650 Owens St, San Francisco, CA 94158 USA.	bfarese@gladstone.ucsf.edu			National Institutes of Health [DK-056084, DK36870]; National Center for Research Resources extramural research facilities Grant [C06 RR018928]; J. David Gladstone Institutes; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056084, R01DK056084, R01DK036870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources extramural research facilities Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); J. David Gladstone Institutes(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-056084 (to R. F.) and DK36870 (to J. L. N.). This work was also supported by National Center for Research Resources extramural research facilities Grant C06 RR018928 and by the J. David Gladstone Institutes. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Azais-Braesco V, 2000, AM J CLIN NUTR, V71, p1325S, DOI 10.1093/ajcn/71.5.1325s; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BAZZANO G, 1993, J INVEST DERMATOL, V101, pS138, DOI 10.1111/1523-1747.ep12363264; BAZZANO GS, 1986, J AM ACAD DERMATOL, V15, P880, DOI 10.1016/S0190-9622(86)80024-X; BERTHJONES J, 1995, BRIT J DERMATOL, V132, P367, DOI 10.1111/j.1365-2133.1995.tb08669.x; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Cases S, 2004, DEVELOPMENT, V131, P3047, DOI 10.1242/dev.01158; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Clarke SB, 2007, DERMATOL CLIN, V25, P137, DOI 10.1016/j.det.2007.01.004; Dassule HR, 2000, DEVELOPMENT, V127, P4775; ELIAS PM, 1986, J AM ACAD DERMATOL, V15, P797, DOI 10.1016/S0190-9622(86)70236-3; Everts HB, 2004, J INVEST DERMATOL, V123, P258, DOI 10.1111/j.0022-202X.2004.23223.x; Everts HB, 2007, J INVEST DERMATOL, V127, P1593, DOI 10.1038/sj.jid.5700753; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Foitzik K, 2005, J INVEST DERMATOL, V124, P1119, DOI 10.1111/j.0022-202X.2005.23686.x; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Hanakawa Y, 2002, J INVEST DERMATOL, V119, P27, DOI 10.1046/j.1523-1747.2002.01780.x; Hansen LA, 2000, CARCINOGENESIS, V21, P1271, DOI 10.1093/carcin/21.7.1271; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Kurlandsky SB, 1996, J BIOL CHEM, V271, P15346, DOI 10.1074/jbc.271.26.15346; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; LOOK J, 1995, AM J PHYSIOL-ENDOC M, V269, pE91, DOI 10.1152/ajpendo.1995.269.1.E91; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Matsuda D, 2007, CURR OPIN INVEST DR, V8, P836; Meiner V, 1997, J LIPID RES, V38, P1928; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; ONG DE, 1987, J BIOL CHEM, V262, P2729; Orland MD, 2005, BBA-MOL CELL BIOL L, V1737, P76, DOI 10.1016/j.bbalip.2005.09.003; Randolph RK, 1997, J LIPID RES, V38, P1374; RANDOLPH RK, 1991, ARCH BIOCHEM BIOPHYS, V288, P500, DOI 10.1016/0003-9861(91)90227-A; RANDOLPH RK, 1993, J BIOL CHEM, V268, P9198; Reichrath J, 2007, HORM METAB RES, V39, P71, DOI 10.1055/s-2007-958715; ROSS AC, 1982, J LIPID RES, V23, P133; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; TORMA H, 1987, J INVEST DERMATOL, V88, P398, DOI 10.1111/1523-1747.ep12469726; Wongsiriroj N, 2008, J BIOL CHEM, V283, P13510, DOI 10.1074/jbc.M800777200; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhao G, 2008, J MED CHEM, V51, P380, DOI 10.1021/jm7013887; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; Zouboulis CC, 2001, SKIN PHARMACOL APPL, V14, P303, DOI 10.1159/000056361	49	68	71	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4292	4299		10.1074/jbc.M807503200	http://dx.doi.org/10.1074/jbc.M807503200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19028692	Green Published, hybrid			2022-12-27	WOS:000263134400027
J	Nithianantham, S; Xu, M; Yamada, M; Ikegami, A; Shoham, M; Han, YW				Nithianantham, Stanley; Xu, Minghua; Yamada, Mitsunori; Ikegami, Akihiko; Shoham, Menachem; Han, Yiping W.			Crystal Structure of FadA Adhesin from Fusobacterium nucleatum Reveals a Novel Oligomerization Motif, the Leucine Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAXIMUM-LIKELIHOOD; COLICIN-E3; BACTERIA; CELLS; MICE	Many bacterial appendages have filamentous structures, often composed of repeating monomers assembled in a head-to-tail manner. The mechanisms of such linkages vary. We report here a novel protein oligomerization motif identified in the FadA adhesin from the Gram-negative bacterium Fusobacterium nucleatum. The 2.0 angstrom crystal structure of the secreted form of FadA (mFadA) reveals two antiparallel alpha-helices connected by an intervening 8-residue hairpin loop. Leucine-leucine contacts play a prominent dual intra- and intermolecular role in the structure and function of FadA. First, they comprise the main association between the two helical arms of the monomer; second, they mediate the head-to-tail association of monomers to form the elongated polymers. This leucine-mediated filamentous assembly of FadA molecules constitutes a novel structural motif termed the "leucine chain." The essential role of these residues in FadA is corroborated by mutagenesis of selected leucine residues, which leads to the abrogation of oligomerization, filament formation, and binding to host cells.	[Nithianantham, Stanley; Shoham, Menachem] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Xu, Minghua; Yamada, Mitsunori; Ikegami, Akihiko; Han, Yiping W.] Case Western Reserve Univ, Dept Periodont, Cleveland, OH 44106 USA; [Han, Yiping W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Han, YW (corresponding author), 2123 Abington Rd,Rm 3580, Cleveland, OH 44106 USA.	yiping.han@case.edu			National Institutes of Health [RO1DE14924, KO2DE16102, R21DE17165]; Philip Morris External Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K02DE016102, R21DE017165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris External Research Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DE14924, KO2DE16102, and R21DE17165 (to Y.W.H.). This work was also supported by a grant from the Philip Morris External Research Program (to Y.W.H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAIM W, 1992, ARCH GYNECOL OBSTET, V251, P9, DOI 10.1007/BF02718273; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Nithianantham S, 2006, ACTA CRYSTALLOGR F, V62, P1215, DOI 10.1107/S1744309106045593; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Xu MH, 2007, J BIOL CHEM, V282, P25000, DOI 10.1074/jbc.M611567200	21	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3865	3872		10.1074/jbc.M805503200	http://dx.doi.org/10.1074/jbc.M805503200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	18996848	hybrid, Green Published			2022-12-27	WOS:000262872500055
J	Popp, MW; Artavanis-Tsakonas, K; Ploegh, HL				Popp, Maximilian W.; Artavanis-Tsakonas, Katerina; Ploegh, Hidde L.			Substrate Filtering by the Active Site Crossover Loop in UCHL3 Revealed by Sortagging and Gain-of-function Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL HYDROLASES; DEUBIQUITINATING ENZYMES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; UBIQUITIN; SPECIFICITY; UCH-L3; MEMBRANE; PROTEINS; A20	Determining how deubiquitinating enzymes discriminate between ubiquitin-conjugated substrates is critical to understand their function. Through application of a novel protein cleavage and tagging technique, sortagging, we show that human UCHL3 and the Plasmodium falciparum homologue, members of the ubiquitin C-terminal hydrolase family, use a unique active site crossover loop to restrict access of bulky ubiquitin adducts to the active site. Although it provides connectivity for critical active site residues in UCHL3, physical integrity of the crossover loop is dispensable for catalysis. By enlarging the active site crossover loop, we have constructed gain-of-function mutants that can accept substrates that the parent enzyme cannot, including ubiquitin chains of various linkages.	[Popp, Maximilian W.; Artavanis-Tsakonas, Katerina; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Popp, Maximilian W.; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by grants from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Frickel EM, 2007, CELL MICROBIOL, V9, P1601, DOI 10.1111/j.1462-5822.2007.00896.x; Hassiepen U, 2007, ANAL BIOCHEM, V371, P201, DOI 10.1016/j.ab.2007.07.034; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	26	48	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3593	3602		10.1074/jbc.M807172200	http://dx.doi.org/10.1074/jbc.M807172200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19047059	Green Published, hybrid			2022-12-27	WOS:000262872500027
J	Becker, D; Krayl, M; Strub, A; Li, Y; Mayer, MP; Voos, W				Becker, Dorothea; Krayl, Martin; Strub, Andreas; Li, Yanfeng; Mayer, Matthias P.; Voos, Wolfgang			Impaired Interdomain Communication in Mitochondrial Hsp70 Results in the Loss of Inward-directed Translocation Force	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT MOTOR; SUBSTRATE-BINDING; MOLECULAR CHAPERONES; CONFORMATIONAL-CHANGES; ALLOSTERIC REGULATION; STRUCTURAL BASIS; COCHAPERONE; PREPROTEINS; MECHANISM; COMPLEX	The essential mitochondrial Hsp70 (mtHsp70) is required for the import of mitochondrial preproteins into the matrix compartment. The translocation-specific activity of mtHsp70 is coordinated by its interaction with specific partner proteins, forming the import motor complex that provides the energy for unfolding and complete translocation of precursor polypeptide chains. A major biochemical characteristic of Hsp70-type chaperones is their nucleotide-regulated affinity to polypeptide substrates. To study the role of this allosteric regulation in the course of preprotein translocation, we have generated specific mtHsp70 mutations located within or close to the interface between the nucleotide-binding and the substrate-binding domains. Mitochondria isolated from the mtHsp70 mutants displayed severely reduced import efficiencies in vitro. Two of the mutants exhibited strong growth defects in vivo and were significantly impaired in the generation of an inward-directed, ATP-dependent import force on precursor proteins in transit. The biochemical properties of these two mutant proteins were consistent with defects in the transfer of conformational signals to the substrate-binding domain, resulting in a prolonged and enhanced interaction with imported substrate proteins. Furthermore, interference with the allosteric mechanism resulted in defects of translocation-specific partner protein interaction. We conclude that even a partial disruption of the interdomain communication in the mtHsp70 chaperone results in an almost complete breakdown of its translocation-driving properties.	[Becker, Dorothea; Voos, Wolfgang] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Becker, Dorothea; Krayl, Martin; Strub, Andreas; Li, Yanfeng] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Mayer, Matthias P.] Heidelberg Univ, ZMBH, D-69120 Heidelberg, Germany	University of Bonn; University of Freiburg; Ruprecht Karls University Heidelberg	Voos, W (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	wolfgang.voos@uni-bonn.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112	Deutsche Forschungsgemeinschaft [SFB 388]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 388, Teilprojekt A11 (to W. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bomer U, 1998, EMBO J, V17, P4226, DOI 10.1093/emboj/17.15.4226; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; D'Silva P, 2004, NAT STRUCT MOL BIOL, V11, P1084, DOI 10.1038/nsmb846; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Erbse A, 2004, BIOCHEM SOC T, V32, P617, DOI 10.1042/BST0320617; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; Krayl M, 2007, MOL CELL BIOL, V27, P411, DOI 10.1128/MCB.01391-06; LALORAYA S, 1995, MOL CELL BIOL, V15, P7098; Lim JH, 2001, EMBO J, V20, P941, DOI 10.1093/emboj/20.5.941; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Merlin A, 1999, J CELL BIOL, V145, P961, DOI 10.1083/jcb.145.5.961; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Revington M, 2005, J MOL BIOL, V349, P163, DOI 10.1016/j.jmb.2005.03.033; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Ryan MT, 2002, ADV PROTEIN CHEM, V59, P223; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schmidt S, 2001, J MOL BIOL, V313, P13, DOI 10.1006/jmbi.2001.5013; Schneider HC, 1996, EMBO J, V15, P5796, DOI 10.1002/j.1460-2075.1996.tb00966.x; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sousa R, 2006, TRAFFIC, V7, P1596, DOI 10.1111/j.1600-0854.2006.00497.x; Strub A, 2000, BIOL CHEM, V381, P943, DOI 10.1515/BC.2000.115; Strub A, 2002, EMBO J, V21, P2626, DOI 10.1093/emboj/21.11.2626; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Tomkiewicz D, 2007, FEBS LETT, V581, P2820, DOI 10.1016/j.febslet.2007.04.015; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Ungermann C, 1996, EMBO J, V15, P735, DOI 10.1002/j.1460-2075.1996.tb00409.x; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; VOOS W, 1994, MOL CELL BIOL, V14, P6627, DOI 10.1128/MCB.14.10.6627; Voos W, 1996, EMBO J, V15, P2668, DOI 10.1002/j.1460-2075.1996.tb00627.x; VOOS W, 1993, J CELL BIOL, V123, P119, DOI 10.1083/jcb.123.1.119; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; WAGGONER A, 1976, J MEMBRANE BIOL, V27, P317, DOI 10.1007/BF01869143; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x; Westermann B, 1996, MOL CELL BIOL, V16, P7063; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	64	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2934	2946		10.1074/jbc.M803557200	http://dx.doi.org/10.1074/jbc.M803557200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19036727	hybrid			2022-12-27	WOS:000262700900038
J	Porcelli, AM; Angelin, A; Ghelli, A; Mariani, E; Martinuzzi, A; Carelli, V; Petronilli, V; Bernardi, P; Rugolo, M				Porcelli, Anna Maria; Angelin, Alessia; Ghelli, Anna; Mariani, Elisa; Martinuzzi, Andrea; Carelli, Valerio; Petronilli, Valeria; Bernardi, Paolo; Rugolo, Michela			Respiratory Complex I Dysfunction Due to Mitochondrial DNA Mutations Shifts the Voltage Threshold for Opening of the Permeability Transition Pore toward Resting Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY-OPTIC-NEUROPATHY; UBIQUINONE OXIDOREDUCTASE DEFICIENCY; CONGENITAL MUSCULAR-DYSTROPHY; CYTOCHROME-C RELEASE; CYCLOSPORINE-A; OXIDATIVE-PHOSPHORYLATION; CELL-DEATH; CA2+ HOMEOSTASIS; INDUCED APOPTOSIS; GALACTOSE MEDIUM	We have studied mitochondrial bioenergetics in HL180 cells ( a cybrid line harboring the T14484C/ND6 and G14279A/ND6 mtDNA mutations of Leber hereditary optic neuropathy, leading to an similar to 50% decrease of ATP synthesis) and XTC.UC1 cells ( derived from a thyroid oncocytoma bearing a disruptive frame-shift mutation in MT-ND1, which impairs complex I assembly). The addition of rotenone to HL180 cells and of antimycin A to XTC.UC1 cells caused fast mitochondrial membrane depolarization that was prevented by treatment with cyclosporin A, intracellular Ca2+ chelators, and antioxidant. Both cell lines also displayed an anomalous response to oligomycin, with rapid onset of depolarization that was prevented by cyclosporin A and by overexpression of Bcl-2. These findings indicate that depolarization by respiratory chain inhibitors and oligomycin was due to opening of the mitochondrial permeability transition pore (PTP). A shift of the threshold voltage for PTP opening close to the resting potential may therefore be the underlying cause facilitating cell death in diseases affecting complex I activity. This study provides a unifying reading frame for previous observations on mitochondrial dysfunction, bioenergetic defects, and Ca2+ deregulation in mitochondrial diseases. Therapeutic strategies aimed at normalizing the PTP voltage threshold may be instrumental in ameliorating the course of complex I-dependent mitochondrial diseases.	[Angelin, Alessia; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Angelin, Alessia; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Consiglio Nazl Ric Inst Neurosci, I-35121 Padua, Italy; [Porcelli, Anna Maria; Ghelli, Anna; Mariani, Elisa; Rugolo, Michela] Univ Bologna, Dept Evolut & Expt Biol, I-40126 Bologna, Italy; [Carelli, Valerio] Univ Bologna, Dept Neurol Sci, I-40126 Bologna, Italy; [Martinuzzi, Andrea] Ist Ricovero & Cura Carattere Sci E Medea, I-31015 Conegliano, Italy	University of Padua; University of Padua; University of Bologna; University of Bologna; IRCCS Eugenio Medea	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@bio.unipd.it	Rugolo, Michela/AAY-8640-2020; Petronilli, Valeria/C-3558-2015; Martinuzzi, Andrea/K-3887-2016; Bernardi, Paolo/C-3656-2008	Petronilli, Valeria/0000-0003-4026-6404; Martinuzzi, Andrea/0000-0002-0319-3579; GHELLI, ANNA MARIA/0000-0003-0830-0000; Porcelli, Anna Maria/0000-0002-6209-0692; CARELLI, VALERIO/0000-0003-4923-6404; Bernardi, Paolo/0000-0001-9187-3736; Rugolo, Michela/0000-0002-4597-0452	Associazione Italiana per la Ricerca sul Cancro and Ministero della Universita e Ricerca; Fondazione Cariparo Progetti di Eccellenza; Telethon [GGP06233]	Associazione Italiana per la Ricerca sul Cancro and Ministero della Universita e Ricerca(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariparo Progetti di Eccellenza(Fondazione Cariparo); Telethon(Fondazione Telethon)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro and Ministero della Universita e Ricerca ( to M. R. and P. B.), Fondazione Cariparo Progetti di Eccellenza ( to P. B.) and Telethon Grant GGP06233 ( to V. C.).	Angelin A, 2008, BBA-BIOENERGETICS, V1777, P893, DOI 10.1016/j.bbabio.2008.03.026; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Battisti C, 2004, J NEUROL NEUROSUR PS, V75, P1731, DOI 10.1136/jnnp.2003.024372; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; Brini M, 1997, MOL BIOL CELL, V8, P129, DOI 10.1091/mbc.8.1.129; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; BYRNE E, 1991, ACTA NEUROPATHOL, V81, P318, DOI 10.1007/BF00305874; Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2; Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Danielson SR, 2002, J BIOL CHEM, V277, P5810, DOI 10.1074/jbc.M110119200; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Gasparre G, 2007, P NATL ACAD SCI USA, V104, P9001, DOI 10.1073/pnas.0703056104; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Haroon MF, 2007, NEUROBIOL DIS, V28, P237, DOI 10.1016/j.nbd.2007.07.021; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Jun AS, 1996, MOL CELL BIOL, V16, P771; Kaasik A, 2003, FASEB J, V17, DOI 10.1096/fj.02-0684fje; Koopman WJH, 2008, BBA-BIOENERGETICS, V1777, P853, DOI 10.1016/j.bbabio.2008.03.028; Koopman WJH, 2007, AM J PHYSIOL-CELL PH, V293, pC22, DOI 10.1152/ajpcell.00194.2006; Kowaltowski A, 2000, CELL DEATH DIFFER, V7, P903, DOI 10.1038/sj.cdd.4400722; Kubota M, 2006, J NEUROSCI, V26, P12314, DOI 10.1523/JNEUROSCI.3933-06.2006; Manfredi G, 2003, J BIOL CHEM, V278, P5639, DOI 10.1074/jbc.M203080200; McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Milanesi E, 2006, J BIOL CHEM, V281, P10066, DOI 10.1074/jbc.M513708200; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Mott JL, 2004, BIOCHEM BIOPH RES CO, V319, P1210, DOI 10.1016/j.bbrc.2004.05.104; Mott JL, 2006, BBA-BIOENERGETICS, V1757, P596, DOI 10.1016/j.bbabio.2006.04.014; MOUDY AM, 1995, P NATL ACAD SCI USA, V92, P729, DOI 10.1073/pnas.92.3.729; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Qi XP, 2003, INVEST OPHTH VIS SCI, V44, P1088, DOI 10.1167/iovs.02-0864; Ricci C, 2008, AM J PHYSIOL-CELL PH, V294, pC413, DOI 10.1152/ajpcell.00362.2007; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SRERE PA, 1969, ARCH BIOCHEM BIOPHYS, V129, P708, DOI 10.1016/0003-9861(69)90231-8; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; von Kleist-Retzow JC, 2007, EXP CELL RES, V313, P3076, DOI 10.1016/j.yexcr.2007.04.015; Willems PHGM, 2008, CELL CALCIUM, V44, P123, DOI 10.1016/j.ceca.2008.01.002; Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431; Wong A, 1997, BIOCHEM BIOPH RES CO, V239, P139, DOI 10.1006/bbrc.1997.7443; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989; Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zhadanov SI, 2005, BIOCHEM BIOPH RES CO, V332, P1115, DOI 10.1016/j.bbrc.2005.05.059; Zielke A, 1998, THYROID, V8, P475, DOI 10.1089/thy.1998.8.475	73	81	82	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2045	2052		10.1074/jbc.M807321200	http://dx.doi.org/10.1074/jbc.M807321200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047048	hybrid			2022-12-27	WOS:000262545600012
J	Wilson, SR; Peters, C; Saftig, P; Bromme, D				Wilson, Susan R.; Peters, Christoph; Saftig, Paul; Broemme, Dieter			Cathepsin K Activity-dependent Regulation of Osteoclast Actin Ring Formation and Bone Resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN TYPE-I; MATRIX METALLOPROTEINASES; INTEGRIN ALPHA-V-BETA-3; VITRONECTIN RECEPTOR; RAT OSTEOCLASTS; VINYL SULFONES; DEFICIENT MICE; SEALING ZONE; PROTEINASES; EXPRESSION	Cathepsin K is responsible for the degradation of type I collagen in osteoclast-mediated bone resorption. Collagen fragments are known to be biologically active in a number of cell types. Here, we investigate their potential to regulate osteoclast activity. Mature murine osteoclasts were seeded on type I collagen for actin ring assays or dentine discs for resorption assays. Cells were treated with cathepsins K-, L-, or MMP-1-predigested type I collagen or soluble bone fragments for 24 h. The presence of actin rings was determined fluorescently by staining for actin. We found that the percentage of osteoclasts displaying actin rings and the area of resorbed dentine decreased significantly on addition of cathepsin K-digested type I collagen or bone fragments, but not with cathepsin L or MMP-1 digests. Counterintuitively, actin ring formation was found to decrease in the presence of the cysteine proteinase inhibitor LHVS and in cathepsin K-deficient osteoclasts. However, cathepsin L deficiency or the general MMP inhibitor GM6001 had no effect on the presence of actin rings. Predigestion of the collagen matrix with cathepsin K, but not by cathepsin L or MMP-1 resulted in an increased actin ring presence in cathepsin K-deficient osteoclasts. These studies suggest that cathepsin K interaction with type I collagen is required for 1) the release of cryptic Arg-Gly-Asp motifs during the initial attachment of osteoclasts and 2) termination of resorption via the creation of autocrine signals originating from type I collagen degradation.	[Wilson, Susan R.; Broemme, Dieter] Univ British Columbia, Fac Dent, Vancouver, BC V6T 1Z3, Canada; [Wilson, Susan R.; Broemme, Dieter] Univ British Columbia, UBC Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Peters, Christoph] Univ Freiburg, Inst Mol Med & Zellforsch, D-79104 Freiburg, Germany; [Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	University of British Columbia; University of British Columbia; University of Freiburg; University of Kiel	Bromme, D (corresponding author), Univ British Columbia, Fac Dent, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	dbromme@interchange.ubc.ca	Saftig, Paul/A-7966-2010		National Institutes of Health [AR48669, DK072070]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR48669 and DK072070. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALBINI A, 1985, EUR J CELL BIOL, V36, P104; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Chellaiah MA, 2006, EUR J CELL BIOL, V85, P311, DOI 10.1016/j.ejcb.2006.01.008; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; Everts V, 2003, CALCIFIED TISSUE INT, V73, P380, DOI 10.1007/s00223-002-2092-4; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; FITZSIMMONS CM, 1986, THROMB HAEMOSTASIS, V56, P95; Flores ME, 1996, EXP CELL RES, V227, P40, DOI 10.1006/excr.1996.0247; FLORES ME, 1992, EXP CELL RES, V201, P526, DOI 10.1016/0014-4827(92)90305-R; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Goto T, 2003, J ELECTRON MICROSC, V52, P551, DOI 10.1093/jmicro/52.6.551; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Graebert KS, 1997, EXP CELL RES, V231, P214, DOI 10.1006/excr.1996.3456; Helfrich MH, 1996, BONE, V19, P317, DOI 10.1016/S8756-3282(96)00223-2; Hoebertz A, 2003, METH MOLEC MED, V80, P53; Holliday LS, 2003, CALCIFIED TISSUE INT, V72, P206, DOI 10.1007/s00223-002-1008-7; HORTON MA, 1991, EXP CELL RES, V195, P368, DOI 10.1016/0014-4827(91)90386-9; HYNES RO, 1992, COLD SPRING HARB SYM, V57, P249, DOI 10.1101/SQB.1992.057.01.030; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Inui T, 1997, J BIOL CHEM, V272, P8109, DOI 10.1074/jbc.272.13.8109; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; KING KL, 1994, J BONE MINER RES, V9, P381; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; Laitala-Leinonen T, 2006, MATRIX BIOL, V25, P149, DOI 10.1016/j.matbio.2005.10.005; Lakkakorpi PT, 1996, MICROSC RES TECHNIQ, V33, P171, DOI 10.1002/(SICI)1097-0029(19960201)33:2<171::AID-JEMT7>3.0.CO;2-W; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; MALONE JD, 1991, MATRIX, V11, P289; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2; Masarachia P, 1998, ENDOCRINOLOGY, V139, P1401, DOI 10.1210/en.139.3.1401; MOONGA BS, 1990, J PHYSIOL-LONDON, V429, P29, DOI 10.1113/jphysiol.1990.sp018242; Nakagawa H, 2003, BONE, V33, P443, DOI 10.1016/S8756-3282(03)00201-1; Nakamura I, 1999, J CELL SCI, V112, P3985; Nakamura I, 1998, ENDOCRINOLOGY, V139, P5182, DOI 10.1210/en.139.12.5182; NESBITT S, 1993, J BIOL CHEM, V268, P16737; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pfaff M, 2001, J CELL SCI, V114, P2775; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sato T, 1998, J BONE MINER RES, V13, P59, DOI 10.1359/jbmr.1998.13.1.59; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Sharan K, 2008, INDIAN J MED RES, V127, P274; Takahashi N, 2007, ODONTOLOGY, V95, P1, DOI 10.1007/s10266-007-0071-y; VANDERPLUIJM G, 1994, J BONE MINER RES, V9, P1021; Xia LH, 1999, BIOL CHEM, V380, P679, DOI 10.1515/BC.1999.084	55	160	170	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2584	2592		10.1074/jbc.M805280200	http://dx.doi.org/10.1074/jbc.M805280200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028686	hybrid, Green Published			2022-12-27	WOS:000262545600063
J	Chen, SC; Lin, YH; Yu, HC; Liaw, SH				Chen, Sheng-Chia; Lin, Yu-Hsin; Yu, Hui-Chia; Liaw, Shwu-Huey			Complex Structure of Bacillus subtilis RibG: THE REDUCTION MECHANISM DURING RIBOFLAVIN BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIFUNCTIONAL DEAMINASE-REDUCTASE; DIHYDROFOLATE-REDUCTASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; INHIBITORS; FOLATE	Bacterial RibG is a potent target for antimicrobial agents, because it catalyzes consecutive deamination and reduction steps in the riboflavin biosynthesis. In the N-terminal deaminase domain of Bacillus subtilis RibG, structure-based mutational analyses demonstrated that Glu(51) and Lys(79) are essential for the deaminase activity. In the C-terminal reductase domain, the complex structure with the substrate at 2.56-angstrom resolution unexpectedly showed a ribitylimino intermediate bound at the active site, and hence suggested that the ribosyl reduction occurs through a Schiff base pathway. Lys(151) seems to have evolved to ensure specific recognition of the deaminase product rather than the substrate. Glu(290), instead of the previously proposed Asp(199), would seem to assist in the proton transfer in the reduction reaction. A detailed comparison reveals that the reductase and the pharmaceutically important enzyme, dihydrofolate reductase involved in the riboflavin and folate biosyntheses, share strong conservation of the core structure, cofactor binding, catalytic mechanism, even the substrate binding architecture.	[Yu, Hui-Chia; Liaw, Shwu-Huey] Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan; [Yu, Hui-Chia; Liaw, Shwu-Huey] Natl Yang Ming Univ, Inst Genome Sci, Taipei 11221, Taiwan; [Chen, Sheng-Chia; Lin, Yu-Hsin; Liaw, Shwu-Huey] Natl Yang Ming Univ, Struct Biol Program, Taipei 11221, Taiwan; [Chen, Sheng-Chia] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Lin, Yu-Hsin] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 11221, Taiwan; [Liaw, Shwu-Huey] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 11217, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Liaw, SH (corresponding author), Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan.	shliaw@ym.edu.tw			National Science Council [NSC96-2311-B010017]; Ministry of Education; Aim for the Top University Plan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education; Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by National Science Council (NSC96-2311-B010017) and a grant from the Ministry of Education, Aim for the Top University Plan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Almog R, 2004, BIOCHEMISTRY-US, V43, P13715, DOI 10.1021/bi048928h; Behm-Ansmant I, 2004, J BIOL CHEM, V279, P52998, DOI 10.1074/jbc.M409581200; BRESLER SE, 1977, GENETIKA+, V13, P2007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURROWS RB, 1978, J BACTERIOL, V136, P657, DOI 10.1128/JB.136.2.657-667.1978; BYSTROFF C, 1990, BIOCHEMISTRY-US, V29, P3263, DOI 10.1021/bi00465a018; Chatwell L, 2006, J MOL BIOL, V359, P1334, DOI 10.1016/j.jmb.2006.04.045; Chen SC, 2006, J BIOL CHEM, V281, P7605, DOI 10.1074/jbc.M510254200; Cody V, 1999, BIOCHEMISTRY-US, V38, P4303, DOI 10.1021/bi982728m; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Dams T, 2000, J MOL BIOL, V297, P659, DOI 10.1006/jmbi.2000.3570; DIETRICH R, 1979, J AM CHEM SOC, V101, P6144, DOI 10.1021/ja00514a059; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fischer M, 2005, NAT PROD REP, V22, P324, DOI 10.1039/b210142b; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Graupner M, 2002, J BACTERIOL, V184, P1952, DOI 10.1128/JB.184.7.1952-1957.2002; Hawser S, 2006, BIOCHEM PHARMACOL, V71, P941, DOI 10.1016/j.bcp.2005.10.052; Kaiser J, 2007, ANAL BIOCHEM, V365, P52, DOI 10.1016/j.ab.2007.02.033; KELLER PJ, 1988, BIOCHEMISTRY-US, V27, P1117, DOI 10.1021/bi00404a006; Ko TP, 2003, J BIOL CHEM, V278, P19111, DOI 10.1074/jbc.M300874200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumasaka T, 2007, J BIOL CHEM, V282, P37103, DOI 10.1074/jbc.M704476200; Liaw SH, 2004, J BIOL CHEM, V279, P35479, DOI 10.1074/jbc.M405304200; Magalhaes MLB, 2008, BIOCHEMISTRY-US, V47, P6499, DOI 10.1021/bi800264g; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Richter G, 1997, J BACTERIOL, V179, P2022, DOI 10.1128/jb.179.6.2022-2028.1997; Ritz H, 2001, J BIOL CHEM, V276, P22273, DOI 10.1074/jbc.M100752200; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Stenmark P, 2007, J MOL BIOL, V373, P48, DOI 10.1016/j.jmb.2006.12.009; Xiang SB, 1997, BIOCHEMISTRY-US, V36, P4768, DOI 10.1021/bi963091e	33	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1725	1731		10.1074/jbc.M805820200	http://dx.doi.org/10.1074/jbc.M805820200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18986985	hybrid			2022-12-27	WOS:000262330100042
J	Bernardo, LMD; Johansson, LUM; Skarfstad, E; Shingler, V				Bernardo, Lisandro M. D.; Johansson, Linda U. M.; Skarfstad, Eleonore; Shingler, Victoria			sigma(54)-Promoter Discrimination and Regulation by ppGpp and DksA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; SIGMA(54)-DEPENDENT PO PROMOTER; COLI RNA-POLYMERASE; GUANOSINE TETRAPHOSPHATE PPGPP; TRANSCRIPTIONAL ACTIVATOR DMPR; PSEUDOMONAS-PUTIDA; ESCHERICHIA-COLI; GROWTH-PHASE; PU PROMOTER; TOL PLASMID	The sigma(54)-factor controls expression of a variety of genes in response to environmental cues. Much previous work has implicated the nucleotide alarmone ppGpp and its co-factor DksA in control of sigma(54)-dependent transcription in the gut commensal Escherichia coli, which has evolved to live under very different environmental conditions than Pseudomonas putida. Here we compared ppGpp/DksA mediated control of sigma(54)-dependent transcription in these two organisms. Our in vivo experiments employed P. putida mutants and manipulations of factors implicated in ppGpp/DksA mediated control of sigma(54)-dependent transcription in combination with a series of sigma(54)-promoters with graded affinities for sigma(54)-RNA polymerase. For in vitro analysis we used a P. putida-based reconstituted sigma(54)-transcription assay system in conjunction with DNA-binding plasmon resonance analysis of native and heterologous sigma(54)-RNA polymerase holoenzymes. In comparison with E. coli, ppGpp/DksA responsive sigma(54)-transcription in the environmentally adaptable P. putida was found to be more robust under low energy conditions that occur upon nutrient depletion. The mechanism behind this difference can be traced to reduced promoter discrimination of low affinity sigma(54)-promoters that is conferred by the strong DNA binding properties of the P. putida sigma(54)-RNA polymerase holoenzyme.	[Bernardo, Lisandro M. D.; Johansson, Linda U. M.; Skarfstad, Eleonore; Shingler, Victoria] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden	Umea University	Shingler, V (corresponding author), Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden.	victoria.shingler@molbiol.umu.se		Holmfeldt, Linda/0000-0003-4140-3423; Shingler, Victoria/0000-0002-7349-1678	J. C. Kempe Foundation; Swedish Research Council	J. C. Kempe Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by grants from the J. C. Kempe Foundation and the Swedish Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AVIV M, 1994, MOL MICROBIOL, V14, P1021, DOI 10.1111/j.1365-2958.1994.tb01336.x; Beck LL, 2007, TRENDS MICROBIOL, V15, P530, DOI 10.1016/j.tim.2007.09.008; Bernardo LMD, 2006, MOL MICROBIOL, V60, P749, DOI 10.1111/j.1365-2958.2006.05129.x; Bertoni G, 1998, EMBO J, V17, P5120, DOI 10.1093/emboj/17.17.5120; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Carmona M, 1999, J BIOL CHEM, V274, P33790, DOI 10.1074/jbc.274.47.33790; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Cases I, 2003, ENVIRON MICROBIOL, V5, P1281, DOI 10.1111/j.1462-2920.2003.00528.x; CASHEL M, 1974, ANAL BIOCHEM, V57, P100, DOI 10.1016/0003-2697(74)90056-6; DE LV, 1994, METHOD ENZYMOL, V235, P386; DELORENZO V, 1991, EMBO J, V10, P1159, DOI 10.1002/j.1460-2075.1991.tb08056.x; Dennis JJ, 1998, BIOTECHNIQUES, V25, P772, DOI 10.2144/98255bm04; DITTO MD, 1994, J BACTERIOL, V176, P3738, DOI 10.1128/JB.176.12.3738-3748.1994; Dominguez-Cuevas P, 2006, J BIOL CHEM, V281, P11981, DOI 10.1074/jbc.M509848200; ELLIOTT T, 1984, CELL, V36, P211, DOI 10.1016/0092-8674(84)90091-6; FERNANDEZ S, 1994, J BACTERIOL, V176, P5052, DOI 10.1128/jb.176.16.5052-5058.1994; Fraile S, 2001, J BACTERIOL, V183, P5571, DOI 10.1128/JB.183.19.5571-5579.2001; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; GOODRICH JA, 1990, NUCLEIC ACIDS RES, V18, P4993, DOI 10.1093/nar/18.17.4993; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Ilag LL, 2004, STRUCTURE, V12, P269, DOI 10.1016/j.str.2004.01.007; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jishage M, 2001, J BACTERIOL, V183, P2952, DOI 10.1128/JB.183.9.2952-2956.2001; Johansson LUM, 2008, MOL MICROBIOL, V70, P709, DOI 10.1111/j.1365-2958.2008.06440.x; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; KOHLER T, 1989, J BACTERIOL, V171, P4326; Laurie AD, 2003, J BIOL CHEM, V278, P1494, DOI 10.1074/jbc.M209268200; Macchi R, 2003, J BIOL CHEM, V278, P27695, DOI 10.1074/jbc.M303031200; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mitchell JE, 2007, J BACTERIOL, V189, P3489, DOI 10.1128/JB.00019-07; Murphy H, 2003, METHOD ENZYMOL, V371, P596; O'Neill E, 1998, MOL MICROBIOL, V28, P131, DOI 10.1046/j.1365-2958.1998.00780.x; O'Neill E, 2001, EMBO J, V20, P819, DOI 10.1093/emboj/20.4.819; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; PerezMartin J, 1996, J MOL BIOL, V258, P562, DOI 10.1006/jmbi.1996.0269; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sarand I, 2008, ENVIRON MICROBIOL, V10, P1320, DOI 10.1111/j.1462-2920.2007.01546.x; Shingler V, 2003, ENVIRON MICROBIOL, V5, P1226, DOI 10.1111/j.1462-2920.2003.00472.x; SHINGLER V, 1995, MOL MICROBIOL, V17, P505, DOI 10.1111/j.1365-2958.1995.mmi_17030505.x; SHINGLER V, 2004, PSEUDOMONAS, V2, P451; Szalewska-Palasz A, 2007, J BIOL CHEM, V282, P18046, DOI 10.1074/jbc.M610181200; Sze CC, 2002, J BACTERIOL, V184, P760, DOI 10.1128/JB.184.3.760-770.2002; Sze CC, 1999, MOL MICROBIOL, V31, P1217, DOI 10.1046/j.1365-2958.1999.01264.x; Sze CC, 2001, J BACTERIOL, V183, P2842, DOI 10.1128/JB.183.9.2842-2851.2001; Sze CC, 1996, J BACTERIOL, V178, P3727, DOI 10.1128/jb.178.13.3727-3735.1996; Teras R, 2000, J BACTERIOL, V182, P589, DOI 10.1128/JB.182.3.589-598.2000; Timmis KN, 2002, ENVIRON MICROBIOL, V4, P779, DOI 10.1046/j.1462-2920.2002.00365.x; Valls M, 2002, J BIOL CHEM, V277, P2169, DOI 10.1074/jbc.M108162200; VALLS M, 2004, PSEUDOMONAS VIRULENC, V2, P289; Westblade LF, 2004, J MOL BIOL, V335, P685, DOI 10.1016/j.jmb.2003.11.004; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x; Wikstrom P, 2001, J MOL BIOL, V314, P971, DOI 10.1006/jmbi.2000.5212; XIAO H, 1991, J BIOL CHEM, V266, P5980	60	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					828	838		10.1074/jbc.M807707200	http://dx.doi.org/10.1074/jbc.M807707200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008221	hybrid			2022-12-27	WOS:000262122900017
J	Gao, X; Lorinczi, M; Hill, KS; Brooks, NC; Dokainish, H; Ireton, K; Elferink, LA				Gao, Xiu; Lorinczi, Marta; Hill, Kristen S.; Brooks, Natasha C.; Dokainish, Hatem; Ireton, Keith; Elferink, Lisa A.			Met Receptor Tyrosine Kinase Degradation Is Altered in Response to the Leucine-rich Repeat of the Listeria Invasion Protein Internalin B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; DOMAIN BINDING-SITE; DOWN-REGULATION; SIGNALING PATHWAY; SURFACE PROTEIN; C-CBL; MONOCYTOGENES; COMPLEX; CELLS; INLB	Entry of the bacterial pathogen Listeria monocytogenes into host epithelial cells is critical for infection and virulence. One major pathway for Listeria entry involves binding of the bacterial protein Internalin B to the host receptor tyrosine kinase Met ( hepatocyte growth factor receptor). Activation of Met and downstream signaling cascades is critical for Listeria entry. Internalin B is composed of several structural domains including an N-terminal leucine-rich repeat that is sufficient for binding Met and stimulating downstream signal transduction. Internalin B is monomeric, whereas the leucine-rich repeat is dimeric when expressed as an isolated fragment. The different quaternary states of Internalin B and the leucine-rich repeat suggest that these two Met ligands might cause distinct biological effects. Here we demonstrate that Internalin B and the leucine-rich repeat fragment exhibit agonist properties that differentially influence Met down-regulation in lysosomes. Specifically, Met stability is increased in response to the leucine-rich repeat fragment compared with Internalin B. Interestingly, Internalin B and the leucine-rich repeat stimulate equivalent rates of clathrin-mediated Met internalization. However, the leucine-rich repeat is defective in promoting lysosomal down-regulation of Met and instead enhances receptor recycling to the cell surface. In addition, the leucine-rich repeat causes prolonged Met activation ( phosphorylation) and increased cell motility compared with Internalin B. Taken together, our findings indicate that individual domains of Internalin B differentially regulate Met trafficking. The ability of the leucine-rich repeat fragment to promote Met recycling could account for the increased cell motility induced by this ligand.	[Gao, Xiu; Lorinczi, Marta; Hill, Kristen S.; Brooks, Natasha C.; Elferink, Lisa A.] Univ Texas Galveston, Med Branch, Dept Cell Biol & Neurosci, Galveston, TX 77555 USA; [Elferink, Lisa A.] Univ Texas Galveston, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Dokainish, Hatem] Univ Toronto, Dept Mol Genet, Toronto, ON M55 1A8, Canada; [Ireton, Keith] Univ Cent Florida, Burnett Sch Biomol Sci, Dept Mol Biol & Microbiol, Orlando, FL 32826 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Toronto; State University System of Florida; University of Central Florida	Elferink, LA (corresponding author), Univ Texas Galveston, Med Branch, Dept Cell Biol & Neurosci, Galveston, TX 77555 USA.	laelferi@utmb.edu		Hill, Kristen/0000-0003-3757-2822	National Institutes of Health [CA-112605, CA-119075]; National Science Foundation [IBN-343739]; Canadian Institutes of Health Research [MT-15497]; NATIONAL CANCER INSTITUTE [R01CA119075, R21CA112605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-112605 and CA-119075 ( to L. A. E.). This work was also supported by National Science Foundation Grant IBN-343739 ( to L. A. E.) and Canadian Institutes of Health Research Grant MT-15497 ( to K. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Bierne H, 2002, J CELL SCI, V115, P3357; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Copp J, 2003, J BIOL CHEM, V278, P7783, DOI 10.1074/jbc.M211666200; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; EBNER R, 1991, CELL REGUL, V2, P599, DOI 10.1091/mbc.2.8.599; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; GHERARDI E, 1989, P NATL ACAD SCI USA, V86, P5844, DOI 10.1073/pnas.86.15.5844; Greiffenberg L, 1998, INFECT IMMUN, V66, P5260, DOI 10.1128/IAI.66.11.5260-5267.1998; Hammond DE, 2003, MOL BIOL CELL, V14, P1346, DOI 10.1091/mbc.E02-09-0578; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Hassan GS, 2006, AM J PHYSIOL-HEART C, V290, pH2393, DOI 10.1152/ajpheart.01161.2005; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Hubbard SR, 2006, CELL, V125, P1029, DOI 10.1016/j.cell.2006.05.028; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Kjelsberg C, 1997, AM J PHYSIOL-RENAL, V272, pF222, DOI 10.1152/ajprenal.1997.272.2.F222; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li N, 2005, TRAFFIC, V6, P459, DOI 10.1111/j.1600-0854.2005.00290.x; Li N, 2007, J BIOL CHEM, V282, P16764, DOI 10.1074/jbc.M610835200; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Niemann HH, 2008, J MOL BIOL, V377, P489, DOI 10.1016/j.jmb.2008.01.027; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Peschard P, 2003, CANCER CELL, V3, P519, DOI 10.1016/S1535-6108(03)00136-3; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Prat M, 1998, J CELL SCI, V111, P237; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Santos MF, 1997, J CLIN INVEST, V100, P216, DOI 10.1172/JCI119515; Schlegel A, 2001, CYTOKINE GROWTH F R, V12, P41, DOI 10.1016/S1359-6101(00)00022-8; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Strick DJ, 2005, MOL BIOL CELL, V16, P5699, DOI 10.1091/mbc.E05-03-0204; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	59	5	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					774	783		10.1074/jbc.M805989200	http://dx.doi.org/10.1074/jbc.M805989200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18990695	Green Published, hybrid			2022-12-27	WOS:000262122900011
J	Lafrance-Vanasse, J; Lefebvre, M; Di Lello, P; Sygusch, J; Omichinski, JG				Lafrance-Vanasse, Julien; Lefebvre, Maryse; Di Lello, Paola; Sygusch, Jurgen; Omichinski, James G.			Crystal Structures of the Organomercurial Lyase MerB in Its Free and Mercury-bound Forms INSIGHTS INTO THE MECHANISM OF METHYLMERCURY DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMID-BEARING STRAIN; RESISTANCE; PROTEIN; MODEL; GENES; EXPRESSION; IDENTIFICATION; CATALYSIS; SOFTWARE; SYSTEM	Bacteria resistant to methylmercury utilize two enzymes (MerA and MerB) to degrade methylmercury to the less toxic elemental mercury. The crucial step is the cleavage of the carbon-mercury bond of methylmercury by the organomercurial lyase (MerB). In this study, we determined high resolution crystal structures of MerB in both the free (1.76-angstrom resolution) and mercury-bound (1.64-angstrom resolution) states. The crystal structure of free MerB is very similar to the NMR structure, but important differences are observed when comparing the two structures. In the crystal structure, an amino-terminal alpha-helix that is not present in the NMR structure makes contact with the core region adjacent to the catalytic site. This interaction between the amino-terminal helix and the core serves to bury the active site of MerB. The crystal structures also provide detailed insights into the mechanism of carbon-mercury bond cleavage by MerB. The structures demonstrate that two conserved cysteines (Cys-96 and Cys-159) play a role in substrate binding, carbon-mercury bond cleavage, and controlled product (ionic mercury) release. In addition, the structures establish that an aspartic acid (Asp-99) in the active site plays a crucial role in the proton transfer step required for the cleavage of the carbon-mercury bond. These findings are an important step in understanding the mechanism of carbon-mercury bond cleavage by MerB.	[Lafrance-Vanasse, Julien; Lefebvre, Maryse; Di Lello, Paola; Sygusch, Jurgen; Omichinski, James G.] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sygusch, J (corresponding author), Univ Montreal, Dept Biochem, CP 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	jurgen.sygusch@umontreal.ca; jg.omichinski@umontreal.ca	di lello, paola/C-8605-2013; Lafrance-Vanasse, Julien/B-1952-2009; Lafrance-Vanasse, Julien/ABG-9263-2020	Lafrance-Vanasse, Julien/0000-0001-8807-6277	Natural Science and Engineering Council of Canada; Canadian Institutes of Health Research (CIHR)	Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Natural Science and Engineering Council of Canada (to J. G. O. and J. S.) and Canadian Institutes of Health Research (CIHR) (to J. S). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P., 2005, CCP4 NEWSLETTER, V42; BEGLEY TP, 1986, BIOCHEMISTRY-US, V25, P7186, DOI 10.1021/bi00370a063; BEGLEY TP, 1986, BIOCHEMISTRY-US, V25, P7192, DOI 10.1021/bi00370a064; Benison GC, 2004, BIOCHEMISTRY-US, V43, P8333, DOI 10.1021/bi049662h; Bizily SP, 1999, P NATL ACAD SCI USA, V96, P6808, DOI 10.1073/pnas.96.12.6808; Bizily SP, 2000, NAT BIOTECHNOL, V18, P213, DOI 10.1038/72678; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Che DS, 2006, IN VITRO CELL DEV-PL, V42, P228, DOI 10.1079/IVP2006771; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Di Lello P, 2004, BIOCHEMISTRY-US, V43, P8322, DOI 10.1021/bi049669z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOPINATH E, 1987, J AM CHEM SOC, V109, P7903, DOI 10.1021/ja00259a061; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huang CC, 1999, GENE, V239, P361, DOI 10.1016/S0378-1119(99)00388-1; Lyyra S, 2007, PLANT BIOTECHNOL J, V5, P254, DOI 10.1111/j.1467-7652.2006.00236.x; Melnick JG, 2007, SCIENCE, V317, P225, DOI 10.1126/science.1144314; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; MOORE B, 1960, LANCET, V2, P453; NOVICK RP, 1968, J BACTERIOL, V95, P1335, DOI 10.1128/JB.95.4.1335-1342.1968; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pitts KE, 2002, BIOCHEMISTRY-US, V41, P10287, DOI 10.1021/bi0259148; RICHARDS FM, 1988, PROTEINS, V3, P71, DOI 10.1002/prot.340030202; RICHMOND MH, 1964, NATURE, V202, P1360, DOI 10.1038/2021360a0; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; SCHOTTEL JL, 1978, J BIOL CHEM, V253, P4341; SUMMERS AO, 1974, J BACTERIOL, V119, P242, DOI 10.1128/JB.119.1.242-249.1974; SUMMERS AO, 1986, ANNU REV MICROBIOL, V40, P607, DOI 10.1146/annurev.mi.40.100186.003135; Taubner LM, 2006, BIOCHEMISTRY-US, V45, P12240, DOI 10.1021/bi061089+; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Wilhelm M, 2004, EUR J INORG CHEM, P2301, DOI 10.1002/ejic.200300907	37	35	37	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					938	944		10.1074/jbc.M807143200	http://dx.doi.org/10.1074/jbc.M807143200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004822	hybrid			2022-12-27	WOS:000262122900029
J	Lin, HT; Bavro, VN; Barrera, NP; Frankish, HM; Velamakanni, S; van Veen, HW; Robinson, CV; Borges-Walmsley, MI; Walmsley, AR				Lin, Hong Ting; Bavro, Vassiliy N.; Barrera, Nelson P.; Frankish, Helen M.; Velamakanni, Saroj; van Veen, Hendrik W.; Robinson, Carol V.; Borges-Walmsley, M. Ines; Walmsley, Adrian R.			MacB ABC Transporter Is a Dimer Whose ATPase Activity and Macrolide-binding Capacity Are Regulated by the Membrane Fusion Protein MacA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG EFFLUX TRANSPORTER; ESCHERICHIA-COLI; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; CASSETTE TRANSPORTER; ACRB; PUMP; MECHANISM; STATE; DETERGENT	Gram-negative bacteria utilize specialized machinery to translocate drugs and protein toxins across the inner and outer membranes, consisting of a tripartite complex composed of an inner membrane secondary or primary active transporter (IMP), a periplasmic membrane fusion protein, and an outer membrane channel. We have investigated the assembly and function of the MacAB/TolC system that confers resistance to macrolides in Escherichia coli. The membrane fusion protein MacA not only stabilizes the tripartite assembly by interacting with both the inner membrane protein MacB and the outer membrane protein TolC, but also has a role in regulating the function of MacB, apparently increasing its affinity for both erythromycin and ATP. Analysis of the kinetic behavior of ATP hydrolysis indicated that MacA promotes and stabilizes the ATP-binding form of the MacB transporter. For the first time, we have established unambiguously the dimeric nature of a noncanonic ABC transporter, MacB that has an N-terminal nucleotide binding domain, by means of nondissociating mass spectrometry, analytical ultracentrifugation, and atomic force microscopy. Structural studies of ABC transporters indicate that ATP is bound between a pair of nucleotide binding domains to stabilize a conformation in which the substrate-binding site is outward-facing. Consequently, our data suggest that in the presence of ATP the same conformation of MacB is promoted and stabilized by MacA. Thus, MacA would facilitate the delivery of drugs by MacB to TolC by enhancing the binding of drugs to it and inducing a conformation of MacB that is primed and competent for binding TolC. Our structural studies are an important first step in understanding how the tripartite complex is assembled.	[Lin, Hong Ting; Frankish, Helen M.; Borges-Walmsley, M. Ines; Walmsley, Adrian R.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Bavro, Vassiliy N.] Univ Oxford, Clarendon Lab, Dept Phys, Oxford OX1 3PU, England; [Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Velamakanni, Saroj; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	Durham University; University of Oxford; University of Cambridge; University of Cambridge	Borges-Walmsley, MI (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	m.i.borges-walmsley@durham.ac.uk; a.r.walmsley@durham.ac.uk	van Veen, Hendrik W./A-4162-2008; Bavro, Vassiliy/I-4846-2019	van Veen, Hendrik W./0000-0002-9658-8077; Bavro, Vassiliy/0000-0003-2330-8924; robinson, carol/0000-0001-7829-5505; Barrera, Nelson/0000-0001-7825-1406	Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/F008333/1] Funding Source: researchfish; BBSRC [BB/F008333/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Wellcome Trust (Durham group). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aires JR, 2005, J BACTERIOL, V187, P1923, DOI 10.1128/JB.187.6.1923-1929.2005; Andersen C, 2002, P NATL ACAD SCI USA, V99, P11103, DOI 10.1073/pnas.162039399; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; Bokma E, 2006, FEBS LETT, V580, P5339, DOI 10.1016/j.febslet.2006.09.005; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Daus ML, 2006, J BIOL CHEM, V281, P3856, DOI 10.1074/jbc.M511953200; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Elkins CA, 2003, J BACTERIOL, V185, P5349, DOI 10.1128/JB.185.18.5349-5356.2003; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Federici L, 2005, J BIOL CHEM, V280, P15307, DOI 10.1074/jbc.M500401200; Hanson CL, 2003, BIOPHYS J, V85, P3802, DOI 10.1016/S0006-3495(03)74795-X; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Ilag LL, 2004, J AM CHEM SOC, V126, P14362, DOI 10.1021/ja0450307; Kobayashi N, 2003, FEBS LETT, V546, P241, DOI 10.1016/S0014-5793(03)00579-9; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lengqvist J, 2004, J BIOL CHEM, V279, P13311, DOI 10.1074/jbc.M310958200; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oloo EO, 2006, J BIOL CHEM, V281, P28397, DOI 10.1074/jbc.M513614200; REYNOLDS JA, 1976, P NATL ACAD SCI USA, V73, P4467, DOI 10.1073/pnas.73.12.4467; Seeger MA, 2008, NAT STRUCT MOL BIOL, V15, P199, DOI 10.1038/nsmb.1379; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stroebel D, 2007, BBA-BIOMEMBRANES, V1768, P1567, DOI 10.1016/j.bbamem.2007.03.008; Tamura N, 2005, BIOCHEMISTRY-US, V44, P11115, DOI 10.1021/bi050452u; Tikhonova EB, 2004, J BIOL CHEM, V279, P32116, DOI 10.1074/jbc.M402230200; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Vediyappan G, 2006, J BACTERIOL, V188, P3757, DOI 10.1128/JB.00038-06; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zgurskaya HI, 1999, J MOL BIOL, V285, P409, DOI 10.1006/jmbi.1998.2313	50	74	82	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1145	1154		10.1074/jbc.M806964200	http://dx.doi.org/10.1074/jbc.M806964200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18955484	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000262122900051
J	Wang, ZH; Wang, YX; Hegg, EL				Wang, Zhihong; Wang, Yuxin; Hegg, Eric L.			Regulation of the Heme A Biosynthetic Pathway DIFFERENTIAL REGULATION OF HEME A SYNTHASE AND HEME O SYNTHASE IN SACCHAROMYCES CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; BACILLUS-SUBTILIS-CTAA; A BIOSYNTHESIS; ESCHERICHIA-COLI; GENE-EXPRESSION; FUNCTIONAL-ROLE; ACTIVATOR HAP1; BC(1) COMPLEX; HUMAN-CELLS; YEAST	The assembly and activity of cytochrome c oxidase is dependent on the availability of heme A, one of its essential cofactors. In eukaryotes, two inner mitochondrial membrane proteins, heme O synthase (Cox10) and heme A synthase (Cox15), are required for heme A biosynthesis. In this report, we demonstrate that in Saccharomyces cerevisiae the transcription of COX15 is regulated by Hap1, a transcription factor whose activity is positively controlled by intracellular heme concentration. Conversely, COX10, the physiological partner of COX15, does not share the same regulatory mechanism with COX15. Interestingly, protein quantification identified an 8: 1 protein ratio between Cox15 and Cox10. Together, these results suggest that heme A synthase and/or heme O synthase might play a new, unidentified role in addition to heme A biosynthesis.	[Wang, Zhihong; Wang, Yuxin; Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48823 USA	Michigan State University	Hegg, EL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48823 USA.	erichegg@msu.edu	Wang, Zhihong/J-3175-2015	Wang, Zhihong/0000-0003-3686-6618	National Institutes of Health [GM66236]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM66236 ( to E. L. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; Beauvoit B, 1999, EUR J BIOCHEM, V263, P118, DOI 10.1046/j.1432-1327.1999.00475.x; Brown BM, 2004, BIOCHEMISTRY-US, V43, P13541, DOI 10.1021/bi048469k; Brown KR, 2002, BIOCHEMISTRY-US, V41, P10906, DOI 10.1021/bi0203536; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hach A, 2000, J BIOL CHEM, V275, P248, DOI 10.1074/jbc.275.1.248; HALDI ML, 1995, MOL GEN GENET, V248, P229, DOI 10.1007/BF02190805; Hon T, 2003, J BIOL CHEM, V278, P50771, DOI 10.1074/jbc.M303677200; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Kennedy MA, 1999, BBA-GENE STRUCT EXPR, V1445, P110, DOI 10.1016/S0167-4781(99)00035-4; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001; Lee SY, 2001, ARCH BIOCHEM BIOPHYS, V393, P207, DOI 10.1006/abbi.2001.2497; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; MOGI T, 1994, MOL MICROBIOL, V14, P391, DOI 10.1111/j.1365-2958.1994.tb02174.x; Morrison MS, 2005, BIOCHEMISTRY-US, V44, P12554, DOI 10.1021/bi050893d; Murakami T, 1997, GENOMICS, V42, P161, DOI 10.1006/geno.1997.4711; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; PFEIFER K, 1987, CELL, V49, P19, DOI 10.1016/0092-8674(87)90751-3; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; PUUSTINEN A, 1991, P NATL ACAD SCI USA, V88, P6122, DOI 10.1073/pnas.88.14.6122; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; SILVERMAN SJ, 1982, MOL CELL BIOL, V2, P1212, DOI 10.1128/MCB.2.10.1212; Smith D, 2005, J BIOL CHEM, V280, P17652, DOI 10.1074/jbc.C500061200; Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8; SVENSSON B, 1993, MOL MICROBIOL, V10, P193, DOI 10.1111/j.1365-2958.1993.tb00915.x; SVENSSON B, 1994, J BACTERIOL, V176, P6663, DOI 10.1128/JB.176.21.6663-6671.1994; Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; URBANGRIMAL D, 1986, EUR J BIOCHEM, V156, P511, DOI 10.1111/j.1432-1033.1986.tb09610.x; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Zambrano A, 2007, MOL BIOL CELL, V18, P523, DOI 10.1091/mbc.E06-09-0803; Zhuang JY, 2006, BIOCHEMISTRY-US, V45, P12530, DOI 10.1021/bi060565t	55	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					839	847		10.1074/jbc.M804167200	http://dx.doi.org/10.1074/jbc.M804167200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18953022	Green Published, hybrid			2022-12-27	WOS:000262122900018
J	Wang, L; Li, SJ; Sidhu, A; Zhu, L; Liang, Y; Freedman, RB; Wang, CC				Wang, Lei; Li, Sheng-jian; Sidhu, Ateesh; Zhu, Li; Liang, Yi; Freedman, Robert B.; Wang, Chih-chen			Reconstitution of Human Ero1-L alpha/Protein-Disulfide Isomerase Oxidative Folding Pathway in Vitro POSITION-DEPENDENT DIFFERENCES IN ROLE BETWEEN THE a AND a ' DOMAINS OF PROTEIN-DISULFIDE ISOMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; BOND FORMATION; CRYSTAL-STRUCTURE; BINDING SITE; REDOX STATE; GLUTATHIONE; ERP57; YEAST; ERO1; THIOREDOXIN	Protein-disulfide isomerase (PDI), a critical enzyme responsible for oxidative protein folding in the eukaryotic endoplasmic reticulum, is composed of four thioredoxin domains a, b, b', a', and a linker x between b' and a'. Ero1-L alpha, an oxidase for human PDI (hPDI), has been determined to have one molecular flavin adenine dinucleotide (FAD) as its prosthetic group. Oxygen consumption assays with purified recombinant Ero1-L alpha revealed that it utilizes oxygen as a terminal electron acceptor producing one disulfide bond and one molecule of hydrogen peroxide per dioxygen molecule consumed. Exogenous FAD is not required for recombinant Ero1-L alpha activity. By monitoring the reactivation of denatured and reduced RNase A, we reconstituted the Ero1-L alpha/hPDI oxidative folding system in vitro and determined the enzymatic activities of hPDI in this system. Mutagenesis studies suggested that the a' domain of hPDI is much more active than the a domain in Ero1-L alpha-mediated oxidative folding. A domain swapping study revealed that one catalytic thioredoxin domain to the C-terminal of bb' x, whether a or a' , is essential in Ero1-L alpha-mediated oxidative folding. These data, combined with a pull-down assay and isothermal titration calorimetry measurements, enabled the minimal element for binding with Ero1-L alpha be mapped to the b' xa' fragment of hPDI.	[Wang, Lei; Li, Sheng-jian; Zhu, Li; Wang, Chih-chen] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Lei; Li, Sheng-jian; Zhu, Li] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; [Sidhu, Ateesh; Freedman, Robert B.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Warwick; Wuhan University	Wang, CC (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	chihwang@sun5.ibp.ac.cn	Liang, Yi/V-1396-2017; li, shengjian/B-4866-2013	Liang, Yi/0000-0002-7349-8300; Wang, Lei/0000-0002-5071-5800	Chinese Ministry of Science and Technology [2006CB910903, 2006CB806508, 2006CB910301]; Chinese Natural Science Foundation [30620130109]; UK BBSRC (Biotechnology and Biological Sciences Research Council) [BB/D017807/1, PA1339]; Biotechnology and Biological Sciences Research Council [BB/D017807/1] Funding Source: researchfish; BBSRC [BB/D017807/1] Funding Source: UKRI	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); UK BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants 2006CB910903, 2006CB806508, and 2006CB910301 from the Chinese Ministry of Science and Technology; 30620130109 from the Chinese Natural Science Foundation; BB/D017807/1 from the UK BBSRC (Biotechnology and Biological Sciences Research Council); and by a UK/China Partnering Award (PA1339) from the BBSRC (to A. S., L. W., and R. B. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bass R, 2004, J BIOL CHEM, V279, P5257, DOI 10.1074/jbc.M304951200; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651	35	118	118	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					199	206		10.1074/jbc.M806645200	http://dx.doi.org/10.1074/jbc.M806645200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001419	hybrid			2022-12-27	WOS:000261974800023
J	Williams, NK; Lucet, IS; Klinken, SP; Ingley, E; Rossjohn, J				Williams, Neal K.; Lucet, Isabelle S.; Klinken, S. Peter; Ingley, Evan; Rossjohn, Jamie			Crystal Structures of the Lyn Protein Tyrosine Kinase Domain in Its Apo- and Inhibitor-bound State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; ERYTHROPOIETIN-INDUCED DIFFERENTIATION; MYELOGENOUS LEUKEMIA-CELLS; BCR-ABL; PROSTATE-CANCER; DEFICIENT MICE; RESISTANT; ACTIVATION; REGRESSION; BMS-354825	The Src-family protein-tyrosine kinase (PTK) Lyn is the most important Src-family kinase in B cells, having both inhibitory and stimulatory activity that is dependent on the receptor, ligand, and developmental context of the B cell. An important role for Lyn has been reported in acute myeloid leukemia and chronic myeloid leukemia, as well as certain solid tumors. Although several Src-family inhibitors are available, the development of Lyn-specific inhibitors, or inhibitors with reduced off-target activity to Lyn, has been hampered by the lack of structural data on the Lyn kinase. Here we report the crystal structure of the non-liganded form of Lyn kinase domain, as well as in complex with three different inhibitors: the ATP analogue AMP-PNP; the pan Src kinase inhibitor PP2; and the BCR-Abl/Src-family inhibitor Dasatinib. The Lyn kinase domain was determined in its "active" conformation, but in the unphosphorylated state. All three inhibitors are bound at the ATP-binding site, with PP2 and Dasatinib extending into a hydrophobic pocket deep in the substrate cleft, thereby providing a basis for the Src-specific inhibition. Analysis of sequence and structural differences around the active site region of the Src-family PTKs were evident. Accordingly, our data provide valuable information for the further development of therapeutics targeting Lyn and the important Src-family of kinases.	[Williams, Neal K.; Lucet, Isabelle S.; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Prot Crystallog Unit, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Ingley, Evan] Univ Western Australia, Cell Signalling Grp, Western Australian Inst Med Res, Perth, WA 6000, Australia; [Ingley, Evan] Univ Western Australia, Med Res Ctr, Perth, WA 6000, Australia; [Klinken, S. Peter; Ingley, Evan] Univ Western Australia, Lab Canc Med, Perth, WA 6000, Australia	Monash University; University of Western Australia; University of Western Australia; University of Western Australia	Rossjohn, J (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Prot Crystallog Unit, Sch Biomed Sci, Clayton, Vic 3800, Australia.	jamie.rossjohn@med.monash.edu.au	Rossjohn, Jamie/F-9032-2013; Ingley, Evan/C-2401-2013	Rossjohn, Jamie/0000-0002-2020-7522; Ingley, Evan/0000-0002-8112-9134	National Health and Medical Research Council (NHMRC) of Australia [303101, 403987, 313714]; Medical Research Foundation of Royal Perth Hospital; Centre for Food and Genomic Medicine	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Foundation of Royal Perth Hospital; Centre for Food and Genomic Medicine	This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (303101, 403987, and 513714), the Medical Research Foundation of Royal Perth Hospital, and the Centre for Food and Genomic Medicine and by a NHMRC Industry Fellowship (to N.K.W.) and ARC Federation Fellowship (to J.R.).	Bates RC, 2001, CANCER RES, V61, P5275; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Chin H, 1998, BLOOD, V91, P3734; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; DeFranceschi L, 1997, J CLIN INVEST, V99, P220, DOI 10.1172/JCI119150; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Golas JM, 2003, CANCER RES, V63, P375; Goldenberg-Furmanov M, 2004, CANCER RES, V64, P1058, DOI 10.1158/0008-5472.CAN-03-2420; Harder KW, 2004, BLOOD, V104, P3901, DOI 10.1182/blood-2003-12-4396; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Ingley E, 2005, ONCOGENE, V24, P336, DOI 10.1038/sj.onc.1208199; Ingley E, 2001, J BIOL CHEM, V276, P43428, DOI 10.1074/jbc.M106645200; Ingley E, 2000, J BIOL CHEM, V275, P7887, DOI 10.1074/jbc.275.11.7887; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Ingley E, 2006, J BIOL CHEM, V281, P31920, DOI 10.1074/jbc.M602637200; Lannutti BJ, 2004, BLOOD, V103, P3736, DOI 10.1182/blood-2003-10-3566; Linnekin D, 1997, J BIOL CHEM, V272, P27450, DOI 10.1074/jbc.272.43.27450; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pawson T, 2000, GENE DEV, V14, P1027; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Ptasznik A, 2004, NAT MED, V10, P1187, DOI 10.1038/nm1127; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Robinson D, 1998, J BIOMED SCI, V5, P93, DOI 10.1159/000025318; Roginskaya V, 1999, LEUKEMIA, V13, P855, DOI 10.1038/sj.leu.2401429; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sumitomo M, 2000, J CLIN INVEST, V106, P1399, DOI 10.1172/JCI10536; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tilbrook PA, 1997, EMBO J, V16, P1610, DOI 10.1093/emboj/16.7.1610; Tilbrook PA, 2001, CANCER RES, V61, P2453; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Warmuth M, 2003, BLOOD, V101, P664, DOI 10.1182/blood-2002-01-0288; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wilson MB, 2002, ONCOGENE, V21, P8075, DOI 10.1038/sj.onc.1206008; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	45	49	54	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					284	291		10.1074/jbc.M807850200	http://dx.doi.org/10.1074/jbc.M807850200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984583	Green Published, hybrid			2022-12-27	WOS:000261974800032
J	Caloca, MJ; Zugaza, JL; Bustelo, XR				Caloca, Maria J.; Zugaza, Jose L.; Bustelo, Xose R.			Mechanistic Analysis of the Amplification and Diversification Events Induced by Vav Proteins in B-lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-D ACTIVATION; CELL-RECEPTOR SIGNALS; GDP/GTP EXCHANGE; GROWTH-FACTOR; KINASE-C; PROTOONCOGENE PRODUCT; 3-KINASE ACTIVATION; BINDING PROTEINS; RAS ACTIVATION; T-CELLS	Vav proteins participate in the assembly of a multibranched signal transduction pathway in lymphocytes, including the stimulation of the phosphatidylinositol 3-kinase/protein kinase B and the phospholipase C-gamma/Ras GDP-releasing protein/Ras/Erk routes. In the present work, we used a genetic approach in chicken DT40 B-cell lines to investigate additional elements of the Vav route, the synergisms existing among the different Vav signaling branches, and the activities exerted by wild-type and oncogenic Vav proteins in B-lymphocytes. We show here that the Vav pathway is ramified in B-lymphocytes in additional diacylglycerol-dependent signaling branches such as those involving protein kinase C, protein kinase D, and phospholipase D. By using side-by-side comparisons of the activation levels of those signal transduction pathways in inhibitor-treated and knockout DT40 cells, we show that B-cells have different requirements regarding Vav proteins for the activation of antigen receptor downstream elements. Furthermore, we have detected interpathway cross-talk at the level of the most proximal elements but not among the most distal effector molecules of the Vav route. Finally, we show that the oncogenic versions of Vav1 and RhoA can activate alternative routes that could contribute to signal amplification and diversification events in transformed lymphocytes.	[Bustelo, Xose R.] Univ Salamanca, CSIC, Ctr Invest Canc, E-37007 Salamanca, Spain; Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Bustelo, XR (corresponding author), Univ Salamanca, CSIC, Ctr Invest Canc, Campus Unamuno, E-37007 Salamanca, Spain.	xbustelo@usal.es	Caloca, María-José/K-9357-2014; Bustelo, Xose R./A-9526-2010; Bustelo, Xose R./AAD-2081-2022	Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072; ZUGAZA GURRUCHAGA, JOSE LUIS/0000-0003-2287-6671; Caloca, Maria-Jose/0000-0002-1003-2685	NCI [5R01-CA73735-12]; European Union; NATIONAL CANCER INSTITUTE [R01CA073735] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01-CA73735-12 (to X. R. B.) from NCI. All Spanish funding is co-sponsored by Fondo de Desarrollo Regional of the European Union. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Bustelo XR, 2002, FRONT BIOSCI, V7, pD24, DOI 10.2741/bustelo; BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; BUSTELO XR, 2008, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A002361.002301; BUSTELO XR, 2008, UCSD NAT MOL PAGES, DOI DOI 10.1038/MP.A002362.002301; Caloca MJ, 2008, CELL SIGNAL, V20, P758, DOI 10.1016/j.cellsig.2007.12.015; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; COPPOLA J, 1991, CELL GROWTH DIFFER, V2, P95; Couceiro JR, 2005, EXP CELL RES, V308, P364, DOI 10.1016/j.yexcr.2005.04.035; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; de Miranda MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001654; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Hess JA, 1998, J BIOL CHEM, V273, P20517, DOI 10.1074/jbc.273.32.20517; Hitomi T, 2001, GENES CELLS, V6, P475, DOI 10.1046/j.1365-2443.2001.00434.x; Hitomi T, 1999, FEBS LETT, V445, P371, DOI 10.1016/S0014-5793(99)00153-2; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Johmura S, 2003, IMMUNITY, V18, P777, DOI 10.1016/S1074-7613(03)00139-0; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Kuhne MR, 2000, J BIOL CHEM, V275, P2185, DOI 10.1074/jbc.275.3.2185; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Patel V, 2007, CARCINOGENESIS, V28, P1145, DOI 10.1093/carcin/bgm008; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Rodrigues L, 2006, J VIROL, V80, P6123, DOI 10.1128/JVI.02700-05; Roose JP, 2007, MOL CELL BIOL, V27, P2732, DOI 10.1128/MCB.01882-06; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Schuebel KE, 1996, ONCOGENE, V13, P363; Shinohara Hisaaki, 2006, Subcell Biochem, V40, P145; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; Vigorito E, 2004, J IMMUNOL, V173, P3209, DOI 10.4049/jimmunol.173.5.3209; Wood CD, 2005, J BIOL CHEM, V280, P6245, DOI 10.1074/jbc.M411564200; WU J, 1995, MOL CELL BIOL, V15, P4337; YEO EJ, 1994, J BIOL CHEM, V269, P27823; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	54	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36454	36464		10.1074/jbc.M803814200	http://dx.doi.org/10.1074/jbc.M803814200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974050	Green Published, hybrid			2022-12-27	WOS:000261840500043
J	Ma, W; Mishra, S; Gajanayaka, N; Angel, JB; Kumar, A				Ma, Wei; Mishra, Sasmita; Gajanayaka, Niranjala; Angel, Jonathan B.; Kumar, Ashok			HIV-1 Nef Inhibits Lipopolysaccharide- induced IL-12p40 Expression by Inhibiting JNK-activated NF kappa B in Human Monocytic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DEPENDENT PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAY; BLOOD MONONUCLEAR-CELLS; TERMINAL KINASE; INTERLEUKIN-12 PRODUCTION; INFECTED INDIVIDUALS; GENE-EXPRESSION; DOWN-REGULATION; IN-VITRO	Impaired cellular immunity caused by decreased production of Th1-type cytokines, including interleukin-12 (IL-12) is a major feature of HIV-1-associated immunodeficiency and acquired immunodeficiency syndrome. IL-12p40, an inducible subunit shared between IL-12 and IL-23, plays a critical role in the development of cellular immunity, and its production is significantly decreased during HIV infection. The mechanism by which HIV induces loss of IL-12p40 production remains poorly understood. We have previously shown that lipopolysaccharide (LPS)-induced IL-12p40 production in monocytic cells is regulated by NF kappa B and AP-1 transcription factors through the activation of two distinct upstream signaling pathways, namely the c-Jun-N-terminal kinase (JNK) and the calmodulin-dependent protein kinase-II-activated pathways. Herein, we show that intracellular nef expressed through transduction of primary monocytes and promonocytic THP-1 cells with retroviral-mediated nef gene inhibited LPS-induced IL-12p40 transcription by inhibiting the JNK mitogen-activated protein kinases without affecting the calmodulin-dependent protein kinase-II-activated pathway. In addition, nef inhibited JNK-activated NF kappa B without affecting the AP-1 activity. Overall, our results suggest for the first time that intracellular nef inhibited LPS-activated JNK, which may cause inhibition of IL-12p40 expression in human monocytic cells by selectively inhibiting NF kappa B activity.	[Kumar, Ashok] Childrens Hosp Eastern Ontario, Res Inst, Div Virol, Dept Pathol & Lab Med, Ottawa, ON K1H 8L1, Canada; [Ma, Wei; Mishra, Sasmita; Angel, Jonathan B.; Kumar, Ashok] Childrens Hosp Eastern Ontario, Res Inst, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8L1, Canada; [Angel, Jonathan B.] Univ Ottawa, Ottawa Hosp Gen Campus, Div Infect Dis, Ottawa, ON K1H 8L1, Canada; [Angel, Jonathan B.] Univ Ottawa, Ottawa Hosp Gen Campus, Ottawa Hlth Res Inst, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Kumar, A (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Div Virol, Dept Pathol & Lab Med, 501 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	akumar@uottawa.ca		Angel, Jonathan B/0000-0003-3102-4462				Angel JB, 1998, J INFECT DIS, V177, P898, DOI 10.1086/515244; Angel JB, 2001, J INFECT DIS, V183, P546, DOI 10.1086/318547; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brigino E, 1997, P NATL ACAD SCI USA, V94, P3178, DOI 10.1073/pnas.94.7.3178; Bubici C, 2004, CELL CYCLE, V3, P1524, DOI 10.4161/cc.3.12.1321; Chambers KA, 2002, CELL IMMUNOL, V215, P120, DOI 10.1016/S0008-8749(02)00020-5; CHEHIMI J, 1994, J EXP MED, V179, P1361, DOI 10.1084/jem.179.4.1361; Chougnet C, 1996, J INFECT DIS, V174, P46, DOI 10.1093/infdis/174.1.46; CLERICI M, 1993, SCIENCE, V262, P1721, DOI 10.1126/science.7903123; Collette Y, 1996, J IMMUNOL, V156, P360; Collman RG, 2003, J LEUKOCYTE BIOL, V74, P631, DOI 10.1189/jlb.0703357; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Creery D, 2002, CLIN DIAGN LAB IMMUN, V9, P1212, DOI 10.1128/CDLI.9.6.1212-1221.2002; DAFTARIAN MP, 1995, CLIN DIAGN LAB IMMUN, V2, P712, DOI 10.1128/CDLI.2.6.712-718.1995; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dybul M, 2000, J IMMUNOL, V165, P1685, DOI 10.4049/jimmunol.165.3.1685; Fackler OT, 2000, MOL CELL BIOL, V20, P2619, DOI 10.1128/MCB.20.7.2619-2627.2000; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; Feng GJ, 1999, J IMMUNOL, V163, P6403; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Gee K, 2006, J BIOL CHEM, V281, P31647, DOI 10.1074/jbc.M512109200; Geyer M, 1999, J MOL BIOL, V289, P123, DOI 10.1006/jmbi.1999.2740; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Ito M, 1998, AIDS RES HUM RETROV, V14, P845, DOI 10.1089/aid.1998.14.845; Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935; Landay AL, 1996, J INFECT DIS, V173, P1085, DOI 10.1093/infdis/173.5.1085; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lehmann MH, 2006, J CELL SCI, V119, P4520, DOI 10.1242/jcs.03231; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Ma W, 2004, J IMMUNOL, V172, P318, DOI 10.4049/jimmunol.172.1.318; Ma W, 2007, J BIOL CHEM, V282, P13351, DOI 10.1074/jbc.M611522200; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Ma XJ, 2001, ADV IMMUNOL, V79, P55; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Manninen A, 2001, J VIROL, V75, P3034, DOI 10.1128/JVI.75.6.3034-3037.2001; Marshall JD, 1999, BLOOD, V94, P1003, DOI 10.1182/blood.V94.3.1003.415a15_1003_1011; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Messmer D, 2002, J IMMUNOL, V169, P4172, DOI 10.4049/jimmunol.169.8.4172; Mirani M, 2002, J IMMUNOL, V169, P6361, DOI 10.4049/jimmunol.169.11.6361; Mishra S, 2005, J BIOL CHEM, V280, P37536, DOI 10.1074/jbc.M504971200; Mishra S, 2007, J BIOL CHEM, V282, P4288, DOI 10.1074/jbc.M608307200; Muthumani K, 2005, BLOOD, V106, P2059, DOI 10.1182/blood-2005-03-0932; Natoli G, 1997, J BIOL CHEM, V272, P26079, DOI 10.1074/jbc.272.42.26079; Nishigaki K, 2005, J VIROL, V79, P12752, DOI 10.1128/JVI.79.20.12752-12762.2005; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; Orange JS, 2005, IMMUNOL REV, V203, P21, DOI 10.1111/j.0105-2896.2005.00221.x; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Rabson A B, 2000, Adv Pharmacol, V48, P161; Romero IA, 1998, J NEUROCHEM, V70, P778, DOI 10.1046/j.1471-4159.1998.70020778.x; Sabapathy K, 2004, CELL CYCLE, V3, P1520, DOI 10.4161/cc.3.12.1315; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Suzu S, 2005, BLOOD, V105, P3230, DOI 10.1182/blood-2004-06-2084; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Utsugi M, 2003, J IMMUNOL, V171, P628, DOI 10.4049/jimmunol.171.2.628; Varin A, 2003, J BIOL CHEM, V278, P2219, DOI 10.1074/jbc.M209622200; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; YAN MH, 1994, NATURE, V372, P798; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yu YC, 2005, CELL CYCLE, V4, P1043, DOI 10.4161/cc.4.8.1928; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200; Zou WP, 1997, J VIROL, V71, P1227, DOI 10.1128/JVI.71.2.1227-1236.1997	70	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7578	7587		10.1074/jbc.M710013200	http://dx.doi.org/10.1074/jbc.M710013200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19019824	Green Published, hybrid			2022-12-27	WOS:000264195600020
J	Madison, BB; McKenna, LB; Dolson, D; Epstein, DJ; Kaestner, KH				Madison, Blair B.; McKenna, Lindsay B.; Dolson, Diane; Epstein, Douglas J.; Kaestner, Klaus H.			FoxF1 and FoxL1 Link Hedgehog Signaling and the Control of Epithelial Proliferation in the Developing Stomach and Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD BOX F1; GASTROINTESTINAL DEVELOPMENT; EXPRESSION; GENE; GUT; MORPHOGENESIS; BETA; MICE; GLI3; DIFFERENTIATION	The hedgehog (Hh) signaling pathway is a key component of cross-talk during vertebrate gut development, involving endodermally secreted Sonic (Shh) and Indian hedgehog (Ihh) proteins that directly signal to adjacent mesoderm. Here we show that the closely linked mesenchymal forkhead transcription factors Foxf1 and Foxl1 are part of this signaling cascade. Analysis of conserved non-coding sequences surrounding Foxf1 and Foxl1 identified seven Gli binding sites, with two sites near Foxl1 being identical among mammalian, bird, fish, and amphibian species. In vitro experiments indicate that Gli2 binds to these Gli sites, several of which are critical for Gli2-mediated activation of a luciferase reporter in 293 cells. In addition, we demonstrate occupancy of one of these elements by Gli proteins in the intestine in vivo using chromatin immunoprecipitation. Furthermore, expression of both Foxf1 and Foxl1 is reduced in the Gli2/Gli3 mutant gut. These results provide compelling evidence that Foxf1 and Foxl1 are mediators of the Hh (endoderm) to mesoderm signaling pathway.	[Madison, Blair B.; McKenna, Lindsay B.; Dolson, Diane; Epstein, Douglas J.; Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Kaestner, KH (corresponding author), 752B Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	kaestner@mail.med.upenn.edu			National Institutes of Health [DK-053839]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, R01DK053839, R37DK053839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-053839 through the NIDDK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Batts LE, 2006, DEV DYNAM, V235, P1563, DOI 10.1002/dvdy.20741; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fukuda K, 2003, DEV BIOL, V255, P278, DOI 10.1016/S0012-1606(02)00088-X; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Kaestner KH, 1996, DEVELOPMENT, V122, P1751; Kaestner KH, 1997, GENE DEV, V11, P1583, DOI 10.1101/gad.11.12.1583; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Kim IM, 2005, J BIOL CHEM, V280, P37908, DOI 10.1074/jbc.M506531200; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06; Mo R, 1997, DEVELOPMENT, V124, P113; Motoyama J, 1998, MECH DEVELOP, V78, P81, DOI 10.1016/S0925-4773(98)00149-X; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Perreault N, 2005, GENE DEV, V19, P311, DOI 10.1101/gad.1260605; Perreault N, 2001, J BIOL CHEM, V276, P43328, DOI 10.1074/jbc.M104366200; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Rubins NE, 2005, MOL CELL BIOL, V25, P7069, DOI 10.1128/MCB.25.16.7069-7077.2005; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang LC, 2002, GASTROENTEROLOGY, V122, P469, DOI 10.1053/gast.2002.31102; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005	37	103	105	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5936	5944		10.1074/jbc.M808103200	http://dx.doi.org/10.1074/jbc.M808103200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19049965	Green Published, hybrid			2022-12-27	WOS:000263560600057
J	Burns, KE; Liu, WT; Boshoff, HIM; Dorrestein, PC; Barry, CE				Burns, Kristin E.; Liu, Wei-Ting; Boshoff, Helena I. M.; Dorrestein, Pieter C.; Barry, Clifton E.			Proteasomal Protein Degradation in Mycobacteria Is Dependent upon a Prokaryotic Ubiquitin-like Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBERCULOSIS PROTEASOME; 20S PROTEASOME; FAMILY; GENES; IDENTIFICATION; COMPLEX	The striking identification of an apparent proteasome core in Mycobacteria and allied actinomycetes suggested that additional elements of this otherwise strictly eukaryotic system for regulated protein degradation might be conserved. The genes encoding this prokaryotic proteasome are clustered in an operon with a short open reading frame that encodes a small protein of 64 amino acids resembling ubiquitin with a carboxyl-terminal di-glycine-glutamine motif ( herein called Pup for prokaryotic ubiquitin-like protein). Expression of a polyhistidine-tagged Pup followed by pulldown revealed that a broad spectrum of proteins were post-translationally modified by Pup. Two-dimensional gel electrophoresis allowed us to conclusively identify two targets of this modification as myoinositol-1-phosphate synthase and superoxide dismutase. Deletion of the penultimate di-glycine motif or the terminal glutamine completely abrogated modification of cellular proteins with Pup. Further mass spectral analysis demonstrated that Pup was attached to a lysine residue on its target protein via the carboxyl-terminal glutamine with deamidation of this residue. Finally, we showed that cell lysates of wild type ( but not a proteasome mutant) efficiently degraded Pup-modified proteins. These data therefore establish that, despite differences in both sequence and target linkage, Pup plays an analogous role to ubiquitin in targeting proteins to the proteasome for degradation.	[Burns, Kristin E.; Boshoff, Helena I. M.; Barry, Clifton E.] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA; [Liu, Wei-Ting; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, La Jolla, CA 92093 USA; [Liu, Wei-Ting; Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Chem & Biochem, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Diego; University of California System; University of California San Diego	Barry, CE (corresponding author), NIAID, TB Res Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cbarry@mail.nih.gov	Dorrestein, Pieter/ABF-2930-2020; Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020; Dorrestein, Pieter/D-5012-2012	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; 	National Institutes of Health; Intramural Research Program, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health, Intramural Research Program, NIAID. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAHLMANN B, 1989, FEBS LETT, V251, P125, DOI 10.1016/0014-5793(89)81441-3; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Dorrestein PC, 2006, NAT PROD REP, V23, P893, DOI 10.1039/b511400b; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; Lin G, 2008, J BIOL CHEM, V283, P34423, DOI 10.1074/jbc.M805324200; LUND PK, 1985, J BIOL CHEM, V260, P7609; LUPAS A, 1994, TRENDS BIOCHEM SCI, V19, P533, DOI 10.1016/0968-0004(94)90054-X; Nagy I, 1998, J BACTERIOL, V180, P5448, DOI 10.1128/JB.180.20.5448-5453.1998; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589; Zwickl P, 1999, PHILOS T R SOC B, V354, P1501, DOI 10.1098/rstb.1999.0494	29	112	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3069	3075		10.1074/jbc.M808032200	http://dx.doi.org/10.1074/jbc.M808032200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19028679	Green Published, hybrid			2022-12-27	WOS:000262700900051
J	Willoughby, JA; Sundar, SN; Cheung, M; Tin, AS; Modiano, J; Firestone, GL				Willoughby, Jamin A., Sr.; Sundar, Shyam N.; Cheung, Mark; Tin, Antony S.; Modiano, Jaime; Firestone, Gary L.			Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELLS; PROTEIN; ANTIMALARIAL; ANGIOGENESIS; ACTIVATION; CASTRATION; ARTESUNATE; STABILITY; CARCINOMA; SURVIVAL	Artemisinin, a naturally occurring component of Artemisia annua, or sweet wormwood, is a potent anti-malaria compound that has recently been shown to have anti-proliferative effects on a number of human cancer cell types, although little is know about the molecular mechanisms of this response. We have observed that artemisinin treatment triggers a stringent G(1) cell cycle arrest of LNCaP (lymph node carcinoma of the prostate) human prostate cancer cells that is accompanied by a rapid down-regulation of CDK2 and CDK4 protein and transcript levels. Transient transfection with promoter-linked luciferase reporter plasmids revealed that artemisinin strongly inhibits CDK2 and CDK4 promoter activity. Deletion analysis of the CDK4 promoter revealed a 231-bp artemisinin-responsive region between -1737 and -1506. Site-specific mutations revealed that the Sp1 site at -1531 was necessary for artemisinin responsiveness in the context of the CDK4 promoter. DNA binding assays as well as chromatin immunoprecipitation assays demonstrated that this Sp1-binding site in the CDK4 promoter forms a specific artemisinin-responsive DNA-protein complex that contains the Sp1 transcription factor. Artemisinin reduced phosphorylation of Sp1, and when dephosphorylation of Sp1 was inhibited by treatment of cells with the phosphatase inhibitor okadaic acid, the ability of artemisinin to down-regulate Sp1 interactions with the CDK4 promoter was ablated, rendering the CDK4 promoter unresponsive to artemisinin. Finally, overexpression of Sp1 mostly reversed the artemisinin down-regulation of CDK4 promoter activity and partially reversed the cell cycle arrest. Taken together, our results demonstrate that a key event in the artemisinin anti-proliferative effects in prostate cancer cells is the transcriptional down-regulation of CDK4 expression by disruption of Sp1 interactions with the CDK4 promoter.	[Willoughby, Jamin A., Sr.; Sundar, Shyam N.; Cheung, Mark; Tin, Antony S.; Firestone, Gary L.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Willoughby, Jamin A., Sr.; Sundar, Shyam N.; Cheung, Mark; Tin, Antony S.; Firestone, Gary L.] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Modiano, Jaime] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Modiano, Jaime] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Firestone, GL (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 591 LSA, Berkeley, CA 94720 USA.	glfire@berkeley.edu	MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648	National Institutes of Health [CA102360]; NCI; NATIONAL CANCER INSTITUTE [R01CA102360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA102360 from NCI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beekman AC, 1997, J PHARM PHARMACOL, V49, P1254, DOI 10.1111/j.2042-7158.1997.tb06080.x; Chen HH, 2004, PHARMACOLOGY, V71, P1, DOI 10.1159/000076256; Chen HH, 2003, PHARMACOL RES, V48, P231, DOI 10.1016/S1043-6618(03)00107-5; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Cram EJ, 2001, J BIOL CHEM, V276, P22332, DOI 10.1074/jbc.M010539200; Dalrymple SL, 2007, PROSTATE, V67, P790, DOI 10.1002/pros.20573; Duffy PE, 2004, LANCET, V363, P3, DOI 10.1016/S0140-6736(03)15230-0; Efferth T, 2001, INT J ONCOL, V18, P767; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Garcia HH, 2005, J BIOL CHEM, V280, P8756, DOI 10.1074/jbc.M407957200; Halabi S, 2003, J CLIN ONCOL, V21, P1232, DOI 10.1200/JCO.2003.06.100; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; Hong CB, 2002, CARCINOGENESIS, V23, P1297, DOI 10.1093/carcin/23.8.1297; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; LABRIE F, 1989, BRIT J UROL, V63, P634, DOI 10.1111/j.1464-410X.1989.tb05260.x; Lynch J H, 2001, Rev Urol, V3 Suppl 2, pS39; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; Paik IH, 2006, J MED CHEM, V49, P2731, DOI 10.1021/jm058288w; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; REIZENSTEIN P, 1991, MED ONCOL TUMOR PHAR, V8, P229; Sadava D, 2002, CANCER LETT, V179, P151, DOI 10.1016/S0304-3835(02)00005-8; Samson SLA, 2002, J MOL ENDOCRINOL, V29, P265, DOI 10.1677/jme.0.0290265; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yamachika E, 2004, ANTICANCER RES, V24, P2153; Yokota T, 2007, CANCER SCI, V98, P1447, DOI 10.1111/j.1349-7006.2007.00560.x	27	111	123	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2203	2213		10.1074/jbc.M804491200	http://dx.doi.org/10.1074/jbc.M804491200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017637	Green Published, hybrid			2022-12-27	WOS:000262545600030
J	Elzinga, BM; Twomey, C; Powell, JC; Harte, F; McCarthy, JV				Elzinga, Baukje M.; Twomey, Ciara; Powell, James C.; Harte, Frances; McCarthy, Justin V.			Interleukin-1 Receptor Type 1 Is a Substrate for gamma-Secretase-dependent Regulated Intramembrane Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NF-KAPPA-B; P75 NEUROTROPHIN RECEPTOR; C-TERMINAL FRAGMENT; SOLUBLE CYTOKINE RECEPTORS; TOLL-LIKE RECEPTORS; PRESENILIN FUNCTION; BETA-CATENIN; MOLECULAR-MECHANISM; LIGAND-BINDING; SHEDDING LIGHT	Biochemical and genetic studies have revealed that the presenilins interact with several proteins and are involved in the regulated intramembrane proteolysis of numerous type 1 membrane proteins, thereby linking presenilins to a range of cellular processes. In this study, we report the characterization of a highly conserved tumor necrosis factor receptor-associated factor-6 (TRAF6) consensus-binding site within the hydrophilic loop domain of presenilin-1 (PS-1). In coimmunoprecipitation studies we indicate that presenilin-1 interacts with TRAF6 and interleukin-1 receptor-associated kinase 2. Substitution of presenilin-1 residues Pro-374 and Glu-376 by site-directed mutagenesis greatly reduces the ability of PS1 to associate with TRAF6. By studying these interactions, we also demonstrate that the interleukin-1 receptor type 1 (IL-1R1) undergoes intramembrane proteolytic processing, mediated by presenilin-dependent gamma-secretase activity. A metalloprotease-dependent proteolytic event liberates soluble IL-1R1 ectodomain and produces an similar to 32-kDa C-terminal domain. This IL-1R1 C-terminal domain is a substrate for subsequent gamma-secretase cleavage, which generates an similar to 26-kDa intracellular domain. Specific pharmacological gamma-secretase inhibitors, expression of dominant negative presenilin-1, or presenilin deficiency independently inhibit generation of the IL-1 beta 1 intracellular domain. Attenuation of gamma-secretase activity also impairs responsiveness to IL-1-stimulated activation of the MAPKs and cytokine secretion. Thus, TRAF6 and interleukin receptor-associated kinase 2 are novel binding partners for PS1, and IL-1R1 is a new substrate for presenilin-dependent gamma-secretase cleavage. These findings also suggest that regulated intramembrane proteolysis may be a control mechanism for IL-1R1-mediated signaling.	[McCarthy, Justin V.] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Analyt & Biol Chem Res Facil, Signal Transduct Lab, Cork, Ireland	University College Cork	McCarthy, JV (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, Analyt & Biol Chem Res Facil, Signal Transduct Lab, Cavanagh Pharm Bldg, Cork, Ireland.	jv.mccarthy@ucc.ie	mccarthy, justin/AAG-7550-2019	mccarthy, justin/0000-0002-2667-7365	Science Foundation Ireland [02/IN1/B218]; Irish Research Council for Science, Engineering, and Technology [SC/2003/544/Y, IC/2004/103]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR)	This work was supported by Science Foundation Ireland Grant 02/IN1/B218 and the Irish Research Council for Science, Engineering, and Technology Grants SC/2003/544/Y and IC/2004/103. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Akiyama S, 2004, J BIOL CHEM, V279, P36616, DOI 10.1074/jbc.M406610200; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bohm C, 2006, J BIOL CHEM, V281, P14547, DOI 10.1074/jbc.M601660200; Brissoni B, 2006, CURR BIOL, V16, P2265, DOI 10.1016/j.cub.2006.09.062; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunkan AL, 2005, MOL CELL NEUROSCI, V29, P65, DOI 10.1016/j.mcn.2004.12.012; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carey BW, 2007, BIOCHEM J, V401, P121, DOI 10.1042/BJ20060847; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; Cowan JW, 2005, J BIOL CHEM, V280, P19331, DOI 10.1074/jbc.M500621200; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; CURTIS BM, 1990, J IMMUNOL, V144, P1295; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; DE SB, 1999, NATURE, V398, P518; De Strooper B, 2005, CELL, V122, P318, DOI 10.1016/j.cell.2005.07.021; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; DOWER SK, 1989, J IMMUNOL, V142, P4314; Drevlow BE, 1996, ARTHRITIS RHEUM-US, V39, P257, DOI 10.1002/art.1780390212; Dunne A, 2005, FEBS LETT, V579, P3330, DOI 10.1016/j.febslet.2005.04.024; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; FANSLOW WC, 1990, SCIENCE, V248, P739, DOI 10.1126/science.2139736; Fernandez-Botran R, 2002, EXPERT OPIN BIOL TH, V2, P585, DOI 10.1517/14712598.2.6.585; FernandezBotran R, 1996, ADV IMMUNOL, V63, P269, DOI 10.1016/S0065-2776(08)60858-5; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; GALLIS B, 1989, J IMMUNOL, V143, P3235; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kim JW, 2001, J CELL BIOL, V153, P457, DOI 10.1083/jcb.153.3.457; Kim MY, 2005, BIOCHEM BIOPH RES CO, V332, P609, DOI 10.1016/j.bbrc.2005.05.001; Kirschenbaum F, 2001, J BIOL CHEM, V276, P30701, DOI 10.1074/jbc.M102849200; Kirschenbaum F, 2001, J BIOL CHEM, V276, P7366, DOI 10.1074/jbc.M004697200; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Landman N, 2004, CYTOKINE GROWTH F R, V15, P337, DOI 10.1016/j.cytogfr.2004.04.001; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Li JH, 2002, J NEUROCHEM, V82, P1540, DOI 10.1046/j.1471-4159.2002.01105.x; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Lichtenthaler SF, 2007, EMBO REP, V8, P537, DOI 10.1038/sj.embor.7400978; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Liu QA, 1999, ANN NY ACAD SCI, V887, P92, DOI 10.1111/j.1749-6632.1999.tb07925.x; Lleo A, 2008, CURR TOP MED CHEM, V8, P9; Lu CF, 2005, J BIOL CHEM, V280, P16278, DOI 10.1074/jbc.M410114200; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Mantovani A, 1998, ANN NY ACAD SCI, V840, P338, DOI 10.1111/j.1749-6632.1998.tb09573.x; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Maraver A, 2007, BLOOD, V110, P3218, DOI 10.1182/blood-2007-01-070359; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; McCarthy JV, 2005, BIOCHEM SOC T, V33, P568, DOI 10.1042/BST0330568; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Moss ML, 2004, BIOCHEMISTRY-US, V43, P7227, DOI 10.1021/bi049677f; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; NICOLETTI F, 1994, EUR J IMMUNOL, V24, P1843, DOI 10.1002/eji.1830240818; Nishina H, 2004, J BIOCHEM, V136, P123, DOI 10.1093/jb/mvh117; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schneider I, 2001, J BIOL CHEM, V276, P11539, DOI 10.1074/jbc.M010977200; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Serban G, 2005, J BIOL CHEM, V280, P36007, DOI 10.1074/jbc.M507503200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; SLACK J, 1993, J BIOL CHEM, V268, P2513; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Subramaniam S, 2004, DEV COMP IMMUNOL, V28, P415, DOI 10.1016/j.dci.2003.09.016; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tournoy J, 2004, HUM MOL GENET, V13, P1321, DOI 10.1093/hmg/ddh151; Twomey C, 2006, FEBS LETT, V580, P4015, DOI 10.1016/j.febslet.2006.06.035; Uemura K, 2007, NEUROSCIENCE, V145, P5, DOI 10.1016/j.neuroscience.2006.12.022; Underwood CK, 2008, MOL CELL NEUROSCI, V37, P346, DOI 10.1016/j.mcn.2007.10.005; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651; Yagi T, 2008, P NATL ACAD SCI USA, V105, P979, DOI 10.1073/pnas.0707755105; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	130	38	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1394	1409		10.1074/jbc.M803108200	http://dx.doi.org/10.1074/jbc.M803108200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18996842	hybrid			2022-12-27	WOS:000262330100007
J	Tasaki, T; Zakrzewska, A; Dudgeon, DD; Jiang, YH; Lazo, JS; Kwon, YT				Tasaki, Takafumi; Zakrzewska, Adriana; Dudgeon, Drew D.; Jiang, Yonghua; Lazo, John S.; Kwon, Yong Tae			The Substrate Recognition Domains of the N-end Rule Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASES; MICE LACKING; CARDIOVASCULAR DEVELOPMENT; PROTEIN; DEGRADATION; COMPONENT; ARABIDOPSIS; UBR1; APOPTOSIS; AMIDASE	The N-end rule pathway is a ubiquitin-dependent system where E3 ligases called N-recognins, including UBR1 and UBR2, recognize type-1 (basic) and type-2 (bulky hydrophobic) N-terminal residues as part of N-degrons. We have recently reported an E3 family (termed UBR1 through UBR7) characterized by the 70-residue UBR box, among which UBR1, UBR2, UBR4, and UBR5 were captured during affinity-based proteomics with synthetic degrons. Here we characterized substrate binding specificity and recognition domains of UBR proteins. Pull-down assays with recombinant UBR proteins suggest that 570-kDa UBR4 and 300-kDa UBR5 bind N-degron, whereas UBR3, UBR6, and UBR7 do not. Binding assays with 24 UBR1 deletion mutants and 31 site-directed UBR1 mutations narrow down the degron-binding activity to a 72-residue UBR box-only fragment that recognizes type-1 but not type-2 residues. A surface plasmon-resonance assay shows that the UBR box binds to the type-1 substrate Arg-peptide with K-d of similar to 3.4 mu M. Downstream from the UBR box, we identify a second substrate recognition domain, termed the N-domain, required for type-2 substrate recognition. The similar to 80-residue N-domain shows structural and functional similarity to 106-residue Escherichia coli ClpS, a bacterial N-recognin. We propose a model where the 70-residue UBRbox functions as a common structural element essential for binding to all known destabilizing N-terminal residues, whereas specific residues localized in the UBR box (for type 1) or the N-domain (for type 2) provide substrate selectivity through interaction with the side group of an N-terminal amino acid. Our work provides new insights into substrate recognition in the N-end rule pathway.	[Zakrzewska, Adriana; Jiang, Yonghua; Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Tasaki, Takafumi; Zakrzewska, Adriana; Jiang, Yonghua; Kwon, Yong Tae] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Dudgeon, Drew D.; Lazo, John S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh Mol Lib Screening Ctr, Pittsburgh, PA 15260 USA; [Zakrzewska, Adriana; Lazo, John S.] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kwon, YT (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, 3501 Terrace St, Pittsburgh, PA 15261 USA.	yok5@pitt.edu			National Institutes of Health [GM69482, GM074000, HL083365, CA078039]; American Heart Association; Hartwell Foundation; NATIONAL CANCER INSTITUTE [P01CA078039] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069482, R01GM074000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Hartwell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM69482, GM074000, HL083365 ( to Y.T.K.), and CA078039 ( to J.S.L.). This work was also supported by grants from the American Heart Association ( to Y.T.K.) and the Hartwell Foundation ( to J. S. L. and D. D. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Balogh SA, 2000, LEARN MEMORY, V7, P279, DOI 10.1101/lm.33500; Balogh SA, 2001, BRAIN RES, V892, P336, DOI 10.1016/S0006-8993(00)03268-6; Callaghan MJ, 1998, ONCOGENE, V17, P3479, DOI 10.1038/sj.onc.1202249; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Grigoryev S, 1996, J BIOL CHEM, V271, P28521, DOI 10.1074/jbc.271.45.28521; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann Michael, 2004, Biotechnol Annu Rev, V10, P1, DOI 10.1016/S1387-2656(04)10001-X; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; JOHANSON A, 1971, J PEDIATR-US, V79, P982, DOI 10.1016/S0022-3476(71)80194-4; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Kwon YT, 1999, J BIOL CHEM, V274, P18135, DOI 10.1074/jbc.274.25.18135; Lecker SH, 1999, J CLIN INVEST, V104, P1411, DOI 10.1172/JCI7300; Lee MJ, 2008, P NATL ACAD SCI USA, V105, P100, DOI 10.1073/pnas.0708465105; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lloyd AG, 2007, VIROLOGY, V360, P129, DOI 10.1016/j.virol.2006.10.007; Lupas AN, 2003, J STRUCT BIOL, V141, P77, DOI 10.1016/S1047-8477(02)00582-8; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Potuschak T, 1998, P NATL ACAD SCI USA, V95, P7904, DOI 10.1073/pnas.95.14.7904; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Stary S, 2003, PLANT PHYSIOL, V133, P1360, DOI 10.1104/pp.103.029272; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Yan OY, 2006, MUTAT RES-FUND MOL M, V596, P64, DOI 10.1016/j.mrfmmm.2005.12.016; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	45	91	95	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1884	1895		10.1074/jbc.M803641200	http://dx.doi.org/10.1074/jbc.M803641200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19008229	Green Published, hybrid			2022-12-27	WOS:000262330100059
J	Hao, Q; Wang, L; Zhao, ZJ; Tang, H				Hao, Qin; Wang, Linping; Zhao, Z. Joe; Tang, Hua			Identification of Protein Kinase D2 as a Pivotal Regulator of Endothelial Cell Proliferation, Migration, and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GROWTH-FACTOR; NUCLEAR-LOCALIZATION; TYROSINE KINASE; DEFICIENT MICE; ACTIVATION; ATHEROSCLEROSIS; PHOSPHORYLATION; VEGF; NEOVASCULARIZATION	Angiogenesis, the formation of new blood vessels, plays a crucial role in normal physiological processes and in various pathological conditions. In the present study, we have investigated the physiological function of a newly described serine/threonine protein kinase D2 (PKD2) in aspects of endothelial cell biology involved in angiogenesis. We found that PKD2 was expressed in primary human endothelial cells from different tissues and was a critical PKD isoform mediating the phosphorylation of PKD substrates in endothelial cells. By using small interference RNAs that target different PKD2 regions, we found that silencing PKD2, but not PKD1 isoform, markedly inhibited the proliferation, migration, and in vitro angiogenesis of endothelial cells cultured in EGM-2 complete medium. We further showed that PKD2, but not PKD1, was required for the expression of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 that are two key growth factor receptors involved in angiogenesis. These findings indicate that PKD2 plays a pivotal role in endothelial cell proliferation and migration necessary for angiogenesis at least in part through modulation of the expression of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1.	[Hao, Qin; Wang, Linping; Tang, Hua] Univ Texas Hlth Ctr Tyler, Dept Biochem, Tyler, TX 75708 USA; [Zhao, Z. Joe] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Oklahoma System; University of Oklahoma Health Sciences Center	Tang, H (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Biochem, 11937 US Highway 271, Tyler, TX 75708 USA.	hua.tang@uthct.edu			American Heart Association [0855188F]	American Heart Association(American Heart Association)	This work was supported by American Heart Association Grant-in-Aid 0855188F ( to H. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson EM, 2008, RNA, V14, P853, DOI 10.1261/rna.704708; Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Duval M, 2003, J BIOL CHEM, V278, P20091, DOI 10.1074/jbc.M301410200; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Hauer AD, 2007, ARTERIOSCL THROM VAS, V27, P2050, DOI 10.1161/ATVBAHA.107.143743; Jacobs J, 2007, DRUG DISCOV TODAY, V12, P1040, DOI 10.1016/j.drudis.2007.08.018; Liu P, 2007, FEBS LETT, V581, P1377, DOI 10.1016/j.febslet.2007.02.055; Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Papazyan R, 2006, BIOCHEM BIOPH RES CO, V342, P685, DOI 10.1016/j.bbrc.2006.02.013; Petrovan RJ, 2007, ARTERIOSCL THROM VAS, V27, P1095, DOI 10.1161/ATVBAHA.106.139246; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Quesada AR, 2007, BIOESSAYS, V29, P1159, DOI 10.1002/bies.20655; Rahimi N, 2006, EXP EYE RES, V83, P1005, DOI 10.1016/j.exer.2006.03.019; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Ronicke V, 1996, CIRC RES, V79, P277, DOI 10.1161/01.RES.79.2.277; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Tang H, 2000, J BIOL CHEM, V275, P8389, DOI 10.1074/jbc.275.12.8389; Tang H, 2002, J BIOL CHEM, V277, P5441, DOI 10.1074/jbc.M110673200; van Buul JD, 2007, ARTERIOSCL THROM VAS, V27, P1870, DOI 10.1161/ATVBAHA.107.145821; von Blume J, 2007, EMBO J, V26, P4619, DOI 10.1038/sj.emboj.7601891; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	33	45	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					799	806		10.1074/jbc.M807546200	http://dx.doi.org/10.1074/jbc.M807546200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001381	hybrid			2022-12-27	WOS:000262122900014
J	Singh, K; Sinha, S; Malonia, SK; Bist, P; Tergaonkar, V; Chattopadhyay, S				Singh, Kamini; Sinha, Surajit; Malonia, Sunil Kumar; Bist, Pradeep; Tergaonkar, Vinay; Chattopadhyay, Samit			Tumor Suppressor SMAR1 Represses I kappa B alpha Expression and Inhibits p65 Transactivation through Matrix Attachment Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BETA LOCUS; HISTONE DEACETYLATION; THERAPEUTIC TARGET; GENE-EXPRESSION; NUCLEAR-MATRIX; CANCER-CELLS; IKK-ALPHA; ACTIVATION; CHROMATIN; TRANSCRIPTION	Aberrant NF-kappa B activity promotes tumorigenesis. However, NF-kappa B also inhibits tumor growth where tumor suppressor pathways remain unaltered. Thus, its role in tumorigenesis depends upon the function of other cellular factors. Tumor suppressor SMAR1 down-modulated in high grade breast cancers is regulated by p53 and is reported to interact and stabilize p53. Because both SMAR1 and NF-kappa B are involved in tumorigenesis, we investigated the effect of SMAR1 upon NF-kappa B activity. We show that SMAR1 induction by doxorubicin or overexpression produces functional NF-kappa B complexes that are competent for binding to NF-kappa B consensus sequence. However, SMAR1 induced p65-p50 complex is phosphorylation- and transactivation deficient. Induction of functional NF-kappa B complexes stems from down-regulation of I kappa B alpha transcription through direct binding of SMAR1 to the matrix attachment region site present in I kappa B alpha promoter and recruitment of corepressor complex. Real time PCR array for NF-kappa B target genes revealed that SMAR1 down-regulates a subset of NF-kappa B target genes that are involved in tumorigenesis. We also show that SMAR1 inhibits tumor necrosis factor alpha-induced induction of NF-kappa B suggesting that activation of NF-kappa B by SMAR1 is independent and different from classical pathway. Thus, for the first time we report that a tumor suppressor protein SMAR1 can modulate NF-kappa B transactivation and inhibit tumorigenesis by regulating NF-kappa B target genes.	[Singh, Kamini; Sinha, Surajit; Malonia, Sunil Kumar; Chattopadhyay, Samit] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India; [Bist, Pradeep; Tergaonkar, Vinay] Inst Mol & Cellular Biol, Singapore 138673, Singapore	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Chattopadhyay, S (corresponding author), Natl Ctr Cell Sci, Pune Univ Campus, Pune 411007, Maharashtra, India.	samit@nccs.res.in	Malonia, Sunil/ABH-2506-2020; Malonia, Sunil/AAA-2470-2019; BIST, PRADEEP/AAG-7986-2019; Malonia, Sunil/AAX-3008-2020	Malonia, Sunil/0000-0002-2727-5165	Department of Biotechnology; Indian Council of Medical Research (ICMR), New Delhi, India	Department of Biotechnology; Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported in part by grants from the Department of Biotechnology and Indian Council of Medical Research (ICMR), New Delhi, India. The costs of publication of this article were defrayed in part by the payment of page charges.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; BLASQUEZ VC, 1989, GENOME, V31, P503, DOI 10.1139/g89-098; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Chattopadhyay S, 2000, GENOMICS, V68, P93, DOI 10.1006/geno.2000.6279; Cortes J, 1997, LEUKEMIA LYMPHOMA, V26, P251, DOI 10.3109/10428199709051774; Craig MJ, 2006, CANCER METAST REV, V25, P611, DOI 10.1007/s10555-006-9027-x; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Gapuzan MER, 2002, ONCOGENE, V21, P2484, DOI 10.1038/sj.onc.1205333; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goswami A, 2006, CANCER RES, V66, P2889, DOI 10.1158/0008-5472.CAN-05-4458; Guschin D, 2000, BIOCHEMISTRY-US, V39, P5238, DOI 10.1021/bi000421t; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Ho WC, 2005, CANCER RES, V65, P4273, DOI 10.1158/0008-5472.CAN-04-3494; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; Jalota-Badhwar A, 2007, J BIOL CHEM, V282, P9902, DOI 10.1074/jbc.M608434200; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Juillerat-Jeanneret L, 2004, BRIT J CANCER, V90, P1059, DOI 10.1038/sj.bjc.6601646; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kaul R, 2003, INT J CANCER, V103, P606, DOI 10.1002/ijc.10881; Kaul-Ghanekar R, 2005, J BIOL CHEM, V280, P9450, DOI 10.1074/jbc.M412206200; Kaul-Ghanekar R, 2004, NUCLEIC ACIDS RES, V32, P4862, DOI 10.1093/nar/gkh807; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Perkins ND, 2003, ONCOGENE, V22, P7553, DOI 10.1038/sj.onc.1207139; Perkins ND, 2004, TRENDS CELL BIOL, V14, P64, DOI 10.1016/j.tcb.2003.12.004; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Singh GB, 1997, NUCLEIC ACIDS RES, V25, P1419, DOI 10.1093/nar/25.7.1419; Singh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000660; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Tergaonkar V, 2007, MOL CELL, V26, P158, DOI 10.1016/j.molcel.2007.04.006; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	63	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1267	1278		10.1074/jbc.M801088200	http://dx.doi.org/10.1074/jbc.M801088200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18981184	hybrid			2022-12-27	WOS:000262122900062
J	Vincent, HA; Deutscher, MP				Vincent, Helen A.; Deutscher, Murray P.			The Roles of Individual Domains of RNase R in Substrate Binding and Exoribonuclease Activity THE NUCLEASE DOMAIN IS SUFFICIENT FOR DIGESTION OF STRUCTURED RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CSPE; RIBOSOMAL-PROTEIN S1; ACID MELTING ACTIVITY; MESSENGER-RNA; RIBONUCLEASE-II; POLYNUCLEOTIDE PHOSPHORYLASE; SHOCK PROTEIN; TRANSCRIPTION ANTITERMINATION; PHYLOGENETIC DISTRIBUTION; SECONDARY STRUCTURE	RNase R and RNase II are the two representatives from the RNR family of processive, 3' to 5' exoribonucleases in Escherichia coli. Although RNase II is specific for single-stranded RNA, RNase R readily degrades through structured RNA. Furthermore, RNase R appears to be the only known 3' to 5' exoribonuclease that is able to degrade through double-stranded RNA without the aid of a helicase activity. Consequently, its functional domains and mechanism of action are of great interest. Using a series of truncated RNase R proteins we show that the cold-shock and S1 domains contribute to substrate binding. The cold-shock domains appear to play a role in substrate recruitment, whereas the S1 domain is most likely required to position substrates for efficient catalysis. Most importantly, the nuclease domain alone, devoid of the cold-shock and S1 domains, is sufficient for RNase R to bind and degrade structured RNAs. Moreover, this is a unique property of the nuclease domain of RNase R because this domain in RNase II stalls as it approaches a duplex. We also show that the nuclease domain of RNase R binds RNA more tightly than the nuclease domain of RNase II. This tighter binding may help to explain the difference in catalytic properties between RNase R and RNase II.	[Vincent, Helen A.; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Vincent, Helen/GZK-3422-2022		National Institutes of Health [GM16317]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amblar M, 2007, RNA, V13, P317, DOI 10.1261/rna.220407; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Barbas A, 2008, J BIOL CHEM, V283, P13070, DOI 10.1074/jbc.M709989200; BEAR DG, 1976, P NATL ACAD SCI USA, V73, P1824, DOI 10.1073/pnas.73.6.1824; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cannistraro VJ, 1999, BBA-PROTEIN STRUCT M, V1433, P170, DOI 10.1016/S0167-4838(99)00136-3; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Coburn GA, 1996, J BIOL CHEM, V271, P1048, DOI 10.1074/jbc.271.2.1048; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Jiang WN, 1997, J BIOL CHEM, V272, P196; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; KOLB A, 1977, P NATL ACAD SCI USA, V74, P2379, DOI 10.1073/pnas.74.6.2379; Li ZW, 2002, EMBO J, V21, P1132, DOI 10.1093/emboj/21.5.1132; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mohanty BK, 2003, MOL MICROBIOL, V50, P645, DOI 10.1046/j.1365-2958.2003.03724.x; NEWKIRK K, 1994, P NATL ACAD SCI USA, V91, P5114, DOI 10.1073/pnas.91.11.5114; Phadtare S, 2004, J MOL BIOL, V337, P147, DOI 10.1016/j.jmb.2004.01.023; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Phadtare S, 2002, J BIOL CHEM, V277, P46706, DOI 10.1074/jbc.M208118200; Phadtare S, 2002, J BIOL CHEM, V277, P7239, DOI 10.1074/jbc.M111496200; Phadtare S, 2005, NUCLEIC ACIDS RES, V33, P5583, DOI 10.1093/nar/gki859; SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SUBRAMANIAN AR, 1983, PROG NUCLEIC ACID RE, V28, P101, DOI 10.1016/S0079-6603(08)60085-9; Suzuki H, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl151; SZER W, 1976, BIOCHEM BIOPH RES CO, V70, P957, DOI 10.1016/0006-291X(76)90685-9; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; THOMAS JO, 1978, J MOL BIOL, V123, P163, DOI 10.1016/0022-2836(78)90319-4; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	41	44	46	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					486	494		10.1074/jbc.M806468200	http://dx.doi.org/10.1074/jbc.M806468200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19004832	hybrid, Green Published			2022-12-27	WOS:000261974800053
J	Beckman, JW; Wang, QX; Guengerich, FP				Beckman, Jeff W.; Wang, Qixin; Guengerich, F. Peter			Kinetic Analysis of Correct Nucleotide Insertion by a Y-family DNA Polymerase Reveals Conformational Changes Both Prior to and following Phosphodiester Bond Formation as Detected by Tryptophan Fluorescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEADY-STATE KINETICS; I KLENOW FRAGMENT; SULFOLOBUS-SOLFATARICUS; CRYSTAL-STRUCTURES; INDUCED-FIT; STRUCTURAL BASIS; MOLECULAR-BASIS; FINGER DOMAIN; ERROR-PRONE; FIDELITY	The Sulfolobus solfataricus Y-family DNA polymerase Dpo4 is a model for translesion replication and has been used in the analysis of individual steps involved in catalysis. The role of conformational changes has not been clear. Introduction of Trp residues into the Trp-devoid wild-type protein provided fluorescence probes of these events, particularly in the case of mutants T239W and N188W. With both mutants, a rapid increase in Trp fluorescence was observed only in the case of normal base pairing (G:C), was saturable with respect to dCTP concentration, and occurred in the absence of phosphodiester bond formation. A subsequent decrease in the Trp fluorescence occurred when phosphodiester bond formation was permitted, and these rates were independent of the dCTP concentration. This step is relatively slow and is attributed to a conformational relaxation step occurring after pyrophosphate release, which was measured and shown to be fast in a separate experiment. The measured rate of release of DNA from Dpo4 was rapid and is not rate-limiting. Overall, the measurements provide a kinetic scheme for Dpo4 different than generally accepted for replicative polymerases or proposed for Dpo4 and other Y-family polymerases: the initial enzyme.DNA.dNTP complex undergoes a rapid (18 s(-1)), reversible (21 s(-1)) conformational change, followed by relatively rapid phosphodiester bond formation (11 s(-1)) and then fast release of pyrophosphate, followed by a rate- limiting relaxation of the active conformation (2 s(-1)) and then rapid DNA release, yielding an overall steady-state k(cat) of <1 s(-1).	[Beckman, Jeff W.; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Beckman, Jeff W.; Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA; [Wang, Qixin] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R01 ES010375, P30 ES000267]; United States Public Health Service; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F.P.G.) and P30 ES000267 (to F.P.G.) from the United States Public Health Service. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; Cramer J, 2005, J BIOL CHEM, V280, P40552, DOI 10.1074/jbc.M504481200; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; DeLucia AM, 2007, BIOCHEMISTRY-US, V46, P10790, DOI 10.1021/bi7006756; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2008, ANAL BIOCHEM, V372, P125, DOI 10.1016/j.ab.2007.08.004; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Irimia A, 2007, J BIOL CHEM, V282, P36421, DOI 10.1074/jbc.M707267200; Irimia A, 2006, BIOCHEMISTRY-US, V45, P5949, DOI 10.1021/bi052511+; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson Kenneth A., 2003, P1; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Maniatis T., 1982, MOL CLONING; McCulloch SD, 2004, NUCLEIC ACIDS RES, V32, P4665, DOI 10.1093/nar/gkh777; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Roettger MP, 2008, BIOCHEMISTRY-US, V47, P9718, DOI 10.1021/bi800689d; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wang YL, 2006, PROTEIN SCI, V15, P135, DOI 10.1110/ps.051726906; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Wong JH, 2008, J MOL BIOL, V379, P317, DOI 10.1016/j.jmb.2008.03.038; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200	55	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36711	36723		10.1074/jbc.M806785200	http://dx.doi.org/10.1074/jbc.M806785200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984592	hybrid, Green Published			2022-12-27	WOS:000261840500069
J	Expert, D; Boughammoura, A; Franza, T				Expert, Dominique; Boughammoura, Aida; Franza, Thierry			Siderophore-controlled Iron Assimilation in the Enterobacterium Erwinia chrysanthemi EVIDENCE FOR THE INVOLVEMENT OF BACTERIOFERRITIN AND THE Suf IRON-SULFUR CLUSTER ASSEMBLY MACHINERY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; GENETIC-ANALYSIS; PROTEIN; FERRITIN; YGGX; ACQUISITION; FRATAXIN; BINDING; IDENTIFICATION	The intracellular fate of iron acquired by bacteria during siderophore-mediated assimilation is poorly understood. We investigated this question in the pathogenic enterobacterium Erwinia chrysanthemi. This bacterium produces two siderophores, chrysobactin and achromobactin, during plant infection. We analyzed the distribution of iron into cytosolic proteins in bacterial cells supplied with Fe-59-chrysobactin using native gel electrophoresis. A parental strain and mutants deficientin bacterioferritin(bfr), mini-ferritin (dps), ferritin (ftnA), bacterioferredoxin (bfd), or iron-sulfur cluster assembly machinery (sufABCDSE) were studied. In the parental strain, we observed two rapidly Fe-59-labeled protein signals identified as bacterioferritin and an iron pool associated to the protein chain-elongation process. In the presence of increased Fe-59-chrysobactin concentrations, we detected mini-ferritin bound iron. Iron incorporation into bacterioferritin was severely reduced in nonpolar sufA, sufB, sufD, sufS, and sufE mutants but not in a sufC background. Iron recycling from bacterioferritin did not occur in bfd and sufC mutants. Iron depletion caused a loss of aconitase activity, whereas ferric chrysobactin supplementation stimulated the production of active aconitase in parental cells and in bfr and bfd mutants. Aconitase activity in sufA, sufB, sufD, sufS, and sufE mutant strains was 10 times lower than that in parental cells. In the sufC mutant, it was twice as low as that in the parental strain. Defects observed in the mutants were not caused by altered ferric chrysobactin transport. Our data demonstrate a functional link between bacterioferritin, bacterioferredoxin, and the Suf protein machinery resulting in optimal bacterial growth and a balanced distribution of iron between essential metalloproteins.	[Expert, Dominique; Boughammoura, Aida; Franza, Thierry] Univ Paris 06, INRA, UMR 217, Lab Interact Plantes Pathogenes, F-75005 Paris, France	INRAE; UDICE-French Research Universities; Sorbonne Universite	Expert, D (corresponding author), 16 Rue Claude Bernard, F-75005 Paris, France.	expert@agroparistech.fr		Thierry, Franza/0000-0003-3147-8210; Boughammoura, Aida/0000-0002-3718-2886	Institut National de la Recherche Agronomique	Institut National de la Recherche Agronomique	This work was supported by the Institut National de la Recherche Agronomique. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANDREWS SC, 1989, J BACTERIOL, V171, P3940, DOI 10.1128/jb.171.7.3940-3947.1989; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; Boughammoura A, 2008, J BACTERIOL, V190, P1518, DOI 10.1128/JB.01640-07; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chiancone E, 2004, BIOMETALS, V17, P197, DOI 10.1023/B:BIOM.0000027692.24395.76; Ding HG, 2007, J BIOL CHEM, V282, P7997, DOI 10.1074/jbc.M609665200; Expert D, 1999, ANNU REV PHYTOPATHOL, V37, P307, DOI 10.1146/annurev.phyto.37.1.307; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Franza T, 1999, MOL PLANT MICROBE IN, V12, P119, DOI 10.1094/MPMI.1999.12.2.119; FRANZA T, 1991, MOL MICROBIOL, V5, P1319, DOI 10.1111/j.1365-2958.1991.tb00778.x; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Frazzon APG, 2007, PLANT MOL BIOL, V64, P225, DOI 10.1007/s11103-007-9147-x; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Garg RP, 1996, BIOCHEMISTRY-US, V35, P6297, DOI 10.1021/bi9600862; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gralnick JA, 2003, J BIOL CHEM, V278, P20708, DOI 10.1074/jbc.M301577200; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; Justino MC, 2006, FEMS MICROBIOL LETT, V257, P278, DOI 10.1111/j.1574-6968.2006.00179.x; KREUZER KN, 1979, J BACTERIOL, V140, P424, DOI 10.1128/JB.140.2.424-435.1979; KREWULAK KD, 2008, J BIOCH BIOPHYS ACTA, V1778, P1781; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; LEBRUN NE, 1995, BIOCHEM J, V312, P385, DOI 10.1042/bj3120385; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Liu XF, 2004, P NATL ACAD SCI USA, V101, P8557, DOI 10.1073/pnas.0401146101; LUCASLENARD J, 1971, ANNU REV BIOCHEM, V40, P409, DOI 10.1146/annurev.bi.40.070171.002205; Matzanke BF, 1997, TRANSITION METALS IN MICROBIAL METABOLISM, P117; MENARD R, 1993, J BACTERIOL, V175, P5899; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nachin L, 2001, MOL MICROBIOL, V39, P960, DOI 10.1046/j.1365-2958.2001.02288.x; NEILANDS JB, 1991, BIOL MET, V4, P1, DOI 10.1007/BF01135550; Osborne MJ, 2005, PROTEIN SCI, V14, P1673, DOI 10.1110/ps.051358105; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Pierre JL, 1999, BIOMETALS, V12, P195, DOI 10.1023/A:1009252919854; Pomposiello PJ, 2003, J BACTERIOL, V185, P6624, DOI 10.1128/JB.185.22.6624-6632.2003; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Quail MA, 1996, BIOCHEM BIOPH RES CO, V229, P635, DOI 10.1006/bbrc.1996.1856; Rauscher L, 2002, J BIOL CHEM, V277, P2385, DOI 10.1074/jbc.M107530200; RESIBOIS A, 1984, VIROLOGY, V137, P102, DOI 10.1016/0042-6822(84)90013-8; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Skovran E, 2004, J BACTERIOL, V186, P7626, DOI 10.1128/JB.186.22.7626-7634.2004; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; Stillman TJ, 2003, J BIOL CHEM, V278, P26275, DOI 10.1074/jbc.M207354200; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; WALKER AC, 1976, P NATL ACAD SCI USA, V73, P1126, DOI 10.1073/pnas.73.4.1126; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; ZAZIALOV AV, 2003, CELL, V114, P113	59	31	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36564	36572		10.1074/jbc.M807749200	http://dx.doi.org/10.1074/jbc.M807749200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990691	Green Published, hybrid			2022-12-27	WOS:000261840500054
J	Ding, N; Tomomori-Sato, C; Sato, S; Conaway, RC; Conaway, JW; Boyer, TG				Ding, Ning; Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C.; Conaway, Joan W.; Boyer, Thomas G.			MED19 and MED26 Are Synergistic Functional Targets of the RE1 Silencing Transcription Factor in Epigenetic Silencing of Neuronal Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MEDIATOR COMPLEX; LINKED MENTAL-RETARDATION; HISTONE DEACETYLASE; NUCLEAR RECEPTORS; IN-VIVO; NEURAL INDUCTION; STEM-CELLS; REST; REPRESSOR; COACTIVATOR	A key hub for the orchestration of epigenetic modifications necessary to restrict neuronal gene expression to the nervous system is the RE1 silencing transcription factor (REST; also known as neuron restrictive silencer factor, NRSF). REST suppresses the nonspecific and premature expression of neuronal genes in non-neuronal and neural progenitor cells, respectively, via recruitment of enzymatically diverse corepressors, including G9a histone methyltransferase (HMTase) that catalyzes di-methylation of histone 3-lysine 9 (H3K9me2). Recently, we identified the RNA polymerase II transcriptional Mediator to be an essential link between RE1-bound REST and G9a in epigenetic suppression of neuronal genes in non-neuronal cells. However, the means by which REST recruits Mediator to facilitate G9a-dependent extra-neuronal gene silencing remains to be elucidated. Here, we identify the MED19 and MED26 subunits in Mediator as direct physical and synergistic functional targets of REST. We show that although REST independently binds to both MED19 and MED26 in isolation, combined depletion of both subunits is required to disrupt the association of REST with Mediator. Furthermore, combined, but not individual, depletion of MED19/MED26 impairs REST-directed recruitment to RE1 elements of Mediator and G9a, leading to a reversal of G9a-dependent H3K9me2 and de-repression of REST-target gene expression. Together, these findings identify MED19/MED26 as a probable composite REST interface in Mediator and further clarify the mechanistic basis by which Mediator facilitates REST-imposed epigenetic restrictions on neuronal gene expression.	[Ding, Ning; Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA; [Ding, Ning; Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA; [Tomomori-Sato, Chieri; Sato, Shigeo; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Boyer, TG (corresponding author), 19715 Lambda Dr, San Antonio, TX 78245 USA.	boyer@uthscsa.edu	Ding, Ning/B-4072-2012	Conaway, Joan/0000-0002-2786-0663; Tomomori-Sato, Chieri/0000-0002-2543-293X	NCI [CA-0908301]; National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085320] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by Public Health Service Grant CA-0908301 from NCI, National Institutes of Health (to T. G. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Asada S, 2002, P NATL ACAD SCI USA, V99, P12747, DOI 10.1073/pnas.202162199; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; Bingham AJ, 2007, MOL CELL BIOL, V27, P4082, DOI 10.1128/MCB.00269-07; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Calderone A, 2003, J NEUROSCI, V23, P2112; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Coulson JM, 2000, CANCER RES, V60, P1840; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Drane P, 1997, ONCOGENE, V15, P3013, DOI 10.1038/sj.onc.1201492; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Fuller GN, 2005, MOL CANCER THER, V4, P343; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gonzalez D, 2007, MOL CELL BIOL, V27, P5306, DOI 10.1128/MCB.01912-06; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Gwack Y, 2003, MOL CELL BIOL, V23, P2055, DOI 10.1128/MCB.23.6.2055-2067.2003; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2002, EMBO J, V21, P3464, DOI 10.1093/emboj/cdf348; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kallunki P, 1997, J CELL BIOL, V138, P1343, DOI 10.1083/jcb.138.6.1343; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Kim TW, 2004, P NATL ACAD SCI USA, V101, P12153, DOI 10.1073/pnas.0401985101; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; Lau JF, 2003, MOL CELL BIOL, V23, P620, DOI 10.1128/MCB.23.2.620-628.2003; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Lee JE, 2005, J BIOL CHEM, V280, P8819, DOI 10.1074/jbc.M413184200; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Palm K, 1999, MOL BRAIN RES, V72, P30, DOI 10.1016/S0169-328X(99)00196-5; Palm K, 1998, J NEUROSCI, V18, P1280; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Sasai Y, 1998, NEURON, V21, P455, DOI 10.1016/S0896-6273(00)80554-1; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sato S, 2003, J BIOL CHEM, V278, P49671, DOI 10.1074/jbc.C300444200; Sato S, 2003, J BIOL CHEM, V278, P15123, DOI 10.1074/jbc.C300054200; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Stumpf M, 2006, P NATL ACAD SCI USA, V103, P18504, DOI 10.1073/pnas.0604494103; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Tomomori-Sato C, 2004, J BIOL CHEM, V279, P5846, DOI 10.1074/jbc.M312523200; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06; Zhou RJ, 2002, NUCLEIC ACIDS RES, V30, P3245, DOI 10.1093/nar/gkf443; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	82	57	67	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2648	2656		10.1074/jbc.M806514200	http://dx.doi.org/10.1074/jbc.M806514200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049968	hybrid, Green Published			2022-12-27	WOS:000262700900007
J	Mavridou, DAI; Stevens, JM; Goddard, AD; Willis, AC; Ferguson, SJ; Redfield, C				Mavridou, Despoina A. I.; Stevens, Julie M.; Goddard, Alan D.; Willis, Antony C.; Ferguson, Stuart J.; Redfield, Christina			Control of Periplasmic Interdomain Thiol: Disulfide Exchange in the Transmembrane Oxidoreductase DsbD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; CYTOCHROME-C MATURATION; ACTIVE-SITE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TERMINAL DOMAIN; BOND FORMATION; PK(A) VALUES; PROTEIN; MECHANISM	The bacterial protein DsbD transfers reductant from the cytoplasm to the otherwise oxidizing environment of the periplasm. This reducing power is required for several essential pathways, including disulfide bond formation and cytochrome c maturation. DsbD includes a transmembrane domain (tmDsbD) flanked by two globular periplasmic domains (nDsbD/cDsbD); each contains a cysteine pair involved in electron transfer via a disulfide exchange cascade. The final step in the cascade involves reduction of the Cys(103) -Cys(109) disulfide of nDsbD by Cys(461) of cDsbD. Here we show that a complex between the globular periplasmic domains is trapped in vivo only when both are linked by tmDsbD. We have found previously (Mavridou, D. A., Stevens, J.M., Ferguson, S.J., & Redfield, C. ( 2007) J. Mol. Biol. 370, 643-658) that the attacking cysteine ( Cys461) in isolated cDsbD has a high pK(a) value (10.5) that makes this thiol relatively unreactive toward the target disulfide in nDsbD. Here we show using NMR that active-site pK(a) values change significantly when cDsbD forms a complex with nDsbD. This modulation of pK(a) values is critical for the specificity and function of cDsbD. Uncomplexed cDsbD is a poor nucleophile, allowing it to avoid nonspecific reoxidation; however, in complex with nDsbD, the nucleophilicity of cDsbD increases permitting reductant transfer. The observation of significant changes in active-site pK(a) values upon complex formation has wider implications for understanding reactivity in thiol: disulfide oxidoreductases.	[Mavridou, Despoina A. I.; Stevens, Julie M.; Goddard, Alan D.; Ferguson, Stuart J.; Redfield, Christina] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Willis, Antony C.] Univ Oxford, MRC, Immunochem Unit, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk; christina.redfield@bioch.ox.ac.uk	Goddard, Alan/E-9328-2013; Mavridou, Despoina/ABG-5940-2020	Mavridou, Despoina/0000-0002-7449-1151; Redfield, Christina/0000-0001-7297-7708; Goddard, Alan/0000-0003-4950-7470	Biotechnology and Biological Sciences Research Council [BBD5230191, BBE0048651, BB/E004865/1] Funding Source: Medline; Wellcome Trust [079440] Funding Source: Medline; BBSRC [BB/E004865/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ausubel FM, 2003, CURRENT PROTOCOLS MO; Carvalho ATP, 2008, J PHYS CHEM B, V112, P2511, DOI 10.1021/jp7104665; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Chung J, 2000, MOL MICROBIOL, V35, P1099, DOI 10.1046/j.1365-2958.2000.01778.x; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; CROOKE H, 1995, MOL MICROBIOL, V15, P1139, DOI 10.1111/j.1365-2958.1995.tb02287.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gordon EHJ, 2000, MOL MICROBIOL, V35, P1360, DOI 10.1046/j.1365-2958.2000.01796.x; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Hiniker A, 2006, J BACTERIOL, V188, P7317, DOI 10.1128/JB.00383-06; Hodson CTC, 2008, J BACTERIOL, V190, P4697, DOI 10.1128/JB.00145-08; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Jeng MF, 1996, BIOCHEMISTRY-US, V35, P1, DOI 10.1021/bi952404n; JENG MF, 1995, BIOCHEMISTRY-US, V34, P10101, DOI 10.1021/bi00032a001; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Katzen F, 2003, P NATL ACAD SCI USA, V100, P10471, DOI 10.1073/pnas.1334136100; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mavridou DAI, 2007, J MOL BIOL, V370, P643, DOI 10.1016/j.jmb.2007.04.038; Menchise V, 2001, BIOCHEM J, V359, P65, DOI 10.1042/0264-6021:3590065; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; SHRAGER RI, 1972, BIOCHEMISTRY-US, V11, P541, DOI 10.1021/bi00754a010; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; Stirnimann CU, 2006, J MOL BIOL, V358, P829, DOI 10.1016/j.jmb.2006.02.030; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014	29	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3219	3226		10.1074/jbc.M805963200	http://dx.doi.org/10.1074/jbc.M805963200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19004826	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000262700900065
J	Sun, QX; Collins, R; Huang, SF; Holmberg-Schiavone, L; Anand, GS; Tan, CH; Van-Den-Berg, S; Deng, LW; Moore, PK; Karlberg, T; Sivaraman, J				Sun, Qingxiang; Collins, Ruairi; Huang, Shufen; Holmberg-Schiavone, Lovisa; Anand, Ganesh S.; Tan, Choon-Hong; van-den-Berg, Susanne; Deng, Lih-Wen; Moore, Philip K.; Karlberg, Tobias; Sivaraman, J.			Structural Basis for the Inhibition Mechanism of Human Cystathionine gamma-Lyase, an Enzyme Responsible for the Production of H2S	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-STRUCTURE DATABASE; HYDROGEN-SULFIDE; CRYSTAL-STRUCTURE; THREONINE SYNTHASE; VASORELAXANT; SPECIFICITY; METABOLISM; SEARCH; MICE; RAT	Impairment of the formation or action of hydrogen sulfide (H2S), an endogenous gasotransmitter, is associated with various diseases, such as hypertension, diabetes mellitus, septic and hemorrhagic shock, and pancreatitis. Cystathionine beta-synthase and cystathionine gamma-lyase (CSE) are two pyridoxal-5'-phosphate ( PLP)-dependent enzymes largely responsible for the production of H2S in mammals. Inhibition of CSE by DL-propargylglycine (PAG) has been shown to alleviate disease symptoms. Here we report crystal structures of human CSE (hCSE), in apo form, and in complex with PLP and PLP (.) PAG. Structural characterization, combined with biophysical and biochemical studies, provides new insights into the inhibition mechanism of hCSE-mediated production of H2S. Transition from the open form of apo-hCSE to the closed PLP-bound form reveals large conformational changes hitherto not reported. In addition, PAG binds hCSE via a unique binding mode, not observed in PAG-enzyme complexes previously. The interaction of PAG-hCSE was not predicted based on existing information from known PAG complexes. The structure of hCSE (.) PLP (.) PAG complex highlights the particular importance of Tyr(114) in hCSE and the mechanism of PAG-dependent inhibition of hCSE. These results provide significant insights, which will facilitate the structure-based design of novel inhibitors of hCSE to aid in the development of therapies for diseases involving disorders of sulfur metabolism.	[Collins, Ruairi; Holmberg-Schiavone, Lovisa; van-den-Berg, Susanne; Karlberg, Tobias] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, SE-17177 Stockholm, Sweden; [Sun, Qingxiang; Anand, Ganesh S.; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Huang, Shufen; Tan, Choon-Hong] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Deng, Lih-Wen] Natl Univ Singapore, Dept Biochem, Singapore 117543, Singapore; [Moore, Philip K.] Univ London, Univ London Kings Coll, Div Pharmaceut Sci, London SW3 6LX, England	Karolinska Institutet; National University of Singapore; National University of Singapore; National University of Singapore; University of London; King's College London	Karlberg, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, SE-17177 Stockholm, Sweden.	tobias.karlberg@ki.se; dbsjayar@nus.edu.sg	Sivaraman, J/H-8028-2012	Deng, Lih-Wen/0000-0002-4985-7844; J, Sivaraman/0000-0001-9781-5326				Bruger AT, 1998, ACTA CRYSTALLOGR D, V54, P905; Clausen T, 1998, EMBO J, V17, P6827, DOI 10.1093/emboj/17.23.6827; Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giles K, 2004, RAPID COMMUN MASS SP, V18, P2401, DOI 10.1002/rcm.1641; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Karsten WE, 2002, METHOD ENZYMOL, V354, P223; Li L, 2008, TRENDS PHARMACOL SCI, V29, P84, DOI 10.1016/j.tips.2007.11.003; Li L, 2006, CURR OPIN PHARMACOL, V6, P125, DOI 10.1016/j.coph.2005.10.007; Mas-Droux C, 2006, J BIOL CHEM, V281, P5188, DOI 10.1074/jbc.M509798200; Messerschmidt A, 2003, BIOL CHEM, V384, P373, DOI 10.1515/BC.2003.043; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ruotolo BT, 2006, CURR OPIN CHEM BIOL, V10, P402, DOI 10.1016/j.cbpa.2006.08.020; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Steegborn C, 1999, J BIOL CHEM, V274, P12675, DOI 10.1074/jbc.274.18.12675; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tang Chaoshu, 2006, Current Vascular Pharmacology, V4, P17; Thomazeau K, 2001, PROTEIN SCI, V10, P638, DOI 10.1110/ps.44301; Tokoro M, 2003, J BIOL CHEM, V278, P42717, DOI 10.1074/jbc.M212414200; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; UREN JR, 1978, BIOCHEM PHARMACOL, V27, P2807, DOI 10.1016/0006-2952(78)90194-6; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu WD, 2008, BIOCHEMISTRY-US, V47, P6226, DOI 10.1021/bi800351a	34	135	144	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3076	3085		10.1074/jbc.M805459200	http://dx.doi.org/10.1074/jbc.M805459200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19019829	hybrid			2022-12-27	WOS:000262700900052
J	Topol, LL; Chen, W; Song, H; Day, TF; Yang, YZ				Topol, Lilia; Chen, Wen; Song, Hai; Day, Timothy F.; Yang, Yingzi			Sox9 Inhibits Wnt Signaling by Promoting beta-Catenin Phosphorylation in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL SEX REVERSAL; F-BOX PROTEIN; I-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3; SYNOVIAL JOINT FORMATION; COLON-CARCINOMA CELLS; CRANIAL NEURAL CREST; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; CHONDROCYTE DIFFERENTIATION	Chondrocyte fate determination and maintenance requires Sox9, an intrinsic transcription factor, but is inhibited by Wnt/beta-catenin signaling activated by extrinsic Wnt ligands. Here we explored the underlying molecular mechanism by which Sox9 antagonizes the Wnt/beta-catenin signaling in chondrocyte differentiation. We found that Sox9 employed two distinct mechanisms to inhibit Wnt/beta-catenin signaling: the Sox9 N terminus is necessary and sufficient to promote beta-catenin degradation, whereas the C terminus is required to inhibit beta-catenin transcriptional activity without affecting its stability. Sox9 binds to beta-catenin and components of the beta-catenin "destruction complex," glycogen synthase kinase 3 and beta-transducin repeat containing protein, to promote their nuclear localization. Independent of its DNA binding ability, nuclear localization of Sox9 is both necessary and sufficient to enhance beta-catenin phosphorylation and its subsequent degradation. Thus, one mechanism whereby Sox9 regulates chondrogenesis is to promote efficient beta-catenin phosphorylation in the nucleus. This mechanism may be broadly employed by other intrinsic cell fate determining transcription factors to promptly turn off extrinsic inhibitory Wnt signaling mediated by beta-catenin.	[Topol, Lilia; Chen, Wen; Song, Hai; Day, Timothy F.; Yang, Yingzi] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Yang, YZ (corresponding author), 49 Convent Dr,MSC 4472, Bethesda, MD 20892 USA.	yingzi@mail.nih.gov		Day, Timothy/0000-0002-3786-2152	National Institutes of Health; NHGRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000187, Z01HG000187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by the National Institutes of Health, NHGRI intramural research program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Amati B, 2007, NAT CELL BIOL, V9, P729, DOI 10.1038/ncb0707-729; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; HARLEY VR, 1994, MOL REPROD DEV, V39, P184, DOI 10.1002/mrd.1080390211; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; KWOK C, 1995, AM J HUM GENET, V57, P1028; Lagna G, 1999, MECH DEVELOP, V80, P101, DOI 10.1016/S0925-4773(98)00208-1; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; McDowall S, 1999, J BIOL CHEM, V274, P24023, DOI 10.1074/jbc.274.34.24023; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Primot A, 2000, PROTEIN EXPRES PURIF, V20, P394, DOI 10.1006/prep.2000.1321; Reinhardt J, 2007, PROTEIN EXPRES PURIF, V54, P101, DOI 10.1016/j.pep.2007.02.020; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Spokony RF, 2002, DEVELOPMENT, V129, P421; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; Sudbeck P, 1997, J BIOL CHEM, V272, P27848, DOI 10.1074/jbc.272.44.27848; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	61	165	180	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3323	3333		10.1074/jbc.M808048200	http://dx.doi.org/10.1074/jbc.M808048200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047045	hybrid, Green Published			2022-12-27	WOS:000262700900075
J	Aguilar, HC; Ataman, ZA; Aspericueta, V; Fang, AQ; Stroud, M; Negrete, OA; Kammerer, RA; Lee, B				Aguilar, Hector C.; Ataman, Zeynep Akyol; Aspericueta, Vanessa; Fang, Angela Q.; Stroud, Matthew; Negrete, Oscar A.; Kammerer, Richard A.; Lee, Benhur			A Novel Receptor-induced Activation Site in the Nipah Virus Attachment Glycoprotein (G) Involved in Triggering the Fusion Glycoprotein (F)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMAGGLUTININ-NEURAMINIDASE PROTEIN; MEMBRANE-FUSION; HENDRA-VIRUS; HN PROTEIN; CELL-FUSION; STRUCTURAL BASIS; PARAMYXOVIRUS FUSION; MEASLES-VIRUS; STALK DOMAIN; BINDING-SITE	Cellular entry of paramyxoviruses requires the coordinated action of both the attachment (G/H/HN) and fusion (F) glycoproteins, but how receptor binding activates G to trigger F-mediated fusion during viral entry is not known. Here, we identify a receptor (ephrinB2)-induced allosteric activation site in Nipahvirus(NiV) G involved in triggering F-mediated fusion. We first generated a conformational monoclonal antibody (monoclonal antibody 45 (Mab45)) whose binding to NiV-G was enhanced upon NiV-GephrinB2 binding. However, Mab45 also inhibited viral entry, and its receptor binding-enhanced (RBE) epitope was temperature-dependent, suggesting that the Mab45 RBE epitope on G may be involved in triggering F. The Mab45 RBE epitope was mapped to the base of the globular domain (beta 6S4/beta 1H1). Alanine scan mutants within this region that did not exhibit this RBE epitope were also nonfusogenic despite their ability to bind ephrinB2, oligomerize, and associate with Fat wild-type (WT) levels. Although circular dichroism revealed conformational changes in the soluble ectodomain of WT NiV-G upon ephrinB2 addition, no such changes were detected with soluble RBE epitope mutants or short-stalk G mutants. Additionally, WTG, but not a RBE epitope mutant, could dissociate from F upon ephrinB2 engagement. Finally, using a biotinylated HR2 peptide to detect pre-hairpin intermediate formation, a cardinal feature of F-triggering, we showed that ephrinB2 binding to WT G, but not the RBE-epitope mutants, could trigger F. In sum, we implicate the coordinated interaction between the base of NiV-Gglobular head domain and the stalk domain in mediating receptor-induced F triggering during viral entry.	[Aguilar, Hector C.; Ataman, Zeynep Akyol; Aspericueta, Vanessa; Fang, Angela Q.; Negrete, Oscar A.; Lee, Benhur] Univ Calif Los Angeles, Dept MIMG, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lee, Benhur] Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lee, Benhur] Univ Calif Los Angeles, AIDS Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Stroud, Matthew; Kammerer, Richard A.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Manchester	Lee, B (corresponding author), Univ Calif Los Angeles, Dept MIMG, David Geffen Sch Med, 257 BSRB,615 Charles E Young Dr E, Los Angeles, CA 90095 USA.	bleebhL@ucla.edu	Lee, Benhur/A-8554-2016; Aguilar, Hector/AAD-6663-2022	Lee, Benhur/0000-0003-0760-1709; Stroud, Matthew/0000-0003-0451-3367; Stroud, Matthew John/0000-0002-3337-6851; Kammerer, Richard/0000-0003-4570-5197	National Institutes of Health [AI070495, AI060694, AI069317]; Rockefeller Brothers Fund; Burroughs Welcome Fund Career Development Award; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069317, R01AI060694, U01AI070495, P30AI028697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller Brothers Fund; Burroughs Welcome Fund Career Development Award(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI070495, AI060694, and AI069317 (to B. L.). Additional support was provided by a Charles E. Culpepper Medical Scholarship from the Rockefeller Brothers Fund and a Burroughs Welcome Fund Career Development Award. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked 'advertisement'in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aguilar HC, 2007, J VIROL, V81, P4520, DOI 10.1128/JVI.02205-06; Aguilar HC, 2006, J VIROL, V80, P4878, DOI 10.1128/JVI.80.10.4878-4889.2006; Bishop KA, 2008, J VIROL, V82, P11398, DOI 10.1128/JVI.02654-07; Bishop KA, 2007, J VIROL, V81, P5893, DOI 10.1128/JVI.02022-06; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bossart KN, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-57; BOUSSE T, 1994, VIROLOGY, V204, P506, DOI 10.1006/viro.1994.1564; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Connolly SA, 2006, VIROLOGY, V355, P203, DOI 10.1016/j.virol.2006.07.021; Corey EA, 2007, J VIROL, V81, P9900, DOI 10.1128/JVI.00909-07; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; DENG RT, 1994, VIROLOGY, V204, P17, DOI 10.1006/viro.1994.1506; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; Finnegan C., 2006, Infectious Disorders - Drug Targets, V6, P355, DOI 10.2174/187152606779025851; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Lawrence MC, 2004, J MOL BIOL, V335, P1343, DOI 10.1016/j.jmb.2003.11.032; Lee B, 2008, NAT STRUCT MOL BIOL, V15, P540, DOI 10.1038/nsmb0608-540; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Lorio RM, 2008, TRENDS MICROBIOL, V16, P135, DOI 10.1016/j.tim.2008.01.006; MCCUBBIN WD, 1974, BIOCHEMISTRY-US, V13, P2689, DOI 10.1021/bi00710a005; MCGINNES L, 1993, VIROLOGY, V196, P101, DOI 10.1006/viro.1993.1458; Melanson VR, 2006, J VIROL, V80, P623, DOI 10.1128/JVI.80.2.623-633.2006; Melanson VR, 2004, J VIROL, V78, P13053, DOI 10.1128/JVI.78.23.13053-13061.2004; MIRZA AM, 1994, J VIROL, V68, P5093, DOI 10.1128/JVI.68.8.5093-5099.1994; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete OA, 2007, J VIROL, V81, P10804, DOI 10.1128/JVI.00999-07; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; Plemper RK, 2002, J VIROL, V76, P5051, DOI 10.1128/JVI.76.10.5051-5061.2002; Porotto M, 2003, J VIROL, V77, P3647, DOI 10.1128/JVI.77.6.3647-3654.2003; Porotto M, 2007, J VIROL, V81, P3216, DOI 10.1128/JVI.02617-06; Russell CJ, 2006, TRENDS MICROBIOL, V14, P243, DOI 10.1016/j.tim.2006.04.004; Russell CJ, 2003, J CELL BIOL, V163, P363, DOI 10.1083/jcb.200305130; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; SERGEL T, 1993, VIROLOGY, V193, P717, DOI 10.1006/viro.1993.1180; Stone-Hulslander J, 1999, J VIROL, V73, P3630, DOI 10.1128/JVI.73.5.3630-3637.1999; TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; WILD TF, 2008, PATHOL BIOL IN PRESS; Xu K, 2008, P NATL ACAD SCI USA, V105, P9953, DOI 10.1073/pnas.0804797105; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; YUASA T, 1995, VIROLOGY, V206, P1117, DOI 10.1006/viro.1995.1035; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004	45	70	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1628	1635		10.1074/jbc.M807469200	http://dx.doi.org/10.1074/jbc.M807469200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19019819	hybrid, Green Published			2022-12-27	WOS:000262330100031
J	Nakayama, M; Hisatsune, J; Yamasaki, E; Isomoto, H; Kurazono, H; Hatakeyama, M; Azuma, T; Yamaoka, Y; Yahiro, K; Moss, J; Hirayama, T				Nakayama, Masaaki; Hisatsune, Junzo; Yamasaki, Eiki; Isomoto, Hajime; Kurazono, Hisao; Hatakeyama, Masanori; Azuma, Takeshi; Yamaoka, Yoshio; Yahiro, Kinnosuke; Moss, Joel; Hirayama, Toshiya			Helicobacter pylori VacA-induced Inhibition of GSK3 through the PI3K/Akt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GASTRIC EPITHELIAL-CELLS; BETA-CATENIN SIGNAL; AZ-521 CELLS; VACUOLATING TOXIN; WNT PATHWAY; ACTIVATION; PROTEIN; INDUCTION; CYTOTOXIN	Helicobacter pylori VacA toxin contributes to the pathogenesis and severity of gastric injury. We found that incubation of AZ-521 cells with VacA resulted in phosphorylation of protein kinase B (Akt) and glycogen synthase kinase-3 beta (GSK3 beta) through a PI3K-dependent pathway. Following phosphorylation and inhibition of GSK3 beta,beta-catenin was released from a GSK3 beta/beta-catenin complex, with subsequent nuclear translocation. Methyl-beta-cyclodextrin (MCD) and phosphatidylinositol-specific phospholipase C (PIPLC), but not 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB) and bafilomycin A1, inhibited VacA-induced phosphorylation of Akt, indicating that it does not require VacA internalization and is independent of vacuolation. VacA treatment of AZ-521 cells transfected with TOPtkLuciferase reporter plasmid or control FOPtkLucifease reporter plasmid resulted in activation of TOPtkLuciferase, but not FOPtkLucifease. In addition, VacA transactivated the beta-catenin-dependent cyclin D1 promoter in a luciferase reporter assay. Infection of AZ-521 cells by a vacA mutant strain of H. pylori failed to induce phosphorylation of Akt and GSK3 beta, or release of beta-catenin from a GSK3 beta/beta-catenin complex. Taken together, these results support the conclusion that VacA activates the PI3K/Akt signaling pathway, resulting in phosphorylation and inhibition of GSK3 beta, and subsequent translocation of beta-catenin to the nucleus, consistent with effects of VacA on beta-catenin-regulated transcriptional activity. These data introduce the possibility that Wnt-dependent signaling might play a role in the pathogenesis of H. pylori infection, including the development of gastric cancer.	[Nakayama, Masaaki; Hisatsune, Junzo; Hirayama, Toshiya] Nagasaki Univ, Dept Bacteriol, Inst Trop Med, Nagasaki 8528523, Japan; [Yamasaki, Eiki; Kurazono, Hisao] Obihiro Univ Agr & Vet Med, Dept Appl Vet Med & Publ Hlth, Obihiro, Hokkaido 0808555, Japan; [Isomoto, Hajime] Nagasaki Univ, Dept Endoscopy, Sch Med, Nagasaki 8528523, Japan; [Hatakeyama, Masanori] Hokkaido Univ, Div Mol Oncol, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; [Azuma, Takeshi] Kobe Univ, Sch Med, Dept Gastroenterol, Kobe, Hyogo 6500017, Japan; [Yamaoka, Yoshio] Michael E DeBakey Vet Affairs Med Ctr, Dept Med Gastroenterol, Houston, TX 77030 USA; [Yamaoka, Yoshio] Baylor Coll Med, Houston, TX 77030 USA; [Yahiro, Kinnosuke; Moss, Joel] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA	Nagasaki University; Obihiro University of Agriculture & Veterinary Medicine; Nagasaki University; Hokkaido University; Kobe University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hirayama, T (corresponding author), Nagasaki Univ, Dept Bacteriol, Inst Trop Med, Nagasaki 8528523, Japan.	hirayama@net.nagasaki-u.ac.jp		Yahiro, Kinnosuke/0000-0002-9813-0780; Yamaoka, Yoshio/0000-0002-1222-5819	Intramural Research Program of the NHLBI; National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the NHLBI, National Institutes of Health (to J. M.). This work was also supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Clements WM, 2002, CANCER RES, V62, P3503; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; D'Elios MM, 2007, CLIN CHIM ACTA, V381, P32, DOI 10.1016/j.cca.2007.02.026; Doucas H, 2005, EUR J CANCER, V41, P365, DOI 10.1016/j.ejca.2004.11.005; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; Hisatsune J, 2007, INFECT IMMUN, V75, P4472, DOI 10.1128/IAI.00500-07; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Kurashima Y, 2008, INT J CANCER, V122, P823, DOI 10.1002/ijc.23190; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Li Y, 2004, MOL BIOL CELL, V15, P1946, DOI 10.1091/mbc.e03-08-0618; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; MANETTI R, 1995, INFECT IMMUN, V63, P4476, DOI 10.1128/IAI.63.11.4476-4480.1995; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nakayama M, 2004, J BIOL CHEM, V279, P7024, DOI 10.1074/jbc.M308898200; Nakayama M, 2006, INFECT IMMUN, V74, P6571, DOI 10.1128/IAI.00356-06; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; PAPINI E, 1993, MOL MICROBIOL, V7, P323, DOI 10.1111/j.1365-2958.1993.tb01123.x; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Szabo I, 1999, EMBO J, V18, P5517, DOI 10.1093/emboj/18.20.5517; Szabo IL, 2002, EXP BIOL MED, V227, P412, DOI 10.1177/153537020222700607; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; Yamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200; Yum HK, 2001, J IMMUNOL, V167, P6601, DOI 10.4049/jimmunol.167.11.6601	36	101	110	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1612	1619		10.1074/jbc.M806981200	http://dx.doi.org/10.1074/jbc.M806981200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18996844	hybrid, Green Published			2022-12-27	WOS:000262330100029
J	Jarczowski, F; Jahreis, G; Erdmann, F; Schierhorn, A; Fischer, G; Edlich, F				Jarczowski, Franziska; Jahreis, Guenther; Erdmann, Frank; Schierhorn, Angelika; Fischer, Gunter; Edlich, Frank			FKBP36 Is an Inherent Multifunctional Glyceraldehyde-3-phosphate Dehydrogenase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACHYTENE PRIMARY SPERMATOCYTES; GENE-EXPRESSION; RAT TESTES; HSP90; TISSUES; PROTEIN; CELLS; GAPDH; RNA	FKBP36 has been previously shown to be a crucial factor in spermatogenesis because of its interplay with the synaptonemal complex protein SCPI. Here we show that beyond this function, FKBP36 forms complexes with glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12) and Hsp90. Both proteins bind independently to different sites of the FKBP36 tetratricopeptide repeat domain. The interaction between FKBP36 and GAPDH directly inhibits the catalytic activity of GAPDH. In addition, FKBP36 expression causes a significant reduction of the GAPDH level and activity in COS-7 cells. Particularly in the cytosolic fraction, GAPDH was depleted by FKBP36 expression. Thus, FKBP36 diminishes GAPDH activity by direct interaction and down-regulation of GAPDH, which represents a previously unknown mechanism of GAPDH regulation and a novel function of FKBP36 in testis-specific signaling.	[Jarczowski, Franziska; Jahreis, Guenther; Erdmann, Frank; Schierhorn, Angelika; Fischer, Gunter; Edlich, Frank] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany	Max Planck Society	Edlich, F (corresponding author), NINDS, Surg Neurol Branch, NIH, Porter Neurosci Res Ctr, 35 Convent Dr,MSC 3704, Bethesda, MD 20892 USA.	fischer@enzyme-halle.mpg.de; edlichf@ninds.nih.gov	Erdmann, Frank/AAF-1091-2021	Erdmann, Frank/0000-0001-5261-0984	Sonderforschungsbereich 604 of the Deutsche Forschungsgemeinschaft	Sonderforschungsbereich 604 of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Sonderforschungsbereich 604 of the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALEXANDER MC, 1988, P NATL ACAD SCI USA, V85, P5092, DOI 10.1073/pnas.85.14.5092; Banerjee K, 1998, ALCOHOL CLIN EXP RES, V22, P2093, DOI 10.1111/j.1530-0277.1998.tb05921.x; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Buchczyk DP, 2003, BIOL CHEM, V384, P237, DOI 10.1515/BC.2003.026; Claeyssens S, 2003, AM J PHYSIOL-GASTR L, V285, pG840, DOI 10.1152/ajpgi.00060.2003; Crackower MA, 2003, SCIENCE, V300, P1291, DOI 10.1126/science.1083022; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; HENIS YI, 1980, P NATL ACAD SCI-BIOL, V77, P5055, DOI 10.1073/pnas.77.9.5055; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Meng X, 1998, GENOMICS, V52, P130, DOI 10.1006/geno.1998.5412; MEUNIER JC, 1978, EUR J BIOCHEM, V82, P483, DOI 10.1111/j.1432-1033.1978.tb12042.x; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Mohr S, 1996, J BIOL CHEM, V271, P4209; Nagradova NK, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1067, DOI 10.1023/A:1012472627801; NAKAMURA M, 1984, ANDROLOGIA, V16, P446; NAKAMURA M, 1984, BIOL REPROD, V30, P1187, DOI 10.1095/biolreprod30.5.1187; Olah J, 2006, FEBS LETT, V580, P5807, DOI 10.1016/j.febslet.2006.09.037; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; Pirkl F, 2001, J MOL BIOL, V308, P795, DOI 10.1006/jmbi.2001.4595; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; SMITH DF, 1993, J BIOL CHEM, V268, P18365; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Welch JE, 2006, MOL REPROD DEV, V73, P1052, DOI 10.1002/mrd.20235; Welch JE, 2000, J ANDROL, V21, P328; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; ZAKERI ZF, 1987, MOL CELL BIOL, V7, P1791, DOI 10.1128/MCB.7.5.1791; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	33	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					766	773		10.1074/jbc.M709779200	http://dx.doi.org/10.1074/jbc.M709779200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001379	hybrid			2022-12-27	WOS:000262122900010
J	Belenky, P; Christensen, KC; Gazzaniga, F; Pletnev, AA; Brenner, C				Belenky, Peter; Christensen, Kathryn C.; Gazzaniga, Francesca; Pletnev, Alexandre A.; Brenner, Charles			Nicotinamide Riboside and Nicotinic Acid Riboside Salvage in Fungi and Mammals QUANTITATIVE BASIS FOR Urh1 AND PURINE NUCLEOSIDE PHOSPHORYLASE FUNCTION IN NAD(+) METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIR2 PROTEIN; SIRTUINS; METHYLTHIOADENOSINE; POLY(ADP-RIBOSE); RIBOHYDROLASE; PURIFICATION; SYNTHETASE; MECHANISM; SUBSTRATE; ESTABLISH	NAD(+) is a co-enzyme for hydride transfer enzymes and an essential substrate of ADP-ribose transfer enzymes and sirtuins, the type III protein lysine deacetylases related to yeast Sir2. Supplementation of yeast cells with nicotinamide riboside extends replicative lifespan and increases Sir2-dependent gene silencing by virtue of increasing net NAD(+) synthesis. Nicotinamide riboside elevates NAD(+) levels via the nicotinamide riboside kinase pathway and by a pathway initiated by splitting the nucleoside into a nicotinamide base followed by nicotinamide salvage. Genetic evidence has established that uridine hydrolase, purine nucleoside phosphorylase, and methylthioadenosine phosphorylase are required for Nrk-independent utilization of nicotinamide riboside in yeast. Here we show that mammalian purine nucleoside phosphorylase but not methylthioadenosine phosphorylase is responsible for mammalian nicotinamide riboside kinase-independent nicotinamide riboside utilization. We demonstrate that so-called uridine hydrolase is 100-fold more active as a nicotinamide riboside hydrolase than as a uridine hydrolase and that uridine hydrolase and mammalian purine nucleoside phosphorylase cleave nicotinic acid riboside, whereas the yeast phosphorylase has little activity on nicotinic acid riboside. Finally, we show that yeast nicotinic acid riboside utilization largely depends on uridine hydrolase and nicotinamide riboside kinase and that nicotinic acid riboside bioavailability is increased by ester modification.	[Brenner, Charles] Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA; Dartmouth Med Sch, Dept Biochem, Lebanon, NH 03756 USA; Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Brenner, C (corresponding author), Dartmouth Med Sch, Dept Genet, Lebanon, NH 03756 USA.	charles.brenner@dartmouth.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Belenky, Peter/0000-0002-1682-945X	National Institutes of Health Training [T32GM008704]; Shaklee Corp.; National Science Foundation [MCB-0822581]; Div Of Molecular and Cellular Bioscience [0946313] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER	National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shaklee Corp.; National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Training Grant T32GM008704 (to P. B.). This work was also supported in part by a grant from the Shaklee Corp. and by National Science Foundation Grant MCB-0822581 (to C. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chattopadhyay MK, 2006, BIOCHEM BIOPH RES CO, V343, P203, DOI 10.1016/j.bbrc.2006.02.144; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Fernandez-Irigoyen J, 2008, BIOCHEM J, V411, P457, DOI 10.1042/BJ20071569; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guarente L, 2000, GENE DEV, V14, P1021; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; IMAI T, 1987, ARCH BIOCHEM BIOPHYS, V254, P253, DOI 10.1016/0003-9861(87)90101-9; Kurtz JE, 2002, CURR GENET, V41, P132, DOI 10.1007/s00294-002-0296-9; Lecoq K, 2001, J BACTERIOL, V183, P4910, DOI 10.1128/JB.183.16.4910-4913.2001; Lee HC, 2000, CHEM IMMUNOL, V75, P39; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Lovane E, 2008, BIOCHEMISTRY-US, V47, P4418, DOI 10.1021/bi702448s; Ma B, 2007, MOL MICROBIOL, V66, P14, DOI 10.1111/j.1365-2958.2007.05886.x; MAGNI G, 1975, J BIOL CHEM, V250, P9; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Mao C, 1998, BIOCHEMISTRY-US, V37, P7135, DOI 10.1021/bi9723919; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; Markert ML, 1997, HUM MUTAT, V9, P118, DOI 10.1002/(SICI)1098-1004(1997)9:2<118::AID-HUMU3>3.0.CO;2-5; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mitterbauer R, 2002, APPL ENVIRON MICROB, V68, P1336, DOI 10.1128/AEM.68.3.1336-1343.2002; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; ROWEN JW, 1951, J BIOL CHEM, V193, P497; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schramm Vern L, 2008, Nucleic Acids Symp Ser (Oxf), P75, DOI 10.1093/nass/nrn038; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Stoeckler JD, 1997, BIOCHEMISTRY-US, V36, P11749, DOI 10.1021/bi961971n; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; WielgusKutrowska B, 1997, EUR J BIOCHEM, V243, P408, DOI 10.1111/j.1432-1033.1997.0408a.x; Wojcik M, 2006, J BIOL CHEM, V281, P33395, DOI 10.1074/jbc.M607111200; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c; Ying WH, 2007, FRONT BIOSCI-LANDMRK, V12, P1863, DOI 10.2741/2194	43	58	61	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					158	164		10.1074/jbc.M807976200	http://dx.doi.org/10.1074/jbc.M807976200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001417	Green Published, hybrid			2022-12-27	WOS:000261974800018
J	Song, XF; Coffa, S; Fu, HA; Gurevich, VV				Song, Xiufeng; Coffa, Sergio; Fu, Haian; Gurevich, Vsevolod V.			How Does Arrestin Assemble MAPKs into a Signaling Complex?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NUCLEAR EXPORT SIGNAL; BETA-ARRESTIN; VISUAL ARRESTIN; CRYSTAL-STRUCTURE; REGULATED KINASES; FUNCTIONAL-CHARACTERIZATION; INOSITOL HEXAKISPHOSPHATE; SELF-ASSOCIATION; CONE ARRESTIN	Arrestins bind active phosphorylated G protein-coupled receptors, precluding G protein activation and channeling signaling to alternative pathways. Arrestins also function as mitogen-activated protein kinase (MAPK) scaffolds, bringing together three components of MAPK signaling modules. Here we have demonstrated that all four vertebrate arrestins interact with JNK3, MKK4, and ASK1, but only arrestin3 facilitates JNK3 activation. Thus, the functional specificity of arrestins is not determined by differential binding of the kinases. Using receptor binding-impaired mutant, we have shown that free arrestin3 readily promotes JNK3 phosphorylation. We identified key arrestin-binding elements in JNK3 and ASK1 and investigated the molecular interactions of arrestin2 and arrestin3 and their individual domains with the components of the two MAPK cascades, ASK1-MKK4-JNK3 and c-Raf-1-MEK1-ERK2. We found that both arrestin domains interact with all six kinases. These findings shed new light on the mechanism of arrestin-mediated MAPK activation and the spatial arrangement of the three kinases on arrestin molecule.	[Song, Xiufeng; Coffa, Sergio; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Fu, Haian] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA	Vanderbilt University; Emory University	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, 2200 Pierce Ave,PRB,Rm 418, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health [GM077561, GM081756, EY011500]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077561, GM081756, and EY011500 (to V. V. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed MR, 2008, J NEUROCHEM, V104, P1622, DOI 10.1111/j.1471-4159.2007.05104.x; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich V. V., 2008, V186, P15, DOI 10.1007/978-3-540-72843-6_2; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; GUREVICH VV, 1994, J BIOL CHEM, V269, P8721; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; GUREVICH VV, 2004, TIPS, V25, P59; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2008, BIOCHEMISTRY-US, V47, P1070, DOI 10.1021/bi7021359; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Johnson GL, 2005, CURR OPIN CHEM BIOL, V9, P325, DOI 10.1016/j.cbpa.2005.04.004; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; LUO J, 2008, MOL PHARM, V74, P312; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Smith WC, 2000, INVEST OPHTH VIS SCI, V41, P2445; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Waetzig V, 2003, J BIOL CHEM, V278, P567, DOI 10.1074/jbc.M207391200; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842	72	109	114	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					685	695		10.1074/jbc.M806124200	http://dx.doi.org/10.1074/jbc.M806124200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001375	hybrid, Green Published			2022-12-27	WOS:000261974800073
J	Caswell, CC; Barczyk, M; Keene, DR; Lukomska, E; Gullberg, DE; Lukomski, S				Caswell, Clayton C.; Barczyk, Malgorzata; Keene, Douglas R.; Lukomska, Ewa; Gullberg, Donald E.; Lukomski, Slawomir			Identification of the First Prokaryotic Collagen Sequence Motif That Mediates Binding to Human Collagen Receptors, Integrins alpha(2)beta(1) and alpha(11)beta(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; BACILLUS-ANTHRACIS; SURFACE PROTEIN; SCL2 PROTEINS; ALPHA(1)BETA(1); GLYCOPROTEIN; RECOGNITION; GFOGER; SITES	Many pathogenic bacteria interact with human integrins to enter host cells and to augment host colonization. Group A Streptococcus (GAS) employs molecular mimicry by direct interactions between the cell surface streptococcal collagen-like protein-1 (Scl1) and the human collagen receptor, integrin alpha(2)beta(1). The collagen-like (CL) region of the Scl1 protein mediates integrin-binding, although, the integrin binding motif was not defined. Here, we used molecular cloning and site-directed mutagenesis to identify the GLPGER sequence as the alpha(2)beta(1) and the alpha(11)beta(1) binding motif. Electron microscopy experiments mapped binding sites of the recombinant alpha(2)-integrin-inserted domain to the GLPGER motif of the recombinant Scl (rScl) protein. rScl proteins and a synthetic peptide harboring the GLPGER motif mediated the attachment of C2C12-alpha 2 + myoblasts expressing the alpha(2)beta(1) integrin as the sole collagen receptor. The C2C12-alpha(11) + myoblasts expressing the alpha(11)beta(1) integrin also attached to GLPGER-harboring rScl proteins. Furthermore, the C2C12-alpha(11) + cells attached to rScl1 more efficiently than C2C12-alpha(2) + cells, suggesting that the alpha(11)beta(1) integrin may have a higher binding affinity for the GLPGER sequence. Human endothelial cells and dermal fibroblasts adhered to rScl proteins, indicating that multiple cell types may recognize and bind the Scl proteins via their collagen receptors. This work is a stepping stone toward defining the utilization of collagen receptors by microbial collagen-like proteins that are expressed by pathogenic bacteria.	[Caswell, Clayton C.; Lukomska, Ewa; Lukomski, Slawomir] W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Lukomski, Slawomir] W Virginia Univ, Sch Med, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Barczyk, Malgorzata; Gullberg, Donald E.] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Keene, Douglas R.] Shriners Hosp Children, Portland, OR 97201 USA	West Virginia University; West Virginia University; University of Bergen	Lukomski, S (corresponding author), W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Box 9177, Morgantown, WV 26506 USA.	slukomski@hsc.wvu.edu	Gullberg, Donald/H-2495-2016	Gullberg, Donald/0000-0002-7245-4437	National Institutes of Health [AI50666]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI50666 (to S. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beres SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003026; BUJNICKI JM, 2003, FUNCTIONAL GENOMICS, P10; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; DAVIES M, 1992, KIDNEY INT, V41, P671, DOI 10.1038/ki.1992.103; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Engel J, 1997, SCIENCE, V277, P1785, DOI 10.1126/science.277.5333.1785; Gullberg Donald E., 2002, Progress in Histochemistry and Cytochemistry, V37, P3, DOI 10.1016/S0079-6336(02)80008-0; Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Karlstrom A, 2004, VET MICROBIOL, V104, P179, DOI 10.1016/j.vetmic.2004.09.014; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Layton BE, 2008, J MOL EVOL, V66, P539, DOI 10.1007/s00239-008-9111-7; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Paterson GK, 2008, FEMS MICROBIOL LETT, V285, P170, DOI 10.1111/j.1574-6968.2008.01217.x; Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200; Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; RUGGIERO F, 1994, EXP CELL RES, V210, P215, DOI 10.1006/excr.1994.1032; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Steichen C, 2003, J BACTERIOL, V185, P1903, DOI 10.1128/JB.185.6.1903-1910.2003; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Waller LN, 2005, J BACTERIOL, V187, P4592, DOI 10.1128/JB.187.13.4592-4597.2005; Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; ZUTTER MM, 1990, AM J PATHOL, V137, P113	40	64	66	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36168	36175		10.1074/jbc.M806865200	http://dx.doi.org/10.1074/jbc.M806865200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990704	hybrid, Green Published			2022-12-27	WOS:000261840500011
J	Higashi, S; Oeda, M; Yamamoto, K; Miyazaki, K				Higashi, Shouichi; Oeda, Miwa; Yamamoto, Kazuhiro; Miyazaki, Kaoru			Identification of Amino Acid Residues of Matrix Metalloproteinase-7 Essential for Binding to Cholesterol Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELLS; GELATINASE-A; MATRILYSIN; INHIBITOR; PRECURSOR; FRAGMENT; PROTEOLYSIS; PROGRESSION; SYNDECAN-1; MIGRATION	Matrix metalloproteinase-7 (MMP-7; matrilysin) induces homotypic adhesion of colon cancer cells by cleaving cell surface protein(s) and enhances their metastatic potential. Our previous study (Yamamoto, K., Higashi, S., Kioi, M., Tsunezumi, J., Honke, K., and Miyazaki, K. (2006) J. Biol. Chem. 281, 9170-9180) demonstrated that binding of MMP-7 to cell surface cholesterol sulfate (CS) is essential for the cell membrane-associated proteolytic action of the protease. To determine the region of MMP-7 essential for binding to CS, we constructed chimeric proteases consisting of various parts of MMP-7 and those of the catalytic domain of MMP-2; the latter protease does not have an affinity for CS. Studies of these chimeric proteases and other mutants of MMP-7 revealed that Ile(29), Arg(33), Arg(51), and Trp(55), in the internal sequence, and the C-terminal three residues corresponding to residues 171-173 of MMP-7 are essential for binding to CS. An MMP-7 mutant, which had the internal 4 residues at positions 29, 33, 51, and 55 of MMP-7 replaced with the corresponding residues of MMP-2 and the C-terminal 3 residues deleted, had essentially no affinity for CS. This mutant and wild-type MMP-7 showed similar proteolytic activity toward fibronectin, whereas the mutant lacked the ability to induce the colon cancer cell aggregation. In the three-dimensional structure of MMP-7, the residues essential for binding to CS are located on the molecular surface in the opposite side of the catalytic cleft of the protease. Therefore, it is assumed that the active site of MMP-7 bound to cell surface is directed outside. We speculate that the direction of the cell-bound MMP-7 makes it feasible for the protease to cleave its substrates on cell surface.	[Higashi, Shouichi; Oeda, Miwa; Yamamoto, Kazuhiro; Miyazaki, Kaoru] Yokohama City Univ, Int Grad Sch Arts & Sci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan	Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Int Grad Sch Arts & Sci, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	shigashi@yokohama-cu.ac.jp	Yamamoto, Kazuhiro/AAD-9650-2019		Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Ganguly B, 2007, FEBS LETT, V581, P5723, DOI 10.1016/j.febslet.2007.11.042; Haro H, 2000, J CLIN INVEST, V105, P143, DOI 10.1172/JCI7091; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; Higashi S, 2003, BIOCHEMISTRY-US, V42, P6514, DOI 10.1021/bi020643m; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Higashi S, 1999, J BIOL CHEM, V274, P10497, DOI 10.1074/jbc.274.15.10497; Higashi S, 2008, J BIOL CHEM, V283, P10068, DOI 10.1074/jbc.M709509200; Ishikawa T, 1996, CANCER LETT, V107, P5, DOI 10.1016/0304-3835(96)04336-4; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kioi M, 2003, ONCOGENE, V22, P8662, DOI 10.1038/sj.onc.1207181; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Mitsiades N, 2001, CANCER RES, V61, P577; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagashima Y, 1997, INT J CANCER, V72, P441, DOI 10.1002/(SICI)1097-0215(19970729)72:3<441::AID-IJC11>3.0.CO;2-F; Noe V, 2001, J CELL SCI, V114, P111; Oneda H, 1999, J BIOCHEM-TOKYO, V126, P905, DOI 10.1093/oxfordjournals.jbchem.a022533; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Yamamoto K, 2006, J BIOL CHEM, V281, P9170, DOI 10.1074/jbc.M510377200; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	29	23	23	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35735	35744		10.1074/jbc.M806285200	http://dx.doi.org/10.1074/jbc.M806285200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955490	hybrid			2022-12-27	WOS:000261687900047
J	Fomenko, DE; Novoselov, SV; Natarajan, SK; Lee, BC; Koc, A; Carlson, BA; Lee, TH; Kim, HY; Hatfield, DL; Gladyshev, VN				Fomenko, Dmitri E.; Novoselov, Sergey V.; Natarajan, Sathish Kumar; Lee, Byung Cheon; Koc, Ahmet; Carlson, Bradley A.; Lee, Tae-Hyung; Kim, Hwa-Young; Hatfield, Dolph L.; Gladyshev, Vadim N.			MsrB1 (Methionine-R-sulfoxide Reductase 1) Knock-out Mice ROLES OF MsrB1 IN REDOX REGULATION AND IDENTIFICATION OF A NOVEL SELENOPROTEIN FORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN OXIDATION; LIFE-SPAN; A MSRA; MOUSE; SELENIUM; CELLS; MITOCHONDRIAL; MAMMALS; STRESS; DAMAGE	Protein oxidation has been linked to accelerated aging and is a contributing factor to many diseases. Methionine residues are particularly susceptible to oxidation, but the resulting mixture of methionine R-sulfoxide (Met-RO) and methionine S-sulfoxide (Met-SO) can be repaired by thioredoxin-dependent enzymes MsrB and MsrA, respectively. Here, we describe a knock-out mouse deficient in selenoprotein MsrB1, the main mammalian MsrB located in the cytosol and nucleus. In these mice, in addition to the deletion of 14-kDa MsrB1, a 5-kDa selenoprotein form was specifically removed. Further studies revealed that the 5-kDa protein occurred in both mouse tissues and human HEK 293 cells; was down-regulated by MsrB1 small interfering RNA, selenium deficiency, and selenocysteine tRNA mutations; and was immunoprecipitated and recognized by MsrB1 antibodies. Specific labeling with Se-75 and mass spectrometry analyses revealed that the 5-kDa selenoprotein corresponded to the C-terminal sequence of MsrB1. The MsrB1 knock-out mice lacked both 5-and 14-kDa MsrB1 forms and showed reduced MsrB activity, with the strongest effect seen in liver and kidney. In addition, MsrA activity was decreased by MsrB1 deficiency. Liver and kidney of the MsrB1 knock-out mice also showed increased levels of malondialdehyde, protein carbonyls, protein methionine sulfoxide, and oxidized glutathione as well as reduced levels of free and protein thiols, whereas these parameters were little changed in other organs examined. Overall, this study established an important contribution of MsrB1 to the redox control in mouse liver and kidney and identified a novel form of this protein.	[Fomenko, Dmitri E.; Novoselov, Sergey V.; Natarajan, Sathish Kumar; Lee, Byung Cheon; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Fomenko, Dmitri E.; Novoselov, Sergey V.; Natarajan, Sathish Kumar; Lee, Byung Cheon; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Koc, Ahmet] Izmir Inst Technol, Dept Mol Biol & Genet, TR-35430 Izmir, Turkey; [Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, CCR,NIH, Bethesda, MD 20892 USA; [Lee, Tae-Hyung; Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Aging Associated Vasc Dis Res Ctr, Taegu 705717, South Korea	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Izmir Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeungnam University	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/J-6187-2013; KOÇ, AHMET/ABI-3322-2020; Gladyshev, Vadim N/A-9894-2013	KOÇ, AHMET/0000-0003-3484-2137; Novoselov, Sergey/0000-0003-0104-6492; Lee, Byung Cheon/0000-0003-1467-1940; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [AG021518, RR017675]; Korea Science and Engineering Foundation [R13-2005-005-01004-0]; NATIONAL CANCER INSTITUTE [ZIABC005317, ZIABC010889] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021518 (to V.N.G.) and the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health (to D.L.H.). The Nebraska Redox Biology Center is supported by National Institutes of Health Grant RR017675.This work was also supported by Korea Science and Engineering Foundation Grant R13-2005-005-01004-0 (to H.Y.K.). The costs of publication of this article were defrayed in part by the payment of page charges.This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C.Section 1734 solely to indicate this fact.	Burke D, 2002, ANIM COGN, V5, P79, DOI 10.1007/s10071-002-0131-1; Hansel A, 2005, BBA-PROTEINS PROTEOM, V1703, P239, DOI 10.1016/j.bbapap.2004.09.010; HAYASHI R, 1985, ANAL BIOCHEM, V149, P521, DOI 10.1016/0003-2697(85)90608-6; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kim HY, 2005, BIOCHEMISTRY-US, V44, P8059, DOI 10.1021/bi0501131; Kim HY, 2004, BIOCHEM BIOPH RES CO, V320, P1277, DOI 10.1016/j.bbrc.2004.06.078; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Marchetti MA, 2005, INVEST OPHTH VIS SCI, V46, P2107, DOI 10.1167/iovs.05-0018; Moskovitz J, 2003, P NATL ACAD SCI USA, V100, P7486, DOI 10.1073/pnas.1332607100; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Natarajan SK, 2006, J GASTROEN HEPATOL, V21, P947, DOI 10.1111/j.1440-1746.2006.04231.x; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; Oien D, 2007, AMINO ACIDS, V32, P603, DOI 10.1007/s00726-006-0448-1; Oien DB, 2008, FREE RADICAL BIO MED, V45, P193, DOI 10.1016/j.freeradbiomed.2008.04.003; Pal R, 2007, EXP BRAIN RES, V180, P765, DOI 10.1007/s00221-007-0903-6; Picot CR, 2006, EXP GERONTOL, V41, P663, DOI 10.1016/j.exger.2006.03.011; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Uthus EO, 2007, BIOL TRACE ELEM RES, V115, P265, DOI 10.1007/BF02686001; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	27	94	95	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5986	5993		10.1074/jbc.M805770200	http://dx.doi.org/10.1074/jbc.M805770200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	18990697	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000263560600062
J	Inoue, H; Kobayashi, T; Nozoye, T; Takahashi, M; Kakei, Y; Suzuki, K; Nakazono, M; Nakanishi, H; Mori, S; Nishizawa, NK				Inoue, Haruhiko; Kobayashi, Takanori; Nozoye, Tomoko; Takahashi, Michiko; Kakei, Yusuke; Suzuki, Kazumasa; Nakazono, Mikio; Nakanishi, Hiromi; Mori, Satoshi; Nishizawa, Naoko K.			Rice OsYSL15 Is an Iron-regulated Iron(III)-Deoxymugineic Acid Transporter Expressed in the Roots and Is Essential for Iron Uptake in Early Growth of the Seedlings	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTIANAMINE SYNTHASE GENES; FERRIC-CHELATE REDUCTASE; TRANSCRIPTION FACTOR; PHYTOSIDEROPHORE SYNTHESIS; MEMBRANE TRANSPORTER; YELLOW STRIPE1; CLONING; BARLEY; MAIZE; HOMEOSTASIS	Graminaceous plants take up iron through YS1 (yellow stripe 1) and YS1-like (YSL) transporters using iron-chelating compounds known as mugineic acid family phytosiderophores. We examined the expression of 18 rice (Oryza sativa L.) YSL genes (OsYSL1-18) in the epidermis/exodermis, cortex, and stele of rice roots. Expression of OsYSL15 in root epidermis and stele was induced by iron deficiency and showed daily fluctuation. OsYSL15 restored a yeast mutant defective in iron uptake when supplied with iron(III)-deoxymugineic acid and transported iron(III)-deoxymugineic acid in Xenopus laevis oocytes. An OsYSL15-green fluorescent protein fusion was localized to the plasma membrane when transiently expressed in onion epidermal cells. OsYSL15 promoter-beta-glucuronidase analysis revealed that OsYSL15 expression in roots was dominant in the epidermis/exodermis and phloem cells under conditions of iron deficiency and was detected only in phloem under iron sufficiency. These results strongly suggest that OsYSL15 is the dominant iron(III)-deoxymugineic acid transporter responsible for iron uptake from the rhizosphere and is also responsible for phloem transport of iron. OsYSL15 was also expressed in flowers, developing seeds, and in the embryonic scutellar epithelial cells during seed germination. OsYSL15 knockdown seedlings showed severe arrest in germination and early growth and were rescued by high iron supply. These results demonstrate that rice OsYSL15 plays a crucial role in iron homeostasis during the early stages of growth.	[Inoue, Haruhiko; Kobayashi, Takanori; Nozoye, Tomoko; Takahashi, Michiko; Kakei, Yusuke; Suzuki, Kazumasa; Nakazono, Mikio; Nakanishi, Hiromi; Mori, Satoshi; Nishizawa, Naoko K.] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Nishizawa, NK (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Kakei, Yusuke/AAF-7408-2020; Nakanishi, Hiromi/C-6461-2015	Nakanishi, Hiromi/0000-0001-5556-5058	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bagnaresi P, 1999, BIOCHEM J, V338, P499, DOI 10.1042/0264-6021:3380499; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; BRUNE M, 1992, J NUTR, V122, P442, DOI 10.1093/jn/122.3.442; Cheng LJ, 2007, PLANT PHYSIOL, V145, P1647, DOI 10.1104/pp.107.107912; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; DiDonato RJ, 2004, PLANT J, V39, P403, DOI 10.1111/j.1365-313X.2004.02128.x; DIX DR, 1994, J BIOL CHEM, V269, P26092; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Gendre D, 2007, PLANT J, V49, P1, DOI 10.1111/j.1365-313X.2006.02937.x; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Harada E, 2007, FEBS LETT, V581, P4298, DOI 10.1016/j.febslet.2007.08.011; Herbik A, 1999, EUR J BIOCHEM, V265, P231, DOI 10.1046/j.1432-1327.1999.00717.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; HOSHIKAWA K, 1989, GROWING RICE PLANT, P28; Inoue H, 2004, SOIL SCI PLANT NUTR, V50, P1133, DOI 10.1080/00380768.2004.10408586; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Inoue H, 2008, PLANT MOL BIOL, V66, P193, DOI 10.1007/s11103-007-9262-8; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; JACOBSEN T, 1983, CEREAL CHEM, V60, P392; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kobayashi T, 2003, PLANT J, V36, P780, DOI 10.1046/j.1365-313X.2003.01920.x; Kobayashi T, 2007, P NATL ACAD SCI USA, V104, P19150, DOI 10.1073/pnas.0707010104; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Le Jean M, 2005, PLANT J, V44, P769, DOI 10.1111/j.1365-313X.2005.02569.x; Lott JNA., 1984, SEED PHYSL, P139; Ma JF, 1999, PLANTA, V207, P590, DOI 10.1007/s004250050522; MA JF, 1993, PLANT PHYSIOL, V102, P373, DOI 10.1104/pp.102.2.373; Marschner H., 1995, MINERAL NUTR HIGHER, P313, DOI DOI 10.1016/B978-012473542-2/50011-0; MASON JB, 2001, MICRONUTRIENT REPORT, P1; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; Mihashi S., 1989, Biology of Metals, V2, P146, DOI 10.1007/BF01142553; Mizuno D, 2003, PLANT PHYSIOL, V132, P1989, DOI 10.1104/pp.102.019869; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; MORI S, 1991, PLANT SOIL, V130, P143, DOI 10.1007/BF00011869; MORRIS ER, 1976, J NUTR, V106, P753, DOI 10.1093/jn/106.6.753; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Nagasaka S, 2009, PLANT MOL BIOL, V69, P621, DOI 10.1007/s11103-008-9443-0; Nakazono M, 2003, PLANT CELL, V15, P583, DOI 10.1105/tpc.008102; Nozoye T, 2004, SOIL SCI PLANT NUTR, V50, P1125, DOI 10.1080/00380768.2004.10408585; Nozoye T, 2007, PLANT MOL BIOL, V64, P35, DOI 10.1007/s11103-007-9132-4; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; Raboy V, 1997, ADV CELL MOL BIOL PL, V4, P441; Roberts LA, 2004, PLANT PHYSIOL, V135, P112, DOI 10.1104/pp.103.037572; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; SASAMOTO H, 2005, ABSTR PLANT NUTR FOO, P1116; Schaaf G, 2005, PLANT CELL PHYSIOL, V46, P762, DOI 10.1093/pcp/pci081; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; SCHMIDKE I, 1995, PHYSIOL PLANTARUM, V95, P147, DOI 10.1111/j.1399-3054.1995.tb00821.x; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; Suzuki M, 2008, PLANT MOL BIOL, V66, P609, DOI 10.1007/s11103-008-9292-x; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; VONWIREN N, 1994, PLANT PHYSIOL, V106, P71, DOI 10.1104/pp.106.1.71; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586	68	324	349	6	72	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3470	3479		10.1074/jbc.M806042200	http://dx.doi.org/10.1074/jbc.M806042200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19049971	hybrid			2022-12-27	WOS:000262872500013
J	Ballabeni, A; Zamponi, R; Caprara, G; Melixetian, M; Bossi, S; Masiero, L; Helin, K				Ballabeni, Andrea; Zamponi, Raffaella; Caprara, Greta; Melixetian, Marina; Bossi, Sergio; Masiero, Laura; Helin, Kristian			Human CDT1 Associates with CDC7 and Recruits CDC45 to Chromatin during S Phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; XENOPUS EGG EXTRACTS; ORIGIN RECOGNITION COMPLEX; KINASE REGULATORY SUBUNIT; HUMAN CDC7-RELATED KINASE; CYCLIN-DEPENDENT KINASES; LICENSING FACTOR CDT1; CELL-CYCLE; MAMMALIAN-CELLS; PROTEIN-KINASE	The initiation of DNA replication is a tightly controlled process that involves the formation of distinct complexes at origins of DNA replication at specific periods of the cell cycle. Pre-replicative complexes are formed during telophase and early G(1). They rearrange at the start of S phase to form pre-initiation complexes, which are a prerequisite for DNA replication. The CDT1 protein is required for the formation of the pre-replicative complexes. Here we show that human CDT1 associates with the CDC7 kinase and recruits CDC45 to chromatin. Moreover, we show that the amount of CDT1 bound to chromatin is regulated by CDC7. We propose a model in which chromatin-bound CDT1 is first stabilized and subsequently displaced by CDC7 activity, thereby ensuring the timely execution of DNA replication.	[Ballabeni, Andrea; Zamponi, Raffaella; Caprara, Greta; Melixetian, Marina; Bossi, Sergio; Masiero, Laura; Helin, Kristian] European Inst Oncol, Dept Expt Oncol, I-20135 Milan, Italy; [Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark	IRCCS European Institute of Oncology (IEO); University of Copenhagen; University of Copenhagen	Helin, K (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20135 Milan, Italy.	kristian.helin@bric.dk	Caprara, Greta/AAM-8110-2020; Melixetian, Marine/AAR-1524-2020; Helin, Kristian/K-2526-2019; Zamponi, Raffaella/V-5683-2018; Helin, Kristian/HDM-8306-2022	Caprara, Greta/0000-0001-9975-4395; Melixetian, Marine/0000-0002-8454-8262; Helin, Kristian/0000-0003-1975-6097; Zamponi, Raffaella/0000-0002-3313-1387	Associazione Italiana per la Ricerca sul Cancro; Fondazione Italiana per la Ricerca sul Cancro; Danish Cancer Society; European Union	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Danish Cancer Society(Danish Cancer Society); European Union(European Commission)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro, Fondazione Italiana per la Ricerca sul Cancro, the Danish Cancer Society and the European Union. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; HEREFORD LM, 1974, J MOL BIOL, V84, P445, DOI 10.1016/0022-2836(74)90451-3; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kondo T, 2004, J BIOL CHEM, V279, P27315, DOI 10.1074/jbc.M314023200; Kulartz M, 2004, J BIOL CHEM, V279, P41686, DOI 10.1074/jbc.M405798200; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lei M, 2001, J CELL SCI, V114, P1447; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Maiorano D, 2005, CURR BIOL, V15, P146, DOI 10.1016/j.cub.2004.12.002; Maiorano D, 2004, EXP CELL RES, V295, P138, DOI 10.1016/j.yexcr.2003.11.018; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Masai H, 2005, IUBMB LIFE, V57, P323, DOI 10.1080/15216540500092419; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Owens JC, 1997, P NATL ACAD SCI USA, V94, P12521, DOI 10.1073/pnas.94.23.12521; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pasero P, 1999, GENE DEV, V13, P2159, DOI 10.1101/gad.13.16.2159; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shechter D, 2004, J BIOL CHEM, V279, P45586, DOI 10.1074/jbc.M407772200; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000; Zou L, 1997, MOL CELL BIOL, V17, P553, DOI 10.1128/MCB.17.2.553	61	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3028	3036		10.1074/jbc.M803609200	http://dx.doi.org/10.1074/jbc.M803609200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054765	hybrid			2022-12-27	WOS:000262700900047
J	Wang, CH; Liu, ML; Riojas, RA; Xin, XB; Gao, ZG; Zeng, R; Wu, JR; Dong, LQ; Liu, F				Wang, Changhua; Liu, Meilian; Riojas, Ramon A.; Xin, Xiaoban; Gao, Zhanguo; Zeng, Rong; Wu, Jiarui; Dong, Lily Q.; Liu, Feng			Protein Kinase C theta (PKC theta)-dependent Phosphorylation of PDK1 at Ser(504) and Ser(532) Contributes to Palmitate-induced Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACID; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; SKELETAL-MUSCLE CELLS; PKC-THETA; RECEPTOR SUBSTRATE-1; SIGNALING CASCADE; ACTIVATION; INHIBITION; EXPRESSION; LOCALIZATION	Clinical, epidemiological, and biochemical studies have highlighted the role of obesity-induced insulin resistance in various metabolic diseases. However, the underlying molecular mechanisms remain to be established. In the present study, we show that palmitate-induced serine phosphorylation of phosphoinositide-dependent protein kinase-1 (PDK1) negatively regulates insulin signaling. PDK1-mediated Akt phosphorylation at Thr(308) in the activation loop is reduced in C2C12 myotubes treated with palmitate or overexpressing protein kinase C theta (PKC theta), a kinase that has been implicated in hyperlipidemia-induced insulin resistance. Palmitate treatment also inhibited platelet-derived growth factor-stimulated Akt phosphorylation, suggesting that the inhibition could occur at a site independent of IRS1/2. The inhibitory effect of palmitate on PDK1 and Akt was diminished in PKC theta-deficient mouse embryonic fibroblasts (MEFs) by treating C2C12 myotubes with PKC theta pseudosubstrates. In vivo labeling studies revealed that PDK1 undergoes palmitate-induced phosphorylation at two novel sites, Ser(504) and Ser(532). Replacing Ser(504/532) with alanine disrupted PKC theta-catalyzed PDK1 phosphorylation in vitro and palmitate-induced PDK1 phosphorylation in cells. PDK1-deficient MEFs transiently expressing PDK1(S504A/S532A) but not PDK1(S504E/S532D) showed increased basal and insulin-stimulated Akt phosphorylation at Thr308 when compared with MEFs expressing wild-type PDK1. Taken together, our results identify PDK1 as a novel target in free fatty acid-induced insulin resistance and PKC theta as the kinase mediating the negative regulation.	[Wang, Changhua; Liu, Meilian; Dong, Lily Q.; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Riojas, Ramon A.; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Xin, Xiaoban; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Barshop Ctr Longev & Aging Studies, San Antonio, TX 78229 USA; [Gao, Zhanguo] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Zeng, Rong; Wu, Jiarui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Beijing 100864, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liu, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	liuf@uthscsa.edu	Xin, Xiaoban/D-2338-2012; Liu, Feng/CAG-8962-2022		American Diabetes Association; American Heart Association, Texas Affiliate [0355076Y]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056166, R01DK069930, R01DK080344] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); American Heart Association, Texas Affiliate(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a research award from the American Diabetes Association ( to F. L.) and Grant 0355076Y from the American Heart Association, Texas Affiliate ( to L. Q. D.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bell KS, 2000, AM J PHYSIOL-ENDOC M, V279, pE1196, DOI 10.1152/ajpendo.2000.279.5.E1196; BERTI L, 1994, J BIOL CHEM, V269, P3381; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chalfant CE, 2000, ENDOCRINOLOGY, V141, P2773, DOI 10.1210/en.141.8.2773; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dong LQ, 1999, J BIOL CHEM, V274, P8117, DOI 10.1074/jbc.274.12.8117; Donnelly R, 1998, CLIN EXP PHARMACOL P, V25, P79, DOI 10.1111/j.1440-1681.1998.tb02181.x; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Frayn Keith N., 1993, Current Opinion in Lipidology, V4, P197, DOI 10.1097/00041433-199306000-00004; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haasch D, 2006, BIOCHEM BIOPH RES CO, V343, P361, DOI 10.1016/j.bbrc.2006.02.177; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Kenchappa P, 2004, J NEUROSCI RES, V76, P466, DOI 10.1002/jnr.20081; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kondo T, 2004, J BIOL CHEM, V279, P37997, DOI 10.1074/jbc.M401339200; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Nakamura K, 2008, J BIOL CHEM, V283, P17702, DOI 10.1074/jbc.M802589200; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; STEINER G, 1980, DIABETES, V29, P899, DOI 10.2337/diabetes.29.11.899; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Wick MJ, 2002, J BIOL CHEM, V277, P16632, DOI 10.1074/jbc.M112402200; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	35	37	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2038	2044		10.1074/jbc.M806336200	http://dx.doi.org/10.1074/jbc.M806336200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047061	hybrid			2022-12-27	WOS:000262545600011
J	Rousseau, E; Kojima, R; Hoffner, G; Djian, P; Bertolotti, A				Rousseau, Erwann; Kojima, Rieko; Hoffner, Guylaine; Djian, Philippe; Bertolotti, Anne			Misfolding of Proteins with a Polyglutamine Expansion Is Facilitated by Proteasomal Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; HUNTINGTONS-DISEASE; REGULATORY PARTICLE; NEURODEGENERATIVE DISEASES; EXPANDED POLYGLUTAMINE; GLUTAMINE REPEATS; BINDING PROTEIN; 26S PROTEASOME; AGGREGATION; DEGRADATION	Deposition of misfolded proteins with a polyglutamine expansion is a hallmark of Huntington disease and other neurodegenerative disorders. Impairment of the proteolytic function of the proteasome has been reported to be both a cause and a consequence of polyglutamine accumulation. Here we found that the proteasomal chaperones that unfold proteins to be degraded by the proteasome but also have non-proteolytic functions colocalized with huntingtin inclusions both in primary neurons and in Huntington disease patients and formed a complex independently of the proteolytic particle. Overexpression of Rpt4 or Rpt6 facilitated aggregation of mutant huntingtin and ataxin-3 without affecting proteasomal degradation. Conversely, reducing Rpt6 or Rpt4 levels decreased the number of inclusions in primary neurons, indicating that endogenous Rpt4 and Rpt6 facilitate inclusion formation. In vitro reconstitution experiments revealed that purified 19S particles promote mutant huntingtin aggregation. When fused to the ornithine decarboxylase destabilizing sequence, proteins with expanded polyglutamine were efficiently degraded and did not aggregate. We propose that aggregation of proteins with expanded polyglutamine is not a consequence of a proteolytic failure of the 20S proteasome. Rather, aggregation is elicited by chaperone subunits of the 19S particle independently of proteolysis.	[Rousseau, Erwann; Kojima, Rieko; Bertolotti, Anne] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Hoffner, Guylaine; Djian, Philippe] Ctr Univ St Peres, Univ Paris Descartes, Unite Propre Rech 2228, CNRS, F-75006 Paris, France	MRC Laboratory Molecular Biology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Bertolotti, A (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	aberto@mrc-lmb.cam.ac.uk	Hoffner, Guylaine/A-4310-2009; HOFFNER, Guylaine/C-1563-2018	HOFFNER, Guylaine/0000-0001-7027-7919; Djian, Philippe/0000-0001-9586-0254	Fondation pour La Recherche sur le Cerveau; Fondation NRJ-Institut de France; MRC [MC_U105185860] Funding Source: UKRI; Medical Research Council [MC_U105185860] Funding Source: researchfish	Fondation pour La Recherche sur le Cerveau; Fondation NRJ-Institut de France(Fondation de France); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was initiated with support from the Fondation pour La Recherche sur le Cerveau and the Fondation NRJ-Institut de France. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Baker SP, 2005, CELL, V123, P361, DOI 10.1016/j.cell.2005.10.013; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Hoffner G, 2002, J CELL SCI, V115, P941; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kaytor MD, 2004, J NEUROCHEM, V89, P962, DOI 10.1111/j.1471-4159.2004.02376.x; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; Martin J, 2004, TRENDS BIOCHEM SCI, V29, P455, DOI 10.1016/j.tibs.2004.07.004; Masino L, 2002, FEBS LETT, V513, P267, DOI 10.1016/S0014-5793(02)02335-9; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pratt G, 2008, J BIOL CHEM, V283, P12919, DOI 10.1074/jbc.M709347200; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Rousseau E, 2004, P NATL ACAD SCI USA, V101, P9648, DOI 10.1073/pnas.0403015101; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schmidt T, 2002, ANN NEUROL, V51, P302, DOI 10.1002/ana.10101; Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Temussi PA, 2003, EMBO J, V22, P355, DOI 10.1093/emboj/cdg044; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zouambia M, 2008, PROTEOMICS, V8, P1221, DOI 10.1002/pmic.200700679	55	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1917	1929		10.1074/jbc.M806256200	http://dx.doi.org/10.1074/jbc.M806256200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18986984	hybrid, Green Published			2022-12-27	WOS:000262330100062
J	Kress, E; Rezza, A; Nadjar, J; Samarut, J; Plateroti, M				Kress, Elsa; Rezza, Amelie; Nadjar, Julien; Samarut, Jacques; Plateroti, Michelina			The Frizzled-related sFRP2 Gene Is a Target of Thyroid Hormone Receptor alpha 1 and Activates beta-Catenin Signaling in Mouse Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1 GENE; TR-ALPHA; PROTEIN EXPRESSION; WNT; COLON; LIVER; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; ASSOCIATION	The thyroid hormone receptor TR alpha 1 regulates intestinal development and homeostasis by controlling epithelial proliferation in the crypts. This involves positive control of the Wnt/beta-catenin pathway. To further investigate the effect of thyroid hormone-TR alpha 1 signaling on the intestinal epithelium proliferating compartment, we performed a comparative transcription profile analysis on laser microdissected crypt cells recovered from wild type animals with normal or perturbed hormonal status, as well as from TR knock-out mice. Statistical analysis and an in silico approach allowed us to identify 179 differentially regulated genes and to group them into organized functional networks. We focused on the "cell cycle/cell proliferation" network and, in particular, on the Frizzled-related protein sFRP2, whose expression was greatly increased in response to thyroid hormones. In vitro and in vivo analyses showed that the expression of sFRP2 is directly regulated by TR alpha 1 and that it activates beta-catenin signaling via Frizzled receptors. Indeed, sFRP2 stabilizes beta-catenin, activates its target genes, and enhances cell proliferation. In conclusion, these new data, in conjunction with our previous results, indicate a complex interplay between TR alpha 1 and components of the Wnt/beta-catenin pathway. Moreover, we describe in this study a novel mechanism of action of sFRP2, responsible for the activation of beta-catenin signaling.	[Kress, Elsa; Rezza, Amelie; Nadjar, Julien; Samarut, Jacques; Plateroti, Michelina] Univ Lyon 1, Ecole Normale Super Lyon, INRA, CNRS,Inst Genom Fonctionnelle Lyon, F-69364 Lyon 07, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Plateroti, M (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, INRA, CNRS,Inst Genom Fonctionnelle Lyon, 46 Allee Italie, F-69364 Lyon 07, France.	Michela.Plateroti@ens-lyon.fr	Samarut, Jacques/AAD-2587-2019; Plateroti, Michelina/F-2928-2017		Reseau National des Genopoles [186]; Agence Nationale pour la Recherche [ANR-06-BLAN-0232-01]; Ligue Nationale Contre le Cancer; European Network of excellence CRESCENDO	Reseau National des Genopoles; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); European Network of excellence CRESCENDO	This work was supported in part by the Reseau National des Genopoles Project 186, Agence Nationale pour la Recherche Grant ANR-06-BLAN-0232-01, Program Equipe Labelisee of the Ligue Nationale Contre le Cancer, and the European Network of excellence CRESCENDO. The costs of publication of this article were defrayed in part by the payment of page charges.	Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Bockhorn M, 2007, EUR SURG RES, V39, P58, DOI 10.1159/000098443; Buchholz DR, 2007, DEV BIOL, V303, P576, DOI 10.1016/j.ydbio.2006.11.037; Chandrasekaran C, 1996, J BIOL CHEM, V271, P28414, DOI 10.1074/jbc.271.45.28414; Cheng SY, 2003, MOL CELL ENDOCRINOL, V213, P23, DOI 10.1016/j.mce.2003.10.051; Cho SW, 2008, BIOCHEM BIOPH RES CO, V367, P399, DOI 10.1016/j.bbrc.2007.12.128; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Columbano A, 2006, ENDOCRINOLOGY, V147, P3211, DOI 10.1210/en.2005-1561; Flamant F, 2002, MOL ENDOCRINOL, V16, P24, DOI 10.1210/me.16.1.24; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Gonzalez-Sancho JM, 2003, CANCER LETT, V192, P121, DOI 10.1016/S0304-3835(02)00614-6; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Horkko TT, 2006, INT J CANCER, V118, P1653, DOI 10.1002/ijc.21556; IISHI H, 1992, INT J CANCER, V50, P974, DOI 10.1002/ijc.2910500625; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Jones SE, 2002, BIOESSAYS, V24, P811, DOI 10.1002/bies.10136; Karam Sherif M., 1999, Frontiers in Bioscience, V4, pD286, DOI 10.2741/Karam; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kress E, 2008, MOL ENDOCRINOL, V22, P47, DOI 10.1210/me.2007-0278; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; Lee JL, 2004, BREAST CANCER RES TR, V84, P139, DOI 10.1023/B:BREA.0000018412.83348.ff; Lee JL, 2003, IN VITRO CELL DEV-AN, V39, P221; Lin KH, 1999, MOL CARCINOGEN, V26, P53, DOI 10.1002/(SICI)1098-2744(199909)26:1<53::AID-MC7>3.0.CO;2-Z; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lynch J, 2003, ONCOGENE, V22, P6395, DOI 10.1038/sj.onc.1206770; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Miller LD, 2001, MOL CELL BIOL, V21, P6626, DOI 10.1128/MCB.21.19.6626-6639.2001; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Natsume H, 2003, BIOCHEM BIOPH RES CO, V309, P408, DOI 10.1016/j.bbrc.2003.08.019; PASQUINI JM, 1994, DEV NEUROSCI-BASEL, V16, P1, DOI 10.1159/000112080; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Plateroti M, 2001, MOL CELL BIOL, V21, P4761, DOI 10.1128/MCB.21.14.4761-4772.2001; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; ROSE DP, 1981, ARCH INTERN MED, V141, P1161, DOI 10.1001/archinte.141.9.1161; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stappenbeck TS, 2002, METHOD ENZYMOL, V356, P167; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tata JR, 2006, MOL CELL ENDOCRINOL, V246, P10, DOI 10.1016/j.mce.2005.11.024; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wang CS, 2002, CANCER LETT, V175, P121, DOI 10.1016/S0304-3835(01)00722-4; Wang HY, 2004, FRONT BIOSCI-LANDMRK, V9, P1043, DOI 10.2741/1310; Wang YS, 1996, J BIOL CHEM, V271, P4468; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yoshino K, 2001, MECH DEVELOP, V102, P45, DOI 10.1016/S0925-4773(01)00282-9	57	95	95	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1234	1241		10.1074/jbc.M806548200	http://dx.doi.org/10.1074/jbc.M806548200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001373	Green Published, hybrid			2022-12-27	WOS:000262122900059
J	Ozawa, D; Yagi, H; Ban, T; Kameda, A; Kawakami, T; Naiki, H; Goto, Y				Ozawa, Daisaku; Yagi, Hisashi; Ban, Tadato; Kameda, Atsushi; Kawakami, Toru; Naiki, Hironobu; Goto, Yuji			Destruction of Amyloid Fibrils of a beta(2)-Microglobulin Fragment by Laser Beam Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOFLAVIN-T; PROTEIN; BINDING; GROWTH; PROPAGATION; MATURATION; SUGGESTS; FORM	To understand the mechanism by which amyloid fibrils form, we have been making real-time observations of the growth of individual fibrils, using total internal fluorescence microscopy combined with an amyloid-specific fluorescence dye, thioflavin T (ThT). At neutral pH, irradiation at 442 nm with a laser beam to excite ThT inhibited the fibril growth of beta(2)-microglobulin (beta(2)-m), a major component of amyloid fibrils deposited in patients with dialysis-related amyloidosis. Examination with a 22-residue K3 fragment of beta(2)-m showed that the inhibition of fibril growth and moreover the destruction of preformed fibrils were coupled with the excitation of ThT. Several pieces of evidence suggest that the excited ThT transfers energy to ground state molecular oxygen, producing active oxygen, which causes various types of chemical modifications. The results imply a novel strategy for preventing the deposition of amyloid fibrils and for destroying preformed amyloid deposits.	[Ozawa, Daisaku; Yagi, Hisashi; Kameda, Atsushi; Kawakami, Toru; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Ozawa, Daisaku; Yagi, Hisashi; Kameda, Atsushi; Kawakami, Toru; Goto, Yuji] Japan Sci & Technol Agcy, CREST, Suita, Osaka 5650871, Japan; [Ban, Tadato] Natl Inst Adv Ind Sci & Technol, Osaka 5638577, Japan; [Naiki, Hironobu] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Fukui 9101193, Japan; [Naiki, Hironobu] Japan Sci & Technol Agcy, CREST, Fukui 9101193, Japan	Osaka University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); University of Fukui; Japan Science & Technology Agency (JST)	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014		Takeda Science Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology on Priority Areas [40153770]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Ministry of Education, Culture, Sports, Science and Technology on Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Takeda Science Foundation and by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology on Priority Areas (No. 40153770). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agon VV, 2006, FREE RADICAL BIO MED, V40, P698, DOI 10.1016/j.freeradbiomed.2005.09.039; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, J BIOL CHEM, V281, P33677, DOI 10.1074/jbc.M606072200; Ban T, 2006, ACCOUNTS CHEM RES, V39, P663, DOI 10.1021/ar050074l; Bieschke J, 2006, ACCOUNTS CHEM RES, V39, P611, DOI 10.1021/ar0500766; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Calabrese MF, 2007, J MOL BIOL, V367, P1, DOI 10.1016/j.jmb.2006.12.034; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Giuliano EA, 2007, VET OPHTHALMOL, V10, P337, DOI 10.1111/j.1463-5224.2007.00578.x; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Maskevich AA, 2007, J PROTEOME RES, V6, P1392, DOI 10.1021/pr0605567; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ohhashi Y, 2004, J BIOL CHEM, V279, P10814, DOI 10.1074/jbc.M310334200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yamamoto K, 2008, J MOL BIOL, V376, P258, DOI 10.1016/j.jmb.2007.12.002; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	40	40	41	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1009	1017		10.1074/jbc.M805118200	http://dx.doi.org/10.1074/jbc.M805118200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010783	Green Published, hybrid			2022-12-27	WOS:000262122900037
J	Sasaki, Y; Negishi, H; Koyama, R; Anbo, N; Ohori, K; Idogawa, M; Mita, H; Toyota, M; Imai, K; Shinomura, Y; Tokino, T				Sasaki, Yasushi; Negishi, Hideaki; Koyama, Ryota; Anbo, Naoki; Ohori, Kanae; Idogawa, Masashi; Mita, Hiroaki; Toyota, Minoru; Imai, Kohzoh; Shinomura, Yasuhisa; Tokino, Takashi			p53 Family Members Regulate the Expression of the Apolipoprotein D Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; ADENOVIRUS-MEDIATED TRANSFER; BREAST-CANCER CELLS; KINASE C-ABL; DIRECT TARGET; DNA-DAMAGE; DIFFERENTIAL EXPRESSION; RECOMBINANT ADENOVIRUS; APOPTOTIC RESPONSE; SPONTANEOUS TUMORS	p73 and p63 are members of the p53 gene family that play an important role in development and homeostasis, mainly by regulating transcription of a variety of genes. We report here that apolipoproteinD( apoD), a member of the lipocalin superfamily of lipid transport proteins, is a direct transcriptional target of the p53 family member genes. We found that the expression of apoD was specifically up-regulated by either TAp73 or TAp63 but not significantly by p53. In addition, apoD transcription is activated in response to cisplatin in a manner dependent on endogenous p73. By using small interference RNA designed to target p73, we demonstrated that silencing endogenous p73 abolishes induction of apoD transcription following cisplatin treatment. We also identified a p73/p63- binding site in the promoter of the apoD gene that is responsive to the p53 family members. The ectopic expression of TAp73 as well as the addition of recombinant human apoD to culture medium induced the osteoblastic differentiation of the human osteosarcoma cell line Saos-2, as assessed by alkaline phosphatase activity. Importantly, apoD knockdown abrogated p73-mediated alkaline phosphatase induction. Moreover, TAp73-mediated apoD expression was able to induce morphological differentiation, as well as expression of neuronal markers, in the human neuroblastoma cell line SH-SY5Y. These results suggest that apoD induction may mediate the activity of p73 in normal development.	[Sasaki, Yasushi; Negishi, Hideaki; Koyama, Ryota; Anbo, Naoki; Ohori, Kanae; Idogawa, Masashi; Mita, Hiroaki; Toyota, Minoru; Tokino, Takashi] Sapporo Med Univ, Canc Res Inst, Dept Mol Biol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Sasaki, Yasushi; Idogawa, Masashi; Mita, Hiroaki; Toyota, Minoru; Imai, Kohzoh; Shinomura, Yasuhisa] Sapporo Med Univ, Canc Res Inst, Dept Internal Med 1, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University	Tokino, T (corresponding author), Sapporo Med Univ, Canc Res Inst, Dept Mol Biol, Chuo Ku, S-1,W-17, Sapporo, Hokkaido 0608556, Japan.	tokino@sapmed.ac.jp	Idogawa, Masashi/B-5208-2008; Tokino, Takashi/AAI-9887-2021; Sasaki, Yasushi/AAA-3079-2019	Idogawa, Masashi/0000-0002-8507-1726; Sasaki, Yasushi/0000-0002-3500-8059	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for cancer research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agami R, 1999, NATURE, V399, P809; Bouvet M, 1998, CANCER RES, V58, P2288; Caserta TM, 2006, MOL CANCER RES, V4, P759, DOI 10.1158/1541-7786.MCR-05-0149; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chen XB, 2001, ONCOGENE, V20, P769, DOI 10.1038/sj.onc.1204149; Das S, 2005, CANCER GENE THER, V12, P417, DOI 10.1038/sj.cgt.7700803; Do Carmo S, 2002, J BIOL CHEM, V277, P5514, DOI 10.1074/jbc.M105057200; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; EL DW, 1993, CELL, V75, P817; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Frank DK, 1998, CLIN CANCER RES, V4, P2521; Ganfornina MD, 2005, DEV DYNAM, V232, P191, DOI 10.1002/dvdy.20193; Gong JG, 1999, NATURE, V399, P806; Hunter S, 2005, HUM PATHOL, V36, P987, DOI 10.1016/j.humpath.2005.06.018; Hunter S, 2002, J NEUROPATH EXP NEUR, V61, P275, DOI 10.1093/jnen/61.3.275; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Ishida S, 2000, JPN J CANCER RES, V91, P174, DOI 10.1111/j.1349-7006.2000.tb00929.x; Jin DC, 2006, INT J ONCOL, V29, P1591; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kalman J, 2000, NEUROL RES, V22, P330; Kobayashi D, 1996, J BIOCHEM, V119, P475; LopezBoado YS, 1997, CANCER RES, V57, P4091; LOPEZBOADO YS, 1994, J BIOL CHEM, V269, P26871; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; McNeish IA, 2004, GENE THER, V11, P497, DOI 10.1038/sj.gt.3302238; MEIRI KF, 1991, J CELL BIOL, V112, P991, DOI 10.1083/jcb.112.5.991; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Navarro A, 2004, J HISTOCHEM CYTOCHEM, V52, P1031, DOI 10.1369/jhc.3a6213.2004; Nishizaki M, 1999, CLIN CANCER RES, V5, P1015; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Oshima Y, 2007, CANCER BIOL THER, V6, P1058, DOI 10.4161/cbt.6.7.4320; Perez-Juste G, 1999, J BIOL CHEM, V274, P5026, DOI 10.1074/jbc.274.8.5026; Pozniak CD, 2002, J NEUROSCI, V22, P9800; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sanchez D, 2002, MECH DEVELOP, V110, P225, DOI 10.1016/S0925-4773(01)00578-0; Sarjeant JM, 2003, ARTERIOSCL THROM VAS, V23, P2172, DOI 10.1161/01.ATV.0000100404.05459.39; Sasaki Y, 2005, ONCOGENE, V24, P5131, DOI 10.1038/sj.onc.1208695; Sasaki Y, 2003, CANCER RES, V63, P8145; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Sasaki Y, 2001, GENE THER, V8, P1401, DOI 10.1038/sj.gt.3301538; Sasaki Y, 2008, MOL CANCER RES, V6, P395, DOI 10.1158/1541-7786.MCR-07-0108; SUGIMOTO K, 1994, J STEROID BIOCHEM, V51, P167, DOI 10.1016/0960-0760(94)90090-6; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; Utsunomiya T, 2005, INT J CANCER, V116, P105, DOI 10.1002/ijc.20986; Vazquez J, 2000, GYNECOL ONCOL, V76, P340, DOI 10.1006/gyno.1999.5678; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Walker DW, 2006, CURR BIOL, V16, P674, DOI 10.1016/j.cub.2006.01.057; Walsh GS, 2004, J NEUROSCI, V24, P9638, DOI 10.1523/JNEUROSCI.1299-04.2004; WEECH PK, 1991, PROG LIPID RES, V30, P259, DOI 10.1016/0163-7827(91)90023-X; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zheng XJ, 2001, FEBS LETT, V489, P4, DOI 10.1016/S0014-5793(00)02437-6	68	19	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					872	883		10.1074/jbc.M807185200	http://dx.doi.org/10.1074/jbc.M807185200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001418	hybrid			2022-12-27	WOS:000262122900022
J	Wimmer, B; Raja, M; Hinterdorfer, P; Gruber, HJ; Kinne, RKH				Wimmer, Barbara; Raja, Mobeen; Hinterdorfer, Peter; Gruber, Hermann J.; Kinne, Rolf K. -H.			C-terminal Loop 13 of Na+/Glucose Cotransporter 1 Contains Both Stereospecific and Non-stereospecific Sugar Interaction Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANES; GLUCOSE COTRANSPORTER; COMPETITIVE INHIBITION; FORCE MICROSCOPY; RAT KIDNEY; SGLT1; BINDING; PHLORHIZIN; TRANSPORT; SODIUM	To investigate whether the C-terminal loop 13 of rabbit sodium/glucose cotransporter SGLT1 is involved in the recognition of the substrate D-glucose, isolated loop 13 (amino acids (aa) 541-638) was immobilized to a lipid bilayer. Interactions were investigated by surface plasmon resonance spectroscopy using an antibody directed against the late part of the loop (aa 606 631) or the glucoside transport inhibitor phlorizin. Specific binding of the antibody to the loop could be detected. The number of bound antibodies decreased upon the addition of D-glucose but not upon the addition of L-glucose. Phlorizin also significantly lowered the number of bound antibodies. Binding of phlorizin to the loop could also be demonstrated directly. Binding of phlorizin was, however, reduced to a similar extent upon the addition of either D-glucose or L-glucose, indicating their unspecific competition with the inhibitor's sugar moiety. Thus, the presence of a stereospecific glucose interaction site in the late part of the loop and a second, but non-stereospecific, sugar binding site on the same loop was assumed. To investigate whether the early part of loop 13 contains this non-stereospecific sugar binding site, peptides containing aa 541-598 were expressed in Escherichia coli and purified. Both D-glucose and L-glucose quenched the peptides tryptophan fluorescence and reduced the Trp accessibility to acrylamide to a similar degree. In view of the recently proposed transmembrane orientation of loop 13, the two binding sites may be part of the extracellular (stereospecific) and intracellular (non-stereospecific) sugar interaction sites of SGLT1.	[Wimmer, Barbara; Raja, Mobeen; Kinne, Rolf K. -H.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Wimmer, Barbara; Raja, Mobeen; Hinterdorfer, Peter; Gruber, Hermann J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria	Max Planck Society; Johannes Kepler University Linz	Kinne, RKH (corresponding author), Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	barbara.wimmer@mymail.unisa.edu.au; rolf.kinne@mpi-dortmund.mpg.de	Gruber, Hermann J./C-4234-2013; Hinterdorfer, Peter/C-4235-2013	Hinterdorfer, Peter/0000-0003-2583-1305	Austrian Science Fund [FWF 0350300]; Max Planck Society	Austrian Science Fund(Austrian Science Fund (FWF)); Max Planck Society(Max Planck Society)	This work was supported by Austrian Science Fund Project FWF 0350300 and the Max Planck Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARFUSS DW, 1981, AM J PHYSIOL, V241, pF322, DOI 10.1152/ajprenal.1981.241.3.F322; BAUMANN K, 1969, PFLUG ARCH EUR J PHY, V305, P155, DOI 10.1007/BF00585842; Berteloot A, 2003, J MEMBRANE BIOL, V192, P89, DOI 10.1007/s00232-002-1066-9; DIEDRICH DF, 1966, ARCH BIOCHEM BIOPHYS, V117, P248, DOI 10.1016/0003-9861(66)90409-7; Diez-Sampedro A, 2004, BIOCHEMISTRY-US, V43, P13175, DOI 10.1021/bi048652d; Erb EM, 2000, ANAL BIOCHEM, V280, P29, DOI 10.1006/abio.1999.4469; Firnges MA, 2001, J MEMBRANE BIOL, V179, P143, DOI 10.1007/s002320010044; FRASCH W, 1970, PFLUG ARCH EUR J PHY, V320, P265, DOI 10.1007/BF00587458; GLOSSMANN H, 1972, J BIOL CHEM, V247, P7779; Holzl M, 2007, LANGMUIR, V23, P5571, DOI 10.1021/la0627664; Kipp H, 1996, BBA-BIOMEMBRANES, V1282, P124, DOI 10.1016/0005-2736(96)00049-1; Kipp H, 1997, AM J PHYSIOL-REG I, V273, pR134, DOI 10.1152/ajpregu.1997.273.1.R134; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lin JT, 1999, J MEMBRANE BIOL, V170, P243, DOI 10.1007/s002329900553; LOWRY OH, 1951, J BIOL CHEM, V193, P25; Mizuma T, 1998, BBA-GEN SUBJECTS, V1381, P340, DOI 10.1016/S0304-4165(98)00061-0; Novakova R, 2001, J MEMBRANE BIOL, V184, P55, DOI 10.1007/s00232-001-0073-6; PANAYOTOVAHEIERMANN M, 1994, J BIOL CHEM, V269, P21016; PanayotovaHeiermann M, 1997, J BIOL CHEM, V272, P20324, DOI 10.1074/jbc.272.33.20324; PanayotovaHeiermann M, 1996, J BIOL CHEM, V271, P10029, DOI 10.1074/jbc.271.17.10029; Puntheeranurak T, 2007, BIOCHEMISTRY-US, V46, P2797, DOI 10.1021/bi061917z; Puntheeranurak T, 2006, J CELL SCI, V119, P2960, DOI 10.1242/jcs.03035; Raja MM, 2005, BIOCHEMISTRY-US, V44, P9123, DOI 10.1021/bi050323d; Raja MM, 2003, J BIOL CHEM, V278, P49154, DOI 10.1074/jbc.M306881200; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; TURNER RJ, 1977, P NATL ACAD SCI USA, V74, P2825, DOI 10.1073/pnas.74.7.2825; Tyagi NK, 2007, BIOCHEMISTRY-US, V46, P13616, DOI 10.1021/bi701193x; Vayro S, 1999, AM J PHYSIOL-CELL PH, V276, pC1053, DOI 10.1152/ajpcell.1999.276.5.C1053; Wielert-Badt S, 2000, J MED CHEM, V43, P1692, DOI 10.1021/jm9905460; Wielert-Badt S, 2002, BIOPHYS J, V82, P2767, DOI 10.1016/S0006-3495(02)75617-8; WIMMER B, 2005, THESIS J KEPLER U LI; Xia XB, 2003, BIOCHEMISTRY-US, V42, P6115, DOI 10.1021/bi020695b	32	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					983	991		10.1074/jbc.M805082200	http://dx.doi.org/10.1074/jbc.M805082200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010790	hybrid			2022-12-27	WOS:000262122900034
J	Raber, ML; Freeman, MF; Townsend, CA				Raber, Mary L.; Freeman, Michael F.; Townsend, Craig A.			Dissection of the Stepwise Mechanism to beta-Lactam Formation and Elucidation of a Rate-determining Conformational Change in beta-Lactam Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-CATALYZED REACTIONS; BARRIER HYDROGEN-BOND; CLAVULANIC ACID; STREPTOMYCES-CLAVULIGERUS; TRIOSEPHOSPHATE ISOMERASE; CARBAPENAM SYNTHETASE; CHEMICAL MECHANISMS; KINETIC MECHANISM; TRANSITION-STATE; PRODUCT RELEASE	Clavulanic acid is a widely used beta-lactamase inhibitor whose key beta-lactam core is formed by beta-lactam synthetase. beta-Lactam synthetase exhibits a Bi-Ter mechanism consisting of two chemical steps, acyl-adenylation followed by beta-lactam formation. (PPi)-P-32-ATP exchange assays showed the first irreversible step of catalysis is acyl-adenylation. From a small, normal solvent isotope effect (1.38 +/- 0.04), it was concluded that beta-lactam synthesis contributes at least partially to k(cat). Site-specific mutation of Lys-443 identified this residue as the ionizable group at pK(a) similar to 8.1 apparent in the pH-k(cat) profile that stabilizes the beta-lactam-forming step. Viscosity studies demonstrated that a protein conformational change was also partially rate-limiting on kcat attenuating the observed solvent isotope effect on beta-lactam formation. Adherence to Kramers' theory gave a slope of 1.66 +/- 0.08 from a plot of log((o)k(cat)/k(cat)) versus log(eta/eta(o)) consistent with opening of a structured loop visible in x-ray data preceding product release. Internal "friction" within the enzyme contributes to a slope of > 1 in this analysis. Correspondingly, earlier in the catalytic cycle ordering of a mobile active site loop upon substrate binding was manifested by an inverse solvent isotope effect (0.67 +/- 0.15) on k(cat)/K-m. The increased second-order rate constant in heavy water was expected from ordering of this loop over the active site imposing torsional strain. Finally, an Eyring plot displayed a large enthalpic change accompanying loop movement (Delta H double dagger similar to 20 kcal/mol) comparable to the chemical barrier of beta-lactam formation.	[Raber, Mary L.; Townsend, Craig A.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA; [Freeman, Michael F.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Townsend, CA (corresponding author), 3400 N Charles St, Baltimore, MD 21218 USA.	ctownsend@jhu.edu	Johnson, Mary L Raber/AAF-3596-2020; Freeman, Michael/AIA-1555-2022	Johnson, Mary L Raber/0000-0003-4334-114X; Freeman, Michael/0000-0002-0491-9618	National Institutes of Health [AI014937]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014937, R01AI014937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI014937. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALMAGOR A, 1992, BIOPHYS J, V61, P480, DOI 10.1016/S0006-3495(92)81852-0; ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Anslyn E.V., 2006, MODERN PHYS ORGANIC, P365; Arnett SO, 2007, BIOCHEMISTRY-US, V46, P9337, DOI 10.1021/bi0618464; Bachmann BO, 2000, BIOCHEMISTRY-US, V39, P11187, DOI 10.1021/bi000709i; Bachmann BO, 1998, P NATL ACAD SCI USA, V95, P9082, DOI 10.1073/pnas.95.16.9082; Baggaley KH, 1997, NAT PROD REP, V14, P309, DOI 10.1039/np9971400309; BAZELYANSKY M, 1986, BIOCHEMISTRY-US, V25, P125, DOI 10.1021/bi00349a019; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; Boehlein SK, 1998, BIOCHEMISTRY-US, V37, P13230, DOI 10.1021/bi981058h; Bott RR, 2003, BIOCHEMISTRY-US, V42, P10545, DOI 10.1021/bi034773m; BROUWER AC, 1982, BIOCHEMISTRY-US, V21, P1302, DOI 10.1021/bi00535a030; Chen GJ, 1997, BIOCHEMISTRY-US, V36, P4278, DOI 10.1021/bi9618676; Chopra S, 2006, BIOCHEMISTRY-US, V45, P6596, DOI 10.1021/bi052504l; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; CLELAND WW, 1987, BIOORG CHEM, V15, P283, DOI 10.1016/0045-2068(87)90026-5; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; CLELAND WW, 1982, METHOD ENZYMOL, V87, P390; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Elander RP, 2003, APPL MICROBIOL BIOT, V61, P385, DOI 10.1007/s00253-003-1274-y; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Frisch C, 2001, J MOL BIOL, V308, P69, DOI 10.1006/jmbi.2001.4577; GAVISH B, 1979, BIOCHEMISTRY-US, V18, P1269, DOI 10.1021/bi00574a023; GAVISH B, 1980, PHYS REV LETT, V44, P1160, DOI 10.1103/PhysRevLett.44.1160; Gerratana B, 2003, BIOCHEMISTRY-US, V42, P7836, DOI 10.1021/bi034361d; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hung, 2007, J MICROBIOL BIOTECHN, V17, P1538; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8454, DOI 10.1021/bi00098a024; Jensen SE, 1999, ANTON LEEUW INT J G, V75, P125, DOI 10.1023/A:1001755724055; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; Kershaw NJ, 2005, CHEM COMMUN, P4251, DOI 10.1039/b505964j; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Li RF, 2000, J BACTERIOL, V182, P4087, DOI 10.1128/JB.182.14.4087-4095.2000; Li RF, 2006, METAB ENG, V8, P240, DOI 10.1016/j.ymben.2006.01.003; Lloyd MD, 1999, TETRAHEDRON, V55, P10201, DOI 10.1016/S0040-4020(99)00547-5; LUMRY R, 1951, J AM CHEM SOC, V73, P4330, DOI 10.1021/ja01153a090; MASSEY V, 1966, J BIOL CHEM, V241, P2347; MCELROY WD, 1967, SCIENCE, V157, P150, DOI 10.1126/science.157.3785.150; McGowan SJ, 1996, MOL MICROBIOL, V22, P415, DOI 10.1046/j.1365-2958.1996.00125.x; McKay GA, 1996, BIOCHEMISTRY-US, V35, P8680, DOI 10.1021/bi9603884; Miller MT, 2003, J BIOL CHEM, V278, P40996, DOI 10.1074/jbc.M307901200; Miller MT, 2002, P NATL ACAD SCI USA, V99, P14752, DOI 10.1073/pnas.232361199; Mukherjee A, 2007, BIOCHEMISTRY-US, V46, P3975, DOI 10.1021/bi602502j; NG KM, 1991, BIOPHYS CHEM, V39, P57, DOI 10.1016/0301-4622(91)85006-C; Northrop DB, 2000, BIOPHYS J, V79, P1621, DOI 10.1016/S0006-3495(00)76412-5; Northrop DB, 2001, ACCOUNTS CHEM RES, V34, P790, DOI 10.1021/ar000184m; NORTHROP DB, 1996, HIGH PRESSURE EFFECT, P222; OhOka H, 1997, BIOCHEMISTRY-US, V36, P9267, DOI 10.1021/bi9701787; Otero C, 2005, J MOL CATAL B-ENZYM, V32, P225, DOI 10.1016/j.molcatb.2004.12.008; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; QUINN DM, 1985, BIOCHEMISTRY-US, V24, P3144, DOI 10.1021/bi00334a011; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; RAINES RT, 1987, BIOCHEMISTRY-US, V26, P7014, DOI 10.1021/bi00396a024; REBHOLZ KL, 1991, BIOCHEM BIOPH RES CO, V176, P65, DOI 10.1016/0006-291X(91)90890-J; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Rozovsky S, 2007, P NATL ACAD SCI USA, V104, P2080, DOI 10.1073/PNAS.0608876104; Schlarb-Ridley BG, 2005, BIOCHEMISTRY-US, V44, P6232, DOI 10.1021/bi047322q; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Schowen R. L, 1978, TRANSIT STATES BIOCH, P225; Sierks MR, 1997, BIOTECHNOL PROGR, V13, P601, DOI 10.1021/bp9700824; Silver LL, 2007, EXPERT OPIN THER PAT, V17, P1175, DOI 10.1517/13543776.17.9.1175; Simpson IN, 2003, J ANTIBIOT, V56, P838, DOI 10.7164/antibiotics.56.838; Sleeman MC, 2002, BIOORG MED CHEM LETT, V12, P597, DOI 10.1016/S0960-894X(01)00806-X; TAYLOR JR, 1997, INTRO ERROR ANAL, P57; Toulokhonova L, 2003, J BIOL CHEM, V278, P4582, DOI 10.1074/jbc.M210471200; Townsend CA, 2002, CURR OPIN CHEM BIOL, V6, P583, DOI 10.1016/S1367-5931(02)00392-7; VANPELT JE, 1984, ARCH BIOCHEM BIOPHYS, V230, P250, DOI 10.1016/0003-9861(84)90106-1	69	23	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					207	217		10.1074/jbc.M805390200	http://dx.doi.org/10.1074/jbc.M805390200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18955494	Green Published, hybrid			2022-12-27	WOS:000261974800024
J	Kitamura, M; Okuyama, M; Tanzawa, F; Mori, H; Kitago, Y; Watanabe, N; Kimura, A; Tanaka, I; Yao, M				Kitamura, Momoyo; Okuyama, Masayuki; Tanzawa, Fumiko; Mori, Haruhide; Kitago, Yu; Watanabe, Nobuhisa; Kimura, Atsuo; Tanaka, Isao; Yao, Min			Structural and Functional Analysis of a Glycoside Hydrolase Family 97 Enzyme from Bacteroides thetaiotaomicron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MALTOGENIC AMYLASE; ALPHA-GLUCOSIDASE; PROTEIN; CLASSIFICATION; STARCH; CYCLOMALTODEXTRINASE; NEOPULLULANASE; COMBINATION; PULLULAN	SusB, an 84-kDa alpha-glucoside hydrolase involved in the starch utilization system (sus) of Bacteroides thetaiotaomicron, belongs to glycoside hydrolase (GH) family 97. We have determined the enzymatic characteristics and the crystal structures in free and acarbose-bound form at 1.6 angstrom resolution. SusB hydrolyzes the alpha-glucosidic linkage, with inversion of anomeric configuration liberating the beta-anomer of glucose as the reaction product. The substrate specificity of SusB, hydrolyzing not only alpha-1,4-glucosidic linkages but also alpha-1,6-, alpha-1,3-, and alpha-1,2-glucosidic linkages, is clearly different from other well known glucoamylases belonging to GH15. The structure of SusB was solved by the single-wavelength anomalous diffraction method with sulfur atoms as anomalous scatterers using an in-house x-ray source. SusB includes three domains as follows: the N-terminal, catalytic, and C-terminal domains. The structure of the SusB-acarbose complex shows a constellation of carboxyl groups at the catalytic center; Glu(532) is positioned to provide protonic assistance to leaving group departure, with Glu(439) and Glu(508) both positioned to provide base-catalyzed assistance for inverting nucleophilic attack by water. A structural comparison with other glycoside hydrolases revealed significant similarity between the catalytic domain of SusB and those of alpha-retaining glycoside hydrolases belonging to GH27, -36, and -31 despite the differences in catalytic mechanism. SusB and the other retaining enzymes appear to have diverged from a common ancestor and individually acquired the functional carboxyl groups during the process of evolution. Furthermore, sequence comparison of the active site based on the structure of SusB indicated that GH97 included both retaining and inverting enzymes.	[Kitamura, Momoyo; Kitago, Yu; Watanabe, Nobuhisa; Tanaka, Isao; Yao, Min] Hokkaido Univ, Grad Sch Agr, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan; [Okuyama, Masayuki; Tanzawa, Fumiko; Mori, Haruhide; Kimura, Atsuo] Hokkaido Univ, Grad Sch Agr, Fac Appl Biosci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University	Yao, M (corresponding author), Hokkaido Univ, Grad Sch Agr, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan.	yao@castor.sci.hokudai.ac.jp	Watanabe, Nobuhisa/B-1187-2008; Okuyama, Masayuki/D-8739-2012; yao, min/F-5287-2011; Mori, Haruhide/B-7777-2012; Mori, Haruhide/AAV-6374-2021	Watanabe, Nobuhisa/0000-0002-0118-5815; Okuyama, Masayuki/0000-0001-7013-6032; yao, min/0000-0003-1687-5904; Mori, Haruhide/0000-0001-7346-9131; Kitago, Yu/0000-0003-2325-6917	National Project on Protein Structural and Functional Analyses; Ministry of Education, Culture, Sports, Science, and Technology of Japan	National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe A, 2005, FEBS J, V272, P6145, DOI 10.1111/j.1742-4658.2005.05013.x; Aleshin AE, 2003, J MOL BIOL, V327, P61, DOI 10.1016/S0022-2836(03)00084-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho KH, 2001, J BACTERIOL, V183, P7198, DOI 10.1128/JB.183.24.7198-7205.2001; Comstock LE, 2003, BIOESSAYS, V25, P926, DOI 10.1002/bies.10350; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DElla JN, 1996, J BACTERIOL, V178, P7173; Della JN, 1996, J BACTERIOL, V178, P7180; Dominguez R, 1996, J MOL BIOL, V257, P1042, DOI 10.1006/jmbi.1996.0222; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hughes CV, 2003, ORAL MICROBIOL IMMUN, V18, P309, DOI 10.1034/j.1399-302X.2003.00091.x; Kamitori S, 1999, J MOL BIOL, V287, P907, DOI 10.1006/jmbi.1999.2647; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Kitago Y, 2005, ACTA CRYSTALLOGR D, V61, P1013, DOI 10.1107/S0907444905012734; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mikami B, 1999, BIOCHEMISTRY-US, V38, P7050, DOI 10.1021/bi9829377; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mosi R, 1998, BIOCHEMISTRY-US, V37, P17192, DOI 10.1021/bi981109a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park KH, 2000, BBA-PROTEIN STRUCT M, V1478, P165, DOI 10.1016/S0167-4838(00)00041-8; PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2; Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997; SMITH KA, 1991, J BACTERIOL, V173, P2962, DOI 10.1128/JB.173.9.2962-2968.1991; SVENSSON B, 1992, CARBOHYD RES, V227, P29, DOI 10.1016/0008-6215(92)85059-9; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P17, DOI 10.1107/S0907444993008236; Thoden JB, 2002, J BIOL CHEM, V277, P20854, DOI 10.1074/jbc.M201415200; TRUSCHEIT E, 1981, ANGEW CHEM INT EDIT, V20, P744, DOI 10.1002/anie.198107441; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yang JK, 2004, J MOL BIOL, V335, P155, DOI 10.1016/j.jmb.2003.10.026; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965	40	71	75	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36328	36337		10.1074/jbc.M806115200	http://dx.doi.org/10.1074/jbc.M806115200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981178	Green Published, hybrid			2022-12-27	WOS:000261840500029
J	Pochynyuk, O; Bugaj, V; Rieg, T; Insel, PA; Mironova, E; Vallon, V; Stockand, JD				Pochynyuk, Oleh; Bugaj, Vladislav; Rieg, Timo; Insel, Paul A.; Mironova, Elena; Vallon, Volker; Stockand, James D.			Paracrine Regulation of the Epithelial Na+ Channel in the Mammalian Collecting Duct by Purinergic P2Y(2) Receptor Tone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATES CL-SECRETION; CONDUCTANCE K-CHANNEL; APICAL P2 RECEPTORS; PRINCIPAL CELLS; LUMINAL P2Y(2); MEDIATED INHIBITION; SODIUM-TRANSPORT; PLASMA-MEMBRANE; ATP RELEASE; 3-OH KINASE	Growing evidence implicates a key role for extracellular nucleotides in cellular regulation, including of ion channels and renal function, but the mechanisms for such actions are inadequately defined. We investigated purinergic regulation of the epithelial Na+ channel (ENaC) in mammalian collecting duct. We find that ATP decreases ENa Cactivity in both mouse and rat collecting duct principal cells. ATP and other nucleotides, including UTP, decrease ENaC activity via apical P2Y(2) receptors. ENaC in collecting ducts isolated from mice lacking this receptor have blunted responses to ATP. P2Y2 couples to ENaC via PLC; direct activation of PLC mimics ATP action. Tonic regulation of ENaC in the collecting duct occurs via locally released ATP; scavenging endogenous ATP and inhibiting P2 receptors, in the absence of other stimuli, rapidly increases ENaC activity. Moreover, ENaC has greater resting activity in collecting ducts from P2Y(2)(-/-) mice. Loss of collecting duct P2Y(2) receptors in the knock- out mouse is the primary defect leading to increased ENaC activity based on the ability of direct PLC stimulation to decrease ENaC activity in collecting ducts from P2Y(2)(-/-) mice in a manner similar to ATP in collecting ducts from wild-type mice. These findings demonstrate that locally released ATP acts in an autocrine/paracrine manner to tonically regulate ENaC in mammalian collecting duct. Loss of this intrinsic regulation leads to ENaC hyperactivity and contributes to hypertension that occurs in P2Y(2) receptor(-/-) mice. P2Y(2) receptor activation by nucleotides thus provides physiologically important regulation of ENaC and electrolyte handling in mammalian kidney.	[Pochynyuk, Oleh; Bugaj, Vladislav; Mironova, Elena; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Rieg, Timo; Insel, Paul A.; Vallon, Volker] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rieg, Timo; Insel, Paul A.; Vallon, Volker] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Diego; University of California System; University of California San Diego	Pochynyuk, O (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	pochynyuk@uthscsa.edu	Rieg, Timo/W-7478-2019	Rieg, Timo/0000-0001-6082-662X; Stockand, James/0000-0002-3817-4319; Vallon, Volker/0000-0002-9211-2063	National Institutes of Health [R01DK59594, R01DK70571, R01DK56248, R01DK28602, R01GM66232]; American Heart Association (AHA) [0640054N, 0655232Y, 085062F]; German Research Foundation [RI1535/3-1, 3-2]; National Kidney Foundation Fellowship; Research Service of the Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056248, R01DK028602, R01DK070571, R01DK059594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); German Research Foundation(German Research Foundation (DFG)); National Kidney Foundation Fellowship; Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK59594 and R01DK70571 (to J.D.S.), R01DK56248 and R01DK28602 (to V.V.), and R01GM66232 (to P.A.I.). This work was also supported by American Heart Association (AHA) Established Investigator Award 0640054N (to J.D.S.), AHA Grant-in-Aid 0655232Y (to V.V.), AHA Fellowship 085062F (to O.P.), German Research Foundation Grants RI1535/3-1 and 3-2 (to T. R.), a National Kidney Foundation Fellowship (to T. R.), and the Research Service of the Department of Veterans Affairs (to V.V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bonny O, 2000, KIDNEY INT, V57, P1313, DOI 10.1046/j.1523-1755.2000.00968.x; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock Geoffrey, 2006, Novartis Found Symp, V276, P26; Cuffe JE, 2000, J PHYSIOL-LONDON, V524, P77, DOI 10.1111/j.1469-7793.2000.00077.x; Deetjen P, 2000, J AM SOC NEPHROL, V11, P1798, DOI 10.1681/ASN.V11101798; ECELBARGER CA, 1994, AM J PHYSIOL-RENAL, V267, pF998, DOI 10.1152/ajprenal.1994.267.6.F998; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Gamper Nikita, 2006, V337, P27; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Geyti CS, 2008, PFLUG ARCH EUR J PHY, V455, P1105, DOI 10.1007/s00424-007-0366-4; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hovater MB, 2008, PURINERG SIGNAL, V4, P109, DOI 10.1007/s11302-008-9102-6; Hovater MB, 2008, PURINERG SIGNAL, V4, P155, DOI 10.1007/s11302-007-9072-0; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lehrmann H, 2002, J AM SOC NEPHROL, V13, P10, DOI 10.1681/ASN.V13110; Li DM, 2006, AM J PHYSIOL-RENAL, V290, pF806, DOI 10.1152/ajprenal.00352.2005; Li LZ, 2007, BIOCHEM BIOPH RES CO, V359, P438, DOI 10.1016/j.bbrc.2007.05.143; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lu M, 2000, J GEN PHYSIOL, V116, P299, DOI 10.1085/jgp.116.2.299; Ma HP, 2002, AM J PHYSIOL-RENAL, V282, pF501, DOI 10.1152/ajprenal.00147.2001; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Matos JE, 2007, PFLUG ARCH EUR J PHY, V454, P977, DOI 10.1007/s00424-007-0248-9; Matos JE, 2005, J PHYSIOL-LONDON, V564, P269, DOI 10.1113/jphysiol.2004.080002; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; Poulsen AN, 2005, PFLUG ARCH EUR J PHY, V450, P227, DOI 10.1007/s00424-005-1388-4; Rieg T, 2007, FASEB J, V21, P3717, DOI 10.1096/fj.07-8807com; Schwiebert EM, 2001, AM J PHYSIOL-RENAL, V280, pF945, DOI 10.1152/ajprenal.2001.280.6.F945; Shirley DG, 2005, AM J PHYSIOL-RENAL, V288, pF1243, DOI 10.1152/ajprenal.00152.2004; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Sun P, 2006, AM J PHYSIOL-RENAL, V291, pF1192, DOI 10.1152/ajprenal.00112.2006; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Thomas J, 2001, J MEMBRANE BIOL, V183, P115, DOI 10.1007/s00232-001-0059-4; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; Unwin RJ, 2003, NEWS PHYSIOL SCI, V18, P237, DOI 10.1152/nips.01436.2003; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF10, DOI 10.1152/ajprenal.00432.2007; Vekaria RM, 2006, J AM SOC NEPHROL, V17, P1841, DOI 10.1681/ASN.2005111171; Wildman SSP, 2008, J AM SOC NEPHROL, V19, P731, DOI 10.1681/ASN.2007040443; Wildman SS, 2005, J AM SOC NEPHROL, V16, P2586, DOI 10.1681/ASN.2005020130; Wildman SS, 2003, BRIT J PHARMACOL, V140, P1177, DOI 10.1038/sj.bjp.0705544; Woda CB, 2002, AM J PHYSIOL-RENAL, V283, pF437, DOI 10.1152/ajprenal.00316.2001; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015; Xie Y, 2008, PURINERG SIGNAL, V4, P125, DOI 10.1007/s11302-007-9053-3; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005	51	106	106	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36599	36607		10.1074/jbc.M807129200	http://dx.doi.org/10.1074/jbc.M807129200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981175	Green Published, hybrid			2022-12-27	WOS:000261840500058
J	Bych, K; Netz, DJA; Vigani, G; Bill, E; Lill, R; Pierik, AJ; Balk, J				Bych, Katrine; Netz, Daili J. A.; Vigani, Gianpiero; Bill, Eckhard; Lill, Roland; Pierik, Antonio J.; Balk, Janneke			The Essential Cytosolic Iron-Sulfur Protein Nbp35 Acts without Cfd1 Partner in the Green Lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOGENESIS; LOCALIZATION; EXPRESSION; MATURATION; SCAFFOLD; VECTORS; IMPORT; GENES	In photosynthetic eukaryotes assembly components of iron-sulfur (Fe-S) cofactors have been studied in plastids and mitochondria, but how cytosolic and nuclear Fe-S cluster proteins are assembled is not known. We have characterized a plant P loop NTPase with sequence similarity to Nbp35 of yeast and mammals, a protein of the cytosolic Cfd1-Nbp35 complex mediating Fe-S cluster assembly. Genome analysis revealed that NBP35 is conserved in the green lineage but that CFD1 is absent. Moreover, plant and algal NBP35 proteins lack the characteristic CXXC motif in the C terminus, thought to be required for Fe-S cluster binding. Nevertheless, chemical reconstitution and spectroscopy showed that Arabidopsis (At) NBP35 bound a [4Fe-4S] cluster in the C terminus as well as a stable [4Fe-4S] cluster in the N terminus. Holo-AtNBP35 was able to transfer an Fe-S cluster to an apoprotein in vitro. When expressed in yeast, AtNBP35 bound Fe-55 dependent on the cysteine desulfurase Nfs1 and was able to partially rescue the growth of a cfd1 mutant but not of an nbp35 mutant. The AtNBP35 gene is constitutively expressed in planta, and its disruption was associated with an arrest of embryo development. These results show that despite considerable divergence from the yeast Cfd1-Nbp35 Fe-S scaffold complex, AtNBP35 has retained similar Fe-S cluster binding and transfer properties and performs an essential function.	[Bych, Katrine; Vigani, Gianpiero; Balk, Janneke] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Netz, Daili J. A.; Lill, Roland; Pierik, Antonio J.] Univ Marburg, Inst Zytobiol, D-35033 Marburg, Germany; [Bill, Eckhard] MPI Bioanorgan Chem, D-45470 Mulheim, Germany	University of Cambridge; Philipps University Marburg	Balk, J (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	jb511@cam.ac.uk	Pierik, Antonio J/G-1108-2010; Vigani, Gianpiero/R-5539-2019	Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518; Vigani, Gianpiero/0000-0001-8852-3866	Royal Society; Danish Research Agency; Carlsberg Foundation; Ministero dell'Istruzione, dell'Universita` e della Ricerca; Deutsche Forschungsgemeinschaft [593, GRK 1216]; Fonds der Chemischen Industrie	Royal Society(Royal Society of London); Danish Research Agency; Carlsberg Foundation(Carlsberg Foundation); Ministero dell'Istruzione, dell'Universita` e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This research was funded by the Royal Society (to J.B.), the Danish Research Agency and the Carlsberg Foundation (to K.B.), Ministero dell'Istruzione, dell'Universita` e della Ricerca (to G.V.), Deutsche Forschungsgemeinschaft (SFB 593 and TR1, Gottfried-Wilhelm Leibniz Programm, and GRK 1216), and Fonds der Chemischen Industrie (to R.L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Balk J, 2003, PLANT J, V34, P573, DOI 10.1046/j.1365-313X.2003.01748.x; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Cavazza C, 2008, J INORG BIOCHEM, V102, P1359, DOI 10.1016/j.jinorgbio.2008.01.027; FERREIRA GC, 1994, J BIOL CHEM, V269, P7062; Frazzon APG, 2007, PLANT MOL BIOL, V64, P225, DOI 10.1007/s11103-007-9147-x; Godman J, 2008, GENETICS, V179, P59, DOI 10.1534/genetics.107.086033; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kessler D, 2005, PHOTOSYNTH RES, V86, P391, DOI 10.1007/s11120-005-5913-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Leon S, 2005, FEBS LETT, V579, P1930, DOI 10.1016/j.febslet.2005.02.038; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; ORMEJOHNSON WH, 1982, IRON SULFUR PROTEINS, P67; Peeters NM, 2000, J MOL EVOL, V50, P413, DOI 10.1007/s002390010044; Pilon Marinus, 2006, Genet Eng (N Y), V27, P101, DOI 10.1007/0-387-25856-6_7; Prime TA, 2000, ELECTROPHORESIS, V21, P3488, DOI 10.1002/1522-2683(20001001)21:16&lt;3488::AID-ELPS3488&gt;3.0.CO;2-3; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; SALTER AH, 1992, PLANT MOL BIOL, V20, P569, DOI 10.1007/BF00040617; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stockel J, 2004, J BIOL CHEM, V279, P10243, DOI 10.1074/jbc.M309246200; Sweetlove Lee J, 2007, Methods Mol Biol, V372, P125, DOI 10.1007/978-1-59745-365-3_9; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540	42	50	51	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35797	35804		10.1074/jbc.M807303200	http://dx.doi.org/10.1074/jbc.M807303200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957412	hybrid, Green Submitted			2022-12-27	WOS:000261687900054
J	Higashimoto, T; Chan, N; Lee, YK; Zandi, E				Higashimoto, Tomoyasu; Chan, Nymph; Lee, Yung-Kang; Zandi, Ebrahim			Regulation of I kappa B Kinase Complex by Phosphorylation of gamma-Binding Domain of I kappa B Kinase beta by Polo-like Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; IKK-BETA; TRANSCRIPTION FACTOR; UBIQUITIN LIGASE; TUMOR-CELLS; CYCLIN D1; ACTIVATION; PROTEIN; IDENTIFICATION; CANCER	I kappa B kinase (IKK) complex is a key regulator of NF-kappa B pathways. Signal-induced interaction of the IKK gamma ( NEMO) subunit with the C-terminal IKK gamma/NEMO-binding domain (gamma BD) of IKK beta is an essential interaction for IKK regulation. Underlying regulatory mechanism(s) of this interaction are not known. Phosphorylation of gamma BD has been suggested to play a regulatory role for IKK activation. However, a kinase that phosphorylates gamma BD has not been identified. In this study, we used a C-terminal fragment of IKK beta as substrate and purified Polo-like kinase 1 (Plk1) from HeLa cell extracts by standard chromatography as a gamma BD kinase. Plk1 phosphorylates serines 733, 740, and 750 in the gamma BD of IKK beta in vitro. Phosphorylating gamma BD with Plk1 decreased its affinity for IKK gamma in pulldown assay. We generated phosphoantibodies against serine 740 and showed that gamma BD is phosphorylated in vivo. Expressing a constitutively active Plk1 in mammalian cells reduced tumor necrosis factor (TNF)-induced IKK activation, resulting in decreased phosphorylation of endogenous I kappa B alpha and reduced NF-kappa B activation. To activate endogenous Plk1, cells were treated with nocodazole, which reduced TNF-induced IKK activation, and increased the phosphorylation of gamma BD. Knocking down Plk1 in mammalian cells restored TNF-induced IKK activation in nocodazole-treated cells. Activation of Plk1 inhibited TNF-induced expression of cyclin D1. In cells in which Plk1 was knocked down, TNF alpha increased expression of cyclin D1 and the proportion of cells in the S phase of the cell cycle. Taken together, this study shows that phosphorylation regulates the interaction of gamma BD of IKK beta with IKK gamma and therefore plays a critical role for IKK activation. Moreover, we identify Plk1 as a gamma BD kinase, which negatively regulates TNF-induced IKK activation and cyclin D1 expression, thereby affecting cell cycle regulation. Untimely activation of cyclin D1 by TNF alpha can provide a potential mechanism for an involvement of TNF alpha in inflammation-induced cancer.	[Higashimoto, Tomoyasu; Zandi, Ebrahim] USC, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90033 USA; [Chan, Nymph] USC, Norris Comprehens Canc Ctr, Dept Pathol, Keck Sch Med, Los Angeles, CA 90033 USA; [Lee, Yung-Kang] Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California Keck Hospital; University of Southern California; University of Southern California Keck Hospital; University of Southern California	Zandi, E (corresponding author), USC, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Keck Sch Med, 1441 Eastlake Ave,Norris 6429, Los Angeles, CA 90033 USA.	Zandi@usc.edu		Higashimoto, Tomoyasu/0000-0003-0435-065X	National Institutes of Health [R01 MG065325]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 MG065325 (to E.Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; CLAY FJ, 1993, P NATL ACAD SCI USA, V90, P4882, DOI 10.1073/pnas.90.11.4882; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fujiki H, 2000, CANCER DETECT PREV, V24, P91; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Harhaj EW, 1997, J BIOL CHEM, V272, P5409, DOI 10.1074/jbc.272.9.5409; Higashimoto T, 2006, CYTOKINE, V34, P39, DOI 10.1016/j.cyto.2006.03.015; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; Liao D. Joshua, 2007, Critical Reviews in Oncogenesis, V13, P93; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Strack P, 2000, ONCOGENE, V19, P3529, DOI 10.1038/sj.onc.1203647; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tsvetkov L, 2005, CELL CYCLE, V4, P166, DOI 10.4161/cc.4.1.1348; VOLLAND S, 1994, INT J CANCER, V56, P698, DOI 10.1002/ijc.2910560515; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang LC, 2005, J BIOL CHEM, V280, P7634, DOI 10.1074/jbc.M413384200; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Ye JJ, 2000, J BIOL CHEM, V275, P9882, DOI 10.1074/jbc.275.13.9882; Zandi E, 1997, GENE DEV, V11, P1299, DOI 10.1101/gad.11.10.1299; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	50	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35354	35367		10.1074/jbc.M806258200	http://dx.doi.org/10.1074/jbc.M806258200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957422	hybrid, Green Published			2022-12-27	WOS:000261687900006
J	Le, DT; Lee, BC; Marino, SM; Zhang, Y; Fomenko, DE; Kaya, A; Hacioglu, E; Kwak, GH; Koc, A; Kim, HY; Gladyshev, VN				Le, Dung Tien; Lee, Byung Cheon; Marino, Stefano M.; Zhang, Yan; Fomenko, Dmitri E.; Kaya, Alaattin; Hacioglu, Elise; Kwak, Geun-Hee; Koc, Ahmet; Kim, Hwa-Young; Gladyshev, Vadim N.			Functional Analysis of Free Methionine-R-sulfoxide Reductase from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CATALYTIC MECHANISM; OXIDATIVE STRESS; GAF DOMAIN; LIFE-SPAN; PROTEINS; MAMMALS; DAMAGE; SITES; MSRA	Methionine sulfoxide reductases (Msrs) are oxidoreductases that catalyze thiol-dependent reduction of oxidized methionines. MsrA and MsrB are the best known Msrs that repair methionine-S-sulfoxide (Met-S-SO) and methionine-R-sulfoxide (Met-R-SO) residues in proteins, respectively. In addition, an Escherichia coli enzyme specific for free Met-R-SO, designated fRMsr, was recently discovered. In this work, we carried out comparative genomic and experimental analyses to examine occurrence, evolution, and function of fRMsr. This protein is present in single copies and two mutually exclusive subtypes in about half of prokaryotes and unicellular eukaryotes but is missing in higher plants and animals. A Saccharomyces cerevisiae fRMsr homolog was found to reduce free Met-R-SO but not free Met-S-SO or dabsyl-Met-R-SO. fRMsr was responsible for growth of yeast cells on Met-R-SO, and the double fRMsr/MsrA mutant could not grow on a mixture of methionine sulfoxides. However, in the presence of methionine, even the triple fRMsr/MsrA/MsrB mutant was viable. In addition, fRMsr deletion strain showed an increased sensitivity to oxidative stress and a decreased life span, whereas overexpression of fRMsr conferred higher resistance to oxidants. Molecular modeling and cysteine residue targeting by thioredoxin pointed to Cys(101) as catalytic and Cys(125) as resolving residues in yeast fRMsr. These residues as well as a third Cys, resolving Cys(91), clustered in the structure, and each was required for the catalytic activity of the enzyme. The data show that fRMsr is the main enzyme responsible for the reduction of free Met-R-SO in S. cerevisiae.	[Le, Dung Tien; Lee, Byung Cheon; Marino, Stefano M.; Zhang, Yan; Fomenko, Dmitri E.; Kaya, Alaattin; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Le, Dung Tien; Lee, Byung Cheon; Marino, Stefano M.; Zhang, Yan; Fomenko, Dmitri E.; Kaya, Alaattin; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA; [Hacioglu, Elise; Koc, Ahmet] Izmir Inst Technol, Dept Mol Biol & Genet, TR-35430 Izmir, Turkey; [Kwak, Geun-Hee; Kim, Hwa-Young] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Izmir Institute of Technology; Yeungnam University	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/J-6187-2013; KOÇ, AHMET/ABI-3322-2020; Le, Dung Tien/A-7276-2008; Kaya, Alaattin/T-6427-2017; Gladyshev, Vadim N/A-9894-2013	KOÇ, AHMET/0000-0003-3484-2137; Le, Dung Tien/0000-0002-5117-3476; Kaya, Alaattin/0000-0002-6132-5197; Lee, Byung Cheon/0000-0003-1467-1940; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [AG021518, RR017675]; Korea Research Foundation [KRF-2007-331-C00198]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021518 (to V.N.G.). This work was also supported by Korea Research Foundation Grant KRF-2007-331-C00198 ( to H.-Y.K.). The Nebraska Redox Biology Center is supported by National Institutes of Health Grant RR017675.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Boschi-Muller S, 2000, J BIOL CHEM, V275, P35908, DOI 10.1074/jbc.M006137200; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; BOSCHIMULLER S, 2002, J BIOL CHEM, V17, P35908; Cabreiro F, 2007, BIOCHIMIE, V89, P1388, DOI 10.1016/j.biochi.2007.05.005; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Etienne F, 2003, BIOCHEM BIOPH RES CO, V300, P378, DOI 10.1016/S0006-291X(02)02870-X; Ezraty B, 2004, EMBO J, V23, P1868, DOI 10.1038/sj.emboj.7600172; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Kantorow M, 2004, P NATL ACAD SCI USA, V101, P9654, DOI 10.1073/pnas.0403532101; Kim HY, 2005, PLOS BIOL, V3, P2080, DOI 10.1371/journal.pbio.0030375; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Ko JJ, 2005, PROTEINS, V59, P183, DOI 10.1002/prot.20418; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Picot CR, 2005, FREE RADICAL BIO MED, V39, P1332, DOI 10.1016/j.freeradbiomed.2005.06.017; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Slyshenkov VS, 2002, ACTA BIOCHIM POL, V49, P907; Smetana JHC, 2007, FEBS J, V274, P5891, DOI 10.1111/j.1742-4658.2007.06112.x; Spector D, 2003, BIOCHEM BIOPH RES CO, V302, P284, DOI 10.1016/S0006-291X(03)00163-3; Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583; Tai SL, 2005, J BIOL CHEM, V280, P437, DOI 10.1074/jbc.M410573200; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wei Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-119; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	43	64	69	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4354	4364		10.1074/jbc.M805891200	http://dx.doi.org/10.1074/jbc.M805891200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19049972	Green Published, hybrid			2022-12-27	WOS:000263134400034
J	Masada, N; Ciruela, A; MacDougall, DA; Cooper, DMF				Masada, Nanako; Ciruela, Antonio; MacDougall, David A.; Cooper, Dermot M. F.			Distinct Mechanisms of Regulation by Ca2+/Calmodulin of Type 1 and 8 Adenylyl Cyclases Support Their Different Physiological Roles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CA2+ ENTRY; LIGHT-CHAIN KINASE; CALMODULIN-BINDING DOMAIN; BARREL MAP DEVELOPMENT; NITRIC-OXIDE SYNTHASE; CALCIUM-BINDING; GENETIC-EVIDENCE; MOUSE-BRAIN; CYCLIC-AMP; CELL-LINE	Nine membrane-bound mammalian adenylyl cyclases (ACs) have been identified. Type 1 and 8 ACs (AC1 and AC8), which are both expressed in the brain and are stimulated by Ca2+/calmodulin (CaM), have discrete neuronal functions. Although the Ca2+ sensitivity of AC1 is higher than that of AC8, precisely how these two ACs are regulated by Ca2+/CaM remains elusive, and the basis for their diverse physiological roles is quite unknown. Distinct localization of the CaM binding domains within the two enzymes may be essential to differential regulation of the ACs by Ca2+/CaM. In this study we compare in detail the regulation of AC1 and AC8 by Ca2+/CaM both in vivo and in vitro and explore the different role of each Ca2+-binding lobe of CaM in regulating the two enzymes. We also assess the relative dependence of AC1 and AC8 on capacitative Ca2+ entry. Finally, in real-time fluorescence resonance energy transfer-based imaging experiments, we examine the effects of dynamic Ca2+ events on the production of cAMP in cells expressing AC1 and AC8. Our data demonstrate distinct patterns of regulation and Ca2+ dependence of AC1 and AC8, which seems to emanate from their mode of regulation by CaM. Such distinctive properties may contribute significantly to the divergent physiological roles in which these ACs have been implicated.	[Masada, Nanako; Ciruela, Antonio; MacDougall, David A.; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk		MacDougall, David/0000-0003-1811-288X	Wellcome Trust [RG31760]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported in part by the Wellcome Trust (Grant RG31760).	BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; BOYAJIAN CL, 1991, J BIOL CHEM, V266, P4995; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIONO M, 1995, J BIOL CHEM, V270, P1149, DOI 10.1074/jbc.270.3.1149; CHOI EJ, 1992, BIOCHEMISTRY-US, V31, P6492, DOI 10.1021/bi00143a019; Conti AC, 2007, NEUROSCIENCE, V146, P713, DOI 10.1016/j.neuroscience.2007.01.045; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Crossthwaite AJ, 2006, MOL PHARMACOL, V69, P608, DOI 10.1124/mol.105.018275; Crossthwaite AJ, 2005, J BIOL CHEM, V280, P6380, DOI 10.1074/jbc.M411987200; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; EVANS T, 1984, MOL PHARMACOL, V26, P395; Fagan KA, 2000, J BIOL CHEM, V275, P26530, DOI 10.1074/jbc.M001369200; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; FINDLAY WA, 1995, BIOCHEMISTRY-US, V34, P2087, DOI 10.1021/bi00007a001; GAO ZH, 1993, J BIOL CHEM, V268, P20096; Gong B, 2007, EUR J NEUROSCI, V26, P275, DOI 10.1111/j.1460-9568.2007.05669.x; Goraya TA, 2008, CELL SIGNAL, V20, P359, DOI 10.1016/j.cellsig.2007.10.024; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu C, 1999, J BIOL CHEM, V274, P8012, DOI 10.1074/jbc.274.12.8012; HELLEVUO K, 1993, BIOCHEM BIOPH RES CO, V192, P311, DOI 10.1006/bbrc.1993.1415; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; LEVIN LR, 1995, J BIOL CHEM, V270, P7573, DOI 10.1074/jbc.270.13.7573; LINSE S, 1991, J BIOL CHEM, V266, P8050; LIVINGSTONE MS, 1985, P NATL ACAD SCI USA, V82, P5992, DOI 10.1073/pnas.82.17.5992; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Lu HC, 2006, J NEUROSCI, V26, P2692, DOI 10.1523/JNEUROSCI.3956-05.2006; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Martin ACL, 2006, MOL PHARMACOL, V70, P769, DOI 10.1124/mol.106.025213; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mons N, 1999, CELL MOL LIFE SCI, V55, P525, DOI 10.1007/s000180050311; Moulder KL, 2008, J NEUROSCI, V28, P5159, DOI 10.1523/JNEUROSCI.5317-07.2008; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nicol X, 2005, J COMP NEUROL, V486, P281, DOI 10.1002/cne.20528; Nicol X, 2006, EUR J NEUROSCI, V24, P3401, DOI 10.1111/j.1460-9568.2006.05227.x; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; OLWIN BB, 1984, J BIOL CHEM, V259, P949; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Persechini A, 1996, J BIOL CHEM, V271, P62, DOI 10.1074/jbc.271.1.62; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Plas DT, 2004, VISION RES, V44, P3357, DOI 10.1016/j.visres.2004.09.036; Ravary A, 2003, J NEUROSCI, V23, P2228; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Shuttleworth TJ, 1999, J BIOL CHEM, V274, P31174, DOI 10.1074/jbc.274.44.31174; Simpson RE, 2006, J BIOL CHEM, V281, P17379, DOI 10.1074/jbc.M510992200; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; TANG WJ, 1991, J BIOL CHEM, V266, P8595; VILLACRES EC, 1995, J BIOL CHEM, V270, P14352, DOI 10.1074/jbc.270.24.14352; VORHERR T, 1993, BIOCHEMISTRY-US, V32, P6081, DOI 10.1021/bi00074a020; Wang HS, 2007, J BIOL CHEM, V282, P1507, DOI 10.1074/jbc.M607291200; WAYMAN GA, 1995, J BIOL CHEM, V270, P21480, DOI 10.1074/jbc.270.37.21480; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; WU ZL, 1993, J BIOL CHEM, V268, P23766; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Zhang M, 2008, J NEUROSCI, V28, P4736, DOI 10.1523/JNEUROSCI.1177-08.2008	72	44	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4451	4463		10.1074/jbc.M807359200	http://dx.doi.org/10.1074/jbc.M807359200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19029295	Green Published, hybrid			2022-12-27	WOS:000263134400045
J	Norton, JT; Wang, C; Gjidoda, A; Henry, RW; Huang, S				Norton, John T.; Wang, Chen; Gjidoda, Alison; Henry, R. William; Huang, Sui			The Perinucleolar Compartment Is Directly Associated with DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III TRANSCRIPTS; TRACT-BINDING-PROTEIN; TOPOISOMERASE-II; RNA; CAMPTOTHECIN; INHIBITION; PREVALENCE; DISTAMYCIN; RESISTANT; NETROPSIN	The perinucleolar compartment (PNC) is a nuclear subdomain that is unique to tumor cells, and the percentage of cells in a population containing PNCs ( PNC prevalence) indicates the level of malignancy of that population. Here, we utilize anticancer drugs and other exogenous stimuli to investigate the structure and function of the PNC. Screening of clinically used anti-cancer drugs revealed two types of drugs disassemble PNCs and do so through their specific molecular actions. Transcription inhibitors reduce PNC prevalence in parallel with RNA polymerase III transcription reduction, and a subset of DNA-damaging drugs and stimuli (UV radiation) disassemble the PNC. Inhibition of cellular DNA damage response demonstrated that the DNA damage itself, not the response or polymerase III inhibition, is responsible for PNC disassembly, suggesting that the maintenance of the PNC is dependent upon DNA integrity. Analyses of the types of DNA damage that cause PNC disassembly show that interstrand DNA base pairing, not strand continuity, is important for PNC integrity, indicating that the PNC components are directly interacting with the DNA. Complementary cell biology experiments demonstrated that the number of PNCs per cell increases with the rounds of endoreplication and that PNCs split into doublets during mid S phase, both of which are phenotypes that are typical of a replicating DNA loci. Together, these studies validate PNC disassembly as a screening marker to identify chemical probes and revealed that the PNC is directly nucleated on a DNA locus, suggesting a potential role for the PNC in gene expression regulation.	[Norton, John T.; Wang, Chen; Huang, Sui] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Gjidoda, Alison; Henry, R. William] Michigan State Univ, E Lansing, MI 48824 USA	Northwestern University; Michigan State University	Huang, S (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	s-huang2@northwestern.edu			NCI NIH HHS [T32CA09560] Funding Source: Medline; NIA NIH HHS [T32AG000260] Funding Source: Medline; NIGMS NIH HHS [GM078555-01A1, 1-R01-GM79098] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079098, R01GM078555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000260] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CAMPAIN JA, 1993, J CELL PHYSIOL, V155, P414, DOI 10.1002/jcp.1041550224; Fortune JM, 1998, J BIOL CHEM, V273, P17643, DOI 10.1074/jbc.273.28.17643; Hall MP, 2004, MOL BIOL CELL, V15, P774, DOI 10.1091/mbc.E03-09-0692; Huang S, 1997, J CELL BIOL, V137, P965, DOI 10.1083/jcb.137.5.965; Huang S, 1998, J CELL BIOL, V143, P35, DOI 10.1083/jcb.143.1.35; Huttelmaier S, 2001, J CELL BIOL, V155, P775, DOI 10.1083/jcb.200105044; ISHIDA R, 1991, CANCER RES, V51, P4909; Kamath RV, 2005, CANCER RES, V65, P246; KIM SK, 1993, FEBS LETT, V315, P61, DOI 10.1016/0014-5793(93)81133-K; Kleinhenz B, 2005, FEBS LETT, V579, P4254, DOI 10.1016/j.febslet.2005.07.001; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; Kopp K, 2005, J CELL BIOCHEM, V95, P217, DOI 10.1002/jcb.20403; Laronne A, 2003, MOL BIOL CELL, V14, P3730, DOI 10.1091/mbc.E02-12-0850; LI LH, 1972, CANCER RES, V32, P2643; MATERA AG, 1995, J CELL BIOL, V129, P1181, DOI 10.1083/jcb.129.5.1181; Norton JT, 2008, CANCER-AM CANCER SOC, V113, P861, DOI 10.1002/cncr.23632; PORTUGAL J, 1987, EUR J BIOCHEM, V167, P281, DOI 10.1111/j.1432-1033.1987.tb13334.x; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Urasaki Y, 2001, CANCER RES, V61, P1964; Wang C, 2003, MOL BIOL CELL, V14, P2425, DOI 10.1091/mbc.E02-12-0818; Won JJ, 2006, NAT CHEM BIOL, V2, P369, DOI 10.1038/nchembio800; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	22	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4090	4101		10.1074/jbc.M807255200	http://dx.doi.org/10.1074/jbc.M807255200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19015260	Green Published, hybrid			2022-12-27	WOS:000263134400006
J	Bergo, VB; Sineshchekov, OA; Kralj, JM; Partha, R; Spudich, EN; Rothschild, KJ; Spudich, JL				Bergo, Vladislav B.; Sineshchekov, Oleg A.; Kralj, Joel M.; Partha, Ranga; Spudich, Elena N.; Rothschild, Kenneth J.; Spudich, John L.			His-75 in Proteorhodopsin, a Novel Component in Light-driven Proton Translocation by Primary Pumps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANABAENA SENSORY RHODOPSIN; SCHIFF-BASE COUNTERION; HISTIDINE; SITE; BACTERIORHODOPSIN; SPECTROSCOPY; PHOTOTROPHY; CATALYSIS; PROTEINS; H-1-NMR	Proteorhodopsins (PRs), photoactive retinylidene membrane proteins ubiquitous in marine eubacteria, exhibit light-driven proton transport activity similar to that of the well studied bacteriorhodopsin from halophilic archaea. However, unlike bacteriorhodopsin, PRs have a single highly conserved histidine located near the photoactive site of the protein. Time-resolved Fourier transform IR difference spectroscopy combined with visible absorption spectroscopy, isotope labeling, and electrical measurements of light-induced charge movements reveal participation of His-75 in the proton translocation mechanism of PR. Substitution of His-75 with Ala or Glu perturbed the structure of the photoactive site and resulted in significantly shifted visible absorption spectra. In contrast, His-75 substitution with a positively charged Arg did not shift the visible absorption spectrum of PR. The mutation to Arg also blocks the light-induced proton transfer from the Schiff base to its counterion Asp-97 during the photocycle and the acid-induced protonation of Asp-97 in the dark state of the protein. Isotope labeling of histidine revealed that His-75 undergoes deprotonation during the photocycle in the proton-pumping (high pH) form of PR, a reaction further supported by results from H75E. Finally, all His-75 mutations greatly affect charge movements within the PR and shift its pH dependence to acidic values. A model of the proteorhodopsin proton transport process is proposed as follows: (i) in the dark state His-75 is positively charged (protonated) over a wide pH range and interacts directly with the Schiff base counterion Asp-97; and (ii) photoisomerization-induced transfer of the Schiff base proton to the Asp-97 counterion disrupts its interaction with His-75 and triggers a histidine deprotonation.	[Bergo, Vladislav B.; Kralj, Joel M.; Rothschild, Kenneth J.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Bergo, Vladislav B.; Kralj, Joel M.; Rothschild, Kenneth J.] Boston Univ, Mol Biophys Lab, Photon Ctr, Boston, MA 02215 USA; [Bergo, Vladislav B.; Sineshchekov, Oleg A.; Partha, Ranga; Spudich, Elena N.; Spudich, John L.] Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA	Boston University; Boston University; University of Texas System; University of Texas Health Science Center Houston	Rothschild, KJ (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	kjr@bu.edu; John.L.Spudich@uth.tmc.edu	Rothschild, Kenneth J/P-6177-2018	Rothschild, Kenneth J/0000-0002-2847-6671	National Institutes of Health [R01GM069969, R37GM27750]; United States Department of Energy [DE-FG02-07ER15867]; Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069969, R37GM027750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM069969 (to K. J. R.) and R37GM27750 (to J. L. S.). This work was also supported by United States Department of Energy Grant DE-FG02-07ER15867 and The Robert A. Welch Foundation grant (to J. L. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bergo V, 2000, BIOCHEMISTRY-US, V39, P2823, DOI 10.1021/bi991676d; Bergo V, 2004, BIOCHEMISTRY-US, V43, P9075, DOI 10.1021/bi0361968; Bergo V, 2002, PHOTOCHEM PHOTOBIOL, V76, P341, DOI 10.1562/0031-8655(2002)076<0341:AFTISO>2.0.CO;2; Bergo VB, 2006, J BIOL CHEM, V281, P15208, DOI 10.1074/jbc.M600033200; BOUSCHE O, 1992, PHOTOCHEM PHOTOBIOL, V56, P1085, DOI 10.1111/j.1751-1097.1992.tb09732.x; Bruylants G, 2007, CHEMBIOCHEM, V8, P51, DOI 10.1002/cbic.200600433; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Fisher Z, 2005, BIOCHEMISTRY-US, V44, P1097, DOI 10.1021/bi0480279; Friedrich T, 2002, J MOL BIOL, V321, P821, DOI 10.1016/S0022-2836(02)00696-4; Hasegawa K, 2000, J PHYS CHEM B, V104, P4253, DOI 10.1021/jp000157d; Hienerwadel R, 1997, BIOCHEMISTRY-US, V36, P14712, DOI 10.1021/bi971521a; Kraj JM, 2008, BIOCHEMISTRY-US, V47, P3447, DOI 10.1021/bi7018964; Krebs Richard A, 2002, BMC Physiol, V2, P5, DOI 10.1186/1472-6793-2-5; LeBrun LA, 2004, BIOCHEMISTRY-US, V43, P3014, DOI 10.1021/bi036103m; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; Mankelow TJ, 2003, PROTOPLASMA, V221, P101, DOI 10.1007/s00709-002-0056-1; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Nie BN, 2005, BIOPHYS J, V88, P2833, DOI 10.1529/biophysj.104.047639; Noguchi T, 1999, BIOCHEMISTRY-US, V38, P10187, DOI 10.1021/bi990631+; Partha R, 2005, BBA-BIOENERGETICS, V1708, P6, DOI 10.1016/j.bbabio.2004.12.009; Rangarajan R, 2007, BIOCHEMISTRY-US, V46, P12679, DOI 10.1021/bi700955x; Rath P, 1996, BIOCHEMISTRY-US, V35, P6690, DOI 10.1021/bi9600355; ROTHSCHILD KJ, 1988, BIOCHEMISTRY-US, V27, P2420, DOI 10.1021/bi00407a026; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Sineshchekov OA, 2004, PHOTOCH PHOTOBIO SCI, V3, P548, DOI 10.1039/b316207a; Sineshchekov OA, 2006, BIOPHYS J, V91, P4519, DOI 10.1529/biophysj.106.093641; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; Venter H, 2002, BIOCHEM J, V363, P243, DOI 10.1042/0264-6021:3630243; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1259, DOI 10.1002/bip.360301310; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200	35	60	62	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2836	2843		10.1074/jbc.M803792200	http://dx.doi.org/10.1074/jbc.M803792200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19015272	hybrid, Green Published			2022-12-27	WOS:000262700900027
J	Kim, C; Jeon, D; Kim, YH; Lee, CJ; Kim, H; Shin, HS				Kim, Chanki; Jeon, Daejong; Kim, Young-Hoon; Lee, C. Justin; Kim, Hyun; Shin, Hee-Sup			Deletion of N-type Ca2+ Channel Ca(v)2.2 Results in Hyperaggressive Behaviors in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL RAPHE NUCLEUS; CEREBROSPINAL-FLUID MONOAMINE; LONG-TERM POTENTIATION; KNOCK-OUT MICE; AGGRESSIVE-BEHAVIOR; ANTERIOR HYPOTHALAMUS; ALPHA(1B) SUBUNIT; CALCIUM-CHANNELS; RAT-BRAIN; PERSONALITY-DISORDERS	Voltage-dependent N-type Ca2+ channels play important roles in the regulation of diverse neuronal functions in the brain, but little is known about its role in social aggressive behaviors. Mice lacking the alpha 1B subunit (Ca(v)2.2) of N-type Ca2+ channels showed markedly enhanced aggressive behaviors to an intruder mouse in the resident-intruder test. The dorsal raphe nucleus (DRN), which contains serotonin neurons, is known to be involved in aggression in animals. We thus examined the DRN neurons in the Ca(v)2.2-deficient (Cav2.2(-/-)) mice. Microinjection of omega-conotoxin GVIA, an N-type Ca2+ channel-specific blocker, into the DRN of wild type mice resulted in escalated aggression, mimicking the phenotypes of Ca(v)2.2(-/-). Electrophysiological analysis showed increased firing activity of serotonin neurons with a reduced inhibitory neurotransmission in the Ca(v)2.2(-/-) DRN. Ca(v)2.2(-/-) mice showed an elevated level of arginine vasopressin, an aggression-related hormone, in the cerebrospinal fluid. In addition, Ca(v)2.2(-/-) mice showed an increase of serotonin in the hypothalamus. These results suggest that N-type Ca2+ channels at the DRN have a key role in the control of aggression.	[Kim, Chanki; Jeon, Daejong; Lee, C. Justin; Shin, Hee-Sup] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea; [Kim, Chanki] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, Young-Hoon] Inje Univ, Paik Inst Clin Res, Pusan 614735, South Korea; [Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 1261, South Korea	Korea Institute of Science & Technology (KIST); Korea University; Inje University; Korea University; Korea University Medicine (KU Medicine)	Shin, HS (corresponding author), 39-1 Hawolgok Dong, Seoul 136791, South Korea.	shin@kist.re.kr	Lee, C. Justin/AAC-1663-2019; Jeon, Daejong/C-1814-2011	Jeon, Daejong/0000-0002-6998-7603; Lee, C Justin/0000-0002-3555-0980; Kim, Hyun/0000-0002-7210-5798	Ministry of Science and Technology, Korea; Chemoinformatics program, the Center-of-Excellence program; Korea Institute of Science and Technology, Korea	Ministry of Science and Technology, Korea(Ministry of Science & Technology (MOST), Republic of Korea); Chemoinformatics program, the Center-of-Excellence program; Korea Institute of Science and Technology, Korea(Korea Institute of Science & Technology (KIST))	This work was supported by a National Honor Scientist grant from the Ministry of Science and Technology, Korea, and the Chemoinformatics program, the Center-of-Excellence program, and the Top-Brand program in Korea Institute of Science and Technology, Korea. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adell A, 2002, BRAIN RES REV, V39, P154, DOI 10.1016/S0165-0173(02)00182-0; Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; Bannai M, 2007, PSYCHOPHARMACOLOGY, V193, P295, DOI 10.1007/s00213-007-0780-5; Beuckmann CT, 2003, J NEUROSCI, V23, P6793; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; Casanovas JM, 1997, BRIT J PHARMACOL, V122, P733, DOI 10.1038/sj.bjp.0701420; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; CASTELLANOS FX, 1994, PSYCHIAT RES, V52, P305, DOI 10.1016/0165-1781(94)90076-0; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; COCCARO EF, 1989, ARCH GEN PSYCHIAT, V46, P587; Coccaro EF, 1998, ARCH GEN PSYCHIAT, V55, P708, DOI 10.1001/archpsyc.55.8.708; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Davis ES, 2004, NEUROSCIENCE, V127, P611, DOI 10.1016/j.neuroscience.2004.05.034; de Boer SF, 2000, NEUROPSYCHOPHARMACOL, V23, P20, DOI 10.1016/S0893-133X(00)00092-0; de Boer SF, 2005, EUR J PHARMACOL, V526, P125, DOI 10.1016/j.ejphar.2005.09.065; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; Delville Y, 2000, BRAIN BEHAV EVOLUT, V55, P53, DOI 10.1159/000006642; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; DEVRIES GJ, 1985, J COMP NEUROL, V233, P236, DOI 10.1002/cne.902330206; FERRIS CF, 1988, PHYSIOL BEHAV, V44, P235, DOI 10.1016/0031-9384(88)90144-8; Ferris CF, 1997, J NEUROSCI, V17, P4331; Fountoulakis KN, 2008, CURR OPIN PSYCHIATR, V21, P84, DOI 10.1097/YCO.0b013e3282f31137; Gammie SC, 2001, BRAIN RES, V898, P232, DOI 10.1016/S0006-8993(01)02189-8; Haller J, 1996, J NEUROENDOCRINOL, V8, P361, DOI 10.1046/j.1365-2826.1996.04654.x; Halperin JM, 1997, BIOL PSYCHIAT, V41, P682, DOI 10.1016/S0006-3223(96)00168-0; Ino M, 2001, P NATL ACAD SCI USA, V98, P5323, DOI 10.1073/pnas.081089398; IVERSEN LL, 1966, J NEUROCHEM, V13, P671, DOI 10.1111/j.1471-4159.1966.tb09874.x; Jeon D, 2007, GENES BRAIN BEHAV, V6, P375, DOI 10.1111/j.1601-183X.2006.00267.x; Jeon D, 2008, J BIOL CHEM, V283, P12093, DOI 10.1074/jbc.M800816200; Jorgensen H, 2003, J NEUROENDOCRINOL, V15, P564, DOI 10.1046/j.1365-2826.2003.01032.x; Kang SJ, 2008, MOL CELLS, V25, P124; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; la Cour CM, 2004, J NEUROCHEM, V89, P886, DOI 10.1111/j.1471-4159.2004.02367.x; Larsen PJ, 1996, NEUROSCIENCE, V70, P963, DOI 10.1016/0306-4522(95)00415-7; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; Matter JM, 1998, BRAIN BEHAV EVOLUT, V51, P23; MEHLMAN PT, 1994, AM J PSYCHIAT, V151, P1485; MOS J, 1993, EUR J PHARMACOL, V238, P411, DOI 10.1016/0014-2999(93)90877-K; MUEHLENKAMP F, 1995, PHARMACOL BIOCHEM BE, V50, P671, DOI 10.1016/0091-3057(95)00351-7; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Newton PM, 2004, J NEUROSCI, V24, P9862, DOI 10.1523/JNEUROSCI.3446-04.2004; Olivier B, 2004, ANN NY ACAD SCI, V1036, P382, DOI 10.1196/annals.1330.022; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pudovkina OL, 2003, SYNAPSE, V50, P77, DOI 10.1002/syn.10245; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; SAWCHENKO PE, 1983, BRAIN RES, V277, P355, DOI 10.1016/0006-8993(83)90945-9; SIJBESMA H, 1991, PHARMACOL BIOCHEM BE, V38, P447, DOI 10.1016/0091-3057(91)90305-L; Summers CH, 1998, NEUROSCIENCE, V87, P489, DOI 10.1016/S0306-4522(98)00144-4; Summers CH, 2001, BRAIN BEHAV EVOLUT, V57, P283, DOI 10.1159/000047246; TANAKA O, 1995, BRAIN RES MOL BRAIN, V30, P1, DOI DOI 10.1016/0169-328X(94)00265-G; Tao R, 2003, BRAIN RES, V961, P109, DOI 10.1016/S0006-8993(02)03851-9; Timmermann DB, 2002, J NEUROSCI RES, V67, P48, DOI 10.1002/jnr.10074; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; Vacher CM, 2002, J NEUROSCI, V22, P1513, DOI 10.1523/JNEUROSCI.22-05-01513.2002; van der Vegt BJ, 2003, HORM BEHAV, V44, P199, DOI 10.1016/S0018-506X(03)00132-6; van der Vegt BJ, 2003, BEHAV NEUROSCI, V117, P667, DOI 10.1037/0735-7044.117.4.667; VANDEKAR LD, 1991, ANNU REV PHARMACOL, V31, P289; VANDERMAELEN CP, 1983, BRAIN RES, V289, P109, DOI 10.1016/0006-8993(83)90011-2; Veenema AH, 2006, EUR J NEUROSCI, V24, P1711, DOI 10.1111/j.1460-9568.2006.05045.x; Zepf FD, 2008, HUM PSYCHOPHARM CLIN, V23, P43, DOI 10.1002/hup.896	61	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2738	2745		10.1074/jbc.M807179200	http://dx.doi.org/10.1074/jbc.M807179200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19004821	hybrid			2022-12-27	WOS:000262700900016
J	Forgacs, E; Sakamoto, T; Cartwright, S; Belknap, B; Kovacs, M; Toth, J; Webb, MR; Sellers, JR; White, HD				Forgacs, Eva; Sakamoto, Takeshi; Cartwright, Suzanne; Belknap, Betty; Kovacs, Mihaly; Toth, Judit; Webb, Martin R.; Sellers, James R.; White, Howard D.			Switch 1 Mutation S217A Converts Myosin V into a Low Duty Ratio Motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC MECHANISM; NECK LENGTH; PHOSPHATE; DOMAIN; ADP; PROCESSIVITY; ACTOMYOSIN; ANALOGS; COMPLEX; BINDING	We have determined the kinetic mechanism and motile properties of the switch 1 mutant S217A of myosin Va. Phosphate dissociation from myosin V-ADP-P-i (inorganic phosphate) and actomyosin V-ADP-P-i and the rate of the hydrolysis step ( myosin V-ATP -> myosin V-ADP-P-i) were all similar to 10-fold slower in the S217A mutant than in wild type (WT) myosin V, resulting in a slower steady-state rate of basal and filamentous actin (actin)-activated ATP hydrolysis. Substrate binding and ADP dissociation kinetics were all similar to or slightly faster in S217A than in WT myosin V and mechanochemical gating of the rates of dissociation of ADP between trail and lead heads is maintained. The reduction in the rate constants of the hydrolysis and phosphate dissociation steps reduces the duty ratio from similar to 0.85 in WT myosin V to similar to 0.25 in S217A and produces a motor in which the average run length on actin at physiological concentrations of ATP is reduced 10-fold. Thus we demonstrate that, by mutational perturbation of the switch 1 structure, myosin V can be converted into a low duty ratio motor that is processive only at low substrate concentrations.	[Forgacs, Eva; Cartwright, Suzanne; Belknap, Betty; White, Howard D.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA; [Webb, Martin R.] Natl Inst Med Res, Div Phys Biochem, London NW7 1AA, England; [Sakamoto, Takeshi; Kovacs, Mihaly; Toth, Judit; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Toth, Judit] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary	Eastern Virginia Medical School; MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	White, HD (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA.	whitehd@evms.edu	Kovacs, Mihaly/A-6841-2011	Webb, Martin/0000-0002-0134-9621; Kovacs, Mihaly/0000-0002-1200-4741	National Institutes of Health [EB00209]; Medical Research Council [MC_U117512742] Funding Source: researchfish; MRC [MC_U117512742] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant EB00209 ( to H. D. W.).	Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Batra R, 1999, BIOL CHEM, V380, P1017, DOI 10.1515/BC.1999.126; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; FINER JT, 1995, BIOPHYS J, V68, pS291; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Park S, 2000, BIOCHEMISTRY-US, V39, P11732, DOI 10.1021/bi000945t; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TRENTHAM DR, 1972, BIOCHEM J, V126, P635, DOI 10.1042/bj1260635; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Wu XF, 1997, J CELL SCI, V110, P847; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	37	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2138	2149		10.1074/jbc.M805530200	http://dx.doi.org/10.1074/jbc.M805530200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19008235	Green Published, hybrid			2022-12-27	WOS:000262545600023
J	Soberanes, S; Urich, D; Baker, CM; Burgess, Z; Chiarella, SE; Bell, EL; Ghio, AJ; De Vizcaya-Ruiz, A; Liu, J; Ridge, KM; Kamp, DW; Chandel, NS; Schumacker, PT; Mutlu, GM; Budinger, GRS				Soberanes, Saul; Urich, Daniela; Baker, Christina M.; Burgess, Zach; Chiarella, Sergio E.; Bell, Eric L.; Ghio, Andrew J.; De Vizcaya-Ruiz, Andrea; Liu, Jing; Ridge, Karen M.; Kamp, David W.; Chandel, Navdeep S.; Schumacker, Paul T.; Mutlu, Goekhan M.; Budinger, G. R. Scott			Mitochondrial Complex III-generated Oxidants Activate ASK1 and JNK to Induce Alveolar Epithelial Cell Death following Exposure to Particulate Matter Air Pollution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATING KINASE 1; REDOX GENE-THERAPY; LONG-TERM EXPOSURE; OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; APOPTOSIS; MORTALITY; PHOSPHORYLATION; DYSFUNCTION; SUPEROXIDE	We have previously reported that airborne particulate matter air pollution (PM) activates the intrinsic apoptotic pathway in alveolar epithelial cells through a pathway that requires the mitochondrial generation of reactive oxygen species (ROS) and the activation of p53. We sought to examine the source of mitochondrial oxidant production and the molecular links between ROS generation and the activation of p53 in response to PM exposure. Using a mitochondrially targeted ratiometric sensor (Ro-GFP) in cells lacking mitochondrial DNA (rho(0) cells) and cells stably expressing a small hairpin RNA directed against the Rieske iron-sulfur protein, we show that site III of the mitochondrial electron transport chain is primarily responsible for fine PM (PM2.5)-induced oxidant production. In alveolar epithelial cells, the overexpression of SOD1 prevented the PM2.5-induced ROS generation from the mitochondria and prevented cell death. Infection of mice with an adenovirus encoding SOD1 prevented the PM2.5-induced death of alveolar epithelial cells and the associated increase inalveolar-capillary permeability. Treatment with PM2.5 resulted in the ROS-mediated activation of the oxidant-sensitive kinase ASK1 and its downstream kinase JNK. Murine embryonic fibroblasts from ASK1 knock-out mice, alveolar epithelial cells transfected with dominant negative constructs against ASK1, and pharmacologic inhibition of JNK with SP600125 (25 mu M) prevented the PM2.5-induced phosphorylation of p53 and cell death. We conclude that particulate matter air pollution induces the generation of ROS primarily from site III of the mitochondrial electron transport chain and that these ROS activate the intrinsic apoptotic pathway through ASK1, JNK, and p53.	[Soberanes, Saul; Urich, Daniela; Baker, Christina M.; Chiarella, Sergio E.; Bell, Eric L.; Liu, Jing; Ridge, Karen M.; Kamp, David W.; Chandel, Navdeep S.; Mutlu, Goekhan M.; Budinger, G. R. Scott] Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Schumacker, Paul T.] Northwestern Univ, Div Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Ghio, Andrew J.] US EPA, Res Triangle Pk, NC 27709 USA; [De Vizcaya-Ruiz, Andrea] IPN, Ctr Invest & Estudios Avanzados, Secc Externa Toxicol, Mexico City 07360, DF, Mexico	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; United States Environmental Protection Agency; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Budinger, GRS (corresponding author), Northwestern Univ, Div Pulm & Crit Care Med, Feinberg Sch Med, 240 E Huron,McGaw Pavil M300, Chicago, IL 60611 USA.	s-buding@northwestern.edu	Bell, Eric/F-6368-2012	Chiarella, Sergio/0000-0002-0445-4929; Schumacker, Paul T/0000-0001-9591-2034; De Vizcaya-Ruiz, Andrea/0000-0002-2097-0464	National Institutes of Health [HL071643, GM060472, HL067835, ES015024, ES013995]; American Lung Association and the Veterans Affairs Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL067835, P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995, R01ES015024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association and the Veterans Affairs Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL071643, GM060472, HL067835, ES015024, and ES013995. This work was also supported by the American Lung Association and the Veterans Affairs Administration. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABBEY DE, 1991, ENVIRON HEALTH PERSP, V94, P43, DOI 10.2307/3431291; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; Budinger GRS, 2002, J BIOL CHEM, V277, P15654, DOI 10.1074/jbc.M109317200; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Cheng WH, 2003, BIOCHEM J, V370, P927, DOI 10.1042/BJ20021870; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Dominici F, 2003, ENVIRON HEALTH PERSP, V111, P39, DOI 10.1289/ehp.5181; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Huggins FE, 2000, J HAZARD MATER, V74, P1, DOI 10.1016/S0304-3894(99)00195-8; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Li N, 2000, J IMMUNOL, V165, P3393, DOI 10.4049/jimmunol.165.6.3393; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Mutlu G, 2005, CIRC RES, V96, P999, DOI 10.1161/01.RES.0000164554.21993.AC; Mutlu GM, 2004, CIRC RES, V94, P1091, DOI 10.1161/01.RES.0000125623.56442.20; MUTLU GM, 2006, AM J RESP CELL MOL B; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Soberanes S, 2006, AM J RESP CRIT CARE, V174, P1229, DOI 10.1164/rccm.200602-203OC; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WISE SA, 2007, CERTIFICATE ANAL STA; Xia T, 2004, ENVIRON HEALTH PERSP, V112, P1347, DOI 10.1289/ehp.7167; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698; Zwacka RM, 1998, HUM GENE THER, V9, P1381, DOI 10.1089/hum.1998.9.9-1381	49	104	108	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2176	2186		10.1074/jbc.M808844200	http://dx.doi.org/10.1074/jbc.M808844200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19033436	hybrid, Green Published			2022-12-27	WOS:000262545600027
J	King, JD; Vinogradov, E; Preston, A; Li, JJ; Maskell, DJ				King, Jerry D.; Vinogradov, Evgeny; Preston, Andrew; Li, Jianjun; Maskell, Duncan J.			Post-assembly Modification of Bordetella bronchiseptica O Polysaccharide by a Novel Periplasmic Enzyme Encoded by wbmE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; VIRULENCE CONTROL-SYSTEM; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; SHIGELLA-FLEXNERI; POLYACRYLAMIDE GELS; RESPIRATORY-TRACT; ANTIGEN; GENE; PROTEINS	Bordetella bronchiseptica is a pathogen of humans and animals that colonizes the respiratory tract. It produces a lipopolysaccharide O antigen that contains a homopolymer of 2,3-dideoxy-2,3-diacetamido-L- galacturonic acid (L-GalNAc3NAcA). Some of these sugars are found in the uronamide form (L-GalNAc3NAcAN), and there is no discernible pattern in the distribution of amides along the chain. A B. bronchiseptica wbmE mutant expresses an O polysaccharide unusually rich in uronamides. The WbmE protein localizes to the periplasm and catalyzes the deamidation of uronamide-rich O chains in lipopolysaccharide purified from the mutant, to attain a wildtype uronamide/uronic acid ratio. WbmE is a member of the papain-like transglutaminase superfamily, and this categorization is consistent with a deamidase role. The periplasmic location of WbmE and its acceptance of complete lipopolysaccharide as substrate indicate that it operates at a late stage in lipopolysaccharide biosynthesis, after polymerization and export of the O chain from the cytoplasm. This is the first report of such a modification of O antigen after assembly. The expression of wbmE is controlled by the Bordetella virulence gene two-component-regulatory system, BvgAS, suggesting that this deamidation is a novel mechanism by which these bacteria modify their cell surface charge in response to environmental stimuli.	[King, Jerry D.; Preston, Andrew] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [King, Jerry D.; Preston, Andrew; Maskell, Duncan J.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Vinogradov, Evgeny; Li, Jianjun] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; University of Cambridge; National Research Council Canada	King, JD (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jeguel@gmail.com		Vinogradov, Evgeny/0000-0002-5364-1376; Preston, Andrew/0000-0002-1489-280X	Wellcome Trust [054588]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Programme Grant Number 054588 (to D.J.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AKERLEY BJ, 1993, J BACTERIOL, V175, P3468, DOI 10.1128/jb.175.11.3468-3479.1993; AKERLEY BJ, 1992, J BACTERIOL, V174, P980, DOI 10.1128/jb.174.3.980-990.1992; Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; ANTOINE R, 1992, MOL MICROBIOL, V6, P1785, DOI 10.1111/j.1365-2958.1992.tb01351.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; CHANTER N, 1989, RES VET SCI, V47, P48, DOI 10.1016/S0034-5288(18)31230-X; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; DIFABIO JL, 1992, FEMS MICROBIOL LETT, V97, P275, DOI 10.1111/j.1574-6968.1992.tb05475.x; Feng L, 2004, MICROB PATHOGENESIS, V36, P109, DOI 10.1016/j.micpath.2003.10.003; FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/JB.176.7.1821-1830.1994; Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; GRINTER NJ, 1989, PLASMID, V22, P203, DOI 10.1016/0147-619X(89)90003-6; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; JOHNSON KG, 1975, CAN J MICROBIOL, V21, P1969, DOI 10.1139/m75-285; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; JUNCKER AS, 2003, LIPOP 1 0 SIGNAL PEP; King JD, 2008, J BACTERIOL, V190, P1671, DOI 10.1128/JB.01708-07; Korres H, 2005, BIOCHEM BIOPH RES CO, V328, P1252, DOI 10.1016/j.bbrc.2005.01.087; Li JJ, 2007, MASS SPECTROM REV, V26, P35, DOI 10.1002/mas.20105; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Luo YN, 2002, FEMS MICROBIOL LETT, V208, P47; Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; MCGRATH BC, 1991, J BACTERIOL, V173, P649, DOI 10.1128/jb.173.2.649-654.1991; MICHAELIS S, 1983, J BACTERIOL, V154, P366, DOI 10.1128/JB.154.1.366-374.1983; MOXON ER, 1990, CURR TOP MICROBIOL, V150, P65; PEDERSEN LC, 1994, PROTEIN SCI, V3, P1131, DOI 10.1002/pro.5560030720; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Preston A, 2003, MOL MICROBIOL, V48, P725, DOI 10.1046/j.1365-2958.2003.03484.x; Preston A, 1996, J BACTERIOL, V178, P396, DOI 10.1128/jb.178.2.396-402.1996; Preston A, 2006, J BIOL CHEM, V281, P18135, DOI 10.1074/jbc.M513904200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STIBITZ S, 1991, J BACTERIOL, V173, P4288, DOI 10.1128/JB.173.14.4288-4296.1991; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; van den Akker WMR, 1998, MICROBIOL-SGM, V144, P1527, DOI 10.1099/00221287-144-6-1527; Vander Byl C, 2000, J BACTERIOL, V182, P6472, DOI 10.1128/JB.182.22.6472-6481.2000; Vinogradov E, 2004, CARBOHYD RES, V339, P649, DOI 10.1016/j.carres.2003.12.013; Vinogradov E, 2000, EUR J BIOCHEM, V267, P7230, DOI 10.1046/j.1432-1327.2000.01835.x; VINOGRADOV EV, 1991, CARBOHYD RES, V214, P289, DOI 10.1016/0008-6215(91)80036-M; WAGENER JS, 1984, AM J VET RES, V45, P1862; WEISGERBER C, 1982, EUR J BIOCHEM, V127, P165, DOI 10.1111/j.1432-1033.1982.tb06851.x	53	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1474	1483		10.1074/jbc.M807729200	http://dx.doi.org/10.1074/jbc.M807729200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015265	Green Published, hybrid			2022-12-27	WOS:000262330100015
J	Ku, CP; Lio, JCW; Wang, SH; Lin, CN; Syu, WJ				Ku, Chen-Peng; Lio, Joaquim Chan-Wang; Wang, Shao-Hung; Lin, Chin-Nan; Syu, Wan-Jr			Identification of a Third EspA-binding Protein That Forms Part of the Type III Secretion System of Enterohemorrhagic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCYTE EFFACEMENT; PATHOGENICITY ISLAND; SUBCELLULAR-LOCALIZATION; 2ND CHAPERONE; APPARATUS; ATPASE; LOCUS; COMPONENTS; REGULATOR; VIRULENCE	Enterohemorrhagic Escherichia coli utilizes a type III secretion system to deliver virulent effectors into cells. The secretion apparatus comprises a membrane basal body and an external needle complex of which EspA is the major component. An l0050-deletion (Delta L50) mutation was found to impair type III secretion and bacterial adherence. These phenotypes and the localization of the gene product to the inner membrane support the hypothesis that L0050, renamed EscL, forms part of the secretion apparatus. Furthermore, in Delta L50, the amount of EspA present within the cell lysate was found to have diminished, whereas the EspA co-cistron-expressed partner protein EspB remained unaffected. The decreased EspA level appeared to result from instability of the newly synthesized EspA protein in Delta L50 rather than a decrease in EspA mRNA. Using both biochemical co-purification and a bacterial two-hybrid interaction system, we were able to conclude that EscL is a third protein that, in addition to CesAB and CesA2, interacts with EspA and enhances the stability of intracellular EspA.	[Ku, Chen-Peng; Lio, Joaquim Chan-Wang; Wang, Shao-Hung; Lin, Chin-Nan; Syu, Wan-Jr] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University	Syu, WJ (corresponding author), 155 Sec 2,Li Nong St, Taipei 112, Taiwan.	wjsyu@ym.edu.tw	wang, shaohung/E-4017-2015	wang, shaohung/0000-0002-6824-0372; Lio, Jerry/0000-0003-3876-6741	National Science Council [97-2627-M-120-003, 97-2320-B-010-005-MY3]; Department of Education, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Department of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported in part by National Science Council Grants 97-2627-M-120-003 and 97-2320-B-010-005-MY3 and a grant from "A Plan Aim for the Top University" from the Department of Education, Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Chiu HJ, 2005, MICROBIOL-SGM, V151, P3277, DOI 10.1099/mic.0.28115-0; Chiu HJ, 2003, ARCH MICROBIOL, V180, P218, DOI 10.1007/s00203-003-0579-7; Chuang CH, 2001, J BIOMED SCI, V8, P170, DOI 10.1007/BF02256409; Clarke SC, 2003, CLIN MICROBIOL REV, V16, P365, DOI 10.1128/CMR.16.3.365-378.2003; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Creasey EA, 2003, MICROBIOL-SGM, V149, P3639, DOI 10.1099/mic.0.26735-0; Creasey EA, 2003, MICROBIOL-SGM, V149, P2093, DOI 10.1099/mic.0.26355-0; Daniell SJ, 2003, MOL MICROBIOL, V49, P301, DOI 10.1046/j.1365-2958.2003.03555.x; Delahay RM, 1999, J BIOL CHEM, V274, P35969, DOI 10.1074/jbc.274.50.35969; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Deng WY, 2001, INFECT IMMUN, V69, P6323, DOI 10.1128/IAI.69.10.6323-6335.2001; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Hartland EL, 2000, MOL MICROBIOL, V35, P1483, DOI 10.1046/j.1365-2958.2000.01814.x; Hsu SC, 2000, HEPATOLOGY, V32, P1111, DOI 10.1053/jhep.2000.19257; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x; Imai K, 2008, BIOINFORMATION, V2, P417, DOI 10.6026/97320630002417; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kenny B, 1997, INFECT IMMUN, V65, P2606, DOI 10.1128/IAI.65.7.2606-2612.1997; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lio JCW, 2004, J BIOMED SCI, V11, P855, DOI 10.1159/000081833; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Miller J. H, 1972, EXPT MOL GENETICS; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Neves BC, 2003, INFECT IMMUN, V71, P2130, DOI 10.1128/IAI.71.4.2130-2141.2003; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Shaw RK, 2005, INFECT IMMUN, V73, P1243, DOI 10.1128/IAI.73.2.1243-1251.2005; Su MSW, 2008, MICROBIOL-SGM, V154, P1094, DOI 10.1099/mic.0.2007/013946-0; Tsai NP, 2006, BIOCHEM J, V393, P591, DOI 10.1042/BJ20051201; Wainwright LA, 1998, MOL MICROBIOL, V27, P1247, DOI 10.1046/j.1365-2958.1998.00771.x; Wang GH, 2002, J MICROBIOL METH, V51, P119, DOI 10.1016/S0167-7012(02)00041-6; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493	42	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1686	1693		10.1074/jbc.M807478200	http://dx.doi.org/10.1074/jbc.M807478200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028682	hybrid			2022-12-27	WOS:000262330100037
J	MacFarlane, AJ; Perry, CA; Girnary, HH; Gao, D; Allen, RH; Stabler, SP; Shane, B; Stover, PJ				MacFarlane, Amanda J.; Perry, Cheryll A.; Girnary, Hussein H.; Gao, Dacao; Allen, Robert H.; Stabler, Sally P.; Shane, Barry; Stover, Patrick J.			Mthfd1 Is an Essential Gene in Mice and Alters Biomarkers of Impaired One-carbon Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE-METHENYLTETRAHYDROFOLATE-CYCLOHYDROLASE; DEPENDENT METHYLENETETRAHYDROFOLATE DEHYDROGENASE; NEURAL-TUBE DEFECTS; TRIFUNCTIONAL ENZYME; FORMYLTETRAHYDROFOLATE SYNTHETASE; TISSUE DISTRIBUTION; R653Q POLYMORPHISM; RISK-FACTOR; FOLATE; SERINE	Cytoplasmic folate-mediated one carbon (1C) metabolism functions to carry and activate single carbons for the de novo synthesis of purines, thymidylate, and for the remethylation of homocysteine to methionine. C1 tetrahydrofolate (THF) synthase, encoded by Mthfd1, is an entry point of 1Cs into folate metabolism through its formyl-THF synthetase (FTHFS) activity that catalyzes the ATP-dependent conversion of formate and THF to 10-formyl-THF. Disruption of FTHFS activity by the insertion of a gene trap vector into the Mthfd1 gene results in embryonic lethality in mice. Mthfd1(gt/+) mice demonstrated lower hepatic adenosylmethionine levels, which is consistent with formate serving as a source of 1Cs for cellular methylation reactions. Surprisingly, Mthfd1(gt/+) mice exhibited decreased levels of uracil in nuclear DNA, indicating enhanced de novo thymidylate synthesis, and suggesting that serine hydroxymethyltransferase and FTHFS compete for a limiting pool of unsubstituted THF. This study demonstrates the essentiality of the Mthfd1 gene and indicates that formate-derived 1Cs are utilized for de novo purine synthesis and the remethylation of homocysteine in liver. Further, the depletion of cytoplasmic FTHFS activity enhances thymidylate synthesis, affirming the competition between thymidylate synthesis and homocysteine remethylation for THF cofactors.	[MacFarlane, Amanda J.; Perry, Cheryll A.; Girnary, Hussein H.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Gao, Dacao; Shane, Barry] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Hlth Sci Ctr, Div Hematol, Denver, CO 80262 USA	Cornell University; University of California System; University of California Berkeley; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, 127 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu			National Institutes of Health [CA105440, DK42033]; NATIONAL CANCER INSTITUTE [R01CA105440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058144, R01DK042033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105440 (to P.J.S. and B. S.) and DK42033 (to B.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALLEN RH, 1993, METABOLISM, V42, P1448, DOI 10.1016/0026-0495(93)90198-W; Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Brody LC, 2002, AM J HUM GENET, V71, P1207, DOI 10.1086/344213; CHEEK WD, 1989, ARCH BIOCHEM BIOPHYS, V270, P504, DOI 10.1016/0003-9861(89)90532-8; Christensen KE, 2005, J BIOL CHEM, V280, P7597, DOI 10.1074/jbc.M409380200; CHRISTENSEN KE, 2008, HUM MUTAT IN PRESS; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; De Marco P, 2006, J HUM GENET, V51, P98, DOI 10.1007/s10038-005-0329-6; Di Pietro E, 2002, MOL CELL BIOL, V22, P4158, DOI 10.1128/MCB.22.12.4158-4166.2002; Duthie SJ, 1998, FASEB J, V12, P1491, DOI 10.1096/fasebj.12.14.1491; Elmore CL, 2007, MOL GENET METAB, V91, P85, DOI 10.1016/j.ymgme.2007.02.001; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Hol FA, 1998, CLIN GENET, V53, P119; HUM DW, 1988, J BIOL CHEM, V263, P15946; Kondo M, 2000, J BIOCHEM, V128, P57, DOI 10.1093/oxfordjournals.jbchem.a022730; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MEJIA NR, 1988, BIOCHEM BIOPH RES CO, V155, P1, DOI 10.1016/S0006-291X(88)81040-4; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; MOTOKAWA Y, 1971, ARCH BIOCHEM BIOPHYS, V146, P461, DOI 10.1016/0003-9861(71)90149-4; Parle-McDermott A, 2005, MOL HUM REPROD, V11, P477, DOI 10.1093/molehr/gah204; Parle-McDermott A, 2005, AM J MED GENET A, V132A, P365, DOI 10.1002/ajmg.a.30354; Parle-McDermott A, 2006, EUR J HUM GENET, V14, P768, DOI 10.1038/sj.ejhg.5201603; PELLETIER JN, 1995, BIOCHEMISTRY-US, V34, P12673, DOI 10.1021/bi00039a025; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Skarnes WC, 2000, METHOD ENZYMOL, V328, P592, DOI 10.1016/S0076-6879(00)28420-6; STABLER SP, 1993, BLOOD, V81, P3404; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Suh JR, 2000, J BIOL CHEM, V275, P35646, DOI 10.1074/jbc.M005864200; TAN LUL, 1977, J BIOL CHEM, V252, P1117; VANONI MA, 1984, BIOCHEMISTRY-US, V23, P5272, DOI 10.1021/bi00317a027; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	33	60	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1533	1539		10.1074/jbc.M808281200	http://dx.doi.org/10.1074/jbc.M808281200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19033438	hybrid, Green Published			2022-12-27	WOS:000262330100021
J	Pence, MG; Blans, P; Zink, CN; Hollis, T; Fishbein, JC; Perrino, FW				Pence, Matthew G.; Blans, Patrick; Zink, Charles N.; Hollis, Thomas; Fishbein, James C.; Perrino, Fred W.			Lesion Bypass of N-2-Ethylguanine by Human DNA Polymerase i	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINOR-GROOVE ADDUCT; ESCHERICHIA-COLI; TRANSLESION SYNTHESIS; NUCLEOTIDE INCORPORATION; SEQUENTIAL ACTION; KLENOW FRAGMENT; IOTA; REPLICATION; METAL; FIDELITY	Nucleotide incorporation and extension opposite N-2-ethyl-Gua by DNA polymerase i was measured and structures of the DNA polymerase i-N-2-ethyl-Gua complex with incoming nucleotides were solved. Efficiency and fidelity of DNA polymerase i opposite N-2-ethyl-Gua was determined by steady state kinetic analysis with Mg2+ or Mn2+ as the activating metal. DNA polymerase i incorporates dCMP opposite N-2-ethyl-Gua and unadducted Gua with similar efficiencies in the presence of Mg2+ and with greater efficiencies in the presence of Mn2+. However, the fidelity of nucleotide incorporation by DNA polymerase i opposite N-2-ethyl-Gua and Gua using Mn2+ is lower relative to that using Mg2+ indicating a metal-dependent effect. DNA polymerase i extends from the N-2-ethyl-Gua: Cyt3' terminus more efficiently than from the Gua:Cyt base pair. Together these kinetic data indicate that the DNA polymerase i catalyzed reaction is well suited for N-2-ethyl-Gua bypass. The structure of DNA polymerase with N-2-ethyl-Gua at the active site reveals the adducted base in the syn configuration when the correct incoming nucleotide is present. Positioning of the ethyl adduct into the major groove removes potential steric overlap between the adducted template base and the incoming dCTP. Comparing structures of DNA polymerase i complexed with N-2-ethyl-Gua and Gua at the active site suggests movements in the DNA polymerase i polymerase-associated domain to accommodate the adduct providing direct evidence that DNA polymerase i efficiently replicates past a minor groove DNA adduct by positioning the adducted base in the syn configuration.	[Pence, Matthew G.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA; [Pence, Matthew G.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Univ Hlth Sci, Struct Biol Ctr, Winston Salem, NC 27157 USA; [Blans, Patrick; Zink, Charles N.; Fishbein, James C.] Univ Maryland, Dept Chem & Biochem, Baltimore, MD 21250 USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; University System of Maryland; University of Maryland Baltimore	Perrino, FW (corresponding author), Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu	Pence, Matthew/J-1379-2012	Pence, Matthew/0000-0003-2271-789X	National Institutes of Health [GM069962, CA52881]; American Cancer Society [RSG-04-187-01-GMC]; NATIONAL CANCER INSTITUTE [R01CA052881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069962 (to F. W. P.) and CA52881 (to J. C. F.). This work was also supported by American Cancer Society Grant RSG-04-187-01-GMC (to T. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Choi JY, 2006, J BIOL CHEM, V281, P12315, DOI 10.1074/jbc.M600112200; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; DeLano W, 2002, PYMOL 0 99; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FANG JL, 1997, CARCINOGENESIS, V18, P632; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garcia-Diaz M, 2007, DNA REPAIR, V6, P1333, DOI 10.1016/j.dnarep.2007.03.005; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P10466, DOI 10.1073/pnas.0503859102; Johnson RE, 2006, MOL CELL BIOL, V26, P6435, DOI 10.1128/MCB.00851-06; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kehres DG, 2003, FEMS MICROBIOL REV, V27, P263, DOI 10.1016/S0168-6445(03)00052-4; KUNKEL TA, 1979, J BIOL CHEM, V254, P5718; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Matsuda T, 1999, BIOCHEMISTRY-US, V38, P929, DOI 10.1021/bi982134j; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Perrino FW, 2005, CHEM RES TOXICOL, V18, P1451, DOI 10.1021/tx050114u; Perrino FW, 2003, CHEM RES TOXICOL, V16, P1616, DOI 10.1021/tx034164f; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; RABKIN SD, 1983, P NATL ACAD SCI-BIOL, V80, P1541, DOI 10.1073/pnas.80.6.1541; Romani A, 2007, ARCH BIOCHEM BIOPHYS, V458, P90, DOI 10.1016/j.abb.2006.07.012; Seitz HK, 2007, ALCOHOL RES HEALTH, V30, P38; SIROVER MA, 1976, SCIENCE, V194, P1434, DOI 10.1126/science.1006310; SIROVER MA, 1976, P NATL ACAD SCI USA, V73, P2331, DOI 10.1073/pnas.73.7.2331; Terashima I, 2001, BIOCHEMISTRY-US, V40, P4106, DOI 10.1021/bi002719p; Tissier A, 2000, GENE DEV, V14, P1642; Upton DC, 2006, CHEM RES TOXICOL, V19, P960, DOI 10.1021/tx060084a; Upton DC, 2006, MUTAT RES-FUND MOL M, V599, P1, DOI 10.1016/j.mrfmmm.2005.12.014; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wolfle WT, 2006, MOL CELL BIOL, V26, P381, DOI 10.1128/MCB.26.1.381-386.2006; Wolfle WT, 2005, MOL CELL BIOL, V25, P8748, DOI 10.1128/MCB.25.19.8748-8754.2005; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	47	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1732	1740		10.1074/jbc.M807296200	http://dx.doi.org/10.1074/jbc.M807296200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18984581	Green Published, hybrid			2022-12-27	WOS:000262330100043
J	Lu, ZB; Wang, LB; Dunaway-Mariano, D; Allen, KN				Lu, Zhibing; Wang, Liangbing; Dunaway-Mariano, Debra; Allen, Karen N.			Structure-Function Analysis of 2-Keto-3-deoxy-D-glycero-D-galactonononate-9-phosphate Phosphatase Defines Specificity Elements in Type C0 Haloalkanoate Dehalogenase Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME SUPERFAMILY; CRYSTAL-STRUCTURE; ACID; PROGRAM; DIVERSIFICATION; BIOCHEMISTRY; REPLACEMENT; DIVERSITY; SOFTWARE; SYNTHASE	The phosphotransferases of the haloalkanoate dehalogenase superfamily (HADSF) act upon a wide range of metabolites in all eukaryotes and prokaryotes and thus constitute a significant force in cell function. The challenge posed for biochemical function assignment of HADSF members is the identification of the structural determinants that target a specific metabolite. The "8KDOP" subfamily of the HADSF is defined by the known structure and catalytic activity of 2-keto-3-deoxy-8-phospho-D-manno-octulosonic acid (KDO-8-P) phosphatase. Homologues of this enzyme have been uniformly annotated as KDO-8-P phosphatase. One such gene, BT1713, from the Bacteroides thetaiotaomicron genome was recently found to encode the enzyme 2-keto-3-deoxy-D-glycero-D-galacto-9-phosphonononic acid (KDN-9-P) phosphatase in the biosynthetic pathway of the 9-carbon alpha-keto acid, 2-keto-3-deoxy-D-glycero-D-galactonononic acid (KDN). To find the structural elements that provide substrate- specific interactions and to allow identification of genomic sequence markers, the x-ray crystal structures of BT1713 liganded to the cofactor Mg2+ and complexed with tungstate or VO3-/Neu5Ac were determined to 1.1, 1.85, and 1.63 angstrom resolution, respectively. The structures define the active site to be at the subunit interface and, as confirmed by steady-state kinetics and site-directed mutagenesis, reveal Arg-64*, Lys-67*, and Glu-56 to be the key residues involved in sugar binding that are essential for BT1713 catalytic function. Bioinformatic analyses of the differentially conserved residues between BT1713 and KDO-8-P phosphatase homologues guided by the knowledge of the structure-based specificity determinants define Glu-56 and Lys-67* to be the key residues that can be used in future annotations.	[Wang, Liangbing; Dunaway-Mariano, Debra] Univ New Mexico, Dept Chem & Biol Chem, Albuquerque, NM 87131 USA; [Lu, Zhibing; Allen, Karen N.] Boston Univ, Dept Chem, Boston, MA 02215 USA	University of New Mexico; Boston University	Dunaway-Mariano, D (corresponding author), Univ New Mexico, Dept Chem & Biol Chem, Albuquerque, NM 87131 USA.	dd39@unm.edu; drkallen@bu.edu	Allen, Karen N./J-7045-2019	Allen, Karen N./0000-0001-7296-0551	National Institutes of Health [GM61099]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health GM61099 (to K.N.A. and D.D.-M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felts RL, 2007, BIOCHEMISTRY-US, V46, P11110, DOI 10.1021/bi701016m; Higgins D G, 1994, Methods Mol Biol, V25, P307; Inoue S, 2006, GLYCOCONJUGATE J, V23, P277, DOI 10.1007/s10719-006-6484-y; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105; Morais MC, 2000, BIOCHEMISTRY-US, V39, P10385, DOI 10.1021/bi001171j; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JF, 2002, PROTEINS, V46, P393, DOI 10.1002/prot.10057; Peisach E, 2004, BIOCHEMISTRY-US, V43, P12770, DOI 10.1021/bi0490688; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Reaves ML, 2008, BMB REP, V41, P72, DOI 10.5483/BMBRep.2008.41.1.072; Tanner ME, 2005, BIOORG CHEM, V33, P216, DOI 10.1016/j.bioorg.2005.01.005; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Veige AS, 2003, INORG CHEM, V42, P6204, DOI 10.1021/ic0300114; Wang LB, 2008, CHEM BIOL, V15, P893, DOI 10.1016/j.chembiol.2008.08.005; Wu J, 2003, J BIOL CHEM, V278, P18117, DOI 10.1074/jbc.M301983200	30	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1224	1233		10.1074/jbc.M807056200	http://dx.doi.org/10.1074/jbc.M807056200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18986982	Green Published, hybrid			2022-12-27	WOS:000262122900058
J	Pilpa, RM; Robson, SA; Villareal, VA; Wong, ML; Phillips, M; Clubb, RT				Pilpa, Rosemarie M.; Robson, Scott A.; Villareal, Valerie A.; Wong, Melissa L.; Phillips, Martin; Clubb, Robert T.			Functionally Distinct NEAT (NEAr Transporter) Domains within the Staphylococcus aureus IsdH/HarA Protein Extract Heme from Methemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN; HEMOGLOBIN RECEPTOR; CRYSTAL-STRUCTURE; HUMAN HAPTOGLOBIN; IRON ACQUISITION; SERINE-PROTEASE; ISDC; BINDING; SYSTEM; IDENTIFICATION	The pathogen Staphylococcus aureus uses iron-regulated surface determinant (Isd) proteins to scavenge the essential nutrient iron from host hemoproteins. The IsdH protein (also known as HarA) is a receptor for hemoglobin (Hb), haptoglobin (Hp), and the Hb-Hp complex. It contains three NEAT (NEAr Transporter) domains: IsdHN1, IsdHN2, and IsdHN3. Here we show that they have different functions; IsdHN1 binds Hb and Hp, whereas IsdHN3 captures heme that is released from Hb. The staphylococcal IsdB protein also functions as an Hb receptor. Primary sequence homology to IsdH indicates that it will also employ functionally distinct NEAT domains to bind heme and Hb. We have used site-directed mutagenesis and surface plasmon resonance methods to localize the Hp and Hb binding surface on IsdHN1. High affinity binding to these structurally unrelated proteins requires residues located within a conserved aromatic motif that is positioned at the end of the beta-barrel structure. Interestingly, this site is quite malleable, as other NEAT domains use it to bind heme. We also demonstrate that the IsdC NEAT domain can capture heme directly from Hb, suggesting that there are multiple pathways for heme transfer across the cell wall.	[Clubb, Robert T.] Univ Calif Los Angeles, DOE, Inst Genom & Prote, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clubb, RT (corresponding author), Univ Calif Los Angeles, DOE, Inst Genom & Prote, Dept Chem & Biochem, 611 Charles E Young Dr, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu		Robson, Scott/0000-0002-0529-0399	National Institutes of Health [AI52217]; Department of Energy [DE-FC-03-87ER60615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI52217. This work was also supported by Department of Energy Grant DE-FC-03-87ER60615.	Andrade MA, 2002, GENOME BIOL, V3; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Brown JS, 2002, MICROBES INFECT, V4, P1149, DOI 10.1016/S1286-4579(02)01640-4; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Ettrich R, 2002, BIOL CHEM, V383, P1667, DOI 10.1515/BC.2002.187; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; KUROSKY A, 1980, P NATL ACAD SCI-BIOL, V77, P3388, DOI 10.1073/pnas.77.6.3388; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; OKUDA M, 1992, BIOCHIM BIOPHYS ACTA, V1136, P143, DOI 10.1016/0167-4889(92)90249-B; Pilpa RM, 2005, J BIOMOL NMR, V33, P137, DOI 10.1007/s10858-005-2898-2; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; WISEMAN GM, 1975, BACTERIOL REV, V39, P317, DOI 10.1128/MMBR.39.4.317-344.1975; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	39	92	98	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1166	1176		10.1074/jbc.M806007200	http://dx.doi.org/10.1074/jbc.M806007200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18984582	Green Published, hybrid			2022-12-27	WOS:000262122900053
J	Greenwood, C; Selth, LA; Dirac-Svejstrup, AB; Svejstrup, JQ				Greenwood, Catherine; Selth, Luke A.; Dirac-Svejstrup, A. Barbara; Svejstrup, Jesper Q.			An Iron-Sulfur Cluster Domain in Elp3 Important for the Structural Integrity of Elongator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLUYVEROMYCES-LACTIS ZYMOCIN; POLYMERASE-II HOLOENZYME; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLTRANSFERASE; HOLO-ELONGATOR; IN-VIVO; COMPLEX; GENES; SUBUNIT; TRANSCRIPTION	The Elongator complex functions in diverse cellular processes, such as RNA polymerase II transcription and tRNA modification. The Elp3 subunit possesses a C-terminal histone acetyltransferase (HAT) domain and an N-terminal sequence that resembles an iron-sulfur (FeS) cluster motif. The HAT domain is well characterized, but the role of the FeS cluster is unknown, although one report proposed that it might be involved in catalyzing histone demethylation. We investigated the importance and function of the yeast Elp3 FeS cluster by a combination of genetic and biochemical means. To minimize oxidation of the Elp3 FeS cluster during purification, we also developed a novel tandem affinity tag and an accompanying isolation procedure that enables purification of tagged proteins to virtual homogeneity within a few hours of cell disruption. Our results failed to support a role for Elongator in histone demethylation. Moreover FeS cluster integrity was not required for the HAT or RNA binding activities of Elongator. However, a fully functional FeS cluster was required for Elongator integrity and for the association of the complex with its accessory factors Kti11 and Kti12. In contrast, the association of Elongator with RNA polymerase II in chromatin was unaffected by FeS cluster mutations. Together our data support the idea that the Elp3 FeS cluster is essential for normal Elongator function in vivo primarily as a structural, rather than catalytic, domain.	[Greenwood, Catherine; Selth, Luke A.; Dirac-Svejstrup, A. Barbara; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk	Selth, Luke/AAH-4823-2021	Selth, Luke/0000-0002-4686-1418; Svejstrup, Jesper/0000-0003-4964-6147	European Molecular Biology Organization; Cancer Research UK	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	This work was supported by a European Molecular Biology Organization long term postdoctoral fellowship (to L.A.S.) and by a grant from Cancer Research UK (to J.Q.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BUTLER AR, 1991, YEAST, V7, P617, DOI 10.1002/yea.320070610; Chinenov Y, 2002, TRENDS BIOCHEM SCI, V27, P115, DOI 10.1016/S0968-0004(02)02058-3; Close P, 2006, MOL CELL, V22, P521, DOI 10.1016/j.molcel.2006.04.017; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Fichtner L, 2002, MOL MICROBIOL, V43, P783, DOI 10.1046/j.1365-2958.2002.02794.x; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Gilbert C., 2006, CURRENT PROTOCOLS MO; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Jablonowski D, 2001, MOL MICROBIOL, V42, P1095, DOI 10.1046/j.1365-2958.2001.02705.x; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kishida M, 1996, BIOSCI BIOTECH BIOCH, V60, P798, DOI 10.1271/bbb.60.798; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Petrakis TG, 2005, J BIOL CHEM, V280, P19454, DOI 10.1074/jbc.M413373200; Petrakis TG, 2004, J BIOL CHEM, V279, P32087, DOI 10.1074/jbc.M403361200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sun JP, 2005, BIOCHEMISTRY-US, V44, P8801, DOI 10.1021/bi0504714; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yajima H, 1997, BIOSCI BIOTECH BIOCH, V61, P704, DOI 10.1271/bbb.61.704; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201	35	41	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					141	149		10.1074/jbc.M805312200	http://dx.doi.org/10.1074/jbc.M805312200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18986986	hybrid			2022-12-27	WOS:000261974800016
J	Tallent, MK; Varghis, N; Skorobogatko, Y; Hernandez-Cuebas, L; Whelan, K; Vocadlo, DJ; Vosseller, K				Tallent, Melanie K.; Varghis, Neal; Skorobogatko, Yuliya; Hernandez-Cuebas, Lisa; Whelan, Kelly; Vocadlo, David J.; Vosseller, Keith			In Vivo Modulation of O-GlcNAc Levels Regulates Hippocampal Synaptic Plasticity through Interplay with Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; LONG-TERM POTENTIATION; ACTIVATED PROTEIN-KINASES; ESTROGEN-RECEPTOR-BETA; RNA-POLYMERASE-II; SYNAPSIN-I; NEUROTRANSMITTER RELEASE; POSTTRANSLATIONAL MODIFICATION; NUCLEOCYTOPLASMIC PROTEINS; PRESYNAPTIC PLASTICITY	O-Linked N-acetylglucosamine (O-GlcNAc) is a cytosolic and nuclear carbohydrate post-translational modification most abundant in brain. We recently reported uniquely extensive O-GlcNAc modification of proteins that function in synaptic vesicle release and post-synaptic signal transduction. Here we examined potential roles for O-GlcNAc in mouse hippocampal synaptic transmission and plasticity. O-GlcNAc modifications and the enzyme catalyzing their addition (O-GlcNAc transferase) were enriched in hippocampal synaptosomes. Pharmacological elevation or reduction of O-GlcNAc levels had no effect on Schaffer collateral CA1 basal hippocampal synaptic transmission. However, in vivo elevation of O-GlcNAc levels enhanced long term potentiation (LTP), an electrophysiological correlate to some forms of learning/memory. Reciprocally, pharmacological reduction of O-GlcNAc levels blocked LTP. Additionally, elevated O-GlcNAc led to reduced paired-pulse facilitation, a form of short term plasticity attributed to presynaptic mechanisms. Synapsin I and II are presynaptic proteins that increase synaptic vesicle availability for release when phosphorylated, thus contributing to hippocampal synaptic plasticity. Synapsins are among the most extensively O-GlcNAc- modified proteins known. Elevating O-GlcNAc levels increased phosphorylation of Synapsin I/II at serine 9 (cAMP-dependent protein kinase substrate site), serine 62/67 (Erk 1/2 (MAPK 1/2) substrate site), and serine 603 (calmodulin kinase II site). Activation-specific phosphorylation events on Erk 1/2 and calmodulin kinase II, two proteins required for CA1 hippocampal LTP establishment, were increased in response to elevation of O-GlcNAc levels. Thus, O-GlcNAc is a novel regulatory signaling component of excitatory synapses, with specific roles in synaptic plasticity that involve interplay with phosphorylation.	[Tallent, Melanie K.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Varghis, Neal; Skorobogatko, Yuliya; Hernandez-Cuebas, Lisa; Whelan, Kelly; Vosseller, Keith] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Drexel University; Drexel University; Simon Fraser University	Vosseller, K (corresponding author), 245 N 15th St, Philadelphia, PA 19102 USA.	keith.vosseller@drexelmed.edu	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558	Alzheimer's Association [NIRG-07-59591]; Drexel University	Alzheimer's Association(Alzheimer's Association); Drexel University	This work was supported in part by Grant NIRG-07-59591( to K. V.) from the Alzheimer's Association and start-up funds from Drexel University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Baratta MV, 2002, J NEUROPHYSIOL, V88, P3078, DOI 10.1152/jn.00398.2002; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Dehennaut V, 2007, J BIOL CHEM, V282, P12527, DOI 10.1074/jbc.M700444200; Dobrunz LE, 2002, NATURE, V415, P277, DOI 10.1038/415277a; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Fiumara F, 2004, J CELL SCI, V117, P5145, DOI 10.1242/jcs.01388; Fukunaga K, 2000, NEUROSCI RES, V38, P3, DOI 10.1016/S0168-0102(00)00139-5; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Giovannini MG, 2006, REV NEUROSCIENCE, V17, P619; GOOLD R, 1994, EUR J BIOCHEM, V224, P229, DOI 10.1111/j.1432-1033.1994.tb20016.x; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hvalby O, 2006, J PHYSIOL-LONDON, V571, P75, DOI 10.1113/jphysiol.2005.100685; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jensen V, 2007, J PHYSIOL-LONDON, V583, P129, DOI 10.1113/jphysiol.2007.131300; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kneass ZT, 2005, J BIOL CHEM, V280, P14579, DOI 10.1074/jbc.M414066200; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Leenders AGM, 2005, PHARMACOL THERAPEUT, V105, P69, DOI 10.1016/j.pharmthera.2004.10.012; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Lisman J., 2006, SCI STKE, V2006, pr; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Okuyama R, 2003, J NEUROCHEM, V86, P1271, DOI 10.1046/j.1471-4159.2003.01939.x; Qiu C, 2008, J NEUROSCI, V28, P3567, DOI 10.1523/JNEUROSCI.4679-07.2008; Raymond CR, 2007, TRENDS NEUROSCI, V30, P167, DOI 10.1016/j.tins.2007.01.007; Rengifo J, 2007, J NEUROSCI, V27, P13813, DOI 10.1523/JNEUROSCI.2069-07.2007; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200	65	101	103	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					174	181		10.1074/jbc.M807431200	http://dx.doi.org/10.1074/jbc.M807431200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19004831	hybrid			2022-12-27	WOS:000261974800020
J	Zhao, GY; Chen, XL; Zhao, HL; Xie, BB; Zhou, BC; Zhang, YZ				Zhao, Guo-Yan; Chen, Xiu-Lan; Zhao, Hui-Lin; Xie, Bin-Bin; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Hydrolysis of Insoluble Collagen by Deseasin MCP-01 from Deep-sea Pseudoalteromonas sp SM9913 COLLAGENOLYTIC CHARACTERS, COLLAGEN-BINDING ABILITY OF C-TERMINAL POLYCYSTIC KIDNEY DISEASE DOMAIN, AND IMPLICATION FOR ITS NOVEL ROLE IN DEEP-SEA SEDIMENTARY PARTICULATE ORGANIC NITROGEN DEGRADATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN O-7; PIVOTAL ROLE; GENE; CHITINASE; PROTEASES; MO-1; PSYCHROTOLERANT; THERMOPHILE; EXPRESSION; AUTOLYSIS	Collagens are the most abundant proteins in marine animals and their degradation is important for the recycling of marine nitrogen. However, it is rather unclear how marine collagens are degraded because few marine collagenolytic proteases are studied in detail. Deseasins are a new type of multidomain subtilases. Here, the collagenolytic activity of deseasin MCP-01, the type example of deseasins, was studied. MCP-01 had broad substrate specificity to various type collagens from terrestrial and marine animals. It completely decomposed insoluble collagen into soluble peptides and amino acids, and was more prone to degrade marine collagen than terrestrial collagen. Thirty-seven cleavage sites of MCP-01 on bovine collagen chains were elucidated, showing the cleavage is various but specific. As the main extracellular cold-adapted protease from deep-sea bacterium Pseudoalteromonas sp. SM9913, MCP-01 displayed high activity at low temperature and alkaline range. Our data also showed that the C-terminal polycystic kidney disease (PKD) domain of MCP-01 was able to bind insoluble collagen and facilitate the insoluble collagen digestion by MCP-01. Site-directed mutagenesis demonstrated that Trp-36 of the PKD domain played a key role in its binding to insoluble collagen. It is the first time that the structure and function of a marine collagenolytic protease, deseasin MCP-01, has been studied in detail. Moreover, the PKD domain was experimentally proven to bind to insoluble protein for the first time. These results imply that MCP-01 would play an important role in the degradation of deep-sea sedimentary particulate organic nitrogen.	[Zhao, Guo-Yan; Chen, Xiu-Lan; Zhao, Hui-Lin; Xie, Bin-Bin; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn			Hi-Tech Research and Development Program of China [2006AA09Z414, 2007AA091903]; National Natural Science Foundation of China [30770040]; Program for New Century Excellent Talents in University [NCET-06-0578]; Foundation for Young Excellent Scientists in Shandong Province [2006BS02002]; COMRA [DYXM-115-02-2-6]	Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Foundation for Young Excellent Scientists in Shandong Province; COMRA	The work was supported by Hi-Tech Research and Development Program of China Grants 2006AA09Z414 and 2007AA091903, National Natural Science Foundation of China Grant 30770040, Program for New Century Excellent Talents in University Grant NCET-06-0578, Foundation for Young Excellent Scientists in Shandong Province Grant 2006BS02002, and COMRA Program Grant DYXM-115-02-2-6. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahsan MM, 1996, J BACTERIOL, V178, P5732, DOI 10.1128/jb.178.19.5732-5740.1996; An YF, 2005, APPL MICROBIOL BIOT, V68, P774, DOI 10.1007/s00253-005-1948-8; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Brunnegard J, 2004, PROG OCEANOGR, V63, P159, DOI 10.1016/j.pocean.2004.09.004; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; CAWSTON TE, 2004, HDB PROTEOLYTIC ENZY, P472; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; Chen XL, 2007, BIOCHEM BIOPH RES CO, V358, P704, DOI 10.1016/j.bbrc.2007.04.193; Chen XL, 2003, MAR BIOL, V143, P989, DOI 10.1007/s00227-003-1128-2; Chen XL, 2003, BIOTECHNOL LETT, V25, P1763, DOI 10.1023/A:1026040012947; DREISBACH JH, 1978, J BACTERIOL, V135, P521, DOI 10.1128/JB.135.2.521-527.1978; Ferrandon S, 2003, BBA-GEN SUBJECTS, V1621, P31, DOI 10.1016/S0304-4165(03)00029-1; HENRIET P, 2004, HDB PROTEOLYTIC ENZY, P486; Itoi Y, 2006, J BACTERIOL, V188, P6572, DOI 10.1128/JB.00767-06; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kurata A, 2007, INT J SYST EVOL MICR, V57, P1549, DOI 10.1099/ijs.0.65084-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; MERKEL JR, 1975, APPL MICROBIOL, V29, P145, DOI 10.1128/AEM.29.2.145-151.1975; MERKEL JR, 1978, BIOCHEMISTRY-US, V17, P2857, DOI 10.1021/bi00607a025; Miyake R, 2005, J BACTERIOL, V187, P4140, DOI 10.1128/JB.187.12.4140-4148.2005; Miyamoto K, 2002, J BACTERIOL, V184, P1865, DOI 10.1128/JB.184.7.1865-1872.2002; Nagy T, 1998, FEBS LETT, V429, P312, DOI 10.1016/S0014-5793(98)00625-5; Oda K, 1996, J BIOCHEM, V120, P564; Okamoto M, 2001, APPL MICROBIOL BIOT, V57, P103, DOI 10.1007/s002530100731; Orikoshi H, 2005, J APPL MICROBIOL, V99, P551, DOI 10.1111/j.1365-2672.2005.02630.x; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOMME P, 1995, ENZYMATIC DEGRADATIO, V618, P142; WAITE JH, 1980, J BIOL CHEM, V255, P3596; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; Worthington Biochemical Corporation, 1972, WORTH ENZ MAN, P43	35	57	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36100	36107		10.1074/jbc.M804438200	http://dx.doi.org/10.1074/jbc.M804438200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18977758	Green Published, hybrid			2022-12-27	WOS:000261840500005
J	Ludwig, T; Theissen, SM; Morton, MJ; Caplan, MJ				Ludwig, Thomas; Theissen, Sarah M.; Morton, Michael J.; Caplan, Michael J.			The Cytoplasmic Tail Dileucine Motif LL572 Determines the Glycosylation Pattern of Membrane-type 1 Matrix Metalloproteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DARBY CANINE KIDNEY; LOCAL PROTEOLYTIC ACTIVITY; TUMOR-CELL INVASION; 1-MATRIX METALLOPROTEINASE; SORTING SIGNALS; TISSUE INHIBITOR; SIALIC ACIDS; MT1-MMP; SURFACE; ACTIVATION	Membrane-type 1 matrix metalloproteinase (MT1-MMP; MMP-14) drives fundamental physiological and pathological processes, due to its ability to process a broad spectrum of substrates. Because subtle changes in its activity can produce profound physiological effects, MT1-MMP is tightly regulated. Currently, many aspects of this regulation remain to be elucidated. It has recently been discovered that O-linked glycosylation defines the substrate spectrum of MT1-MMP. We hypothesized that a mutual interdependency exists between MT1-MMP trafficking and glycosylation. Lectin precipitation, metabolic labeling, enzymatic deglycosylation, and site-directed mutagenesis studies demonstrate that the LL572 motif in the cytoplasmic tail of MT1-MMP influences the composition of the complex O-linked carbohydrates attached to the hinge region of the protein. This influence appears to be independent from major effects on cell surface trafficking. MT1-MMP undergoes extensive processing after its synthesis. The origins and the molecular characters of its multiple forms are incompletely understood. Here, we develop and present a model for the sequential, post-translational processing of MT1-MMP that defines stages in the post-synthetic pathway pursued by the protein.	[Ludwig, Thomas; Theissen, Sarah M.] BIOQUANT Zentrum, German Canc Res Ctr Heidelberg, D-69120 Heidelberg, Germany; [Ludwig, Thomas; Morton, Michael J.; Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Yale University	Ludwig, T (corresponding author), BIOQUANT Zentrum, German Canc Res Ctr Heidelberg, BQ 0009 NWG Ludwig,Neuenheimer Feld 267, D-69120 Heidelberg, Germany.	t.ludwig@dkfz.de	Theissen, Sarah Maria/J-1570-2019; Ludwig, Thomas/A-5691-2011	Theissen, Sarah Maria/0000-0002-3341-5953; Caplan, Michael/0000-0001-5768-4405	National Institutes of Health [DK17433, DK072614]; Deutsche Forschungsgemeinschaft [LU 854/2-1, LU 854/3-1]; FRONTIER program of the Excellence Initiative at Heidelberg University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072614, P01DK017433, R56DK072614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FRONTIER program of the Excellence Initiative at Heidelberg University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK17433 and DK072614 ( to M. J. C.). This work was also supported by the Deutsche Forschungsgemeinschaft ( Grants LU 854/2-1 and LU 854/3-1) and the FRONTIER program of the Excellence Initiative at Heidelberg University ( to T. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; CAPLAN MJ, 1990, J BIOL CHEM, V265, P3528; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Itoh Y, 2004, TRENDS BIOCHEM SCI, V29, P285, DOI 10.1016/j.tibs.2004.04.001; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kusick S, 2005, J CELL PHYSIOL, V204, P767, DOI 10.1002/jcp.20328; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Ludwig T, 2005, BIOESSAYS, V27, P1181, DOI 10.1002/bies.20306; Ludwig T, 2005, J CELL PHYSIOL, V202, P690, DOI 10.1002/jcp.20168; Ludwig T, 2002, AM J PHYSIOL-RENAL, V283, pF319, DOI 10.1152/ajprenal.00327.2001; LUDWIG T, 2006, NANOMATERIALS CANC D, P377; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Osenkowski P, 2005, J BIOL CHEM, V280, P26160, DOI 10.1074/jbc.M414379200; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Remacle AG, 2006, J BIOL CHEM, V281, P16897, DOI 10.1074/jbc.M600295200; Roush DL, 1998, J BIOL CHEM, V273, P26862, DOI 10.1074/jbc.273.41.26862; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Shaw Leslie M., 2004, V294, P97; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Teuchert M, 1999, J BIOL CHEM, V274, P36781, DOI 10.1074/jbc.274.51.36781; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Urena JM, 1999, J CELL SCI, V112, P773; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200; Yana I, 2002, CLIN EXP METASTAS, V19, P209, DOI 10.1023/A:1015527220537; Yarema KJ, 2001, GENOME BIOL, V2; Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929; Zanetta JP, 2001, GLYCOBIOLOGY, V11, P663, DOI 10.1093/glycob/11.8.663; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	55	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35410	35418		10.1074/jbc.M801816200	http://dx.doi.org/10.1074/jbc.M801816200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955496	Green Published, hybrid			2022-12-27	WOS:000261687900012
J	Luo, BH; Karanicolas, J; Harmacek, LD; Baker, D; Springer, TA				Luo, Bing-Hao; Karanicolas, John; Harmacek, Laura D.; Baker, David; Springer, Timothy A.			Rationally Designed Integrin beta 3 Mutants Stabilized in the High Affinity Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE MONOCLONAL-ANTIBODY; CD11B A-DOMAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; I-DOMAIN; EXTRACELLULAR SEGMENT; GLYCOPROTEIN-IIIA; HYBRID DOMAIN; OUTSIDE-IN; PROTEIN	Integrins are important cell surface receptors that transmit bidirectional signals across the membrane. It has been shown that a conformational change of the integrin beta-subunit head-piece (i.e. the beta I domain and the hybrid domain) plays a critical role in regulating integrin ligand binding affinity and function. Previous studies have used coarse methods (a glycan wedge, mutations in transmembrane contacts) to force the beta-subunit into either the open or closed conformation. Here, we demonstrate a detailed understanding of this conformational change by applying computational design techniques to select five amino acid side chains that play an important role in the energetic balance between the open and closed conformations of alpha(IIb)beta(3). Eight single-point mutants were designed at these sites, of which five bound ligands much better than wild type. Further, these mutants were found to be in a more extended conformation than wild type, suggesting that the conformational change at the ligand binding headpiece was propagated to the legs of the integrin. This detailed understanding of the conformational change will assist in the development of allosteric drugs that either stabilize or destabilize specific integrin conformations without occluding the ligand-binding site.	[Luo, Bing-Hao; Harmacek, Laura D.; Springer, Timothy A.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Luo, Bing-Hao; Harmacek, Laura D.; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Luo, Bing-Hao] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Karanicolas, John; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Karanicolas, John; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Louisiana State University System; Louisiana State University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Springer, TA (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 200 Longwood Ave, Boston, MA 02115 USA.	SpringerOffice@idi.harvard.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217	National Institutes of Health [HL48675]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant HL48675 (to T.A.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ambroggio XI, 2006, CURR OPIN STRUC BIOL, V16, P525, DOI 10.1016/j.sbi.2006.05.014; Bennett JS, 2001, ANNU REV MED, V52, P161, DOI 10.1146/annurev.med.52.1.161; Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; DELANO WL, 2004, PYMOL; Giorgetti A, 2005, BIOINFORMATICS, V21, P72, DOI 10.1093/bioinformatics/bti1112; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Ireton GC, 2003, STRUCTURE, V11, P961, DOI 10.1016/S0969-2126(03)00153-9; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; KOUNS WC, 1990, J BIOL CHEM, V265, P20594; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; McCleverty CJ, 2003, BIOCHEM J, V372, P121, DOI 10.1042/BJ20021273; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	37	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3917	3924		10.1074/jbc.M806312200	http://dx.doi.org/10.1074/jbc.M806312200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19019827	Green Published, hybrid			2022-12-27	WOS:000262872500060
J	Mileykovskaya, E; Ryan, AC; Mo, X; Lin, CC; Khalaf, KI; Dowhan, W; Garrett, TA				Mileykovskaya, Eugenia; Ryan, Andrea C.; Mo, Xi; Lin, Chun-Chieh; Khalaf, Khaled I.; Dowhan, William; Garrett, Teresa A.			Phosphatidic Acid and N-Acylphosphatidylethanolamine Form Membrane Domains in Escherichia coli Mutant Lacking Cardiolipin and Phosphatidylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION-SITE SELECTION; OSMOSENSORY TRANSPORTER PROP; TANDEM MASS-SPECTROMETRY; PGSA NULL MUTANT; ACYL-PHOSPHATIDYLETHANOLAMINE; ELECTROSPRAY-IONIZATION; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; ACRIDINE-ORANGE; CELL-DIVISION	The pgsA null Escherichia coli strain, UE54, lacks the major anionic phospholipids phosphatidylglycerol and cardiolipin. Despite these alterations the strain exhibits relatively normal cell division. Analysis of the UE54 phospholipids using negativeion electrospray ionization mass spectrometry resulted in identification of a new anionic phospholipid, N-acylphosphatidylethanolamine. Staining with the fluorescent dye 10-N-nonyl acridine orange revealed anionic phospholipid membrane domains at the septal and polar regions. Making UE54 null in minCDE resulted in budding off of minicells from polar domains. Analysis of lipid composition by mass spectrometry revealed that minicells relative to parent cells were significantly enriched in phosphatidic acid and N-acylphosphatidylethanolamine. Thus despite the absence of cardiolipin, which forms membrane domains at the cell pole and division sites in wildtype cells, the mutant cells still maintain polar/septal localization of anionic phospholipids. These three anionic phospholipids share common physical properties that favor polar/septal domain formation. The findings support the proposed role for anionic phospholipids in organizing amphitropic cell division proteins at specific sites on the membrane surface.	[Mileykovskaya, Eugenia; Mo, Xi; Lin, Chun-Chieh; Khalaf, Khaled I.; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ryan, Andrea C.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Garrett, Teresa A.] Vassar Coll, Dept Chem, Poughkeepsie, NY 12604 USA	University of Texas System; University of Texas Health Science Center Houston; Duke University; Vassar College	Mileykovskaya, E (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	Eugenia.Mileykovskaya@uth.tmc.edu; William.Dowhan@uth.tmc.edu; tegarrett@vassar.edu		Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health [GM R37-20478]; LIPID MAPS Large Scale Collaborative [GM-069338]; Johns Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LIPID MAPS Large Scale Collaborative; Johns Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM R37-20478 (to W. D.). This work was also supported by the LIPID MAPS Large Scale Collaborative (Grant GM-069338) and by funds from the Johns Dunn Research Foundation (to W. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bernal P, 2007, ENVIRON MICROBIOL, V9, P1135, DOI 10.1111/j.1462-2920.2006.01236.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chapman KD, 2000, CHEM PHYS LIPIDS, V108, P221, DOI 10.1016/S0009-3084(00)00198-5; Corbin BD, 2002, EMBO J, V21, P1998, DOI 10.1093/emboj/21.8.1998; Cravatt BF, 2004, J NEUROBIOL, V61, P149, DOI 10.1002/neu.20080; Cytrynbaum EN, 2007, BIOPHYS J, V93, P1134, DOI 10.1529/biophysj.106.097162; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Dowhan W, 2004, BBA-BIOMEMBRANES, V1666, P19, DOI 10.1016/j.bbamem.2004.04.010; Drew DA, 2005, P NATL ACAD SCI USA, V102, P6114, DOI 10.1073/pnas.0502037102; Garrett TA, 2007, METHOD ENZYMOL, V432, P117, DOI 10.1016/S0076-6879(07)32005-3; Ghosh AS, 2005, J BACTERIOL, V187, P1913, DOI 10.1128/JB.187.6.1913-1922.2005; Hansen HS, 1998, BIOCHEM PHARMACOL, V55, P719, DOI 10.1016/S0006-2952(97)00396-1; Helmy FM, 2002, JPC-J PLANAR CHROMAT, V15, P23, DOI 10.1556/JPC.15.2002.1.4; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P1, DOI 10.1016/j.jasms.2003.08.006; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Kanjilal-Kolar S, 2006, J BIOL CHEM, V281, P12865, DOI 10.1074/jbc.M513864200; KATES M, 1993, LIPIDS, V28, P877, DOI 10.1007/BF02537494; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Kikuchi S, 2000, J BACTERIOL, V182, P371, DOI 10.1128/JB.182.2.371-376.2000; Koivusalo M, 2001, J LIPID RES, V42, P663; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; Lai EM, 2004, MOL MICROBIOL, V52, P1029, DOI 10.1111/j.1365-2958.2004.04040.x; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Merkel O, 2005, BBA-MOL CELL BIOL L, V1734, P215, DOI 10.1016/j.bbalip.2005.03.004; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2001, FEBS LETT, V507, P187, DOI 10.1016/S0014-5793(01)02948-9; Mileykovskaya E, 2007, MOL MICROBIOL, V64, P1419, DOI 10.1111/j.1365-2958.2007.05766.x; Nagahama H, 2006, J GEN APPL MICROBIOL, V52, P91, DOI 10.2323/jgam.52.91; Norris V, 2004, FEBS LETT, V561, P3, DOI 10.1016/S0014-5793(04)00135-8; OKUYAMA H, 1976, J BIOL CHEM, V251, P2487; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Rahman MM, 2000, MICROBIOL-UK, V146, P1901, DOI 10.1099/00221287-146-8-1901; Rawyler AJ, 2001, PLANT PHYSIOL, V127, P240, DOI 10.1104/pp.127.1.240; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Rosch JW, 2007, J BACTERIOL, V189, P801, DOI 10.1128/JB.01549-06; Schaaf G, 2006, ACTA CRYSTALLOGR F, V62, P1156, DOI 10.1107/S1744309106041728; Shangguan T, 1998, BBA-BIOMEMBRANES, V1368, P171, DOI 10.1016/S0005-2736(97)00151-X; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; SNIDER MD, 1977, J BACTERIOL, V130, P1072, DOI 10.1128/JB.130.3.1072-1083.1977; Suzuki M, 2002, J BACTERIOL, V184, P5418, DOI 10.1128/JB.184.19.5418-5425.2002; TEATHER RM, 1974, J BACTERIOL, V118, P407, DOI 10.1128/JB.118.2.407-413.1974; Vermehren C, 2003, INT J PHARMACEUT, V254, P49, DOI 10.1016/S0378-5173(02)00681-6; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999	54	60	61	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2990	3000		10.1074/jbc.M805189200	http://dx.doi.org/10.1074/jbc.M805189200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049984	Green Published, hybrid			2022-12-27	WOS:000262700900043
J	Hui, DW; Kumar, KN; Mach, JR; Srinivasan, A; Pal, R; Bao, XD; Agbas, A; Hoefner, G; Wanner, KT; Michaelis, EK				Hui, Dongwei; Kumar, Keshava N.; Mach, Julie R.; Srinivasan, Ashik; Pal, Ranu; Bao, Xiaodong; Agbas, Abdulbaki; Hoefner, Georg; Wanner, Klaus T.; Michaelis, Elias K.			A Rat Brain Bicistronic Gene with an Internal Ribosome Entry Site Codes for a Phencyclidine-binding Protein with Cytotoxic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-D-ASPARTATE; RNA SECONDARY STRUCTURE; NMDA RECEPTOR COMPLEX; GLUTAMATE-BINDING; SYNAPTIC-MEMBRANES; MESSENGER-RNA; IMMUNOCHEMICAL CHARACTERIZATION; GLYCINE-BINDING; PURIFICATION; EXPRESSION	The cloning and characterization of the gene for the fourth subunit of a glutamate-binding protein complex in rat brain synaptic membranes are described. The cloned rat brain cDNA contained two open reading frames (ORFs) encoding 8.9-(PRO1) and 9.5kDa (PRO2) proteins. The cDNA sequence matched contiguous genomic DNA sequences in rat chromosome 17. Both ORFs were expressed within the structure of a single brain mRNA and antibodies against unique sequences in PRO1- and PRO2-labeled brain neurons in situ, indicative of bicistronic gene expression. Dicistronic vectors in which ORF1 and ORF2 were substituted by either two different fluorescent proteins or two luciferases indicated concurrent, yet independent translation of the two ORFs. Transfection with noncapped mRNA led to cap-independent translation of only ORF2 through an internal ribosome entry sequence preceding ORF2. In vitro or cell expression of the cloned cDNA led to the formation of multimeric protein complexes containing both PRO1 and PRO2. These complexes had low affinity (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (MK-801)-sensitive phencyclidine-binding sites. Overexpression of PRO1 and PRO2 in CHO cells, but not neuroblastoma cells, caused cell death within 24 -48 h. The cytotoxicity was blocked by concurrent treatment with MK-801 or by two tetrahydroisoquinolines that bind to phencyclidine sites in neuronal membranes. Co-expression of two of the other subunits of the protein complex together with PRO1/PRO2 abrogated the cytotoxic effect without altering PRO1/PRO2 protein levels. Thus, this rare mammalian bicistronic gene coded for two tightly interacting brain proteins forming a low affinity phencyclidine-binding entity in a synaptic membrane complex.	[Hui, Dongwei; Kumar, Keshava N.; Mach, Julie R.; Srinivasan, Ashik; Pal, Ranu; Bao, Xiaodong; Agbas, Abdulbaki; Michaelis, Elias K.] Univ Kansas, Dept Pharmacol & Toxicol, Lawrence, KS 66047 USA; [Kumar, Keshava N.; Hoefner, Georg; Michaelis, Elias K.] Univ Kansas, Ctr Neurobiol & Immunol Res, Lawrence, KS 66047 USA; [Wanner, Klaus T.] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, D-81377 Munich, Germany	University of Kansas; University of Kansas; University of Munich	Michaelis, EK (corresponding author), Univ Kansas, Dept Pharmacol & Toxicol, 5064 Malott Hall,1251 Wescoe Dr, Lawrence, KS 66045 USA.	emichaelis@ku.edu			National Institutes of Health [AA11419, AA04732]; National Institute on Alcohol Abuse and Aging [AG12993, HD02528]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG012993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA004732, R01AA011419, R37AA004732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA11419 and AA04732 (National Institute on Alcohol Abuse and Aging), AG12993 (NICHD), and HD02528 (NIA). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agbas A, 2005, BRAIN RES, V1059, P59, DOI 10.1016/j.brainres.2005.08.008; Agbas A, 2002, FREE RADICAL BIO MED, V32, P512, DOI 10.1016/S0891-5849(01)00818-8; Aistrup GL, 1996, FEBS LETT, V394, P141, DOI 10.1016/0014-5793(96)00938-6; ATKINS JF, 1990, CELL, V62, P413, DOI 10.1016/0092-8674(90)90007-2; Babcock KK, 1996, NEUROCHEM INT, V29, P507, DOI 10.1016/0197-0186(96)00019-8; Bonaglia MC, 2005, EUR J HUM GENET, V13, P586, DOI 10.1038/sj.ejhg.5201369; CHEN JW, 1988, J BIOL CHEM, V263, P417; CUNNINGHAM MD, 1990, J BIOL CHEM, V265, P7768; EATON MJ, 1990, J BIOL CHEM, V265, P16195; EGGEMAN KT, 1993, NEUROSCI LETT, V158, P173, DOI 10.1016/0304-3940(93)90257-L; Hirbec H, 2002, J NEUROSCI RES, V68, P305, DOI 10.1002/jnr.10203; Hofner G, 1996, J RECEPT SIGNAL TR R, V16, P297, DOI 10.3109/10799899609039953; IKIN AF, 1990, BIOCHEMISTRY-US, V29, P2290, DOI 10.1021/bi00461a012; JACKSON RJ, 1994, MOL BIOL REP, V19, P147, DOI 10.1007/BF00986957; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KUMAR KN, 1991, NATURE, V354, P70, DOI 10.1038/354070a0; KUMAR KN, 1994, J BIOL CHEM, V269, P27384; Kumar KN, 1998, BIOCHEM BIOPH RES CO, V253, P463, DOI 10.1006/bbrc.1998.9800; KUMAR KN, 1995, BIOCHEM BIOPH RES CO, V216, P390, DOI 10.1006/bbrc.1995.2636; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Ludwig M, 2003, HETEROCYCLES, V61, P299; LUDWIG M, 1998, THESIS LUDWIGMAXIMIL; Ludwig M, 2006, EUR J MED CHEM, V41, P1003, DOI 10.1016/j.ejmech.2006.03.005; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Michaelis EK, 1996, J NEUROCHEM, V67, P201; Pal R, 2003, BRAIN RES, V994, P1, DOI 10.1016/j.brainres.2003.08.046; Pal R, 1999, NEUROSCIENCE, V94, P1291, DOI 10.1016/S0306-4522(99)00386-3; Palecek J, 1999, EUR J NEUROSCI, V11, P827, DOI 10.1046/j.1460-9568.1999.00489.x; PELLEGRINIGIAMPIETRO DE, 1991, P NATL ACAD SCI USA, V88, P4157, DOI 10.1073/pnas.88.10.4157; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; SHERRIFFS HJ, 1993, EUR J PHARM-MOLEC PH, V247, P319, DOI 10.1016/0922-4106(93)90201-J; STERN P, 1992, P ROY SOC B-BIOL SCI, V250, P271, DOI 10.1098/rspb.1992.0159; Tsuchida H, 2001, BIOCHEM BIOPH RES CO, V280, P1189, DOI 10.1006/bbrc.2001.4255; WANG H, 1992, NEUROSCIENCE, V46, P793, DOI 10.1016/0306-4522(92)90186-6; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; XIA Y, 1995, NEUROCHEM RES, V20, P617, DOI 10.1007/BF01694545; Zhao H, 2006, GENES GENET SYST, V81, P41, DOI 10.1266/ggs.81.41	40	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2245	2257		10.1074/jbc.M807063200	http://dx.doi.org/10.1074/jbc.M807063200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028684	Green Published, hybrid			2022-12-27	WOS:000262545600034
J	Kummer, MP; Maruyama, H; Huelsmann, C; Baches, S; Weggen, S; Koo, EH				Kummer, Markus P.; Maruyama, Hiroko; Huelsmann, Claudia; Baches, Sandra; Weggen, Sascha; Koo, Edward H.			Formation of Pmel17 Amyloid Is Regulated by Juxtamembrane Metalloproteinase Cleavage, and the Resulting C-terminal Fragment Is a Substrate for gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; MATRIX PROTEIN PMEL17/GP100; PRECURSOR PROTEIN; INTRAMEMBRANE PROTEOLYSIS; CONVERTING ENZYME; SILVER; MELANOCYTES; ACTIVATION; PRESENILIN; DOMAIN	The formation of insoluble cross beta-sheet amyloid is pathologically associated with disorders such as Alzheimer, Parkinson, and Huntington diseases. One exception is the nonpathological amyloid derived from the protein Pmel17 within melanosomes to generate melanin pigment. Here we show that the formation of insoluble M alpha C intracellular fragments of Pmel17, which are the direct precursors to Pmel17 amyloid, depends on a novel juxtamembrane cleavage at amino acid position 583 between the furin-like proprotein convertase cleavage site and the transmembrane domain. The resulting Pmel17 C-terminal fragment is then processed by the gamma-secretase complex to release a shortlived intracellular domain fragment. Thus, by analogy to the Notch receptor, we designate this cleavage the S2 cleavage site, whereas gamma-secretase mediates proteolysis at the intramembrane S3 site. Substitutions or deletions at this S2 cleavage site, the use of the metalloproteinase inhibitor TAPI-2, as well as small interfering RNA-mediated knock-down of the metalloproteinases ADAM10 and 17 reduced the formation of insoluble Pmel17 fragments. These results demonstrate that the release of the Pmel17 ectodomain, which is critical for melanin amyloidogenesis, is initiated by S2 cleavage at a juxtamembrane position.	[Kummer, Markus P.; Maruyama, Hiroko; Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Baches, Sandra; Weggen, Sascha] Univ Dusseldorf, Mol Neuropathol Grp, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Kummer, Markus P.; Huelsmann, Claudia] Univ Bonn, Clin Neurosci Grp, Dept Neurol, D-53127 Bonn, Germany	University of California System; University of California San Diego; Heinrich Heine University Dusseldorf; University of Bonn	Koo, EH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	edkoo@ucsd.edu	Kummer, Markus/A-3860-2009	Kummer, Markus P./0000-0002-0993-2918	National Institutes of Health [AG12376]; Deutsche Forschungsgemeinschaft Emmy Noether Program [WE 2561/1-3]; NATIONAL INSTITUTE ON AGING [R01AG012376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Emmy Noether Program(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG12376 (to E. H. K.). This work was also supported by Deutsche Forschungsgemeinschaft Emmy Noether Program Grant WE 2561/1-3 (to S. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; Brunkan AL, 2005, J NEUROCHEM, V93, P769, DOI 10.1111/j.1471-4159.2005.03099.x; Canet-Aviles RM, 2002, MOL BRAIN RES, V102, P62, DOI 10.1016/S0169-328X(02)00184-5; Chen CD, 2001, EMBO J, V20, P6277, DOI 10.1093/emboj/20.22.6277; Cheng QC, 2003, J BIOL CHEM, V278, P38421, DOI 10.1074/jbc.M302111200; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Hu DN, 1997, EXP EYE RES, V64, P397, DOI 10.1006/exer.1996.0223; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Hwang EM, 2006, BIOCHEM BIOPH RES CO, V349, P654, DOI 10.1016/j.bbrc.2006.08.077; Kang TB, 2002, J BIOL CHEM, V277, P25583, DOI 10.1074/jbc.M203532200; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; KWON BS, 1995, NUCLEIC ACIDS RES, V23, P154, DOI 10.1093/nar/23.1.154; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; MARESH GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P95, DOI 10.1006/abbi.1994.1213; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Page LJ, 2005, EMBO J, V24, P4124, DOI 10.1038/sj.emboj.7600872; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SPANAKIS E, 1992, DEVELOPMENT, V114, P675; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Yang HQ, 2007, EUR J NEUROSCI, V26, P381, DOI 10.1111/j.1460-9568.2007.05648.x; Yasumoto K, 2004, J BIOL CHEM, V279, P28330, DOI 10.1074/jbc.M401269200	48	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2296	2306		10.1074/jbc.M808904200	http://dx.doi.org/10.1074/jbc.M808904200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047044	hybrid, Green Published			2022-12-27	WOS:000262545600039
J	Lima, WF; Murray, H; Nichols, JG; Wu, HJ; Sun, H; Prakash, TP; Berdeja, AR; Gaus, HJ; Crooke, ST				Lima, Walt F.; Murray, Heather; Nichols, Josh G.; Wu, Hongjiang; Sun, Hong; Prakash, Thazha P.; Berdeja, Andres R.; Gaus, Hans J.; Crooke, Stanley T.			Human Dicer Binds Short Single-strand and Double-strand RNA with High Affinity and Interacts with Different Regions of the Nucleic Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGONAUTE2 PAZ DOMAIN; OLIGONUCLEOTIDE DUPLEXES; CAENORHABDITIS-ELEGANS; MAMMALIAN-CELLS; INTERFERING-RNA; C-ELEGANS; EXPRESSION; RIBONUCLEASE; SPECIFICITY; COMPLEXES	Human Dicer is an integral component of the RNA interference pathway. Dicer processes premicro-RNA and double-strand RNA to, respectively, mature micro-RNA and short interfering RNA (siRNA) and transfers the processed products to the RNA-induced silencing complex. To better understand the factors that are important for the binding, translocation, and selective recognition of the siRNA strands, we determined the binding affinities of human Dicer for processed products (siRNA) and short single-strand RNAs (ssRNA). siRNAs and ssRNAs competitively inhibited human Dicer activity, suggesting that they are interacting with the active site of the enzyme. The dissociation constants (K-d) for unmodified siRNAs were 5-11-fold weaker compared with a 27-nucleotide double-strand RNA substrate. Chemically modified siRNAs exhibited binding affinities for Dicer comparable with the substrate. 3'-Dinucleotide overhangs in the siRNA affected the binding affinity of human Dicer for the siRNA and biased strand loading into RNA-induced silencing complex. The K-d values for the ssRNAs ranged from 3- to 40-fold weaker than the K-d for the substrate. Sequence composition of the 3'-terminal nucleotides of the ssRNAs exhibited the greatest effect on Dicer binding. Dicer cleaved substrates containing short siRNA-like double-strand regions and extended 3' or 5' ssRNA overhangs in the adjacent ssRNA regions. Remarkably, cleavage sites were observed consistent with the enzyme entering the substrate from the extended 3' ssRNA terminus. These data suggest that the siRNAs and ssRNAs interact predominantly with the PAZ domain of the enzyme. Finally, the tightest binding siRNAs were also more potent inhibitors of gene expression.	[Lima, Walt F.; Murray, Heather; Nichols, Josh G.; Wu, Hongjiang; Sun, Hong; Prakash, Thazha P.; Berdeja, Andres R.; Gaus, Hans J.; Crooke, Stanley T.] ISIS Pharmaceut, Dept Mol & Struct Biol, Carlsbad, CA 92008 USA	Isis Pharmaceuticals Inc	Lima, WF (corresponding author), ISIS Pharmaceut, Dept Mol & Struct Biol, 1896 Rutherford Rd, Carlsbad, CA 92008 USA.	wlima@isisph.com	Murray, Heather/GQY-8016-2022	Gaus, Hans/0000-0002-7471-8619				Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698; BOULTA A, 2003, OLIGONUCLEOTIDES, V13, P295; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hohjoh H, 2002, FEBS LETT, V521, P195, DOI 10.1016/S0014-5793(02)02860-0; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee HS, 2007, J MOL GRAPH MODEL, V25, P784, DOI 10.1016/j.jmgm.2006.07.002; Lima WF, 1997, BIOCHEMISTRY-US, V36, P390, DOI 10.1021/bi962230p; Lima WF, 1997, J BIOL CHEM, V272, P27513, DOI 10.1074/jbc.272.44.27513; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Vickers TA, 2007, NUCLEIC ACIDS RES, V35, P6598, DOI 10.1093/nar/gkm663; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	34	35	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2535	2548		10.1074/jbc.M803748200	http://dx.doi.org/10.1074/jbc.M803748200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017633	hybrid			2022-12-27	WOS:000262545600059
J	Collier, DM; Snyder, PM				Collier, Daniel M.; Snyder, Peter M.			Extracellular Protons Regulate Human ENaC by Modulating Na+ Self-inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNELS; EXHALED BREATH CONDENSATE; HISTIDINE-RESIDUES; ALPHA-SUBUNIT; TRANSPORT; ACTIVATION; ACIDIFICATION; EXPRESSION; CLONING; PH	The epithelial Na+ channel, ENaC, is exposed to a wide range of proton concentrations in the kidney, lung, and sweat duct. We, therefore, tested whether pH alters ENaC activity. In Xenopus oocytes expressing human alpha-, beta-, and gamma ENaC, amiloride-sensitive current was altered by protons in the physiologically relevant range ( pH 8.5-6.0). Compared with pH 7.4, acidic pH increased ENaC current, whereas alkaline pH decreased current (pH(50) = 7.2). Acidic pH also increased ENaC current in H441 epithelia and in human primary airway epithelia. In contrast to human ENaC, pH did not alter rat ENaC current, indicating that there are species differences in ENaC regulation by protons. This resulted predominantly from species differences in gamma ENaC. Maneuvers that lock ENaC in a high open-probability state ("DEG" mutation, proteolytic cleavage) abolished the effect of pHon human ENaC, indicating that protons alter ENaC current by modulating channel gating. Previous work showed that ENaC gating is regulated in part by extracellular Na+ ("Na+ self-inhibition"). Based on several observations, we conclude that protons regulate ENaC by altering Na+ self-inhibition. First, protons reduced Na+ self- inhibition in a dose-dependent manner. Second, ENaC regulation by pH was abolished by removing Na+ from the extracellular bathing solution. Third, mutations that alter Na+ self- inhibition produced corresponding changes in ENaC regulation by pH. Together, the data support a model in which protons modulate ENaC gating by relieving Na+ self- inhibition. We speculate that this may be an important mechanism to facilitate epithelial Na+ transport under conditions of acidosis.	[Snyder, Peter M.] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Collier, Daniel/GVU-0199-2022		National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by a National Institutes of Health grant ( to P. M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; ALAWQATI Q, 1977, AM J PHYSIOL, V233, pF502, DOI 10.1152/ajprenal.1977.233.6.F502; Awayda MS, 2000, AM J PHYSIOL-CELL PH, V279, pC1896, DOI 10.1152/ajpcell.2000.279.6.C1896; BATLLE DC, 1986, METABOLISM, V35, P852, DOI 10.1016/0026-0495(86)90228-3; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Chalfant ML, 1999, AM J PHYSIOL-CELL PH, V276, pC477, DOI 10.1152/ajpcell.1999.276.2.C477; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hunt J, 2007, IMMUNOL ALLERGY CLIN, V27, P597, DOI 10.1016/j.iac.2007.09.006; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; KAISER D, 1974, PFLUG ARCH EUR J PHY, V349, P63, DOI 10.1007/BF00587917; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; LEAF A, 1964, AM J PHYSIOL, V207, P547, DOI 10.1152/ajplegacy.1964.207.3.547; LEVI H, 1949, NATURE, V164, P928, DOI 10.1038/164928a0; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Paget-Brown AO, 2006, CHEST, V129, P426, DOI 10.1378/chest.129.2.426; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; ROSE BD, 1984, CLIN PHYSL ACID BASE, P225; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Yamamura H, 2004, J BIOL CHEM, V279, P12529, DOI 10.1074/jbc.M400274200; Zhang P, 1999, BIOPHYS J, V77, P3043, DOI 10.1016/S0006-3495(99)77135-3	40	66	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					792	798		10.1074/jbc.M806954200	http://dx.doi.org/10.1074/jbc.M806954200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18990692	hybrid, Green Published			2022-12-27	WOS:000262122900013
J	Guo, SL; Burnette, R; Zhao, L; Vanderford, NL; Poitout, V; Hagman, DK; Henderson, E; Ozcan, S; Wadzinski, BE; Stein, R				Guo, Shuangli; Burnette, Ryan; Zhao, Li; Vanderford, Nathan L.; Poitout, Vincent; Hagman, Derek K.; Henderson, Eva; Ozcan, Sabire; Wadzinski, Brian E.; Stein, Roland			The Stability and Transactivation Potential of the Mammalian MafA Transcription Factor Are Regulated by Serinei 65 Phosphorylation.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-TRANSCRIPTION; PANCREATIC BETA-CELLS; DNA-BINDING ACTIVITY; KEY REGULATOR; EXPRESSION; GLUCOSE; PROTEIN; ACTIVATOR; TYROSINE; RIPE3B1	The level of the MafA transcription factor is regulated by a variety of effectors of beta cell function, including glucose, fatty acids, and insulin. Here, we show that phosphorylation at Ser(65) of mammalian MafA influences both protein stability and transactivation potential. Replacement of Ser65 with Glu to mimic phosphorylation produced a protein that was as unstable as the wild type, whereas Asp or Ala mutation blocked degradation. Analysis of MafA chimeric and deletion constructs suggests that protein phosphorylation at Ser65 alone represents the initial degradation signal, with ubiquitinylation occurring within the C terminus (amino acids 234-359). Although only wild type MafA and S65E were polyubiquitinylated, both S65D and S65E potently stimulated transactivation compared with S65A. Phosphorylation at Ser(14) also enhanced activation, although it had no impact on protein turnover. The mobility of MafA S65A was profoundly affected upon SDS-PAGE, with the S65E and S65D mutants influenced less due to their ability to serve as substrates for glycogen synthase kinase 3, which acts at neighboring N-terminal residues after Ser65 phosphorylation. Our observations not only illustrate the sensitivity of the cellular transcriptional and degradation machinery to phosphomimetic mutants at Ser65, but also demonstrate the singular importance of phosphorylation at this amino acid in regulating MafA activity.	[Stein, Roland] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Wadzinski, Brian E.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Vanderford, Nathan L.; Ozcan, Sabire] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Poitout, Vincent; Hagman, Derek K.] Univ Montreal, Ctr Rech, Ctr Hosp, Montreal Diabet Res Ctr, Montreal, PQ H2X 1P1, Canada	Vanderbilt University; Vanderbilt University; University of Kentucky; Universite de Montreal	Stein, R (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 723 Light Hall, Nashville, TN 37232 USA.	roland.stein@vanderbilt.edu		Poitout, Vincent/0000-0002-6555-5053	National Institutes of Health [P01 DK42502]; Molecular Endocrinology Training Program Postdoctoral Training [5T32 DK07563-20]; Diabetes and Endocrinology [5T32 DK007061-34, R01 DK58096, F32 DK070406, R01 DK067581, DK70787]; American Heart Association; Molecular Biology Core Laboratory; Vanderbilt University Diabetes Research and Training Center [P60DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, F32DK070406, R01DK067581, T32DK007563, R01DK058096, R01DK070787, P01DK042502, T32DK007061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Endocrinology Training Program Postdoctoral Training; Diabetes and Endocrinology; American Heart Association(American Heart Association); Molecular Biology Core Laboratory; Vanderbilt University Diabetes Research and Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DK42502 ( to R. S.), Molecular Endocrinology Training Program Postdoctoral Training Grant 5T32 DK07563-20 (to R. B.), Postdoctoral Research Training Grant in Diabetes and Endocrinology 5T32 DK007061-34 to ( N. L. V.), Grant R01 DK58096 ( to V. P.), Postdoctoral Fellowship F32 DK070406 ( to D. K. H.), Grant R01 DK067581 ( to S. O.), and Grant DK70787 ( to B. E. W.). This work was also supported by an American Heart Association Predoctoral fellowship ( to N. L. V.). Partial support was also provided to the Molecular Biology Core Laboratory by the Vanderbilt University Diabetes Research and Training Center ( United States Public Health Service Grant P60DK20593). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aramata S, 2007, ENDOCR J, V54, P659, DOI 10.1507/endocrj.KR-101; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Civil A, 2002, NUCLEIC ACIDS RES, V30, P975, DOI 10.1093/nar/30.4.975; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; Matsuoka T, 2001, J BIOL CHEM, V276, P22071, DOI 10.1074/jbc.M010321200; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nishimura W, 2008, DEV BIOL, V314, P443, DOI 10.1016/j.ydbio.2007.12.009; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; OSTROVSKY PC, 1995, GENE DEV, V9, P2034, DOI 10.1101/gad.9.16.2034; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sii-Felice K, 2005, FEBS LETT, V579, P3547, DOI 10.1016/j.febslet.2005.04.086; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Wang JC, 1998, J BIOL CHEM, V273, P30847, DOI 10.1074/jbc.273.47.30847; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2000, J BIOL CHEM, V275, P10532, DOI 10.1074/jbc.275.14.10532; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	37	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					759	765		10.1074/jbc.M806314200	http://dx.doi.org/10.1074/jbc.M806314200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004825	hybrid, Green Published			2022-12-27	WOS:000262122900009
J	Hammarberg, T; Hamberg, M; Wetterholm, A; Hansson, H; Samuelsson, B; Haeggstrom, JZ				Hammarberg, Tove; Hamberg, Mats; Wetterholm, Anders; Hansson, Henrik; Samuelsson, Bengt; Haeggstrom, Jesper Z.			Mutation of a Critical Arginine in Microsomal Prostaglandin E Synthase-1 Shifts the Isomerase Activity to a Reductase Activity That Converts Prostaglandin H-2 into Prostaglandin F-2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CRYSTAL-STRUCTURE; E-2 SYNTHASE; IDENTIFICATION; BIOSYNTHESIS; PURIFICATION; ENZYME	Microsomal prostaglandin E synthase type 1 (mPGES-1) converts prostaglandin endoperoxides, generated from arachidonic acid by cyclooxygenases, into prostaglandin E-2. This enzyme belongs to the membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG) family of integral membrane proteins, and because of its link to inflammatory conditions and preferential coupling to cyclooxygenase 2, it has received considerable attention as a drug target. Based on the high resolution crystal structure of human leukotriene C-4 synthase, a model of mPGES-1 has been constructed in which the tripeptide co-substrate glutathione is bound in a horseshoe-shaped conformation with its thiol group positioned in close proximity to Arg-126. Mutation of Arg-126 into an Ala or Gln strongly reduces the enzyme's prostaglandin E synthase activity (85-95%), whereas mutation of a neighboring Arg-122 does not have any significant effect. Interestingly, R126A and R126Q mPGES-1 exhibit a novel, glutathione-dependent, reductase activity, which allows conversion of prostaglandin H-2 into prostaglandin F-2 alpha. Our data show that Arg-126 is a catalytic residue in mPGES-1 and suggest that MAPEG enzymes share significant structural components of their active sites.	[Hammarberg, Tove; Hamberg, Mats; Wetterholm, Anders; Samuelsson, Bengt; Haeggstrom, Jesper Z.] Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Hansson, Henrik] Swedish Univ Agr Sci, Dept Mol Biol, S-75124 Uppsala, Sweden	Karolinska Institutet; Swedish University of Agricultural Sciences	Haeggstrom, JZ (corresponding author), Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	jesper.haeggstrom@ki.se		Hansson, Henrik/0000-0002-6003-2982; Hamberg, Mats/0000-0002-8910-7810	Swedish Research Council [10350, 20854]; Linneus; CERIC [2001-2553]; CIDaT consortium (Vinnova); Sorderberg Foundation; European Commission FP6 [LSHM-CT2004-005033]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Linneus; CERIC; CIDaT consortium (Vinnova)(Vinnova); Sorderberg Foundation; European Commission FP6(European CommissionEuropean Commission Joint Research Centre)	The work was supported by Swedish Research Council Grants 10350, 20854, Linneus Grant CERIC, and 2001-2553, the CIDaT consortium (Vinnova), the Sorderberg Foundation, and European Commission FP6 Grant LSHM-CT2004-005033.	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Burgess JR, 1997, BIOCHEM MOL BIOL INT, V41, P217; BURGESS JR, 1989, BIOCHEM BIOPH RES CO, V158, P497, DOI 10.1016/S0006-291X(89)80076-2; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Jakobsson PJ, 2000, AM J RESP CRIT CARE, V161, pS20, DOI 10.1164/ajrccm.161.supplement_1.ltta-5; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jegerschold C, 2008, P NATL ACAD SCI USA, V105, P11110, DOI 10.1073/pnas.0802894105; Kobayashi T, 2002, PROSTAG OTH LIPID M, V68-9, P557, DOI 10.1016/S0090-6980(02)00055-2; LANDS W, 1971, ANN NY ACAD SCI, V180, P107, DOI 10.1111/j.1749-6632.1971.tb53190.x; MIYAMOTO T, 1974, P NATL ACAD SCI USA, V71, P3645, DOI 10.1073/pnas.71.9.3645; Molina DM, 2008, CURR OPIN STRUC BIOL, V18, P442, DOI 10.1016/j.sbi.2008.04.005; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; SAMUELSSON B, 1978, ANNU REV BIOCHEM, V47, P997, DOI 10.1146/annurev.bi.47.070178.005025; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; Watanabe K, 1999, BBA-MOL CELL BIOL L, V1439, P406, DOI 10.1016/S1388-1981(99)00084-0	20	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					301	305		10.1074/jbc.M808365200	http://dx.doi.org/10.1074/jbc.M808365200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984580	hybrid, Green Published			2022-12-27	WOS:000261974800034
J	Sharff, KA; Song, WX; Luo, XJ; Tang, N; Luo, JY; Chen, J; Bi, Y; He, BC; Huang, JY; Li, XM; Jiang, W; Zhu, GH; Su, YX; He, Y; Shen, JK; Wang, Y; Chen, L; Zuo, GW; Liu, B; Pan, XC; Reid, RR; Luu, HH; Haydon, RC; He, TC				Sharff, Katie A.; Song, Wen-Xin; Luo, Xiaoji; Tang, Ni; Luo, Jinyong; Chen, Jin; Bi, Yang; He, Bai-Cheng; Huang, Jiayi; Li, Xinmin; Jiang, Wei; Zhu, Gao-Hui; Su, Yuxi; He, Yun; Shen, Jikun; Wang, Yi; Chen, Liang; Zuo, Guo-Wei; Liu, Bo; Pan, Xiaochuan; Reid, Russell R.; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan			Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; STEM-CELLS; TRANSCRIPTION FACTORS; GENE; TARGET; CBFA1; EXPRESSION; NOTCH; BMP	Pluripotent mesenchymal stem cells (MSCs) are bone marrow stromal progenitor cells that can differentiate into osteogenic, chondrogenic, adipogenic, and myogenic lineages. We previously demonstrated that bone morphogenetic protein (BMP) 9 is one of the most potent and yet least characterized BMPs that are able to induce osteogenic differentiation of MSCs both in vitro and in vivo. Here, we conducted gene expression-profiling analysis and identified that Hey1 of the hairy/Enhancer of split-related repressor protein basic helix-loop-helix family was among the most significantly up-regulated early targets in BMP9-stimulated MSCs. We demonstrated that Hey1 expression was up-regulated at the immediate early stage of BMP9-induced osteogenic differentiation. Chromatin immunoprecipitation analysis indicated that Hey1 may be a direct target of the BMP9-induced Smad signaling pathway. Silencing Hey1 expression diminished BMP9-induced osteogenic differentiation both in vitro and in vivo and led to chondrogenic differentiation. Likewise, constitutive Hey1 expression augmented BMP9-mediated bone matrix mineralization. Hey1 and Runx2 were shown to act synergistically in BMP9-induced osteogenic differentiation, and Runx2 expression significantly decreased in the absence of Hey1, suggesting that Runx2 may function downstream of Hey1. Accordingly, the defective osteogenic differentiation caused by Hey1 knockdown was rescued by exogenous Runx2 expression. Thus, our findings suggest that Hey1, through its interplay with Runx2, may play an important role in regulating BMP9-induced osteoblast lineage differentiation of MSCs.	[Sharff, Katie A.; Song, Wen-Xin; Luo, Xiaoji; Tang, Ni; Luo, Jinyong; Chen, Jin; Bi, Yang; He, Bai-Cheng; Huang, Jiayi; Jiang, Wei; Zhu, Gao-Hui; Su, Yuxi; He, Yun; Shen, Jikun; Wang, Yi; Chen, Liang; Zuo, Guo-Wei; Liu, Bo; Reid, Russell R.; Luu, Hue H.; Haydon, Rex C.; He, Tong-Chuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA; [Song, Wen-Xin; Luo, Xiaoji; Tang, Ni; Luo, Jinyong; Chen, Jin; Bi, Yang; He, Bai-Cheng; Huang, Jiayi; Zhu, Gao-Hui; Su, Yuxi; He, Yun; Wang, Yi; Chen, Liang; Zuo, Guo-Wei; Liu, Bo; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing 400016, Peoples R China; [Song, Wen-Xin; Luo, Xiaoji; Tang, Ni; Luo, Jinyong; Chen, Jin; Bi, Yang; He, Bai-Cheng; Huang, Jiayi; Zhu, Gao-Hui; Su, Yuxi; He, Yun; Wang, Yi; Chen, Liang; Zuo, Guo-Wei; Liu, Bo; He, Tong-Chuan] Chongqing Med Univ, Chinese Minist Educ, Key Lab Diagnost Med, Chongqing 400016, Peoples R China; [Li, Xinmin] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Pan, Xiaochuan] Univ Chicago, Med Ctr, Dept Radiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; University of California System; University of California Los Angeles; University of Chicago; University of Chicago Medical Center	Haydon, RC (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA.	rhaydon@surgery.bsd.uchicago.edu			National Institutes of Health [CA106569, AR50142, AR054381]; American Cancer Society; The Brinson Foundation; Orthopaedic Research and Education Foundation; NATIONAL CANCER INSTITUTE [R01CA106569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR050142, K08AR054381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE020140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); The Brinson Foundation; Orthopaedic Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106569, AR50142, and AR054381 (to R. C. H., T. C. H., and H. H. L.). This work was also supported by research grants from the American Cancer Society (to T. C. H. and H. H. L.), The Brinson Foundation (to T. C. H.), and the Orthopaedic Research and Education Foundation (OREF) (to R. C. H. and H. H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; de Jong DS, 2004, J BONE MINER RES, V19, P947, DOI 10.1359/JBMR.040216; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Fuke S, 2006, J NEUROSCI RES, V84, P1555, DOI 10.1002/jnr.21062; Gu K, 2004, CELLS TISSUES ORGANS, V176, P28, DOI 10.1159/000075025; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jane JA, 2002, MOL THER, V6, P464, DOI 10.1006/mthe.2002.0691; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; KANG Q, 2008, STEM CELLS DEV, V18, P545, DOI DOI 10.1089/SCD.2008.0130; Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0188; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo J, 2005, CURR GENE THER, V5, P167, DOI 10.2174/1566523053544218; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	57	152	166	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					649	659		10.1074/jbc.M806389200	http://dx.doi.org/10.1074/jbc.M806389200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18986983	hybrid, Green Published			2022-12-27	WOS:000261974800070
J	Uray, IP; Shen, Q; Seo, HS; Kim, H; Lamph, WW; Bissonnette, RP; Brown, PH				Uray, Ivan P.; Shen, Qiang; Seo, Hye-Sook; Kim, HeeTae; Lamph, William W.; Bissonnette, Reid P.; Brown, Powel H.			Rexinoid-induced Expression of IGFBP-6 Requires RAR beta-dependent Permissive Cooperation of Retinoid Receptors and AP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; BREAST-CANCER CELLS; II IGF-II; GROWTH-FACTOR; MAMMARY TUMORIGENESIS; TRANSCRIPTION FACTOR; ESTROGEN-RECEPTOR; TRANSGENIC MICE; 9-CIS-RETINOIC ACID; BINDING PROTEIN-6	The synthetic rexinoid bexarotene (Targretin, LGD 1069) inhibits the formation of both estrogen receptor-negative and estrogen receptor-positive breast cancer in preclinical models and controls the expression of growth-regulatory biomarkers, such as IGFBP-6 (insulin-like growth factor-binding protein 6), RAR beta, or cyclin D1. In this study, we identified a classical retinoic acid-responsive element in the first intron in the IGFBP-6 gene adjacent to a consensus AP-1 binding site, both elements essential for rexinoid-induced expression of IGFBP-6. In chromatin binding experiments, bexarotene increased the occupancy of the identified enhancer element by RXR alpha, RAR alpha, cJun, cFos, and p300. In normal mammary epithelial cells and T47D breast cancer cells, small interfering RNA-mediated knockdown of all RXR isoforms or RAR beta, but not RAR alpha or RAR gamma alone, blocked the induction of IGFBP-6 by bexarotene. Simultaneous knockdown of RAR alpha and RAR gamma abrogated both the induction of RAR alpha and the up-regulation and secretion of IGFBP-6. The suppression of either RAR beta or cJun by small interfering RNA blocked the recruitment of RXR alpha and cJun to the enhancer. These results demonstrate a novel cooperative interaction between retinoid receptors and AP-1 orchestrated by RAR alpha and highlight a novel mechanism by which RAR gamma can mediate the cancer-preventive effects of rexinoids.	[Uray, Ivan P.; Shen, Qiang; Seo, Hye-Sook; Kim, HeeTae; Brown, Powel H.] Baylor Coll Med, Breast Canc Ctr, Houston, TX 77030 USA; [Uray, Ivan P.; Shen, Qiang; Brown, Powel H.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lamph, William W.; Bissonnette, Reid P.] Ligand Pharmaceut Ltd, San Diego, CA 92121 USA	Baylor College of Medicine; Baylor College of Medicine; Ligand Pharmaceuticals	Brown, PH (corresponding author), 1 Baylor Plaza,MS 600, Houston, TX 77030 USA.	pbrown@breastcenter.tmc.edu		Shen, Qiang/0000-0002-1491-5434; Brown, Powel/0000-0002-3398-163X	National Institutes of Health; NCI [RO1 CA10121, RO1 CA78480, U19 CA086809]; NATIONAL CANCER INSTITUTE [U19CA086809, R01CA078480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants RO1 CA10121, RO1 CA78480, and U19 CA086809 (to P.H.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BACH LA, 1994, ENDOCRINOLOGY, V135, P2168, DOI 10.1210/en.135.5.2168; BATES P, 1995, BRIT J CANCER, V72, P1189, DOI 10.1038/bjc.1995.484; Chambery D, 2000, GROWTH HORM IGF RES, V10, P349, DOI 10.1054/ghir.2000.0179; Cohen MH, 2001, ONCOLOGIST, V6, P4, DOI 10.1634/theoncologist.6-1-4; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; DiSepio D, 1999, Mol Cell Biol Res Commun, V1, P7, DOI 10.1006/mcbr.1999.0101; Giani C, 1996, BREAST CANCER RES TR, V41, P43, DOI 10.1007/BF01807035; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; Imai Y, 2000, J BIOL CHEM, V275, P18188, DOI 10.1074/jbc.M000070200; Kaulsay KK, 1999, EUR J ENDOCRINOL, V140, P164, DOI 10.1530/eje.0.1400164; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; Kim HT, 2006, CANCER RES, V66, P12009, DOI 10.1158/0008-5472.CAN-05-2515; Kong G, 2005, CANCER RES, V65, P3462, DOI 10.1158/0008-5472.CAN-03-2912; LI XS, 1995, J CELL PHYSIOL, V165, P449, DOI 10.1002/jcp.1041650302; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Liby K, 2006, CLIN CANCER RES, V12, P5902, DOI 10.1158/1078-0432.CCR-06-1119; Lin F, 2002, J BIOL CHEM, V277, P21414, DOI 10.1074/jbc.M201885200; LIPPMAN SM, 1992, JNCI-J NATL CANCER I, V13, P111; Liu Y, 1996, MOL CELL BIOL, V16, P1138; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Mehrian-Shai R, 2007, P NATL ACAD SCI USA, V104, P5563, DOI 10.1073/pnas.0609139104; Mita K, 2007, JPN J CLIN ONCOL, V37, P575, DOI 10.1093/jjco/hym066; Moon RC, 1997, BREAST CANCER RES TR, V46, P181, DOI 10.1023/A:1005995925246; MOON RC, 1979, CANCER RES, V39, P1339; OSBORNE CK, 1989, MOL ENDOCRINOL, V3, P1701, DOI 10.1210/mend-3-11-1701; Sachdev D, 2001, ENDOCR-RELAT CANCER, V8, P197, DOI 10.1677/erc.0.0080197; Sachdev D, 2006, J MAMMARY GLAND BIOL, V11, P27, DOI 10.1007/s10911-006-9010-8; SALBERT G, 1993, MOL ENDOCRINOL, V7, P1347, DOI 10.1210/me.7.10.1347; Sirchia SM, 2002, CANCER RES, V62, P2455; Sueoka N, 2000, AM J RESP CELL MOL, V23, P297, DOI 10.1165/ajrcmb.23.3.4013; Teplitzky SR, 2001, CANCER LETT, V168, P155, DOI 10.1016/S0304-3835(01)00548-1; Virmani AK, 2000, J NATL CANCER I, V92, P1303, DOI 10.1093/jnci/92.16.1303; Wan HS, 1999, CANCER RES, V59, P3518; Wan HS, 2001, CANCER RES, V61, P556; WARRELL RP, 1994, LEUKEMIA, V8, P929; Wu K, 2000, CLIN CANCER RES, V6, P3696; Wu K, 2002, CANCER EPIDEM BIOMAR, V11, P467; Zhu YL, 2006, INT J ONCOL, V29, P1581; Zhuang Y, 2003, MOL CANCER RES, V1, P619	40	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					345	353		10.1074/jbc.M804721200	http://dx.doi.org/10.1074/jbc.M804721200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18957410	hybrid, Green Published			2022-12-27	WOS:000261974800039
J	Yin, WB; Grundmann, A; Cheng, J; Li, SM				Yin, Wen-Bing; Grundmann, Alexander; Cheng, Jun; Li, Shu-Ming			Acetylaszonalenin Biosynthesis in Neosartorya fischeri IDENTIFICATION OF THE BIOSYNTHETIC GENE CLUSTER BY GENOMIC MINING AND FUNCTIONAL PROOF OF THE GENES BY BIOCHEMICAL INVESTIGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRENYLATED INDOLE-DERIVATIVES; MOLD METABOLITES ROQUEFORTINE; ASPERGILLUS-FUMIGATUS; N-PRENYLTRANSFERASE; BLUE CHEESE; PENICILLIUM; ALKALOIDS; PURIFICATION; SYNTHASE; TRYPTOPHAN	Based on the structural information of acetylaszonalenin isolated from Neosartorya fischeri, a putative biosynthetic gene cluster was identified in the genome sequence of this fungus by genomic mining. This cluster consists of three genes coding for a putative non-ribosomal peptide synthetase (AnaPS), a prenyltransferase (AnaPT), and an acetyltransferase (AnaAT). The coding sequences of anaPT and anaAT were cloned in pQE70 and pQE60, respectively, and overexpressed in Escherichia coli. The soluble His(6) fusion proteins were purified to near homogeneity and characterized biochemically. The structures of the enzymatic products were elucidated by NMR and mass spectroscopy analysis. AnaPT was found to catalyze the reverse prenylation of (R)-benzodiazepinedione at position C3 of the indole moiety in the presence of dimethylallyl diphosphate, resulting in formation of aszonalenin. AnaAT was found to catalyze the acetylation of aszonalenin at position N1 of the indoline moiety in the presence of acetyl coenzyme A, resulting in formation of acetylaszonalenin. K-m values of AnaPT were determined for dimethylallyl diphosphate at 156 mu M and for (R)-benzodiazepinedione at 232 mu M. K-m values of AnaAT were determined for acetyl coenzyme A at 96 mu M and for aszonalenin at 61 mu M. The turnover numbers of the AnaPT and AnaAT reactions were determined at 1.5 and 0.14 s(-1), respectively.	[Yin, Wen-Bing; Grundmann, Alexander; Cheng, Jun; Li, Shu-Ming] Univ Marburg, Inst Pharmazeut Biol, D-35037 Marburg, Germany	Philipps University Marburg	Li, SM (corresponding author), Univ Marburg, Inst Pharmazeut Biol, Deutsch Str 17A, D-35037 Marburg, Germany.	shuming.li@staff.uni-marburg.de	Yin, Wen-Bing/AAF-4825-2021	yin, wen bing/0000-0002-9184-3198	Deutsche Forschungsgemeinschaft [SPP1152]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft Grant SPP1152 (to S.-M. Li). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe K, 2006, MYCOPATHOLOGIA, V162, P143, DOI 10.1007/s11046-006-0049-2; ARAI K, 1989, CHEM PHARM BULL, V37, P2937; AUSUBEL FM, 1996, CURRENT PROTOCOLS MO, P158; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15029, DOI 10.1021/bi061845b; BARROW CJ, 1994, J NAT PROD, V57, P471, DOI 10.1021/np50106a005; BARROW KD, 1979, J CHEM SOC CHEM COMM, P225, DOI 10.1039/c39790000225; BHAT B, 1993, TETRAHEDRON, V49, P10663, DOI 10.1016/S0040-4020(01)81556-8; BHAT B, 1990, J CHEM SOC CHEM COMM, P1518, DOI 10.1039/c39900001518; Capon RJ, 2003, ORG BIOMOL CHEM, V1, P1856, DOI 10.1039/b302306k; DEGUZMAN FS, 1992, J NAT PROD, V55, P931, DOI 10.1021/np50085a013; ELLESTAD GA, 1973, J ORG CHEM, V38, P4204, DOI 10.1021/jo00963a024; Finoli C, 2001, J FOOD PROTECT, V64, P246, DOI 10.4315/0362-028X-64.2.246; GEBLER JC, 1992, ARCH BIOCHEM BIOPHYS, V296, P308, DOI 10.1016/0003-9861(92)90577-J; GORSTALLMAN CP, 1982, J CHEM SOC CHEM COMM, P652, DOI 10.1039/c39820000652; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Grundmann A, 2008, CHEMBIOCHEM, V9, P2059, DOI 10.1002/cbic.200800240; Hayashi A, 2007, BIOSCI BIOTECH BIOCH, V71, P1697, DOI 10.1271/bbb.70110; HOCHLOWSKI JE, 1993, J ANTIBIOT, V46, P380, DOI 10.7164/antibiotics.46.380; HODGE RP, 1988, J NAT PROD, V51, P66, DOI 10.1021/np50055a008; Jones MG, 2007, MICROBIOL-SGM, V153, P1, DOI 10.1099/mic.0.2006/001479-0; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; KIMURA Y, 1982, TETRAHEDRON LETT, V23, P225, DOI 10.1016/S0040-4039(00)86791-X; Kozlovsky AG, 2001, APPL BIOCHEM MICRO+, V37, P253, DOI 10.1023/A:1010225017054; Kremer A, 2008, APPL MICROBIOL BIOT, V79, P951, DOI 10.1007/s00253-008-1505-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li SM, 2006, PLANTA MED, V72, P1117, DOI 10.1055/s-2006-947195; Maiya S, 2006, CHEMBIOCHEM, V7, P1062, DOI 10.1002/cbic.200600003; Rank C, 2006, TETRAHEDRON LETT, V47, P6099, DOI 10.1016/j.tetlet.2006.06.086; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; RESHETILOVA TA, 1995, MICROBIOLOGY+, V64, P27; Ruan HL, 2008, CHEMBIOCHEM, V9, P1044, DOI 10.1002/cbic.200700723; Rundberget T, 2004, INT J FOOD MICROBIOL, V90, P181, DOI 10.1016/S0168-1605(03)00291-5; Sambrook J, 2001, MOL CLONING LAB MANU, P4; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; SCOTT PM, 1976, J AGR FOOD CHEM, V24, P865, DOI 10.1021/jf60206a028; Steffan N, 2007, CHEMBIOCHEM, V8, P1298, DOI 10.1002/cbic.200700107; STEYN PS, 1983, J CHEM SOC CHEM COMM, P560, DOI 10.1039/c39830000560; Stocking EM, 2000, J AM CHEM SOC, V122, P9089, DOI 10.1021/ja993593q; TAKASE S, 1985, TETRAHEDRON, V41, P3037, DOI 10.1016/S0040-4020(01)96656-6; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Tokai T, 2005, MICROBIOL-SGM, V151, P509, DOI 10.1099/mic.0.27435-0; Unsold IA, 2006, CHEMBIOCHEM, V7, P158, DOI 10.1002/cbic.200500318; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Wakana D., 2006, MYCOTOXINS, V56, P3, DOI DOI 10.2520/MYC0.56.3; Williams RM, 2000, TOP CURR CHEM, V209, P97; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Yin WB, 2007, CHEMBIOCHEM, V8, P1154, DOI 10.1002/cbic.200700079; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	48	128	133	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					100	109		10.1074/jbc.M807606200	http://dx.doi.org/10.1074/jbc.M807606200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001367	hybrid			2022-12-27	WOS:000261974800012
J	Cassese, A; Esposito, I; Fiory, F; Barbagallo, APM; Paturzo, F; Mirra, P; Ulianich, L; Giacco, F; Iadicicco, C; Lombardi, A; Oriente, F; Van Obberghen, E; Beguinot, F; Formisano, P; Miele, C				Cassese, Angela; Esposito, Iolanda; Fiory, Francesca; Barbagallo, Alessia P. M.; Paturzo, Flora; Mirra, Paola; Ulianich, Luca; Giacco, Ferdinando; Iadicicco, Claudia; Lombardi, Angela; Oriente, Francesco; Van Obberghen, Emmanuel; Beguinot, Francesco; Formisano, Pietro; Miele, Claudia			In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ENDOTHELIAL GROWTH-FACTOR; DIABETIC-NEPHROPATHY; CELL-PROLIFERATION; GLUCOSE-METABOLISM; SRC KINASE; KAPPA-B; V-SRC; ACTIVATION; ALPHA	Chronic hyperglycemia promotes insulin resistance at least in part by increasing the formation of advanced glycation end products (AGEs). We have previously shown that in L6 myotubes human glycated albumin (HGA) induces insulin resistance by activating protein kinase C alpha(PKC alpha). Here we show that HGA-induced PKC alpha activation is mediated by Src. Coprecipitation experiments showed that Src interacts with both the receptor for AGE (RAGE) and PKC alpha in HGA-treated L6 cells. A direct interaction of PKC alpha with Src and insulin receptor substrate-1 (IRS-1) has also been detected. In addition, silencing of IRS-1 expression abolished HGA-induced RAGE-PKC alpha co-precipitation. AGEs were able to induce insulin resistance also in vivo, as insulin tolerance tests revealed a significant impairment of insulin sensitivity in C57/BL6 mice fed a high AGEs diet (HAD). In tibialis muscle of HAD-fed mice, insulin-induced glucose uptake and protein kinase B phosphorylation were reduced. This was paralleled by a 2.5-fold increase in PKC alpha activity. Similarly to in vitro observations, Src phosphorylation was increased in tibialis muscle of HAD-fed mice, and co-precipitation experiments showed that Src interacts with both RAGE and PKC alpha. These results indicate that AGEs impairment of insulin action in the muscle might be mediated by the formation of a multimolecular complex including RAGE/IRS-1/Src and PKC alpha	[Cassese, Angela; Esposito, Iolanda; Fiory, Francesca; Barbagallo, Alessia P. M.; Paturzo, Flora; Mirra, Paola; Ulianich, Luca; Giacco, Ferdinando; Iadicicco, Claudia; Lombardi, Angela; Oriente, Francesco; Beguinot, Francesco; Formisano, Pietro; Miele, Claudia] Univ Naples Federico 2, CNR, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy; [Cassese, Angela; Esposito, Iolanda; Fiory, Francesca; Barbagallo, Alessia P. M.; Paturzo, Flora; Mirra, Paola; Ulianich, Luca; Giacco, Ferdinando; Iadicicco, Claudia; Lombardi, Angela; Oriente, Francesco; Beguinot, Francesco; Formisano, Pietro; Miele, Claudia] Univ Naples Federico 2, CNR, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; [Van Obberghen, Emmanuel] Univ Nice Sophia Antipolis, INSERM, Fac Med, IFR 50,U907,Ex U145, F-06107 Nice, France	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Miele, C (corresponding author), Univ Naples Federico 2, CNR, Ist Endocrinol & Oncol Sperimentale, Via Sergio Pansini 5, I-80131 Naples, Italy.	c.miele@ieos.cnr.it	Formisano, Pietro/J-4237-2018; Ulianich, Luca/ABD-2530-2020; ORIENTE, Francesco/J-6652-2018	Formisano, Pietro/0000-0001-7020-6870; ORIENTE, Francesco/0000-0003-4375-4526	European Foundation; GlaxoSmithKline Programme; Consiglio Nazionale delle Ricerche Grant RSLT; European Community FP6 EUGENE2 [LSHM-CT-2004-512013]; PRE-POBEDIA; Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Universitae della Ricerca Scientifica [PRIN, FIRB RBNE0155LB]; INSERM; Universite de Nice-Sophia-Antipolis; Conseil Regional PACA; Conseil General des Alpes-Maritimes; Fondation de France; PRND	European Foundation(European Science Foundation (ESF)); GlaxoSmithKline Programme(GlaxoSmithKline); Consiglio Nazionale delle Ricerche Grant RSLT(Consiglio Nazionale delle Ricerche (CNR)); European Community FP6 EUGENE2(European Commission); PRE-POBEDIA; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universitae della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Nice-Sophia-Antipolis; Conseil Regional PACA(Region Provence-Alpes-Cote d'Azur); Conseil General des Alpes-Maritimes(Region Provence-Alpes-Cote d'Azur); Fondation de France(Fondation de France); PRND	This work was supported by the European Foundation for the Study of Diabetes and the GlaxoSmithKline Programme for the Study of Metabolic Toxicity in Diabetes, Consiglio Nazionale delle Ricerche Grant RSLT, European Community FP6 EUGENE2 Grant LSHM-CT-2004-512013 and PRE-POBEDIA, by grants from the Associazione Italiana per la Ricerca sul Cancro, and by the Ministero dell'Universitae della Ricerca Scientifica Grants PRIN and FIRB RBNE0155LB. The work in Nice was supported by European Community FP6 EUGENE2 Grant LSHM-CT-2004-512013, the INSERM, Universite de Nice-Sophia-Antipolis, Conseil Regional PACA and Conseil General des Alpes-Maritimes, the Fondation de France (Paris, France, 2007-2008), and the PRND (Programme de Recherche Nationale sur le Diabete, France, 2003-2007). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bossenmaier B, 1997, DIABETOLOGIA, V40, P863, DOI 10.1007/s001250050761; Brizzi MF, 2002, DIABETES, V51, P3311, DOI 10.2337/diabetes.51.11.3311; Bucciarelli LG, 2002, CELL MOL LIFE SCI, V59, P1117, DOI 10.1007/s00018-002-8491-x; CHIN JE, 1993, J BIOL CHEM, V268, P6338; Cho HM, 2005, MOL CELLS, V19, P60; DAVIDSON MB, 1994, AM J PHYSIOL-ENDOC M, V267, pE808, DOI 10.1152/ajpendo.1994.267.6.E808; Fiory F, 2004, J BIOL CHEM, V279, P11137, DOI 10.1074/jbc.M308751200; Flyvbjerg A, 2000, DIABETOLOGIA, V43, P1205, DOI 10.1007/s001250051515; Formisano P, 2000, MOL CELL BIOL, V20, P6323, DOI 10.1128/MCB.20.17.6323-6333.2000; Formisano P, 2001, J ENDOCRINOL INVEST, V24, P460, DOI 10.1007/BF03351048; HAGER SR, 1991, AM J PHYSIOL, V260, pE353, DOI 10.1152/ajpendo.1991.260.3.E353; Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300; HE C, 2001, DIABETES S1, V50, P48; He CJ, 1999, DIABETES, V48, P1308, DOI 10.2337/diabetes.48.6.1308; Hoffmann S, 2002, GRAEF ARCH CLIN EXP, V240, P996, DOI 10.1007/s00417-002-0568-6; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Idris I, 2002, ANN NY ACAD SCI, V967, P176; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kellerer M, 1998, DIABETOLOGIA, V41, P833, DOI 10.1007/s001250050995; Khare S, 1997, J CLIN INVEST, V99, P1831, DOI 10.1172/JCI119350; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; LIN R, 2001, DIABETES S2, V50, P48; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu XJ, 2006, CELL SIGNAL, V18, P2071, DOI 10.1016/j.cellsig.2006.04.007; Makita Z, 1995, J DIABETES COMPLICAT, V9, P265, DOI 10.1016/1056-8727(95)80018-A; Miele C, 2003, J BIOL CHEM, V278, P47376, DOI 10.1074/jbc.M301088200; Miele C, 2007, J BIOL CHEM, V282, P31835, DOI 10.1074/jbc.M702481200; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; Morcos M, 2002, DIABETES, V51, P3532, DOI 10.2337/diabetes.51.12.3532; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OBRIEN J, 1989, CRIT REV FOOD SCI, V28, P211, DOI 10.1080/10408398909527499; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oriente F, 2005, J BIOL CHEM, V280, P40642, DOI 10.1074/jbc.M508570200; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; RuggieroLopez D, 1997, DIABETES RES CLIN PR, V34, P135, DOI 10.1016/S0168-8227(96)01352-6; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; SONG JG, 1991, MOL CELL BIOL, V11, P4903, DOI 10.1128/MCB.11.10.4903; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tajiri Y, 1997, ENDOCRINOLOGY, V138, P273, DOI 10.1210/en.138.1.273; Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013; Treins C, 2001, J BIOL CHEM, V276, P43836, DOI 10.1074/jbc.M106534200; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; Vlassara H, 2000, HOSP PRACT, V35, P25, DOI 10.3810/hp.2000.11.218; Yamagishi S, 2002, J BIOL CHEM, V277, P20309, DOI 10.1074/jbc.M202634200; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; ZANG Q, 1995, CELL GROWTH DIFFER, V6, P1367	54	82	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36088	36099		10.1074/jbc.M801698200	http://dx.doi.org/10.1074/jbc.M801698200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18955497	Green Published, hybrid			2022-12-27	WOS:000261840500004
J	EnayetAllah, AE; Luria, A; Luo, BB; Tsai, HJ; Sura, P; Hammock, BD; Grant, DF				EnayetAllah, Ahmed E.; Luria, Ayala; Luo, Beibei; Tsai, Hsing-Ju; Sura, Priyanka; Hammock, Bruce D.; Grant, David F.			Opposite Regulation of Cholesterol Levels by the Phosphatase and Hydrolase Domains of Soluble Epoxide Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE REGULATION; ACTIVATED-RECEPTOR-ALPHA; EPOXYEICOSATRIENOIC ACIDS; PPAR-GAMMA; MICE; HYPERTENSION; METABOLISM; INHIBITORS; ATHEROSCLEROSIS; ROSIGLITAZONE	Soluble epoxide hydrolase (sEH) is a bifunctional enzyme with two catalytic domains: a C-terminal epoxide hydrolase domain and an N-terminal phosphatase domain. Epidemiology and animal studies have attributed a variety of cardiovascular and anti-inflammatory effects to the C-terminal epoxide hydrolase domain. The recent association of sEH with cholesterol-related disorders, peroxisome proliferator-activated receptor activity, and the isoprenoid/ cholesterol biosynthesis pathway additionally suggest a role of sEH in regulating cholesterol metabolism. Here we used sEH knock-out (sEH-KO) mice and transfected HepG2 cells to evaluate the phosphatase and hydrolase domains in regulating cholesterol levels. In sEH-KO male mice we found a similar to 25% decrease in plasma total cholesterol as compared with wild type (sEH-WT) male mice. Consistent with plasma cholesterol levels, liver expression of HMG-CoA reductase was found to be similar to 2-fold lower in sEH-KO male mice. Additionally, HepG2 cells stably expressing human sEH with phosphatase only orhydrolase only activity demonstrate independent and opposite roles of the two sEH domains. Whereas the phosphatase domain elevated cholesterol levels, the hydrolase domain lowered cholesterol levels. Hydrolase inhibitor treatment in sEH-WT male and female mice as well as HepG2 cells expressing human sEH resulted in higher cholesterol levels, thus mimicking the effect of expressing the phosphatase domain in HepG2 cells. In conclusion, we show that sEH regulates cholesterol levels in vivo and in vitro, and we propose the phosphatase domain as a potential therapeutic target in hypercholesterolemia-related disorders.	[EnayetAllah, Ahmed E.; Luo, Beibei; Sura, Priyanka; Grant, David F.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Luria, Ayala; Tsai, Hsing-Ju; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Luria, Ayala; Tsai, Hsing-Ju; Hammock, Bruce D.] Univ Calif Davis, UCD Canc Ctr, Davis, CA 95616 USA	University of Connecticut; University of California System; University of California Davis; University of California System; University of California Davis	Grant, DF (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	david.grant@uconn.edu			National Institutes of Health [ES011630]; University of Connecticut Foundation; National Institute of Environmental Health [R37 ES002710]; National Institute of Environmental Health Sciences Superfund Basic Research Program [P42 ES004699]; University of Connecticut Tobacco-related Disease Research Program New Investigator Award [16KT-0037]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R01ES011630, R37ES002710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Connecticut Foundation; National Institute of Environmental Health; National Institute of Environmental Health Sciences Superfund Basic Research Program; University of Connecticut Tobacco-related Disease Research Program New Investigator Award(University of California System); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES011630. This work was also supported by a grant from the University of Connecticut Foundation. Additional funding was from the National Institute of Environmental Health Sciences R37 ES002710, the National Institute of Environmental Health Sciences Superfund Basic Research Program P42 ES004699 and the University of Connecticut Tobacco-related Disease Research Program New Investigator Award 16KT-0037. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200; BORHAN B, 1995, ANAL BIOCHEM, V231, P188, DOI 10.1006/abio.1995.1520; Capdevila JH, 2001, BIOCHEM BIOPH RES CO, V285, P571, DOI 10.1006/bbrc.2001.5167; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Cronin A, 2003, P NATL ACAD SCI USA, V100, P1552, DOI 10.1073/pnas.0437829100; Derosa G, 2006, CLIN THER, V28, P679, DOI 10.1016/j.clinthera.2006.05.012; Enayetallah AE, 2006, BIOCHEM BIOPH RES CO, V341, P254, DOI 10.1016/j.bbrc.2005.12.180; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Fang X, 2006, AM J PHYSIOL-HEART C, V290, pH55, DOI 10.1152/ajpheart.00427.2005; Fang X, 2005, J PHARMACOL EXP THER, V314, P260, DOI 10.1124/jpet.105.085605; Ferreira AVM, 2006, METABOLISM, V55, P731, DOI 10.1016/j.metabol.2006.01.020; Fleming I, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000208597.87957.89; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Fornage M, 2004, CIRCULATION, V109, P335, DOI 10.1161/01.CIR.0000109487.46725.02; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; GILL SS, 1980, BIOCHEM PHARMACOL, V29, P389, DOI 10.1016/0006-2952(80)90518-3; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; INOUE N, 1993, BIOL PHARM BULL, V16, P1004; Jin LM, 2006, FASEB J, V20, P539, DOI 10.1096/fj.05-4341fje; Johnston TP, 2001, INT J PHARMACEUT, V229, P75, DOI 10.1016/S0378-5173(01)00834-1; Jones PD, 2006, BIOORG MED CHEM LETT, V16, P5212, DOI 10.1016/j.bmcl.2006.07.009; Klopotek A, 2006, EXP BIOL MED, V231, P1365, DOI 10.1177/153537020623100810; Kovacs WJ, 2002, PROG LIPID RES, V41, P369, DOI 10.1016/S0163-7827(02)00002-4; Larsen BT, 2007, TRENDS PHARMACOL SCI, V28, P32, DOI 10.1016/j.tips.2006.11.002; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Llaverias G, 2006, BIOCHEM PHARMACOL, V71, P605, DOI 10.1016/j.bcp.2005.11.022; Luo B, 2008, J MOL BIOL, V380, P31, DOI 10.1016/j.jmb.2008.04.064; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; MIMURA K, 1994, DIABETIC MED, V11, P685, DOI 10.1111/j.1464-5491.1994.tb00333.x; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Ng VY, 2007, DRUG METAB DISPOS, V35, P1126, DOI 10.1124/dmd.106.013839; PINOT F, 1995, BIOCHEM PHARMACOL, V50, P501, DOI 10.1016/0006-2952(95)00167-X; Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482; Robins SJ, 2006, CURR OPIN LIPIDOL, V17, P431; Sato K, 2004, J HUM GENET, V49, P29, DOI 10.1007/s10038-003-0103-6; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Tran KL, 2005, BIOCHEMISTRY-US, V44, P12179, DOI 10.1021/bi050842g; Watanabe T, 2006, ANAL CHIM ACTA, V559, P37, DOI 10.1016/j.aca.2005.11.049; Wei Q, 2007, ATHEROSCLEROSIS, V190, P26, DOI 10.1016/j.atherosclerosis.2006.02.021	45	47	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36592	36598		10.1074/jbc.M806315200	http://dx.doi.org/10.1074/jbc.M806315200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974052	hybrid, Green Published			2022-12-27	WOS:000261840500057
J	Luthra, A; Mahmood, A; Arora, A; Ramachandran, R				Luthra, Amit; Mahmood, Anjum; Arora, Ashish; Ramachandran, Ravishankar			Characterization of Rv3868, an Essential Hypothetical Protein of the ESX-1 Secretion System in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESAT-6-CFP-10 COMPLEX; PHAGOSOME MATURATION; CALMETTE-GUERIN; BOVIS BCG; VIRULENCE; ESAT-6; OLIGOMERIZATION; ATTENUATION; SEQUENCE; ATPASE	Rv3868, a conserved hypothetical protein of the ESAT-6 secretion system of Mycobacterium tuberculosis, is essential for the secretion of at least four virulence factors. Each protein chain is similar to 63 kDa and assembles into a hexamer. Limited proteolysis demonstrates that it consists of two domains joined by a linker. The N-terminal domain is a compact, helical domain of similar to 30 kDa and apparently functions to regulate the ATPase activity of the C-terminal domain and the oligomerization. The nucleotide binding site is situated in the C-terminal domain, which exhibits ATP-dependent self-association. It is also the oligomerization domain. Dynamic fluorescence quenching studies demonstrate that the domain is proximal to the C terminus in the apoprotein and exhibits a specific movement upon ATP binding. In silico modeling of the domains suggests that Arg-429 of a neighboring subunit forms a part of the binding site upon oligomerization. Mutational analysis of binding site residues demonstrates that the Arg-429 functions as the important "sensor arginine" in AAA-ATPases. Protein NMR experiments involving CFP-10 and activity assays rule out a general chaperone-like function for Rv3868. On the other hand, ATP-dependent "open-close" movements of the individual domains apparently enable it to interact and transfer energy to co-proteins in the ESX-1 pathway.	[Luthra, Amit; Mahmood, Anjum; Arora, Ashish; Ramachandran, Ravishankar] Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ramachandran, R (corresponding author), Cent Drug Res Inst, Mol & Struct Biol Div, POB 173,Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.	r_ravishankar@cdri.res.in	Ramachandran, Ravishankar/D-1979-2010	Ramachandran, Ravishankar/0000-0002-0723-9861	Intramural [MLP007]; Council of Scientific and Industrial Research, India [CMM0017]; Central Drug Research Institute	Intramural; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Central Drug Research Institute	This work was supported by Intramural Grant MLP007, and computational support was from the Council of Scientific and Industrial Research, India, Grant CMM0017. This is communication 7469 from the Central Drug Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; DeLano W.L, PYMOL MOL GRAPHICS S; Ferreira RM, 2006, PROTEIN EXPRES PURIF, V47, P384, DOI 10.1016/j.pep.2006.02.006; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Georlette D, 2004, BIOPHYS J, V86, P1089, DOI 10.1016/S0006-3495(04)74184-3; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Maier UG, 2000, MOL BIOL EVOL, V17, P576, DOI 10.1093/oxfordjournals.molbev.a026337; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Meher AK, 2006, FEBS J, V273, P1445, DOI 10.1111/j.1742-4658.2006.05166.x; Neuwald AF, 1999, GENOME RES, V9, P27; Nowak E, 2006, STRUCTURE, V14, P275, DOI 10.1016/j.str.2005.10.006; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; PURKEY RM, 1977, EUR J BIOCHEM, V75, P303, DOI 10.1111/j.1432-1033.1977.tb11530.x; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Teutschbein J, 2009, MICROBIOL RES, V164, P253, DOI 10.1016/j.micres.2006.11.016; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOSHIAKI H, 1983, BIOCHIM BIOPHYS ACTA, V742, P496; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	40	30	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36532	36541		10.1074/jbc.M807144200	http://dx.doi.org/10.1074/jbc.M807144200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974091	Green Published, hybrid			2022-12-27	WOS:000261840500051
J	Sun, BF; Hong, J; Zhang, P; Dong, XC; Shen, X; Lin, DH; Ding, JP				Sun, Bingfa; Hong, Jing; Zhang, Peng; Dong, Xianchi; Shen, Xu; Lin, Donghai; Ding, Jianping			Molecular Basis of the Interaction of Saccharomyces cerevisiae Eaf3 Chromo Domain with Methylated H3K36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOSAGE COMPENSATION COMPLEX; HISTONE H3 TAIL; FUNCTIONAL-INTEGRATION; STRUCTURAL BASIS; BINDING MODULES; MSL COMPLEX; LYSINE 9; TRANSCRIPTION; ACETYLATION; PROTEIN	Eaf3 is a component of both NuA4 histone acetyltransferase and Rpd3S histone deacetylase complexes in Saccharomyces cerevisiae. It is involved in the regulation of the global pattern of histone acetylation that distinguishes promoters from coding regions. Eaf3 contains a chromo domain at the N terminus that can bind to methylated Lys-36 of histone H3 (H3K36). We report here the crystal structures of the Eaf3 chromo domain in two truncation forms. Unlike the typical HP1 and Polycomb chromo domains, which contain a large groove to bind the modified histone tail, the Eaf3 chromo domain assumes an autoinhibited chromo barrel domain similar to the human MRG15 chromo domain. Compared with other chromo domains, the Eaf3 chromo domain contains a unique 38-residue insertion that folds into two short beta-strands and a long flexible loop to flank the beta-barrel core. Both isothermal titration calorimetry and surface plasmon resonance studies indicate that the interaction between the Eaf3 chromo domain and the trimethylated H3K36 peptide is relatively weak, with a K-D of similar to 10(-4) M. NMR titration studies demonstrate that the methylated H3K36 peptide is bound to the cleft formed by the C-terminal alpha-helix and the beta-barrel core. Site-directed mutagenesis study and in vitro binding assay results show that the conserved aromatic residues Tyr-23, Tyr-81, Trp-84, and Trp-88, which form a hydrophobic pocket at one end of the beta-barrel, are essential for the binding of the methylated H3K36. These results reveal the molecular mechanism of the recognition and binding of the methylated H3K36 by Eaf3 and provide new insights into the functional roles of the Eaf3 chromo domain.	[Hong, Jing; Shen, Xu; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Sun, Bingfa; Zhang, Peng; Dong, Xianchi; Ding, Jianping] Chinese Acad Sci, State Key Lab Mol Biol, Shanghai 201203, Peoples R China; [Sun, Bingfa; Zhang, Peng; Dong, Xianchi; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Res Ctr Struct Biol, Shanghai 201203, Peoples R China; [Dong, Xianchi] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Lin, DH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China.	dhlin@mail.shcnc.ac.cn; jpding@sibs.ac.cn	Dong, Xianchi/C-1393-2015	Dong, Xianchi/0000-0001-5121-1236; Sun, Bingfa/0000-0001-5001-5065; zhang, peng/0000-0003-0408-2923; ding, jian ping/0000-0001-7029-7346	Ministry of Science and Technology of China [2006CB806501, 2006AA02Z112, 2006AA02A313, 2007CB914302, 2007CB914304]; National Natural Science Foundation of China [30570379, 30570352, 30623002, 30730028]; Chinese Academy of Sciences [KSCX2-YW-R-107, KSCX2-YW-R-104]; Science and Technology Commission of Shanghai Municipality [07XD14032, 07DZ22009]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of China Grants 2006CB806501, 2006AA02Z112, 2006AA02A313, 2007CB914302, and 2007CB914304; National Natural Science Foundation of China Grants 30570379, 30570352, 30623002, and 30730028; Chinese Academy of Sciences Grants KSCX2-YW-R-107 and KSCX2-YW-R-104; and Science and Technology Commission of Shanghai Municipality Grants 07XD14032 and 07DZ22009. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bertram MJ, 1999, MOL CELL BIOL, V19, P1479; Bertram MJ, 2001, GENE, V266, P111, DOI 10.1016/S0378-1119(01)00372-9; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fujita M, 2002, MECH DEVELOP, V114, P61, DOI 10.1016/S0925-4773(02)00058-8; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Morales V, 2005, MOL CELL BIOL, V25, P5947, DOI 10.1128/MCB.25.14.5947-5954.2005; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakayama J, 2003, EMBO J, V22, P2776, DOI 10.1093/emboj/cdg248; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Tominaga K, 2005, MOL CELL BIOL, V25, P2924, DOI 10.1128/MCB.25.8.2924-2937.2005; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Yochum GS, 2002, MOL CELL BIOL, V22, P7868, DOI 10.1128/MCB.22.22.7868-7876.2002; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	45	53	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36504	36512		10.1074/jbc.M806564200	http://dx.doi.org/10.1074/jbc.M806564200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984594	Green Published, hybrid			2022-12-27	WOS:000261840500048
J	Tsika, RW; Schramm, C; Simmer, G; Fitzsimons, DP; Moss, RL; Ji, J				Tsika, Richard W.; Schramm, Christine; Simmer, Gretchen; Fitzsimons, Daniel P.; Moss, Richard L.; Ji, Juan			Overexpression of TEAD-1 in Transgenic Mouse Striated Muscles Produces a Slower Skeletal Muscle Contractile Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN HEAVY-CHAIN; CREATINE-KINASE GENE; GLYCOGEN-SYNTHASE KINASE-3; M-CAT ELEMENTS; FIBER-TYPE; ENHANCER FACTOR-1; CARDIAC-MUSCLE; DEVELOPMENTAL REGULATION; TRANSCRIPTION FACTORS; SIGNALING PATHWAYS	TEA domain (TEAD) transcription factors serve important functional roles during embryonic development and in striated muscle gene expression. Our previous work has implicated a role for TEAD-1 in the fast-to-slow fiber-type transition in response to mechanical overload. To investigate whether TEAD-1 is a modulator of slow muscle gene expression in vivo, we developed transgenic mice expressing hemagglutinin (HA)-tagged TEAD-1 under the control of the muscle creatine kinase promoter. We show that striated muscle-restricted HA-TEAD-1 expression induced a transition toward a slow muscle contractile protein phenotype, slower shortening velocity (V-max), and longer contraction and relaxation times in adult fast twitch extensor digitalis longus muscle. Notably, HA-TEAD-1 overexpression resulted in an unexpected activation of GSK-3 alpha/beta and decreased nuclear beta-catenin and NFATc1/c3 protein. These effects could be reversed in vivo by mechanical overload, which decreased muscle creatine kinase-driven TEAD-1 transgene expression, and in cultured satellite cells by TEAD-1-specific small interfering RNA. These novel in vivo data support a role for TEAD-1 in modulating slow muscle gene expression.	[Tsika, Richard W.; Schramm, Christine; Simmer, Gretchen; Ji, Juan] Univ Missouri, Sch Med, Dept Biochem, Columbia, MO 65211 USA; [Tsika, Richard W.; Schramm, Christine; Simmer, Gretchen; Ji, Juan] Univ Missouri, Sch Vet Med, Dept Biomed Sci, Columbia, MO 65211 USA; [Fitzsimons, Daniel P.; Moss, Richard L.] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison	Tsika, RW (corresponding author), Univ Missouri, Sch Med, Dept Biochem, 440D Bond Life Sci Ctr, Columbia, MO 65211 USA.	tsikar@missouri.edu			National Institutes of Health, NIAMS [AR41464, AR47197]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041464, R01AR047197] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grants AR41464 and AR47197 (to R. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baldwin KM, 2001, J APPL PHYSIOL, V90, P345, DOI 10.1152/jappl.2001.90.1.345; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; BOOTH FW, 1996, HDB PHYSL, V12, P1075; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; BOTTINELLI R, 1994, J PHYSIOL-LONDON, V478, P341, DOI 10.1113/jphysiol.1994.sp020254; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Calvo S, 2001, MOL CELL BIOL, V21, P8490, DOI 10.1128/MCB.21.24.8490-8503.2001; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Farrance IKG, 1996, J BIOL CHEM, V271, P8266, DOI 10.1074/jbc.271.14.8266; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Grifone R, 2004, MOL CELL BIOL, V24, P6253, DOI 10.1128/MCB.24.14.6253-6267.2004; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Herron TJ, 2001, AM J PHYSIOL-HEART C, V281, pH1217, DOI 10.1152/ajpheart.2001.281.3.H1217; Issa LL, 2006, DEV BIOL, V293, P104, DOI 10.1016/j.ydbio.2006.01.019; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Kaneko KJ, 2007, GENESIS, V45, P577, DOI 10.1002/dvg.20330; Karasseva N, 2003, MOL CELL BIOL, V23, P5143, DOI 10.1128/MCB.23.15.5143-5164.2003; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim MS, 2008, MOL CELL BIOL, V28, P3600, DOI 10.1128/MCB.00189-08; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; LARKIN SB, 1999, HEART DEV, P307; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; MOSS RL, 1995, REV PHYSIOL BIOCH P, V126, P1, DOI 10.1007/BFb0049775; Naujokat C, 2007, STEM CELLS, V25, P2408, DOI 10.1634/stemcells.2007-0255; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Nguyen QGV, 2003, J BIOL CHEM, V278, P46494, DOI 10.1074/jbc.M308194200; Nguyen QGV, 2003, TRANSGENIC RES, V12, P337, DOI 10.1023/A:1023369225799; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Potthoff MJ, 2007, CURR OPIN RHEUMATOL, V19, P542, DOI 10.1097/BOR.0b013e3282efb761; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; SAWADA A, 2008, MOL CELL BI IN PRESS; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Shen TS, 2007, J PHYSIOL-LONDON, V579, P535, DOI 10.1113/jphysiol.2006.120048; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; Swoap SJ, 1998, AM J PHYSIOL-CELL PH, V274, pC681, DOI 10.1152/ajpcell.1998.274.3.C681; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Tothova J, 2006, J CELL SCI, V119, P1604, DOI 10.1242/jcs.02875; TRASK RV, 1990, BIOCHIM BIOPHYS ACTA, V1049, P182, DOI 10.1016/0167-4781(90)90039-5; Tsika GL, 1996, AM J PHYSIOL-CELL PH, V271, pC690, DOI 10.1152/ajpcell.1996.271.2.C690; Tsika R W, 1994, Exerc Sport Sci Rev, V22, P361; TSIKA RW, 1995, AM J PHYSIOL-CELL PH, V269, pC665, DOI 10.1152/ajpcell.1995.269.3.C665; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Vyas DR, 1999, J BIOL CHEM, V274, P30832, DOI 10.1074/jbc.274.43.30832; Vyas DR, 2001, J BIOL CHEM, V276, P1173, DOI 10.1074/jbc.M007750200; Wiedenman JL, 1996, AM J PHYSIOL-CELL PH, V270, pC1111, DOI 10.1152/ajpcell.1996.270.4.C1111; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788	75	45	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36154	36167		10.1074/jbc.M807461200	http://dx.doi.org/10.1074/jbc.M807461200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18978355	Green Published, hybrid			2022-12-27	WOS:000261840500010
J	Yamazoe, M; Nishitani, C; Takahashi, M; Katoh, T; Ariki, S; Shimizu, T; Mitsuzawa, H; Sawada, K; Voelker, DR; Takahashi, H; Kuroki, Y				Yamazoe, Masami; Nishitani, Chiaki; Takahashi, Motoko; Katoh, Tsuyoshi; Ariki, Shigeru; Shimizu, Takeyuki; Mitsuzawa, Hiroaki; Sawada, Kaku; Voelker, Dennis R.; Takahashi, Hiroki; Kuroki, Yoshio			Pulmonary Surfactant Protein D Inhibits Lipopolysaccharide (LPS)-induced Inflammatory Cell Responses by Altering LPS Binding to Its Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; EXTRACELLULAR TLR4 DOMAIN; SITE-DIRECTED MUTAGENESIS; BRONCHOALVEOLAR LAVAGE; ALVEOLAR MACROPHAGES; OLIGOMERIC STRUCTURE; SIGNAL-TRANSDUCTION; ALPHA SECRETION; IN-VIVO; MD-2	Pulmonary surfactant protein D (SP-D) is a member of the collectin family that plays an important role in regulating innate immunity of the lung. We examined the mechanisms by which SP-D modulates lipopolysaccharide (LPS)-elicited inflammatory cell responses. SP-D bound to a complex of recombinant soluble forms of Toll-like receptor 4 (TLR4) and MD-2 with high affinity and down-regulated tumor necrosis factor-alpha secretion and NF-kappa B activation elicited by rough and smooth LPS, in alveolar macrophages and TLR4/MD-2-transfected HEK293 cells. Cell surface binding of both serotypes of LPS to TLR4/MD-2-expressing cells was attenuated by SP-D. In addition, SP-D significantly reduced MD-2 binding to both serotypes of LPS. A chimera containing the N-terminal region and the collagenous domain of surfactant protein A, and the coiled-coil neck and lectin domains of SP-D, was a weak inhibitor of LPS-induced cell responses and MD-2 binding to LPS, compared with native SP-D. The collagenase-resistant fragment consisting of the neck plus the carbohydrate recognition domain of SP-D also was a very weak inhibitor of LPS activation. This study demonstrates that SP-D down-regulates LPS-elicited inflammatory responses by altering LPS binding to its receptors and reveals the importance of the correct oligomeric structure of the protein in this process.	[Yamazoe, Masami; Nishitani, Chiaki; Takahashi, Motoko; Ariki, Shigeru; Shimizu, Takeyuki; Mitsuzawa, Hiroaki; Sawada, Kaku; Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Yamazoe, Masami; Sawada, Kaku; Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Mitsuzawa, Hiroaki] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Katoh, Tsuyoshi] Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan; [Voelker, Dennis R.] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; [Yamazoe, Masami; Nishitani, Chiaki; Takahashi, Motoko; Ariki, Shigeru; Shimizu, Takeyuki; Sawada, Kaku; Kuroki, Yoshio] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Asahikawa Medical College; National Jewish Health; Japan Science & Technology Agency (JST)	Kuroki, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	kurokiy@sapmed.ac.jp	Ariki, Shigeru/E-3861-2014; Takahashi, Motoko/I-3154-2013	Ariki, Shigeru/0000-0001-5838-499X; Takahashi, Motoko/0000-0002-2112-6142	Ministry of Education, Science, Sports and Culture, Japan; Akiyama Foundation	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Akiyama Foundation	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture, Japan and by Akiyama Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; AUSBEL FM, 1992, CURRENT PROTOCOLS MO; BASTACKY J, 1995, J APPL PHYSIOL, V79, P1615, DOI 10.1152/jappl.1995.79.5.1615; BAUGHMAN RP, 1993, AM REV RESPIR DIS, V147, P653, DOI 10.1164/ajrccm/147.3.653; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; BrownAugsburger P, 1996, J BIOL CHEM, V271, P13724, DOI 10.1074/jbc.271.23.13724; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CROUCH E, 1994, J BIOL CHEM, V269, P17311; CROUCH E, 1994, J BIOL CHEM, V269, P15808; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; HANCOCK REW, 1994, N COMP BIOC, V27, P263, DOI DOI 10.1016/S0167-7306(08)60415-9; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Ikegami M, 2006, AM J RESP CRIT CARE, V173, P1342, DOI 10.1164/rccm.200509-1485OC; Ikegami M, 2007, CHEST, V132, P1447, DOI 10.1378/chest.07-0864; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; McIntosh JC, 1996, AM J PHYSIOL-LUNG C, V271, pL310, DOI 10.1152/ajplung.1996.271.2.L310; Mitsuzawa H, 2006, J IMMUNOL, V177, P8133, DOI 10.4049/jimmunol.177.11.8133; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Nagae H, 1997, CLIN CHIM ACTA, V266, P157, DOI 10.1016/S0009-8981(97)00124-1; Nishitani C, 2006, J BIOL CHEM, V281, P38322, DOI 10.1074/jbc.M606904200; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; PERSSON A, 1990, J BIOL CHEM, V265, P5755; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; RUST K, 1991, ARCH BIOCHEM BIOPHYS, V290, P116, DOI 10.1016/0003-9861(91)90597-C; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tino MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL164, DOI 10.1152/ajplung.1999.276.1.L164; Uemura T, 2006, BIOCHEMISTRY-US, V45, P14543, DOI 10.1021/bi061338u; VANDEGRAAF EA, 1992, J LAB CLIN MED, V120, P252; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; VOSS T, 1988, J MOL BIOL, V201, P219, DOI 10.1016/0022-2836(88)90448-2; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Zhang LQ, 2001, J BIOL CHEM, V276, P19214, DOI 10.1074/jbc.M010191200	45	74	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35878	35888		10.1074/jbc.M807268200	http://dx.doi.org/10.1074/jbc.M807268200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18990700	hybrid			2022-12-27	WOS:000261687900063
J	Egerer, M; Giesemann, T; Herrmann, C; Aktories, K				Egerer, Martina; Giesemann, Torsten; Herrmann, Christian; Aktories, Klaus			Autocatalytic Processing of Clostridium difficile Toxin B BINDING OF INOSITOL HEXAKISPHOSPHATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE DOMAIN; RTX TOXIN; CLEAVAGE; CELLS; GLYCOSYLTRANSFERASES; INTERNALIZATION; PROTEINS; COLITIS; SITE	Clostridium difficile toxins A and B are major virulence factors responsible for induction of pseudomembranous colitis and antibiotic-associated diarrhea in men. The toxins possess a multidomain structure and only the N-terminal glucosyl-transferase domain, which inactivates Rho GTPases by glucosylation, is translocated into the cytosol of target cells. Processing of the toxin occurs by autocatalytic cleavage and is activated by inositol hexakisphosphate (InsP(6)). Here we studied the inherent protease activity in fragments of toxin B and determined the site of toxin B that interacts with InsP(6). We report that a fragment of toxin B, comprised of residues 1-955, is cleaved in the presence of InsP(6). In contrast, mutants of the catalytic triad of the putative cysteine protease domain did not cleave this fragment. [H-3] InsP(6) bound to holotoxin B and to the fragment 1-955, but not to a fragment comprising residues 900-2366 or the glucosyltransferase domain (residues 1-544). Binding to the putative cysteine protease domain (residues 544-955) was also observed. InsP(6)-binding was specific and saturable. Isothermal titration calorimetry revealed a K-d value of 2.4 mu M for binding of InsP(6) to toxin fragment 544-955 with a stoichiometry factor of 0.86. Lysine 600 of toxin B was identified as essential amino acid for InsP(6) binding and for InsP(6)-dependent activation of the protease activity.	[Egerer, Martina; Giesemann, Torsten; Aktories, Klaus] Univ Freiburg, Inst Expt, D-79104 Freiburg, Germany; [Egerer, Martina; Giesemann, Torsten; Aktories, Klaus] Univ Freiburg, Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Egerer, Martina] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Herrmann, Christian] Ruhr Univ Bochum, Fak Chem & Biochem, D-44780 Bochum, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Ruhr University Bochum	Aktories, K (corresponding author), Univ Freiburg, Inst Expt, Albertstr 25, D-79104 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436	Deutsche Forschungsgemeinschaft Projects [GI684, AK6/16]; research group Klinische Infektiologie Freiburg, TP 1a	Deutsche Forschungsgemeinschaft Projects(German Research Foundation (DFG)); research group Klinische Infektiologie Freiburg, TP 1a	This work was supported by Deutsche Forschungsgemeinschaft Projects GI684 and AK6/16 and by the research group Klinische Infektiologie Freiburg, TP 1a. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; DOVE CH, 1990, INFECT IMMUN, V58, P480, DOI 10.1128/IAI.58.2.480-488.1990; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; FLORIN I, 1983, BIOCHIM BIOPHYS ACTA, V763, P383, DOI 10.1016/0167-4889(83)90100-3; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; HENRIQUES B, 1987, MICROB PATHOGENESIS, V2, P455, DOI 10.1016/0882-4010(87)90052-0; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Jank T, 2005, J BIOL CHEM, V280, P37833, DOI 10.1074/jbc.M506836200; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; JUST I, 1997, BACTERIAL TOXINS TOO; KRIVAN HC, 1987, INFECT IMMUN, V55, P1873, DOI 10.1128/IAI.55.8.1873-1877.1987; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; RIFKIN GD, 1977, LANCET, V2, P1103; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; vonEichelStreiber C, 1996, TRENDS MICROBIOL, V4, P375, DOI 10.1016/0966-842X(96)10061-5; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005	25	51	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3389	3395		10.1074/jbc.M806002200	http://dx.doi.org/10.1074/jbc.M806002200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19047051	hybrid			2022-12-27	WOS:000262872500004
J	Lee, EK; Bae, GU; You, JS; Lee, JC; Jeon, YJ; Park, JW; Park, JH; Ahn, SH; Kim, YK; Choi, WS; Kang, JS; Han, G; Han, JW				Lee, Eun Kyung; Bae, Gyu-Un; You, Jueng Soo; Lee, Jae Cheol; Jeon, Yae Jee; Park, Jong Woo; Park, Jae Hyun; Ahn, Seong Hoon; Kim, Yong Kee; Choi, Wahn Soo; Kang, Jong-Sun; Han, Gyoonhee; Han, Jeung-Whan			Reversine Increases the Plasticity of Lineage-committed Cells toward Neuroectodermal Lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; MARROW STROMAL CELLS; IN-VITRO; NEURONAL PHENOTYPE; MAMMALIAN-CELLS; SOMATIC-CELLS; GERM-CELLS; DIFFERENTIATION; EXPRESSION; MYOBLASTS	Functional dedifferentiation of lineage-committed cells toward pluripotency may have a great potential in regenerative medicine. Reversine has been shown to induce dedifferentiation of multiple terminally differentiated mesodermal origin cells, which are capable of being directed to differentiate into other cell types within mesodermal lineages. However, the possibilities of these cells to give rise to other lineages have not been examined. Here we show that large scale gene expression profiling of reversine-treated C2C12 myoblasts identifies a subset of up-regulated genes involved in specification of neuroectodermal as well as mesodermal lineages. Reversine treatment leads to up-regulation of priming genes of neuroectodermal lineages, such as Ngn2, Nts, Irx3, Pax7, Hes1, and Hes6, through active histone modifications in the promoter regions of these genes. Additionally, reversine increases the expression of markers for other cell types of mesodermal lineages, Ogn and apoE, via inducing active histone modifications, while down-regulating the myogenic basic helix-loop-helix factor, MyoD, via repressive histone modifications. Consistent with up-regulation of these genes, reversine-treated C2C12 myoblasts redifferentiate into neural as well as mesodermal lineages, under appropriate stimuli. Taken together, these results indicate that reversine induces a multipotency of C2C12 myoblasts via inducing a specific combination of active histone modifications. Collectively, our findings provide a mechanistic rationale for the application of reversine to dedifferentiation of somatic cells.	[Lee, Eun Kyung; You, Jueng Soo; Lee, Jae Cheol; Jeon, Yae Jee; Park, Jong Woo; Park, Jae Hyun; Han, Jeung-Whan] Sungkyunkwan Univ, Coll Pharm, Dept Biochem & Mol Biol, Suwon 440746, South Korea; [Bae, Gyu-Un; Kang, Jong-Sun] Sungkyunkwan Univ, Samsung Biomed Res Inst, Suwon 440746, South Korea; [Ahn, Seong Hoon] Hanyang Univ, Div Mol & Life Sci, Ansan 426791, South Korea; [Kim, Yong Kee] Kwandong Univ, Coll Med, Kangnung 210701, South Korea; [Choi, Wahn Soo] Konkuk Univ, Coll Med, Chungju 380701, South Korea; [Han, Gyoonhee] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Hanyang University; Catholic Kwandong University; Konkuk University; Konkuk University Medical Center; Yonsei University	Han, JW (corresponding author), Sungkyunkwan Univ, Coll Pharm, Dept Biochem & Mol Biol, Suwon 440746, South Korea.	jhhan551@skku.edu	lee, jaecheol/AAS-3747-2020	lee, jaecheol/0000-0002-2070-7463; Ahn, Seong-Hoon/0000-0002-9174-4966	Korea Food & Drug Administration in 2006 and 2007 [06122KFDA426, 07132KFDA688]	Korea Food & Drug Administration in 2006 and 2007(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This work was supported by Grants 06122KFDA426 and 07132KFDA688 from Korea Food & Drug Administration in 2006 and 2007. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.. S The on-line version of this article (availableathttp://www.jbc.org) contains supplemental Fig. S1 and Table S1.	Anastasia L, 2006, CELL DEATH DIFFER, V13, P2042, DOI 10.1038/sj.cdd.4401958; Chen SB, 2004, J AM CHEM SOC, V126, P410, DOI 10.1021/ja037390k; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Chen XP, 2005, MOL BIOL CELL, V16, P3140, DOI 10.1091/mbc.E05-03-0218; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Fairchild PJ, 2004, TRENDS IMMUNOL, V25, P465, DOI 10.1016/j.it.2004.07.005; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Inoue C, 2001, GENES CELLS, V6, P977, DOI 10.1046/j.1365-2443.2001.00476.x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; KONIECZNY SF, 1988, MOL CELL BIOL, V29, P21; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lee JE, 1997, DEV NEUROSCI-BASEL, V19, P27, DOI 10.1159/000111182; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Pachernik J, 2005, PHYSIOL RES, V54, P115, DOI 10.33549/physiolres.930526; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Watanabe Y, 2004, GENE DEV, V18, P889, DOI 10.1101/gad.1179004; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WILMUT I, 1997, NATURE, V385, P813; Witusik M, 2007, BRAIN RES, V1186, P65, DOI 10.1016/j.brainres.2007.10.039; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang W, 2006, MOL CELL BIOL, V26, P3764, DOI 10.1128/MCB.26.10.3764-3772.2006	44	32	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2891	2901		10.1074/jbc.M804055200	http://dx.doi.org/10.1074/jbc.M804055200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19015271	hybrid			2022-12-27	WOS:000262700900033
J	Maresova, L; Muend, S; Zhang, YQ; Sychrova, H; Rao, R				Maresova, Lydie; Muend, Sabina; Zhang, Yong-Qiang; Sychrova, Hana; Rao, Rajini			Membrane Hyperpolarization Drives Cation Influx and Fungicidal Activity of Amiodarone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; INTRACELLULAR ACIDIFICATION; DIS-C-3(3) FLUORESCENCE; NEUROSPORA-CRASSA; POTENTIAL CHANGES; CA-2+ INFLUX; YEAST; CHANNEL; RESISTANT	Cationic amphipathic drugs, such as amiodarone, interact preferentially with lipid membranes to exert their biological effect. In the yeast Saccharomyces cerevisiae, toxic levels of amiodarone trigger a rapid influx of Ca2+ that can overwhelm cellular homeostasis and lead to cell death. To better understand the mechanistic basis of antifungal activity, we assessed the effect of the drug on membrane potential. We show that low concentrations of amiodarone (0.1-2 mu M) elicit an immediate, dose-dependent hyperpolarization of the membrane. At higher doses (>3 mu M), hyperpolarization is transient and is followed by depolarization, coincident with influx of Ca2+ and H+ and loss in cell viability. Proton and alkali metal cation transporters play reciprocal roles in membrane polarization, depending on the availability of glucose. Diminishment of membrane potential by glucose removal or addition of salts or in pma1, tok1 Delta, ena1-4 Delta, or nha1 Delta mutants protected against drug toxicity, suggesting that initial hyperpolarization was important in the mechanism of antifungal activity. Furthermore, we show that the link between membrane hyperpolarization and drug toxicity is pH-dependent. We propose the existence of pH- and hyperpolarization-activated Ca2+ channels in yeast, similar to those described in plant root hair and pollen tubes that are critical for cell elongation and growth. Our findings illustrate how membrane-active compounds can be effective microbicidals and may pave the way to developing membrane-selective agents.	[Muend, Sabina; Zhang, Yong-Qiang; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Maresova, Lydie; Sychrova, Hana] Acad Sci CR, Inst Physiol, Dept Membrane Transport, Prague, Czech Republic	Johns Hopkins University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	rrao@jhmi.edu	Sychrova, Hana/B-1350-2012	Sychrova, Hana/0000-0001-5967-5019	National Institutes of Health [R01AI065983]; Czech Grants [MSMTLC531, AV0Z 50110509]; GAAS CR [KJB500110701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Grants; GAAS CR(Grant Agency of the Czech Republic); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI065983 (to R. R.). This work was also supported by Czech Grants MSMTLC531 and AV0Z 50110509 (to H. S.) and GAAS CR KJB500110701 (to L. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afeltra J, 2004, ANTIMICROB AGENTS CH, V48, P1335, DOI 10.1128/AAC.48.4.1335-1343.2004; BALLARINDENTI A, 1994, BBA-BIOMEMBRANES, V1190, P43, DOI 10.1016/0005-2736(94)90033-7; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Carmelo V, 1997, BBA-BIOMEMBRANES, V1325, P63, DOI 10.1016/S0005-2736(96)00245-3; CHATELAIN P, 1985, J PHARM SCI, V74, P783, DOI 10.1002/jps.2600740720; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; Courchesne WE, 2002, J PHARMACOL EXP THER, V300, P195, DOI 10.1124/jpet.300.1.195; Denksteinova B, 1997, FOLIA MICROBIOL, V42, P221, DOI 10.1007/BF02818983; EILAM Y, 1990, J GEN MICROBIOL, V136, P861, DOI 10.1099/00221287-136-5-861; EILAM Y, 1990, J GEN MICROBIOL, V136, P2537, DOI 10.1099/00221287-136-12-2537; EILAM Y, 1987, J GEN MICROBIOL, V133, P1641; GRADMANN D, 1978, J MEMBRANE BIOL, V39, P333, DOI 10.1007/BF01869898; Guo Q, 2008, J MED MICROBIOL, V57, P457, DOI 10.1099/jmm.0.47651-0; HERBETTE LG, 1988, J MOL CELL CARDIOL, V20, P373, DOI 10.1016/S0022-2828(88)80128-7; Kinclova-Zimmermannova O, 2005, J BIOL CHEM, V280, P30638, DOI 10.1074/jbc.M506341200; Malac J, 2005, INT J BIOCHEM CELL B, V37, P2536, DOI 10.1016/j.biocel.2005.06.005; Maresova L, 2007, BIOTECHNIQUES, V43, P667, DOI 10.2144/000112620; Maresova L, 2006, FEMS YEAST RES, V6, P1039, DOI 10.1111/j.1567-1364.2006.00140.x; Marx F, 2008, CELL MOL LIFE SCI, V65, P445, DOI 10.1007/s00018-007-7364-8; Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200; Muend S, 2008, FEMS YEAST RES, V8, P425, DOI 10.1111/j.1567-1364.2008.00354.x; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Qu HY, 2007, NEW PHYTOL, V174, P524, DOI 10.1111/j.1469-8137.2007.02069.x; RAMOS S, 1989, J GEN MICROBIOL, V135, P2413; Roberts SK, 2003, EUKARYOT CELL, V2, P181, DOI 10.1128/EC.2.1.181-190.2003; Rosa SMLJ, 2000, BBA-MOL CELL BIOL L, V1487, P286, DOI 10.1016/S1388-1981(00)00122-0; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Shang ZL, 2005, PLANT CELL PHYSIOL, V46, P598, DOI 10.1093/pcp/pci063; Stevens HC, 2007, J BIOL CHEM, V282, P17563, DOI 10.1074/jbc.M700454200; TRUMBORE M, 1988, BIOPHYS J, V54, P535, DOI 10.1016/S0006-3495(88)82986-2; Vergani P, 1997, FEBS LETT, V405, P337, DOI 10.1016/S0014-5793(97)00211-1; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Zhang YQ, 2007, J BIOL CHEM, V282, P37844, DOI 10.1074/jbc.M707593200	35	67	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2795	2802		10.1074/jbc.M806693200	http://dx.doi.org/10.1074/jbc.M806693200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19054772	Green Published, hybrid			2022-12-27	WOS:000262700900022
J	Zhang, H; Stavnezer, E				Zhang, Hong; Stavnezer, Ed			Ski Regulates Muscle Terminal Differentiation by Transcriptional Activation of Myog in a Complex with Six1 and Eya3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING-GROWTH-FACTOR; C-SKI; SKELETAL-MUSCLE; GENE-EXPRESSION; EYE DEVELOPMENT; POSITIVE AUTOREGULATION; ONCOPROTEIN INTERACTS; DROSOPHILA-DACHSHUND; MAMMALIAN-CELLS; SATELLITE CELLS	Overexpression of the Ski pro-oncogene has been shown to induce myogenesis in non-muscle cells, to promote muscle hypertrophy in postnatal mice, and to activate transcription of muscle-specific genes. However, the precise role of Ski in muscle cell differentiation and its underlying molecular mechanism are not fully understood. To elucidate the involvement of Ski in muscle terminal differentiation, two retroviral systems were used to achieve conditional overexpression or knockdown of Ski in satellite cell-derived C2C12 myoblasts. We found that enforced expression of Ski promoted differentiation, whereas loss of Ski severely impaired it. Compromised terminal differentiation in the absence of Ski was likely because of the failure to induce myogenin (Myog) and p21 despite normal expression of MyoD. Chromatin immunoprecipitation and transcriptional reporter experiments showed that Ski occupied the endogenous Myog regulatory region and activated transcription from the Myog regulatory region upon differentiation. Transactivation of Myog was largely dependent on a MEF3 site bound by Six1, not on the binding site of MyoD or MEF2. Activation of the MEF3 site required direct interaction of Ski with Six1 and Eya3 mediated by the evolutionarily conserved Dachshund homology domain of Ski. Our results indicate that Ski is necessary for muscle terminal differentiation and that it exerts this role, at least in part, through its association with Six1 and Eya3 to regulate the Myog transcription.	[Zhang, Hong; Stavnezer, Ed] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Stavnezer, E (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	ed.stavnezer@case.edu			National Institutes of Health Grant [CA43600]; NATIONAL CANCER INSTITUTE [R01CA043600] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA43600 (to E. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Arndt S, 2005, LAB INVEST, V85, P1330, DOI 10.1038/labinvest.3700344; Arndt S, 2007, MOL CELL NEUROSCI, V34, P603, DOI 10.1016/j.mcn.2007.01.002; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; Chen DH, 2003, CANCER RES, V63, P6626; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; CHENG TC, 1995, P NATL ACAD SCI USA, V92, P561, DOI 10.1073/pnas.92.2.561; Colmenares C, 1990, Semin Cancer Biol, V1, P383; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; COLMENARES C, 1991, J VIROL, V65, P4929, DOI 10.1128/JVI.65.9.4929-4935.1991; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; COLMENARES C, 1991, MOL CELL BIOL, V11, P1167, DOI 10.1128/MCB.11.2.1167; Dahl R, 1998, P NATL ACAD SCI USA, V95, P11187, DOI 10.1073/pnas.95.19.11187; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Davis RJ, 1999, DEV GENES EVOL, V209, P526, DOI 10.1007/s004270050285; Denissova NG, 2004, J BIOL CHEM, V279, P28143, DOI 10.1074/jbc.M404961200; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; ENGERT JC, 1995, NUCLEIC ACIDS RES, V23, P2988, DOI 10.1093/nar/23.15.2988; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Hammond KL, 1998, MECH DEVELOP, V74, P121, DOI 10.1016/S0925-4773(98)00071-9; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Heidt AB, 2007, MOL CELL BIOL, V27, P5910, DOI 10.1128/MCB.01700-06; HEYMAN HC, 1994, J BIOL CHEM, V269, P26996; Ichikawa K, 1997, BIOCHEM J, V328, P607, DOI 10.1042/bj3280607; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kobayashi N, 2007, GENES CELLS, V12, P375, DOI 10.1111/j.1365-2443.2007.01052.x; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Laclef C, 2003, MECH DEVELOP, V120, P669, DOI 10.1016/S0925-4773(03)00065-0; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Li X, 2002, SCIENCE, V297, P1180; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; MONAGHAN AP, 1991, DEVELOPMENT, V112, P1053; NAGASE T, 1990, NUCLEIC ACIDS RES, V18, P337, DOI 10.1093/nar/18.2.337; NAMCIU S, 1995, DEV DYNAM, V204, P291, DOI 10.1002/aja.1002040307; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Oliver G, 1995, DEVELOPMENT, V121, P4045; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Ozaki H, 2002, J HUM GENET, V47, P107, DOI 10.1007/s100380200011; PEARSONWHITE S, 1993, NUCLEIC ACIDS RES, V21, P4632, DOI 10.1093/nar/21.19.4632; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Prathapam T, 2001, NUCLEIC ACIDS RES, V29, P3469, DOI 10.1093/nar/29.17.3469; ROSENTHAL N, 1990, NUCLEIC ACIDS RES, V18, P6239, DOI 10.1093/nar/18.21.6239; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; STAVNEZER E, 1986, J VIROL, V57, P1073, DOI 10.1128/JVI.57.3.1073-1083.1986; STAVNEZER E, 1981, J VIROL, V39, P920, DOI 10.1128/JVI.39.3.920-934.1981; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Takeda M, 2004, MOL BIOL CELL, V15, P963, DOI 10.1091/mbc.E03-07-0478; Tokitou F, 1999, J BIOL CHEM, V274, P4485, DOI 10.1074/jbc.274.8.4485; WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242; Wilson JJ, 2004, STRUCTURE, V12, P785, DOI 10.1016/S0969-2126(04)00118-2; Xu PX, 1997, DEVELOPMENT, V124, P219; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Young DP, 2008, J IMMUNOL, V181, P2420, DOI 10.4049/jimmunol.181.4.2420; Zhang L, 2007, ONCOGENE, V26, P1595, DOI 10.1038/sj.onc.1209958; ZHENG G, 1990, ONCOGENE, V15, P459	81	34	36	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2867	2879		10.1074/jbc.M807526200	http://dx.doi.org/10.1074/jbc.M807526200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19008232	hybrid, Green Published			2022-12-27	WOS:000262700900031
J	Zhang, Y; Kobayashi, A; Yamamoto, M; Hayes, JD				Zhang, Yiguo; Kobayashi, Akira; Yamamoto, Masayuki; Hayes, John D.			The Nrf3 Transcription Factor Is a Membrane-bound Glycoprotein Targeted to the Endoplasmic Reticulum through Its N-terminal Homology Box 1 Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT-RESPONSE ELEMENT; NEGATIVE REGULATION; CONSENSUS SEQUENCE; OXIDATIVE STRESS; SIGNAL SEQUENCES; GENE-EXPRESSION; PHOSPHORYLATION; ACTIVATION; IDENTIFICATION; GLYCOSYLATION	Transcription factor Nrf3 (NF-E2 p45-related factor 3) is targeted to the endoplasmic reticulum ( ER). Mouse Nrf3 is subject to proteolysis, Asn glycosylation, and deglycosylation reactions. It is synthesized as a similar to 96-kDa protein that is subsequently converted into isoforms of similar to 90, 80, and 70 kDa. In the ER, the similar to 90kDa glycoprotein is predominant and gives rise to similar to 80- and similar to 70- kDa isoforms. The similar to 90- and similar to 80- kDa polypeptides were observed in the nuclear envelope, whereas the similar to 70- kDa isoform was detected primarily in the nucleoplasm. Our experiments showed the N-terminal homology box 1 (NHB1, residues 12-31) is part of a tripartite signal peptide sequence, comprising n, h, and c regions. The h region ( residues 12-23) was demonstrated to target Nrf3 to the ER and is necessary for its Asn glycosylation. The n region ( residues 1-11) controlled the abundance of the similar to 90- kDa glycoprotein. The c region ( residues 24-39) was found to contain a signal peptidase cleavage site that is responsible for production of the similar to 90- kDa mature Nrf3 glycoprotein from a similar to 96-kDa precursor. We have found that Nrf3 is activated by the ER stressors tunicamycin and brefeldin A, and that NHB1 is required for this response. Amino acids between the c region and NHB2 ( residues 76-100) controlled the proteolytic processing of mouse Nrf3 into cleavage products of similar to 80- kDa ( glycated) and similar to 70- kDa (non-glycated); by contrast, human Nrf3 lacked a signal peptidase cleavage site between its c region and NHB2. Lastly, data are presented suggesting that the NHB2 sequence in mouse Nrf3 may regulate the topology of the transcription factor within the ER membrane.	[Zhang, Yiguo; Hayes, John D.] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Zhang, Yiguo; Hayes, John D.] Univ Dundee, Sch Med, Dundee DD1 9SY, Scotland; [Kobayashi, Akira] Tohoku Univ, Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808577, Japan; [Yamamoto, Masayuki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan	University of Dundee; University of Dundee; Tohoku University; Tohoku University; University of Tsukuba	Zhang, Y (corresponding author), Univ Dundee, Ninewells Hosp, Biomed Res Inst, Dundee DD1 9SY, Scotland.	y.z.zhang@dundee.ac.uk	Kobayashi, Akira/AAN-8003-2020; Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436; Zhang, Yiguo/0000-0003-3910-2779; Hayes, John/0000-0002-2927-5548; Kobayashi, Akira/0000-0001-9727-1218	Association for International Cancer Research [06-015]	Association for International Cancer Research	This work was supported by Association for International Cancer Research Grant 06-015. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Chenais B, 2005, MOL ENDOCRINOL, V19, P125, DOI 10.1210/me.2003-0379; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Derjuga A, 2004, MOL CELL BIOL, V24, P3286, DOI 10.1128/MCB.24.8.3286-3294.2004; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Etchevers HC, 2005, INT J DEV BIOL, V49, P363, DOI 10.1387/ijdb.041942he; Farley JR, 2005, CALCIFIED TISSUE INT, V76, P63, DOI 10.1007/s00223-004-0023-2; KAUFMANN SH, 1983, J BIOL CHEM, V258, P2710; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Liu H, 2005, BIOCHEM BIOPH RES CO, V338, P1005, DOI 10.1016/j.bbrc.2005.10.046; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Nouhi Z, 2007, FEBS LETT, V581, P5401, DOI 10.1016/j.febslet.2007.10.041; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sankaranarayanan K, 2004, J BIOL CHEM, V279, P50810, DOI 10.1074/jbc.M404984200; Schow SR, 1997, CELL IMMUNOL, V175, P199, DOI 10.1006/cimm.1996.1061; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zeghouf M, 2005, BIOCHEM SOC T, V33, P1265, DOI 10.1042/BST0331265; Zhang YG, 2003, J BIOL CHEM, V278, P12650, DOI 10.1074/jbc.M210368200; Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200; Zhang YG, 2001, J BIOL CHEM, V276, P14572, DOI 10.1074/jbc.M004615200; Zhang YG, 2001, J BIOL CHEM, V276, P11775, DOI 10.1074/jbc.M006000200; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2009, BIOCHEM J, V418, P293, DOI 10.1042/BJ20081575	32	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3195	3210		10.1074/jbc.M805337200	http://dx.doi.org/10.1074/jbc.M805337200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047052	hybrid			2022-12-27	WOS:000262700900063
J	Ferguson, T; Soares, JA; Lienard, T; Gottschalk, G; Krzycki, JA				Ferguson, Tsuneo; Soares, Jitesh A.; Lienard, Tanja; Gottschalk, Gerhard; Krzycki, Joseph A.			RamA, a Protein Required for Reductive Activation of Corrinoid-dependent Methylamine Methyltransferase Reactions in Methanogenic Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-M METHYLTRANSFERASE; METHANOSARCINA-BARKERI; METHIONINE SYNTHASE; ACETOBACTERIUM-DEHALOGENANS; ACID METHYLTRANSFERASE; O-DEMETHYLASE; L-PYRROLYSINE; ISOENZYME-II; ACETIVORANS; METABOLISM	Archaeal methane formation from methylamines is initiated by distinct methyltransferases with specificity for monomethylamine, dimethylamine, or trimethylamine. Each methylamine methyltransferase methylates a cognate corrinoid protein, which is subsequently demethylated by a second methyltransferase to form methyl-coenzyme M, the direct methane precursor. Methylation of the corrinoid protein requires reduction of the central cobalt to the highly reducing and nucleophilic Co(I) state. RamA, a 60-kDa monomeric iron-sulfur protein, was isolated from Methanosarcina barkeri and is required for in vitro ATP-dependent reductive activation of methylamine: CoM methyl transfer from all three methylamines. In the absence of the methyltransferases, highly purified RamA was shown to mediate the ATP-dependent reductive activation of Co(II) corrinoid to the Co(I) state for the monomethylamine corrinoid protein, MtmC. The ramA gene is located near a cluster of genes required for monomethylamine methyltransferase activity, including MtbA, the methylamine-specific CoM methylase and the pyl operon required for co-translational insertion of pyrrolysine into the active site of methylamine methyltransferases. RamA possesses a C-terminal ferredoxinlike domain capable of binding two tetranuclear iron-sulfur proteins. Mutliple ramA homologs were identified in genomes of methanogenic Archaea, often encoded near methyltrophic methyltransferase genes. RamA homologs are also encoded in a diverse selection of bacterial genomes, often located near genes for corrinoid-dependent methyltransferases. These results suggest that RamA mediates reductive activation of corrinoid proteins and that it is the first functional archetype of COG3894, a family of redox proteins of unknown function.	[Ferguson, Tsuneo; Soares, Jitesh A.; Krzycki, Joseph A.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Krzycki, Joseph A.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Lienard, Tanja; Gottschalk, Gerhard] Univ Gottingen, Gottingen Gen Lab, Inst Microbiol & Genet, D-37077 Gottingen, Germany	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Gottingen	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 West,12th Ave, Columbus, OH 43210 USA.	Krzycki.1@osu.edu			National Institutes of Health [GM070663]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant GM070663 (to J. A. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Boll M, 2005, BBA-BIOENERGETICS, V1707, P34, DOI 10.1016/j.bbabio.2004.01.009; Borodina E, 2004, APPL ENVIRON MICROB, V70, P4177, DOI 10.1128/AEM.70.7.4177-4186.2004; Bose A, 2008, J BACTERIOL, V190, P4017, DOI 10.1128/JB.00117-08; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; BURKE SA, 1995, J BACTERIOL, V177, P4410, DOI 10.1128/jb.177.15.4410-4416.1995; Daas PJH, 1996, J BIOL CHEM, V271, P22346, DOI 10.1074/jbc.271.37.22346; Daas PJH, 1996, J BIOL CHEM, V271, P22339, DOI 10.1074/jbc.271.37.22339; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Deppenmeier U, 2004, J BIOENERG BIOMEMBR, V36, P55, DOI 10.1023/B:JOBB.0000019598.64642.97; Deppenmeier U, 1999, FEBS LETT, V457, P291, DOI 10.1016/S0014-5793(99)01026-1; Di Luccio E, 2007, J MOL BIOL, V365, P783, DOI 10.1016/j.jmb.2006.10.068; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Engelmann T, 2001, ARCH MICROBIOL, V175, P376, DOI 10.1007/s002030100275; Ferguson DJ, 1997, J BACTERIOL, V179, P846, DOI 10.1128/jb.179.3.846-852.1997; Ferguson DJ, 1996, J BIOL CHEM, V271, P5189; Ferguson DJ, 2000, J BIOL CHEM, V275, P29053, DOI 10.1074/jbc.M910218199; Ferry JG, 1999, FEMS MICROBIOL REV, V23, P13, DOI 10.1016/S0168-6445(98)00029-1; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; GRAHAME DA, 1991, J BIOL CHEM, V266, P22227; Hagemeier CH, 2006, P NATL ACAD SCI USA, V103, P18917, DOI 10.1073/pnas.0603650103; Hao B, 2004, CHEM BIOL, V11, P1317, DOI 10.1016/j.chembiol.2004.07.011; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Heider J, 1997, EUR J BIOCHEM, V243, P577, DOI 10.1111/j.1432-1033.1997.00577.x; Jarrett JT, 1997, BIOCHEMISTRY-US, V36, P15739, DOI 10.1021/bi971987t; Krzycki JA, 2004, CURR OPIN CHEM BIOL, V8, P484, DOI 10.1016/j.cbpa.2004.08.012; Krzycki JA, 2005, CURR OPIN MICROBIOL, V8, P706, DOI 10.1016/j.mib.2005.10.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeClerc GM, 1996, J BIOL CHEM, V271, P18725, DOI 10.1074/jbc.271.31.18725; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Maeder DL, 2006, J BACTERIOL, V188, P7922, DOI 10.1128/JB.00810-06; Mahapatra A, 2006, MOL MICROBIOL, V59, P56, DOI 10.1111/j.1365-2958.2005.04927.x; Matthews RG, 2001, ACCOUNTS CHEM RES, V34, P681, DOI 10.1021/ar0000051; Naidu D, 2001, J BACTERIOL, V183, P3276, DOI 10.1128/JB.183.11.3276-3281.2001; NAUMANN E, 1984, ARCH MICROBIOL, V138, P79, DOI 10.1007/BF00425412; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Paul L, 1996, J BACTERIOL, V178, P6599, DOI 10.1128/jb.178.22.6599-6607.1996; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Sauer K, 1997, EUR J BIOCHEM, V243, P670, DOI 10.1111/j.1432-1033.1997.t01-1-00670.x; SEEFELDT LC, 1994, ANAL BIOCHEM, V221, P379, DOI 10.1006/abio.1994.1429; Siebert A, 2005, ARCH MICROBIOL, V183, P378, DOI 10.1007/s00203-005-0001-8; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Tallant TC, 1997, J BACTERIOL, V179, P6902, DOI 10.1128/jb.179.22.6902-6911.1997; Tallant TC, 2001, J BIOL CHEM, V276, P4485, DOI 10.1074/jbc.M007514200; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; VANDERMEIJDEN P, 1983, ARCH MICROBIOL, V134, P238, DOI 10.1007/BF00407765; VANDERMEIJDEN P, 1983, J BACTERIOL, V153, P6, DOI 10.1128/JB.153.1.6-11.1983; Vannelli T, 1999, P NATL ACAD SCI USA, V96, P4615, DOI 10.1073/pnas.96.8.4615; Wassenaar RW, 1996, J BACTERIOL, V178, P6937, DOI 10.1128/jb.178.23.6937-6944.1996; YELISEEV A, 1993, ARCH MICROBIOL, V159, P530, DOI 10.1007/BF00249031	57	42	42	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2285	2295		10.1074/jbc.M807392200	http://dx.doi.org/10.1074/jbc.M807392200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19043046	Green Published, hybrid			2022-12-27	WOS:000262545600038
J	Jensen, ED; Gopalakrishnan, R; Westendorf, JJ				Jensen, Eric D.; Gopalakrishnan, Rajaram; Westendorf, Jennifer J.			Bone Morphogenic Protein 2 Activates Protein Kinase D to Regulate Histone Deacetylase 7 Localization and Repression of Runx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEF2 TRANSCRIPTION FACTOR; OSTEOBLASTIC CELL-DIFFERENTIATION; GENE-EXPRESSION; NUCLEAR EXPORT; MUSCLE DIFFERENTIATION; CARDIAC-HYPERTROPHY; SIGNAL-TRANSDUCTION; OSTEOCALCIN GENE; TGF-BETA; INDUCTION	The transcriptional activity of Runx2 is determined by associations with co-repressors including histone deacetylase 7 (HDAC7). We previously found that bone morphogenic protein 2 (BMP2) induces export of HDAC7 from the nucleus. In this study we demonstrate that BMP2 specifically stimulates redistribution of HDAC7 but not HDAC 4, 5, or 6. HDAC7 subcellular redistribution in mesenchymal cells requires Crm1-mediated nuclear export, is associated with increased HDAC7 serine phosphorylation, and requires conserved serines in the HDAC7 amino terminus. The protein kinase D (PKD) inhibitor Go6976 blocked both basal and BMP2-directed HDAC7 nuclear export. Protein kinase D1 (PKD1) associated with HDAC7 in a BMP2-enhanced manner, and a constitutively active form of PKD1 stimulated HDAC7 nuclear export. Furthermore, active PKD1 inhibited repression of Runx2-mediated transcription by HDAC7. Suppression of HDAC7 was not sufficient to rescue BMP2 induction of osteoblast marker genes in Go6976-treated cells, indicating that PKD-dependent factors beyond attenuation of HDAC7-repressive activity are required for osteoblast differentiation. These results establish a novel pathway by which BMP signaling regulates Runx2 activity via PKD-dependent inhibition of HDAC7 transcriptional repression.	[Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Jensen, Eric D.; Gopalakrishnan, Rajaram] Univ Minnesota, Sch Dent, Minneapolis, MN 55455 USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Westendorf, JJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 1s St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu			National Institutes of Health [AR48147, AR50074, AR50938]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048147, T32AR050938, R01AR050074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR48147, AR50074, and AR50938. This work was also supported by the V Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afzal F, 2005, J CELL PHYSIOL, V204, P63, DOI 10.1002/jcp.20258; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Blanchard F, 2005, DRUG DISCOV TODAY, V10, P197, DOI 10.1016/S1359-6446(04)03309-4; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Harrison BC, 2004, MOL CELL BIOL, V24, P10636, DOI 10.1128/MCB.24.24.10636-10649.2004; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Huynh QK, 2006, ARCH BIOCHEM BIOPHYS, V450, P141, DOI 10.1016/j.abb.2006.02.014; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jensen ED, 2007, CRIT REV EUKAR GENE, V17, P187; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2004, TRENDS GENET, V20, P206, DOI 10.1016/j.tig.2004.02.002; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Medeiros RB, 2005, IMMUNITY, V23, P213, DOI 10.1016/j.immuni.2005.07.006; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Sucharov CC, 2006, AM J PHYSIOL-HEART C, V291, pH1299, DOI 10.1152/ajpheart.00017.2006; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zaidi SK, 2001, J CELL SCI, V114, P3093; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	66	55	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2225	2234		10.1074/jbc.M800586200	http://dx.doi.org/10.1074/jbc.M800586200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19029091	hybrid, Green Published			2022-12-27	WOS:000262545600032
J	Hasan, MK; Cheung, C; Kaul, Z; Shah, N; Sakaushi, S; Sugimoto, K; Oka, S; Kaul, SC; Wadhwa, R				Hasan, Md. Kamrul; Cheung, Caroline; Kaul, Zeenia; Shah, Navjot; Sakaushi, Shinji; Sugimoto, Kenji; Oka, Shigenori; Kaul, Sunil C.; Wadhwa, Renu			CARF Is a Vital Dual Regulator of Cellular Senescence and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; HISTONE H3; CENTROSOME DUPLICATION; CANCER DEVELOPMENT; TUMOR SUPPRESSION; HUMAN FIBROBLASTS; P53 RESTORATION; PROTEIN; PHOSPHORYLATION	The tumor suppressor protein, p53, is central to the pathways that monitor the stress, DNA damage repair, cell cycle, aging, and cancer. Highly complex p53 networks involving its upstream sensors and regulators, downstream effectors and regulatory feedback loops have been identified. CARF (Collaborator of ARF) was shown to enhance ARF-dependent and -independent wild-type p53 function. Here we report that (i) CARF overexpression causes premature senescence of human fibroblasts, (ii) it is vital for replicative and stress-induced senescence, and (iii) the lack of CARF function causes aneuploidy and apoptosis. We provide evidence that CARF plays a dual role in regulating p53-mediated senescence and apoptosis, the two major tumor suppressor mechanisms.	[Hasan, Md. Kamrul; Cheung, Caroline; Kaul, Zeenia; Shah, Navjot; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Kaul, Zeenia] Univ Sydney, Childrens Med Res Inst, Fac Med, Westmead, NSW 2145, Australia; [Sakaushi, Shinji; Sugimoto, Kenji; Oka, Shigenori] Osaka Prefecture Univ, Lab Mol Biol & Cell Informat, Grad Sch Life & Environm Sci, Naka Ku, Osaka 5998531, Japan; [Oka, Shigenori] Nagase & Co Ltd, Recombinant Prot Developing Team, Ctr Res & Dev, Nishi Ku, Kobe, Hyogo 6512241, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Children's Medical Research Institute - Australia; University of Sydney; Nagase & Co., Ltd.	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Cent 4,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192	NEDO (New Energy and Industrial Technology Development Organization) of Japan	NEDO (New Energy and Industrial Technology Development Organization) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported in part by grants from the NEDO (New Energy and Industrial Technology Development Organization) of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Campisi J, 2007, AGING CELL, V6, P261, DOI 10.1111/j.1474-9726.2007.00292.x; CHEUNG CT, 2008, MECH AGEING IN PRESS; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 2008, BBA-REV CANCER, V1786, P15, DOI 10.1016/j.bbcan.2008.04.002; Gire V, 2005, M S-MED SCI, V21, P491, DOI 10.1051/medsci/2005215491; Gniadecki R, 2000, CELL MOL BIOL, V46, P121; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hampel B, 2005, AGING CELL, V4, P325, DOI 10.1111/j.1474-9726.2005.00180.x; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hasan MK, 2008, INT J ONCOL, V32, P663; Hasan MK, 2004, BIOCHEM J, V380, P605, DOI 10.1042/BJ20040337; Hasan MK, 2002, J BIOL CHEM, V277, P37765, DOI 10.1074/jbc.M204177200; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kaul SC, 2006, ANN NY ACAD SCI, V1067, P217, DOI 10.1196/annals.1354.026; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Rochette PJ, 2008, MECH AGEING DEV, V129, P207, DOI 10.1016/j.mad.2007.12.007; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Sauve DM, 1999, J CELL BIOL, V145, P225, DOI 10.1083/jcb.145.2.225; Serrano M, 1997, EXP CELL RES, V237, P7, DOI 10.1006/excr.1997.3824; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Stearns T, 2001, CELL, V105, P417, DOI 10.1016/S0092-8674(01)00366-X; Sugimoto K, 2002, CELL STRUCT FUNCT, V27, P457, DOI 10.1247/csf.27.457; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wadhwa R, 2003, EXP GERONTOL, V38, P245, DOI 10.1016/S0531-5565(02)00180-8; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	38	30	31	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1664	1672		10.1074/jbc.M805778200	http://dx.doi.org/10.1074/jbc.M805778200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19001376	hybrid			2022-12-27	WOS:000262330100035
J	Herrera, M; Hong, NJ; Ortiz, PA; Garvin, JL				Herrera, Marcela; Hong, Nancy J.; Ortiz, Pablo A.; Garvin, Jeffrey L.			Endothelin-1 Inhibits Thick Ascending Limb Transport via Akt-stimulated Nitric Oxide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY COLLECTING DUCT; NO PRODUCTION; HIGH-SALT; CHLORIDE ABSORPTION; NACL COTRANSPORT; ENOS ACTIVATION; ETB RECEPTORS; L-ARGININE; IN-VIVO; SYNTHASE	Endothelin-1 inhibits sodium reabsorption in the thick ascending limb (THAL) via stimulation of nitric oxide (NO) production. The mechanism whereby endothelin-1 stimulates THAL NO is unknown. We hypothesized that endothelin-1 stimulates THAL NO production by activating phosphatidylinositol 3-kinase(PI3K), stimulating Akt activity, and phosphorylating NOS3 at Ser(1177). This enhances NO production and inhibits sodium transport. We measured 1) NO production by fluorescence microscopy using DAF2-DA, 2) Akt activity using a fluorescence resonance energy transfer-based Akt reporter, 3) phosphorylated NOS3 and Akt by Western blotting, and 4) NKCC2 activity by fluorescence microscopy. In isolated THAL, endothelin-1 (1 nmol/liter) increased NO production from 0.23 +/- 0.24 to 2.81 +/- 0.32 fluorescence units/min (p < 0.001; n = 5) but failed to stimulate NO production in THALs isolated from NOS3(-/-) mice. Wortmannin (150 nmol/liter), a PI3K inhibitor, reduced endothelin-1-stimulated NO by 83% (0.49 +/- 0.13 versus 3.31 +/- 0.49 fluorescence units/min for endothelin-1 alone; p < 0.006; n = 5). Endothelin-1 stimulated Akt activity by 0.16 +/- 0.02 arbitrary units as measured by fluorescence resonance energy transfer (p < 0.001; n = 5) and increased phosphorylation of Akt at Ser(473) by 56 +/- 11% ( p < 0.002; n = 7). Dominant-negative Akt blocked endothelin-1- induced NO by 60 +/- 8% (p < 0.001 versus control; n = 6), and an Akt inhibitor had a similar effect. Endothelin-1 increased phosphorylation of NOS3 at Ser(1177) by 89 +/- 24% (p < 0.01; n = 7) but had no effect on Ser(633). Endothelin-1 inhibited NKCC2 activity, an effect that was blocked by dominant-negative Akt and NOS inhibition. We conclude that endothelin-1 stimulates THAL NO production by activating PI3K, stimulating Akt activity, and phosphorylating NOS3 at Ser(1177). This enhances NO production and inhibits sodium transport.	[Herrera, Marcela; Hong, Nancy J.; Ortiz, Pablo A.; Garvin, Jeffrey L.] Henry Ford Hosp, Hypertens & Vasc Res Div, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Garvin, JL (corresponding author), Henry Ford Hosp, Hypertens & Vasc Res Div, 2799 W Grand Blvd,E&R 7018, Detroit, MI 48202 USA.	jgarvin1@hfhs.org		Ortiz, Pablo/0000-0002-7512-7255	NHLBI [HL-28982, HL-70985]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070985, P01HL028982] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-28982 and HL-70985 from NHLBI (to J.L.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abassi ZA, 2001, NEWS PHYSIOL SCI, V16, P152; Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Boo YC, 2003, FREE RADICAL BIO MED, V35, P729, DOI 10.1016/S0891-5849(03)00397-6; Coffer PJ, 1998, BIOCHEM J, V335, P1; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ferreira NCD, 1997, J PHYSIOL-LONDON, V505, P749, DOI 10.1111/j.1469-7793.1997.749ba.x; Fisslthaler B, 2000, ACTA PHYSIOL SCAND, V168, P81; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia NH, 1999, HYPERTENSION, V34, P508, DOI 10.1161/01.HYP.34.3.508; GARVIN J L, 1988, American Journal of Physiology, V255, pF57; Granger JP, 2006, CURR HYPERTENS REP, V8, P298, DOI 10.1007/s11906-006-0068-x; HEBERT SC, 1981, AM J PHYSIOL, V241, pF412, DOI 10.1152/ajprenal.1981.241.4.F412; HEBERT SC, 1981, AM J PHYSIOL, V241, pF432, DOI 10.1152/ajprenal.1981.241.4.F432; Herrera M, 2006, HYPERTENSION, V47, P95, DOI 10.1161/01.HYP.0000196274.78603.85; Herrera M, 2005, AM J PHYSIOL-RENAL, V288, pF58, DOI 10.1152/ajprenal.00209.2004; Herrera M, 2004, AM J PHYSIOL-RENAL, V287, pF231, DOI 10.1152/ajprenal.00413.2003; KOHAN DE, 1994, AM J PHYSIOL, V266, pF291, DOI 10.1152/ajprenal.1994.266.2.F291; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; NADLER SP, 1992, J CLIN INVEST, V90, P1458, DOI 10.1172/JCI116013; Nakano D, 2008, AM J PHYSIOL-RENAL, V294, pF1205, DOI 10.1152/ajprenal.00578.2007; Notenboom S, 2002, AM J PHYSIOL-RENAL, V282, pF458, DOI 10.1152/ajprenal.00173.2001; Ortiz PA, 2004, AM J PHYSIOL-RENAL, V287, pF274, DOI 10.1152/ajprenal.00382.2003; Ortiz PA, 2004, AM J PHYSIOL-RENAL, V287, pF281, DOI 10.1152/ajprenal.00383.2003; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Ortiz PA, 2002, HYPERTENSION, V39, P591, DOI 10.1161/hy0202.103287; Ortiz PA, 2001, AM J PHYSIOL-RENAL, V281, pF819, DOI 10.1152/ajprenal.0075.2001; Plato CF, 2000, HYPERTENSION, V35, P319, DOI 10.1161/01.HYP.35.1.319; Plato CF, 2000, AM J PHYSIOL-RENAL, V279, pF326, DOI 10.1152/ajprenal.2000.279.2.F326; Plato CF, 2001, AM J PHYSIOL-RENAL, V281, pF679, DOI 10.1152/ajprenal.2001.281.4.F679; Pollock DM, 2001, AM J PHYSIOL-RENAL, V281, pF144, DOI 10.1152/ajprenal.2001.281.1.F144; Pollock JS, 2006, HYPERTENSION, V47, P19, DOI 10.1161/01.HYP.0000196276.29211.6f; Scotland RS, 2002, CIRC RES, V90, P904, DOI 10.1161/01.RES.0000016506.04193.96; SHMIDT HHHW, 1992, CELL CALCIUM, V13, P427, DOI 10.1016/0143-4160(92)90055-W; Sorenson J, 2005, STROKE, V36, P158, DOI 10.1161/01.STR.0000150489.47080.67; Stricklett PK, 2006, AM J PHYSIOL-RENAL, V290, pF1315, DOI 10.1152/ajprenal.00450.2005; Vassileva I, 2003, HYPERTENSION, V41, P1359, DOI 10.1161/01.HYP.0000070958.39174.7E; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Zou AP, 1996, HYPERTENSION, V27, P631, DOI 10.1161/01.HYP.27.3.631	41	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1454	1460		10.1074/jbc.M804322200	http://dx.doi.org/10.1074/jbc.M804322200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19033447	hybrid, Green Published			2022-12-27	WOS:000262330100013
J	Wikstrom, M; Kelly, AA; Georgiev, A; Eriksson, HM; Klement, MR; Bogdanov, M; Dowhan, W; Wieslander, A				Wikstrom, Malin; Kelly, Amelie A.; Georgiev, Alexander; Eriksson, Hanna M.; Klement, Maria Rosen; Bogdanov, Mikhail; Dowhan, William; Wieslander, Ake			Lipid-engineered Escherichia coli Membranes Reveal Critical Lipid Headgroup Size for Protein Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACHOLEPLASMA-LAIDLAWII MEMBRANES; PHOSPHOLIPID-COMPOSITION; SPONTANEOUS CURVATURE; DIGLUCOSYLDIACYLGLYCEROL SYNTHASE; TOPOLOGICAL ORGANIZATION; LIPOSOMAL MEMBRANES; INDIVIDUAL LIPIDS; LATERAL PRESSURE; LACTOSE PERMEASE; ACYL CHAINS	Escherichia coli membranes have a substantial bilayer curvature stress due to a large fraction of the nonbilayer-prone lipid phosphatidylethanolamine, and a mutant (AD93) lacking this lipid is severely crippled in several membrane-associated processes. Introduction of four lipid glycosyltransferases from Acholeplasma laidlawii and Arabidopsis thaliana, synthesizing large amounts of two nonbilayer-prone, and two bilayer-forming gluco-and galacto-lipids, (i) restored the curvature stress with the two nonbilayer lipids, and (ii) diluted the high negative lipid surface charge in all AD93 bilayers. Surprisingly, the bilayer-forming diglucosyl-diacylglycerol was almost as good in improving AD93 membrane processes as the two nonbilayer-prone glucosyl-diacylglycerol and galactosyl-diacylglycerol lipids, strongly suggesting that lipid surface charge dilution by these neutral lipids is very important for E. coli. Increased acyl chain length and unsaturation, plus cardiolipin (nonbilayer-prone) content, were probably also beneficial in the modified strains. However, despite a correct transmembrane topology for the transporter LacY in the diglucosyl-diacylglycerol clone, active transport failed in the absence of a nonbilayer-prone glycolipid. The corresponding digalactosyl-diacylglycerol bilayer lipid did not restore AD93 membrane processes, despite analogous acyl chain and cardiolipin contents. Chain ordering, probed by bis-pyrene lipids, was substantially lower in the digalactosyldiacylglycerol strain lipids due to its extended headgroup. Hence, a low surface charge density of anionic lipids is important in E. coli membranes, but is inefficient if the headgroup of the diluting lipid is too large. This strongly indicates that a certain magnitude of the curvature stress is crucial for the bilayer in vivo.	[Bogdanov, Mikhail; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA; [Wikstrom, Malin; Kelly, Amelie A.; Georgiev, Alexander; Eriksson, Hanna M.; Klement, Maria Rosen; Wieslander, Ake] Univ Stockholm, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	University of Texas System; University of Texas Health Science Center Houston; Stockholm University	Dowhan, W (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77225 USA.	William.Dowhan@uth.tmc.edu; ake@dbb.su.se	Georgiev, Alexander/D-3258-2011; Bogdanov, Mikhail/J-3695-2017	Georgiev, Alexander/0000-0001-5669-5962; 	National Institutes of Health [R37 GM20478]; Swedish Research Council and the Wenner-Gren Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council and the Wenner-Gren Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM20478 (to W. D.). This work was also supported by the Swedish Research Council and the Wenner-Gren Foundations (to A. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alley SH, 2008, BIOPHYS J, V94, P2938, DOI 10.1529/biophysj.107.118380; Alley SH, 2008, CHEM PHYS LIPIDS, V154, P64, DOI 10.1016/j.chemphyslip.2008.03.007; Andersson AS, 1998, BBA-BIOMEMBRANES, V1369, P94, DOI 10.1016/S0005-2736(97)00212-5; Berg S, 2001, J BIOL CHEM, V276, P22056, DOI 10.1074/jbc.M102576200; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Ces O., 2006, SIGNAL TRANSDUCT, V6, P112, DOI [10.1002/sita.200500079, DOI 10.1002/SITA.200500079]; Chen JP, 2006, PLANT CELL ENVIRON, V29, P1437, DOI 10.1111/j.1365-3040.2006.01527.x; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P10710; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Goss R, 2005, BIOCHEMISTRY-US, V44, P4028, DOI 10.1021/bi047464k; Guan L, 2006, P NATL ACAD SCI USA, V103, P1723, DOI 10.1073/pnas.0510922103; Holzl G, 2006, P NATL ACAD SCI USA, V103, P7512, DOI 10.1073/pnas.0600525103; Howard KP, 1996, J AM CHEM SOC, V118, P3345, DOI 10.1021/ja952971y; IWAMOTO K, 1982, BIOCHIM BIOPHYS ACTA, V691, P44, DOI 10.1016/0005-2736(82)90212-7; JARRELL HC, 1987, BIOCHEMISTRY-US, V26, P1805, DOI 10.1021/bi00381a003; Karlsson OP, 1996, BIOCHEMISTRY-US, V35, P10094, DOI 10.1021/bi9602876; Katona G, 2003, J MOL BIOL, V331, P681, DOI 10.1016/S0022-2836(03)00751-4; KELLY A, 2007, P 17 C PLANT LIP, P25; KILLIAN JA, 1994, BBA-BIOMEMBRANES, V1189, P225; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; LINDBLOM G, 1986, BIOCHEMISTRY-US, V25, P7502, DOI 10.1021/bi00371a037; Lindblom G, 2002, BIOCHEMISTRY-US, V41, P11512, DOI 10.1021/bi0263098; Mannock DA, 2004, CURR OPIN COLLOID IN, V8, P426, DOI 10.1016/j.cocis.2004.01.009; Mannock DA, 2001, EUR BIOPHYS J BIOPHY, V30, P537, DOI 10.1007/s002490010185z; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; NAKANO Y, 1995, GENE, V162, P157, DOI 10.1016/0378-1119(95)00320-6; NAVARRO J, 1984, BIOCHEMISTRY-US, V23, P130, DOI 10.1021/bi00296a021; Oradd G, 2000, BBA-BIOMEMBRANES, V1468, P329, DOI 10.1016/S0005-2736(00)00273-X; OSTERBERG F, 1995, BBA-LIPID LIPID MET, V1257, P18, DOI 10.1016/0005-2760(95)00042-B; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; RIETVELD AG, 1993, J BIOL CHEM, V268, P12427; RIVAS E, 1969, J MOL BIOL, V41, P261, DOI 10.1016/0022-2836(69)90391-X; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Storm P, 2003, EUR J BIOCHEM, V270, P1699, DOI 10.1046/j.1432-1033.2003.03527.x; Sun C, 2007, J BACTERIOL, V189, P1171, DOI 10.1128/JB.01589-06; SUNAMOTO J, 1980, J BIOCHEM-TOKYO, V88, P1219, DOI 10.1093/oxfordjournals.jbchem.a133089; Templer RH, 1998, FARADAY DISCUSS, V111, P41; THURMOND RL, 1994, BIOCHEMISTRY-US, V33, P13178, DOI 10.1021/bi00249a004; Torres-Franklin ML, 2007, PHYSIOL PLANTARUM, V131, P201, DOI 10.1111/j.1399-3054.2007.00943.x; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; WIESLANDER A, 1987, BIOCHIM BIOPHYS ACTA, V901, P250, DOI 10.1016/0005-2736(87)90121-0; Wikstrom M, 2004, J BIOL CHEM, V279, P10484, DOI 10.1074/jbc.M310183200; XIANG TX, 1993, BIOPHYS J, V65, P1108, DOI 10.1016/S0006-3495(93)81156-1; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	62	60	61	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					954	965		10.1074/jbc.M804482200	http://dx.doi.org/10.1074/jbc.M804482200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18981182	Green Published, hybrid			2022-12-27	WOS:000262122900031
J	Chen, YH; Caldwell, JM; Pereira, E; Baker, RW; Sanchez, Y				Chen, Yinhuai; Caldwell, Julie M.; Pereira, Elizabeth; Baker, Robert W.; Sanchez, Yolanda			ATR(Mec1) Phosphorylation-independent Activation of Chk1 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASES; BUDDING YEAST; S-PHASE; REPLICATION; PATHWAYS; RAD53; AUTOINHIBITION; MECHANISMS	The conserved protein kinase Chk1 is a player in the defense against DNA damage and replication blocks. The current model is that after DNA damage or replication blocks, ATR(Mec1) phosphorylates Chk1 on the non-catalytic C-terminal domain. However, the mechanism of activation of Chk1 and the function of the Chk1 C terminus in vivo remains largely unknown. In this study we used an in vivo assay to examine the role of the C terminus of Chk1 in the response to DNA damage and replication blocks. The conserved ATR(Mec1) phosphorylation sites were essential for the checkpoint response to DNA damage and replication blocks in vivo; that is, that mutation of the sites caused lethality when DNA replication was stalled by hydroxyurea. Despite this, loss of the ATR(Mec1) phosphorylation sites did not change the kinase activity of Chk1 in vitro. Furthermore, a single amino acid substitution at an invariant leucine in a conserved domain of the non-catalytic C terminus restored viability to cells expressing the ATR(Mec1) phosphorylation site-mutated protein and relieved the requirement of an upstream mediator for Chk1 activation. Our findings show that a single amino acid substitution in the C terminus, which could lead to an allosteric change in Chk1, allows it to bypass the requirement of the conserved ATR(Mec1) phosphorylation sites for checkpoint function.	[Pereira, Elizabeth; Baker, Robert W.; Sanchez, Yolanda] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Chen, Yinhuai; Caldwell, Julie M.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Dartmouth College; Norris Cotton Cancer Center; University System of Ohio; University of Cincinnati	Sanchez, Y (corresponding author), Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.	Yolanda.Sanchez@Dartmouth.edu			National Institutes of Health (NIEHS) [P30 ES06096, U01 ES11038]; NCI [RO1 CA84463]; Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA084463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, U01ES011038] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 ES06096 and U01 ES11038 (NIEHS) and RO1 CA84463 (NCI) to Y.S.). This work was also supported by Pew Scholars Program in the Biomedical Sciences to Y.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Caldwell JM, 2008, J CELL BIOL, V180, P1073, DOI 10.1083/jcb.200706009; Cheetham GMT, 2004, CURR OPIN STRUC BIOL, V14, P700, DOI 10.1016/j.sbi.2004.10.011; Cohen-Fix O, 1997, P NATL ACAD SCI USA, V94, P14361, DOI 10.1073/pnas.94.26.14361; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gardner R, 1999, EMBO J, V18, P3173, DOI 10.1093/emboj/18.11.3173; James P, 1996, GENETICS, V144, P1425; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Liu QH, 2000, GENE DEV, V14, P1448; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Navas TA, 1996, GENE DEV, V10, P2632, DOI 10.1101/gad.10.20.2632; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Palermo C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001427; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Purdy A, 2005, J CELL SCI, V118, P3305, DOI 10.1242/jcs.02454; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Schollaert KL, 2004, MOL BIOL CELL, V15, P4051, DOI 10.1091/mbc.e03-11-0792; Searle JS, 2004, NAT CELL BIOL, V6, P138, DOI 10.1038/ncb1092; SIKORSKI RS, 1989, GENETICS, V122, P19; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Wang SX, 2000, FEBS LETT, V487, P277, DOI 10.1016/S0014-5793(00)02370-X; WEINERT TA, 1993, GENETICS, V134, P63; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652	27	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					182	190		10.1074/jbc.M806530200	http://dx.doi.org/10.1074/jbc.M806530200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984588	hybrid, Green Published			2022-12-27	WOS:000261974800021
J	Li, YH; Ghavampur, S; Bondallaz, P; Will, L; Grenningloh, G; Puschel, AW				Li, Ying-Hua; Ghavampur, Sharang; Bondallaz, Percy; Will, Lena; Grenningloh, Gabriele; Pueschel, Andreas W.			Rnd1 Regulates Axon Extension by Enhancing the Microtubule Destabilizing Activity of SCG10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-NEURONS; PROTEIN SCG10; NEURITE OUTGROWTH; RHO-GTPASES; PC12 CELLS; ACTIN CYTOSKELETON; GROWTH-FACTOR; IN-VITRO; ROCK-I; STATHMIN	The GTPase Rnd1 affects actin dynamics antagonistically to Rho and has been implicated in the regulation of neurite outgrowth, dendrite development, and axon guidance. Here we show that Rnd1 interacts with the microtubule regulator SCG10. This interaction requires a central domain of SCG10 comprising about 40 amino acids located within the N-terminal half of a putative alpha-helical domain and is independent of phosphorylation at the four identified phosphorylation sites that regulate SCG10 activity. Rnd1 enhances the microtubule destabilizing activity of SCG10 and both proteins colocalize in neurons. Knockdown of Rnd1 or SCG10 by RNAi suppressed axon extension, indicating a critical role for both proteins during neuronal differentiation. Overexpression of Rnd1 in neurons induces the formation of multiple axons. The effect of Rnd1 on axon extension depends on SCG10. These results indicate that SCG10 acts as an effector downstream of Rnd1 to regulate axon extensions by modulating microtubule organization.	[Li, Ying-Hua; Ghavampur, Sharang; Will, Lena; Pueschel, Andreas W.] Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, D-48149 Munster, Germany; [Bondallaz, Percy; Grenningloh, Gabriele] Univ Lausanne, CHU Vaudois, Dept Psychiat, Ctr Psychiat Neurosci, CH-1008 Prilly, Switzerland	University of Munster; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Puschel, AW (corresponding author), Univ Munster, Mol Biol Abt, Inst Allgemeine Zool & Genet, Schlosspl 5, D-48149 Munster, Germany.	apuschel@uni-muenster.de			Deutsche Forschungsgemeinschaft [SFB 629, SPP 1090]; Swiss National Science Foundation [3100AO-10425]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 629 and SPP 1090 (to A. W. P.) and the Swiss National Science Foundation Grant 3100AO-10425 (to G. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S.C. Section 1734 solely to indicate this fact.	Antonsson B, 1997, PROTEIN EXPRES PURIF, V9, P295, DOI 10.1006/prep.1996.0679; Antonsson B, 1998, J BIOL CHEM, V273, P8439, DOI 10.1074/jbc.273.14.8439; Aoki J, 2000, BIOCHEM BIOPH RES CO, V278, P604, DOI 10.1006/bbrc.2000.3842; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; Di Paolo G, 1997, J NEUROSCI RES, V50, P1000, DOI 10.1002/(SICI)1097-4547(19971215)50:6<1000::AID-JNR10>3.0.CO;2-8; DiPaolo G, 1997, J BIOL CHEM, V272, P5175, DOI 10.1074/jbc.272.8.5175; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Foster R, 1996, MOL CELL BIOL, V16, P2689; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Grenningloh G, 2004, J NEUROBIOL, V58, P60, DOI 10.1002/neu.10279; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Harada A, 2005, J BIOL CHEM, V280, P18418, DOI 10.1074/jbc.M411356200; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Ishikawa Y, 2006, NEUROSCI LETT, V400, P218, DOI 10.1016/j.neulet.2006.02.064; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Manna T, 2007, BIOCHEMISTRY-US, V46, P3543, DOI 10.1021/bi061819d; Mori N, 2002, J NEUROSCI RES, V70, P264, DOI 10.1002/jnr.10353; Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295; Neidhart S, 2001, FEBS LETT, V508, P259, DOI 10.1016/S0014-5793(01)03090-3; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ohkawa N, 2007, J CELL SCI, V120, P1447, DOI 10.1242/jcs.001461; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1999, J NEUROSCI RES, V56, P553, DOI 10.1002/(SICI)1097-4547(19990601)56:5<553::AID-JNR11>3.0.CO;2-J; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Schubart UK, 1996, J BIOL CHEM, V271, P14062, DOI 10.1074/jbc.271.24.14062; Schwamborn JC, 2006, METHOD ENZYMOL, V406, P715, DOI 10.1016/S0076-6879(06)06056-3; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; Suh LH, 2004, J NEUROSCI, V24, P1976, DOI 10.1523/JNEUROSCI.1670-03.2004; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002	61	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					363	371		10.1074/jbc.M808126200	http://dx.doi.org/10.1074/jbc.M808126200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18996843	Green Published, hybrid			2022-12-27	WOS:000261974800041
J	Wood, LK; Thiele, DJ				Wood, L. Kent; Thiele, Dennis J.			Transcriptional Activation in Yeast in Response to Copper Deficiency Involves Copper-Zinc Superoxide Dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SACCHAROMYCES-CEREVISIAE; REDOX SWITCH; CYTOCHROME-OXIDASE; HYDROGEN-PEROXIDE; OXYGEN-TOXICITY; GLOBAL ANALYSIS; BUDDING YEAST; CHAPERONE CCS; FACTOR MAC1	Copper is an essential trace element, yet excess copper can lead to membrane damage, protein oxidation, and DNA cleavage. To balance the need for copper with the necessity to prevent accumulation to toxic levels, cells have evolved sophisticated mechanisms to regulate copper acquisition, distribution, and storage. In Saccharomyces cerevisiae, transcriptional responses to copper deficiency are mediated by the copper-responsive transcription factor Mac1. Although Mac1 activates the transcription of genes involved in high affinity copper uptake during periods of deficiency, little is known about the mechanisms by which Mac1 senses or responds to reduced copper availability. Here we show that the copper-dependent enzyme Sod1 (Cu, Zn-superoxide dismutase) and its intracellular copper chaperone Ccs1 function in the activation of Mac1 in response to an external copper deficiency. Genetic ablation of either CCS1 or SOD1 results in a severe defect in the ability of yeast cells to activate the transcription of Mac1 target genes. The catalytic activity of Sod1 is essential for Mac1 activation and promotes a regulated increase in binding of Mac1 to copper response elements in the promoter regions of genomic Mac1 target genes. Although there is precedent for additional roles of Sod1 beyond protection of the cell from oxygen radicals, the involvement of this protein in copper-responsive transcriptional regulation has not previously been observed. Given the presence of both Sod1 and copper-responsive transcription factors in higher eukaryotes, these studies may yield important insights into how copper deficiency is sensed and appropriate cellular responses are coordinated.	[Wood, L. Kent; Thiele, Dennis J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Thiele, DJ (corresponding author), 3813 Res Dr,C 134B, Durham, NC 27710 USA.	dennis.thiele@duke.edu			National Institutes of Health [GM41840-21]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41840-21 (to D.J.T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S. C. Section 1734 solely to indicate this fact.	Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Bai C, 1997, METHOD ENZYMOL, V283, P141; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; BERMINGHAMMCDONOGH O, 1988, P NATL ACAD SCI USA, V85, P4789, DOI 10.1073/pnas.85.13.4789; Brown KR, 2002, BIOCHEMISTRY-US, V41, P6469, DOI 10.1021/bi0160664; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; CHANG EC, 1989, J BIOL CHEM, V264, P12172; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; FISHER CL, 1994, PROTEINS, V19, P24, DOI 10.1002/prot.340190105; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Graden JA, 1997, P NATL ACAD SCI USA, V94, P5550, DOI 10.1073/pnas.94.11.5550; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Heredia J, 2001, J BIOL CHEM, V276, P8793, DOI 10.1074/jbc.M008179200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Jensen LT, 1998, EMBO J, V17, P5400, DOI 10.1093/emboj/17.18.5400; Joshi A, 1999, J BIOL CHEM, V274, P218, DOI 10.1074/jbc.274.1.218; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Keller G, 2000, J BIOL CHEM, V275, P29193, DOI 10.1074/jbc.M001552200; Keller G, 2005, EUKARYOT CELL, V4, P1863, DOI 10.1128/EC.4.11.1863-1871.2005; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Knight SAB, 1996, GENE DEV, V10, P1917, DOI 10.1101/gad.10.15.1917; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; Lin SJ, 1997, J BIOL CHEM, V272, P9215; Liochev SI, 2005, FREE RADICAL BIO MED, V38, P146, DOI 10.1016/j.freeradbiomed.2004.10.017; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Maxfield AB, 2004, J BIOL CHEM, V279, P5072, DOI 10.1074/jbc.M311772200; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McDaniels CPJ, 1999, J BIOL CHEM, V274, P26962, DOI 10.1074/jbc.274.38.26962; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Prohaska JR, 2004, J NUTR, V134, P1003, DOI 10.1093/jn/134.5.1003; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rees EM, 2004, CURR OPIN MICROBIOL, V7, P175, DOI 10.1016/j.mib.2004.02.004; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHNELL N, 1992, CURR GENET, V21, P269, DOI 10.1007/BF00351681; Serpe M, 1999, J BIOL CHEM, V274, P29211, DOI 10.1074/jbc.274.41.29211; SIKORSKI RS, 1989, GENETICS, V122, P19; Srinivasan C, 1998, BIOCHEMISTRY-US, V37, P7572, DOI 10.1021/bi980418y; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; Yoshida T, 2000, CIRC RES, V86, P264, DOI 10.1161/01.RES.86.3.264; Zhang J, 2000, J NEUROPATH EXP NEUR, V59, P53, DOI 10.1093/jnen/59.1.53; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	72	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					404	413		10.1074/jbc.M807027200	http://dx.doi.org/10.1074/jbc.M807027200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18977757	hybrid, Green Published			2022-12-27	WOS:000261974800045
J	Brown, TA; Tkachuk, AN; Clayton, DA				Brown, Timothy A.; Tkachuk, Ariana N.; Clayton, David A.			Native R-loops Persist throughout the Mouse Mitochondrial DNA Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEADING-STRAND ORIGIN; TRANSCRIPTION ELONGATION; RIBONUCLEASE-H; LAGGING-STRAND; COLE1 DNA; IN-VITRO; L-CELLS; REPLICATION; RNA; POLYMERASE	Mammalian mtDNA has been found here to harbor RNA-DNA hybrids at a variety of locations throughout the genome. The R-loop, previously characterized in vitro at the leading strand replication origin (OH), is isolated as a native RNA-DNA hybrid copurifying with mtDNA. Surprisingly, other mitochondrial transcripts also form stable partial R-loops. These are abundant and affect mtDNA conformation. Current models regarding the mechanism of mammalian mtDNA replication have been expanded by recent data and discordant hypotheses. The presence of stable, nonreplicative, and partially hybridized RNA on the mtDNA template is significant for the reevaluation of replication models based on two-dimensional agarose gel analyses. In addition, the close association of a subpopulation of mtRNA with the DNA template has further implications regarding the structure, maintenance, and expression of the mitochondrial genome. These results demonstrate that variously processed and targeted mtRNAs within mammalian mitochondria likely have multiple functions in addition to their conventional roles.	[Brown, Timothy A.; Tkachuk, Ariana N.; Clayton, David A.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Clayton, DA (corresponding author), 19700 Helix Dr, Ashburn, VA 20147 USA.	claytond@janelia.hhmi.org		Tkachuk, Ariana/0000-0001-8991-9643; Brown, Timothy/0000-0001-8941-7678	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ALONI Y, 1972, J MOL BIOL, V70, P363, DOI 10.1016/0022-2836(72)90545-1; BOGENHAGEN D, 1978, J MOL BIOL, V119, P69, DOI 10.1016/0022-2836(78)90270-X; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Broccoli S, 2004, MOL MICROBIOL, V52, P1769, DOI 10.1111/j.1365-2958.2004.04092.x; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; Brown TA, 2002, NUCLEIC ACIDS RES, V30, P2004, DOI 10.1093/nar/30.9.2004; Brown TA, 2006, CELL CYCLE, V5, P917, DOI 10.4161/cc.5.9.2710; Camps M, 2005, FRONT BIOSCI-LANDMRK, V10, P689, DOI 10.2741/1564; CARRE D, 1978, BIOCHEMISTRY-US, V17, P3263, DOI 10.1021/bi00609a014; CHANG DD, 1985, EMBO J, V4, P1559, DOI 10.1002/j.1460-2075.1985.tb03817.x; Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824; DASGUPTA S, 1987, CELL, V51, P1113, DOI 10.1016/0092-8674(87)90597-6; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; Kaneko S, 2007, P NATL ACAD SCI USA, V104, P17620, DOI 10.1073/pnas.0708866104; Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275; KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252; Kusov YY, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e57; Lee DY, 1996, J BIOL CHEM, V271, P24262, DOI 10.1074/jbc.271.39.24262; Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614; Lee DY, 1997, GENE DEV, V11, P582, DOI 10.1101/gad.11.5.582; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; PIKO L, 1984, MECH AGEING DEV, V26, P113, DOI 10.1016/0047-6374(84)90170-2; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; TAPPER DP, 1983, METHOD ENZYMOL, V97, P426; TAUTZ D, 1983, ANAL BIOCHEM, V132, P14, DOI 10.1016/0003-2697(83)90419-0; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Wanrooij S, 2008, P NATL ACAD SCI USA, V105, P11122, DOI 10.1073/pnas.0805399105; XU BJ, 1995, MOL CELL BIOL, V15, P580, DOI 10.1128/MCB.15.1.580; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	40	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36743	36751		10.1074/jbc.M806174200	http://dx.doi.org/10.1074/jbc.M806174200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18986989	Green Published, hybrid			2022-12-27	WOS:000261840500072
J	Kelley, EE; Batthyany, CI; Hundley, NJ; Woodcock, SR; Bonacci, G; Del Rio, JM; Schopfer, FJ; Lancaster, JR; Freeman, BA; Tarpey, MM				Kelley, Eric E.; Batthyany, Carlos I.; Hundley, Nicholas J.; Woodcock, Steven R.; Bonacci, Gustavo; Del Rio, J. Mauricio; Schopfer, Francisco J.; Lancaster, Jack R., Jr.; Freeman, Bruce A.; Tarpey, Margaret M.			Nitro-oleic Acid, a Novel and Irreversible Inhibitor of Xanthine Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRATED FATTY-ACIDS; HUMAN BLOOD-PLASMA; SUPEROXIDE-DISMUTASE; NITROLINOLEIC ACID; REACTIVE NITROGEN; OXIDASE; PEROXYNITRITE; BINDING; DEHYDROGENASE; TRANSDUCTION	Xanthine oxidoreductase (XOR) generates proinflammatory oxidants and secondary nitrating species, with inhibition of XOR proving beneficial in a variety of disorders. Electrophilic nitrated fatty acid derivatives, such as nitro-oleic acid (OA-NO2), display anti-inflammatory effects with pleiotropic properties. Nitro-oleic acid inhibits XOR activity in a concentration-dependent manner with an IC50 of 0.6 mu M, limiting both purine oxidation and formation of superoxide (O-2((center dot) over bar).). Enzyme inhibition by OA-NO2 is not reversed by thiol reagents, including glutathione, beta-mercaptoethanol, and dithiothreitol. Structure-function studies indicate that the carboxylic acid moiety, nitration at the 9 or 10 olefinic carbon, and unsaturation is required for XOR inhibition. Enzyme turnover and competitive reactivation studies reveal inhibition of electron transfer reactions at the molybdenum cofactor accounts for OA-NO2-induced inhibition. Importantly, OA-NO2 more potently inhibits cell-associated XOR-dependent O-2((center dot) over bar). production than does allopurinol. Combined, these data establish a novel role for OA-NO2 in the inhibition of XOR-derived oxidant formation.	[Kelley, Eric E.; Hundley, Nicholas J.; Del Rio, J. Mauricio; Tarpey, Margaret M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Batthyany, Carlos I.; Woodcock, Steven R.; Bonacci, Gustavo; Schopfer, Francisco J.; Freeman, Bruce A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA; [Batthyany, Carlos I.] Inst Pasteur Montevideo, Montevideo 11400, Uruguay	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Kelley, EE (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, W-1357 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	ekelley@pitt.edu	Del Rio, J. Mauricio/Q-2580-2018; Schopfer, Francisco/AAW-6505-2021; Freeman, Bruce A/H-9342-2012; Schopfer, Francisco Jose/AAE-8125-2020; Woodcock, Steven/AAE-9199-2020	Del Rio, J. Mauricio/0000-0002-3961-2851; Schopfer, Francisco Jose/0000-0001-9526-695X; Batthyany, Carlos/0000-0002-0627-1982	National Institutes of Health [HL58115, HL64937, HL71189, HL074391]; American Heart Association [0665378U, 0665418U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064937, R01HL058115, R37HL058115, R01HL071189, R01HL074391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58115 and HL64937 (to B. A. F.) and HL71189 and HL074391 (to J.L.). This work was also supported by the American Heart Association Beginning Grants-in-Aid 0665378U (to E. E. K.), 0665418U (to F.J.S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BRITIGAN BE, 1990, J BIOL CHEM, V265, P17533; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; Coles B, 2002, J BIOL CHEM, V277, P5832, DOI 10.1074/jbc.M105209200; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; FINKELSTEIN E, 1982, MOL PHARMACOL, V21, P262; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; GILER S, 1975, CLIN CHIM ACTA, V63, P37, DOI 10.1016/0009-8981(75)90375-7; GRANGER DN, 1981, GASTROENTEROLOGY, V81, P22; GURTOO HL, 1971, J BIOL CHEM, V246, P286; Harris CM, 1997, J BIOL CHEM, V272, P8370, DOI 10.1074/jbc.272.13.8370; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Houston M, 1999, J BIOL CHEM, V274, P4985, DOI 10.1074/jbc.274.8.4985; Ichimori K, 1999, J BIOL CHEM, V274, P7763, DOI 10.1074/jbc.274.12.7763; Kelley EE, 2004, J BIOL CHEM, V279, P37231, DOI 10.1074/jbc.M402077200; KERDESKY FAJ, 1987, J MED CHEM, V30, P1177, DOI 10.1021/jm00390a010; Lima ES, 2003, J LIPID RES, V44, P1660, DOI 10.1194/jlr.M200467-JLR200; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; Manini P, 2005, CHEM PHYS LIPIDS, V134, P161, DOI 10.1016/j.chemphyslip.2005.01.005; Masuoka N, 2004, BBA-MOL BASIS DIS, V1688, P245, DOI 10.1016/j.bbadis.2003.12.010; Masuoka N, 2006, MOL NUTR FOOD RES, V50, P725, DOI 10.1002/mnfr.200500250; MCCORD JM, 1970, J BIOL CHEM, V245, P1374; Napolitano A, 2000, J ORG CHEM, V65, P4853, DOI 10.1021/jo000090q; O'Donnell VB, 1999, CHEM RES TOXICOL, V12, P83, DOI 10.1021/tx980207u; Radi R, 1997, ARCH BIOCHEM BIOPHYS, V339, P125, DOI 10.1006/abbi.1996.9844; RAMBOER C, 1972, DIGESTION, V7, P183, DOI 10.1159/000197273; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Tamta H, 2006, BIOCHEMISTRY-MOSCOW+, V71, pS49, DOI 10.1134/S0006297906130086; Tan S, 1998, J NEUROPATH EXP NEUR, V57, P544, DOI 10.1097/00005072-199806000-00002; WAUD WR, 1975, ARCH BIOCHEM BIOPHYS, V169, P695, DOI 10.1016/0003-9861(75)90214-3; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463	39	67	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36176	36184		10.1074/jbc.M802402200	http://dx.doi.org/10.1074/jbc.M802402200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974051	Green Published, hybrid			2022-12-27	WOS:000261840500012
J	Pino, S; Ciciriello, F; Costanzo, G; Di Mauro, E				Pino, Samanta; Ciciriello, Fabiana; Costanzo, Giovanna; Di Mauro, Ernesto			Nonenzymatic RNA Ligation in Water	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT HAIRPIN RIBOZYMES; INFORMATIONAL POLYMERS; POLYRIBOADENYLIC ACID; DIFFERENTIAL STABILITY; TEMPERATURE-DEPENDENCE; NUCLEIC-ACIDS; ORIGIN; STACKING; DNA; ADENINE	We describe the nonenzymatic ligation of RNA oligomers in water. Dimers and tetramers are formed in a time-, pH-, and temperature-dependent reaction. Ligation efficiency depends on oligonucleotide length and sequence and is strongly enhanced by adenine-based nucleotide cofactors. Ligation of short RNA fragments could have liberated the prebiotic polymerization systems from the thermodynamically demanding task of reaching a (pre) genetically meaningful size by stepwise addition of one precursor monomer at the time.	[Di Mauro, Ernesto] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Pino, Samanta; Ciciriello, Fabiana] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Costanzo, Giovanna] CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Di Mauro, E (corresponding author), Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, Fdn Ist Pasteur Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	Ernesto.dimauro@uniroma1.it	Ciciriello, Fabiana/AAA-8065-2020	Ciciriello, Fabiana/0000-0003-1493-9767	Italian Space Agency Molecules-to-Man (MoMa); Agenzia Spaziale Italiana - Istituto Nazionale di Astrofisica (ASI-INAF) [I/015/07/0]; National Science Foundation Chemical Bond Center (CBC)	Italian Space Agency Molecules-to-Man (MoMa); Agenzia Spaziale Italiana - Istituto Nazionale di Astrofisica (ASI-INAF)(Istituto Nazionale Astrofisica (INAF)); National Science Foundation Chemical Bond Center (CBC)(National Science Foundation (NSF))	This work was supported by the Italian Space Agency Molecules-to-Man (MoMa) Project, by Agenzia Spaziale Italiana - Istituto Nazionale di Astrofisica (ASI-INAF) Grant I/015/07/0 Esplorazione del Sistema Solare, and by the National Science Foundation Chemical Bond Center (CBC) Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baldwin GS, 2008, J PHYS CHEM B, V112, P1060, DOI 10.1021/jp7112297; BRAHMS J, 1966, J MOL BIOL, V15, P467, DOI 10.1016/S0022-2836(66)80122-5; Ciciriello F, 2008, BIOCHEMISTRY-US, V47, P2732, DOI 10.1021/bi7021014; Costanzo G, 2007, J BIOL CHEM, V282, P16729, DOI 10.1074/jbc.M611346200; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; DEKKER CA, 1954, J AM CHEM SOC, V76, P3522, DOI 10.1021/ja01642a049; FINCH JT, 1969, J MOL BIOL, V46, P597, DOI 10.1016/0022-2836(69)90201-0; FRITZ HJ, 1978, BIOCHEMISTRY-US, V17, P1257, DOI 10.1021/bi00600a020; GILHAM PT, 1958, J AM CHEM SOC, V80, P6212, DOI 10.1021/ja01556a016; HOLCOMB DN, 1965, BIOPOLYMERS, V3, P121, DOI 10.1002/bip.360030203; Jain SS, 2004, ANGEW CHEM INT EDIT, V43, P2004, DOI 10.1002/anie.200353155; Laneve P, 2003, J BIOL CHEM, V278, P13026, DOI 10.1074/jbc.M211937200; LERMAN LS, 1961, J MOL BIOL, V3, P18, DOI 10.1016/S0022-2836(61)80004-1; Levy M, 1998, P NATL ACAD SCI USA, V95, P7933, DOI 10.1073/pnas.95.14.7933; Li YL, 2008, EUR BIOPHYS J BIOPHY, V37, P173, DOI 10.1007/s00249-007-0213-8; Meli M, 2003, J BIOL CHEM, V278, P9835, DOI 10.1074/jbc.M213058200; Meli M, 2002, J BIOL CHEM, V277, P2104, DOI 10.1074/jbc.M107130200; MORROW JR, 1995, J CHEM SOC CHEM COMM, P2431, DOI 10.1039/c39950002431; Nakata M, 2007, SCIENCE, V318, P1276, DOI 10.1126/science.1143826; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Norberg J, 1996, BIOPOLYMERS, V39, P765, DOI 10.1002/(SICI)1097-0282(199612)39:6<765::AID-BIP3>3.3.CO;2-G; NORBERG J, 1995, J AM CHEM SOC, V117, P10832, DOI 10.1021/ja00149a006; Norberg J, 1998, BIOPHYS J, V74, P394, DOI 10.1016/S0006-3495(98)77796-3; NORBERG J, 1995, J PHYS CHEM-US, V99, P13056, DOI 10.1021/j100035a002; OLSON WK, 1975, NUCLEIC ACIDS RES, V2, P2055, DOI 10.1093/nar/2.11.2055; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Orgel LE, 1998, TRENDS BIOCHEM SCI, V23, P491, DOI 10.1016/S0968-0004(98)01300-0; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; ORO J, 1961, NATURE, V191, P1193, DOI 10.1038/1911193a0; Paul N, 2002, P NATL ACAD SCI USA, V99, P12733, DOI 10.1073/pnas.202471099; Petrovic AG, 2005, J PHYS CHEM B, V109, P23698, DOI 10.1021/jp054280m; PINDER JC, 1974, BIOCHEMISTRY-US, V13, P5373, DOI 10.1021/bi00723a019; Reader JS, 2002, NATURE, V420, P841, DOI 10.1038/nature01185; READER JS, 2001, RNA, V7, P395; Rich A., 1962, HORIZONS BIOCH, P103; Saenger W., 1984, PRINCIPLES NUCL ACID, P116, DOI DOI 10.1007/978-1-4612-5190-3_6; Saladino R, 2006, J BIOL CHEM, V281, P5790, DOI 10.1074/jbc.M512545200; Saladino R, 2005, J BIOL CHEM, V280, P35658, DOI 10.1074/jbc.M504537200; Saladino R, 2007, CHEM BIODIVERS, V4, P694, DOI 10.1002/cbdv.200790059; Saladino R, 2006, CHEMBIOCHEM, V7, P1707, DOI 10.1002/cbic.200600139; SANCHEZ RA, 1968, J MOL BIOL, V38, P121, DOI 10.1016/0022-2836(68)90132-0; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; SUCK D, 1976, ACTA CRYSTALLOGR B, V32, P1727, DOI 10.1107/S0567740876006316; TSO POP, 1962, P NATL ACAD SCI USA, V48, P686, DOI 10.1073/pnas.48.4.686; VANHOLDE K, 1980, ORIGINS LIFE EVOL B, P31; VONHIPPE PH, 1972, ANNU REV BIOCHEM, V41, P231, DOI 10.1146/annurev.bi.41.070172.001311; WACHTERSHAUSER G, 1988, P NATL ACAD SCI USA, V85, P1134, DOI 10.1073/pnas.85.4.1134; ZUBAY G, 1991, CHEMTRACTS, V2, P439	48	37	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36494	36503		10.1074/jbc.M805333200	http://dx.doi.org/10.1074/jbc.M805333200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18977755	Green Published, hybrid			2022-12-27	WOS:000261840500047
J	Zhao, R; Du, LP; Huang, YL; Wu, YD; Gunst, SJ				Zhao, Rong; Du, Liping; Huang, Youliang; Wu, Yidi; Gunst, Susan J.			Actin Depolymerization Factor/Cofilin Activation Regulates Actin Polymerization and Tension Development in Canine Tracheal Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARP2/3 COMPLEX; TYROSINE PHOSPHORYLATION; COFILIN PHOSPHORYLATION; FILAMENT TURNOVER; LIM-KINASE; F-ACTIN; DYNAMICS; CONTRACTION; TROPOMYOSIN; ADF/COFILIN	The contractile activation of airway smooth muscle tissues stimulates actin polymerization, and the inhibition of actin polymerization inhibits tension development. Actin-depolymerizing factor (ADF) and cofilin are members of a family of actin-binding proteins that mediate the severing of F-actin when activated by dephosphorylation at serine 3. The role of ADF/cofilin activation in the regulation of actin dynamics and tension development during the contractile activation of smooth muscle was evaluated in intact canine tracheal smooth muscle tissues. Two-dimensional gel electrophoresis revealed that ADF and cofilin exist in similar proportions in the muscle tissues, and that similar to 40% of the total ADF/cofilin in unstimulated tissues is phosphorylated. Phospho-ADF/cofilin decreased concurrently with tension development in response to stimulation with acetylcholine (ACh) or potassium depolarization indicating the activation of ADF/cofilin. Expression of an inactive phospho-cofilin mimetic (cofilin S3E) but not wild type cofilin in the smooth muscle tissues inhibited endogenous ADF/cofilin dephosphorylation and ACh-induced actin polymerization. Expression of cofilin S3E in the tissues depressed tension development in response to ACh, but it did not affect myosin light chain phosphorylation. The ACh-induced dephosphorylation of ADF/cofilin required the Ca2+-dependent activation of calcineurin (PP2B). The results indicate that the activation of ADF/cofilin is regulated by contractile stimulation in tracheal smooth muscle and that cofilin activation is required for actin polymerization and tension development in response to contractile stimulation.	[Zhao, Rong; Du, Liping; Huang, Youliang; Wu, Yidi; Gunst, Susan J.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Gunst, SJ (corresponding author), Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr,MS313, Indianapolis, IN 46202 USA.	sgunst@iupui.edu		Gunst, Susan/0000-0001-9836-4782	National Institutes of Health [R01 HL 29289, R01 HL 074099]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029289, R01HL074099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL 29289 and R01 HL 074099 (USPHS). This work was also supported by a predoctoral fellowship from the American Heart Association (to R. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; An SS, 2002, AM J PHYSIOL-CELL PH, V283, pC792, DOI 10.1152/ajpcell.00425.2001; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Barany M, 2001, J BIOL CHEM, V276, P48398, DOI 10.1074/jbc.M106227200; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen XM, 2004, INFECT IMMUN, V72, P3011, DOI 10.1128/IAI.72.5.3011-3021.2004; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Gunst SJ, 2003, J APPL PHYSIOL, V95, P413, DOI 10.1152/japplphysiol.00277.2003; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hirshman CA, 1999, AM J PHYSIOL-LUNG C, V277, pL653, DOI 10.1152/ajplung.1999.277.3.L653; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Jones KA, 1999, J PHYSIOL-LONDON, V519, P527, DOI 10.1111/j.1469-7793.1999.0527m.x; KIM HR, 2008, AM J PHYSIOL, V295, pC68; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Konakahara S, 2004, GENES CELLS, V9, P345, DOI 10.1111/j.1356-9597.2004.00726.x; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Lehman W, 1996, BIOCH SMOOTH MUSCLE, P47; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Mehta D, 2000, AM J PHYSIOL-CELL PH, V279, pC308, DOI 10.1152/ajpcell.2000.279.2.C308; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Rosok O, 1999, GENOMICS, V61, P44, DOI 10.1006/geno.1999.5922; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Tang D, 1999, AM J PHYSIOL-CELL PH, V276, pC250, DOI 10.1152/ajpcell.1999.276.1.C250; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004	48	58	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36522	36531		10.1074/jbc.M805294200	http://dx.doi.org/10.1074/jbc.M805294200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957424	Green Published, hybrid			2022-12-27	WOS:000261840500050
J	O'Neill, LAJ				O'Neill, Luke A. J.			Regulation of Signaling by Non-degradative Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Keating SE, 2009, J BIOL CHEM, V284, P8211, DOI 10.1074/jbc.R800038200; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	6	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8209	8209		10.1074/jbc.R800070200	http://dx.doi.org/10.1074/jbc.R800070200			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19008216	Green Published, hybrid			2022-12-27	WOS:000264397800001
J	Bourguignon, LYW; Xia, WL; Wong, G				Bourguignon, Lilly Y. W.; Xia, Weiliang; Wong, Gabriel			Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates beta-Catenin Signaling and NF kappa B-specific Transcription Activity Leading to MDR1 and Bcl-x(L) Gene Expression and Chemoresistance in Breast Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MULTIDRUG-RESISTANCE GENE; GROWTH-FACTOR RECEPTOR; CANCER-CELLS; E-CADHERIN; CYTOSKELETON FUNCTION; TOPOISOMERASE-II; HOMING RECEPTOR; OVARIAN; ACTIVATION; CHEMOTHERAPY	In this study we have investigated hyaluronan (HA)-mediated CD44 (an HA receptor) interactions with p300 (a histone acetyltransferase) and SIRT1 (a histone deacetylase) in human breast tumor cells (MCF-7 cells). Specifically, our results indicate that HA binding to CD44 up-regulates p300 expression and its acetyltransferase activity that, in turn, promotes acetylation of beta-catenin and NF kappa B-p65 leading to activation of beta-catenin-associated T-cell factor/lymphocyte enhancer factor transcriptional co-activation and NF kappa B-specific transcriptional up-regulation, respectively. These changes then cause the expression of the MDR1 (P-glycoprotein/P-gp) gene and the anti-apoptotic gene Bcl-x(L) resulting in chemoresistance in MCF-7 cells. Our data also show that down-regulation of p300, beta-catenin, or NF kappa B-p65 in MCF-7 cells (by transfecting cells with p300-, beta-catenin-, or NF kappa B-p65-specific small interfering RNA) inhibits the HA/CD44-mediated beta-catenin/NF kappa B-p65 acetylation and abrogates the aforementioned transcriptional activities. Subsequently, there is a significant decrease in both MDR1 and Bcl-x(L) gene expression and an enhancement in caspase-3 activity and chemosensitivity in the breast tumor cells. Further analyses indicate that activation of SIRT1 (deacetylase) by resveratrol (a natural antioxidant) induces SIRT1-p300 association and acetyltransferase inactivation, leading to deacetylation of HA/CD44-induced beta-catenin and NF kappa B-p65, inhibition of beta-catenin-T-cell factor/lymphocyte enhancer factor and NF kappa B-specific transcriptional activation, and the impairment of MDR1 and Bcl-x(L) gene expression. All these multiple effects lead to an activation of caspase-3 and a reduction of chemoresistance. Together, these findings suggest that the interactions between HA/CD44-stimulated p300 (acetyltransferase) and resveratrol-activated SIRT1 (deacetylase) play pivotal roles in regulating the balance between cell survival versus apoptosis, and multidrug resistance versus sensitivity in breast tumor cells.	[Bourguignon, Lilly Y. W.] Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu	Xia, Weiliang/C-2650-2008; XIA, WEILIANG/AEA-0835-2022	Xia, Weiliang/0000-0002-0256-4219; XIA, WEILIANG/0000-0002-0256-4219	National Institutes of Health [R01 CA66163, R01 CA 78633, P01 AR39448]; Veterans Affairs merit review grant; Department of Defense grant; NATIONAL CANCER INSTITUTE [R01CA066163, R01CA078633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit review grant(US Department of Veterans Affairs); Department of Defense grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA66163, R01 CA 78633, and P01 AR39448 ( USPHS). This work was also supported by a Veterans Affairs merit review grant and a Department of Defense grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; Auvinen P, 2005, HISTOPATHOLOGY, V47, P420, DOI 10.1111/j.1365-2559.2005.02220.x; Baker EK, 2004, CANCER BIOL THER, V3, P819, DOI 10.4161/cbt.3.9.1101; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Cain K, 2002, BIOCHIMIE, V84, P203, DOI 10.1016/S0300-9084(02)01376-7; Cal C., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P77, DOI 10.2174/1568011033353443; Chan HM, 2001, J CELL SCI, V114, P2363; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Chuthapisith S, 2006, SURG-J R COLL SURG E, V4, P211, DOI 10.1016/S1479-666X(06)80062-4; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Debatin KM, 2002, ONCOGENE, V21, P8786, DOI 10.1038/sj.onc.1206039; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; DELPECH B, 1990, INT J CANCER, V46, P388, DOI 10.1002/ijc.2910460309; Engel N, 2008, INT J MOL MED, V21, P223; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Graham B, 2005, CELL CYCLE, V4, P1342, DOI 10.4161/cc.4.10.2047; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hill A, 2006, ONCOGENE, V25, P6079, DOI 10.1038/sj.onc.1209628; Hoei-Hansen CE, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-12; Iida N, 1997, J CELL PHYSIOL, V171, P152, DOI 10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.3.CO;2-6; IIDA N, 1995, J CELL PHYSIOL, V162, P127, DOI 10.1002/jcp.1041620115; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; JABNKNECHT R, 1996, CURR BIOL, V6, P22; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Li HZ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1632; Li NX, 2000, METHOD ENZYMOL, V319, P273; Lonning PE, 2003, LANCET ONCOL, V4, P177; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Muggia FM, 1997, DRUGS, V54, P22, DOI 10.2165/00003495-199700544-00006; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ohashi R, 2007, CANCER LETT, V252, P225, DOI 10.1016/j.canlet.2006.12.025; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752; Pervaiz S, 2004, DRUG RESIST UPDATE, V7, P333, DOI 10.1016/j.drup.2004.11.001; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Porter ACG, 2004, CHROMOSOME RES, V12, P569, DOI 10.1023/B:CHRO.0000036608.91085.d1; Pumfery A, 2003, CURR HIV RES, V1, P343, DOI 10.2174/1570162033485186; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Russo RIC, 2008, INT J CANCER, V122, P1012, DOI 10.1002/ijc.23122; Schultz J, 2004, J NATL CANCER I, V96, P1497, DOI 10.1093/jnci/96.20.1497; SCREATON GR, 1993, J BIOL CHEM, V268, P12235; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Shibata T, 1996, ONCOGENE, V13, P883; Smith H S, 1991, Basic Life Sci, V57, P329; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; UNDERHILL C, 1992, J CELL SCI, V103, P293; Van Beekum Olivier, 2007, Subcell Biochem, V41, P233; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vincent T, 2003, BRIT J HAEMATOL, V121, P259, DOI 10.1046/j.1365-2141.2003.04282.x; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P19, DOI 10.1001/archotol.132.1.19; Wang SJ, 2007, ARCH OTOLARYNGOL, V133, P281, DOI 10.1001/archotol.133.3.281; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Yang XH, 2001, CANCER RES, V61, P348; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhu D, 1998, CELL MOTIL CYTOSKEL, V39, P209, DOI 10.1002/(SICI)1097-0169(1998)39:3<209::AID-CM4>3.0.CO;2-#	110	144	148	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2657	2671		10.1074/jbc.M806708200	http://dx.doi.org/10.1074/jbc.M806708200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047049	Green Published, hybrid			2022-12-27	WOS:000262700900008
J	Du, L; Hickey, RW; Bayir, H; Watkins, SC; Tyurin, VA; Guo, FL; Kochanek, PM; Jenkins, LW; Ren, J; Gibson, G; Chu, CT; Kagan, VE; Clark, RSB				Du, Lina; Hickey, Robert W.; Bayir, Huelya; Watkins, Simon C.; Tyurin, Vladimir A.; Guo, Fengli; Kochanek, Patrick M.; Jenkins, Larry W.; Ren, Jin; Gibson, Greg; Chu, Charleen T.; Kagan, Valerian E.; Clark, Robert S. B.			Starving Neurons Show Sex Difference in Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; FATTY-ACIDS; CELL-DEATH; LIPID DROPLETS; GENDER; MICE; 3-METHYLADENINE; METABOLISM; INHIBITION; SURVIVAL	Sex-dependent differences in adaptation to famine have long been appreciated, thought to hinge on female versus male preferences for fat versus protein sources, respectively. However, whether these differences can be reduced to neurons, independent of typical nutrient depots, such as adipose tissue, skeletal muscle, and liver, was heretofore unknown. A vital adaptation to starvation is autophagy, a mechanism for recycling amino acids from organelles and proteins. Here we show that segregated neurons from males in culture are more vulnerable to starvation than neurons from females. Nutrient deprivation decreased mitochondrial respiration, increased autophagosome formation, and produced cell death more profoundly in neurons from males versus females. Starvation-induced neuronal death was attenuated by 3-methyladenine, an inhibitor of autophagy; Atg7 knockdown using small interfering RNA; or L-carnitine, essential for transport of fatty acids into mitochondria, all more effective in neurons from males versus females. Relative tolerance to nutrient deprivation in neurons from females was associated with a marked increase in triglyceride and free fatty acid content and a cytosolic phospholipase A2-dependent increase in formation of lipid droplets. Similar sex differences in sensitivity to nutrient deprivation were seen in fibroblasts. However, although inhibition of autophagy using Atg7 small interfering RNA inhibited cell death during starvation in neurons, it increased cell death in fibroblasts, implying that the role of autophagy during starvation is both sex-and tissue-dependent. Thus, during starvation, neurons from males more readily undergo autophagy and die, whereas neurons from females mobilize fatty acids, accumulate triglycerides, form lipid droplets, and survive longer.	[Du, Lina; Bayir, Huelya; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Du, Lina; Bayir, Huelya; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Hickey, Robert W.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; [Bayir, Huelya; Tyurin, Vladimir A.; Ren, Jin; Kagan, Valerian E.] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Watkins, Simon C.; Guo, Fengli; Gibson, Greg] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Jenkins, Larry W.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Hickey, Robert W.; Bayir, Huelya; Clark, Robert S. B.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Chu, Charleen T/B-1601-2008; Watkins, Simon/ABG-2590-2021	Kochanek, Patrick M/0000-0002-2627-913X; Chu, Charleen T/0000-0002-5052-8271; Watkins, Simon/0000-0003-4092-1552; Tyurin, Vladimir/0000-0002-3474-1697; Kagan, Valerian E./0000-0002-7245-1885	National Institutes of Health [NS38620, NS30318, HD045968, NS061817, AG026389]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P20NS030318, P50NS030318, R01NS038620, P01NS030318, R01NS061817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS38620, NS30318, HD045968, NS061817, and AG026389. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Baker RR, 1999, BBA-MOL CELL BIOL L, V1438, P253, DOI 10.1016/S1388-1981(99)00057-8; Bakewell L, 2006, BRIT J NUTR, V96, P93, DOI 10.1079/BJN20061801; BALLOU LR, 1985, P NATL ACAD SCI USA, V82, P371, DOI 10.1073/pnas.82.2.371; Basoglu M, 2006, EUR J NEUROL, V13, P1089, DOI 10.1111/j.1468-1331.2006.01531.x; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Connan F, 2006, PSYCHIAT RES-NEUROIM, V146, P117, DOI 10.1016/j.pscychresns.2005.10.006; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fujimoto T, 2006, ANN NY ACAD SCI, V1086, P104, DOI 10.1196/annals.1377.010; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; HILL JO, 1984, AM J PHYSIOL, V247, pR318, DOI 10.1152/ajpregu.1984.247.2.R318; Hopkins RO, 2007, CURR OPIN CRIT CARE, V13, P497, DOI 10.1097/MCC.0b013e3282efd19c; HOYENGA KB, 1982, PHYSIOL BEHAV, V28, P545, DOI 10.1016/0031-9384(82)90153-6; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Katzman D K, 2001, Semin Clin Neuropsychiatry, V6, P146, DOI 10.1053/scnp.2001.22263; Kim HY, 2003, LIPIDS, V38, P453, DOI 10.1007/s11745-003-1083-z; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lamont LS, 2003, J APPL PHYSIOL, V95, P1259, DOI 10.1152/japplphysiol.01028.2002; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; LUXON BA, 1993, AM J PHYSIOL, V265, pG831, DOI 10.1152/ajpgi.1993.265.5.G831; McAnoy AM, 2005, J AM SOC MASS SPECTR, V16, P1498, DOI 10.1016/j.jasms.2005.04.017; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; NEELY N, 1974, BIOCHEM BIOPH RES CO, V59, P680, DOI 10.1016/S0006-291X(74)80033-1; Niskanen LK, 1997, EUR J ENDOCRINOL, V137, P61, DOI 10.1530/eje.0.1370061; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Patil S, 2005, NEUROSCI LETT, V384, P288, DOI 10.1016/j.neulet.2005.05.003; Rodriguez-Rodriguez RA, 2004, J NEUROCHEM, V88, P1041, DOI 10.1046/j.1471-4159.2003.02262.x; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Ulloth JE, 2003, J NEUROCHEM, V84, P655, DOI 10.1046/j.1471-4159.2003.01571.x; WIDDOWSON EM, 1976, P NUTR SOC, V35, P175, DOI 10.1079/PNS19760030; Wolf I, 2006, CANCER-AM CANCER SOC, V106, P966, DOI 10.1002/cncr.21690; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	42	155	157	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2383	2396		10.1074/jbc.M804396200	http://dx.doi.org/10.1074/jbc.M804396200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19036730	Green Published, hybrid			2022-12-27	WOS:000262545600047
J	Ezezika, OC; Younger, NS; Lu, J; Kaiser, DA; Corbin, ZA; Nolen, BJ; Kovar, DR; Pollard, TD				Ezezika, Obidimma C.; Younger, Noah S.; Lu, Jia; Kaiser, Donald A.; Corbin, Zachary A.; Nolen, Bradley J.; Kovar, David R.; Pollard, Thomas D.			Incompatibility with Formin Cdc12p Prevents Human Profilin from Substituting for Fission Yeast Profilin INSIGHTS FROM CRYSTAL STRUCTURES OF FISSION YEAST PROFILIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY-L-PROLINE; ACTIN-FILAMENT ELONGATION; NUCLEOTIDE EXCHANGE; BINDING-SITE; CHICK-EMBRYOS; ADP-ACTIN; MODEL; CYTOKINESIS; REFINEMENT; NUCLEATION	Expression of human profilin-I does not complement the temperature-sensitive cdc3-124 mutation of the single profilin gene in fission yeast Schizosaccharomyces pombe, resulting in death from cytokinesis defects. Human profilin-I and S. pombe profilin have similar affinities for actin monomers, the FH1 domain of fission yeast formin Cdc12p and poly-L-proline (Lu, J., and Pollard, T. D. ( 2001) Mol. Biol. Cell 12, 1161-1175), but human profilin-I does not stimulate actin filament elongation by formin Cdc12p like S. pombe profilin. Two crystal structures of S. pombe profilin and homology models of S. pombe profilin bound to actin show how the two profilins bind to identical surfaces on animal and yeast actins even though 75% of the residues on the profilin side of the interaction differ in the two profilins. Overexpression of human profilin-I in fission yeast expressing native profilin also causes cytokinesis defects incompatible with viability. Human profilin-I with the R88E mutation has no detectable affinity for actin and does not have this dominant overexpression phenotype. The Y6D mutation reduces the affinity of human profilin-I for poly-L-proline by 1000-fold, but overexpression of Y6D profilin in fission yeast is lethal. The most likely hypotheses to explain the incompatibility of human profilin-I with Cdc12p are differences in interactions with the proline-rich sequences in the FH1 domain of Cdc12p and wider "wings" that interact with actin.	[Ezezika, Obidimma C.; Corbin, Zachary A.; Nolen, Bradley J.; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Younger, Noah S.; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Younger, Noah S.; Kovar, David R.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Lu, Jia; Kaiser, Donald A.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Yale University; Yale University; Yale University; University of Chicago; University of Chicago; Salk Institute	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	thomas.pollard@yale.edu		Ezezika, Obidimma/0000-0001-7832-0483	National Institutes of Health [GM-026338, GM-066311, GM-079265]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066311, R01GM026338, R01GM079265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-026338 and GM-066311 ( to T. D. P.) and GM-079265 ( to D. R. K.).	ALMO SC, 1994, J MOL BIOL, V236, P950, DOI 10.1006/jmbi.1994.1200; ARCHER SJ, 1994, FEBS LETT, V337, P145, DOI 10.1016/0014-5793(94)80262-9; BALASUBRAMANIAN MK, 1994, J CELL BIOL, V125, P1289, DOI 10.1083/jcb.125.6.1289; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Christensen HEM, 1996, PLANT J, V10, P269, DOI 10.1046/j.1365-313X.1996.10020269.x; DeLano W, 2002, PYMOL 0 99; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu SP, 1998, J STRUCT BIOL, V123, P22, DOI 10.1006/jsbi.1998.4009; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; METZLER WJ, 1994, J BIOL CHEM, V269, P4620; Mimuro H, 2000, J BIOL CHEM, V275, P28893, DOI 10.1074/jbc.M003882200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ostrander DB, 1999, EUR J BIOCHEM, V262, P26, DOI 10.1046/j.1432-1327.1999.00354.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; PERELROIZEN I, 1995, J BIOL CHEM, V270, P1501, DOI 10.1074/jbc.270.4.1501; PERELROIZEN I, 1994, BIOCHEMISTRY-US, V33, P8472, DOI 10.1021/bi00194a011; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; TANAKA M, 1985, EUR J BIOCHEM, V151, P291, DOI 10.1111/j.1432-1033.1985.tb09099.x; TUDERMAN L, 1975, EUR J BIOCHEM, V52, P9, DOI 10.1111/j.1432-1033.1975.tb03967.x; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873	47	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2088	2097		10.1074/jbc.M807073200	http://dx.doi.org/10.1074/jbc.M807073200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028693	Green Published, hybrid			2022-12-27	WOS:000262545600017
J	Jessop, CE; Tavender, TJ; Watkins, RH; Chambers, JE; Bulleid, NJ				Jessop, Catherine E.; Tavender, Timothy J.; Watkins, Rachel H.; Chambers, Joseph E.; Bulleid, Neil J.			Substrate Specificity of the Oxidoreductase ERp57 Is Determined Primarily by Its Interaction with Calnexin and Calreticulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; PEPTIDE-LOADING COMPLEX; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; SECRETORY PATHWAY; BINDING SITE; ER; TAPASIN; CELLS; GLYCOPROTEINS	The formation of disulfides within proteins entering the secretory pathway is catalyzed by the protein disulfide isomerase family of endoplasmic reticulum localized oxidoreductases. One such enzyme, ERp57, is thought to catalyze the isomerization of non-native disulfide bonds formed in glycoproteins with unstructured disulfide-rich domains. Here we investigated the mechanism underlying ERp57 specificity toward glycoprotein substrates and the interdependence of ERp57 and the calnexin cycle for their correct folding. Our results clearly show that ERp57 must be physically associated with the calnexin cycle to catalyze isomerization reactions with most of its substrates. In addition, some glycoproteins only require ERp57 for correct disulfide formation if they enter the calnexin cycle. Hence, the specificity of ER oxidoreductases is not only determined by the physical association of enzyme and substrate but also by accessory factors, such as calnexin and calreticulin in the case of ERp57. These conclusions suggest that the calnexin cycle has evolved with a specialized oxidoreductase to facilitate native disulfide formation in complex glycoproteins.	[Jessop, Catherine E.; Tavender, Timothy J.; Watkins, Rachel H.; Chambers, Joseph E.; Bulleid, Neil J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Bulleid, NJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	neil.bulleid@manchester.ac.uk	Chambers, Joseph/Z-5212-2019	Chambers, Joseph/0000-0003-4675-0053; Bulleid, Neil/0000-0002-9839-5279	Wellcome Trust [074081]; Biotechnology and Biological Sciences Research Council [D00764]; Biotechnology and Biological Sciences Research Council [BB/D00764X/1] Funding Source: researchfish; BBSRC [BB/D00764X/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by grants from the Wellcome Trust (Reference 074081) and the Biotechnology and Biological Sciences Research Council (Reference D00764). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen S, 1997, BIOCHEM J, V328, P113, DOI 10.1042/bj3280113; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Bulleid NJ, 1996, BIOCHEM J, V317, P195, DOI 10.1042/bj3170195; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Chambers JE, 2008, J BIOL CHEM, V283, P1862, DOI 10.1074/jbc.M708196200; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Maggioni MC, 2005, NAT STRUCT MOL BIOL, V12, P258, DOI 10.1038/nsmb897; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; ROBERTS PC, 1993, J VIROL, V67, P3048, DOI 10.1128/JVI.67.6.3048-3060.1993; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Simons JF, 1998, EMBO J, V17, P396, DOI 10.1093/emboj/17.2.396; Solda T, 2006, J BIOL CHEM, V281, P6219, DOI 10.1074/jbc.M513595200; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009	28	65	69	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2194	2202		10.1074/jbc.M808054200	http://dx.doi.org/10.1074/jbc.M808054200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19054761	Green Published, hybrid			2022-12-27	WOS:000262545600029
J	Chenal, A; Guijarro, JI; Raynal, B; Delepierre, M; Ladant, D				Chenal, Alexandre; Guijarro, J. Inaki; Raynal, Bertrand; Delepierre, Muriel; Ladant, Daniel			RTX Calcium Binding Motifs Are Intrinsically Disordered in the Absence of Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HEMOLYSIN; ADENYLATE-CYCLASE TOXIN; SERRATIA-MARCESCENS; CRYSTAL-STRUCTURE; ABC-TRANSPORTER; SECB CHAPERONE; REPEAT DOMAIN; SECRETION; PROTEIN; HLYA	The Repeat in Toxin (RTX) motif is a tandemly repeated calcium-binding nonapeptide sequence present in proteins that are secreted by the type I secretion system (T1SS) of Gram-negative bacteria. Here, we have characterized the structural and hydrodynamic properties of the RTX Repeat Domain (RD) of the CyaA toxin from Bordetella pertussis. This 701-amino acid long domain contains about 40 RTX motifs. We showed that, in the absence of calcium, RD was natively disordered, weakly stable, and highly hydrated. Calcium binding induced compaction and dehydration of RD, along with the formation of stable secondary and tertiary structures. The calcium-induced conformational switch between unfolded conformations of apo-RD and stable structures of holo-RD is likely to be a key property for the biological function of the CyaA toxin: in the low calcium environment of the bacterial cytosol, the intrinsically disordered character of the protein may facilitate its secretion through the secretion machinery. In the extracellular medium, calcium binding can then trigger the folding of the polypeptide into its functional state. The intrinsic disorder of RTX-containing proteins in the absence of calcium may thus be directly involved in the efficient secretion of proteins through T1SS.	[Chenal, Alexandre] Inst Pasteur, Unite Biochim Interact Macromol, CNRS URA 2185, F-75724 Paris 15, France; [Guijarro, J. Inaki; Delepierre, Muriel] Inst Pasteur, Unite RMN Biomol, F-75724 Paris 15, France; [Raynal, Bertrand] Inst Pasteur, Dept Biol Struct & Chim, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chenal, A (corresponding author), Inst Pasteur, Unite Biochim Interact Macromol, CNRS URA 2185, 28 Rue Dr Roux, F-75724 Paris 15, France.	alexandre.chenal@pasteur.fr; daniel.ladant@pasteur.fr	Guijarro, J. Inaki/E-6438-2019; Chenal, Alexandre/C-2240-2009	Guijarro, J. Inaki/0000-0002-3826-5245; Chenal, Alexandre/0000-0002-4959-1003; raynal, Bertrand/0000-0001-5634-0408; LADANT, Daniel/0000-0003-1955-548X	Institut Pasteur; Centre National de la Recherche Scientifique [CNRS URA 2185]; European Union 6th Framework Programme [LSHB-CT-2004-503582]; Region Ile de France	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Union 6th Framework Programme(European Commission); Region Ile de France(Region Ile-de-France)	This work was supported by Institut Pasteur, the Centre National de la Recherche Scientifique (CNRS URA 2185, Biologie Structurale et Agents Infectieux), and the European Union 6th Framework Programme contract LSHB-CT-2004-503582 (Theravac). The 600 MHz spectrometer was funded by the Region Ile de France and the Institut Pasteur. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; BOEHM DF, 1990, INFECT IMMUN, V58, P1959, DOI 10.1128/IAI.58.6.1959-1964.1990; Dalvit C, 1999, MAGN RESON CHEM, V37, P7, DOI 10.1002/(SICI)1097-458X(199901)37:1<7::AID-MRC398>3.0.CO;2-F; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Delepelaire P, 1998, EMBO J, V17, P936, DOI 10.1093/emboj/17.4.936; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; FELMLEE T, 1988, P NATL ACAD SCI USA, V85, P5269, DOI 10.1073/pnas.85.14.5269; FELMLEE T, 1985, J BACTERIOL, V163, P88, DOI 10.1128/JB.163.1.88-93.1985; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Harding SE, 1997, PROG BIOPHYS MOL BIO, V68, P207, DOI 10.1016/S0079-6107(97)00027-8; HARDING SE, 1995, ANAL BIOCHEM, V228, P131, DOI 10.1006/abio.1995.1324; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LETOFFE S, 1992, J BACTERIOL, V174, P4920; LUDWIG A, 1988, MOL GEN GENET, V214, P553, DOI 10.1007/BF00330494; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; NICAUD JM, 1986, FEBS LETT, V204, P331, DOI 10.1016/0014-5793(86)80838-9; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; Sanchez-Magraner L, 2007, J BIOL CHEM, V282, P11827, DOI 10.1074/jbc.M700547200; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; Wolff N, 2003, J BIOL CHEM, V278, P38247, DOI 10.1074/jbc.M302322200	31	104	107	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1781	1789		10.1074/jbc.M807312200	http://dx.doi.org/10.1074/jbc.M807312200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015266	hybrid			2022-12-27	WOS:000262330100049
J	Lin, HY; Fridy, PC; Ribeiro, AA; Choi, JH; Barma, DK; Vogel, G; Falck, JR; Shears, SB; York, JD; Mayr, GW				Lin, Hongying; Fridy, Peter C.; Ribeiro, Anthony A.; Choi, Jae H.; Barma, Deb K.; Vogel, Guenter; Falck, J. R.; Shears, Stephen B.; York, John D.; Mayr, Georg W.			Structural Analysis and Detection of Biological Inositol Pyrophosphates Reveal That the Family of VIP/Diphosphoinositol Pentakisphosphate Kinases Are 1/3-Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE; HEXAKISPHOSPHATE KINASE; DICTYOSTELIUM; TETRAKISPHOSPHATE; PHOSPHATES; IDENTIFICATION; PURIFICATION; METABOLISM; CELLS; POLYSPHONDYLIUM	We have characterized the positional specificity of the mammalian and yeast VIP/diphosphoinositol pentakisphosphate kinase (PPIP5K) family of inositol phosphate kinases. We deployed a microscale metal dye detection protocol coupled to a high performance liquid chromatography system that was calibrated with synthetic and biologically synthesized standards of inositol pyrophosphates. In addition, we have directly analyzed the structures of biological inositol pyrophosphates using two-dimensional H-1-H-1 and H-1-P-31 nuclear magnetic resonance spectroscopy. Using these tools, we have determined that the mammalian and yeast VIP/PPIP5K family phosphorylates the 1/3-position of the inositol ring in vitro and in vivo. For example, the VIP/PPIP5K enzymes convert inositol hexakisphosphate to 1/3-diphosphoinositol pentakisphosphate. The latter compound has not previously been identified in any organism. We have also unequivocally determined that 1/3,5-(PP)(2)-IP4 is the isomeric structure of the bis-diphosphoinositol tetrakisphosphate that is synthesized by yeasts and mammals, through a collaboration between the inositol hexakisphosphate kinase and VIP/PPIP5K enzymes. These data uncover phylogenetic variability within the crown taxa in the structures of inositol pyrophosphates. For example, in the Dictyostelids, the major bis-diphosphoinositol tetrakisphosphate is 5,6-(PP)(2)-IP4 (Laussmann, T., Eujen, R., Weisshuhn, C. M., Thiel, U., Falck, J. R., and Vogel, G. (1996) Biochem. J. 315, 715-725). Our study brings us closer to the goal of understanding the structure/function relationships that control specificity in the synthesis and biological actions of inositol pyrophosphates.	[Lin, Hongying; Mayr, Georg W.] Univ Klinikum Hamburg Eppendorf, Inst Biochem & Mol Biol Zellulare Signaltransdukt, D-20246 Hamburg, Germany; [Fridy, Peter C.; York, John D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Ribeiro, Anthony A.] Duke Univ, Med Ctr, NMR Ctr, Durham, NC 27710 USA; [Ribeiro, Anthony A.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Ribeiro, Anthony A.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Choi, Jae H.; Shears, Stephen B.] NIEHS, Inositide Signaling Grp, Lab Signal Transduct, NIH,Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Barma, Deb K.; Falck, J. R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Vogel, Guenter] Berg Univ Wuppertal, Fachbereich Math & Nat Wissensch Biochem, D-42097 Wuppertal, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Wuppertal	Mayr, GW (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Biochem & Mol Biol Zellulare Signaltransdukt, Martinistr 52, D-20246 Hamburg, Germany.	mayr@uke.uni-hamburg.de	Falck, John R/B-3030-2011; Shears, Stephen B/C-6335-2019	Falck, John R/0000-0002-9219-7845; Shears, Stephen B/0000-0001-7309-8916; Fridy, Peter/0000-0002-8208-9154	National Institutes of Health (NIH) Intramural Research Program of the NIEHS; NIH [R01 HL-55672, R01 A1057588]; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft [MA 989/2-3]; National Science Foundation; NIH; North Carolina Biotechnology Center; Duke University;  [NCI P30CA- 14236]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080046] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Intramural Research Program of the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Biotechnology Center; Duke University; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health (NIH) Intramural Research Program of the NIEHS ( to S. B. S.) and NIH Grants R01 HL-55672 ( to J. D. Y.), R01 A1057588 ( to A. A. R.), and NCI P30CA- 14236 ( to A. A. R.). This research was also supported by the Howard Hughes Medical Institute ( to J. D. Y.) and Deutsche Forschungsgemeinschaft Grant MA 989/2-3 ( to G. W. M.). Instrumentation in the Duke NMR Center is funded by the National Science Foundation, the NIH, the North Carolina Biotechnology Center, and Duke University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albert C, 1997, BIOCHEM J, V327, P553, DOI 10.1042/bj3270553; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Choi K, 2005, CELL SIGNAL, V17, P1533, DOI 10.1016/j.cellsig.2005.03.021; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Fridy PC, 2007, J BIOL CHEM, V282, P30754, DOI 10.1074/jbc.M704656200; Hand CE, 2007, BIOORG MED CHEM LETT, V17, P183, DOI 10.1016/j.bmcl.2006.09.066; Huang CF, 1998, BIOCHEMISTRY-US, V37, P14998, DOI 10.1021/bi981920l; Ingram SW, 2003, BIOCHEM J, V369, P519, DOI 10.1042/BJ20020733; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; JOHNSON K, 1995, ANAL BIOCHEM, V231, P421, DOI 10.1006/abio.1995.0073; Laussmann T, 2000, EUR J BIOCHEM, V267, P2447, DOI 10.1046/j.1432-1327.2000.01264.x; Laussmann T, 1997, BIOCHEM J, V322, P31, DOI 10.1042/bj3220031; Laussmann T, 1996, BIOCHEM J, V315, P715, DOI 10.1042/bj3150715; Laussmann T, 1998, FEBS LETT, V426, P145, DOI 10.1016/S0014-5793(98)00329-9; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; LIN HY, 2009, METHODS MOL BIOL INO; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; MAYR GW, 1992, CARBOHYD RES, V234, P247, DOI 10.1016/0008-6215(92)85052-2; MAYR GW, 1988, BIOCHEM J, V254, P585, DOI 10.1042/bj2540585; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Onnebo SMN, 2007, CELL, V129, P647, DOI 10.1016/j.cell.2007.05.002; Otto JC, 2007, P NATL ACAD SCI USA, V104, P15653, DOI 10.1073/pnas.0705729104; Ribeiro AA, 1999, MAGN RESON CHEM, V37, P620, DOI 10.1002/(SICI)1097-458X(199909)37:9<620::AID-MRC517>3.0.CO;2-Q; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; SCHOLZ P, 1990, METHODS INOSITIDE RE; SHEARS SB, 1995, J BIOL CHEM, V270, P10489, DOI 10.1074/jbc.270.18.10489; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; Yang XN, 1999, J BIOL CHEM, V274, P35434, DOI 10.1074/jbc.274.50.35434; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	38	92	99	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1863	1872		10.1074/jbc.M805686200	http://dx.doi.org/10.1074/jbc.M805686200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18981179	Green Published, hybrid			2022-12-27	WOS:000262330100057
J	Park, Y; Yoon, SK; Yoon, JB				Park, Yoon; Yoon, Sungjoo Kim; Yoon, Jong-Bok			The HECT Domain of TRIP12 Ubiquitinates Substrates of the Ubiquitin Fusion Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN UBIQUITINATION; POLYUBIQUITIN CHAINS; MULTIUBIQUITIN CHAIN; CONJUGATING ENZYME; CRYSTAL-STRUCTURE; PROTEOLYSIS; MECHANISMS; ALZHEIMERS; DISEASE; COMPLEX	The ubiquitin fusion degradation (UFD) pathway is a proteolytic system conserved in yeast and mammals in which an uncleavable ubiquitin moiety linked to the N terminus of a protein functions as a degradation signal of the fusion protein. Although key components of the UFD pathway in yeast have been identified, the E3 enzyme of the human UFD pathway has not been studied. In this work, we show that TRIP12 is the E3 enzyme of the human UFD pathway. Thus, TRIP12 catalyzes in vitro ubiquitination of UFD substrates in conjunction with E1, E2, and E4 enzymes. Knockdown of TRIP12 stabilizes not only artificial UFD substrates but a physiological substrate UBB+1. Moreover, TRIP12 knockdown reduces UBB+1-induced cell death in human neuroblastoma cells. Surprisingly, complementation of TRIP12 knockdown cells with the TRIP12 HECT domain mostly restores efficient degradation of UFD substrates, indicating that the TRIP12 HECT domain can act as the E3 enzyme for the UFD pathway in human cells. The TRIP12 HECT domain directs ubiquitination of UFD substrates in vitro and can be specifically cross-linked to the ubiquitin moiety of the substrates in vivo, suggesting that the TRIP12 HECT domain possesses a noncovalent ubiquitin-binding site. In addition, we demonstrate that Ub Delta GG, a mutant ubiquitin that cannot be conjugated to other proteins, is a substrate of the TRIP12 HECT domain both in vivo and in vitro, indicating that the C-terminal extension fused to the uncleavable ubiquitin is not required for substrate recognition in the UFD pathway. These results provide new insights into the mechanism of the mammalian UFD pathway and the functional nonequivalence of different HECT domains.	[Park, Yoon; Yoon, Jong-Bok] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Park, Yoon; Yoon, Jong-Bok] Yonsei Univ, Prot Network Res Ctr, Seoul 120749, South Korea; [Yoon, Sungjoo Kim] Catholic Univ Korea, Dept Biomed Sci, Seoul 137040, South Korea	Yonsei University; Yonsei University; Catholic University of Korea	Yoon, JB (corresponding author), Yonsei Univ, Dept Biochem, 134 Shinchon Dong, Seoul 120749, South Korea.	yoonj@yonsei.ac.kr		Yoon, Jong-Bok/0000-0002-3563-0702	Korean Ministry of Science and Technology; Korea Science and Engineering Foundation through the Protein Network Research Center at Yonsei University; Seoul RBD Program [10527]	Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Korea Science and Engineering Foundation through the Protein Network Research Center at Yonsei University(Korea Science and Engineering Foundation); Seoul RBD Program(Seoul RBD program)	This work was supported in part by grants from the Korean Ministry of Science and Technology through the Studies on Ubiquitome Functions Project, the Korea Science and Engineering Foundation through the Protein Network Research Center at Yonsei University, and Seoul R&BD Program Grant 10527. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; De Vrij FMS, 2001, FASEB J, V15, P2680, DOI 10.1096/fj.01-0438com; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DH, 2007, FEBS LETT, V581, P265, DOI 10.1016/j.febslet.2006.12.024; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200	27	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1540	1549		10.1074/jbc.M807554200	http://dx.doi.org/10.1074/jbc.M807554200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028681	hybrid			2022-12-27	WOS:000262330100022
J	Mason, AJ; Moussaoui, W; Abdelrahman, T; Boukhari, A; Bertani, P; Marquette, A; Shooshtarizaheh, P; Moulay, G; Boehm, N; Guerold, B; Sawers, RJH; Kichler, A; Metz-Boutigue, MH; Candolfi, E; Prevost, G; Bechinger, B				Mason, A. James; Moussaoui, Wardi; Abdelrahman, Tamer; Boukhari, Alyae; Bertani, Philippe; Marquette, Arnaud; Shooshtarizaheh, Peiman; Moulay, Gilles; Boehm, Nelly; Guerold, Bernard; Sawers, Ruairidh J. H.; Kichler, Antoine; Metz-Boutigue, Marie-Helene; Candolfi, Ermanno; Prevost, Gilles; Bechinger, Burkhard			Structural Determinants of Antimicrobial and Antiplasmodial Activity and Selectivity in Histidine-rich Amphipathic Cationic Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; LACTOFERRIN-DERIVED PEPTIDES; DERMASEPTIN S4 DERIVATIVES; MEMBRANE-LIPID-COMPOSITION; CELL-PENETRATING PEPTIDE; PLASMODIUM-FALCIPARUM; IN-VITRO; HYDROPHOBIC MISMATCH; SECONDARY STRUCTURE; MAGNETIC-RESONANCE	Designed histidine-rich amphipathic cationic peptides, such as LAH4, have enhanced membrane disruption and antibiotic properties when the peptide adopts an alignment parallel to the membrane surface. Although this was previously achieved by lowering the pH, here we have designed a new generation of histidine-rich peptides that adopt a surface alignment at neutral pH. In vitro, this new generation of peptides are powerful antibiotics in terms of the concentrations required for antibiotic activity; the spectrum of target bacteria, fungi, and parasites; and the speed with which they kill. Further modifications to the peptides, including the addition of more hydrophobic residues at the N terminus, the inclusion of a helix-breaking proline residue or using D-amino acids as building blocks, modulated the biophysical properties of the peptides and led to substantial changes in toxicity to human and parasite cells but had only a minimal effect on the antibacterial and antifungal activity. Using a range of biophysical methods, in particular solid-state NMR, we show that the peptides are highly efficient at disrupting the anionic lipid component of model membranes. However, we also show that effective pore formation in such model membranes may be related to, but is not essential for, high antimicrobial activity by cationic amphipathic helical peptides. The information in this study comprises a new layer of detail in the understanding of the action of cationic helical antimicrobial peptides and shows that rational design is capable of producing potentially therapeutic membrane active peptides with properties tailored to their function.	[Mason, A. James; Bertani, Philippe; Marquette, Arnaud; Bechinger, Burkhard] Univ Strasbourg, CNRS, UMR7177, Inst Chim, F-67070 Strasbourg, France; [Moussaoui, Wardi; Boukhari, Alyae; Prevost, Gilles] Univ Strasbourg, Hop Univ Strasbourg, Inst Bacteriol, UPRES EA3432, F-67000 Strasbourg, France; [Abdelrahman, Tamer; Candolfi, Ermanno] Univ Strasbourg, Fac Med, Inst Parasitol & Pathol Trop, UPRES EA3950, F-67000 Strasbourg, France; [Shooshtarizaheh, Peiman; Guerold, Bernard; Metz-Boutigue, Marie-Helene] INSERM, U575, F-67084 Strasbourg, France; [Moulay, Gilles; Kichler, Antoine] CNRS, FRE Genethon 3087, F-91002 Evry, France; [Boehm, Nelly] Univ Strasbourg, INSERM, U666, F-67085 Strasbourg, France; [Boehm, Nelly] Univ Strasbourg, Serv Cent Microscopie Elect, F-67085 Strasbourg, France; [Sawers, Ruairidh J. H.] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lausanne	Mason, AJ (corresponding author), Kings Coll London, Div Pharmaceut Sci, 150 Stamford St, London SE1 9NH, England.	james.mason@kcl.ac.uk	Mason, James/J-2273-2012	Mason, James/0000-0003-0411-602X; Abdelrahman, Tamir/0000-0003-0381-9524; MOULAY, Gilles/0000-0002-4913-9893; Kichler, Antoine/0000-0003-0593-2424; Sawers, Ruairidh James Hay/0000-0002-8945-3078	Vaincre la Mucoviscidose, Inserm [TG0501]; Hopitaux Universitaires de Strasbourg [PHRC3150]; CNRS; Universite Louis Pasteur [EA-3432]	Vaincre la Mucoviscidose, Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); Hopitaux Universitaires de Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Louis Pasteur	This work was supported by Vaincre la Mucoviscidose Grant TG0501 (to B. B.) Inserm, Hopitaux Universitaires de Strasbourg Grant PHRC3150 (to M.-H. M.-B.), and CNRS and Universite Louis Pasteur (postdoctoral grants to A.J.M. and EA-3432). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLEY MC, 1988, CANCER RES, V48, P589; Bechinger B, 1996, J MOL BIOL, V263, P768, DOI 10.1006/jmbi.1996.0614; Bechinger B, 2004, CRIT REV PLANT SCI, V23, P271, DOI 10.1080/07352680490452825; BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208; Bechinger B., 2003, CONCEPT MAGN RESON A, V18A, P130; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; BENBASSAT I, 1972, J CLIN INVEST, V51, P1833, DOI 10.1172/JCI106985; Blazyk J, 2001, J BIOL CHEM, V276, P27899, DOI 10.1074/jbc.M102865200; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chekmenev EY, 2006, BBA-BIOMEMBRANES, V1758, P1359, DOI 10.1016/j.bbamem.2006.03.034; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; Dagan A, 2002, ANTIMICROB AGENTS CH, V46, P1059, DOI 10.1128/AAC.46.4.1059-1066.2002; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; Doderer C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-19; Efron L, 2002, J BIOL CHEM, V277, P24067, DOI 10.1074/jbc.M202089200; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Gelhaus C, 2008, ANTIMICROB AGENTS CH, V52, P1713, DOI 10.1128/AAC.01342-07; Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i; Hallock KJ, 2002, BIOPHYS J, V82, P2499, DOI 10.1016/S0006-3495(02)75592-6; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harzer U, 2000, BIOCHEMISTRY-US, V39, P13106, DOI 10.1021/bi000770n; Hong SY, 1999, BIOCHEM PHARMACOL, V58, P1775, DOI 10.1016/S0006-2952(99)00259-2; HSIAO LL, 1991, BIOCHEM J, V274, P121, DOI 10.1042/bj2740121; HUSCHTSCHA LI, 1983, J CELL SCI, V63, P77; Jin Y, 2005, ANTIMICROB AGENTS CH, V49, P4957, DOI 10.1128/AAC.49.12.4957-4964.2005; Killian JA, 1996, BIOCHEMISTRY-US, V35, P1037, DOI 10.1021/bi9519258; Krugliak M, 2000, ANTIMICROB AGENTS CH, V44, P2442, DOI 10.1128/AAC.44.9.2442-2451.2000; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Leontiadou H, 2006, J AM CHEM SOC, V128, P12156, DOI 10.1021/ja062927q; MAGUIRE PA, 1990, MOL BIOCHEM PARASIT, V38, P105, DOI 10.1016/0166-6851(90)90210-D; Marquette A, 2008, J PEPT SCI, V14, P488, DOI 10.1002/psc.966; Mason AJ, 2007, MINI-REV MED CHEM, V7, P491, DOI 10.2174/138955707780619563; Mason AJ, 2007, BIOCHEMISTRY-US, V46, P15175, DOI 10.1021/bi701344m; Mason AJ, 2007, BIOPHYS J, V93, P4289, DOI 10.1529/biophysj.107.116681; Mason AJ, 2006, FASEB J, V20, P320, DOI 10.1096/fj.05-4293fje; Mason AJ, 2006, ANTIMICROB AGENTS CH, V50, P3305, DOI 10.1128/AAC.00490-06; Mason AJ, 2006, MOL MEMBR BIOL, V23, P185, DOI 10.1080/09687860500485303; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Nishikawa M, 2004, FEMS MICROBIOL LETT, V239, P255, DOI 10.1016/j.femsle.2004.08.043; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Radzishevsky I, 2007, ANTIMICROB AGENTS CH, V51, P1753, DOI 10.1128/AAC.01288-06; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Rinaldi AC, 2002, BIOCHEM J, V368, P91, DOI 10.1042/BJ20020806; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; Saint N, 2002, BBA-BIOMEMBRANES, V1564, P359, DOI 10.1016/S0005-2736(02)00470-4; SCHAFER H, 1995, J MAGN RESON SER A, V116, P145, DOI 10.1006/jmra.1995.0002; Schroder-Borm H, 2005, FEBS LETT, V579, P6128, DOI 10.1016/j.febslet.2005.09.084; SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024; SHERMAN IW, 1984, T ROY SOC TROP MED H, V78, P641, DOI 10.1016/0035-9203(84)90227-X; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; Shin SY, 2001, J PEPT RES, V58, P504, DOI 10.1034/j.1399-3011.2001.00934.x; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STERNIN E, 1983, J MAGN RESON, V55, P274, DOI 10.1016/0022-2364(83)90239-1; TYTLER EM, 1993, J BIOL CHEM, V268, P22122; UTSUGI T, 1991, CANCER RES, V51, P3062; Vial Henri J., 1992, V18, P259; Vogt TCB, 1999, J BIOL CHEM, V274, P29115, DOI 10.1074/jbc.274.41.29115; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P12869, DOI 10.1021/bi971398n; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198; Yang N, 2004, J PEPT SCI, V10, P37, DOI 10.1002/psc.470; Yang N, 2002, J PEPT RES, V60, P187, DOI 10.1034/j.1399-3011.2002.21008.x; Yoshida K, 2001, J PEPT RES, V57, P119, DOI 10.1034/j.1399-3011.2001.00802.x; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	67	81	84	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					119	133		10.1074/jbc.M806201200	http://dx.doi.org/10.1074/jbc.M806201200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984589	hybrid			2022-12-27	WOS:000261974800014
J	Sliter, DA; Kubota, K; Kirkpatrick, DS; Alzayady, KJ; Gygi, SP; Wojcikiewicz, RJH				Sliter, Danielle A.; Kubota, Kazuishi; Kirkpatrick, Donald S.; Alzayady, Kamil J.; Gygi, Steven P.; Wojcikiewicz, Richard J. H.			Mass Spectrometric Analysis of Type 1 Inositol 1,4,5-Trisphosphate Receptor Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; CONJUGATING ENZYMES E2S; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; POLYUBIQUITIN CHAINS; DEUBIQUITINATING ENZYMES; PROTEASOMAL DEGRADATION; TRISPHOSPHATE RECEPTORS; PROTEIN; CELLS	Inositol 1,4,5-trisphosphate (IP3)receptors form tetrameric channels in endoplasmic reticulum membranes of mammalian cells and mediate IP3-induced calcium mobilization. In response to various extracellular stimuli that persistently elevate IP3 levels, IP3 receptors are also ubiquitinated and then degraded by the proteasome. Here, for endogenous type 1 IP3 receptor (IP(3)R1) activated by endogenous signaling pathways and processed by endogenous enzymes, we sought to determine the sites of ubiquitination and the composition of attached ubiquitin conjugates. Our findings are (i) that at least 11 of the 167 lysines in IP(3)R1 can be ubiquitinated and that these are clustered in the regulatory domain and are found in surface regions, (ii) that at least similar to 40% of the IP(3)R1-associated ubiquitin is monoubiquitin, (iii) that both Lys(48) and Lys(63) linkages are abundant in attached ubiquitin chains, and (iv) that Lys(63) linkages accumulate most rapidly. Additionally, we find that not all IP(3)R1 subunits in a tetramer are ubiquitinated and that nontetrameric IP(3)R1 complexes form as degradation proceeds, suggesting that ubiquitinated subunits may be selectively extracted and degraded. Overall, these data show that endogenous IP3R1 is tagged with an array of ubiquitin conjugates at multiple sites and that both IP(3)R1 ubiquitination and degradation are highly complex processes.	[Sliter, Danielle A.; Alzayady, Kamil J.; Wojcikiewicz, Richard J. H.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Kubota, Kazuishi; Kirkpatrick, Donald S.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@upstate.edu		Kirkpatrick, Donald/0000-0003-3091-2804	National Institutes of Health [DK49194, GM67945]; American Heart Association [0815754D]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049194, R29DK049194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK49194 (to R. J. H. W.) and GM67945 ( to S. P. G.). This work was also supported by American Heart Association Grant 0815754D (to D. A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alzayady KJ, 2005, BIOCHEM J, V392, P601, DOI 10.1042/BJ20050949; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Bhanumathy CD, 2006, J BIOL CHEM, V281, P3722, DOI 10.1074/jbc.M509966200; Bokkala S, 1997, J BIOL CHEM, V272, P12454, DOI 10.1074/jbc.272.19.12454; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; KIRKPATRICK DS, 2008, PROTOCOLS BIOANALYTI, P103; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Taylor CW, 2004, TRENDS BIOCHEM SCI, V29, P210, DOI 10.1016/j.tibs.2004.02.010; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Webster JM, 2003, J BIOL CHEM, V278, P38238, DOI 10.1074/jbc.M305600200; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wojcikiewicz RJH, 1999, GASTROENTEROLOGY, V116, P1194, DOI 10.1016/S0016-5085(99)70023-5; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316	47	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35319	35328		10.1074/jbc.M807288200	http://dx.doi.org/10.1074/jbc.M807288200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955483	Green Published, hybrid			2022-12-27	WOS:000261687900003
J	Yeh, ETH				Yeh, Edward T. H.			SUMOylation and De-SUMOylation: Wrestling with Life's Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SUMO-SPECIFIC PROTEASE; NUCLEAR-PORE COMPLEX; ANDROGEN RECEPTOR; DEPENDENT TRANSCRIPTION; DIFFERENTIAL REGULATION; PROSTATE-CANCER; CELL-DIVISION; DESUMOYLATION; SENP1; YEAST	The small ubiquitin-like modifier (SUMO) is a ubiquitin-like protein that covalently modifies a large number of cellular proteins. SUMO modification has emerged as an important regulatory mechanism for protein function and localization. SUMOylation is a dynamic process that is mediated by activating (E1), conjugating (E2), and ligating (E3) enzymes and readily reversed by a family of ubiquitin-like protein-specific proteases (U1p) in yeast and sentrin/SUMO-specific proteases (SENP) in human. This review will focus on the de-SUMOylating enzymes with special attention to their biological function.	Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Yeh, ETH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA.	etyeh@mdanderson.org						Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Di Bacco A, 2006, MOL CELL BIOL, V26, P4489, DOI 10.1128/MCB.02301-05; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Itahana Y, 2006, MOL CELL BIOL, V26, P4675, DOI 10.1128/MCB.01830-05; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kadoya T, 2002, MOL CELL BIOL, V22, P3803, DOI 10.1128/MCB.22.11.3803-3819.2002; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kim KI, 2000, J BIOL CHEM, V275, P14102, DOI 10.1074/jbc.275.19.14102; Kim YH, 2005, FEBS LETT, V579, P6272, DOI 10.1016/j.febslet.2005.10.010; Lewis A, 2007, J CELL BIOL, V178, P813, DOI 10.1083/jcb.200702154; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li X, 2008, CELL DEATH DIFFER, V15, P739, DOI 10.1038/sj.cdd.4402303; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V371, P823, DOI 10.1016/j.bbrc.2008.04.179; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Schwartz DC, 2007, MOL CELL BIOL, V27, P6948, DOI 10.1128/MCB.00774-07; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172; Taylor DL, 2002, J CELL SCI, V115, P1113; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	50	358	375	3	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8223	8227		10.1074/jbc.R800050200	http://dx.doi.org/10.1074/jbc.R800050200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19008217	Green Published, hybrid			2022-12-27	WOS:000264397800004
J	Orr, HT				Orr, Harry T.			Unstable Nucleotide Repeat Minireview Series: A Molecular Biography of Unstable Repeat Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Expansion of an unstable nucleotide repeat is a mutational mechanism that is apparently unique to humans and is known to cause a variety of neurological disorders. This collection of minireviews examines several of these unstable repeats, focusing on those where there is considerable molecular information on how the mutation alters function.	[Orr, Harry T.] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; [Orr, Harry T.] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; [Orr, Harry T.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Orr, Harry T.] Univ Minnesota, Dept Biophys, Minneapolis, MN 55455 USA; [Orr, Harry T.] Univ Minnesota, Dept Mol Biol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Orr, HT (corresponding author), Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA.	orrxx002@umn.edu		Orr, Harry/0000-0001-6118-741X				Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042	1	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7405	7405		10.1074/jbc.R800067200	http://dx.doi.org/10.1074/jbc.R800067200			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	18957428	Green Published, hybrid			2022-12-27	WOS:000264195600001
J	Youm, YH; Yang, HW; Sun, YX; Smith, RG; Manley, NR; Vandanmagsar, B; Dixit, VD				Youm, Yun-Hee; Yang, Hyunwon; Sun, Yuxiang; Smith, Roy G.; Manley, Nancy R.; Vandanmagsar, Bolormaa; Dixit, Vishwa Deep			Deficient Ghrelin Receptor-mediated Signaling Compromises Thymic Stromal Cell Microenvironment by Accelerating Thymic Adiposity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; AGE; EXPRESSION; THYMOPOIESIS; PROGENITORS; MECHANISMS; CAPACITY; DEFECTS; OBESITY; MICE	With progressive aging, adipocytes are the major cell types that constitute the bulk of thymic microenvironment. Understanding the origin of thymic adipocytes and mechanisms responsible for age-related thymic adiposity is thus germane for the design of long lasting thymic rejuvenation strategies. We have recently identified that ghrelin, an orexigenic anti-inflammatory peptide, can partially reverse age-related thymic involution. Here we demonstrate that Ghrl and ghrelin receptor (growth hormone secretagogue receptor (GHSR)) are expressed in thymic stromal cells and that their expression declines with physiological aging. Genetic ablation of ghrelin and GHSR leads to loss of thymic epithelial cells (TEC) and an increase in adipogenic fibroblasts in the thymus, suggesting potential cellular transitions. Using FoxN1Cre; R26RstopLacZ double transgenic mice, we provide qualitative evidence that thymic epithelial cells can transition to mesenchymal cells that express proadipogenic regulators in the thymus. We found that loss of functional Ghrl-GHSR interactions facilitates EMT and induces thymic adipogenesis with age. In addition, the compromised thymic stromal microenvironment due to lack of Ghrl-GHSR interactions is associated with reduced number of naive T cells. These data suggest that Ghrl may be a novel regulator of EMT and preserves thymic stromal cell microenvironment by controlling age-related adipocyte development within the thymus.	[Youm, Yun-Hee; Yang, Hyunwon; Vandanmagsar, Bolormaa; Dixit, Vishwa Deep] Louisiana State Univ, Pennington Biomed Res Ctr, Lab Neuroendocrine Immunol, Baton Rouge, LA 70808 USA; [Manley, Nancy R.] Univ Georgia, Coverdell Ctr Biomed & Hlth Sci, Dept Genet, Athens, GA 30602 USA; [Sun, Yuxiang; Smith, Roy G.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University System of Georgia; University of Georgia; Baylor College of Medicine	Dixit, VD (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Lab Neuroendocrine Immunol, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	Vishwa.Dixit@pbrc.edu	Vandanmagsar, Bolormaa/R-4565-2018	Youm, Yun-Hee/0000-0002-8098-8527	COYPU; Pennington Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	COYPU; Pennington Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the COYPU and Pennington Foundation grants (to V. D. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson M, 2000, INT IMMUNOL, V12, P1105, DOI 10.1093/intimm/12.7.1105; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Clise-Dwyer K, 2007, J IMMUNOL, V178, P1321, DOI 10.4049/jimmunol.178.3.1321; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Dixit VD, 2007, J CLIN INVEST, V117, P2778, DOI 10.1172/JCI30248; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; FRIEDENSTEIN A, 1962, NATURE, V194, P698, DOI 10.1038/194698a0; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V130, P1707, DOI 10.1053/j.gastro.2006.01.041; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Gray DHD, 2007, J IMMUNOL, V178, P4956, DOI 10.4049/jimmunol.178.8.4956; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Gui JG, 2007, INT IMMUNOL, V19, P1201, DOI 10.1093/intimm/dxm095; Hale LP, 2001, DEV COMP IMMUNOL, V25, P509, DOI 10.1016/S0145-305X(00)00071-9; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kenins L, 2008, J EXP MED, V205, P523, DOI 10.1084/jem.20072065; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Mackall CL, 1998, EUR J IMMUNOL, V28, P1886, DOI 10.1002/(SICI)1521-4141(199806)28:06<1886::AID-IMMU1886>3.0.CO;2-M; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Min H, 2004, J IMMUNOL, V173, P245, DOI 10.4049/jimmunol.173.1.245; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rossi S, 2002, BLOOD, V100, P682, DOI 10.1182/blood.V100.2.682; Steinmann G G, 1986, Curr Top Pathol, V75, P43; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; Zediak VP, 2007, BLOOD, V110, P1161, DOI 10.1182/blood-2007-01-071605	35	64	67	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7068	7077		10.1074/jbc.M808302200	http://dx.doi.org/10.1074/jbc.M808302200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19054770	Green Published, hybrid			2022-12-27	WOS:000263919000055
J	Chanoux, RA; Yin, B; Urtishak, KA; Asare, A; Bassing, CH; Brown, EJ				Chanoux, Rebecca A.; Yin, Bu; Urtishak, Karen A.; Asare, Amma; Bassing, Craig H.; Brown, Eric J.			ATR and H2AX Cooperate in Maintaining Genome Stability under Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE-RESPONSE; HOMOLOGOUS RECOMBINATION REPAIR; S-PHASE ARREST; HISTONE H2AX; FUNCTIONAL INTERACTION; IONIZING-RADIATION; FORK PROGRESSION; BLM HELICASE; CHECKPOINT	Chromosomal abnormalities are frequently caused by problems encountered during DNA replication. Although the ATR-Chk1 pathway has previously been implicated in preventing the collapse of stalled replication forks into double-strand breaks (DSB), the importance of the response to fork collapse in ATR-deficient cells has not been well characterized. Herein, we demonstrate that, upon stalled replication, ATR deficiency leads to the phosphorylation of H2AX by ATM and DNA-PKcs and to the focal accumulation of Rad51, a marker of homologous recombination and fork restart. Because H2AX has been shown to play a facilitative role in homologous recombination, we hypothesized that H2AX participates in Rad51-mediated suppression of DSBs generated in the absence of ATR. Consistent with this model, increased Rad51 focal accumulation in ATR-deficient cells is largely dependent on H2AX, and dual deficiencies in ATR and H2AX lead to synergistic increases in chromatid breaks and translocations. Importantly, the ATM and DNA-PK phosphorylation site on H2AX (Ser(139)) is required for genome stabilization in the absence of ATR; therefore, phosphorylation of H2AX by ATM and DNA-PKcs plays a pivotal role in suppressing DSBs during DNA synthesis in instances of ATR pathway failure. These results imply that ATR-dependent fork stabilization and H2AX/ATM/DNA-PKcs-dependent restart pathways cooperatively suppress double-strand breaks as a layered response network when replication stalls.	[Chanoux, Rebecca A.; Yin, Bu; Urtishak, Karen A.; Asare, Amma; Bassing, Craig H.; Brown, Eric J.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Chanoux, Rebecca A.; Urtishak, Karen A.; Asare, Amma; Brown, Eric J.] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Yin, Bu; Bassing, Craig H.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Brown, EJ (corresponding author), 514 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	brownej@mail.med.upenn.edu	Yin, Bu/A-2327-2011	Asare, Amma/0000-0002-4865-6864	National Institutes of Health NIA [R01AG027376]; Pennsylvania Department of Health; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA125195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027376] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pennsylvania Department of Health; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health NIA Grant R01AG027376. This work was also supported by the Pennsylvania Department of Health and the Abramson Family Cancer Research Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALKHODAIRY F, 1992, EMBO J, V11, P1343, DOI 10.1002/j.1460-2075.1992.tb05179.x; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Davalos AR, 2004, CELL CYCLE, V3, P1579, DOI 10.4161/cc.3.12.1286; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Durkin SG, 2006, ONCOGENE, V25, P4381, DOI 10.1038/sj.onc.1209466; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Lewis KA, 2005, CANCER RES, V65, P7091, DOI 10.1158/0008-5472.CAN-05-1019; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Marians KJ, 2000, CURR OPIN GENET DEV, V10, P151, DOI 10.1016/S0959-437X(00)00059-9; Meister P, 2005, J CELL BIOL, V168, P537, DOI 10.1083/jcb.200410006; Menoyo A, 2001, CANCER RES, V61, P7727; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Sonoda E, 2007, DNA REPAIR, V6, P280, DOI 10.1016/j.dnarep.2006.10.025; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Veuger SJ, 2003, CANCER RES, V63, P6008; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhu M, 2007, MOL BIOL CELL, V18, P1044, DOI 10.1091/mbc.E06-10-0957; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	62	93	96	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2009	284	9					5994	6003		10.1074/jbc.M806739200	http://dx.doi.org/10.1074/jbc.M806739200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	410EP	19049966	Green Published, hybrid			2022-12-27	WOS:000263560600063
J	Izu, Y; Mizoguchi, F; Kawamata, A; Hayata, T; Nakamoto, T; Nakashima, K; Inagami, T; Ezura, Y; Noda, M				Izu, Yayoi; Mizoguchi, Fumitaka; Kawamata, Aya; Hayata, Tadayoshi; Nakamoto, Testuya; Nakashima, Kazuhisa; Inagami, Tadashi; Ezura, Yoichi; Noda, Masaki			Angiotensin II Type 2 Receptor Blockade Increases Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; PARATHYROID-HORMONE; CELLS; OSTEOPOROSIS; EXPRESSION; RESORPTION; OSTEOPONTIN; MARROW; DIFFERENTIATION; OSTEOBLASTS	Renin angiotensin system (RAS) regulates circulating blood volume and blood pressure systemically, whereas RAS also plays a role in the local milieu. Previous in vitro studies suggested that RAS may be involved in the regulation of bone cells. However, it was not known whether molecules involved in RAS are present in bone in vivo. In this study, we examined the presence of RAS components in adult bone and the effects of angiotensin II type 2 (AT2) receptor blocker on bone mass. Immunohistochemistry revealed that AT2 receptor protein was expressed in both osteoblasts and osteoclasts. In addition, renin and angiotensin II-converting enzyme were expressed in bone cells in vivo. Treatment with AT2 receptor blocker significantly enhanced the levels of bone mass, and this effect was based on the enhancement of osteoblastic activity as well as the suppression of osteoclastic activity in vivo. These results indicate that RAS components are present in adult bone and that blockade of AT2 receptor results in alteration in bone mass.	[Izu, Yayoi; Mizoguchi, Fumitaka; Kawamata, Aya; Hayata, Tadayoshi; Nakamoto, Testuya; Nakashima, Kazuhisa; Ezura, Yoichi; Noda, Masaki] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pharmacol, Tokyo 1010062, Japan; [Mizoguchi, Fumitaka; Nakamoto, Testuya] Tokyo Med & Dent Univ, Dept Med & Rheumatol & Maxillofacial Surg, Tokyo 1138510, Japan; [Mizoguchi, Fumitaka; Nakamoto, Testuya; Nakashima, Kazuhisa; Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo 1010062, Japan; [Inagami, Tadashi] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Vanderbilt University	Ezura, Y (corresponding author), 3-10 Kanda Surugadai,2 Chome,Chiyoda Ku, Tokyo 1010062, Japan.	ezura.mph@mri.tmd.ac.jp; noda.mph@mri.tmd.ac.jp	Hayata, Tadayoshi/AAE-9712-2021; Ezura, Yoichi/L-9485-2016; Mizoguchi, Fumitaka/Y-3271-2018	Mizoguchi, Fumitaka/0000-0002-3956-7122; Nakashima, Kazuhisa/0000-0003-0491-2149	Japanese Ministry of Education [17012008, 18109011, 18659438, 18123456]; Japan Space Forum; NASDA; Advanced Bone and Joint Science Strategic Research Networks Projects	Japanese Ministry of Education(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Space Forum; NASDA; Advanced Bone and Joint Science Strategic Research Networks Projects	This work was supported by the Grants-in-aid from the Japanese Ministry of Education (21st Century Center of Excellence Program, Frontier Research for Molecular Destruction and Reconstitution of Tooth and Bone) 17012008, 18109011, 18659438, and 18123456, grants from Japan Space Forum, NASDA, and Advanced Bone and Joint Science Strategic Research Networks Projects (Japan Society for Promotion of Science Core to Core Program, Research for the Future Program, Genome Science). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aspenberg P, 2008, ACTA ORTHOP, V79, P111, DOI 10.1080/17453670710014851; Bandow K, 2007, J CELL PHYSIOL, V211, P392, DOI 10.1002/jcp.20944; Broulik PD, 2001, PHYSIOL RES, V50, P353; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Girotra M, 2006, REV ENDOCR METAB DIS, V7, P113, DOI 10.1007/s11154-006-9007-z; Hagiwara H, 1998, J ENDOCRINOL, V156, P543, DOI 10.1677/joe.0.1560543; Hatton R, 1997, J ENDOCRINOL, V152, P5, DOI 10.1677/joe.0.1520005; Hiruma Y, 1997, BIOCHEM BIOPH RES CO, V230, P176, DOI 10.1006/bbrc.1996.5914; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Ihara H, 2001, J BIOL CHEM, V276, P13065, DOI 10.1074/jbc.M010938200; Ishijima M, 2007, J ENDOCRINOL, V193, P235, DOI 10.1677/joe.1.06704; Kanis JA, 2008, BONE, V42, P4, DOI 10.1016/j.bone.2007.10.019; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kitahara K, 2003, ENDOCRINOLOGY, V144, P2132, DOI 10.1210/en.2002-220996; Kizer N, 1997, P NATL ACAD SCI USA, V94, P1013, DOI 10.1073/pnas.94.3.1013; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Lavoie JL, 2003, ENDOCRINOLOGY, V144, P2179, DOI 10.1210/en.2003-0150; Loghman-Adham M, 2005, J HISTOCHEM CYTOCHEM, V53, P979, DOI 10.1369/jhc.4A6494.2005; Lynn H, 2006, BONE, V38, P584, DOI 10.1016/j.bone.2005.09.011; Migliaccio S, 2007, CLIN INTERV AGING, V2, P55, DOI 10.2147/ciia.2007.2.1.55; Miyazono K, 2004, ONCOGENE, V23, P4232, DOI 10.1038/sj.onc.1207131; Mizoguchi F, 2008, J CELL PHYSIOL, V216, P47, DOI 10.1002/jcp.21374; Morinobu M, 2005, J EXP MED, V201, P961, DOI 10.1084/jem.20041097; Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe; Ono N, 2007, J BIOL CHEM, V282, P25509, DOI 10.1074/jbc.M610782200; Rejnmark L, 2006, J HYPERTENS, V24, P581, DOI 10.1097/01.hjh.0000203845.26690.cb; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sakai K, 2007, J CLIN INVEST, V117, P1088, DOI 10.1172/JCI31242; Sanada M, 2004, ATHEROSCLEROSIS, V176, P387, DOI 10.1016/j.atherosclerosis.2004.05.021; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Trujillo E, 1999, HISTOL HISTOPATHOL, V14, P1023, DOI 10.14670/HH-14.1023; Usui M, 2004, P NATL ACAD SCI USA, V101, P6653, DOI 10.1073/pnas.0303093101; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	35	98	113	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4857	4864		10.1074/jbc.M807610200	http://dx.doi.org/10.1074/jbc.M807610200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19004830	hybrid, Green Published			2022-12-27	WOS:000263416600014
J	Barros, SA; Srimaroeng, C; Perry, JL; Walden, R; Dembla-Rajpal, N; Sweet, DH; Pritchard, JB				Barros, Scott A.; Srimaroeng, Chutima; Perry, Jennifer L.; Walden, Ramsey; Dembla-Rajpal, Neetu; Sweet, Douglas H.; Pritchard, John B.			Activation of Protein Kinase C zeta Increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORT; BREAST-CANCER CELLS; SUBSTRATE-SPECIFICITY; CELLULAR PHYSIOLOGY; SULFATE TRANSPORT; PROXIMAL TUBULES; LLC-PK1 CELLS; PDZ; KIDNEY; MEMBRANE	Organic anion transporters (OATs) play a pivotal role in the clearance of small organic anions by the kidney, yet little is known about how their activity is regulated. A yeast two-hybrid assay was used to identify putative OAT3-associated proteins in the kidney. Atypical protein kinase C zeta(PKC zeta) was shown to bind to OAT3. Binding was confirmed in immunoprecipitation assays. The OAT3/PKC zeta interaction was investigated in rodent renal cortical slices from fasted animals. Insulin, an upstream activator of PKC zeta, increased both OAT3-mediated uptake of estrone sulfate (ES) and PKC zeta activity. Both effects were abolished by a PKC zeta-specific pseudosubstrate inhibitor. Increased ES transport was not observed in renal slices from OAT3-null mice. Transport of the shared OAT1/OAT3 substrate, p-aminohippurate, behaved similarly, except that stimulation was reduced, not abolished, in the OAT3-null mice. This suggested that OAT1 activity was also modified by PKC zeta, subsequently confirmed using an OAT1-specific substrate, adefovir. Inhibition of PKC zeta also blocked the increase in ES uptake seen in response to epidermal growth factor and to activation of protein kinase A. Thus, PKC zeta acted downstream of the epidermal growth factor to protein kinase A signaling pathway. Activation of transport was accompanied by an increase in V-max and was blocked by microtubule disruption, indicating that activation may result from trafficking of OAT3 into the plasma membrane. These data demonstrate that PKC zeta activation up-regulates OAT1 and OAT3 function, and that protein-protein interactions play a central role controlling these two important renal drug transporters.	[Barros, Scott A.; Srimaroeng, Chutima; Perry, Jennifer L.; Walden, Ramsey; Dembla-Rajpal, Neetu; Pritchard, John B.] NIEHS, NIH, Pharmacol Lab, Res Triangle Pk, NC 27709 USA; [Sweet, Douglas H.] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Medical University of South Carolina	Pritchard, JB (corresponding author), 111 TW Alexander Dr,MD F1-03, Res Triangle Pk, NC 27709 USA.	pritcha3@niehs.nih.gov	Cecile, Jennifer/H-4245-2012; Sweet, Douglas H/H-7914-2013	Cecile, Jennifer/0000-0002-2149-2222; Sweet, Douglas H/0000-0002-8911-9184; Srimaroeng, Chutima/0000-0002-5537-1023	National Institutes of Health Intramural Research Program from the NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES080031, ZIAES080031] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program from the NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program from the NIEHS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both authors contributed equally to this study.	Anzai N, 2005, J PHARMACOL SCI, V97, p120P; Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; Aslamkhan AG, 2006, AM J PHYSIOL-REG I, V291, pR1773, DOI 10.1152/ajpregu.00326.2006; Banan A, 2003, J PHARMACOL EXP THER, V307, P53, DOI 10.1124/jpet.103.053835; Biber J, 2005, J MEMBRANE BIOL, V203, P111, DOI 10.1007/s00232-005-0738-7; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Cihlar T, 1999, MOL PHARMACOL, V56, P570, DOI 10.1124/mol.56.3.570; Dantzler WH, 2003, BBA-BIOMEMBRANES, V1618, P185, DOI 10.1016/j.bbamem.2003.08.015; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; Kato Y, 2005, MOL PHARMACOL, V67, P734, DOI 10.1124/mol.104.002212; Lu R, 1999, AM J PHYSIOL-RENAL, V276, pF295, DOI 10.1152/ajprenal.1999.276.2.F295; Mikkaichi T, 2004, P NATL ACAD SCI USA, V101, P3569, DOI 10.1073/pnas.0304987101; Miller DS, 1998, AM J PHYSIOL-RENAL, V274, pF156, DOI 10.1152/ajprenal.1998.274.1.F156; Miyazaki H, 2005, J AM SOC NEPHROL, V16, P3498, DOI 10.1681/ASN.2005030306; Mulato AS, 2000, J PHARMACOL EXP THER, V295, P10; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nozawa T, 2005, PHARM RES-DORDR, V22, P1634, DOI 10.1007/s11095-005-7096-0; PRITCHARD JB, 1983, P NATL ACAD SCI-BIOL, V80, P2603, DOI 10.1073/pnas.80.9.2603; Soodvilai S, 2004, AM J PHYSIOL-RENAL, V287, pF1021, DOI 10.1152/ajprenal.00080.2004; Spears KJ, 2005, BIOCHEM PHARMACOL, V69, P415, DOI 10.1016/j.bcp.2004.09.026; STANDAERT ML, 2001, BIOCHEMISTRY-US, V40, P1; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Sweet DH, 2003, AM J PHYSIOL-RENAL, V284, pF763, DOI 10.1152/ajprenal.00405.2002; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Takano M, 1996, AM J PHYSIOL-RENAL, V271, pF469, DOI 10.1152/ajprenal.1996.271.2.F469; Wolff NA, 2003, J AM SOC NEPHROL, V14, P1959, DOI 10.1097/01.ASN.0000079040.55124.25; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; You GF, 2000, J BIOL CHEM, V275, P10278, DOI 10.1074/jbc.275.14.10278	30	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2672	2679		10.1074/jbc.M808078200	http://dx.doi.org/10.1074/jbc.M808078200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19028678	Green Published, hybrid			2022-12-27	WOS:000262700900009
J	Chen, LA; Li, J; Silva, SR; Jackson, LN; Zhou, YN; Watanabe, H; Ives, KL; Hellmich, MR; Evers, BM				Chen, L. Andy; Li, Jing; Silva, Scott R.; Jackson, Lindsey N.; Zhou, Yuning; Watanabe, Hiroaki; Ives, Kirk L.; Hellmich, Mark R.; Evers, B. Mark			PKD3 Is the Predominant Protein Kinase D Isoform in Mouse Exocrine Pancreas and Promotes Hormone-induced Amylase Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; ACINAR-CELLS; C-MU; PLASMA-MEMBRANE; DNA-SYNTHESIS; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; INDEPENDENT ACTIVATION; NEUROTENSIN SECRETION; SWISS 3T3-CELLS	The protein kinase D (PKD) family of serine/threonine kinases, which can be activated by gastrointestinal hormones, consists of three distinct isoforms that modulate a variety of cellular processes including intracellular protein transport as well as constitutive and regulated secretion. Although isoform-specific functions have been identified in a variety of cell lines, the expression and function of PKD isoforms in normal, differentiated secretory tissues is unknown. Here, we demonstrate that PKD isoforms are differentially expressed in the exocrine and endocrine cells of the pancreas. Specifically, PKD3 is the predominant isoform expressed in exocrine cells of the mouse and human pancreas, whereas PKD1 and PKD2 are more abundantly expressed in the pancreatic islets. Within isolated mouse pancreatic acinar cells, PKD3 undergoes rapid membrane translocation, trans-activating phosphorylation, and kinase activation after gastrointestinal hormone or cholinergic stimulation. PKD phosphorylation in pancreatic acinar cells occurs via a Ca2+-independent, diacylglycerol-and protein kinase C-dependent mechanism. PKD phosphorylation can also be induced by physiologic concentrations of secretagogues and by in vivo stimulation of the pancreas. Furthermore, activation of PKD3 potentiates MEK/ERK/RSK (RSK, ribosomal S6 kinase) signaling and significantly enhances cholecystokinin-mediated pancreatic amylase secretion. These findings reveal a novel distinction between the exocrine and endocrine cells of the pancreas and further identify PKD3 as a signaling molecule that promotes hormone-stimulated amylase secretion.	[Chen, L. Andy; Li, Jing; Silva, Scott R.; Jackson, Lindsey N.; Zhou, Yuning; Watanabe, Hiroaki; Ives, Kirk L.; Hellmich, Mark R.; Evers, B. Mark] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Li, Jing; Hellmich, Mark R.; Evers, B. Mark] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Evers, BM (corresponding author), Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA.	mevers@utmb.edu	Li, Jing/B-7206-2011; WATANABE, HIROAKI/I-1094-2019	Watanabe, Hiroaki/0000-0001-6065-3925	National Institutes of Health;  [PO1 DK35608];  [RO1 DK48489];  [T32 DK007639]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007639, P01DK035608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 DK35608, RO1 DK48489, and T32 DK007639. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.. S The on-line version of this article (available at http://www.jbc.org)	Anderson G, 2005, CELL SIGNAL, V17, P1397, DOI 10.1016/j.cellsig.2005.02.007; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Berna MJ, 2007, BBA-MOL CELL RES, V1773, P483, DOI 10.1016/j.bbamcr.2006.12.008; Brandlin I, 2002, J BIOL CHEM, V277, P45451, DOI 10.1074/jbc.M205299200; BURGOYNE RD, 1993, BIOCHEM J, V293, P305, DOI 10.1042/bj2930305; CASE RM, 1978, BIOL REV, V53, P211, DOI 10.1111/j.1469-185X.1978.tb01437.x; Chen J, 2005, MOL PHARMACOL, V67, P152, DOI 10.1124/mol.104.004200; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu T, 2001, FEBS LETT, V489, P101, DOI 10.1016/S0014-5793(01)02076-2; Chung OW, 2004, GASTROENTEROLOGY, V127, P957, DOI 10.1053/j.gastro.2004.05.002; Cosen-Binker LI, 2007, J BIOL CHEM, V282, P13047, DOI 10.1074/jbc.M611132200; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Ellwanger K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-47; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Ethridge RT, 2002, GASTROENTEROLOGY, V123, P1311, DOI 10.1053/gast.2002.35951; Gautam D, 2005, J PHARMACOL EXP THER, V313, P995, DOI 10.1124/jpet.105.084855; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guha S, 2002, CANCER RES, V62, P1632; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Jackson LN, 2006, BIOCHEM BIOPH RES CO, V348, P945, DOI 10.1016/j.bbrc.2006.07.142; Jaggi M, 2005, CANCER RES, V65, P483; Ji B, 2001, GASTROENTEROLOGY, V121, P1380, DOI 10.1053/gast.2001.29557; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Li CW, 2004, AM J PHYSIOL-GASTR L, V287, pG764, DOI 10.1152/ajpgi.00111.2004; Li J, 2004, J BIOL CHEM, V279, P28466, DOI 10.1074/jbc.M314307200; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Lu GW, 2007, CELL SIGNAL, V19, P867, DOI 10.1016/j.cellsig.2006.10.012; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Maier D, 2006, GENE EXPR PATTERNS, V6, P849, DOI 10.1016/j.modgep.2006.03.007; Marklund U, 2003, IMMUNITY, V19, P491, DOI 10.1016/S1074-7613(03)00260-7; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; McKay C, 1996, ENDOCRINOLOGY, V137, P2473, DOI 10.1210/en.137.6.2473; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Olszewska-Pazdrak B, 2004, J BIOL CHEM, V279, P40400, DOI 10.1074/jbc.C400208200; Oster H, 2006, GENE EXPR PATTERNS, V6, P400, DOI 10.1016/j.modgep.2005.09.006; Papazyan R, 2006, BIOCHEM BIOPH RES CO, V342, P685, DOI 10.1016/j.bbrc.2006.02.013; Pickett JA, 2005, J BIOL CHEM, V280, P1506, DOI 10.1074/jbc.M411967200; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rey O, 2006, J BIOL CHEM, V281, P5149, DOI 10.1074/jbc.M508014200; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sabbatini MAE, 2007, AM J PHYSIOL-GASTR L, V293, pG987, DOI 10.1152/ajpgi.00268.2007; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; SCHEELE GA, 1978, J CELL BIOL, V78, P110, DOI 10.1083/jcb.78.1.110; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Song SY, 1999, GASTROENTEROLOGY, V117, P1416, DOI 10.1016/S0016-5085(99)70292-1; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Tapia JA, 2003, J BIOL CHEM, V278, P35220, DOI 10.1074/jbc.M303119200; Thomas RP, 2003, ENDOCR REV, V24, P571, DOI 10.1210/er.2002-0028; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TSIEN RY, 1990, CELL CALCIUM, V11, P93, DOI 10.1016/0143-4160(90)90063-Z; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Wang BJ, 2007, AM J PHYSIOL-REG I, V292, pR666, DOI 10.1152/ajpregu.00131.2006; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; WANK SA, 1995, AM J PHYSIOL-GASTR L, V269, pG628, DOI 10.1152/ajpgi.1995.269.5.G628; Watanabe H, 2005, GASTROENTEROLOGY, V128, P1391, DOI 10.1053/j.gastro.2005.03.016; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; WERNER MH, 1992, MOL PHARMACOL, V41, P382; Williams JA, 2001, ANNU REV PHYSIOL, V63, P77, DOI 10.1146/annurev.physiol.63.1.77; Williams JA, 2006, CURR OPIN GASTROEN, V22, P498, DOI 10.1097/01.mog.0000239863.96833.c0; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Yuan JZ, 2006, CELL SIGNAL, V18, P1051, DOI 10.1016/j.cellsig.2005.08.017; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	73	26	26	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2459	2471		10.1074/jbc.M801697200	http://dx.doi.org/10.1074/jbc.M801697200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19028687	Green Published, hybrid			2022-12-27	WOS:000262545600053
J	Young, JE; Martinez, RA; La Spada, AR				Young, Jessica E.; Martinez, Refugio A.; La Spada, Albert R.			Nutrient Deprivation Induces Neuronal Autophagy and Implicates Reduced Insulin Signaling in Neuroprotective Autophagy Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BULBAR MUSCULAR-ATROPHY; EXPANDED ANDROGEN RECEPTOR; TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; PROTEIN-DEGRADATION; HUNTINGTONS-DISEASE; DEPENDENT MANNER; CELLS	Although autophagy maintains normal neural function by degrading misfolded proteins, little is known about how neurons activate this integral response. Furthermore, classical methods of autophagy induction used with nonneural cells, such as starvation, simply result in neuron death. To study neuronal autophagy, we cultured primary cortical neurons from transgenic mice that ubiquitously express green fluorescent protein-tagged LC3 and monitored LC3-I to LC3-II conversion by immunohistochemistry and immunoblotting. Evaluation of different culture media led us to discover that culturing primary neurons in Dulbecco's modified Eagle's medium without B27 supplementation robustly activates autophagy. We validated this nutrient-limited media approach for inducing autophagy by showing that 3-methyl-adenine treatment and Atg5 RNA interference knockdown each inhibits LC3-I to LC3-II conversion. Evaluation of B27 supplement components yielded insulin as the factor whose absence induced autophagy in primary neurons, and this activation was mammalian target of rapamycin-dependent. When we tested if nutrient-limited media could protect neurons expressing polyglutamine-expanded proteins against cell death, we observed a strong protective effect, probably due to autophagy activation. Our results indicate that nutrient deprivation can be used to understand the regulatory basis of neuronal autophagy and implicate diminished insulin signaling in the activation of neuronal autophagy.	[Young, Jessica E.; Martinez, Refugio A.; La Spada, Albert R.] Univ Washington, Dept Lab Med, Med Ctr, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Washington, Dept Med Med Genet, Med Ctr, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Washington, Dept Neurol, Med Ctr, Seattle, WA 98195 USA; [La Spada, Albert R.] Univ Washington, Ctr Neurogenet & Neurotherapeut, Med Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	La Spada, AR (corresponding author), Univ Washington, Dept Lab Med, Med Ctr, Box 357110,Rm NW 120, Seattle, WA 98195 USA.	laspada@u.washington.edu	La Spada, Albert/AAG-8809-2020		National Institutes of Health [NS41648, EY14997, T32-AG00057]; Muscular Dystrophy Association; NATIONAL EYE INSTITUTE [R01EY014997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS41648 (to A. R. L.), EY14997 (to A. R. L.), and T32-AG00057 (to J. E. Y.). This work was also supported by a grant from the Muscular Dystrophy Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Darrington RS, 2002, NEUROREPORT, V13, P2117, DOI 10.1097/00001756-200211150-00025; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kobayashi Y, 1998, BIOCHEM BIOPH RES CO, V252, P145, DOI 10.1006/bbrc.1998.9624; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; LA SA, 1991, NATURE, V352, P77; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ryu BR, 1999, J NEUROBIOL, V39, P536, DOI 10.1002/(SICI)1097-4695(19990615)39:4<536::AID-NEU7>3.0.CO;2-J; Sale EM, 2008, CELL MOL LIFE SCI, V65, P113, DOI 10.1007/s00018-007-7274-9; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; van der Heide LP, 2003, J NEUROCHEM, V86, P86, DOI 10.1046/j.1471-4159.2003.01828.x; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065	50	99	99	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2363	2373		10.1074/jbc.M806088200	http://dx.doi.org/10.1074/jbc.M806088200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017649	hybrid, Green Published			2022-12-27	WOS:000262545600045
J	Cavanaugh, NA; Kuchta, RD				Cavanaugh, Nisha A.; Kuchta, Robert D.			Initiation of New DNA Strands by the Herpes Simplex Virus-1 Primase-Helicase Complex and Either Herpes DNA Polymerase or Human DNA Polymerase alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; PRIMER SYNTHESIS; UL8 SUBUNIT; REPLICATION PROTEINS; HYBRID DUPLEXES; INFECTED CELLS; GENE-PRODUCTS; UL42; TEMPLATE; UL52	A key set of reactions for the initiation of new DNA strands during herpes simplex virus-1 replication consists of the primase-catalyzed synthesis of short RNA primers followed by polymerase-catalyzed DNA synthesis (i.e. primase-coupled polymerase activity). Herpes primase (UL5-UL52-UL8) synthesizes products from 2 to similar to 13 nucleotides long. However, the herpes polymerase (UL30 or UL30-UL42) only elongates those at least 8 nucleotides long. Surprisingly, coupled activity was remarkably inefficient, even considering only those primers at least 8 nucleotides long, and herpes polymerase typically elongated <2% of the primase-synthesized primers. Of those primers elongated, only 4-26% of the primers were passed directly from the primase to the polymerase (UL30-UL42) without dissociating into solution. Comparing RNA primer-templates and DNA primer-templates of identical sequence showed that herpes polymerase greatly preferred to elongate the DNA primer by 650-26,000-fold, thus accounting for the extremely low efficiency with which herpes polymerase elongated primase-synthesized primers. Curiously, one of the DNA polymerases of the host cell, polymerase alpha (p70-p180 or p49-p58-p70-p180 complex), extended herpes primase-synthesized RNA primers much more efficiently than the viral polymerase, raising the possibility that the viral polymerase may not be the only one involved in herpes DNA replication.	[Cavanaugh, Nisha A.; Kuchta, Robert D.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Kuchta, RD (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 215, Boulder, CO 80309 USA.	kuchta@colorado.edu			National Institutes of Health [AI59764, GM073832]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073832, T32GM008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI59764 and GM073832. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arana ME, 2004, DNA REPAIR, V3, P659, DOI 10.1016/j.dnarep.2004.02.006; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Biswas N, 1999, J BIOL CHEM, V274, P8068, DOI 10.1074/jbc.274.12.8068; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; CALDER JM, 1990, NUCLEIC ACIDS RES, V18, P3573, DOI 10.1093/nar/18.12.3573; CARMICHAEL EP, 1989, J VIROL, V63, P591, DOI 10.1128/JVI.63.2.591-599.1989; Chaudhuri M, 2003, J BIOL CHEM, V278, P8996, DOI 10.1074/jbc.M210023200; Chen Y, 2005, J VIROL, V79, P9088, DOI 10.1128/JVI.79.14.9088-9096.2005; CHOW CS, 1995, J VIROL, V69, P6965, DOI 10.1128/JVI.69.11.6965-6971.1995; Coll JM, 1997, ONCOL RES, V9, P629; CRUTE JJ, 1991, J BIOL CHEM, V266, P4484; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; DODSON MS, 1989, J BIOL CHEM, V264, P20835; DODSON MS, 1991, P NATL ACAD SCI USA, V88, P1105, DOI 10.1073/pnas.88.4.1105; Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766; GALLO ML, 1988, J VIROL, V62, P2874, DOI 10.1128/JVI.62.8.2874-2883.1988; GALLO ML, 1989, J VIROL, V63, P5023, DOI 10.1128/JVI.63.12.5023-5029.1989; GOTTLIEB J, 1994, J VIROL, V68, P4937, DOI 10.1128/JVI.68.8.4937-4945.1994; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; GravesWoodward KL, 1997, J BIOL CHEM, V272, P4623, DOI 10.1074/jbc.272.7.4623; HALL JD, 1989, NUCLEIC ACIDS RES, V17, P9231, DOI 10.1093/nar/17.22.9231; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; HU SZ, 1984, J BIOL CHEM, V259, P2602; Jiang HY, 2002, J CELL BIOCHEM, V85, P762, DOI 10.1002/jcb.10182; KAGUNI LS, 1983, P NATL ACAD SCI-BIOL, V80, P2221, DOI 10.1073/pnas.80.8.2221; Keller KE, 2008, BIOCHEMISTRY-US, V47, P8977, DOI 10.1021/bi8008467; Kim DK, 1996, J BIOL CHEM, V271, P15124, DOI 10.1074/jbc.271.25.15124; Kincaid K, 2005, NUCLEIC ACIDS RES, V33, P2620, DOI 10.1093/nar/gki563; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; KUNKEL TA, 1985, J BIOL CHEM, V260, P2866; Kusakabe T, 1998, EMBO J, V17, P1542, DOI 10.1093/emboj/17.5.1542; LEE SSK, 1995, P NATL ACAD SCI USA, V92, P7882, DOI 10.1073/pnas.92.17.7882; LeGac NT, 1996, J BIOL CHEM, V271, P21645; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; LESNIK EA, 1995, BIOCHEMISTRY-US, V34, P10807, DOI 10.1021/bi00034a013; Marsden HS, 1996, J GEN VIROL, V77, P2241, DOI 10.1099/0022-1317-77-9-2241; Marsden HS, 1997, J VIROL, V71, P6390, DOI 10.1128/JVI.71.9.6390-6397.1997; Nimonkar AV, 2003, P NATL ACAD SCI USA, V100, P10201, DOI 10.1073/pnas.1534569100; Okorokov AL, 1997, PROTEIN ENG, V10, P273, DOI 10.1093/protein/10.3.273; PODUST VN, 1993, NUCLEIC ACIDS RES, V21, P841, DOI 10.1093/nar/21.4.841; Ramirez-Aguilar KA, 2004, BIOCHEMISTRY-US, V43, P1754, DOI 10.1021/bi035519x; Ramirez-Aguilar KA, 2002, BIOCHEMISTRY-US, V41, P14569, DOI 10.1021/bi026680v; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHEAFF RJ, 1994, BIOCHEMISTRY-US, V33, P2247, DOI 10.1021/bi00174a035; SHERMAN G, 1992, J VIROL, V66, P4884, DOI 10.1128/JVI.66.8.4884-4892.1992; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; TENNEY DJ, 1994, J BIOL CHEM, V269, P5030; TENNEY DJ, 1993, J VIROL, V67, P1959, DOI 10.1128/JVI.67.4.1959-1966.1993; THOMPSON HC, 1995, NUCLEIC ACIDS RES, V23, P4109, DOI 10.1093/nar/23.20.4109; TSURUMI T, 1987, J VIROL, V61, P388, DOI 10.1128/JVI.61.2.388-394.1987; VISHWANATHA JK, 1986, NUCLEIC ACIDS RES, V14, P7305, DOI 10.1093/nar/14.18.7305; Weisshart K, 1999, J VIROL, V73, P55, DOI 10.1128/JVI.73.1.55-66.1999; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; YODA KY, 1988, NUCLEIC ACIDS RES, V16, P6531, DOI 10.1093/nar/16.14.6531	54	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1523	1532		10.1074/jbc.M805476200	http://dx.doi.org/10.1074/jbc.M805476200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028696	Green Published, hybrid			2022-12-27	WOS:000262330100020
J	Alves, CS; Yakovlev, S; Medved, L; Konstantopoulos, K				Alves, Christina S.; Yakovlev, Sergiy; Medved, Leonid; Konstantopoulos, Konstantinos			Biomolecular Characterization of CD44-Fibrin(ogen) Binding DISTINCT MOLECULAR REQUIREMENTS MEDIATE BINDING OF STANDARD AND VARIANT ISOFORMS OF CD44 TO IMMOBILIZED FIBRIN(OGEN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CARCINOMA CELLS; SELECTIN LIGAND; FLAVOBACTERIUM-HEPARINUM; STRUCTURAL ORGANIZATION; COLORECTAL-CANCER; HEPARAN-SULFATE; TUMOR-GROWTH; FIBRINOGEN; ADHESION; EXPRESSION	CD44 and fibrin(ogen) play critical roles in the hematogenous dissemination of tumor cells, including colon carcinomas. We recently reported that CD44 is the primary fibrin, but not fibrinogen, receptor on LS174T colon carcinomas. However, the biochemical nature of this interaction and the roles of CD44 standard (CD44s) versus CD44 variant (CD44v) isoforms in fibrin( ogen) recognition have yet to be delineated. Microspheres, coated with CD44 immunopurified from LS174T or T84 colon carcinoma cells, which express primarily CD44v, effectively bind to immobilized fibrin, but not fibrinogen, in shear flow. In contrast, CD44s from HL-60 cells binds to both immobilized fibrin and fibrinogen under flow. Use of highly specific enzymes and metabolic inhibitors reveals that LS174T CD44 binding to fibrin is dependent on O-glycosylation of CD44, whereas CD44s-fibrin(ogen) interaction has an absolute requirement for N-, but not O-, linked glycans. The presence of chondroitin and dermatan sulfate on CD44 standard and variant isoforms facilitates fibrin recognition. Use of the anti-CD44 function-blocking monoclonal antibody Hermes-1 nearly abolishes binding of LS174T CD44 to fibrin, although it has no effect on CD44s-fibrin(ogen) interaction. The CD44-binding site is localized within the N-terminal portion of the fibrin beta chains, including amino acid residues (beta 15-66). Surface plasmon resonance experiments revealed high affinity binding of immobilized CD44 with solubilized fibrin but not fibrinogen. Collectively, these data suggest that immobilization of fibrinogen exposes a cryptic site that mediates binding to CD44s but not CD44v. Our findings may provide a rational basis for designing novel therapeutic strategies to combat metastasis.	[Alves, Christina S.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Yakovlev, Sergiy; Medved, Leonid] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Yakovlev, Sergiy; Medved, Leonid] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	kkonsta1@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011	Yakovlev, Sergiy/0000-0002-2078-5218; Medved, Leonid/0000-0002-3665-9849	National Institutes of Health [R01 CA101135, HL-56051]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA101135] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA101135 (NCI) (to K.K.) and by National Institute of Health Grant HL-56051 (to L.M.). This work was also supported by a predoctoral fellowship from the American Heart Association (to C.S.A.).	ALVES CS, 2008, AM J PHYSL, V294; Burdick MM, 2004, AM J PHYSIOL-CELL PH, V287, pC539, DOI 10.1152/ajpcell.00450.2003; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Gorlatov S, 2002, BIOCHEMISTRY-US, V41, P4107, DOI 10.1021/bi0160314; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; Harada N, 2001, INT J CANCER, V91, P67, DOI 10.1002/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D; Henke CA, 1996, J CLIN INVEST, V97, P2541, DOI 10.1172/JCI118702; Herbold KW, 1996, J INVEST DERMATOL, V106, P1230, DOI 10.1111/1523-1747.ep12348871; HOFMANN M, 1991, CANCER RES, V51, P5292; ISHII S, 1993, SURG ONCOL, V2, P255, DOI 10.1016/0960-7404(93)90015-Q; Iversen LH, 2003, THROMB HAEMOSTASIS, V89, P726; Jadhav S, 2002, AM J PHYSIOL-CELL PH, V283, pC1133, DOI 10.1152/ajpcell.00104.2002; KIM H, 1994, ARCH BIOCHEM BIOPHYS, V310, P504, DOI 10.1006/abbi.1994.1199; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; LUZZATTO G, 1990, SEMIN ONCOL, V17, P147; Madrazo J, 2001, P NATL ACAD SCI USA, V98, P11967, DOI 10.1073/pnas.211439798; MANNORI G, 1995, CANCER RES, V55, P4425; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Matsuka YV, 1996, BIOCHEMISTRY-US, V35, P5810, DOI 10.1021/bi952294k; McCarty OJT, 2000, BLOOD, V96, P1789, DOI 10.1182/blood.V96.5.1789.h8001789_1789_1797; MEDVED LV, 1983, FEBS LETT, V160, P291, DOI 10.1016/0014-5793(83)80985-5; MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121; NADER HB, 1990, J BIOL CHEM, V265, P16807; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Palumbo JS, 2002, CANCER RES, V62, P6966; Plaas AHK, 2001, GLYCOBIOLOGY, V11, P779, DOI 10.1093/glycob/11.10.779; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; PRIVALOV PL, 1982, J MOL BIOL, V159, P665, DOI 10.1016/0022-2836(82)90107-3; Ruffell B, 2005, BIOCHEM BIOPH RES CO, V334, P306, DOI 10.1016/j.bbrc.2005.06.108; Schuck P, 1996, TRENDS BIOCHEM SCI, V21, P458, DOI 10.1016/S0968-0004(96)20025-8; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Thomas SN, 2008, J BIOL CHEM, V283, P15647, DOI 10.1074/jbc.M800543200; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Tsurupa G, 2002, BIOCHEMISTRY-US, V41, P6449, DOI 10.1021/bi025584r; Tsurupa G, 2006, BIOCHEMISTRY-US, V45, P10624, DOI 10.1021/bi060526h; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; WIELENGA VJM, 1993, CANCER RES, V53, P4754; WOJTUKIEWICZ MZ, 1992, BLOOD COAGUL FIBRIN, V3, P429, DOI 10.1097/00001721-199203040-00010; Yakovlev S, 2003, BIOCHEMISTRY-US, V42, P7709, DOI 10.1021/bi0344073; Yakovlev S, 2000, BIOCHEMISTRY-US, V39, P15730, DOI 10.1021/bi001847a	51	42	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1177	1189		10.1074/jbc.M805144200	http://dx.doi.org/10.1074/jbc.M805144200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004834	Green Published, hybrid			2022-12-27	WOS:000262122900054
J	Shechter, D; Nicklay, JJ; Chitta, RK; Shabanowitz, J; Hunt, DF; Allis, CD				Shechter, David; Nicklay, Joshua J.; Chitta, Raghu K.; Shabanowitz, Jeffrey; Hunt, Donald F.; Allis, C. David			Analysis of Histones in Xenopus laevis I. A DISTINCT INDEX OF ENRICHED VARIANTS AND MODIFICATIONS EXISTS IN EACH CELL TYPE AND IS REMODELED DURING DEVELOPMENTAL TRANSITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME ASSEMBLY INVITRO; ARGININE METHYLATION; CHROMATIN-STRUCTURE; OOCYTE MATURATION; BINDING MODULES; DNA-REPLICATION; EGG EXTRACTS; TRANSCRIPTION; ACETYLATION; PHOSPHORYLATION	Histone proteins contain epigenetic information that is encoded both in the relative abundance of core histones and variants and particularly in the post-translational modification of these proteins. We determined the presence of such variants and covalent modifications in seven tissue types of the anuran Xenopus laevis, including oocyte, egg, sperm, early embryo equivalent (pronuclei incubated in egg extract), S3 neurula cells, A6 kidney cells, and erythrocytes. We first developed a new robust method for isolating the stored, predeposition histones from oocytes and eggs via chromatography on heparin-Sepharose, whereas we isolated chromatinized histones via conventional acid extraction. We identified two previously unknown H1 isoforms (H1fx and H1B.Sp) present on sperm chromatin. We immunoblotted this global collection of histones with many specific post-translational modification antibodies, including antibodies against methylated histone H3 on Lys(4), Lys(9), Lys(27), Lys(79), Arg(2), Arg(17), and Arg(26); methylated histone H4 on Lys(20); methylated H2A and H4 on Arg(3); acetylated H4 on Lys(5), Lys(8), Lys(12), and Lys(16) and H3 on Lys(9) and Lys(14); and phosphorylated H3 on Ser(10) and H2A/H4 on Ser(1). Furthermore, we subjected a subset of these histones to two-dimensional gel analysis and subsequent immunoblotting and mass spectrometry to determine the global remodeling of histone modifications that occurs as development proceeds. Overall, our observations suggest that each metazoan cell type may have a unique histone modification signature correlated with its differentiation status.	[Shechter, David; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA; [Nicklay, Joshua J.; Chitta, Raghu K.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22901 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22901 USA	Rockefeller University; University of Virginia; University of Virginia	Allis, CD (corresponding author), Box 78,1230 York Ave, New York, NY 10065 USA.	alliscd@rockefeller.edu	Chitta, Raghu/T-8938-2019; Shechter, David/B-4660-2008; Hunt, Donald F/I-6936-2012	Shechter, David/0000-0001-9388-6004; Hunt, Donald F/0000-0003-2815-6368	National Institutes of Health National Research Service Award/Kirschstein Fellowship [GM075486, GM37537, GM53512]; Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053512, R01GM037537, F32GM075486, R01GM053512] Funding Source: NIH RePORTER	National Institutes of Health National Research Service Award/Kirschstein Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health National Research Service Award/Kirschstein Fellowship GM075486 (to D. S.), Grant GM37537 (to D. F. H.), and Grant GM53512 (to C. D. A.). This work was also supported by Rockefeller University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAMSON ED, 1974, J MOL BIOL, V88, P263, DOI 10.1016/0022-2836(74)90481-1; ADAMSON ED, 1977, DEV BIOL, V57, P136, DOI 10.1016/0012-1606(77)90360-8; ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; ALMOUZNI G, 1990, EMBO J, V9, P573, DOI 10.1002/j.1460-2075.1990.tb08145.x; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, BIOCHEM CELL BIOL, V84, P505, DOI 10.1139/O06-085; Czermin B, 2003, GENETICA, V117, P159, DOI 10.1023/A:1022927725945; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; Dimitrov S, 1996, EMBO J, V15, P5897, DOI 10.1002/j.1460-2075.1996.tb00976.x; Frehlick LJ, 2007, BIOCHEMISTRY-US, V46, P12700, DOI 10.1021/bi701274s; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Garcia BA, 2007, CURR OPIN CHEM BIOL, V11, P66, DOI 10.1016/j.cbpa.2006.11.022; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Happel N, 2005, BIOL CHEM, V386, P541, DOI 10.1515/BC.2005.064; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; HUMPHRIES SE, 1979, BIOCHEMISTRY-US, V18, P3223, DOI 10.1021/bi00582a006; KLEINSCHMIDT JA, 1990, EMBO J, V9, P1309, DOI 10.1002/j.1460-2075.1990.tb08240.x; LASKEY RA, 1977, CELL, V10, P237, DOI 10.1016/0092-8674(77)90217-3; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; LIN R, 1989, J CELL BIOL, V108, P1577, DOI 10.1083/jcb.108.5.1577; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Maller JL, 2001, NOVART FDN SYMP, V237, P58, DOI 10.1002/0470846666.ch6; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; RUDERMAN JV, 1979, DEV BIOL, V71, P71, DOI 10.1016/0012-1606(79)90083-6; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; SCHMIEDEKE TMJ, 1989, J EXP MED, V169, P1879, DOI 10.1084/jem.169.6.1879; Schmitt A, 2002, FEBS LETT, V518, P23, DOI 10.1016/S0014-5793(02)02630-3; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; WOODLAND HR, 1980, FEBS LETT, V121, P1, DOI 10.1016/0014-5793(80)81252-X; WOODLAND HR, 1979, DEV BIOL, V68, P360, DOI 10.1016/0012-1606(79)90210-0; WOODLAND HR, 1977, DEV BIOL, V57, P118, DOI 10.1016/0012-1606(77)90359-1; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; ZUCKER K, 1990, J BIOL CHEM, V265, P14487	45	56	57	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1064	1074		10.1074/jbc.M807273200	http://dx.doi.org/10.1074/jbc.M807273200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18957438	hybrid, Green Published			2022-12-27	WOS:000262122900043
J	Terrand, J; Bruban, V; Zhou, L; Gong, WF; El Asmar, Z; May, P; Zurhove, K; Haffner, P; Philippe, C; Woldt, E; Matz, RL; Gracia, C; Metzger, D; Auwerx, J; Herz, J; Boucher, P				Terrand, Jerome; Bruban, Veronique; Zhou, Li; Gong, Wanfeng; El Asmar, Zeina; May, Petra; Zurhove, Kai; Haffner, Philipp; Philippe, Claude; Woldt, Estelle; Matz, Rachel L.; Gracia, Celine; Metzger, Daniel; Auwerx, Johan; Herz, Joachim; Boucher, Philippe			LRP1 Controls Intracellular Cholesterol Storage and Fatty Acid Synthesis through Modulation of Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; GLYCOGEN-SYNTHASE KINASE; ACTIVATED RECEPTOR-GAMMA; INSULIN-RESISTANCE; CRE RECOMBINASE; PROTEIN-KINASE; VASCULAR WALL; PPAR-GAMMA; TISSUE; MICE	The low-density lipoprotein receptor-related protein LRP1 is a cell surface receptor with functions in diverse physiological pathways, including lipid metabolism. Here we show that LRP1-deficient fibroblasts accumulate high levels of intracellular cholesterol and cholesteryl-ester when stimulated for adipocyte differentiation. We demonstrate that LRP1 stimulates a canonical Wnt5a signaling pathway that prevents cholesterol accumulation. Moreover, we show that LRP1 is required for lipolysis and stimulates fatty acid synthesis independently of the noradrenergic pathway, through inhibition of GSK3 beta and its previously unknown target acetyl-CoA carboxylase (ACC). As a result of ACC inhibition, mature LRP1-deficient adipocytes of adult mice are hypotrophic, and lower uptake of fatty acids into adipose tissue leads to their redistribution to the liver. These results establish LRP1 as a novel integrator of adipogenic differentiation and fat storage signals.	[Terrand, Jerome; Bruban, Veronique; Gong, Wanfeng; El Asmar, Zeina; Philippe, Claude; Woldt, Estelle; Matz, Rachel L.; Gracia, Celine; Herz, Joachim; Boucher, Philippe] Univ Strasbourg 1, CNRS, UMR7175, F-67401 Illkirch Graffenstaden, France; [May, Petra; Zurhove, Kai; Haffner, Philipp] Univ Freiburg, Zentrum Neurowissensch, D-79104 Freiburg, Germany; [Metzger, Daniel] IGBMC, Dept Funct Genom, F-67400 Illkirch Graffenstaden, France; [Auwerx, Johan] Univ Strasbourg, Inst Clin Souris, F-67000 Strasbourg, France; [Zhou, Li; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Strasbourg 1, CNRS, UMR7175, 74 Route Rhin, F-67401 Illkirch Graffenstaden, France.	joachim.herz@utsouthwestern.edu; philippe.boucher@pharma.u-strasbg.fr	Auwerx, Johan/ABE-9307-2021; Asmar, Zeina El/AAR-7053-2021	Boucher, Philippe/0000-0002-3928-9812; Terrand, jerome/0000-0002-8169-7713; MATZ, Rachel/0000-0001-5832-7063; Auwerx, Johan/0000-0002-5065-5393; Metzger, Daniel/0000-0002-5555-046X; Gracia, Celine/0000-0002-3312-6465	National Institutes of Health [HL20948, HL63762, NS43408, DK067320]; center national pour la recherche scientifique (CNRS); Fondation pour la Recherche Medicale (FRM); Fondation de France; Universite Louis Pasteur de Strasbourg; agence nationale de la recherche [ANR-05-PCOD-020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762, R01HL063762, P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); center national pour la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); Universite Louis Pasteur de Strasbourg; agence nationale de la recherche(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grants HL20948, HL63762, NS43408, and DK067320 from the National Institutes of Health. This work was also supported by grants from the center national pour la recherche scientifique (CNRS), Fondation pour la Recherche Medicale (FRM), Fondation de France, Universite Louis Pasteur de Strasbourg, agence nationale de la recherche (ANR-05-PCOD-020). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Herz J, 2004, CURR OPIN LIPIDOL, V15, P175, DOI 10.1097/00041433-200404000-00010; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	30	85	93	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					381	388		10.1074/jbc.M806538200	http://dx.doi.org/10.1074/jbc.M806538200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990694	Green Published, hybrid			2022-12-27	WOS:000261974800043
J	Passero, CJ; Mueller, GM; Rondon-Berrios, H; Tofovic, SP; Hughey, RP; Kleyman, TR				Passero, Christopher J.; Mueller, Gunhild M.; Rondon-Berrios, Helbert; Tofovic, Stevan P.; Hughey, Rebecca P.; Kleyman, Thomas R.			Plasmin Activates Epithelial Na+ Channels by Cleaving the gamma Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELASTASE ACTIVATION; NEPHROTIC SYNDROME; SODIUM-CHANNELS; ALPHA-SUBUNIT; EXPRESSION; PEPTIDE; FURIN; MESSENGER; CLEAVAGE	Proteolytic processing of epithelial sodium channel ( ENaC) subunits occurs as channels mature within the biosynthetic pathway. The proteolytic processing events of the alpha and gamma subunits are associated with channel activation. Furin cleaves the alpha subunit ectodomain at two sites, releasing an inhibitory tract and activating the channel. However, furin cleaves the gamma subunit ectodomain only once. A second distal cleavage in the gamma subunit induced by other proteases, such as prostasin and elastase, is required to release a second inhibitory tract and further activate the channel. We found that the serine protease plasmin activates ENaC in association with inducing cleavage of the gamma subunit at gamma Lys(194), a site distal to the furin site. A gamma K194A mutant prevented both plasmin-dependent activation of ENaC and plasmin-dependent production of a unique 70-kDa carboxyl-terminal gamma subunit cleavage fragment. Plasmin-dependent cleavage and activation of ENaC may have a role in extracellular volume expansion in human disorders associated with proteinuria, as filtered plasminogen may be processed by urokinase, released from renal tubular epithelium, to generate active plasmin.	[Passero, Christopher J.; Mueller, Gunhild M.; Rondon-Berrios, Helbert; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Tofovic, Stevan P.] Univ Pittsburgh, Sch Med, Ctr Clin Pharmacol, Dept Med, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hughey, RP (corresponding author), Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Dept Med, S-933 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hugheyr@pitt.edu	Rondon-Berrios, Helbert/H-3573-2019	Rondon-Berrios, Helbert/0000-0002-7109-146X	National Institutes of Health [R01/R56 DK065161, P30 DK079307, F32 DK080574]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065161, F32DK080574, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or part, by National Institutes of Health Grants R01/R56 DK065161 and P30 DK079307. This work was also supported by postdoctoral fellowship awards from the American Heart Association and the National Institutes of Health (F32 DK080574) (to C.J.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Gosalia DN, 2005, PROTEOMICS, V5, P1292, DOI 10.1002/pmic.200401011; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Kim H, 2007, J COMPUT-MEDIAT COMM, V12, P1183, DOI 10.1111/j.1083-6101.2007.00369.x; Kim SW, 2006, AM J PHYSIOL-RENAL, V290, pF674, DOI 10.1152/ajprenal.00084.2005; Kleyman TR, 2006, KIDNEY INT, V70, P1391, DOI 10.1038/sj.ki.5001860; KRISTENSEN P, 1991, J HISTOCHEM CYTOCHEM, V39, P341, DOI 10.1177/39.3.1899685; LAU SO, 1980, J PEDIATR-US, V96, P390, DOI 10.1016/S0022-3476(80)80678-0; Picard N, 2008, J BIOL CHEM, V283, P4602, DOI 10.1074/jbc.M705664200; Piedagnel R, 2006, J CELL PHYSIOL, V206, P394, DOI 10.1002/jcp.20485; Rafikova O, 2008, METABOLISM, V57, P1434, DOI 10.1016/j.metabol.2008.05.014; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng S., 2008, KIDNEY PHYSL PATHOPH, P743; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; SVENNINGSEN P, 2009, J AM SOC NE IN PRESS; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; TROLL W, 1954, J BIOL CHEM, V208, P85; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; VAZIRI ND, 1994, J LAB CLIN MED, V124, P118; Wagner SN, 1996, HISTOCHEM CELL BIOL, V105, P53, DOI 10.1007/BF01450878	30	142	147	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36586	36591		10.1074/jbc.M805676200	http://dx.doi.org/10.1074/jbc.M805676200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981180	Green Published, hybrid			2022-12-27	WOS:000261840500056
J	Ruvolo, VR; Kurinna, SM; Karanjeet, KB; Schuster, TF; Martelli, AM; McCubrey, JA; Ruvolo, PP				Ruvolo, Vivian R.; Kurinna, Svitlana M.; Karanjeet, Kul B.; Schuster, Todd F.; Martelli, Alberto M.; McCubrey, James A.; Ruvolo, Peter P.			PKR Regulates B56 alpha-mediated BCL2 Phosphatase Activity in Acute Lymphoblastic Leukemia-derived REH Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PKR; CHRONIC LYMPHOCYTIC-LEUKEMIA; GLYCOGEN-SYNTHASE KINASE-3; TUMOR-SUPPRESSOR; FUNCTIONAL-ROLE; BLAST CRISIS; 2A; PP2A; PHOSPHORYLATION; APOPTOSIS	Protein phosphatase 2A (PP2A) is a heterotrimer comprising catalytic, scaffold, and regulatory (B) subunits. There are at least 21 B subunit family members. Thus PP2A is actually a family of enzymes defined by which B subunit is used. The B56 family member B56 alpha is a phosphoprotein that regulates dephosphorylation of BCL2. The stress kinase PKR has been shown to phosphorylate B56 alpha at serine 28 in vitro, but it has been unclear how PKR might regulate the BCL2 phosphatase. In the present study, PKR regulation of B56 alpha in REH cells was examined, because these cells exhibit robust BCL2 phosphatase activity. PKR was found to be basally active in REH cells as would be predicted if the kinase supports B56 alpha-mediated dephosphorylation of BCL2. Suppression of PKR promoted BCL2 phosphorylation with concomitant loss of B56 alpha phosphorylation at serine 28 and inhibition of mitochondrial PP2A activity. PKR supports stress signaling in REH cells, as suppression of PKR promoted chemoresistance to etoposide. Suppression of PKR promoted B56 alpha proteolysis, which could be blocked by a proteasome inhibitor. However, the mechanism by which PKR supports B56 alpha protein does not involve PKR-mediated phosphorylation of the B subunit at serine 28 but may involve eIF2 alpha activation of AKT. Phosphorylation of serine 28 by PKR promotes mitochondrial localization of B56 alpha, because wild-type but not mutant S28A B56 alpha promoted mitochondrial PP2A activity. Cells expressing wildtype B56 alpha but not S28A B56 alpha were sensitized to etoposide. These results suggest that PKR regulates B56 alpha-mediated PP2A signaling in REH cells.	[Ruvolo, Vivian R.; Karanjeet, Kul B.; Schuster, Todd F.; Ruvolo, Peter P.] Univ Minnesota, Hormel Inst, Sect Signal Transduct & Apoptosis, Austin, MN 55912 USA; [Kurinna, Svitlana M.; Ruvolo, Peter P.] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Div Cell Signaling, Houston, TX 77030 USA; [Martelli, Alberto M.] Univ Bologna, Dept Human Anat Sci, I-40126 Bologna, Italy; [McCubrey, James A.] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA	University of Minnesota System; University of Texas System; University of Texas Health Science Center Houston; University of Bologna; University of North Carolina; East Carolina University	Ruvolo, PP (corresponding author), Univ Minnesota, Hormel Inst, Sect Signal Transduct & Apoptosis, 801 16th Ave NE, Austin, MN 55912 USA.	pruvolo@hi.umn.edu		McCubrey, James/0000-0001-6027-3156; Kurinna, Svitlana/0000-0002-2157-667X	National Institutes of Health [CA30715]; Hormel Foundation and the Office of the Dean of the Graduate School of the University of Minnesota; NATIONAL CANCER INSTITUTE [R01CA030715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation and the Office of the Dean of the Graduate School of the University of Minnesota; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA30715 ( to P. P. R.). This work was also supported by the Hormel Foundation and the Office of the Dean of the Graduate School of the University of Minnesota ( to P. P. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham N, 1998, EXP CELL RES, V244, P394, DOI 10.1006/excr.1998.4201; Basu S, 1997, CANCER RES, V57, P943; Beretta L, 1996, ONCOGENE, V12, P1593; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; FUJIKI H, 1993, ADV CANCER RES, V61, P143, DOI 10.1016/S0065-230X(08)60958-6; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Guo CY, 2002, J BIOL CHEM, V277, P4839, DOI 10.1074/jbc.M110092200; Hii SI, 2004, INT J CANCER, V109, P329, DOI 10.1002/ijc.11714; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Murad JM, 2005, BLOOD CELL MOL DIS, V34, P1, DOI 10.1016/j.bcmd.2004.08.025; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Perrotti D, 2006, BRIT J CANCER, V95, P775, DOI 10.1038/sj.bjc.6603317; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; RUEDIGER R, 1991, MOL CELL BIOL, V11, P4282, DOI 10.1128/MCB.11.8.4282; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Steelman LS, 2008, EXPERT OPIN THER TAR, V12, P1139, DOI [10.1517/14728222.12.9.1139, 10.1517/14728222.12.9.1139 ]; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000	43	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35474	35485		10.1074/jbc.M800951200	http://dx.doi.org/10.1074/jbc.M800951200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957415	hybrid, Green Published			2022-12-27	WOS:000261687900019
J	Zurbriggen, A; Jeckelmann, JM; Christen, S; Bieniossek, C; Baumann, U; Erni, B				Zurbriggen, Andreas; Jeckelmann, Jean-Marc; Christen, Sandra; Bieniossek, Christoph; Baumann, Ulrich; Erni, Bernhard			X-ray Structures of the Three Lactococcus lactis Dihydroxyacetone Kinase Subunits and of a Transient Intersubunit Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYL TRANSFER COMPLEX; NUCLEOTIDE-BINDING SUBUNIT; COVALENT SUBSTRATE-BINDING; ESCHERICHIA-COLI; PHOSPHOTRANSFERASE SYSTEM; CRYSTAL-STRUCTURE; CITROBACTER-FREUNDII; MANNOSE TRANSPORTER; ANGSTROM RESOLUTION; DOMAIN	Bacterial dihydroxyacetone (Dha) kinases do not exchange the ADP for ATP but utilize a subunit of the phosphoenolpyruvate carbohydrate phosphotransferase system for in situ rephosphorylation of a permanently bound ADP-cofactor. Here we report the 2.1-angstrom crystal structure of the transient complex between the phosphotransferase subunit DhaM of the phosphotransferase system and the nucleotide binding subunit DhaL of the Dha kinase of Lactococcus lactis, the 1.1-angstrom structure of the free DhaM dimer, and the 2.5-angstrom structure of the Dha-binding DhaK subunit. Conserved salt bridges and an edge-to-plane stacking contact between two tyrosines serve to orient DhaL relative to the DhaM dimer. The distance between the imidazole N epsilon 2 of the DhaM His-10 and the beta-phosphate oxygen of ADP, between which the gamma-phosphate is transferred, is 4.9 angstrom. An invariant arginine, which is essential for activity, is appropriately positioned to stabilize the gamma-phosphate in the transition state. The (beta alpha)(4)alpha fold of DhaM occurs a second time as a subfold, in the DhaK subunit. By docking DhaL-ADP to this subfold, the nucleotide bound to DhaL and the C1-hydroxyl of Dha bound to DhaK are positioned for in-line transfer of phosphate.	[Zurbriggen, Andreas; Jeckelmann, Jean-Marc; Christen, Sandra; Bieniossek, Christoph; Baumann, Ulrich; Erni, Bernhard] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Baumann, U (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	ulrich.baumann@ibc.unibe.ch; bernhard.erni@ibc.unibe.ch	Baumann, Ulrich/B-1220-2013	Jeckelmann, Jean-Marc/0000-0001-9973-2700	Swiss National Science Foundation [3100A0-105247]; Ciba-Geigy Jubilaumsstiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ciba-Geigy Jubilaumsstiftung	This work was supported by the Swiss National Science Foundation (Grant 3100A0-105247) and the Ciba-Geigy Jubilaumsstiftung. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bachler C, 2005, J BIOL CHEM, V280, P18321, DOI 10.1074/jbc.M500279200; Bachler C, 2005, EMBO J, V24, P283, DOI 10.1038/sj.emboj.7600517; Bressi JC, 2000, J MED CHEM, V43, P4135, DOI 10.1021/jm000287a; Cai ML, 2003, J BIOL CHEM, V278, P25191, DOI 10.1074/jbc.M302677200; Chelli R, 2002, J AM CHEM SOC, V124, P6133, DOI 10.1021/ja0121639; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; DANIEL R, 1995, J BACTERIOL, V177, P4392, DOI 10.1128/jb.177.15.4392-4401.1995; Deppenmeier U, 2002, APPL MICROBIOL BIOT, V60, P233, DOI 10.1007/s00253-002-1114-5; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Erni B, 2006, CELL MOL LIFE SCI, V63, P890, DOI 10.1007/s00018-005-5518-0; ERNI B, 1982, J BIOL CHEM, V257, P13726; Garcia-Alles LF, 2004, BIOCHEMISTRY-US, V43, P13037, DOI 10.1021/bi048575m; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Gutknecht R, 2001, EMBO J, V20, P2480, DOI 10.1093/emboj/20.10.2480; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kinch LN, 2005, PROTEIN SCI, V14, P360, DOI 10.1110/ps.041114805; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; Luers GH, 1998, YEAST, V14, P759; Nunn RS, 1996, J MOL BIOL, V259, P502, DOI 10.1006/jmbi.1996.0335; Oberholzer AE, 2006, J MOL BIOL, V359, P539, DOI 10.1016/j.jmb.2006.03.057; Orriss GL, 2003, J MOL BIOL, V327, P1111, DOI 10.1016/S0022-2836(03)00215-8; Peterkofsky A, 2001, J MOL MICROB BIOTECH, V3, P347; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Schauder S, 1998, J MOL BIOL, V276, P591, DOI 10.1006/jmbi.1997.1544; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; Siebold C, 2003, J BIOL CHEM, V278, P48236, DOI 10.1074/jbc.M305942200; Siebold C, 2003, P NATL ACAD SCI USA, V100, P8188, DOI 10.1073/pnas.0932787100; Wang GS, 2000, EMBO J, V19, P5635, DOI 10.1093/emboj/19.21.5635; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200	32	18	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35789	35796		10.1074/jbc.M804893200	http://dx.doi.org/10.1074/jbc.M804893200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957416	hybrid, Green Published			2022-12-27	WOS:000261687900053
J	Fox, KE; Colton, LA; Erickson, PF; Friedman, JE; Cha, HC; Keller, P; MacDougald, OA; Klemm, DJ				Fox, Keith E.; Colton, Lillester A.; Erickson, Paul F.; Friedman, Jacob E.; Cha, Hyuk C.; Keller, Pernille; MacDougald, Ormond A.; Klemm, Dwight J.			Regulation of Cyclin D1 and Wnt10b Gene Expression by cAMP-responsive Element-binding Protein during Early Adipogenesis Involves Differential Promoter Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; BETA-CATENIN; ADIPOCYTE DIFFERENTIATION; CREB; ACTIVATION; INHIBITION; INSULIN; RECEPTOR; ALPHA; CELLS	Cyclin D1 expression is elevated and Wnt10b is repressed by cAMP during the first few hours of adipogenesis. cAMP-responsive element-binding protein (CREB) is a primary target for cAMP signaling, and we have shown that activation of CREB promotes adipogenesis and adipocyte survival. Here we tested the impact of CREB on expression of cyclin D1 and wingless-related mouse mammary tumor virus integration site 10b (Wnt10b) in 3T3-L1 cells. Forced depletion of CREB blocked Bt2cAMP-stimulated cyclin D1 expression and basal Wnt10b gene expression. Two CREB-binding sites were identified in the Wnt10b promoter region. Ablation of either site partially blocked promoter activity, while mutation of both sites completely suppressed promoter activity. These results suggest that CREB activates transcription from both the cyclin D1 and Wnt10b gene promoters. What accounts for the differential regulation of cyclin D1 and Wnt10b genes by cAMP? Chromatin immunoprecipitation revealed CREB bound to the Wnt10b promoter in untreated preadipocytes but not following treatment with Bt(2)cAMP. CREB binding to the cyclin D1 promoter was detected in untreated cells and post-Bt(2)cAMP. Differences between CREB binding to the two genes correlated with increasing methylation of the Wnt10b promoter following Bt2cAMP treatment, whereas no methylation of the cyclin D1 promoter was observed. Treatment of cells with the methylase inhibitor 5-azacytidine restored CREB binding to the Wnt10b gene promoter and prevented the inhibition of Wnt10b RNA expression by Bt2cAMP. We conclude that cAMP stimulates phosphorylation and binding of CREB to the cyclin D1 gene promoter. Simultaneously, hypermethylation of the Wnt10b gene promoter suppresses binding of CREB, allowing adipogenesis to proceed.	[Fox, Keith E.; Colton, Lillester A.; Erickson, Paul F.; Friedman, Jacob E.; Klemm, Dwight J.] Univ Colorado Denver, Cardiovasc Pulm Res Lab, Aurora, CO 80045 USA; [Fox, Keith E.; Colton, Lillester A.; Erickson, Paul F.; Friedman, Jacob E.; Klemm, Dwight J.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Cha, Hyuk C.; Keller, Pernille; MacDougald, Ormond A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan	Klemm, DJ (corresponding author), Univ Colorado Denver, Cardiovasc Pulm Res Lab, Res 2,Mail Stop B-133,12700 E 19th Ave, Aurora, CO 80045 USA.	Dwight.Klemm@UCHSC.edu		MacDougald, Ormond/0000-0001-6907-7960	National Institutes of Health [DK053969, DK51563]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053969, R01DK051563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK053969 (to D.J.K.) and DK51563 (to O.A.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; ANTRAS J, 1989, BIOL CELL, V66, P247, DOI 10.1016/0248-4900(89)90177-9; Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bowers RR, 2006, P NATL ACAD SCI USA, V103, P13022, DOI 10.1073/pnas.0605789103; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Casimir DA, 1996, J BIOL CHEM, V271, P29847, DOI 10.1074/jbc.271.47.29847; Cha HC, 2008, J BIOL CHEM, V283, P18002, DOI 10.1074/jbc.M800419200; D'Amico M, 2000, J BIOL CHEM, V275, P32649, DOI 10.1074/jbc.M000643200; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; Fox KE, 2006, J BIOL CHEM, V281, P40341, DOI 10.1074/jbc.M605077200; Gustafson B, 2003, BIOCHEM BIOPH RES CO, V308, P933, DOI 10.1016/S0006-291X(03)01518-3; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hishida T, 2008, BIOCHEM BIOPH RES CO, V370, P289, DOI 10.1016/j.bbrc.2008.03.091; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Kim HS, 2001, OBES RES, V9, P572, DOI 10.1038/oby.2001.74; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Klemm DJ, 1998, J BIOL CHEM, V273, P917, DOI 10.1074/jbc.273.2.917; Kumar AP, 2007, CLIN CANCER RES, V13, P2784, DOI 10.1158/1078-0432.CCR-06-2974; LEE FS, 1995, P NATL ACAD SCI USA, V92, P2268, DOI 10.1073/pnas.92.6.2268; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; Musri MM, 2007, BIOCHEM CELL BIOL, V85, P397, DOI 10.1139/O07-068; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; POISSONNET CM, 1988, J PEDIATR-US, V113, P1, DOI 10.1016/S0022-3476(88)80520-1; POISSONNET CM, 1984, EARLY HUM DEV, V10, P1, DOI 10.1016/0378-3782(84)90106-3; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Reusch JEB, 2002, J BIOL CHEM, V277, P1426, DOI 10.1074/jbc.M107923200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; SAGER R, 1982, P NATL ACAD SCI-BIOL, V79, P480, DOI 10.1073/pnas.79.2.480; Sakamoto H, 2008, BIOCHEM BIOPH RES CO, V366, P360, DOI 10.1016/j.bbrc.2007.11.137; Sharma C, 2004, J BIOL CHEM, V279, P16927, DOI 10.1074/jbc.M309045200; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Stoger R, 2006, EPIGENETICS-US, V1, P155; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Yokomori N, 1999, DIABETES, V48, P685, DOI 10.2337/diabetes.48.4.685; Zeng G, 1997, ONCOL RES, V9, P205; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	47	38	42	4	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					35096	35105		10.1074/jbc.M806423200	http://dx.doi.org/10.1074/jbc.M806423200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18957421	Green Published, hybrid			2022-12-27	WOS:000261469100067
J	Harmey, D; Smith, A; Simanski, S; Moussa, CZ; Ayad, NG				Harmey, Dympna; Smith, Anthony; Simanski, Scott; Moussa, Carole Zaki; Ayad, Nagi G.			The Anaphase Promoting Complex Induces Substrate Degradation during Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE EXIT; S-PHASE ENTRY; UBIQUITIN LIGASE; POSTMITOTIC NEURONS; AXONAL GROWTH; MITOSIS; ACCUMULATION; PROTEOLYSIS; PROTEIN; SKP2	The anaphase promoting complex (APC) is an E3 ubiquitin ligase required for the metaphase-to-anaphase transition and mitotic exit. However, APC also plays roles in G(1), where it is regulated by Cdh1, and APC activity has also been detected in differentiated and non-proliferating cells, suggesting that it may play roles outside the cell cycle. Here, we report that disrupting APC(Cdh1) activity inhibits neurite outgrowth of both PC12 pheochromocytoma cells and primary cerebellar granule cells. APC(Cdh1) activity dramatically increases as PC12 cells differentiate in response to nerve growth factor. Furthermore, a key target degraded by APC(Cdh1) following nerve growth factor treatment is the F-box protein Skp2, and APC(Cdh1)-mediated destruction of Skp2 is essential for proper terminal differentiation of neuronal precursors.	[Harmey, Dympna; Smith, Anthony; Simanski, Scott; Moussa, Carole Zaki; Ayad, Nagi G.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	Scripps Research Institute	Ayad, NG (corresponding author), Scripps Res Inst, Dept Canc Biol, 5353 Parkside Dr, Jupiter, FL 33458 USA.	nayad@scripps.edu		Simanski, Scott/0000-0002-7594-5952	Landenberger Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067289] Funding Source: NIH RePORTER	Landenberger Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Landenberger Foundation.	Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Araki M, 2003, EMBO J, V22, P6115, DOI 10.1093/emboj/cdg573; Ayad NG, 2005, METHOD ENZYMOL, V399, P404, DOI 10.1016/S0076-6879(05)99028-9; Bai S, 2007, J BIOL CHEM, V282, P27171, DOI 10.1074/jbc.M700691200; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cuende J, 2008, ONCOGENE, V27, P3339, DOI 10.1038/sj.onc.1210987; Durand B, 1998, CURR BIOL, V8, P431, DOI 10.1016/S0960-9822(98)70177-0; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sorensen CS, 2000, MOL CELL BIOL, V20, P7613, DOI 10.1128/MCB.20.20.7613-7623.2000; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Vernon AE, 2003, DEVELOPMENT, V130, P85, DOI 10.1242/dev.00193; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wu G, 2007, MOL BIOL CELL, V18, P1018, DOI 10.1091/mbc.E06-09-0809	35	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2009	284	7					4317	4323		10.1074/jbc.M804944200	http://dx.doi.org/10.1074/jbc.M804944200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	404ET	19047054	hybrid			2022-12-27	WOS:000263134400030
J	Andersson, T; Sodersten, E; Duckworth, JK; Cascante, A; Fritz, N; Sacchetti, P; Cervenka, I; Bryja, V; Hermanson, O				Andersson, Therese; Soedersten, Erik; Duckworth, Joshua K.; Cascante, Anna; Fritz, Nicolas; Sacchetti, Paola; Cervenka, Igor; Bryja, Vitezslav; Hermanson, Ola			CXXC5 Is a Novel BMP4-regulated Modulator of Wnt Signaling in Neural Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-CORTEX; FATE CHOICE; DIFFERENTIATION; PATHWAY; BMP; IDENTIFICATION; NA,K-ATPASE; INHIBITION; EXPRESSION; RECEPTORS	Bone morphogenetic proteins such as BMP4 are essential for proper development of telencephalic forebrain structures and induce differentiation of telencephalic neural stem cells into a variety of cellular fates, including astrocytic, neuronal, and mesenchymal cells. Little is yet understood regarding the mechanisms that underlie the spatiotemporal differences in progenitor response to BMP4. In a screen designed to identify novel targets of BMP4 signaling in telencephalic neural stem cells, we found the mRNA levels of the previously uncharacterized factor CXXC5 reproducibly up-regulated upon BMP4 stimulation. In vivo, CXXC5 expression overlapped with BMP4 adjacent to Wnt3a expression in the dorsal regions of the telencephalon, including the developing choroid plexus. CXXC5 showed partial homology with Idax, a related protein previously shown to interact with the Wnt-signaling intermediate Dishevelled (Dvl). Indeed CXXC5 and Dvl co-localized in the cytoplasm and interacted in co-immunoprecipitation experiments. Moreover, fluorescence resonance energy transfer (FRET) experiments verified that CXXC5 and Dvl2 were located in close spatial proximity in neural stem cells. Studies of the functional role of CXXC5 revealed that overexpression of CXXC5 or exposure to BMP4 repressed the levels of the canonical Wnt signaling target Axin2, and CXXC5 attenuated Wnt3a-mediated increase in TOPflash reporter activity. Accordingly, RNA interference of CXXC5 attenuated the BMP4-mediated decrease in Axin2 levels and facilitated the response to Wnt3a in neural stem cells. We propose that CXXC5 is acting as a BMP4-induced inhibitor of Wnt signaling in neural stem cells.	[Andersson, Therese; Soedersten, Erik; Duckworth, Joshua K.; Cascante, Anna; Hermanson, Ola] Karolinska Inst, CoE Dev Biol Regenerat Med CEDB DBRM, Dept Neurosci, SE-17177 Stockholm, Sweden; [Fritz, Nicolas; Sacchetti, Paola] Karolinska Inst, CoE Dev Biol Regenerat Med CEDB DBRM, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Cervenka, Igor; Bryja, Vitezslav] Acad Sci Czech Republic, Dept Cytokinet, Brno 61137, Czech Republic; [Cervenka, Igor; Bryja, Vitezslav] Masaryk Univ, Inst Expt Biol, Fac Sci, CS-61137 Brno, Czech Republic	Karolinska Institutet; Karolinska Institutet; Czech Academy of Sciences; Masaryk University Brno	Hermanson, O (corresponding author), Karolinska Inst, CoE Dev Biol Regenerat Med CEDB DBRM, Dept Neurosci, SE-17177 Stockholm, Sweden.	Ola.Hermanson@ki.se	Bryja, Vítězslav/P-4217-2019; Fritz, Nicolas/P-1290-2019; Fritz, Nicolas/N-1030-2013; , Ola/AAF-5126-2021; Bryja, Vít?zslav/H-1925-2014; Sacchetti, Paola/ABC-8884-2021	Bryja, Vítězslav/0000-0002-9136-5085; Fritz, Nicolas/0000-0002-9722-7425; Fritz, Nicolas/0000-0002-9722-7425; Bryja, Vít?zslav/0000-0002-9136-5085; Sacchetti, Paola/0000-0002-6390-2744; Cascante, Anna/0000-0002-8272-3098; Sodersten, Erik/0000-0002-2998-4889; Hermanson, Ola/0000-0001-9320-7921	K&A Wallenberg Foundation; Swedish Research Council (VR); Swedish Cancer Society (CF); Jeansson Foundation; Ake Wiberg Foundation; Ahlen Foundation; Swedish Medical Society; Karolinska Institutet; Swedish Foundation for Strategic Research (SSF); Swedish Children's Cancer Foundation (BCF)	K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council (VR)(Swedish Research Council); Swedish Cancer Society (CF)(Swedish Cancer Society); Jeansson Foundation; Ake Wiberg Foundation; Ahlen Foundation; Swedish Medical Society; Karolinska Institutet(Karolinska Institutet); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Children's Cancer Foundation (BCF)	This study was supported in part by grants from K&A Wallenberg Foundation, the Swedish Research Council (VR), the Swedish Cancer Society (CF), the Jeansson Foundation, the Ake Wiberg Foundation, the Ahlen Foundation, the Swedish Medical Society, Karolinska Institutet, the Swedish Foundation for Strategic Research (SSF), and the Swedish Children's Cancer Foundation (BCF) (to O. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Biemar F, 2006, P NATL ACAD SCI USA, V103, P12763, DOI 10.1073/pnas.0604484103; Brunkhorst A, 2005, MOL CELL NEUROSCI, V29, P250, DOI 10.1016/j.mcn.2005.02.015; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Hebert JM, 2002, NEURON, V35, P1029, DOI 10.1016/S0896-6273(02)00900-5; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018; Ille F, 2007, DEV BIOL, V304, P394, DOI 10.1016/j.ydbio.2006.12.045; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Katoh M, 2004, INT J ONCOL, V25, P1193; Kawate T, 2005, ORG LETT, V7, P3865, DOI 10.1021/ol051144r; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Lee CS, 2001, P NATL ACAD SCI USA, V98, P11347, DOI 10.1073/pnas.201418298; Leonard JD, 2007, DEV BIOL, V306, P50, DOI 10.1016/j.ydbio.2007.02.041; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Marko NF, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-27; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; Michiue T, 2004, DEV DYNAM, V230, P79, DOI 10.1002/dvdy.20037; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Ossipova O, 2005, DEV CELL, V8, P829, DOI 10.1016/j.devcel.2005.04.011; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Sacchetti P, 2002, J BIOL CHEM, V277, P35088, DOI 10.1074/jbc.M205816200; Sailer MHM, 2005, J CELL SCI, V118, P5849, DOI 10.1242/jcs.02708; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Tsai RYL, 2000, J NEUROSCI, V20, P3725, DOI 10.1523/JNEUROSCI.20-10-03725.2000; Uhlen P, 2003, ANN NY ACAD SCI, V986, P514, DOI 10.1111/j.1749-6632.2003.tb07237.x; van Grunsven LA, 2005, CYTOKINE GROWTH F R, V16, P495, DOI 10.1016/j.cytogfr.2005.05.006; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498	41	78	83	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3672	3681		10.1074/jbc.M808119200	http://dx.doi.org/10.1074/jbc.M808119200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19001364	hybrid			2022-12-27	WOS:000262872500035
J	Delisle, BP; Underkofler, HAS; Moungey, BM; Slind, JK; Kilby, JA; Best, JM; Foell, JD; Balijepalli, RC; Kamp, TJ; January, CT				Delisle, Brian P.; Underkofler, Heather A. S.; Moungey, Brooke M.; Slind, Jessica K.; Kilby, Jennifer A.; Best, Jabe M.; Foell, Jason D.; Balijepalli, Ravi C.; Kamp, Timothy J.; January, Craig T.			Small GTPase Determinants for the Golgi Processing and Plasmalemmal Expression of Human Ether-a-go-go Related (hERG) K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; ENDOPLASMIC-RETICULUM; BETA-COP; POTASSIUM CHANNEL; MUTANT CHANNELS; TRANSPORT; TRAFFICKING; PROTEIN; ER; RAB6	The pro-arrhythmic Long QT syndrome (LQT) is linked to 10 different genes (LQT1-10). Approximately 40% of genotype-positive LQT patients have LQT2, which is characterized by mutations in the human ether-a-go-go related gene (hERG). hERG encodes the voltage-gated K+ channel alpha-subunits that form the pore of the rapidly activating delayed rectifier K+ current in the heart. The purpose of this study was to elucidate the mechanisms that regulate the intracellular transport or trafficking of hERG, because trafficking is impaired for about 90% of LQT2 missense mutations. Protein trafficking is regulated by small GTPases. To identify the small GTPases that are critical for hERG trafficking, we coexpressed hERG and dominant negative (DN) GTPase mutations in HEK293 cells. The GTPases Sar1 and ARF1 regulate the endoplasmic reticulum (ER) export of proteins in COPII and COPI vesicles, respectively. Expression of DN Sar1 inhibited the Golgi processing of hERG, decreased hERG current (I-hERG) by 85%(n >= 8 cells per group, *, p< 0.01), and reduced the plasmalemmal staining of hERG. The coexpression of DNARF1 had relatively small effects on hERG trafficking. Surprisingly, the coexpression of DN Rab11B, which regulates the endosomal recycling, inhibited the Golgi processing of hERG, decreased I-hERG by 79% (n >= 8 cells per group; *, p < 0.01), and reduced the plasmalemmal staining of hERG. These data suggest that hERG undergoes ER export in COPII vesicles and endosomal recycling prior to being processed in the Golgi. We conclude that hERG trafficking involves a pathway between the ER and endosomal compartments that influences expression in the plasmalemma.	[Delisle, Brian P.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Underkofler, Heather A. S.; Moungey, Brooke M.; Slind, Jessica K.; Kilby, Jennifer A.; Best, Jabe M.; Foell, Jason D.; Balijepalli, Ravi C.; Kamp, Timothy J.; January, Craig T.] Univ Wisconsin, Cellular & Mol Arrhythmia Res Program, Dept Med, Madison, WI 53706 USA; [Underkofler, Heather A. S.; Moungey, Brooke M.; Slind, Jessica K.; Kilby, Jennifer A.; Best, Jabe M.; Foell, Jason D.; Balijepalli, Ravi C.; Kamp, Timothy J.; January, Craig T.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	University of Kentucky; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Delisle, BP (corresponding author), Univ Kentucky, Dept Physiol, 800 Rose St MS508, Lexington, KY 40536 USA.	brian.delisle@uky.edu	Kamp, Timothy/ABD-1343-2020	Kamp, Timothy/0000-0003-2103-7876; Delisle, Brian/0000-0002-2146-327X	NHLBI, National Institutes of Health [R01 HL087039, R01 HL60723]; Scientist Development [0535068N, 0730010N]; American Heart Association; Mabel Lent Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060723, R01HL087039] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Scientist Development; American Heart Association(American Heart Association); Mabel Lent Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant R01 HL087039 (to B. P. D.) and Grant R01 HL60723 (to C. T. J.). This work was also supported by the Scientist Development Grants 0535068N and 0730010N from the American Heart Association (to B. P. D. and to R. C. B., respectively) and the Mabel Lent Foundation (to C. T. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 To whom correspondence may be addressed: Dept. of Physiology, University of Kentucky, 800 Rose St. MS508, Lexington, KY 40536. Tel.: 859-3232797; Fax: 859-323-1070; E-mail: brian.delisle@uky.edu.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; BARLOWE C, 1993, J BIOL CHEM, V268, P873; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Delisle BP, 2005, MOL PHARMACOL, V68, P233, DOI 10.1124/mol.105.012914; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Eckhardt LL, 2007, HEART RHYTHM, V4, P323, DOI 10.1016/j.hrthm.2006.10.025; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; GOUD B, 1994, ANN NY ACAD SCI, V710, P192, DOI 10.1111/j.1749-6632.1994.tb26627.x; GRIFFITHS G, 1995, J CELL SCI, V108, P2839; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; PETER F, 1993, J CELL BIOL, V122, P1155, DOI 10.1083/jcb.122.6.1155; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Trudeau MC, 1996, SCIENCE, V272, P1087; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	42	38	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2844	2853		10.1074/jbc.M807289200	http://dx.doi.org/10.1074/jbc.M807289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029296	Green Published, hybrid			2022-12-27	WOS:000262700900028
J	Luther, KB; Schindelin, H; Haltiwanger, RS				Luther, Kelvin B.; Schindelin, Hermann; Haltiwanger, Robert S.			Structural and Mechanistic Insights into Lunatic Fringe from a Kinetic Analysis of Enzyme Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAUSES SPONDYLOCOSTAL DYSOSTOSIS; FACTOR-LIKE REPEATS; CRYSTAL-STRUCTURE; GLYCOSYLTRANSFERASE FRINGE; URIDINE DIPHOSPHOGLUCOSE; BETA-GLUCOSYLTRANSFERASE; CATALYTIC MECHANISM; NOTCH-GENE; DROSOPHILA; GLYCOSYLATION	The Notch receptor is critical for proper development where it orchestrates numerous cell fate decisions. The Fringe family of beta 1,3-N-acetylglucosaminyltransferases are regulators of this pathway. Fringe enzymes add N-acetylglucosamine to O-linked fucose on the epidermal growth factor repeats of Notch. Here we have analyzed the reaction catalyzed by Lunatic Fringe (Lfng) in detail. A mutagenesis strategy for Lfng was guided by a multiple sequence alignment of Fringe proteins and solutions from docking an epidermal growth factor-like O-fucose acceptor substrate onto a homology model of Lfng. We targeted three main areas as follows: residues that could help resolve where the fucose binds, residues in two conserved loops not observed in the published structure of Manic Fringe, and residues predicted to be involved in UDP-N-acetylglucosamine (UDP-GlcNAc) donor specificity. We utilized a kinetic analysis of mutant enzyme activity toward the small molecule acceptor substrate 4-nitrophenyl-alpha-L-fucopyranoside to judge their effect on Lfng activity. Our results support the positioning of O-fucose in a specific orientation to the catalytic residue. We also found evidence that one loop closes off the active site coincident with, or subsequent to, substrate binding. We propose a mechanism whereby the ordering of this short loop may alter the conformation of the catalytic aspartate. Finally, we identify several residues near the UDP-GlcNAc-binding site, which are specifically permissive toward UDP-GlcNAc utilization.	[Luther, Kelvin B.; Schindelin, Hermann; Haltiwanger, Robert S.] SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Inst Cell & Dev Biol, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	rhaltiwanger@ms.cc.sunysb.edu	Schindelin, Hermann/Q-2697-2019	Luther, Kelvin/0000-0001-9438-9675	National Institutes of Health [GM061126, DK54835]; Deutsche Forschungsgemeinschaft [FZ82]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061126 ( to R. S. H.) and DK54835 ( to H. S.). This work was also supported by Deutsche Forschungsgemeinschaft Grant FZ82 ( to H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Correia T, 2003, P NATL ACAD SCI USA, V100, P6404, DOI 10.1073/pnas.1131007100; DeLano W.L, PYMOL MOL GRAPHICS S; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Eswar N., 2007, CURR PROTOC PROTEIN; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Jinek M, 2006, NAT STRUCT MOL BIOL, V13, P945, DOI 10.1038/nsmb1144; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kleywegt GJ, 2003, STRUCTURE, V11, P1051, DOI 10.1016/S0969-2126(03)00186-2; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI 10.1090/qam/10666; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MIYAMOTO Y, 1990, BIOCHEM BIOPH RES CO, V168, P1149, DOI 10.1016/0006-291X(90)91149-M; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; NOVIKOFF AB, 1961, P NATL ACAD SCI USA, V47, P802, DOI 10.1073/pnas.47.6.802; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Ritchie DW, 2003, PROTEINS, V52, P98, DOI 10.1002/prot.10379; ROBBINS J, 1992, J VIROL, V66, P2594, DOI 10.1128/JVI.66.4.2594-2599.1992; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; Sparrow Duncan B., 2007, Birth Defects Research, V81, P93, DOI 10.1002/bdrc.20093; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Yuan YQ, 2007, P NATL ACAD SCI USA, V104, P5348, DOI 10.1073/pnas.0701160104; Zhang N, 2002, GENESIS, V33, P21, DOI 10.1002/gene.10081; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	52	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3294	3305		10.1074/jbc.M805502200	http://dx.doi.org/10.1074/jbc.M805502200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19028689	Green Published, hybrid			2022-12-27	WOS:000262700900072
J	Farver, O; Vitu, E; Wherland, S; Fass, D; Pecht, I				Farver, Ole; Vitu, Elvira; Wherland, Scot; Fass, Deborah; Pecht, Israel			Electron Transfer Reactivity of the Arabidopsis thaliana Sulfhydryl Oxidase AtErv1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE-BOND FORMATION; ENDOPLASMIC-RETICULUM; INTERMEMBRANE SPACE; LIVER-REGENERATION; PROTEIN FAMILY; CYTOCHROME-C; RELAY SYSTEM; MITOCHONDRIA; ERO1P; AUGMENTOR	The redox reactivity of the three disulfide bridges and the flavin present in each protomer of the wild-type Arabidopsis thaliana mitochondrial sulfhydryl oxidase (AtErv1) homodimer has been investigated. Pulse radiolytically produced CO2- radical ions were found to reduce the disulfide bridges to yield disulfide radicals, RSS*R-. Rates and absorption changes due to formation or decay of RSS*R- and the flavin quinone, semiquinone, and hydroquinone were measured and analyzed. During the first 100 mu s following the pulse, the flavin was reduced to the semiquinone by intramolecular electron transfer from the active site disulfide radical. The semiquinone and the remaining disulfide radicals then reacted by much slower, 40 ms to 40 s, inter-homodimer electron transfer reactions, culminating in reduced flavin and dithiols. The dithiols were then subject to oxidation by enzyme molecules via their intrinsic enzymatic activity, at a rate comparable to the slower intermolecular processes in the 10-s time regime. Mutants of AtErv1 lacking each of the three individual cysteine pairs were studied to determine the involvement of the respective disulfide groups in these reactions. Elimination of the active site disulfide bridge increased the stability of the flavin semiquinone making it a long-lived product. Relevance of these observations to the design and function of the sulfhydryl oxidases is discussed.	[Vitu, Elvira; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Pecht, Israel] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Farver, Ole] Univ Copenhagen, Inst Analyt Chem, DK-2100 Copenhagen, Denmark; [Wherland, Scot] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Weizmann Institute of Science; Weizmann Institute of Science; University of Copenhagen; Washington State University	Fass, D (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	Deborah.Fass@weizmann.ac.il; Israel.Pecht@weizmann.ac.il	Vitu, Elvira/V-8201-2017	Wherland, Scot/0000-0003-1699-5594; Pecht, Israel/0000-0002-1883-9547	Kimmelman Center for Macromolecular Assemblies	Kimmelman Center for Macromolecular Assemblies	This work was supported by the Kimmelman Center for Macromolecular Assemblies ( to D. F.).	Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; FARVER O, 1992, J AM CHEM SOC, V114, P5764, DOI 10.1021/ja00040a043; Farver O, 1999, J BIOL CHEM, V274, P26135, DOI 10.1074/jbc.274.37.26135; Farver O, 2007, PROG INORG CHEM, V55, P1, DOI 10.1002/9780470144428.ch1; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gerber J, 2001, J BIOL CHEM, V276, P23486, DOI 10.1074/jbc.M100134200; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HERRMANN JM, 2009, BIOCH BIOPHYS ACTA M, P71; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; HILLE R, 1991, J BIOL CHEM, V266, P5608; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Mairet-Coello G, 2004, J COMP NEUROL, V473, P334, DOI 10.1002/cne.20126; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; OSTROWSKI MC, 1980, BIOCHEMISTRY-US, V19, P2639, DOI 10.1021/bi00553a016; Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z; Rodriguez I, 2006, J VIROL, V80, P3157, DOI 10.1128/JVI.80.7.3157-3166.2006; Senkevich TG, 2000, P NATL ACAD SCI USA, V97, P12068, DOI 10.1073/pnas.210397997; Senkevich TG, 2002, P NATL ACAD SCI USA, V99, P6667, DOI 10.1073/pnas.062163799; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Su HP, 2005, P NATL ACAD SCI USA, V102, P4240, DOI 10.1073/pnas.0501103102; Thorpe C, 2002, ARCH BIOCHEM BIOPHYS, V405, P1, DOI 10.1016/S0003-9861(02)00337-5; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070	28	4	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2098	2105		10.1074/jbc.M806316200	http://dx.doi.org/10.1074/jbc.M806316200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017646	hybrid			2022-12-27	WOS:000262545600018
J	Halaszovich, CR; Schreiber, DN; Oliver, D				Halaszovich, Christian R.; Schreiber, Daniela N.; Oliver, Dominik			Ci-VSP Is a Depolarization-activated Phosphatidylinositol-4,5-bisphosphate and Phosphatidylinositol-3,4,5-trisphosphate 5 '-Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PLASMA-MEMBRANE; LIVING CELLS; PHOSPHOINOSITIDE 3-KINASE; PH DOMAINS; PROTEIN; 4,5-BISPHOSPHATE; PHOSPHATASE; BINDING; KINASE	Phosphoinositides are membrane-delimited regulators of protein function and control many different cellular targets. The differentially phosphorylated isoforms have distinct concentrations in various subcellular membranes, which can change dynamically in response to cellular signaling events. Maintenance and dynamics of phosphoinositide levels involve a complex set of enzymes, among them phospholipases and lipid kinases and phosphatases. Recently, a novel type of phosphoinositide-converting protein ( termed Ci-VSP) that contains a voltage sensor domain was isolated. It was already shown that Ci-VSP can alter phosphoinositide levels in a voltage-dependent manner. However, the exact enzymatic reaction catalyzed by Ci-VSP is not known. We used fluorescent phosphoinositide-binding probes and total internal reflection microscopy together with patch-clamp measurements from living cells to delineate substrates and products of Ci-VSP. Upon activation of Ci-VSP by membrane depolarization, membrane association of phosphatidylinositol ( PI) (4,5)P-2- and PI( 3,4,5)P-3-specific binding domains decreased, revealing consumption of these phosphoinositides by Ci-VSP. Depletion of PI(4,5)P-2 was coincident with an increase in membrane PI(4)P. Similarly, PI(3,4)P-2 was generated during depletion of PI(3,4,5)P-3. These results suggest that Ci-VSP acts as a 5'-phosphatase of PI(4,5)P-2 and PI(3,4,5)P-3.	[Halaszovich, Christian R.; Schreiber, Daniela N.; Oliver, Dominik] Univ Marburg, Inst Physiol & Pathophysiol, Dept Neurophysiol, D-35037 Marburg, Germany	Philipps University Marburg	Oliver, D (corresponding author), Univ Marburg, Inst Physiol & Pathophysiol, Dept Neurophysiol, Deutschhausstr 2, D-35037 Marburg, Germany.	oliverd@staff.uni-marburg.de	Oliver, Dominik/F-5845-2013; Halaszovich, Christian/I-7231-2012	Oliver, Dominik/0000-0002-8368-0923; 	Deutsche Forschungsgemeinschaft [OI 240/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant OI 240/2 (to D.O.).	Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla T, 2001, CURR PHARM DESIGN, V7, P475, DOI 10.2174/1381612013397906; Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; BAZENET CE, 1990, J BIOL CHEM, V265, P18012; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cheung SMS, 2007, CELL SIGNAL, V19, P902, DOI 10.1016/j.cellsig.2006.10.013; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Weixel KM, 2007, J BIOL CHEM, V282, P36534, DOI 10.1074/jbc.M703970200; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	42	80	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2106	2113		10.1074/jbc.M803543200	http://dx.doi.org/10.1074/jbc.M803543200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047057	hybrid			2022-12-27	WOS:000262545600019
J	Lin, HY; Underhill, C; Gardill, BR; Muller, YA; Hammond, GL				Lin, Hai-Yan; Underhill, Caroline; Gardill, Bernd R.; Muller, Yves A.; Hammond, Geoffrey L.			Residues in the Human Corticosteroid-binding Globulin Reactive Center Loop That Influence Steroid Binding before and after Elastase Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERPIN CONFORMATIONAL CHANGE; SERINE-PROTEASE INHIBITORS; POLYMERASE CHAIN-REACTION; AMINO-ACID SUBSTITUTION; HINGE REGION MUTATIONS; HEPARIN-COFACTOR-II; ALPHA-1-PROTEINASE INHIBITOR; HORMONE-RELEASE; BETA-SHEET; CORTISOL	Corticosteroid-binding globulin (CBG) is a non-inhibitory serine proteinase inhibitor (serpin) that transports cortisol and progesterone in blood. Crystal structures of rat CBG and a thrombin-cleaved human CBG: anti-trypsin (Pittsburgh) chimera show how structural transitions after proteolytic cleavage of the CBG reactive center loop (RCL) could disrupt steroid binding. This ligand release mechanism is assumed to involve insertion of the cleaved RCL into the beta-sheet A of the serpin structure. We have, therefore, examined how amino acid substitutions in the human CBG RCL influence steroid binding before and after its cleavage by neutrophil elastase. Elastase-cleaved wild-type CBG or variants with substitutions at P15 and/or P16 (E334G/G335N or E334A) lost steroid binding completely, whereas deletion of Glu-334 resulted in no loss of steroid binding after RCL cleavage, presumably because this prevents its insertion into beta-sheet A. Similarly, the steroid binding properties of CBG variants with substitutions at P15 (G335P), P14 (V336R), or P12 (T338P) in the RCL hinge were largely unaffected after elastase cleavage, most likely because the re-orientation and/or insertion of the cleaved RCL was blocked. Substitutions at P10 (G340P, G340S) or P8 (T342P, T342N) resulted in a partial loss of steroid binding after proteolysis which we attribute to incomplete insertion of the cleaved RCL. Remarkably, several substitutions (E334A, V336R, G340S, and T342P) increased the steroid binding affinities of human CBG even before elastase cleavage, consistent with the concept that CBG normally toggles between a high affinity ligand binding state where the RCL is fully exposed and a lower affinity state in which the RCL is partly inserted into beta-sheet A.	[Lin, Hai-Yan; Underhill, Caroline; Hammond, Geoffrey L.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Lin, Hai-Yan; Underhill, Caroline; Hammond, Geoffrey L.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 4H4, Canada; [Gardill, Bernd R.; Muller, Yves A.] Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biotech, D-91052 Erlangen, Germany	Child & Family Research Institute; University of British Columbia; University of British Columbia; University of Erlangen Nuremberg	Hammond, GL (corresponding author), Univ British Columbia, Child & Family Res Inst, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	ghammond@cw.bc.ca	Muller, Yves A/R-5397-2016	Muller, Yves A/0000-0003-0519-8928; Hammond, Geoffrey/0000-0002-4639-7336	Canadian Institutes of Health Research [MOP 77586]; Deutsche Forschungsgemeinschaft [Mu1477-5]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Canadian Institutes of Health Research Grant MOP 77586 ( to G. L. H.) and in part by Deutsche Forschungsgemeinschaft Grant Mu1477-5. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AULAK KS, 1993, J BIOL CHEM, V268, P18088; AVVAKUMOV GV, 1993, J BIOL CHEM, V268, P862; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; BANDA MJ, 1987, J CLIN INVEST, V79, P1314, DOI 10.1172/JCI112955; Breuner CW, 2002, J ENDOCRINOL, V175, P99, DOI 10.1677/joe.0.1750099; CASO R, 1991, BRIT J HAEMATOL, V77, P87, DOI 10.1111/j.1365-2141.1991.tb07953.x; Corral J, 2004, CIRCULATION, V110, P1303, DOI 10.1161/01.CIR.0000140763.51679.D9; DAVIS AE, 1992, NAT GENET, V1, P354, DOI 10.1038/ng0892-354; Emptoz-Bonneton A, 2000, J CLIN ENDOCR METAB, V85, P361, DOI 10.1210/jc.85.1.361; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Grasberger H, 2002, BIOCHEM J, V365, P311, DOI 10.1042/BJ20020014; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; Hammond GL, 2002, OBSTET GYN CLIN N AM, V29, P411, DOI 10.1016/S0889-8545(02)00008-6; HAMMOND GL, 1990, BIOCHEM BIOPH RES CO, V172, P172, DOI 10.1016/S0006-291X(05)80189-5; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HAMMOND GL, 1991, J STEROID BIOCHEM, V40, P755, DOI 10.1016/0960-0760(91)90300-T; HAMMOND GL, 1990, ENDOCR REV, V11, P65, DOI 10.1210/edrv-11-1-65; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; Huntington JA, 1997, BIOCHEMISTRY-US, V36, P5432, DOI 10.1021/bi9702142; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Janssen OE, 2002, J CLIN ENDOCR METAB, V87, P1217, DOI 10.1210/jc.87.3.1217; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Jirasakuldech B, 2000, J CLIN ENDOCR METAB, V85, P3996, DOI 10.1210/jc.85.11.3996; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lawrence DA, 2000, J BIOL CHEM, V275, P5839, DOI 10.1074/jbc.275.8.5839; Lukacs CM, 1996, NAT STRUCT BIOL, V3, P888, DOI 10.1038/nsb1096-888; MOLHOSABATIER P, 1989, J CLIN INVEST, V84, P1236, DOI 10.1172/JCI114290; ORAVA M, 1994, GENE, V144, P259, DOI 10.1016/0378-1119(94)90387-5; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; PERRY DJ, 1989, FEBS LETT, V254, P174, DOI 10.1016/0014-5793(89)81033-6; ROBINSON PA, 1985, J ENDOCRINOL, V104, P259, DOI 10.1677/joe.0.1040259; SKRIVER K, 1991, J BIOL CHEM, V266, P9216; SMITH CL, 1991, J BIOL CHEM, V266, P18555; SMITH CL, 1992, J STEROID BIOCHEM, V42, P671, DOI 10.1016/0960-0760(92)90107-T; STEINBERGER D, 1995, HUM GENET, V96, P113, DOI 10.1007/BF00214198; VANBAELEN H, 1993, STEROIDS, V58, P275, DOI 10.1016/0039-128X(93)90072-U; Whisstock JC, 2000, J MOL BIOL, V296, P685, DOI 10.1006/jmbi.1999.3520; WRIGHT HT, 1990, J MOL BIOL, V213, P513; Yamasaki M, 2002, J MOL BIOL, V315, P113, DOI 10.1006/jmbi.2001.5056; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103	45	39	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					884	896		10.1074/jbc.M807376200	http://dx.doi.org/10.1074/jbc.M807376200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19011238	hybrid			2022-12-27	WOS:000262122900023
J	Bergfeld, AK; Claus, H; Lorenzen, NK; Spielmann, F; Vogel, U; Muhlenhoff, M				Bergfeld, Anne K.; Claus, Heike; Lorenzen, Nina K.; Spielmann, Fabian; Vogel, Ulrich; Muehlenhoff, Martina			The Polysialic Acid-specific O-Acetyltransferase OatC from Neisseria meningitidis Serogroup C Evolved Apart from Other Bacterial Sialate O-Acetyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA/BETA-HYDROLASE-FOLD; ESCHERICHIA-COLI K1; N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; SITE-DIRECTED MUTAGENESIS; SIALIC-ACID; MENINGOCOCCAL DISEASE; CRYSTAL-STRUCTURE; SERINE PROTEASES; CATALYTIC TRIAD; HOMOSERINE TRANSACETYLASE	Neisseria meningitidis serogroup C is a major cause of bacterial meningitis and septicaemia. This human pathogen is protected by a capsule composed of alpha 2,9-linked polysialic acid that represents an important virulence factor. In the majority of strains, the capsular polysaccharide is modified by O-acetylation at C-7 or C-8 of the sialic acid residues. The gene encoding the capsule modifying O-acetyltransferase is part of the capsule gene complex and shares no sequence similarities with other proteins. Here, we describe the purification and biochemical characterization of recombinant OatC. The enzyme was found as a homodimer, with the first 34 amino acids forming an efficient oligomerization domain that worked even in a different protein context. Using acetyl-CoA as donor substrate, OatC transferred acetyl groups exclusively onto polysialic acid joined by alpha 2,9-linkages and did not act on free or CMP-activated sialic acid. Motif scanning revealed a nucleophile elbow motif (GXS(286)XGG), which is a hallmark of alpha/beta-hydrolase fold enzymes. In a comprehensive site-directed mutagenesis study, we identified a catalytic triad composed of Ser-286, Asp-376, and His-399. Consistent with a double-displacement mechanism common to alpha/beta-hydrolase fold enzymes, a covalent acetylenzyme intermediate was found. Together with secondary structure prediction highlighting an alpha/beta-hydrolase fold topology, our data provide strong evidence that OatC belongs to the alpha/beta-hydrolase fold family. This clearly distinguishes OatC from all other bacterial sialate O-acetyltransferases known so far because these are members of the hexapeptide repeat family, a class of acyltransferases that adopt a left-handed beta-helix fold and assemble into catalytic trimers.	[Muehlenhoff, Martina] Hannover Med Sch, Abt Zellulare Chem, Dept Cellular Chem, D-30623 Hannover, Germany; [Claus, Heike; Spielmann, Fabian; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany	Hannover Medical School; University of Wurzburg	Muhlenhoff, M (corresponding author), Hannover Med Sch, Abt Zellulare Chem, Dept Cellular Chem, Carl Neuberg Str 1, D-30623 Hannover, Germany.	muehlenhoff.martina@mh-hannover.de			Deutsche Forschungsgemeinschaft [VO 718/4-1, MU 1774/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants VO 718/4-1 (to U. V.) and MU 1774/2-1 (to M. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Bergfeld AK, 2007, J BIOL CHEM, V282, P22217, DOI 10.1074/jbc.M703044200; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; BLONDEL A, 1991, PROTEIN ENG, V4, P457, DOI 10.1093/protein/4.4.457; BLONDEL A, 1990, EUR J BIOCHEM, V193, P325, DOI 10.1111/j.1432-1033.1990.tb19341.x; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Born TL, 2000, BIOCHEMISTRY-US, V39, P8556, DOI 10.1021/bi000462p; Borrow R, 2000, FEMS IMMUNOL MED MIC, V28, P189, DOI 10.1111/j.1574-695X.2000.tb01475.x; BUTOR C, 1993, J BIOL CHEM, V268, P10197; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Campobasso N, 2004, J BIOL CHEM, V279, P44883, DOI 10.1074/jbc.M407882200; Claus H, 1997, MOL GEN GENET, V257, P28, DOI 10.1007/s004380050620; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Connolly M, 1999, EPIDEMIOL INFECT, V122, P41, DOI 10.1017/S0950268898001848; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Deszo EL, 2005, P NATL ACAD SCI USA, V102, P5564, DOI 10.1073/pnas.0407428102; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Fujino S, 2006, BIOSCI BIOTECH BIOCH, V70, P377, DOI 10.1271/bbb.70.377; Fusco PC, 2007, CLIN VACCINE IMMUNOL, V14, P577, DOI 10.1128/CVI.00009-07; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; HENDLE J, 1995, BIOCHEMISTRY-US, V34, P4287, DOI 10.1021/bi00013a018; HIGA HH, 1988, J BIOL CHEM, V263, P8872; HILDEBRANDT H, 2008, NEUROCHEM RES, DOI DOI 10.1007/S11064-008-9724-7; Hindson VJ, 2003, BIOCHEMISTRY-US, V42, P3113, DOI 10.1021/bi0267893; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Ho MM, 2001, BIOTECHNOL APPL BIOC, V33, P91, DOI 10.1042/BA20000078; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Houliston RS, 2006, J BIOL CHEM, V281, P11480, DOI 10.1074/jbc.M512183200; Ishida T, 2006, BIOCHEMISTRY-US, V45, P5413, DOI 10.1021/bi051515b; Ishida T, 2004, J AM CHEM SOC, V126, P7111, DOI 10.1021/ja030405u; Iwersen M, 2003, BIOL CHEM, V384, P1035, DOI 10.1515/BC.2003.116; JENNINGS HJ, 1977, J INFECT DIS, V136, pS78, DOI 10.1093/infdis/136.Supplement.S78; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016/S0140-6736(02)08416-7; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Kolkenbrock S, 2006, J BACTERIOL, V188, P8430, DOI 10.1128/JB.01085-06; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Lemercinier X, 1996, CARBOHYD RES, V296, P83, DOI 10.1016/S0008-6215(96)00253-4; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Longworth E, 2002, FEMS IMMUNOL MED MIC, V32, P119, DOI 10.1111/j.1574-695X.2002.tb00543.x; Lrhorfi LA, 2007, BIOL CHEM, V388, P297, DOI 10.1515/BC.2007.033; Michon F, 2000, Dev Biol (Basel), V103, P151; Milkowski C, 2004, PHYTOCHEMISTRY, V65, P517, DOI 10.1016/j.phytochem.2003.12.018; Mirza IA, 2005, BIOCHEMISTRY-US, V44, P15768, DOI 10.1021/bi051951y; Nandhagopal N, 2001, J MOL BIOL, V309, P1139, DOI 10.1006/jmbi.2001.4737; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nazi I, 2005, BIOCHEMISTRY-US, V44, P13560, DOI 10.1021/bi0514764; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; Olsen LR, 2001, BIOCHEMISTRY-US, V40, P1913, DOI 10.1021/bi002503n; Pagni M, 2004, NUCLEIC ACIDS RES, V32, pW332, DOI 10.1093/nar/gkh479; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; POOLMAN JT, 1995, CLIN DIAGN LAB IMMUN, V2, P69, DOI 10.1128/CDLI.2.1.69-72.1995; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; Ravenscroft N, 1999, VACCINE, V17, P2802, DOI 10.1016/S0264-410X(99)00092-4; Rode B, 2008, J BIOTECHNOL, V135, P202, DOI 10.1016/j.jbiotec.2008.03.012; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Shen YQ, 2004, BIOL CHEM, V385, P145, DOI 10.1515/BC.2004.033; Shen YQ, 2002, BIOL CHEM, V383, P307, DOI 10.1515/BC.2002.033; Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06; Srivatsan M, 2006, BIOINFORMATION, V1, P281, DOI 10.6026/97320630001281; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; VAARA M, 1992, FEMS MICROBIOL LETT, V97, P249, DOI 10.1016/0378-1097(92)90344-N; VANN WF, 1978, J BACTERIOL, V133, P1300, DOI 10.1128/JB.133.3.1300-1306.1978; Villwock A, 2008, INT J MED MICROBIOL, V298, P591, DOI 10.1016/j.ijmm.2007.11.003; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Vogel U, 1998, J CLIN MICROBIOL, V36, P2465, DOI 10.1128/JCM.36.9.2465-2470.1998; Wahab HA, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-23; Wajant H, 1996, J BIOL CHEM, V271, P25830, DOI 10.1074/jbc.271.42.25830; Wang M, 2007, BIOCHEM BIOPH RES CO, V363, P1050, DOI 10.1016/j.bbrc.2007.08.153; Weadge JT, 2007, BIOCHEMISTRY-US, V46, P4932, DOI 10.1021/bi700254m; Westwood IM, 2006, CURR TOP MED CHEM, V6, P1641, DOI 10.2174/156802606778108979; Wyckoff TJO, 1999, J BIOL CHEM, V274, P27047, DOI 10.1074/jbc.274.38.27047; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105	87	29	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					6	16		10.1074/jbc.M807518200	http://dx.doi.org/10.1074/jbc.M807518200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18986988	hybrid			2022-12-27	WOS:000261974800002
J	Sellick, CA; Jowitt, TA; Reece, RJ				Sellick, Christopher A.; Jowitt, Thomas A.; Reece, Richard J.			The Effect of Ligand Binding on the Galactokinase Activity of Yeast Gal1p and Its Ability to Activate Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; KLUYVEROMYCES-LACTIS; MOLECULAR-STRUCTURE; GENE SWITCH; PROTEIN; GAL80P; INDUCTION; INDUCER; SPECIFICITY; COMPLEX	The galactokinase from Saccharomyces cerevisiae (ScGal1p) is a bifunctional protein. It is an enzyme responsible for the conversion of alpha-D-galactose into galactose 1-phosphate at the expense of ATP but can also function as a transcriptional inducer of the yeast GAL genes. For both of these activities, the protein requires two ligands; a sugar (galactose) and a nucleotide (ATP). Here we investigate the effect of these ligands on the stability and conformation of ScGal1p to determine how the ligands alter protein function. We show that nucleotide binding increases the thermal stability of ScGal1p, whereas binding of galactose alone had no effect on the stability of the protein. This nucleotide stabilization effect is also observed for the related proteins S. cerevisiae Gal3p and Kluyveromyces lactis Gal1p and suggests that nucleotide binding results in the formation of, or the unmasking of, the galactose-binding site. We also show that the increase in stability of ScGal1p does not result from a large conformational change but is instead the result of a smaller more energetically favorable stabilization event. Finally, we have used mutant versions of ScGal1p to show that the galactokinase and transcriptional induction functions of the protein are distinct and separable. Mutations resulting in constitutive induction do not function by mimicking the more stable active conformation but have highlighted a possible site of interaction between ScGal1p and ScGal80p. These data give significant insights into the mechanism of action of both a galactokinase and a transcriptional inducer.	[Sellick, Christopher A.; Jowitt, Thomas A.; Reece, Richard J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Reece, RJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	richard.reece@manchester.ac.uk		Jowitt, Thomas/0000-0002-4045-0933	Wellcome Trust and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	Wellcome Trust and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	This research was supported by grants from the Wellcome Trust and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (to R.J.R.).	ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Anders A, 2006, J BIOL CHEM, V281, P29337, DOI 10.1074/jbc.M604271200; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; BHAT PJ, 1992, MOL CELL BIOL, V12, P2701, DOI 10.1128/MCB.12.6.2701; Blank TE, 1997, MOL CELL BIOL, V17, P2566, DOI 10.1128/MCB.17.5.2566; DeLano W.L, PYMOL MOL GRAPHICS S; Diep CQ, 2006, GENETICS, V172, P77, DOI 10.1534/genetics.105.050807; Diep CQ, 2008, GENETICS, V178, P725, DOI 10.1534/genetics.107.074799; Hartley A, 2004, J MOL BIOL, V337, P387, DOI 10.1016/j.jmb.2004.01.043; Inagaki E, 2006, ACTA CRYSTALLOGR F, V62, P169, DOI 10.1107/S1744309106001813; Kumar PR, 2008, SCIENCE, V319, P1090, DOI 10.1126/science.1151903; MEYER J, 1991, MOL CELL BIOL, V11, P5454, DOI 10.1128/MCB.11.11.5454; Platt A, 2000, P NATL ACAD SCI USA, V97, P3154, DOI 10.1073/pnas.97.7.3154; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Rai N, 2005, STRUCTURE, V13, P723, DOI 10.1016/j.str.2005.02.012; SALMERON JM, 1986, NUCLEIC ACIDS RES, V14, P7767, DOI 10.1093/nar/14.19.7767; SALMERON JM, 1989, MOL CELL BIOL, V9, P2950, DOI 10.1128/MCB.9.7.2950; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; Sellick CA, 2006, J BIOL CHEM, V281, P17150, DOI 10.1074/jbc.M602086200; Thoden JB, 2008, J BIOL CHEM, V283, P30266, DOI 10.1074/jbc.M805200200; Thoden JB, 2007, J BIOL CHEM, V282, P1534, DOI 10.1074/jbc.C600285200; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Thoden JB, 2005, J BIOL CHEM, V280, P9662, DOI 10.1074/jbc.M412916200; Timson DJ, 2002, BIOCHEM J, V363, P515, DOI 10.1042/0264-6021:3630515; Timson DJ, 2002, BIOCHIMIE, V84, P265, DOI 10.1016/S0300-9084(02)01399-8; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WEBSTER TD, 1988, NUCLEIC ACIDS RES, V16, P8011, DOI 10.1093/nar/16.16.8011; Zenke FT, 1996, SCIENCE, V272, P1662, DOI 10.1126/science.272.5268.1662	30	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					229	236		10.1074/jbc.M807878200	http://dx.doi.org/10.1074/jbc.M807878200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18957435	hybrid			2022-12-27	WOS:000261974800026
J	Torres, VA; Mielgo, A; Barila, D; Anderson, DH; Stupack, D				Torres, Vicente A.; Mielgo, Ainhoa; Barila, Daniela; Anderson, Deborah H.; Stupack, Dwayne			Caspase 8 Promotes Peripheral Localization and Activation of Rab5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL GTPASE RAB5; CELL-MIGRATION; PHOSPHATIDYLINOSITOL 3-KINASE; MEMBRANE-FUSION; ENDOSOME FUSION; P85 SUBUNIT; CD95; APOPTOSIS; PROTEINS; MOTILITY	Caspase 8 is a cysteine protease that initiates apoptotic signaling via the extrinsic pathway in a manner dependent upon association with early endosomes. Previously, we identified caspase 8 as an effector of migration, promoting motility in a manner dependent upon phosphorylation on Tyr-380 by Src family kinases and its subsequent association with Src homology 2 domain-containing proteins. Here we demonstrate the regulation of the small GTPase Rab5, which mediates early endosome formation, homotypic fusion, and maturation by caspase 8. Regulation requires the Tyr-380 phosphorylation site but not caspase proteolytic activity. Tyr-380 is essential for interaction with the Src homology 2 domains of p85 alpha, a multifunctional adaptor for phosphatidylinositol 3-kinase, that possesses Rab-GAP activity. Interaction between caspase 8 and p85 alpha promotes Rab5 GTP loading, alters endosomal trafficking, and results in the accumulation of Rab5-positive endosomes at the edge of the cell. Conversely, caspase 8-dependent GTP loading of Rab5 is overcome by increased expression of p85 alpha in a Rab-GAP-dependent manner. Thus, we demonstrate a novel function for caspase 8 as a modulator of p85 alpha Rab-GAP activity and endosomal trafficking.	[Stupack, Dwayne] Univ Calif San Diego, Ctr Canc, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Torres, Vicente A.; Mielgo, Ainhoa; Stupack, Dwayne] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Barila, Daniela] Univ Roma Tor Vergata, Dept Biol, I-00179 Rome, Italy; [Barila, Daniela] Ist Ricovero, Lab Cell Signaling, I-00179 Rome, Italy; [Barila, Daniela] Cura Carattere Sci Fdn Santa Lucia, I-00179 Rome, Italy; [Anderson, Deborah H.] Saskatchewan Canc Agcy, Canc Res Unit, Saskatoon, SK S7N 4H4, Canada	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Rome Tor Vergata; IRCCS Santa Lucia; University of Saskatchewan	Stupack, D (corresponding author), Univ Calif San Diego, Ctr Canc, Sch Med, Dept Pathol, 3855 Hlth Sci Way,MC0803, La Jolla, CA 92093 USA.	dstupack@ucsd.edu	Torres, Vicente/I-2437-2013; Barilà, Daniela/K-8506-2016	Barilà, Daniela/0000-0002-6192-1562; Torres, Vicente A/0000-0002-5973-7248	National Institutes of Health [CA107263]; Canadian Cancer Society [019040]; Italian Association for Cancer Research; International Association for Cancer Research [AICR 07-0461]; NATIONAL CANCER INSTITUTE [R01CA107263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society(Canadian Cancer Society (CCS)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); International Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107263 (NCI, to D. S.). This work was also supported by Canadian Cancer Society, Saskatchewan Division Grant 019040 (to D. A.) and by grants from the Italian Association for Cancer Research and International Association for Cancer Research Grant AICR 07-0461 (to D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Chamberlain MD, 2008, J BIOL CHEM, V283, P15861, DOI 10.1074/jbc.M800941200; Chamberlain MD, 2004, J BIOL CHEM, V279, P48607, DOI 10.1074/jbc.M409769200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Frisch SM, 2008, CANCER RES, V68, P4491, DOI 10.1158/0008-5472.CAN-08-0952; Galperin E, 2003, J CELL SCI, V116, P4799, DOI 10.1242/jcs.00801; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Reinehr R, 2008, J BIOL CHEM, V283, P2211, DOI 10.1074/jbc.M706853200; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Wrasidlo W, 2008, P NATL ACAD SCI USA, V105, P2313, DOI 10.1073/pnas.0712198105; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	38	42	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36280	36289		10.1074/jbc.M805878200	http://dx.doi.org/10.1074/jbc.M805878200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974049	Green Published, hybrid			2022-12-27	WOS:000261840500024
J	Trentmann, O; Jung, B; Neuhaus, HE; Haferkamp, I				Trentmann, Oliver; Jung, Benjamin; Neuhaus, Horst Ekkehard; Haferkamp, Ilka			Nonmitochondrial ATP/ADP Transporters Accept Phosphate as Third Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICKETTSIA-PROWAZEKII; ESCHERICHIA-COLI; ATP TRANSPORT; CHLAMYDIA-TRACHOMATIS; ADENINE-NUCLEOTIDE; GENOME SEQUENCE; ARABIDOPSIS; MITOCHONDRIA; PROTEINS; CARRIER	Chlamydiales and Rickettsiales as metabolically impaired, intracellular pathogenic bacteria essentially rely on "energy parasitism" by the help of nucleotide transporters (NTTs). Also in plant plastids NTT-type carriers catalyze ATP/ADP exchange to fuel metabolic processes. The uptake of ATP(4-), followed by energy consumption and the release of ADP(3-), would lead to a metabolically disadvantageous accumulation of negative charges in form of inorganic phosphate (Pi) in the bacterium or organelle if no interacting P-i export system exists. We identified that Pi is a third substrate of several NTT-type ATP/ADP transporters. During adenine nucleotide hetero-exchange, Pi is cotransported with ADP in a one-to-one stoichiometry. Additionally, Pi can be transported in exchange with solely P-i. This P-i homo-exchange depends on the presence of ADP and provides a first indication for only one binding center involved in import and export. Furthermore, analyses of mutant proteins revealed that Pi interacts with the same amino acid residue as the gamma-phosphate of ATP. Import of ATP in exchange with ADP plus Pi is obviously an efficient way to couple energy provision with the export of the two metabolic products (ADP plus P-i) and to maintain cellular phosphate homeostasis in intracellular living "energy parasites" and plant plastids. The additional Pi transport capacity of NTT-type ATP/ADP transporters makes the existence of an interacting P-i exporter dispensable and might explain why a corresponding protein so far has not been identified.	[Trentmann, Oliver; Jung, Benjamin; Neuhaus, Horst Ekkehard; Haferkamp, Ilka] TU Kaiserslautern, D-67653 Kaiserslautern, Germany	University of Kaiserslautern	Haferkamp, I (corresponding author), TU Kaiserslautern, Erwin Schrodinger Str 22, D-67653 Kaiserslautern, Germany.	haferk@rhrk.uni-kl.de			Deutsche Forschungsgemeinschaft [SPP 1131]; Graduate Research School [845]; Stiftung Rheinland-Pfalz Innovation [766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate Research School; Stiftung Rheinland-Pfalz Innovation	This work was supported by the Deutsche Forschungsgemeinschaft Grant SPP 1131 and Graduate Research School Grant 845 and by the Stiftung Rheinland-Pfalz Innovation Project 766. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Audia JP, 2006, J BACTERIOL, V188, P6261, DOI 10.1128/JB.00371-06; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan FY, 1996, J BACTERIOL, V178, P3974, DOI 10.1128/jb.178.13.3974-3977.1996; Daugherty RM, 2004, J BACTERIOL, V186, P3262, DOI 10.1128/JB.186.10.3262-3265.2004; Flugge UI, 1999, ANNU REV PLANT PHYS, V50, P27, DOI 10.1146/annurev.arplant.50.1.27; Guo B, 2008, NEW PHYTOL, V177, P889, DOI 10.1111/j.1469-8137.2007.02331.x; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Harris RM, 2001, J BACTERIOL, V183, P5008, DOI 10.1128/JB.183.17.5008-5014.2001; HATCH TP, 1982, J BACTERIOL, V150, P662, DOI 10.1128/JB.150.2.662-670.1982; Hatch TP, 1999, CHLAMYDIA, P29; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KRAMER R, 1980, BIOCHEMISTRY-US, V19, P556; KRAUSE DC, 1985, P NATL ACAD SCI USA, V82, P3015, DOI 10.1073/pnas.82.9.3015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linka N, 2003, GENE, V306, P27, DOI 10.1016/S0378-1119(03)00429-3; MAHONY JB, 2003, MANUAL CLIN MICROBIO, P991; Mohlmann T, 1998, EUR J BIOCHEM, V252, P353, DOI 10.1046/j.1432-1327.1998.2520353.x; Reinhold T, 2007, PLANT J, V50, P293, DOI 10.1111/j.1365-313X.2007.03049.x; Reiser J, 2004, PLANT PHYSIOL, V136, P3524, DOI 10.1104/pp.104.049502; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Schmitz-Esser S, 2008, J BACTERIOL, V190, P5746, DOI 10.1128/JB.00391-08; Schwoppe C, 2002, J BACTERIOL, V184, P2108, DOI 10.1128/JB.184.8.2108-2115.2002; STAPPEN R, 1994, J BIOL CHEM, V269, P11240; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Tjaden J, 1998, PLANT J, V16, P531, DOI 10.1046/j.1365-313X.1998.00317.x; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; Trentmann O, 2000, EUR J BIOCHEM, V267, P4098, DOI 10.1046/j.1432-1033.2000.01468.x; Trentmann O, 2007, PLOS BIOL, V5, P1938, DOI 10.1371/journal.pbio.0050231; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; WEISBURG WG, 1989, J BACTERIOL, V171, P4202, DOI 10.1128/JB.171.8.4202-4206.1989; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; WINKLER HH, 1976, J BIOL CHEM, V251, P389; WINKLER HH, 1986, METHOD ENZYMOL, V125, P253; WINKLER HH, 1984, J BACTERIOL, V169, P76	38	41	41	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36486	36493		10.1074/jbc.M806903200	http://dx.doi.org/10.1074/jbc.M806903200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	19001371	Green Published, hybrid			2022-12-27	WOS:000261840500046
J	Zhou, XL; Zhu, B; Wang, ED				Zhou, Xiao-Long; Zhu, Bin; Wang, En-Duo			The CP2 Domain of Leucyl-tRNA Synthetase Is Crucial for Amino Acid Activation and Post-transfer Editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; TRNA(LEU); COMPLEX; DISCRIMINATION; PURIFICATION; POLYMERASE	Leucyl-tRNA synthetase (LeuRS) has an insertion domain, called connective peptide 2 (CP2), either directly preceding or following the editing domain (CP1 domain), depending on the species. The global structures of the CP2 domains from all LeuRSs are similar. Although the CP1 domain has been extensively explored to be responsible for hydrolysis of mischarged tRNALeu, the role of the CP2 domain remains undefined. In the present work, deletion of the CP2 domain of Giardia lamblia LeuRS (GlLeuRS) showed that the CP2 domain is indispensable for amino acid activation and post-transfer editing and that it contributes to LeuRS-tRNA(Leu) binding affinity. In addition, its functions are conserved in both eukaryotic/archaeal and prokaryotic LeuRSs from G. lamblia, Pyrococcus horikoshii (PhLeuRS), and Escherichia coli (EcLeuRS). Alanine scanning and site-directed mutagenesis assays of the CP2 domain identified several residues that are crucial for its various functions. Data from the chimeric mutants, which replaced the CP2 domain of GlLeuRS with either PhLeuRS or EcLeuRS, showed that the CP2 domain of PhLeuRS but not that of EcLeuRS can partially restore amino acid activation and post-transfer editing functions, suggesting that the functions of the CP2 domain are dependent on its location in the primary sequence of LeuRS.	Chinese Acad Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, ED (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibs.ac.cn			National Key Basic Research Foundation of China [2006CB910301]; Natural Science Foundation of China [30670463]; Committee of Science and Technology in Shanghai [06JC14076]	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee)	This work was funded by the National Key Basic Research Foundation of China (Grant 2006CB910301), the Natural Science Foundation of China (Grant 30670463), and the Committee of Science and Technology in Shanghai (Grant 06JC14076). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Li Y, 1999, PROTEIN EXPRES PURIF, V16, P355, DOI 10.1006/prep.1999.1083; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Xu MG, 2004, BIOCHEM BIOPH RES CO, V318, P11, DOI 10.1016/j.bbrc.2004.03.180; Xu MG, 2002, J BIOL CHEM, V277, P41590, DOI 10.1074/jbc.M205126200; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618; Zuniga R, 2002, FEBS LETT, V532, P387, DOI 10.1016/S0014-5793(02)03720-1	20	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36608	36616		10.1074/jbc.M806745200	http://dx.doi.org/10.1074/jbc.M806745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18955487	hybrid, Green Published			2022-12-27	WOS:000261840500059
J	Jerng, HH; Pfaffinger, PJ				Jerng, Henry H.; Pfaffinger, Paul J.			Multiple Kv Channel-interacting Proteins Contain an N-terminal Transmembrane Domain That Regulates Kv4 Channel Trafficking and Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; POTASSIUM CHANNELS; K+ CHANNELS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; STRUCTURAL BASIS; MODULATION; INACTIVATION; RETRIEVAL; KCHIP1	Kv channel-interacting proteins (KChIPs) are auxiliary subunits of the heteromultimeric channel complexes that underlie neuronal I-SA, the subthreshold transient K+ current that dynamically regulates membrane excitability, action potential firing properties, and long term potentiation. KChIPs form cytoplasmic associations with the principal pore-forming Kv4 subunits and typically mediate enhanced surface expression and accelerated recovery from depolarization-induced inactivation. An exception is KChIP4a, which dramatically suppresses Kv4 inactivation while promoting neither surface expression nor recovery. These unusual properties are attributed to the effects of a K channel inactivation suppressor domain (KISD) encoded within the variable N terminus of KChIP4a. Here, we have functionally and biochemically characterized two brain KChIP isoforms, KChIP2x and KChIP3x (also known as KChIP3b) and show that they also contain a functional KISD. Like KChIP4a and in contrast with non-KISD-containing KChIPs, both KChIP2x and KChIP3x strongly suppress inactivation and slow activation and inhibit the typical increases in surface expression of Kv4.2 channels. We then examined the properties of the KISD to determine potential mechanisms for its action. Subcellular fractionation shows that KChIP4a, KChIP2x, and KChIP3x are highly associated with the membrane fraction. Fluorescent confocal imaging of enhanced green fluorescent proteins (eGFP) N-terminally fused with KISD in HEK293T cells indicates that KISDs of KChIP4a, KChIP2x, and KChIP3x all autonomously target eGFP to intracellular membranes. Cell surface biotinylation experiments on KChIP4a indicate that the N terminus is exposed extracellularly, consistent with a transmembrane KISD. In summary, KChIP4a, KChIP2x, and KChIP3x comprise a novel class of KChIP isoforms characterized by an unusual transmembrane domain at their N termini that modulates Kv4 channel gating and trafficking.	[Jerng, Henry H.; Pfaffinger, Paul J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Jerng, HH (corresponding author), Baylor Coll Med, Dept Neurosci, 1 Baylor Plaza,S630, Houston, TX 77030 USA.	hjerng@cns.bcm.tmc.edu			National Institutes of Health [PO1 NS37444]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037444, R01NS031583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 NS37444. Some of the data presented here have previously appeared in abstract form (17). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Baranauskas G, 2004, EUR J NEUROSCI, V20, P385, DOI 10.1111/j.1460-9568.2004.03494.x; Beck EJ, 2002, J PHYSIOL-LONDON, V538, P691, DOI 10.1113/jphysiol.2001.013127; CHABALA LD, 1993, J GEN PHYSIOL, V102, P713, DOI 10.1085/jgp.102.4.713; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Deschenes I, 2002, FEBS LETT, V528, P183, DOI 10.1016/S0014-5793(02)03296-9; Dougherty K, 2006, J GEN PHYSIOL, V128, P745, DOI 10.1085/jgp.200609668; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Gebauer M, 2004, BIOPHYS J, V86, P210, DOI 10.1016/S0006-3495(04)74097-7; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JERNG H, 2008, BIOPHYS J, V94, P521; Jerng HH, 2007, MOL CELL NEUROSCI, V35, P604, DOI 10.1016/j.mcn.2007.03.008; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; O'Callaghan DW, 2003, J CELL SCI, V116, P4833, DOI 10.1242/jcs.00803; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Schultz JH, 2007, PFLUG ARCH EUR J PHY, V454, P195, DOI 10.1007/s00424-006-0203-1; Schwenk J, 2008, J BIOL CHEM, V283, P18937, DOI 10.1074/jbc.M800976200; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Tinel N, 2000, FEBS LETT, V480, P137, DOI 10.1016/S0014-5793(00)01918-9; TOWNSLEY FM, 1994, EUR J CELL BIOL, V64, P211; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Woo HN, 2008, NEUROREPORT, V19, P1193, DOI 10.1097/WNR.0b013e3283089209; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5	45	29	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					36046	36059		10.1074/jbc.M806852200	http://dx.doi.org/10.1074/jbc.M806852200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957440	Green Published, hybrid			2022-12-27	WOS:000261687900079
J	Nightingale, TD; Frayne, MEF; Clasper, S; Banerji, S; Jackson, DG				Nightingale, Thomas D.; Frayne, Matthew E. F.; Clasper, Steven; Banerji, Suneale; Jackson, David G.			A Mechanism of Sialylation Functionally Silences the Hyaluronan Receptor LYVE-1 in Lymphatic Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLATION MUTANTS; ADHESION MOLECULES; N-GLYCOSYLATION; BINDING DOMAIN; CELL-SURFACE; CD44; INFLAMMATION; LYMPHANGIOGENESIS; EXPRESSION; MUTATIONS	The major lymphatic endothelial hyaluronan receptor LYVE-1, a Link superfamily glycoprotein similar to the hyaluronan-binding/inflammatory leukocyte homing receptor CD44, was initially implicated in hyaluronan (HA)-mediated cell adhesion and lymph-borne hyaluronan metabolism. However, the apparently normal phenotype of Lyve-1 knock-out mice and the recent demonstration that the receptor undergoes cytokine-induced endocytosis independent of HA uptake have cast doubt on such functions. Here we present new data that reconcile these anomalies by showing that LYVE-1 is functionally "silenced" in a cell-specific fashion by autoinhibitory glycosylation. We demonstrate that LYVE-1 transfected in HEK 293T fibroblasts and Jurkat T cells is competent to bind HA, whereas the endogenous receptor in cultured lymphatic endothelial cells or the receptor transfected in Chinese hamster ovary and HeLa cells is not. Moreover, through a combination of mutagenesis and functional analysis in HEK 293T fibroblasts and glycosylation-defective Chinese hamster ovary cell lines, we reveal that the inhibitory mechanism is reversible and is exerted by terminal sialylation, most likely through alpha 2-3 or alpha 2-6 linkage to O-glycans. Finally, we provide evidence that the mechanism operates in vivo by showing that native LYVE-1 in primary lymphatic endothelial cells is extensively sialylated and that HA binding can be reactivated by neuraminidase treatment of the soluble ectodomain. These results reveal unexpected complexity in the regulation of LYVE-1 function and raise the possibility that this receptor, like CD44, may become active after appropriate unmasking in vivo.	[Nightingale, Thomas D.; Frayne, Matthew E. F.; Clasper, Steven; Banerji, Suneale; Jackson, David G.] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England	University of Oxford	Jackson, DG (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford OX3 9DS, England.	djackson@hammer.imm.ox.ac.uk		, david/0000-0002-4133-9364; Nightingale, Thomas/0000-0002-3429-0988	United Kingdom Medical Research Council (MRC); MRC; Medical Research Council [MC_U137884182] Funding Source: researchfish; MRC [MC_U137884182] Funding Source: UKRI	United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the United Kingdom Medical Research Council (MRC) (to D. G. J.) and by MRC D. Phil studentships (to T. D. N. and M. E. F. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Carreira CM, 2001, CANCER RES, V61, P8079; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; English NM, 1998, CANCER RES, V58, P3736; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; FRASER JRE, 1988, BIOCHEM J, V256, P153, DOI 10.1042/bj2560153; Gale NW, 2007, MOL CELL BIOL, V27, P595, DOI 10.1128/MCB.01503-06; Gee K, 2003, J BIOL CHEM, V278, P37275, DOI 10.1074/jbc.M302309200; Hong YJ, 2003, J BIOL CHEM, V278, P53045, DOI 10.1074/jbc.M309967200; Huang SS, 2006, FEBS LETT, V580, P6259, DOI 10.1016/j.febslet.2006.10.028; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Jackson DG, 2007, CANCER TREAT RES, P39; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Katoh S, 1999, J IMMUNOL, V162, P5058; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; Kincade PW, 1997, CURR OPIN CELL BIOL, V9, P635, DOI 10.1016/S0955-0674(97)80116-0; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; TENGBLAD A, 1986, BIOCHEM J, V236, P521, DOI 10.1042/bj2360521; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Witte MH, 2006, CANCER METAST REV, V25, P159, DOI 10.1007/s10555-006-8496-2; Xu Z, 2002, NAT IMMUNOL, V3, P764, DOI 10.1038/ni822; YU Q, 1995, BIOTECHNIQUES, V19, P122	45	44	47	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3935	3945		10.1074/jbc.M805105200	http://dx.doi.org/10.1074/jbc.M805105200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19033446	hybrid			2022-12-27	WOS:000262872500062
J	Balsera, M; Goetze, TA; Kovacs-Bogdan, E; Schurmann, P; Wagner, R; Buchanan, BB; Soll, J; Bolter, B				Balsera, Monica; Goetze, Tom A.; Kovacs-Bogdan, Erika; Schuermann, Peter; Wagner, Richard; Buchanan, Bob B.; Soll, Juergen; Boelter, Bettina			Characterization of Tic110, a Channel-forming Protein at the Inner Envelope Membrane of Chloroplasts, Unveils a Response to Ca2+ and a Stromal Regulatory Disulfide Bridge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; CIRCULAR-DICHROISM SPECTRA; IMPORT MACHINERY; CONDUCTING CHANNEL; CALCIUM REGULATION; TRANSLOCATION; COMPONENT; PRECURSOR; PLASTIDS; IDENTIFICATION	Tic110 has been proposed to be a channel-forming protein at the inner envelope of chloroplasts whose function is essential for the import of proteins synthesized in the cytosol. Sequence features and topology determination experiments presently summarized suggest that Tic110 consists of six transmembrane helices. Its topology has been mapped by limited proteolysis experiments in combination with mass spectrometric determinations and cysteine modification analysis. Two hydrophobic transmembrane helices located in the N terminus serve as a signal for the localization of the protein to the membrane as shown previously. The other amphipathic transmembrane helices are located in the region composed of residues 92-959 in the pea sequence. This results in two regions in the intermembrane space localized to form supercomplexes with the TOC machinery and to receive the transit peptide of preproteins. A large region also resides in the stroma for interaction with proteins such as molecular chaperones. In addition to characterizing the topology of Tic110, we show that Ca2+ has a dramatic effect on channel activity in vitro and that the protein has a redox-active disulfide with the potential to interact with stromal thioredoxin.	[Balsera, Monica; Kovacs-Bogdan, Erika; Soll, Juergen; Boelter, Bettina] Univ Munich, Munich Integrated Prot Sci CiPSM, D-81377 Munich, Germany; [Balsera, Monica; Kovacs-Bogdan, Erika; Buchanan, Bob B.; Soll, Juergen; Boelter, Bettina] Univ Munich, Dept Biol Bot 1, D-82152 Planegg Martinsried, Germany; [Goetze, Tom A.; Wagner, Richard] Univ Osnabruck, Dept Biophys, D-49076 Osnabruck, Germany; [Schuermann, Peter] Univ Neuchatel, Mol & Cellular Biol Lab, CH-2009 Neuchatel, Switzerland; [Buchanan, Bob B.] Univ Calif Berkeley, Dept Astrophys Planetary & Atmospher Sci, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of Munich; University of Munich; University Osnabruck; University of Neuchatel; University of California System; University of California Berkeley	Balsera, M (corresponding author), Paul Scherrer Inst, Dept Biol Struct, CH-5232 Villigen, Switzerland.	monica.balsera@psi.ch	Balsera, Monica/K-2877-2014; Goetze, Tom/I-1891-2013	Balsera, Monica/0000-0002-5586-6050; 	Deutsche Forschungsgemeinschaft [SFB594]; Fundacion Ramon Areces; International Max-Planck Research School for Life Sciences; Bayerische Hochschulzentrum furr Mittel-, Ost-, und Surdosteuropa	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fundacion Ramon Areces; International Max-Planck Research School for Life Sciences; Bayerische Hochschulzentrum furr Mittel-, Ost-, und Surdosteuropa	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB594, Fundacion Ramon Areces ( to M. B.), International Max-Planck Research School for Life Sciences ( to E. K. B.), and Bayerische Hochschulzentrum furr Mittel-, Ost-, und Surdosteuropa ( to E. K. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexandrov N N, 1996, Pac Symp Biocomput, P53; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BALSERA M, 2007, BMC EVOL BIOL, P7; BARTSCH S, 2008, NATL ACAD SCI US, V105, P4933; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chigri F, 2005, PLANT J, V42, P821, DOI 10.1111/j.1365-313X.2005.02414.x; Chigri F, 2006, P NATL ACAD SCI USA, V103, P16051, DOI 10.1073/pnas.0607150103; DALMAS B, 1994, BIOCHEM MOL BIOL INT, V34, P17; DOMINGUEZSOLIS JR, 2008, NATL ACAD SCI US, V105, P16386; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Eyre TA, 2004, PROTEIN ENG DES SEL, V17, P613, DOI 10.1093/protein/gzh072; Fernandez-Vidall M, 2007, J MOL BIOL, V370, P459, DOI 10.1016/j.jmb.2007.05.016; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Goetze TA, 2006, J BIOL CHEM, V281, P17989, DOI 10.1074/jbc.M600700200; Heins L, 2002, EMBO J, V21, P2616, DOI 10.1093/emboj/21.11.2616; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hille B, 2001, ION CHANNELS EXCITAB, V3rd, P445; Hirohashi T, 2001, PLANT PHYSIOL, V125, P2154, DOI 10.1104/pp.125.4.2154; Horling F, 2002, PLANT PHYSIOL BIOCH, V40, P491, DOI 10.1016/S0981-9428(02)01396-7; Hormann F, 2004, J BIOL CHEM, V279, P34756, DOI 10.1074/jbc.M402817200; Inaba T, 2005, PLANT CELL, V17, P1482, DOI 10.1105/tpc.105.030700; Inaba T, 2003, J BIOL CHEM, V278, P38617, DOI 10.1074/jbc.M306367200; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Kuchler M, 2002, EMBO J, V21, P6136, DOI 10.1093/emboj/cdf621; Lemker T, 2003, FEBS LETT, V544, P206, DOI 10.1016/S0014-5793(03)00496-4; Lubeck J, 1996, EMBO J, V15, P4230, DOI 10.1002/j.1460-2075.1996.tb00797.x; McFadden GI, 2004, CURR BIOL, V14, pR514, DOI 10.1016/j.cub.2004.06.041; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oreb M, 2008, TRENDS CELL BIOL, V18, P19, DOI 10.1016/j.tcb.2007.10.002; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pesaresi P, 2007, CURR OPIN PLANT BIOL, V10, P600, DOI 10.1016/j.pbi.2007.07.007; Phoenix DA, 2002, CURR PROTEIN PEPT SC, V3, P201, DOI 10.2174/1389203024605368; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stengel A, 2008, J BIOL CHEM, V283, P6656, DOI 10.1074/jbc.M706719200; Stengel A, 2007, BIOL CHEM, V388, P765, DOI 10.1515/BC.2007.099; Sveshnikova N, 2000, BIOL CHEM, V381, P687, DOI 10.1515/BC.2000.089; Trebitsh T, 2000, MOL CELL BIOL, V20, P1116, DOI 10.1128/MCB.20.4.1116-1123.2000; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vojta A, 2005, ANAL BIOCHEM, V347, P24, DOI 10.1016/j.ab.2005.09.003; Waegemann K, 1995, METHOD CELL BIOL, V50, P255, DOI 10.1016/S0091-679X(08)61035-3; Wirth A, 2003, MOL CELL, V12, P261, DOI 10.1016/S1097-2765(03)00283-1; WU CB, 1994, J BIOL CHEM, V269, P32264	59	79	84	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2603	2616		10.1074/jbc.M807134200	http://dx.doi.org/10.1074/jbc.M807134200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	18986981	Green Submitted, hybrid			2022-12-27	WOS:000262700900003
J	Goodwin, JS; Larson, GA; Swant, J; Sen, N; Javitch, JA; Zahniser, NR; De Felice, LJ; Khoshbouei, H				Goodwin, J. Shawn; Larson, Gaynor A.; Swant, Jarod; Sen, Namita; Javitch, Jonathan A.; Zahniser, Nancy R.; De Felice, Louis J.; Khoshbouei, Habibeh			Amphetamine and Methamphetamine Differentially Affect Dopamine Transporters in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NUCLEUS-ACCUMBENS; PLASMA-MEMBRANE; MONOAMINE TRANSPORTERS; BEHAVIORAL-RESPONSES; LOCOMOTOR-ACTIVITY; UPTAKE INHIBITORS; CROSS-LINKING; CELL LINES; RELEASE	The psychostimulants D-amphetamine (AMPH) and methamphetamine (METH) release excess dopamine (DA) into the synaptic clefts of dopaminergic neurons. Abnormal DA release is thought to occur by reverse transport through the DA transporter (DAT), and it is believed to underlie the severe behavioral effects of these drugs. Here we compare structurally similar AMPH and METH on DAT function in a heterologous expression system and in an animal model. In the in vitro expression system, DAT-mediated whole-cell currents were greater for METH stimulation than for AMPH. At the same voltage and concentration, METH released five times more DA than AMPH and did so at physiological membrane potentials. At maximally effective concentrations, METH released twice as much [Ca2+](i) from internal stores compared with AMPH. [Ca2+](i) responses to both drugs were independent of membrane voltage but inhibited by DAT antagonists. Intact phosphorylation sites in the N-terminal domain of DAT were required for the AMPH-and METH-induced increase in [Ca2+](i) and for the enhanced effects of METH on [Ca2+](i) elevation. Calmodulin-dependent protein kinase II and protein kinase C inhibitors alone or in combination also blocked AMPH-or METH-induced Ca2+ responses. Finally, in the rat nucleus accumbens, in vivo voltammetry showed that systemic application of METH inhibited DAT-mediated DA clearance more efficiently than AMPH, resulting in excess external DA. Together these data demonstrate that METH has a stronger effect on DAT-mediated cell physiology than AMPH, which may contribute to the euphoric and addictive properties of METH compared with AMPH.	[Swant, Jarod; Khoshbouei, Habibeh] Meharry Med Coll, Dept Neurobiol & Neurotoxicol, Nashville, TN 37208 USA; [Goodwin, J. Shawn; De Felice, Louis J.] Meharry Med Coll, Dept Canc Biol, Nashville, TN 37208 USA; [Larson, Gaynor A.; Zahniser, Nancy R.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [De Felice, Louis J.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; [De Felice, Louis J.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, Dept Pharmacol, New York, NY 10027 USA; [Sen, Namita; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, New York, NY 10027 USA	Meharry Medical College; Meharry Medical College; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University; Vanderbilt University; Columbia University; Columbia University	Khoshbouei, H (corresponding author), Meharry Med Coll, Dept Neurobiol & Neurotoxicol, 3244 W Basic Sci Bldg,1005 Dr B Todd Jr Blvd, Nashville, TN 37208 USA.			Khoshbouei, Habibeh/0000-0002-1533-8771; Javitch, Jonathan/0000-0001-7395-2967; De Felice, Louis/0000-0002-4594-3171	National Institutes of Health [HL076133, DA021471, NS034075, DA06338, DA012408, DA022413, DA004216, DA015050, U54NS041071, G12RR03032, U54CA91408, U54RR019192]; National Science Foundation [IOS-0642188]; Meharry Medical College Morphology Core; NATIONAL CANCER INSTITUTE [U54CA091408] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019192, G12RR003032] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034075, U54NS041071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, R37DA004216, P01DA012408, R01DA004216, K05DA015050, R24DA021471, R01DA026947] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Meharry Medical College Morphology Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL076133 (to J.S.), DA021471 (to H. K.), NS034075 and DA06338 (to L. J. D. F.), DA012408 and DA022413 (to J. A. J.), and DA004216 and DA015050 (to N.R.Z.). This work was also supported by National Science Foundation Award IOS-0642188 (to H. K.). Microscopy experiments and data analysis were performed through the use of the Meharry Medical College Morphology Core, which is supported in part by National Institutes of Health Grants U54NS041071, G12RR03032, U54CA91408, and U54RR019192. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Broom SL, 2005, PSYCHOPHARMACOLOGY, V181, P467, DOI 10.1007/s00213-005-0007-6; Browman KE, 1998, BRAIN RES, V814, P112, DOI 10.1016/S0006-8993(98)01040-3; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; CASS WA, 1993, J NEUROCHEM, V61, P273, DOI 10.1111/j.1471-4159.1993.tb03565.x; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chan SL, 2006, J BIOL CHEM, V281, P37391, DOI 10.1074/jbc.M605552200; Colliver J. D., 2006, MISUSE PRESCRIPTION; COX RH, 1972, J PHARMACOL-PARIS, V181, P1; Doolen S, 2002, FEBS LETT, V516, P187, DOI 10.1016/S0014-5793(02)02554-1; Doolen S, 2001, J PHARMACOL EXP THER, V296, P931; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; FISCHER JF, 1976, P W PHARMACOL SOC, V19, P179; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Foster JD, 2003, MOL BRAIN RES, V110, P100, DOI 10.1016/S0169-328X(02)00645-9; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Fujimoto Y, 2007, EXP ANIM TOKYO, V56, P119, DOI 10.1538/expanim.56.119; Garcia BG, 2005, MOL PHARMACOL, V68, P102, DOI 10.1124/mol.104.009092; GIAMBALVO CT, 1989, BIOCHEM PHARMACOL, V38, P4445, DOI 10.1016/0006-2952(89)90655-2; GIAMBALVO CT, 1988, BIOCHEM PHARMACOL, V37, P4009, DOI 10.1016/0006-2952(88)90087-1; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; Gorentla BK, 2005, NEUROPHARMACOLOGY, V49, P759, DOI 10.1016/j.neuropharm.2005.08.011; Gulley JM, 2007, BRAIN RES, V1151, P32, DOI 10.1016/j.brainres.2007.03.009; Hall DA, 2008, PSYCHOPHARMACOLOGY, V195, P469, DOI 10.1007/s00213-007-0923-8; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Hanson GR, 2004, NEUROPHARMACOLOGY, V47, P92, DOI 10.1016/j.neuropharm.2004.06.004; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Huff RA, 1997, J NEUROCHEM, V68, P225; John CE, 2007, NEUROPHARMACOLOGY, V52, P1596, DOI 10.1016/j.neuropharm.2007.03.004; Johnson RA, 1998, SYNAPSE, V30, P97, DOI 10.1002/(SICI)1098-2396(199809)30:1<97::AID-SYN12>3.0.CO;2-M; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1998, J NEUROSCI, V18, P1979; Joyce BM, 2007, PSYCHOPHARMACOLOGY, V191, P669, DOI 10.1007/s00213-006-0550-9; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kahlig KM, 2003, EUR J PHARMACOL, V479, P153, DOI 10.1016/j.ejphar.2003.08.065; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kantor L, 1998, J PHARMACOL EXP THER, V284, P592; Kantor L, 2001, J PHARMACOL EXP THER, V297, P1016; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Kitaichi K, 2003, EUR J PHARMACOL, V464, P39, DOI 10.1016/S0014-2999(03)01321-9; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; LUCAJ Z, 1994, BRAIN RES, V660, P1, DOI 10.1016/0006-8993(94)90832-X; LYTTON J, 1991, J BIOL CHEM, V266, P17067; National Toxicology Program, 2006, Natl Toxicol Program Tech Rep Ser, P1; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PEACHEY JE, 1977, PSYCHOPHARMACOLOGY, V51, P137, DOI 10.1007/BF00431729; Rees S, 1996, BIOTECHNIQUES, V20, P102; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Robbins AK, 1998, BIOTECHNIQUES, V25, P240, DOI 10.2144/98252st04; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sandoval V, 2001, J NEUROSCI, V21, P1413; Segal DS, 1997, J PHARMACOL EXP THER, V282, P561; Shoblock JR, 2003, PSYCHOPHARMACOLOGY, V165, P359, DOI 10.1007/s00213-002-1288-7; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Vaughan RA, 2004, J PHARMACOL EXP THER, V310, P1, DOI 10.1124/jpet.103.052423; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; WALL SC, 1995, MOL PHARMACOL, V47, P544; Zahniser NR, 1998, METHOD ENZYMOL, V296, P708; Zahniser NR, 1999, ALCOHOL CLIN EXP RES, V23, P1721, DOI 10.1111/j.1530-0277.1999.tb04066.x	69	131	132	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2978	2989		10.1074/jbc.M805298200	http://dx.doi.org/10.1074/jbc.M805298200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047053	Green Published, hybrid			2022-12-27	WOS:000262700900042
J	Liu, CL; Wu, J; Zhu, J; Kuei, C; Yu, JX; Shelton, J; Sutton, SW; Li, X; Yun, SJ; Mirzadegan, T; Mazur, C; Kamme, F; Lovenberg, TW				Liu, Changlu; Wu, Jiejun; Zhu, Jessica; Kuei, Chester; Yu, Jingxue; Shelton, Jonathan; Sutton, Steven W.; Li, Xiaorong; Yun, Su Jin; Mirzadegan, Taraneh; Mazur, Curt; Kamme, Fredrik; Lovenberg, Timothy W.			Lactate Inhibits Lipolysis in Fat Cells through Activation of an Orphan G-protein-coupled Receptor, GPR81	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL LACTIC-ACIDOSIS; NICOTINIC-ACID; GAMMA-HYDROXYBUTYRATE; ADIPOSE-TISSUE; SELECTIVE LIGAND; BLOOD LACTATE; CANCER-CELLS; PUMA-G; DICHLOROACETATE; METABOLISM	Lactic acid is a well known metabolic by-product of intense exercise, particularly under anaerobic conditions. Lactate is also a key source of energy and an important metabolic substrate, and it has also been hypothesized to be a signaling molecule directing metabolic activity. Here we show that GPR81, an orphan G-protein-coupled receptor highly expressed in fat, is in fact a sensor for lactate. Lactate activates GPR81 in its physiological concentration range of 1-20 mM and suppresses lipolysis in mouse, rat, and human adipocytes as well as in differentiated 3T3-L1 cells. Adipocytes from GPR81-deficient mice lack an antilipolytic response to lactate but are responsive to other antilipolytic agents. Lactate specifically induces internalization of GPR81 after receptor activation. Site-directed mutagenesis of GPR81 coupled with homology modeling demonstrates that classically conserved key residues in the transmembrane binding domains are responsible for interacting with lactate. Our results indicate that lactate suppresses lipolysis in adipose tissue through a direct activation of GPR81. GPR81 may thus be an attractive target for the treatment of dyslipidemia and other metabolic disorders.	[Liu, Changlu; Wu, Jiejun; Zhu, Jessica; Kuei, Chester; Yu, Jingxue; Shelton, Jonathan; Sutton, Steven W.; Li, Xiaorong; Yun, Su Jin; Mirzadegan, Taraneh; Mazur, Curt; Kamme, Fredrik; Lovenberg, Timothy W.] Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA	Liu, CL (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, 3210 Merryfield Row, San Diego, CA 92121 USA.	cliu9@its.jnj.com						Achten J, 2004, INT J SPORTS MED, V25, P32, DOI 10.1055/s-2003-45231; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; BJORNTORP P, 1965, ACTA MED SCAND, V178, P253; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Borgen LA, 2004, J CLIN PHARMACOL, V44, P253, DOI 10.1177/0091270003262795; BOYD AE, 1974, METABOLISM, V23, P531, DOI 10.1016/0026-0495(74)90081-X; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; CHEETHAM ME, 1986, J APPL PHYSIOL, V61, P54, DOI 10.1152/jappl.1986.61.1.54; Cheng K, 2006, P NATL ACAD SCI USA, V103, P6682, DOI 10.1073/pnas.0601574103; CLARK AS, 1987, J CLIN INVEST, V79, P588, DOI 10.1172/JCI112851; DEPERGOLA G, 1989, HORM METAB RES, V21, P210, DOI 10.1055/s-2007-1009193; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; Elliott SP, 2004, THER DRUG MONIT, V26, P432, DOI 10.1097/00007691-200408000-00014; FAIN JN, 1976, J LIPID RES, V17, P377; FERRANNINI E, 1993, AM J PHYSIOL, V265, pE504, DOI 10.1152/ajpendo.1993.265.3.E504; GARG A, 1990, JAMA-J AM MED ASSOC, V264, P723, DOI 10.1001/jama.264.6.723; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Ge H, 2008, J LIPID RES, V49, P797, DOI 10.1194/jlr.M700513-JLR200; Gonzalez A, 2005, J PSYCHOPHARMACOL, V19, P195, DOI 10.1177/0269881105049041; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; HAGSTROM E, 1990, AM J PHYSIOL, V258, pE888, DOI 10.1152/ajpendo.1990.258.5.E888; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hosoi T, 2002, J BIOL CHEM, V277, P31459, DOI 10.1074/jbc.M203194200; HUGHSON RL, 1987, J APPL PHYSIOL, V62, P1975, DOI 10.1152/jappl.1987.62.5.1975; Kamijo Y, 2000, J APPL PHYSIOL, V89, P2196, DOI 10.1152/jappl.2000.89.6.2196; Kato-Weinstein J, 1998, TOXICOLOGY, V130, P141, DOI 10.1016/S0300-483X(98)00106-1; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; LeBeau MA, 2006, J ANAL TOXICOL, V30, P98, DOI 10.1093/jat/30.2.98; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Lingohr MK, 2002, TOXICOL SCI, V68, P508, DOI 10.1093/toxsci/68.2.508; Liu CL, 2005, J BIOL CHEM, V280, P292, DOI 10.1074/jbc.M409916200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Maitre M, 1997, PROG NEUROBIOL, V51, P337, DOI 10.1016/S0301-0082(96)00064-0; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; OHKUWA T, 1984, EUR J APPL PHYSIOL O, V53, P213, DOI 10.1007/BF00776592; SHUMATE JS, 1979, RES COMMUN CHEM PATH, V25, P241; SOLAPENNA M, 2008, IUBMB LIFE, V49, P797; Stacpoole PW, 2008, PEDIATRICS, V121, pE1223, DOI 10.1542/peds.2007-2062; Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226; Stacpoole PW, 2003, J CLIN PHARMACOL, V43, P683, DOI 10.1177/0091270003254637; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Wong CGT, 2004, TRENDS PHARMACOL SCI, V25, P29, DOI 10.1016/j.tips.2003.11.001; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038	53	305	319	4	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2811	2822		10.1074/jbc.M806409200	http://dx.doi.org/10.1074/jbc.M806409200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047060	hybrid			2022-12-27	WOS:000262700900024
J	Wang, S; Alimi, Y; Tong, A; Nichols, CG; Enkvetchakul, D				Wang, Shizhen; Alimi, Yewande; Tong, Ailing; Nichols, Colin G.; Enkvetchakul, Decha			Differential Roles of Blocking Ions in KirBac1.1 Tetramer Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNELS; RECTIFYING POTASSIUM CHANNELS; INWARD-RECTIFIER; SELECTIVITY FILTER; CRYSTAL-STRUCTURE; KIR CHANNEL; FUNCTIONAL-CHARACTERIZATION; 2.0-ANGSTROM RESOLUTION; KCSA; PORE	Potassium channels are tetrameric proteins that mediate K+-selective transmembrane diffusion. For KcsA, tetramer stability depends on interactions between permeant ions and the channel pore. We have examined the role of pore blockers on the tetramer stability of KirBac1.1. In 150 mM KCl, purified KirBac1.1 protein migrates as a monomer (similar to 40 kDa) on SDS-PAGE. Addition of Ba2+ (K-1/2 similar to 50 mu M) prior to loading results in an additional tetramer band (similar to 160 kDa). Mutation A109C, at a residue located near the expected Ba2+-binding site, decreased tetramer stabilization by Ba2+ (K-1/2 similar to 300 mu M), whereas I131C, located nearby, stabilized tetramers in the absence of Ba2+. Neither mutation affected Ba2+ block of channel activity (using Rb-86(+) flux assay). In contrast to Ba2+, Mg2+ had no effect on tetramer stability (even though Mg2+ was a potent blocker). Many studies have shown Cd2+ block of K+ channels as a result of cysteine substitution of cavity-lining M2 (S6) residues, with the implicit interpretation that coordination of a single ion by cysteine side chains along the central axis effectively blocks the pore. We examined blocking and tetramer-stabilizing effects of Cd2+ on KirBac1.1 with cysteine substitutions in M2. Cd2+ block potency followed an alpha-helical pattern consistent with the crystal structure. Significantly, Cd2+ strongly stabilized tetramers of I138C, located in the center of the inner cavity. This stabilization was additive with the effect of Ba2+, consistent with both ions simultaneously occupying the channel: Ba2+ at the selectivity filter entrance and Cd2+ coordinated by I138C side chains in the inner cavity.	[Wang, Shizhen; Alimi, Yewande; Enkvetchakul, Decha] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Wang, Shizhen; Tong, Ailing; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL)	Enkvetchakul, D (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	denkvetc@slu.edu	Nichols, Colin/D-6336-2012; Wang, Shizhen/N-6577-2017	Wang, Shizhen/0000-0003-1065-4756; Alimi, Yewande/0000-0002-7318-7158	National Institutes of Health [DK069424, DK069424-02S1, HL54171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK069424 and DK069424-02S1 (to D. E.) and HL54171 (to C. G. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; ChauhanPatel R, 1997, J MEMBRANE BIOL, V158, P265, DOI 10.1007/s002329900263; Compoint M, 2004, BBA-BIOMEMBRANES, V1661, P26, DOI 10.1016/j.bbamem.2003.11.019; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-14; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; FAKLER B, 1994, FEBS LETT, V356, P199, DOI 10.1016/0014-5793(94)01258-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Fujiwara Y, 2002, J GEN PHYSIOL, V120, P677, DOI 10.1085/jgp.20028663; Irizarry SN, 2002, BIOCHEMISTRY-US, V41, P13653, DOI 10.1021/bi026393r; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Krishnan MN, 2008, BIOCHEMISTRY-US, V47, P5354, DOI 10.1021/bi702281p; Krishnan MN, 2005, J GEN PHYSIOL, V126, P271, DOI 10.1085/jgp.200509323; Kubo Y, 2005, PHARMACOL REV, V57, P509, DOI 10.1124/pr.57.4.11; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Leung YM, 2000, CAN J PHYSIOL PHARM, V78, P751, DOI 10.1139/cjpp-78-9-751; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Loboda A, 2001, BIOPHYS J, V80, P2704, DOI 10.1016/S0006-3495(01)76239-X; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Melishchuk A, 1998, BIOPHYS J, V75, P1828, DOI 10.1016/S0006-3495(98)77624-6; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Neamtu A, 2004, Rom J Physiol, V41, P69; Nichols CG, 1996, CIRC RES, V78, P1, DOI 10.1161/01.RES.78.1.1; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; RANSOM CB, 1995, J NEUROPHYSIOL, V73, P333, DOI 10.1152/jn.1995.73.1.333; REES DC, 1989, ANNU REV BIOCHEM, V58, P607; Renart ML, 2006, J BIOL CHEM, V281, P29905, DOI 10.1074/jbc.M602636200; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; Sun S, 2006, PHYSIOL GENOMICS, V26, P1, DOI 10.1152/physiolgenomics.00026.2006; Szendroedi J, 2007, BIOPHYS J, V93, P4209, DOI 10.1529/biophysj.107.104794; van Dalen A, 2002, FEBS LETT, V525, P33, DOI 10.1016/S0014-5793(02)03061-2; van den Brink-van der Laan E, 2004, BIOCHEMISTRY-US, V43, P4240, DOI 10.1021/bi036129d; WISCHMEYER E, 1995, PFLUG ARCH EUR J PHY, V429, P809, DOI 10.1007/BF00374805; Xiao J, 2003, NAT NEUROSCI, V6, P811, DOI 10.1038/nn1090; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Zhou Y, 2004, BIOCHEMISTRY-US, V43, P4978, DOI 10.1021/bi049876z; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	52	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2854	2860		10.1074/jbc.M807474200	http://dx.doi.org/10.1074/jbc.M807474200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19033439	hybrid, Green Published			2022-12-27	WOS:000262700900029
J	Gayer, CP; Chaturvedi, LS; Wang, SY; Craig, DH; Flanigan, T; Basson, MD				Gayer, Christopher P.; Chaturvedi, Lakshmi S.; Wang, Shouye; Craig, David H.; Flanigan, Thomas; Basson, Marc D.			Strain-induced Proliferation Requires the Phosphatidylinositol 3-Kinase/AKT/Glycogen Synthase Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; INTESTINAL EPITHELIAL PROLIFERATION; SIGNAL-REGULATED KINASE; CYCLIC STRAIN; CELL-SURVIVAL; BACTERIAL TRANSLOCATION; REPETITIVE DEFORMATION; MECHANICAL STRAIN; MUSCLE-CELLS; SMALL-BOWEL	The intestinal epithelium is repetitively deformed by shear, peristalsis, and villous motility. Such repetitive deformation stimulates the proliferation of intestinal epithelial cells on collagen or laminin substrates via ERK, but the upstream mediators of this effect are poorly understood. We hypothesized that the phosphatidylinositol 3-kinase (PI3K)/AKT cascade mediates this mitogenic effect. PI3K, AKT, and glycogen synthase kinase-3 beta (GSK-3 beta) were phosphorylated by 10 cycles/min strain at an average 10% deformation, and pharmacologic blockade of these molecules or reduction by small interfering RNA ( siRNA) prevented the mitogenic effect of strain in Caco-2 or IEC-6 intestinal epithelial cells. Strain MAPK activation required PI3K but not AKT. AKT isoform-specific siRNA transfection demonstrated that AKT2 but not AKT1 is required for GSK-3 beta phosphorylation and the strain mitogenic effect. Furthermore, overexpression of AKT1 or an AKT chimera including the PH domain and hinge region of AKT2 and the catalytic domain and C-tail of AKT1 prevented strain activation of GSK-3 beta, but overexpression of AKT2 or a chimera including the PH domain and hinge region of AKT1 and the catalytic domain and C-tail of AKT2 did not. These data delineate a role for PI3K, AKT2, and GSK-3 beta in the mitogenic effect of strain. PI3K is required for both ERK and AKT2 activation, whereas AKT2 is sequentially required for GSK-3 beta. Furthermore, AKT2 specificity requires its catalytic domain and tail region. Manipulating this pathway may prevent mucosal atrophy and maintain the mucosal barrier in conditions such as ileus, sepsis, and prolonged fasting when peristalsis and villous motility are decreased and the mucosal barrier fails.	[Gayer, Christopher P.; Chaturvedi, Lakshmi S.; Wang, Shouye; Craig, David H.; Flanigan, Thomas; Basson, Marc D.] John Dingell VAMC, Surg Serv 11S, Dept Surg, Detroit, MI 48301 USA; [Gayer, Christopher P.; Flanigan, Thomas; Basson, Marc D.] Detroit Med Ctr, Detroit, MI 48301 USA; [Gayer, Christopher P.; Flanigan, Thomas; Basson, Marc D.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Detroit Medical Center; Wayne State University	Basson, MD (corresponding author), John Dingell VAMC, Surg Serv 11S, Dept Surg, 4646 John R St, Detroit, MI 48301 USA.	mdbasson@gmail.com	Wang, Shouye/B-1992-2008		National Institutes of Health [RO1 DK067257, 2 T32 GM008420]; Veterans Affairs Merit Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK067257 ( to M. D. B.) and by 2 T32 GM008420 ( to M. D. B. and C. P. G.). This work was also supported in part by a Veterans Affairs Merit Award.	Basson MD, 1996, J CELL PHYSIOL, V168, P476, DOI 10.1002/(SICI)1097-4652(199608)168:2<476::AID-JCP26>3.0.CO;2-#; Basson MD, 2003, DIGESTION, V68, P217, DOI 10.1159/000076385; Basson MD, 2002, METABOLISM, V51, P1525, DOI 10.1053/meta.2002.36303; Basson MD, 1996, CANCER LETT, V99, P155, DOI 10.1016/0304-3835(95)04058-7; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; CARR KE, 1991, J SUBMICR CYTOL PATH, V23, P569; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Chen AL, 2005, SURGERY, V138, P382, DOI 10.1016/j.surg.2005.04.012; Chen B, 2005, MOL ENDOCRINOL, V19, P1978, DOI 10.1210/me.2004-0274; Chen QH, 2003, J VASC SURG, V37, P660, DOI 10.1067/mva.2003.95; Cheng HL, 2000, J BIOL CHEM, V275, P27197; Chess PR, 2000, AM J PHYSIOL-LUNG C, V279, pL43; Chess PR, 2005, J APPL PHYSIOL, V99, P1226, DOI 10.1152/japplphysiol.01105.2004; Chong ZZ, 2007, CELL SIGNAL, V19, P1150, DOI 10.1016/j.cellsig.2006.12.009; Dufour G, 2004, J BIOL CHEM, V279, P44113, DOI 10.1074/jbc.M405323200; Fenton JI, 2005, CANCER EPIDEM BIOMAR, V14, P1646, DOI 10.1158/1055-9965.EPI-04-0916; Ferrand A, 2005, CANCER RES, V65, P2770, DOI 10.1158/0008-5472.CAN-04-0978; Flanigan TL, 2008, AM J SURG, V196, P683, DOI 10.1016/j.amjsurg.2008.07.016; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gu J, 2008, EXP EYE RES, V86, P322, DOI 10.1016/j.exer.2007.11.004; Han EKH, 2008, ANTICANCER RES, V28, P957; Han OH, 1998, AM J PHYSIOL-GASTR L, V275, pG534, DOI 10.1152/ajpgi.1998.275.3.G534; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; Hennig GW, 1999, J PHYSIOL-LONDON, V517, P575, DOI 10.1111/j.1469-7793.1999.0575t.x; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Hsiung SC, 2005, J NEUROCHEM, V95, P1653, DOI 10.1111/j.1471-4159.2005.03496.x; Jakubikova J, 2005, BIOCHEM PHARMACOL, V69, P1543, DOI 10.1016/j.bcp.2005.03.015; Johnson FE, 2000, INT J ONCOL, V16, P617; JONES WG, 1990, ANN SURG, V211, P399, DOI 10.1097/00000658-199004000-00004; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Kim Y, 2004, MOL CELLS, V18, P353; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Koyama M, 2007, MOL CANCER THER, V6, P1579, DOI 10.1158/1535-7163.MCT-06-0814; Li W, 2005, AM J PHYSIOL-HEART C, V288, pH1591, DOI 10.1152/ajpheart.00382.2004; Li W, 2001, AM J PHYSIOL-GASTR L, V280, P75; Litovchick L, 2004, MOL CELL BIOL, V24, P8970, DOI 10.1128/MCB.24.20.8970-8980.2004; Liu LL, 2008, MOL BIOL+, V42, P403, DOI 10.1134/S0026893308030084; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Masure S, 1999, EUR J BIOCHEM, V265, P353, DOI 10.1046/j.1432-1327.1999.00774.x; MCNEIL PL, 1990, J CELL SCI, V96, P549; MCNEIL PL, 1989, GASTROENTEROLOGY, V96, P1238, DOI 10.1016/S0016-5085(89)80010-1; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Mettler SE, 2007, AM J PHYSIOL-GASTR L, V293, pG532, DOI 10.1152/ajpgi.00138.2007; MIFTAKHOV R, 1994, BIORHEOLOGY, V31, P309; MOORE R, 1989, AM J PHYSIOL, V257, pG274, DOI 10.1152/ajpgi.1989.257.2.G274; Murnin M, 2000, J GASTROINTEST SURG, V4, P435, DOI 10.1016/S1091-255X(00)80025-6; Ngan ESW, 2007, BBA-MOL CELL RES, V1773, P536, DOI 10.1016/j.bbamcr.2007.01.013; Nguyen T, 2007, AM J PATHOL, V170, P1219, DOI 10.2353/ajpath.2007.060745; Nishimura K, 2006, AM J PHYSIOL-CELL PH, V290, pC812, DOI 10.1152/ajpcell.00347.2005; Osada T, 1999, GUT, V45, P508, DOI 10.1136/gut.45.4.508; Palanivel R, 2006, DIABETOLOGIA, V49, P183, DOI 10.1007/s00125-005-0060-z; Palma-Nicolas JP, 2008, BIOSCIENCE REP, V28, P307, DOI 10.1042/BSR20080083; PETERSON MD, 1993, J CELL SCI, V105, P461; PETERSON MD, 1992, J CELL SCI, V102, P581; Potoka DA, 2003, AM J PHYSIOL-GASTR L, V285, pG861, DOI 10.1152/ajpgi.00412.2002; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Shen XL, 2007, REGUL PEPTIDES, V141, P61, DOI 10.1016/j.regpep.2006.12.017; Sheng H, 2003, GUT, V52, P1472, DOI 10.1136/gut.52.10.1472; Shimizu N, 2008, J APPL PHYSIOL, V104, P766, DOI 10.1152/japplphysiol.00870.2007; Shiratsuchi H, 2007, J CELL BIOCHEM, V102, P353, DOI 10.1002/jcb.21295; Song Guanbin, 2007, Molecular & Cellular Biomechanics, V4, P201; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; Spencer AU, 2006, SURGERY, V140, P212, DOI 10.1016/j.surg.2006.03.005; Tanaka M, 1999, BIOCHEM BIOPH RES CO, V255, P169, DOI 10.1006/bbrc.1999.0162; Thamilselvan V, 2007, FASEB J, V21, P1730, DOI 10.1096/fj.06-6545com; Tian Q, 2005, CELL CYCLE, V4, P215; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Wang' S, 2008, EXP CELL RES, V314, P286, DOI 10.1016/j.yexcr.2007.08.005; WOMACK WA, 1987, AM J PHYSIOL, V252, pG250, DOI 10.1152/ajpgi.1987.252.2.G250; Yanagihara M, 2005, CANCER SCI, V96, P620, DOI 10.1111/j.1349-7006.2005.00088.x; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yu P, 2000, CRIT CARE MED, V28, P2573, DOI 10.1097/00003246-200007000-00065; Zhai H, 2005, EUR J PHARMACOL, V516, P112, DOI 10.1016/j.ejphar.2005.04.035; Zhang JH, 2003, FASEB J, V17, P926, DOI 10.1096/fj.02-0663fje; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	76	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2001	2011		10.1074/jbc.M804576200	http://dx.doi.org/10.1074/jbc.M804576200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19047055	Green Published, hybrid			2022-12-27	WOS:000262545600007
J	Jobling, AI; Gentle, A; Metlapally, R; McGowan, BJ; McBrien, NA				Jobling, Andrew I.; Gentle, Alex; Metlapally, Ravikanth; McGowan, Bryan J.; McBrien, Neville A.			Regulation of Scleral Cell Contraction by Transforming Growth Factor-beta and Stress COMPETING ROLES IN MYOPIC EYE GROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX SYNTHESIS; TREE SHREW SCLERA; FIBROBLAST CONTRACTION; MECHANICAL STRETCH; GENE-EXPRESSION; COLLAGEN GELS; AXIAL MYOPIA; IN-VITRO; MYOFIBROBLASTS; MODULATION	Reduced extracellular matrix accumulation in the sclera of myopic eyes leads to increased ocular extensibility and is related to reduced levels of scleral transforming growth factor-beta(TGF-beta). The current study investigated the impact of this extracellular environment on scleral cell phenotype and cellular biomechanical characteristics. Scleral cell phenotype was investigated in vivo in a mammalian model of myopia using the myofibroblast marker, alpha-smooth muscle actin (alpha-SMA). In eyes developing myopia alpha-SMA levels were increased, suggesting increased numbers of contractile myofibroblasts, and decreased in eyes recovering from myopia. To understand the factors regulating this change in scleral phenotype, the competing roles of TGF-beta and mechanical stress were investigated in scleral cells cultured in three-dimensional collagen gels. All three mammalian isoforms of TGF-beta altered scleral cell phenotype to produce highly contractile, alpha-SMA-expressing myofibroblasts (TGF-beta 3 > TGF-beta 2 > TGF-beta 1). Exposure of cells to the reduced levels of TGF-beta found in the sclera in myopia produced decreased cell-mediated contraction and reduced alpha-SMA expression. These findings are contrary to the in vivo gene expression data. However, when cells were exposed to both the increased stress and the reduced levels of TGF-beta found in myopia, increased alpha-SMA expression was observed, replicating in vivo findings. These results show that although reduced scleral TGF-beta is a major contributor to the extracellular matrix remodeling in the myopic eye, it is the resulting increase in scleral stress that dominates the competing TGF-beta effect, inducing increased alpha-SMA expression and, hence, producing a larger population of contractile cells in the myopic eye.	[Jobling, Andrew I.; Gentle, Alex; Metlapally, Ravikanth; McGowan, Bryan J.; McBrien, Neville A.] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic 3010, Australia	University of Melbourne	McBrien, NA (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic 3010, Australia.	nmcbrien@unimelb.edu.au	Jobling, Andrew/C-8221-2015	Jobling, Andrew/0000-0002-7827-3135	National Health and Medical Research Council of Australia [251557, 454602]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by National Health and Medical Research Council of Australia Grants 251557 and 454602.	AVETISOV ES, 1984, METAB PEDIATR SYST O, V7, P183; Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Cordeiro MF, 2000, INVEST OPHTH VIS SCI, V41, P756; Cui W, 2004, EXP EYE RES, V78, P275, DOI 10.1016/j.exer.2003.10.007; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; Ehrlich HP, 2000, J CELL PHYSIOL, V185, P432, DOI 10.1002/1097-4652(200012)185:3<432::AID-JCP14>3.0.CO;2-R; Fujikura H, 2002, JPN J OPHTHALMOL, V46, P24, DOI 10.1016/S0021-5155(01)00451-8; Gentle A, 1999, EXP EYE RES, V68, P155, DOI 10.1006/exer.1998.0587; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; HE YJ, 1994, J CELL BIOL, V126, P457, DOI 10.1083/jcb.126.2.457; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Jobling AI, 2004, J BIOL CHEM, V279, P18121, DOI 10.1074/jbc.M400381200; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; MacKenna D, 2000, CARDIOVASC RES, V46, P257, DOI 10.1016/S0008-6363(00)00030-4; McBrien NA, 2000, INVEST OPHTH VIS SCI, V41, P3713; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; MCBRIEN NA, 1992, VISION RES, V32, P843, DOI 10.1016/0042-6989(92)90027-G; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; Moring AG, 2007, INVEST OPHTH VIS SCI, V48, P2947, DOI 10.1167/iovs.06-0906; NORTON TT, 1995, INVESTIG OPHTHALMOL, V3517, P760; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Phillips JR, 2004, INVEST OPHTH VIS SCI, V45, P758, DOI 10.1167/iovs.03-0732; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; Poukens V, 1998, INVEST OPHTH VIS SCI, V39, P1765; Redden RA, 2006, IN VITRO CELL DEV-AN, V42, P70; SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; SHAH M, 1995, J CELL SCI, V108, P985; Shelton L, 2007, EXP EYE RES, V84, P314, DOI 10.1016/j.exer.2006.10.004; Siegwart JT, 1999, VISION RES, V39, P387, DOI 10.1016/S0042-6989(98)00150-3; SIEGWART JT, 1994, LAB ANIM SCI, V44, P213; TOMASEK JJ, 1992, ANAT REC, V232, P359, DOI 10.1002/ar.1092320305; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; ZORN N, 1992, INVESTIG OPHTHALMOL, V1811, P1053	39	34	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2072	2079		10.1074/jbc.M807521200	http://dx.doi.org/10.1074/jbc.M807521200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19011237	hybrid, Green Submitted			2022-12-27	WOS:000262545600015
J	Vercauteren, K; Gleyzer, N; Scarpulla, RC				Vercauteren, Kristel; Gleyzer, Natalie; Scarpulla, Richard C.			Short Hairpin RNA-mediated Silencing of PRC (PGC-1-related Coactivator) Results in a Severe Respiratory Chain Deficiency Associated with the Proliferation of Aberrant Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-PHOSPHORYLATION; INDUCIBLE COACTIVATOR; PGC-1 FAMILY; TRANSCRIPTION; PGC-1-ALPHA; BIOGENESIS; METABOLISM; EXPRESSION; CELLS; THERMOGENESIS	PRC, a member of the PGC-1 coactivator family, is responsive to serum growth factors and up-regulated in proliferating cells. Here, we investigated its in vivo role by stably silencing PRC expression with two different short hairpin RNAs (shRNA1 and shRNA4) that were lentivirally introduced into U2OS cells. shRNA1 transductants exhibited nearly complete knockdown of PRC protein, whereas shRNA4 transductants expressed PRC protein at similar to 15% of the control level. Complete PRC silencing by shRNA1 resulted in a severe inhibition of respiratory growth; reduced expression of respiratory protein subunits from complexes I, II, III, and IV; markedly lower complex I and IV respiratory enzyme levels; and diminished mitochondrial ATP production. Surprisingly, shRNA1 transductants exhibited a striking proliferation of abnormal mitochondria that were devoid of organized cristae and displayed severe membrane abnormalities. Although shRNA4 transductants had normal respiratory subunit expression and a moderately diminished respiratory growth rate, both transductants showed markedly reduced growth on glucose accompanied by inhibition of G(1)/S cell cycle progression. Microarray analysis revealed striking overlaps in the genes affected by PRC silencing in the two transductants, and the functional identities of these overlapping genes were consistent with the observed mitochondrial and cell growth phenotypes. The consistency between phenotype and PRC expression levels in the two independent transductant lines argues that the defects result from PRC silencing and not from off target effects. These results support a role for PRC in the integration of pathways directing mitochondrial respiratory function and cell growth.	[Vercauteren, Kristel; Gleyzer, Natalie; Scarpulla, Richard C.] NW Med Sch, Dept Cell & Mol Biol, Chicago, IL 60611 USA		Scarpulla, RC (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	rsc248@northwestern.edu			National Institutes of Health [GM32525-26]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032525, R56GM032525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32525-26. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adan C, 2008, J BIOL CHEM, V283, P12333, DOI 10.1074/jbc.M801342200; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; BALABAN RS, 1990, AM J PHYSIOL, V258, pC377, DOI 10.1152/ajpcell.1990.258.3.C377; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Dhar SS, 2008, J BIOL CHEM, V283, P3120, DOI 10.1074/jbc.M707587200; DOENCH JG, 2008, GENE DEV, V17, P438; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Metivier D, 1998, IMMUNOL LETT, V61, P157, DOI 10.1016/S0165-2478(98)00013-3; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Robinson B H, 1996, Methods Enzymol, V264, P454, DOI 10.1016/S0076-6879(96)64041-5; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SEPTINUS M, 1985, HISTOCHEMISTRY, V82, P51, DOI 10.1007/BF00502091; Sledz CA, 2004, BIOCHEM SOC T, V32, P952, DOI 10.1042/BST0320952; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Vogel JL, 2000, EMBO J, V19, P683, DOI 10.1093/emboj/19.4.683; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	55	53	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2307	2319		10.1074/jbc.M806434200	http://dx.doi.org/10.1074/jbc.M806434200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19036724	Green Published, hybrid			2022-12-27	WOS:000262545600040
J	Kim, I; Shu, CW; Xu, WJ; Shiau, CW; Grant, D; Vasile, S; Cosford, NDP; Reed, JC				Kim, InKi; Shu, Chih-Wen; Xu, Wenjie; Shiau, Chung-Wai; Grant, Daniel; Vasile, Stefan; Cosford, Nicholas D. P.; Reed, John C.			Chemical Biology Investigation of Cell Death Pathways Activated by Endoplasmic Reticulum Stress Reveals Cytoprotective Modulators of ASK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATING KINASE-1; PROTEIN-KINASE; ER STRESS; CANCER-CELLS; MAP KINASES; IN-VITRO; 18 KDA; APOPTOSIS; RECEPTOR; P38	The accumulation of unfolded proteins in the endoplasmic reticulum (ER) is caused by many disease-relevant conditions, inducing conserved signaling events collectively known as the unfolded protein response. When ER stress is excessive or prolonged, cell death (usually occurring by apoptosis) is triggered. We undertook a chemical biology approach for investigating mechanisms of ER stress-induced cell death. Using a cell-based high throughput screening assay to identify compounds that rescued a neuronal cell line from thapsigargin-induced cell death, we identified benzodiazepinones that selectively inhibit cell death caused by inducers of ER stress (thapsigargin and tunicamycin) but not by inducers of extrinsic (tumor necrosis factor) or intrinsic (mitochondrial) cell death pathways. The compounds displayed activity in several cell lines and primary cultured neurons. Mechanism of action studies revealed that these compounds inhibit ER stress-induced activation of p38 MAPK and kinases responsible for c-Jun phosphorylation. Active benzodiazepinones suppressed cell death at the level of apoptotic signal kinase-1 (ASK1) within the IRE1 pathway but without directly inhibiting the kinase activity of ASK1 or > 400 other kinases tested. Rather, active compounds enhanced phosphorylation of serine 967 of ASK1, promoting ASK1 binding to 14-3-3, an event associated with suppression of ASK1 function. Reducing ASK1 protein expression using small interfering RNA also protected cells from ER stress-induced apoptosis, confirming the importance of this protein kinase. Taken together, these findings demonstrate an essential role for ASK1 in cell death induced by ER stress. The compounds identified may prove useful for revealing endogenous mechanisms that regulate inhibitory phosphorylation of ASK1.	[Kim, InKi; Shu, Chih-Wen; Xu, Wenjie; Shiau, Chung-Wai; Grant, Daniel; Vasile, Stefan; Cosford, Nicholas D. P.; Reed, John C.] Burnham Inst Med Res, Burnham Ctr Chem Genom, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst Med Res, Burnham Ctr Chem Genom, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@burnham.org	Shu, Chih-Wen/AAE-9652-2019; Longo, Kenneth A/A-5631-2010; Xu, Wenjie/F-5453-2010	Cosford, Nic/0000-0001-7228-4709; Shu, Chih-Wen/0000-0002-7774-0002	National Institutes of Health [HG003916, DA024887, AG15393]; Department of Defense [W81XWH-07-1-0569]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HG003916, DA024887, and AG15393. This work was also supported by Department of Defense Grant W81XWH-07-1-0569. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anzini M, 2003, J MED CHEM, V46, P3853, DOI 10.1021/jm0307640; Blatt NB, 2002, J CLIN INVEST, V110, P1123, DOI 10.1172/JCI200216029; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chelli B, 2008, J CELL BIOCHEM, V105, P712, DOI 10.1002/jcb.21865; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Cheng MF, 2004, J COMB CHEM, V6, P99, DOI 10.1021/cc030034d; Churcher I, 2003, J MED CHEM, V46, P2275, DOI 10.1021/jm034058a; Decaudin D, 2002, CANCER RES, V62, P1388; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gao F, 2008, BIOORG MED CHEM LETT, V18, P4401, DOI 10.1016/j.bmcl.2008.06.053; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Haas SJP, 2002, J ANAT, V201, P61, DOI 10.1046/j.1469-7580.2002.00072.x; HUANG SC, 1989, AM J PHYSIOL, V257, pG169, DOI 10.1152/ajpgi.1989.257.1.G169; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ikeda F, 2008, J BONE MINER RES, V23, P907, DOI 10.1359/JBMR.080211; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mills C, 2008, EUR J NEUROSCI, V27, P937, DOI 10.1111/j.1460-9568.2008.06065.x; Nelson FC, 2002, BIOORG MED CHEM LETT, V12, P2867, DOI 10.1016/S0960-894X(02)00633-9; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sundberg TB, 2006, CANCER RES, V66, P1775, DOI 10.1158/0008-5472.CAN-05-3476; TALLMAN JF, 1985, ANNU REV NEUROSCI, V8, P21, DOI 10.1146/annurev.ne.08.030185.000321; Tobiume K, 1997, BIOCHEM BIOPH RES CO, V239, P905, DOI 10.1006/bbrc.1997.7580; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TSUKAMOTO A, 1993, CELL BIOL INT, V17, P969, DOI 10.1006/cbir.1993.1021; Valladares A, 2000, ENDOCRINOLOGY, V141, P4383, DOI 10.1210/en.141.12.4383; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	54	105	121	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1593	1603		10.1074/jbc.M807308200	http://dx.doi.org/10.1074/jbc.M807308200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19004820	hybrid, Green Published			2022-12-27	WOS:000262330100027
J	Ramakrishnan, NA; Drescher, MJ; Drescher, DG				Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Drescher, Dennis G.			Direct Interaction of Otoferlin with Syntaxin 1A, SNAP-25, and the L-type Voltage-gated Calcium Channel Ca(V)1.3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; SURFACE-PLASMON RESONANCE; SYNAPTIC VESICLE; HAIR-CELLS; C2 DOMAIN; ENCODING OTOFERLIN; RECESSIVE DEAFNESS; MISSENSE MUTATION; RIBBON SYNAPSE; CA2+ CHANNELS	The molecular mechanisms underlying synaptic exocytosis in the hair cell, the auditory and vestibular receptor cell, are not well understood. Otoferlin, a C2 domain-containing Ca2+-binding protein, has been implicated as having a role in vesicular release. Mutations in the OTOF gene cause nonsyndromic deafness in humans, and OTOF knock-out mice are deaf. In the present study, we generated otoferlin fusion proteins containing two of the same amino acid substitutions detected in DFNB9 patients (P1825A in C2F and L1011P in C2D). The native otoferlin C2F domain bound syntaxin 1A and SNAP-25 in a Ca2+-dependent manner (with optimal 61 mu M free Ca2+ required for binding). These interactions were greatly diminished for C2F with the P1825A mutation, possibly because of a reduction in tertiary structural change, induced by Ca2+, for the mutated C2F compared with the native C2F. The otoferlin C2D domain also bound syntaxin 1A, but with weaker affinity (K-d = 1.7 x 10(-5) M) than for the C2F interaction (K-d = 2.6 x 10(-9) M). In contrast, it was the otoferlin C2D domain that bound the Ca(v)1.3 II-III loop, in a Ca2+- dependent manner. The L1011P mutation in C2D rendered this binding insensitive to Ca2+ and considerably diminished. Overall, we demonstrated that otoferlin interacts with two main target-SNARE proteins of the hair-cell synaptic complex, syntaxin 1A and SNAP-25, as well as the calcium channel, with the otoferlin C2F and C2D domains of central importance for binding. Because mutations in the otoferlin C2 domains that cause deafness in humans impair the ability of otoferlin to bind syntaxin, SNAP-25, and the Ca(v)1.3 calcium channel, it is these interactions that may mediate regulation by otoferlin of hair cell synaptic exocytosis critical to inner ear hair cell function.	[Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Otolaryngol, Detroit, MI 48201 USA; [Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Drescher, DG (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol, 259 Lande Med Res Bldg,540 E Canfield Ave, Detroit, MI 48201 USA.	ddresche@med.wayne.edu			National Institutes of Health [DC000156, DC004076]; American Hearing Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000156, R01DC004076] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearing Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC000156 and DC004076. This work was also supported by a grant from the American Hearing Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Cohen R, 2003, J BIOL CHEM, V278, P9258, DOI 10.1074/jbc.M210270200; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kee Y, 1996, J NEUROSCI, V16, P1975; LEWIS RS, 1983, NATURE, V304, P538, DOI 10.1038/304538a0; Longo-Guess C, 2007, HEARING RES, V234, P21, DOI 10.1016/j.heares.2007.09.005; Lynch KL, 2007, MOL BIOL CELL, V18, P4957, DOI 10.1091/mbc.E07-04-0368; MARKEY F, 1999, BIA J, V1, P5; Migliosi V, 2002, J MED GENET, V39, P502, DOI 10.1136/jmg.39.7.502; Mirghomizadeh F, 2002, NEUROBIOL DIS, V10, P157, DOI 10.1006/nbdi.2002.0488; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; Schuck P, 1996, BIOPHYS J, V70, P1230, DOI 10.1016/S0006-3495(96)79681-9; Schug N, 2006, EUR J NEUROSCI, V24, P3372, DOI 10.1111/j.1460-9568.2006.05225.x; Simon SM, 2008, P NATL ACAD SCI USA, V105, P1152, DOI 10.1073/pnas.0706067105; Simons JWFA, 2002, ARCH BIOCHEM BIOPHYS, V406, P143, DOI 10.1016/S0003-9861(02)00429-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 1999, PROTEIN SCI, V8, P370; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tekin M, 2005, AM J MED GENET A, V138A, P6, DOI 10.1002/ajmg.a.30907; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	36	84	87	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1364	1372		10.1074/jbc.M803605200	http://dx.doi.org/10.1074/jbc.M803605200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19004828	Green Published, hybrid			2022-12-27	WOS:000262330100004
J	Spender, LC; Inman, GJ				Spender, Lindsay C.; Inman, Gareth J.			TGF-beta Induces Growth Arrest in Burkitt Lymphoma Cells via Transcriptional Repression of E2F-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK INHIBITOR P15(INK4B); EPSTEIN-BARR-VIRUS; HUMAN B-CELLS; C-MYC; UP-REGULATION; CYCLE ARREST; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; CANCER-CELLS; G(1) ARREST	Transforming growth factor-beta(TGF-beta) is a potent regulator of tissue homeostasis and can act as both a tumor suppressor and a tumor promoter. The ability to induce cell cycle arrest is a major component of the tumor suppressor function of TGF-beta. Lung, mammary, and skin epithelial cells exhibit a common minimal cytostatic program in response to TGF-beta signaling involving the repression of the growth-promoting factors c-MYC, Id1, Id2, and Id3. Loss of c-MYC expression is a pivotal event in this process, resulting in derepression of the cyclin-dependent kinase inhibitors CDKN1A (p21) and CDKN2B (p15) and ultimately leading to growth arrest. It is not clear, however, which responses are necessary for TGF-beta-mediated growth arrest in other cell types. Here, in human Burkitt lymphoma cells transformed by deregulated c-MYC expression, we demonstrate that efficient TGF-beta-induced cytostasis can occur despite both maintenance of c-MYC levels and a lack of p21 and p15 induction. TGF-beta treatment also results in induction, rather than repression, of Id1 and Id2 expression. In this context, growth arrest correlates with transcriptional repression of E2F-1, and overexpression of E2F-1 in Burkitt lymphoma cells largely overcomes the TGF-beta-mediated G(1) arrest phenotype. These data indicate that deregulation of c-MYC in lymphoma cells does not overcome the tumor suppressor function of TGF-beta and that repression of E2F-1 transcription is sufficient for the efficient induction of cytostasis.	[Spender, Lindsay C.; Inman, Gareth J.] Beatson Inst Canc Res, Growth Factor Signalling Lab, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Inman, GJ (corresponding author), Beatson Inst Canc Res, Growth Factor Signalling Lab, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	g.inman@beatson.gla.ac.uk		Inman, Gareth/0000-0002-6264-4253	Cancer Research UK; International Cancer Research	Cancer Research UK(Cancer Research UK); International Cancer Research	This work was supported by Cancer Research UK and an Association for International Cancer Research fellowship (to G.J.I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Cherney BW, 1997, CANCER RES, V57, P2508; Depoortere F, 2000, MOL BIOL CELL, V11, P1061, DOI 10.1091/mbc.11.3.1061; Doucet JP, 2004, LEUKEMIA LYMPHOMA, V45, P357, DOI 10.1080/10428190310001595713; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Iavarone A, 1997, NATURE, V387, P417; Inman GJ, 2000, J GEN VIROL, V81, P1567, DOI 10.1099/0022-1317-81-6-1567; Kamesaki H, 1998, J IMMUNOL, V160, P770; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kee BL, 2005, J IMMUNOL, V175, P4518, DOI 10.4049/jimmunol.175.7.4518; Kee BL, 2001, NAT IMMUNOL, V2, P242, DOI 10.1038/85303; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Li JM, 1997, P NATL ACAD SCI USA, V94, P4948, DOI 10.1073/pnas.94.10.4948; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Rotzer D, 2006, ONCOGENE, V25, P2070, DOI 10.1038/sj.onc.1209230; Santoni-Rugiu E, 2002, ONCOGENE, V21, P6498, DOI 10.1038/sj.onc.1205828; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; SCHWARZ JK, 1995, P NATL ACAD SCI USA, V92, P483, DOI 10.1073/pnas.92.2.483; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Siegel PM, 2003, J BIOL CHEM, V278, P35444, DOI 10.1074/jbc.M301413200; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Spender LC, 1999, J VIROL, V73, P4678, DOI 10.1128/JVI.73.6.4678-4688.1999; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100	43	28	30	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1435	1442		10.1074/jbc.M808080200	http://dx.doi.org/10.1074/jbc.M808080200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19022773	hybrid			2022-12-27	WOS:000262330100011
J	Berntzen, G; Andersen, JT; Ustgard, K; Michaelsen, TE; Mousavi, SA; Qian, JD; Kristiansen, PE; Lauvrak, V; Sandlie, I				Berntzen, Goril; Andersen, Jan Terje; Ustgard, Kristine; Michaelsen, Terje E.; Mousavi, Seyed Ali; Qian, Julie Dee; Kristiansen, Per Eugen; Lauvrak, Vigdis; Sandlie, Inger			Identification of a High Affinity Fc gamma RIIA-binding Peptide That Distinguishes Fc gamma RIIA from Fc gamma RIIB and Exploits Fc gamma RIIA-mediated Phagocytosis and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; CRYSTAL-STRUCTURE; IGG FC; RECEPTOR-BINDING; IMMUNOGLOBULIN-G; DENDRITIC CELLS; PHAGE DISPLAY; POLYMORPHISMS; ANTIBODIES; RECOGNITION	Fc gamma RIIA is a key activating receptor linking immune complex formation with cellular effector functions. Fc gamma RIIA has 93% identity with an inhibitory receptor, Fc gamma RIIB, which negatively regulates Fc gamma RIIA. Fc gamma RIIA is important in the therapeutic action of several monoclonal antibodies. Binding molecules that discriminate Fc gamma RIIA from Fc gamma RIIB may optimize receptor activity and serve as a lead for development of therapeutics with Fc gamma RIIA as a key target. Here we report the use of phage display libraries to select short peptides with distinct Fc gamma RIIA binding properties. An 11-mer peptide (WAWVWLTETAV) was characterized that bound Fc gamma RIIA with a K-d of 500 nM. It mediated cell internalization and degradation of a model antigen. The peptide-binding site on Fc gamma RIIA was shown to involve Phe(163) and the IgG binding amino acids Trp(90) and Trp(113). It is thus overlapping but not identical to that of IgG. Neither activating receptors Fc gamma RI and Fc gamma RIII, nor Fc gamma RIIB, all of which lack Phe(163), bound the peptide.	[Berntzen, Goril; Andersen, Jan Terje; Ustgard, Kristine; Mousavi, Seyed Ali; Qian, Julie Dee; Kristiansen, Per Eugen; Lauvrak, Vigdis; Sandlie, Inger] Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; [Berntzen, Goril; Andersen, Jan Terje; Ustgard, Kristine; Qian, Julie Dee; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, N-0316 Oslo, Norway; [Michaelsen, Terje E.] Univ Oslo, Norwegian Inst Publ Hlth, N-0316 Oslo, Norway; [Michaelsen, Terje E.] Univ Oslo, Inst Pharm, N-0316 Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo	Berntzen, G (corresponding author), Univ Oslo, Dept Mol Biosci, POB 1041, N-0316 Oslo, Norway.	goril.berntzen@imbv.uio.no; inger.sandlie@imbv.uio.no	Kristiansen, Per Eugen/L-5798-2019; Andersen, Jan Terje/AAB-6209-2020	Andersen, Jan Terje/0000-0003-1710-1628	Research Council of Norway, the Norwegian Cancer Society; Steering Board for Research in Molecular Biology, Biotechnology and Bioinformatics (EMBIO) at the University of Oslo	Research Council of Norway, the Norwegian Cancer Society(Norwegian Cancer SocietyResearch Council of Norway); Steering Board for Research in Molecular Biology, Biotechnology and Bioinformatics (EMBIO) at the University of Oslo	The work was supported by the Research Council of Norway, the Norwegian Cancer Society, and the Steering Board for Research in Molecular Biology, Biotechnology and Bioinformatics (EMBIO) at the University of Oslo. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albertsson PA, 2003, TRENDS IMMUNOL, V24, P603, DOI 10.1016/j.it.2003.09.007; Armour KL, 2003, MOL IMMUNOL, V40, P585, DOI 10.1016/j.molimm.2003.08.004; Benitez-Ribas D, 2006, J EXP MED, V203, P1629, DOI 10.1084/jem.20052364; Berntzen G, 2006, PROTEIN ENG DES SEL, V19, P121, DOI 10.1093/protein/gzj011; Braathen R, 2006, J BIOL CHEM, V281, P7075, DOI 10.1074/jbc.M508509200; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Cendron AC, 2008, MOL IMMUNOL, V45, P307, DOI 10.1016/j.molimm.2007.06.152; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Gebhardt K, 1996, PEPTIDE RES, V9, P269; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Hsu CL, 2003, J BIOL CHEM, V278, P23691, DOI 10.1074/jbc.M211908200; Hunter S, 1998, BLOOD, V91, P1762, DOI 10.1182/blood.V91.5.1762.1762_1762_1768; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kaplan W, 1997, PROTEIN SCI, V6, P399; Lauvrak V, 2004, SCAND J IMMUNOL, V59, P373, DOI 10.1111/j.1365-3083.2004.01400.x; Liu Y, 2006, J IMMUNOL, V177, P8440, DOI 10.4049/jimmunol.177.12.8440; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Medgyesi W, 2004, EUR J IMMUNOL, V34, P1127, DOI 10.1002/eji.200324733; MICHAELSEN TE, 1991, EUR J IMMUNOL, V21, P11, DOI 10.1002/eji.1830210103; Michaelsen TE, 2003, INFECT IMMUN, V71, P5714, DOI 10.1128/IAI.71.10.5714-5723.2003; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Platonov AE, 1998, CLIN INFECT DIS, V27, P746, DOI 10.1086/514935; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; RAINE ARC, 1995, PROTEIN SCI, V4, P2625, DOI 10.1002/pro.5560041222; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Sheridan JA, 1999, J PEPT SCI, V5, P555, DOI 10.1002/(SICI)1099-1387(199912)5:12<555::AID-PSC220>3.0.CO;2-G; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sondermann P, 1999, BIOCHEMISTRY-US, V38, P8469, DOI 10.1021/bi982889q; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Stockmeyer B, 1997, CANCER RES, V57, P696; Sulica A, 2001, Int Rev Immunol, V20, P371, DOI 10.3109/08830180109054414; Tudyka T, 1997, PROTEIN SCI, V6, P2180; Uray K, 2004, J MOL RECOGNIT, V17, P95, DOI 10.1002/jmr.652; VANDENHERIKOUDIJK IE, 1995, BLOOD, V85, P2202, DOI 10.1182/blood.V85.8.2202.bloodjournal8582202; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Xu XH, 2007, J MOL BIOL, V373, P367, DOI 10.1016/j.jmb.2007.07.069; Yuan FF, 2003, IMMUNOL CELL BIOL, V81, P192, DOI 10.1046/j.1440-1711.2003.01158.x; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021; Zhang YH, 2000, IMMUNITY, V13, P387, DOI 10.1016/S1074-7613(00)00038-8	47	5	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1126	1135		10.1074/jbc.M803584200	http://dx.doi.org/10.1074/jbc.M803584200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18957413	Green Published, hybrid			2022-12-27	WOS:000262122900049
J	Isenberg, JS; Annis, DS; Pendrak, ML; Ptaszynska, M; Frazier, WA; Mosher, DF; Roberts, DD				Isenberg, Jeff S.; Annis, Douglas S.; Pendrak, Michael L.; Ptaszynska, Malgorzata; Frazier, William A.; Mosher, Deane F.; Roberts, David D.			Differential Interactions of Thrombospondin-1,-2, and-4 with CD47 and Effects on cGMP Signaling and Ischemic Injury Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-ASSOCIATED PROTEIN; C-TERMINAL DOMAIN; GROWTH-FACTOR-I; NITRIC-OXIDE; TISSUE SURVIVAL; SIGNATURE DOMAINS; CELL RESPONSES; LIGAND-BINDING; RECEPTOR; IDENTIFICATION	Thrombospondin-1 regulates nitric oxide (NO) signaling in vascular cells via CD47. Because CD47 binding motifs are conserved in the C-terminal signature domains of all five thrombospondins and indirect evidence has implied CD47 interactions with other family members, we compared activities of recombinant signature domains of thrombospondin-1, -2, and -4 to interact with CD47 and modulate cGMP signaling. Signature domains of thrombospondin-2 and -4 were less active than that of thrombospondin-1 for inhibiting binding of radiolabeled signature domain of thrombospondin-1 or SIRP alpha (signal-regulatory protein) to cells expressing CD47. Consistent with this binding selectivity, the signature domain of thrombospondin-1 was more potent than those of thrombospondin-2 or -4 for inhibiting NO-stimulated cGMP synthesis in vascular smooth muscle cells and downstream effects on cell adhesion. In contrast to thrombospondin-1-and CD47-null cells, primary vascular cells from thrombospondin-2-null mice lack enhanced basal and NO-stimulated cGMP signaling. Effects of endogenous thrombospondin-2 on NO/cGMP signaling could be detected only in thrombospondin-1-null cells. Furthermore, tissue survival of ischemic injury and acute recovery of blood flow in thrombospondin-2-nulls resembles that of wild type mice. Therefore, thrombospondin-1 is the dominant regulator of NO/cGMP signaling via CD47, and its limiting role in acute ischemic injury responses is not shared by thrombospondin-2.	[Isenberg, Jeff S.; Pendrak, Michael L.; Ptaszynska, Malgorzata; Roberts, David D.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Frazier, William A.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Roberts, DD (corresponding author), NCI, Pathol Lab, NIH, Bldg 10,Rm 2A33,10 Ctr Dr MSC1500, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008	Roberts, David D./0000-0002-2481-2981	National Institutes of Health [HL54462, HL54390]; Intramural Research Program of the NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIASC009172] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054390, R56HL054390, R01HL054462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants National HL54462 (to D. F. M.) and HL54390 (to W. A. F.) and by the Intramural Research Program of the NCI, National Institutes of Health, Center for Cancer Research (to D. D. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams JC, 2008, J CELL SCI, V121, P784, DOI 10.1242/jcs.021006; Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Boekholdt SM, 2002, ARTERIOSCL THROM VAS, V22, pE24, DOI 10.1161/01.ATV.0000046235.22451.66; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chandrasekaran S, 1999, J BIOL CHEM, V274, P11408, DOI 10.1074/jbc.274.16.11408; Congote LF, 2004, FEBS LETT, V576, P343, DOI 10.1016/j.febslet.2004.09.035; Cui JX, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.06.002; Floquet N, 2008, ARCH BIOCHEM BIOPHYS, V478, P103, DOI 10.1016/j.abb.2008.07.015; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; Hankenson KD, 2005, MOL CELL BIOL, V25, P5599, DOI 10.1128/MCB.25.13.5599-5606.2005; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Isenberg JS, 2008, AM J PATHOL, V173, P1100, DOI 10.2353/ajpath.2008.080237; Isenberg JS, 2008, ANN SURG, V247, P860, DOI 10.1097/SLA.0b013e31816c4006; Isenberg JS, 2008, ANN SURG, V247, P180, DOI 10.1097/SLA.0b013e31815685dc; Isenberg JS, 2007, ARTERIOSCL THROM VAS, V27, P2582, DOI 10.1161/ATVBAHA.107.155390; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Isenberg JS, 2007, CIRC RES, V100, P712, DOI 10.1161/01.RES.0000259579.35787.4e; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Isenberg JS, 2006, CARDIOVASC RES, V71, P785, DOI 10.1016/j.cardiores.2006.05.024; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Karen LP, 2004, INT J BIOCHEM CELL B, V36, P1005, DOI 10.1016/j.biocel.2004.01.011; Krady MM, 2008, AM J PATHOL, V173, P879, DOI 10.2353/ajpath.2008.080128; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; LAWLER J, 1993, J CELL BIOL, V120, P1059, DOI 10.1083/jcb.120.4.1059; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Maile LA, 2003, CIRC RES, V93, P925, DOI 10.1161/01.RES.0000101754.33652.B7; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Piccio L, 2005, BLOOD, V105, P2421, DOI 10.1182/blood-2004-07-2823; Rebres RA, 2001, J BIOL CHEM, V276, P34607, DOI 10.1074/jbc.M106107200; Roberts David D., 1994, Journal of Tissue Culture Methods, V16, P217, DOI 10.1007/BF01540654; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Stenina OI, 2003, CIRCULATION, V108, P1514, DOI 10.1161/01.CIR.0000089085.76320.4E; Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Ticchioni M, 2001, FASEB J, V15, P341, DOI 10.1096/fj.99-0833com; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Wessel J, 2004, AM HEART J, V147, P905, DOI 10.1016/j.ahj.2003.12.013; Yamaguchi S, 2007, INT J MOL MED, V19, P631	48	98	103	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1116	1125		10.1074/jbc.M804860200	http://dx.doi.org/10.1074/jbc.M804860200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004835	Green Published, hybrid			2022-12-27	WOS:000262122900048
J	Marmol, P; Pardo, B; Wiederkehr, A; del Arco, A; Wollheim, CB; Satrustegui, J				Marmol, Patricia; Pardo, Beatriz; Wiederkehr, Andreas; del Arco, Araceli; Wollheim, Claes B.; Satrustegui, Jorgina			Requirement for Aralar and Its Ca2+-binding Sites in Ca2+ Signal Transduction in Mitochondria from INS-1 Clonal beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; MEMBRANE-POTENTIAL CHANGES; ASPARTATE NADH SHUTTLE; INTRACELLULAR CA2+; CYTOSOLIC CA2+; PANCREATIC-ISLETS; GLUCAGON-RELEASE; METABOLIC-FATE; GLUCOSE; CALCIUM	Aralar, the mitochondrial aspartate-glutamate carrier present in beta-cells, is a component of the malate-aspartate NADH shuttle (MAS). MAS is activated by Ca2+ in mitochondria from tissues with aralar as the only AGC isoform with an S-0.5 of similar to 300 nM. We have studied the role of aralar and its Ca2+-binding EF-hand motifs in glucose-induced mitochondrial NAD(P)H generation by two-photon microscopy imaging in INS-1 beta-cells lacking aralar or expressing aralar mutants blocked for Ca2+ binding. Aralar knock-down in INS-1 beta-cell lines resulted in undetectable levels of aralar protein and complete loss of MAS activity in isolated mitochondria and in a 25% decrease in glucose-stimulated insulin secretion. MAS activity in mitochondria from INS-1 cells was activated 2-3-fold by extramitochondrial Ca2+, whereas aralar mutants were Ca2+ insensitive. In Ca2+-free medium, glucose-induced increases in mitochondrial NAD(P) H were small (1.3-fold) and unchanged regardless of the lack of aralar. In the presence of 1.5 mM Ca2+, glucose induced robust increases in mitochondrial NAD(P) H (similar to 2-fold) in cell lines with wild-type or mutant aralar. There was a similar to 20% reduction in NAD(P) H response in cells lacking aralar, illustrating the importance of MAS in glucose action. When small Ca2+ signals that resulted in extremely small mitochondrial Ca2+ transients were induced in the presence of glucose, the rise in mitochondrial NAD(P) H was maintained in cells with wild-type aralar but was reduced by similar to 50% in cells lacking or expressing mutant aralar. These results indicate that 1) glucose-induced activation of MAS requires Ca2+ potentiation; 2) Ca2+ activation of MAS represents a larger fraction of glucose-induced mitochondrial NAD(P) H production under conditions where suboptimal Ca2+ signals are associated with a glucose challenge (50 versus 20%, respectively); 3) inactivation of EF-hand motifs in aralar prevents activation of MAS by small Ca2+ signals. The results suggest a possible role for aralar and MAS in priming the beta-cell by Ca2+-mobilizing neurotransmitter or hormones.	[Marmol, Patricia; Pardo, Beatriz; del Arco, Araceli; Satrustegui, Jorgina] Univ Autonoma Madrid, CSIC, CIBER Enfermedades Raras, Dept Biol Mol, E-28049 Madrid, Spain; [Marmol, Patricia; Pardo, Beatriz; del Arco, Araceli; Satrustegui, Jorgina] Univ Autonoma Madrid, CSIC, CIBER Enfermedades Raras, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [del Arco, Araceli] Univ Castilla La Mancha, Fac Ciencias Medio Ambiente, Area Bioquim, CRIB, Toledo 48071, Spain; [Wiederkehr, Andreas; Wollheim, Claes B.] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de Castilla-La Mancha; University of Geneva	Satrustegui, J (corresponding author), Univ Autonoma Madrid, CSIC, CIBER Enfermedades Raras, Dept Biol Mol, E-28049 Madrid, Spain.	jsatrustegui@cbm.uam.es	del Arco, Araceli/R-5653-2019; Satrustegui, Jorgina/R-6732-2019; Pardo, Beatriz/C-3234-2016	Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667; del Arco, Araceli/0000-0002-6839-542X	Ministerio de Educacion y Ciencia [BFU2005-C02-01, GEN2003-20235-C05-03/NAC]; Comunidad de Madrid [S-GEN-0269-2006 MITOLAB-CM]; European Union [LSHM-CT-2006-518153]	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); European Union(European Commission)	This work was supported in part by Ministerio de Educacion y Ciencia Grants BFU2005-C02-01 and GEN2003-20235-C05-03/NAC, Comunidad de Madrid Grant S-GEN-0269-2006 MITOLAB-CM ( to J.S.), and European Union Grant LSHM-CT-2006-518153 ( to J.S. and C. B. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; 1 Recipient of a Formacion de Personal Investigador fellowship from the Comunidad de Madrid.; 2 Supported by Swiss National Foundation Grant 310000-116750/1.	Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Contreras L, 2007, J BIOL CHEM, V282, P7098, DOI 10.1074/jbc.M610491200; del Arco A, 2000, BIOCHEM J, V345, P725, DOI 10.1042/0264-6021:3450725; del Arco A, 2002, EUR J BIOCHEM, V269, P3313, DOI 10.1046/j.1432-1033.2002.03018.x; del Arco A, 1998, J BIOL CHEM, V273, P23327, DOI 10.1074/jbc.273.36.23327; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; GARCIA MC, 1988, BIOCHEM J, V254, P211, DOI 10.1042/bj2540211; GILON P, 1992, J BIOL CHEM, V267, P20713; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; HELLMAN B, 1974, BIOCHEM J, V138, P33, DOI 10.1042/bj1380033; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Kennedy ED, 1998, DIABETES, V47, P374, DOI 10.2337/diabetes.47.3.374; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; LI GD, 1991, J BIOL CHEM, V266, P3449; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; Maechler P, 2002, CELL MOL LIFE SCI, V59, P1803, DOI 10.1007/PL00012507; MARTINEZ A, 1988, NEUROSCI LETT, V88, P336, DOI 10.1016/0304-3940(88)90234-0; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pardo B, 2006, J BIOL CHEM, V281, P1039, DOI 10.1074/jbc.M507270200; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; PRALONG WF, 1994, J BIOL CHEM, V269, P27310; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rocheleau JV, 2002, J BIOL CHEM, V277, P30914, DOI 10.1074/jbc.M202314200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Ruiz F, 1998, NEUROREPORT, V9, P1277; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1990, BIOCHIM BIOPHYS ACTA, V1019, P42, DOI 10.1016/0005-2728(90)90122-K; THELER JM, 1992, J BIOL CHEM, V267, P18110; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057	45	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					515	524		10.1074/jbc.M806729200	http://dx.doi.org/10.1074/jbc.M806729200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18996845	Green Published, hybrid			2022-12-27	WOS:000261974800056
J	Sanders, MA; Ampasala, D; Basson, MD				Sanders, Matthew A.; Ampasala, Dinakar; Basson, Marc D.			DOCK5 and DOCK1 Regulate Caco-2 Intestinal Epithelial Cell Spreading and Migration on Collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE ACTIVITY; TERMINAL SH3 DOMAIN; CRYPT-VILLUS AXIS; IN-VITRO MODEL; MYOBLAST FUSION; ERK ACTIVATION; RAC-GEF; CRK; PROTEINS; EXPRESSION	We observed previously that combined small interfering RNAs (siRNAs) targeting CrkII and CrkL, known activators of guanine nucleotide exchange factor DOCK1, strongly inhibit Caco-2 intestinal epithelial cell spreading and migration on collagen IV. DOCK1 siRNA reduced its expression > 95% in Caco-2 cells but inhibited spreading much less than combined CrkII/CrkL siRNAs, suggesting that CrkII/CrkL interact with additional DOCK proteins. siRNA targeting DOCK5, a closely related DOCK1 family member, inhibited Caco-2 spreading similarly to DOCK1 siRNA, and the combined siRNAs synergistically inhibited spreading. Similar results were observed in human umbilical vein endothelial cells, and reverse transcriptase PCR demonstrated DOCK5 siRNA reduction of DOCK5 expression in both cell types. Combined DOCK1/DOCK5 siRNAs also inhibited Caco-2 migration and lamellipodial extension. Expression of DOCK5 cDNA, with silent mutations in the siRNA target region allowing expression simultaneously with DOCK5 siRNA, required CrkII/CrkL to restore cell spreading and DOCK5 coimmunoprecipitated with CrkII and CrkL. DOCK5 association with CrkII and CrkL was greatly reduced by mutations in their NH2-terminal SH3 domains. Expression of the DOCK5 COOH-terminal region (Met(1738) - Gln(1870)), containing potential Src homology 3 domain-binding proline-rich sites but lacking other functional regions, inhibited Caco-2 spreading and coimmunoprecipitated with CrkL. Coimmunoprecipitation of full-length DOCK5 with CrkL was strongly reduced by deletion of DOCK5 COOH-terminal amino acids 1832-1870. Green fluorescent protein-tagged DOCK5 localized to the membrane of Caco-2 cells spreading on collagen IV. In these studies, we describe human DOCK5 cloning and expression, our results indicating that, along with DOCK1, DOCK5 is an important mediator of CrkII/CrkL regulation of Caco-2 spreading and migration on collagen	[Sanders, Matthew A.; Ampasala, Dinakar] John D Dingell Vet Affairs Med Ctr, Res Serv, Detroit, MI 48201 USA; [Basson, Marc D.] John D Dingell Vet Affairs Med Ctr, Surg Serv, Detroit, MI 48201 USA; [Sanders, Matthew A.; Ampasala, Dinakar; Basson, Marc D.] Wayne State Univ, Dept Surg, Detroit, MI 48201 USA	Wayne State University	Sanders, MA (corresponding author), John D Dingell Vet Affairs Med Ctr, Res Serv, 4646 John R St, Detroit, MI 48201 USA.	matt.sanders2@gmail.com			National Institutes of Health [RO1DK067257]; Veterans Affairs Merit Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK067257. This work was also supported by a Veterans Affairs Merit Award (to M. D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; BASSON MD, 1992, J CLIN INVEST, V90, P15, DOI 10.1172/JCI115828; BEAULIEU JF, 1994, GASTROENTEROLOGY, V106, P829, DOI 10.1016/0016-5085(94)90740-4; Beaulieu JF, 1997, PROG HISTOCHEM CYTOC, V31, P1; BEAULIEU JF, 1992, J CELL SCI, V102, P427; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2006, METHOD ENZYMOL, V406, P41, DOI 10.1016/S0076-6879(06)06004-6; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; De Arcangelis A, 1996, J CELL BIOL, V133, P417, DOI 10.1083/jcb.133.2.417; FELLER SM, 1995, ONCOGENE, V10, P1465; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lotz MM, 2000, AM J PATHOL, V156, P985, DOI 10.1016/S0002-9440(10)64966-8; Lotz MM, 1997, AM J PATHOL, V150, P747; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; MADRI JA, 1988, AM J PATHOL, V132, P18; Matsuda M, 1996, J BIOL CHEM, V271, P14468, DOI 10.1074/jbc.271.24.14468; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Nishihara H, 2002, BLOOD, V100, P3968, DOI 10.1182/blood-2001-11-0032; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Omi N, 2008, EXP EYE RES, V86, P828, DOI 10.1016/j.exer.2008.02.011; PETERSON MD, 1993, J CELL SCI, V105, P461; PETERSON MD, 1993, J CELL SCI, V105, P445; Posern G, 1998, ONCOGENE, V16, P1903, DOI 10.1038/sj.onc.1201714; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Sanders MA, 2000, J BIOL CHEM, V275, P38040, DOI 10.1074/jbc.M003871200; Sanders MA, 2005, J BIOL CHEM, V280, P23516, DOI 10.1074/jbc.M413165200; Sanders MA, 2004, AM J PHYSIOL-GASTR L, V286, pG547, DOI 10.1152/ajpgi.00262.2003; Sattler M, 1996, ONCOGENE, V12, P839; TANAKA S, 1993, MOL CELL BIOL, V13, P4409, DOI 10.1128/MCB.13.7.4409; VACHON PH, 1995, AM J PHYSIOL-GASTR L, V268, pG857, DOI 10.1152/ajpgi.1995.268.5.G857; Wolpert S, 1996, AM J SURG, V171, P109, DOI 10.1016/S0002-9610(99)80083-X; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yu CF, 2000, AM J PHYSIOL-GASTR L, V278, pG952, DOI 10.1152/ajpgi.2000.278.6.G952	47	17	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					27	35		10.1074/jbc.M808010200	http://dx.doi.org/10.1074/jbc.M808010200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19004829	Green Published, hybrid			2022-12-27	WOS:000261974800004
J	Blodgett, DM; Graybill, C; Carruthers, A				Blodgett, David M.; Graybill, Christopher; Carruthers, Anthony			Analysis of Glucose Transporter Topology and Structural Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; OLIGOMERIC STRUCTURE; HEXOSE TRANSPORTER; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; SUGAR-TRANSPORT; CYTOCHALASIN-B	Homology modeling and scanning cysteine mutagenesis studies suggest that the human glucose transport protein GLUT1 and its distant bacterial homologs LacY and GlpT share similar structures. We tested this hypothesis by mapping the accessibility of purified, reconstituted human erythrocyte GLUT1 to aqueous probes. GLUT1 contains 35 potential tryptic cleavage sites. Fourteen of 16 lysine residues and 18 of 19 arginine residues were accessible to trypsin. GLUT1 lysine residues were modified by isothiocyanates and N-hydroxysuccinimide (NHS) esters in a substrate-dependent manner. Twelve lysine residues were accessible to sulfo-NHS-LC-biotin. GLUT1 trypsinization released full-length transmembrane helix 1, cytoplasmic loop 6-7, and the long cytoplasmic C terminus from membranes. Trypsin-digested GLUT1 retained cytochalasin B and D-glucose binding capacity and released full-length transmembrane helix 8 upon cytochalasin B (but not D-glucose) binding. Transmembrane helix 8 release did not abrogate cytochalasin B binding. GLUT1 was extensively proteolyzed by alpha-chymotrypsin, which cuts putative pore-forming amphipathic alpha-helices 1, 2, 4, 7, 8, 10, and 11 at multiple sites to release transmembrane peptide fragments into the aqueous solvent. Putative scaffolding membrane helices 3, 6, 9, and 12 are strongly hydrophobic, resistant to alpha-chymotrypsin, and retained by the membrane bilayer. These observations provide experimental support for the proposed GLUT1 architecture; indicate that the proposed topology of membrane helices 5, 6, and 12 requires adjustment; and suggest that the metastable conformations of transmembrane helices 1 and 8 within the GLUT1 scaffold destabilize a sugar translocation intermediate.	[Blodgett, David M.; Graybill, Christopher; Carruthers, Anthony] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, 364 Plantat St, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK44888, DK36081]; American Diabetes Association [1-06-IN-04]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036081, R56DK036081, R01DK044888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44888 and DK36081. This work was also supported by American Diabetes Association Grant 1-06-IN-04 ( Gail Patrick Innovation Award supported by a generous gift from the Estate of Gail Patrick). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe Y, 2004, J BIOCHEM, V136, P97, DOI 10.1093/jb/mvh100; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; APPLEMAN JR, 1989, BIOCHEMISTRY-US, V28, P8221, DOI 10.1021/bi00446a038; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Blodgett DM, 2005, BIOCHEMISTRY-US, V44, P2650, DOI 10.1021/bi048247m; CAIRNS MT, 1987, BIOCHIM BIOPHYS ACTA, V905, P295, DOI 10.1016/0005-2736(87)90458-5; CODERRE PE, 1995, BIOCHEMISTRY-US, V34, P9762, DOI 10.1021/bi00030a014; Dahl SG, 2004, J PHARMACOL EXP THER, V309, P853, DOI 10.1124/jpet.103.059972; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Graybill C, 2006, BIOCHEMISTRY-US, V45, P8096, DOI 10.1021/bi060398x; Guo XL, 2005, BIOCHEM GENET, V43, P175, DOI 10.1007/s10528-005-1510-5; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; HOLMAN GD, 1987, BIOCHIM BIOPHYS ACTA, V897, P395, DOI 10.1016/0005-2736(87)90437-8; Holyoake J, 2006, BIOPHYS J, V91, pL84, DOI 10.1529/biophysj.106.093971; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; INUKAI K, 1994, BIOCHEM J, V302, P355, DOI 10.1042/bj3020355; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; JUNG EKY, 1986, J BIOL CHEM, V261, P9155; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; KARIM AR, 1987, BIOCHIM BIOPHYS ACTA, V902, P402, DOI 10.1016/0005-2736(87)90208-2; Kasho VN, 2006, J MOL BIOL, V358, P1060, DOI 10.1016/j.jmb.2006.02.049; Krokhin OV, 2004, MOL CELL PROTEOMICS, V3, P908, DOI 10.1074/mcp.M400031-MCP200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2006, J BIOL CHEM, V281, P36993, DOI 10.1074/jbc.M608158200; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; STECK T L, 1973, Journal of Supramolecular Structure, V1, P220, DOI 10.1002/jss.400010307; Sultzman LA, 1999, BIOCHEMISTRY-US, V38, P6640, DOI 10.1021/bi990130o; Weinglass A, 2004, J BIOL CHEM, V279, P41858, DOI 10.1074/jbc.M407555200; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	42	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36416	36424		10.1074/jbc.M804802200	http://dx.doi.org/10.1074/jbc.M804802200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18981181	Green Published, hybrid			2022-12-27	WOS:000261840500039
J	Vaysberg, M; Hatton, O; Lambert, SL; Snow, AL; Wong, B; Krams, SM; Martinez, OM				Vaysberg, Maria; Hatton, Olivia; Lambert, Stacie L.; Snow, Andrew L.; Wong, Bonnie; Krams, Sheri M.; Martinez, Olivia M.			Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-Fos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HUMAN EPITHELIAL-CELLS; LYMPHOCYTE GROWTH TRANSFORMATION; TERMINAL KINASE PATHWAY; EARLY GENE-PRODUCTS; NASOPHARYNGEAL CARCINOMA; FUNCTIONAL DIFFERENCES; ENCODED LMP1; BINDING-SITE; MEMBRANE-PROTEIN-1	Latent membrane protein 1 (LMP1) of Epstein-Barr virus (EBV) is a proven oncogene that is essential for transformation of human B cells by the virus. LMP1 induces constitutive activation of several signal transduction pathways involving nuclear factor kappa B, phosphatidylinositol 3-kinase/Akt, and the mitogenactivated protein kinases (MAPK) p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (Erk). Sequencing of LMP1 isolated from a panel of EBV+ B cell lymphomas identified three different variants of LMP1, each distinct from the B95.8 prototype isoform. All tumor variants of LMP1 as well as the B95.8 LMP1 isoform were able to induce rapid p38 phosphorylation as well as Akt and JNK activation. Additionally all variants showed similar ability to activate nuclear factor kappa B. In contrast, only tumor-derived LMP1 variants induced prolonged Erk activation and c-Fos expression. Sequence analysis revealed only two amino acids, 212 and 366, shared by the tumor variants but distinct from B95.8. Point mutation of either amino acids 212 (glycine to serine) or 366 (serine to threonine) from the B95.8 isoform to the tumor variant version of LMP1 was sufficient for gain of function characterized by sustained activation of Erk and subsequent c-Fos induction and binding to the AP1 site. Our results indicate that the enhanced ability of tumorderived LMP1 to induce and stabilize the c-Fos oncogene can be localized to two amino acids in the C terminus of LMP1.	[Vaysberg, Maria; Hatton, Olivia; Lambert, Stacie L.; Snow, Andrew L.; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Vaysberg, Maria; Hatton, Olivia; Lambert, Stacie L.; Snow, Andrew L.; Wong, Bonnie; Krams, Sheri M.; Martinez, Olivia M.] Stanford Univ, Sch Med, Dept Surg, Div Transplantat, Stanford, CA 94305 USA	Stanford University; Stanford University	Martinez, OM (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.	omm@stanford.edu	Wong, Bonnie/T-7110-2019	, Olivia/0000-0002-2798-0251; Snow, Andrew/0000-0002-8728-6691; Krams, Sheri/0000-0002-6049-5119	National Institutes of Health [RO1AI41789, RO1 CA105157]; Mason Case Fellowship; American Cancer Society Fellowship; NATIONAL CANCER INSTITUTE [R01CA105157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mason Case Fellowship; American Cancer Society Fellowship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI41789 (to O.M.M.) and RO1 CA105157 (to O.M.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. Supported by the Mason Case Fellowship. Supported by an American Cancer Society Fellowship.	Beatty PR, 1997, J IMMUNOL, V158, P4045; Brodeur SR, 1997, J BIOL CHEM, V272, P19777, DOI 10.1074/jbc.272.32.19777; Chen RH, 1996, ONCOGENE, V12, P1493; Chuang HC, 2005, BLOOD, V106, P3090, DOI 10.1182/blood-2005-04-1406; CURRAN T, 1984, CELL, V36, P259; Dawson CW, 2008, J VIROL, V82, P3654, DOI 10.1128/JVI.01888-07; Dawson CW, 2000, VIROLOGY, V272, P204, DOI 10.1006/viro.2000.0344; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Devergne O, 1996, MOL CELL BIOL, V16, P7098; Devergne O, 1998, J VIROL, V72, P7900, DOI 10.1128/JVI.72.10.7900-7908.1998; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Eliopoulos AG, 1998, ONCOGENE, V16, P1731, DOI 10.1038/sj.onc.1201694; Fielding CA, 2001, J VIROL, V75, P9129, DOI 10.1128/JVI.75.19.9129-9141.2001; Gires O, 1997, EMBO J, V16, P6131, DOI 10.1093/emboj/16.20.6131; Guiretti DM, 2007, J MED VIROL, V79, P1722, DOI 10.1002/jmv.21020; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HU LF, 1991, J GEN VIROL, V72, P2399, DOI 10.1099/0022-1317-72-10-2399; HU LF, 1993, ONCOGENE, V8, P1575; HUEN DS, 1995, ONCOGENE, V10, P549; Izumi KM, 1999, MOL CELL BIOL, V19, P5759; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; Johnson RJ, 1998, J VIROL, V72, P4038, DOI 10.1128/JVI.72.5.4038-4048.1998; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; Kutz H, 2008, VIROLOGY, V371, P246, DOI 10.1016/j.virol.2007.09.044; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Liu LT, 2003, ONCOGENE, V22, P8263, DOI 10.1038/sj.onc.1207157; Mainou BA, 2005, ONCOGENE, V24, P6917, DOI 10.1038/sj.onc.1208846; Mainou BA, 2006, J VIROL, V80, P6458, DOI 10.1128/JVI.00135-06; Mehl AM, 2001, J BIOL CHEM, V276, P984, DOI 10.1074/jbc.M003758200; MITCHELL T, 1995, J VIROL, V69, P2968, DOI 10.1128/JVI.69.5.2968-2976.1995; MOORTHY RK, 1993, J VIROL, V67, P1638, DOI 10.1128/JVI.67.3.1638-1646.1993; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nepomuceno RR, 2002, TRANSPLANTATION, V74, P396, DOI 10.1097/00007890-200208150-00017; Nicholson LJ, 1997, ONCOGENE, V15, P275, DOI 10.1038/sj.onc.1201187; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; Sandberg M, 1997, J VIROL, V71, P4649, DOI 10.1128/JVI.71.6.4649-4656.1997; Sandvej K, 1997, BLOOD, V90, P323; SKARE J, 1982, J VIROL, V44, P1088, DOI 10.1128/JVI.44.3.1088-1091.1982; Song X, 2004, CELL SIGNAL, V16, P1153, DOI 10.1016/j.cellsig.2004.03.014; Tang WG, 2003, J BIOL CHEM, V278, P48942, DOI 10.1074/jbc.M307962200; Vockerodt M, 2001, GENES IMMUN, V2, P433, DOI 10.1038/sj.gene.6363803; Wan J, 2004, MOL CELL BIOL, V24, P192, DOI 10.1128/MCB.24.1.192-199.2004; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9	49	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36573	36585		10.1074/jbc.M802968200	http://dx.doi.org/10.1074/jbc.M802968200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18986987	hybrid, Green Published			2022-12-27	WOS:000261840500055
J	Wertheimer, EV; Salicioni, AM; Liu, WM; Trevino, CL; Chavez, J; Hernandez-Gonzalez, EO; Darszon, A; Visconti, PE				Wertheimer, Eva V.; Salicioni, Ana M.; Liu, Weimin; Trevino, Claudia L.; Chavez, Julio; Hernandez-Gonzalez, Enrique O.; Darszon, Alberto; Visconti, Pablo E.			Chloride Is Essential for Capacitation and for the Capacitation-associated Increase in Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERM CAPACITATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; INDUCED ACROSOMAL EXOCYTOSIS; CAMP-DEPENDENT PATHWAY; K-CL COTRANSPORTER; ADENYLYL-CYCLASE; ZONA-PELLUCIDA; NA+-K+-2CL(-) COTRANSPORTER; FERTILIZING-CAPACITY; SPERMATOGENIC CELLS	After epididymal maturation, sperm capacitation, which encompasses a complex series of molecular events, endows the sperm with the ability to fertilize an egg. This process can be mimicked in vitro in defined media, the composition of which is based on the electrolyte concentration of the oviductal fluid. It is well established that capacitation requires Na+, HCO3-, Ca-2(+), and a cholesterol acceptor; however, little is known about the function of Cl- during this important process. To determine whether Cl-, in addition to maintaining osmolarity, actively participates in signaling pathways that regulate capacitation, Cl- was replaced by either methanesulfonate or gluconate two nonpermeable anions. The absence of Cl- did not affect sperm viability, but capacitation-associated processes such as the increase in tyrosine phosphorylation, the increase in cAMP levels, hyperactivation, the zona pellucidae-induced acrosome reaction, and most importantly, fertilization were abolished or significantly reduced. Interestingly, the addition of cyclic AMP agonists to sperm incubated in Cl--free medium rescued the increase in tyrosine phosphorylation and hyperactivation suggesting that Cl- acts upstream of the cAMP/protein kinase A signaling pathway. To investigate Cl- transport, sperm incubated in complete capacitation medium were exposed to a battery of anion transport inhibitors. Among them, bumetanide and furosemide, two blockers of Na+/K+/Cl- cotransporters (NKCC), inhibited all capacitation-associated events, suggesting that these transporters may mediate Cl- movements in sperm. Consistent with these results, Western blots using anti-NKCC1 antibodies showed the presence of this cotransporter in mature sperm.	[Wertheimer, Eva V.; Salicioni, Ana M.; Liu, Weimin; Visconti, Pablo E.] Univ Massachusetts, Paige Labs 208, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Trevino, Claudia L.; Chavez, Julio; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Genet Desarrollo & Fisiiol Mol, Cuernavaca 62250, Morelos, Mexico; [Hernandez-Gonzalez, Enrique O.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City, DF, Mexico	University of Massachusetts System; University of Massachusetts Amherst; Universidad Nacional Autonoma de Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Visconti, PE (corresponding author), Univ Massachusetts, Paige Labs 208, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	pvisconti@vasci.umass.edu	Salicioni, Ana Maria/ABD-8384-2021; Hernández-González, Enrique/AAU-8526-2020	Salicioni, Ana Maria/0000-0002-8951-3587; Darszon, Alberto/0000-0002-2502-0505; Chavez, Julio/0000-0002-7375-9531; Trevino, Claudia L/0000-0002-7281-0534	National Institutes of Health [HD38082, HD44044]; Eunice Kennedy Shriver NICHD; Fogarty International Research Collaboration [RO3 TW006121]; Consejo Nacional de Ciencia y Tecnologia [CONACyT 49113]; Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico [DGAPA IN225406, IN227806-3]; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038082, R01HD044044] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW006121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fogarty International Research Collaboration(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by National Institutes of Health Grants HD38082 and HD44044 (to P E V.) from the Eunice Kennedy Shriver NICHD. This work was also supported by Fogarty International Research Collaboration Award Grant RO3 TW006121 (to P.E.V. and A.D.) and by funds from the Consejo Nacional de Ciencia y Tecnologia (CONACyT 49113 to A.D.), the Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico (DGAPA IN225406 to A. D. and IN227806-3 to C.T.), and the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AKABAS MH, 2001, ENCY LIFE SCI, P1; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; BOATMAN DE, 1991, BIOL REPROD, V44, P806, DOI 10.1095/biolreprod44.5.806; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Bray C, 2005, BIOL REPROD, V73, P807, DOI 10.1095/biolreprod.105.042184; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Culliford SJ, 2003, CELL PHYSIOL BIOCHEM, V13, P181, DOI 10.1159/000072420; de Tassigny AD, 2003, FUND CLIN PHARMACOL, V17, P539, DOI 10.1046/j.1472-8206.2003.00197.x; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Estevez R, 2003, NEURON, V38, P47, DOI 10.1016/S0896-6273(03)00168-5; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; Garg P, 2007, AM J PHYSIOL-HEART C, V292, pH2100, DOI 10.1152/ajpheart.01402.2006; Gatto C, 1997, ARCH BIOCHEM BIOPHYS, V340, P90, DOI 10.1006/abbi.1997.9879; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Hasannejad H, 2004, J PHARMACOL EXP THER, V308, P1021, DOI 10.1124/jpet.103.059139; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Ianowski JP, 2004, J EXP BIOL, V207, P3707, DOI 10.1242/jeb.01203; Isenring P, 2001, COMP BIOCHEM PHYS A, V130, P487, DOI 10.1016/S1095-6433(01)00420-2; KALAB P, 1994, J BIOL CHEM, V269, P3810; Kalab P, 1998, MOL REPROD DEV, V51, P304, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;304::AID-MRD10&gt;3.0.CO;2-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leclerc P, 1998, J ANDROL, V19, P434; Lopez-Gonzalez I, 2001, DEV BIOL, V236, P210, DOI 10.1006/dbio.2001.0314; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; McAvey BA, 2002, BIOL REPROD, V67, P1342, DOI 10.1095/biolreprod67.4.1342; Meizel S, 2004, BIOL REV, V79, P713, DOI 10.1017/S1464793103006407; MELENDREZ CS, 1995, BIOL REPROD, V53, P676, DOI 10.1095/biolreprod53.3.676; MOORE GD, 1994, DEVELOPMENT, V120, P3313; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; NEILL JM, 1987, GAMETE RES, V18, P121, DOI 10.1002/mrd.1120180204; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; Proks P, 2001, BRIT J PHARMACOL, V132, P973, DOI 10.1038/sj.bjp.0703916; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; SHI QX, 1995, BIOL REPROD, V52, P373, DOI 10.1095/biolreprod52.2.373; Simard CF, 2004, J BIOL CHEM, V279, P48449, DOI 10.1074/jbc.M407012200; Sokal R.R., 2012, BIOMETRY; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; Tutuncu L, 2004, DEV BIOL, V270, P246, DOI 10.1016/j.ydbio.2004.02.008; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; Visconti PE, 1996, MOL REPROD DEV, V43, P82; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; WARD CR, 1992, J BIOL CHEM, V267, P14061; WEBERSCHURHOLZ S, 1993, J BIOL CHEM, V268, P547; WHITE MM, 1990, MOL PHARMACOL, V37, P720; Wuttke M S, 2001, JOP, V2, P154; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Yanagimachi R., 1994, P189; YOSHIMATSU N, 1988, DEV GROWTH DIFFER, V30, P651	60	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35539	35550		10.1074/jbc.M804586200	http://dx.doi.org/10.1074/jbc.M804586200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957426	Green Published, hybrid			2022-12-27	WOS:000261687900026
J	Hiltunen, JK; Schonauer, MS; Autio, KJ; Mittelmeier, TM; Kastaniotis, AJ; Dieckmann, CL				Hiltunen, J. Kalervo; Schonauer, Melissa S.; Autio, Kaija J.; Mittelmeier, Telsa M.; Kastaniotis, Alexander J.; Dieckmann, Carol L.			Mitochondrial Fatty Acid Synthesis Type II: More than Just Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACYL-CARRIER PROTEIN; PYRUVATE-DEHYDROGENASE COMPLEX; 2-ENOYL THIOESTER REDUCTASE; BOVINE HEART-MITOCHONDRIA; TRANSFER-RNA-SYNTHETASE; SACCHAROMYCES-CEREVISIAE; LIPOIC ACID; TRYPANOSOMA-BRUCEI; 3-HYDROXYACYL-ACP DEHYDRATASE; NEUROSPORA MITOCHONDRIA	Eukaryotes harbor a highly conserved mitochondrial pathway for fatty acid synthesis (FAS), which is completely independent of the eukaryotic cytosolic FAS apparatus. The activities of the mitochondrial FAS system are catalyzed by soluble enzymes, and the pathway thus resembles its prokaryotic counterparts. Except for octanoic acid, which is the direct precursor for lipoic acid synthesis, other end products and functions of the mitochondrial FAS pathway are still largely enigmatic. In addition to low cellular levels of lipoic acid, disruption of genes encoding mitochondrial FAS enzymes in yeast results in a respiratory-deficient phenotype and small rudimentary mitochondria. Recently, two distinct links between mitochondrial FAS and RNA processing have been discovered in vertebrates and yeast, respectively. In vertebrates, the mitochondrial 3-hydroxyacyl-acyl carrier protein dehydratase and the RPP14 subunit of RNase P are encoded by the same bicistronic transcript in an evolutionarily conserved arrangement that is unusual for eukaryotes. In yeast, defects in mitochondrial FAS result in inefficient RNase P cleavage in the organelle. The intersection of mitochondrial FAS and RNA metabolism in both systems provides a novel mechanism for the coordination of intermediary metabolism in eukaryotic cells.	[Hiltunen, J. Kalervo; Autio, Kaija J.; Kastaniotis, Alexander J.] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Hiltunen, J. Kalervo; Autio, Kaija J.; Kastaniotis, Alexander J.] Univ Oulu, Bioctr Oulu, FI-90014 Oulu, Finland; [Mittelmeier, Telsa M.; Dieckmann, Carol L.] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Schonauer, Melissa S.; Dieckmann, Carol L.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Arizona; University of Arizona	Hiltunen, JK (corresponding author), Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland.	kalervo.hiltunen@oulu.fi		Kastaniotis, Alexander/0000-0003-3624-9214; Autio, Kaija/0000-0001-9398-7649	National Institutes of Health [GM34893]; Sigrid Juselius Foundation; Academy of Finland; Nordic Center of Excellence Programme in Food, Nutrition, and Health Project [070010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Nordic Center of Excellence Programme in Food, Nutrition, and Health Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34893 (to C. L. D.). This work was also supported by a grant from the Sigrid Juselius Foundation, the Academy of Finland, and Nordic Center of Excellence Programme in Food, Nutrition, and Health Project (070010) "MitoHealth" (to J. K. H.). This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; Autio KJ, 2008, FEBS LETT, V582, P729, DOI 10.1016/j.febslet.2008.01.051; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; BRODY S, 1988, EUR J BIOCHEM, V173, P353, DOI 10.1111/j.1432-1033.1988.tb14005.x; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Challem JJ, 1999, MED HYPOTHESES, V52, P417, DOI 10.1054/mehy.1997.0685; CHEN JY, 1988, J BIOL CHEM, V263, P13677; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; CHUMAN L, 1989, EUR J BIOCHEM, V184, P643, DOI 10.1111/j.1432-1033.1989.tb15061.x; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; DANG YL, 1993, J BIOL CHEM, V268, P19791; DIECKMANN CL, 1994, INT REV CYTOL, V152, P145, DOI 10.1016/S0074-7696(08)62556-5; Fujiwara K, 2001, J BIOL CHEM, V276, P28819, DOI 10.1074/jbc.M101748200; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; Guler JL, 2008, MOL MICROBIOL, V67, P1125, DOI 10.1111/j.1365-2958.2008.06112.x; HARINGTON A, 1993, MOL MICROBIOL, V9, P545, DOI 10.1111/j.1365-2958.1993.tb01715.x; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; HOLLINGSWORTH MJ, 1987, NUCLEIC ACIDS RES, V15, P8845, DOI 10.1093/nar/15.21.8845; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kozak M, 2007, J CELL BIOCHEM, V102, P280, DOI 10.1002/jcb.21464; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; MIKOLAJCZYK S, 1990, EUR J BIOCHEM, V187, P431, DOI 10.1111/j.1432-1033.1990.tb15322.x; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; Morikawa T, 2001, FEBS LETT, V498, P16, DOI 10.1016/S0014-5793(01)02469-3; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Rodeheffer MS, 2003, J BIOL CHEM, V278, P18695, DOI 10.1074/jbc.M301399200; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Schafer B, 2005, GENE, V354, P80, DOI 10.1016/j.gene.2005.03.032; Schneider R, 1997, CURR GENET, V32, P384, DOI 10.1007/s002940050292; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; Stuible HP, 1998, J BIOL CHEM, V273, P22334, DOI 10.1074/jbc.273.35.22334; SULO P, 1993, J BIOL CHEM, V268, P17634; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Witkowski A, 2007, J BIOL CHEM, V282, P14178, DOI 10.1074/jbc.M701486200; YAMAZOE M, 1994, J BIOL CHEM, V269, P15244; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Zhang L, 2005, J BIOL CHEM, V280, P12422, DOI 10.1074/jbc.M413686200; Zhang L, 2003, J BIOL CHEM, V278, P40067, DOI 10.1074/jbc.M306121200	46	114	117	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2009	284	14					9011	9015		10.1074/jbc.R800068200	http://dx.doi.org/10.1074/jbc.R800068200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	425WS	19028688	hybrid, Green Published			2022-12-27	WOS:000264669100002
J	Arzoine, L; Zilberberg, N; Ben-Romano, R; Shoshan-Barmatz, V				Arzoine, Laetitia; Zilberberg, Noam; Ben-Romano, Ronit; Shoshan-Barmatz, Varda			Voltage-dependent Anion Channel 1-based Peptides Interact with Hexokinase to Prevent Its Anti-apoptotic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN HEXOKINASE; CYTOCHROME-C; CELL LIFE; MITOCHONDRIA; ACTIVATION; BINDING; VDAC; GLYCOLYSIS; CANCERS; DOMAIN	In brain and tumor cells, the hexokinase isoforms, HK-I and HK-II, bind to the voltage-dependent anion channel (VDAC) in the outer mitochondrial membrane. The VDAC domains interacting with these anti-apoptotic proteins were recently defined using site-directed mutagenesis. Now, we demonstrate that synthetic peptides corresponding to the VDAC1 N-terminal region and selected sequences bound specifically, in a concentration- and time-dependent manner, to immobilized HK-I, as revealed by real time surface plasmon resonance technology. The same VDAC1-based peptides also detached HK bound to brain or tumor-derived mitochondria. Moreover, expression of the VDAC1-based peptides in cells overexpressing HK-I or HK-II prevented HK-mediated protection against staurosporine-induced release of cytochrome c and subsequent cell death. One loop-shaped VDAC1-based peptide corresponding to a selected sequence and fused to a cell-penetrating peptide entered the cell and prevented the anti-apoptotic effects of HK-I and HK-II. This peptide detached mitochondrial-bound HK better than did the same peptide in its linear form. Both cell-expressed and exogenously added cell-penetrating peptide detached mitochondrial-bound HK-I-GFP. These results point to HK-I and HK-II as promoting tumor cell survival through binding to VDAC1, thereby inhibiting cytochrome c release and apoptotic cell death. Moreover, VDAC1-based peptides interfering with HK-mediated anti-apoptotic activity may potentiate the efficacy of conventional chemotherapeutic agents.	[Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, POB 653, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il	Zilberberg, Noam/F-2005-2012	Zilberberg, Noam/0000-0002-7848-2391	Israel Science Foundation; Johnson and Johnson Corporate Office of Science and Technology	Israel Science Foundation(Israel Science Foundation); Johnson and Johnson Corporate Office of Science and Technology(Johnson & JohnsonJohnson & Johnson USA)	This work was supported, in part, by grants from the Israel Science Foundation and the Johnson and Johnson Corporate Office of Science and Technology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Al jamal JA, 2005, PROTEIN J, V24, P1, DOI 10.1007/s10930-004-0600-2; ARORA KK, 1990, J BIOL CHEM, V265, P6481; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Beutner G, 1998, BBA-BIOMEMBRANES, V1368, P7, DOI 10.1016/S0005-2736(97)00175-2; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; De Pinto Vito, 2003, Ital J Biochem, V52, P17; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; Dinnen RD, 2007, J BIOL CHEM, V282, P26675, DOI 10.1074/jbc.M701864200; FANCIULLI M, 1994, ONCOL RES, V6, P405; GELB BD, 1992, P NATL ACAD SCI USA, V89, P202, DOI 10.1073/pnas.89.1.202; Geschwind JFH, 2002, CANCER RES, V62, P3909; Goldin N, 2008, ONCOGENE, V27, P4636, DOI 10.1038/onc.2008.108; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Holinger EP, 1999, J BIOL CHEM, V274, P13298, DOI 10.1074/jbc.274.19.13298; Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Moin SM, 2007, J BIOL CHEM, V282, P21124, DOI 10.1074/jbc.M701696200; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; Oudard Stephane, 2004, Bull Cancer, V91, pE184; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; POLAKIS PG, 1985, ARCH BIOCHEM BIOPHYS, V236, P328, DOI 10.1016/0003-9861(85)90633-2; Robey RB, 2005, CELL CYCLE, V4, P654, DOI 10.4161/cc.4.5.1678; Rotem R, 2005, CANCER RES, V65, P1984, DOI 10.1158/0008-5472.CAN-04-3091; Sade H, 2004, EUR J IMMUNOL, V34, P119, DOI 10.1002/eji.200324650; Schimmer AD, 2001, CELL DEATH DIFFER, V8, P725, DOI 10.1038/sj.cdd.4400870; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shimizu S, 2001, J CELL BIOL, V152, P237, DOI 10.1083/jcb.152.2.237; Shinohara Y, 2000, EUR J BIOCHEM, V267, P6067, DOI 10.1046/j.1432-1327.2000.01687.x; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; WILSON JE, 1995, REV PHYSIOL BIOCH P, V126, P65, DOI 10.1007/BFb0049776; WILSON JE, 1989, ARCH BIOCHEM BIOPHYS, V269, P517, DOI 10.1016/0003-9861(89)90135-5; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599	50	136	143	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3946	3955		10.1074/jbc.M803614200	http://dx.doi.org/10.1074/jbc.M803614200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19049977	hybrid			2022-12-27	WOS:000262872500063
J	Omura, A; Matsuzaki, T; Mio, K; Ogura, T; Yamamoto, M; Fujita, A; Okawa, K; Kitayama, H; Takahashi, C; Sato, C; Noda, M				Omura, Akira; Matsuzaki, Tomoko; Mio, Kazuhiro; Ogura, Toshihiko; Yamamoto, Mako; Fujita, Akiko; Okawa, Katsuya; Kitayama, Hitoshi; Takahashi, Chiaki; Sato, Chikara; Noda, Makoto			RECK Forms Cowbell-shaped Dimers and Inhibits Matrix Metalloproteinase-catalyzed Cleavage of Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MMP-REGULATOR RECK; AUTOMATIC PARTICLE PICKUP; FAS LIGAND; MATRILYSIN; METASTASIS; PROTEIN; ANGIOGENESIS; INVASION; RECONSTRUCTION; IDENTIFICATION	The membrane-anchored protease regulator RECK plays important roles in mammalian development and tumor suppression. The biochemical bases of these bioactivities, however, remain poorly understood. Here we report on the properties of a recombinant RECK protein expressed in mouse fibroblasts and purified to near homogeneity. Multiple lines of evidence indicate that RECK forms dimers. Single particle reconstruction using transmission electron microscopy revealed a unique cowbell-like shaped RECK dimer. RECK is cleaved by MMP-2 and MMP-7 and competitively inhibits MMP-7-catalyzed cleavage of fibronectin. Forced RECK expression in HT1080 cells, whose endogenous RECK expression is minimal, leads to an increase in the amount of fibronectin associated with the cell. Our data demonstrate the ability of RECK to protect fibronectin from MMP-mediated degradation.	[Omura, Akira; Matsuzaki, Tomoko; Yamamoto, Mako; Fujita, Akiko; Kitayama, Hitoshi; Takahashi, Chiaki; Noda, Makoto] Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Sakyo Ku, Kyoto 6068501, Japan; [Takahashi, Chiaki] Kyoto Univ, Grad Sch Med, Century COE Format 21st, Sakyo Ku, Kyoto 6068501, Japan; [Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba 3058568, Japan; [Mio, Kazuhiro; Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tsukuba 3058568, Japan; [Ogura, Toshihiko] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Kyoto University; Kyoto University; Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Noda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Kyoto 6068501, Japan.	mnoda@virus.kyoto-u.ac.jp	Mio, Kazuhiro/L-7488-2018; Sato, Chikara/M-7183-2016; Ogura, Toshihiko/M-4089-2018	Mio, Kazuhiro/0000-0002-1655-8231; Sato, Chikara/0000-0001-5543-4496; Matsuzaki, Tomoko/0000-0002-9878-0433	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, and Science and Technology; New Energy and Industrial Technology Development Organization; Japan Science and Technology Agency	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, and Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant-in-aid for creative scientific research from Japan Society for the Promotion of Science, a grant-in-aid for priority areas (Structure of Biological Macromolecular Assemblies) from Ministry of Education, Culture, Sports, and Science and Technology, a grant from New Energy and Industrial Technology Development Organization, and a PRESTO grant from Japan Science and Technology Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Barilla ML, 2000, SEMIN ARTHRITIS RHEU, V29, P252, DOI 10.1016/S0049-0172(00)80012-8; Echizenya M, 2005, ONCOGENE, V24, P5850, DOI 10.1038/sj.onc.1208733; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Frank J, 2006, 3 DIMENSIONAL ELECT; FUKAI F, 1995, BIOCHEMISTRY-US, V34, P11453, DOI 10.1021/bi00036a018; Fukui N, 2002, J BIOL CHEM, V277, P2193, DOI 10.1074/jbc.M105485200; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; HARAUZ G, 1986, OPTIK, V73, P146; Itoh T, 1998, CANCER RES, V58, P1048; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Kawashima S, 2008, J NEUROCHEM, V104, P376, DOI 10.1111/j.1471-4159.2007.04977.x; Kondo S, 2007, J CELL SCI, V120, P849, DOI 10.1242/jcs.03388; Kozaki T, 2003, J BIOL CHEM, V278, P50546, DOI 10.1074/jbc.M307432200; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Miki T, 2007, J BIOL CHEM, V282, P12341, DOI 10.1074/jbc.M610948200; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MILLER AD, 1989, BIOTECHNIQUES, V7, P984; MILLER AD, 1989, BIOTECHNIQUES, V7, P989; Miyamoto S, 2004, CANCER RES, V64, P665, DOI 10.1158/0008-5472.CAN-03-1916; MIYAZAKI K, 1990, CANCER RES, V50, P7758; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Noda M, 2007, CANCER SCI, V98, P1659, DOI 10.1111/j.1349-7006.2007.00588.x; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; OLDEN K, 1977, CELL, V11, P957, DOI 10.1016/0092-8674(77)90307-5; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Sasahara RM, 1999, BIOCHEM BIOPH RES CO, V264, P668, DOI 10.1006/bbrc.1999.1552; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Simizu S, 2005, CANCER RES, V65, P7455, DOI 10.1158/0008-5472.CAN-04-4446; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620	48	47	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3461	3469		10.1074/jbc.M806212200	http://dx.doi.org/10.1074/jbc.M806212200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19022775	hybrid			2022-12-27	WOS:000262872500012
J	Scarselli, M; Donaldson, JG				Scarselli, Marco; Donaldson, Julie G.			Constitutive Internalization of G Protein-coupled Receptors and G Proteins via Clathrin-independent Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; BETA-ARRESTINS; MEDIATED ENDOCYTOSIS; DOWN-REGULATION; TRAFFICKING; ACTIVATION; ENDOSOMES; PATHWAYS; SEQUESTRATION; BINDING	Although agonist-dependent endocytosis of G protein-coupled receptors (GPCRs) as a means to modulate receptor signaling has been widely studied, the constitutive endocytosis of GPCRs has received little attention. Here we show that two prototypical class I GPCRs, the beta 2 adrenergic and M3 muscarinic receptors, enter cells constitutively by clathrin-independent endocytosis and colocalize with markers of this endosomal pathway on recycling tubular endosomes, indicating that these receptors can subsequently recycle back to the plasma membrane (PM). This constitutive endocytosis of these receptors was not blocked by antagonists, indicating that receptor signaling was not required. Interestingly, the G proteins that these receptors couple to, G alpha(s) and G alpha(q), localized together with their receptors at the plasma membrane and on tubular recycling endosomes. Upon agonist stimulation, G alpha(s) and G alpha(q) remained associated with the PM and these endosomal membranes, whereas beta 2 and M3 receptors now entered cells via clathrin-dependent endocytosis. Deletion of the third intracellular loop (i3 loop), which is thought to play a role in agonist-dependent endocytosis of the M3 receptor, had no effect on the constitutive internalization of the receptor. Surprisingly, with agonist, the mutated M3 receptor still internalized and accumulated in cells but through clathrin-independent and not clathrin-dependent endocytosis. These findings demonstrate that GPCRs are versatile PM proteins that can utilize different mechanisms of internalization depending upon ligand activation.	[Scarselli, Marco; Donaldson, Julie G.] NHLBI, NIH, Cell Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Donaldson, JG (corresponding author), NHLBI, NIH, Cell Biol Lab, Bldg 50,Rm 2503, Bethesda, MD 20892 USA.	jdonalds@helix.nih.gov		Scarselli, Marco/0000-0001-5087-3182	Intramural Research Program of the NHLBI; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000517, Z01HL000517] Funding Source: NIH RePORTER	Intramural Research Program of the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Intramural Research Program of the NHLBI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bohn LM, 2007, MOL PHARMACOL, V71, P957, DOI 10.1124/mol.107.034223; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Delaney KA, 2002, J BIOL CHEM, V277, P33439, DOI 10.1074/jbc.M205293200; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; LAMEH J, 1992, J BIOL CHEM, V267, P13406; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; MORO O, 1993, J BIOL CHEM, V268, P6862; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nathanson NM, 2008, PHARMACOL THERAPEUT, V119, P33, DOI 10.1016/j.pharmthera.2008.04.006; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Novi F, 2005, J BIOL CHEM, V280, P19768, DOI 10.1074/jbc.M411281200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Popova JS, 2004, J BIOL CHEM, V279, P30410, DOI 10.1074/jbc.M402871200; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Roseberry AG, 1999, J BIOL CHEM, V274, P33671, DOI 10.1074/jbc.274.47.33671; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; Vogler O, 1999, J BIOL CHEM, V274, P12333, DOI 10.1074/jbc.274.18.12333; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154	55	73	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3577	3585		10.1074/jbc.M806819200	http://dx.doi.org/10.1074/jbc.M806819200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19033440	hybrid, Green Published			2022-12-27	WOS:000262872500025
J	Davison, JM; Mellott, TJ; Kovacheva, VP; Blusztajn, JK				Davison, Jessica M.; Mellott, Tiffany J.; Kovacheva, Vesela P.; Blusztajn, Jan Krzysztof			Gestational Choline Supply Regulates Methylation of Histone H3, Expression of Histone Methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA Methylation of Their Genes in Rat Fetal Liver and Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AVAILABILITY MODULATES HIPPOCAMPAL; ENHANCED VISUOSPATIAL MEMORY; PROGENITOR-CELL MITOSIS; LYSINE-9 METHYLATION; SUPPLEMENTATION INCREASES; EMBRYONIC-DEVELOPMENT; DEFICIENCY; PROTEIN; IGF2; HYPERMETHYLATION	Choline is an essential nutrient that, via its metabolite betaine, serves as a donor of methyl groups used in fetal development to establish the epigenetic DNA and histone methylation patterns. Supplementation with choline during embryonic days (E) 11-17 in rats improves memory performance in adulthood and protects against age-related memory decline, whereas choline deficiency impairs certain cognitive functions. We previously reported that global and gene-specific DNA methylation increased in choline-deficient fetal brain and liver, and these changes in DNA methylation correlated with an apparently compensatory up-regulation of the expression of DNA methyltransferase Dnmt1. In the current study, pregnant rats were fed a diet containing varying amounts of choline (mmol/kg: 0 (deficient), 8 (control), or 36 (supplemented)) during E11-17, and indices of histone methylation were assessed in liver and frontal cortex on E17. The mRNA and protein expression of histone methyltransferases G9a and Suv39h1 were directly related to the availability of choline. DNA methylation of the G9a and Suv39h1 genes was up-regulated by choline deficiency, suggesting that the expression of these enzymes is under negative control by methylation of their genes. The levels of H3K9Me2 and H3K27Me3, tags of transcriptionally repressed chromatin, were up-regulated by choline supplementation, whereas the levels of H3K4Me2, associated with active promoters, were highest in choline-deficient rats. These data show that maternal choline supply during pregnancy modifies fetal histone and DNA methylation, suggesting that a concerted epigenomic mechanism contributes to the long term developmental effects of varied choline intake in utero.	[Blusztajn, Jan Krzysztof] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; Boston Univ, Sch Med, Lab Med, Boston, MA 02118 USA	Boston University; Boston University	Blusztajn, JK (corresponding author), Boston Univ, Sch Med, Dept Pathol, 72 E Concord St,L804, Boston, MA 02118 USA.	jbluszta@bu.edu		/0000-0001-8438-3122; Mellott, Tiffany/0000-0003-3287-9374	National Institutes of Health [AG009525]; NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG009525 from the NIA.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Albright CD, 1999, DEV BRAIN RES, V115, P123, DOI 10.1016/S0165-3806(99)00057-7; Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BIERI JG, 1977, J NUTR, V107, P1394; Bieri JG., 1980, J NUTR, V110, P1726, DOI [10.1093/jn/110.8.1726, DOI 10.1093/JN/110.8.1726]; Blusztajn JK, 1998, SCIENCE, V281, P794, DOI 10.1126/science.281.5378.794; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cermak JM, 1998, FASEB J, V12, P349, DOI 10.1096/fasebj.12.3.349; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTMAN JK, 1993, CARCINOGENESIS, V14, P551, DOI 10.1093/carcin/14.4.551; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Dobosy JR, 2008, PROSTATE, V68, P1187, DOI 10.1002/pros.20782; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FINKELSTEIN JD, 1983, J NUTR, V113, P519, DOI 10.1093/jn/113.3.519; Food andNutrition Board Institute of Medicine, 1998, DIET REF INT THIAM R, DOI 10.17226/6015; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; Glenn MJ, 2008, BRAIN RES, V1237, P110, DOI 10.1016/j.brainres.2008.08.049; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Higashimoto K, 2003, AM J HUM GENET, V73, P948, DOI 10.1086/378595; HolmesMcNary MQ, 1997, DEV BRAIN RES, V101, P9, DOI 10.1016/S0165-3806(97)00044-8; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Jones JP, 1999, DEV BRAIN RES, V118, P159, DOI 10.1016/S0165-3806(99)00103-0; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Kovacheva VP, 2009, FASEB J, V23, P1054, DOI 10.1096/fj.08-122168; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; McCann JC, 2006, NEUROSCI BIOBEHAV R, V30, P696, DOI 10.1016/j.neubiorev.2005.12.003; Meck WH, 2008, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.007.2007; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; Meck WH, 1997, NEUROREPORT, V8, P3053, DOI 10.1097/00001756-199709290-00010; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 1997, NEUROREPORT, V8, P3045, DOI 10.1097/00001756-199709290-00009; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Meck WH, 1997, NEUROREPORT, V8, P2831, DOI 10.1097/00001756-199709080-00005; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mellott TJ, 2007, FASEB J, V21, P1311, DOI 10.1096/fj.06-6597com; Mellott TJ, 2004, FASEB J, V18, P545, DOI 10.1096/fj.03-0877fje; Nakayama T, 2001, LAB INVEST, V81, P1049, DOI 10.1038/labinvest.3780316; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Napoli I, 2008, BRAIN RES, V1237, P124, DOI 10.1016/j.brainres.2008.08.046; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Niculescu MD, 2005, MOL BRAIN RES, V134, P309, DOI 10.1016/j.molbrainres.2004.11.001; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Ooi L, 2008, BIOCHEM J, V414, P327, DOI 10.1042/BJ20080963; Pogribny IP, 2007, J NUTR, V137, p216S, DOI 10.1093/jn/137.1.216S; Pogribny IP, 2006, CARCINOGENESIS, V27, P1180, DOI 10.1093/carcin/bgi364; Pogribny IP, 2008, BRAIN RES, V1237, P25, DOI 10.1016/j.brainres.2008.07.077; Pyapali GK, 1998, J NEUROPHYSIOL, V79, P1790, DOI 10.1152/jn.1998.79.4.1790; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Sandstrom NJ, 2002, BRAIN RES, V947, P9, DOI 10.1016/S0006-8993(02)02900-1; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Slack A, 1999, EUR J BIOCHEM, V264, P191, DOI 10.1046/j.1432-1327.1999.00603.x; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Van den Veyver IB, 2002, ANNU REV NUTR, V22, P255, DOI 10.1146/annurev.nutr.22.010402.102932; WAINFAN E, 1989, CANCER RES, V49, P4094; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Williams CL, 1998, BRAIN RES, V794, P225, DOI 10.1016/S0006-8993(98)00229-7; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; ZEISEL SH, 1995, J NUTR, V125, P3049; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zeisel SH, 2008, BRAIN RES, V1237, P5, DOI 10.1016/j.brainres.2008.08.059; Zhu XN, 2004, DEV BRAIN RES, V149, P121, DOI 10.1016/j.devbrainres.2004.01.004	83	99	102	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1982	1989		10.1074/jbc.M807651200	http://dx.doi.org/10.1074/jbc.M807651200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19001366	Green Published, hybrid			2022-12-27	WOS:000262545600005
J	Kouchi, Z; Barthet, G; Serban, G; Georgakopoulos, A; Shioi, J; Robakis, NK				Kouchi, Zen; Barthet, Gael; Serban, Geo; Georgakopoulos, Anastasios; Shioi, Junichi; Robakis, Nikolaos K.			p120 Catenin Recruits Cadherins to gamma-Secretase and Inhibits Production of A beta Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; CELL-CELL ADHESION; SYNAPTIC PLASTICITY; CYTOPLASMIC DOMAIN; DELTA-CATENIN; PRESENILIN-1; BINDING; P120-CATENIN; NEURODEGENERATION; ENDOPROTEOLYSIS	The gamma-secretase complex cleaves many transmembrane proteins, including amyloid precursor protein, EphB and ErbB tyrosine kinase receptors, Notch1 receptors, and adhesion factors. Presenilin 1, the catalytic subunit of gamma-secretase, associates with the cadherin/catenin cell-cell adhesion/communication system and promotes cadherin processing (Georgakopoulos, A., et al. (1999) Mol. Cell 4, 893-902; Marambaud, P., et al. (2002) EMBO J. 21, 1948-1956), but the mechanism by which gamma-secretase and cadherins associate is unclear. Here we report that p120 catenin (p120ctn), a component of the cadherin-catenin complex, recruits gamma-secretase to cadherins, thus stimulating their processing while inhibiting production of A beta peptide and the amyloid precursor protein intracellular domain. This function of p120ctn depends on both p120ctn-cadherin and p120ctn-presenilin 1 binding, indicating that p120ctn is the central factor that bridges gamma-secretase and cadherin-catenin complexes. Our data show that p120ctn is a unique positive regulator of the gamma-secretase processing of cadherins and a negative regulator of the amyloid precursor protein processing. Furthermore, our data suggest that specific members of the gamma-secretase complex may be used to recruit different substrates and that distinct PS1 sequences are required for processing of APP and cadherins.	[Shioi, Junichi] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Shioi, J (corresponding author), Mt Sinai Sch Med, Dept Psychiat, 1 Gustave L Levy Pl,Box 1229, New York, NY 10029 USA.	junichi.shioi@mssm.edu; nikos.robakis@mssm.edu	Serban, Geo/AAO-8819-2020; Robakis, Nikolaos/AAA-1838-2021	Barthet, Gael/0000-0003-4025-1616; Serban, Geo/0000-0002-4985-7035	National Institutes of Health [AG-17926, NS047229, AG-08200]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG017926, R01AG017926, R01AG008200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or part, by National Institutes of Health Grants AG-17926, NS047229, and AG-08200.	Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mathews PM, 2002, J BIOL CHEM, V277, P36415, DOI 10.1074/jbc.M205208200; McCrea PD, 2007, BBA-MOL CELL RES, V1773, P17, DOI 10.1016/j.bbamcr.2006.06.009; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; Onishi M, 1996, EXP HEMATOL, V24, P324; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Serban G, 2005, J BIOL CHEM, V280, P36007, DOI 10.1074/jbc.M507503200; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shioi J, 2007, J NEUROCHEM, V101, P674, DOI 10.1111/j.1471-4159.2006.04391.x; Soriano S, 2001, J BIOL CHEM, V276, P29045, DOI 10.1074/jbc.M102456200; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	36	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1954	1961		10.1074/jbc.M806250200	http://dx.doi.org/10.1074/jbc.M806250200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19008223	Green Published, hybrid			2022-12-27	WOS:000262545600002
J	Morel, E; Gruenberg, J				Morel, Etienne; Gruenberg, Jean			Annexin A2 Binding to Endosomes and Functions in Endosomal Transport Are Regulated by Tyrosine 23 Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; II TETRAMER; DISCONTINUOUS EPITOPE; INVITRO; FUSION; SITE; TRANSLOCATION; AGGREGATION; ASSOCIATION; DEGRADATION	The phospholipid-binding annexin A2 (AnxA2) is known to play a role in the regulation of membrane and actin dynamics, in particular in the endocytic pathway. The protein is present on early endosomes, where it regulates membrane traffic, including the biogenesis of multivesicular transport intermediates destined for late endosomes. AnxA2 membrane association depends on the protein N terminus and membrane cholesterol but does not involve the AnxA2 ligand p11/S100A10. However, the precise mechanisms that control AnxA2 membrane association and function are not clear. In the present study, we have investigated the role of AnxA2 N-terminal phosphorylation in controlling association to endosomal membranes and functions. We found that endosomal AnxA2 was partially tyrosine-phosphorylated and that mutation of Tyr-23 to Ala (AnxA2Y23A), but not of Ser-25 to Ala, impaired AnxA2 endosome association. We then found that the AnxA2Y23A mutant was unable to bind endosomes in vivo, whereas a phospho-mimicking AnxA2 mutant (Y23D) showed efficient endosome binding capacity. Similarly, we found that AnxA2Y23D interacted more efficiently with liposomes in vitro when compared with AnxA2Y23A. To investigate the role of Tyr-23 in vivo, AnxA2 was knocked down with small interfering RNAs, and then cells were recomplemented with RNA interferenceresistant forms of the protein. Using this strategy, we could show that AnxA2Y23D, but not AnxA2Y23A, could restore earlytolate endosome transport after AnxA2 depletion. We conclude that phosphorylation of Tyr-23 is essential for proper endosomal association and function of AnxA2, perhaps because it stabilizes membrane-associated protein via a conformational change.	[Morel, Etienne; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland	University of Geneva	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, Sci 2,30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	jean.gruenberg@biochem.unige.ch	MOREL, Etienne L/F-4765-2010; MOREL, Etienne/N-2194-2014	MOREL, Etienne L/0000-0001-7340-1313; MOREL, Etienne/0000-0002-4763-4954	Swiss National Science Foundation; Telethon Foundation; Fondation pour la Recherche Medicale; Roche Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Telethon Foundation(Fondazione Telethon); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Roche Research Foundation	This work was supported by grants from the Swiss National Science Foundation and the Telethon Foundation (to J. G.), as well as grants from the Fondation pour la Recherche Medicale (FRM) and the Roche Research Foundation (to E. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bellagamba C, 1997, J BIOL CHEM, V272, P3195, DOI 10.1074/jbc.272.6.3195; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Futter CE, 2007, TRAFFIC, V8, P951, DOI 10.1111/j.1600-0854.2007.00590.x; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GLENNEY JR, 1985, FEBS LETT, V192, P79, DOI 10.1016/0014-5793(85)80047-8; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; HUBAISHY I, 1995, BIOCHEMISTRY-US, V34, P14527, DOI 10.1021/bi00044a031; JOHNSSON N, 1988, FEBS LETT, V236, P201, DOI 10.1016/0014-5793(88)80314-4; JOHNSTONE SA, 1992, J BIOL CHEM, V267, P25976; Jost M, 1997, J CELL SCI, V110, P221; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Morel E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001118; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; REGNOUF F, 1995, J BIOL CHEM, V270, P27143, DOI 10.1074/jbc.270.45.27143; Rescher U, 2000, J CELL SCI, V113, P3931; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Rety S, 1999, NAT STRUCT BIOL, V6, P89; THIEL C, 1991, FEBS LETT, V285, P59, DOI 10.1016/0014-5793(91)80724-H; TUOMIKOSKI T, 1989, NATURE, V342, P942, DOI 10.1038/342942a0; Zibouche M, 2008, J BIOL CHEM, V283, P22121, DOI 10.1074/jbc.M801000200; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	34	77	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1604	1611		10.1074/jbc.M806499200	http://dx.doi.org/10.1074/jbc.M806499200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18990701	hybrid, Green Accepted			2022-12-27	WOS:000262330100028
J	Xiong, WF; Knispel, R; MacTaggart, J; Greiner, TC; Weiss, SJ; Baxter, T				Xiong, Wanfen; Knispel, Rebecca; MacTaggart, Jason; Greiner, Timothy C.; Weiss, Stephen J.; Baxter, Timothy			Membrane-type 1 Matrix Metalloproteinase Regulates Macrophage-dependent Elastolytic Activity and Aneurysm Formation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABDOMINAL AORTIC-ANEURYSMS; EXTRACELLULAR-MATRIX; 1-MATRIX METALLOPROTEINASE; ATHEROSCLEROTIC PLAQUES; MMP-2 ACTIVITY; MURINE MODEL; CELLS; EXPRESSION; MICE; LOCALIZATION	During arterial aneurysm formation, levels of the membrane-anchored matrix metalloproteinase, MT1-MMP, are elevated dramatically. Although MT1-MMP is expressed predominately by infiltrating macrophages, the roles played by the proteinase in abdominal aortic aneurysm (AAA) formation in vivo remain undefined. Using a newly developed chimeric mouse model of AAA, we now demonstrate that macrophage-derived MT1MMP plays a dominant role in disease progression. In wild-type mice transplanted with MT1-MMP-null marrow, aneurysm formation induced by the application of CaCl2 to the aortic surface was almost completely ablated. Macrophage infiltration into the aortic media was unaffected by MT1-MMP deletion, and AAA formation could be reconstituted when MT1-MMP+/+ macrophages, but not MT1-MMP+/+ lymphocytes, were infused into MT1-MMP-null marrow recipients. In vitro studies using macrophages isolated from either WT/MT1-MMP-/- chimeric mice, MMP-2-null mice, or MMP-9-null mice demonstrate that MT1-MMP alone plays a dominant role in macrophage-mediated elastolysis. These studies demonstrate that destruction of the elastin fiber network during AAA formation is dependent on macrophage-derived MT1-MMP, which unexpectedly serves as a direct-acting regulator of macrophage proteolytic activity.	[Xiong, Wanfen; Knispel, Rebecca; MacTaggart, Jason; Baxter, Timothy] Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68198 USA; [Greiner, Timothy C.; Baxter, Timothy] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Baxter, Timothy] Univ Nebraska, Med Ctr, Dept Cell Biol & Anat, Omaha, NE 68198 USA; [Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Inst Life Sci, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Michigan System; University of Michigan	Xiong, WF (corresponding author), 987690 Nebraska Med Ctr, Omaha, NE 68198 USA.	wxiong@unmc.edu			National Institutes of Health [5RO1HL62400-02, RO1 CA088308]; American Heart Association [974015N]; NATIONAL CANCER INSTITUTE [R01CA088308] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1HL62400-02 ( to B. T. B.) and RO1 CA088308 ( to S. J. W.). This work was also supported by American Heart Association Grant 974015N ( to B. T. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BANDA MJ, 1987, METHOD ENZYMOL, V144, P288; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Chute JP, 2004, EXP HEMATOL, V32, P308, DOI 10.1016/j.exphem.2003.12.002; Crowther M, 2000, BRIT J SURG, V87, P1391, DOI 10.1046/j.1365-2168.2000.01554.x; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Filippov S, 2003, J EXP MED, V198, P925, DOI 10.1084/jem.20030626; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Hayashi K, 2000, J PATHOL, V191, P299, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH637>3.0.CO;2-L; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Ichiyasu H, 2004, AM J RESP CELL MOL, V30, P761, DOI 10.1165/rcmb.2003-0370OC; Isenburg JC, 2007, CIRCULATION, V115, P1729, DOI 10.1161/CIRCULATIONAHA.106.672873; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kelleher CM, 2004, CURR TOP DEV BIOL, V62, P153; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Matias-Roman S, 2005, BLOOD, V105, P3956, DOI 10.1182/blood-2004-06-2382; Nollendorfs A, 2001, J VASC SURG, V34, P316, DOI 10.1067/mva.2001.115962; Punturieri A, 2000, J EXP MED, V192, P789, DOI 10.1084/jem.192.6.789; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rajavashisth TB, 1999, CIRCULATION, V99, P3103, DOI 10.1161/01.CIR.99.24.3103; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; Sinha I, 2004, SURGERY, V136, P176, DOI 10.1016/j.surg.2004.04.010; Sithu SD, 2007, J BIOL CHEM, V282, P25010, DOI 10.1074/jbc.M611273200; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Xiong WF, 2004, J IMMUNOL, V172, P2607, DOI 10.4049/jimmunol.172.4.2607; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	34	72	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1765	1771		10.1074/jbc.M806239200	http://dx.doi.org/10.1074/jbc.M806239200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19010778	Green Published, hybrid			2022-12-27	WOS:000262330100047
J	Kimura, Y; Yu, LJ; Hirano, Y; Suzuki, H; Wang, ZY				Kimura, Yukihiro; Yu, Long-Jiang; Hirano, Yu; Suzuki, Hiroaki; Wang, Zheng-Yu			Calcium Ions Are Required for the Enhanced Thermal Stability of the Light-harvesting-Reaction Center Core Complex from Thermophilic Purple Sulfur Bacterium Thermochromatium tepidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC REACTION-CENTER; CHROMATIUM-TEPIDUM; RHODOSPIRILLUM-RUBRUM; RHODOPSEUDOMONAS-VIRIDIS; CRYSTAL-STRUCTURE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; RHODOBACTER-SPHAEROIDES; ROSEOSPIRILLUM-PARVUM; PROJECTION STRUCTURE; NONSULFUR BACTERIUM	sThermochromatium tepidum is a thermophilic purple sulfur photosynthetic bacterium collected from the Mammoth Hot Springs, Yellowstone National Park. A previous study showed that the light-harvesting-reaction center core complex (LH1-RC) purified from this bacterium is highly stable at room temperature (Suzuki, H., Hirano, Y., Kimura, Y., Takaichi, S., Kobayashi, M., Miki, K., and Wang, Z.-Y. (2007) Biochim. Biophys. Acta 1767, 1057 - 1063). In this work, we demonstrate that thermal stability of the Tch. tepidum LH1-RC is much higher than that of its mesophilic counterparts, and the enhanced thermal stability requires Ca2+ as a cofactor. Removal of the Ca2+ from Tch. tepidum LH1-RC resulted in a complex with the same degree of thermal stability as that of the LH1-RCs purified from mesophilic bacteria. The enhanced thermal stability can be restored by addition of Ca2+ to the Ca2+-depleted LH1-RC, and this process is fully reversible. Interchange of the thermal stability between the two forms is accompanied by a shift of the LH1 Q(y) transition between 915 nm for the native and 880 nm for the Ca2+-depleted LH1-RC. Differential scanning calorimetry measurements reveal that degradation temperature of the native LH1-RC is 15 degrees C higher and the enthalpy change is about 28% larger than the Ca2+-depleted LH1-RC. Substitution of the Ca2+ with other metal cations caused a decrease in thermal stability of an extent depending on the properties of the cations. These results indicate that Ca2+ ions play a dual role in stabilizing the structure of the pigment-membrane protein complex and in altering its spectroscopic properties, and hence provide insight into the adaptive strategy of this photosynthetic organism to survive in extreme environments using natural resources.	[Kimura, Yukihiro; Yu, Long-Jiang; Hirano, Yu; Suzuki, Hiroaki; Wang, Zheng-Yu] Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan	Ibaraki University	Wang, ZY (corresponding author), Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan.	wang@mx.ibaraki.ac.jp	Kimura, Yukihiro/AAI-6300-2020	, Wang-Otomo/0000-0003-1676-2002	Ministry of Education, Culture, Sports, Science and Technology of Japan; The Kurata Memorial Hitachi Science and Technology Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Kurata Memorial Hitachi Science and Technology Foundation	This work was supported by grants-in-aid for scientific research on priority areas "Structures of Biological Macromolecular Assemblies" from the Ministry of Education, Culture, Sports, Science and Technology of Japan and in part by The Kurata Memorial Hitachi Science and Technology Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLEN JP, 1986, P NATL ACAD SCI USA, V83, P8589, DOI 10.1073/pnas.83.22.8589; Arluison W, 2004, BIOCHEMISTRY-US, V43, P1276, DOI 10.1021/bi030205v; Christova P, 2000, PROTEINS, V40, P177, DOI 10.1002/(SICI)1097-0134(20000801)40:2<177::AID-PROT10>3.0.CO;2-T; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Dudev T, 2007, ACCOUNTS CHEM RES, V40, P85, DOI 10.1021/ar068181i; Fathir I, 1997, PHOTOSYNTH RES, V51, P71, DOI 10.1023/A:1005718404736; Glaeser J, 1999, ARCH MICROBIOL, V171, P405, DOI 10.1007/s002030050727; HEDA GD, 1989, EUR J BIOCHEM, V184, P313, DOI 10.1111/j.1432-1033.1989.tb15021.x; HEDA GD, 1988, FEMS MICROBIOL LETT, V51, P45; Henzl MT, 2003, BIOCHEMISTRY-US, V42, P3594, DOI 10.1021/bi027060x; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; Kimura Y, 2008, J BIOL CHEM, V283, P13867, DOI 10.1074/jbc.M800256200; Kobayashi M, 2005, B CHEM SOC JPN, V78, P2164, DOI 10.1246/bcsj.78.2164; Kobayashi M, 2005, BIOSCI BIOTECH BIOCH, V69, P1130, DOI 10.1271/bbb.69.1130; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; Liu LJ, 2002, ACTA CRYSTALLOGR D, V58, P1085, DOI 10.1107/S0907444902006261; Ma F, 2008, BIOPHYS J, V95, P3349, DOI 10.1529/biophysj.108.133835; MADIGAN MT, 1984, SCIENCE, V225, P313, DOI 10.1126/science.225.4659.313; Madigan MT, 2003, PHOTOSYNTH RES, V76, P157, DOI 10.1023/A:1024998212684; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; MOULIS JM, 1993, ARCH BIOCHEM BIOPHYS, V305, P186, DOI 10.1006/abbi.1993.1409; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; NOZAWA T, 1991, J BIOCHEM-TOKYO, V110, P588, DOI 10.1093/oxfordjournals.jbchem.a123624; Pandit A, 2001, BIOCHEMISTRY-US, V40, P12913, DOI 10.1021/bi010163f; Permentier HP, 2001, BIOCHEMISTRY-US, V40, P5573, DOI 10.1021/bi0024308; Qian P, 2005, J MOL BIOL, V349, P948, DOI 10.1016/j.jmb.2005.04.032; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Suzuki H, 2007, BBA-BIOENERGETICS, V1767, P1057, DOI 10.1016/j.bbabio.2007.06.002; Tuschak C, 2004, PHOTOSYNTH RES, V81, P181, DOI 10.1023/B:PRES.0000035046.91126.bd; Vegh AP, 2002, FEBS LETT, V528, P222, DOI 10.1016/S0014-5793(02)03314-8; Wang ZY, 2003, PHOTOSYNTH RES, V78, P133, DOI 10.1023/B:PRES.0000004328.11219.79; Watson AJ, 2005, PHOTOSYNTH RES, V86, P81, DOI 10.1007/s11120-005-4047-x	36	45	48	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					93	99		10.1074/jbc.M806840200	http://dx.doi.org/10.1074/jbc.M806840200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18977753	hybrid			2022-12-27	WOS:000261974800011
J	Zhang, XF; Zhang, J; Wang, T; Esteban, MA; Pei, DQ				Zhang, Xiaofei; Zhang, Juan; Wang, Tao; Esteban, Miguel A.; Pei, Duanqing			Esrrb Activates Oct4 Transcription and Sustains Self-renewal and Pluripotency in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTORS; MOUSE EMBRYOS; ES CELLS; REGULATORY CIRCUITRY; SOMATIC-CELLS; NANOG; EXPRESSION; NETWORK; GENE; EMBRYOGENESIS	The genetic program of embryonic stem (ES) cells is orchestrated by a core of transcription factors that has OCT4, SOX2, and NANOG as master regulators. Protein levels of these core factors are tightly controlled by autoregulatory and feed-forward transcriptional mechanisms in order to prevent early differentiation. Recent studies have shown that knockdown of Esrrb (estrogen-related-receptor beta), a member of the nuclear orphan receptor family, induces differentiation of mouse ES cells cultured in the presence of leukemia inhibitory factor. It was however not known how knocking down Esrrb exerts this effect. Herein we have identified two ESRRB binding sites in the proximal 5'-untranslated region of the mouse Oct4 gene, one of which is in close proximity to a NANOG binding site. Both ESRRB and NANOG are necessary for maintaining the activity of this promoter in ES cell lines. We have also demonstrated that the two transcription factors interact through their DNA binding domains. This interaction reciprocally modulates their transcriptional activities and may be important to fine-tune ES cell pluripotency. Supporting all of these data, stable transfection of Esrrb in ES cell lines proved sufficient to sustain their characteristics in the absence of leukemia-inhibitory factor. In summary, our experiments help to understand how Esrrb coordinates with Nanog and Oct4 to activate the internal machinery of ES cells.	[Zhang, Xiaofei; Wang, Tao; Esteban, Miguel A.; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Stem Cell & Canc Biol Grp,Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Guangdong, Peoples R China; [Zhang, Xiaofei] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China; [Zhang, Juan] Tsinghua Univ, Inst Biomed, Sch Med, Dept Biol Sci & Biotechnol,Lab Stem Cell Biol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Tsinghua University	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Stem Cell & Canc Biol Grp,Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Zhang, Xiafoei/C-8471-2014; zhou, xingru/G-4442-2012		Natural Science Foundation of China [30725012, 30630039, 90813033]; Chinese Academy of Science [KSCX2-YW-R-48]; Guangzhou Science and Technology [2008A1-E4011]; Ministry of Science and Technology 973 [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Guangzhou Science and Technology; Ministry of Science and Technology 973(National Basic Research Program of China)	This work was supported in part by Natural Science Foundation of China Grants 30725012, 30630039, and 90813033; Chinese Academy of Science Grant KSCX2-YW-R-48; Guangzhou Science and Technology Grant 2008A1-E4011; and Ministry of Science and Technology 973 Grants 2006CB701504, 2006CB943600, 2007CB948002, and 2007CB947804. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu DS, 2001, CANCER RES, V61, P6755; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mitsunaga K, 2004, MECH DEVELOP, V121, P237, DOI 10.1016/j.mod.2004.01.006; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Niakan KK, 2005, MOL GENET METAB, V86, P70, DOI 10.1016/j.ymgme.2005.07.019; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Z, 2008, J BIOL CHEM, V283, P4480, DOI 10.1074/jbc.M706009200; WILMUT I, 1997, NATURE, V385, P813; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	32	116	117	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35825	35833		10.1074/jbc.M803481200	http://dx.doi.org/10.1074/jbc.M803481200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957414	hybrid			2022-12-27	WOS:000261687900057
J	Zhang, ZY; Zheng, Y; Mazon, H; Milgrom, E; Kitagawa, N; Kish-Trier, E; Heck, AJR; Kane, PM; Wilkens, S				Zhang, Zhenyu; Zheng, Yesha; Mazon, Hortense; Milgrom, Elena; Kitagawa, Norton; Kish-Trier, Erik; Heck, Albert J. R.; Kane, Patricia M.; Wilkens, Stephan			Structure of the Yeast Vacuolar ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT-C VMA5P; RENAL TUBULAR-ACIDOSIS; V-ATPASE; H+-ATPASE; 3-DIMENSIONAL STRUCTURE; MASS-SPECTROMETRY; PERIPHERAL STALK; MANDUCA-SEXTA; MUTATIONAL ANALYSIS; CROSS-LINKING	The subunit architecture of the yeast vacuolar ATPase (V-ATPase) was analyzed by single particle transmission electron microscopy and electrospray ionization (ESI) tandem mass spectrometry. A three-dimensional model of the intact V-ATPase was calculated from two-dimensional projections of the complex at a resolution of 25 angstrom. Images of yeast V-ATPase decorated with monoclonal antibodies against subunits A, E, and G position subunit A within the pseudo-hexagonal arrangement in the V-1, the N terminus of subunit G in the V-1-V-0 interface, and the C terminus of subunit E at the top of the V1 domain. ESI tandem mass spectrometry of yeast V-1-ATPase showed that subunits E and G are most easily lost in collision-induced dissociation, consistent with a peripheral location of the subunits. An atomic model of the yeast V-ATPase was generated by fitting of the available x-ray crystal structures into the electron microscopy-derived electron density map. The resulting atomic model of the yeast vacuolar ATPase serves as a framework to help understand the role the peripheral stalk subunits are playing in the regulation of the ATP hydrolysis driven proton pumping activity of the vacuolar ATPase.	[Milgrom, Elena; Kitagawa, Norton; Kish-Trier, Erik; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Zhang, Zhenyu; Zheng, Yesha; Kitagawa, Norton; Wilkens, Stephan] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Mazon, Hortense; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Proteom Grp, NL-3584 CA Utrecht, Netherlands; [Mazon, Hortense; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of California System; University of California Riverside; Utrecht University; Utrecht University	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404	National Institutes of Health [GM58600, CA100246, GM50322]; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322, R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58600 and CA100246 (to S.W.) and GM50322 (to P.M.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Armbruster A, 2005, FEBS LETT, V579, P1961, DOI 10.1016/j.febslet.2005.02.042; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Clare DK, 2006, STRUCTURE, V14, P1149, DOI 10.1016/j.str.2006.05.014; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Dunn SD, 2000, BBA-BIOENERGETICS, V1458, P356, DOI 10.1016/S0005-2728(00)00086-4; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Gruber G, 2000, BIOCHEMISTRY-US, V39, P8609, DOI 10.1021/bi000103u; Hahn H, 2003, AM J KIDNEY DIS, V41, P238, DOI 10.1053/ajkd.2003.50014; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; HO MN, 1993, J BIOL CHEM, V268, P18286; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Li Z, 2004, PLANTA, V219, P948, DOI 10.1007/s00425-004-1298-2; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; Lorenzen K, 2007, INT J MASS SPECTROM, V268, P198, DOI 10.1016/j.ijms.2007.06.012; Lorenzen K, 2007, STRUCTURE, V15, P1237, DOI 10.1016/j.str.2007.07.016; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Maegawa Y, 2006, ACTA CRYSTALLOGR D, V62, P483, DOI 10.1107/S0907444906006329; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Merzendorfer H, 1999, J BIOL CHEM, V274, P17372, DOI 10.1074/jbc.274.24.17372; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; Rizzo VF, 2003, J BIOL CHEM, V278, P270, DOI 10.1074/jbc.M208623200; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Sambade M, 2004, J BIOL CHEM, V279, P17361, DOI 10.1074/jbc.M314104200; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Supekova L, 1996, J EXP BIOL, V199, P1147; van den Heuvel RHH, 2006, ANAL CHEM, V78, P7473, DOI 10.1021/ac061039a; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Venzke D, 2005, J MOL BIOL, V349, P659, DOI 10.1016/j.jmb.2005.04.033; Visentin L, 2000, J CLIN INVEST, V106, P309, DOI 10.1172/JCI6145; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wilkens S, 2005, BIOCHEMISTRY-US, V44, P11786, DOI 10.1021/bi0510678; Wilkens S, 2005, MICRON, V36, P109, DOI 10.1016/j.micron.2004.10.002; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	77	95	104	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35983	35995		10.1074/jbc.M805345200	http://dx.doi.org/10.1074/jbc.M805345200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955482	Green Published, hybrid			2022-12-27	WOS:000261687900073
J	van Rossum, DB; Oberdick, D; Rbaibi, Y; Bhardwaj, G; Barrow, RK; Nikolaidis, N; Snyder, SH; Kiselyov, K; Patterson, RL				van Rossum, Damian B.; Oberdick, Daniel; Rbaibi, Youssef; Bhardwaj, Gaurav; Barrow, Roxanne K.; Nikolaidis, Nikolas; Snyder, Solomon H.; Kiselyov, Kirill; Patterson, Randen L.			TRP_2, a Lipid/Trafficking Domain That Mediates Diacylglycerol-induced Vesicle Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH CONES; PROTEIN-KINASE-C; TRPC3 CHANNELS; CA2+ ENTRY; ACTIVATION; RECEPTOR; CELLS; REQUIREMENT; GUIDANCE; MUTATION	We recently modeled transient receptor potential (TRP) channels using the Gestalt Domain Detection Algorithm-Basic Local Alignment Tool (GDDA-BLAST), which derives structural, functional, and evolutionary information from primary amino acid sequences using phylogenetic profiles (Ko, K. D., Hong, Y., Chang, G. S., Bhardwaj, G., van Rossum, D. B., and Patterson, R. L. (2008) Physics Arch. Quant. Methods arXiv:0806.2394v1). Herein we test our functional predictions for the TRP_2 domain of TRPC3; a domain of unknown function that is conserved in all TRPC channels. Our functional models of this domain identify both lipid binding and trafficking activities. In this study, we reveal: (i) a novel structural determinant of ion channel sensitivity to lipids, (ii) a molecular mechanism for the difference between diacylglycerol (DAG)-sensitive and DAG-insensitive TRPC subfamilies, and (iii) evidence that TRPC3 can comprise part of the vesicle fusion machinery. Indeed, the TRPC3 TRP_2 domain mediates channel trafficking to the plasma membrane and binds to plasma membrane lipids. Further, mutations in TRP_2, which alter lipid binding, also disrupt the DAG-mediated fusion of TRPC3-containing vesicles with the plasma membrane without disrupting SNARE interactions. Importantly, these data agree with the known role of DAG in membrane destabilization, which facilitates SNARE-dependent synaptic vesicle fusion (Villar, A. V., Goni, F. M., and Alonso, A. (2001) FEBS Lett. 494, 117-120 and Goni, F. M., and Alonso, A. (1999) Prog. Lipid Res. 38, 1-48). Taken together, functional models generated by GDDA-BLAST provide a computational platform for deriving domain functionality, which can have in vivo and mechanistic relevance.	[van Rossum, Damian B.; Bhardwaj, Gaurav; Patterson, Randen L.] Penn State Univ, Ctr Computat Prote, University Pk, PA 16802 USA; [van Rossum, Damian B.; Bhardwaj, Gaurav; Nikolaidis, Nikolas; Patterson, Randen L.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Oberdick, Daniel; Rbaibi, Youssef; Kiselyov, Kirill] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Barrow, Roxanne K.; Snyder, Solomon H.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kiselyov, K (corresponding author), 519 Langley Hall,4249 5th Ave, Pittsburgh, PA 15260 USA.	kiselyov@pitt.edu; rlp25@psu.edu	Bhardwaj, Gaurav/H-7609-2016	Kiselyov, Kirill/0000-0001-6683-2895; van Rossum, Damian/0000-0003-1011-2586; Bhardwaj, Gaurav/0000-0001-6554-2335	Searle Young Investigators Award; NCSA [MCB070027N]; T. O. Magnetti Fund; ML4 Foundation [MH18501]; Research Scientist Award [DA00074]; Eberly College of Sciences; Huck Institutes of the Life Sciences; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074] Funding Source: NIH RePORTER	Searle Young Investigators Award; NCSA; T. O. Magnetti Fund; ML4 Foundation; Research Scientist Award; Eberly College of Sciences; Huck Institutes of the Life Sciences; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the Searle Young Investigators Award and start-up funds from PSU (to R. L. P.), NCSA Grant TG-MCB070027N (to R. L. P. and D. V. R.), the T. O. Magnetti Fund (to R. L. P. and D. V. R.), a grant from the ML4 Foundation (to K. K.), Grant MH18501, and Research Scientist Award DA00074 (to S. H. S.). This project was also funded by a fellowship from the Eberly College of Sciences and the Huck Institutes of the Life Sciences (to D. V. R.) and a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds (to D. V. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Chahl LA, 2007, BBA-MOL BASIS DIS, V1772, P968, DOI 10.1016/j.bbadis.2007.05.003; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Cozier GE, 2000, J BIOL CHEM, V275, P28261; Dietrich A, 2007, CELL CALCIUM, V42, P233, DOI 10.1016/j.ceca.2007.02.009; EKENA K, 1993, CIBA F SYMP, V176, P198; Firth AL, 2007, BBA-MOL BASIS DIS, V1772, P895, DOI 10.1016/j.bbadis.2007.02.009; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jordt S. E., 2007, V45, P253; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Kiselyov K, 2007, J PHYSIOL-LONDON, V578, P641, DOI 10.1113/jphysiol.2006.119024; KO KD, 2008, PHYS ARCH QUANT METH; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Kwan HY, 2006, J CELL PHYSIOL, V207, P315, DOI 10.1002/jcp.20567; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Soboloff J., 2007, V179, P575; Tabuchi K, 2005, NEUROSCI LETT, V382, P304, DOI 10.1016/j.neulet.2005.03.035; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Villar AV, 2001, FEBS LETT, V494, P117, DOI 10.1016/S0014-5793(01)02333-X; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	38	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					34384	34392		10.1074/jbc.M804707200	http://dx.doi.org/10.1074/jbc.M804707200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	19043047	Green Published, hybrid			2022-12-27	WOS:000261277700066
J	Russo, S; Schweitzer, JE; Polen, T; Bott, M; Pohl, E				Russo, Santina; Schweitzer, Jens-Eric; Polen, Tino; Bott, Michael; Pohl, Ehmke			Crystal Structure of the Caseinolytic Protease Gene Regulator, a Transcriptional Activator in Actinomycetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; HEAT-SHOCK RESPONSE; BACILLUS-SUBTILIS; MACROMOLECULAR CRYSTALLOGRAPHY; CORYNEBACTERIUM-GLUTAMICUM; STREPTOMYCES-LIVIDANS; STRUCTURE VALIDATION; DIFFRACTION DATA; HIGH-RESOLUTION; CLGR	Human pathogens of the genera Corynebacterium and Mycobacterium possess the transcriptional activator ClgR (clp gene regulator) which in Corynebacterium glutamicum has been shown to regulate the expression of the ClpCP protease genes. ClgR specifically binds to pseudo-palindromic operator regions upstream of clpC and clpP1P2. Here, we present the first crystal structure of a ClgR protein from C. glutamicum. The structure was determined from two different crystal forms to resolutions of 1.75 and 2.05 angstrom, respectively. ClgR folds into a five-helix bundle with a helix-turn-helix motif typical for DNA-binding proteins. Upon dimerization the two DNA-recognition helices are arranged opposite to each other at the protein surface in a distance of similar to 30 angstrom, which suggests that they bind into two adjacent major grooves of B-DNA in an anti-parallel manner. A binding pocket is situated at a strategic position in the dimer interface and could possess a regulatory role altering the positions of the DNA-binding helices.	[Schweitzer, Jens-Eric; Polen, Tino; Bott, Michael] Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany; [Russo, Santina] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Pohl, Ehmke] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Pohl, Ehmke] Univ Durham, Sch Biol & Biomed Sci, Univ Sci Labs, Durham DH1 3LE, England	Helmholtz Association; Research Center Julich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Durham University; Durham University	Bott, M (corresponding author), Forschungszentrum Julich, Inst Biotechnol 1, Postfach 1913, D-52425 Julich, Germany.	m.bott@fz-juelich.de; ehmke.pohl@durham.ac.uk	Polen, Tino/G-4017-2016; Pohl, Ehmke/I-2408-2012; Bott, Michael/E-8004-2011	Polen, Tino/0000-0002-0065-3007; Pohl, Ehmke/0000-0002-9949-4471; Bott, Michael/0000-0002-4701-8254				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Albright RA, 1998, J MOL BIOL, V280, P137, DOI 10.1006/jmbi.1998.1848; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Bellier A, 2006, MICROBIOL-SGM, V152, P1021, DOI 10.1099/mic.0.28564-0; Bellier A, 2004, J BACTERIOL, V186, P3238, DOI 10.1128/JB.186.10.3238-3248.2004; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derre I, 1999, MOL MICROBIOL, V32, P581, DOI 10.1046/j.1365-2958.1999.01374.x; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kruger E, 1998, J BACTERIOL, V180, P6681; Kruger E, 2001, EMBO J, V20, P852, DOI 10.1093/emboj/20.4.852; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeehan JE, 2005, J MOL BIOL, V346, P689, DOI 10.1016/j.jmb.2004.12.025; MONDRAGON A, 1991, J MOL BIOL, V219, P321, DOI 10.1016/0022-2836(91)90568-Q; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Pohl E., 2006, SYNCHROTRON RAD NEWS, V19, P24; Sawaya MR, 2005, STRUCTURE, V13, P1837, DOI 10.1016/j.str.2005.08.017; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHIMON LJW, 1993, J MOL BIOL, V232, P826, DOI 10.1006/jmbi.1993.1434; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turgay K, 1998, EMBO J, V17, P6730; Ventura M, 2005, J BACTERIOL, V187, P8411, DOI 10.1128/JB.187.24.8411-8426.2005; Viala J, 2002, MOL MICROBIOL, V44, P633, DOI 10.1046/j.1365-2958.2002.02907.x; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; WOLBERGER C, 1988, NATURE, V335, P789, DOI 10.1038/335789a0	42	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5208	5216		10.1074/jbc.M806591200	http://dx.doi.org/10.1074/jbc.M806591200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19019826	Green Published, hybrid			2022-12-27	WOS:000263416600051
J	Bergbrede, T; Chuky, N; Schoebel, S; Blankenfeldt, W; Geyer, M; Fuchs, E; Goody, RS; Barr, F; Alexandrov, K				Bergbrede, Tim; Chuky, Nam; Schoebel, Stefan; Blankenfeldt, Wulf; Geyer, Matthias; Fuchs, Evelyn; Goody, Roger S.; Barr, Francis; Alexandrov, Kirill			Biophysical Analysis of the Interaction of Rab6a GTPase with Its Effector Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; GOLGI-APPARATUS; PROTEINS; FAMILY; RECRUITMENT; TRANSPORT	Rab GTPases are key regulators of intracellular vesicular transport that control vesicle budding, cargo sorting, transport, tethering, and fusion. In the inactive (GDP-bound) conformation, Rab GTPases are targeted to intracellular compartments where they are converted into the active GTP-bound form and recruit effector domain containing proteins. Rab6a has been implicated in dynein-mediated vesicle movement at the Golgi apparatus and shown to interact with a plethora of effector proteins. In this study, we identify minimal Rab6a binding domains of three Rab6a effector proteins: PIST, BicaudalD2, and p150(glued). All three domains are >15-kDa fragments predicted to form coiled-coil structures that display no sequence homology to each other. Complex formation with BicaudalD2 and p150 has a moderate inhibitory effect on the intrinsic GTPase activity of Rab6a, while interaction with PIST has no influence on the hydrolysis rate. The effectors bind activated Rab6a with comparable affinities with K-d values ranging from high nanomolar to low micromolar. Transient kinetic analysis revealed that effectors bind to Rab6a in an apparent single-step reaction characterized by relatively rapid on- and off-rates. We propose that the high off-rates of Rab6.effector complexes enable GTPase-activating protein-mediated net dissociation, which would not be possible if the off-rate were significantly slower.	[Bergbrede, Tim; Chuky, Nam; Schoebel, Stefan; Blankenfeldt, Wulf; Geyer, Matthias; Goody, Roger S.; Alexandrov, Kirill] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Fuchs, Evelyn; Barr, Francis] Univ Liverpool, Canc Res Ctr, Liverpool L3 9TA, Merseyside, England	Max Planck Society; University of Queensland; University of Liverpool	Alexandrov, K (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	k.alexandrov@imb.uq.edu.au	Alexandrov, Kirill/A-5830-2013; Chu, Nam/AAY-8247-2021; Goody, Roger S/J-8845-2014; Blankenfeldt, Wulf/F-8877-2010	Alexandrov, Kirill/0000-0002-0957-6511; Goody, Roger S/0000-0002-0772-0444; Blankenfeldt, Wulf/0000-0001-9886-9668; Geyer, Matthias/0000-0002-7718-5002; Barr, Francis/0000-0001-7518-253X; Chu, Nam/0000-0001-9717-5007; Bergbrede, Tim/0000-0002-0930-1884	DFG [AL 484/7-2]; SFB [642]	DFG(German Research Foundation (DFG)); SFB(Austrian Science Fund (FWF))	This work was supported in part by DFG Grant AL 484/7-2 (to K. A.) and Grant SFB 642 (to K. A. and R. S. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILLY E, 1991, NATURE, V350, P715, DOI 10.1038/350715a0; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Bergbrede T, 2005, J STRUCT BIOL, V152, P235, DOI 10.1016/j.jsb.2005.10.001; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Indyk L, 1998, METHOD ENZYMOL, V295, P350; KISHIDA S, 1993, J BIOL CHEM, V268, P22259; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Miserey-Lenkei S, 2006, EMBO J, V25, P278, DOI 10.1038/sj.emboj.7600929; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; Nagelkerken B, 2000, BIOCHEM J, V346, P593, DOI 10.1042/0264-6021:3460593; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Teber I, 2005, BIOL CHEM, V386, P671, DOI 10.1515/BC.2005.078; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	21	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2628	2635		10.1074/jbc.M806003200	http://dx.doi.org/10.1074/jbc.M806003200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19019823	hybrid			2022-12-27	WOS:000262700900005
J	Jin, L; Yoshida, T; Ho, RY; Owens, GK; Somlyo, AV				Jin, Li; Yoshida, Tadashi; Ho, Ruoya; Owens, Gary K.; Somlyo, Avril V.			The Actin-associated Protein Palladin Is Required for Development of Normal Contractile Properties of Smooth Muscle Cells Derived from Embryoid Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; STEM-CELLS; SIGNAL-TRANSDUCTION; NONMUSCLE MYOSIN; BINDING PARTNER; GENE-EXPRESSION; MARKER GENES; DIFFERENTIATION; MYOCARDIN; KINASE	Palladin is a widely expressed actin-associated protein localized at stress fibers, focal adhesions, and other actin-based structures, playing a significant role in cell adhesion and cell motility. Knockout of Palladin in mice is embryonic lethal, demonstrating the importance of Palladin in development yet its role in the vasculature is not known. In the present study, smooth muscle cell (SMC) markers, such as myosin, actin, caldesmon, calponin, and LPP, were down-regulated in embryoid bodies (EBs) derived from embryonic stem cells lacking Palladin. Transgenic embryonic stem cell lines were generated that stably expressed a puromycin-resistance gene under the control of a SM alpha-actin (SMA) promoter. Negative selection was then used to purify SMCs from EBs. Purified SMCs expressing multiple SMC markers were designated APSCs (SMA-puromycin-selected cells). Palladin null APSCs express significantly less myosin, actin, calponin, and h-caldesmon. The filamentous ( F) to globular ( G) actin ratio, known to regulate myocardin family transcription factors, was also decreased. Palladin null APSCs showed increased cell adhesion and decreased cell motility. Importantly, Palladin null APSCs within collagen gels generated less maximum contractile force when stimulated with endothelin-1, sphingosine 1-phosphate (S1P), and thrombin. Myosin light chains (MLC20) were phosphorylated by lysophosphatidic acid to the same extent in Palladin null and wild type APSCs but myosin content/total protein was reduced by >50%, consistent with the observed decreases in contractility. All together, these results suggest that Palladin is essential for expression of the full complement of contractile proteins necessary for optimal force development of SMCs derived from EBs.	[Jin, Li; Yoshida, Tadashi; Ho, Ruoya; Owens, Gary K.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia	Somlyo, AV (corresponding author), 415 Jordan Hall,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	avs5u@virginia.edu			National Institutes of Health [PO1 HL48807, PO1 HL 19242]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL019242, P01HL048807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL48807 ( to A. V. S.) and PO1 HL 19242 ( to A. V. S. and G. K. O.).	BOND M, 1982, J CELL BIOL, V95, P403, DOI 10.1083/jcb.95.2.403; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Gailly P, 1997, J PHYSIOL-LONDON, V500, P95, DOI 10.1113/jphysiol.1997.sp022002; Gammill LS, 2002, DEVELOPMENT, V129, P5731, DOI 10.1242/dev.00175; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Gorenne I, 2006, CIRC RES, V98, P378, DOI 10.1161/01.RES.0000202802.34727.fd; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hoofnagle MH, 2006, ARTERIOSCL THROM VAS, V26, P2579, DOI 10.1161/01.ATV.0000249623.79871.bc; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Jin L, 2007, CIRC RES, V100, P817, DOI 10.1161/01.RES.0000261351.54147.de; Jones PL, 2007, CIRC RES, V100, P757, DOI 10.1161/01.RES.0000263446.33849.ed; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Liu XS, 2007, BLOOD, V110, P870, DOI 10.1182/blood-2007-01-068528; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Matthew JD, 2000, J PHYSIOL-LONDON, V529, P811, DOI 10.1111/j.1469-7793.2000.00811.x; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Ogut O, 2007, J MUSCLE RES CELL M, V28, P409, DOI 10.1007/s10974-008-9132-2; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ronty M, 2004, FEBS LETT, V566, P30, DOI 10.1061/j.febslet.2004.04.006; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Ryu B, 2001, CANCER RES, V61, P1833; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Sinha S, 2006, STEM CELLS, V24, P1678, DOI 10.1634/stemcells.2006-0002; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Woodsome TP, 2006, J CELL SCI, V119, P1769, DOI 10.1242/jcs.02805; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006	43	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2121	2130		10.1074/jbc.M806095200	http://dx.doi.org/10.1074/jbc.M806095200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19015263	hybrid, Green Published			2022-12-27	WOS:000262545600021
J	Utreras, E; Futatsugi, A; Rudrabhatla, P; Keller, J; Iadarola, MJ; Pant, HC; Kulkarni, AB				Utreras, Elias; Futatsugi, Akira; Rudrabhatla, Parvathi; Keller, Jason; Iadarola, Michael J.; Pant, Harish C.; Kulkarni, Ashok B.			Tumor Necrosis Factor-alpha Regulates Cyclin-dependent Kinase 5 Activity during Pain Signaling through Transcriptional Activation of p35	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; MESSENGER-RNA; UP-REGULATION; SPINAL-CORD; PC12 CELLS; PHOSPHORYLATION; EXPRESSION; CDK5; ERK; NEURONS	Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/ threonine kinase. We have previously reported that Cdk5 participates in the regulation of nociceptive signaling, and the expression of Cdk5 and its activator, p35, are up-regulated in nociceptive neurons during peripheral inflammation. The aim of our current study was to identify the proinflammatory molecules that regulate Cdk5/p35 activity in response to inflammation. We constructed a vector that contains the mouse p35 promoter driving luciferase expression. We transiently transfected this vector in PC12 cells to test the effect of several cytokines on p35 transcriptional activity and Cdk5 activity. Our results indicate that tumor necrosis factor-alpha (TNF-alpha) activates p35 promoter activity in a dose- and time-dependent manner and concomitantly up-regulates Cdk5 activity. Because TNF-alpha is known to activate ERK1/2, p38 MAPK, JNK, and NF-kappa B signaling pathways, we examined their involvement in the activation of p35 promoter activity. MEK inhibitor, which inhibits ERK activation, decreased p35 promoter activity, whereas the inhibitors of p38 MAPK, JNK, and NF-kappa B increased p35 promoter activity, indicating that these pathways regulate p35 expression differently. The mRNA and protein levels of Egr-1, a transcription factor, were increased by TNF-alpha treatment, and this increase was dependent on ERK signaling. In a mouse model of inflammation-induced pain in which carrageenan injection into the hind paw causes hypersensitivity to heat stimuli, TNF-alpha mRNA was increased at the site of injection. These findings suggest that TNF-alpha-mediated regulation of Cdk5 activity plays an important role in inflammation-induced pain signaling.	[Kulkarni, Ashok B.] NIH, LCDB, NIDCR, Funct Gen Sect, Bethesda, MD 20892 USA; [Keller, Jason; Iadarola, Michael J.] NIH, Neurobiol & Pain Therapeut Sect, NIDCR, Bethesda, MD 20892 USA; [Rudrabhatla, Parvathi; Pant, Harish C.] NIH, Neurochem Lab, NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kulkarni, AB (corresponding author), NIH, LCDB, NIDCR, Funct Gen Sect, 30 Convent Dr,Bldg 30,Rm 130,MSC 4395, Bethesda, MD 20892 USA.	ak40m@nih.gov	Utreras, Elias/I-1038-2013	Utreras, Elias/0000-0002-1004-0466; Rudrabhatla, Parvathi/0000-0002-7537-3130	National Institutes of Health; Division of Intramural Research of NIDCR; NINDS; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000688, ZIADE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000688, Z01DE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the National Institutes of Health, Division of Intramural Research of NIDCR and NINDS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arruda JL, 1998, MOL BRAIN RES, V62, P228, DOI 10.1016/S0169-328X(98)00257-5; Barbin G, 2001, NEUROCHEM RES, V26, P107, DOI 10.1023/A:1011086426652; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DeLeo JA, 2000, NEUROREPORT, V11, P599, DOI 10.1097/00001756-200002280-00033; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Friedrichsen S, 2006, ENDOCRINOLOGY, V147, P773, DOI 10.1210/en.2005-0967; Glicksman MA, 2007, CURR ALZHEIMER RES, V4, P547, DOI 10.2174/156720507783018181; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Humbert S, 2000, NEUROREPORT, V11, P2213, DOI 10.1097/00001756-200007140-00030; Lee HJ, 2006, CYTOKINE, V35, P67, DOI 10.1016/j.cyto.2006.07.009; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Loram LC, 2007, J PAIN, V8, P127, DOI 10.1016/j.jpain.2006.06.010; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Marz P, 1996, BRAIN RES, V706, P71, DOI 10.1016/0006-8993(95)01210-9; Mielke K, 2002, MOL CELL NEUROSCI, V20, P211, DOI 10.1006/mcne.2002.1132; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 1996, GENOMICS, V35, P372, DOI 10.1006/geno.1996.0370; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Pareek TK, 2006, CELL CYCLE, V5, P585, DOI 10.4161/cc.5.6.2578; Pareek Tej K., 2008, P211, DOI 10.1007/978-0-387-78887-6_15; Pareek TK, 2006, P NATL ACAD SCI USA, V103, P791, DOI 10.1073/pnas.0510405103; Quintanilla RA, 2004, EXP CELL RES, V295, P245, DOI 10.1016/j.yexcr.2004.01.002; Rocha ACC, 2006, BRIT J PHARMACOL, V148, P688, DOI 10.1038/sj.bjp.0706775; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Saikkonen B, 2008, CELL CYCLE, V7, P750, DOI 10.4161/cc.7.6.5494; Schafers M, 2003, NEUROSCI LETT, V347, P179, DOI 10.1016/S0304-3940(03)00695-5; Shu HF, 2007, RESP PHYSIOL NEUROBI, V157, P187, DOI 10.1016/j.resp.2007.01.010; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Takahashi N, 2006, SPINE, V31, P523, DOI 10.1097/01.brs.0000201305.01522.17; Takahashi S, 2005, P NATL ACAD SCI USA, V102, P1737, DOI 10.1073/pnas.0409456102; Tobe M, 2003, BIOORGAN MED CHEM, V11, P383, DOI 10.1016/S0968-0896(02)00440-6; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Ulfhammer E, 2006, J THROMB HAEMOST, V4, P1781, DOI 10.1111/j.1538-7836.2006.02035.x; Yang HYT, 2007, J NEUROCHEM, V103, P1628, DOI 10.1111/j.1471-4159.2007.04874.x; Yang YR, 2007, PAIN, V127, P109, DOI 10.1016/j.pain.2006.08.008; Zhang JH, 2006, CHINESE MED J-PEKING, V119, P930, DOI 10.1097/00029330-200606010-00009	46	76	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2275	2284		10.1074/jbc.M805052200	http://dx.doi.org/10.1074/jbc.M805052200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19049962	Green Published, hybrid			2022-12-27	WOS:000262545600037
J	Wang, YQ; Feechan, A; Yun, BW; Shafiei, R; Hofmann, A; Taylor, P; Xue, P; Yang, FQ; Xie, ZS; Pallas, JA; Chu, CC; Loake, GJ				Wang, Yi-Qin; Feechan, Angela; Yun, Byung-Wook; Shafiei, Reza; Hofmann, Andreas; Taylor, Paul; Xue, Peng; Yang, Fu-Quan; Xie, Zhen-Sheng; Pallas, Jacqueline A.; Chu, Cheng-Cai; Loake, Gary J.			S-Nitrosylation of AtSABP3 Antagonizes the Expression of Plant Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; CARBONIC-ANHYDRASE; ARABIDOPSIS-THALIANA; RESISTANCE GENE; TOBACCO; SIGNAL; IDENTIFICATION; SPECIFICITY; AVIRULENCE; INHIBITION	Changes in cellular redox status are a well established response across phyla following pathogen challenge. In this context, the synthesis of nitric oxide ( NO) is a conspicuous feature of plants responding to attempted microbial infection and this redox-based regulator underpins the development of plant immunity. However, the associated molecular mechanism(s) have not been defined. Here we show that NO accretion during the nitrosative burst promotes increasing S-nitrosylation of the Arabidopsis thaliana salicylic acid-binding protein 3 (AtSABP3) at cysteine (Cys) 280, suppressing both binding of the immune activator, salicylic acid ( SA), and the carbonic anhydrase ( CA) activity of this protein. The CA function of AtSABP3 is required for the expression of resistance in the host against attempted pathogen infection. Therefore, inhibition of AtSBAP3 CA function by S-nitrosylation could contribute to a negative feedback loop that modulates the plant defense response. Thus, AtSABP3 is one of the first targets for S-nitrosylation in plants for which the biological function of this redox-based post-translational modification has been uncovered. These data provide a molecular connection between the changes in NO levels triggered by attempted pathogen infection and the expression of disease resistance.	[Wang, Yi-Qin; Feechan, Angela; Yun, Byung-Wook; Shafiei, Reza; Loake, Gary J.] Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Hofmann, Andreas; Taylor, Paul] Univ Edinburgh, Sch Biol Sci, Inst Struct & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Wang, Yi-Qin; Chu, Cheng-Cai] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Xue, Peng; Yang, Fu-Quan; Xie, Zhen-Sheng] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Pallas, Jacqueline A.] Syngenta, Trait Res, Bracknell RG42 6EY, Berks, England	University of Edinburgh; University of Edinburgh; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Syngenta	Loake, GJ (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	gloake@ed.ac.uk	Chu, Chengcai/AAF-6083-2019; Wang, Yiqin/AAJ-8144-2020; Feechan, Angela/A-1296-2010; Hofmann, Andreas/B-9515-2008; Hofmann, Andreas/M-9870-2019; Pallas, Jacqueline A/C-2994-2008; Shafiei, Reza/ABE-2427-2020	Chu, Chengcai/0000-0001-8097-6115; Hofmann, Andreas/0000-0003-4408-5467; Hofmann, Andreas/0000-0003-4408-5467; Shafiei, Reza/0000-0003-0891-0730; Pallas, Jacqueline/0000-0002-2207-3185; Feechan, Angela/0000-0002-4954-5613; Taylor, Paul/0000-0002-8213-0380; Loake, Gary/0000-0002-7989-9180	Biological Sciences Research Council [BB/D011809/1]; BBSRC [BB/D011809/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011809/1] Funding Source: researchfish	Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biological Sciences Research Council Grant BB/D011809/1.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandra-Shekara AC, 2007, P NATL ACAD SCI USA, V104, P7277, DOI 10.1073/pnas.0609259104; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hess DT, 2001, NAT CELL BIOL, V3, pE46, DOI 10.1038/35055152; Hoang CV, 2002, PLANT PHYSIOL, V128, P1417, DOI 10.1104/pp.010879; Hong JK, 2008, J EXP BOT, V59, P147, DOI 10.1093/jxb/erm244; INGARRO LJ, 2000, NITRIC OXIDE BIOL PA; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kimber MS, 2000, EMBO J, V19, P1407, DOI 10.1093/emboj/19.7.1407; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Lindermayr C, 2006, J BIOL CHEM, V281, P4285, DOI 10.1074/jbc.M511635200; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Marshall HE, 2004, P NATL ACAD SCI USA, V101, P8841, DOI 10.1073/pnas.0403034101; Miles Allen M., 1995, Methods (Orlando), V7, P40, DOI 10.1006/meth.1995.1006; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; Polverari A, 2003, MOL PLANT MICROBE IN, V16, P1094, DOI 10.1094/MPMI.2003.16.12.1094; Restrepo S, 2005, MOL PLANT MICROBE IN, V18, P913, DOI 10.1094/MPMI-18-0913; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Wang YQ, 2006, J EXP BOT, V57, P1777, DOI 10.1093/jxb/erj211; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; WILBUR KM, 1948, J BIOL CHEM, V176, P147	40	175	184	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2131	2137		10.1074/jbc.M806782200	http://dx.doi.org/10.1074/jbc.M806782200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017644	Green Submitted, hybrid			2022-12-27	WOS:000262545600022
J	Li, H; Jogl, G				Li, Hua; Jogl, Gerwald			Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOGLYCERATE MUTASE HOMOLOG; BROAD-SPECIFICITY PHOSPHATASE; BACILLUS-STEAROTHERMOPHILUS; FRUCTOSE 2,6-BISPHOSPHATE; CRYSTAL-STRUCTURE; BIFUNCTIONAL ENZYME; METABOLISM; PROTEIN; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE; FRUCTOSE-2,6-BISPHOSPHATASE	Activation of the p53 tumor suppressor by cellular stress leads to variable responses ranging from growth inhibition to apoptosis. TIGAR is a novel p53-inducible gene that inhibits glycolysis by reducing cellular levels of fructose-2,6-bisphosphate, an activator of glycolysis and inhibitor of gluconeogenesis. Here we describe structural and biochemical studies of TIGAR from Danio rerio. The overall structure forms a histidine phosphatase fold with a phosphate molecule coordinated to the catalytic histidine residue and a second phosphate molecule in a position not observed in other phosphatases. The recombinant human and zebra fish enzymes hydrolyze fructose-2,6-bisphosphate as well as fructose-1,6-bisphosphate but not fructose 6-phosphate in vitro. The TIGAR active site is open and positively charged, consistent with its enzymatic function as bisphosphatase. The closest related structures are the bacterial broad specificity phosphatase PhoE and the fructose-2,6-bisphosphatase domain of the bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. The structural comparison shows that TIGAR combines an accessible active site as observed in PhoE with a charged substrate-binding pocket as seen in the fructose-2,6-bisphosphatase domain of the bifunctional enzyme.	[Li, Hua; Jogl, Gerwald] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA	Brown University	Jogl, G (corresponding author), Brown Univ, Dept Biochem Mol Biol & Cell Biol, Box G-E129, Providence, RI 02912 USA.	Gerwald_Jogl@brown.edu	Jogl, Gerwald/AAJ-5783-2021; Li, Hua/ABH-1613-2021	Jogl, Gerwald/0000-0002-5465-5315; Li, Hua/0000-0003-1903-836X	National Institutes of Health [P20RR15578]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR15578. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hasemann CA, 1996, STRUCTURE, V4, P1017, DOI 10.1016/S0969-2126(96)00109-8; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Michels PAM, 2006, IUBMB LIFE, V58, P133, DOI 10.1080/15216540600688280; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Mizuguchi H, 1999, J BIOL CHEM, V274, P2166, DOI 10.1074/jbc.274.4.2166; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Muller P, 2005, ACTA CRYSTALLOGR D, V61, P309, DOI 10.1107/S0907444904033190; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PILKIS SJ, 1982, METHOD ENZYMOL, V89, P101; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rigden DJ, 2002, J MOL BIOL, V315, P1129, DOI 10.1006/jmbi.2001.5290; Rigden DJ, 2003, J MOL BIOL, V325, P411, DOI 10.1016/S0022-2836(02)01229-9; Rigden DJ, 1999, J MOL BIOL, V289, P691, DOI 10.1006/jmbi.1999.2848; TAULER A, 1990, J BIOL CHEM, V265, P15617; TEDOKON M, 1992, CLIN CHEM, V38, P512; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANSCHAFTINGEN E, 1981, EUR J BIOCHEM, V117, P319, DOI 10.1111/j.1432-1033.1981.tb06339.x; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wu CD, 2006, ADV ENZYME REGUL, V46, P72, DOI 10.1016/j.advenzreg.2006.01.010; Yuen MH, 1999, J BIOL CHEM, V274, P2176, DOI 10.1074/jbc.274.4.2176	38	88	96	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1748	1754		10.1074/jbc.M807821200	http://dx.doi.org/10.1074/jbc.M807821200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19015259	Green Published, hybrid			2022-12-27	WOS:000262330100045
J	Ooe, N; Motonaga, K; Kobayashi, K; Saito, K; Kaneko, H				Ooe, Norihisa; Motonaga, Kozo; Kobayashi, Kentaro; Saito, Koichi; Kaneko, Hideo			Functional Characterization of Basic Helix-Loop-Helix-PAS Type Transcription Factor NXF in Vivo PUTATIVE INVOLVEMENT IN AN "ON DEMAND" NEUROPROTECTION SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; INDUCTION; DEATH; SIM2; MICE; LOCALIZATION; ACTIVATION; APOPTOSIS	NXF, a member of the basic helix-loop-helix-PAS transcription factor family, is thought to be involved in functional regulation of neurons, because significant expression is found in the mature brain. To elucidate functions of NXF in vivo, here we generated mice lacking NXF using homologous recombination with embryonic stem cells. NXF-/- mice were morphologically indistinguishable (with no growth retardation) from their littermates (wild type) at birth. However, they started to die at a rate of 1 death/20-30 animals per week under specific pathogen-free grade breeding conditions when over 3 months old. Histological analyses revealed age-dependent neurodegeneration in brain, and only 20-30% of the NXF-/- mice survived for 16 months. To clarify the role of NXF in protection against neurodegeneration in normal cells, we analyzed gene expression under several conditions in vitro and in vivo. The NXF gene was up-regulated by several neurodegenerative cell-stress inducers such as thapsigargin (endoplasmic reticulum stress), SIN-1 (oxidative stress), and sorbitol (osmotic stress) in cultured cells. Furthermore, elevated NXF gene expression was apparent with in vivo stroke models featuring kainate-induced hippocampal injury and transient global ischemia. When NXF-/- mice were evaluated in the glutamate excitotoxicity model, they proved more susceptible to hippocampal injury at 15 weeks after birth. The findings in this study suggest that the NXF gene could be induced in response to several neurodegenerative stimuli/excitations for the cell protection, and thus provide an "on demand" cell-protection system in nervous tissue.	[Ooe, Norihisa; Motonaga, Kozo; Kobayashi, Kentaro; Saito, Koichi; Kaneko, Hideo] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana ku, Osaka 5548558, Japan	Sumitomo Chem Co Ltd	Ooe, N (corresponding author), Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana ku, Osaka 5548558, Japan.	ooe@sc.sumitomo-chem.co.jp		Saito, Koichi/0000-0001-6497-5286				Abu-Qare AW, 2001, J TOXICOL ENV HEAL B, V4, P313, DOI 10.1080/109374001301419737; Barone FC, 2004, METH MOLEC MED, V104, P105; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Caccamo D, 2004, AMINO ACIDS, V27, P373, DOI 10.1007/s00726-004-0117-1; Chrast R, 2000, HUM MOL GENET, V9, P1853, DOI 10.1093/hmg/9.12.1853; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; del Zoppo GJ, 2007, STROKE, V38, P646, DOI 10.1161/01.STR.0000254477.34231.cb; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Ema M, 1999, HUM MOL GENET, V8, P1409, DOI 10.1093/hmg/8.8.1409; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; Herrmann M, 2003, RESTOR NEUROL NEUROS, V21, P177; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Huerta S, 2007, J SURG RES, V139, P143, DOI 10.1016/j.jss.2006.07.034; Jiang L, 2006, MOL CELL BIOL, V26, P6547, DOI 10.1128/MCB.00284-06; Kass GEN, 1999, ENVIRON HEALTH PERSP, V107, P25, DOI 10.2307/3434469; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Lei XG, 2001, BIOFACTORS, V14, P93, DOI 10.1002/biof.5520140113; MORI K, 1993, CELL, V74, P743; Naoi M, 2005, MOL NEUROBIOL, V31, P81, DOI 10.1385/MN:31:1-3:081; NITATORI T, 1995, J NEUROSCI, V15, P1001; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Probst MR, 1997, J BIOL CHEM, V272, P4451, DOI 10.1074/jbc.272.7.4451; Puig B, 2002, NEUROSCI LETT, V321, P182, DOI 10.1016/S0304-3940(01)02518-6; Rachidi M, 2005, INT J DEV NEUROSCI, V23, P475, DOI 10.1016/j.ijdevneu.2005.05.004; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200	30	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1057	1063		10.1074/jbc.M805196200	http://dx.doi.org/10.1074/jbc.M805196200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001414	hybrid			2022-12-27	WOS:000262122900042
J	Zheng, WH; Quirion, R				Zheng, Wen-Hua; Quirion, Remi			Glutamate Acting on N-Methyl-D-aspartate Receptors Attenuates Insulin-like Growth Factor-1 Receptor Tyrosine Phosphorylation and Its Survival Signaling Properties in Rat Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FKHRL1; CEREBELLAR GRANULE NEURONS; PROTEIN-KINASE-B; FACTOR-1-INDUCED PHOSPHORYLATION; DEPENDENT REGULATION; PHOSPHATASE SHP-2; AKT ACTIVATION; CELL-SURVIVAL; PC12 CELLS; EXCITOTOXICITY	Impairing intracellular signaling induced by survival factors and excess glutamate have recently been suggested to play important role in neurodegenerative processes. However, the underlying mechanism(s) and interrelationships between these factors mostly remain to be established. In the present study, we show that glutamate attenuates the tyrosine phosphorylation of the insulin-like growth factor-1 (IGF-1) receptor and the survival effect of IGF-1 (100 nM) in hippocampal cultured neurons. Pretreatment of cultured hippocampal neurons with glutamate concentration dependently inhibited the tyrosine phosphorylation of IGF-1 receptors as well as that of IRS-1 and Shc, two IGF-1 receptor adapter proteins. The effect of glutamate was also evident on the phosphorylation of Akt, as well as its upstream kinase PI3K/PDK1 and downstream targets, GSK3 beta and FOXO3a. The inhibitory effect of glutamate (1 mM) was blocked by antagonists of the N-methyl-D-aspartate (NMDA) receptor, including MK801 (20 mu M) and AP5 (100 mu M), but not by blockers of other ionotropic or metabotropic glutamate receptor sub-types demonstrating the involvement of the NMDA receptor. This hypothesis is supported further by the observation that treatment with NMDA concentration dependently inhibited the activation and phosphorylation of IGF-1 receptors and downstream targets induced by IGF-1 (100 nM). These findings demonstrate that glutamate can block the effect of IGF-1 by decreasing IGF-1 receptor signaling and responsiveness, hence attenuating the survival properties of this trophic factor in neuronal cells. Our results also suggest a novel mechanism by which glutamate can reduce cell viability and induce neurotoxicity.	[Zheng, Wen-Hua; Quirion, Remi] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada; [Zheng, Wen-Hua] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol, Guangzhou 510275, Guangdong, Peoples R China	McGill University; Sun Yat Sen University	Quirion, R (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.	remi.quirion@douglas.mcgill.ca			Canadian Institutes of Health Research; National Natural Science Fund of China [30670652, 30711120565]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Canadian Institutes of Health Research and by the National Natural Science Fund of China (Grants 30670652 and 30711120565). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; BEAL MF, 1992, FASEB J, V6, P3338, DOI 10.1096/fasebj.6.15.1464368; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bulleit RF, 1998, TOXICOL APPL PHARM, V153, P161, DOI 10.1006/taap.1998.8561; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DEL PL, 1997, SCIENCE, V278, P687; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Garcia-Galloway E, 2003, MOL CELL NEUROSCI, V24, P1027, DOI 10.1016/j.mcn.2003.08.005; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Kitamura T, 1998, MOL CELL BIOL, V18, P3708, DOI 10.1128/MCB.18.7.3708; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Loddick SA, 1999, P NATL ACAD SCI USA, V96, P9449, DOI 10.1073/pnas.96.17.9449; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Maniar R, 2005, MOL CELL BIOCHEM, V275, P15, DOI 10.1007/s11010-005-7264-x; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Matsuzaki H, 1999, J NEUROCHEM, V73, P2037; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Ostlund P, 2001, J BIOL CHEM, V276, P36110, DOI 10.1074/jbc.M105710200; Rocchi S, 1996, ENDOCRINOLOGY, V137, P4944, DOI 10.1210/en.137.11.4944; Rusanescu G, 2005, EMBO J, V24, P305, DOI 10.1038/sj.emboj.7600522; SASAOKA T, 1994, J BIOL CHEM, V269, P13689; Tagami M, 1997, LAB INVEST, V76, P613; Venters HD, 1999, P NATL ACAD SCI USA, V96, P9879, DOI 10.1073/pnas.96.17.9879; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200; Zhang FX, 1998, J NEUROCHEM, V71, P196, DOI 10.1046/j.1471-4159.1998.71010196.x; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x; Zheng WH, 2000, J BIOL CHEM, V275, P13377, DOI 10.1074/jbc.275.18.13377; Zheng WH, 2002, MOL PHARMACOL, V62, P225, DOI 10.1124/mol.62.2.225; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	40	49	51	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					855	861		10.1074/jbc.M807914200	http://dx.doi.org/10.1074/jbc.M807914200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18981172	hybrid			2022-12-27	WOS:000262122900020
J	Bouet, JY; Lane, D				Bouet, Jean-Yves; Lane, David			Molecular Basis of the Supercoil Deficit Induced by the Mini-F Plasmid Partition Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; ESCHERICHIA-COLI; P1 PLASMID; CENTROMERE; SEGREGATION; LOCUS; SOPA; REPLICATION; SEGROSOME; MECHANISM	Formation of a partition complex on plasmid F by binding of SopB protein to the sopC centromere is the first step in the partition process that ensures stability of F in dividing cells. Establishment of the complex enables nonspecific binding of SopB to neighboring DNA, which extends the partition complex and provokes reduction of negative supercoiling of the plasmid. This reduction is believed to reflect winding of DNA into positive supercoils about SopB to create a nucleoprotein structure of probable importance to partition. We have searched for evidence that SopB alters plasmid topology. Permutation analysis indicated only modest bending of linear DNA fragments, and in vivo DNase I footprinting revealed no enhanced cleavages indicating curvature. In vitro, SopB binding left no topological trace in relaxed-circular DNA treated with topoisomerase I or in nicked circles closed by ligase. In vivo, novobiocin-mediated inhibition of DNA gyrase relaxed a plasmid carrying the partition complex but left no residue of positive supercoils. Hence, SopB does not reduce plasmid supercoiling directly. We did observe that SopB partly prevented removal of negative supercoils from plasmid DNA by topoisomerase I and partly prevented ligation of nicked circles, indicating that it acts as a physical obstacle. The supercoil deficit is thus better explained as SopB recoating of just-replicated DNA, which shelters it from gyrase and from topological changes in SopB-free DNA. This topological simplicity distinguishes the Sop partition complex from other complexes described.	[Bouet, Jean-Yves; Lane, David] CNRS, Lab Microbiol & Genet Mol, F-31000 Toulouse, France; [Bouet, Jean-Yves] Univ Toulouse, UPS, LMGM, F-31000 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Bouet, JY (corresponding author), Univ Toulouse 3, CNRS, Lab Microbiol & Genet Mol, Bat IBCG, 118 Route Narbonne, F-31062 Toulouse, France.	jean-yves.bouet@ibcg.biotoul.fr	Bouet, Jean-Yves/H-8469-2019	Bouet, Jean-Yves/0000-0003-1488-5455	soutien de base du Laboratoire de Microbiologie et Genetique Moleculaires; Agence National de Recherche [06-BLAN-0280-01]	soutien de base du Laboratoire de Microbiologie et Genetique Moleculaires; Agence National de Recherche(French National Research Agency (ANR))	This work was supported by the soutien de base du Laboratoire de Microbiologie et Genetique Moleculaires and Agence National de Recherche Grant 06-BLAN-0280-01. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BIEK DP, 1995, J MOL BIOL, V246, P388, DOI 10.1006/jmbi.1994.0094; BIEK DP, 1994, P NATL ACAD SCI USA, V91, P8027, DOI 10.1073/pnas.91.17.8027; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Bouet JY, 2006, MOL MICROBIOL, V62, P1447, DOI 10.1111/j.1365-2958.2006.05454.x; Bouet JY, 2005, MOL MICROBIOL, V55, P511, DOI 10.1111/j.1365-2958.2004.04396.x; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; Breuner A, 1996, MOL MICROBIOL, V20, P581, DOI 10.1046/j.1365-2958.1996.5351063.x; Cassler MR, 1999, NUCLEIC ACIDS RES, V27, P4570, DOI 10.1093/nar/27.23.4570; CODERONI S, 1990, MOL BIOL REP, V14, P255, DOI 10.1007/BF00429894; DAVIS MA, 1992, MOL MICROBIOL, V6, P1141, DOI 10.1111/j.1365-2958.1992.tb01552.x; Derome A, 2008, P NATL ACAD SCI USA, V105, P2151, DOI 10.1073/pnas.0704681105; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Edgar R, 2001, MOL MICROBIOL, V42, P1363, DOI 10.1046/j.1365-2958.2001.02717.x; FUNNELL BE, 1991, J BIOL CHEM, V266, P14328; GARTENBERG MR, 1988, NATURE, V333, P824, DOI 10.1038/333824a0; Gordon GS, 2000, ANNU REV MICROBIOL, V54, P681, DOI 10.1146/annurev.micro.54.1.681; Hanai R, 1996, J BIOL CHEM, V271, P17469, DOI 10.1074/jbc.271.29.17469; HAYAKAWA Y, 1985, J BACTERIOL, V163, P349, DOI 10.1128/JB.163.1.349-354.1985; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hirano M, 1998, MOL GEN GENET, V257, P392, DOI 10.1007/s004380050663; Hoischen C, 2008, NUCLEIC ACIDS RES, V36, P607, DOI 10.1093/nar/gkm672; Jensen RB, 1998, P NATL ACAD SCI USA, V95, P8550, DOI 10.1073/pnas.95.15.8550; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; KOLB A, 1983, NUCLEIC ACIDS RES, V11, P7833, DOI 10.1093/nar/11.22.7833; Lemonnier M, 2000, MOL MICROBIOL, V38, P493, DOI 10.1046/j.1365-2958.2000.02101.x; Lewis DEA, 1999, MOL MICROBIOL, V31, P451, DOI 10.1046/j.1365-2958.1999.01186.x; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; LLOUBES R, 1988, J MOL BIOL, V204, P1049, DOI 10.1016/0022-2836(88)90062-9; Lobner-Olesen A, 1999, EMBO J, V18, P1712, DOI 10.1093/emboj/18.6.1712; LOCKSHON D, 1983, NUCLEIC ACIDS RES, V11, P2999, DOI 10.1093/nar/11.10.2999; LYNCH AS, 1994, J MOL BIOL, V236, P679, DOI 10.1006/jmbi.1994.1179; LYNCH AS, 1995, P NATL ACAD SCI USA, V92, P1896, DOI 10.1073/pnas.92.6.1896; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; MORI H, 1989, J BIOL CHEM, V264, P15535; MUSGRAVE DR, 1991, P NATL ACAD SCI USA, V88, P10397, DOI 10.1073/pnas.88.23.10397; Nagaich AK, 1997, J BIOL CHEM, V272, P14842, DOI 10.1074/jbc.272.23.14842; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Ravin N, 1999, J BACTERIOL, V181, P6898, DOI 10.1128/JB.181.22.6898-6906.1999; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; SCHROTH GP, 1991, NUCLEIC ACIDS RES, V19, P511, DOI 10.1093/nar/19.3.511; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Schumacher MA, 2007, J BIOL CHEM, V282, P10456, DOI 10.1074/jbc.M610603200; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TIMMIS K, 1976, NATURE, V261, P512, DOI 10.1038/261512a0; WATANABE E, 1989, MOL GEN GENET, V218, P431, DOI 10.1007/BF00332406; WATANABE E, 1992, MOL GEN GENET, V234, P346, DOI 10.1007/BF00538693; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; Yates P, 1999, J MOL BIOL, V290, P627, DOI 10.1006/jmbi.1999.2909	52	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					165	173		10.1074/jbc.M802752200	http://dx.doi.org/10.1074/jbc.M802752200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001378	hybrid			2022-12-27	WOS:000261974800019
J	Dhakal, BK; Mulvey, MA				Dhakal, Bijaya K.; Mulvey, Matthew A.			Uropathogenic Escherichia coli Invades Host Cells via an HDAC6-modulated Microtubule-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED BACTERIAL INVASION; POSTTRANSLATIONAL MODIFICATIONS; DYNAMIC MICROTUBULES; FOCAL ADHESIONS; STRESS FIBERS; ALPHA-TUBULIN; PROTEIN; HDAC6; ACETYLATION; CYTOSKELETON	Strains of uropathogenic Escherichia coli (UPEC) encode filamentous adhesive organelles called type 1 pili that promote bacterial colonization and invasion of the bladder epithelium. Type 1 pilus-mediated interactions with host receptors, including alpha 3 beta 1 integrin, trigger localized actin rearrangements that lead to internalization of adherent bacteria via a zipper-like mechanism. Here we report that type 1 pilus-mediated bacterial invasion of bladder cells also requires input from host microtubules and histone deacetylase 6 (HDAC6), a cytosolic enzyme that, by deacetylating alpha-tubulin, can alter the stability of microtubules along with the recruitment and directional trafficking of the kinesin-1 motor complex. We found that disruption of microtubules by nocodazole or vinblastine treatment, as well as microtubule stabilization by taxol, inhibited host cell invasion by UPEC, as did silencing of HDAC6 expression or pharmacological inhibition of HDAC6 activity. Invasion did not require two alternate HDAC6 substrates, Hsp90 and cortactin, but was dependent upon the kinesin-1 light chain KLC2 and an upstream activator of HDAC6, aurora A kinase. These results indicate that HDAC6 and microtubules act as vital regulatory elements during the invasion process, possibly via indirect effects on kinesin-1 and associated cargos.	[Dhakal, Bijaya K.; Mulvey, Matthew A.] Univ Utah, Dept Pathol, Div Cell Biol & Immunol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Mulvey, MA (corresponding author), Rm 2100 JMRB,15 N Med Dr E, Salt Lake City, UT 84112 USA.	mulvey@path.utah.edu		Mulvey, Matthew/0000-0002-6016-7510	National Institutes of Health [DK068585]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK068585. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; BELLESTRAM C, 2004, CELL MOTILITY MOL OR; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Bougneres L, 2004, J CELL BIOL, V166, P225, DOI 10.1083/jcb.200402073; Bower JM, 2005, TRAFFIC, V6, P18, DOI 10.1111/j.1600-0854.2004.00251.x; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; DANOWSKI BA, 1989, J CELL SCI, V93, P255; DEBRABANDER M, 1977, CELL BIOL INT REP, V1, P177, DOI 10.1016/0309-1651(77)90038-8; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Eto DS, 2008, CELL MICROBIOL, V10, P2553, DOI 10.1111/j.1462-5822.2008.01229.x; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; Foxman B, 2002, AM J MED, V113, p5S; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; Hopkins SC, 2000, BIOCHEMISTRY-US, V39, P2805, DOI 10.1021/bi992474k; Hu L, 1999, INFECT IMMUN, V67, P4171, DOI 10.1128/IAI.67.8.4171-4182.1999; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Hvidberg H, 2000, ANTIMICROB AGENTS CH, V44, P156, DOI 10.1128/AAC.44.1.156-163.2000; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kerrn MB, 2005, J ANTIMICROB CHEMOTH, V55, P383, DOI 10.1093/jac/dki002; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; LIAO GJ, 1995, J CELL SCI, V108, P3473; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; MacRae TH, 1997, EUR J BIOCHEM, V244, P265, DOI 10.1111/j.1432-1033.1997.00265.x; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Martinez JJ, 2002, CELL MICROBIOL, V4, P19, DOI 10.1046/j.1462-5822.2002.00166.x; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Ronald A, 2002, AM J MED, V113, p14S; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; RUSSELL PW, 1992, J BACTERIOL, V174, P5923, DOI 10.1128/jb.174.18.5923-5935.1992; Schilling JD, 2002, INFECT IMMUN, V70, P7042, DOI 10.1128/IAI.70.12.7042-7049.2002; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Unsworth KE, 2004, CELL MICROBIOL, V6, P1041, DOI 10.1111/j.1462-5822.2004.00417.x; Valenzuela-Fernandez A, 2005, MOL BIOL CELL, V16, P5445, DOI 10.1091/mbc.e05-04-0354; Wang HB, 2008, J HISTOCHEM CYTOCHEM, V56, P597, DOI 10.1369/jhc.2008.950923; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	68	41	58	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					446	454		10.1074/jbc.M805010200	http://dx.doi.org/10.1074/jbc.M805010200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18996840	Green Published, hybrid			2022-12-27	WOS:000261974800049
J	Eliezer, Y; Argaman, L; Rhie, A; Doherty, AJ; Goldberg, M				Eliezer, Yifat; Argaman, Liron; Rhie, Alexandre; Doherty, Aidan J.; Goldberg, Michal			The Direct Interaction between 53BP1 and MDC1 Is Required for the Recruitment of 53BP1 to Sites of Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE; TUMOR-SUPPRESSOR; BRCT DOMAINS; FHA DOMAIN; CHECKPOINT; BINDING; REPAIR; CHROMATIN; PROTEINS	The DNA damage response mediators, 53BP1 and MDC1, play a central role in checkpoint activation and DNA repair. Here we establish that human 53BP1 and MDC1 interact directly through the tandem BRCT domain of MDC1 and residues 1288-1409 of 53BP1. Following induction of DNA double strand breaks the interaction is reduced, probably due to competition between gamma-H2AX and 53BP1 for the binding of the tandem BRCT domain of MDC1. Furthermore, the MDC1 binding region of 53BP1 is required for focus formation by 53BP1. During mitosis the interaction between 53BP1 and MDC1 is enhanced. The interaction is augmented in a phospho-dependent manner, and the MDC1 binding region of 53BP1 is phosphorylated in vivo in mitotic cells; therefore, it is probably modulated by cell cycle-regulated kinases. Our results demonstrate that the 53BP1-MDC1 interaction per se is required for the recruitment of 53BP1 to sites of DNA breaks, which is known to be crucial for an efficient activation of the DNA damage response. Moreover, the results presented here suggest that the interaction between 53BP1 and MDC1 plays a role in the regulation of mitosis.	[Eliezer, Yifat; Argaman, Liron; Goldberg, Michal] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [Rhie, Alexandre; Doherty, Aidan J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Hebrew University of Jerusalem; University of Sussex	Goldberg, M (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	goldbergm@vms.huji.ac.il		Goldberg, Michal/0000-0001-9397-2383; Doherty, Aidan/0000-0002-6370-1109	Association for International Cancer Research (AICR); Biotechnology and Biological Sciences Research Council, Cancer Research-UK (CR-UK); the Royal Society; Medical Research Council [G0801130B] Funding Source: researchfish	Association for International Cancer Research (AICR); Biotechnology and Biological Sciences Research Council, Cancer Research-UK (CR-UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Cancer Research UK); the Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Association for International Cancer Research (AICR), Biotechnology and Biological Sciences Research Council, Cancer Research-UK (CR-UK), and the Royal Society.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Adams MM, 2005, CELL CYCLE, V4, P1854, DOI 10.4161/cc.4.12.2282; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Boisvert FM, 2005, CELL CYCLE, V4, P1834, DOI 10.4161/cc.4.12.2250; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jullien D, 2002, J CELL SCI, V115, P71; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991	37	44	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					426	435		10.1074/jbc.M807375200	http://dx.doi.org/10.1074/jbc.M807375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18986980	hybrid			2022-12-27	WOS:000261974800047
J	Rokudai, S; Aikawa, Y; Tagata, Y; Tsuchida, N; Taya, Y; Kitabayashi, I				Rokudai, Susumu; Aikawa, Yukiko; Tagata, Yusuke; Tsuchida, Nobuo; Taya, Yoichi; Kitabayashi, Issay			Monocytic Leukemia Zinc Finger (MOZ) Interacts with p53 to Induce p21 Expression and Cell-cycle Arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; DNA-DAMAGE; NUCLEAR RECEPTORS; PROTEIN KINASE-2; AMINO-TERMINUS; ACETYLATION; ACTIVATION; PHOSPHORYLATION; APOPTOSIS	Upon DNA damage, p53 can induce either cell-cycle arrest or apoptosis. Here we show that monocytic leukemia zinc finger (MOZ) forms a complex with p53 to induce p21 expression and cell-cycle arrest. The levels of the p53-MOZ complex increased in response to DNA damage to levels that induce cell-cycle arrest. MOZ(-/-) mouse embryonic fibroblasts failed to arrest in G(1) in response to DNA damage, and DNA damage-induced expression of p21 was impaired in MOZ(-/-) cells. These results suggest that MOZ is involved in regulating cell-cycle arrest in the G(1) phase. Screening of tumor-associated p53 mutants demonstrated that the G279E mutation in p53 disrupts interactions between p53 and MOZ, but does not affect the DNA binding activity of p53. The leukemia-associated MOZ-CBP fusion protein inhibits p53-mediated transcription. These results suggest that inhibition of p53/MOZ-mediated transcription is involved in tumor pathogenesis and leukemogenesis.	[Rokudai, Susumu; Aikawa, Yukiko; Tagata, Yusuke; Kitabayashi, Issay] Natl Canc Ctr, Res Inst, Div Mol Oncol, Tokyo 1040045, Japan; [Taya, Yoichi] Natl Canc Ctr, Res Inst, Div Radiobiol, Tokyo 1040045, Japan; [Tsuchida, Nobuo] Tokyo Med & Dent Univ, Dept Mol Cellular Oncol & Microbiol, Tokyo 1138510, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Kitabayashi, I (corresponding author), 5-1-1 Tsukiji,Chuo Ku, Tokyo 1040045, Japan.	ikitabay@ncc.go.jp	Rokudai, Susumu/O-6771-2018; Kitabayashi, Issay/G-2204-2017	Rokudai, Susumu/0000-0003-0300-0391; Kitabayashi, Issay/0000-0002-8409-0407	Scientific Research from the Ministry of Health, Labor and Welfare, the Ministry of Education, Culture, Sports, Science and Technology; Program for Promotion of Fundamental Studies from the National Institute of Biomedical Innovation of Japan.	Scientific Research from the Ministry of Health, Labor and Welfare, the Ministry of Education, Culture, Sports, Science and Technology; Program for Promotion of Fundamental Studies from the National Institute of Biomedical Innovation of Japan.(National Institute of Biomedical Innovation)	This work was supported by Grants-in-aid for Scientific Research from the Ministry of Health, Labor and Welfare, the Ministry of Education, Culture, Sports, Science and Technology, and the Program for Promotion of Fundamental Studies from the National Institute of Biomedical Innovation of Japan.	Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Bristow CAP, 2003, NUCLEIC ACIDS RES, V31, P2735, DOI 10.1093/nar/gkg401; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carapeti M, 1998, BLOOD, V91, P3127, DOI 10.1182/blood.V91.9.3127.3127_3127_3133; Chaffanet M, 2000, GENE CHROMOSOME CANC, V28, P138, DOI 10.1002/(SICI)1098-2264(200006)28:2<138::AID-GCC2>3.0.CO;2-2; CHITTENDEN T, 1993, MOL CELL BIOL, V13, P3975, DOI 10.1128/MCB.13.7.3975; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Deguchi K, 2003, CANCER CELL, V3, P259, DOI 10.1016/S1535-6108(03)00051-5; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; EL DW, 1993, CELL, V75, P817; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kindle KB, 2005, MOL CELL BIOL, V25, P988, DOI 10.1128/MCB.25.3.988-1002.2005; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Kitabayashi I, 2001, LEUKEMIA, V15, P89, DOI 10.1038/sj.leu.2401983; Kitabayashi I, 1998, EMBO J, V17, P2994, DOI 10.1093/emboj/17.11.2994; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liang J, 1998, BLOOD, V92, P2118, DOI 10.1182/blood.V92.6.2118.418k09_2118_2122; MacPherson D, 2004, EMBO J, V23, P3689, DOI 10.1038/sj.emboj.7600363; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Prives C, 1999, J PATHOL, V187, P112; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Shieh SY, 2000, GENE DEV, V14, P289; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864	52	54	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					237	244		10.1074/jbc.M805101200	http://dx.doi.org/10.1074/jbc.M805101200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001415	hybrid			2022-12-27	WOS:000261974800027
J	Wu, YD; Evers, BM; Zhou, BHP				Wu, Yadi; Evers, B. Mark; Zhou, Binhua P.			Small C-terminal Domain Phosphatase Enhances Snail Activity through Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTORS SNAIL; E-CADHERIN; TUMOR PROGRESSION; GENE-EXPRESSION; TGF-BETA; BREAST-CARCINOMA; CELL-DEATH; CANCER; METASTASIS	Down-regulation of E-cadherin plays an important role in epithelial-mesenchymal transition (EMT), which is critical in normal development and disease states such as tissue fibrosis and metastasis. Snail, a key transcription repressor of E-cadherin, is a labile protein with a short half-life and is regulated through phosphorylation, ubiquitination, and degradation. Previously, we showed that GSK-3 beta phosphorylated two stretches of serine residues within the nuclear export signal and the destruction box of Snail, provoking its cytoplasmic export for ubiquitin-mediated proteasome degradation. However, the mechanism of Snail dephosphorylation and the identity of the Snail-specific phosphatase remain elusive. Using a functional genomic screening, we found that the small C-terminal domain phosphatase (SCP) is a specific phosphatase for Snail. SCP interacted and co-localized with Snail in the nucleus. We also found that SCP expression induced Snail dephosphorylation and stabilization in vitro and in vivo. However, a catalytically inactive mutant of SCP had no effect on Snail. Furthermore, we found that Snail stabilization induced by SCP enhanced snail activity in the suppression of E-cadherin and increased cell migration. Thus, our findings indicate that SCP functions as a Snail phosphatase to control its phosphorylation and stabilization, and our study provides novel insights for the regulation of Snail during EMT and cancer metastasis.	[Wu, Yadi; Zhou, Binhua P.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Evers, B. Mark] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Wu, Yadi; Evers, B. Mark; Zhou, Binhua P.] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Zhou, BHP (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	bpzhou@utmb.edu			National Institutes of Health [R01CA125454]; ACS [IRG-110376]; Susan G. Komen Foundation [KG081310]; NATIONAL CANCER INSTITUTE [T32CA117834, R01CA125454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA125454 ( to B. P. Z.). This work was also supported by the John Sealy Memorial Endowment Fund, a pilot award from the ACS (IRG-110376), and grants from the Susan G. Komen Foundation (KG081310). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Davidson NE, 2005, CANCER CELL, V8, P173, DOI 10.1016/j.ccr.2005.08.006; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sapkota G, 2006, J BIOL CHEM, V281, P40412, DOI 10.1074/jbc.M610172200; Schlessinger K, 2004, NAT CELL BIOL, V6, P913, DOI 10.1038/ncb1004-913; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Taylor KM, 2004, TRENDS ENDOCRIN MET, V15, P461, DOI 10.1016/j.tem.2004.10.003; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson J, 2006, EMBO J, V25, P2757, DOI 10.1038/sj.emboj.7601161; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhou BHP, 2005, CELL CYCLE, V4, P772, DOI 10.4161/cc.4.6.1744; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	43	82	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					640	648		10.1074/jbc.M806916200	http://dx.doi.org/10.1074/jbc.M806916200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19004823	Green Published, hybrid			2022-12-27	WOS:000261974800069
J	Li, M; Li, CG; Liu, YH; Xing, YM; Hu, LY; Borok, Z; Kwong, KYC; Minoo, P				Li, Min; Li, Changgong; Liu, Yi-hsin; Xing, Yiming; Hu, Lingyan; Borok, Zea; Kwong, Kenny Y. -C.; Minoo, Parviz			Mesodermal Deletion of Transforming Growth Factor-beta Receptor II Disrupts Lung Epithelial Morphogenesis CROSS-TALK BETWEEN TGF-beta AND SONIC HEDGEHOG PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE EMBRYONIC LUNG; SMOOTH-MUSCLE-CELLS; IN-VIVO; CONDITIONAL INACTIVATION; BRANCHING MORPHOGENESIS; TRANSGENIC MICE; EXPRESSION; DEFECTS; NKX2.1; FGF10	In vertebrates, Sonic hedgehog (Shh) and transforming growth factor-beta(TGF-beta) signaling pathways occur in an overlapping manner in many morphogenetic processes. In vitro data indicate that the two pathways may interact. Whether such interactions occur during embryonic development remains unknown. Using embryonic lung morphogenesis as a model, we generated transgenic mice in which exon 2 of the T beta RII gene, which encodes the type II TGF-beta receptor, was deleted via a mesodermal-specific Cre. Mesodermal-specific deletion of T beta RII (T beta RII Delta/Delta) resulted in embryonic lethality. The lungs showed abnormalities in both number and shape of cartilage in trachea and bronchi. In the lung parenchyma, where epithelial-mesenchymal interactions are critical for normal development, deletion of mesenchymal T beta RII caused abnormalities in epithelial morphogenesis. Failure in normal epithelial branching morphogenesis in the T beta RII Delta/Delta lungs caused cystic airway malformations. Interruption of the T beta RII locus in the lung mesenchyme increased mRNA for Patched and Gli-1, two downstream targets of Shh signaling, without alterations in Shh ligand levels produced in the epithelium. Therefore, we conclude that T beta RII-mediated signaling in the lung mesenchyme modulates transduction of Shh signaling that originates from the epithelium. To our knowledge, this is the first in vivo evidence for a reciprocal and novel mode of cross-communication between Shh and TGF-beta pathways during embryonic development.	[Li, Min; Li, Changgong; Xing, Yiming; Hu, Lingyan; Kwong, Kenny Y. -C.; Minoo, Parviz] Univ So Calif, Sch Med, Dept Pediat, Div Neonatol, Los Angeles, CA 90033 USA; [Liu, Yi-hsin] Univ So Calif, Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Borok, Zea] Univ So Calif, Sch Med, Pulm Res Ctr, Will Rogers Inst,Dept Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Minoo, P (corresponding author), Gen Labs Bldg,1801 E Marengo St,Rm 1G1, Los Angeles, CA 90033 USA.	minoo@usc.edu	Borok, Zea/J-9015-2013	Borok, Zea/0000-0001-8673-8177	NHLBI; National Institutes of Health; Hastings Foundation	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hastings Foundation	This work was supported, in whole or in part, by NHLBI, National Institutes of Health. This work was also supported by the Hastings Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beer HD, 1997, ONCOGENE, V15, P2211, DOI 10.1038/sj.onc.1201383; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bellusci S, 1997, DEVELOPMENT, V124, P53; Black PN, 1996, AM J PHYSIOL-LUNG C, V271, pL910, DOI 10.1152/ajplung.1996.271.6.L910; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chen H, 2005, AM J PHYSIOL-LUNG C, V288, pL683, DOI 10.1152/ajplung.00298.2004; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Cohen P, 2000, AM J PHYSIOL-LUNG C, V278, pL545, DOI 10.1152/ajplung.2000.278.3.L545; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; De Langhe SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001516; del Moral PM, 2006, DEV BIOL, V293, P77, DOI 10.1016/j.ydbio.2006.01.020; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Grindley JC, 1997, DEV BIOL, V188, P337, DOI 10.1006/dbio.1997.8644; Hamdan H, 1998, BBA-GENE STRUCT EXPR, V1396, P336, DOI 10.1016/S0167-4781(97)00210-8; INGHAM PW, 1995, CURR OPIN GENET DEV, V5, P492, DOI 10.1016/0959-437X(95)90054-K; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Li CG, 2005, DEV BIOL, V287, P86, DOI 10.1016/j.ydbio.2005.08.035; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li M, 2003, DEV DYNAM, V228, P273, DOI 10.1002/dvdy.10367; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Miller LAD, 2001, J HISTOCHEM CYTOCHEM, V49, P1593, DOI 10.1177/002215540104901213; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Minoo P, 2007, MOL CELL BIOL, V27, P2155, DOI 10.1128/MCB.01133-06; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Pan QP, 2004, GENE, V331, P73, DOI 10.1016/j.gene.2004.01.026; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; Tomlinson DC, 2004, ENDOCRINOLOGY, V145, P1988, DOI 10.1210/en.2003-0842; Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1; WRANA JL, 2000, SCI STKE, pRE1; Xing YM, 2008, DEV BIOL, V320, P340, DOI 10.1016/j.ydbio.2008.04.044; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zeng X, 2001, DEV DYNAM, V221, P289, DOI 10.1002/dvdy.1140; Zhao Y, 2000, EXP MOL PATHOL, V69, P67, DOI 10.1006/exmp.2000.2319; Zhou L, 1996, DEV BIOL, V175, P227, DOI 10.1006/dbio.1996.0110	46	28	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36257	36264		10.1074/jbc.M806786200	http://dx.doi.org/10.1074/jbc.M806786200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990706	Green Published, hybrid			2022-12-27	WOS:000261840500021
J	Taguchi, H; Planque, S; Sapparapu, G; Boivin, S; Hara, M; Nishiyama, Y; Paul, S				Taguchi, Hiroaki; Planque, Stephanie; Sapparapu, Gopal; Boivin, Stephane; Hara, Mariko; Nishiyama, Yasuhiro; Paul, Sudhir			Exceptional Amyloid beta Peptide Hydrolyzing Activity of Nonphysiological Immunoglobulin Variable Domain Scaffolds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBODY LIGHT-CHAIN; VASOACTIVE-INTESTINAL-PEPTIDE; ALZHEIMERS-DISEASE; PROTEOLYTIC ANTIBODY; IRREVERSIBLE INHIBITORS; REPERTOIRE DEVELOPMENT; SERINE PROTEASES; LIGAND-BINDING; FC FUSIONS; SITE	Nucleophilic sites in the paired variable domains of the light and heavy chains (V-L and V-H domains) of Ig can catalyze peptide bond hydrolysis. Amyloid beta(A beta)-binding Igs are under consideration for immunotherapy of Alzheimer disease. We searched for A beta-hydrolyzing human IgV domains (IgVs) in a library containing a majority of single chain Fv clones mimicking physiological V-L-V-H-combining sites and minority IgV populations with nonphysiological structures generated by cloning errors. Random screening and covalent selection of phage- displayed IgVs with an electrophilic A beta analog identified rare IgVs that hydrolyzed A beta mainly at His(14)-Gln(15). Inhibition of IgV catalysis and irreversible binding by an electrophilic hapten suggested a nucleophilic catalytic mechanism. Structural analysis indicated that the catalytic IgVs are nonphysiological structures, a two domain heterodimeric VL (IgV(L2)-t) and single domain V-L clones with aberrant polypeptide tags (IgV(L)-t'). The IgVs hydrolyzed A beta at rates superior to naturally occurring Igs by 3-4 orders of magnitude. Forced pairing of the single domain V-L with V-H or V-L domains resulted in reduced A beta hydrolysis, suggesting catalysis by the unpaired V-L domain. angstrom ngstrom level amino acid displacements evident in molecular models of the two domain and unpaired V-L domain clones explain alterations of catalytic activity. In view of their superior catalytic activity, the V-L domain IgVs may help attain clearance of medically important antigens more efficiently than natural Igs.	[Taguchi, Hiroaki; Planque, Stephanie; Sapparapu, Gopal; Boivin, Stephane; Hara, Mariko; Nishiyama, Yasuhiro; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Chem Immunol Res Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Paul, S (corresponding author), Univ Texas Houston, Sch Med, Dept Pathol, 6431 Fannin, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu	Sapparapu, Gopal/B-5896-2009; Boivin, Stephane/K-4018-2012	Boivin, Stephane/0000-0003-1460-326X	National Institutes of Health [R01AG025304]; NATIONAL INSTITUTE ON AGING [R01AG025304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG025304. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BJORK I, 1971, BIOCHEMISTRY-US, V10, P1280; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burbach GJ, 2007, NEUROBIOL AGING, V28, P202, DOI 10.1016/j.neurobiolaging.2005.12.003; Chakrabarti R, 2005, P NATL ACAD SCI USA, V102, P10153, DOI 10.1073/pnas.0504023102; COLOMA MJ, 1992, J IMMUNOL METHODS, V152, P89, DOI 10.1016/0022-1759(92)90092-8; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; De Genst E, 2006, DEV COMP IMMUNOL, V30, P187, DOI 10.1016/j.dci.2005.06.010; Deane R, 2005, J NEUROSCI, V25, P11495, DOI 10.1523/JNEUROSCI.3697-05.2005; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dijkstra BW, 2003, CURR OPIN STRUC BIOL, V13, P706, DOI 10.1016/j.sbi.2003.10.014; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Dooley H, 2006, DEV COMP IMMUNOL, V30, P43, DOI 10.1016/j.dci.2005.06.022; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; EDMUNDSON AB, 1987, MOL IMMUNOL, V24, P915, DOI 10.1016/0161-5890(87)90003-4; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Forloni G, 1996, PROG NEUROBIOL, V49, P287, DOI 10.1016/0301-0082(96)00013-5; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; GRUNDMAN M, 2008, INT C ALZH DIS JUL 2; Hanson CV, 2005, CURR OPIN BIOTECH, V16, P631, DOI 10.1016/j.copbio.2005.10.003; Harris DL, 2000, J MOL RECOGNIT, V13, P198, DOI 10.1002/1099-1352(200007/08)13:4<198::AID-JMR499>3.0.CO;2-D; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; HOOD L, 1975, ANNU REV GENET, V9, P305, DOI 10.1146/annurev.ge.09.120175.001513; Hosia W, 2005, J MASS SPECTROM, V40, P142, DOI 10.1002/jms.732; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Kanyshkova TG, 1997, FEBS LETT, V416, P23, DOI 10.1016/S0014-5793(97)01163-0; Knobloch M, 2007, J NEUROSCI, V27, P7648, DOI 10.1523/JNEUROSCI.0395-07.2007; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; KOHEN F, 1979, FEBS LETT, V100, P137, DOI 10.1016/0014-5793(79)81149-7; Krasnorutskii MA, 2008, J MOL RECOGNIT, V21, P233, DOI 10.1002/jmr.890; Kubetzko S, 2006, J BIOL CHEM, V281, P35186, DOI 10.1074/jbc.M604127200; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Liu R, 2004, BIOCHEMISTRY-US, V43, P9999, DOI 10.1021/bi0492354; Lue LF, 2002, J NEUROSCI RES, V70, P599, DOI 10.1002/jnr.10422; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; MEI S, 1991, J BIOL CHEM, V266, P15571; Morgan D, 2005, NEURODEGENER DIS, V2, P261, DOI 10.1159/000090366; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Nishiyama Y, 2007, MOL IMMUNOL, V44, P2707, DOI 10.1016/j.molimm.2006.12.005; OLEKSYSZYN J, 1994, J MED CHEM, V37, P226, DOI 10.1021/jm00028a004; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Powers DB, 2001, J IMMUNOL METHODS, V251, P123, DOI 10.1016/S0022-1759(00)00290-8; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; RAO G, 1991, J PROTEIN CHEM, V10, P117, DOI 10.1007/BF01024661; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Solomon B, 1997, P NATL ACAD SCI USA, V94, P4109, DOI 10.1073/pnas.94.8.4109; Sun M, 1997, J MOL BIOL, V271, P374, DOI 10.1006/jmbi.1997.1196; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Thayer MM, 1999, J MOL BIOL, V291, P329, DOI 10.1006/jmbi.1999.2960; Tucker HM, 2002, J NEUROSCI RES, V70, P249, DOI 10.1002/jnr.10417; White AR, 2003, J NEUROCHEM, V87, P801, DOI 10.1046/j.1471-4159.2003.02064.x; Yang K, 2003, PROTEIN ENG, V16, P761, DOI 10.1093/protein/gzg093	62	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36724	36733		10.1074/jbc.M806766200	http://dx.doi.org/10.1074/jbc.M806766200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18974093	Green Published, hybrid			2022-12-27	WOS:000261840500070
J	Huynh, KK; Gershenzon, E; Grinstein, S				Huynh, Kassidy K.; Gershenzon, Elena; Grinstein, Sergio			Cholesterol Accumulation by Macrophages Impairs Phagosome Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA-RIIA; LIPOPROTEIN-DERIVED CHOLESTEROL; HAMSTER OVARY CELLS; INTRACELLULAR-TRANSPORT; PHOSPHATIDYLINOSITOL 3-KINASE; LIPID RAFTS; FOAM CELLS; IN-VITRO; LYSOSOMES; RAB7	Macrophages are key to the pathogenesis of atherosclerosis. They take up and store excessive amounts of cholesterol associated with modified low density lipoprotein, eventually becoming foam cells that display altered immune responsiveness. We studied the effects of cholesterol accumulation on phagosome formation and maturation, using lipid transport antagonists and cholesterol transport-deficient mutants. In macrophages treated with U18666A, a transport antagonist that prevents cholesterol exit from late endosomes/lysosomes, the early stages of maturation proceeded normally; phagosomes acquired Rab5, phosphatidylinositol 3-phosphate, and EEA1 and merged with LAMP-containing vesicles. However, fusion with lysosomes was impaired. Rab7, which is required for phagolysosome formation, was acquired by phagosomes but remained inactive. Maturation was also studied in fibroblasts from Niemann-Pick type C individuals that have defective cholesterol transport. Transfection of Fc gamma IIA receptors was used to confer phagocytic capability to these fibroblasts. Niemann-Pick type C phagosomes failed to fuse with lysosomes, whereas wild type fibroblasts formed normal phagolysosomes. These findings indicate that cholesterol accumulation can have a detrimental effect on phagosome maturation by impairing the activation of Rab7, sequestering it and its effectors in cholesterol-enriched multilamellar compartments.	[Huynh, Kassidy K.; Gershenzon, Elena; Grinstein, Sergio] Univ Toronto, Cell Biol Programme, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Huynh, Kassidy K.; Grinstein, Sergio] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Gershenzon, Elena; Grinstein, Sergio] Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Grinstein, S (corresponding author), Univ Toronto, Cell Biol Programme, Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca			Heart and Stroke Foundation of Ontario, Canada; Canadian Institutes of Health Research [T5944]	Heart and Stroke Foundation of Ontario, Canada(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Heart and Stroke Foundation of Ontario, Canada and by the Canadian Institutes of Health Research Grant T5944. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bobryshev YV, 2006, MICRON, V37, P208, DOI 10.1016/j.micron.2005.10.007; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; CLINTON SK, 1992, AM J PATHOL, V140, P301; Downey GP, 1999, J BIOL CHEM, V274, P28436, DOI 10.1074/jbc.274.40.28436; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jahraus A, 1998, J BIOL CHEM, V273, P30379, DOI 10.1074/jbc.273.46.30379; Kono H, 2002, J IMMUNOL, V169, P193, DOI 10.4049/jimmunol.169.1.193; Lange Y, 1997, J BIOL CHEM, V272, P17018, DOI 10.1074/jbc.272.27.17018; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; LISCUM L, 1990, BIOCHIM BIOPHYS ACTA, V1045, P40, DOI 10.1016/0005-2760(90)90201-8; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Lucas A D, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003696; Mansfield PJ, 2005, BIOCHEM BIOPH RES CO, V331, P132, DOI 10.1016/j.bbrc.2005.02.191; ROFF CF, 1991, DEV NEUROSCI-BASEL, V13, P315, DOI 10.1159/000112179; ROSENFELD ME, 1992, AM J PATHOL, V140, P291; Scott CC, 2002, J BIOL CHEM, V277, P12770, DOI 10.1074/jbc.M110399200; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Takahashi M, 2007, MOL BIOL CELL, V18, P2667, DOI 10.1091/mbc.E06-10-0924; TANGIRALA RK, 1993, J BIOL CHEM, V268, P9653; Vainio S, 2003, ANN MED, V35, P146, DOI 10.1080/07853890310008198; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wustner D, 2005, TRAFFIC, V6, P396, DOI 10.1111/j.1600-0854.2005.00285.x	33	65	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35745	35755		10.1074/jbc.M806232200	http://dx.doi.org/10.1074/jbc.M806232200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955491	hybrid			2022-12-27	WOS:000261687900048
J	Shirra, MK; McCartney, RR; Zhang, C; Shokat, KM; Schmidt, MC; Arndt, KM				Shirra, Margaret K.; McCartney, Rhonda R.; Zhang, Chao; Shokat, Kevan M.; Schmidt, Martin C.; Arndt, Karen M.			A Chemical Genomics Study Identifies Snf1 as a Repressor of GCN4 Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; TRANSFER-RNA BINDING; PROTEIN-KINASE; GENE-EXPRESSION; TRANSCRIPTION FACTORS; MASTER REGULATOR; BETA-SUBUNITS; YEAST SNF1; IN-VIVO; ACTIVATION	The Saccharomyces cerevisiae Snf1 kinase plays a critical role in recalibrating cellular metabolism in response to glucose depletion. Hundreds of genes show changes in expression levels when the SNF1 gene is deleted. However, cells can adapt to the absence of a specific gene when grown in long term culture. Here we apply a chemical genetic method to rapidly and selectively inactivate a modified Snf1 kinase using a pyrazolopyrimidine inhibitor. By allowing cells to adjust to a change in carbon source prior to inhibition of the Snf1 kinase activity, we identified a set of genes whose expression increased when Snf1 was inhibited. Prominent in this set are genes that are activated by Gcn4, a transcriptional activator of amino acid biosynthetic genes. Deletion of Snf1 increased Gcn4 protein levels without affecting its mRNA levels. The increased Gcn4 protein levels required the Gcn2 kinase and Gcn20, regulators of GCN4 translation. These data indicate that Snf1 functions upstream of Gcn20 to regulate control of GCN4 translation in S. cerevisiae.	[Shirra, Margaret K.; Arndt, Karen M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [McCartney, Rhonda R.; Schmidt, Martin C.] Univ Pittsburgh, Sch Med, Biochem & Mol Genet Program, Pittsburgh, PA 15261 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Arndt, KM (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	arndt@pitt.edu			National Institutes of Health [GM46443, GM52593, DK74654, AI44009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK074654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052593, R29GM046443, R01GM046443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM46443 (to M.C.S.), GM52593 (to K.M.A.), DK74654 (to K.M.A.), and AI44009 (to K.M.S.) from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARNDT KM, 1995, EMBO J, V14, P1490, DOI 10.1002/j.1460-2075.1995.tb07135.x; ARNDT KT, 1987, SCIENCE, V237, P874, DOI 10.1126/science.3303332; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Brachmann CB, 1998, YEAST, V14, P115; CELENZA JL, 1989, MOL CELL BIOL, V9, P5045, DOI 10.1128/MCB.9.11.5045; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Garcia-Barrio M, 2002, J BIOL CHEM, V277, P30675, DOI 10.1074/jbc.M203187200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Irniger S, 2003, CURR GENET, V44, P8, DOI 10.1007/s00294-003-0422-3; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Liu Y, 2005, MOL CELL BIOL, V25, P10566, DOI 10.1128/MCB.25.23.10566-10579.2005; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; ROLFES RJ, 1993, MOL CELL BIOL, V13, P5099, DOI 10.1128/MCB.13.8.5099; ROSE M, 1983, METHOD ENZYMOL, V101, P167; ROSE MD, 1990, METHODS YEAST GENETI, P179; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Schmidt MC, 2000, EMBO J, V19, P4936, DOI 10.1093/emboj/19.18.4936; Shirra MK, 2005, GENETICS, V169, P1957, DOI 10.1534/genetics.104.038075; Shirra MK, 1999, GENETICS, V152, P73; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; Usaite R, 2008, J PROTEOME RES, V7, P266, DOI 10.1021/pr700580m; Van de Velde S, 2008, EUKARYOT CELL, V7, P286, DOI 10.1128/EC.00276-07; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOODS A, 1994, J BIOL CHEM, V269, P19509; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	45	39	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35889	35898		10.1074/jbc.M805325200	http://dx.doi.org/10.1074/jbc.M805325200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955495	Green Published, hybrid			2022-12-27	WOS:000261687900064
J	Watanabe, H; Nakanishi, T; Umetsu, M; Kumagai, I				Watanabe, Hideki; Nakanishi, Takeshi; Umetsu, Mitsuo; Kumagai, Izumi			Human Anti-gold Antibodies BIOFUNCTIONALIZATION OF GOLD NANOPARTICLES AND SURFACES WITH ANTI-GOLD ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BISPECIFIC DIABODY; QUANTUM DOTS; BINDING; CANCER; SPECIFICITY; RECOGNITION; FRAGMENTS; SELECTION; PHAGE; SEMICONDUCTOR	The interface molecules designed to exhibit molecular recognitions between different species have become attractive tools for the bottom-up fabrication and hybridization of nanostructured units. Here, we focus on antibodies with high binding ability and specificity to construct a novel biomolecule interface for recognizing an inorganic material. Careful selection from a phage-displayed library of variable region heavy and light Fv chains of human antibodies using enzyme-linked immunosorbent assay and surface plasmon resonance assay resulted in the identification of an antibody fragment, A14P-b2, with high affinity (K-D = 1.7 nM) and specificity for gold materials. Our results indicated the potential usefulness of human antibody libraries and the effectiveness of the antibody framework for recognizing bulk material surfaces. Construction of bivalent and bispecific antibodies on the A14P-b2 platform with high affinity by means of fusion technology enabled the functionalization of gold nanoparticles and allowed selective protein accumulation on gold spots patterned on a silicon substrate. This type of antibody engineering is potentially applicable to bio-inspired materials and nanobiosensing.	[Watanabe, Hideki; Nakanishi, Takeshi; Umetsu, Mitsuo; Kumagai, Izumi] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan	Tohoku University	Kumagai, I (corresponding author), Aoba 6-6-11-606,Aoba Ku, Sendai, Miyagi 9808579, Japan.	kmiz@kuma.che.tohoku.ac.jp	Watanabe, Hideki/M-2711-2018	Watanabe, Hideki/0000-0002-9561-4077	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-aid for Scientific Research and Grant-in-aid for Young Scientists from Japan Society for the Promotion of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P6385, DOI 10.1073/pnas.90.14.6385; Benson JD, 2006, NATURE, V441, P451, DOI 10.1038/nature04873; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Braden BC, 2000, P NATL ACAD SCI USA, V97, P12193, DOI 10.1073/pnas.210396197; Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269; Cai WB, 2006, NANO LETT, V6, P669, DOI 10.1021/nl052405t; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Denkberg G, 2006, AUTOIMMUN REV, V5, P252, DOI 10.1016/j.autrev.2005.07.004; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; Geva M, 2003, J AM CHEM SOC, V125, P696, DOI 10.1021/ja027942j; Hayashi H, 2004, CANCER IMMUNOL IMMUN, V53, P497, DOI 10.1007/s00262-003-0465-9; Helfrich W, 1998, INT J CANCER, V76, P232, DOI 10.1002/(SICI)1097-0215(19980413)76:2<232::AID-IJC11>3.3.CO;2-N; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Itoh Y, 2002, BIOSCI BIOTECH BIOCH, V66, P1084, DOI 10.1271/bbb.66.1084; Kasuya K, 1999, INT J BIOL MACROMOL, V24, P329, DOI 10.1016/S0141-8130(99)00046-X; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100; MIRKIN CA, 1996, NATURE, V382, P609; Murcia M. J., 2005, NANOTECHNOLOGIES LIF; Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758; Oguri H, 2003, J AM CHEM SOC, V125, P7608, DOI 10.1021/ja034990a; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Schaferling M, 2004, PROTEIN MICROARRAY T, P11; Schnirman AA, 2006, NANO LETT, V6, P1870, DOI 10.1021/nl0607636; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Seeman NC, 2002, P NATL ACAD SCI USA, V99, P6451, DOI 10.1073/pnas.221458298; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SMITHGILL SJ, 1984, J IMMUNOL, V132, P963; Tamerler C, 2006, LANGMUIR, V22, P7712, DOI 10.1021/la0606897; TSUMOTO K, 1994, J BIOL CHEM, V269, P28777; Ueda H, 1996, NAT BIOTECHNOL, V14, P1714, DOI 10.1038/nbt1296-1714; Umetsu M, 2005, ADV MATER, V17, P2571, DOI 10.1002/adma.200500863; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; Watanabe H, 2002, BIOCHEM BIOPH RES CO, V295, P31, DOI 10.1016/S0006-291X(02)00616-2; Watanabe H, 2007, BIOCONJUGATE CHEM, V18, P645, DOI 10.1021/bc060203y; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141	44	27	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					36031	36038		10.1074/jbc.M805547200	http://dx.doi.org/10.1074/jbc.M805547200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955492	hybrid			2022-12-27	WOS:000261687900077
J	Fan, SJ; Meng, QH; Laterra, JJ; Rosen, EM				Fan, Saijun; Meng, Qinghui; Laterra, John J.; Rosen, Eliot M.			Role of Src Signal Transduction Pathways in Scatter Factor-mediated Cellular Protection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HEPATOCYTE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; MAMMARY-CARCINOMA CELLS; C-SRC; BREAST-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; FACTOR/SCATTER FACTOR; GENE-EXPRESSION	Scatter factor (SF) (hepatocyte growth factor) is a pleiotrophic cytokine that accumulates in tumors, where it may induce invasion, angiogenesis, and chemoresistance. We have studied the mechanisms by which SF and its receptor (c-Met) protect cells against the DNA-damaging agent adriamycin (ADR) as a model for chemoresistance of SF/c-Met-overexpressing tumors. Previous studies identified a phosphatidylinositol 3-kinase/c-Akt/Pak1/NF-kappa B cell survival pathway in DU-145 prostate cancer and Madin-Darby canine kidney epithelial cells. Here we studied Src signaling pathways involved in SF cell protection. Src enhanced basal and SF stimulated NF-kappa B activity and SF protection against ADR, in a manner dependent upon its kinase and Src homology 3 domains; and endogenous Src was required for SF stimulation of NF-kappa B activity and cell protection. The ability of Src to enhance SF stimulation of NF-kappa B activity was due, in part, to its ability to stimulate Akt and I kappa B kinase activity; and Src-mediated stimulation of NF-kappa B was due, in part, to a Rac1/MKK3/6/p38 pathway and was Akt-dependent. SF caused the activation of Src and the Rac1 effector Pak1. Furthermore, SF induced activating phosphorylations of MKK3, MKK6, and p38 within the c-Met signalsome in an Src-dependent manner. The NF-kappa B-inducing kinase was found to act downstream of TAK1 (transforming growth factor-beta-activated kinase 1) as a mediator of SF- and Src-stimulated NF-kappa B activity. Finally, the Src/Rac1/MKK3/6/p38 and Src/TAK1/NF-kappa B-inducing kinase pathways exhibited cross-talk at the level of MKK3. These findings delineate some novel signaling pathways for SF- mediated resistance to ADR.	[Fan, Saijun; Meng, Qinghui; Rosen, Eliot M.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA; [Laterra, John J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Georgetown University; Johns Hopkins University	Rosen, EM (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, 3970 Reservoir Rd,NW,Box 571469, Washington, DC 20057 USA.	emr36@georgetown.edu	Meng, Q./GSI-6185-2022		National Institutes of Health [RO1-ES09169, RO1-NS43987]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032148, R01NS043987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-ES09169 (to E.M.R.) and RO1-NS43987	Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; ALLEY MC, 1988, CANCER RES, V48, P589; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Bardelli A, 1996, EMBO J, V15, P6205, DOI 10.1002/j.1460-2075.1996.tb01009.x; Bottero V, 2001, CANCER RES, V61, P7785; Bowers DC, 2000, CANCER RES, V60, P4277; Chini CCS, 2000, EUR J IMMUNOL, V30, P2791, DOI 10.1002/1521-4141(200010)30:10<2791::AID-IMMU2791>3.0.CO;2-D; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Ding JB, 1996, J BIOL CHEM, V271, P24869, DOI 10.1074/jbc.271.40.24869; Fan S, 2007, ONCOGENE, V26, P4774, DOI 10.1038/sj.onc.1210271; Fan SJ, 2000, ONCOGENE, V19, P2212, DOI 10.1038/sj.onc.1203566; Fan SJ, 2005, ONCOGENE, V24, P1749, DOI 10.1038/sj.onc.1208327; Fan SJ, 2001, MOL CELL BIOL, V21, P4968, DOI 10.1128/MCB.21.15.4968-4984.2001; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Funakoshi-Tago M, 2005, J BIOCHEM, V137, P189, DOI 10.1093/jb/mvi018; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; Han QW, 2002, J BIOL CHEM, V277, P48379, DOI 10.1074/jbc.M209542200; Higashio K, 1993, EXS, V65, P351; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Hurle RA, 2005, HISTOL HISTOPATHOL, V20, P1339, DOI 10.14670/HH-20.1339; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Kaminska B, 2005, ACTA BIOCHIM POL, V52, P329; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kang JY, 2003, CANCER RES, V63, P1101; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Levin Victor A, 2004, Cancer Treat Res, V119, P89; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liu AX, 1998, CANCER RES, V58, P2973; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mikami F, 2005, J BIOL CHEM, V280, P36185, DOI 10.1074/jbc.M503941200; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ozes ON, 1999, NATURE, V401, P82; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Popsueva A, 2003, J CELL BIOL, V161, P119, DOI 10.1083/jcb.200212174; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; REDDY S, 1990, J VIROL, V64, P3545, DOI 10.1128/JVI.64.7.3545-3550.1990; Rosen EM, 1997, CIBA F SYMP, V212, P215; ROSEN EM, 1994, J CELL BIOL, V127, P1783, DOI 10.1083/jcb.127.6.1783; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Siegfried JM, 1997, CANCER RES, V57, P433; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tsukinoki K, 2004, ONCOL REP, V12, P1017; WENG ZG, 1995, MOL CELL BIOL, V15, P5627; Wojcik EJ, 2006, ONCOGENE, V25, P2773, DOI 10.1038/sj.onc.1209306; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; YAMASHITA J, 1994, CANCER RES, V54, P1630; Yamauchi J, 2001, J BIOL CHEM, V276, P23362, DOI 10.1074/jbc.M011752200; Yang XH, 2004, J BIOL CHEM, V279, P38099, DOI 10.1074/jbc.C400318200; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zeng QH, 2002, J BIOL CHEM, V277, P50137, DOI 10.1074/jbc.M208952200; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949	62	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7561	7577		10.1074/jbc.M807497200	http://dx.doi.org/10.1074/jbc.M807497200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	19047046	Green Published, hybrid			2022-12-27	WOS:000264195600019
J	Zhang, JH; Ge, RS; Matte-Martone, C; Goodwin, J; Shlomchik, WD; Mamula, MJ; Kooshkabadi, A; Hardy, MP; Geller, D				Zhang, Junhui; Ge, Renshang; Matte-Martone, Catherine; Goodwin, Julie; Shlomchik, Warren D.; Mamula, Mark J.; Kooshkabadi, Ali; Hardy, Matthew P.; Geller, David			Characterization of a Novel Gain of Function Glucocorticoid Receptor Knock-in Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT LEYDIG-CELLS; FOLLICLE-STIMULATING-HORMONE; ADRENAL AXIS REGULATION; LUTEINIZING-HORMONE; BINDING DOMAIN; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; MINERALOCORTICOID RECEPTORS; CUSHINGS-SYNDROME; GENE; SENSITIVITY	Glucocorticoids (GCs) exert profound influences on many physiologic functions by virtue of their diverse roles in growth, development, and maintenance of homeostasis. We previously created a novel gain of function in the human glucocorticoid receptor (hGR), hGR(M604L), which is active at GC concentrations 5-10-fold lower than wild-type GR. To gain a greater insight into GC physiology in vivo, we inserted this mutant GR (GR(M610L) in mice) into mice via homologous recombination. Mice expressing the allele are phenotypically normal with respect to GC function. However, corticosterone levels, ACTH levels, and adrenocortical size are markedly reduced, suggesting they are phenotypically normal because the mutant GR alters the basal regulation of the hypothalamic-pituitary-adrenal axis. We demonstrate via physiologic and immunologic studies that GR(M610L) mice have increased sensitivity to GCs in vivo. Sensitivity to the actions of endogenous GCs may be an important factor underlying the development of many human diseases including hypertension, obesity, and diabetes. Our model may provide a new and powerful tool for the study of GC physiological and pathological processes in vivo.	[Matte-Martone, Catherine; Shlomchik, Warren D.; Mamula, Mark J.; Kooshkabadi, Ali; Geller, David] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Zhang, Junhui] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Goodwin, Julie] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Ge, Renshang; Hardy, Matthew P.] Rockefeller Univ, New York, NY 10065 USA; [Ge, Renshang; Hardy, Matthew P.] Populat Council, New York, NY 10065 USA	Yale University; Yale University; Yale University; Rockefeller University; Population Council	Geller, D (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA.		Goodwin, Julie/AAF-5754-2020		National Institutes of Health [R03-DK064907]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK064907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R03-DK064907 (to D.S.G.) from the NIDDK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; AGULAR BM, 1995, J STEROID BIOCHEM, V54, P75, DOI 10.1016/0960-0760(95)00058-8; AGULAR BM, 1992, J STEROID BIOCHEM, V43, P565, DOI 10.1016/0960-0760(92)90245-E; AXELROD L, 1976, MEDICINE, V55, P39, DOI 10.1097/00005792-197601000-00003; BAIN PA, 1991, P NATL ACAD SCI USA, V88, P8870, DOI 10.1073/pnas.88.20.8870; BALDWIN BA, 1979, J NEUROSCI METH, V1, P243, DOI 10.1016/0165-0270(79)90035-9; BAMBINO TH, 1981, ENDOCRINOLOGY, V108, P2142, DOI 10.1210/endo-108-6-2142; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Buemann B, 2005, OBES RES, V13, P862, DOI 10.1038/oby.2005.99; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Charmandari E, 2005, J CLIN ENDOCR METAB, V90, P3696, DOI 10.1210/jc.2004-1920; COCHRAN RC, 1981, INVEST UROL, V19, P142; de Kloet ER, 2000, KIDNEY INT, V57, P1329, DOI 10.1046/j.1523-1755.2000.00971.x; Deschepper CF, 2004, J APPL PHYSIOL, V97, P369, DOI 10.1152/japplphysiol.00073.2004; Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788; Feng JO, 2000, AM J MED GENET, V96, P412, DOI 10.1002/1096-8628(20000612)96:3<412::AID-AJMG33>3.0.CO;2-C; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Ge RS, 1997, ENDOCRINOLOGY, V138, P5089, DOI 10.1210/en.138.12.5089; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; Giordano R, 2005, J CLIN ENDOCR METAB, V90, P5656, DOI 10.1210/jc.2005-0105; Gomez F, 1998, AM J PHYSIOL-REG I, V274, pR420, DOI 10.1152/ajpregu.1998.274.2.R420; HALES DB, 1989, ENDOCRINOLOGY, V124, P2099, DOI 10.1210/endo-124-5-2099; Howell MP, 2006, FRONT NEUROENDOCRIN, V27, P275, DOI 10.1016/j.yfrne.2006.05.001; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144; IIDA S, 1990, J CLIN ENDOCR METAB, V70, P729, DOI 10.1210/jcem-70-3-729; Irving JAE, 2005, CANCER RES, V65, P9712, DOI 10.1158/0008-5472.CAN-05-1227; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Juruena MF, 2006, PSYCHOPHARMACOLOGY, V189, P225, DOI 10.1007/s00213-006-0555-4; KARL M, 1993, J CLIN ENDOCR METAB, V76, P683, DOI 10.1210/jc.76.3.683; Kelly JJ, 1998, CLIN EXP PHARMACOL P, V25, pS51, DOI 10.1111/j.1440-1681.1998.tb02301.x; LAKSHMI V, 1985, J STEROID BIOCHEM, V22, P331, DOI 10.1016/0022-4731(85)90435-2; Lamberts SWJ, 1996, STEROIDS, V61, P157, DOI 10.1016/0039-128X(96)00005-0; LAMBERTS SWJ, 1986, J CLIN ENDOCR METAB, V63, P1328, DOI 10.1210/jcem-63-6-1328; MANTERO F, 1992, J STEROID BIOCHEM, V43, P409, DOI 10.1016/0960-0760(92)90077-V; Matte CC, 2004, NAT MED, V10, P987, DOI 10.1038/nm1089; MONDER C, 1992, SERONO SYM, V86, P145; MONDER C, 1994, ENDOCRINOLOGY, V134, P1193, DOI 10.1210/en.134.3.1193; Nagano M, 2002, CANCER LETT, V181, P109, DOI 10.1016/S0304-3835(02)00042-3; ORR TE, 1994, J ANDROL, V15, P302; Paust HJ, 2006, EXP CLIN ENDOCR DIAB, V114, P6, DOI 10.1055/s-2005-873007; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SUTER DE, 1985, ENDOCRINOLOGY, V117, P855, DOI 10.1210/endo-117-3-855; SVEC F, 1985, LIFE SCI, V36, P2359, DOI 10.1016/0024-3205(85)90339-X; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; TROSTEL KA, 1992, AM J PHYSIOL, V263, pR1265, DOI 10.1152/ajpregu.1992.263.6.R1265; van Winsen LLM, 2005, J NEUROIMMUNOL, V167, P150, DOI 10.1016/j.jneuroim.2005.06.010; VINGERHOEDS ACM, 1976, J CLIN ENDOCR METAB, V43, P1128, DOI 10.1210/jcem-43-5-1128; Walker BR, 1996, HYPERTENSION, V27, P190, DOI 10.1161/01.HYP.27.2.190; WARRIAR N, 1994, J BIOL CHEM, V269, P29010; YU CY, 1995, BIOCHEMISTRY-US, V34, P14163, DOI 10.1021/bi00043a022; Zhang JH, 2005, P NATL ACAD SCI USA, V102, P2707, DOI 10.1073/pnas.0409663102; Zhang JH, 2006, J MOL ENDOCRINOL, V37, P163, DOI 10.1677/jme.1.02089	56	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2009	284	10					6249	6259		10.1074/jbc.M807997200	http://dx.doi.org/10.1074/jbc.M807997200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	412RU	19017639	Green Published, hybrid			2022-12-27	WOS:000263742700028
J	Yi, YH; Ho, PY; Chen, TW; Lin, WJ; Gukassyan, V; Tsai, TH; Wang, DW; Lew, TS; Tang, CY; Lo, SJ; Chen, TY; Kao, FJ; Lin, CH				Yi, Yung-Hsiang; Ho, Pei-Yun; Chen, Tung-Wei; Lin, Wen-Jie; Gukassyan, Vladimir; Tsai, Tsung-Heng; Wang, Da-Wei; Lew, Tien-Shen; Tang, Chih-Yung; Lo, Szecheng J.; Chen, Tsung-Yu; Kao, Fu-Jen; Lin, Chi-Hung			Membrane Targeting and Coupling of NHE1-Integrin alpha(IIb)beta(3)-NCX1 by Lipid Rafts following Integrin-Ligand Interactions Trigger Ca2+ Oscillations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER; HUMAN-PLATELETS; NA+/CA2+ EXCHANGER; PLASMA-MEMBRANE; CALCIUM; SODIUM; CELLS; ACTIVATION; FIBRINOGEN; TRANSPORT	The cyclic calcium release and uptake during calcium oscillation are thought to result from calcium-induced calcium release (CICR); however, it is unclear, especially in nonexcitable cells, how the initial calcium mobilization that triggers CICR occurs. We report here a novel mechanism, other than conventional calcium channels or the phopholipase C-inositol trisphosphate system, for initiating calcium oscillation downstream of integrin signaling. Upon integrin alpha(IIb)beta(3) binding to fibrinogen ligand or the disintegrin rhodostomin, sodium-proton exchanger NHE1 and sodium-calcium exchanger NCX1 are actively transported to the plasma membrane, and they become physically coupled to integrin alpha(IIb)beta(3). Lipid raft-dependent mechanisms modulate the membrane targeting and formation of the NHE1-integrin alpha(IIb)beta(3)-NCX1 protein complex. NHE1 and NCX1 within such protein complex are functionally coupled, such that a local increase of sodium concentration caused by NHE1 can drive NCX1 to generate sodium efflux in exchange for calcium influx. The resulting calcium increase inside the cell can then trigger CICR as a prelude to calcium oscillation downstream of integrin alpha(IIb)beta(3) signaling. Fluorescence resonance energy transfer based on fluorescence lifetime measurements is employed here to monitor the intermolecular interactions among NHE1-integrin alpha(IIb)beta(3)-NCX1, which could not be properly detected using conventional biochemical assays.	[Ho, Pei-Yun; Chen, Tung-Wei; Gukassyan, Vladimir; Kao, Fu-Jen] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Tsai, Tsung-Heng; Wang, Da-Wei] Acad Sinica, Inst Informat Sci, Taipei 11529, Taiwan; [Lew, Tien-Shen] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei 112, Taiwan; [Tang, Chih-Yung] Natl Taiwan Univ, Dept Physiol, Taipei 100, Taiwan; [Lo, Szecheng J.] Chang Gung Univ, Dept Life Sci, Taipei 333, Taiwan; [Chen, Tsung-Yu] Univ Calif Davis, Ctr Neurosci, Davis, CA 95618 USA; [Chen, Tsung-Yu] Univ Calif Davis, Dept Neurol, Davis, CA 95618 USA; [Lin, Chi-Hung] Taipei Vet Gen Hosp, Dept Surg, Taipei 112, Taiwan; [Lin, Chi-Hung] Taipei City Hosp, Dept Med Educ & Res, Taipei 10341, Taiwan; [Lin, Chi-Hung] Natl Nano Device Lab, Hsinchu 30078, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; Chang Gung University; University of California System; University of California Davis; University of California System; University of California Davis; Taipei Veterans General Hospital; Taipei City Hospital	Lin, CH (corresponding author), 155,Sec 2,Linong St, Taipei 112, Taiwan.	linch@ym.edu.tw	Kao, Fu-Jen/GYQ-6902-2022; Kao, Fu-Jen/C-8269-2012	TANG, CHIH-YUNG/0000-0003-1065-2865; Tsai, Tsung-Heng/0000-0001-5211-2985; Kao, Fu-Jen/0000-0001-8361-3942	Ministry of Education; Aim for the Top University Plan; National Science Council, Taiwan [NSC 91-2320-B-010-051, NSC (94-96)-2627-B-010-005, NSC 97-3112-B-010-017, NSC 95-2321-B-010-005]	Ministry of Education; Aim for the Top University Plan(Ministry of Education, Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Microscopy for this study was supported by the Biophotonics Interdisciplinary Research Center and the Genome Research Center of National Yang-Ming University. This work was supported by Ministry of Education, Aim for the Top University Plan and National Science Council, Taiwan Grants NSC 91-2320-B-010-051, NSC (94-96)-2627-B-010-005, NSC 97-3112-B-010-017, and NSC 95-2321-B-010-005. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALTIERI DC, 1990, J BIOL CHEM, V265, P12119; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bodin S, 2003, BBA-BIOMEMBRANES, V1610, P247, DOI 10.1016/S0005-2736(03)00022-1; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; BORLE AB, 1991, AM J PHYSIOL, V261, pC482, DOI 10.1152/ajpcell.1991.261.3.C482; Bossuyt J, 2002, FEBS LETT, V511, P113, DOI 10.1016/S0014-5793(01)03323-3; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chang HH, 1999, EXP CELL RES, V250, P387, DOI 10.1006/excr.1999.4547; Cingolani HE, 2001, NEWS PHYSIOL SCI, V16, P88; CROMPTON M, 1978, EUR J BIOCHEM, V82, P25, DOI 10.1111/j.1432-1033.1978.tb11993.x; Demaurex N, 1996, J CELL BIOL, V133, P1391, DOI 10.1083/jcb.133.6.1391; Dorahy DJ, 1996, BIOCHEM J, V319, P67, DOI 10.1042/bj3190067; Dreval V, 2005, CELL PHYSIOL BIOCHEM, V16, P119, DOI 10.1159/000087738; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Ghukasyan V, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718582; GILLESPIE JI, 1992, EXP PHYSIOL, V77, P141, DOI 10.1113/expphysiol.1992.sp003568; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Hsieh CF, 2006, J BIOL CHEM, V281, P25466, DOI 10.1074/jbc.M601793200; Huang J, 2008, AM J PHYSIOL-CELL PH, V294, pC516, DOI 10.1152/ajpcell.00417.2007; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwamoto T, 2006, KIDNEY INT, V69, P2148, DOI 10.1038/sj.ki.5000421; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jackson SP, 2003, J THROMB HAEMOST, V1, P1602, DOI 10.1046/j.1538-7836.2003.00267.x; Jen CJ, 1996, BLOOD, V87, P3775, DOI 10.1182/blood.V87.9.3775.bloodjournal8793775; KIEFFER N, 1990, ANNU REV CELL BIOL, V6, P329; Lian WN, 1999, HEPATOLOGY, V30, P748, DOI 10.1002/hep.510300302; Lian WN, 2006, J CELL SCI, V119, P11, DOI 10.1242/jcs.02706; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; LIU PS, 1990, CELL CALCIUM, V11, P573, DOI 10.1016/0143-4160(90)90011-I; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; Orlov SN, 1999, AM J PHYSIOL-CELL PH, V276, pC511, DOI 10.1152/ajpcell.1999.276.3.C511; Petrie RJ, 2000, J IMMUNOL, V165, P1220, DOI 10.4049/jimmunol.165.3.1220; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Roberts DE, 2004, J BIOL CHEM, V279, P19421, DOI 10.1074/jbc.M308864200; Rosskopf D, 1999, J THROMB THROMBOLYS, V8, P15, DOI 10.1023/A:1008986329267; Shiraga M, 1998, BLOOD, V92, P3710, DOI 10.1182/blood.V92.10.3710.422k13_3710_3720; SIFFERT W, 1987, NATURE, V325, P456, DOI 10.1038/325456a0; SIFFERT W, 1988, TRENDS BIOCHEM SCI, V13, P148, DOI 10.1016/0968-0004(88)90074-6; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Thomas MJ, 2003, J MOL CELL CARDIOL, V35, P1325, DOI 10.1016/j.yjmcc.2003.08.005; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Viatchenko-Karpinski S, 2005, J PHYSIOL-LONDON, V567, P493, DOI 10.1113/jphysiol.2005.091280; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang Y, 2007, METHOD ENZYMOL, V426, P177, DOI 10.1016/S0076-6879(07)26009-4; Xie X, 2004, NEUROCHEM RES, V29, P2135, DOI 10.1007/s11064-004-6887-8; YLANNE J, 1993, J CELL BIOL, V122, P223, DOI 10.1083/jcb.122.1.223	51	23	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3855	3864		10.1074/jbc.M804334200	http://dx.doi.org/10.1074/jbc.M804334200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	18996841	hybrid			2022-12-27	WOS:000262872500054
J	Thiriet, C; Hayes, JJ				Thiriet, Christophe; Hayes, Jeffrey J.			Linker Histone Phosphorylation Regulates Global Timing of Replication Origin Firing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACT; IN-VIVO; PHYSARUM-POLYCEPHALUM; GENE-EXPRESSION; CHROMATIN-STRUCTURE; H1 PHOSPHORYLATION; MOUSE DEVELOPMENT; DNA-REPLICATION; CELL-CYCLE; SITES	Despite the presence of linker histone in all eukaryotes, the primary function(s) of this histone have been difficult to clarify. Knock-out experiments indicate that H1s play a role in regulation of only a small subset of genes but are an essential component in mouse development. Here, we show that linker histone (H1) is involved in the global regulation of DNA replication in Physarum polycephalum. We find that genomic DNA of H1 knock-down cells is more rapidly replicated, an effect due at least in part to disruption of the native timing of replication fork firing. Immunoprecipitation experiments demonstrate that H1 is transiently lost from replicating chromatin via a process facilitated by phosphorylation. Our results suggest that linker histones generate a chromatin environment refractory to replication and that their transient removal via protein phosphorylation during S phase is a critical step in the epigenetic regulation of replication timing.	[Hayes, Jeffrey J.] Univ Nantes, CNRS, UMR 1 6204 U3B, F-44322 Nantes, France; [Hayes, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	Centre National de la Recherche Scientifique (CNRS); Nantes Universite; University of Rochester	Thiriet, C (corresponding author), Univ Nantes, CNRS, UMR 1 6204 U3B, F-44322 Nantes, France.	christophe.thiriet@univ-nantes.fr; Jeffrey_Hayes@urmc.rochester.edu			National Institutes of Health [GM052426]; Action The matique et Incitative sur Programme from Centre National de la Recherche Scientifique; Foridation pour la Recherche Medicale; National Science Foundation [MCB0317935]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Action The matique et Incitative sur Programme from Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Foridation pour la Recherche Medicale; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM052426 (to J.J.H.). This work was also supported by an Action The matique et Incitative sur Programme from Centre National de la Recherche Scientifique and a Foridation pour la Recherche Medicale grant (to C. T.) and National Science Foundation Grant MCB0317935. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Dou YL, 2002, P NATL ACAD SCI USA, V99, P6142, DOI 10.1073/pnas.092029599; Downs JA, 2007, ONCOGENE, V26, P7765, DOI 10.1038/sj.onc.1210874; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; FISCHER SG, 1980, BIOCHEMISTRY-US, V19, P2240, DOI 10.1021/bi00551a038; Folco HD, 2003, EUKARYOT CELL, V2, P341, DOI 10.1128/EC.2.2.341-350.2003; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Hellauer K, 2001, J BIOL CHEM, V276, P13587, DOI 10.1074/jbc.M011196200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lu ZH, 1998, MOL BIOL CELL, V9, P1163, DOI 10.1091/mbc.9.5.1163; Lu ZH, 1997, J CELL SCI, V110, P2745; Maric C, 2003, EMBO REP, V4, P474, DOI 10.1038/sj.embor.embor822; MUELLER RD, 1985, J BIOL CHEM, V260, P5081; PIERRON G, 1989, NUCLEIC ACIDS RES, V17, P553, DOI 10.1093/nar/17.2.553; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; SMITH RC, 1988, GENE DEV, V2, P1284, DOI 10.1101/gad.2.10.1284; Steinbach OC, 1997, NATURE, V389, P395, DOI 10.1038/38755; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Thiriet C, 2004, METHODS, V33, P86, DOI 10.1016/j.ymeth.2003.10.023; Thiriet C, 1997, J BIOL CHEM, V272, P18740, DOI 10.1074/jbc.272.30.18740; Thiriet C, 2001, J CELL SCI, V114, P965; Thiriet C, 2001, GENE DEV, V15, P2048, DOI 10.1101/gad.910201; van Holde KE., 1989, SPRINGER SERIES MOL; VASSILEV L, 1988, NUCLEIC ACIDS RES, V16, P10397, DOI 10.1093/nar/16.21.10397; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311	35	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2823	2829		10.1074/jbc.M805617200	http://dx.doi.org/10.1074/jbc.M805617200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19015270	hybrid, Green Published			2022-12-27	WOS:000262700900025
J	Metral, S; Machnicka, B; Bigot, S; Colin, Y; Dhermy, D; Lecomte, MC				Metral, Sylvain; Machnicka, Beata; Bigot, Sylvain; Colin, Yves; Dhermy, Didier; Lecomte, Marie-Christine			alpha II-Spectrin Is Critical for Cell Adhesion and Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; BETA-SPECTRIN; ANKYRIN-G; EXTRACELLULAR-MATRIX; ACTIN POLYMERIZATION; ENA/VASP PROTEINS; LATERAL MEMBRANE; ELF; INACTIVATION; CYTOSKELETON	Spectrins are ubiquitous scaffolding components of the membrane skeleton that organize and stabilize microdomains on both the plasma membrane and the intracellular organelles. By way of their numerous interactions with diverse protein families, they are implicated in various cellular functions. Using small interfering RNA strategy in the WM-266 cell line derived from human melanoma, we found that alpha II-spectrin deficiency is associated with a defect in cell proliferation, which is related to a cell cycle arrest at the G(1) phase (first gap phase), as evaluated by DNA analysis and Rb phosphorylation. These observations coincided with elevated expression of the cyclin-dependent kinase inhibitor, p21(Cip). Concomitantly, spectrin loss impaired cell adhesion and spreading. These cell adhesion defects were associated with modifications of the actin cytoskeleton, such as loss of stress fibers, alterations of focal adhesions, and modified expression of some integrins. Our results provide novel insights into spectrin functions by demonstrating the involvement of alpha II-spectrin in cell cycle regulation and actin organization.	[Lecomte, Marie-Christine] Inst Natl Transfus Sanguine, INSERM, U665, F-75015 Paris, France; [Metral, Sylvain; Machnicka, Beata; Bigot, Sylvain; Colin, Yves; Dhermy, Didier; Lecomte, Marie-Christine] Univ Paris 07, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lecomte, MC (corresponding author), Inst Natl Transfus Sanguine, INSERM, U665, 6 Rue Alexandre Cabanel, F-75015 Paris, France.	marie-christine.lecomte@inserm.fr	colin, yves/O-1910-2017; Machnicka, Beata/AAF-1814-2019; METRAL, Sylvain/P-5833-2017; Machnicka, Beata/AAF-1677-2019	colin, yves/0000-0001-5196-4254; Machnicka, Beata/0000-0002-9664-8252; METRAL, Sylvain/0000-0001-6244-8546; 				Baek HJ, 2006, BIOCHEM BIOPH RES CO, V346, P1150, DOI 10.1016/j.bbrc.2006.05.195; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Bialkowska K, 2005, J CELL SCI, V118, P381, DOI 10.1242/jcs.01625; Bottazzi ME, 1997, TRENDS CELL BIOL, V7, P348, DOI 10.1016/S0962-8924(97)01114-8; Bournier O, 2006, BIOL CELL, V98, P279, DOI 10.1042/BC20050024; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; Drusco A, 2005, P NATL ACAD SCI USA, V102, P10947, DOI 10.1073/pnas.0504934102; Dubreuil RR, 2000, J CELL BIOL, V149, P647, DOI 10.1083/jcb.149.3.647; Gallagher Patrick G, 2004, Curr Hematol Rep, V3, P85; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052; Grimber Gisele, 1992, Transgenic Research, V1, P268, DOI 10.1007/BF02525168; HU RJ, 1995, J CELL BIOL, V128, P1069, DOI 10.1083/jcb.128.6.1069; Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Kim SS, 2006, BIOCHEM BIOPH RES CO, V344, P1216, DOI 10.1016/j.bbrc.2006.03.236; Kitisin K, 2007, ONCOGENE, V26, P7103, DOI 10.1038/sj.onc.1210513; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LECOMTE MC, 1993, BRIT J HAEMATOL, V85, P584; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Li W, 2006, PATHOLOGY, V38, P287, DOI 10.1080/00313020600817951; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Nicolas G, 2002, MOL CELL BIOL, V22, P3527, DOI 10.1128/MCB.22.10.3527-3536.2002; Norman KR, 2002, J CELL BIOL, V157, P665, DOI 10.1083/jcb.200111051; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Pinder JC, 2000, NATURE, V406, P253, DOI 10.1038/35018679; Praitis V, 2005, DEV BIOL, V283, P157, DOI 10.1016/j.ydbio.2005.04.002; Pugacheva EN, 2006, CURR OPIN CELL BIOL, V18, P507, DOI 10.1016/j.ceb.2006.08.014; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Rotter B, 2005, BIOCHEM J, V388, P631, DOI 10.1042/BJ20041502; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Walker JL, 2005, CYTOKINE GROWTH F R, V16, P395, DOI 10.1016/j.cytogfr.2005.03.003; Wandersee NJ, 2003, BLOOD, V101, P325, DOI 10.1182/blood-2002-01-0113; Wong GK, 1996, DEV BIOL, V180, P199, DOI 10.1006/dbio.1996.0295; Zuhlke C, 2007, J NEUROL, V254, P1649, DOI 10.1007/s00415-007-0600-1	43	50	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2409	2418		10.1074/jbc.M801324200	http://dx.doi.org/10.1074/jbc.M801324200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	18978357	Green Submitted, hybrid			2022-12-27	WOS:000262545600049
J	Tateishi, Y; Ariyoshi, M; Igarashi, R; Hara, H; Mizuguchi, K; Seto, A; Nakai, A; Kokubo, T; Tochio, H; Shirakawa, M				Tateishi, Yukihiro; Ariyoshi, Mariko; Igarashi, Ryuji; Hara, Hideyuki; Mizuguchi, Kenji; Seto, Azusa; Nakai, Akira; Kokubo, Tetsuro; Tochio, Hidehito; Shirakawa, Masahiro			Molecular Basis for SUMOylation-dependent Regulation of DNA Binding Activity of Heat Shock Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUANTUM COHERENCE ESR; SUMO MODIFICATION; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; E3 LIGASE; UBIQUITIN; PROTEIN; NUCLEAR; HSF2; STRESS	Heat shock factor 2 (HSF2) is a member of a vertebrate transcription factor family for genes of heat shock proteins and is involved in the regulation of development and cellular differentiation. The DNA binding property of HSF2 is modulated by the post-translational modification of a specific lysine residue in its DNA binding domain by small ubiquitin-like modifier (SUMO), but the consequences of SUMOylation and its underlying molecular mechanism remain unclear. Here we show the inhibitory effect of SUMOylation on the interaction between HSF2 and DNA based on biochemical analysis using isolated recombinant HSF2. NMR study of the SUMOylated DNA binding domain of HSF2 indicates that the SUMO moiety is flexible with respect to the DNA binding domain and has neither a noncovalent interface with nor a structural effect on the domain. Combined with data from double electron-electron resonance and paramagnetic NMR relaxation enhancement experiments, these results suggest that SUMO attachment negatively modulates the formation of the protein-DNA complex through a randomly distributed steric interference.	[Tateishi, Yukihiro; Ariyoshi, Mariko; Igarashi, Ryuji; Seto, Azusa; Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Tateishi, Yukihiro; Kokubo, Tetsuro] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan; [Hara, Hideyuki] Bruker Bioispin KK, ESR Applicat, Ibaraki 3050051, Japan; [Mizuguchi, Kenji] Natl Inst Biomed Innovat, Ibaraki, Osaka 5670085, Japan; [Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Biochem & Mol Biol, Ube, Yamaguchi 7668505, Japan	Kyoto University; Yokohama City University; National Institute of Health Sciences - Japan; Yamaguchi University	Ariyoshi, M (corresponding author), Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	ma4@eng.mbox.kyoto-u.ac.jp; shirakawa@moleng.kyoto-u.a.cjp	Tochio, Hidehito/GWV-0429-2022; Igarashi, Ryuji/GON-5988-2022; Mizuguchi, Kenji/GVS-5857-2022; Tochio, Hidehito/F-6109-2011	Tochio, Hidehito/0000-0003-3843-3330; Mizuguchi, Kenji/0000-0003-3021-7078; Ariyoshi, Mariko/0000-0002-1361-2642; Igarashi, Ryuji/0000-0003-4415-9702	Ministry of Education, Culture, Sports, Science and Technology of Japan; Global COE Program	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants (to M. S. and H. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and in part by the Global COE Program "International Center for Integrated Research and Advanced Education in Materials Science" the Ministry of Education, Culture, Sports, Science and Technology of Japan, administrated by the Japan Society for the Promotion of Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Alastalo TP, 2003, J CELL SCI, V116, P3557, DOI 10.1242/jcs.00671; Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; BLOEMBERGEN N, 1961, J CHEM PHYS, V34, P842, DOI 10.1063/1.1731684; BONNER JJ, 1994, MOL CELL BIOL, V14, P501, DOI 10.1128/MCB.14.1.501; Borbat PP, 2002, J AM CHEM SOC, V124, P5304, DOI 10.1021/ja020040y; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chou CC, 2007, J BIOL CHEM, V282, P27239, DOI 10.1074/jbc.M700351200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Goddard T.D, 2002, SPARKY3; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Hara H, 2007, J MAGN RESON, V184, P78, DOI 10.1016/j.jmr.2006.09.017; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hilgarth RS, 2004, CELL STRESS CHAPERON, V9, P214, DOI 10.1379/CSC-8R.1; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; Loones MT, 1997, CELL MOL LIFE SCI, V53, P179, DOI 10.1007/PL00000590; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Morimoto RI, 2002, CELL, V110, P281, DOI 10.1016/S0092-8674(02)00860-7; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Stankovic-Valentin N, 2007, MOL CELL BIOL, V27, P2661, DOI 10.1128/MCB.01098-06; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; VUISTER GW, 1994, J AM CHEM SOC, V116, P9206, DOI 10.1021/ja00099a041; VUISTER GW, 1994, NAT STRUCT BIOL, V1, P605, DOI 10.1038/nsb0994-605; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Zhang J, 2008, J BIOL CHEM, V283, P7464, DOI 10.1074/jbc.M707122200	55	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2435	2447		10.1074/jbc.M806392200	http://dx.doi.org/10.1074/jbc.M806392200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017645	hybrid			2022-12-27	WOS:000262545600051
J	Cheng, HP; Vetrivel, KS; Drisdel, RC; Meckler, X; Gong, P; Leem, JY; Li, T; Carter, M; Chen, Y; Nguyen, P; Iwatsubo, T; Tomita, T; Wong, PC; Green, WN; Kounnas, MZ; Thinakaran, G				Cheng, Haipeng; Vetrivel, Kulandaivelu S.; Drisdel, Renaldo C.; Meckler, Xavier; Gong, Ping; Leem, Jae Yoon; Li, Tong; Carter, Meghan; Chen, Ying; Nguyen, Phuong; Iwatsubo, Takeshi; Tomita, Taisuke; Wong, Philip C.; Green, William N.; Kounnas, Maria Z.; Thinakaran, Gopal			S-Palmitoylation of gamma-Secretase Subunits Nicastrin and APH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; LIPID RAFTS; A-BETA; PROTEIN PALMITOYLATION; PRESENILIN; COMPLEX; APP; ASSOCIATION; ACCUMULATION; DEGRADATION	Proteolytic processing of amyloid precursor protein (APP) by beta- and gamma-secretases generates beta-amyloid (A beta) peptides, which accumulate in the brains of individuals affected by Alzheimer disease. Detergent-resistant membrane microdomains (DRM) rich in cholesterol and sphingolipid, termed lipid rafts, have been implicated in A beta production. Previously, we and others reported that the four integral subunits of the gamma-secretase associate with DRM. In this study we investigated the mechanisms underlying DRM association of gamma-secretase subunits. We report that in cultured cells and in brain the gamma-secretase subunits nicastrin and APH-1 undergo S-palmitoylation, the post-translational covalent attachment of the long chain fatty acid palmitate common in lipid raft-associated proteins. By mutagenesis we show that nicastrin is S-palmitoylated at Cys(689), and APH-1 is S-palmitoylated at Cys(182) and Cys(245). S-Palmitoylation-defective nicastrin and APH-1 form stable gamma-secretase complexes when expressed in knock-out fibroblasts lacking wild type subunits, suggesting that S-palmitoylation is not essential for gamma-secretase assembly. Nevertheless, fractionation studies show that S-palmitoylation contributes to DRM association of nicastrin and APH-1. Moreover, pulse-chase analyses reveal that S-palmitoylation is important for nascent polypeptide stability of both proteins. Co-expression of S-palmitoylation- deficient nicastrin and APH-1 in cultured cells neither affects A beta 40, A beta 42, and AICD production, nor intramembrane processing of Notch and N-cadherin. Our findings suggest that S-palmitoylation plays a role in stability and raft localization of nicastrin and APH-1, but does not directly modulate gamma-secretase processing of APP and other substrates.	[Cheng, Haipeng; Vetrivel, Kulandaivelu S.; Drisdel, Renaldo C.; Meckler, Xavier; Gong, Ping; Leem, Jae Yoon; Carter, Meghan; Chen, Ying; Green, William N.; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Nguyen, Phuong; Kounnas, Maria Z.] TorreyPines Therapeut Inc, La Jolla, CA 92037 USA; [Iwatsubo, Takeshi; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; [Iwatsubo, Takeshi; Tomita, Taisuke] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Bunkyo Ku, Tokyo 1130033, Japan	University of Chicago; University of Chicago; University of Chicago; Johns Hopkins University; University of Tokyo; Japan Science & Technology Agency (JST)	Thinakaran, G (corresponding author), Univ Chicago, Dept Neurobiol, Knapp R212,924 E 57th St, Chicago, IL 60637 USA.	gopal@uchicago.edu	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943	National Institutes of Health [AG021495, AG019070, NS45150, P01 NS047308]; Alzheimer Association; American Health Assistance Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047308, R01NS045150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019070, R01AG021495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); American Health Assistance Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021495 (to G.T.), AG019070 (to G.T.), NS45150 (to P.C.W.), and P01 NS047308 (to P.C.W.). This work was also supported by grants from the Alzheimer Association (to G.T. and K.S.V.) and American Health Assistance Foundation (to G.T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Breuer P, 1998, J BIOL CHEM, V273, P33254, DOI 10.1074/jbc.273.50.33254; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Cheng HP, 2007, NAT CLIN PRACT NEURO, V3, P374, DOI 10.1038/ncpneuro0549; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; DE SB, 1999, NATURE, V398, P518; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tanimura N, 2006, BIOCHEM BIOPH RES CO, V341, P1177, DOI 10.1016/j.bbrc.2006.01.076; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Tsvetkov P, 2008, PROTEINS, V70, P1357, DOI 10.1002/prot.21614; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Veit M, 2000, MOL CELL NEUROSCI, V15, P408, DOI 10.1006/mcne.1999.0830; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100	57	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1373	1384		10.1074/jbc.M806380200	http://dx.doi.org/10.1074/jbc.M806380200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028695	hybrid, Green Published			2022-12-27	WOS:000262330100005
J	Oestreich, EA; Malik, S; Goonasekera, SA; Blaxall, BC; Kelley, GG; Dirksen, RT; Smrcka, AV				Oestreich, Emily A.; Malik, Sundeep; Goonasekera, Sanjeewa A.; Blaxall, Burns C.; Kelley, Grant G.; Dirksen, Robert T.; Smrcka, Alan V.			Epac and Phospholipase C epsilon Regulate Ca2+ Release in the Heart by Activation of Protein Kinase C epsilon and Calcium-Calmodulin Kinase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC MYOCYTES; VENTRICULAR MYOCYTES; RYANODINE RECEPTOR; SIGNALING PATHWAY; CONTRACTION; EFFECTOR; RAS; HYPERTROPHY; CHANNEL; DELTA	Recently, we identified a novel signaling pathway involving Epac, Rap, and phospholipase C (PLC)epsilon that plays a critical role in maximal beta-adrenergic receptor (beta AR) stimulation of Ca2+-induced Ca2+ release (CICR) in cardiac myocytes. Here we demonstrate that PLC epsilon phosphatidylinositol 4,5-bisphosphate hydrolytic activity and PLC epsilon-stimulated Rap1 GEF activity are both required for PLC epsilon-mediated enhancement of sarcoplasmic reticulum Ca2+ release and that PLC epsilon significantly enhances Rap activation in response to beta AR stimulation in the heart. Downstream of PLC epsilon hydrolytic activity, pharmacological inhibition of PKC significantly inhibited both beta AR- and Epac-stimulated increases in CICR in PLC epsilon(+/+) myocytes but had no effect in PLC epsilon(-/-) myocytes. beta AR and Epac activation caused membrane translocation of PKC epsilon in PLC epsilon(+/+) but not PLC epsilon(-/-) myocytes and small interfering RNA- mediated PKC epsilon knockdown significantly inhibited both beta AR and Epac-mediated CICR enhancement. Further downstream, the Ca2+/calmodulin-dependent protein kinase II (CamKII) inhibitor, KN93, inhibited beta AR- and Epac-mediated CICR in PLC epsilon(+/+) but not PLC epsilon(-/-) myocytes. Epac activation increased CamKII Thr(286) phosphorylation and enhanced phosphorylation at CamKII phosphorylation sites on the ryanodine receptor (RyR2) (Ser(2815)) and phospholamban (Thr(17)) in a PKC-dependent manner. Perforated patch clamp experiments revealed that basal and beta AR-stimulated peak L-type current density are similar in PLC epsilon(+/+) and PLC epsilon(-/-) myocytes suggesting that control of sarcoplasmic reticulum Ca2+ release, rather than Ca2+ influx through L-type Ca2+ channels, is the target of regulation of a novel signal transduction pathway involving sequential activation of Epac, PLC epsilon, PKC epsilon, and CamKII downstream of beta AR activation.	[Oestreich, Emily A.; Malik, Sundeep; Goonasekera, Sanjeewa A.; Blaxall, Burns C.; Dirksen, Robert T.; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Blaxall, Burns C.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Kelley, Grant G.] SUNY Upstate Med Ctr, Dept Pharmacol, Syracuse, NY 14620 USA; [Kelley, Grant G.] SUNY Upstate Med Ctr, Dept Med, Syracuse, NY 14620 USA	University of Rochester; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Smrcka, AV (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14642 USA.	Alan_Smrcka@urmc.rochester.edu	Blaxall, Burns/ABD-8289-2021		National Institutes of Health [GMR01053536, AR044657, DK56294]; American Heart Association Scientist Development [045343T]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044657, R29AR044657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GMR01053536 (to A.V.S.), AR044657 (to R.T.D.), and DK56294 (to G.G.K.). This work was also supported by American Heart Association Scientist Development Grant 045343T (to B.C.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Currie S, 2004, BIOCHEM J, V377, P357, DOI 10.1042/BJ20031043; DISATNIK MH, 1994, EXP CELL RES, V210, P287, DOI 10.1006/excr.1994.1041; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kang MS, 2005, J MOL CELL CARDIOL, V38, P753, DOI 10.1016/j.yjmcc.2005.02.017; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; O-Uchi J, 2005, P NATL ACAD SCI USA, V102, P9400, DOI 10.1073/pnas.0503569102; O-Uchi J, 2008, CIRC RES, V102, P1378, DOI 10.1161/CIRCRESAHA.107.167734; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Pereira L, 2007, J PHYSIOL-LONDON, V583, P685, DOI 10.1113/jphysiol.2007.133066; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; WAXHAM MN, 1993, BIOCHEMISTRY-US, V32, P2923, DOI 10.1021/bi00062a024; Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Woodcock EA, 2005, PHARMACOL THERAPEUT, V107, P240, DOI 10.1016/j.pharmthera.2005.04.002	28	143	147	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1514	1522		10.1074/jbc.M806994200	http://dx.doi.org/10.1074/jbc.M806994200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18957419	Green Published, hybrid			2022-12-27	WOS:000262330100019
J	Tocchini-Valentini, GD; Rochel, N; Escriva, H; Germain, P; Peluso-Iltis, C; Paris, M; Sanglier-Cianferani, S; Van Dorsselaer, A; Moras, D; Laudet, V				Tocchini-Valentini, Giuseppe D.; Rochel, Natacha; Escriva, Hector; Germain, Pierre; Peluso-Iltis, Carole; Paris, Mathilde; Sanglier-Cianferani, Sarah; Van Dorsselaer, Alain; Moras, Dino; Laudet, Vincent			Structural and Functional Insights into the Ligand-binding Domain of a Nonduplicated Retinoid X Nuclear Receptor from the Invertebrate Chordate Amphioxus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNION-OF-PHARMACOLOGY; CRYSTAL-STRUCTURE; MASS-SPECTROMETRY; HETERODIMERIC COMPLEX; ECDYSONE RECEPTOR; ORPHAN RECEPTOR; ACID RECEPTORS; RXR-ALPHA; EVOLUTION; SUPERFAMILY	Retinoid X nuclear receptors (RXRs), as well as their insect orthologue, ultraspiracle protein (USP), play an important role in the transcription regulation mediated by the nuclear receptors as the common partner of many other nuclear receptors. Phylogenetic and structural studies have shown that the several evolutionary shifts have modified the ligand binding ability of RXRs. To understand the vertebrate-specific character of RXRs, we have studied the RXR ligand-binding domain of the cephalochordate amphioxus (Branchiostoma floridae), an invertebrate chordate that predates the genome duplication that produced the three vertebrates RXRs (alpha, beta, and gamma). Here we report the crystal structure of a novel apotetramer conformation of the AmphiRXR ligand-binding domain, which shows some similarity with the structures of the arthropods RXR/USPs. AmphiRXR adopts an apo antagonist conformation with a peculiar conformation of helix H11 filling the binding pocket. In contrast to the arthropods RXR/USPs, which cannot be activated by any RXR ligands, our functional data show that AmphiRXR, like the vertebrates/mollusk RXRs, is able to bind and be activated by RXR ligands but less efficiently than vertebrate RXRs. Our data suggest that amphioxus RXR is, functionally, an intermediate between arthropods RXR/USPs and vertebrate RXRs.	[Tocchini-Valentini, Giuseppe D.; Rochel, Natacha; Peluso-Iltis, Carole; Moras, Dino] Univ Strasbourg 1, Dept Biol & Genom Struct, F-67400 Illkirch Graffenstaden, France; [Germain, Pierre] Univ Strasbourg 1, Dept Canc Biol, Inst Genet & Biol Mol & Celluaire, CNRS,UMR7104,U596,INSERM, F-67400 Illkirch Graffenstaden, France; [Escriva, Hector; Paris, Mathilde; Laudet, Vincent] Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS,INRA,Inst Federatif Biosci Gerland 128, F-69364 Lyon, France; [Sanglier-Cianferani, Sarah; Van Dorsselaer, Alain] Univ Strasbourg, Lab Spectrometrie Masse Bioorgan, CNRS,UMR 7178, Inst Pluridisciplinaire Hubert CURIEN,Ecole Chim, F-67087 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Laudet, V (corresponding author), Ecole Normale Super Lyon 1, Inst Genom Fonct Lyon, Mol Zool Team, Inst Federatif Biosci Gerland 128, F-69364 Lyon, France.	vincent.laudet@ens-lyon.fr	Escriva, Hector/K-8325-2013; Tocchini-Valentini, Giuseppe D./AAL-4889-2021; Rochel, Natacha/A-5718-2016	Escriva, Hector/0000-0001-7577-5028; Tocchini-Valentini, Giuseppe D./0000-0002-4454-9543; Rochel, Natacha/0000-0002-3573-5889; PARIS, Mathilde/0000-0001-6166-6672; Germain, Pierre/0000-0003-2962-9593; Cianferani, Sarah/0000-0003-4013-4129	CNRS; INSERM; Universite Louis Pasteur; European Commission on Structural Proteomics in Europe (SPINE) [QLG2CT-220-0098]; SPINE2-Complexes [LSHG-CT-2006-031220]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Louis Pasteur; European Commission on Structural Proteomics in Europe (SPINE)(European CommissionEuropean Commission Joint Research Centre); SPINE2-Complexes	This study was supported by CNRS, INSERM, Universite Louis Pasteur, European Commission on Structural Proteomics in Europe (SPINE) Grant QLG2CT-220-0098, and SPINE2-Complexes Grant LSHG-CT-2006-031220 under the integrated program, Quality of Life and Management of Living Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bitsch F, 2003, ANAL BIOCHEM, V323, P139, DOI 10.1016/j.ab.2003.08.029; Bonneton F, 2003, MOL BIOL EVOL, V20, P541, DOI 10.1093/molbev/msg054; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Bouton D, 2005, J MOL ENDOCRINOL, V34, P567, DOI 10.1677/jme.1.01766; Bovet C, 2007, PROTEIN SCI, V16, P938, DOI 10.1110/ps.062664107; Brelivet Y, 2004, EMBO REP, V5, P423, DOI 10.1038/sj.embor.7400119; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calleja C, 2006, GENE DEV, V20, P1525, DOI 10.1101/gad.368706; Carmichael JA, 2005, J BIOL CHEM, V280, P22258, DOI 10.1074/jbc.M500661200; de Groot A, 2005, J MOL BIOL, V354, P841, DOI 10.1016/j.jmb.2005.09.090; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Escriva H, 2004, ESSAYS BIOCHEM, V40, P11, DOI 10.1042/bse0400011; Escriva H, 2002, DEVELOPMENT, V129, P2905; Escriva H, 1997, P NATL ACAD SCI USA, V94, P6803, DOI 10.1073/pnas.94.13.6803; Escriva H, 2000, BIOESSAYS, V22, P717; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gustafsson JA, 1999, SCIENCE, V284, P1285, DOI 10.1126/science.284.5418.1285; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Iwema T, 2007, EMBO J, V26, P3770, DOI 10.1038/sj.emboj.7601810; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; Kostrouch Z, 1998, P NATL ACAD SCI USA, V95, P13442, DOI 10.1073/pnas.95.23.13442; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; Laudet V., 2002, NUCL RECEPTOR FACTS; Lengqvist J, 2005, J AM SOC MASS SPECTR, V16, P1631, DOI 10.1016/j.jasms.2005.06.003; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Love JD, 2002, J BIOL CHEM, V277, P11385, DOI 10.1074/jbc.M110869200; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paris M, 2008, CURR BIOL, V18, P825, DOI 10.1016/j.cub.2008.04.078; Peschke M, 2004, J AM SOC MASS SPECTR, V15, P1424, DOI 10.1016/j.jasms.2004.05.005; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Robinson-Rechavi M, 2001, TRENDS GENET, V17, P554, DOI 10.1016/S0168-9525(01)02417-9; Sanglier S, 2004, EUR J BIOCHEM, V271, P4958, DOI 10.1111/j.1432-1033.2004.04466.x; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87	50	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1938	1948		10.1074/jbc.M805692200	http://dx.doi.org/10.1074/jbc.M805692200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18986992	Green Published, hybrid			2022-12-27	WOS:000262330100064
J	van Horssen, R; Janssen, E; Peters, W; Van de Pasch, L; Lindert, MMT; van Dommelen, MMT; Linssen, PC; ten Hagen, TLM; Fransen, JAM; Wieringa, B				van Horssen, Remco; Janssen, Edwin; Peters, Wilma; Van de Pasch, Loes; Lindert, Mariska M. te; van Dommelen, Michiel M. T.; Linssen, Peter C.; ten Hagen, Timo L. M.; Fransen, Jack A. M.; Wieringa, Be			Modulation of Cell Motility by Spatial Repositioning of Enzymatic ATP/ADP Exchange Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE KINASE; NEUTROPHIL CHEMOTAXIS; ATP HYDROLYSIS; RHO-GTPASES; ACTIN; MIGRATION; DYNAMICS; GENE; EXPRESSION; ISOFORM	ATP is the "principal energy currency" in metabolism and the most versatile small molecular regulator of cellular activities. Although already much is known about the role of ATP in fundamental processes of living systems, data about its compartmentalization are rather scarce, and we still have only very limited understanding of whether patterns in the distribution of intracellular ATP concentration ("ATP inhomogeneity") do exist and have a regulatory role. Here we report on the analysis of coupling of local ATP supply to regulation of actomyosin behavior, a widespread and dynamic process with conspicuous high ATP dependence, which is central to cell shape changes and cell motility. As an experimental model, we use embryonic fibroblasts from knock-out mice without major ATP-ADP exchange enzymes, in which we (re) introduce the ATP/ADP exchange enzyme adenylate kinase-1 (AK1) and deliberately manipulate its spatial positioning by coupling to different artificial location tags. By transfection-complementation of AK1 variants and comparison with yellow fluorescent protein controls, we found that motility and spreading were enhanced in cells with AK1 with a focal contact guidance tag. Intermediary enhancement was observed in cells with membrane-targeted or cytosolic AK1. Use of a heterodimer-inducing approach for transient translocation of AK1 to focal contacts under conditions of constant global AK1 activity in the cell corroborated these results. Based on our findings with these model systems, we propose that local ATP supply in the cell periphery and "on site" fuelling of the actomyosin machinery, when maintained via enzymes involved in phosphoryl transfer, are codetermining factors in the control of cell motility.	[van Horssen, Remco; Janssen, Edwin; Peters, Wilma; Van de Pasch, Loes; Lindert, Mariska M. te; van Dommelen, Michiel M. T.; Fransen, Jack A. M.; Wieringa, Be] Radboud Univ Nijmegen, Dept Cell Biol, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Linssen, Peter C.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6500 HB Nijmegen, Netherlands; [ten Hagen, Timo L. M.] Erasmus MC, Dept Surg Oncol, NL-3000 DR Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	Wieringa, B (corresponding author), Radboud Univ Nijmegen, Dept Cell Biol, Nijmegen Ctr Mol Life Sci, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	b.wieringa@ncmls.ru.nl	Wieringa, Berend/A-5346-2011; Fransen, Jack/E-8924-2010	Wieringa, Berend/0000-0001-9192-8020; Fransen, Jack/0000-0002-0571-7639	Dutch Cancer Society [KUN 2002-1763]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by Dutch Cancer Society Grant KUN 2002-1763. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BALABAN RS, 1990, AM J PHYSIOL, V258, pC377, DOI 10.1152/ajpcell.1990.258.3.C377; BEREITERHAHN J, 1990, J CELL SCI, V96, P171; Bernstein BW, 2003, J NEUROSCI, V23, P1; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Collavin L, 1999, ONCOGENE, V18, P5879, DOI 10.1038/sj.onc.1202970; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Cuppen E, 1999, J CELL SCI, V112, P3299; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Ginger ML, 2005, J BIOL CHEM, V280, P11781, DOI 10.1074/jbc.M413821200; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Janssen E, 2000, EMBO J, V19, P6371, DOI 10.1093/emboj/19.23.6371; Janssen E, 2004, MOL CELL BIOCHEM, V256, P59, DOI 10.1023/B:MCBI.0000009859.15267.db; Krooshoop DJEB, 2003, J IMMUNOL METHODS, V280, P89, DOI 10.1016/S0022-1759(03)00262-X; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Michiels F, 2000, METHOD ENZYMOL, V325, P295; NODA LH, 1973, ENZYMES, P297; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Ruan QQ, 2002, BIOPHYS J, V83, P3177, DOI 10.1016/S0006-3495(02)75320-4; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; UEDA T, 1987, EXP CELL RES, V169, P191, DOI 10.1016/0014-4827(87)90237-0; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; Volkmann N, 2000, CURR OPIN CELL BIOL, V12, P26, DOI 10.1016/S0955-0674(99)00053-8; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Willemse M, 2007, NAT BIOTECHNOL, V25, P170, DOI 10.1038/nbt0207-170; Yegutkin GG, 2006, MOL BIOL CELL, V17, P3378, DOI 10.1091/mbc.E05-10-0993	34	51	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1620	1627		10.1074/jbc.M806974200	http://dx.doi.org/10.1074/jbc.M806974200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19008233	hybrid, Green Published			2022-12-27	WOS:000262330100030
J	Oshiumi, H; Matsumoto, M; Hatakeyama, S; Seya, T				Oshiumi, Hiroyuki; Matsumoto, Misako; Hatakeyama, Shigetsugu; Seya, Tsukasa			Riplet/RNF135, a RING Finger Protein, Ubiquitinates RIG-I to Promote Interferon-beta Induction during the Early Phase of Viral Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA HELICASE LGP2; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; NF-KAPPA-B; ANTIVIRAL RESPONSES; ISG15 CONJUGATION; INNATE IMMUNITY; NEGATIVE REGULATION; ADAPTER PROTEIN	RIG-I (retinoic acid-inducible gene-I), a cytoplasmic RNA helicase, interacts with IPS-1/MAVS/Cardif/VISA, a protein on the outer membrane of mitochondria, to signal the presence of virus-derived RNA and induce type I interferon production. Activation of RIG-I requires the ubiquitin ligase, TRIM25, which mediates lysine 63-linked polyubiquitination of the RIG-I N-terminal CARD-like region. However, how this modification proceeds for activation of IPS-1 by RIG-I remains unclear. Here we identify an alternative factor, Riplet/RNF135, that promotes RIG-I activation independent of TRIM25. The Riplet/RNF135 protein consists of an N- terminal RING finger domain, C-terminal SPRY and PRY motifs, and shows sequence similarity to TRIM25. Immunoprecipitation analyses demonstrated that the C-terminal helicase and repressor domains of RIG-I interact with the Riplet/RNF135 C-terminal region, whereas the CARD-like region of RIG-I is dispensable for this interaction. Riplet/RNF135 promotes lysine 63-linked polyubiquitination of the C-terminal region of RIG-I, modification of which differs from the N- terminal ubiquitination by TRIM25. Overexpression and knockdown analyses revealed that Riplet/RNF135 promotes RIGI-mediated interferon-beta promoter activation and inhibits propagation of the negative-strand RNA virus, vesicular stomatitis virus. Our data suggest that Riplet/RNF135 is a novel factor of the RIG-I pathway that is involved in the evoking of human innate immunity against RNA virus infection, and activates RIG-I through ubiquitination of its C-terminal region. We infer that a variety of RIG-I-ubiquitinating molecular complexes sustain RIG-I activation to modulate RNA virus replication in the cytoplasm.	[Oshiumi, Hiroyuki; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Hatakeyama, Shigetsugu] Hokkaido Univ, Grad Sch Med, Dept Biochem, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Hokkaido University; Hokkaido University	Seya, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	seya-tu@pop.med.hokudai.ac.jp	Seya, Tsukasa/A-4336-2012; Oshiumi, Hiroyuki/G-1645-2012; Hatakeyama, Shigetsugu/C-8333-2012; 美佐子, 松本/A-4497-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979; Oshiumi, Hiroyuki/0000-0003-1567-8722	Ministry of Education, Science and Culture of Japan; Ministry of Health, Labour, and Welfare; Mitsubishi Foundation; Mochida Memorial Foundation	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Mitsubishi Foundation; Mochida Memorial Foundation	This work was supported in part by grants-in-aid from the Ministry of Education, Science and Culture of Japan, Ministry of Health, Labour, and Welfare, The Mitsubishi Foundation, and The Mochida Memorial Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arimoto KI, 2008, MOL IMMUNOL, V45, P1078, DOI 10.1016/j.molimm.2007.07.021; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Douglas J, 2007, NAT GENET, V39, P963, DOI 10.1038/ng2083; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tanabe M, 2003, BIOCHEM BIOPH RES CO, V311, P39, DOI 10.1016/j.bbrc.2003.09.159; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	34	260	280	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					807	817		10.1074/jbc.M804259200	http://dx.doi.org/10.1074/jbc.M804259200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19017631	hybrid			2022-12-27	WOS:000262122900015
J	Timmer, AM; Timmer, JC; Pence, MA; Hsu, LC; Ghochani, M; Frey, TG; Karin, M; Salvesen, GS; Nizet, V				Timmer, Anjuli M.; Timmer, John C.; Pence, Morgan A.; Hsu, Li-Chung; Ghochani, Mariam; Frey, Terrence G.; Karin, Michael; Salvesen, Guy S.; Nizet, Victor			Streptolysin O Promotes Group A Streptococcus Immune Evasion by Accelerated Macrophage Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASE; GENE-EXPRESSION; III SECRETION; CYTOCHROME-C; ACTIVATION; CASPASE-1; PROGRAM; CYTOLYSIN; BACTERIA; NECROSIS	Group A Streptococcus ( GAS) is a leading human bacterial pathogen capable of producing invasive infections even in previously healthy individuals. As frontline components of host innate defense, macrophages play a key role in control and clearance of GAS infections. We find GAS induces rapid, dose-dependent apoptosis of primary and cultured macrophages and neutrophils. The cell death pathway involves apoptotic caspases, is partly dependent on caspase-1, and requires GAS internalization by the phagocyte. Analysis of GAS virulence factor mutants, heterologous expression, and purified toxin studies identified the pore-forming cytolysin streptolysin O (SLO) as necessary and sufficient for the apoptosis-inducing phenotype. SLO-deficient GAS mutants induced less macrophage apoptosis in vitro and in vivo, allowed macrophage cytokine secretion, and were less virulent in a murine systemic infection model. Ultrastructural evidence of mitochondrial membrane remodeling, coupled with loss of mitochondrial depolarization and cytochrome c release, suggests a direct attack of the toxin initiates the intrinsic apoptosis pathway. A general caspase inhibitor blocked SLO-induced apoptosis and enhanced macrophage killing of GAS. We conclude that accelerated, caspase-dependent macrophage apoptosis induced by the pore-forming cytolysin SLO contributes to GAS immune evasion and virulence.	[Nizet, Victor] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Timmer, Anjuli M.; Timmer, John C.; Pence, Morgan A.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Hsu, Li-Chung; Karin, Michael] Univ Calif San Diego, Lab Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Timmer, John C.; Salvesen, Guy S.] Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Hsu, Li-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 10002, Taiwan; [Ghochani, Mariam] San Diego State Univ, Dept Phys, San Diego, CA 92182 USA; [Frey, Terrence G.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; National Taiwan University; California State University System; San Diego State University; California State University System; San Diego State University	Nizet, V (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, E Rm 1066,9500 Gilman Dr,Mail Code 0687, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Pence, Morgan A./N-1620-2019; Nizet, Victor/AAF-3190-2019	Pence, Morgan A./0000-0003-0239-0228; Nizet, Victor/0000-0003-3847-0422; Hsu, Li-Chung/0000-0001-7206-5231	National Institutes of Health [T32-CA77109]; Crohn's & Colitis Foundation; NATIONAL CANCER INSTITUTE [T32CA077109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grants ( to V. N., M. K., T. G. F., and G. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant T32-CA77109 (training grant).; Supported by the Crohn's & Colitis Foundation.	Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Bentley CC, 2005, CELL MICROBIOL, V7, P945, DOI 10.1111/j.1462-5822.2005.00525.x; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Boise LH, 2001, TRENDS MICROBIOL, V9, P64, DOI 10.1016/S0966-842X(00)01937-5; Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Denault Jean-Bernard, 2008, V414, P191; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Goldmann O, 2004, INFECT IMMUN, V72, P2956, DOI 10.1128/IAI.72.5.2956-2963.2004; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; He YQ, 2006, INFECT IMMUN, V74, P5035, DOI 10.1128/IAI.01998-05; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Jeng A, 2003, J BACTERIOL, V185, P1208, DOI 10.1128/JB.185.4.1208-1217.2003; Kansal RG, 2000, INFECT IMMUN, V68, P6362, DOI 10.1128/IAI.68.11.6362-6369.2000; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kuo CF, 1999, INFECT IMMUN, V67, P126, DOI 10.1128/IAI.67.1.126-130.1999; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Michos A, 2006, J BIOL CHEM, V281, P8216, DOI 10.1074/jbc.M511674200; Monack DM, 2001, CELL MICROBIOL, V3, P825, DOI 10.1046/j.1462-5822.2001.00162.x; Mota LJ, 2005, FEMS MICROBIOL LETT, V252, P1, DOI 10.1016/j.femsle.2005.08.036; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; PALADE GE, 1952, ANAT RECORD, V114, P427, DOI 10.1002/ar.1091140304; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tsai PJ, 1999, INFECT IMMUN, V67, P4334, DOI 10.1128/IAI.67.9.4334-4339.1999	42	117	118	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					862	871		10.1074/jbc.M804632200	http://dx.doi.org/10.1074/jbc.M804632200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001420	hybrid, Green Published			2022-12-27	WOS:000262122900021
J	Abriata, LA; Cassina, A; Tortora, V; Marin, M; Souza, JM; Castro, L; Vila, AJ; Radi, R				Abriata, Luciano A.; Cassina, Adriana; Tortora, Veronica; Marin, Monica; Souza, Jose M.; Castro, Laura; Vila, Alejandro J.; Radi, Rafael			Nitration of Solvent-exposed Tyrosine 74 on Cytochrome c Triggers Heme Iron-Methionine 80 Bond Disruption NUCLEAR MAGNETIC RESONANCE AND OPTICAL SPECTROSCOPY STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKALINE CONFORMATIONAL TRANSITION; FERRICYTOCHROME-C; NITRIC-OXIDE; NITROCYTOCHROME-C; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; PROTEIN; PEROXYNITRITE; MITOCHONDRIAL; APOPTOSIS	Cytochrome c, a mitochondrial electron transfer protein containing a hexacoordinated heme, is involved in other physiologically relevant events, such as the triggering of apoptosis, and the activation of a peroxidatic activity. The latter occurs secondary to interactions with cardiolipin and/or post-translational modifications, including tyrosine nitration by peroxynitrite and other nitric oxide-derived oxidants. The gain of peroxidatic activity in nitrated cytochrome c has been related to a heme site transition in the physiological pH region, which normally occurs at alkaline pH in the native protein. Herein, we report a spectroscopic characterization of two nitrated variants of horse heart cytochrome c by using optical spectroscopy studies and NMR. Highly pure nitrated cytochrome c species modified at solvent-exposed Tyr-74 or Tyr-97 were generated after treatment with a flux of peroxynitrite, separated, purified by preparative high pressure liquid chromatography, and characterized by mass spectrometry-based peptide mapping. It is shown that nitration of Tyr-74 elicits an early alkaline transition with a pK(a) = 7.2, resulting in the displacement of the sixth and axial iron ligand Met-80 and replacement by a weaker Lys ligand to yield an alternative low spin conformation. Based on the study of site-specific Tyr to Phe mutants in the four conserved Tyr residues, we also show that this transition is not due to deprotonation of nitro-Tyr-74, but instead we propose a destabilizing steric effect of the nitro group in the mobile Omega-loop of cytochrome c, which is transmitted to the iron center via the nearby Tyr-67. The key role of Tyr-67 in promoting the transition through interactions with Met-80 was further substantiated in the Y67F mutant. These results therefore provide new insights into how a remote post-translational modification in cytochrome c such as tyrosine nitration triggers profound structural changes in the heme ligation and microenvironment and impacts in protein function.	[Cassina, Adriana; Tortora, Veronica; Souza, Jose M.; Castro, Laura; Radi, Rafael] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay; [Abriata, Luciano A.; Vila, Alejandro J.] Univ Nacl Rosario, Biophys Sect, Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina; [Cassina, Adriana; Tortora, Veronica; Marin, Monica; Souza, Jose M.; Castro, Laura; Radi, Rafael] Univ Republica, Fac Med, Ctr Free Rad & Biomed Res, Montevideo 11800, Uruguay; [Marin, Monica] Univ Republica, Fac Ciencias, Secc Bioquim Biol Mol, Montevideo 11400, Uruguay	Universidad de la Republica, Uruguay; National University of Rosario; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Radi, R (corresponding author), Univ Republica, Fac Med, Dept Bioquim, Avda Gen Flores 2125, Montevideo 11800, Uruguay.	rradi@fmed.edu.uy	Marin, Monica-Paula/Y-3387-2019	Vila, Alejandro/0000-0002-7978-3233	National Institutes of Health [R01-GM068682]; Howard Hughes Medical Institute; International Centre of Genetic Engineering and Biotechnology; Comision Sectorial de Investigacion Cientifica (CSIC); Universidad de la Republica; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); International Centre of Genetic Engineering and Biotechnology; Comision Sectorial de Investigacion Cientifica (CSIC); Universidad de la Republica; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM068682 (to A.J.V.). This work was also supported by grants from the Howard Hughes Medical Institute (to A.J.V. and R. R.), International Centre of Genetic Engineering and Biotechnology (to R. R.), and Comision Sectorial de Investigacion Cientifica (CSIC), Universidad de la Republica (to L.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adams P.A., 1991, PEROXIDASES CHEM BIO, V2, P171; Alonso D, 2002, NEUROSCIENCE, V111, P47, DOI 10.1016/S0306-4522(01)00571-1; Assfalg M, 2003, J AM CHEM SOC, V125, P2913, DOI 10.1021/ja027180s; Banci L, 1998, EUR J BIOCHEM, V256, P271, DOI 10.1046/j.1432-1327.1998.2560271.x; Banci L, 1997, BIOCHEMISTRY-US, V36, P9867, DOI 10.1021/bi970724w; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; Batthyany C, 2005, BIOCHEMISTRY-US, V44, P8038, DOI 10.1021/bi0474620; Belikova NA, 2007, INT J RADIAT ONCOL, V69, P176, DOI 10.1016/j.ijrobp.2007.03.043; BERGHUIS AM, 1994, J MOL BIOL, V235, P1326, DOI 10.1006/jmbi.1994.1086; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; Birnboim HC, 2003, J IMMUNOL, V171, P528, DOI 10.4049/jimmunol.171.2.528; BLAUER G, 1993, BIOCHEMISTRY-US, V32, P6674, DOI 10.1021/bi00077a021; BOSWELL AP, 1983, BIOCHEM J, V213, P679, DOI 10.1042/bj2130679; Bren KL, 2004, INORG CHEM, V43, P7934, DOI 10.1021/ic048925t; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; BUTLER J, 1982, J BIOL CHEM, V257, P747; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Castro L, 2004, ARCH BIOCHEM BIOPHYS, V421, P99, DOI 10.1016/j.abb.2003.08.033; Chen YR, 2004, FREE RADICAL BIO MED, V37, P1591, DOI 10.1016/j.freeradbiomed.2004.07.013; Chen YR, 2004, J BIOL CHEM, V279, P18054, DOI 10.1074/jbc.M307706200; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P14; Cruthirds DL, 2003, ARCH BIOCHEM BIOPHYS, V412, P27, DOI 10.1016/S0003-9861(03)00039-0; Demicheli V, 2007, FREE RADICAL BIO MED, V42, P1359, DOI 10.1016/j.freeradbiomed.2007.01.034; Dickerson R., 1975, ENZYMES, V11, P397; Dopner S, 1998, J AM CHEM SOC, V120, P11246, DOI 10.1021/ja9717572; Droghetti E, 2006, BIOPHYS J, V91, P3022, DOI 10.1529/biophysj.106.079749; FENG YQ, 1990, BIOPHYS J, V57, P15, DOI 10.1016/S0006-3495(90)82502-9; FERRER JC, 1993, J AM CHEM SOC, V115, P7507, DOI 10.1021/ja00069a062; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; HEINEMAN WR, 1975, ANAL CHEM, V47, P79, DOI 10.1021/ac60351a001; HONG XL, 1989, FEBS LETT, V246, P105, DOI 10.1016/0014-5793(89)80262-5; HOSHINO M, 1993, J AM CHEM SOC, V115, P9568, DOI 10.1021/ja00074a023; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Kawai C, 2005, J BIOL CHEM, V280, P34709, DOI 10.1074/jbc.M412532200; Kelm M, 1997, J BIOL CHEM, V272, P9922; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; Kong SK, 1996, P NATL ACAD SCI USA, V93, P3377, DOI 10.1073/pnas.93.8.3377; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; LIU GH, 1995, J INORG BIOCHEM, V60, P123, DOI 10.1016/0162-0134(95)00007-B; LUNTZ TL, 1989, P NATL ACAD SCI USA, V86, P3524, DOI 10.1073/pnas.86.10.3524; Maity H, 2006, PROTEINS, V63, P349, DOI 10.1002/prot.20756; MARGOLIASH E, 1962, J BIOL CHEM, V237, P3397; MARGOLIASH E, 1996, CYTOCHROME C MULTIDI; Moore G. R., 1990, CYTOCHROMES C EVOLUT; Mugnol KCU, 2008, BIOPHYS J, V94, P4066, DOI 10.1529/biophysj.107.116483; Nantes IL, 2001, J BIOL CHEM, V276, P153, DOI 10.1074/jbc.M006338200; OCHI H, 1983, J MOL BIOL, V166, P407, DOI 10.1016/S0022-2836(83)80092-8; OSHEROFF N, 1980, J BIOL CHEM, V255, P1689; PEARCE LL, 1989, BIOCHEMISTRY-US, V28, P3152, DOI 10.1021/bi00434a006; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Pepaj M, 2006, J CHROMATOGR A, V1120, P132, DOI 10.1016/j.chroma.2006.02.031; Pettigrew G.W., 1987, CYTOCHROMES C BIOL A; Pollock WBR, 1998, BIOCHEMISTRY-US, V37, P6124, DOI 10.1021/bi972188d; Quijano C, 2005, FREE RADICAL BIO MED, V39, P728, DOI 10.1016/j.freeradbiomed.2005.04.014; RADI R, 1991, J BIOL CHEM, V266, P4244; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P118, DOI 10.1016/0003-9861(91)90172-F; Radi R, 1996, CHEM RES TOXICOL, V9, P828, DOI 10.1021/tx950176s; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; RODRIGUEZROLDAN V, 2008, BIOCHEMISTR IN PRESS; Rosell FI, 1998, J AM CHEM SOC, V120, P11234, DOI 10.1021/ja971756+; Rumbley JN, 2002, BIOCHEMISTRY-US, V41, P13894, DOI 10.1021/bi026543y; Salamon Z, 1997, J BIOENERG BIOMEMBR, V29, P211, DOI 10.1023/A:1022401825287; SANTUCCI R, 1995, J INORG BIOCHEM, V170, P3197; SCHEJTER A, 1970, BIOCHEMISTRY-US, V9, P5118, DOI 10.1021/bi00828a012; SCHEJTER A, 1971, EUR J BIOCHEM, V20, P414, DOI 10.1111/j.1432-1033.1971.tb01407.x; SCOTT RA, 1996, CYTOCHROME C MULTIDI, P475; SENN H, 1985, Q REV BIOPHYS, V18, P111, DOI 10.1017/S0033583500005151; SKOV K, 1969, CAN J BIOCHEM CELL B, V47, P750, DOI 10.1139/o69-114; Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1; SOKOLOVS.M, 1970, BIOCHEMISTRY-US, V9, P5113, DOI 10.1021/bi00828a011; SOUSSI B, 1990, BIOCHEM J, V265, P227, DOI 10.1042/bj2650227; Souza JM, 2008, FREE RADICAL BIO MED, V45, P357, DOI 10.1016/j.freeradbiomed.2008.04.010; Souza JM, 2008, METHOD ENZYMOL, V441, P197, DOI 10.1016/S0076-6879(08)01211-1; TAKANO T, 1981, J MOL BIOL, V153, P95, DOI 10.1016/0022-2836(81)90529-5; WILKSTROM M, 1984, BIOENERGETICS, V9, P49; WILSON MT, 1971, EUR J BIOCHEM, V22, P11, DOI 10.1111/j.1432-1033.1971.tb01508.x	78	84	87	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					17	26		10.1074/jbc.M807203200	http://dx.doi.org/10.1074/jbc.M807203200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18974097	hybrid, Green Published			2022-12-27	WOS:000261974800003
J	Boyd, JM; Sondelski, JL; Downs, DM				Boyd, Jeffrey M.; Sondelski, Jamie L.; Downs, Diana M.			Bacterial ApbC Protein Has Two Biochemical Activities That Are Required for in Vivo Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTERS; ENTERICA SEROVAR TYPHIMURIUM; DEHYDROGENASE TCUA ENZYME; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; AZOTOBACTER-VINELANDII; NUCLEOTIDE-BINDING; 4FE-4S CLUSTERS; PHOTOSYSTEM-I; FE(II) TRAFFICKING	The ApbC protein has been shown previously to bind and rapidly transfer iron-sulfur ([Fe-S]) clusters to an apoprotein (Boyd, J. M., Pierik, A. J., Netz, D. J., Lill, R., and Downs, D. M. (2008) Biochemistry 47, 8195-8202. This study utilized both in vivo and in vitro assays to examine the function of variant ApbC proteins. The in vivo assays assessed the ability of ApbC proteins to function in pathways with low and high demand for [Fe-S] cluster proteins. Variant ApbC proteins were purified and assayed for the ability to hydrolyze ATP, bind [Fe-S] cluster, and transfer [Fe-S] cluster. This study details the first kinetic analysis of ATP hydrolysis for a member of the ParA subfamily of "deviant" Walker A proteins. Moreover, this study details the first functional analysis of mutant variants of the ever expanding family of ApbC/Nbp35 [Fe-S] cluster biosynthetic proteins. The results herein show that ApbC protein needs ATPase activity and the ability to bind and rapidly transfer [Fe-S] clusters for in vivo function.	[Boyd, Jeffrey M.; Sondelski, Jamie L.; Downs, Diana M.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Downs, DM (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	downs@bact.wisc.edu		Boyd, Jeffrey/0000-0001-7721-3926	National Institutes of Health [GM47296]; J.M. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047296, F32GM079938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.M. McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM47296 (to D. M. D.) and a National Institutes of Health Ruth Kirschstein postdoctoral training fellowship (to J.M.B.). This work was also supported by a 21st Century Scientist Scholars Award from the J.M. McDonnell Foundation (to D. M. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Antonkine ML, 2007, BBA-BIOENERGETICS, V1767, P712, DOI 10.1016/j.bbabio.2007.02.003; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; BATES PA, 1999, PROTEINS, V3, pS47; BATES PA, 2001, PROTEINS, V5, pS39; Beck BJ, 1997, J BACTERIOL, V179, P6504, DOI 10.1128/jb.179.21.6862-6864.1997; Beck BJ, 1998, J BACTERIOL, V180, P885, DOI 10.1128/JB.180.4.885-891.1998; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Boyd JM, 2008, J BACTERIOL, V190, P4596, DOI 10.1128/JB.00262-08; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Cui Q, 2006, PROTEINS, V62, P578, DOI 10.1002/prot.20781; Dos Santos PC, 2004, J BIOL CHEM, V279, P19705, DOI 10.1074/jbc.M400278200; Enos-Berlage JL, 1999, J BACTERIOL, V181, P841, DOI 10.1128/JB.181.3.841-848.1999; Foster MW, 2000, J AM CHEM SOC, V122, P6805, DOI 10.1021/ja000800+; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; FRIEDMAN SA, 1988, PLASMID, V19, P103, DOI 10.1016/0147-619X(88)90049-2; Gibney BR, 1996, P NATL ACAD SCI USA, V93, P15041, DOI 10.1073/pnas.93.26.15041; Gralnick J, 2000, J BACTERIOL, V182, P5180, DOI 10.1128/JB.182.18.5180-5187.2000; Gralnick J, 2001, P NATL ACAD SCI USA, V98, P8030, DOI 10.1073/pnas.151243198; Gralnick JA, 2003, J BIOL CHEM, V278, P20708, DOI 10.1074/jbc.M301577200; GROSS SR, 1963, BIOCHEMISTRY-US, V2, P1046, DOI 10.1021/bi00905a023; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Jin Z, 2008, J BIOL CHEM, V283, P28426, DOI 10.1074/jbc.M803395200; Johnson DC, 2006, J BACTERIOL, V188, P7551, DOI 10.1128/JB.00596-06; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; Justino MC, 2006, FEMS MICROBIOL LETT, V257, P278, DOI 10.1111/j.1574-6968.2006.00179.x; KARKARIA CE, 1990, J BIOL CHEM, V265, P7832; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Leonardi R, 2003, FEBS LETT, V539, P95, DOI 10.1016/S0014-5793(03)00204-7; Lewis JA, 2004, J BACTERIOL, V186, P1629, DOI 10.1128/JB.186.6.1629-1637.2004; Lewis JA, 2007, BIOCHEMISTRY-US, V46, P9107, DOI 10.1021/bi7006564; Lewis JA, 2006, J BACTERIOL, V188, P5479, DOI 10.1128/JB.00514-06; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; Lu JX, 2008, BIOCHEM J, V409, P535, DOI 10.1042/BJ20071166; Lutkenhaus J, 2003, MOL MICROBIOL, V48, P295, DOI 10.1046/j.1365-2958.2003.03427.x; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; Martinez-Gomez NC, 2004, J BIOL CHEM, V279, P40505, DOI 10.1074/jbc.M403985200; Mulholland SE, 1998, J AM CHEM SOC, V120, P10296, DOI 10.1021/ja981279a; NEIDHARDT FC, 1990, PHYSL BACTERIAL CELL, P198; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; PARSONAGE D, 1988, J BIOL CHEM, V263, P4740; Petersen L, 1996, J BACTERIOL, V178, P5676, DOI 10.1128/jb.178.19.5676-5682.1996; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7451, DOI 10.1021/bi00484a014; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; RYLE MJ, 1995, J BIOL CHEM, V270, P13112, DOI 10.1074/jbc.270.22.13112; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P4766, DOI 10.1021/bi960026w; SEEFELDT LC, 1992, J BIOL CHEM, V267, P6680; SEEFELDT LC, 1993, PROTEIN SCI, V2, P93; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; Segel I.H., 1975, ENZYME KINETICS; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Shimomura Y, 2007, J BIOCHEM, V142, P577, DOI 10.1093/jb/mvm163; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; Skovran E, 2004, J BACTERIOL, V186, P7626, DOI 10.1128/JB.186.22.7626-7634.2004; Skovran E, 2003, J BACTERIOL, V185, P98, DOI 10.1128/JB.185.1.98-106.2003; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Stockel J, 2004, J BIOL CHEM, V279, P10243, DOI 10.1074/jbc.M309246200; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; TIAN G, 1990, BIOCHEMISTRY-US, V29, P4296, DOI 10.1021/bi00470a006; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; Vivas E, 2006, J BACTERIOL, V188, P1175, DOI 10.1128/JB.188.3.1175-1179.2006; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; Zhou HJ, 2005, J BACTERIOL, V187, P629, DOI 10.1128/JB.187.2.629-638.2005	80	27	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					110	118		10.1074/jbc.M807003200	http://dx.doi.org/10.1074/jbc.M807003200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001370	Green Published, hybrid			2022-12-27	WOS:000261974800013
J	Kenny, AV; Cousins, SL; Pinho, L; Stephenson, FA				Kenny, Anna V.; Cousins, Sarah L.; Pinho, Leonor; Stephenson, F. Anne			The Integrity of the Glycine Co-agonist Binding Site of N-Methyl-D-aspartate Receptors Is a Functional Quality Control Checkpoint for Cell Surface Delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER RETENTION SIGNAL; NMDA RECEPTOR; ENDOPLASMIC-RETICULUM; LIGAND-BINDING; GLUTAMATE RECEPTORS; PHARMACOLOGICAL CHAPERONES; NR1 SUBUNIT; MOLECULAR DETERMINANTS; NR2A SUBUNIT; SPINAL-CORD	N-Methyl-D-aspartate receptors are a subclass of ligandgated, heteromeric glutamatergic neurotransmitter receptors whose cell surface expression is regulated by quality control mechanisms. Functional quality control checkpoints are known to contribute to cell surface trafficking of non-N-methyl-D-aspartate glutamate receptors. Here we investigated if similar mechanisms operate for the surface delivery of NMDA receptors. Point mutations in the glycine binding domain of the NR1-1a subunit were generated: D732A, a mutation that results in an similar to 3 x 10(4) decrease in glycine binding affinity; D732E, a conservative change; and D723A, a residue in the same NR1-1a domain that has no effect on glycine binding affinity. Each NR1-1a subunit was co-expressed with NR2A in mammalian cells. Immunoblotting and immunoprecipitations showed that all mutants were expressed to similar levels as wild-type NR1-1a and associated with NR2A. Cell surface expression measured by an enzyme-linked immunosorbent assay found that whereas NR1-1a (D732E)/NR2A and NR1-1a (D723A)/NR2A trafficked as efficiently as NR1-1a/NR2A, there was a 90% decrease in surface expression for NR1-1a (D732A)/NR2A. This was confirmed by confocal microscopy imaging and cell surface biotinylation. Further imaging showed that NR1-1a (D732A) and co-transfected NR2A co-localized with an endoplasmic reticulum marker. Dichlorokynurenic acid, a competitive glycine site antagonist, partially rescued surface expression. Mutation of the NR1-1a ER retention motif showed that the ligand binding checkpoint is an early event preceding endoplasmic reticulum sorting mechanisms. These findings demonstrate that integrity of the glycine co-agonist binding site is a functional checkpoint requisite for efficient cell surface trafficking of assembled NMDA receptors.	[Kenny, Anna V.; Cousins, Sarah L.; Pinho, Leonor; Stephenson, F. Anne] Univ London, Sch Pharm, London WC1N 1AX, England	University of London; University College London; University of London School of Pharmacy	Stephenson, FA (corresponding author), Univ London, Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England.	anne.stephenson@pharmacy.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom; Biotechnology and Biological Sciences Research Council [BB/D002753/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), United Kingdom. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S.C. Section 1734 solely to indicate this fact.	Anson LC, 1998, J NEUROSCI, V18, P581; BERGER SJ, 1977, J NEUROCHEM, V28, P149, DOI 10.1111/j.1471-4159.1977.tb07720.x; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Chen PE, 2004, J PHYSIOL-LONDON, V558, P45, DOI 10.1113/jphysiol.2004.063800; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Fujiwara K, 1998, BRAIN RES, V806, P210, DOI 10.1016/S0006-8993(98)00744-6; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Kong MMC, 2006, MOL PHARMACOL, V70, P78, DOI 10.1124/mol.105.021246; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Laube B, 2004, NEUROPHARMACOLOGY, V47, P994, DOI 10.1016/j.neuropharm.2004.07.041; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Lummis SCR, 2002, NEUROPHARMACOLOGY, V42, P437, DOI 10.1016/S0028-3908(02)00002-3; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; MEEKER RB, 1989, NEUROSCIENCE, V33, P157, DOI 10.1016/0306-4522(89)90318-7; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Okabe S, 1999, J NEUROSCI, V19, P7781; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; PRYBLYOWSKI K, 2003, J BIOL CHEM, V279, P9672; Rampon C, 1996, NEUROSCIENCE, V75, P737, DOI 10.1016/0306-4522(96)00278-3; Robben JH, 2006, MOL BIOL CELL, V17, P379, DOI 10.1091/mbc.E05-06-0579; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Rutter AR, 2002, J NEUROCHEM, V81, P1298, DOI 10.1046/j.1471-4159.2002.00923.x; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; VANDENPOL AN, 1988, J NEUROSCI, V8, P472; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; Williams K, 1996, MOL PHARMACOL, V50, P701; Wolosker H, 2007, MOL NEUROBIOL, V36, P152, DOI 10.1007/s12035-007-0038-6; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200	54	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					324	333		10.1074/jbc.M804023200	http://dx.doi.org/10.1074/jbc.M804023200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990687	hybrid			2022-12-27	WOS:000261974800037
J	Pittman, JK; Edmond, C; Sunderland, PA; Bray, CM				Pittman, Jon K.; Edmond, Clare; Sunderland, Paul A.; Bray, Clifford M.			A Cation-regulated and Proton Gradient-dependent Cation Transporter from Chlamydomonas reinhardtii Has a Role in Calcium and Sodium Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR CA2+/H+ EXCHANGER; SACCHAROMYCES-CEREVISIAE; NA+/H+ ANTIPORTER; ESCHERICHIA-COLI; CATION/PROTON ANTIPORTERS; H+/CA2+ ANTIPORTER; SALT TOLERANCE; ARABIDOPSIS; CAX1; IDENTIFICATION	The CrCAX1 gene encoding a Ca2+/H+ and Na+/H+ exchanger was cloned and characterized from the unicellular green alga Chlamydomonas reinhardtii to begin to understand the mechanisms of cation homeostasis in this model organism. CrCAX1 was more closely related to fungal cation exchanger (CAX) genes than those from higher plants but has structural characteristics similar to plant Ca2(+)/H+ exchangers including a long N-terminal tail. When CrCAX1-GFP was expressed in Saccharomyces cerevisiae, it localized at the vacuole. CrCAX1 could suppress the Ca2+-hypersensitive phenotype of a yeast mutant and mediated proton gradient-dependent Ca2+/H+ exchange activity in vacuolar membrane vesicles. Ca2+ transport activity was increased following N-terminal truncation of CrCAX1, suggesting the existence of an N-terminal auto-regulatory mechanism. CrCAX1 could also provide tolerance to Na+ stress when expressed in yeast or Arabidopsis thaliana because of Na+/H+ exchange activity. This Na+/H+ exchange activity was not regulated by the N terminus of the CrCAX1 protein. A subtle tolerance by CrCAX1 in yeast to Co2+ stress was also observed. CrCAX1 was transcriptionally regulated in Chlamydomonas cells grown in elevated Ca2+ or Na+. This study has thus uncovered a novel eukaryotic proton-coupled transporter, CrCAX1, that can transport both monovalent and divalent cations and that appears to play a role in cellular cation homeostasis by the transport of Ca2+ and Na+ into the vacuole.	[Pittman, Jon K.; Edmond, Clare; Sunderland, Paul A.; Bray, Clifford M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Pittman, JK (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	jon.pittman@manchester.ac.uk		Pittman, Jon/0000-0001-7197-1494	Biotechnology and Biological Sciences Research Council [BB/B502152/1, BB/C502030/1]; Leverhulme Trust [F/00120/BG]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust)	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/B502152/1 (to J.K.P.) and BB/C502030/1 (to C. M. B.) and Leverhulme Trust Grant F/00120/BG (to J.K.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bothwell JHF, 2006, PLANT J, V46, P327, DOI 10.1111/j.1365-313X.2006.02687.x; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cheng NH, 2004, J BIOL CHEM, V279, P2922, DOI 10.1074/jbc.M309084200; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Hanikenne M, 2005, PLANT PHYSIOL, V137, P428, DOI 10.1104/pp.104.054189; HARZ H, 1991, NATURE, V351, P489, DOI 10.1038/351489a0; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Kamiya T, 2006, PLANT CELL PHYSIOL, V47, P96, DOI 10.1093/pcp/pci227; Kamiya T, 2005, PLANT CELL PHYSIOL, V46, P1735, DOI 10.1093/pcp/pci173; Kamiya T, 2004, J BIOL CHEM, V279, P812, DOI 10.1074/jbc.M309726200; Komine Y, 2000, PLANTA, V210, P897, DOI 10.1007/s004250050695; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Luo GZ, 2005, PLANT MOL BIOL, V59, P809, DOI 10.1007/s11103-005-1386-0; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Maser P, 2002, PLANT SOIL, V247, P43, DOI 10.1023/A:1021159130729; MCAINSH MR, 2008, NEW PHYTOL IN PRESS; Mei H, 2007, J EXP BOT, V58, P3419, DOI 10.1093/jxb/erm190; Mendez-Alvarez S, 1999, Int Microbiol, V2, P15; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OHYAMA T, 1994, J BACTERIOL, V176, P4311, DOI 10.1128/jb.176.14.4311-4315.1994; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Pittman JK, 2005, FEBS LETT, V579, P2648, DOI 10.1016/j.febslet.2005.03.085; Pittman JK, 2004, MOL MICROBIOL, V54, P1104, DOI 10.1111/j.1365-2958.2004.04332.x; Pittman JK, 2002, J BIOL CHEM, V277, P26452, DOI 10.1074/jbc.M202563200; Pittman JK, 2002, PLANT PHYSIOL, V130, P1054, DOI 10.1104/pp.008193; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Primavesi LF, 2008, TRANSGENIC RES, V17, P529, DOI 10.1007/s11248-007-9126-7; QUARMBY LM, 1994, J CELL BIOL, V124, P807, DOI 10.1083/jcb.124.5.807; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; Shigaki T, 2003, J BIOL CHEM, V278, P6610, DOI 10.1074/jbc.M209952200; Spijkerman E, 2007, EXTREMOPHILES, V11, P551, DOI 10.1007/s00792-007-0067-0; Sunderland PA, 2006, PLANT J, V47, P356, DOI 10.1111/j.1365-313X.2006.02791.x; Tanaka S, 2007, FEMS MICROBIOL LETT, V271, P48, DOI 10.1111/j.1574-6968.2007.00696.x; Waditee R, 2001, J BIOL CHEM, V276, P36931, DOI 10.1074/jbc.M103650200; Wei Y, 2007, MICROBIOL-SGM, V153, P2168, DOI 10.1099/mic.0.2007/007450-0; Wheeler GL, 2008, TRENDS PLANT SCI, V13, P506, DOI 10.1016/j.tplants.2008.06.004; Wheeler GL, 2008, PLANT J, V53, P401, DOI 10.1111/j.1365-313X.2007.03349.x	49	36	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					525	533		10.1074/jbc.M807173200	http://dx.doi.org/10.1074/jbc.M807173200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001368	hybrid			2022-12-27	WOS:000261974800057
J	Coornaert, B; Carpentier, I; Beyaert, R				Coornaert, Beatrice; Carpentier, Isabelle; Beyaert, Rudi			A20: Central Gatekeeper in Inflammation and Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NF-KAPPA-B; ZINC-FINGER PROTEIN; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DEPENDENT GENE-EXPRESSION; EDITING ENZYME A20; A20-BINDING INHIBITOR; RHEUMATOID-ARTHRITIS; RECEPTOR STIMULATION; SIGNALING PATHWAYS; NEGATIVE REGULATOR	Inappropriate functioning of the immune system is linked to immune deficiency, autoimmune disease, and cancer. It is therefore not surprising that intracellular immune signaling pathways are tightly controlled. One of the best studied transcription factors in immune signaling is NF-kappa B, which is activated by multiple receptors and regulates the expression of a wide variety of proteins that control innate and adaptive immunity. A20 is an early NF-kappa B-responsive gene that encodes a ubiquitin-editing protein that is involved in the negative feedback regulation of NF-kappa B signaling. Here, we discuss the mechanism of action of A20 and its role in the regulation of inflammation and immunity.	[Beyaert, Rudi] Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium; VIB, Unit Mol Signal Transduct Inflammat, Dept Mol Biomed Res, B-9052 Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB)	Beyaert, R (corresponding author), Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium.	rudi.beyaert@dmbr.ugent.be	Beyaert, Rudi/B-2589-2009	Beyaert, Rudi/0000-0002-5704-582X	Fonds voor Wetenschappelijk Onderzoek; Centrum voor Gezwelziekten; Geconcerteerde Onderzoeksacties of Ghent University;  [IAP6/18]	Fonds voor Wetenschappelijk Onderzoek(FWO); Centrum voor Gezwelziekten; Geconcerteerde Onderzoeksacties of Ghent University(Ghent University); 	This work was supported in part by grants from IAP6/18, the Fonds voor Wetenschappelijk Onderzoek, the Centrum voor Gezwelziekten, and the Geconcerteerde Onderzoeksacties of Ghent University. This is the second of three articles in the Thematic Minireview Series on Regulation of Signaling by Non-degradative Ubiquitination. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; DeValck D, 1997, BIOCHEM BIOPH RES CO, V238, P590, DOI 10.1006/bbrc.1997.7343; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Evans PC, 2004, BIOCHEM J, V378, P727, DOI 10.1042/BJ20031377; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Honma K, 2008, GENE CHROMOSOME CANC, V47, P1, DOI 10.1002/gcc.20499; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Idel S, 2003, P NATL ACAD SCI USA, V100, P14235, DOI 10.1073/pnas.1835672100; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Klinkenberg M, 2001, FEBS LETT, V498, P93, DOI 10.1016/S0014-5793(01)02504-2; Komander D, 2008, BIOCHEM J, V409, P77, DOI 10.1042/BJ20071399; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Li LY, 2008, BBA-MOL CELL RES, V1783, P1140, DOI 10.1016/j.bbamcr.2008.01.029; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Raiborg C, 2006, TRENDS BIOCHEM SCI, V31, P541, DOI 10.1016/j.tibs.2006.07.009; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Staege H, 2001, IMMUNOGENETICS, V53, P105, DOI 10.1007/s002510100306; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; TEWARI M, 1995, J IMMUNOL, V154, P1699; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Van Huffel S, 2001, J BIOL CHEM, V276, P30216, DOI 10.1074/jbc.M100048200; Verstrepen L, 2008, J CELL MOL MED, V12, P316, DOI 10.1111/j.1582-4934.2007.00187.x; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Weaver BK, 2007, MOL CELL BIOL, V27, P4603, DOI 10.1128/MCB.00223-07; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wolfrum S, 2007, P NATL ACAD SCI USA, V104, P18601, DOI 10.1073/pnas.0709011104; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wullaert A, 2007, J BIOL CHEM, V282, P81, DOI 10.1074/jbc.M607481200; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	66	238	247	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8217	8221		10.1074/jbc.R800032200	http://dx.doi.org/10.1074/jbc.R800032200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	19008218	hybrid, Green Published			2022-12-27	WOS:000264397800003
J	Mullins, LJ; Peter, A; Wrobel, N; McNeilly, JR; McNeilly, AS; Al-Dujaili, EAS; Brownstein, DG; Mullins, JJ; Kenyon, CJ				Mullins, Linda J.; Peter, Audrey; Wrobel, Nicola; McNeilly, Judith R.; McNeilly, Alan S.; Al-Dujaili, Emad A. S.; Brownstein, David G.; Mullins, John J.; Kenyon, Christopher J.			Cyp11b1 Null Mouse, a Model of Congenital Adrenal Hyperplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							11-BETA-HYDROXYLASE DEFICIENCY; 21-HYDROXYLASE DEFICIENCY; PRIMARY ALDOSTERONISM; PRENATAL-DIAGNOSIS; METABOLIC SYNDROME; INSULIN-SECRETION; GLUCOSE-TOLERANCE; BLOOD-PRESSURE; MICE; CELLS	Patients with congenital adrenal hyperplasia arising from mutations of 11 beta-hydroxylase, the final enzyme in the glucocorticoid biosynthetic pathway, exhibit glucocorticoid deficiency, adrenal hyperplasia driven by unsuppressed hypothalamo-pituitary-adrenal activity, and excess mineralocorticoid activity caused by the accumulation of deoxycorticosterone. A mouse model, in which exons 3-7 of Cyp11b1 (the gene encoding 11 beta-hydroxylase) were replaced with cDNA encoding enhanced cyan fluorescent protein, was generated to investigate the underlying disease mechanisms. Enhanced cyan fluorescent protein was expressed appropriately in the zona fasciculata of the adrenal gland, and targeted knock-out was confirmed by urinary steroid profiles and, immunocytochemically, by the absence of 11 beta-hydroxylase. The null mice exhibited glucocorticoid deficiency, mineralocorticoid excess, adrenal hyperplasia, mild hypertension, and hypokalemia. They also displayed glucose intolerance. Because rodents do not synthesize adrenal androgens, changes in reproductive function such as genital virilization of females were not anticipated. However, adult homozygote females were infertile, their ovaries showing an absence of corpora lutea and a central proliferation of disorganized steroidogenic tissue. Null females responded normally to superovulation, suggesting that raised systemic progesterone levels also contribute to infertility problems. The model reveals previously unrecognized phenotypic subtleties of congenital adrenal hyperplasia.	[Kenyon, Christopher J.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [McNeilly, Judith R.; McNeilly, Alan S.] Univ Edinburgh, Ctr Reprod Biol, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Kenyon, CJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	chris.kenyon@ed.ac.uk		Mullins, Linda/0000-0002-6743-8707	Medical Research Council (United Kingdom); Medical Research Council [G0500026, G9900991B, MC_U127685843] Funding Source: researchfish; MRC [G0500026, MC_U127685843] Funding Source: UKRI	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (United Kingdom). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Al-Dujaili EAS, 2006, CLIN CHIM ACTA, V364, P172, DOI 10.1016/j.cccn.2005.06.019; ALDUJAILI EAS, 1984, J STEROID BIOCHEM, V20, P849, DOI 10.1016/0022-4731(84)90394-7; ALDUJAILI EAS, 1981, CLIN CHIM ACTA, V116, P277, DOI 10.1016/0009-8981(81)90047-4; ALDUJAILI EAS, 1981, STEROIDS, V37, P157, DOI 10.1016/S0039-128X(81)80015-3; Barr M, 2006, CLIN ENDOCRINOL, V65, P816, DOI 10.1111/j.1365-2265.2006.02673.x; Boini KM, 2006, DIABETES, V55, P2059, DOI 10.2337/db05-1038; Catena C, 2006, J CLIN ENDOCR METAB, V91, P3457, DOI 10.1210/jc.2006-0736; Cerame BI, 1999, J CLIN ENDOCR METAB, V84, P3129, DOI 10.1210/jc.84.9.3129; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Claahsen-van der Grinten HL, 2006, J PEDIATR ENDOCR MET, V19, P677; Coll AP, 2005, DIABETES, V54, P2269, DOI 10.2337/diabetes.54.8.2269; CONN JW, 1965, NEW ENGL J MED, V273, P1135, DOI 10.1056/NEJM196511182732106; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; De Geyter C, 2002, HUM REPROD, V17, P933, DOI 10.1093/humrep/17.4.933; DOMALIK LJ, 1991, MOL ENDOCRINOL, V5, P1853, DOI 10.1210/mend-5-12-1853; EVANS AL, 1994, MED BIOL ENG COMPUT, V32, P101, DOI 10.1007/BF02512487; FEEK CM, 1989, J STEROID BIOCHEM, V32, P573, DOI 10.1016/0022-4731(89)90392-0; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; GOTOH H, 1988, ENDOCRINOLOGY, V123, P1923, DOI 10.1210/endo-123-4-1923; Greaves P, 2006, BEST PRACT RES CL OB, V20, P503, DOI 10.1016/j.bpobgyn.2006.01.003; Grosse SD, 2007, HORM RES, V67, P284, DOI 10.1159/000098400; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kotelevtsev Y, 1999, J CLIN INVEST, V103, P683, DOI 10.1172/JCI4445; Krone N, 2005, J CLIN ENDOCR METAB, V90, P3724, DOI 10.1210/jc.2005-0089; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lin HY, 2005, DIABETES, V54, P1717, DOI 10.2337/diabetes.54.6.1717; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MARSHALL E, 2003, END ABSTR, V5, pP231; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; McNeilly JR, 2000, ENDOCRINOLOGY, V141, P4284, DOI 10.1210/en.141.11.4284; Michael AE, 2003, REPRODUCTION, V126, P425, DOI 10.1530/rep.0.1260425; Michailidou Z, 2007, J ENDOCRINOL, V194, P161, DOI 10.1677/JOE-07-0090; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; Motaghedi R, 2005, J PEDIATR ENDOCR MET, V18, P133; Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283; Ortiz LA, 2001, KIDNEY INT, V59, P1663, DOI 10.1046/j.1523-1755.2001.0590051663.x; ORTMANN O, 1994, J STEROID BIOCHEM, V48, P47, DOI 10.1016/0960-0760(94)90249-6; Paperna T, 2005, J CLIN ENDOCR METAB, V90, P5463, DOI 10.1210/jc.2005-1145; PAULA FJA, 1994, HORM METAB RES, V26, P552, DOI 10.1055/s-2007-1001755; Peeke PM, 1995, ANN NY ACAD SCI, V771, P665, DOI 10.1111/j.1749-6632.1995.tb44719.x; PHILIPPE J, 1992, J CLIN INVEST, V90, P2228, DOI 10.1172/JCI116108; QUARMBY VE, 1984, ENDOCRINOLOGY, V114, P108, DOI 10.1210/endo-114-1-108; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Rae MT, 2004, J CLIN ENDOCR METAB, V89, P4538, DOI 10.1210/jc.2003-032225; Riepe FG, 2005, ENDOCRINOLOGY, V146, P2563, DOI 10.1210/en.2004-1563; RODRIGUEZSARGEN.C, 1990, HYPERTENSION S1, V15, P112; SALICIONI AM, 1993, J ENDOCRINOL, V139, P253, DOI 10.1677/joe.0.1390253; SHIMAMOTO K, 1994, J HUM HYPERTENS, V8, P755; Simm PJ, 2007, HORM RES, V68, P294, DOI 10.1159/000107651; Speiser PW, 2003, NEW ENGL J MED, V349, P776, DOI 10.1056/NEJMra021561; Stubbe J, 2006, AM J PHYSIOL-RENAL, V291, pF812, DOI 10.1152/ajprenal.00477.2005; Takeda K, 2003, J ENDOCRINOL, V176, P237, DOI 10.1677/joe.0.1760237; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Ullrich S, 2007, BIOCHEM BIOPH RES CO, V352, P662, DOI 10.1016/j.bbrc.2006.11.065; Wang Q, 2005, HYPERTENSION, V46, P547, DOI 10.1161/01.HYP.0000178572.63064.73; Wulff C, 2001, J CLIN ENDOCR METAB, V86, P3377, DOI 10.1210/jc.86.7.3377; Yazawa T, 2008, ENDOCRINOLOGY, V149, P1786, DOI 10.1210/en.2007-1015	59	27	27	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3925	3934		10.1074/jbc.M805081200	http://dx.doi.org/10.1074/jbc.M805081200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19029289	hybrid			2022-12-27	WOS:000262872500061
J	Soeda, T; Nogami, K; Nishiya, K; Takeyama, M; Ogiwara, K; Sakata, Y; Yoshioka, A; Shima, M				Soeda, Tetsuhiro; Nogami, Keiji; Nishiya, Katsumi; Takeyama, Masahiro; Ogiwara, Kenichi; Sakata, Yoichi; Yoshioka, Akira; Shima, Midori			The Factor VIIIa C2 Domain (Residues 2228-2240) Interacts with the Factor IXa Gla Domain in the Factor Xase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	49th Annual Meeting of the American-Society-of-Hematology	DEC 08-11, 2007	Atlanta, GA	Amer Soc Hematol			VON-WILLEBRAND-FACTOR; COAGULATION-FACTOR-VIII; GAMMA-CARBOXYGLUTAMIC ACID; BINDING-SITE; INHIBITOR ALLOANTIBODIES; CRYSTAL-STRUCTURE; LIGHT-CHAIN; A2 SUBUNIT; FACTOR-X; SEQUENCE	Factor VIIIa functions as a cofactor for factor IXa in the phospholipid surface-dependent activation of factor X. Both the C2 domain of factor VIIIa and the Gla domain of factor IXa are involved in phospholipid binding and are required for the activation of factor X. In this study, we have examined the close relationship between these domains in the factor Xase complex. Enzyme-linked immunosorbent assay-based and surface plasmon resonance-based assays in the absence of phospholipid showed that Glu-Gly-Arg active site-modified factor IXa bound to immobilized recombinant C2 domain (rC2) dose-dependently (K-d = 108 nM). This binding ability was optimal under physiological conditions. A monoclonal antibody against the Gla domain of factor IXa inhibited binding by similar to 95%, and Gla domainless factor IXa failed to bind to rC2. The addition of monoclonal antibody or rC2 with factor VIIIa inhibited factor IXa-catalyzed factor X activation in the absence of phospholipid. Inhibition was not evident, however, in similar experiments in the absence of factor VIIIa, indicating that the C2 domain interacted with the Gla domain of factor IXa. A fragment designated C2-(2182-2259), derived from V8 proteasecleaved rC2, bound to Glu-Gly-Arg active site-modified factor IXa. Competitive assays, using overlapping synthetic peptides encompassing residues 2182-2259, demonstrated that peptide 2228-2240 significantly inhibited both this binding and factor Xa generation, independently of phospholipid. Our results indicated that residues 2228-2240 in the factor VIIIa C2 domain constitutes an interactive site for the Gla domain of factor IXa. The findings provide the first evidence for an essential role for this interaction in factor Xase assembly.	[Soeda, Tetsuhiro; Nogami, Keiji; Nishiya, Katsumi; Takeyama, Masahiro; Ogiwara, Kenichi; Yoshioka, Akira; Shima, Midori] Nara Med Univ, Dept Pediat, Nara 6348522, Japan	Nara Medical University	Shima, M (corresponding author), Nara Med Univ, Dept Pediat, 840 Shijo Cho, Nara 6348522, Japan.	roc-noga@naramed-u.ac.jp	Ogiwara, Kenichi/ABD-7067-2021	Ogiwara, Kenichi/0000-0002-3046-6915				Bajaj SP, 2001, J BIOL CHEM, V276, P16302, DOI 10.1074/jbc.M011680200; Barrow RT, 2001, BLOOD, V97, P169, DOI 10.1182/blood.V97.1.169; Blostein MD, 2003, J BIOL CHEM, V278, P31297, DOI 10.1074/jbc.M302840200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cameron C, 1998, THROMB HAEMOSTASIS, V79, P317, DOI 10.1055/s-0037-1614984; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; ELDER B, 1993, GENOMICS, V16, P374, DOI 10.1006/geno.1993.1200; Fay PJ, 1999, J BIOL CHEM, V274, P29826, DOI 10.1074/jbc.274.42.29826; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; FAY PJ, 1994, J BIOL CHEM, V269, P20522; FOSTER PA, 1990, BLOOD, V75, P1999; Freedman SJ, 1996, J BIOL CHEM, V271, P16227, DOI 10.1074/jbc.271.27.16227; GERSTEIN M, 1992, ACTA CRYSTALLOGR A, V48, P271, DOI 10.1107/S0108767391012680; Hay CRM, 1998, HAEMOPHILIA, V4, P558, DOI 10.1046/j.1365-2516.1998.440558.x; Healey JF, 1998, BLOOD, V92, P3701, DOI 10.1182/blood.V92.10.3701.422k22_3701_3709; Healey JF, 1996, BLOOD, V88, P4209; Jenkins PV, 2004, BIOCHEMISTRY-US, V43, P5094, DOI 10.1021/bi036289p; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; Larson PJ, 1996, J BIOL CHEM, V271, P3869; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Liu ML, 2000, BLOOD, V96, P979, DOI 10.1182/blood.V96.3.979.015k42a_979_987; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Mimuro J, 2004, J THROMB HAEMOST, V2, P275, DOI 10.1046/j.1538-7933.2003.00572.x; MORITA T, 1985, BIOCHEM BIOPH RES CO, V130, P841, DOI 10.1016/0006-291X(85)90493-0; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Nogami K, 2004, J BIOL CHEM, V279, P33104, DOI 10.1074/jbc.M405537200; Nogami K, 2000, J BIOL CHEM, V275, P25774, DOI 10.1074/jbc.M002007200; Nogami K, 1999, J BIOL CHEM, V274, P31000, DOI 10.1074/jbc.274.43.31000; Nogami K, 1999, BRIT J HAEMATOL, V107, P196, DOI 10.1046/j.1365-2141.1999.01673.x; Nogami K, 2007, INT J HEMATOL, V85, P317, DOI 10.1532/IJH97.06192; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Saenko EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/jbc.272.29.18007; Saenko EL, 1998, J BIOL CHEM, V273, P27918, DOI 10.1074/jbc.273.43.27918; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Schmidt AE, 2005, J MOL BIOL, V350, P78, DOI 10.1016/j.jmb.2005.04.052; Schmidt AE, 2003, TRENDS CARDIOVAS MED, V13, P39, DOI 10.1016/S1050-1738(02)00210-4; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; SHIMA M, 1995, BRIT J HAEMATOL, V91, P714, DOI 10.1111/j.1365-2141.1995.tb05374.x; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; Stoilova-McPhie S, 2002, BLOOD, V99, P1215, DOI 10.1182/blood.V99.4.1215; SUGO T, 1990, THROMB RES, V58, P603, DOI 10.1016/0049-3848(90)90306-W; Takeshima K, 2003, THROMB HAEMOSTASIS, V89, P788, DOI 10.1055/s-0037-1613463; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	48	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3379	3388		10.1074/jbc.M804955200	http://dx.doi.org/10.1074/jbc.M804955200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	400MO	19047063	hybrid, Green Submitted			2022-12-27	WOS:000262872500003
J	Hu, GD; Barnes, BJ				Hu, Guodong; Barnes, Betsy J.			IRF-5 Is a Mediator of the Death Receptor-induced Apoptotic Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR; TRAIL-INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; GENE INDUCTION; CASPASE-8 GENE; CELL-CYCLE; EXPRESSION; ACTIVATION; FADD; DR5	The efficient and regulated response to cellular stress is coordinated by a genetic regulatory network in which a given transcription factor controls the expression of diverse target genes depending on the cell type and/or nature of the stimuli. The tumor suppressor p53 is thought to preferentially regulate the balance between cell survival and death. The interferon regulatory factor 5 (IRF-5), known to be involved in the innate immune response to pathogens, is also a critical regulator of DNA damage-induced apoptosis. Here, we provide direct evidence that IRF-5 promotes apoptosis upon signaling through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptors (DR). We report that IRF-5 sensitizes tumor cells to TRAIL-induced apoptosis and cell death that is further enhanced by type I interferons. Cells deficient of IRF-5 gave a significantly diminished response to these agents. IRF-5 is involved in DR signaling upstream of caspase 8, in part because of an IRF-5-dependent increase in caspase 8 activation. We provide evidence that TRAIL induces a signaling cascade that leads to the phosphorylation and nuclear localization of IRF-5, resulting in transactivation of key DR signaling components. The results presented here identify IRF-5 as a new mediator of DR signaling and provides molecular insight into the mechanism of TRAIL-induced IRF-5 signaling.	[Hu, Guodong; Barnes, Betsy J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Univ Hosp, Ctr Canc, Newark, NJ 07103 USA; [Barnes, Betsy J.] Univ Med & Dent New Jersey, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Hu, Guodong; Barnes, Betsy J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; Johns Hopkins Medicine	Barnes, BJ (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Univ Hosp, Ctr Canc, G1224,205 S Orange Ave, Newark, NJ 07103 USA.	barnesbe@umdnj.edu	hu, guodong/B-4794-2010		Flight Attendant Medical Research Institute; New Jersey Medical School-University Hospital Cancer Center	Flight Attendant Medical Research Institute; New Jersey Medical School-University Hospital Cancer Center	This work was supported in part by the Flight Attendant Medical Research Institute and the New Jersey Medical School-University Hospital Cancer Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Casciano I, 2004, CELL DEATH DIFFER, V11, P131, DOI 10.1038/sj.cdd.4401327; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Finnberg N, 2005, MOL CELL BIOL, V25, P2000, DOI 10.1128/MCB.25.5.2000-2013.2005; Horak P, 2005, MOL CANCER RES, V3, P335, DOI 10.1158/1541-7786.MCR-04-0136; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Izeradjene K, 2005, ONCOGENE, V24, P2050, DOI 10.1038/sj.onc.1208397; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Korz C, 2002, BLOOD, V99, P4554, DOI 10.1182/blood.V99.12.4554; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Ren YG, 2004, MOL BIOL CELL, V15, P5064, DOI 10.1091/mbc.e04-03-0184; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Sato M, 2001, CYTOKINE GROWTH F R, V12, P133, DOI 10.1016/S1359-6101(00)00032-0; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Shigeno M, 2003, ONCOGENE, V22, P1653, DOI 10.1038/sj.onc.1206139; Stang MT, 2007, ONCOGENE, V26, P6420, DOI 10.1038/sj.onc.1210470; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Van Valen F, 2003, INT J CANCER, V107, P929, DOI 10.1002/ijc.11503; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yang P, 2007, INVEST OPHTH VIS SCI, V48, P3341, DOI 10.1167/iovs.06-1340; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7	39	60	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2767	2777		10.1074/jbc.M804744200	http://dx.doi.org/10.1074/jbc.M804744200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19028697	hybrid			2022-12-27	WOS:000262700900019
J	Pattingre, S; Bauvy, C; Carpentier, S; Levade, T; Levine, B; Codogno, P				Pattingre, Sophie; Bauvy, Chantal; Carpentier, Stephane; Levade, Thierry; Levine, Beth; Codogno, Patrice			Role of JNK1-dependent Bcl-2 Phosphorylation in Ceramide-induced Macroautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR FUNCTION; JUN NH2-TERMINAL KINASE; AUTOPHAGIC CELL-DEATH; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; SELF-DIGESTION; FAMILY-MEMBERS; APOPTOSIS; BECLIN-1; PROTEIN	Macroautophagy is a vacuolar lysosomal catabolic pathway that is stimulated during periods of nutrient starvation to preserve cell integrity. Ceramide is a bioactive sphingolipid associated with a large range of cell processes. Here we show that short-chain ceramides (C-2-ceramide and C-6-ceramide) and stimulation of the de novo ceramide synthesis by tamoxifen induce the dissociation of the complex formed between the autophagy protein Beclin 1 and the anti-apoptotic protein Bcl-2. This dissociation is required for macroautophagy to be induced either in response to ceramide or to starvation. Three potential phosphorylation sites, Thr(69), Ser(70), and Ser(87), located in the non-structural N-terminal loop of Bcl-2, play major roles in the dissociation of Bcl-2 from Beclin 1. We further show that activation of c-Jun N-terminal protein kinase 1 by ceramide is required both to phosphorylate Bcl-2 and to stimulate macroautophagy. These findings reveal a new aspect of sphingolipid signaling in up-regulating a major cell process involved in cell adaptation to stress.	[Pattingre, Sophie; Bauvy, Chantal; Codogno, Patrice] INSERM U756, F-92296 Chatenay Malabry, France; [Pattingre, Sophie; Bauvy, Chantal; Codogno, Patrice] Univ Paris 11, Fac Pharm, F-92296 Chatenay Malabry, France; [Carpentier, Stephane] Univ Toulouse 3, INSERM U858, F-31000 Toulouse, France; [Carpentier, Stephane; Levade, Thierry] Univ Toulouse 3, Inst Med Mol Rangueil, F-31000 Toulouse, France; [Levine, Beth] Howard Hughes Med Inst, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Codogno, P (corresponding author), INSERM U756, 5 Rue Jean Baptiste Clement, F-92296 Chatenay Malabry, France.	patrice.codogno@u-psud.fr	Levade, Thierry/O-8948-2014; Codogno, Patrice/G-1384-2013	Codogno, Patrice/0000-0002-5492-3180; Pattingre, Sophie/0000-0001-6284-6050	National Institutes of Health [R01 CA109618]; INSERM; University Paris-Sud 11; Association pour la Recherche sur le Cancer [3503, 4006]; NATIONAL CANCER INSTITUTE [R01CA109618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris-Sud 11; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA109618 ( to B. L.). This work was also supported by institutional funding from INSERM, from University Paris-Sud 11, and from the Association pour la Recherche sur le Cancer ( Grant 3503 to P. C. and Grant 4006 to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Basu S, 1998, ONCOGENE, V17, P3277, DOI 10.1038/sj.onc.1202570; BAUVY C, 2008, METHODS ENZ IN PRESS; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; Birbes H, 2002, ADV ENZYME REGUL, V42, P113, DOI 10.1016/S0065-2571(01)00026-7; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Bleicher RJ, 2002, BBA-MOL CELL BIOL L, V1585, P172, DOI 10.1016/S1388-1981(02)00338-4; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chaumorcel M, 2008, AUTOPHAGY, V4, P46, DOI 10.4161/auto.5184; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kurinna SM, 2004, CANCER RES, V64, P7852, DOI 10.1158/0008-5472.CAN-04-1552; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lavieu G, 2007, AUTOPHAGY, V3, P45, DOI 10.4161/auto.3416; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Liang CG, 2008, AUTOPHAGY, V4, P268, DOI 10.4161/auto.5210; Liang XH, 2001, CANCER RES, V61, P3443; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; SASLOWSKY DE, 2008, FASEB J IN PRESS; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	78	214	222	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2719	2728		10.1074/jbc.M805920200	http://dx.doi.org/10.1074/jbc.M805920200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029119	Green Published, hybrid			2022-12-27	WOS:000262700900014
J	Wakatsuki, S; Yumoto, N; Komatsu, K; Araki, T; Sehara-Fujisawa, A				Wakatsuki, Shuji; Yumoto, Norihiro; Komatsu, Koji; Araki, Toshiyuki; Sehara-Fujisawa, Atsuko			Roles of Meltrin-beta/ADAM19 in Progression of Schwann Cell Differentiation and Myelination during Sciatic Nerve Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; MELTRIN-BETA ADAM19; AXONAL REGULATION; PERIPHERAL-NERVE; SYSTEM; EXPRESSION; NEUREGULIN-1; CLEAVAGE; INJURY; HEART	Remyelination is an important aspect of nerve regeneration after nerve injury, but the underlying mechanisms are not fully understood. Here, we show that meltrin-beta(ADAM19), a member of the ADAM (a disintegrin and metalloprotease) family, plays crucial roles in nerve regeneration after a crush injury to the sciatic nerves. The expression of meltrin-beta was up-regulated in neurons after the crush injury. Morphometrical analysis revealed a delay in remyelination in meltrin-beta-deficient nerves, whereas no significant defects were observed in their axon elongation. The activation of Krox-20, an indispensable transcription factor for myelination, was delayed in meltrin-beta-deficient nerves and was accompanied by the retarded expression of myelin-related proteins. Expression of Krox-20 in Schwann cells was mediated by Akt. Phosphorylation of Akt but not that of Erks was reduced in regenerating nerves of meltrin-beta-deficient mice. The cell membrane fraction prepared from meltrin-beta-deficient nerves showed a defective activation of Akt in the membrane-loaded Schwann cells. Meltrin-beta-deficient mice exhibited delayed sciatic functional recovery after the nerve crush. Altogether, these results reveal a role of meltrin-beta in Schwann cell differentiation and re-myelination in nerve regeneration. Moreover, this study suggests that meltrin-beta functions as a modulator of juxtacrine signaling from axons that activate the Akt pathway and the Krox-20 expression, which is the prerequisite for Schwann cell differentiation.	[Wakatsuki, Shuji; Yumoto, Norihiro; Komatsu, Koji; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto 6068507, Japan; [Wakatsuki, Shuji; Araki, Toshiyuki] Natl Ctr Neurol & Psychiat, Dept Peripheral Nervous Syst Res, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan	Kyoto University; National Center for Neurology & Psychiatry - Japan	Sehara-Fujisawa, A (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kawahara Cho 53, Kyoto 6068507, Japan.	asehara@frontier.kyoto-u.ac.jp	Messier, Claude/A-2322-2008; Araki, Toshiyuki/H-4289-2019	Messier, Claude/0000-0002-4791-1763; Araki, Toshiyuki/0000-0003-3625-2042	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare; Research for Evolutional Science and Technology; Japan Science and Technology Corporation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST))	This work was funded in part by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology, a Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare, and a Research Grant from Core Research for Evolutional Science and Technology, the Japan Science and Technology Corporation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068; CONTRERAS PC, 1995, J PHARMACOL EXP THER, V274, P1443; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Holmes FE, 2003, P NATL ACAD SCI USA, V100, P6180, DOI 10.1073/pnas.0937087100; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; Inoue D, 1998, J BIOL CHEM, V273, P4180, DOI 10.1074/jbc.273.7.4180; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kim JE, 2003, MOL CELL NEUROSCI, V23, P451, DOI 10.1016/S1044-7431(03)00076-9; Komatsu K, 2007, DEV BIOL, V303, P82, DOI 10.1016/j.ydbio.2006.10.037; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kurohara K, 2004, DEV BIOL, V267, P14, DOI 10.1016/j.ydbio.2003.10.021; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Maurel P, 2000, J NEUROSCI, V20, P4635, DOI 10.1523/JNEUROSCI.20-12-04635.2000; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Pot C, 2002, J CELL BIOL, V159, P29, DOI 10.1083/jcb.200206068; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Salzer JL, 2008, J CELL BIOL, V181, P575, DOI 10.1083/jcb.200804136; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Wakatsuki S, 2004, J NEUROCHEM, V89, P119, DOI 10.1046/j.1471-4159.2003.02303.x; Waller Augustus, 1851, Edinb Med Surg J, V76, P369; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Yin X, 2000, J CELL BIOL, V148, P1009, DOI 10.1083/jcb.148.5.1009; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Zanazzi G, 2001, J CELL BIOL, V152, P1289, DOI 10.1083/jcb.152.6.1289; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	43	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2957	2966		10.1074/jbc.M803191200	http://dx.doi.org/10.1074/jbc.M803191200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049978	hybrid			2022-12-27	WOS:000262700900040
J	Lauffer, BEL; Chen, S; Melero, C; Kortemme, T; von Zastrow, M; Vargas, GA				Lauffer, Benjamin E. L.; Chen, Stanford; Melero, Cristina; Kortemme, Tanja; von Zastrow, Mark; Vargas, Gabriel A.			Engineered Protein Connectivity to Actin Mimics PDZ-dependent Recycling of G Protein-coupled Receptors but Not Its Regulation by Hrs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; MEMBRANE TRAFFICKING; ENDOCYTIC PATHWAY; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; PLASMA-MEMBRANE; SIGNAL; DOMAIN; RESENSITIZATION; BINDING	Many G protein-coupled receptors (GPCRs) recycle after agonist-induced endocytosis by a sequence-dependent mechanism, which is distinct from default membrane flow and remains poorly understood. Efficient recycling of the beta 2-adrenergic receptor (beta 2AR) requires a C-terminal PDZ (PSD-95/Discs Large/ZO-1) protein-binding determinant (PDZbd), an intact actin cytoskeleton, and is regulated by the endosomal protein Hrs (hepatocyte growth factor-regulated substrate). The PDZbd is thought to link receptors to actin through a series of protein interaction modules present in NHERF/EBP50 (Na+/H+ exchanger 3 regulatory factor/ezrin-binding phosphoprotein of 50 kDa) family and ERM(ezrin/radixin/moesin) family proteins. It is not known, however, if such actin connectivity is sufficient to recapitulate the natural features of sequence-dependent recycling. We addressed this question using a receptor fusion approach based on the sufficiency of the PDZbd to promote recycling when fused to a distinct GPCR, the delta-opioid receptor, which normally recycles inefficiently in HEK293 cells. Modular domains mediating actin connectivity promoted receptor recycling with similarly high efficiency as the PDZbd itself, and recycling promoted by all of the domains was actin-dependent. Regulation of receptor recycling by Hrs, however, was conferred only by the PDZbd and not by downstream interaction modules. These results suggest that actin connectivity is sufficient to mimic the core recycling activity of a GPCR-linked PDZbd but not its cellular regulation.	[Chen, Stanford; von Zastrow, Mark; Vargas, Gabriel A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Lauffer, Benjamin E. L.] Univ Calif San Francisco, Program Pharmaceut Sci & Pharmacogenom, San Francisco, CA 94158 USA; [Melero, Cristina; Kortemme, Tanja] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94158 USA; [von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu	Kortemme, Tanja/AAN-3180-2021	Kortemme, Tanja/0000-0002-8494-680X	National Institutes of Health; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by research grants from the National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Galet C, 2004, MOL ENDOCRINOL, V18, P434, DOI 10.1210/me.2003-0293; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; GORDON DJ, 1976, J BIOL CHEM, V251, P4778; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Law PY, 1999, J PHARMACOL EXP THER, V289, P607; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Paasche JD, 2005, MOL PHARMACOL, V67, P1581, DOI 10.1124/mol.104.007013; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reczek D, 2001, J CELL BIOL, V153, P191, DOI 10.1083/jcb.153.1.191; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stanasila L, 2006, J BIOL CHEM, V281, P4354, DOI 10.1074/jbc.M511989200; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; VON ZM, 1992, J BIOL CHEM, V267, P3530; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679	44	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2448	2458		10.1074/jbc.M806370200	http://dx.doi.org/10.1074/jbc.M806370200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19001361	hybrid, Green Published			2022-12-27	WOS:000262545600052
J	Lee, YH; Chatani, E; Sasahara, K; Naiki, H; Goto, Y				Lee, Young-Ho; Chatani, Eri; Sasahara, Kenji; Naiki, Hironobu; Goto, Yuji			A Comprehensive Model for Packing and Hydration for Amyloid Fibrils of beta(2)-Microglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEEDING-DEPENDENT PROPAGATION; SOLID-STATE NMR; GLOBULAR-PROTEINS; HIGH-PRESSURE; H/D-EXCHANGE; 3D STRUCTURE; VOLUME; COMPRESSIBILITY; CONFORMATION; CORE	Volume can provide informative structural descriptions of macromolecules such as proteins in solution because a final volumetric outcome accompanies the exquisite equipoise of packing effects between residues, and residues and waters inside and outside proteins. Here we performed systematic investigations on the volumetric nature of the amyloidogenic conformations of beta(2)-microglobulin (beta 2-m) and its amyloidogenic core peptide, K3, using a high precision densitometer. The transition from the acid-denatured beta 2-m to the mature amyloid fibrils was accompanied by a positive change in the partial specific volume, which was larger than that observed for the transition from the acid-denatured beta(2)-m to the native structure. The data imply that the mature amyloid fibrils are more voluminous than the native structure because of a sparse packing density of side chains. In contrast, the formation of the mature amyloid-like fibrils of the K3 from the random coil was followed by a considerable decrease in the partial specific volume, suggesting a highly compact core structure. Interestingly, the immature amyloid-like fibrils of beta(2)-m exhibited a volume intermediate between those of the mature fibrils of beta(2)- m and K3, because of the core structure at their center and the relatively noncompact region around the core with much hydration. These volumetric differences would result from the nature of main-chain-dominated fibrillogenesis. We suggest comprehensive models for these three types of fibrils illustrating packing and hydrational states.	[Lee, Young-Ho; Chatani, Eri; Sasahara, Kenji; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Lee, Young-Ho; Chatani, Eri; Sasahara, Kenji; Goto, Yuji] Japan Sci & Technol Agcy, CREST, Suita, Osaka 5650871, Japan; [Naiki, Hironobu] Univ Fukui, Fac Med Sci, Fukui 9101193, Japan; [Naiki, Hironobu] Japan Sci & Technol Agcy, CREST, Fukui 9101193, Japan	Osaka University; Japan Science & Technology Agency (JST); University of Fukui; Japan Science & Technology Agency (JST)	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ygoto@protein.osaka-u.ac.jp	Naiki, Hironobu/G-5599-2014		Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for Promotion of Science postdoctoral fellowship	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to Y. G.) and by the Japan Society for Promotion of Science postdoctoral fellowship (to Y.- H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akasaka K, 2007, BIOCHEMISTRY-US, V46, P10444, DOI 10.1021/bi700648b; Chalikian TV, 2003, ANNU REV BIOPH BIOM, V32, P207, DOI 10.1146/annurev.biophys.32.110601.141709; Chalikian TV, 1996, J MOL BIOL, V260, P588, DOI 10.1006/jmbi.1996.0423; Chalikian TV, 1997, J MOL BIOL, V274, P237, DOI 10.1006/jmbi.1997.1394; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chatani E, 2006, J MOL BIOL, V359, P1086, DOI 10.1016/j.jmb.2006.04.023; DeLano W.L, PYMOL MOL GRAPHICS S; DILL KA, 1995, PROTEIN SCI, V4, P561; Dirix C, 2005, J MOL BIOL, V347, P903, DOI 10.1016/j.jmb.2005.01.073; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Gekko K, 2003, BIOCHEMISTRY-US, V42, P13746, DOI 10.1021/bi030115q; GEKKO K, 1979, J PHYS CHEM-US, V83, P2706, DOI 10.1021/j100484a006; Hiramatsu H, 2004, J AM CHEM SOC, V126, P3008, DOI 10.1021/ja0383017; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kihara M, 2006, J BIOL CHEM, V281, P31061, DOI 10.1074/jbc.M605358200; Kozhukh GV, 2002, J BIOL CHEM, V277, P1310, DOI 10.1074/jbc.M108753200; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Plattt GW, 2005, J MOL BIOL, V346, P279, DOI 10.1016/j.jmb.2004.11.035; Royer CA, 2002, BBA-PROTEIN STRUCT M, V1595, P201, DOI 10.1016/S0167-4838(01)00344-2; Sasahara K, 2005, J MOL BIOL, V352, P700, DOI 10.1016/j.jmb.2005.07.033; Sasahara K, 1999, J MOL BIOL, V291, P693, DOI 10.1006/jmbi.1999.2982; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Silva JL, 2002, BBA-PROTEIN STRUCT M, V1595, P250, DOI 10.1016/S0167-4838(01)00348-X; Smirnovas V, 2005, J PHYS CHEM B, V109, P19043, DOI 10.1021/jp053283w; Smirnovas V, 2006, CHEMPHYSCHEM, V7, P1046, DOI 10.1002/cphc.200500717; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; Yamazaki T, 2008, BIOPHYS J, V95, P4540, DOI 10.1529/biophysj.107.123000	38	46	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2169	2175		10.1074/jbc.M806939200	http://dx.doi.org/10.1074/jbc.M806939200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19017634	hybrid, Green Published			2022-12-27	WOS:000262545600026
J	Li, HB; Ray, G; Yoo, BH; Erdogan, M; Rosen, KV				Li, Hongbing; Ray, Gibanananda; Yoo, Byong Hoon; Erdogan, Mete; Rosen, Kirill V.			Down-regulation of Death-associated Protein Kinase-2 Is Required for beta-Catenin-induced Anoikis Resistance of Malignant Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS-INDUCED TRANSFORMATION; COLON-CANCER; UP-REGULATION; C-MYC; EXPRESSION; APOPTOSIS; GROWTH; ACTIVATION; DETACHMENT; TARGET	Resistance of solid tumor cells to anoikis, apoptosis induced by cell detachment from the extracellular matrix, is thought to be critical for the ability of these cells to grow anchorage independently within thee-dimensional tumor masses and from metastases. beta-Catenin, a major oncoprotein, can inhibit anoikis of cancer cells via unknown mechanisms. In an effort to identify these mechanisms we found that beta-catenin blocks anoikis of malignant kidney and intestinal epithelial cells and promotes their anchorage-independent growth by down-regulating death-associated protein kinase-2 (DAPk-2), a pro-apoptotic protein whose cellular functions have so far remained unexplored. We found that beta-catenin-induced down-regulation of DAPk-2 requires the presence of the transcription factor Tcf-4, a known mediator of beta-catenin signaling. We also observed that DAPk-2 contributes to the execution of anoikis of the non-malignant epithelial cells. Thus, beta-catenin-induced down-regulation of DAPk-2 represents a novel signaling mechanism by which beta-catenin promotes the survival of malignant epithelial cells following their detachment from the ECM and enables these cells to grow in an anchorage-independent manner.	[Rosen, Kirill V.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat & Biochem, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Atlantic Res Ctr, Dept Mol Biol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	Rosen, KV (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat & Biochem, Rm C-302,CRC,5849 Univ Ave, Halifax, NS B3H 4H7, Canada.	kirill.rosen@dal.ca		Rosen, Kirill/0000-0002-4317-9907	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada.	Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hiendlmeyer E, 2004, CANCER RES, V64, P1209, DOI 10.1158/0008-5472.CAN-3627-2; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; Inbal B, 2000, MOL CELL BIOL, V20, P1044, DOI 10.1128/MCB.20.3.1044-1054.2000; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kawai T, 1999, ONCOGENE, V18, P3471, DOI 10.1038/sj.onc.1202701; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Labhart P, 2005, P NATL ACAD SCI USA, V102, P1339, DOI 10.1073/pnas.0409578102; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Liu ZP, 2006, J BIOL CHEM, V281, P14738, DOI 10.1074/jbc.M508664200; Liu ZP, 2005, J BIOL CHEM, V280, P37383, DOI 10.1074/jbc.M503724200; LJUBIMOV AV, 1992, INT J CANCER, V50, P562, DOI 10.1002/ijc.2910500412; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Rosen K, 1998, CURR BIOL, V8, P1331, DOI 10.1016/S0960-9822(07)00564-7; Rosen K, 2000, J CELL BIOL, V149, P447, DOI 10.1083/jcb.149.2.447; Rosen K, 2002, J BIOL CHEM, V277, P46123, DOI 10.1074/jbc.M207883200; Rosen K, 2001, J BIOL CHEM, V276, P37273, DOI 10.1074/jbc.M106424200; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Weng ZG, 2002, J BIOL CHEM, V277, P18677, DOI 10.1074/jbc.M105331200; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651	39	34	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2012	2022		10.1074/jbc.M805612200	http://dx.doi.org/10.1074/jbc.M805612200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	18957423	hybrid			2022-12-27	WOS:000262545600008
J	Radyuk, SN; Rebrin, I; Luchak, JM; Michalak, K; Klichko, VI; Sohal, RS; Orr, WC				Radyuk, Svetlana N.; Rebrin, Igor; Luchak, James M.; Michalak, Katarzyna; Klichko, Vladimir I.; Sohal, Rajindar S.; Orr, William C.			The Catalytic Subunit of Drosophila Glutamate-Cysteine Ligase Is a Nucleocytoplasmic Shuttling Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; GLUTATHIONE REDOX STATE; NUCLEAR-LOCALIZATION; MODIFIER SUBUNIT; MELANOGASTER; CELLS; CADMIUM; OVEREXPRESSION; TRAFFICKING; MECHANISMS	GSH concentration is considerably lower in the nucleus than in the cytoplasm; however, it is significantly elevated during active cell proliferation. The main purpose of this study was to understand the mechanism underlying these variations in nuclear/cytoplasmic distribution of GSH. The rate-limiting step in the de novo GSH biosynthesis pathway is catalyzed by glutamate cysteine ligase (GCL), a heterodimer, composed of a catalytic subunit (GCLc) and a modulatory subunit (GCLm). In Drosophila, GCLc, but not GCLm, contains a nuclear localization signal (NLS). Drosophila S2 cells, constitutively expressing regular GCLc protein or expressing GCLc protein with a mutated NLS motif, were generated by transfection. In quiescent S2 cells, GCLc is aggregated in the perinuclear cytosol and the nucleus, whereas GLCm resides solely in the cytosol. In actively proliferating S2 cells, expressing the normal NLS motif, GCLc migrates from the perinuclear cytoplasm into the nucleus, and the nuclear GSH level becomes elevated; in contrast, in proliferating cells, expressing the mutated NLS motif, neither does the GCLc migrate into the nucleus nor does the nuclear GSH amount rise. In S2 cells expressing wild type GCLc, perturbation of cellular redox state by exposure to cadmium resulted in the migration of GCLc into the nucleus but not in cells expressing GCLc with the mutated NLS motif. Overall, results indicated that GSH biosynthesis in the nucleus is associated with migration of only the GCLc subunit from the cytoplasm into the nucleus, and this migration requires the presence of an intact NLS.	[Radyuk, Svetlana N.; Luchak, James M.; Michalak, Katarzyna; Klichko, Vladimir I.; Orr, William C.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; [Rebrin, Igor; Sohal, Rajindar S.] Univ So Calif, Dept Mol Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	Southern Methodist University; University of Southern California	Orr, WC (corresponding author), Dedman Life Sci Bldg,6105 Airline Rd, Dallas, TX 75275 USA.	borr@smu.edu		Radyuk, Svetlana/0000-0002-3467-5255	National Institutes of Health; NIA [RO1-AG15122]; NATIONAL INSTITUTE ON AGING [R01AG015122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, Grant RO1-AG15122 from NIA. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BELLOMO G, 1992, P NATL ACAD SCI USA, V89, P4412, DOI 10.1073/pnas.89.10.4412; Chen ZF, 1998, J PHARMACOL EXP THER, V285, P608; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Daniel S, 2008, BBA-MOL CELL RES, V1783, P1003, DOI 10.1016/j.bbamcr.2008.01.014; Das GC, 2006, MOL CARCINOGEN, V45, P635, DOI 10.1002/mc.20184; Dixon BM, 2008, ANTIOXID REDOX SIGN, V10, P963, DOI 10.1089/ars.2007.1869; Engel R, 2004, EXP CELL RES, V295, P421, DOI 10.1016/j.yexcr.2004.01.012; Fraser JA, 2003, J BIOL CHEM, V278, P46369, DOI 10.1074/jbc.M308035200; Fraser JA, 2002, J BIOL CHEM, V277, P1158, DOI 10.1074/jbc.M106683200; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Hasbold J, 2000, CYTOMETRY, V40, P230, DOI 10.1002/1097-0320(20000701)40:3<230::AID-CYTO8>3.0.CO;2-E; Ho Y.F., 1994, TOXICOLOGIST, V14, P178; HUANG CS, 1993, J BIOL CHEM, V268, P20578; Katti MV, 2000, PROTEIN SCI, V9, P1203, DOI 10.1110/ps.9.6.1203; LASH LH, 1993, PHARMACOLOGIST, V35, P148; Lu Q, 2007, J CELL PHYSIOL, V212, P827, DOI 10.1002/jcp.21079; Manna SK, 1999, ONCOGENE, V18, P4371, DOI 10.1038/sj.onc.1202811; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Patrick Lyn, 2003, Altern Med Rev, V8, P106; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; Rebrin I, 2004, BIOCHEM J, V382, P131, DOI 10.1042/BJ20040506; RIZZINO A, 1978, IN VITRO CELL DEV B, V14, P437; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rodriguez JA, 2004, ONCOGENE, V23, P1809, DOI 10.1038/sj.onc.1207302; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Shi S, 2007, CYTOM PART A, V71A, P686, DOI 10.1002/cyto.a.20434; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Yang PM, 2004, CHEM-BIOL INTERACT, V149, P125, DOI 10.1016/j.cbi.2004.08.001; Zegura B, 2006, MUTAT RES-GEN TOX EN, V611, P25, DOI 10.1016/j.mrgentox.2006.06.038; Zhou T, 2004, TOXICOL LETT, V154, P191, DOI 10.1016/j.toxlet.2004.07.015	35	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2266	2274		10.1074/jbc.M805913200	http://dx.doi.org/10.1074/jbc.M805913200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19036725	Green Published, hybrid			2022-12-27	WOS:000262545600036
J	Tate, JJ; Georis, I; Feller, A; Dubois, E; Cooper, TG				Tate, Jennifer J.; Georis, Isabelle; Feller, Andre; Dubois, Evelyne; Cooper, Terrance G.			Rapamycin-induced Gln3 Dephosphorylation Is Insufficient for Nuclear Localization Sit4 AND PP2A PHOSPHATASES ARE REGULATED AND FUNCTION DIFFERENTLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROGEN CATABOLITE REPRESSION; METHIONINE SULFOXIMINE TREATMENT; RETROGRADE GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TOR PROTEINS; CARBON STARVATION; CELL-GROWTH; PHOSPHORYLATION; TRANSCRIPTION; TAP42	Gln3, the major activator of nitrogen catabolite repression (NCR)-sensitive transcription, is often used as an assay of Tor pathway regulation in Saccharomyces cerevisiae. Gln3 is cytoplasmic in cells cultured with repressive nitrogen sources (Gln) and nuclear with derepressive ones (Pro) or after treating Gln-grown cells with the Tor inhibitor, rapamycin (Rap). In Rap-treated or Pro-grown cells, Sit4 is posited to dephosphorylate Gln3, which then dissociates from a Gln3-Ure2 complex and enters the nucleus. However, in contrast with this view, Sit4-dependent Gln3 dephosphorylation is greater in Gln than Pro. Investigating this paradox, we show that PP2A (another Tor pathway phosphatase)-dependent Gln3 dephosphorylation is regulated oppositely to that of Sit4, being greatest in Pro-and least in Gln-grown cells. It thus parallels nuclear Gln3 localization and NCR-sensitive transcription. However, because PP2A is not required for nuclear Gln3 localization in Pro, PP2A-dependent Gln3 dephosphorylation and nuclear localization are likely parallel responses to derepressive nitrogen sources. In contrast, Rap-induced nuclear Gln3 localization absolutely requires all four PP2A components (Pph21/22, Tpd3, Cdc55, and Rts1). In pph21 Delta 22 Delta, tpd3 Delta, or cdc55 Delta cells, however, Gln3 is dephosphorylated to the same level as in Rap-treated wildtype cells, indicating Rap-induced Gln3 dephosphorylation is insufficient to achieve nuclear localization. Finally, PP2A-dependent Gln3 dephosphorylation parallels conditions where Gln3 is mostly nuclear, while Sit4-dependent and Rap-induced dephosphorylation parallels those where Gln3 is mostly cytoplasmic, suggesting the effects of these phosphatases on Gln3 may occur in different cellular compartments.	[Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; [Georis, Isabelle; Feller, Andre; Dubois, Evelyne] Univ Libre Bruxelles, Microbiol Lab, Inst Rech Microbiol JM Wiame, B-1070 Brussels, Belgium	University of Tennessee System; University of Tennessee Health Science Center; Universite Libre de Bruxelles	Cooper, TG (corresponding author), Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA.	tcooper@utmem.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642]; National Science Foundation [DMS-0443901]; COCOF (Commission de la Communaute francaise); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); COCOF (Commission de la Communaute francaise); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM-35642 from the National Institutes of Health. This work was also supported by the National Science Foundation (DMS-0443901) (to T. C.) and COCOF (Commission de la Communaute francaise) (to E. D. and I. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, MYCOTA, V3, P81; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Puria R, 2008, P NATL ACAD SCI USA, V105, P7194, DOI 10.1073/pnas.0801087105; Rohde JR, 2003, CURR TOP MICROBIOL, V279, P53; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2006, J BIOL CHEM, V281, P28460, DOI 10.1074/jbc.M604171200; Tate JJ, 2002, J BIOL CHEM, V277, P20477, DOI 10.1074/jbc.M200962200; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	42	44	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2522	2534		10.1074/jbc.M806162200	http://dx.doi.org/10.1074/jbc.M806162200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19015262	Green Published, hybrid			2022-12-27	WOS:000262545600058
J	Daniels, RL; Takashima, Y; McKemy, DD				Daniels, Richard L.; Takashima, Yoshio; McKemy, David D.			Activity of the Neuronal Cold Sensor TRPM8 Is Regulated by Phospholipase C via the Phospholipid Phosphoinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; RECEPTOR POTENTIAL MELASTATIN-8; PROTEIN-KINASE-C; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ION CHANNELS; CAPSAICIN RECEPTOR; CATION CHANNEL; LIVING CELLS; K+ CHANNEL; MENTHOL	Cold temperatures robustly activate a small cohort of somatosensory nerves, yet during a prolonged cold stimulus their activity will decrease, or adapt, over time. This process allows for the discrimination of subtle changes in temperature. At the molecular level, cold is detected by transient receptor potential melastatin 8 (TRPM8), a nonselective cation channel expressed on a subset of peripheral afferent fibers. We and others have reported that TRPM8 channels also adapt in a calcium-dependent manner when activated by the cooling compound menthol. Additionally, TRPM8 activity is sensitive to the phospholipid phosphoinositol 4,5-bisphosphate (PIP2), a substrate for the enzyme phospholipase C (PLC). These results suggest an adaptation model whereby TRPM8-mediated Ca2+ influx activates PLC, thereby decreasing PIP2 levels and resulting in reduced TRPM8 activity. Here we tested this model using pharmacological activation of PLC and by manipulating PIP2 levels independent of both PLC and Ca2+. PLC activation leads to adaptation-like reductions in cold- or menthol-evoked TRPM8 currents in both heterologous and native cells. Moreover, PLC-independent reductions in PIP2 had a similar effect on cold- and menthol-evoked currents. Mechanistically, either form of adaptation does not alter temperature sensitivity of TRPM8 but does lead to a change in channel gating. Our results show that adaptation is a shift in voltage dependence toward more positive potentials, reversing the trend toward negative potentials caused by agonist. These data suggest that PLC activity not only mediates adaptation to thermal stimuli, but likely underlies a more general mechanism that establishes the temperature sensitivity of somatosensory neurons.	[Daniels, Richard L.; Takashima, Yoshio; McKemy, David D.] Univ So Calif, Dept Biol Sci, Grad Program Neurosci, Los Angeles, CA 90089 USA; [McKemy, David D.] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	McKemy, DD (corresponding author), 3641 Watt Way,HNB228, Los Angeles, CA 90089 USA.	mckemy@usc.edu		Daniels, Richard/0000-0003-2477-6025	National Institutes of Health (NINDS) [R01 NS054069]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054069] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS054069 (NINDS) (to D.D.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abe J, 2006, NEUROSCI LETT, V397, P140, DOI 10.1016/j.neulet.2005.12.005; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; BYERS MR, 2002, DENT PULP, V3, P151; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Daniels RL, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-23; DARIANSMITH I, 1973, J NEUROPHYSIOL, V36, P325, DOI 10.1152/jn.1973.36.2.325; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hui KY, 2005, BIOCHEM BIOPH RES CO, V333, P374, DOI 10.1016/j.bbrc.2005.05.123; Jajoo S, 2008, NEUROSCIENCE, V151, P525, DOI 10.1016/j.neuroscience.2007.11.010; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KENSHALO DR, 1977, J NEUROPHYSIOL, V40, P319, DOI 10.1152/jn.1977.40.2.319; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Linte RM, 2007, EXP BRAIN RES, V178, P89, DOI 10.1007/s00221-006-0712-3; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nam JH, 2007, J PHYSIOL-LONDON, V582, P977, DOI 10.1113/jphysiol.2007.128413; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Reid G, 2002, NEUROSCI LETT, V324, P164, DOI 10.1016/S0304-3940(02)00181-7; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2008, MOL NEUROBIOL, V37, P153, DOI 10.1007/s12035-008-8027-y; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V455, P157, DOI 10.1007/s00424-007-0275-6; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V453, P753, DOI 10.1007/s00424-006-0153-7; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Xing H, 2006, J NEUROPHYSIOL, V95, P1221, DOI 10.1152/jn.01035.2005; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	60	103	110	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1570	1582		10.1074/jbc.M807270200	http://dx.doi.org/10.1074/jbc.M807270200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19019830	Green Published, hybrid			2022-12-27	WOS:000262330100025
J	Palhano, FL; Leme, LP; Busnardo, RG; Foguel, D				Palhano, Fernando L.; Leme, Larissa P.; Busnardo, Roberta G.; Foguel, Debora			Trapping the Monomer of a Non-amyloidogenic Variant of Transthyretin EXPLORING ITS POSSIBLE USE AS A THERAPEUTIC STRATEGY AGAINST TRANSTHYRETIN AMYLOIDOGENIC DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESSURE; PROTEIN; BINDING; DENATURATION; POLYNEUROPATHY; DISSOCIATION; STABILITY; FIBRIL; INTERMEDIATE; INHIBITORS	Transthyretin (TTR) is a 127-residue homotetrameric beta-sheet-rich protein that transports thyroxine in the blood and cerebrospinal fluid. The deposition of fibrils and amorphous aggregates of TTR in patients' tissues is a hallmark of TTR amyloid disease. Familial amyloidotic polyneuropathy is a hereditary form of TTR amyloidosis that is associated with one among 80 different variants of TTR. The most aggressive variants of TTR are V30M, L55P, and A25T, and the propensity to undergo aggregation seems to be linked to tetramer stability. T119M is a very stable, non-amyloidogenic variant of TTR. Here we show that the combination of high hydrostatic pressure with subdenaturing concentrations of urea (4 M) at 1 degrees C irreversibly dissociates T119M into monomers in less than 30 min in a concentration-dependent fashion. After pressure and urea removal, long lived monomers are the only species present in solution. We took advantage of the slow reassociation kinetics of these monomers into tetramers to produce heterotetramers by mixing the T119M monomers with the tetramers of the aggressive mutants of TTR. Our data show that T119M monomers can be successfully incorporated into all of these tetramers even when the exchange is performed in a more physiological environment such as human plasma; these monomers render the resultant heterotetramers less amyloidogenic. The data presented here are relevant for the understanding of T119M folding and association reactions and provide a protocol for producing T119M monomers that function as inhibitors of TTR aggregation when incorporated into tetramers. This protocol may provide a new strategy for treating TTR diseases for which there is no therapy available other than liver transplantation.	[Foguel, Debora] Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Inst Milenio Biol Estrutural & Biotecnol, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Foguel, D (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrutural, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.	foguel@bioqmed.ufrj.br	Palhano, Fernando/C-2586-2008; Palhano, Fernando/AAB-3144-2021	Palhano, Fernando/0000-0001-5336-632X; Palhano, Fernando/0000-0001-5336-632X; Foguel, Debora/0000-0001-7312-7115	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Comissao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa no Estado do Rio de Janeiro	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Comissao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa no Estado do Rio de Janeiro	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Comissao de Aperfeicoamento de Pessoal de Nivel Superior, and Fundacao de Amparo a Pesquisa no Estado do Rio de Janeiro. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Almeida MR, 2004, BIOCHEM J, V381, P351, DOI 10.1042/BJ20040011; Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; Alves IL, 1997, EUR J BIOCHEM, V249, P662, DOI 10.1111/j.1432-1033.1997.00662.x; Ando Yukio, 2005, Medical Molecular Morphology, V38, P142, DOI 10.1007/s00795-005-0288-1; BRANDTS JF, 1970, BIOCHEMISTRY-US, V9, P1038, DOI 10.1021/bi00806a045; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Eneqvist T, 2000, MOL CELL, V6, P1207, DOI 10.1016/S1097-2765(00)00117-9; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Foguel B, 2004, BIOCHEMISTRY-US, V43, P11361; Foguel D, 2003, P NATL ACAD SCI USA, V100, P9831, DOI 10.1073/pnas.1734009100; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; KITAMURA Y, 1987, J SOLUTION CHEM, V16, P715, DOI 10.1007/BF00652574; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Niraula TN, 2002, J MOL BIOL, V320, P333, DOI 10.1016/S0022-2836(02)00425-4; Olofsson A, 2001, J BIOL CHEM, V276, P39592, DOI 10.1074/jbc.M103599200; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034; Quintas A, 1997, FEBS LETT, V418, P297, DOI 10.1016/S0014-5793(97)01398-7; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; RASBAND W, 2007, IMAGEJ; Reixach N, 2008, J BIOL CHEM, V283, P2098, DOI 10.1074/jbc.M708028200; Royer CA, 2002, BBA-PROTEIN STRUCT M, V1595, P201, DOI 10.1016/S0167-4838(01)00344-2; Saraiva Maria Joao Mascarenhas, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004647; SCHREIBER G, 1995, EXP CLIN ENDOCR DIAB, V103, P75, DOI 10.1055/s-0029-1211332; Sebastiao MP, 2001, J MOL BIOL, V306, P733, DOI 10.1006/jmbi.2000.4415; Sekijima Y, 2003, LAB INVEST, V83, P409, DOI 10.1097/01.LAB.0000059937.11023.1F; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Sousa MM, 2003, PROG NEUROBIOL, V71, P385, DOI 10.1016/j.pneurobio.2003.11.002; TAKASHI R, 1977, P NATL ACAD SCI USA, V74, P2334, DOI 10.1073/pnas.74.6.2334; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843	44	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1443	1453		10.1074/jbc.M807100200	http://dx.doi.org/10.1074/jbc.M807100200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18984591	hybrid			2022-12-27	WOS:000262330100012
J	Singh, M; Gonzales, FA; Cascio, D; Heckmann, N; Chanfreau, G; Feigon, J				Singh, Mahavir; Gonzales, Fernando A.; Cascio, Duilio; Heckmann, Nathanael; Chanfreau, Guillaume; Feigon, Juli			Structure and Functional Studies of the CS Domain of the Essential H/ACA Ribonucleoparticle Assembly Protein SHQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; HUMAN TELOMERASE RNA; HEAT-SHOCK-PROTEIN; CRYSTAL-STRUCTURE; YEAST; P23; LOCALIZATION; SGT1; PSEUDOURIDYLATION; NAF1P	H/ACA ribonucleoprotein particles are essential for ribosomal RNA and telomerase RNA processing and metabolism. Shq1p has been identified as an essential eukaryotic H/ACA small nucleolar (sno) ribonucleoparticle (snoRNP) biogenesis and assembly factor. Shq1p is postulated to be involved in the early biogenesis steps of H/ACA snoRNP complexes, and Shq1p depletion leads to a specific decrease in H/ACA small nucleolar RNA levels and to defects in ribosomal RNA processing. Shq1p contains two predicted domains as follows: an N-terminal CS (named after CHORD-containing proteins and SGT1) or HSP20-like domain, and a C-terminal region of high sequence homology called the Shq1 domain. Here we report the crystal structure and functional studies of the Saccharomyces cerevisiae Shq1p CS domain. The structure consists of a compact anti-parallel beta-sandwich fold that is composed of two beta-sheets containing four and three beta-strands, respectively, and a short alpha-helix. Deletion studies showed that the CS domain is required for the essential functions of Shq1p. Point mutations in residues Phe-6, Gln-10, and Lys-80 destabilize Shq1p in vivo and induce a temperature-sensitive phenotype with depletion of H/ACA small nucleolar RNAs and defects in rRNA processing. Although CS domains are frequently found in co-chaperones of the Hsp90 molecular chaperone, no interaction was detected between the Shq1p CS domain and yeast Hsp90 in vitro. These results show that the CS domain is essential for Shq1p function in H/ACA snoRNP biogenesis in vivo, possibly in an Hsp90-independent manner.	[Singh, Mahavir; Gonzales, Fernando A.; Heckmann, Nathanael; Chanfreau, Guillaume; Feigon, Juli] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cascio, Duilio; Chanfreau, Guillaume; Feigon, Juli] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Feigon, J (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, POB 951569, Los Angeles, CA 90095 USA.	feigon@mbi.ucla.edu	Chanfreau, Guillaume/S-7421-2019; Gonzales-Zubiate, Fernando A/O-2709-2014; Heckmann, Nathanael/GXV-2765-2022	Gonzales-Zubiate, Fernando A/0000-0001-9519-4079; 	National Institutes of Health [GM37254, GM48123]; American Cancer Society Research Scholar [RSG-06-040]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048123, R01GM037254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM37254 and GM48123 (to J.F.). This work was also supported by American Cancer Society Research Scholar Grant RSG-06-040 ( to G. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; Boter M, 2007, PLANT CELL, V19, P3791, DOI 10.1105/tpc.107.050427; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; Charpentier B, 2005, NUCLEIC ACIDS RES, V33, P3133, DOI 10.1093/nar/gki630; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; Dez C, 2002, MOL CELL BIOL, V22, P7053, DOI 10.1128/MCB.22.20.7053-7065.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fatica A, 2002, RNA, V8, P1502, DOI 10.1017/S1355838202022094; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldwasser E, 1966, Prog Nucleic Acid Res Mol Biol, V5, P399, DOI 10.1016/S0079-6603(08)60241-X; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Haslbeck Martin, 2002, Prog Mol Subcell Biol, V28, P37; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Henras A, 1998, EMBO J, V17, P7078, DOI 10.1093/emboj/17.23.7078; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Jin H, 2007, MOL CELL, V26, P205, DOI 10.1016/j.molcel.2007.03.014; Kadota Y, 2008, EMBO REP, V9, P1209, DOI 10.1038/embor.2008.185; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; KOLODRUBETZ D, 1991, YEAST, V7, P79, DOI 10.1002/yea.320070202; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Leulliot N, 2007, J MOL BIOL, V371, P1338, DOI 10.1016/j.jmb.2007.06.031; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Martinez-Yamout MA, 2006, J BIOL CHEM, V281, P14457, DOI 10.1074/jbc.M601759200; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; MORRISSEY JP, 1993, MOL CELL BIOL, V13, P2469, DOI 10.1128/MCB.13.4.2469; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Rozhdestvensky TS, 2003, NUCLEIC ACIDS RES, V31, P869, DOI 10.1093/nar/gkg175; Sambrook J., 2001, MOL CLONING; Sherman F., 1974, METHODS YEAST GENETI; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Theimer CA, 2007, MOL CELL, V27, P869, DOI 10.1016/j.molcel.2007.07.017; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Toogun OA, 2008, MOL CELL BIOL, V28, P457, DOI 10.1128/MCB.01417-07; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Wu HH, 2007, P NATL ACAD SCI USA, V104, P6655, DOI 10.1073/pnas.0701534104; Yang PK, 2002, J BIOL CHEM, V277, P45235, DOI 10.1074/jbc.M207669200; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhu SY, 2004, FASEB J, V18, P940, DOI 10.1096/fj.04-1570hyp; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	66	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1906	1916		10.1074/jbc.M807337200	http://dx.doi.org/10.1074/jbc.M807337200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19019820	Green Published, hybrid			2022-12-27	WOS:000262330100061
J	Crabtree, MJ; Tatham, AL; Al-Wakeel, Y; Warrick, N; Hale, AB; Cai, S; Channon, KM; Alp, NJ				Crabtree, Mark J.; Tatham, Amy L.; Al-Wakeel, Yasir; Warrick, Nicholas; Hale, Ashley B.; Cai, Shijie; Channon, Keith M.; Alp, Nicholas J.			Quantitative Regulation of Intracellular Endothelial Nitric-oxide Synthase (eNOS) Coupling by Both Tetrahydrobiopterin-eNOS Stoichiometry and Biopterin Redox Status INSIGHTS FROM CELLS WITH TET-REGULATED GTP CYCLOHYDROLASE I EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT VASODILATION; SUPEROXIDE-PRODUCTION; DIABETES-MELLITUS; HYPERCHOLESTEROLEMIA; MICE; OVEREXPRESSION; PEROXYNITRITE; NO; 5,6,7,8-TETRAHYDROBIOPTERIN; ATHEROSCLEROSIS	Tetrahydrobiopterin (BH4) is a critical determinant of endothelial nitric-oxide synthase (eNOS) activity. In the absence of BH4, eNOS becomes "uncoupled" and generates superoxide rather than NO. However, the stoichiometry of intracellular BH4/eNOS interactions is not well defined, and it is unclear whether intracellular BH4 deficiency alone is sufficient to induce eNOS uncoupling. To address these questions, we developed novel cell lines with tet-regulated expression of human GTP cyclohydrolase I (GTPCH), the rate-limiting enzyme in BH4 synthesis, to selectively induce intracellular BH4 deficiency by incubation with doxycycline. These cells were stably co-transfected to express a human eNOS-green fluorescent protein fusion protein, selecting clones expressing either low (GCH/eNOS-LOW) or high (GCH/eNOS-HIGH) levels. Doxycycline abolished GTPCH mRNA expression and GTPCH protein, leading to markedly diminished total biopterin levels and a decreased ratio of BH4 to oxidized biopterins in cells expressing eNOS. Intracellular BH4 deficiency induced superoxide generation from eNOS, as assessed by N-nitro-L-arginine methyl ester inhibitable 2-hydroxyethidium generation, and attenuated NO production. Quantitative analysis of cellular BH4 versus superoxide production between GCH/eNOS-LOW and GCH/eNOS-HIGH cells revealed a striking linear relationship between eNOS protein and cellular BH4 stoichiometry, with eNOS uncoupling at eNOS: BH4 molar ratio >1. Furthermore, increasing the intracellular BH2 concentration in the presence of a constant eNOS: BH4 ratio was sufficient to induce eNOS-dependent superoxide production. This specific, reductionist approach in a cell-based system reveals that eNOS: BH4 reaction stoichiometry together with the intracellular BH4:BH2 ratio, rather than absolute concentrations of BH4, are the key determinants of eNOS uncoupling, even in the absence of exogenous oxidative stress.	[Crabtree, Mark J.; Tatham, Amy L.; Al-Wakeel, Yasir; Warrick, Nicholas; Hale, Ashley B.; Cai, Shijie; Channon, Keith M.; Alp, Nicholas J.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Oxford	Alp, NJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	nicholas.alp@well.ox.ac.uk		Crabtree, Mark/0000-0003-3298-2697; channon, keith/0000-0002-1043-4342	British Heart Foundation [PG/05/141/20098, RG/02/006]; Wellcome Trust Clinician Scientist Fellowship [GR074428/Z/04/Z]; British Heart Foundation [RG/07/003/23133] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust Clinician Scientist Fellowship(Wellcome Trust); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Project Grant PG/05/141/20098, British Heart Foundation Programme Grant RG/02/006, and Wellcome Trust Clinician Scientist Fellowship GR074428/Z/04/Z. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Antoniades C, 2006, CIRCULATION, V114, P1193, DOI 10.1161/CIRCULATIONAHA.106.612325; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; Cai SJ, 2005, CARDIOVASC RES, V65, P823, DOI 10.1016/j.cardiores.2004.10.040; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; de Bono JP, 2007, NITRIC OXIDE-BIOL CH, V16, P1, DOI 10.1016/j.niox.2006.03.008; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Fukuda Y, 2002, HEART, V87, P264, DOI 10.1136/heart.87.3.264; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; HEALES S, 1989, J CHROMATOGR-BIOMED, V494, P77, DOI 10.1016/S0378-4347(00)82658-4; Heitzer T, 2000, CIRC RES, V86, pE36, DOI 10.1161/01.RES.86.2.e36; Heitzer T, 2000, DIABETOLOGIA, V43, P1435, DOI 10.1007/s001250051551; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Hurshman AR, 1999, BIOCHEMISTRY-US, V38, P15689, DOI 10.1021/bi992026c; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; KOJIMA S, 1995, FREE RADICAL RES, V23, P419, DOI 10.3109/10715769509065263; Kuzkaya N, 2003, J BIOL CHEM, V278, P22546, DOI 10.1074/jbc.M302227200; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; McDonald DM, 2004, PHARMACOGENETICS, V14, P831, DOI 10.1097/00008571-200412000-00006; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; PANZA JA, 1995, CIRCULATION, V91, P1732, DOI 10.1161/01.CIR.91.6.1732; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; Schmidt PP, 2001, J BIOL INORG CHEM, V6, P151, DOI 10.1007/s007750000185; Stroes E, 1998, FEBS LETT, V438, P161, DOI 10.1016/S0014-5793(98)01292-7; Stroes E, 1997, J CLIN INVEST, V99, P41, DOI 10.1172/JCI119131; Timimi FK, 1998, J AM COLL CARDIOL, V31, P552, DOI 10.1016/S0735-1097(97)00536-6; Ting HH, 1997, CIRCULATION, V95, P2617, DOI 10.1161/01.CIR.95.12.2617; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 2003, FREE RADICAL RES, V37, P121, DOI 10.1080/1071576021000040655; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Vasquez-Vivar J, 2001, FREE RADICAL BIO MED, V31, P975, DOI 10.1016/S0891-5849(01)00680-3; Vasquez-Vivar J., 2004, BIOL MAGN RESON, P75; Werner-Felmayer G, 1996, METHODS NITRIC OXIDE, P271; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	40	146	154	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1136	1144		10.1074/jbc.M805403200	http://dx.doi.org/10.1074/jbc.M805403200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19011239	hybrid			2022-12-27	WOS:000262122900050
J	Roland, JT; Lapierre, LA; Goldenring, JR				Roland, Joseph T.; Lapierre, Lynne A.; Goldenring, James R.			Alternative Splicing in Class V Myosins Determines Association with Rab10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; UNCONVENTIONAL MYOSIN; INTERACTING PROTEIN-2; FLUORESCENT PROTEIN; AMPA RECEPTORS; EXON-B; TRANSPORT; EXPRESSION; FAMILY; IDENTIFICATION	Rab proteins influence vesicle trafficking pathways through the assembly of regulatory protein complexes. Previous investigations have documented that Rab11a and Rab8a can interact with the tail region of myosin Vb and regulate distinct trafficking pathways. We have now determined that a related Rab protein, Rab10, can interact with myosin Va, myosin Vb, and myosin Vc. Rab10 localized to a system of tubules and vesicles that have partially overlapping localization with Rab8a. Both Rab8a and Rab10 were mislocalized by the expression of dominant-negative myosin V tails. Interaction with Rab10 was dependent on the presence of the alternatively spliced exon D in myosin Va and myosin Vb and the homologous region in myosin Vc. Yeast two-hybrid assays and fluorescence resonance energy transfer studies confirmed that Rab10 binding to myosin V tails in vivo required the alternatively spliced exon D. In contrast to our previous work, we found that Rab11a can interact with both myosin Va and myosin Vb tails independent of their splice isoform. These results indicate that Rab GTPases regulate diverse endocytic trafficking pathways through recruitment of multiple myosin V isoforms.	[Goldenring, James R.] Vanderbilt Univ, Sch Med, Dept Surg, Epithelial Biol Program, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Nashville Vet Affairs Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Goldenring, JR (corresponding author), Vanderbilt Univ, Sch Med, Dept Surg, Epithelial Biol Program, 4160A MRB III,465 21st St S, Nashville, TN 37232 USA.	jim.goldenring@vanderbilt.edu	Roland, Joseph/C-9592-2013		National Institutes of Health [R01 DK070856, R01 DK48370, F32 DK072789]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK072789, R01DK048370, P30DK020593, U2CDK059637, P60DK020593, P30DK058404, U24DK059637, R01DK070856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK070856 ( NIDDK) and R01 DK48370 ( to J. R. G.) and F32 DK072789 ( to J. T. R.).	Au JSY, 2002, CELL MOTIL CYTOSKEL, V53, P89, DOI 10.1002/cm.10061; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P6549, DOI 10.1073/pnas.91.14.6549; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Casavola EC, 2008, MOL MICROBIOL, V67, P1051, DOI 10.1111/j.1365-2958.2008.06106.x; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; CHEN YT, 1993, P NATL ACAD SCI USA, V90, P6508, DOI 10.1073/pnas.90.14.6508; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; ESPINDOLA FS, 1992, J CELL BIOL, V118, P359, DOI 10.1083/jcb.118.2.359; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Futter CE, 2006, PIGM CELL RES, V19, P104, DOI 10.1111/j.1600-0749.2006.00303.x; Goldenring JR, 1996, AM J PHYSIOL-GASTR L, V270, pG515, DOI 10.1152/ajpgi.1996.270.3.G515; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hobdy-Henderson KC, 2003, TRAFFIC, V4, P681, DOI 10.1034/j.1600-0854.2003.00124.x; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; Huang JD, 1998, GENETICS, V148, P1963; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Lambert J, 1998, BIOCHEM BIOPH RES CO, V252, P329, DOI 10.1006/bbrc.1998.9644; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lapierre LA, 2007, AM J PHYSIOL-GASTR L, V292, pG1249, DOI 10.1152/ajpgi.00505.2006; Lindsay AJ, 2002, J BIOL CHEM, V277, P27193, DOI 10.1074/jbc.M200757200; Lipatova Z, 2008, MOL BIOL CELL, V19, P4177, DOI 10.1091/mbc.E08-02-0220; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NAGATA K, 1990, FEBS LETT, V275, P29, DOI 10.1016/0014-5793(90)81431-M; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schuck S, 2007, TRAFFIC, V8, P47, DOI 10.1111/j.1600-0854.2006.00506.x; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Westbroek W, 2003, J INVEST DERMATOL, V120, P465, DOI 10.1046/j.1523-1747.2003.12068.x; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760	55	80	83	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1213	1223		10.1074/jbc.M805957200	http://dx.doi.org/10.1074/jbc.M805957200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008234	hybrid, Green Published			2022-12-27	WOS:000262122900057
J	Guo, J; Longshore, S; Nair, R; Warner, BW				Guo, Jun; Longshore, Shannon; Nair, Rajalakshmi; Warner, Brad W.			Retinoblastoma Protein (pRb), but Not p107 or p130, Is Required for Maintenance of Enterocyte Quiescence and Differentiation in Small Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN SYNTHESIS; CELL-SURFACE MEMBRANE; RB FAMILY PROTEINS; CRYPT-VILLUS AXIS; STEM-CELLS; GASTROINTESTINAL-TRACT; EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; POCKET PROTEINS	The function of retinoblastoma protein (pRb) in the regulation of small intestine epithelial cell homeostasis has been challenged by several groups using various promoter-based Cre transgenic mouse lines. Interestingly, different pRb deletion systems yield dramatically disparate small intestinal phenotypes. These findings confound the function of pRb in this dynamic tissue. In this study, Villin-Cre transgenic mice were crossed with Rb (flox/flox) mice to conditionally delete pRb protein in small intestine enterocytes. We discovered a novel hyperplasia phenotype as well as ectopic cell cycle reentry within villus enterocytes in the small intestine. This phenotype was not seen in other pRb family member (p107 or p130) null mice. Using a newly developed crypt/villus isolation method, we uncovered that expression of pRb was undetectable, whereas proliferating cell nuclear antigen, p107, cyclin E, cyclin D3, Cdk2, and Cdc2 were dramatically increased in pRb-deficient villus cells. Cyclin A, cyclin D1, cyclin D2, and Cdk4/6 expression was not affected by absent pRb expression. pRb-deficient villus cells appeared capable of progressing to mitosis but with higher rates of apoptosis. However, the cycling villus enterocytes were not completely differentiated as gauged by significant reduction of intestinal fatty acid-binding protein expression. In summary, pRb, but not p107 or p130, is required for maintaining the postmitotic villus cell in quiescence, governing the expression of cell cycle regulatory proteins, and completing of absorptive enterocyte differentiation in the small intestine.	[Guo, Jun; Longshore, Shannon; Nair, Rajalakshmi; Warner, Brad W.] Washington Univ, St Louis Childrens Hosp, Sch Med, Div Pediat Surg, St Louis, MO 63110 USA	St. Louis Children's Hospital; Washington University (WUSTL)	Warner, BW (corresponding author), Washington Univ, St Louis Childrens Hosp, Sch Med, Div Pediat Surg, 1 Childrens Pl,Ste 5S60, St Louis, MO 63110 USA.	Brad.Warner@wustl.edu			National Institutes of Health [RO1 DK53234, T32 CA009621, P30DK52574]; NATIONAL CANCER INSTITUTE [T32CA009621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK053234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK53234 (to B. W. W.), T32 CA009621 (to S. L.), and P30DK52574 (to Morphology and Murine Models Cores of the Digestive Diseases Research Core Center of the Washington University School of Medicine). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Chandrasekaran C, 1996, J BIOL CHEM, V271, P28414, DOI 10.1074/jbc.271.45.28414; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P4614, DOI 10.3748/wjg.v12.i29.4614; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FLINT N, 1991, BIOCHEM J, V280, P331, DOI 10.1042/bj2800331; Haegebarth A, 2006, MOL CELL BIOL, V26, P4949, DOI 10.1128/MCB.01901-05; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; HAUFT SM, 1992, J CELL BIOL, V117, P825, DOI 10.1083/jcb.117.4.825; Kucherlapati MH, 2008, P NATL ACAD SCI USA, V105, P15493, DOI 10.1073/pnas.0802933105; Kucherlapati MH, 2006, CANCER RES, V66, P3576, DOI 10.1158/0008-5472.CAN-05-2699; Levine RA, 1998, EXP CELL RES, V239, P264, DOI 10.1006/excr.1997.3898; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; Marino S, 2000, GENE DEV, V14, P994; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rathi AV, 2007, J VIROL, V81, P9481, DOI 10.1128/JVI.00922-07; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Saenz-Robles MT, 2007, J VIROL, V81, P13191, DOI 10.1128/JVI.01658-07; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Smartt HJM, 2007, GASTROENTEROLOGY, V133, P232, DOI 10.1053/j.gastro.2007.04.043; Taylor JA, 2008, J PEDIATR SURG, V43, P1018, DOI 10.1016/j.jpedsurg.2008.02.025; TRABER PG, 1991, AM J PHYSIOL, V260, pG895, DOI 10.1152/ajpgi.1991.260.6.G895; Vidal A, 2007, FRONT BIOSCI-LANDMRK, V12, P4483, DOI 10.2741/2403; Wang Y, 2007, DEV BIOL, V311, P478, DOI 10.1016/j.ydbio.2007.08.052; WEISER MM, 1973, J BIOL CHEM, V248, P2542; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; Wikenheiser-Brokamp KA, 2004, DEVELOPMENT, V131, P4299, DOI 10.1242/dev.01232; Yang HS, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-6	37	57	58	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					134	140		10.1074/jbc.M806133200	http://dx.doi.org/10.1074/jbc.M806133200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18981186	Green Published, hybrid			2022-12-27	WOS:000261974800015
J	Horiguchi, K; Shirakihara, T; Nakano, A; Imamura, T; Miyazono, K; Saitoh, M				Horiguchi, Kana; Shirakihara, Takuya; Nakano, Ayako; Imamura, Takeshi; Miyazono, Kohei; Saitoh, Masao			Role of Ras Signaling in the Induction of Snail by Transforming Growth Factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TGF-BETA; CANCER PROGRESSION; TUMOR SUPPRESSION; H-RAS; CELLS; PATHWAYS; METASTASIS; PANCREAS; ADENOCARCINOMA	The epithelial-mesenchymal transition (EMT) is a crucial morphological event that occurs during the progression of epithelial tumors. EMT can be induced by transforming growth factor (TGF)-beta in some tumor cells. Here, we demonstrate the molecular mechanism whereby Snail, a key regulator of EMT, is induced by TGF-beta in tumor cells. Snail induction by TGF-beta was highly dependent on cooperation with active Ras signals, and silencing of Ras abolished Snail induction by TGF-beta in pancreatic cancer Panc-1 cells. Transfection of constitutively active Ras into HeLa cells led to induction of Snail by TGF-beta, while representative direct targets of TGF-beta, including Smad7 and PAI-1, were not affected by Ras signaling. Using mitogen-activated protein kinase inhibitors or Smad3 or Smad2 mutants, we found that phosphorylation at the linker region of Smad2/3 was not required for the induction of Snail by TGF-beta. Taken together, these findings indicate that Ras and TGF-beta-Smad signaling selectively cooperate in the induction of Snail, which occurs in a Smad-dependent manner, but independently of phosphorylation at the linker region of R-Smads by Ras signaling.	[Horiguchi, Kana; Shirakihara, Takuya; Miyazono, Kohei; Saitoh, Masao] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Nakano, Ayako; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, Tokyo 1358550, Japan	University of Tokyo; Japanese Foundation for Cancer Research	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp		Shirakihara, Takuya/0000-0002-6222-0143	KAKENHI; Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by KAKENHI (Grants-in-Aid for Scientific Research) and the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges.	Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; EHATA S, 2006, CANCER SCI, V67, P9694; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Filmus Jorge, 1993, Current Opinion in Oncology, V5, P123; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; HOUCK KA, 1989, ONCOGENE, V4, P19; HOWE PH, 1993, J BIOL CHEM, V268, P21448; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kawasaki K, 2008, J CELL BIOL, V181, P131, DOI 10.1083/jcb.200709127; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; LONGSTREET M, 1992, ONCOGENE, V7, P1549; MITCHELL CE, 1995, ANAL BIOCHEM, V224, P148, DOI 10.1006/abio.1995.1020; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Rajesh D, 1999, MOL PHARMACOL, V56, P515, DOI 10.1124/mol.56.3.515; Sakorafas GH, 2000, CANCER TREAT REV, V26, P29, DOI 10.1053/ctrv.1999.0144; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; SCHWARZ LC, 1988, CANCER RES, V48, P6999; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; VALVERIUS EM, 1989, CANCER RES, V49, P6269; Watanabe M, 1996, INT J CANCER, V67, P264, DOI 10.1002/(SICI)1097-0215(19960717)67:2<264::AID-IJC18>3.0.CO;2-B; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	40	170	173	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					245	253		10.1074/jbc.M804777200	http://dx.doi.org/10.1074/jbc.M804777200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19010789	hybrid			2022-12-27	WOS:000261974800028
J	Furuta, K; Edamatsu, M; Maeda, Y; Toyoshima, YY				Furuta, Ken'ya; Edamatsu, Masaki; Maeda, Yurina; Toyoshima, Yoko Y.			Diffusion and Directed Movement IN VITRO MOTILE PROPERTIES OF FISSION YEAST KINESIN-14 Pkl1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE MOTOR PROTEIN; MITOTIC SPINDLE FUNCTION; DIRECTIONAL MOTILITY; COILED-COIL; TAIL DOMAIN; NCD; MOLECULES; KAR3; GENE; ORGANIZATION	Fission yeast Pkl1 is a kinesin-14A family member that is known to be localized at the cellular spindle and is capable of hydrolyzing ATP. However, its motility has not been detected. Here, we show that Pkl1 is a slow, minus end-directed microtubule motor with a maximum velocity of 33 +/- 9 nm/s. The K-m,K-MT value of steady-state ATPase activity of Pkl1 was as low as 6.4 +/- 1.1 nM, which is 20-30 times smaller than that of kinesin-1 and another kinesin-14A family member, Ncd, indicating a high affinity of Pkl1 for microtubules. However, the duty ratio of 0.05 indicates that Pkl1 spends only a small fraction of the ATPase cycle strongly associated with a microtubule. By using total internal reflection fluorescence microscopy, we demonstrated that single molecules of Pkl1 were not highly processive but only exhibited biased one-dimensional diffusion along microtubules, whereas several molecules of Pkl1, probably fewer than 10 molecules, cooperatively moved along microtubules and substantially reduced the diffusive component in the movement. Our results suggest that Pkl1 molecules work in groups to move and generate forces in a cooperative manner for their mitotic functions.	[Furuta, Ken'ya; Edamatsu, Masaki; Maeda, Yurina; Toyoshima, Yoko Y.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	University of Tokyo	Toyoshima, YY (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.	cyytoyo@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant-in-aid for scientific research (B) from the Japan Society for the Promotion of Science (JSPS), a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology, a Core Research for Evolutional Science and Technology program grant from the Japan Science and Technology Agency, and a grant-in-aid for JSPS fellows from JSPS. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P591; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; deCastro MJ, 1999, BIOCHEMISTRY-US, V38, P5076, DOI 10.1021/bi9829175; ENDOW SA, 1994, EMBO J, V13, P2708, DOI 10.1002/j.1460-2075.1994.tb06561.x; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; Garcia MA, 2002, CURR BIOL, V12, P610, DOI 10.1016/S0960-9822(02)00761-3; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Grishchuk EL, 2007, MOL BIOL CELL, V18, P2216, DOI 10.1091/mbc.E06-11-0987; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; HAGAN I, 1990, NATURE, V347, P563, DOI 10.1038/347563a0; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; HATSUMI M, 1992, J CELL SCI, V103, P1013; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J., 2001, MECH MOTOR PROTEINS; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Inoue Y, 2001, BIOPHYS J, V81, P2838, DOI 10.1016/S0006-3495(01)75925-5; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Lakamper S, 2003, BIOPHYS J, V84, P1833, DOI 10.1016/S0006-3495(03)74991-1; Lupas A, 1996, METHOD ENZYMOL, V266, P513; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; OCONNELL MJ, 1993, J CELL BIOL, V120, P153, DOI 10.1083/jcb.120.1.153; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Paluh JL, 2000, MOL BIOL CELL, V11, P1225, DOI 10.1091/mbc.11.4.1225; Pidoux AL, 1996, MOL BIOL CELL, V7, P1639, DOI 10.1091/mbc.7.10.1639; Pierce DW, 1999, BIOCHEMISTRY-US, V38, P5412, DOI 10.1021/bi9830009; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rodriguez AS, 2008, CELL CYCLE, V7, P1246, DOI 10.4161/cc.7.9.5808; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Stock MF, 2003, J BIOL CHEM, V278, P52315, DOI 10.1074/jbc.M309419200; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tao L, 2006, CURR BIOL, V16, P2293, DOI 10.1016/j.cub.2006.09.064; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858	47	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36465	36473		10.1074/jbc.M803730200	http://dx.doi.org/10.1074/jbc.M803730200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984586	Green Published, hybrid			2022-12-27	WOS:000261840500044
J	Willard, FS; Zheng, Z; Guo, J; Digby, GJ; Kimple, AJ; Conley, JM; Johnston, CA; Bosch, D; Willard, MD; Watts, VJ; Lambert, NA; Ikeda, SR; Du, QS; Siderovski, DP				Willard, Francis S.; Zheng, Zhen; Guo, Juan; Digby, Gregory J.; Kimple, Adam J.; Conley, Jason M.; Johnston, Christopher A.; Bosch, Dustin; Willard, Melinda D.; Watts, Val J.; Lambert, Nevin A.; Ikeda, Stephen R.; Du, Quansheng; Siderovski, David P.			A Point Mutation to G alpha(i) Selectively Blocks GoLoco Motif Binding DIRECT EVIDENCE FOR G alpha.GoLoco COMPLEXES IN MITOTIC SPINDLE DYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC CELL-DIVISION; HETEROTRIMERIC G-PROTEIN; DISSOCIATION INHIBITOR ACTIVITY; G-ALPHA-I; CAENORHABDITIS-ELEGANS EMBRYOS; VOLTAGE-DEPENDENT MODULATION; GUANINE-NUCLEOTIDE EXCHANGE; RAT SYMPATHETIC NEURONS; ENDOGENOUS RGS PROTEINS; BETA-GAMMA-SUBUNITS	Heterotrimeric G-protein G alpha subunits and GoLoco motif proteins are key members of a conserved set of regulatory proteins that influence invertebrate asymmetric cell division and vertebrate neuroepithelium and epithelial progenitor differentiation. GoLoco motif proteins bind selectively to the inhibitory subclass (G alpha(i)) of G alpha subunits, and thus it is assumed that a G alpha(i.)GoLoco motif protein complex plays a direct functional role in microtubule dynamics underlying spindle orientation and metaphase chromosomal segregation during cell division. To address this hypothesis directly, we rationally identified a point mutation to G alpha(i) subunits that renders a selective loss-of-function for GoLoco motif binding, namely an asparagine-to-isoleucine substitution in the alpha D-alpha E loop of the G alpha helical domain. This GoLoco-insensitivity ("GLi") mutation prevented G alpha(i1) association with all human GoLoco motif proteins and abrogated interaction between the Caenorhabditis elegans G alpha sub-unit GOA-1 and the GPR-1 GoLoco motif. In contrast, the GLi mutation did not perturb any other biochemical or signaling properties of G alpha(i) subunits, including nucleotide binding, intrinsic and RGS protein-accelerated GTP hydrolysis, and interactions with G beta gamma dimers, adenylyl cyclase, and seven transmembrane-domain receptors. GoLoco insensitivity rendered G alpha(i) subunits unable to recruit GoLoco motif proteins such as GPSM2/LGN and GPSM3 to the plasma membrane, and abrogated the exaggerated mitotic spindle rocking normally seen upon ectopic expression of wild type G alpha(i) subunits in kidney epithelial cells. This GLi mutation should prove valuable in establishing the physiological roles of G alpha(i).GoLoco motif protein complexes in microtubule dynamics and spindle function during cell division as well as to delineate potential roles for GoLoco motifs in receptor-mediated signal transduction.	[Willard, Francis S.; Kimple, Adam J.; Johnston, Christopher A.; Bosch, Dustin; Willard, Melinda D.; Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Zheng, Zhen; Du, Quansheng] Med Coll Georgia, Inst Mol Med & Genet, Dept Neurol, Augusta, GA 30912 USA; [Digby, Gregory J.; Lambert, Nevin A.] Med Coll Georgia, Inst Mol Med & Genet, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Guo, Juan; Ikeda, Stephen R.] NIAAA, Lab Mol Physiol, Bethesda, MD 20892 USA; [Conley, Jason M.; Watts, Val J.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47906 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Augusta University; University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Willard, FS (corresponding author), Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.	willardfs@lilly.com	Siderovski, David Peter/AAA-9603-2019; Watts, Val/A-4633-2012	Siderovski, David Peter/0000-0002-0688-8210; Ikeda, Stephen/0000-0002-4088-9508; Bosch, Dustin/0000-0002-7430-2939; Kimple, Adam/0000-0003-1670-8401; Du, Quansheng/0000-0003-4079-8662	National Institutes of Health [R01 GM074268, GM079506, GM078319, MH060397, F32 GM07694, F30 MH074266]; NIAAA intramural program; American Cancer Society [RSG0717601CSM]; National Science Foundation [0620024]; American Heart Association; PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079506, R01GM078319, R01GM074268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH074266, R01MH060397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAAA intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM074268 (to D.P.S.), GM079506 (to Q.D.), GM078319 (to N.A.L.), MH060397 (to V.J.W.), F32 GM07694 (to C.A.J.), and F30 MH074266 (to A.J.K.). This work was also supported by the NIAAA intramural program (to S. R. I.), American Cancer Society Grant RSG0717601CSM (to Q.D.), National Science Foundation Grant MCB 0620024 (to N.A.L.), and fellowships from the American Heart Association (to G.J.D.) and the PhRMA Foundation (to M.D.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; BRANDT DR, 1985, J BIOL CHEM, V260, P266; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; FERGUSON KM, 1986, J BIOL CHEM, V261, P7393; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Fu Y, 2004, METHOD ENZYMOL, V389, P229; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Guo J, 2004, MOL PHARMACOL, V65, P665, DOI 10.1124/mol.65.3.665; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Ikeda SR, 2004, METHOD ENZYMOL, V389, P170; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Jeong SW, 2000, P NATL ACAD SCI USA, V97, P907, DOI 10.1073/pnas.97.2.907; Jeong SW, 1999, J NEUROSCI, V19, P4755; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Johnston CA, 2008, J BIOL CHEM, V283, P21550, DOI 10.1074/jbc.M803023200; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Kammermeier PJ, 2003, MOL PHARMACOL, V63, P183, DOI 10.1124/mol.63.1.183; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Meng JW, 1999, J BIOL CHEM, V274, P36663, DOI 10.1074/jbc.274.51.36663; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Natochin M, 2002, BIOCHEMISTRY-US, V41, P258, DOI 10.1021/bi015708k; Nguyen CH, 2005, BIOCHEM BIOPH RES CO, V332, P913, DOI 10.1016/j.bbrc.2005.05.041; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Vidi PA, 2008, MOL PHARMACOL, V74, P544, DOI 10.1124/mol.108.047472; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Watts VJ, 1999, PSYCHOPHARMACOLOGY, V141, P83, DOI 10.1007/s002130050810; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; Willard FS, 2007, CELL SIGNAL, V19, P428, DOI 10.1016/j.cellsig.2006.07.013; Willard FS, 2006, CELL SIGNAL, V18, P1226, DOI 10.1016/j.cellsig.2005.10.003; Willard FS, 2006, BIOCHEM BIOPH RES CO, V339, P1107, DOI 10.1016/j.bbrc.2005.11.132; Willard FS, 2005, ANAL BIOCHEM, V340, P341, DOI 10.1016/j.ab.2005.02.015; Willard FS, 2004, METHOD ENZYMOL, V389, P320; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; WILLARD MD, 2009, HDB CELL SIGNALING; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	80	38	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36698	36710		10.1074/jbc.M804936200	http://dx.doi.org/10.1074/jbc.M804936200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984596	Green Published, hybrid			2022-12-27	WOS:000261840500068
J	Kumari, D; Usdin, K				Kumari, Daman; Usdin, Karen			Chromatin Remodeling in the Noncoding Repeat Expansion Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FRAGILE-X-SYNDROME; HISTONE DEACETYLASE INHIBITORS; FRIEDREICHS-ATAXIA; MYOTONIC-DYSTROPHY; TRINUCLEOTIDE REPEAT; EPIGENETIC CHANGES; TRIPLET REPEATS; FRATAXIN GENE; CTG REPEATS; FMR-1 GENE	Friedreich ataxia, myotonic dystrophy type 1 and 3 forms of intellectual disability, fragile X syndrome, FRAXE mental retardation, and FRA12A mental retardation are repeat expansion diseases caused by expansion of CTG.CAG, GAA.TTC, or CGG.CCG repeat tracts. These repeats are transcribed but not translated. They are located in different parts of different genes and cause symptoms that range from ataxia and hypertrophic cardiomyopathy to muscle wasting, male infertility, and mental retardation, yet recent reports suggest that, despite these differences, the repeats may share a common property, namely the ability to initiate repeat-mediated epigenetic changes that result in heterochromatin formation.	[Kumari, Daman; Usdin, Karen] NIDDK, Sect Gene Struct & Dis, Mol & Cellular Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Usdin, K (corresponding author), NIDDK, Sect Gene Struct & Dis, Mol & Cellular Biol Lab, NIH, Bethesda, MD 20892 USA.	ku@helix.nih.gov	Kumari, Daman/AAN-6704-2020		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057602, Z01DK057602] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Amiri K, 2008, ARCH NEUROL-CHICAGO, V65, P19, DOI 10.1001/archneurol.2007.30; Beilina A, 2004, HUM MOL GENET, V13, P543, DOI 10.1093/hmg/ddh053; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chiurazzi P, 1998, HUM MOL GENET, V7, P109, DOI 10.1093/hmg/7.1.109; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Fry M., 2006, HUMAN NUCLEOTIDE EXP; Gecz J, 1996, NAT GENET, V13, P105, DOI 10.1038/ng0596-105; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P4930, DOI 10.1093/nar/28.24.4930; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; Handa V, 2003, NUCLEIC ACIDS RES, V31, P6243, DOI 10.1093/nar/gkg818; Heidenfelder BL, 2003, J BIOL CHEM, V278, P2425, DOI 10.1074/jbc.M210643200; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Maueler W, 2001, GENE, V270, P131, DOI 10.1016/S0378-1119(01)00487-5; Naumann F, 2004, GENOMICS, V83, P106, DOI 10.1016/S0888-7543(03)00212-X; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Pietrobono R, 2005, HUM MOL GENET, V14, P267, DOI 10.1093/hmg/ddi024; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; SMITH SS, 1994, J MOL BIOL, V243, P143, DOI 10.1006/jmbi.1994.1640; Sutherland GR, 2003, CYTOGENET GENOME RES, V100, P77, DOI 10.1159/000072840; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115; TOMITA N, 2002, NUCL ACIDS RES S, V2, P231; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang YH, 2007, FRONT BIOSCI-LANDMRK, V12, P4731, DOI 10.2741/2422; Wells R.D., 2006, GENETIC INSTABILITIE; WELLS RD, 2009, FASEB J IN PRESS; Winnepenninckx B, 2007, AM J HUM GENET, V80, P221, DOI 10.1086/510800	44	45	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2009	284	12					7413	7417		10.1074/jbc.R800026200	http://dx.doi.org/10.1074/jbc.R800026200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	419CB	18957431	Green Published, hybrid			2022-12-27	WOS:000264195600003
J	Stone, SJ; Levin, MC; Zhou, P; Han, JY; Walther, TC; Farese, RV				Stone, Scot J.; Levin, Malin C.; Zhou, Ping; Han, Jiayi; Walther, Tobias C.; Farese, Robert V., Jr.			The Endoplasmic Reticulum Enzyme DGAT2 Is Found in Mitochondria-associated Membranes and Has a Mitochondrial Targeting Signal That Promotes Its Association with Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE ACTIVITY; RED FLUORESCENT PROTEIN; RAT-LIVER; TRIACYLGLYCEROL SYNTHESIS; LIPID DROPLETS; ACYL-COA; SACCHAROMYCES-CEREVISIAE; CONTACT SITES; MONOMERIC RED; BIOSYNTHESIS	The synthesis and storage of neutral lipids in lipid droplets is a fundamental property of eukaryotic cells, but the spatial organization of this process is poorly understood. Here we examined the intracellular localization of acyl-CoA: diacylglycerol acyltransferase 2 (DGAT2), an enzyme that catalyzes the final step of triacylglycerol (TG) synthesis in eukaryotes. We found that DGAT2 expressed in cultured cells localizes to the endoplasmic reticulum (ER) under basal conditions. After providing oleate to drive TG synthesis, DGAT2 also localized to near the surface of lipid droplets, where it co-localized with mitochondria. Biochemical fractionation revealed that DGAT2 is present in mitochondria-associated membranes, specialized domains of the ER that are highly enriched in lipid synthetic enzymes and interact tightly with mitochondria. The interaction of DGAT2 with mitochondria depended on 67 N-terminal amino acids of DGAT2, which are not conserved in family members that have different catalytic functions. This targeting signal was sufficient to localize a red fluorescent protein to mitochondria. A highly conserved, positively charged, putative mitochondrial targeting signal was identified in murine DGAT2 between amino acids 61 and 66. Thus, DGAT2, an ER-resident transmembrane domain-containing enzyme, is also found in mitochondria-associated membranes, where its N terminus may promote its association with mitochondria.	[Stone, Scot J.; Han, Jiayi] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Levin, Malin C.; Zhou, Ping; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Levin, Malin C.; Farese, Robert V., Jr.] Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Walther, Tobias C.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Farese, Robert V., Jr.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	University of Saskatchewan; University of California System; University of California San Francisco; The J David Gladstone Institutes; Max Planck Society; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Farese, RV (corresponding author), J David Gladstone Inst, 1650 Owens St, San Francisco, CA 94158 USA.	bfarese@gladstone.ucsf.edu		Levin, Malin/0000-0003-1069-5275; Walther, Tobias/0000-0003-1442-1327	National Institutes of Health [5R01-DK065599]; American Heart Association scientist development grant; Hillblom postdoctoral fellowship;  [CO6RR018928]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association scientist development grant(American Heart Association); Hillblom postdoctoral fellowship; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01-DK065599 ( to R. V. F.). This work was also supported by an American Heart Association scientist development grant ( to S. S.), a Hillblom postdoctoral fellowship ( to M. L.), and the J. David Gladstone Institutes and National Institutes of Health/NCRR Grant CO6RR018928 to the J. David Gladstone Institutes.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ANDERSSON M, 1994, J LIPID RES, V35, P535; ARDAIL D, 1993, J BIOL CHEM, V268, P25985; ARDAIL D, 1991, J BIOL CHEM, V266, P7978; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brindley D. N, 1991, BIOCH LIPIDS LIPOPRO, P171; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; COLEMAN R, 1976, J BIOL CHEM, V251, P4537; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; CUI Z, 1993, J BIOL CHEM, V268, P16655; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; GUNSTONE FD, 1994, LIPID HDB, P646; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; STEMBERGER BH, 1984, CELL TISSUE RES, V236, P471, DOI 10.1007/BF00214252; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Sturmey RG, 2006, REPRODUCTION, V132, P829, DOI 10.1530/REP-06-0073; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wakimoto K, 2003, BIOCHEM BIOPH RES CO, V310, P296, DOI 10.1016/j.bbrc.2003.09.015; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; WILGRAM GF, 1963, J BIOL CHEM, V238, P2615; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200	55	254	263	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					5352	5361		10.1074/jbc.M805768200	http://dx.doi.org/10.1074/jbc.M805768200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19049983	hybrid, Green Published			2022-12-27	WOS:000263416600065
J	Frost, B; Ollesch, J; Wille, H; Diamond, MI				Frost, Bess; Ollesch, Julian; Wille, Holger; Diamond, Marc I.			Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE PRION PROTEIN; MUTANT-TAU; PEPTIDES; DEMENTIA; POLYMERIZATION; PROPAGATION; PHENOTYPES; FILAMENTS; ISOFORMS; FTDP-17	Tauopathies are sporadic and genetic neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau. Tau pathology occurs in over 20 phenotypically distinct neurodegenerative diseases, including Alzheimer disease and frontotemporal dementia. The molecular basis of this diversity among sporadic tauopathies is unknown, but distinct fibrillar wild-type (WT) Tau conformations could play a role. Using Fourier transform infrared spectroscopy, circular dichroism, and electron microscopy, we show that WT Tau fibrils and P301L/V337M Tau fibrils have distinct secondary structures, fragilities, and morphologies. Furthermore, P301L/V337M fibrillar seeds induce WT Tau monomer to form a novel fibrillar conformation, termed WT*, that is maintained over multiple seeding reactions. WT* has secondary structure, fragility, and morphology that are similar to P301L/V337M fibrils and distinct from WT fibrils. WT Tau is thus capable of conformational diversity that arises via templated conformation change, as has been described for amyloid beta, beta(2)-microglobulin, and prion proteins.	[Frost, Bess; Wille, Holger; Diamond, Marc I.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Frost, Bess; Diamond, Marc I.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Frost, Bess; Diamond, Marc I.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [Ollesch, Julian; Wille, Holger; Diamond, Marc I.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Diamond, MI (corresponding author), Univ Calif San Francisco, GH S572B 600 16th St, San Francisco, CA 94143 USA.	marc.diamond@ucsf.edu	Wille, Holger/C-2280-2008	Wille, Holger/0000-0001-5102-8706; Frost, Bess/0000-0002-1212-8138	National Institutes of Health Grant [R01 NS50284-03]; National Institutes of Health Training Grant for Neurodegenerative Diseases; Sandler Family Supporting Foundation; Taube Family Foundation Program in Huntington's Disease Research, and the Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant for Neurodegenerative Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Supporting Foundation; Taube Family Foundation Program in Huntington's Disease Research, and the Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or part, by National Institutes of Health Grant R01 NS50284-03 from NINDS (to M. I. D.) and a National Institutes of Health Training Grant for Neurodegenerative Diseases (to B. F.). This work was also supported by the Sandler Family Supporting Foundation, the Taube Family Foundation Program in Huntington's Disease Research, and the Muscular Dystrophy Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi R, 2007, J BIOL CHEM, V282, P8978, DOI 10.1074/jbc.M611738200; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Hofmann MW, 2004, P NATL ACAD SCI USA, V101, P14776, DOI 10.1073/pnas.0405175101; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; Ollesch J, 2008, EUR BIOPHYS J BIOPHY, V37, P435, DOI 10.1007/s00249-007-0233-4; Ollesch J, 2007, APPL SPECTROSC, V61, P1025, DOI 10.1366/000370207782217680; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wille H, 2007, ARCH BIOCHEM BIOPHYS, V467, P239, DOI 10.1016/j.abb.2007.08.010; WILSON DM, 1995, J BIOL CHEM, V270, P24306, DOI 10.1074/jbc.270.41.24306; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Yamaguchi K, 2005, J MOL BIOL, V352, P952, DOI 10.1016/j.jmb.2005.07.061	25	161	164	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3546	3551		10.1074/jbc.M805627200	http://dx.doi.org/10.1074/jbc.M805627200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19010781	Green Published, hybrid			2022-12-27	WOS:000262872500022
J	Pal, A; Kraetzner, R; Gruene, T; Grapp, M; Schreiber, K; Gronborg, M; Urlaub, H; Becker, S; Asif, AR; Gartner, J; Sheldrick, GM; Steinfeld, R				Pal, Aritra; Kraetzner, Ralph; Gruene, Tim; Grapp, Marcel; Schreiber, Kathrin; Gronborg, Mads; Urlaub, Henning; Becker, Stefan; Asif, Abdul R.; Gaertner, Jutta; Sheldrick, George M.; Steinfeld, Robert			Structure of Tripeptidyl-peptidase I Provides Insight into the Molecular Basis of Late Infantile Neuronal Ceroid Lipofuscinosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; CARBOXYL PROTEINASE; CLN2; AMINOPEPTIDASE; KUMAMOLISIN; INHIBITOR; MUTATIONS; PROTEASE; RAT	Late infantile neuronal ceroid lipofuscinosis, a fatal neurodegenerative disease of childhood, is caused by mutations in the TPP1 gene that encodes tripeptidyl-peptidase I. We show that purified TPP1 requires at least partial glycosylation for in vitro autoprocessing and proteolytic activity. We crystallized the fully glycosylated TPP1 precursor under conditions that implied partial autocatalytic cleavage between the prosegment and the catalytic domain. X-ray crystallographic analysis at 2.35 angstrom resolution reveals a globular structure with a subtilisin-like fold, a Ser(475) -Glu(272) -Asp(360) catalytic triad, and an octahedrally coordinated Ca2+ -binding site that are characteristic features of the S53 sedolisin family of peptidases. In contrast to other S53 peptidases, the TPP1 structure revealed steric constraints on the P4 substrate pocket explaining its preferential cleavage of tripeptides from the unsubstituted N terminus of proteins. Two alternative conformations of the catalytic Asp(276) are associated with the activation status of TPP1. 28 disease-causing missense mutations are analyzed in the light of the TPP1 structure providing insight into the molecular basis of late infantile neuronal ceroid lipofuscinosis.	[Kraetzner, Ralph; Grapp, Marcel; Schreiber, Kathrin; Gaertner, Jutta; Steinfeld, Robert] Univ Gottingen, Dept Pediat & Pediat Neurol, D-37075 Gottingen, Germany; [Pal, Aritra; Gruene, Tim; Sheldrick, George M.] Univ Gottingen, Dept Struct Chem, D-34077 Gottingen, Germany; [Gronborg, Mads; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Becker, Stefan] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Asif, Abdul R.] Univ Gottingen, Dept Clin Chem, Proteom & Mass Spectrometry Facil, D-37075 Gottingen, Germany	University of Gottingen; University of Gottingen; Max Planck Society; Max Planck Society; University of Gottingen	Steinfeld, R (corresponding author), Univ Gottingen, Dept Pediat & Pediat Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany.	rsteinfeld@med.uni-goettingen.de	Asif, Abdul Rahman/G-7924-2011; Asif, Abdul R./A-9432-2016	Asif, Abdul R./0000-0002-8581-3187; Steinfeld, Robert/0000-0003-0956-6601	Fonds der Chemischen Industrie	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; Comellas-Bigler M, 2004, STRUCTURE, V12, P1313, DOI 10.1016/j.str.2004.04.013; Comellas-Bigler M, 2002, STRUCTURE, V10, P865, DOI 10.1016/S0969-2126(02)00772-4; DOEBBER TW, 1978, ENDOCRINOLOGY, V103, P1794, DOI 10.1210/endo-103-5-1794; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezaki J, 2000, BIOCHEM BIOPH RES CO, V268, P904, DOI 10.1006/bbrc.2000.2207; Golabek AA, 2004, J BIOL CHEM, V279, P31058, DOI 10.1074/jbc.M400700200; Golabek AA, 2008, J BIOL CHEM, V283, P16497, DOI 10.1074/jbc.M800458200; GUHANIYOGI J, 2009, J BIOL CHEM IN PRESS, V284; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyama H, 2005, J BIOCHEM, V138, P127, DOI 10.1093/jb/mvi110; Rawlings ND, 1999, BBA-PROTEIN STRUCT M, V1429, P496, DOI 10.1016/S0167-4838(98)00238-6; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sleat DE, 1999, AM J HUM GENET, V64, P1511, DOI 10.1086/302427; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Steinfeld R, 2004, HUM MOL GENET, V13, P2483, DOI 10.1093/hmg/ddh264; Tian Y, 2006, J BIOL CHEM, V281, P6559, DOI 10.1074/jbc.M507336200; Tsiakas K, 2004, GLYCOBIOLOGY, V14, p1C, DOI 10.1093/glycob/cwh054; Vines D, 1998, BBA-PROTEIN STRUCT M, V1384, P233, DOI 10.1016/S0167-4838(98)00012-0; Warburton MJ, 2001, FEBS LETT, V500, P145, DOI 10.1016/S0014-5793(01)02608-4; Wlodawer A, 2004, J BIOL CHEM, V279, P21500, DOI 10.1074/jbc.M401141200; Wlodawer A, 2001, NAT STRUCT BIOL, V8, P442, DOI 10.1038/87610; Wlodawer Alexander, 2003, BMC Struct Biol, V3, P8, DOI 10.1186/1472-6807-3-8; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200	28	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3976	3984		10.1074/jbc.M806947200	http://dx.doi.org/10.1074/jbc.M806947200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19038966	hybrid, Green Published			2022-12-27	WOS:000262872500066
J	Cai, CX; Masumiya, H; Weisleder, N; Pan, Z; Nishi, MK; Komazaki, SJ; Takeshima, H; Ma, JJ				Cai, Chuanxi; Masumiya, Haruko; Weisleder, Noah; Pan, Zui; Nishi, Miyuki; Komazaki, Shinji; Takeshima, Hiroshi; Ma, Jianjie			MG53 Regulates Membrane Budding and Exocytosis in Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE-MUSCULAR-DYSTROPHY; RING-FINGER PROTEIN; SKELETAL-MUSCLE; RYANODINE RECEPTORS; MONKEY TRIM5-ALPHA; SARCOPLASMIC-RETICULUM; TRIAD JUNCTION; CAVEOLIN-3; RESTRICTION; DOMAINS	Membrane recycling and remodeling contribute to multiple cellular functions, including cell fusion events during myogenesis. We have identified a tripartite motif (TRIM72) family member protein named MG53 and defined its role in mediating the dynamic process of membrane fusion and exocytosis in striated muscle. MG53 is a muscle-specific protein that contains a TRIM motif at the amino terminus and a SPRY motif at the carboxyl terminus. Live cell imaging of green fluorescent protein-MG53 fusion construct in cultured myoblasts showed that although MG53 contains no trans-membrane segment it is tightly associated with intracellular vesicles and sarcolemmal membrane. RNA interference-mediated knockdown of MG53 expression impeded myoblast differentiation, whereas overexpression of MG53 enhanced vesicle trafficking to and budding from sarcolemmal membrane. Co-expression studies indicated that MG53 activity is regulated by a functional interaction with caveolin-3. Our data reveal a new function for TRIM family proteins in regulating membrane trafficking and fusion in striated muscles.	[Masumiya, Haruko; Nishi, Miyuki; Takeshima, Hiroshi] Tohoku Univ, Grad Sch Med, Dept Med Chem, Sendai, Miyagi 9808575, Japan; [Cai, Chuanxi; Weisleder, Noah; Pan, Zui; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA; [Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; [Komazaki, Shinji] Saitama Med Univ, Dept Anat, Saitama 3500495, Japan	Tohoku University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Kyoto University; Saitama Medical University	Takeshima, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Chem, Sendai, Miyagi 9808575, Japan.	takeshim@pharm.kyoto-u.ac.jp; maj2@umdnj.edu	Cai, Chuanxi/AAW-1488-2020; Weisleder, Noah L/A-7098-2013; Liu, FL/D-1795-2009	Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088; Takeshima, Hiroshi/0000-0003-4525-3725; Pan, Zui/0000-0003-4105-901X	National Institutes of Health; Chinese Natural Science Foundation; Ministry of Education, Science, Sports and Culture of Japan	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in whole or in part, by National Institutes of Health grants ( to J.M. and N.W.). This work was also supported by grants from the Chinese Natural Science Foundation ( to J.M.) and the Ministry of Education, Science, Sports and Culture of Japan ( to H. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bolanos-Jimenez F, 2001, GENE, V274, P217, DOI 10.1016/S0378-1119(01)00606-0; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chakrabarty T, 2002, P NATL ACAD SCI USA, V99, P6011, DOI 10.1073/pnas.082024299; Fiori MG, 1996, CLIN NEUROPATHOL, V15, P240; FLUCHER BE, 1992, DEV BIOL, V150, P266, DOI 10.1016/0012-1606(92)90241-8; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Galbiati F, 2000, P NATL ACAD SCI USA, V97, P9689, DOI 10.1073/pnas.160249097; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Ho M, 2004, HUM MOL GENET, V13, P1999, DOI 10.1093/hmg/ddh212; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Komazaki S, 1999, DEV DYNAM, V215, P87, DOI 10.1002/(SICI)1097-0177(199906)215:2<87::AID-DVDY1>3.3.CO;2-P; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Li YK, 2001, J BIOL CHEM, V276, P40824, DOI 10.1074/jbc.M106141200; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Nishi M, 1999, J CELL BIOL, V147, P1473, DOI 10.1083/jcb.147.7.1473; Oshikawa J, 2004, P NATL ACAD SCI USA, V101, P12670, DOI 10.1073/pnas.0402053101; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Scriven DRL, 2005, BIOPHYS J, V89, P1893, DOI 10.1529/biophysj.105.064212; Smith RD, 2005, AM J PHYSIOL-CELL PH, V288, pC982, DOI 10.1152/ajpcell.00120.2004; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H, 1998, BIOCHEM J, V331, P317, DOI 10.1042/bj3310317; VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5; van Diepen MT, 2005, MOL CELL NEUROSCI, V29, P74, DOI 10.1016/j.mcn.2005.01.005; Vichi A, 2005, P NATL ACAD SCI USA, V102, P1945, DOI 10.1073/pnas.0409800102; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Wang YQ, 2004, BIOCHEM BIOPH RES CO, V323, P9, DOI 10.1016/j.bbrc.2004.08.048; Ward NL, 2004, BIOCHEM BIOPH RES CO, V323, P937, DOI 10.1016/j.bbrc.2004.08.185; Wei XL, 2003, J BIOL CHEM, V278, P29288, DOI 10.1074/jbc.M212215200; Weisleder N, 2008, CELL CALCIUM, V43, P1, DOI 10.1016/j.ceca.2007.10.006	44	90	100	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3314	3322		10.1074/jbc.M808866200	http://dx.doi.org/10.1074/jbc.M808866200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029292	Green Published, hybrid			2022-12-27	WOS:000262700900074
J	Pan, MR; Chang, HC; Wu, YC; Huang, CC; Hung, WC				Pan, Mei-Ren; Chang, Hui-Chiu; Wu, Yang-Chang; Huang, Chao-Cheng; Hung, Wen-Chun			Tubocapsanolide A Inhibits Transforming Growth Factor-beta-activating Kinase 1 to Suppress NF-kappa B-induced CCR7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPH-NODE METASTASIS; CHEMOKINE RECEPTOR CCR7; WITHANIA-SOMNIFERA LEAVES; CELL LUNG-CANCER; BREAST-CANCER; TUMOR-CELLS; LEUKEMIA-CELLS; WITHAFERIN-A; EXPRESSION; WITHANOLIDES	Withanolides are C-28 steroidal lactones isolated from plants that exhibit potent anti-cancer activity. The chemokine receptor CCR7 is important for lymphatic invasion of cancer cells and is overexpressed in metastatic breast cancer cells. A bioactive withanolide tubocapsanolide A (Tubo A) suppressed NF-kappa B-mediated CCR7 expression in breast cancer cells and attenuated their migration toward lymphatic endothelial cells. Chromatin immunoprecipitation assay confirmed that binding of NF-kappa B to the consensus site localized at the -398/-389 of human CCR7 promoter was repressed by Tubo A. Tubo A inhibited I kappa B kinase (IKK) and p38 kinase and downstream mitogen and stress-activated protein kinase 1 (MSK1) activity to reduce I kappa B degradation and to suppress NF-kappa B activation. Co-expression of IKK and MSK1 fully rescued Tubo A-induced inhibition. In addition, ectopic expression of transforming growth factor-beta-activating kinase (TAK1), the common upstream kinase of IKK and MSK1, also completely reversed the inhibition by Tubo A. Most importantly, Tubo A reduced NF-kappa B activation, CCR7 expression, and lymph node metastasis of breast cancer in vivo. We conclude that Tubo A inhibits TAK1 to repress NF-kappa B-induced CCR7 expression in breast cancer cells and suggest that Tubo A may be useful for the prevention of lymphatic invasion of breast cancer cells.	[Wu, Yang-Chang; Hung, Wen-Chun] Kaohsiung Med Univ, Natl Sun Yat Sen Univ, Joint Res Ctr, Kaohsiung 804, Taiwan; [Pan, Mei-Ren; Chang, Hui-Chiu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung 807, Taiwan; [Wu, Yang-Chang] Kaohsiung Med Univ, Grad Inst Nat Prod, Kaohsiung 807, Taiwan; [Hung, Wen-Chun] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan; [Huang, Chao-Cheng] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Pathol, Kaohsiung 833, Taiwan; [Hung, Wen-Chun] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan	Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University	Hung, WC (corresponding author), Kaohsiung Med Univ, Natl Sun Yat Sen Univ, Joint Res Ctr, Kaohsiung 804, Taiwan.	hung1228@ms10.hinet.net	Hung, Wen-Chun/F-4846-2011; Wu, Yang-Chang/C-5682-2009; Wu, Yang-Chang/D-1471-2011; Pan, Mei-Ren/I-2021-2013	Wu, Yang-Chang/0000-0001-7815-2686; 	National Sun Yat-Sen University; Kaohsiung Medical University Joint Research Center and Center for Gene Regulation and Signal Transduction Research, National Cheng Kung University	National Sun Yat-Sen University; Kaohsiung Medical University Joint Research Center and Center for Gene Regulation and Signal Transduction Research, National Cheng Kung University	This study was supported by the National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center and Center for Gene Regulation and Signal Transduction Research, National Cheng Kung University (to W.-C. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Chang HC, 2007, MOL CANCER THER, V6, P1572, DOI 10.1158/1535-7163.MCT-06-0812; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Chen X, 2005, BLOOD, V106, P2409, DOI 10.1182/blood-2005-03-0854; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Devi P. Uma, 2000, Indian Journal of Experimental Biology, V38, P432; Ding YZ, 2003, CLIN CANCER RES, V9, P3406; Fattal E, 2006, ADV DRUG DELIVER REV, V58, P1203, DOI 10.1016/j.addr.2006.07.020; FUSKA J, 1984, NEOPLASMA, V31, P31; Hasegawa H, 2000, BLOOD, V95, P30; Hopken UE, 2002, BLOOD, V99, P1109, DOI 10.1182/blood.V99.4.1109; Hsieh PW, 2007, J NAT PROD, V70, P747, DOI 10.1021/np0605541; Hsu MC, 2006, J BIOL CHEM, V281, P4718, DOI 10.1074/jbc.M510937200; Ichikawa H, 2006, MOL CANCER THER, V5, P1434, DOI 10.1158/1535-7163.MCT-06-0096; Izbicki JR, 1997, NEW ENGL J MED, V337, P1188, DOI 10.1056/NEJM199710233371702; Jayaprakasam B, 2003, TETRAHEDRON, V59, P841, DOI 10.1016/S0040-4020(02)01601-0; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kubuschok B, 1999, J CLIN ONCOL, V17, P19, DOI 10.1200/JCO.1999.17.1.19; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; LEE YC, 1995, J CELL BIOCHEM, V57, P150, DOI 10.1002/jcb.240570115; Leyon PV, 2004, PHYTOTHER RES, V18, P118, DOI 10.1002/ptr.1378; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; Mashino K, 2002, CANCER RES, V62, P2937; Mathur R, 2006, J ETHNOPHARMACOL, V105, P336, DOI 10.1016/j.jep.2005.11.020; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 2004, J DERMATOL SCI, V36, P71, DOI 10.1016/j.jdermsci.2004.03.002; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Pan MR, 2008, J BIOL CHEM, V283, P11155, DOI 10.1074/jbc.M710038200; Prang N, 2005, BRIT J CANCER, V92, P342, DOI 10.1038/sj.bjc.6602310; Qin W Z, 1983, J Tradit Chin Med, V3, P131; Schimanski CC, 2005, CLIN CANCER RES, V11, P1743, DOI 10.1158/1078-0432.CCR-04-1195; Taichman RS, 2002, CANCER RES, V62, P1832; Takanami I, 2003, INT J CANCER, V105, P186, DOI 10.1002/ijc.11063; Takeuchi H, 2004, CLIN CANCER RES, V10, P2351, DOI 10.1158/1078-0432.CCR-03-0195; TAO XL, 1989, CHINESE MED J-PEKING, V102, P327; THAUKUR RS, 1989, MAJOR MED PLANTS IND, P531; Till KJ, 2002, BLOOD, V99, P2977, DOI 10.1182/blood.V99.8.2977; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769	47	22	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2746	2754		10.1074/jbc.M806223200	http://dx.doi.org/10.1074/jbc.M806223200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049961	hybrid			2022-12-27	WOS:000262700900017
J	Kamiya, T; Tanaka, M; Mitani, N; Ma, JF; Maeshima, M; Fujiwara, T				Kamiya, Takehiro; Tanaka, Mayuki; Mitani, Namiki; Ma, Jian Feng; Maeshima, Masayoshi; Fujiwara, Toru			NIP1;1, an Aquaporin Homolog, Determines the Arsenite Sensitivity of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICE; TRANSPORTERS; EXPRESSION; ANTIMONITE; TOLERANCE; PROTEINS; GROWTH; GENES; SET	Arsenite [As(III)] is highly toxic to organisms, including plants. Very recently, transporters in rice responsible for As(III) transport have been described (Ma, J. F., Yamaji, N., Mitani, N., Xu, X. Y., Su, Y. H., McGrath, S. P., and Zhao, F. J. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 9931-9935), but little is known about As(III) tolerance. In this study, three independent As(III)-tolerant mutants were isolated from ethyl methanesulfonate-mutagenized M2 seeds of Arabidopsis thaliana. All three mutants carried independent mutations in Nodulin 26-like intrinsic protein 1;1 (NIP1;1), a homolog of an aquaporin. Two independent transgenic lines carrying T-DNA in NIP1; 1 were highly tolerant to As(III), establishing that NIP1;1 is the causal gene of As(III) tolerance. Because an aquaglyceroporin is able to transport As(III), we measured As(III) transport activity. When expressed in Xenopus oocytes, NIP1; 1 was capable of transporting As(III). As content in the mutant plants was 30% lower than in wild-type plants. Promoter beta-glucuronidase and real-time PCR analysis showed that NIP1; 1 is highly expressed in roots, and GFP-NIP1;1 is localized to the plasma membrane. These data show that NIP1; 1 is involved in As(III) uptake into roots and that disruption of NIP1; 1 function confers As(III) tolerance to plants. NIP1;2 and NIP5;1, closely related homologs of NIP1;1, were also permeable to As(III). Although the disruption of these genes reduced the As content in plants, As(III) tolerance was not observed in nip1;2 and nip5;1 mutants. This indicates that As(III) tolerance cannot be simply explained by decreased As contents in plants.	[Kamiya, Takehiro; Tanaka, Mayuki; Fujiwara, Toru] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Mitani, Namiki; Ma, Jian Feng] Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan; [Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Fujiwara, Toru] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Chuo Ku, Tokyo 1030027, Japan	University of Tokyo; Okayama University; Nagoya University; Japan Science & Technology Agency (JST)	Fujiwara, T (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	atorufu@mail.ecc.u-tokyo.ac.jp	Kamiya, Takehiro/AAU-1703-2020; Tanaka, Mayuki/GQB-2552-2022; FUJIWARA, Toru/A-4119-2011; Maeshima, Masayoshi/D-3073-2013; Ma, Jianfeng/GZB-0110-2022; Feng, Jian/C-7213-2009	Kamiya, Takehiro/0000-0003-3790-7119; Maeshima, Masayoshi/0000-0002-1611-5481; Feng, Jian/0000-0003-3411-827X	Japanese Society for the Promotion of Science; Ministry of Agriculture, Forestry, and Fisheries of Japan [IPG-0005]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; PROBRAIN; Grants-in-Aid for Scientific Research [21228002] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PROBRAIN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Japanese Society for the Promotion of Science ( to T. K.), from the Ministry of Agriculture, Forestry, and Fisheries of Japan ( Genomics for Agricultural Innovation Grant IPG-0005 ( to T. F.), a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan ( to T. F.), and PROBRAIN ( to M. M.).	Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Figarella K, 2007, MOL MICROBIOL, V65, P1006, DOI 10.1111/j.1365-2958.2007.05845.x; Isayenkov SV, 2008, FEBS LETT, V582, P1625, DOI 10.1016/j.febslet.2008.04.022; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Kamiya T, 2006, PLANT CELL PHYSIOL, V47, P96, DOI 10.1093/pcp/pci227; Kataoka T, 2004, PLANT CELL, V16, P2693, DOI 10.1105/tpc.104.023960; Kinniburgh DG, 2001, ARSENIC CONTAMINATIO; Liu ZJ, 2004, J BIOL CHEM, V279, P17312, DOI 10.1074/jbc.M314006200; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; MARIN AR, 1992, PLANT SOIL, V139, P175, DOI 10.1007/BF00009308; Meharg AA, 2004, TRENDS PLANT SCI, V9, P415, DOI 10.1016/j.tplants.2004.07.002; Meharg AA, 2003, NEW PHYTOL, V157, P39, DOI 10.1046/j.1469-8137.2003.00655.x; Oremland RS, 2003, SCIENCE, V300, P939, DOI 10.1126/science.1081903; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raab A, 2004, PLANT PHYSIOL, V134, P1113, DOI 10.1104/pp.103.033506; Rahman MA, 2007, CHEMOSPHERE, V67, P1072, DOI 10.1016/j.chemosphere.2006.11.061; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Sanders OI, 1997, J BACTERIOL, V179, P3365, DOI 10.1128/jb.179.10.3365-3367.1997; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tripathi RD, 2007, TRENDS BIOTECHNOL, V25, P158, DOI 10.1016/j.tibtech.2007.02.003; *US EPA, 1992, METH DET MET ENV SAM; Weig AR, 2000, FEBS LETT, V481, P293, DOI 10.1016/S0014-5793(00)02027-5; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x; Zardoya R, 2002, P NATL ACAD SCI USA, V99, P14893, DOI 10.1073/pnas.192573799	32	149	158	1	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2114	2120		10.1074/jbc.M806881200	http://dx.doi.org/10.1074/jbc.M806881200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19029297	hybrid			2022-12-27	WOS:000262545600020
J	Jung, S; Dingley, AJ; Augustin, R; Anton-Erxleben, F; Stanisak, M; Gelhaus, C; Gutsmann, T; Hammer, MU; Podschun, R; Bonvin, AMJJ; Leippe, M; Bosch, TCG; Grotzinger, J				Jung, Sascha; Dingley, Andrew J.; Augustin, Rene; Anton-Erxleben, Friederike; Stanisak, Mareike; Gelhaus, Christoph; Gutsmann, Thomas; Hammer, Malte U.; Podschun, Rainer; Bonvin, Alexandre M. J. J.; Leippe, Matthias; Bosch, Thomas C. G.; Groetzinger, Joachim			Hydramacin-1, Structure and Antibacterial Activity of a Protein from the Basal Metazoan Hydra	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; DEFENSIN; ANTIBIOTICS; CHALLENGE; SYSTEM; BONDS; LEECH	Hydramacin-1 is a novel antimicrobial protein recently discovered during investigations of the epithelial defense of the ancient metazoan Hydra. The amino acid sequence of hydramacin-1 shows no sequence homology to any known antimicrobial proteins. Determination of the solution structure revealed that hydramacin-1 possesses a disulfide bridge-stabilized alpha beta motif. This motif is the common scaffold of the knottin protein fold. The structurally closest relatives are the scorpion oxin-like superfamily. Within this superfamily hydramacin-1 establishes a new family of proteins that all share antimicrobial activity. Hydramacin-1 is potently active against Gram-positive and Gram-negative bacteria including multi-resistant human pathogenic strains. It leads to aggregation of bacteria as an initial step of its bactericidal mechanism. Aggregated cells are connected via electron-dense contacts and adopt a thorn apple-like morphology. Analysis of the hydramacin-1 structure revealed an unusual distribution of amino acid side chains on the surface. Abelt of positively charged residues is sandwiched by two hydrophobic areas. Based on this characteristic surface feature and on biophysical analysis of protein-membrane interactions, we propose a model that describes the aggregation effect exhibited by hydramacin-1.	[Jung, Sascha; Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Stanisak, Mareike; Gelhaus, Christoph; Leippe, Matthias] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Dingley, Andrew J.] Univ Auckland, Dept Chem, Auckland 1142, New Zealand; [Dingley, Andrew J.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Augustin, Rene; Anton-Erxleben, Friederike; Bosch, Thomas C. G.] Univ Kiel, Inst Zool Cell & Dev Biol, D-24118 Kiel, Germany; [Gutsmann, Thomas; Hammer, Malte U.] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany; [Podschun, Rainer] Univ Hosp Schleswig Holstein, Inst Infect Med, D-24105 Kiel, Germany; [Bonvin, Alexandre M. J. J.] Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, NL-3584 CH Utrecht, Netherlands	University of Kiel; University of Kiel; University of Auckland; University of Auckland; University of Kiel; Forschungszentrum Borstel; University of Kiel; Schleswig Holstein University Hospital; Utrecht University	Grotzinger, J (corresponding author), Univ Kiel, Inst Biochem, Olshaussenstr 40, D-24098 Kiel, Germany.	jgroetzinger@biochem.uni-kiel.de	Gutsmann, Thomas/E-6100-2011; Bonvin, Alexandre M.J.J./A-5420-2009; Gelhaus, Christoph/D-8050-2011; Bosch, Thomas C. G./D-5218-2011; Dingley, Andrew/G-6427-2013; Leippe, Matthias/AAP-1677-2020	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Dingley, Andrew/0000-0002-6838-5803; Jung, Sascha/0000-0003-4970-6904	Deutsche Forschungsgemeinschaft [SFB 617: A1, A9, A17, and A18]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 617: A1, A9, A17, and A18). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Blanc E, 1998, BIOCHEMISTRY-US, V37, P12412, DOI 10.1021/bi9809371; BOSCH TCG, 2008, DEV COMP IM IN PRESS; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P946; Cook WJ, 2002, PROTEIN SCI, V11, P479, DOI 10.1110/ps.39202; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingley Andrew J., 2008, V451, P441, DOI 10.1007/978-1-59745-102-4_30; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Errington J, 2003, NAT CELL BIOL, V5, P175, DOI 10.1038/ncb0303-175; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herbst R, 2002, J BIOL CHEM, V277, P22353, DOI 10.1074/jbc.M201475200; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Lamberty M, 2001, BIOCHEMISTRY-US, V40, P11995, DOI 10.1021/bi0103563; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; LENGUYEN D, 1990, BIOCHIMIE, V72, P431, DOI 10.1016/0300-9084(90)90067-Q; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Marshall SH, 2003, ELECTRON J BIOTECHN, V6, P271, DOI 10.4067/S0717-34582003000300011; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PICK U, 1981, ARCH BIOCHEM BIOPHYS, V212, P186, DOI 10.1016/0003-9861(81)90358-1; REES DC, 1982, J MOL BIOL, V160, P475, DOI 10.1016/0022-2836(82)90309-6; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Sahly H, 2003, ANTIMICROB AGENTS CH, V47, P1739, DOI 10.1128/AAC.47.5.1739-1741.2003; Schikorski D, 2008, J IMMUNOL, V181, P1083, DOI 10.4049/jimmunol.181.2.1083; Tasiemski A, 2004, J BIOL CHEM, V279, P30973, DOI 10.1074/jbc.M312156200; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	87	94	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1896	1905		10.1074/jbc.M804713200	http://dx.doi.org/10.1074/jbc.M804713200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19019828	Green Published, hybrid			2022-12-27	WOS:000262330100060
J	Salazar, G; Zlatic, S; Craige, B; Peden, AA; Pohl, J; Faundez, V				Salazar, Gloria; Zlatic, Stephanie; Craige, Branch; Peden, Andrew A.; Pohl, Jan; Faundez, Victor			Hermansky-Pudlak Syndrome Protein Complexes Associate with Phosphatidylinositol 4-Kinase Type II alpha in Neuronal and Non-neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOME-RELATED ORGANELLES; CLATHRIN-COATED VESICLES; SORTING MACHINERY; AP-3 ADAPTER; TRAFFICKING; MELANOSOMES; TYROSINASE; ENDOSOMES; BLOC-1; TRANSPORT	The Hermansky-Pudlak syndrome is a disorder affecting endosome sorting. Disease is triggered by defects in any of 15 mouse gene products, which are part of five distinct cytosolic molecular complexes: AP-3, homotypic fusion and vacuole protein sorting, and BLOC-1, -2, and -3. To identify molecular associations of these complexes, we used in vivo cross-linking followed by purification of cross-linked AP-3 complexes and mass spectrometric identification of associated proteins. AP-3 was co-isolated with BLOC-1, BLOC-2, and homotypic fusion and vacuole protein sorting complex subunits; clathrin; and phosphatidylinositol-4- kinase type II alpha ( PI4KII alpha). We previously reported that this membrane-anchored enzyme is a regulator of AP-3 recruitment to membranes and a cargo of AP-3 (Craige, B., Salazar, G., and Faundez, V. (2008) Mol. Biol. Cell 19, 1415 1426). Using cells deficient in different Hermansky-Pudlak syndrome complexes, we identified that BLOC-1, but not BLOC-2 or BLOC-3, deficiencies affect PI4KII alpha inclusion into AP-3 complexes. BLOC-1, PI4KII alpha, and AP-3 belong to a tripartite complex, and down-regulation of either PI4KII alpha, BLOC-1, or AP-3 complexes led to similar LAMP1 phenotypes. Our analysis indicates that BLOC-1 complex modulates the association of PI4KII alpha with AP-3. These results suggest that AP-3 and BLOC-1 act, either in concert or sequentially, to specify sorting of PI4KII alpha along the endocytic route.	[Zlatic, Stephanie; Craige, Branch; Faundez, Victor] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Zlatic, Stephanie; Craige, Branch; Faundez, Victor] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Salazar, Gloria] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Zlatic, Stephanie; Craige, Branch] Emory Univ, Grad Program Biochem Cell & Dev Biol, Atlanta, GA 30322 USA; [Faundez, Victor] Emory Univ, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Pohl, Jan] Emory Univ, Microchem Facil, Atlanta, GA 30322 USA; [Peden, Andrew A.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; University of Cambridge	Faundez, V (corresponding author), Emory Univ, Dept Cell Biol, 615 Michael St,Rm 446, Atlanta, GA 30322 USA.	faundez@cellbio.emory.edu		Peden, Andrew/0000-0003-0144-7712; Faundez, Victor/0000-0002-2114-5271; Zlatic, Stephanie/0000-0003-0758-9500	National Institutes of Health [NS42599, GM 077569]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042599, R56NS042599] Funding Source: NIH RePORTER; Medical Research Council [G120/952] Funding Source: researchfish; MRC [G120/952] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants NS42599 and GM 077569 (to V. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alloza I, 2004, ANAL BIOCHEM, V324, P137, DOI 10.1016/j.ab.2003.09.017; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Baust T, 2008, MOL BIOL CELL, V19, P1942, DOI 10.1091/mbc.E08-02-0110; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Craige B, 2008, MOL BIOL CELL, V19, P1415, DOI 10.1091/mbc.E07-12-1239; Danglot L, 2007, BIOL CELL, V99, P349, DOI 10.1042/BC20070029; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; GIRARD M, 2004, CURRENT PROTOCOLS CE; Helip-Wooley A, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-33; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Khwaja FW, 2007, J PROTEOME RES, V6, P559, DOI 10.1021/pr060240z; Li G, 1997, ELECTROPHORESIS, V18, P391, DOI 10.1002/elps.1150180313; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; LOMANT AJ, 1976, J MOL BIOL, V104, P243, DOI 10.1016/0022-2836(76)90011-5; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Newell-Litwa K, 2007, J CELL SCI, V120, P531, DOI 10.1242/jcs.03365; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Salazar G, 2005, MOL BIOL CELL, V16, P3692, DOI 10.1091/mbc.E05-01-0020; Salazar G, 2004, MOL BIOL CELL, V15, P575, DOI 10.1091/mbc.E03-06-0401; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Styers ML, 2004, MOL BIOL CELL, V15, P5369, DOI 10.1091/mbc.E04-03-0272; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; Xiang CC, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh185	46	71	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1790	1802		10.1074/jbc.M805991200	http://dx.doi.org/10.1074/jbc.M805991200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19010779	Green Published, hybrid			2022-12-27	WOS:000262330100050
J	Shan, L; Yu, XC; Liu, ZY; Hu, Y; Sturgis, LT; Miranda, ML; Liu, QY				Shan, Lu; Yu, Xuan-Chuan; Liu, Ziye; Hu, Yi; Sturgis, Lydia T.; Miranda, Maricar L.; Liu, Qingyun			The Angiopoietin-like Proteins ANGPTL3 and ANGPTL4 Inhibit Lipoprotein Lipase Activity through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-LIPID LEVELS; ADIPOSE-TISSUE; SARCOPLASMIC-RETICULUM; METABOLISM; MICE; ENZYME; OLIGOMERIZATION; CHYLOMICRONS; INACTIVATION; CHOLESTEROL	Two members of the angiopoietin-like family of proteins, ANGPTL3 and ANGPTL4, have been shown to play important roles in modulating lipoprotein metabolism in the body. Both proteins were found to suppress lipoprotein lipase (LPL) activity in vitro as well as in vivo. However, their mechanisms of inhibition remained poorly understood. Using enzyme kinetic analysis with purified recombinant proteins, we have found key mechanistic differences between ANGPTL3 and ANGPTL4. ANGPTL3 reduced LPL catalytic activity but did not significantly alter its self-inactivation rate. In contrast, ANGPTL4 suppressed LPL by accelerating the irreversible inactivation of LPL. Furthermore, heparin was able to overcome the inhibitory effect of ANGPTL3 on LPL but not that of ANGPTL4. Site-directed mutagenesis demonstrated the critical function of Glu(40) in ANGPTL4. In contrast, when cysteine residues involved in disulfide bond formation were mutated to serines, ANGPTL4 retained its activity. Taken together, our data provide a more detailed view of the structure and mechanisms of these proteins. The finding that ANGPTL3 and ANGPTL4 inhibit LPL activity through distinct mechanisms indicates that the two proteins play unique roles in modulation of lipid metabolism in vivo.	[Shan, Lu; Yu, Xuan-Chuan; Liu, Ziye; Sturgis, Lydia T.; Miranda, Maricar L.; Liu, Qingyun] Lexicon Pharmaceut, Dept Pharmaceut Discovery, The Woodlands, TX 77381 USA; [Hu, Yi] Lexicon Pharmaceut, Dept Mol Biol, The Woodlands, TX 77381 USA	Lexicon Pharmaceuticals; Lexicon Pharmaceuticals	Shan, L (corresponding author), Lexicon Pharmaceut, Dept Pharmaceut Discovery, 8800 Technol Forest Pl, The Woodlands, TX 77381 USA.	lshan@lexpharma.com		Shan, Lu/0000-0003-2334-9216	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073837] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM073837] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ando Y, 2003, J LIPID RES, V44, P1216, DOI 10.1194/jlr.M300031-JLR200; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Bergo M, 2002, J BIOL CHEM, V277, P11927, DOI 10.1074/jbc.M200325200; BRAUN JEA, 1992, BIOCHEM J, V287, P337, DOI 10.1042/bj2870337; Copeland R. A., 2005, EVALUATION ENZYME IN; CORBALANGARCIA S, 1993, BIOCHIM BIOPHYS ACTA, V1203, P45, DOI 10.1016/0167-4838(93)90034-O; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; EMMERICH J, 1992, J BIOL CHEM, V267, P4161; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Goldberg IJ, 1996, J LIPID RES, V37, P693; Graca R, 2005, VET CLIN PATH, V34, P39, DOI 10.1111/j.1939-165X.2005.tb00007.x; Hatsuda S, 2007, J VASC RES, V44, P61, DOI 10.1159/000098153; Kobayashi Y, 2002, EUR J BIOCHEM, V269, P4701, DOI 10.1046/j.1432-1033.2002.03179.x; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Li C, 2007, CURR OPIN LIPIDOL, V18, P597, DOI 10.1097/MOL.0b013e3282efa4e1; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Lookene A, 2004, J BIOL CHEM, V279, P49964, DOI 10.1074/jbc.M407419200; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Nordestgaard BG, 1997, CIRCULATION, V96, P1737, DOI 10.1161/01.CIR.96.6.1737; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; OSBORNE JC, 1985, BIOCHEMISTRY-US, V24, P5606, DOI 10.1021/bi00341a048; Panteghini M, 2001, ANN CLIN BIOCHEM, V38, P365, DOI 10.1258/0004563011900876; Potenz R, 1996, METHOD ENZYMOL, V263, P319; Rip J, 2006, ARTERIOSCL THROM VAS, V26, P1236, DOI 10.1161/01.ATV.0000219283.10832.43; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; TERUEL JA, 1986, BIOCHIM BIOPHYS ACTA, V869, P8, DOI 10.1016/0167-4838(86)90303-1; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; Wong H, 1997, P NATL ACAD SCI USA, V94, P5594, DOI 10.1073/pnas.94.11.5594; Wu GS, 2003, J BIOL CHEM, V278, P11925, DOI 10.1074/jbc.M212736200; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Young SG, 2007, CURR OPIN LIPIDOL, V18, P389, DOI 10.1097/MOL.0b013e3281527914	38	106	112	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1419	1424		10.1074/jbc.M808477200	http://dx.doi.org/10.1074/jbc.M808477200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028676	Green Published, hybrid			2022-12-27	WOS:000262330100009
J	Volodin, AA; Bocharova, TN; Smirnova, EA; Camerini-Otero, RD				Volodin, Alexander A.; Bocharova, Tatiana N.; Smirnova, Elena A.; Camerini-Otero, R. Daniel			Reversibility, Equilibration, and Fidelity of Strand Exchange Reaction between Short Oligonucleotides Promoted by RecA Protein from Escherichia coli and Human Rad51 and Dmc1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP HYDROLYSIS; HOMOLOGOUS RECOMBINATION; DUPLEX DNA; HETERODUPLEX PRODUCT; BINDING; RECOGNITION; COMPLEX; FILAMENTS; SEQUENCE; INHIBITION	We demonstrate the reversibility of RecA-promoted strand exchange reaction between short oligonucleotides in the presence of adenosine 5'-O-(thiotriphosphate). The reverse reaction proceeds without the dissociation of RecA from DNA. The reaction reaches equilibrium and its yield depends on the homology between the reaction substrates. We estimate the tolerance of the RecA-promoted strand exchange to individual base substitutions for a comprehensive set of possible base combinations in a selected position along oligonucleotide substrates for strand exchange and find, in agreement with previously reported estimations, that this tolerance is higher than in the case of free DNA. It is demonstrated that the short oligonucleotide-based approach can be applied to the human recombinases Rad51 and Dmc1 when strand exchange is performed in the presence of calcium ions and ATP. Remarkably, despite the commonly held belief that the eukaryotic recombinases have an inherently lower strand exchange activity, in our system their efficiencies in strand exchange are comparable with that of RecA. Under our experimental conditions, the human recombinases exhibit a significantly higher tolerance to interruptions of homology due to point base substitutions than RecA. Finding conditions where a chemical reaction is reversible and reaches equilibrium is critically important for its thermodynamically correct description. We believe that the experimental system described here will substantially facilitate further studies on different aspects of the mechanisms of homologous recombination.	[Volodin, Alexander A.; Bocharova, Tatiana N.; Smirnova, Elena A.] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Camerini-Otero, R. Daniel] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Camerini-Otero, RD (corresponding author), Bldg 5,Rm 205A,5 Mem Dr,MSC0538, Bethesda, MD 20892 USA.	camerini@ncifcrf.gov	Volodin, Alexander/B-9656-2012		National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052033, Z01DK052033, ZIADK052032, Z01DK052032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was authored, in whole or in part, by National Institutes of Health staff. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ADZUMA K, 1992, GENE DEV, V6, P1679, DOI 10.1101/gad.6.9.1679; Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Bazemore LR, 1997, J BIOL CHEM, V272, P14672, DOI 10.1074/jbc.272.23.14672; Bazemore LR, 1997, P NATL ACAD SCI USA, V94, P11863, DOI 10.1073/pnas.94.22.11863; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; CHOW SA, 1988, J BIOL CHEM, V263, P200; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; Dorfman KD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268102; Dutreix Marie, 2003, ComPlexUs, V1, P89, DOI 10.1159/000070465; Egel R, 2007, DNA REPAIR, V6, P669, DOI 10.1016/j.dnarep.2006.12.013; Egelman E, 2000, TRENDS BIOCHEM SCI, V25, P183, DOI 10.1016/S0968-0004(00)01570-X; Egelman E, 2000, Trends Biochem Sci, V25, P179, DOI 10.1016/S0968-0004(00)01555-8; Folta-Stogniew E, 2004, MOL CELL, V15, P965, DOI 10.1016/j.molcel.2004.08.017; GOLUB EI, 1993, P NATL ACAD SCI USA, V90, P7186, DOI 10.1073/pnas.90.15.7186; Gumbs OH, 1998, BIOCHEMISTRY-US, V37, P11692, DOI 10.1021/bi980646s; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; HONIGBERG SM, 1985, J BIOL CHEM, V260, P1845; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Igoucheva O, 2004, CURR MOL MED, V4, P445, DOI 10.2174/1566524043360465; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; Lee AM, 2006, J MOL BIOL, V360, P343, DOI 10.1016/j.jmb.2006.04.065; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; MAKINO O, 1987, J BIOL CHEM, V262, P12237; Malkov VA, 1998, J MOL BIOL, V278, P317, DOI 10.1006/jmbi.1998.1706; Malkov VA, 1997, J MOL BIOL, V271, P168, DOI 10.1006/jmbi.1997.1164; Malkov VA, 2000, J MOL BIOL, V299, P629, DOI 10.1006/jmbi.2000.3770; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Morrison C, 1999, MOL CELL BIOL, V19, P6891; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Prevost C, 2003, Q REV BIOPHYS, V36, P429, DOI 10.1017/S0033583504003956; PUGH BF, 1987, J BIOL CHEM, V262, P1337; Rice KP, 2001, J BIOL CHEM, V276, P38570, DOI 10.1074/jbc.M105678200; RIDDLES PW, 1985, J BIOL CHEM, V260, P170; ROSSELLI W, 1990, J MOL BIOL, V216, P335, DOI 10.1016/S0022-2836(05)80325-0; Sangiuolo F, 2004, CYTOGENET GENOME RES, V105, P435, DOI 10.1159/000078216; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; ULLSPERGER CJ, 1995, BIOCHEMISTRY-US, V34, P10859, DOI 10.1021/bi00034a019; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; Volodin AA, 2005, TRENDS BIOTECHNOL, V23, P97, DOI 10.1016/j.tibtech.2004.12.005; VOLODIN AA, 1994, FEBS LETT, V349, P65, DOI 10.1016/0014-5793(94)00640-7; Volodin AA, 1997, FEBS LETT, V407, P325, DOI 10.1016/S0014-5793(97)00367-0; Volodin AA, 2000, FEBS LETT, V473, P53, DOI 10.1016/S0014-5793(00)01497-6; Volodin AA, 2003, FEBS LETT, V546, P203, DOI 10.1016/S0014-5793(03)00572-6; Volodin AA, 2002, J BIOL CHEM, V277, P1614, DOI 10.1074/jbc.M108871200; Voloshin ON, 2000, J MOL BIOL, V303, P709, DOI 10.1006/jmbi.2000.4163; Voloshin ON, 1997, GENES CELLS, V2, P303, DOI 10.1046/j.1365-2443.1997.1240322.x; Voloshin ON, 2004, MOL CELL, V15, P846, DOI 10.1016/j.molcel.2004.09.010; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Xiao J, 2006, BIOPOLYMERS, V81, P473, DOI 10.1002/bip.20446; Xiao J, 2002, J MOL BIOL, V320, P529, DOI 10.1016/S0022-2836(02)00462-X; Xiao J, 2006, CHEMBIOCHEM, V7, P1265, DOI 10.1002/cbic.200600038; Yu X, 2004, CURR PROTEIN PEPT SC, V5, P73, DOI 10.2174/1389203043486883; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zaitsev EN, 1998, NUCLEIC ACIDS RES, V26, P650, DOI 10.1093/nar/26.2.650; Zaitsev EN, 2000, GENE DEV, V14, P740	65	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1495	1504		10.1074/jbc.M800612200	http://dx.doi.org/10.1074/jbc.M800612200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19004837	Green Published, hybrid			2022-12-27	WOS:000262330100017
J	Ranjith-Kumar, CT; Murali, A; Dong, W; Srisathiyanarayanan, D; Vaughan, R; Ortiz-Alacantara, J; Bhardwaj, K; Li, XJ; Li, PW; Kao, CC				Ranjith-Kumar, C. T.; Murali, Ayaluru; Dong, Wen; Srisathiyanarayanan, Dharmaiah; Vaughan, Robert; Ortiz-Alacantara, Joanna; Bhardwaj, Kanchan; Li, Xiaojun; Li, Pingwei; Kao, Cheng C.			Agonist and Antagonist Recognition by RIG-I, a Cytoplasmic Innate Immunity Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; ANTIVIRAL RESPONSES; FUNCTIONAL ANALYSES; STRUCTURAL BASIS; ADAPTER PROTEIN; IDENTIFICATION; HELICASE	Cytoplasmic RNA receptors are important in the detection of and response to viral infections. We analyzed ligand recognition by the retinoic acid-inducible protein I (RIG-I) protein in biochemical assays and in transiently transfected cells and characterized the requirements for both single- and double-stranded RNA agonists for RIG-I activation of signaling. RIG-I mutants such as K270A and T409A/S411A that were defective in signaling with triphosphorylated single-stranded RNAs were perfectly capable of signaling with dsRNAs. Furthermore, phosphorothioated oligodeoxynucleotides were found to antagonize RIG-I signaling. Both agonists and antagonist bind purified RIG-I protein and a truncated RIG-I protein that lacked the signaling domain. The agonists were necessary to activate RIG-I ATPase activity in vitro, whereas antagonist inhibited ATPase activity. Differential scanning fluorometry showed that RIG-I bound to agonists, and antagonists have different denaturation properties, suggesting a difference in protein conformations. Last, single particle reconstruction was used to generate three-dimensional models of the RIG-I dimers in complex with an agonist and an antagonist. The two complexes exhibited dramatically different structures.	[Ranjith-Kumar, C. T.; Murali, Ayaluru; Dong, Wen; Srisathiyanarayanan, Dharmaiah; Vaughan, Robert; Ortiz-Alacantara, Joanna; Bhardwaj, Kanchan; Li, Xiaojun; Li, Pingwei; Kao, Cheng C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Ranjith-Kumar, CT (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ctrkumar@gmail.com	Bhardwaj, Kanchan/CAH-2291-2022; Kumar CT, Ranjith/J-5701-2016; Dharmaiah, Srisathiyanarayanan/B-2887-2009; Li, Xiaojun/J-4460-2012; Murali, Ayaluru/G-3401-2014	Bhardwaj, Kanchan/0000-0002-7331-7717; Li, Xiaojun/0000-0001-8528-8258; Murali, Ayaluru/0000-0001-6406-6840; Dharmaiah, Srisathiyanarayanan/0000-0001-7630-3962; Ortiz-Alcantara, Joanna Maria/0000-0003-2894-3652	National Institutes of Health [1RO1AI073335]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1AI073335 (NIAID; to C. K.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhardwaj K, 2008, J BIOL CHEM, V283, P3655, DOI 10.1074/jbc.M708375200; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; Gaspari AA, 2006, J AM ACAD DERMATOL, V54, pS67, DOI 10.1016/j.jaad.2005.10.057; Guarino LA, 2005, J MOL BIOL, V353, P1106, DOI 10.1016/j.jmb.2005.09.007; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; Kobayashi T, 2006, NAT IMMUNOL, V7, P123, DOI 10.1038/ni0206-123; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SHINOZUKA K, 1991, NUCL ACIDS S SER, V25, P101; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Underhill DM, 2004, CURR OPIN IMMUNOL, V16, P483, DOI 10.1016/j.coi.2004.05.012; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	37	46	51	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1155	1165		10.1074/jbc.M806219200	http://dx.doi.org/10.1074/jbc.M806219200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19019822	Green Published, hybrid			2022-12-27	WOS:000262122900052
J	Bair, AM; Thippegowda, PB; Freichel, M; Cheng, N; Ye, RD; Vogel, SM; Yu, YN; Flockerzi, V; Malik, AB; Tiruppathi, C				Bair, Angela M.; Thippegowda, Prabhakar B.; Freichel, Marc; Cheng, Ni; Ye, Richard D.; Vogel, Stephen M.; Yu, Yanni; Flockerzi, Veit; Malik, Asrar B.; Tiruppathi, Chinnaswamy			Ca2+ Entry via TRPC Channels Is Necessary for Thrombin-induced NF-kappa B Activation in Endothelial Cells through AMP-activated Protein Kinase and Protein Kinase C delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ADHESION MOLECULE-1; GENE-EXPRESSION; P38 MAPK; PHOSPHORYLATION; TRANSACTIVATION; INCREASE; PATHWAY; BETA; TRANSCRIPTION	The transient receptor potential canonical (TRPC) family channels are proposed to be essential for store-operated Ca2+ entry in endothelial cells. Ca2+ signaling is involved in NF-kappa B activation, but the role of store-operated Ca2+ entry is unclear. Here we show that thrombin-induced Ca2+ entry and the resultant AMP-activated protein kinase (AMPK) activation targets the Ca2+-independent protein kinase C delta (PKC delta) to mediate NF-kappa B activation in endothelial cells. We observed that thrombin-induced p65/RelA, AMPK, and PKC delta activation were markedly reduced by knockdown of the TRPC isoform TRPC1 expressed in human endothelial cells and in endothelial cells obtained from Trpc4 knock-out mice. Inhibition of Ca2+/calmodulin-dependent protein kinase kinase beta downstream of the Ca2+ influx or knockdown of the downstream Ca2+/calmodulin-dependent protein kinase kinase beta target kinase, AMPK, also prevented NF-kappa B activation. Further, we observed that AMPK interacted with PKC delta and phosphorylated Thr(505) in the activation loop of PKC delta in thrombin-stimulated endothelial cells. Expression of a PKC delta-T505A mutant suppressed the thrombin-induced but not the TNF-alpha-induced NF-kappa B activation. These findings demonstrate a novel mechanism for TRPC channels to mediate NF-kappa B activation in endothelial cells that involves the convergence of the TRPC-regulated signaling at AMPK and PKC delta and that may be a target of interference of the inappropriate activation of NF-kappa B associated with thrombosis.	[Bair, Angela M.; Thippegowda, Prabhakar B.; Cheng, Ni; Ye, Richard D.; Vogel, Stephen M.; Yu, Yanni; Malik, Asrar B.; Tiruppathi, Chinnaswamy] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Bair, Angela M.; Thippegowda, Prabhakar B.; Cheng, Ni; Ye, Richard D.; Vogel, Stephen M.; Yu, Yanni; Malik, Asrar B.; Tiruppathi, Chinnaswamy] Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612 USA; [Freichel, Marc; Flockerzi, Veit] Univ Saarland, Inst Pharmakol & Toxikol, D-66421 Homburg, Germany	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Saarland University	Tiruppathi, C (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, M-C868,835 S Wolcott Ave, Chicago, IL 60612 USA.	tiruc@uic.edu	Ye, Richard/ABF-2413-2020; BT, Prabhakar/AAU-5199-2021; Ye, Richard/O-5223-2016	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; Malik, Asrar/0000-0002-8205-7128; BT, Prabhakar/0000-0003-2377-9179	National Institutes of Health [P01HL077806, GM058531, GM066182, T32HL072742]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, T32HL072742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058531, R01GM066182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL077806, GM058531, GM066182, and T32HL072742. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Birnbaum MJ, 2005, MOL CELL, V19, P289, DOI 10.1016/j.molcel.2005.07.012; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Cao HQ, 2006, AM J PHYSIOL-CELL PH, V290, pC172, DOI 10.1152/ajpcell.00284.2005; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cheng N, 2007, J IMMUNOL, V179, P7720, DOI 10.4049/jimmunol.179.11.7720; Cirino G, 2006, CURR OPIN PHARMACOL, V6, P428, DOI 10.1016/j.coph.2006.05.001; Corcoran EE, 2001, J BIOL CHEM, V276, P2975, DOI 10.1074/jbc.R000027200; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037, DOI 10.1152/ajplung.2001.281.5.L1037; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Freichel M, 1999, CELL PHYSIOL BIOCHEM, V9, P270, DOI 10.1159/000016321; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Jang MK, 2001, J BIOL CHEM, V276, P20005, DOI 10.1074/jbc.M010211200; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Liu XB, 2003, J BIOL CHEM, V278, P11337, DOI 10.1074/jbc.M213271200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Motley ED, 2007, HYPERTENSION, V49, P577, DOI 10.1161/01.HYP.0000255954.80025.34; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Norwood N, 2000, AM J PHYSIOL-LUNG C, V279, pL815, DOI 10.1152/ajplung.2000.279.5.L815; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Paria BC, 2003, J BIOL CHEM, V278, P37195, DOI 10.1074/jbc.M304287200; Paria BC, 2006, J BIOL CHEM, V281, P20715, DOI 10.1074/jbc.M600722200; Rahman A, 1999, J IMMUNOL, V162, P5466; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Stull JT, 2001, J BIOL CHEM, V276, P2311, DOI 10.1074/jbc.R000030200; Tan MQ, 2003, J BIOL CHEM, V278, P2824, DOI 10.1074/jbc.M211523200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tiruppathi C, 2001, AM J PHYSIOL-LUNG C, V281, pL958, DOI 10.1152/ajplung.2001.281.4.L958; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137	53	61	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					563	574		10.1074/jbc.M803984200	http://dx.doi.org/10.1074/jbc.M803984200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990707	Green Published, hybrid			2022-12-27	WOS:000261974800062
J	Corsini, L; Hothorn, M; Stier, G; Rybin, V; Scheffzek, K; Gibson, TJ; Sattler, M				Corsini, Lorenzo; Hothorn, Michael; Stier, Gunter; Rybin, Vladimir; Scheffzek, Klaus; Gibson, Toby J.; Sattler, Michael			Dimerization and Protein Binding Specificity of the U2AF Homology Motif of the Splicing Factor Puf60	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-15 NMR RELAXATION; STAPHYLOCOCCAL ALPHA-TOXIN; BACKBONE DYNAMICS; STRUCTURAL BASIS; BRANCH SITE; POLYPYRIMIDINE TRACT; INTERACTION NETWORK; RNA-BINDING; FACTOR SF1; RECOGNITION	PUF60 is an essential splicing factor functionally related and homologous to U2AF(65). Its C-terminal domain belongs to the family of U2AF (U2 auxiliary factor) homology motifs (UHM), a subgroup of RNA recognition motifs that bind to tryptophan-containing linear peptide motifs (UHM ligand motifs, ULMs) in several nuclear proteins. Here, we show that the Puf60 UHM is mainly monomeric in physiological buffer, whereas its dimerization is induced upon the addition of SDS. The crystal structure of PUF60-UHM at 2.2 angstrom resolution, NMR data, and mutational analysis reveal that the dimer interface is mediated by electrostatic interactions involving a flexible loop. Using glutathione S-transferase pulldown experiments, isothermal titration calorimetry, and NMR titrations, we find that Puf60-UHM binds to ULM sequences in the splicing factors SF1, U2AF(65), and SF3b155. Compared with U2AF(65)-UHM, Puf60-UHM has distinct binding preferences to ULMs in the N terminus of SF3b155. Our data suggest that the functional cooperativity between U2AF(65) and Puf60 may involve simultaneous interactions of the two proteins with SF3b155.	[Corsini, Lorenzo; Hothorn, Michael; Stier, Gunter; Rybin, Vladimir; Scheffzek, Klaus; Gibson, Toby J.; Sattler, Michael] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Sattler, Michael] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Sattler, Michael] Tech Univ Munich, Dept Chem, Chair Biomol NMR, D-85747 Garching, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Sattler, M (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	sattler@helmholtz-muenchen.de	Sattler, Michael/A-2407-2012; Sattler, Michael/C-1169-2010; Corsini, Lorenzo/GSR-5058-2022; Hothorn, Michael/C-6807-2011	Sattler, Michael/0000-0002-1594-0527; Corsini, Lorenzo/0000-0002-8077-6559; Hothorn, Michael/0000-0002-3597-5698; Gibson, Toby James/0000-0003-0657-5166	Deutsche Forschungsgemeinschaft Grant Sa [823/5]; European Commission [LSHG-CT-2005-512028]; Peter and Traudl Engelhorn Foundation	Deutsche Forschungsgemeinschaft Grant Sa(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Peter and Traudl Engelhorn Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant Sa 823/5 and European Commission 3D Repertoire Grant LSHG-CT-2005-512028, and funds from the Peter and Traudl Engelhorn Foundation ( to M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Berglund JA, 1997, CELL, V89, P781, DOI 10.1016/S0092-8674(00)80261-5; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; BHAKDI S, 1981, P NATL ACAD SCI-BIOL, V78, P5475, DOI 10.1073/pnas.78.9.5475; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Cass DM, 2006, BIOCHEMISTRY-US, V45, P10092, DOI 10.1021/bi060429o; Chung SH, 2008, ONCOGENE, V27, P1412, DOI 10.1038/sj.onc.1210784; CORSINI L, 2008, PROTEIN SCI IN PRESS; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Crichlow GV, 2008, EMBO J, V27, P277, DOI 10.1038/sj.emboj.7601936; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Forouhar F, 2003, J BIOL CHEM, V278, P21980, DOI 10.1074/jbc.M208650200; FORTI S, 1989, EUR J BIOCHEM, V181, P767, DOI 10.1111/j.1432-1033.1989.tb14790.x; FUSHMAN D, 1994, J BIOMOL NMR, V4, P61, DOI 10.1007/BF00178336; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Manceau V, 2008, J MOL BIOL, V381, P748, DOI 10.1016/j.jmb.2008.06.026; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Page-McCaw PS, 1999, RNA, V5, P1548, DOI 10.1017/S1355838299991938; Poleev A, 2000, EUR J BIOCHEM, V267, P4002, DOI 10.1046/j.1432-1327.2000.01431.x; Query CC, 1997, MOL CELL BIOL, V17, P2944, DOI 10.1128/MCB.17.5.2944; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Quinn LM, 2004, DEVELOPMENT, V131, P1411, DOI 10.1242/dev.01019; Rain JC, 1998, RNA, V4, P551, DOI 10.1017/S1355838298980335; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramu C, 2003, NUCLEIC ACIDS RES, V31, P3771, DOI 10.1093/nar/gkg546; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rudner DZ, 1998, MOL CELL BIOL, V18, P1765, DOI 10.1128/MCB.18.4.1765; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schellenberg MJ, 2006, P NATL ACAD SCI USA, V103, P1266, DOI 10.1073/pnas.0508048103; Selenko P, 2003, MOL CELL, V11, P965, DOI 10.1016/S1097-2765(03)00115-1; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Thickman KR, 2006, J MOL BIOL, V356, P664, DOI 10.1016/j.jmb.2005.11.067; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; Van Buskirk C, 2002, DEV CELL, V2, P343, DOI 10.1016/S1534-5807(02)00128-4; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597	59	44	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					630	639		10.1074/jbc.M805395200	http://dx.doi.org/10.1074/jbc.M805395200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18974054	Green Published, hybrid			2022-12-27	WOS:000261974800068
J	Kawaai, K; Hisatsune, C; Kuroda, Y; Mizutani, A; Tashiro, T; Mikoshiba, K				Kawaai, Katsuhiro; Hisatsune, Chihiro; Kuroda, Yukiko; Mizutani, Akihiro; Tashiro, Tomoko; Mikoshiba, Katsuhiko			80K-H Interacts with Inositol 1,4,5-Trisphosphate (IP3) Receptors and Regulates IP3-induced Calcium Release Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; POLYCYSTIC LIVER-DISEASE; HIPPOCAMPAL CA1 NEURONS; TRISPHOSPHATE RECEPTOR; MONOCLONAL-ANTIBODIES; BINDING PROTEIN; INSP3 RECEPTOR; CA2+; TYPE-1; EXPRESSION	Inositol 1,4,5-trisphosphate receptors (IP(3)Rs) are intracellular channel proteins that mediate calcium (Ca2+) release from the endoplasmic reticulum, and they are involved in many biological processes (e. g. fertilization, secretion, and synaptic plasticity). Recent reports show that IP3R activity is strictly regulated by several interacting molecules (e. g. IP3R binding protein released with inositol 1,4,5-trisphosphate, huntingtin, presenilin, DANGER, and cytochrome c), and perturbation of this regulation causes intracellular Ca2+ elevation leading to several diseases (e. g. Huntington disease and Alzheimer disease). In this study, we identified protein kinase C substrate 80K-H (80K-H) to be a novel molecule interacting with the COOH-terminal tail of IP3Rs by yeast two-hybrid screening. 80K-H directly interacted with IP3R type 1 (IP(3)R1) in vitro and co-immunoprecipitated with IP3R1 in cell lysates. Immunocytochemical and immunohistochemical staining revealed that 80K-H colocalized with IP(3)R1 in COS-7 cells and in hippocampal neurons. We also showed that the purified recombinant 80K-H protein directly enhanced IP3-induced Ca2+ release activity by a Ca2+ release assay using mouse cerebellar microsomes. Furthermore 80K-H was found to regulate ATP-induced Ca2+ release in living cells. Thus, our findings suggest that 80K-H is a novel regulator of IP3R activity, and it may contribute to neuronal functions.	[Kawaai, Katsuhiro; Hisatsune, Chihiro; Kuroda, Yukiko; Mizutani, Akihiro; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Kawaai, Katsuhiro; Tashiro, Tomoko] Aoyama Gakuin Univ, Dept Chem & Biol Sci, Kanagawa 2298558, Japan; [Hisatsune, Chihiro; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Int Cooperat Res Project Solut Oriented Res Sci &, Wako, Saitama 3510198, Japan	RIKEN; Aoyama Gakuin University; Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	mikosiba@brain.riken.jp	Mizutani, Akihiro/GPS-4809-2022; Kuroda, Yukiko/L-6332-2013; Mikoshiba, Katsuhiko/N-7943-2015; Hisatsune, Chihiro/C-6661-2017; Kawaai, Katsuhiro/C-9216-2017; Kuroda, Yukiko/L-6332-2013	Mizutani, Akihiro/0000-0003-4155-802X; Kuroda, Yukiko/0000-0002-5335-4238; Hisatsune, Chihiro/0000-0001-7811-7784; Kawaai, Katsuhiro/0000-0002-7502-0722; Kuroda, Yukiko/0000-0001-7713-9471	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Science and Technology Agency. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Cai WH, 2004, J BIOL CHEM, V279, P23691, DOI 10.1074/jbc.M313296200; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Everson GT, 2004, HEPATOLOGY, V40, P774, DOI 10.1002/hep.20431; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; Fujii S, 2000, LEARN MEMORY, V7, P312, DOI 10.1101/lm.34100; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; Gkika D, 2004, J BIOL CHEM, V279, P26351, DOI 10.1074/jbc.M403801200; Glaser S, 2000, HEPATOLOGY, V32, P17; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hodgkinson CP, 2005, BIOCHEM J, V388, P785, DOI 10.1042/BJ20041845; Hoenderop JGJ, 2004, KIDNEY INT, V65, P531, DOI 10.1111/j.1523-1755.2004.00402.x; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Kanai M, 1997, J BIOL CHEM, V272, P6621, DOI 10.1074/jbc.272.10.6621; KAWAAI K, 2008, BIOCHEMICA, V1, P21; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Maes K, 1999, CELL CALCIUM, V25, P143, DOI 10.1054/ceca.1998.0011; Mailhot G, 2000, ENDOCRINOLOGY, V141, P891, DOI 10.1210/en.141.3.891; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; MIGNERY GA, 1992, J BIOL CHEM, V267, P7450; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; OTSU H, 1990, CELL STRUCT FUNCT, V15, P163, DOI 10.1247/csf.15.163; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Shibao K, 2003, GASTROENTEROLOGY, V125, P1175, DOI 10.1016/S0016-5085(03)01201-0; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; Tang TS, 2004, EUR J NEUROSCI, V20, P1779, DOI 10.1111/j.1460-9568.2004.03633.x; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Taufiq AM, 2005, LEARN MEMORY, V12, P594, DOI 10.1101/lm.17405; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; WORLEY PF, 1987, NATURE, V325, P159, DOI 10.1038/325159a0; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; Zhang SB, 2003, J BIOL CHEM, V278, P4048, DOI 10.1074/jbc.M209960200	47	34	35	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					372	380		10.1074/jbc.M805828200	http://dx.doi.org/10.1074/jbc.M805828200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990696	hybrid			2022-12-27	WOS:000261974800042
J	Boulay, PL; Cotton, M; Melancon, P; Claing, A				Boulay, Pierre-Luc; Cotton, Mathieu; Melancon, Paul; Claing, Audrey			ADP-ribosylation Factor 1 Controls the Activation of the Phosphatidylinositol 3-Kinase Pathway to Regulate Epidermal Growth Factor-dependent Growth and Migration of Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARF ACTIVATION; INVASION; PROTEIN; TRANSPORT; DOMAINS; BINDING; FAMILY; RAC1; ARNO; P85	Activation of intracellular signaling pathways by growth factors is one of the major causes of cancer development and progression. Recent studies have demonstrated that monomeric G proteins of the Ras family are key regulators of cell proliferation, migration, and invasion. Using an invasive breast cancer cell lines, we demonstrate that the ADP-ribosylation factor 1 (ARF1), a small GTPase classically associated with the Golgi, is an important regulator of the biological effects induced by epidermal growth factor. Here, we show that this ARF isoform is activated following epidermal growth factor stimulation and that, in MDA-MB-231 cells, ARF1 is found in dynamic plasma membrane ruffles. Inhibition of endogenous ARF1 expression results in the inhibition of breast cancer cell migration and proliferation. The underlying mechanism involves the activation of the phosphatidylinositol 3-kinase pathway. Our data demonstrate that depletion of ARF1 markedly impairs the recruitment of the phosphatidylinositol 3-kinase catalytic subunit (p110 alpha) to the plasma membrane, and the association of the regulatory subunit (p85 alpha) to the activated receptor. These results uncover a novel molecular mechanism by which ARF1 regulates breast cancer cell growth and invasion during cancer progression.	[Boulay, Pierre-Luc; Cotton, Mathieu; Claing, Audrey] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Melancon, Paul] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	Universite de Montreal; University of Alberta	Claing, A (corresponding author), POB 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	audrey.claing@umontreal.ca	Melancon, Paul/P-1304-2018	Melancon, Paul/0000-0002-8085-3032	Canadian Institutes of Health Research (CIHR) [MOP-79470]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research (CIHR, Grant MOP-79470 to A. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hashimoto S, 2006, P NATL ACAD SCI USA, V103, P7036, DOI 10.1073/pnas.0509166103; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; KLIJN JGM, 1992, ENDOCR REV, V13, P3, DOI 10.1210/er.13.1.3; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Li HS, 2003, BMC CELL BIOL, V4, P1, DOI 10.1186/1471-2121-4-13; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Mitchell R, 2003, J BIOL CHEM, V278, P33818, DOI 10.1074/jbc.M305825200; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; NICHOLSON RI, 1994, BREAST CANCER RES TR, V29, P117, DOI 10.1007/BF00666187; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; NORMANNO N, 1994, BREAST CANCER RES TR, V29, P11, DOI 10.1007/BF00666178; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wells A, 2000, ADV CANCER RES, V78, P31; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	35	72	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36425	36434		10.1074/jbc.M803603200	http://dx.doi.org/10.1074/jbc.M803603200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18990689	Green Published, hybrid			2022-12-27	WOS:000261840500040
J	Hazelwood, LA; Free, RB; Cabrera, DM; Skinbjerg, M; Sibley, DR				Hazelwood, Lisa A.; Free, R. Benjamin; Cabrera, David M.; Skinbjerg, Mette; Sibley, David R.			Reciprocal Modulation of Function between the D-1 and D-2 Dopamine Receptors and the Na+, K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PLASMA-MEMBRANE; NA+,K+-ATPASE ENDOCYTOSIS; INTERACTING PROTEINS; D1; DESENSITIZATION; RECRUITMENT; PHOSPHORYLATION; NA,K-ATPASE; INHIBITION	It is well documented that dopamine can increase or decrease the activity of the Na+, K+-ATPase (NKA, sodium pump) in an organ-specific fashion. This regulation can occur, at least partially, via receptor-mediated second messenger activation and can promote NKA insertion or removal from the plasma membrane. Using co-immunoprecipitation and mass spectrometry, we now show that, in both brain and HEK293T cells, D-1 and D-2 dopamine receptors (DARs) can exist in a complex with the sodium pump. To determine the impact of NKA on DAR function, biological assays were conducted with NKA and DARs co-expressed in HEK293T cells. In this system, expression of NKA dramatically decreased D-1 and D-2 DAR densities with a concomitant functional decrease in DAR-mediated regulation of cAMP levels. Interestingly, pharmacological inhibition of endogenous or overexpressed NKA enhanced DAR function without altering receptor number or localization. Similarly, DAR function was also augmented by small interfering RNA reduction of the endogenous NKA. These data suggest that, under basal conditions, NKA negatively regulates DAR function via protein-protein interactions. In reciprocal fashion, expression of DARs decreases endogenous NKA function in the absence of dopamine, implicating DAR proteins as regulators of NKA activity. Notably, dopamine stimulation or pertussis toxin inhibition of D-2 receptor signaling did not alter NKA activity, indicating that the D-2-mediated decrease in NKA function is dependent upon protein-protein interactions rather than signaling molecules. This evidence for reciprocal regulation between DARs and NKA provides a novel control mechanism for both DAR signaling and cellular ion balance.	[Hazelwood, Lisa A.; Free, R. Benjamin; Cabrera, David M.; Skinbjerg, Mette; Sibley, David R.] NINDS, Mol Neuropharmacol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Sibley, DR (corresponding author), NINDS, Mol Neuropharmacol Sect, NIH, 5625 Fishers Ln,Rm 4S-04,MSC 9405, Bethesda, MD 20852 USA.	sibley@helix.nih.gov	Cabrera, David/I-1013-2014; Sibley, David/AAC-3591-2019; Skinbjerg, Mette/D-6436-2014		National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003028, ZIANS003028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health grant (Intramural Research Program of NINDS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barnard ML, 1997, AM J RESP CRIT CARE, V156, P709, DOI 10.1164/ajrccm.156.3.9610013; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; BERTORELLO AM, 1990, NATURE, V347, P386, DOI 10.1038/347386a0; Bertorello AM, 2005, AM J RESP CELL MOL, V33, P432, DOI 10.1165/rcmb.2005-0297TR; Bockaert J, 2004, BIOCHEM SOC T, V32, P851, DOI 10.1042/BST0320851; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Efendiev R, 2002, J BIOL CHEM, V277, P44108, DOI 10.1074/jbc.M205173200; El-Ghundi M, 2007, REV NEUROSCIENCE, V18, P37; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Gardner B, 2001, MOL PHARMACOL, V59, P310, DOI 10.1124/mol.59.2.310; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; HEINZEL SS, 1988, J VIROL, V62, P3738, DOI 10.1128/JVI.62.10.3738-3746.1988; Heusler P, 2007, NEUROPHARMACOLOGY, V52, P1106, DOI 10.1016/j.neuropharm.2006.11.008; Jose PA, 2003, NEPHRON PHYSIOL, V95, P19, DOI DOI 10.1159/000073676; Kabbani N, 2007, EUR J PHARMACOL, V572, P83, DOI 10.1016/j.ejphar.2007.06.059; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONSMA FJ, 1990, P NATL ACAD SCI USA, V87, P6723, DOI 10.1073/pnas.87.17.6723; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Neve KA, 2005, MOL PHARMACOL, V68, P275, DOI 10.1124/mol.105.015263; Nishi A, 1999, J NEUROCHEM, V73, P1492, DOI 10.1046/j.1471-4159.1999.0731492.x; Ogimoto G, 2000, P NATL ACAD SCI USA, V97, P3242, DOI 10.1073/pnas.060025597; Pei L, 2004, J NEUROSCI, V24, P1149, DOI 10.1523/JNEUROSCI.3922-03.2004; Ridge KM, 2002, MOL BIOL CELL, V13, P1381, DOI 10.1091/mbc.01-07-0323; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Sealfon SC, 2000, TRENDS NEUROSCI, V23, pS34, DOI 10.1016/S1471-1931(00)00025-2; Strange PE, 1999, CLIN EXP PHARMACOL P, V26, pS3; Teixeira VL, 2003, ANN NY ACAD SCI, V986, P587, DOI 10.1111/j.1749-6632.2003.tb07257.x; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Tonini M, 2004, ALIMENT PHARM THER, V19, P379, DOI 10.1111/j.1365-2036.2004.01867.x; Wasserstrom JA, 2005, AM J PHYSIOL-HEART C, V289, pH1781, DOI 10.1152/ajpheart.00707.2004; Woods AS, 2005, J MOL NEUROSCI, V26, P125, DOI 10.1385/JMN:26:2-3:125; Zeng Chunyu, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P241; Zhang JP, 2007, J BIOL CHEM, V282, P15778, DOI 10.1074/jbc.M611485200	36	32	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36441	36453		10.1074/jbc.M805520200	http://dx.doi.org/10.1074/jbc.M805520200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18984584	hybrid, Green Published			2022-12-27	WOS:000261840500042
J	London, TBC; Barber, LJ; Mosedale, G; Kelly, GP; Balasubramanian, S; Hickson, ID; Boulton, SJ; Hiom, K				London, Timothy B. C.; Barber, Louise J.; Mosedale, Georgina; Kelly, Gavin P.; Balasubramanian, Shankar; Hickson, Ian D.; Boulton, Simon J.; Hiom, Kevin			FANCJ Is a Structure-specific DNA Helicase Associated with the Maintenance of Genomic G/C Tracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINK REPAIR; G-QUADRUPLEX DNA; CAENORHABDITIS-ELEGANS; HOMOLOGOUS RECOMBINATION; BREAST-CANCER; G4 DNA; ANEMIA; BACH1; BRIP1; PROTEIN	Fanconi anemia (FA) is a heritable human cancer-susceptibility disorder, delineating a genetically heterogenous pathway for the repair of replication-blocking lesions such as interstrand DNA cross-links. Here we demonstrate that one component of this pathway, FANCJ, is a structure-specific DNA helicase that dissociates guanine quadruplex DNA (G4 DNA) in vitro. Moreover, in contrast with previously identified G4 DNA helicases, such as the Bloom's helicase (BLM), FANCJ unwinds G4 substrates with 5'-3' polarity. In the FA-J human patient cell line EUFA0030 the loss of FANCJ G4 unwinding function correlates with the accumulation of large genomic deletions in the vicinity of sequences, which match the G4 DNA signature. Together these findings support a role for FANCJ in the maintenance of potentially unstable genomic G/C tracts during replication.	[London, Timothy B. C.; Hiom, Kevin] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Mosedale, Georgina; Hickson, Ian D.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Kelly, Gavin P.] Canc Res UK London Res Inst, Bioinformat & Biostat Serv, London WC2A 3PX, England; [Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Barber, Louise J.; Boulton, Simon J.] Imperial Canc Res Fund, Clare Hall Labs, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England	MRC Laboratory Molecular Biology; University of Oxford; Cancer Research UK; University of Cambridge	Hiom, K (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	hiom@mrc-lmb.cam.ac.uk	Hiom, Kevin/B-4374-2009; Barber, Louise J./L-8579-2019; Balasubramanian, Shankar/C-1671-2009; Hickson, Ian/AAJ-7548-2020; Kelly, Gavin/ABG-2715-2021	Barber, Louise J./0000-0001-9265-3516; Kelly, Gavin/0000-0001-7219-560X; Balasubramanian, Shankar/0000-0002-0281-5815; Hickson, Ian/0000-0002-0583-566X	Cancer Research UK; Medical Research Council [MC_U105184300] Funding Source: researchfish; MRC [MC_U105184300] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Cancer Research UK.	Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Paeschke K, 2005, NAT STRUCT MOL BIOL, V12, P847, DOI 10.1038/nsmb982; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; SEN D, 1992, BIOCHEMISTRY-US, V31, P65, DOI 10.1021/bi00116a011; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Youds JL, 2008, MOL CELL BIOL, V28, P1470, DOI 10.1128/MCB.01641-07; Youds JL, 2006, GENETICS, V173, P697, DOI 10.1534/genetics.106.056879; Zhao Y, 2008, DNA REPAIR, V7, P1846, DOI 10.1016/j.dnarep.2008.07.011	28	173	175	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36132	36139		10.1074/jbc.M808152200	http://dx.doi.org/10.1074/jbc.M808152200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18978354	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000261840500008
J	Assil-Kishawi, I; Samra, TA; Mierke, DF; Abou-Samra, AB				Assil-Kishawi, Iman; Samra, Tareq A.; Mierke, Dale F.; Abou-Samra, Abdul B.			Residue 17 of Sauvagine Cross-links to the First Transmembrane Domain of Corticotropin-releasing Factor Receptor 1 (CRFR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; PARATHYROID-HORMONE PTH; N-TERMINAL DOMAIN; FACTOR TYPE-1 RECEPTOR; EXTRACELLULAR DOMAIN; BINDING DOMAIN; LIGAND-BINDING; 1ST-EXTRACELLULAR DOMAIN; CONFORMATIONAL STATES; AMINO-TERMINUS	Corticotropin-releasing factor receptor 1 (CRFR1) mediates the physiological actions of corticotropin-releasing factor in the anterior pituitary gland and the central nervous system. Using chemical cross-linking we have previously reported that residue 16 of sauvagine (SVG) is in a close proximity to the second extracellular loop of CRFR1. Here we introduced p-benzoylphenylalanine (Bpa) at position 17 of a sauvagine analog, [Tyr(0), Gln(1),Bpa(17)] SVG, to covalently label CRFR1 and characterize the cross-linking site. Using a combination of receptor mutagenesis, peptide mapping, and N-terminal sequencing, we identified His(117) within the first transmembrane domain (TM1) of CRFR1 as the cross-linking site for Bpa17 of I-125-[Tyr(0), Gln(1), Bpa17] SVG. These data indicate that, within the SVG-CRFR1 complex, residue 17 of the ligand lies within a 9 angstrom distance from residue 117 of the TM1 of CRFR1. The molecular proximity between residue 17 of the ligand and TM1 of CRFR1 described here and between residue 16 of the ligand and the CRFR1 second extracellular loop described previously provides useful molecular constraints for modeling ligand-receptor interaction in mammalian cells expressing CRFR1.	[Assil-Kishawi, Iman; Samra, Tareq A.; Abou-Samra, Abdul B.] Wayne State Univ, Sch Med, Dept Internal Med, Div Endocrine,Univ Hlth Ctr, Detroit, MI 48201 USA; [Mierke, Dale F.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Wayne State University; Dartmouth College	Abou-Samra, AB (corresponding author), Wayne State Univ, Sch Med, Dept Internal Med, Chief Endocrine Div, 4H-UHC,4201 St Antoine, Detroit, MI 48201 USA.	asamra@med.wayne.edu	Abou-Samra, Abdul/ABE-8723-2020	Abou-Samra, Abdul/0000-0001-8735-1142	National Institutes of Health [7RO1 DK63211, GM54082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054082, R01GM054082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 7RO1 DK63211 ( to A.B.A.-S.) and GM54082 ( to D.F.M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ABOUSAMRA AB, 1987, J BIOL CHEM, V262, P1129; Adams AE, 1998, MOL ENDOCRINOL, V12, P1673, DOI 10.1210/me.12.11.1673; Arai M, 2001, ENDOCRINOLOGY, V142, P446, DOI 10.1210/en.142.1.446; Assil IQ, 2001, PEPTIDES, V22, P1055, DOI 10.1016/S0196-9781(01)00424-7; Assil IQ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1015, DOI 10.1152/ajpendo.2001.281.5.E1015; Assil IQ, 2001, BIOCHEMISTRY-US, V40, P1187, DOI 10.1021/bi001758y; Assil-Kishawi I, 2002, J BIOL CHEM, V277, P32558, DOI 10.1074/jbc.M204964200; Behar V, 2000, J BIOL CHEM, V275, P9, DOI 10.1074/jbc.275.1.9; Behar V, 1999, ENDOCRINOLOGY, V140, P4251, DOI 10.1210/en.140.9.4251; Bisello A, 1998, J BIOL CHEM, V273, P22498, DOI 10.1074/jbc.273.35.22498; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2006, J BIOL CHEM, V281, P32485, DOI 10.1074/JBC.M606179200; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2004, J BIOL CHEM, V279, P1167, DOI 10.1074/jbc.M305719200; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Gensure RC, 2003, MOL ENDOCRINOL, V17, P2647, DOI 10.1210/me.2003-0275; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Grace CRR, 2007, J AM CHEM SOC, V129, P16102, DOI 10.1021/ja0760933; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grammatopoulos DK, 2000, MOL ENDOCRINOL, V14, P2076, DOI 10.1210/me.14.12.2076; Greenberg Z, 2000, BIOCHEMISTRY-US, V39, P8142, DOI 10.1021/bi000195n; Hoare SRJ, 2008, MOL PHARMACOL, V73, P1371, DOI 10.1124/mol.107.042978; Hoare SRJ, 2005, PEPTIDES, V26, P457, DOI 10.1016/j.peptides.2004.10.019; Hoare SRJ, 2003, PEPTIDES, V24, P1881, DOI 10.1016/j.peptides.2003.09.002; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; Hofmann BA, 2001, PROTEIN SCI, V10, P2050, DOI 10.1110/ps.12101; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; INGLIS AS, 1970, ANAL BIOCHEM, V37, P73, DOI 10.1016/0003-2697(70)90259-9; Jean-Rene B, 2005, J BIOL CHEM, V280, P23771, DOI 10.1074/jbc.M500817200; KISHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P1108, DOI 10.1073/pnas.92.4.1108; Klose J, 2005, BIOCHEMISTRY-US, V44, P1614, DOI 10.1021/bi049022e; Klose J, 2004, PROTEIN SCI, V13, P2470, DOI 10.1110/ps.04835904; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; LEDERIS K, 1982, SCIENCE, V218, P162, DOI 10.1126/science.6981844; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Liaw CW, 1997, MOL ENDOCRINOL, V11, P980, DOI 10.1210/me.11.7.980; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; Markovic D, 2008, MOL ENDOCRINOL, V22, P689, DOI 10.1210/me.2007-0136; MONTECUCCHI PC, 1980, INT J PEPT PROT RES, V16, P191; ONEIL KT, 1989, J BIOL CHEM, V264, P14571; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pellegrini M, 1998, BIOCHEMISTRY-US, V37, P12737, DOI 10.1021/bi981265h; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 2007, J BIOL CHEM, V282, P37529, DOI 10.1074/jbc.M703748200; Perrin MH, 2006, ANN NY ACAD SCI, V1070, P105, DOI 10.1196/annals.1317.065; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Pham VI, 2004, J PEPT SCI, V10, P179, DOI 10.1002/psc.541; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Potts JT, 2007, ANN NY ACAD SCI, V1117, P196, DOI 10.1196/annals.1402.088; Qi LJ, 1997, BIOCHEMISTRY-US, V36, P12442, DOI 10.1021/bi970997r; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Shimizu N, 2005, J BIOL CHEM, V280, P1797, DOI 10.1074/jbc.M408270200; STENZEL P, 1995, MOL ENDOCRINOL, V9, P637, DOI 10.1210/me.9.5.637; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; XIONG YT, 1995, ENDOCRINOLOGY, V136, P1828, DOI 10.1210/en.136.5.1828	64	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35644	35651		10.1074/jbc.M806351200	http://dx.doi.org/10.1074/jbc.M806351200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18955489	hybrid, Green Published			2022-12-27	WOS:000261687900038
J	Quevillon-Cheruel, S; Leulliot, N; Muniz, CA; Vincent, M; Gallay, J; Argentini, M; Cornu, D; Boccard, F; Lemaitre, B; van Tilbeurgh, H				Quevillon-Cheruel, Sophie; Leulliot, Nicolas; Muniz, Carlos Acosta; Vincent, Michel; Gallay, Jacques; Argentini, Manuela; Cornu, David; Boccard, Frederic; Lemaitre, Bruno; van Tilbeurgh, Herman			Evf, a Virulence Factor Produced by the Drosophila Pathogen Erwinia carotovora, Is an S-Palmitoylated Protein with a New Fold That Binds to Lipid Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; YERSINIA-PESTIS; VAR ATROSEPTICA; TRANSMISSION; FLUORESCENCE; REFINEMENT; VECTOR; PALMITOYLTRANSFERASE; REPRESENTATION	Erwinia carotovora are phytopathogenic Gram-negative bacteria of agronomic interest as these bacteria are responsible for fruit soft rot and use insects as dissemination vectors. The Erwinia carotovora carotovora strain 15 (Ecc15) is capable of persisting in the Drosophila gut by the sole action of one protein, Erwinia virulence factor (Evf). However, the precise function of Evf is elusive, and its sequence does not provide any indication as to its biochemical function. We have solved the 2.0-angstrom crystal structure of Evf and found a protein with a complex topology and a novel fold. The structure of Evf confirms that Evf is unlike any virulence factors known to date. Most remarkably, we identified palmitoic acid covalently bound to the totally conserved Cys(209), which provides important clues as to the function of Evf. Mutation of the palmitoic binding cysteine leads to a loss of virulence, proving that palmitoylation is at the heart of Evf infectivity and may be a membrane anchoring signal. Fluorescence studies of the sole tryptophan residue (Trp(94)) demonstrated that Evf was indeed able to bind to model membranes containing negatively charged phospholipids and to promote their aggregation.	[Quevillon-Cheruel, Sophie; Leulliot, Nicolas; Vincent, Michel; Gallay, Jacques; van Tilbeurgh, Herman] Univ Paris 11, CNRS, UMR8619, Inst Biochem & Biophys Mol & Cellulaire,IFR115, F-91405 Orsay, France; [Muniz, Carlos Acosta; Boccard, Frederic; Lemaitre, Bruno] CNRS, UPR, Ctr Genet Mol, F-91190 Gif Sur Yvette, France; [Argentini, Manuela; Cornu, David] CNRS, Inst Chim Subst Nat, Lab Spectrometrie Masse, UPR 2301, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	van Tilbeurgh, H (corresponding author), Univ Paris 11, CNRS, UMR8619, Inst Biochem & Biophys Mol & Cellulaire,IFR115, F-91405 Orsay, France.	herman.vantilbeurgh@u-psud.fr	Leulliot, Nicolas/AAA-7160-2019; Lemaitre, Bruno/T-8146-2019	Leulliot, Nicolas/0000-0003-0283-4298; Lemaitre, Bruno/0000-0001-7970-1667; Acosta-Muniz, Carlos/0000-0001-6329-3507; Boccard, Frederic/0000-0002-1866-2489				Abrahams JP, 1998, CURR OPIN STRUC BIOL, V8, P601, DOI 10.1016/S0959-440X(98)80151-6; Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; BARRAS F, 1994, ANNU REV PHYTOPATHOL, V32, P201, DOI 10.1146/annurev.py.32.090194.001221; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Basset A, 2003, EMBO REP, V4, P205, DOI 10.1038/sj.embor.embor730; Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; Bizzozero OA, 2001, BBA-PROTEIN STRUCT M, V1545, P278, DOI 10.1016/S0167-4838(00)00291-0; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BROCHON JC, 1994, METHOD ENZYMOL, V240, P262; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dowling AJ, 2007, CELL MICROBIOL, V9, P2470, DOI 10.1111/j.1462-5822.2007.00974.x; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Espeli O, 2001, J MOL BIOL, V314, P375, DOI 10.1006/jmbi.2001.5150; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; ICHIYE T, 1983, BIOCHEMISTRY-US, V22, P2884, DOI 10.1021/bi00281a017; KINOSITA K, 1977, BIOPHYS J, V20, P289, DOI 10.1016/S0006-3495(77)85550-1; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KLOEPPER JW, 1981, AM POTATO J, V58, P165, DOI 10.1007/BF02854416; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Leulliot N, 2004, J BIOL CHEM, V279, P23447, DOI 10.1074/jbc.M401336200; Leulliot N, 2008, STRUCTURE, V16, P52, DOI 10.1016/j.str.2007.10.025; Leulliot N, 2007, J MOL BIOL, V371, P1338, DOI 10.1016/j.jmb.2007.06.031; Liger D, 2005, PROTEINS, V60, P778, DOI 10.1002/prot.20548; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; MOLINA JJ, 1974, AM POTATO J, V51, P245, DOI 10.1007/BF02851435; Muniz CA, 2007, CELL MICROBIOL, V9, P106, DOI 10.1111/j.1462-5822.2006.00771.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Quevillon-Cheruel Sophie, 2007, Methods Mol Biol, V363, P21, DOI 10.1007/978-1-59745-209-0_2; Romeo Yves, 2008, V415, P379, DOI 10.1007/978-1-59745-570-1_22; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Veit M, 1998, BBA-LIPID LIPID MET, V1394, P90, DOI 10.1016/S0005-2760(98)00097-6; VINCENT M, 1991, EUR BIOPHYS J, V20, P183, DOI 10.1007/BF01561141; Vincent M, 2007, BBA-BIOMEMBRANES, V1768, P538, DOI 10.1016/j.bbamem.2006.11.021; Westhead DR, 1999, PROTEIN SCI, V8, P897	50	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3552	3562		10.1074/jbc.M808334200	http://dx.doi.org/10.1074/jbc.M808334200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	18978353	Green Published, hybrid			2022-12-27	WOS:000262872500023
J	Chen, Y; Chen, CG; Kotsikorou, E; Lynch, DL; Reggio, PH; Liu-Chen, LY				Chen, Yong; Chen, Chongguang; Kotsikorou, Evangelia; Lynch, Diane L.; Reggio, Patricia H.; Liu-Chen, Lee-Yuan			GEC1-kappa Opioid Receptor Binding Involves Hydrophobic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TRANSPORT MODULATOR; PROTEIN GABARAP; CRYSTAL-STRUCTURE; GABA(A)-RECEPTOR-ASSOCIATED PROTEIN; CONFORMATIONAL MEMORIES; GABA(A) RECEPTORS; DOWN-REGULATION; MESSENGER-RNAS; IDENTIFICATION; EXPRESSION	We demonstrated previously that the protein GEC1 (glandular epithelial cell 1) bound to the human kappa opioid receptor (hKOPR) and promoted cell surface expression of the receptor by facilitating its trafficking along the secretory pathway. Here we showed that three hKOPR residues (Phe(345), Pro(346), and Met(350)) and seven GEC1 residues (Tyr(49), Val(51), Leu(55), Thr(56), Val(57), Phe(60), and Ile(64)) are indispensable for the interaction. Modeling studies revealed that the interaction was mediated via direct contacts between the kinked hydrophobic fragment in hKOPR C-tail and the curved hydrophobic surface in GEC1 around the S2 beta-strand. Intramolecular Leu(44)-Tyr(109) interaction in GEC1 was important, likely by maintaining its structural integrity. Microtubule binding mediated by the GEC1 N-terminal domain was essential for the GEC1 effect. Expression of GEC1 also increased cell surface levels of the GluR1 subunit and the prostaglandin EP3.f receptor, which have FPXXM and FPXM sequences, respectively. With its widespread distribution in the nervous system and its predominantly hydrophobic interactions, GEC1 may have chaperone-like effects for many cell surface proteins along the biosynthesis pathway.	[Chen, Yong; Liu-Chen, Lee-Yuan] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Kotsikorou, Evangelia; Lynch, Diane L.; Reggio, Patricia H.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27402 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of North Carolina; University of North Carolina Greensboro	Liu-Chen, LY (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, 3420 N Broad St, Philadelphia, PA 19140 USA.	lliuche@temple.edu		Kotsikorou, Evangelia/0000-0002-8398-2139	National Institutes of Health [DA17302, P30 DA13429]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017302, P30DA013429, R01DA011263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA17302 and P30 DA13429. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barnett-Norris J, 2002, INT J QUANTUM CHEM, V88, P76, DOI 10.1002/qua.10093; Bavro VN, 2002, EMBO REP, V3, P183, DOI 10.1093/embo-reports/kvf026; Beardsley PM, 2005, PSYCHOPHARMACOLOGY, V183, P118, DOI 10.1007/s00213-005-0167-4; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Guarnieri F, 1996, J AM CHEM SOC, V118, P5580, DOI 10.1021/ja952745o; Hassan SA, 2000, J PHYS CHEM B, V104, P6478, DOI 10.1021/jp993895e; Hassan SA, 2001, INT J QUANTUM CHEM, V83, P193, DOI 10.1002/qua.1210; Huang P, 2004, J BIOL CHEM, V279, P25002, DOI 10.1074/jbc.M313366200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kanematsu T, 2007, J PHARMACOL SCI, V104, P285, DOI 10.1254/jphs.CP0070063; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Knight D, 2002, J BIOL CHEM, V277, P5556, DOI 10.1074/jbc.M109753200; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Li J, 2002, MOL PHARMACOL, V61, P73, DOI 10.1124/mol.61.1.73; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Liu-Chen LY, 2004, LIFE SCI, V75, P511, DOI 10.1016/j.lfs.2003.10.041; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malyala A, 2004, NEUROCHEM RES, V29, P1189, DOI 10.1023/B:NERE.0000023606.13670.1d; Mansuy V, 2004, BIOCHEM BIOPH RES CO, V325, P639, DOI 10.1016/j.bbrc.2004.10.072; Mansuy-Schlick V, 2006, BRAIN RES, V1073, P83, DOI 10.1016/j.brainres.2005.11.004; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Mohrluder J, 2007, FEBS J, V274, P5543, DOI 10.1111/j.1742-4658.2007.06073.x; Nemos C, 2003, MOL BRAIN RES, V119, P216, DOI 10.1016/j.molbrainres.2003.09.011; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nymann-Andersen J, 2002, NEUROPHARMACOLOGY, V43, P476, DOI 10.1016/S0028-3908(02)00165-X; Nymann-Andersen J, 2002, J NEUROCHEM, V80, P815, DOI 10.1046/j.0022-3042.2002.00762.x; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; PELLERIN I, 1993, MOL CELL ENDOCRINOL, V90, pR17, DOI 10.1016/0303-7207(93)90161-C; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Schlenkrich M., 1996, BIOL MEMBRANES MOL P; Soellick TR, 2001, GENOME BIOL, V2; Stangler T, 2002, J BIOL CHEM, V277, P13363, DOI 10.1074/jbc.C200050200; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Wang Y, 2006, NEUROSCIENCE, V140, P1265, DOI 10.1016/j.neuroscience.2006.03.013; Whitnell RM, 2008, J COMPUT CHEM, V29, P741, DOI 10.1002/jcc.20822; Wikstrom B, 2005, J AM SOC NEPHROL, V16, P3742, DOI 10.1681/ASN.2005020152; Xin YR, 2001, GENOMICS, V74, P408, DOI 10.1006/geno.2001.6555; Zhang FQ, 2002, J PHARMACOL EXP THER, V302, P1184, DOI 10.1124/jpet.302.3.1184	53	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1673	1685		10.1074/jbc.M808303200	http://dx.doi.org/10.1074/jbc.M808303200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19001416	hybrid, Green Published			2022-12-27	WOS:000262330100036
J	Kondo, M; Shibata, R; Miura, R; Shimano, M; Kondo, K; Li, P; Ohashi, T; Kihara, S; Maeda, N; Walsh, K; Ouchi, N; Murohara, T				Kondo, Megumi; Shibata, Rei; Miura, Rie; Shimano, Masayuki; Kondo, Kazuhisa; Li, Ping; Ohashi, Taiki; Kihara, Shinji; Maeda, Norikazu; Walsh, Kenneth; Ouchi, Noriyuki; Murohara, Toyoaki			Caloric Restriction Stimulates Revascularization in Response to Ischemia via Adiponectin-mediated Activation of Endothelial Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONKEYS MACACA-MULATTA; PROTEIN-KINASE; DIETARY RESTRICTION; TISSUE ISCHEMIA; NO SYNTHASE; ANGIOGENESIS; OBESITY; MICE; EXPRESSION; DISEASE	Caloric restriction (CR) can extend longevity and modulate the features of obesity-related metabolic and vascular diseases. However, the functional roles of CR in regulation of revascularization in response to ischemia have not been examined. Here we investigated whether CR modulates vascular response by employing a murine hindlimb ischemia model. Wild-type (WT) mice were randomly divided into two groups that were fed either ad libitum (AL) or CR (65% of the diet consumption of AL). Four weeks later, mice were subjected to unilateral hindlimb ischemic surgery. Body weight of WT mice fed CR (CR-WT) was decreased by 26% compared with WT mice fed AL (AL-WT). Revascularization of ischemic hindlimb relative to the contralateral limb was accelerated in CR-WT compared with AL-WT as evaluated by laser Doppler blood flow and capillary density analyses. CR-WT mice had significantly higher plasma levels of the fat-derived hormone adiponectin compared with AL-WT mice. In contrast to WT mice, CR did not affect the revascularization of ischemic limbs of adiponectindeficient (APN-KO) mice. CR stimulated the phosphorylation of endothelial nitric-oxide synthase (eNOS) in the ischemic limbs of WT mice. CR increased plasma adiponectin levels in eNOS-KO mice but did not stimulate limb perfusion in this strain. CR-WT mice showed enhanced phosphorylation of AMP-activated protein kinase (AMPK) in ischemic muscle, and administration of AMPK inhibitor compound C abolished CR-induced increase in limb perfusion and eNOS phosphorylation in WT mice. Our observations indicate that CR can promote revascularization in response to tissue ischemia via an AMPK-eNOS-dependent mechanism that is mediated by adiponectin.	[Kondo, Megumi; Shibata, Rei; Miura, Rie; Shimano, Masayuki; Kondo, Kazuhisa; Li, Ping; Ohashi, Taiki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Walsh, Kenneth; Ouchi, Noriyuki] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kihara, Shinji; Maeda, Norikazu] Osaka Univ, Dept Metab Med, Suita, Osaka 5650871, Japan	Nagoya University; Boston University; Osaka University	Shibata, R (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp	Li, Ping/GYV-4914-2022; OUCHI, Noriyuki/I-7306-2014; Murohara, Toyoaki/M-4958-2014		National Institutes of Health [HL86785, HL91949, HL81587]; The Nakashima Foundation; The Aichi D. R. G. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086785, R01HL091949, P01HL081587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Nakashima Foundation; The Aichi D. R. G. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL86785, HL91949, and HL81587 (to K. W.). This work was also supported by a grant-in-aid for young scientists A, The Nakashima Foundation, and The Aichi D. R. G. Foundation (to R. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" U. S. C. Section 1734 solely to indicate this fact.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Guo ZM, 2002, MECH AGEING DEV, V123, P1121, DOI 10.1016/S0047-6374(02)00008-8; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Iwashima Y, 2006, ATHEROSCLEROSIS, V188, P384, DOI 10.1016/j.atherosclerosis.2005.10.039; Kanda T, 2007, INT J CARDIOL, V119, P310, DOI 10.1016/j.ijcard.2006.07.181; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Lane MA, 2000, MECH AGEING DEV, V112, P185, DOI 10.1016/S0047-6374(99)00087-1; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P149, DOI 10.1016/S1089-8603(02)00111-8; Li P, 2008, HYPERTENSION, V51, P252, DOI 10.1161/HYPERTENSIONAHA.107.097394; Mahoney LB, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-13; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nishimura M, 2008, CIRCULATION, V117, P216, DOI 10.1161/CIRCULATIONAHA.107.725044; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Schiekofer S, 2005, ARTERIOSCL THROM VAS, V25, P1603, DOI 10.1161/01.ATV.0000171994.89106.ca; Seymour EM, 2006, J MOL CELL CARDIOL, V41, P661, DOI 10.1016/j.yjmcc.2006.07.012; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2008, FEBS LETT, V582, P1607, DOI 10.1016/j.febslet.2008.04.006; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Shinmura K, 2007, CIRCULATION, V116, P2809, DOI 10.1161/CIRCULATIONAHA.107.725697; Stein O, 2003, BIOCHEM BIOPH RES CO, V308, P29, DOI 10.1016/S0006-291X(03)01313-5; Tirziu D, 2005, CIRCULATION, V112, P2501, DOI 10.1161/CIRCULATIONAHA.105.542829; Verdery RB, 1998, ARCH INTERN MED, V158, P900, DOI 10.1001/archinte.158.8.900; Verdery RB, 1997, AM J PHYSIOL-ENDOC M, V273, pE714, DOI 10.1152/ajpendo.1997.273.4.E714; Williams IL, 2002, INT J OBESITY, V26, P754, DOI 10.1038/sj.ijo.0801995; YAROM R, 1992, J PATHOL, V166, P265, DOI 10.1002/path.1711660308; Yilmaz MB, 2003, INT J OBESITY, V27, P1541, DOI 10.1038/sj.ijo.0802474; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024; ZIMMERMAN J, 1984, ARTERIOSCLEROSIS, V4, P115, DOI 10.1161/01.ATV.4.2.115	41	98	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1718	1724		10.1074/jbc.M805301200	http://dx.doi.org/10.1074/jbc.M805301200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18990685	Green Published, hybrid			2022-12-27	WOS:000262330100041
J	Kruger, WA; Yun, CC; Monteith, GR; Poronnik, P				Kruger, Wade A.; Yun, C. Chris; Monteith, Gregory R.; Poronnik, Philip			Muscarinic-induced Recruitment of Plasma Membrane Ca2+-ATPase Involves PSD-95/Dlg/Zo-1-mediated Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INHIBITION; PROTEIN-KINASE-A; EXCHANGER REGULATORY FACTOR-2; INTACT EPITHELIAL-CELLS; PDZ SCAFFOLD NHERF-2; ILEAL BRUSH-BORDER; NA+-H+ EXCHANGER; CALCIUM-PUMP; CA2+ PUMP; ADAPTER PROTEINS	Efflux of cytosolic Ca2+ mediated by plasma membrane Ca2+-ATPases (PMCA) plays a key role in fine tuning the magnitude and duration of Ca2+ signaling following activation of G-protein-coupled receptors. However, the molecular mechanisms that underpin the trafficking of PMCA to the membrane during Ca2+ signaling remain largely unexplored in native cell models. One potential mechanism for the recruitment of proteins to the plasma membrane involves PDZ interactions. In this context, we investigated the role of PMCA interactions with the Na+/H+ exchanger regulatory factor 2 (NHERF-2) during muscarinic-induced Ca2+ mobilization in the HT-29 epithelial cell line. GST pull-downs in HT-29 cell lysates showed that the PDZ2 module of NHERF-2 bound to the PDZ binding motif on the C terminus of PMCA. Co-immunoprecipitations confirmed that PMCA1b and NHERF-2 associated under normal conditions in HT-29 cells. Cell surface biotinylations revealed significant increases in membrane-associated NHERF-2 and PMCA within 60 s following muscarinic activation, accompanied by increased association of the two proteins as seen by confocal microscopy. The recruitment of NHERF-2 to the membrane preceded that of PMCA, suggesting that NHERF-2 was involved in nucleating an efflux complex at the membrane. The muscarinic-mediated translocation of PMCA was abolished when NHERF-2 was silenced, and the rate of relative Ca2+ efflux was also reduced. These experiments also uncovered a NHERF-2-independent PMCA retrieval mechanism. Our findings describe rapid agonist-induced translocation of PMCA in a native cell model and suggest that NHERF-2 plays a key role in scaffolding and maintaining PMCA at the cell membrane.	[Kruger, Wade A.; Poronnik, Philip] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Yun, C. Chris] Emory Univ, Dept Med, Atlanta, GA 30322 USA	University of Queensland; University of Queensland; Emory University	Poronnik, P (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	p.poronnik@uq.edu.au	Monteith, Gregory/B-1626-2008	Monteith, Gregory/0000-0002-4345-530X; Poronnik, Philip/0000-0002-6246-528X	National Institutes of Health [DK061418]; Australian Research Council; National Health and Medical Research Council of Australia; University of Queensland Development Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Development Grant(University of Queensland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grant DK061418 from the National Institutes of Health ( to C. C. Y.). This work was also supported by grants from the Australian Research Council and National Health and Medical Research Council of Australia ( to P. P.) and a University of Queensland Development Grant ( to P. P. and G. R. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambudkar IS, 2007, PFLUG ARCH EUR J PHY, V455, P187, DOI 10.1007/s00424-007-0252-0; Ambudkar IS, 2006, TRENDS PHARMACOL SCI, V27, P25, DOI 10.1016/j.tips.2005.11.008; Aung CS, 2007, BIOCHEM BIOPH RES CO, V355, P932, DOI 10.1016/j.bbrc.2007.02.050; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Bruce JIE, 2002, J BIOL CHEM, V277, P48172, DOI 10.1074/jbc.M208393200; Carafoli E, 2003, NAT REV MOL CELL BIO, V4, P326, DOI 10.1038/nrm1073; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Cummins MM, 2000, IMMUNOL CELL BIOL, V78, P375, DOI 10.1046/j.1440-1711.2000.00932.x; Cummins MM, 2002, PFLUG ARCH EUR J PHY, V444, P644, DOI 10.1007/s00424-002-0856-3; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Duman JG, 2008, J GEN PHYSIOL, V131, P307, DOI 10.1085/jgp.200709915; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Goellner GM, 2003, ANN NY ACAD SCI, V986, P461, DOI 10.1111/j.1749-6632.2003.tb07230.x; Guerini D, 2003, J BIOL CHEM, V278, P38141, DOI 10.1074/jbc.M302400200; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Ingraffea J, 2002, EUR J CELL BIOL, V81, P61, DOI 10.1078/0171-9335-00218; KESSLER F, 1990, J BIOL CHEM, V265, P16012; Kim JY, 2006, J BIOL CHEM, V281, P32540, DOI 10.1074/jbc.M602496200; KOPP R, 1989, EUR J PHARM-MOLEC PH, V172, P397, DOI 10.1016/0922-4106(89)90021-7; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lee WJ, 2005, J BIOL CHEM, V280, P27076, DOI 10.1074/jbc.M414142200; Lee-Kwon W, 2005, AM J PHYSIOL-CELL PH, V288, pC942, DOI 10.1152/ajpcell.00417.2004; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; MONTEITH GR, 1995, CELL CALCIUM, V18, P459, DOI 10.1016/0143-4160(95)90009-8; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Oceandy D, 2007, BIOCHEM SOC T, V35, P927, DOI 10.1042/BST0350927; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Padanyi R, 2003, J BIOL CHEM, V278, P35798, DOI 10.1074/jbc.M305794200; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paquet M, 2006, J COMP NEUROL, V494, P752, DOI 10.1002/cne.20854; Paquet M, 2006, J BIOL CHEM, V281, P29949, DOI 10.1074/jbc.M602262200; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Poronnik P, 2002, CELL BIOCHEM BIOPHYS, V36, P221, DOI 10.1385/CBB:36:2-3:221; SCHATZMANN HJ, 1966, EXPERIENTIA, V22, P364, DOI 10.1007/BF01901136; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Stauffer TP, 1997, BRAIN RES, V748, P21, DOI 10.1016/S0006-8993(96)01282-6; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Wanaverbecq N, 2003, J PHYSIOL-LONDON, V550, P83, DOI 10.1113/jphysiol.2002.035782; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zabe M, 2001, J BIOL CHEM, V276, P14704, DOI 10.1074/jbc.M009850200; Zylinska L, 1998, BBA-MOL CELL RES, V1448, P99, DOI 10.1016/S0167-4889(98)00128-1; Zylinska L, 2002, CELL MOL BIOL LETT, V7, P1037	66	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1820	1830		10.1074/jbc.M804590200	http://dx.doi.org/10.1074/jbc.M804590200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017653	hybrid, Green Published			2022-12-27	WOS:000262330100053
J	Culyba, MJ; Hwang, Y; Minkah, N; Bushman, FD				Culyba, Matthew J.; Hwang, Young; Minkah, Nana; Bushman, Frederic D.			DNA Binding and Cleavage by the Fowlpox Virus Resolvase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION RESOLVASE; ENZYME CCE1; QUATERNARY STRUCTURE; VACCINIA VIRUS; ENDONUCLEASE; SPECIFICITY; RESOLUTION; DISTORTION; SEQUENCE; RUVC	The first steps of poxvirus DNA synthesis yield concatemeric arrays of covalently linked genomes. The virus-encoded Holliday junction resolvase is required to process concatemers into unit-length genomes for packaging. Previous studies of the vaccinia virus resolvase have been problematic due to poor protein solubility. We found that fowlpox virus resolvase was much more tractable. Fowlpox resolvase formed complexes with a variety of branched DNA substrates, but not linear DNA, and had the highest affinity for a Holliday junction substrate, illustrating a previously unappreciated affinity for Holliday junctions over other substrates. The cleavage activity was monitored in fixed time assays, showing that, as with vaccinia resolvase, the fowlpox enzyme could cleave a wide array of branched DNA substrates. Single turnover kinetic analysis revealed the Holliday junction substrate was cleaved 90-fold faster than a splayed duplex substrate containing a single to double strand transition. Multiple turnover kinetic analysis, however, showed that the cleavage step was not limiting for the full reaction cycle. Cleavage by resolvase was also tightly coupled at symmetrical positions across the junction, and coupling required the complete Holliday junction structure. Last, we found that cleavage of an extruded cruciform yielded a product, which after treatment with ligase, had the properties expected for covalently closed DNA hairpin ends, as is seen for poxvirus genome monomers. These findings provide a tractable poxvirus resolvase usable for the development of small molecule inhibitors.	[Culyba, Matthew J.; Hwang, Young; Minkah, Nana; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Bushman, FD (corresponding author), 402C Johnson Pavilion,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu		Bushman, Frederic/0000-0003-4740-4056	National Institutes of Health [U54 AI057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007324, U54AI057168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health NIAID Mid-Atlantic Regional Center of Excellence for Biodefense Research Grant U54 AI057168.	BENNETT RJ, 1993, CELL, V74, P1021, DOI 10.1016/0092-8674(93)90724-5; Culyba MJ, 2007, J BIOL CHEM, V282, P34644, DOI 10.1074/jbc.M705322200; Culyba MJ, 2006, VIROLOGY, V352, P466, DOI 10.1016/j.virol.2006.05.007; DICKIE P, 1987, J MOL BIOL, V196, P541, DOI 10.1016/0022-2836(87)90031-3; Fogg JM, 2000, BIOCHEMISTRY-US, V39, P4082, DOI 10.1021/bi992785v; Fogg JM, 2000, BIOCHEMISTRY-US, V39, P16125, DOI 10.1021/bi001886m; Garcia AD, 2000, P NATL ACAD SCI USA, V97, P8926, DOI 10.1073/pnas.150238697; Garcia AD, 2006, J BIOL CHEM, V281, P11618, DOI 10.1074/jbc.M600182200; Garcia AD, 2001, J VIROL, V75, P6460, DOI 10.1128/JVI.75.14.6460-6471.2001; Giraud-Panis MJE, 1998, J MOL BIOL, V278, P117, DOI 10.1006/jmbi.1998.1681; GiraudPanis MJE, 1996, J BIOL CHEM, V271, P33148, DOI 10.1074/jbc.271.51.33148; GREAVES DR, 1985, J MOL BIOL, V185, P461, DOI 10.1016/0022-2836(85)90064-6; Moss B, 2001, VIROLOGY, P2637; Parkinson MJ, 1997, J MOL BIOL, V270, P169, DOI 10.1006/jmbi.1997.1128; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; White MF, 1996, J MOL BIOL, V257, P330, DOI 10.1006/jmbi.1996.0166; White MF, 1997, J MOL BIOL, V266, P122, DOI 10.1006/jmbi.1996.0795	17	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1190	1201		10.1074/jbc.M807864200	http://dx.doi.org/10.1074/jbc.M807864200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004818	Green Published, hybrid			2022-12-27	WOS:000262122900055
J	Du, XY; Zabel, BA; Myles, T; Allen, SJ; Handel, TM; Lee, PP; Butcher, EC; Leung, LL				Du, Xiao-Yan; Zabel, Brian A.; Myles, Timothy; Allen, Samantha J.; Handel, Tracy M.; Lee, Peter P.; Butcher, Eugene C.; Leung, Lawrence L.			Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; PROCARBOXYPEPTIDASE-B; IN-VIVO; PLASMINOGEN; EXPRESSION; CELLS; INFLAMMATION; CHEMOKINES; RECEPTORS; COAGULATION	Chemerin is a potent chemoattractant for cells expressing the serpentine receptor CMKLR1(chemokine- like receptor 1), such as plasmacytoid dendritic cells and tissue macrophages. The bioactivity of chemerin is post-translationally regulated; the attractant circulates in blood in a relatively inactive form (prochemerin) and is activated by carboxyl-terminal proteolytic cleavage. We discovered that plasma carboxypeptidase N (CPN) and B (CPB or activated thrombin-activable fibrinolysis inhibitor, TAFIa) enhanced the bioactivity of 10-mer chemerin peptide NH2-YFPGQFAFSK-COOH by removing the carboxyl-terminal lysine ( K). Sequential cleavages of either a prochemerin peptide (NH2-YFPGQFAFSKALPRS-COOH) or recombinant full-length prochemerin by plasmin and CPN/CPB substantially increased their chemotactic activities. Endogenous CPN present in circulating plasma enhanced the activity of plasmin-cleaved prochemerin. In addition, we discovered that platelets store chemerin protein and release it upon stimulation. Thus circulating CPN/CPB and platelets may potentially contribute to regulating the bioactivity of leukocyte chemoattractant chemerin, and further extend the molecular link between blood coagulation/fibrinolysis and CMKLR1-mediated immune responses.	[Zabel, Brian A.; Butcher, Eugene C.; Leung, Lawrence L.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Du, Xiao-Yan; Myles, Timothy; Lee, Peter P.; Leung, Lawrence L.] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Zabel, Brian A.; Butcher, Eugene C.; Leung, Lawrence L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Allen, Samantha J.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; University of California System; University of California San Diego	Leung, LL (corresponding author), VA Palo Alto Hlth Care Syst, 3801 Miranda Ave 11, Palo Alto, CA 94304 USA.	lawrence.leung@stanford.edu		Lee, Peter P./0000-0002-2660-4377	National Institutes of Health [RO1 HL57530, AI59625, AI057229, DK56339]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229, R21AI059625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL57530 ( to L. L.) and AI59625, AI057229, and DK56339 ( to E. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Boehlen F, 2001, TRANSFUSION MED, V11, P403, DOI 10.1046/j.1365-3148.2001.00340.x; Brandt E, 2000, IMMUNOL REV, V177, P204, DOI 10.1034/j.1600-065X.2000.17705.x; Ceresa E, 2006, J BIOL CHEM, V281, P15878, DOI 10.1074/jbc.M509839200; Cines DB, 2007, J CLIN APHERESIS, V22, P31, DOI 10.1002/jca.20109; Clemetson KJ, 2007, CURR PHARM DESIGN, V13, P2673, DOI 10.2174/138161207781662894; Clemetson KJ, 2000, BLOOD, V96, P4046; Du XY, 2006, BLOOD CELL MOL DIS, V36, P414, DOI 10.1016/j.bcmd.2006.03.001; Du XY, 2002, J BIOL CHEM, V277, P35124, DOI 10.1074/jbc.M204372200; Gonzalez-Gronow M, 2008, FRONT BIOSCI-LANDMRK, V13, P1610, DOI 10.2741/2785; Hildebrandt M, 2008, FRONT BIOSCI-LANDMRK, V13, P1774, DOI 10.2741/2798; Kulig P, 2007, J IMMUNOL, V178, P3713, DOI 10.4049/jimmunol.178.6.3713; Lenich C, 1997, BLOOD, V90, P3579, DOI 10.1182/blood.V90.9.3579; Matthews KW, 2004, MOL IMMUNOL, V40, P785, DOI 10.1016/j.molimm.2003.10.002; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; MILES LA, 1985, J BIOL CHEM, V260, P4303; MILES LA, 1986, J CLIN INVEST, V77, P2001, DOI 10.1172/JCI112529; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Myles T, 2008, J BIOL CHEM, V283, P17789, DOI 10.1074/jbc.M708629200; Nishimura T, 2007, BLOOD, V109, P1992, DOI 10.1182/blood-2006-03-012567; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; PLOW EF, 1981, BLOOD, V58, P1069; POWER CA, 1995, CYTOKINE, V7, P479, DOI 10.1006/cyto.1995.0065; REDLITZ A, 1995, J CLIN INVEST, V96, P2534, DOI 10.1172/JCI118315; Stellos K, 2007, THROMB HAEMOSTASIS, V98, P922, DOI 10.1160/TH07-02-0147; von Hundelshausen P, 2007, THROMB HAEMOSTASIS, V97, P704, DOI 10.1160/TH07-01-0066; Warkentin TE, 1998, THROMB HAEMOSTASIS, V79, P1; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011; Zhang Z, 2005, CELL MOL IMMUNOL, V2, P411	36	91	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					751	758		10.1074/jbc.M805000200	http://dx.doi.org/10.1074/jbc.M805000200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010784	Green Published, hybrid			2022-12-27	WOS:000262122900008
J	Ilari, A; Franceschini, S; Bonamore, A; Arenghi, F; Botta, B; Macone, A; Pasquo, A; Bellucci, L; Boffi, A				Ilari, Andrea; Franceschini, Stefano; Bonamore, Alessandra; Arenghi, Fabio; Botta, Bruno; Macone, Alberto; Pasquo, Alessandra; Bellucci, Luca; Boffi, Alberto			Structural Basis of Enzymatic (S)-Norcoclaurine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZYLISOQUINOLINE ALKALOID BIOSYNTHESIS; NORCOCLAURINE SYNTHASE; X-RAY; PROTEIN; STRICTOSIDINE; CLONING	The enzyme norcoclaurine synthase (NCS) catalyzes the stereospecific Pictet-Spengler cyclization between dopamine and 4-hydroxyphenylacetaldehyde, the key step in the benzylisoquinoline alkaloid biosynthetic pathway. The crystallographic structure of norcoclaurine synthase from Thalictrum flavum in its complex with dopamine substrate and the nonreactive substrate analogue 4-hydroxybenzaldehyde has been solved at 2.1 angstrom resolution. NCS shares no common features with the functionally correlated "Pictet-Spenglerases" that catalyze the first step of the indole alkaloids pathways and conforms to the overall fold of the Bet v1-like protein. The active site of NCS is located within a 20-angstrom-long catalytic tunnel and is shaped by the side chains of a tyrosine, a lysine, an aspartic, and a glutamic acid. The geometry of the amino acid side chains with respect to the substrates reveals the structural determinants that govern the mechanism of the stereoselective Pictet-Spengler cyclization, thus establishing an excellent foundation for the understanding of the finer details of the catalytic process. Site-directed mutations of the relevant residues confirm the assignment based on crystallographic findings.	[Ilari, Andrea; Franceschini, Stefano; Bonamore, Alessandra; Macone, Alberto; Boffi, Alberto] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy; [Ilari, Andrea; Franceschini, Stefano; Bonamore, Alessandra; Macone, Alberto; Boffi, Alberto] Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, I-00185 Rome, Italy; [Arenghi, Fabio] CPC Biotech Srl, I-80121 Naples, Italy; [Botta, Bruno] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy; [Pasquo, Alessandra] ENEA Casaccia Res Ctr, Dipartimento BIOTEC, Sez Genet & Genom Vegetale, I-00100 Rome, Italy; [Bellucci, Luca] Univ Siena, Ist Tecn Chim Farmacol, I-53110 Siena, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Sapienza University Rome; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Siena	Boffi, A (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	alberto.boffi@uniroma1.it	Bellucci, Luca/AAB-2834-2021; Macone, Alberto/AAB-2570-2019; Ilari, Andrea/AAC-7670-2022; Bonamore, Alessandra/AAB-2587-2019; Ilari, Andrea/T-5501-2017; Bellucci, Luca/J-9096-2016	Bellucci, Luca/0000-0003-2031-064X; Macone, Alberto/0000-0003-0455-1400; Ilari, Andrea/0000-0002-7754-399X; Bonamore, Alessandra/0000-0002-3940-4657; Ilari, Andrea/0000-0002-7754-399X; Bellucci, Luca/0000-0003-2031-064X; Botta, Bruno/0000-0001-8707-4333	Ministero dell' Istruzione dell' Universita' e della Ricerca Scientifica; European Community Research Infrastructure Action; European Research Area Programme [R II 3-CT-2004-506008]	Ministero dell' Istruzione dell' Universita' e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); European Community Research Infrastructure Action(European Commission); European Research Area Programme	This work was supported by Project FIRB 2003 from Ministero dell' Istruzione dell' Universita' e della Ricerca Scientifica ( to A. B., B. B., and F. A.), local university grants ( to A. B. and B. B.), and the European Community Research Infrastructure Action under the FP6 Structuring the European Research Area Programme ( through the Integrated Infrastructure Initiative" Integrating Activity on Synchroton and Free Electron Laser Science, Contract R II 3-CT-2004-506008). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; Berkner H, 2008, BIOCHEM J, V413, P281, DOI 10.1042/BJ20080306; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facchini PJ, 2005, CURR OPIN PLANT BIOL, V8, P657, DOI 10.1016/j.pbi.2005.09.008; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Hazen SL, 1997, J BIOL CHEM, V272, P16990, DOI 10.1074/jbc.272.27.16990; KUTCHAN TM, 1993, PHYTOCHEMISTRY, V32, P493, DOI 10.1016/S0031-9422(00)95128-8; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luk LYP, 2007, BIOCHEMISTRY-US, V46, P10153, DOI 10.1021/bi700752n; Ma XY, 2006, PLANT CELL, V18, P907, DOI 10.1105/tpc.105.038018; Maryanoff BE, 2004, CHEM REV, V104, P1431, DOI 10.1021/cr0306182; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Minami H, 2007, J BIOL CHEM, V282, P6274, DOI 10.1074/jbc.M608933200; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; NOYORI R, 1989, Patent No. 4851537; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasquo A, 2008, ACTA CRYSTALLOGR F, V64, P281, DOI 10.1107/S1744309108005678; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Samanani N, 2004, PLANT J, V40, P302, DOI 10.1111/j.1365-313X.2004.02210.x; Samanani N, 2002, J BIOL CHEM, V277, P33878, DOI 10.1074/jbc.M203051200; Seayad J, 2006, J AM CHEM SOC, V128, P1086, DOI 10.1021/ja057444l; STADLER R, 1990, LIEBIGS ANN CHEM, P555; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730	30	84	91	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					897	904		10.1074/jbc.M803738200	http://dx.doi.org/10.1074/jbc.M803738200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19004827	hybrid			2022-12-27	WOS:000262122900024
J	Wang, XJ; Levic, S; Gratton, MA; Doyle, KJ; Yamoah, EN; Pegg, AE				Wang, Xiaojing; Levic, Snezana; Gratton, Michael Anne; Doyle, Karen Jo; Yamoah, Ebenezer N.; Pegg, Anthony E.			Spermine Synthase Deficiency Leads to Deafness and a Profound Sensitivity to alpha-Difluoromethylornithine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECARBOXYLATED-S-ADENOSYLMETHIONINE; X-LINKED HYPOPHOSPHATEMIA; ORNITHINE-DECARBOXYLASE; POLYAMINE METABOLISM; MAMMALIAN-CELLS; INWARD RECTIFICATION; CLINICAL-TRIAL; PEX GENE; GY MICE; MOUSE	Male gyro (Gy) mice, which have an X chromosomal deletion inactivating the SpmS and Phex genes, were found to be profoundly hearing impaired. This defect was due to alteration in polyamine content due to the absence of spermine synthase, the product of the SpmS gene. It was reversed by breeding the Gy strain with CAG/SpmS mice, a transgenic line that ubiquitously expresses spermine synthase under the control of a composite cytomegalovirus-IE enhancer/chicken beta-actin promoter. There was an almost complete loss of the endocochlear potential in the Gy mice, which parallels the hearing deficiency, and this was also reversed by the production of spermine from the spermine synthase transgene. Gy mice showed a striking toxic response to treatment with the ornithine decarboxylase inhibitor alpha-difluoromethylornithine (DFMO). Within 2-3 days of exposure to DFMO in the drinking water, the Gy mice suffered a catastrophic loss of motor function resulting in death within 5 days. This effect was due to an inability to maintain normal balance and was also prevented by the transgenic expression of spermine synthase. DFMO treatment of control mice or Gy-CAG/SpmS had no effect on balance. The loss of balance in Gy mice treated with DFMO was due to inhibition of polyamine synthesis because it was prevented by administration of putrescine. Our results are consistent with a critical role for polyamines in regulation of Kir channels that maintain the endocochlear potential and emphasize the importance of normal spermidine: spermine ratio in the hearing and balance functions of the inner ear.	[Wang, Xiaojing; Pegg, Anthony E.] Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA; [Gratton, Michael Anne] Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19014 USA; [Levic, Snezana; Doyle, Karen Jo; Yamoah, Ebenezer N.] Univ Calif Davis, Program Commun Sci, Ctr Neurosci, Davis, CA 95618 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Pennsylvania; University of California System; University of California Davis	Pegg, AE (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA 17033 USA.	aep1@psu.edu		Levic, Snezana/0000-0002-6171-896X	National Institutes of Health (USPHS) [R01 GM26290, DC007592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007592] Funding Source: NIH RePORTER	National Institutes of Health (USPHS)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health (USPHS) Grants R01 GM26290 (to A. E. P.) and DC007592 (to E. N. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABELOFF MD, 1986, CANCER TREAT REP, V70, P843; BARKER BO, 1989, AM J DISTANCE ED, V3, P20, DOI DOI 10.1080/08923648909526647; BARKWAY C, 1988, HERED DEAFNESS NEWSL, V1, P20; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; BROCK M, 1994, HEARING RES, V72, P37, DOI 10.1016/0378-5955(94)90203-8; Casimiro MC, 2004, GENOMICS, V84, P555, DOI 10.1016/j.ygeno.2004.06.007; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Clay NK, 2005, PLANT PHYSIOL, V138, P767, DOI 10.1104/pp.104.055756; Danzin C., 1987, INHIBITION POLYAMINE, P141; de Alencastro G, 2008, J MED GENET, V45, P539, DOI 10.1136/jmg.2007.056713; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Dou HV, 2004, JARO-J ASSOC RES OTO, V5, P215, DOI 10.1007/s10162-003-4020-3; Doyle KJ, 2001, ARCH OTOLARYNGOL, V127, P553, DOI 10.1001/archotol.127.5.553; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Feith DJ, 2005, CANCER RES, V65, P572; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Fong LYY, 1998, CANCER RES, V58, P5380; Grieff M, 1997, GENOMICS, V44, P227, DOI 10.1006/geno.1997.4876; HAEGELE KD, 1987, CANCER RES, V47, P890; Hamasaki-Katagiri N, 1998, GENE, V210, P195, DOI 10.1016/S0378-1119(98)00027-4; Hamzavi I, 2007, J AM ACAD DERMATOL, V57, P54, DOI 10.1016/j.jaad.2006.09.025; HENLEY CM, 1995, HEARING RES, V84, P99, DOI 10.1016/0378-5955(95)00017-X; Hoffmann R, 2008, EUR J DERMATOL, V18, P65; HORN Y, 1987, EUR J CANCER CLIN ON, V23, P1103, DOI 10.1016/0277-5379(87)90141-6; Hoshino K, 2005, J BIOL CHEM, V280, P42801, DOI 10.1074/jbc.M505445200; Ikeguchi Y, 2004, BIOCHEM J, V381, P701, DOI 10.1042/BJ20040419; Imai A, 2004, FEBS LETT, V556, P148, DOI 10.1016/S0014-5793(03)01395-4; John SA, 2004, J GEN PHYSIOL, V123, P623, DOI 10.1085/jgp.200409017; Kato M, 1999, MOL REPROD DEV, V54, P43, DOI 10.1002/(SICI)1098-2795(199909)54:1&lt;43::AID-MRD6&gt;3.0.CO;2-N; Knott JM, 2007, FEBS LETT, V581, P3081, DOI 10.1016/j.febslet.2007.05.074; Korhonen VP, 2001, MOL PHARMACOL, V59, P231, DOI 10.1124/mol.59.2.231; Kurata HT, 2006, J GEN PHYSIOL, V127, P467, DOI 10.1085/jgp.200509467; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lao CD, 2004, CANCER EPIDEM BIOMAR, V13, P1250; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lorenz B, 1998, HUM MOL GENET, V7, P541, DOI 10.1093/hmg/7.3.541; LYON MF, 1986, P NATL ACAD SCI USA, V83, P4899, DOI 10.1073/pnas.83.13.4899; Mackintosh CA, 2000, BIOCHEM J, V351, P439, DOI 10.1042/0264-6021:3510439; MAMONT PS, 1982, EUR J BIOCHEM, V123, P499; MARKS SC, 1991, HEARING RES, V53, P230, DOI 10.1016/0378-5955(91)90057-G; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; MEYER RA, 1995, J ORTHOPAED RES, V13, P30, DOI 10.1002/jor.1100130107; Meyer RA, 1998, GENOMICS, V48, P289, DOI 10.1006/geno.1997.5169; Meyskens FL, 1999, CLIN CANCER RES, V5, P945; MEYSKENS FL, 2008, CANC PREV RES, P9; Nie LP, 2005, J BIOL CHEM, V280, P15097, DOI 10.1074/jbc.M409856200; Nilsson J, 2000, BIOCHEM J, V352, P381, DOI 10.1042/0264-6021:3520381; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; PAJULA RL, 1979, EUR J BIOCHEM, V101, P619, DOI 10.1111/j.1432-1033.1979.tb19756.x; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Pasic TR, 1997, ARCH OTOLARYNGOL, V123, P1281; PEGG AE, 1969, BIOCHEM J, V115, P241, DOI 10.1042/bj1150241; PEGG AE, 1985, BIOCHEM BIOPH RES CO, V133, P82, DOI 10.1016/0006-291X(85)91844-3; PEGG AE, 1984, BIOCHEM J, V224, P29, DOI 10.1042/bj2240029; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Priotto G, 2008, BMJ-BRIT MED J, V336, P705, DOI 10.1136/bmj.39485.592674.BE; Sawicki JA, 1998, EXP CELL RES, V244, P367, DOI 10.1006/excr.1998.4175; SEILER N, 1985, J CHROMATOGR, V339, P45, DOI 10.1016/S0378-4347(00)84626-5; Simoneau AR, 2008, CANCER EPIDEM BIOMAR, V17, P292, DOI 10.1158/1055-9965.EPI-07-0658; Smith MC, 2004, LARYNGOSCOPE, V114, P1113, DOI 10.1097/00005537-200406000-00029; Strom TM, 1997, HUM MOL GENET, V6, P165, DOI 10.1093/hmg/6.2.165; TABOR CW, 1956, J PHARMACOL EXP THER, V116, P139; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Williamson RE, 2007, AM J MED GENET A, V143A, P1630, DOI 10.1002/ajmg.a.31724; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Yamaguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P486, DOI 10.1016/j.bbrc.2006.11.041	72	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					930	937		10.1074/jbc.M807758200	http://dx.doi.org/10.1074/jbc.M807758200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001365	Green Published, hybrid			2022-12-27	WOS:000262122900028
J	Yu, SR; Smirnova, JB; Friedberg, EC; Stillman, B; Akiyama, M; Owen-Hughes, T; Waters, R; Reed, SH				Yu, Shirong; Smirnova, Julia B.; Friedberg, Errol C.; Stillman, Bruce; Akiyama, Masahiro; Owen-Hughes, Tom; Waters, Raymond; Reed, Simon H.			ABF1-binding Sites Promote Efficient Global Genome Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SEQUENCE BINDING-FACTOR; III-SENSITIVE SITES; IN-VITRO; DNA TRANSLOCATION; DIRECTIONAL ESTABLISHMENT; UV-IRRADIATION; BUDDING YEAST; ABF1 PROTEIN; HML-ALPHA	Global genome nucleotide excision repair (GG-NER) removes DNA damage from nontranscribing DNA. In Saccharomyces cerevisiae, the RAD7 and RAD16 genes are specifically required for GG-NER. We have reported that autonomously replicating sequence-binding factor 1 (ABF1) protein forms a stable complex with Rad7 and Rad16 proteins. ABF1 functions in transcription, replication, gene silencing, and NER in yeast. Here we show that binding of ABF1 to its DNA recognition sequence found at multiple genomic locations promotes efficient GG-NER in yeast. Mutation of the I silencer ABF1-binding site at the HML alpha locus caused loss of ABF1 binding, which resulted in a domain of reduced GG-NER efficiency on one side of the ABF1-binding site. During GG-NER, nucleosome positioning at this site was not altered, and this correlated with an inability of the GG-NER complex to reposition nucleosomes in vitro. We discuss how the GG-NER complex might facilitate GG-NER while preventing unregulated gene transcription during this process.	[Yu, Shirong; Smirnova, Julia B.; Waters, Raymond; Reed, Simon H.] Cardiff Univ, Sch Med, Dept Pathol, Cardiff CF14 4XN, S Glam, Wales; [Friedberg, Errol C.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Lab Mol Pathol, Dallas, TX 75390 USA; [Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Akiyama, Masahiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Mol Biol, Nara 63001, Japan; [Owen-Hughes, Tom] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat, Dundee DD1 5EH, Scotland	Cardiff University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cold Spring Harbor Laboratory; Nara Institute of Science & Technology; University of Dundee	Reed, SH (corresponding author), Cardiff Univ, Sch Med, Dept Pathol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	reedsh1@cardiff.ac.uk		Reed, Simon/0000-0002-4711-0560; Owen-Hughes, Tom/0000-0002-0618-8185; Stillman, Bruce/0000-0002-9453-4091	Medical Research Council (MRC); MRC [G9900118, G0400113] Funding Source: UKRI; Medical Research Council [G0400113, G9900118] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045436] Funding Source: NIH RePORTER	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Medical Research Council (MRC) career development award and career establishment grant (to S. H. R.) and an MRC program award (to R. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Beinoraviciute-Kellner R, 2005, FEBS LETT, V579, P4535, DOI 10.1016/j.febslet.2005.07.009; Bi X, 1999, P NATL ACAD SCI USA, V96, P11934, DOI 10.1073/pnas.96.21.11934; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; DIFFLEY JFX, 1989, SCIENCE, V246, P1034, DOI 10.1126/science.2511628; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; Flaus A, 1999, METH MOL B, V119, P45; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fourel G, 2002, J BIOL CHEM, V277, P41736, DOI 10.1074/jbc.M202578200; Guzder SN, 1998, J BIOL CHEM, V273, P6292, DOI 10.1074/jbc.273.11.6292; Jaskelioff M, 2003, NAT CELL BIOL, V5, P395, DOI 10.1038/ncb0503-395; Lascaris RF, 2000, NUCLEIC ACIDS RES, V28, P1390, DOI 10.1093/nar/28.6.1390; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; MAHONEY DJ, 1989, MOL CELL BIOL, V9, P4621, DOI 10.1128/MCB.9.11.4621; MCBROOM LDB, 1994, J BIOL CHEM, V269, P16455; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Reed SH, 1996, MOL GEN GENET, V250, P505; Reed SH, 1998, J BIOL CHEM, V273, P29481, DOI 10.1074/jbc.273.45.29481; Reed SH, 1999, GENE DEV, V13, P3052, DOI 10.1101/gad.13.23.3052; Reed SH, 1996, MOL GEN GENET, V250, P515; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; RHODE PR, 1992, MOL CELL BIOL, V12, P1064, DOI 10.1128/MCB.12.3.1064; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; SHEI GJ, 1995, MOL CELL BIOL, V15, P3496; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; Teng Y, 2001, Nucleic Acids Res, V29, pE64, DOI 10.1093/nar/29.13.e64; Teng YM, 1997, J MOL BIOL, V267, P324, DOI 10.1006/jmbi.1996.0908; TERLETH C, 1990, MOL CELL BIOL, V10, P4678, DOI 10.1128/MCB.10.9.4678; THOMA F, 1992, BIOCHIM BIOPHYS ACTA, V1130, P1, DOI 10.1016/0167-4781(92)90455-9; Verhage RA, 1996, MOL CELL BIOL, V16, P496; Verhage RA, 1996, MUTAT RES-DNA REPAIR, V362, P155, DOI 10.1016/0921-8777(95)00045-3; Vujcic M, 1999, MOL CELL BIOL, V19, P6098; WANG ZG, 1992, BIOCHEMISTRY-US, V31, P3694, DOI 10.1021/bi00129a019; Wang ZG, 1997, MOL CELL BIOL, V17, P635, DOI 10.1128/MCB.17.2.635; Wang Zhigang, 1995, Methods (Orlando), V7, P177, DOI 10.1006/meth.1995.1023; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yarragudi A, 2004, MOL CELL BIOL, V24, P9152, DOI 10.1128/MCB.24.20.9152-9164.2004; Yarragudi A, 2007, NUCLEIC ACIDS RES, V35, P193, DOI 10.1093/nar/gkl1059; Yu SR, 2004, DNA REPAIR, V3, P277, DOI 10.1016/j.dnarep.2003.11.004; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zou YF, 2006, MOL CELL BIOL, V26, P7806, DOI 10.1128/MCB.01197-06	47	17	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					966	973		10.1074/jbc.M806830200	http://dx.doi.org/10.1074/jbc.M806830200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18996839	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000262122900032
J	Edinger, RS; Lebowitz, J; Li, H; Alzamora, R; Wang, HM; Johnson, JP; Hallows, KR				Edinger, Robert S.; Lebowitz, Jonathan; Li, Hui; Alzamora, Rodrigo; Wang, Huamin; Johnson, John P.; Hallows, Kenneth R.			Functional Regulation of the Epithelial Na+ Channel by I kappa B Kinase-beta Occurs via Phosphorylation of the Ubiquitin Ligase Nedd4-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; DUCT PRINCIPAL CELLS; SODIUM RETENTION; DOWN-REGULATION; TNF-ALPHA; IKK-BETA; SERUM; SGK1; ENAC	We have previously shown that I kappa B kinase-beta(IKK beta) interacts with the epithelial Na+ channel (ENaC) beta-subunit and enhances ENaC activity by increasing its surface expression in Xenopus oocytes. Here, we show that the IKK beta-ENaC interaction is physiologically relevant in mouse polarized kidney cortical collecting duct (mpkCCD(c14)) cells, as RNA interference-mediated knockdown of endogenous IKK beta in these cells by similar to 50% resulted in a similar reduction in transepithelial ENaC-dependent equivalent short circuit current. Although IKK beta binds to ENaC, there was no detectable phosphorylation of ENaC subunits by IKK beta in vitro. Because IKK beta stimulation of ENaC activity occurs through enhanced channel surface expression and the ubiquitin-protein ligase Nedd4-2 has emerged as a central locus for ENaC regulation at the plasma membrane, we tested the role of Nedd4-2 in this regulation. IKK beta-dependent phosphorylation of Xenopus Nedd4-2 expressed in HEK-293 cells occurred both in vitro and in vivo, suggesting a potential mechanism for regulation of Nedd4-2 and thus ENaC activity. P-32 labeling studies utilizing wild-type or mutant forms of Xenopus Nedd4-2 demonstrated that Ser-444, a key SGK1 and protein kinase A-phosphorylated residue, is also an important IKK beta phosphorylation target. ENaC stimulation by IKK beta was preserved in oocytes expressing wild-type Nedd4-2 but blocked in oocytes expressing either a dominant-negative (C938S) or phospho-deficient (S444A) Nedd4-2 mutant, suggesting that Nedd4-2 function and phosphorylation by IKK beta are required for IKK beta regulation of ENaC. In summary, these results suggest a novel mode of ENaC regulation that occurs throughIKK beta-dependent Nedd4-2 phosphorylation at a recognized SGK1 and protein kinase A target site.	[Edinger, Robert S.; Lebowitz, Jonathan; Li, Hui; Alzamora, Rodrigo; Wang, Huamin; Johnson, John P.; Hallows, Kenneth R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, Pittsburgh, PA 15261 USA; [Johnson, John P.; Hallows, Kenneth R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hallows, KR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Sch Med, S976 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	hallows@pitt.edu		Hallows, Kenneth/0000-0002-2964-2440	National Institutes of Health [K08 DK067143, R01 DK057718, DK047874, R01 DK075048]; American Heart Association [0825540D]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047874, K08DK067143, R01DK075048, R01DK057718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 DK067143 (to J.L.), R01 DK057718 and DK047874 (to J.P.J.), and R01 DK075048 (to K. R. H.). This work was also supported by American Heart Association Postdoctoral Fellowship Award AHA 0825540D (to R. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Booth RE, 2003, AM J PHYSIOL-RENAL, V284, pF938, DOI 10.1152/ajprenal.00373.2002; BUTTERWORTH MB, 2008, AM J PHYSL IN PRESS; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Dagenais A, 2004, AM J PHYSIOL-LUNG C, V286, pL301, DOI 10.1152/ajplung.00326.2002; de Seigneux S, 2008, J BIOL CHEM, V283, P25671, DOI 10.1074/jbc.M803812200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; DiPetrillo K, 2004, KIDNEY INT, V65, P1676, DOI 10.1111/j.1523-1755.2004.00606.x; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fukuda N, 2001, AM J PHYSIOL-LUNG C, V280, pL1258, DOI 10.1152/ajplung.2001.280.6.L1258; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Henke G, 2004, J CELL PHYSIOL, V199, P194, DOI 10.1002/jcp.10430; HUANG NL, 2008, INT J CARDI IN PRESS; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Lang V, 2003, MOL CELL BIOL, V23, P402, DOI 10.1128/MCB.23.1.402-413.2003; Lebowitz J, 2004, J BIOL CHEM, V279, P41985, DOI 10.1074/jbc.M403923200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mohan S, 2004, J BIOL CHEM, V279, P32071, DOI 10.1074/jbc.M405091200; Palmada M, 2004, BIOCHEM BIOPH RES CO, V321, P1001, DOI 10.1016/j.bbrc.2004.07.064; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Rezaiguia S, 1997, J CLIN INVEST, V99, P325, DOI 10.1172/JCI119161; Rodriguez-Iturbe B, 2002, KIDNEY INT, V62, P1379, DOI 10.1111/j.1523-1755.2002.kid561.x; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sanchez-Perez A, 2007, BIOCHEM BIOPH RES CO, V359, P611, DOI 10.1016/j.bbrc.2007.05.134; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Vinciguerra M, 2005, J AM SOC NEPHROL, V16, P2576, DOI 10.1681/ASN.2005040448; Wu C, 2003, J BIOL CHEM, V278, P31980, DOI 10.1074/jbc.M304278200; Wu X, 2007, AM J PHYSIOL-ENDOC M, V293, pE1836, DOI 10.1152/ajpendo.00115.2007; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	39	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					150	157		10.1074/jbc.M807358200	http://dx.doi.org/10.1074/jbc.M807358200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18981174	hybrid, Green Published			2022-12-27	WOS:000261974800017
J	Gevorkyan-Airapetov, L; Zohary, K; Popov-Celeketic, D; Mapa, K; Hell, K; Neupert, W; Azem, A; Mokranjac, D				Gevorkyan-Airapetov, Lada; Zohary, Keren; Popov-Celeketic, Dusan; Mapa, Koyeli; Hell, Kai; Neupert, Walter; Azem, Abdussalam; Mokranjac, Dejana			Interaction of Tim23 with Tim50 Is Essential for Protein Translocation by the Mitochondrial TIM23 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER MEMBRANE; PRESEQUENCE TRANSLOCASE; IMPORT MOTOR; PREPROTEIN TRANSLOCASE; PRECURSOR PROTEINS; HSP70; OUTER; COCHAPERONE; EXPRESSION; COMPONENT	The TIM23 complex is the major translocase of the mitochondrial inner membrane responsible for the import of essentially all matrix proteins and a number of inner membrane proteins. Tim23 and Tim50, two essential proteins of the complex, expose conserved domains into the intermembrane space that interact with each other. Here, we describe in vitro reconstitution of this interaction using recombinantly expressed and purified intermembrane space domains of Tim50 and Tim23. We established two independent methods, chemical cross-linking and surface plasmon resonance, to track their interaction. In addition, we identified mutations in Tim23 that abolish its interaction with Tim50 in vitro. These mutations also destabilized the interaction between the two proteins in vivo, leading to defective import of preproteins via the TIM23 complex and to cell death at higher temperatures. This is the first study to describe the reconstitution of the Tim50-Tim23 interaction in vitro and to identify specific residues of Tim23 that are vital for the interaction with Tim50.	[Gevorkyan-Airapetov, Lada; Zohary, Keren; Azem, Abdussalam] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel; [Popov-Celeketic, Dusan; Mapa, Koyeli; Hell, Kai; Neupert, Walter; Mokranjac, Dejana] Univ Munich, Inst Physiol Chem, Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany	Tel Aviv University; University of Munich	Azem, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel.	azema@tauex.tau.ac.il	Popov-Celeketic, Dusan/O-2371-2016	Popov-Celeketic, Dusan/0000-0002-0512-6900; Mokranjac, Dejana/0000-0002-4005-6979	German-Israeli Foundation for Scientific Research and Development [753/181]; German-Israeli Project Cooperation [F5.1]	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); German-Israeli Project Cooperation	This work was supported by German-Israeli Foundation for Scientific Research and Development Grant 753/181 and German-Israeli Project Cooperation Grant F5.1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alder NN, 2008, MOL BIOL CELL, V19, P159, DOI 10.1091/mbc.E07-07-0669; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; KRONIDOU NG, 1994, P NATL ACAD SCI USA, V91, P12818, DOI 10.1073/pnas.91.26.12818; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; SIKORSKI RS, 1989, GENETICS, V122, P19; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	31	50	50	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4865	4872		10.1074/jbc.M807041200	http://dx.doi.org/10.1074/jbc.M807041200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	19017642	hybrid			2022-12-27	WOS:000263416600015
J	Matsubara, E; Sakai, I; Yamanouchi, J; Fujiwara, H; Yakushijin, Y; Hato, T; Shigemoto, K; Yasukawa, M				Matsubara, Etsuko; Sakai, Ikuya; Yamanouchi, Jun; Fujiwara, Hiroshi; Yakushijin, Yoshihiro; Hato, Takaaki; Shigemoto, Kazuhiro; Yasukawa, Masaki			The Role of Zinc Finger Protein 521/Early Hematopoietic Zinc Finger Protein in Erythroid Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; FUNCTIONAL-CHARACTERIZATION; RETROVIRAL INTEGRATION; GENE; REPRESSION; EXPRESSION; INDUCTION; CLONING; REGULATOR; RECRUITS	ZNF521 (zinc finger protein 521) is a transcription factor with an N-terminal transcriptional repressor motif and 30 zinc finger domains. Although a high expression level of ZNF521 in human CD34(+) progenitors and hematopoietic malignancies has been demonstrated, the functional role of ZNF521 in hematopoietic cell differentiation has not been clarified. In this study, we analyzed the role of ZNF521 in erythroid cell differentiation using the short hairpin RNA (shRNA)-mediated gene silencing method. Down-regulation of ZNF521 mediated by transient expression of shRNA for ZNF521 resulted in increased synthesis of hemoglobin in K562 and HEL cell lines as compared with control cells. K562-derived clones in which ZNF521 was constitutively silenced by shRNA also showed marked synthesis of hemoglobin and an increased expression level of glycophorin A. Since GATA-1 is the key regulator of erythroid differentiation, the effect of ZNF521 on transcription activity of GATA-1 was analyzed using a luciferase assay. GATA-1 activity was markedly inhibited by ZNF521 in a dose-dependent manner. Deletion analysis of ZNF521 showed that the repressive effect requires an N-terminal repression motif. Furthermore, the direct interaction of ZNF521 with GATA-1 was demonstrated. These results indicate that ZNF521 modulates erythroid cell differentiation through direct binding with GATA-1.	[Sakai, Ikuya] Matsuyama Univ, Sch Clin Pharm, Coll Pharmaceut Sci, Dept Pathophysiol, Matsuyama, Ehime 7908578, Japan; [Matsubara, Etsuko; Yamanouchi, Jun; Fujiwara, Hiroshi; Yakushijin, Yoshihiro; Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Bioregulatory Med, Toon, Ehime 7910295, Japan; [Hato, Takaaki] Ehime Univ, Grad Sch Med, Div Blood Transfus & Cell Therapy, Toon, Ehime 7910295, Japan; [Shigemoto, Kazuhiro] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan	Ehime University; Ehime University; Tokyo Metropolitan Institute of Gerontology	Sakai, I (corresponding author), Matsuyama Univ, Sch Clin Pharm, Coll Pharmaceut Sci, Dept Pathophysiol, Matsuyama, Ehime 7908578, Japan.	isakai@cc.matsuyama-u.ac.jp; yasukawa@m.ehime-u.ac.jp	Hato, Takaaki/AAH-8356-2021		Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Dalgin G, 2007, DEV BIOL, V310, P454, DOI 10.1016/j.ydbio.2007.08.012; Eisbacher M, 2003, MOL CELL BIOL, V23, P3427, DOI 10.1128/MCB.23.10.3427-3441.2003; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Fox AH, 1998, J BIOL CHEM, V273, P33595, DOI 10.1074/jbc.273.50.33595; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hentges KE, 2005, ONCOGENE, V24, P1220, DOI 10.1038/sj.onc.1208243; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; JUSTICE MJ, 1994, J VIROL, V68, P1293, DOI 10.1128/JVI.68.3.1293-1300.1994; Ku MC, 2006, J BIOL CHEM, V281, P5277, DOI 10.1074/jbc.M510004200; LABBAYE C, 1995, J CLIN INVEST, V95, P2346, DOI 10.1172/JCI117927; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Maeno M, 1996, BLOOD, V88, P1965, DOI 10.1182/blood.V88.6.1965.bloodjournal8861965; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; OTTMANN OG, 1988, J IMMUNOL, V140, P2661; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; Sitnicka E, 1996, BLOOD, V88, P82; Soderholm J, 1997, LEUKEMIA, V11, P352, DOI 10.1038/sj.leu.2400584; Takahashi T, 2000, ONCOGENE, V19, P134, DOI 10.1038/sj.onc.1203228; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Warming S, 2004, ONCOGENE, V23, P2727, DOI 10.1038/sj.onc.1207452	41	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2009	284	6					3480	3487		10.1074/jbc.M805874200	http://dx.doi.org/10.1074/jbc.M805874200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	400MO	19049973	hybrid			2022-12-27	WOS:000262872500014
J	Agrawal, G; Dighe, RR				Agrawal, Gaurav; Dighe, Rajan R.			Critical Involvement of the Hinge Region of the Follicle-stimulating Hormone Receptor in the Activation of the Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE; THYROTROPIN RECEPTOR; EXTRACELLULAR DOMAIN; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN HORMONES; SIGNAL-TRANSDUCTION; FSH RECEPTOR; TSH RECEPTOR; STRUCTURAL BIOLOGY; LIGAND-BINDING	The follicle-stimulating hormone receptor (FSHR) is a G-protein-coupled receptor with a large hormone-specific extracellular domain (amino acids (aa) 1-366) and a characteristic seven-transmembrane domain (TMD; aa 367-695). The extracellular domain is composed of leucine-rich repeats (LRRs; aa 18-259) connected to TMD by a hinge region (HinR; aa 260-366), whose role in the hormone action is not clearly understood. We generated a novel polyclonal HinR antibody that specifically stimulates cAMP production by HEK 293 cells expressing FSHR in a hormone-independent manner. The monovalent antibody retained the stimulatory potential. The segment of aa 296-331 in HinR was identified as the binding site for the stimulatory antibody. Deletions of this entire segment or any 10 amino acids within this segment from FSHR led to complete loss of antibody response and, surprisingly, response to the hormone as well despite all mutants exhibiting cell surface receptor density and affinity comparable with the wild type receptor. Interestingly, these mutants exhibited higher basal cAMP production. The mutant lacking LRRs with the intact HinR (Delta 18-259) showed suppressed basal activity, which increased significantly with deletions extending to aa 331. These data suggest that the segment 296-331 acts as a tethered inverse agonist of the TMD and plays a very critical role in the hormonal activation of FSHR. The mutants lacking LRRs failed to bind FSH, whereas deletions in HinR had no effect on hormone binding, indicating that the LRRs constitute the primary high affinity binding site, whereas HinR may not play a significant role in FSH binding.	[Dighe, Rajan R.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Dighe, RR (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	rdighe@mrdg.iisc.ernet.in			Department of Biotechnology, Department of Science and Technology; University Grants Commission; Indian Council for Medical Research, Government of India, New Delhi; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, Department of Science and Technology(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India); Indian Council for Medical Research, Government of India, New Delhi(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The work presented in this study was supported by grants from the Department of Biotechnology, Department of Science and Technology, University Grants Commission, and Indian Council for Medical Research, Government of India, New Delhi. This work was reported in abstract form ( 49). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.. S The on-line version of this article ( available at http://www.jbc.org) contains supplemental Figs. 1-3.; 1 Supported by a fellowship from the Council of Scientific and Industrial Research, New Delhi.	AGRAWAL G, 2008, 90 ANN M END SOC END; Ahda Y, 2005, J ANDROL, V26, P494, DOI 10.2164/jandrol.04186; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Bonomi M, 2006, MOL ENDOCRINOL, V20, P3351, DOI 10.1210/me.2005-0521; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Dias JA, 2001, ARCH MED RES, V32, P510, DOI 10.1016/S0188-4409(01)00333-2; DIGHE RR, 1990, J IMMUNOL METHODS, V131, P229, DOI 10.1016/0022-1759(90)90194-Z; DIGHE RR, 1983, ARCH BIOCHEM BIOPHYS, V225, P490, DOI 10.1016/0003-9861(83)90058-9; DIGHE RR, 1990, MOL CELL ENDOCRINOL, V72, P63, DOI 10.1016/0303-7207(90)90240-9; Doherty E, 2002, J CLIN ENDOCR METAB, V87, P1151, DOI 10.1210/jc.87.3.1151; Fan QR, 2005, ENDOCRINE, V26, P179, DOI 10.1385/ENDO:26:3:179; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gadkari R, 2003, PROTEIN EXPRES PURIF, V32, P175, DOI 10.1016/S1046-5928(03)00231-6; Gadkari RA, 2007, MOL CELL ENDOCRINOL, V260, P23, DOI 10.1016/j.mce.2006.07.006; Ghosalkar JD, 2007, J REPROD IMMUNOL, V74, P24, DOI 10.1016/j.jri.2007.01.004; Gromoll J, 1996, J CLIN ENDOCR METAB, V81, P1367, DOI 10.1210/jc.81.4.1367; Gruters A, 1998, J CLIN ENDOCR METAB, V83, P1431, DOI 10.1210/jc.83.5.1431; Karges B, 2005, MOL ENDOCRINOL, V19, P2086, DOI 10.1210/me.2004-0378; Kene PS, 2005, AM J REPROD IMMUNOL, V54, P38, DOI 10.1111/j.1600-0897.2005.00285.x; Kene PS, 2004, J ENDOCRINOL, V182, P501, DOI 10.1677/joe.0.1820501; Khoo TK, 2007, THYROID, V17, P1013, DOI 10.1089/thy.2007.0185; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Moyle WR, 2005, ENDOCRINE, V26, P189, DOI 10.1385/ENDO:26:3:189; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; Nakabayashi K, 2000, J BIOL CHEM, V275, P30264, DOI 10.1074/jbc.M005568200; NALAWADI V, 1999, THESIS INDIAN I SCI; Nishi S, 2002, J BIOL CHEM, V277, P3958, DOI 10.1074/jbc.M109617200; Nurwakagari P, 2007, J MOL ENDOCRINOL, V38, P259, DOI 10.1677/jme.1.02160; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Rannikko A, 2002, MOL HUM REPROD, V8, P311, DOI 10.1093/molehr/8.4.311; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; Sambrook J., 2002, MOL CLONING LAB MANU; Sanders J, 2005, THYROID, V15, P672, DOI 10.1089/thy.2005.15.672; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sangkuhl K, 2002, J BIOL CHEM, V277, P47748, DOI 10.1074/jbc.M203491200; Schmidt A, 2001, J BIOL CHEM, V276, P23373, DOI 10.1074/jbc.M100057200; SHARMA SC, 1995, MOL CELL ENDOCRINOL, V115, P87, DOI 10.1016/0303-7207(95)03673-U; Shenoy AR, 2003, FEBS LETT, V545, P253, DOI 10.1016/S0014-5793(03)00580-5; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Touraine P, 1999, MOL ENDOCRINOL, V13, P1844, DOI 10.1210/me.13.11.1844; VanSande J, 1996, MOL CELL ENDOCRINOL, V119, P161, DOI 10.1016/0303-7207(96)03804-X; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200; Zhang M, 2000, ENDOCRINOLOGY, V141, P3514, DOI 10.1210/en.141.9.3514; ZHANG ML, 1995, BIOCHEM BIOPH RES CO, V211, P205, DOI 10.1006/bbrc.1995.1797	49	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2636	2647		10.1074/jbc.M808199200	http://dx.doi.org/10.1074/jbc.M808199200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029293	hybrid			2022-12-27	WOS:000262700900006
J	Fukuda, R; Tsuchiya, K; Suzuki, K; Itoh, K; Fujita, J; Utsunomiya, A; Tsuji, T				Fukuda, Ryu-ich; Tsuchiya, Kiyohito; Suzuki, Koji; Itoh, Katsuhiko; Fujita, Jun; Utsunomiya, Atae; Tsuji, Takashi			Human T-cell Leukemia Virus Type I Tax Down-regulates the Expression of Phosphatidylinositol 3,4,5-Trisphosphate Inositol Phosphatases via the NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; HTLV-I; ACTIVATION; APOPTOSIS; LYMPHOMA; TRANSFORMATION; 3-KINASE; P300; GENE; CBP	Human T-cell leukemia virus type I (HTLV-I) is an oncogenic retrovirus that causes adult T-cell leukemia/lymphoma (ATLL). The virus encodes an oncoprotein, Tax, which functions in transcriptional regulation, cell cycle control, and transformation. Through its pleiotropic actions, Tax plays critical roles in leukemogenesis. We have previously reported that PTEN and SHIP-1, PIP3 inositol phosphatases that negatively regulate the phosphatidylinositol (PI) 3-kinase signaling cascade, are disrupted in ATLL neoplasias. Overactivation of PI3-kinase signaling has an essential role in both development of ATLL-specific nuclear polymorphisms and onset of ATLL. We report here that both PTEN and SHIP-1 are down-regulated by HTLV-I Tax through the NF-kappa B signaling pathway. Tax expression up-regulated phosphorylated Akt, a downstream serine/threonine kinase in the PI3-kinase signaling cascade. Transduction of NF-kappa B p65, which mimics the activation of NF-kappa B signaling, also suppressed these phosphatases. An I kappa B Delta N mutant that inhibits the activation of NF-kappa B prevented PIP3 phosphatase down-regulation by Tax. The underlying mechanism of NF-kappa B-mediated suppression of PIP3 phosphatases involved sequestration of the coactivator p300 by p65. These down-regulations of PIP3 phosphatases were found to be essential for the Tax-induced cell proliferation. Thus, our results suggest that HTLV-I Tax down-regulates PIP3 phosphatases through the NF-kappa B pathway, resulting in increased activation of the PI3- kinase signaling cascade in human T-cells and contributing to leukemogenesis.	[Fukuda, Ryu-ich; Tsuchiya, Kiyohito; Suzuki, Koji; Tsuji, Takashi] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Chiba 2788510, Japan; [Fukuda, Ryu-ich; Tsuchiya, Kiyohito; Suzuki, Koji; Tsuji, Takashi] Tokyo Univ Sci, Res Inst Biol Sci, Tissue Engn Res Ctr, Chiba 2788510, Japan; [Itoh, Katsuhiko; Fujita, Jun] Kyoto Univ, Fac Med, Dept Clin Mol Biol, Kyoto 6068507, Japan; [Utsunomiya, Atae] Imamura Bun Hosp, Dept Hematol, Kagoshima 8900064, Japan	Tokyo University of Science; Tokyo University of Science; Kyoto University	Tsuji, T (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, 2641 Yamazaki, Chiba 2788510, Japan.	t-tsuji@rs.noda.tus.ac.jp	Tsuji, Takashi/N-6086-2015		Academic Frontier Project for Private Universities 2003-2007; Japan Society for the Promotion of Science; Scientific Research in Priority Areas [18012044]; MEXT Japan	Academic Frontier Project for Private Universities 2003-2007(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Scientific Research in Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Academic Frontier Project for Private Universities 2003-2007 (to T. T.), by Grant-in Aid for Japan Society for the Promotion of Science. Fellows 19-4715 (to R. F.), and by Grant-in Aid for Scientific Research in Priority Areas 18012044 (to T. T.) from MEXT Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Chan HM, 2001, J CELL SCI, V114, P2363; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Furukawa Y, 2001, BLOOD, V97, P987, DOI 10.1182/blood.V97.4.987; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Harrod R, 1998, MOL CELL BIOL, V18, P5052, DOI 10.1128/MCB.18.9.5052; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Higashitsuji H, 2002, CANCER CELL, V2, P335, DOI 10.1016/S1535-6108(02)00152-6; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Hotttiger MO, 1998, J VIROL, V72, P8252, DOI 10.1128/JVI.72.10.8252-8256.1998; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Koiwa T, 2002, J VIROL, V76, P9389, DOI 10.1128/JVI.76.18.9389-9397.2002; Liu Y, 2001, ONCOGENE, V20, P2514, DOI 10.1038/sj.onc.1204364; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; Nakano H, 2006, CELL DEATH DIFFER, V13, P730, DOI 10.1038/sj.cdd.4401830; Nicot C, 2000, ONCOGENE, V19, P2155, DOI 10.1038/sj.onc.1203536; Nicot C, 2000, MOL CELL BIOL, V20, P8580, DOI 10.1128/MCB.20.22.8580-8589.2000; Nicot C, 2005, ONCOGENE, V24, P6026, DOI 10.1038/sj.onc.1208977; Nicot C, 2001, MOL CELL BIOL, V21, P7391, DOI 10.1128/MCB.21.21.7391-7402.2001; Okamoto N, 2003, BIOCHEM BIOPH RES CO, V310, P691, DOI 10.1016/j.bbrc.2003.09.065; Onishi M, 1996, EXP HEMATOL, V24, P324; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; Renne C, 2007, LEUKEMIA, V21, P780, DOI 10.1038/sj.leu.2404594; Rosin O, 1998, J BIOL CHEM, V273, P6698, DOI 10.1074/jbc.273.12.6698; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; SHIMOYAMA M, 1983, JPN J CLIN ONCOL, V13, P165; Shuh M, 2000, J VIROL, V74, P11394, DOI 10.1128/JVI.74.23.11394-11397.2000; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Sun SC, 1996, MOL CELL BIOL, V16, P1058; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Wadgaonkar R, 1999, J BIOL CHEM, V274, P1879, DOI 10.1074/jbc.274.4.1879; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Yasunaga JI, 2003, INT J HEMATOL, V78, P312, DOI 10.1007/BF02983555; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; Youn HG, 2003, J VIROL, V77, P10015, DOI 10.1128/JVI.77.18.10015-10027.2003	47	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2680	2689		10.1074/jbc.M806325200	http://dx.doi.org/10.1074/jbc.M806325200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047050	hybrid			2022-12-27	WOS:000262700900010
J	Sun, FY; Xie, QL; Ma, J; Yang, SH; Chen, QY; Hong, A				Sun, Fenyong; Xie, Qiuling; Ma, Ji; Yang, Songhai; Chen, Qiongyu; Hong, An			Nuclear Factor Y Is Required for Basal Activation and Chromatin Accessibility of Fibroblast Growth Factor Receptor 2 Promoter in Osteoblast-like Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-Y; TRANSCRIPTION FACTOR; HISTONE ACETYLTRANSFERASES; BONE-FORMATION; BINDING; GENE; MUTATIONS; REGION; EXPRESSION; DOMAINS	Fibroblast growth factor receptor 2 (FGFR2) plays an important regulatory role in bone development. However, the regulatory mechanisms controlling FGFR2 expression remain poorly understood. Here we have identified a role for the nuclear factor Y (NF-Y) in constitutive activation of FGFR2. A unique DNase I hypersensitive site was detected in the region encompassing nucleotides -270 to +230 after scanning a large range covering 33.3 kilobases around the transcription start site of FGFR2. Using a PCR-based chromatin accessibility assay, an open chromatin conformation was detected around the proximal 5' fragment of FGFR2 gene. Deletion constructs of the 5'-flanking region of FGFR2 were fused to a luciferase reporter gene. After transient transfection in C3H10T1/2, ME3T3-E1, and C2C12 as well as primary osteoblasts, a minimal region -86/ +139 that is highly homologous to the human sequence and bears a CCAAT box was identified as the core promoter. Electrophoretic mobility shift assay supershift and chromatin immunoprecipitation demonstrated that the CCAAT box was the binding site for NF-Y. Deletion of NF-Y consensus sequence resulted in the total loss of NF-Y promoter activity. Overexpression of NF-Y protein and transfection of NF-Y small interfering RNAs in the cells substantially changed the promoter activity. Moreover, NF-Y small interfering RNAs greatly inhibited the endogenous FGFR2 transcription level and the chromatin accessibility and H3 acetylation across the promoter. Taken together, our results demonstrate that interaction of NF-Y at the CCAAT box is pivotal to FGFR2 gene transcription partly through the construction of a local open chromatin configuration across the promoter.	[Sun, Fenyong; Xie, Qiuling; Ma, Ji; Chen, Qiongyu; Hong, An] Jinan Univ, Inst Genet Engn, Natl Engn Res Ctr Genet Med, Key Lab Genet Med Guangdong Prov, Guangzhou 510632, Guangdong, Peoples R China; [Yang, Songhai] Shaoguan Tielu Hosp, Shaoguan 512023, Guangdong, Peoples R China	Jinan University	Hong, A (corresponding author), Jinan Univ, Inst Genet Engn, Natl Engn Res Ctr Genet Med, Key Lab Genet Med Guangdong Prov, Guangzhou 510632, Guangdong, Peoples R China.	tha@jnu.edu.cn	MA, Ji/GXG-9194-2022	MA, Ji/0000-0001-6904-5360	National Natural Science Foundation of China [30400270,]; National 973 program [2001CB510106]; Science and Technology program of Guangzhou [2006Z1-E0031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 program(National Basic Research Program of China); Science and Technology program of Guangzhou	The work was supported by 211 project, National Natural Science Foundation of China Grant 30400270, National 973 program Grant 2001CB510106, and Science and Technology program of Guangzhou Grant 2006Z1-E0031. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; AVIVI A, 1992, ONCOGENE, V7, P1957; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; Bellorini M, 1997, NUCLEIC ACIDS RES, V25, P2174, DOI 10.1093/nar/25.11.2174; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Brettingham-Moore KH, 2005, NUCLEIC ACIDS RES, V33, P225, DOI 10.1093/nar/gki161; Caretti G, 1999, MOL CELL BIOL, V19, P8591; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Coustry F, 1998, BIOCHEM J, V331, P291, DOI 10.1042/bj3310291; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430; DENNIG J, 1995, J BIOL CHEM, V270, P12737, DOI 10.1074/jbc.270.21.12737; Duan ZJ, 2001, MOL CELL BIOL, V21, P3083, DOI 10.1128/MCB.21.9.3083-3095.2001; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Evers R, 1998, J CLIN INVEST, V101, P1310, DOI 10.1172/JCI119886; FRAMSON P, 1993, J BIOL CHEM, V268, P4989; Francis J, 2006, MOL ENDOCRINOL, V20, P3133, DOI 10.1210/me.2006-0126; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; GORZOWSKI JJ, 1995, J BIOL CHEM, V270, P26940, DOI 10.1074/jbc.270.45.26940; Gui CY, 2001, MOL CELL BIOL, V21, P1155, DOI 10.1128/MCB.21.4.1155-1163.2001; KOLLMAR R, 1994, J BIOL CHEM, V269, P2252; Kubota K, 2002, BONE, V31, P465, DOI 10.1016/S8756-3282(02)00852-9; LANDSBERGER N, 1995, MOL CELL BIOL, V15, P6013; Lemonnier J, 2001, J BONE MINER RES, V16, P832, DOI 10.1359/jbmr.2001.16.5.832; Lemonnier J, 2000, EXP CELL RES, V256, P158, DOI 10.1006/excr.2000.4820; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Motta MC, 1999, J BIOL CHEM, V274, P1326, DOI 10.1074/jbc.274.3.1326; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; Nakamura T, 1998, J BONE MINER RES, V13, P942, DOI 10.1359/jbmr.1998.13.6.942; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; NODA M, 1989, J CELL BIOL, V109, P2529, DOI 10.1083/jcb.109.5.2529; Radomsky ML, 1998, CLIN ORTHOP RELAT R, pS283; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; RAZ V, 1991, ONCOGENE, V6, P753; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Sinha S, 1996, MOL CELL BIOL, V16, P328; Su L, 2004, J IMMUNOL, V173, P4994, DOI 10.4049/jimmunol.173.8.4994; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; Thomas RM, 2005, J IMMUNOL, V174, P4639, DOI 10.4049/jimmunol.174.8.4639; Xu XL, 1999, CELL TISSUE RES, V296, P33, DOI 10.1007/s004410051264; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; ZWICKER J, 1995, NUCLEIC ACIDS RES, V23, P3822, DOI 10.1093/nar/23.19.3822	48	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3136	3147		10.1074/jbc.M808992200	http://dx.doi.org/10.1074/jbc.M808992200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047043	hybrid, Green Published			2022-12-27	WOS:000262700900058
J	Takahashi, Y; Moiseyev, G; Ablonczy, Z; Chen, Y; Crouch, RK; Ma, JX				Takahashi, Yusuke; Moiseyev, Gennadiy; Ablonczy, Zsolt; Chen, Ying; Crouch, Rosalie K.; Ma, Jian-Xing			Identification of a Novel Palmitylation Site Essential for Membrane Association and Isomerohydrolase Activity of RPE65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; 2 POINT MUTATIONS; VISUAL CYCLE; PROTEIN PALMITOYLATION; KEY RESIDUES; IN-VITRO; ISOMERASE; PHOTORECEPTORS; EXPRESSION; STABILITY	RPE65 is a membrane-associated protein abundantly expressed in the retinal pigment epithelium, which converts all-trans-retinyl ester to 11-cis-retinol, a key step in the retinoid visual cycle. Although three cysteine residues (Cys-231, Cys-329, and Cys-330) were identified to be palmitylated in RPE65, recent studies showed that a triple mutant, with all three Cys replaced by an alanine residue, was still palmitylated and remained membrane-associated, suggesting that there are other yet to be identified palmitylated Cys residues in RPE65. Here we mapped the entire RPE65 using mass spectrometry analysis and demonstrated that a trypsin-digested RPE65 fragment ( residues 98-118), which contains two Cys residues (Cys-106 and Cys-112), was singly palmitylated in both native bovine and recombinant human RPE65. To determine whether Cys-106 or Cys-112 is the palmitylation site, these Cys were separately replaced by alanine. Mass spectrometry analysis of purified wild-type RPE65 and C106A and C112A mutants showed that mutation of Cys-106 did not affect the palmitylation status of the fragment 98-118, whereas mutation of Cys-112 abolished palmitylation in this fragment. Subcellular fractionation and immunocytochemistry analyses both showed that mutation of Cys-112 dissociated RPE65 from the membrane, whereas the C106A mutant remained associated with the membrane. In vitro isomerohydrolase activity assay showed that C106A has an intact enzymatic activity similar to that of wtRPE65, whereas C112A lost its enzymatic activity. These results indicate that the newly identified Cys-112 palmitylation site is essential for the membrane association and activity of RPE65.	[Takahashi, Yusuke; Moiseyev, Gennadiy; Chen, Ying; Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Dept Med Endocrinol, Oklahoma City, OK 73104 USA; [Ablonczy, Zsolt; Crouch, Rosalie K.] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Medical University of South Carolina	Ma, JX (corresponding author), 941 Stanton L Young Blvd,BSEB 328B, Oklahoma City, OK 73104 USA.	jian-xing-ma@ouhsc.edu			National Institutes of Health [EY012231, EY015650, EY004939, P20RR024215]; OCAST, Foundation Fighting Blindness, and Research for Prevention of Blindness.; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R33EY015650, R21EY015650, R01EY004939, R01EY012231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OCAST, Foundation Fighting Blindness, and Research for Prevention of Blindness.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012231, EY015650, EY004939, and P20RR024215 (NCRR). This work was also supported by grants from OCAST, Foundation Fighting Blindness, and Research for Prevention of Blindness. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ablonczy Z, 2002, J BIOL CHEM, V277, P40491, DOI 10.1074/jbc.M205507200; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BERNSTEIN PS, 1987, J BIOL CHEM, V262, P16848; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIDGES CDB, 1972, RHODOPSIN PORPHYROPS, P417; Chen Y, 2006, FEBS LETT, V580, P4200, DOI 10.1016/j.febslet.2006.06.078; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Rando RR, 2001, CHEM REV, V101, P1881, DOI 10.1021/cr960141c; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; SEFTON BM, 1987, J CELL BIOL, V104, P1449, DOI 10.1083/jcb.104.6.1449; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Takahashi Y, 2005, FEBS LETT, V579, P5414, DOI 10.1016/j.febslet.2005.09.002; Takahashi Y, 2006, INVEST OPHTH VIS SCI, V47, P5191, DOI 10.1167/iovs.06-0614; Takahashi Y, 2006, J BIOL CHEM, V281, P21820, DOI 10.1074/jbc.M603725200; Trudel E, 2006, BIOCHEMISTRY-US, V45, P3337, DOI 10.1021/bi0519405; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016	29	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3211	3218		10.1074/jbc.M807248200	http://dx.doi.org/10.1074/jbc.M807248200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19049981	Green Published, hybrid			2022-12-27	WOS:000262700900064
J	Cai, QS; Li, J; Gao, TY; Xie, JW; Evers, BM				Cai, Qingsong; Li, Jing; Gao, Tianyan; Xie, Jingwu; Evers, B. Mark			Protein Kinase C delta Negatively Regulates Hedgehog Signaling by Inhibition of Gli1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; PKC-DELTA; PHORBOL ESTER; TYROSINE PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVITY; NEUROTENSIN SECRETION; BREAST-CANCER; KAPPA-B; PATHWAY; ACTIVATION	Constitutive activation of the hedgehog pathway is implicated in the development of many human malignancies; hedgehog targets, PTCH1 and Gli1, are markers of hedgehog signaling activation and are expressed in most hedgehog-associated tumors. Protein kinase C delta (PKC delta) generally slows proliferation and induces cell cycle arrest of various cell lines. In this study, we show that activated PKC delta (wild-type PKC delta stimulated by phorbol 12-myristate 13-acetate or constitutively active PKC delta) decreased Gli-luciferase reporter activity in NIH/3T3 cells, as well as the endogenous hedgehog-responsive gene PTCH1. In human hepatoma (i.e. Hep3B) cells, wild-type PKC delta and constitutively active PKC delta decreased the expression levels of endogenous Gli1 and PTCH1. In contrast, PKC delta siRNA increased the expression levels of these target genes. Silencing of PKC delta by siRNA rescued the inhibition of cell growth by KAAD-cyclopamine, an antagonist of hedgehog signaling element Smoothened, suggesting that PKC delta acts downstream of Smoothened. The biological relevance of our study is shown in hepatocellular carcinoma where we found that hepatocellular carcinoma with detectable hedgehog signaling had weak or no detectable expression of PKC delta, whereas PKC delta highly expressing tumors had no detectable hedgehog signaling. Our results demonstrate that PKC delta alters hedgehog signaling by inhibition of Gli protein transcriptional activity. Furthermore, our findings suggest that, in certain cancers, PKC delta plays a role as a negative regulator of tumorigenesis by regulating hedgehog signaling.	[Cai, Qingsong; Li, Jing; Evers, B. Mark] Univ Texas Galveston, Dept Surg, Med Branch, Galveston, TX 77555 USA; [Cai, Qingsong; Li, Jing; Gao, Tianyan; Xie, Jingwu; Evers, B. Mark] Univ Texas Galveston, Sealy Ctr Canc Cell Biol, Med Branch, Galveston, TX 77555 USA; [Gao, Tianyan; Xie, Jingwu] Univ Texas Galveston, Dept Pharmacol & Toxicol, Med Branch, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Evers, BM (corresponding author), Univ Texas Galveston, Dept Surg, Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	mevers@utmb.edu	Li, Jing/B-7206-2011; Cai, Qingsong/J-6428-2012		National Institutes of Health [R01 CA104748, R01 DK48489, R01 DK35608, R01 CA94160]; NATIONAL CANCER INSTITUTE [R01CA094160, R01CA104748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA104748, R01 DK48489, R01 DK35608, and R01 CA94160.	Ashton AW, 1999, J BIOL CHEM, V274, P20805, DOI 10.1074/jbc.274.30.20805; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Braun MU, 2003, J MOL CELL CARDIOL, V35, P895, DOI 10.1016/S0022-2828(03)00142-1; Brodie C, 2004, MOL PHARMACOL, V66, P76, DOI 10.1124/mol.66.1.76; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; FlorinChristensen J, 1996, BIOCHEM J, V315, P513, DOI 10.1042/bj3150513; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; Hsu SL, 1998, BIOCHEM J, V333, P57, DOI 10.1042/bj3330057; Huang SH, 2006, CARCINOGENESIS, V27, P1334, DOI 10.1093/carcin/bgi378; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; King LB, 1999, J IMMUNOL, V162, P2655; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Kubo Makoto, 2007, Nihon Rinsho, V65 Suppl 6, P142; Lasfer M, 2006, FEBS LETT, V580, P2547, DOI 10.1016/j.febslet.2006.03.089; Leitges M, 2001, LAB INVEST, V81, P1087, DOI 10.1038/labinvest.3780321; Li J, 2005, J BIOL CHEM, V280, P8351, DOI 10.1074/jbc.M409431200; Li J, 2002, AM J PHYSIOL-GASTR L, V283, pG1197, DOI 10.1152/ajpgi.00177.2002; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; Ma XL, 2005, CARCINOGENESIS, V26, P1698, DOI 10.1093/carcin/bgi130; Mackay K, 2001, J MOL CELL CARDIOL, V33, P1301, DOI 10.1006/jmcc.2001.1400; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Neill GW, 2003, CANCER RES, V63, P4692; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; Sanchez P, 2005, CANCER RES, V65, P2990, DOI 10.1158/0008-5472.CAN-05-0439; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wang QD, 2001, GASTROENTEROLOGY, V120, P1381, DOI 10.1053/gast.2001.24044; Wang QD, 2006, INT J CANCER, V118, P326, DOI 10.1002/ijc.21373; Wang QD, 2003, J BIOL CHEM, V278, P51091, DOI 10.1074/jbc.M306541200; Wang XF, 2004, ONCOGENE, V23, P1885, DOI 10.1038/sj.onc.1207312; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	52	34	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2150	2158		10.1074/jbc.M803235200	http://dx.doi.org/10.1074/jbc.M803235200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19015273	Green Published, hybrid			2022-12-27	WOS:000262545600024
J	Lu, WB; Ma, H; Sheng, ZH; Mochida, S				Lu, Wenbo; Ma, Huan; Sheng, Zu-Hang; Mochida, Sumiko			Dynamin and Activity Regulate Synaptic Vesicle Recycling in Sympathetic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMITTER RELEASE; DROSOPHILA MUTANT; ENDOCYTOSIS; MEMBRANE; SYNAPSES; AMPHIPHYSIN; CA2+; GTP; REQUIREMENT; INHIBITION	Neurotransmission in central neuronal synapses is supported by the recycling of synaptic vesicles via endocytosis at different time scales during and after transmitter release. Here, we examine the kinetics and molecular determinants of different modes of synaptic vesicle recycling at a peripheral neuronal synapse formed between superior cervical ganglion neurons in culture, via acute disruption of endocytosis with Dynasore, an inhibitor of dynamin activation, or a dynamin peptide (P4) that perturbs linkage of dynamin to clathrin coats through amphiphysin. When paired action potentials are generated to produce excitatory postsynaptic potential responses, the second response was reduced after application of Dynasore but not P4. In addition, graded reduction in synaptic transmission during a train of action potentials was accelerated by Dynasore but enhanced by P4. After full depletion of releasable vesicles, P4 delayed the recovery of synaptic transmission while Dynasore limited recovery to 10%. In control neurons, synaptic transmission is stable for more than 1 h under low frequency presynaptic stimulation (0.2 Hz), but was reduced gradually by P4 and rapidly but incompletely blocked by Dynasore at a much lower stimulation frequency. These results suggest two essential modes of dynamin-mediated synaptic vesicle recycling, one activity-dependent and the other activity-independent. Our findings extend the current understanding of synaptic vesicle recycling to sympathetic nerve terminals and provide evidence for a physiological and molecular heterogeneity in endocytosis, a key cellular process for efficient replenishment of the vesicle pool, and thus for synaptic plasticity.	[Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Shinjuku Ku, Tokyo 1608402, Japan; [Lu, Wenbo; Ma, Huan; Mochida, Sumiko] Shanghai Jiao Tong Univ, Dept Neurobiol, Sch Med, Shanghai 200025, Peoples R China; [Sheng, Zu-Hang] NINDS, Synapt Funct Sect, NIH, Bethesda, MD 20892 USA	Tokyo Medical University; Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Mochida, S (corresponding author), Tokyo Med Univ, Dept Physiol, Shinjuku Ku, 1-1 Shinjuku 6 Chome, Tokyo 1608402, Japan.	mochida@tokyo-med.ac.jp	Ma, Huan/A-1379-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002946, Z01NS002946, ZIANS003029] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BIRKS RI, 1957, BRIT MED BULL, V13, P157, DOI 10.1093/oxfordjournals.bmb.a069605; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Ertunc M, 2007, J NEUROSCI, V27, P341, DOI 10.1523/JNEUROSCI.4051-06.2007; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JANIG W, 1970, PFLUG ARCH EUR J PHY, V314, P199, DOI 10.1007/BF00592246; Kavalali ET, 2007, J PHYSIOL-LONDON, V585, P669, DOI 10.1113/jphysiol.2007.137745; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klingauf J, 2007, NEURON, V54, P857, DOI 10.1016/j.neuron.2007.06.010; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LoGiudice L, 2006, NEURON, V51, P676, DOI 10.1016/j.neuron.2006.09.004; Ma H, 2007, NEUROSCI RES, V57, P491, DOI 10.1016/j.neures.2006.12.015; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; MOCHIDA S, 1995, J PHYSIOLOGY-PARIS, V89, P83, DOI 10.1016/0928-4257(96)80555-9; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wu LG, 2004, TRENDS NEUROSCI, V27, P548, DOI 10.1016/j.tins.2004.07.001; Xu JH, 2008, NAT NEUROSCI, V11, P45, DOI 10.1038/nn2021; Zhang C, 2004, NEURON, V42, P225, DOI 10.1016/S0896-6273(04)00189-8	46	28	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1930	1937		10.1074/jbc.M803691200	http://dx.doi.org/10.1074/jbc.M803691200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19010787	hybrid			2022-12-27	WOS:000262330100063
J	Brunk, I; Blex, C; Speidel, D; Brose, N; Ahnert-Hilger, G				Brunk, Irene; Blex, Christian; Speidel, Dina; Brose, Nils; Ahnert-Hilger, Gudrun			Ca2+-dependent Activator Proteins of Secretion Promote Vesicular Monoamine Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSE-CORE VESICLES; BINDING-PROTEIN; FAMILY; CAPS; TRANSPORTER; EXOCYTOSIS; EXPRESSION; CLONING; MEMBERS; BRAIN	Ca2+-dependent activator proteins of secretion (CAPS) 1 and 2 are essential regulators of synaptic vesicle and large dense core vesicle priming in mammalian neurons and neuroendocrine cells. CAPS1 appears to have an additional and as yet unexplained function in vesicular catecholamine uptake or storage as CAPS1-deficient chromaffin cells exhibit strongly reduced vesicular catecholamine levels. Here we describe a role of CAPS proteins in vesicular monoamine uptake. Both CAPS1 and CAPS2 promote monoamine uptake and storage mediated by the vesicular monoamine transporters VMAT1 and VMAT2. Monoamine uptake of vesicular preparations from embryonic brains of CAPS1 deletion mutants is decreased as compared with corresponding preparations from wild type littermates, and anti-CAPS1 or anti-CAPS2 antibodies inhibit monoamine sequestration by synaptic vesicles from adult mouse brain. In addition, overexpression of CAPS1 or CAPS2 enhances vesicular monoamine uptake in Chinese hamster ovary cells that stably express VMAT1 or VMAT2. CAPS function has been linked to the heterotrimeric GTPase Go, which modulates vesicular monoamine uptake. We found that the expression of CAPS1 is decreased in brain membrane preparations from mice lacking G(o2)alpha, which may explain the reduced monoamine uptake by G(o2)alpha-deficient synaptic vesicles. Accordingly, anti-CAPS1 antibodies do not further reduce monoamine uptake by G(o2)alpha-deficient synaptic vesicles, whereas antibodies directed against CAPS2, whose expression is not altered in G(o2)alpha-deficient brain, still reduce monoamine uptake into G(o2)alpha-deficient vesicles. We conclude that CAPS proteins are involved in optimizing vesicular monoamine uptake and storage mediated by VMAT1 and VMAT2.	[Brunk, Irene; Blex, Christian; Ahnert-Hilger, Gudrun] Charite Ctr 2 Basic Med, Inst Integrat Neuroanat, AG Funct Cell Biol, D-10115 Berlin, Germany; [Speidel, Dina; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Ahnert-Hilger, G (corresponding author), Charite Ctr 2 Basic Med, Inst Integrat Neuroanat, AG Funct Cell Biol, Philippstr 12, D-10115 Berlin, Germany.	gudrun.ahnert@charite.de		Blex, Christian/0000-0002-8493-3523; Brunk, Irene/0000-0002-2668-7002	Max Planck Society [AH67/3-3]; German Research Foundation [SFB406/A1]	Max Planck Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG))	This work was supported by Max Planck Society Grant AH67/3-3 (to G. A.-H.) and German Research Foundation Grant SFB406/A1 (to N.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Becher A, 1999, J NEUROSCI, V19, P1922; Brunk I, 2006, HANDB EXP PHARM, V175, P305; Brunk I, 2008, FASEB J, V22, P3736, DOI 10.1096/fj.08-111245; Brunk I, 2006, J BIOL CHEM, V281, P33373, DOI 10.1074/jbc.M603204200; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; Fujita Y, 2007, J BIOL CHEM, V282, P21392, DOI 10.1074/jbc.M703699200; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Holtje M, 2000, J NEUROSCI, V20, P2131; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; Pahner I, 2002, EUR J CELL BIOL, V81, P449, DOI 10.1078/0171-9335-00269; Sadakata T, 2006, J COMP NEUROL, V495, P735, DOI 10.1002/cne.20947; Sadakata T, 2007, J HISTOCHEM CYTOCHEM, V55, P301, DOI 10.1369/jhc.6A7033.2006; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Weller U, 1996, EUR J BIOCHEM, V236, P34, DOI 10.1111/j.1432-1033.1996.00034.x	26	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1050	1056		10.1074/jbc.M805328200	http://dx.doi.org/10.1074/jbc.M805328200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008227	hybrid			2022-12-27	WOS:000262122900041
J	Stathopulos, PB; Zheng, L; Ikura, M				Stathopulos, Peter B.; Zheng, Le; Ikura, Mitsuhiko			Stromal Interaction Molecule (STIM) 1 and STIM2 Calcium Sensing Regions Exhibit Distinct Unfolding and Oligomerization Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; CRAC CHANNEL; STORE; ORAI1; SENSOR; ACTIVATION; DEPLETION; PROTEIN; IDENTIFICATION; INITIATION	Stromal interaction molecules (STIM) 1 and STIM2 are regulators of store-operated calcium (Ca2+) entry as well as basal cytoplasmic Ca2+ levels in human cells. Despite a high sequence similarity (>65%) and analogous sequence-based domain architectures, STIM1 and STIM2 differentially influence these phenomena. Among all eukaryotes, the endoplasmic reticulum luminal portion of STIM proteins minimally encode EF-hand and sterile alpha-motif (SAM) domains (EF-SAM), which are responsible for sensing changes in Ca2+ levels and initiating oligomerization. STIM oligomerization is a key induction step in the activation of Ca2+ permeable channels on the plasma membrane. Here, we show that the kinetic half-time of conversion from a monomeric to a steady oligomeric state is > 70 x shorter for STIM1 EF-SAM than STIM2 under similar conditions. Urea-induced rates of unfolding for STIM1 EF-SAM are > 3 x quicker when compared with STIM2, coherent with partial unfolding-coupled aggregation. Additionally, we demonstrate that the isoform-specific N-terminal residues beyond EF-SAM can influence the stability of this region. We postulate that distinct oligomerization dynamics of STIM isoforms have evolved to adapt to differential roles in Ca2+ homeostasis and signaling.	[Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Ikura, M (corresponding author), MaRS Toronto Med Discovery Tower, Rm 4-804,101 Coll St, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca		Stathopulos, Peter B./0000-0002-0536-6656; Ikura, Mitsuhiko/0000-0002-9524-1303	Canadian Institutes of Health Research; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by a Canadian Institutes of Health Research operating grant and by Canadian Foundation for Innovation funding for 800 and 600 MHz NMR spectrometers. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cai XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000609; Chen LH, 2007, CARCINOGENESIS, V28, P2328, DOI 10.1093/carcin/bgm173; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GAO S, 2008, CELL CALCIU IN PRESS; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yan XH, 2006, J GEN PHYSIOL, V128, P443, DOI 10.1085/jgp.200609611; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2008, BIOCHEM BIOPH RES CO, V369, P240, DOI 10.1016/j.bbrc.2007.12.129	35	139	143	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					728	732		10.1074/jbc.C800178200	http://dx.doi.org/10.1074/jbc.C800178200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19019825	hybrid			2022-12-27	WOS:000262122900005
J	Townsend, PD; Holliday, PM; Fenyk, S; Hess, KC; Gray, MA; Hodgson, DRW; Cann, MJ				Townsend, Philip D.; Holliday, Phillip M.; Fenyk, Stepan; Hess, Kenneth C.; Gray, Michael A.; Hodgson, David R. W.; Cann, Martin J.			Stimulation of Mammalian G-protein-responsive Adenylyl Cyclases by Carbon Dioxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CAMP PRODUCTION; NUCLEOTIDE PHOSPHODIESTERASE; CO2; EXPRESSION; PH; AVOIDANCE; MICROTI; SITES; SAC	Carbon dioxide is fundamental to the physiology of all organisms. There is considerable interest in the precise molecular mechanisms that organisms use to directly sense CO2. Here we demonstrate that a mammalian recombinant G-protein-activated adenylyl cyclase and the related Rv1625c adenylyl cyclase of Mycobacterium tuberculosis are specifically stimulated by CO2. Stimulation occurred at physiological concentrations of CO2 through increased kcat.CO2 increased the affinity of enzyme for metal co-factor, but contact with metal was not necessary as CO2 interacted directly with apoenzyme. CO2 stimulated the activity of both G-protein-regulated adenylyl cyclases and Rv1625c in vivo. Activation of G-protein regulated adenylyl cyclases by CO2 gave a corresponding increase in cAMP-response element-binding protein ( CREB) phosphorylation. Comparison of the responses of the G-protein regulated adenylyl cyclases and the molecularly, and biochemically distinct mammalian soluble adenylyl cyclase revealed that whereas G-protein- regulated enzymes are responsive to CO2, the soluble adenylyl cyclase is responsive to both CO2 and bicarbonate ion. We have, thus, identified a signaling enzyme by which eukaryotes can directly detect and respond to fluctuating CO2.	[Townsend, Philip D.; Holliday, Phillip M.; Fenyk, Stepan; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Holliday, Phillip M.; Hodgson, David R. W.] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Hess, Kenneth C.] Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Gray, Michael A.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Durham University; Durham University; Cornell University; Newcastle University - UK	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	m.j.cann@durham.ac.uk	Cann, Martin/G-2864-2012; Hodgson, David/F-7174-2011; Townsend, Phiip/J-3761-2018; Hess, Kenneth/K-6546-2019	Cann, Martin/0000-0001-6305-8769; Hodgson, David/0000-0003-4517-9166; Townsend, Phiip/0000-0001-9235-3492; Hess, Kenneth/0000-0003-1377-6070; GRAY, MICHAEL/0000-0002-6774-6283	Wellcome Trust; Leverhulme Trust; Biotechnology and Biological Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust, the Leverhulme Trust, and the Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bahn YS, 2006, CURR OPIN MICROBIOL, V9, P572, DOI 10.1016/j.mib.2006.09.003; Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Cann MJ, 2003, J BIOL CHEM, V278, P35033, DOI 10.1074/jbc.M303025200; Chen J, 1997, J APPL PHYSIOL, V82, P1771, DOI 10.1152/jappl.1997.82.6.1771; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Clarke LL, 1998, GASTROENTEROLOGY, V114, pA94, DOI 10.1016/S0016-5085(98)80378-8; COOPER TG, 1969, J BIOL CHEM, V244, P1081; Cotelesage JJH, 2007, INT J BIOCHEM CELL B, V39, P1204, DOI 10.1016/j.biocel.2007.03.015; Dessauer CW, 1996, J BIOL CHEM, V271, P16967, DOI 10.1074/jbc.271.28.16967; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES, P156; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hammer A, 2006, BIOCHEM J, V396, P215, DOI 10.1042/BJ20060372; Hegyi P, 2004, PANCREAS, V28, P427, DOI 10.1097/00006676-200405000-00012; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; HOPPE A, 1982, AM J PHYSIOL, V243, pF471, DOI 10.1152/ajprenal.1982.243.5.F471; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Inada T, 1996, MOL GEN GENET, V253, P198, DOI 10.1007/s004380050313; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Klengel T, 2005, CURR BIOL, V15, P2021, DOI 10.1016/j.cub.2005.10.040; Kobayashi M, 2004, DEV GENES EVOL, V214, P503, DOI 10.1007/s00427-004-0432-2; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; LEE E, 1994, METHOD ENZYMOL, V237, P146; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; LORIMER GH, 1979, J BIOL CHEM, V254, P5599; LORIMER GH, 1983, TRENDS BIOCHEM SCI, V8, P65, DOI 10.1016/0968-0004(83)90393-6; LOWRIE DB, 1979, J GEN MICROBIOL, V110, P431, DOI 10.1099/00221287-110-2-431; LOWRIE DB, 1975, NATURE, V254, P600, DOI 10.1038/254600a0; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Morollo AA, 1999, BIOCHEMISTRY-US, V38, P3293, DOI 10.1021/bi9822729; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Raven John A, 2006, Biochem J, V396, pe5; Reddy SK, 2001, J BIOL CHEM, V276, P35141, DOI 10.1074/jbc.M104108200; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2007, J MOL BIOL, V365, P211, DOI 10.1016/j.jmb.2006.10.005; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880; Summers BA, 2002, J NEUROPHYSIOL, V88, P604, DOI 10.1152/jn.2002.88.2.604; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Willoughby D, 2005, J BIOL CHEM, V280, P30864, DOI 10.1074/jbc.M414355200; Xie F, 2004, DEV BIOL, V265, P196, DOI 10.1016/j.ydbio.2003.09.020; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Yan SZ, 2002, METHOD ENZYMOL, V345, P231	55	36	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					784	791		10.1074/jbc.M807239200	http://dx.doi.org/10.1074/jbc.M807239200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008230	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000262122900012
J	Fujii, T; Takahashi, Y; Ikari, A; Morii, M; Tabuchi, Y; Tsukada, K; Takeguchi, N; Sakai, H				Fujii, Takuto; Takahashi, Yuji; Ikari, Akira; Morii, Magotoshi; Tabuchi, Yoshiaki; Tsukada, Kazuhiro; Takeguchi, Noriaki; Sakai, Hideki			Functional Association between K+-Cl- Cotransporter-4 and H+,K+-ATPase in the Apical Canalicular Membrane of Gastric Parietal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SECRETION; ATPASE; LOCALIZATION; EXPRESSION; POTASSIUM; CHANNELS; CLONING; H+; TRAFFICKING; CONDUCTANCE	We studied whether K+-Cl- cotransporters (KCCs) are involved in gastric HCl secretion. We found that KCC4 is expressed in the gastric parietal cells more abundantly at the luminal region of the gland than at the basal region. KCC4 was found in the stimulation-associated vesicles (SAV) derived from the apical canalicular membrane but not in the intracellular tubulovesicles, whereas H+,K+-ATPase was expressed in both of them. In contrast, KCC1, KCC2, and KCC3 were not found in either SAV or tubulovesicles. KCC4 coimmunoprecipitated with H+,K+-ATPase in the lysate of SAV. Interestingly the MgATP-dependent uptake of Cl-36(-) into the SAV was suppressed by either the H+, K+-ATPase inhibitor (SCH28080) or the KCC inhibitor ((R)-(+)-[(2-n-butyl-6,7-dichloro-2-cyclo-pentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]acetic acid). The KCC inhibitor suppressed the H+ uptake into SAV and the H+,K+-ATPase activity of SAV, but the inhibitor had no effects on these activities in the freeze-dried leaky SAV. These results indicate that the K+-Cl- cotransport by KCC4 is tightly coupled with H+/K+ antiport by H+,K (+)-ATPase, resulting in HCl accumulation in SAV. In the tetracycline-regulated expression system of KCC4 in the HEK293 cells stably expressing gastric H+,K+-ATPase, KCC4 was coimmunoprecipitated with H+,K+-ATPase. The rate of recovery of intracellular pH in the KCC4-expressing cells after acid loading through an ammonium pulse was significantly faster than that in the KCC4-nonexpressing cells. Our results suggest that KCC4 and H+,K+-ATPase are the main machineries for basal HCl secretion in the apical canalicular membrane of the resting parietal cell. They also may contribute in part to massive acid secretion in the stimulated state.	[Fujii, Takuto; Takahashi, Yuji; Takeguchi, Noriaki; Sakai, Hideki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut Physiol, Toyama 9300194, Japan; [Tsukada, Kazuhiro] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Surg 2, Toyama 9300194, Japan; [Tabuchi, Yoshiaki] Toyama Univ, Life Sci Res Ctr, Toyama 9300194, Japan; [Ikari, Akira] Univ Shizuoka, Dept Pharmacobiochem, Shizuoka 4228526, Japan; [Morii, Magotoshi] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Lab Phys Sci, Matsusaka, Mie 5138670, Japan	University of Toyama; University of Toyama; University of Toyama; University of Shizuoka	Sakai, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut Physiol, 2630 Sugitani, Toyama 9300194, Japan.	sakaih@pha.u-toyama.ac.jp		Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [15390062, 18390064, 20010617]; Ministry of Education, Culture, Sports, Science and Technology of Japan [16657042, 18059012, 20056010]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 15390062 and 18390064 ( to H. S.) and for JSPS Fellows 20010617 ( to T. F.) from the Japan Society for the Promotion of Science and Grants-in-aid for Scientific Research 16657042, 18059012, and 20056010 ( to H. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; ASANO S, 1988, J BIOCHEM-TOKYO, V103, P672, DOI 10.1093/oxfordjournals.jbchem.a122327; ASANO S, 1994, BIOCHEM J, V299, P59, DOI 10.1042/bj2990059; Asano S, 1996, J BIOL CHEM, V271, P2740, DOI 10.1074/jbc.271.5.2740; BAMBERG K, 1994, BBA-BIOMEMBRANES, V1190, P355, DOI 10.1016/0005-2736(94)90094-9; Bergeron MJ, 2003, AM J PHYSIOL-RENAL, V285, pF68, DOI 10.1152/ajprenal.00032.2003; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Calhoun BC, 1997, BIOCHEM J, V325, P559, DOI 10.1042/bj3250559; Carmosino M, 2001, J CELL BIOL, V154, P1235, DOI 10.1083/jcb.200103010; DEMAREST JR, 1990, ANNU REV PHYSIOL, V52, P307; Fujii T, 2008, J BIOL CHEM, V283, P6869, DOI 10.1074/jbc.M708429200; Fujii T, 2007, EUR J PHARMACOL, V560, P123, DOI 10.1016/j.ejphar.2006.12.031; Fujita A, 2002, J PHYSIOL-LONDON, V540, P85, DOI 10.1113/jphysiol.2001.013439; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GARAY RP, 1988, MOL PHARMACOL, V33, P696; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Grishin AV, 1996, AM J PHYSIOL-RENAL, V271, pF539, DOI 10.1152/ajprenal.1996.271.3.F539; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Heitzmann D, 2007, PHYSIOLOGY, V22, P335, DOI 10.1152/physiol.00016.2007; Jons T, 1999, HISTOCHEM CELL BIOL, V111, P313, DOI 10.1007/s004180050362; Karam SM, 1997, AM J PHYSIOL-GASTR L, V272, pG161, DOI 10.1152/ajpgi.1997.272.1.G161; Karvar S, 2005, TRAFFIC, V6, P654, DOI 10.1111/j.1600-0854.2005.00306.x; Kaufhold MA, 2008, GASTROENTEROLOGY, V134, P1058, DOI 10.1053/j.gastro.2008.01.033; Kimura T, 2002, J BIOL CHEM, V277, P20671, DOI 10.1074/jbc.M200523200; Kimura T, 2002, J BIOCHEM, V131, P923, DOI 10.1093/oxfordjournals.jbchem.a003183; Lapierre LA, 2007, AM J PHYSIOL-GASTR L, V292, pG1249, DOI 10.1152/ajpgi.00505.2006; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; LEE HC, 1979, BIOCHIM BIOPHYS ACTA, V553, P107, DOI 10.1016/0005-2736(79)90034-8; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; MORII M, 1993, J BIOL CHEM, V268, P21553; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Okamoto CT, 2001, J PHYSIOL-LONDON, V532, P287, DOI 10.1111/j.1469-7793.2001.0287f.x; Sachs G, 2001, EUR J GASTROEN HEPAT, V13, pS35; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; Sakai H, 2004, FEBS LETT, V563, P151, DOI 10.1016/S0014-5793(04)00292-3; Sakai H, 2003, J PHYSIOL-LONDON, V551, P207, DOI 10.1113/jphysiol.2003.041921; Sidani SM, 2007, J BIOL CHEM, V282, P6068, DOI 10.1074/jbc.M608427200; TAKEGUCHI N, 1986, J BIOL CHEM, V261, P2560; Urushidani T, 1997, J MEMBRANE BIOL, V159, P99, DOI 10.1007/s002329900274; Velazquez H, 2003, AM J PHYSIOL-RENAL, V285, pF49, DOI 10.1152/ajprenal.00389.2002; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YODA A, 1970, BIOCHEM BIOPH RES CO, V40, P880, DOI 10.1016/0006-291X(70)90985-X	45	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					619	629		10.1074/jbc.M806562200	http://dx.doi.org/10.1074/jbc.M806562200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18984587	hybrid			2022-12-27	WOS:000261974800067
J	Hu, Y; Suarez, J; Fricovsky, E; Wang, H; Scott, BT; Trauger, SA; Han, WL; Hu, Y; Oyeleye, MO; Dillmann, WH				Hu, Yong; Suarez, Jorge; Fricovsky, Eduardo; Wang, Hong; Scott, Brian T.; Trauger, Sunia A.; Han, Wenlong; Hu, Ying; Oyeleye, Mary O.; Dillmann, Wolfgang H.			Increased Enzymatic O-GlcNAcylation of Mitochondrial Proteins Impairs Mitochondrial Function in Cardiac Myocytes Exposed to High Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; POSTTRANSLATIONAL MODIFICATION; DIABETIC CARDIOMYOPATHY; GLCNAC MODIFICATION; CYTOSOLIC PROTEINS; NUCLEAR; INSULIN; IDENTIFICATION; GLYCOSYLATION; OVEREXPRESSION	Increased nuclear protein O-linked beta-N-acetylglucosamine glycosylation (O-GlcNAcylation) mediated by high glucose treatment or the hyperglycemia of diabetes mellitus contributes to cardiac myocyte dysfunction. However, whether mitochondrial proteins in cardiac myocytes are also submitted to O-GlcNAcylation or excessive O-GlcNAcylation alters mitochondrial function is unknown. In this study, we determined if mitochondrial proteins are O-GlcNAcylated and explored if increased O-GlcNAcylation is linked to high glucose-induced mitochondrial dysfunction in neonatal rat cardiomyocytes. By immunoprecipitation, we found that several mitochondrial proteins, which are members of complexes of the respiratory chain, like subunit NDUFA9 of complex I, subunits core 1 and core 2 of complex III, and the mitochondrial DNA-encoded subunit I of complex IV ( COX I) are O-GlcNAcylated. By mass spectrometry, we identified that serine 156 on NDUFA9 is O-GlcNAcylated. High glucose treatment ( 30 mM glucose) increases mitochondrial protein O-GlcNAcylation, including those of COX I and NDUFA9 which are reduced by expression of O-GlcNAcase ( GCA). Increased mitochondrial O-GlcNAcylation is associated with impaired activity of complex I, III, and IV in addition to lower mitochondrial calcium and cellular ATP content. When the excessive O-GlcNAc modification is reduced by GCA expression, mitochondrial function improves; the activity of complex I, III, and IV increases to normal and mitochondrial calcium and cellular ATP content are returned to control levels. From these results we conclude that specific mitochondrial proteins of cardiac myocytes are O-GlcNAcylated and that exposure to high glucose increases mitochondrial protein O-GlcNAcylation, which in turn contributes to impaired mitochondrial function.	[Hu, Yong; Suarez, Jorge; Fricovsky, Eduardo; Wang, Hong; Scott, Brian T.; Han, Wenlong; Hu, Ying; Oyeleye, Mary O.; Dillmann, Wolfgang H.] Univ Calif San Diego, Dept Med, Sch Med, La Jolla, CA 92093 USA; [Trauger, Sunia A.] Scripps Res Inst, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute	Dillmann, WH (corresponding author), Univ Calif San Diego, Dept Med, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wdillmann@ucsd.edu		Scott, Brian/0000-0002-1321-7204; Trauger, Sunia/0000-0002-1678-8715	NHLBI, National Institutes of Health [HL-66917]; San Diego EXPORT Center, National Center of Minority Health and Health Disparities, National Institutes of Health [P60 MD00220]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066917] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); San Diego EXPORT Center, National Center of Minority Health and Health Disparities, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant HL-66917 (to W. H. D.) and by Grant Number P60 MD00220, from the San Diego EXPORT Center, National Center of Minority Health and Health Disparities, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belke DD, 2007, AM J PHYSIOL-HEART C, V292, pH1755, DOI 10.1152/ajpheart.00884.2006; Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; BHIMJI S, 1986, ACTA ANAT, V125, P195; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Chretien D, 2003, BIOCHEM BIOPH RES CO, V301, P222, DOI 10.1016/S0006-291X(02)03016-4; Cieniewski-Bernard C, 2004, MOL CELL PROTEOMICS, V3, P577, DOI 10.1074/mcp.M400024-MCP200; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Davidoff AJ, 1997, AM J PHYSIOL-HEART C, V272, pH159, DOI 10.1152/ajpheart.1997.272.1.H159; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Gandy JC, 2006, FEBS LETT, V580, P3051, DOI 10.1016/j.febslet.2006.04.051; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hartong R, 1996, J MOL CELL CARDIOL, V28, P2467, DOI 10.1006/jmcc.1996.0239; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Hollander JM, 2003, FREE RADICAL BIO MED, V35, P742, DOI 10.1016/S0891-5849(03)00400-3; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; HOLT GD, 1986, J BIOL CHEM, V261, P8049; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Rodrigues B, 1998, MOL CELL BIOCHEM, V180, P53, DOI 10.1023/A:1006882805197; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; ROQUEMORE EP, 1994, METHOD ENZYMOL, V230, P443; Slawson C, 2002, BBA-GEN SUBJECTS, V1573, P121, DOI 10.1016/S0304-4165(02)00369-0; TANAKA Y, 1992, CARDIOVASC RES, V26, P409, DOI 10.1093/cvr/26.4.409; Turko IV, 2003, J BIOL CHEM, V278, P35844, DOI 10.1074/jbc.M303139200; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wang Z, 2007, MOL CELL PROTEOMICS, V6, P1365, DOI 10.1074/mcp.M600453-MCP200; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007	39	174	180	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					547	555		10.1074/jbc.M808518200	http://dx.doi.org/10.1074/jbc.M808518200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19004814	Green Published, hybrid			2022-12-27	WOS:000261974800060
J	Okroj, M; Mark, L; Stokowska, A; Wong, SW; Rose, N; Blackbourn, DJ; Villoutreix, BO; Spiller, OB; Blom, AM				Okroj, Marcin; Mark, Linda; Stokowska, Anna; Wong, Scott W.; Rose, Nicola; Blackbourn, David J.; Villoutreix, Bruno O.; Spiller, O. Brad; Blom, Anna M.			Characterization of the Complement Inhibitory Function of Rhesus Rhadinovirus Complement Control Protein (RCP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; CHARGED AMINO-ACIDS; FACTOR-I; IMMUNE EVASION; BINDING SITES; HEPARIN; SEQUENCE; KCP; IMMUNOLOGY; MACAQUES	Rhesus rhadinovirus (RRV) is currently the closest known, fully sequenced homolog of human Kaposi sarcoma-associated herpesvirus. Both these viruses encode complement inhibitors as follows: Kaposi sarcoma-associated herpesvirus-complement control protein (KCP) and RRV-complement control protein (RCP). Previously we characterized in detail the functional properties of KCP as a complement inhibitor. Here, we performed comparative analyses for two variants of RCP protein, encoded by RRV strains H26-95 and 17577. Both RCP variants and KCP inhibited human and rhesus complement when tested in hemolytic assays measuring all steps of activation via the classical and the alternative pathway. RCP variants from both RRV strains supported C3b and C4b degradation by factor I and decay acceleration of the classical C3 convertase, similar to KCP. Additionally, the 17577 RCP variant accelerated decay of the alternative C3 convertase, which was not seen for KCP. In contrast to KCP, RCP showed no affinity to heparin and is the first described complement inhibitor in which the binding site for C3b/C4b does not interact with heparin. Molecular modeling shows a structural disruption in the region of RCP that corresponds to the KCP-heparin-binding site. This makes RRV a superior model for future in vivo investigations of complement evasion, as RCP does not play a supportive role in viral attachment as KCP does.	[Okroj, Marcin; Mark, Linda; Stokowska, Anna; Blom, Anna M.] Lund Univ, Dept Lab Med, Malmo Univ Hosp, S-20502 Malmo, Sweden; [Wong, Scott W.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Rose, Nicola] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England; [Blackbourn, David J.] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; [Villoutreix, Bruno O.] Univ Paris Diderot, INSERM MTi, F-75013 Paris, France; [Spiller, O. Brad] Cardiff Univ, Wales Sch Med, Dept Child Hlth, Cardiff CF14 4XN, S Glam, Wales	Lund University; Skane University Hospital; Oregon Health & Science University; National Institute for Biological Standards & Control; Cancer Research UK; University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cardiff University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med, Wallenberg Lab, MAS, Entrance 46,Floor 4, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Villoutreix, Bruno/I-4565-2015; Rose, Nicola/E-9366-2013; Blom, Anna/AFS-7369-2022; Spiller, Owen Brad/AAC-2474-2020; Blom, Anna/B-9607-2009	Villoutreix, Bruno/0000-0002-6456-7730; Spiller, Owen Brad/0000-0002-9117-6911; Blom, Anna/0000-0002-1348-1734; Blackbourn, David/0000-0002-6703-4497	Cancerfonden; The Swedish Foundation for Strategic Research; Swedish Research Council; American Cancer Foundation; University Hospital in Malmo; The Foundations of Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg; The Tom Owen Bequest Fund; Cancer Research UK [C7934]; Medical Research Council [G0400408]; FEBS; MRC [G0400408] Funding Source: UKRI	Cancerfonden(Swedish Cancer Society); The Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); American Cancer Foundation; University Hospital in Malmo; The Foundations of Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg; The Tom Owen Bequest Fund; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FEBS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancerfonden, The Swedish Foundation for Strategic Research, Swedish Research Council, American Cancer Foundation, research grants from the University Hospital in Malmo r, The Foundations of Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg ( to A. M. B.), The Tom Owen Bequest Fund ( to O. B. S.), and Cancer Research UK Grant C7934 and the Medical Research Council Grant G0400408 ( to D. J. B.), and a FEBS short term fellowship ( to L. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexander L, 2000, J VIROL, V74, P3388, DOI 10.1128/JVI.74.7.3388-3398.2000; Blom AM, 2003, ARCH BIOCHEM BIOPHYS, V418, P108, DOI 10.1016/j.abb.2003.08.018; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; Blom AM, 2007, ADV EXP MED BIOL, V598, P105; Blue CE, 2004, VIROLOGY, V319, P176, DOI 10.1016/j.virol.2003.11.029; COOPER NR, 1984, J INVEST DERMATOL, V83, pS121, DOI 10.1111/1523-1747.ep12281847; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; Ensser A, 2005, ADV CANCER RES, V93, P91, DOI 10.1016/S0065-230X(05)93003-0; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Judson KA, 2003, J VIROL, V77, P12639, DOI 10.1128/JVI.77.23.12639-12645.2003; Kapadia SB, 2002, IMMUNITY, V17, P143, DOI 10.1016/S1074-7613(02)00369-2; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Krushkal J, 2000, MOL BIOL EVOL, V17, P1718, DOI 10.1093/oxfordjournals.molbev.a026270; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Liszewski MK, 2006, J IMMUNOL, V176, P3725, DOI 10.4049/jimmunol.176.6.3725; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lubinski JM, 2002, J VIROL, V76, P9232, DOI 10.1128/JVI.76.18.9232-9241.2002; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; Mansfield KG, 1999, J VIROL, V73, P10320, DOI 10.1128/JVI.73.12.10320-10328.1999; Mark L, 2006, MOL IMMUNOL, V43, P1665, DOI 10.1016/j.molimm.2005.09.016; Mark L, 2004, J BIOL CHEM, V279, P45093, DOI 10.1074/jbc.M407558200; Mark L, 2007, MOL IMMUNOL, V44, P11, DOI 10.1016/j.molimm.2006.06.018; Mark L, 2007, J VIROL, V81, P4166, DOI 10.1128/JVI.02069-06; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; O'Connor CM, 2006, J VIROL, V80, P1574, DOI 10.1128/JVI.80.3.1574-1583.2006; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; Okroj M, 2007, VACCINE, V25, P8102, DOI 10.1016/j.vaccine.2007.09.046; Orzechowska BU, 2008, BLOOD, V112, P4227, DOI 10.1182/blood-2008-04-151498; Rosengard AM, 2002, P NATL ACAD SCI USA, V99, P8808, DOI 10.1073/pnas.112220499; Ruppert J, 1997, PROTEIN SCI, V6, P524; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Singh AK, 2006, J BIOL CHEM, V281, P23119, DOI 10.1074/jbc.M603085200; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; Spiller OB, 2006, J VIROL, V80, P4068, DOI 10.1128/JVI.80.8.4068-4078.2006; Spiller OB, 2003, J BIOL CHEM, V278, P9283, DOI 10.1074/jbc.M211579200; Spiller OB, 2003, J VIROL, V77, P592, DOI 10.1128/JVI.77.1.592-599.2003; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wong SW, 1999, J EXP MED, V190, P827, DOI 10.1084/jem.190.6.827	40	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					505	514		10.1074/jbc.M806669200	http://dx.doi.org/10.1074/jbc.M806669200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18990693	hybrid			2022-12-27	WOS:000261974800055
J	Koivusalo, M; Kapus, A; Grinstein, S				Koivusalo, Mirkka; Kapus, Andras; Grinstein, Sergio			Sensors, Transducers, and Effectors That Regulate Cell Size and Shape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ASCITES TUMOR-CELLS; K-CL COTRANSPORT; VOLUME REGULATION; PHOSPHOLIPASE A(2); OSMOTIC-STRESS; ION CHANNELS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; HYPEROSMOTIC STRESS; CHLORIDE CHANNELS; MAMMALIAN-CELLS	Cell volume and shape are stringently regulated. This homeostasis requires the cells to sense their size and shape and to convey this information to effectors that will counteract deformations induced by osmotic or mechanical challenges. The sensors, transducers, and effectors of volume change are the subject of this review.	[Koivusalo, Mirkka; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Kapus, Andras] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Kapus, Andras] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Grinstein, S (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca			Canadian Cystic Fibrosis Foundation; Heart and Stroke Foundation of Ontario; Canadian Institutes of Health Research; National Science and Engineering Research Council	Canadian Cystic Fibrosis Foundation; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Cystic Fibrosis Foundation, the Heart and Stroke Foundation of Ontario, the Canadian Institutes of Health Research, and the National Science and Engineering Research Council. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Alexander RT, 2006, ACTA PHYSIOL, V187, P159, DOI 10.1111/j.1748-1716.2006.01558.x; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burg MB, 2000, CELL PHYSIOL BIOCHEM, V10, P251, DOI 10.1159/000016371; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Di Ciano C, 2002, AM J PHYSIOL-CELL PH, V283, pC850, DOI 10.1152/ajpcell.00018.2002; Di Ciano-Oliveira C, 2006, ACTA PHYSIOL, V187, P257, DOI 10.1111/j.1748-1716.2006.01535.x; Di Ciano-Oliveira C, 2003, AM J PHYSIOL-CELL PH, V285, pC555, DOI 10.1152/ajpcell.00086.2003; Dunham PB, 2004, AM J PHYSIOL-CELL PH, V287, pC336, DOI 10.1152/ajpcell.00582.2003; Friis MB, 2008, AM J PHYSIOL-CELL PH, V294, pC1552, DOI 10.1152/ajpcell.00571.2007; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Gasull X, 2003, INVEST OPHTH VIS SCI, V44, P706, DOI 10.1167/iovs.02-0384; GRINSTEIN S, 1985, J GEN PHYSIOL, V85, P765, DOI 10.1085/jgp.85.5.765; GRINSTEIN S, 1992, J BIOL CHEM, V267, P23823; Grunnet M, 2003, J PHYSIOL-LONDON, V549, P419, DOI 10.1113/jphysiol.2003.038455; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; LEHTONEN JYA, 1995, BIOPHYS J, V68, P1888, DOI 10.1016/S0006-3495(95)80366-8; Lepple-Wienhues A, 1998, J CELL BIOL, V141, P281, DOI 10.1083/jcb.141.1.281; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Liedtke CM, 2002, BBA-MOL CELL RES, V1589, P77, DOI 10.1016/S0167-4889(01)00189-6; Liedtke W, 2007, EXP PHYSIOL, V92, P507, DOI 10.1113/expphysiol.2006.035642; Meves H, 2008, BRIT J PHARMACOL, V155, P4, DOI 10.1038/bjp.2008.216; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Nielsen DK, 2007, J PHYSIOL-LONDON, V582, P1027, DOI 10.1113/jphysiol.2007.132308; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Nilius B, 1998, J PHYSIOL-LONDON, V506, P353, DOI 10.1111/j.1469-7793.1998.353bw.x; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; PARKER JC, 1995, J GEN PHYSIOL, V105, P677, DOI 10.1085/jgp.105.6.677; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Pedersen SF, 2001, COMP BIOCHEM PHYS A, V130, P385, DOI 10.1016/S1095-6433(01)00429-9; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V453, P753, DOI 10.1007/s00424-006-0153-7; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Schliess F, 2007, METHOD ENZYMOL, V428, P129, DOI 10.1016/S0076-6879(07)28007-3; Sheikh-Hamad D, 2004, AM J PHYSIOL-RENAL, V287, pF1102, DOI 10.1152/ajprenal.00225.2004; Stutzin A, 2006, ACTA PHYSIOL, V187, P27, DOI 10.1111/j.1748-1716.2006.01537.x; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Thoroed SM, 1997, J MEMBRANE BIOL, V160, P47, DOI 10.1007/s002329900294; Tilly BC, 1996, MOL BIOL CELL, V7, P1419, DOI 10.1091/mbc.7.9.1419; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; Wehner F, 2006, ACTA PHYSIOL, V187, P21, DOI 10.1111/j.1748-1716.2006.01561.x; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Yamamoto M, 2006, J BIOL CHEM, V281, P32630, DOI 10.1074/jbc.M605928200	50	47	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					6595	6599		10.1074/jbc.R800049200	http://dx.doi.org/10.1074/jbc.R800049200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	19004817	hybrid, Green Published			2022-12-27	WOS:000263919000002
J	Yankner, BA; Lu, T				Yankner, Bruce A.; Lu, Tao			Amyloid beta-Protein Toxicity and the Pathogenesis of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NEURONAL CELL-DEATH; A-BETA; PRECURSOR PROTEIN; TRANSGENIC MICE; SCAVENGER RECEPTOR; MISSENSE MUTATIONS; SYNAPSE LOSS; MOUSE MODEL; GENE; DEFICITS		[Yankner, Bruce A.; Lu, Tao] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	yankner@hms.harvard.edu			National Institutes of Health [NS30352, AG26651, P01AG27916]; Ellison Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026651, P01AG027916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS30352, AG26651, and P01AG27916. This work was also supported by an Ellison Medical Foundation Senior Scholar award (to B. A. Y.). This is the eighth article of eleven in the Thematic Minireview Series on the Molecular Basis of Alzheimer Disease. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; BUSCIGLIO J, 1992, NEUROBIOL AGING, V13, P609, DOI 10.1016/0197-4580(92)90065-6; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; ElKhoury J, 1996, NATURE, V382, P716; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Geula C, 2003, J COMP NEUROL, V455, P249, DOI 10.1002/cne.10475; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Isaacs AM, 2006, J BIOL CHEM, V281, P27916, DOI 10.1074/jbc.M602061200; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li JH, 1995, P NATL ACAD SCI USA, V92, P12180, DOI 10.1073/pnas.92.26.12180; Liu TB, 2004, J NEUROCHEM, V88, P554, DOI 10.1046/j.1471-4159.2003.02196.x; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Lu DC, 2003, ANN NEUROL, V54, P781, DOI 10.1002/ana.10761; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Matsui T, 2006, J NEUROPATH EXP NEUR, V65, P508, DOI 10.1097/01.jnen.0000229238.05748.12; MATTSON MP, 1991, NEURON, V6, P41, DOI 10.1016/0896-6273(91)90120-O; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; MORRISSETTE DA, 2009, J BIOL CHEM IN PRESS, V284; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Petrella JR, 2007, RADIOLOGY, V245, P224, DOI 10.1148/radiol.2451061847; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROTH M, 1966, NATURE, V209, P109, DOI 10.1038/209109a0; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Vigo FS, 2009, NEUROBIOL AGING, V30, P1379, DOI 10.1016/j.neurobiolaging.2007.11.017; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stelzma R. A., 1995, CLIN ANAT, V8, P429, DOI [10.1002/ca.980080612, DOI 10.1002/CA.980080612]; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Troy CM, 2000, J NEUROSCI, V20, P1386; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang Y, 2003, J NEUROSCI, V23, P2557; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044	82	160	167	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2009	284	8					4754	4758		10.1074/jbc.R800018200	http://dx.doi.org/10.1074/jbc.R800018200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	408DY	18957434	hybrid, Green Published			2022-12-27	WOS:000263416600002
J	Guallar, V; Lu, CY; Borrelli, K; Egawa, TY; Yeh, SR				Guallar, Victor; Lu, Changyuan; Borrelli, Kenneth; Egawa, Tsuyoshi; Yeh, Syun-Ru			Ligand Migration in the Truncated Hemoglobin-II from Mycobacterium tuberculosis THE ROLE OF G8 TRYPTOPHAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; HYDROGEN-BOND NETWORK; HEME DISTAL SITE; FUNCTIONAL-PROPERTIES; CARBON-MONOXIDE; STRUCTURAL DETERMINANTS; GEMINATE RECOMBINATION; CAMPYLOBACTER-JEJUNI; MOLECULAR-DYNAMICS; ENERGY LANDSCAPE	Resonance Raman studies show that the heme-bound CO in trHbO, a truncated-II hemoglobin from Mycobacterium tuberculosis, is exposed to an environment with a positive electrostatic potential. The mutation of Trp(G8), an absolutely conserved residue in group II and III truncated hemoglobins, to Phe introduces two new Fe-CO conformers, both of which exhibit reduced electrostatic potentials. Computer simulations reveal that the structural perturbation is a result of the increased flexibility of the Tyr(CD1) and Leu(E11) side chains due to the reduction of the size of the G8 residue. Laser flash photolysis studies show that the G8 mutation induces 1) the presence of two new geminate recombination phases, one with a rate faster than the time resolution of our instrument and the other with a rate 13-fold slower than that of the wild type protein, and 2) the reduction of the total geminate recombination yield from 86 to 62% and the increase in the bimolecular recombination rate by a factor of 530. Computer simulations uncover that the photodissociated ligand migrates between three distal temporary docking sites before it subsequently rebinds to the heme iron or ultimately escapes into the solvent via a hydrophobic tunnel. The calculated energy profiles associated with the ligand migration processes are in good agreement with the experimental observations. The results highlight the importance of the Trp( G8) in regulating ligand migration in trHbO, underscoring its pivotal role in the structural and functional properties of the group II and III truncated hemoglobins.	[Guallar, Victor; Borrelli, Kenneth] Barcelona Supercomp Ctr, Life Sci Program, Catalan Inst Res & Adv Studies, Barcelona 08028, Spain; [Lu, Changyuan; Egawa, Tsuyoshi; Yeh, Syun-Ru] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	ICREA; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Yeshiva University; Albert Einstein College of Medicine	Guallar, V (corresponding author), Barcelona Supercomp Ctr, Life Sci Program, Catalan Inst Res & Adv Studies, Edificio Nexus 2, Barcelona 08028, Spain.	victor.guallar@bsc.es; syeh@aecom.yu.edu	Guallar, Victor/B-1579-2013	Guallar, Victor/0000-0002-4580-1114; Yeh, Syun-Ru/0000-0002-9858-386X	Spanish Ministry of Education and Science [CTQ2007-62122/BQU]; ICREA Funding Source: Custom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065465] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); ICREA(ICREA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Spanish Ministry of Education and Science ( to V. G.) through Project CTQ2007-62122/BQU. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alcantara RE, 2007, P NATL ACAD SCI USA, V104, P18451, DOI 10.1073/pnas.0706026104; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Boechi L, 2008, PROTEINS, V73, P372, DOI 10.1002/prot.22072; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; CARVER TE, 1990, J BIOL CHEM, V265, P20007; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Das TK, 2000, BIOCHEMISTRY-US, V39, P837, DOI 10.1021/bi9922087; Das TK, 1999, J BIOL CHEM, V274, P4207, DOI 10.1074/jbc.274.7.4207; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020; Feis A, 1998, BIOCHEMISTRY-US, V37, P13575, DOI 10.1021/bi981399v; Feis A, 2008, BIOCHEMISTRY-US, V47, P902, DOI 10.1021/bi701297f; Friesner RA, 2005, ANNU REV PHYS CHEM, V56, P389, DOI 10.1146/annurev.physchem.55.091602.094410; Guallar V, 2006, J AM CHEM SOC, V128, P5427, DOI 10.1021/ja057318h; Guallar V, 2005, P NATL ACAD SCI USA, V102, P3954, DOI 10.1073/pnas.0500888102; HENRY ER, 1983, J MOL BIOL, V166, P443, DOI 10.1016/S0022-2836(83)80094-1; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; Lu CY, 2008, METHOD ENZYMOL, V437, P255, DOI 10.1016/S0076-6879(07)37014-6; Lu CY, 2007, J BIOL CHEM, V282, P25917, DOI 10.1074/jbc.M704415200; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Ludemann SK, 2000, J MOL BIOL, V303, P797, DOI 10.1006/jmbi.2000.4154; Marti MA, 2008, J AM CHEM SOC, V130, P1688, DOI 10.1021/ja076853+; Milani M, 2005, J INORG BIOCHEM, V99, P97, DOI 10.1016/j.jinorgbio.2004.10.035; Milani M, 2003, P NATL ACAD SCI USA, V100, P5766, DOI 10.1073/pnas.1037676100; Mukai M, 2002, BIOCHEMISTRY-US, V41, P3897, DOI 10.1021/bi0156409; Mukai M, 2001, J BIOL CHEM, V276, P7272, DOI 10.1074/jbc.M009280200; Ouellet H, 2003, BIOCHEMISTRY-US, V42, P5764, DOI 10.1021/bi0270337; Ouellet H, 2007, BIOCHEMISTRY-US, V46, P11440, DOI 10.1021/bi7010288; Samuni U, 2004, J AM CHEM SOC, V126, P2682, DOI 10.1021/ja038093i; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; TILTON RF, 1988, J MOL BIOL, V199, P195, DOI 10.1016/0022-2836(88)90389-0; Vogel KM, 2000, INORG CHIM ACTA, V297, P11, DOI 10.1016/S0020-1693(99)00253-4; WARSHEL A, 1977, P NATL ACAD SCI USA, V74, P1789, DOI 10.1073/pnas.74.5.1789; Wei GH, 2002, J CHEM PHYS, V117, P11379, DOI 10.1063/1.1522373; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Wu GH, 2003, ADV MICROB PHYSIOL, V47, P255, DOI 10.1016/S0065-2911(03)47005-7; Yu N.-T., 1988, BIOL APPLICATIONS RA, V3, P39	40	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3106	3116		10.1074/jbc.M806183200	http://dx.doi.org/10.1074/jbc.M806183200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19019831	hybrid, Green Accepted			2022-12-27	WOS:000262700900055
J	Hoffhines, AJ; Jen, CH; Leary, JA; Moore, KL				Hoffhines, Adam J.; Jen, Constance H.; Leary, Julie A.; Moore, Kevin L.			Tyrosylprotein Sulfotransferase-2 Expression Is Required for Sulfation of RNase 9 and Mfge8 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-O-SULFATION; MOLECULAR CHARACTERIZATION; MASS-SPECTROMETRY; APOPTOTIC CELLS; A SUPERFAMILY; PROTEIN; MOUSE; IDENTIFICATION; MFG-E8; MICE	Protein-tyrosine sulfation is mediated by two Golgi tyrosylprotein sulfotransferases (TPST-1 and TPST-2) that are widely expressed in vivo. However, the full substrate repertoire of this enzyme system is unknown and thus, our understanding of the biological role(s) of tyrosine sulfation is limited. We reported that whereas Tpst1(-/-) male mice have normal fertility, Tpst2(-/-) males are infertile despite normal spermatogenesis. However, Tpst2(-/-) sperm are severely defective in their motility in viscous media and in their ability to fertilize eggs. These findings suggest that sulfation of unidentified substrate( s) is crucial for normal sperm function. We therefore sought to identify tyrosine-sulfated proteins in the male genital tract using affinity chromatography on PSG2, an anti-sulfotyrosine monoclonal antibody, followed by mass spectrometry. Among the several candidate tyrosine-sulfated proteins identified, RNase 9 and Mfge8 were examined in detail. RNase 9, a catalytically inactive RNase A family member of unknown function, is expressed only in the epididymis after onset of sexual maturity. Mfge8 is expressed on mouse sperm and Mfge8(-/-) male mice are subfertile. Metabolic labeling coupled with sulfoamino acid analysis confirmed that both proteins are tyrosine-sulfated and both proteins are expressed at comparable levels in wild type, Tpst1(-/-), and Tpst2(-/-) epididymides. However, we demonstrate that RNase 9 and Mfge8 are tyrosine-sulfated in wild type and Tpst1(-/-), but not in Tpst2(-/-) mice. These findings suggest that lack of sulfation of one or both of these proteins may contribute mechanistically to the infertility of Tpst2(-/-) males.	[Hoffhines, Adam J.; Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Jen, Constance H.; Leary, Julie A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 94616 USA; [Leary, Julie A.] Univ Calif Davis, Dept Chem, Davis, CA 94616 USA; [Moore, Kevin L.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Moore, Kevin L.] Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Davis; University of California System; University of California Davis; Oklahoma Medical Research Foundation	Moore, KL (corresponding author), 825 NE 13th St, Oklahoma City, OK 73104 USA.	kevin-moore@omrf.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056022] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD056022-01A1, HD 056022, R01 HD056022] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Araki Y, 2002, J ANDROL, V23, P854; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; BETTELHEIM FR, 1954, J AM CHEM SOC, V76, P2838, DOI 10.1021/ja01639a073; Borghei A, 2006, J BIOL CHEM, V281, P9423, DOI 10.1074/jbc.M513768200; Bu HF, 2007, J CLIN INVEST, V117, P3673, DOI 10.1172/JCI31841; Burgess B, 2006, MOL VIS, V12, P1437; Cho S, 2005, GENOMICS, V85, P208, DOI 10.1016/j.ygeno.2004.10.008; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Devor EJ, 2004, HUM BIOL, V76, P921, DOI 10.1353/hub.2005.0016; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; HUTTNER WB, 1984, METHOD ENZYMOL, V107, P200; Huttner WB, 1988, MODERN CELL BIOL, V6, P97; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KRAJEWSKI T, 1968, ACTA CHEM SCAND, V22, P1339, DOI 10.3891/acta.chem.scand.22-1339; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Oshima K, 1999, BIOCHEM BIOPH RES CO, V254, P522, DOI 10.1006/bbrc.1998.0107; Ouyang YB, 1998, J BIOL CHEM, V273, P24770, DOI 10.1074/jbc.273.38.24770; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; Ouyang YB, 2002, J BIOL CHEM, V277, P23781, DOI 10.1074/jbc.M202420200; PAULSSON M, 1985, BIOCHEM J, V231, P571, DOI 10.1042/bj2310571; Penttinen J, 2003, MOL ENDOCRINOL, V17, P2138, DOI 10.1210/me.2003-0008; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; ROSA P, 1992, J BIOL CHEM, V267, P12227; Salek M, 2004, ANAL CHEM, V76, P5136, DOI 10.1021/ac0400414; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Yu YH, 2007, NAT METHODS, V4, P583, DOI 10.1038/NMETH1056; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	40	17	20	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3096	3105		10.1074/jbc.M808434200	http://dx.doi.org/10.1074/jbc.M808434200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19047058	hybrid, Green Published			2022-12-27	WOS:000262700900054
J	Kida, Y; Morimoto, F; Sakaguchi, M				Kida, Yuichiro; Morimoto, Fumiko; Sakaguchi, Masao			Signal Anchor Sequence Provides Motive Force for Polypeptide Chain Translocation through the Endoplasmic Reticulum Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; ER MEMBRANE; RECOGNITION; TOPOGENESIS; CHANNEL	Many proteins are translocated across and integrated into the endoplasmic reticulum membrane. The type I signal anchor sequence mediates the translocation of its preceding region through the endoplasmic reticulum membrane, but the source of the motive force has been unclear. Here, we characterized the motive force for N-terminal domain translocation using two probes. First, an Ig-like domain of the muscle protein titin (I27 domain) or its mutants were fused to the N termini, and translocation was examined in a cell-free translation system supplemented with rough microsomal membrane. The N-terminal translocation efficiencies correlated with the mechanical instabilities of the I27 mutants. When the I27 domain was separated from the signal anchor sequence by inserting a spacer, even the most unstable mutant stalled on the cytoplasmic side, whereas its downstream portion spanned the membrane. Proline insertion into the signal anchor sequence also caused a large translocation defect. Second, a streptavidin-binding peptide tag was fused to the N terminus. Titration of streptavidin in the translation system allowed us to estimate the translocation motive force operative on the tag. The motive force was decreased by the proline insertion into the signal anchor sequence as well as by separation from the signal anchor sequence. When the streptavidin-binding peptide tag was separated from the signal anchor, the proline insertion did not induce further deficits in the motive force for the tag. On the basis of the findings obtained by using these two independent techniques, we conclude that the signal sequence itself provides the motive force for N-terminal domain translocation within a limited upstream region.	[Kida, Yuichiro; Morimoto, Fumiko; Sakaguchi, Masao] Univ Hyogo, Grad Sch Life Sci, Ako, Hyogo 6781297, Japan; [Kida, Yuichiro; Sakaguchi, Masao] Univ Hyogo, Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Ako, Hyogo 6781297, Japan	University of Hyogo; Japan Science & Technology Agency (JST); University of Hyogo	Sakaguchi, M (corresponding author), Univ Hyogo, Grad Sch Life Sci, Ako, Hyogo 6781297, Japan.	sakag@sci.u-hyogo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Sumitomo Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Sumitomo Foundation, and the Uehara Memorial Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Belin D, 1996, EMBO J, V15, P468, DOI 10.1002/j.1460-2075.1996.tb00379.x; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kida Y, 2000, J CELL BIOL, V150, P719, DOI 10.1083/jcb.150.4.719; Kida Y, 2005, EMBO J, V24, P3202, DOI 10.1038/sj.emboj.7600788; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Sato T, 2005, P NATL ACAD SCI USA, V102, P17999, DOI 10.1073/pnas.0504495102; Skach WR, 2007, J CELL BIOL, V179, P1333, DOI 10.1083/jcb.200711107; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	15	18	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					2861	2866		10.1074/jbc.M808020200	http://dx.doi.org/10.1074/jbc.M808020200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19010775	hybrid			2022-12-27	WOS:000262700900030
J	Sakai, A; Cox, MM				Sakai, Akiko; Cox, Michael M.			RecFOR and RecOR as Distinct RecA Loading Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI RECF; REPLICATION PROTEIN-A; PHAGE-LAMBDA ORF; BINDING-PROTEIN; GENETIC-RECOMBINATION; SSB PROTEIN; GAPPED DNA; FILAMENTS; MUTATIONS	The molecular role of the RecF protein in loading RecA protein onto single-stranded DNA (ssDNA)-binding protein-coated ssDNA has been obscured by the facility with which the RecO and RecR proteins alone perform this function. We now show that RecFOR and RecOR define distinct RecA loading functions that operate optimally in different contexts. RecFOR, but not RecOR, is most effective when RecF( R) is bound near an ssDNA/double-stranded ( dsDNA) junction. However, RecF( R) has no enhanced binding affinity for such a junction. RecO and RecR proteins are both required under all conditions in which the RecFOR pathway operates. The RecOR pathway is uniquely distinguished by a required interaction between RecO protein and the ssDNA binding protein C terminus. The RecOR pathway is more efficient for RecA loading onto ssDNA when no proximal dsDNA is available. A merger of new and published results leads to a new model for RecFOR function.	[Sakai, Akiko; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@Biochem.wisc.edu	SAKAI, AKIKO/AAC-9814-2020	SAKAI, AKIKO/0000-0002-1258-1725	National Institutes of Health [GM32335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32335 (NIGMS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALONSO JC, 1993, J BIOL CHEM, V268, P1424; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bork JM, 2001, J BIOL CHEM, V276, P45740, DOI 10.1074/jbc.M109247200; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DEFAIS M, 2000, ENCY LIFE SCI; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Grompone G, 2004, MOL MICROBIOL, V52, P551, DOI 10.1111/j.1365-2958.2004.03997.x; Hegde SP, 1996, J BACTERIOL, V178, P184, DOI 10.1128/jb.178.1.184-190.1996; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Honda M, 2006, J BIOL CHEM, V281, P18549, DOI 10.1074/jbc.M512658200; HORII ZI, 1973, J MOL BIOL, V80, P327, DOI 10.1016/0022-2836(73)90176-9; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; KOLODNER R, 1985, J BACTERIOL, V163, P1060, DOI 10.1128/JB.163.3.1060-1066.1985; Koroleva O, 2007, EMBO J, V26, P867, DOI 10.1038/sj.emboj.7601537; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; LAVERY PE, 1988, J MOL BIOL, V203, P861, DOI 10.1016/0022-2836(88)90112-X; Lee BI, 2004, EMBO J, V23, P2029, DOI 10.1038/sj.emboj.7600222; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; Liu YL, 2000, EMBO REP, V1, P85, DOI 10.1093/embo-reports/kvd002; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LUISIDELUCA C, 1994, J MOL BIOL, V236, P124, DOI 10.1006/jmbi.1994.1123; Lusetti SL, 2006, MOL CELL, V21, P41, DOI 10.1016/j.molcel.2005.11.011; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2004, J BIOL CHEM, V279, P55073, DOI 10.1074/jbc.M410371200; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MADIRAJU MVVS, 1988, P NATL ACAD SCI USA, V85, P6592, DOI 10.1073/pnas.85.18.6592; MADIRAJU MVVS, 1992, BIOCHEMISTRY-US, V31, P10529, DOI 10.1021/bi00158a016; MAHDI AA, 1989, NUCLEIC ACIDS RES, V17, P6781, DOI 10.1093/nar/17.17.6781; MAHDI AA, 1989, MOL GEN GENET, V216, P503, DOI 10.1007/BF00334397; Marsin S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000146; Maxwell KL, 2005, P NATL ACAD SCI USA, V102, P11260, DOI 10.1073/pnas.0503399102; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; MOREAU PL, 1988, J BACTERIOL, V170, P2493, DOI 10.1128/jb.170.6.2493-2500.1988; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; SANCAR A, 1993, SCIENCE, V259, P1415, DOI 10.1126/science.8451638; SANDLER SJ, 1994, J BACTERIOL, V176, P3661, DOI 10.1128/JB.176.12.3661-3672.1994; Sandler SJ, 1996, GENETICS, V143, P5; SANDLER SJ, 1994, MOL GEN GENET, V245, P741, DOI 10.1007/BF00297281; SAWITZKE JA, 1992, GENETICS, V130, P7; SAWITZKE JA, 1994, J BACTERIOL, V176, P6730, DOI 10.1128/JB.176.21.6730-6737.1994; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1996, J MOL BIOL, V257, P756, DOI 10.1006/jmbi.1996.0200; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SMITH GR, 1989, GENOME, V31, P520, DOI 10.1139/g89-100; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Walker GC, 2000, BACTERIAL STRESS RESPONSES, P131; WANG TCV, 1993, MUTAT RES, V294, P157, DOI 10.1016/0921-8777(93)90024-B; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Webb BL, 1999, J BIOL CHEM, V274, P15367, DOI 10.1074/jbc.274.22.15367; Webb BL, 1995, J BIOL CHEM, V270, P31397, DOI 10.1074/jbc.270.52.31397; Wernegreen JJ, 2000, J BACTERIOL, V182, P3867, DOI 10.1128/JB.182.13.3867-3869.2000; WHITBY MC, 1995, MOL GEN GENET, V246, P174, DOI 10.1007/BF00294680	71	60	64	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3264	3272		10.1074/jbc.M807220200	http://dx.doi.org/10.1074/jbc.M807220200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	18986990	Green Published, hybrid			2022-12-27	WOS:000262700900069
J	Shao, CL; Cobb, MH				Shao, Chunli; Cobb, Melanie H.			Sumoylation Regulates the Transcriptional Activity of MafA in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-TRANSCRIPTION; BINDING PROTEIN-BETA; NUCLEAR-LOCALIZATION; DIABETES-MELLITUS; KEY REGULATOR; EXPRESSION; SUMO; REPRESSION; GLUCOSE; PHOSPHORYLATION	MafA is a transcriptional regulator expressed primarily in pancreatic beta cells. It binds to the RIPE3b/C1-binding site within the ins gene promoter, which plays a critical role in regulating ins gene expression in response to glucose. Here, we show that MafA is post-translationally modified by the small ubiquitin-related modifiers SUMO-1 and -2. Mutation of a single site in MafA, Lys(32), blocks its sumoylation in beta cells. Incubation of beta cells in low glucose ( 2 mM) or exposure to hydrogen peroxide increases sumoylation of endogenous MafA. Forced sumoylation of MafA results in reduced transcriptional activity toward the ins gene promoter and increased suppression of the CHOP-10 gene promoter. Sumoylation of MafA has no apparent effect on either its nuclear localization in beta cells or its ubiquitin-dependent degradation. This study suggests that modification of MafA by SUMO modulates gene transcription and thereby beta cell function.	[Shao, Chunli; Cobb, Melanie H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Melanie.Cobb@UTSouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473	National Institutes of Health [DK55310]; Robert A. Welch Foundation [I1243]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55310. This work was also supported by Robert A. Welch Foundation Grant I1243. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aramata S, 2007, ENDOCR J, V54, P659, DOI 10.1507/endocrj.KR-101; Benkhelifa S, 2001, MOL CELL BIOL, V21, P4441, DOI 10.1128/MCB.21.14.4441-4452.2001; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Harmon JS, 2005, J BIOL CHEM, V280, P11107, DOI 10.1074/jbc.M410345200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lawrence MC, 2007, P NATL ACAD SCI USA, V104, P11518, DOI 10.1073/pnas.0704618104; Malecki MT, 2005, DIABETES RES CLIN PR, V68, pS10, DOI 10.1016/j.diabres.2005.03.003; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Seufert J, 1998, J CLIN INVEST, V101, P2528, DOI 10.1172/JCI2401; Sii-Felice K, 2005, FEBS LETT, V579, P3547, DOI 10.1016/j.febslet.2005.04.086; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Ye DZ, 2006, DIABETES, V55, P742, DOI 10.2337/diabetes.55.03.06.db05-0653; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200	37	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2009	284	5					3117	3124		10.1074/jbc.M806286200	http://dx.doi.org/10.1074/jbc.M806286200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	397ZL	19029092	Green Published, hybrid			2022-12-27	WOS:000262700900056
J	Boissonneault, V; Plante, I; Rivest, S; Provost, P				Boissonneault, Vincent; Plante, Isabelle; Rivest, Serge; Provost, Patrick			MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse beta-Amyloid Precursor Protein-converting Enzyme 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTAL-RETARDATION PROTEIN; ALZHEIMERS-DISEASE; SECRETASE ACTIVITY; HUMAN DICER; RNASE-III; BACE1; IDENTIFICATION; BRAIN; THERAPEUTICS; HIPPOCAMPUS	MicroRNAs (miRNAs) are key regulatory RNAs known to repress mRNA translation through recognition of specific binding sites located mainly in their 3'-untranslated region (UTR). Loss of specific miRNA control of gene expression is thus expected to underlie serious genetic diseases. Intriguingly, previous post-mortem analyses showed higher beta-amyloid precursor protein-converting enzyme (BACE) protein, but not mRNA, levels in the brain of patients that suffered from Alzheimer disease (AD). Here we also observed a loss of correlation between BACE1 mRNA and protein levels in the hippocampus of a mouse model of AD. Consistent with an impairment of miRNA-mediated regulation of BACE1 expression, these findings prompted us to investigate the regulatory role of the BACE1 3'-UTR element and the possible involvement of specific miRNAs in cultured neuronal (N2a) and fibroblastic (NIH 3T3) cells. Through various experimental approaches, we validated computational predictions and demonstrated that miR-298 and miR-328 recognize specific binding sites in the 3'-UTR of BACE1 mRNA and exert regulatory effects on BACE1 protein expression in cultured neuronal cells. Our results may provide the molecular basis underlying BACE1 deregulation in AD and offer new perspectives on the etiology of this neurological disorder.	[Boissonneault, Vincent; Plante, Isabelle; Provost, Patrick] Ctr Hosp Univ Quebec, Ctr Hosp Univ Laval, Res Ctr, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada; [Boissonneault, Vincent; Plante, Isabelle; Rivest, Serge; Provost, Patrick] Univ Laval, Fac Med, Dept Anat & Physiol, Quebec City, PQ G1V 0A6, Canada; [Rivest, Serge] Ctr Hosp Univ Quebec, Ctr Hosp Univ Laval, Res Ctr, Mol Endocrinol Lab, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University; Laval University	Provost, P (corresponding author), Ctr Hosp Univ Quebec, Ctr Hosp Univ Laval, Res Ctr, Ctr Rech Rhumatol & Immunol, 2705 Blvd Laurier,Local T1-49, Quebec City, PQ G1V 4G2, Canada.	patrick.provost@crchul.ulaval.ca	Provost, Patrick/G-2786-2010	Provost, Patrick/0000-0002-6099-6562; Rivest, Serge/0000-0002-6082-770X	NARSAD; The World's Leading Charity Dedicated to Mental Health Research	NARSAD(NARSAD); The World's Leading Charity Dedicated to Mental Health Research	This work was supported by NARSAD, The World's Leading Charity Dedicated to Mental Health Research, young investigator award ( to P. P.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ouellet DL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/69616; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/16806; Preece P, 2003, MOL BRAIN RES, V116, P155, DOI 10.1016/S0169-328X(03)00233-X; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Reddy PH, 2006, NEUROBIOL AGING, V27, P1060, DOI 10.1016/j.neurobiolaging.2005.04.014; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; WHITEHOUSE PJ, 1985, CRC CR REV CL NEUROB, V1, P319; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	44	239	255	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1971	1981		10.1074/jbc.M807530200	http://dx.doi.org/10.1074/jbc.M807530200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	18986979	Green Accepted, hybrid			2022-12-27	WOS:000262545600004
J	Li, CM; Chan, J; Haeseleer, F; Mikoshiba, K; Palczewski, K; Ikura, M; Ames, JB				Li, Congmin; Chan, Jenny; Haeseleer, Franciose; Mikoshiba, Katsuhiko; Palczewski, Krzysztof; Ikura, Mitsuhiko; Ames, James B.			Structural Insights into Ca2+-dependent Regulation of Inositol 1,4,5-Trisphosphate Receptors by CaBP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN-1; CHEMICAL-SHIFT ASSIGNMENTS; CA2+ RELEASE CHANNELS; CRYSTAL-STRUCTURE; CA2+-BINDING PROTEIN-1; CONFORMATIONAL-CHANGES; TROPONIN-C; CALMODULIN; LIGAND; DOMAIN	Calcium-binding protein 1 (CaBP1), a neuron-specific member of the calmodulin (CaM) superfamily, modulates Ca2+-dependent activity of inositol 1,4,5-trisphosphate receptors (InsP(3)Rs). Here we present NMR structures of CaBP1 in both Mg2+-bound and Ca2+-bound states and their structural interaction with InsP(3)Rs. CaBP1 contains four EF-hands in two separate domains. The N-domain consists of EF1 and EF2 in a closed conformation with Mg2+-bound at EF1. The C-domain binds Ca2+ at EF3 and EF4, and exhibits a Ca2+-induced closed to open transition like that of CaM. The Ca2+-bound C-domain contains exposed hydrophobic residues (Leu(132), His(134), Ile(141), Ile(144), and Val(148)) that may account for selective binding to InsP(3)Rs. Isothermal titration calorimetry analysis reveals a Ca2+-induced binding of the CaBP1 C-domain to the N-terminal region of InsP(3)R (residues 1-587), whereas CaM and the CaBP1 N-domain did not show appreciable binding. CaBP1 binding to InsP(3)Rs requires both the suppressor and ligand-binding core domains, but has no effect on InsP(3) binding to the receptor. We propose that CaBP1 may regulate Ca2+-dependent activity of InsP(3)Rs by promoting structural contacts between the suppressor and core domains.	[Li, Congmin; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Chan, Jenny; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 2M9, Canada; [Chan, Jenny; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Haeseleer, Franciose] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Brain Dev Res Grp, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	University of California System; University of California Davis; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Washington; University of Washington Seattle; RIKEN; Case Western Reserve University	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu	Mikoshiba, Katsuhiko/N-7943-2015	Ikura, Mitsuhiko/0000-0002-9524-1303	National Institutes of Health [EY012347, NS045909, RR11973]; Canadian Institutes of Health Research and the Canada Foundation for Innovation; Canadian Institutes of Health Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR011973] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059969, R01NS045909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research and the Canada Foundation for Innovation(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012347 and NS045909 (to J.B.A.). This work was also supported by Grant RR11973 to the University of California Davis NMR Facility from the National Institutes of Health, the Canadian Institutes of Health Research and the Canada Foundation for Innovation (to M. I.), and a fellowship from the Canadian Institutes of Health Research (to J.C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adkins CE, 2000, BIOCHEM J, V345, P357, DOI 10.1042/0264-6021:3450357; Andersson M, 1997, PROTEIN SCI, V6, P1139, DOI 10.1002/pro.5560060602; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Badger J, 1999, PROTEINS, V35, P25, DOI 10.1002/(SICI)1097-0134(19990401)35:1<25::AID-PROT3>3.3.CO;2-M; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; BROCARD JB, 1993, NEURON, V11, P751, DOI 10.1016/0896-6273(93)90084-5; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; Chang SL, 2003, J AM CHEM SOC, V125, P11379, DOI 10.1021/ja034064w; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; COX JA, 1994, J BIOL CHEM, V269, P32807; Devogelaere B, 2008, CELL CALCIUM, V43, P17, DOI 10.1016/j.ceca.2007.04.005; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Finley NL, 2004, BIOCHEMISTRY-US, V43, P11371, DOI 10.1021/bi049672i; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; Kasri NN, 2004, EMBO J, V23, P312, DOI 10.1038/sj.emboj.7600037; Kinoshita-Kawada M, 2005, PFLUG ARCH EUR J PHY, V450, P345, DOI 10.1007/s00424-005-1419-1; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Laube G, 2002, MOL CELL NEUROSCI, V19, P459, DOI 10.1006/mcne.2001.1078; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Li CM, 2007, BIOMOL NMR ASSIGM, V1, P77, DOI 10.1007/s12104-007-9019-y; Li CM, 2008, BIOMOL NMR ASSIGN, V2, P61, DOI 10.1007/s12104-008-9085-9; Malmendal A, 1998, J BIOL CHEM, V273, P28994, DOI 10.1074/jbc.273.44.28994; Menger N, 1999, CELL TISSUE RES, V298, P21, DOI 10.1007/s004419900060; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Missiaen L, 1999, J BIOL CHEM, V274, P13748, DOI 10.1074/jbc.274.20.13748; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; SCHWIETERS CD, 2003, J BIOL CHEM, V278, P37461; Seidenbecher CI, 2002, ADV EXP MED BIOL, V514, P451; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Varnai P, 2005, P NATL ACAD SCI USA, V102, P7859, DOI 10.1073/pnas.0407535102; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200	57	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2472	2481		10.1074/jbc.M806513200	http://dx.doi.org/10.1074/jbc.M806513200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19008222	Green Published, hybrid			2022-12-27	WOS:000262545600054
J	Pauchet, Y; Freitak, D; Heidel-Fischer, HM; Heckel, DG; Vogel, H				Pauchet, Yannick; Freitak, Dalial; Heidel-Fischer, Hanna M.; Heckel, David G.; Vogel, Heiko			GLUCANASE ACTIVITY IN A GLUCAN-BINDING PROTEIN FAMILY FROM LEPIDOPTERA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; MANDUCA-SEXTA; MOLECULAR-CLONING; PROPHENOLOXIDASE ACTIVATION; HELICOVERPA-ARMIGERA; ANOPHELES-GAMBIAE; MASS-SPECTROMETRY; IMMUNE-RESPONSES; COTTON BOLLWORM; INNATE IMMUNITY	The cell surfaces of microorganisms display distinct molecular patterns formed from lipopolysaccharides, peptidoglycans, or beta 1,3-glucans. Binding of these surfaces by pattern recognition proteins such as beta 1,3-glucan recognition proteins (beta GRPs) activates the immune response in arthropods. We identified a 40-kDa beta 1,3-glucan-binding protein with sequence similarity to previously characterized lepidopteran beta GRPs from hemolymph, but unlike these it is secreted into the larval gut lumen and is an active beta 1,3-glucanase. This glucanase was not detected in hemolymph. Its mRNA is constitutively and predominantly expressed in the midgut and is induced there when larvae feed on a diet containing bacteria. Homologs of this predominantly midgut-expressed gene from many Lepidoptera possess key residues shown to be part of the active site of other glucanases, and form a cluster that is distinct from previously described beta GRPs. In addition, this group includes proteins from insects such as the Anopheles gambiae GNBP subgroup B for which a catalytic role has not been previously suspected. The current domain classification does not distinguish between the catalytic and noncatalytic clades, and should be revised. The noncatalytic beta GRPs may be evolutionarily derived from this newly described enzyme family that continues to function catalytically in digestion and/or pathogen defense.	[Pauchet, Yannick; Freitak, Dalial; Heidel-Fischer, Hanna M.; Heckel, David G.; Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany	Max Planck Society	Pauchet, Y (corresponding author), Univ Exeter, Sch Biosci, Penryn TR10 9EZ, Cornwall, England.	Y.Pauchet@exeter.ac.uk	Heckel, David G/K-2138-2013; Pauchet, Yannick/AAU-9751-2021; Freitak, Dalial/H-4904-2012	Heckel, David G/0000-0001-8991-2150; Pauchet, Yannick/0000-0002-2918-8946; Freitak, Dalial/0000-0001-8574-0531	MaxPlanck Society	MaxPlanck Society(Max Planck Society)	This work was supported by the MaxPlanck Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ao JQ, 2008, MOL IMMUNOL, V45, P543, DOI 10.1016/j.molimm.2007.05.019; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chai LQ, 2008, DEV COMP IMMUNOL, V32, P71, DOI 10.1016/j.dci.2007.04.006; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Fabrick JA, 2004, J BIOL CHEM, V279, P26605, DOI 10.1074/jbc.M403382200; Fabrick JA, 2003, INSECT BIOCHEM MOLEC, V33, P579, DOI 10.1016/S0965-1748(03)00029-8; Fischer HM, 2008, MOL BIOL EVOL, V25, P809, DOI 10.1093/molbev/msn014; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Genta FA, 2003, INSECT BIOCHEM MOLEC, V33, P1085, DOI 10.1016/S0965-1748(03)00121-8; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; HALL M, 1995, P NATL ACAD SCI USA, V92, P7764, DOI 10.1073/pnas.92.17.7764; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; JUNCOSA M, 1994, J BIOL CHEM, V269, P14530; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; LAMB CJ, 1989, CELL, V56, P215, DOI 10.1016/0092-8674(89)90894-5; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; MAUCH F, 1988, PLANT PHYSIOL, V88, P936, DOI 10.1104/pp.88.3.936; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Ping LY, 2007, ENVIRON MICROBIOL, V9, P1572, DOI 10.1111/j.1462-2920.2007.01279.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shin SW, 1998, INSECT BIOCHEM MOLEC, V28, P827, DOI 10.1016/S0965-1748(98)00077-0; Simpson RM, 2007, INSECT MOL BIOL, V16, P675, DOI 10.1111/j.1365-2583.2007.00763.x; Spiteller D, 2000, BIOL CHEM, V381, P755, DOI 10.1515/BC.2000.096; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDERZANT ES, 1968, ANN ENTOMOL SOC AM, V61, P120, DOI 10.1093/aesa/61.1.120; Warr E, 2008, INSECT MOL BIOL, V17, P39, DOI 10.1111/j.1365-2583.2008.00778.x; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	39	71	77	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					2214	2224		10.1074/jbc.M806204200	http://dx.doi.org/10.1074/jbc.M806204200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	19033442	hybrid			2022-12-27	WOS:000262545600031
J	Jian, XY; Brown, P; Schuck, P; Gruschus, JM; Balbo, A; Hinshaw, JE; Randazzo, PA				Jian, Xiaoying; Brown, Patrick; Schuck, Peter; Gruschus, James M.; Balbo, Andrea; Hinshaw, Jenny E.; Randazzo, Paul A.			Autoinhibition of Arf GTPase-activating Protein Activity by the BAR Domain in ASAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE A2 ACTIVITY; MEMBRANE CURVATURE; RECYCLING ENDOSOME; ACTIN CYTOSKELETON; PH DOMAINS; GAPS; BINDING; FAMILY; ULTRACENTRIFUGATION; RECOGNITION	ASAP1 is an Arf GTPase-activating protein (GAP) that functions on membrane surfaces to catalyze the hydrolysis of GTP bound to Arf. ASAP1 contains a tandem of BAR, pleckstrin homology (PH), and Arf GAP domains and contributes to the formation of invadopodia and podosomes. The PH domain interacts with the catalytic domain influencing both the catalytic and Michaelis constants. Tandem BAR-PH domains have been found to fold into a functional unit. The results of sedimentation velocity studies were consistent with predictions from homology models in which the BAR and PH domains of ASAP1 fold together. We set out to test the hypothesis that the BAR domain of ASAP1 affects GAP activity by interacting with the PH and/or Arf GAP domains. Recombinant proteins composed of the BAR, PH, Arf GAP, and Ankyrin repeat domains (called BAR-PZA) and the PH, Arf GAP, and Ankyrin repeat domains (PZA) were compared. Catalytic power for the two proteins was determined using large unilamellar vesicles as a reaction surface. The catalytic power of PZA was greater than that of BAR-PZA. The effect of the BAR domain was dependent on the N-terminal loop of the BAR domain and was not the consequence of differential membrane association or changes in large unilamellar vesicle curvature. The K-m for BAR-PZA was greater and the k(cat) was smaller than for PZA determined by saturation kinetics. Analysis of single turnover kinetics revealed a transition state intermediate that was affected by the BAR domain. We conclude that BAR domains can affect enzymatic activity through intraprotein interactions.	[Randazzo, Paul A.] NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Brown, Patrick; Schuck, Peter; Balbo, Andrea] NIDDK, Sect Dynam Macromol Assembly, NIH, Bethesda, MD 20892 USA; [Gruschus, James M.] NIDDK, NHLBI, NIH, Bethesda, MD 20892 USA; [Hinshaw, Jenny E.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Randazzo, PA (corresponding author), NCI, Cellular & Mol Biol Lab, NIH, Bldg 37,Rm 2042, Bethesda, MD 20892 USA.	randazzo@helix.nih.gov	Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966	NCI; NIBIB; National Institutes of Health; Department of Health and Human Services; NATIONAL CANCER INSTITUTE [Z01BC007365, ZIABC007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000008, ZICEB000008, Z01EB000008] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by the intramural program at NCI and by the NIBIB, National Institutes of Health, Department of Health and Human Services. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Che MM, 2005, METHOD ENZYMOL, V404, P147, DOI 10.1016/S0076-6879(05)04015-2; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DENNIS EA, 1973, ARCH BIOCHEM BIOPHYS, V158, P485, DOI 10.1016/0003-9861(73)90540-7; DENNIS EA, 1973, J LIPID RES, V14, P152; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Inoue H, 2008, MOL BIOL CELL, V19, P4224, DOI 10.1091/mbc.E08-03-0290; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; Lee MCS, 2004, SCIENCE, V303, P479, DOI 10.1126/science.1094231; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LIVESEY AK, 1986, J CHEM PHYS, V84, P5102, DOI 10.1063/1.450663; Luo R, 2008, CELL SIGNAL, V20, P1968, DOI 10.1016/j.cellsig.2008.07.007; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Onodera Y, 2005, EMBO J, V24, P963, DOI 10.1038/sj.emboj.7600588; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Randazzo PA, 2001, METHOD ENZYMOL, V329, P343; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x; Zhu GY, 2007, EMBO J, V26, P3484, DOI 10.1038/sj.emboj.7601771	42	47	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1652	1663		10.1074/jbc.M804218200	http://dx.doi.org/10.1074/jbc.M804218200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19017632	Green Published, hybrid			2022-12-27	WOS:000262330100034
J	McAllister, CS; Samuel, CE				McAllister, Christopher S.; Samuel, Charles E.			The RNA-activated Protein Kinase Enhances the Induction of Interferon-beta and Apoptosis Mediated by Cytoplasmic RNA Sensors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; TOLL-LIKE-RECEPTORS; INDUCIBLE GENE-I; ADAPTER PROTEIN; PKR; TRANSCRIPTION; RECOGNITION; MECHANISM; INFECTION	Detection of foreign RNA by the innate immune system can trigger the induction of type I interferon (IFN) and apoptosis. Important antiviral defense pathways that result in type I IFN production following the recognition of foreign doublestranded RNA (dsRNA) include the RIG-I family helicases and IPS-1 adaptor cytosolic pathway and the Toll-like receptor 3 and TIR domain-containing adaptor-inducing IFN-beta (TRIF) adaptor membrane-associated pathway, both of which activate IFN regulatory factor 3 (IRF3). In addition to triggering an innate immune response, dsRNAs are widely used to mediate geneselective silencing in mammalian cells by the RNA interference pathway. We investigated the ability of short interfering RNAs, including T7 phage polymerase-synthesized RNA (PRNA), which like some viral RNAs contains a 5'-triphosphate, to selectively silence gene expression and to cause induction of IFN-beta and apoptosis. We found that PRNA-mediated gene silencing and associated nonspecific pro-apoptotic and IFN-inducing effects were dependent on the cell line and RNA length. Double-stranded PRNAs 50 nucleotides long as well as polyinosinicpolycytidylic acid activated the RNA-dependent protein kinase (PKR) and induced significant levels of IFN-beta and apoptosis, whereas shorter PRNAs and chemically synthesized dsRNAs did not. Effector caspase activation and apoptosis following RNA transfection was enhanced by pretreatment with IFN, and removal of the 5'-phosphate from PRNAs decreased induction of both IFN-beta and apoptosis. PKR, in addition to IPS-1 and IRF3 but not TRIF, was required for maximal type I IFN-beta induction and the induction of apoptosis by both transfected PRNAs and polyinosinicpolycytidylic acid.	[McAllister, Christopher S.; Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			National Institutes of Health Grants [AI-12520, AI-20611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI012520, R01AI020611, R37AI012520] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-12520 and AI-20611. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; BISCHOFF JR, 1989, VIROLOGY, V172, P106, DOI 10.1016/0042-6822(89)90112-8; Bouxsein NF, 2007, BIOCHEMISTRY-US, V46, P4785, DOI 10.1021/bi062138l; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Das S, 2006, J BIOL CHEM, V281, P3244, DOI 10.1074/jbc.M510612200; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; GAROUFALIS E, 1994, J VIROL, V68, P4707, DOI 10.1128/JVI.68.8.4707-4715.1994; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Heylbroeck C, 2000, J VIROL, V74, P3781, DOI 10.1128/JVI.74.8.3781-3792.2000; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kang DC, 2004, ONCOGENE, V23, P1789, DOI 10.1038/sj.onc.1207300; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; LAMPSON GP, 1967, P NATL ACAD SCI USA, V58, P782, DOI 10.1073/pnas.58.2.782; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Matsukura S, 1999, J IMMUNOL, V163, P6876; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MELLITS KH, 1990, NUCLEIC ACIDS RES, V18, P5401, DOI 10.1093/nar/18.18.5401; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Robbins MA, 2005, NAT MED, V11, P250, DOI 10.1038/nm0305-250; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Samuel CE, 2004, NAT BIOTECHNOL, V22, P280, DOI 10.1038/nbt0304-280; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sioud M, 2006, TRENDS MOL MED, V12, P167, DOI 10.1016/j.molmed.2006.02.004; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Ui-Tei K, 2000, FEBS LETT, V479, P79, DOI 10.1016/S0014-5793(00)01883-4; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	57	83	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1644	1651		10.1074/jbc.M807888200	http://dx.doi.org/10.1074/jbc.M807888200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028691	Green Published			2022-12-27	WOS:000262330100033
J	Wang, YB; Weiss, LM; Orlofsky, A				Wang, Yubao; Weiss, Louis M.; Orlofsky, Amos			Host Cell Autophagy Is Induced by Toxoplasma gondii and Contributes to Parasite Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSCISIC-ACID; APICOMPLEXAN PARASITES; PROTEIN LIPIDATION; AMINO-ACIDS; CALCIUM; MACROAUTOPHAGY; METABOLISM; COMPLEX; INNATE; BIOSYNTHESIS	Autophagy has been shown to contribute to defense against intracellular bacteria and parasites. In comparison, the ability of such pathogens to manipulate host cell autophagy to their advantage has not been examined. Here we present evidence that infection by Toxoplasma gondii, an intracellular protozoan parasite, induces host cell autophagy in both HeLa cells and primary fibroblasts, via a mechanism dependent on host Atg5 but independent of host mammalian target of rapamycin suppression. Infection led to the conversion of LC3 to the autophagosome-associated form LC3-II, to the accumulation of LC3-containing vesicles near the parasitophorous vacuole, and to the relocalization toward the vacuole of structures labeled by the phosphatidylinositol 3-phosphate indicator YFP-2xFYVE. The autophagy regulator beclin 1 was concentrated in the vicinity of the parasitophorous vacuole in infected cells. Inhibitor studies indicated that parasite-induced autophagy is dependent on calcium signaling and on abscisic acid. At physiologically relevant amino acid levels, parasite growth became defective in Atg5-deficient cells, indicating a role for host cell autophagy in parasite recovery of host cell nutrients. A flow cytometric analysis of cell size as a function of parasite content revealed that autophagy-dependent parasite growth correlates with autophagy-dependent consumption of host cell mass that is dependent on parasite progression. These findings indicate a new role for autophagy as a pathway by which parasites may effectively compete with the host cell for limiting anabolic resources.	[Wang, Yubao; Weiss, Louis M.; Orlofsky, Amos] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Weiss, Louis M.] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Orlofsky, A (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, G704,1300 Morris Pk Ave, Bronx, NY 10461 USA.	orlofsky@aecom.yu.edu	Wang, Yubao/L-3912-2014		National Institutes of Health [AI-55358, AI-39454]; Flow Cytometry Core of the Center for AIDS Research [AI-51519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055358, R01AI039454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Core of the Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-55358 (to A. O.) and AI-39454 (to L. M. W.). This work was also supported by the Flow Cytometry Core of the Center for AIDS Research Grant AI-51519. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; AOKI TT, 1975, AM J CLIN NUTR, V28, P507, DOI 10.1093/ajcn/28.5.507; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BRUZZONE S, 2008, J BIOL CHEM; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Calbet JAL, 2002, J NUTR, V132, P2174, DOI 10.1093/jn/132.8.2174; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Fox BA, 2004, INT J PARASITOL, V34, P323, DOI 10.1016/j.ijpara.2003.12.001; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Gherardi A, 2007, TRENDS PARASITOL, V23, P384, DOI 10.1016/j.pt.2007.06.003; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; PALOU A, 1981, HORM METAB RES, V13, P326, DOI 10.1055/s-2007-1019258; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Ravindran S, 2008, TRAFFIC, V9, P647, DOI 10.1111/j.1600-0854.2008.00723.x; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; SCHWARTZ A, 1994, P NATL ACAD SCI USA, V91, P4019, DOI 10.1073/pnas.91.9.4019; Shrestha SP, 2006, INT J PARASITOL, V36, P433, DOI 10.1016/j.ijpara.2006.01.006; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; YOKOGOSHI H, 1986, METABOLISM, V35, P837, DOI 10.1016/0026-0495(86)90225-8; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; ZOCCHI E, 2006, FLURIDONE ANTII 1006	49	90	94	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1694	1701		10.1074/jbc.M807890200	http://dx.doi.org/10.1074/jbc.M807890200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	19028680	hybrid, Green Published			2022-12-27	WOS:000262330100038
J	Carobbio, S; Frigerio, F; Rubi, B; Vetterli, L; Bloksgaard, M; Gjinovci, A; Pournourmohammadi, S; Herrera, PL; Reith, W; Mandrup, S; Maechler, P				Carobbio, Stefania; Frigerio, Francesca; Rubi, Blanca; Vetterli, Laurene; Bloksgaard, Maria; Gjinovci, Asllan; Pournourmohammadi, Shirin; Herrera, Pedro L.; Reith, Walter; Mandrup, Susanne; Maechler, Pierre			Deletion of Glutamate Dehydrogenase in beta-Cells Abolishes Part of the Insulin Secretory Response Not Required for Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELEASE; SIRT4; MICE; MITOCHONDRIA; DEFICIENCY; METABOLISM; RESISTANCE; PATHWAYS; LEUCINE; ISLETS	Insulin exocytosis is regulated in pancreatic beta-cells by a cascade of intracellular signals translating glucose levels into corresponding secretory responses. The mitochondrial enzyme glutamate dehydrogenase (GDH) is regarded as a major player in this process, although its abrogation has not been tested yet in animal models. Here, we generated transgenic mice, named beta Glud1(-/-), with beta-cell-specific GDH deletion. Our results show that GDH plays an essential role in the full development of the insulin secretory response. In situ pancreatic perfusion revealed that glucose-stimulated insulin secretion was reduced by 37% in beta Glud1(-/-). Furthermore, isolated islets with either constitutive or acute adenovirus-mediated knock-out of GDH showed a 49 and 38% reduction in glucose-induced insulin release, respectively. Adenovirus-mediated re-expression of GDH in beta Glud1(-/-) islets fully restored glucose-induced insulin release. Thus, GDH appears to account for about 40% of glucose-stimulated insulin secretion and to lack redundant mechanisms. In beta Glud1(-/-) mice, the reduced secretory capacity resulted in lower plasma insulin levels in response to both feeding and glucose load, while body weight gain was preserved. The results demonstrate that GDH is essential for the full development of the secretory response in beta-cells. However, maximal secretory capacity is not required for maintenance of glucose homeostasis in normo-caloric conditions.	[Carobbio, Stefania; Frigerio, Francesca; Rubi, Blanca; Vetterli, Laurene; Gjinovci, Asllan; Pournourmohammadi, Shirin; Maechler, Pierre] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Herrera, Pedro L.] Univ Geneva, Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Reith, Walter] Univ Geneva, Med Ctr, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Geneva; University of Geneva; University of Geneva; University of Southern Denmark	Maechler, P (corresponding author), Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Pierre.Maechler@medecine.unige.ch	carobbio, stefania/E-7095-2018; Mandrup, Susanne/B-6693-2008	Herrera Merino, Pedro Luis/0000-0003-0771-9504; Maechler, Pierre/0000-0002-2005-1433; Mandrup, Susanne/0000-0002-0961-5787; Bloksgaard, Maria/0000-0002-4474-9553	Swiss National Science Foundation; EFSD/Novo Nordisk research; Dr. Max Cloetta Foundation; Danish Natural Science Research Council and Health Science Research Council; Juvenile Diabetes Research Foundation; Fondation Romande pour la Recherche sur le Diabete	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EFSD/Novo Nordisk research; Dr. Max Cloetta Foundation; Danish Natural Science Research Council and Health Science Research Council; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Fondation Romande pour la Recherche sur le Diabete	This study was supported by the Swiss National Science Foundation (to P. M., W. R., and P. L. H.), an EFSD/Novo Nordisk research grant (to P. M.), the Dr. Max Cloetta Foundation (to P. M.), the Danish Natural Science Research Council and Health Science Research Council (to S. M.), the Juvenile Diabetes Research Foundation (to P. H.), and Fondation Romande pour la Recherche sur le Diabete (to P. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Argmann C, 2006, CELL, V126, P837, DOI 10.1016/j.cell.2006.08.031; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Carobbio S, 2004, DIABETOLOGIA, V47, P266, DOI 10.1007/s00125-003-1306-2; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; Frigerio F, 2008, BBA-BIOENERGETICS, V1777, P965, DOI 10.1016/j.bbabio.2008.04.031; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Gorogawa S, 2004, BIOCHEM BIOPH RES CO, V319, P1159, DOI 10.1016/j.bbrc.2004.05.095; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hoy M, 2002, FEBS LETT, V531, P199, DOI 10.1016/S0014-5793(02)03500-7; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Konrad D, 2007, DIABETOLOGIA, V50, P833, DOI 10.1007/s00125-007-0596-1; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Li CH, 2006, J BIOL CHEM, V281, P15064, DOI 10.1074/jbc.M600994200; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2002, DIABETES, V51, pS99, DOI 10.2337/diabetes.51.2007.S99; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MICHAELIDIS TM, 1993, GENOMICS, V16, P150, DOI 10.1006/geno.1993.1152; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; ORCI L, 1975, LANCET, V2, P1243, DOI 10.1016/S0140-6736(75)92078-4; PANTEN U, 1984, BIOCHEM J, V219, P189, DOI 10.1042/bj2190189; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Produit-Zengaffinen N, 2007, DIABETOLOGIA, V50, P84, DOI 10.1007/s00125-006-0499-6; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Xia Z, 2002, J BIOL CHEM, V277, P45874, DOI 10.1074/jbc.M207281200; Ye F, 2008, J BIOCHEM BIOPH METH, V70, P978, DOI 10.1016/j.jprot.2008.01.003	38	78	78	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					921	929		10.1074/jbc.M806295200	http://dx.doi.org/10.1074/jbc.M806295200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19015267	hybrid			2022-12-27	WOS:000262122900027
J	Shah, GV; Muralidharan, A; Gokulgandhi, M; Soan, K; Thomas, S				Shah, Girish V.; Muralidharan, Anbalagan; Gokulgandhi, Mitan; Soan, Kamal; Thomas, Shibu			Cadherin Switching and Activation of beta-Catenin Signaling Underlie Proinvasive Actions of Calcitonin-Calcitonin Receptor Axis in Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; MESENCHYMAL TRANSITION; N-CADHERIN; INCREASES INVASIVENESS; ADHESION MOLECULES; TIGHT JUNCTIONS; LUMEN FORMATION; CELL-ADHESION; BREAST-CANCER; EXPRESSION	Calcitonin, a neuroendocrine peptide, and its receptor are localized in the basal epithelium of benign prostate but in the secretory epithelium of malignant prostates. The abundance of calcitonin and calcitonin receptor mRNA displays positive correlation with the Gleason grade of primary prostate cancers. Moreover, calcitonin increases tumorigenicity and invasiveness of multiple prostate cancer cell lines by cyclic AMP-dependent protein kinase-mediated actions. These actions include increased secretion of matrix metalloproteinases and urokinase-type plasminogen activator and an increase in prostate cancer cell invasion. Activation of calcitonin-calcitonin receptor autocrine loop in prostate cancer cell lines led to the loss of cell-cell adhesion, destabilization of tight and adherens junctions, and internalization of key integral membrane proteins. In addition, the activation of calcitonin-calcitonin receptor axis induced epithelial-mesenchymal transition of prostate cancer cells as characterized by cadherin switch and the expression of the mesenchymal marker, vimentin. The activated calcitonin receptor phosphorylated glycogen synthase kinase-3, a key regulator of cytosolic beta-catenin degradation within the WNT signaling pathway. This resulted in the accumulation of intracellular beta-catenin, its translocation in the nucleus, and transactivation of beta-catenin-responsive genes. These results for the first time identify actions of calcitonin-calcitonin receptor axis on prostate cancer cells that lead to the destabilization of cell-cell junctions, epithelial to mesenchymal transition, and activation ofWNT/beta-catenin signaling. The results also suggest that cyclic AMP-dependent protein kinase plays a key role in calcitonin receptor-induced destabilization of cell-cell junctions and activation of WNT-beta-catenin signaling.	[Shah, Girish V.; Muralidharan, Anbalagan; Gokulgandhi, Mitan; Soan, Kamal; Thomas, Shibu] Univ Louisiana, Coll Pharm, Dept Pharmacol, Monroe, LA 71209 USA	University of Louisiana System; University of Louisiana Monroe	Shah, GV (corresponding author), 700 Univ Ave, Monroe, LA 71209 USA.	shah@ulm.edu		Anbalagan, Muralidharan/0000-0001-5797-7558	National Institutes of Health [CA96534]; NATIONAL CANCER INSTITUTE [R56CA096534, R01CA096534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA96534 (to G. V. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Bello-Deocampo D, 2001, PROSTATE, V46, P142, DOI 10.1002/1097-0045(20010201)46:2<142::AID-PROS1018>3.0.CO;2-B; Campbell C, 2008, CURR OPIN HEMATOL, V15, P319, DOI 10.1097/MOH.0b013e328303b9df; Chien J, 2001, INT J CANCER, V91, P46, DOI 10.1002/1097-0215(20010101)91:1<46::AID-IJC1008>3.0.CO;2-0; Chien J, 1999, ONCOGENE, V18, P3376, DOI 10.1038/sj.onc.1202690; Chien J, 2001, MOL CELL ENDOCRINOL, V181, P69, DOI 10.1016/S0303-7207(01)00530-5; Chigurupati S, 2005, CANCER RES, V65, P8519, DOI 10.1158/0008-5472.CAN-05-0848; Cooper CR, 2000, PROSTATE CANCER P D, V3, P6, DOI 10.1038/sj.pcan.4500387; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fuchs SY, 2002, CANCER BIOL THER, V1, P337; Furuya Y, 1999, INT J UROL, V6, P240, DOI 10.1046/j.1442-2042.1999.00060.x; Gaujoux S, 2008, J CLIN ENDOCR METAB, V93, P4135, DOI 10.1210/jc.2008-0631; Grande M, 2002, J CELL SCI, V115, P4227, DOI 10.1242/jcs.00091; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; He B, 2007, ERNST SCHERING FOUND, V5, P27, DOI 10.1007/2789_2007_043; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Jankowski JA, 1997, J CLIN PATHOL-MOL PA, V50, P289; KAIGHN ME, 1979, INVEST UROL, V17, P16; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Keiper T, 2005, HISTOL HISTOPATHOL, V20, P197, DOI 10.14670/HH-20.197; Lam JS, 2006, UROL ONCOL-SEMIN ORI, V24, P131, DOI 10.1016/j.urolonc.2005.11.038; Lang SH, 2001, CELL GROWTH DIFFER, V12, P631; LIM DJ, 1993, PROSTATE, V22, P109, DOI 10.1002/pros.2990220203; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; MOORE EE, 1995, MOL ENDOCRINOL, V9, P959, DOI 10.1210/me.9.8.959; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; OTTO T, 1993, UROL RES, V21, P359, DOI 10.1007/BF00296837; Polakis P, 2000, GENE DEV, V14, P1837; Presti JC, 2000, RADIOL CLIN N AM, V38, P49, DOI 10.1016/S0033-8389(05)70149-4; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Rosano L, 2005, CANCER RES, V65, P11649, DOI 10.1158/0008-5472.CAN-05-2123; Sabbisetti V, 2006, INT J CANCER, V118, P2694, DOI 10.1002/ijc.21625; Sabbisetti VS, 2005, INT J CANCER, V117, P551, DOI 10.1002/ijc.21158; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Segawa N, 2001, PATHOL INT, V51, P452, DOI 10.1046/j.1440-1827.2001.01226.x; SHAH GV, 1994, ENDOCRINOLOGY, V134, P596, DOI 10.1210/en.134.2.596; SHAH GV, 2008, ENDOCR-RELAT CANCER, V15, P1; Shih IM, 2000, CANCER RES, V60, P1671; SOMMERS CL, 1992, CANCER RES, V52, P5190; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; THIERY JP, 1988, CIBA F SYMP, V141, P48; Thomas S, 2005, CANCER BIOL THER, V4, P1226, DOI 10.4161/cbt.4.11.2093; Thomas S, 2007, INT J ONCOL, V31, P1425; Thomas S, 2006, MOL ENDOCRINOL, V20, P1894, DOI 10.1210/me.2005-0284; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Torer N, 2007, J SURG ONCOL, V96, P419, DOI 10.1002/jso.20654; Tsukamoto T, 1999, J BIOL CHEM, V274, P24579, DOI 10.1074/jbc.274.35.24579; Tsukita S, 1996, CELL STRUCT FUNCT, V21, P381, DOI 10.1247/csf.21.381; Tyagi N, 1993, J Postgrad Med, V39, P197; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wu GA, 1996, UROLOGY, V47, P376, DOI 10.1016/S0090-4295(99)80456-7; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086	66	29	30	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1018	1030		10.1074/jbc.M807823200	http://dx.doi.org/10.1074/jbc.M807823200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19001380	Green Published, hybrid			2022-12-27	WOS:000262122900038
J	Verpooten, D; Ma, YJ; Hou, SW; Yan, ZP; He, B				Verpooten, Dustin; Ma, Yijie; Hou, Songwang; Yan, Zhipeng; He, Bin			Control of TANK-binding Kinase 1-mediated Signaling by the gamma(1)34.5 Protein of Herpes Simplex Virus 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERFERON ANTIVIRAL RESPONSE; INNATE IMMUNE-RESPONSE; TYPE-1 US11 PROTEIN; IKK-RELATED KINASE; VIRAL-INFECTION; REGULATORY SUBUNIT; STIMULATED GENES; ACTIVATION; CELLS	TANK-binding kinase 1 (TBK1) is a key component of Toll-like receptor-dependent and -independent signaling pathways. In response to microbial components, TBK1 activates interferon regulatory factor 3 (IRF3) and cytokine expression. Here we show that TBK1 is a novel target of the gamma(1)34.5 protein, a virulence factor whose expression is regulated in a temporal fashion. Remarkably, the gamma(1)34.5 protein is required to inhibit IRF3 phosphorylation, nuclear translocation, and the induction of antiviral genes in infected cells. When expressed in mammalian cells, the gamma(1)34.5 protein forms complexes with TBK1 and disrupts the interaction of TBK1 and IRF3, which prevents the induction of interferon and interferon-stimulated gene promoters. Down-regulation of TBK1 requires the amino-terminal domain. In addition, unlike wild type virus, a herpes simplex virus mutant lacking gamma(1)34.5 replicates efficiently in TBK1(-/-) cells but not in TBK1(+/+) cells. Addition of exogenous interferon restores the antiviral activity in both TBK1(-/-) and TBK+/+ cells. Hence, control of TBK1-mediated cell signaling by the gamma(1)34.5 protein contributes to herpes simplex virus infection. These results reveal that TBK1 plays a pivotal role in limiting replication of a DNA virus.	[Verpooten, Dustin; Ma, Yijie; Hou, Songwang; Yan, Zhipeng; He, Bin] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	He, B (corresponding author), 835 S Wolcott Ave, Chicago, IL 60612 USA.	tshuo@uic.edu	Yan, Zhipeng/AHC-7029-2022	Yan, Zhipeng/0000-0002-8463-1891	National Institutes of Health [AI46665]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046665, R56AI046665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI46665 (NIAID) (to B. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BROWN SM, 1994, J GEN VIROL, V75, P3679, DOI 10.1099/0022-1317-75-12-3679; Brown SM, 1997, J VIROL, V71, P9442, DOI 10.1128/JVI.71.12.9442-9449.1997; Chee AV, 2003, J VIROL, V77, P7101, DOI 10.1128/JVI.77.12.7101-7105.2003; Cheng GF, 2002, J VIROL, V76, P9434, DOI 10.1128/JVI.76.18.9434-9445.2002; Cheng GF, 2001, VIROLOGY, V290, P115, DOI 10.1006/viro.2001.1148; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; CHOU J, 1986, J VIROL, V57, P629, DOI 10.1128/JVI.57.2.629-637.1986; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; CHOU J, 1992, P NATL ACAD SCI USA, V89, P3266, DOI 10.1073/pnas.89.8.3266; CHOU J, 1990, J VIROL, V64, P1014, DOI 10.1128/JVI.64.3.1014-1020.1990; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Feng ZD, 2007, J VIROL, V81, P182, DOI 10.1128/JVI.01006-06; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; He B, 1998, J BIOL CHEM, V273, P20737, DOI 10.1074/jbc.273.33.20737; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Jing XH, 2004, J VIROL, V78, P7653, DOI 10.1128/JVI.78.14.7653-7666.2004; Johnson KE, 2008, VIROLOGY, V374, P487, DOI 10.1016/j.virol.2008.01.001; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Leib DA, 2000, P NATL ACAD SCI USA, V97, P6097, DOI 10.1073/pnas.100415697; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Mao HW, 2002, J BIOL CHEM, V277, P11423, DOI 10.1074/jbc.M111553200; MCKAY EM, 1993, J GEN VIROL, V74, P2493, DOI 10.1099/0022-1317-74-11-2493; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Melchjorsen J, 2006, J GEN VIROL, V87, P1099, DOI 10.1099/vir.0.81541-0; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Mohr I, 2001, J VIROL, V75, P5189, DOI 10.1128/JVI.75.11.5189-5196.2001; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Nicholl MJ, 2000, J GEN VIROL, V81, P2215, DOI 10.1099/0022-1317-81-9-2215; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Pasieka TJ, 2006, J VIROL, V80, P7600, DOI 10.1128/JVI.00333-06; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Poppers J, 2000, J VIROL, V74, P11215, DOI 10.1128/JVI.74.23.11215-11221.2000; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Roizman B, 1999, ACTA VIROL, V43, P75; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sanchez R, 2007, J VIROL, V81, P3455, DOI 10.1128/JVI.02520-06; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Trgovcich J, 2002, J VIROL, V76, P6974, DOI 10.1128/JVI.76.14.6974-6986.2002; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	55	148	149	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					1097	1105		10.1074/jbc.M805905200	http://dx.doi.org/10.1074/jbc.M805905200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19010780	hybrid, Green Published			2022-12-27	WOS:000262122900046
J	Wang, SY; Yu, WM; Zhang, WM; McCrae, KR; Neel, BG; Qu, CK				Wang, Siying; Yu, Wen-Mei; Zhang, Wanming; McCrae, Keith R.; Neel, Benjamin G.; Qu, Cheng-Kui			Noonan Syndrome/Leukemia-associated Gain-of-function Mutations in SHP-2 Phosphatase (PTPN11) Enhance Cell Migration and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT KININOGEN; TYROSINE-PHOSPHATASE; SIGNALING PATHWAY; ANTIANGIOGENIC ACTIVITY; FOCAL ADHESION; MOUSE MODEL; STEM-CELLS; IN-VITRO; ACTIVATION; LEUKEMIA	Mutations in SHP-2 phosphatase (PTPN11) that cause hyperactivation of its catalytic activity have been identified in Noonan syndrome and various childhood leukemias. Recent studies suggest that the gain-of-function (GOF) mutations of SHP-2 play a causal role in the pathogenesis of these diseases. However, the molecular mechanisms by which GOF mutations of SHP-2 induce these phenotypes are not fully understood. Here, we show that GOF mutations in SHP-2, such as E76K and D61G, drastically increase spreading and migration of various cell types, including hematopoietic cells, endothelial cells, and fibroblasts. More importantly, in vivo angiogenesis in SHP-2 D61G knock-in mice is also enhanced. Mechanistic studies suggest that the increased cell migration is attributed to the enhanced beta 1 integrin outside-in signaling. In response to beta 1 integrin cross-linking or fibronectin stimulation, activation of ERK and Akt kinases is greatly increased by SHP-2 GOF mutations. Also, integrin-induced activation of RhoA and Rac1 GTPases is elevated. Interestingly, mutant cells with the SHP-2 GOF mutation (D61G) are more sensitive than wild-type cells to the suppression of cell motility by inhibition of these pathways. Collectively, these studies reaffirm the positive role of SHP-2 phosphatase in cell motility and suggest a new mechanism by which SHP-2 GOF mutations contribute to diseases.	[Wang, Siying; Yu, Wen-Mei; Zhang, Wanming; McCrae, Keith R.; Qu, Cheng-Kui] Case Western Reserve Univ Hosp, Dept Med, Div Hematol Oncol, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Neel, Benjamin G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Hematol Oncol,Cancer Biol Program, Boston, MA 02215 USA	Case Western Reserve University; Case Western Reserve University Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Qu, CK (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	cxq6@case.edu		wang, siying/0000-0003-4793-7389	National Institutes of Health [HL068212, HL082670, HL076810, CA049152, CA66600]; NATIONAL CANCER INSTITUTE [R01CA066600, R01CA049152, R37CA049152] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068212, R01HL076810, R21HL082670, R01HL089796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL068212 and HL082670 (to C. K. Q.), HL076810 (to K. R. M.), CA049152 and CA66600 (to B. G. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Chen J, 2004, ONCOGENE, V23, P3659, DOI 10.1038/sj.onc.1207471; Eminaga S, 2008, J BIOL CHEM, V283, P15328, DOI 10.1074/jbc.M801382200; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Juarez JC, 2002, CANCER RES, V62, P5344; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Ke YH, 2006, J BIOL CHEM, V281, P34374, DOI 10.1074/jbc.M607325200; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Manes S, 1999, MOL CELL BIOL, V19, P3125; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; O'Reilly AM, 1998, MOL CELL BIOL, V18, P161, DOI 10.1128/MCB.18.1.161; O'Reilly AM, 2000, MOL CELL BIOL, V20, P299, DOI 10.1128/MCB.20.1.299-311.2000; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Qu CK, 2002, BBA-MOL CELL RES, V1592, P297, DOI 10.1016/S0167-4889(02)00322-1; Qu CK, 2001, BLOOD, V97, P911, DOI 10.1182/blood.V97.4.911; Qu CK, 1998, MOL CELL BIOL, V18, P6075, DOI 10.1128/MCB.18.10.6075; Qu CK, 1997, MOL CELL BIOL, V17, P5499, DOI 10.1128/MCB.17.9.5499; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Yu WM, 2006, J BIOL CHEM, V281, P5426, DOI 10.1074/jbc.M507622200; Yu WM, 2002, BLOOD, V99, P2351, DOI 10.1182/blood.V99.7.2351; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com; Zhang JC, 2002, P NATL ACAD SCI USA, V99, P12224, DOI 10.1073/pnas.192668299	44	32	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					913	920		10.1074/jbc.M804129200	http://dx.doi.org/10.1074/jbc.M804129200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	19008228	hybrid, Green Published			2022-12-27	WOS:000262122900026
J	Kalamajski, S; Oldberg, A				Kalamajski, Sebastian; Oldberg, Ake			Homologous Sequence in Lumican and Fibromodulin Leucine-rich Repeat 5-7 Competes for Collagen Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MICE; DIFFERENTIAL EXPRESSION; PROTEOGLYCAN LUMICAN; TARGETED DISRUPTION; CORNEAL STRUCTURE; SKIN FRAGILITY; NULL MICE; PROTEINS; TENDON; FIBRILS	Lumican and fibromodulin compete for collagen type I binding in vitro, and fibromodulin-deficient mice have 4-fold more lumican in tendons. These observations indicate that homologous sequences in lumican and fibromodulin bind to collagen type I. Here, we demonstrate that lumican binding to collagen type I is mediated mainly by Asp-213 in leucine-rich repeat ( LRR) 7. The mutation D213N in lumican impairs interaction with collagen, and the lumican fragment spanning LRRs 5-7 is an efficient inhibitor of collagen binding. Also, the lumican LRR 7 sequence-based synthetic peptide CYLDNNKC inhibits the binding to collagen. Homologous collagen-binding site in fibromodulin, located in LRRs 5-7, inhibits the binding of lumican to collagen, and the mutation E251Q in this fibromodulin fragment does not inhibit the lumican-collagen binding. Lumican, but not the D213N mutation, lowers the melting point and affects the packing of collagen fibrils.	[Kalamajski, Sebastian; Oldberg, Ake] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden	Lund University	Kalamajski, S (corresponding author), Lund Univ, Dept Expt Med Sci, BMC B12, SE-22184 Lund, Sweden.	Sebastian.Kalamajski@med.lu.se		Kalamajski, Sebastian/0000-0002-6600-9302	Swedish Research Council; Greta and Johan Kock Foundation; Alfred Osterlund Foundation; Royal Physiographic Society in Lund; European Commission [NMP2-CT-2003-504017]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock Foundation; Alfred Osterlund Foundation; Royal Physiographic Society in Lund; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Swedish Research Council, the Greta and Johan Kock Foundation, the Alfred Osterlund Foundation, and the Royal Physiographic Society in Lund, and the European Commission (Cornea Engineering Project, Grant NMP2-CT-2003-504017). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Austin BA, 2002, INVEST OPHTH VIS SCI, V43, P1695; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Gill MR, 2002, OSTEOARTHR CARTILAGE, V10, P751, DOI 10.1053/joca.2002.0527; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall RC, 1997, ARCH ORAL BIOL, V42, P783, DOI 10.1016/S0003-9969(97)00024-1; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035; Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X; Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001; Monfort J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1873; Nurminskaya MV, 1996, BIOCHEM J, V317, P785, DOI 10.1042/bj3170785; Quantock AJ, 2001, INVEST OPHTH VIS SCI, V42, P1750; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Wu F, 2007, J BIOL CHEM, V282, P26409, DOI 10.1074/jbc.M702402200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306; Zhou HY, 2007, ANN NY ACAD SCI, V1116, P323, DOI 10.1196/annals.1402.023	31	76	78	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					534	539		10.1074/jbc.M805721200	http://dx.doi.org/10.1074/jbc.M805721200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19008226	hybrid			2022-12-27	WOS:000261974800058
J	Kleefeld, A; Ackermann, B; Bauer, J; Kramer, J; Unden, G				Kleefeld, Alexandra; Ackermann, Bianca; Bauer, Julia; Kraemer, Jens; Unden, Gottfried			The Fumarate/Succinate Antiporter DcuB of Escherichia coli Is a Bifunctional Protein with Sites for Regulation of DcuS-dependent Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-4-DICARBOXYLATE TRANSPORT; FUMARATE REDUCTASE; BINDING-SITE; SYSTEM; SENSOR; KINASE; DNA; IDENTIFICATION; INACTIVATION; PERMEASE	DcuB of Escherichia coli catalyzes C-4-dicarboxylate/succinate antiport during growth by fumarate respiration. The expression of genes of fumarate respiration, including the genes for DcuB (dcuB) and fumarate reductase (frdABCD) is transcriptionally activated by C-4-dicarboxylates via the DcuS-DcuR two-component system, comprising the sensor kinase DcuS, which contains a periplasmic sensing domain forC(4)-dicarboxylates. Deletion or inactivation of dcuB caused constitutive expression of DcuS-regulated genes in the absence of C-4-dicarboxylates. The effect was specific for DcuB and not observed after inactivation of the homologous DcuA or the more distantly related DcuC transporter. Random and site-directed mutation identified three point mutations (T394I, D398N, and K353A) in DcuB that caused a similar derepression as dcuB deletion, whereas the transport activity of the DcuB mutants was retained. Constitutive expression in the dcuB mutants depended on the presence of a functional DcuS-DcuR two-component system. Mutation of residues E79A, R83A, and R127A of DcuB, on the other hand, inactivated growth by fumarate respiration and transport of [C-14] succinate, whereas the expression of dcuB'-lacZ was not affected. Therefore, the antiporter DcuB is a bifunctional protein and has a regulatory function that is independent from transport, and sites for transport and regulation can be differentiated.	[Kleefeld, Alexandra; Ackermann, Bianca; Bauer, Julia; Kraemer, Jens; Unden, Gottfried] Johannes Gutenberg Univ Mainz, Inst Mikrobiol & Weinforsch, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz	Unden, G (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mikrobiol & Weinforsch, Becherweg 15, D-55099 Mainz, Germany.	unden@uni-mainz.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges.	Abo-Amer AE, 2004, J BACTERIOL, V186, P1879, DOI 10.1128/JB.186.6.1879-1889.2004; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200; COLE ST, 1985, BIOCHIM BIOPHYS ACTA, V811, P381, DOI 10.1016/0304-4173(85)90008-4; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies SJ, 1999, J BACTERIOL, V181, P5624, DOI 10.1128/JB.181.18.5624-5635.1999; ENGEL P, 1994, EUR J BIOCHEM, V222, P605, DOI 10.1111/j.1432-1033.1994.tb18903.x; Etzkorn M, 2008, NAT STRUCT MOL BIOL, V15, P1031, DOI 10.1038/nsmb.1493; FARINHA MA, 1990, FEMS MICROBIOL LETT, V70, P221, DOI 10.1016/S0378-1097(05)80043-6; Golby P, 1998, J BACTERIOL, V180, P4821, DOI 10.1128/JB.180.18.4821-4827.1998; Golby P, 1999, J BACTERIOL, V181, P1238, DOI 10.1128/JB.181.4.1238-1248.1999; Golby P, 1998, J BACTERIOL, V180, P6586, DOI 10.1128/JB.180.24.6586-6596.1998; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Hilger D, 2008, J BIOL CHEM, V283, P4921, DOI 10.1074/jbc.M706741200; HUMPHREYS GO, 1976, MOL GEN GENET, V145, P101, DOI 10.1007/BF00331564; Janausch IG, 2004, MICROBIOL-SGM, V150, P877, DOI 10.1099/mic.0.26900-0; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; KADNER RJ, 1994, RES MICROBIOL, V145, P381, DOI 10.1016/0923-2508(94)90085-X; Kim OB, 2007, ARCH MICROBIOL, V188, P583, DOI 10.1007/s00203-007-0279-9; Kneuper H, 2005, J BIOL CHEM, V280, P20596, DOI 10.1074/jbc.M502015200; Kramer J, 2007, J BACTERIOL, V189, P4290, DOI 10.1128/JB.00168-07; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Reid CJ, 1998, J BACTERIOL, V180, P2660, DOI 10.1128/JB.180.10.2660-2669.1998; Sambrook J., 2001, MOL CLONING LAB MANU; Schwoppe C, 2003, EUR J BIOCHEM, V270, P1450, DOI 10.1046/j.1432-1033.2003.03507.x; Silhavy T. J., 1984, EXPT GENE FUSIONS; SIX S, 1994, J BACTERIOL, V176, P6470, DOI 10.1128/JB.176.21.6470-6478.1994; STEED PM, 1993, J BACTERIOL, V175, P6797, DOI 10.1128/jb.175.21.6797-6809.1993; Tetsch L, 2008, MOL MICROBIOL, V67, P570, DOI 10.1111/j.1365-2958.2007.06070.x; Unden G., 2004, ECOSAL ESCHERICHIA C; Vazquez-Ibar JL, 2004, J BIOL CHEM, V279, P49214, DOI 10.1074/jbc.M407408200; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YAROSH OK, 1989, MOL MICROBIOL, V3, P813, DOI 10.1111/j.1365-2958.1989.tb00230.x; Zientz E, 1999, J BACTERIOL, V181, P3716, DOI 10.1128/JB.181.12.3716-3720.1999; Zientz E, 1998, J BACTERIOL, V180, P5421, DOI 10.1128/JB.180.20.5421-5425.1998; Zientz E, 1996, J BACTERIOL, V178, P7241, DOI 10.1128/jb.178.24.7241-7247.1996	46	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					265	275		10.1074/jbc.M807856200	http://dx.doi.org/10.1074/jbc.M807856200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18957436	hybrid			2022-12-27	WOS:000261974800030
J	Sooksa-Nguan, T; Yakubov, B; Kozlovskyy, VI; Barkume, CM; Howe, KJ; Thannhauser, TW; Rutzke, MA; Hart, JJ; Kochian, LV; Rea, PA; Vatamaniuk, OK				Sooksa-nguan, Thanwalee; Yakubov, Bakhtiyor; Kozlovskyy, Volodymyr I.; Barkume, Caitlin M.; Howe, Kevin J.; Thannhauser, Theodore W.; Rutzke, Michael A.; Hart, Jonathan J.; Kochian, Leon V.; Rea, Philip A.; Vatamaniuk, Olena K.			Drosophila ABC Transporter, DmHMT-1, Confers Tolerance to Cadmium DmHMT-1 AND ITS YEAST HOMOLOG, SpHMT-1, ARE NOT ESSENTIAL FOR VACUOLAR PHYTOCHELATIN SEQUESTRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-METAL DETOXIFICATION; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; CAENORHABDITIS-ELEGANS; ARABIDOPSIS-THALIANA; BINDING PEPTIDES; GENE FAMILY; SYNTHASE; PROTEIN	Half-molecule ATP-binding cassette transporters of the HMT-1 (heavy metal tolerance factor 1) subfamily are required for Cd2+ tolerance in Schizosaccharomyces pombe, Caenorhabditis elegans, and Chlamydomonas reinhardtii. Based on studies of S. pombe, it has been proposed that SpHMT-1 transports heavy metal center dot phytochelatin (PC) complexes into the vacuolysosomal compartment. PCs are glutathione derivatives synthesized by PC synthases (PCS) in plants, fungi, and C. elegans in response to heavy metals. Our previous studies in C. elegans, however, suggested that HMT-1 and PCS-1 do not necessarily act in concert in metal detoxification. To further explore this inconsistency, we have gone on to test whether DmHMT-1, an HMT-1 from a new source, Drosophila, whose genome lacks PCS homologs, functions in heavy metal detoxification. In so doing, we show that heterologously expressed DmHMT-1 suppresses the Cd2+ hypersensitivity of S. pombe hmt-1 mutants and localizes to the vacuolar membrane but does not transport Cd center dot PC complexes. Crucially, similar analyses of S. pombe hmt-1 mutants extend this finding to show that SpHMT-1 itself either does not transport Cd center dot PC complexes or is not the principal Cd center dot PC/apoPC transporter. Consistent with this discovery and with our previous suggestion that HMT-1 and PCS-1 do not operate in a simple linear metal detoxification pathway, we demonstrate that, unlike PCS-deficient cells, which are hypersensitive to several heavy metals, SpHMT-1-deficient cells are hypersensitive to Cd2+, but not to Hg2+ or As3+. These findings significantly change our current understanding of the function of HMT-1 proteins and invoke PC-independent role for these transporters in Cd2+ detoxification.	[Sooksa-nguan, Thanwalee; Yakubov, Bakhtiyor; Kozlovskyy, Volodymyr I.; Barkume, Caitlin M.; Vatamaniuk, Olena K.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Howe, Kevin J.; Thannhauser, Theodore W.; Rutzke, Michael A.; Hart, Jonathan J.; Kochian, Leon V.] Cornell Univ, USDA, Robert W Holley Ctr Agr & Hlth, Agr Res Serv, Ithaca, NY 14853 USA; [Rea, Philip A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Cornell University; Cornell University; United States Department of Agriculture (USDA); University of Pennsylvania	Vatamaniuk, OK (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.	okv2@cornell.edu	Kochian, Leon/ABH-6148-2020	Kochian, Leon/0000-0003-3416-089X; Kozlovskyy, Volodymyr/0000-0002-2401-3178	Cornell's College of Agriculture and Life Sciences	Cornell's College of Agriculture and Life Sciences	This work was supported by Cornell's College of Agriculture and Life Sciences Start-up Funds (to O.K.V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Hanikenne M, 2001, FEMS MICROBIOL LETT, V196, P107; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Hyman MH, 2004, ALTERN THER HEALTH M, V10, P70; Iwaki T, 2004, MOL GENET GENOMICS, V271, P197, DOI 10.1007/s00438-003-0971-7; Iwaki T, 2006, MICROBIOL-SGM, V152, P2309, DOI 10.1099/mic.0.28952-0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lill R, 2001, RES MICROBIOL, V152, P331, DOI 10.1016/S0923-2508(01)01204-9; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; Poyton RO, 1995, METHOD ENZYMOL, V260, P97, DOI 10.1016/0076-6879(95)60133-3; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; SALT DE, 1995, PLANT PHYSIOL, V107, P1293, DOI 10.1104/pp.107.4.1293; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Sarry JE, 2007, FEBS J, V274, P4287, DOI 10.1111/j.1742-4658.2007.05959.x; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Vatamaniuk OK, 2000, J BIOL CHEM, V275, P31451, DOI 10.1074/jbc.M002997200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; Zenk MH, 1996, GENE, V179, P21, DOI 10.1016/S0378-1119(96)00422-2	34	50	52	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					354	362		10.1074/jbc.M806501200	http://dx.doi.org/10.1074/jbc.M806501200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	19001374	hybrid			2022-12-27	WOS:000261974800040
J	Zuo, Y; Zhuang, DZ; Han, R; Isaac, G; Tobin, JJ; Mckee, M; Welti, R; Brissette, JL; Fitzgerald, ML; Freeman, MW				Zuo, Ying; Zhuang, Debbie Z.; Han, Rong; Isaac, Giorgis; Tobin, Jennifer J.; Mckee, Mary; Welti, Ruth; Brissette, Janice L.; Fitzgerald, Michael L.; Freeman, Mason W.			ABCA12 Maintains the Epidermal Lipid Permeability Barrier by Facilitating Formation of Ceramide Linoleic Esters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER 1; HARLEQUIN ICHTHYOSIS; TANGIER-DISEASE; PULMONARY SURFACTANT; LAMELLAR GRANULES; RESPIRATORY-FAILURE; GAUCHER-DISEASE; GENE ABCR; MUTATIONS; MICE	Harlequin ichthyosis is a congenital scaling syndrome of the skin in which affected infants have epidermal hyperkeratosis and a defective permeability barrier. Mutations in the gene encoding a member of the ABCA transporter family, ABCA12, have been linked to harlequin ichthyosis, but the molecular function of the protein is unknown. To investigate the activity of ABCA12, we generated Abca12 null mice and analyzed the impact on skin function and lipid content. Abca12(-/-) mice are born with a thickened epidermis and die shortly after birth, as water rapidly evaporates from their skin. In vivo skin proliferation measurements suggest a lack of desquamation of the skin cells, rather than enhanced proliferation of basal layer keratinocytes, accounts for the 5-fold thickening of the Abca12(-/-) stratum corneum. Electron microscopy revealed a loss of the lamellar permeability barrier in Abca12(-/-) skin. This was associated with a profound reduction in skin linoleic esters of long-chain omega-hydroxyceramides and a corresponding increase in their glucosyl ceramide precursors. Because omega-hydroxyceramides are required for the barrier function of the skin, these results establish that ABCA12 activity is required for the generation of long-chain ceramide esters that are essential for the development of normal skin structure and function.	[Zuo, Ying; Zhuang, Debbie Z.; Tobin, Jennifer J.; Fitzgerald, Michael L.; Freeman, Mason W.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Zuo, Ying; Zhuang, Debbie Z.; Tobin, Jennifer J.; Fitzgerald, Michael L.; Freeman, Mason W.] Massachusetts Gen Hosp, Lipid Metab Unit, Boston, MA 02114 USA; [Zuo, Ying; Zhuang, Debbie Z.; Tobin, Jennifer J.; Fitzgerald, Michael L.; Freeman, Mason W.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Han, Rong; Brissette, Janice L.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Mckee, Mary] Massachusetts Gen Hosp, Ctr Membrane Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; [Isaac, Giorgis; Welti, Ruth] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Kansas State University	Freeman, MW (corresponding author), Massachusetts Gen Hosp, Dept Med, Simches 7214,185 Cambridge St, Boston, MA 02114 USA.	freeman@molbio.mgh.harvard.edu		Welti, Ruth/0000-0003-4373-2538; Han, Rong/0000-0002-5766-8277	National Institutes of Health [RR020345, HL074136]; Inflammatory Bowel Disease [DK43351]; Boston Area Diabetes and Endocrinology Research Center Award [DK57521]; National Science Foundation (NSF) [MCB0455318, 0521587]; NSF EPSCoR [EPS-0236913]; State of Kansas through Kansas Technology Enterprise Corporation; Kansas State University; NIH [P20 RR16475]; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR020345] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055218, R01AR045284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER; Direct For Biological Sciences [0920663] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center Award; National Science Foundation (NSF)(National Science Foundation (NSF)); NSF EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); State of Kansas through Kansas Technology Enterprise Corporation; Kansas State University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants RR020345 (to M.W.F.) and HL074136 (to M.L.F.). The electron microscopy core is supported by an Inflammatory Bowel Disease Grant (DK43351) and a Boston Area Diabetes and Endocrinology Research Center Award (DK57521). The Kansas Lipidomics Research Center (KLRC) was supported by National Science Foundation (NSF) Grants MCB0455318 and DBI 0521587, and NSF EPSCoR Grant EPS-0236913, with matching support from the State of Kansas through Kansas Technology Enterprise Corporation and Kansas State University. The KLRC was also supported by Kansas Idea Network of Biomedical Research Excellence from NIH Grant P20 RR16475, from the Idea Network of Biomedical Research Excellence program of the National Center for Research Resources. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama M, 2008, BRIT J DERMATOL, V158, P864, DOI 10.1111/j.1365-2133.2008.08439.x; Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Akiyama M, 2006, J DERMATOL SCI, V42, P83, DOI 10.1016/j.jdermsci.2006.01.003; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Annilo T, 2002, CYTOGENET GENOME RES, V98, P169, DOI 10.1159/000069811; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brasch F, 2006, AM J RESP CRIT CARE, V174, P571, DOI 10.1164/rccm.200509-1535OC; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; Cheong N, 2007, J BIOL CHEM, V282, P23811, DOI 10.1074/jbc.M703927200; DALE BA, 1990, J INVEST DERMATOL, V94, P6, DOI 10.1111/1523-1747.ep12873301; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; Doering T, 1999, FEBS LETT, V447, P167, DOI 10.1016/S0014-5793(99)00274-4; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; FREINKEL RK, 1985, J INVEST DERMATOL, V85, P295, DOI 10.1111/1523-1747.ep12276831; Hammel M, 2007, BIOCHEM BIOPH RES CO, V359, P947, DOI 10.1016/j.bbrc.2007.05.219; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; HOLLERAN WM, 1993, J CLIN INVEST, V91, P1656, DOI 10.1172/JCI116374; HOLLERAN WM, 1994, J CLIN INVEST, V93, P1756, DOI 10.1172/JCI117160; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; HOU SYE, 1991, J INVEST DERMATOL, V96, P215, DOI 10.1111/1523-1747.ep12461361; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; MILNER ME, 1992, J INVEST DERMATOL, V99, P824, DOI 10.1111/1523-1747.ep12614791; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Rajpar SF, 2006, BRIT J DERMATOL, V155, P204, DOI 10.1111/j.1365-2133.2006.07291.x; RESING KA, 1984, J CELL BIOL, V99, P1372, DOI 10.1083/jcb.99.4.1372; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SAITO M, 1985, J BIOL CHEM, V260, P2295; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yanagi T, 2008, HUM MOL GENET, V17, P3075, DOI 10.1093/hmg/ddn204	42	79	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36624	36635		10.1074/jbc.M807377200	http://dx.doi.org/10.1074/jbc.M807377200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18957418	Green Published, hybrid			2022-12-27	WOS:000261840500061
J	Webb, KJ; Laganowsky, A; Whitelegge, JP; Clarke, SG				Webb, Kristofor J.; Laganowsky, Arthur; Whitelegge, Julian P.; Clarke, Steven G.			Identification of Two SET Domain Proteins Required for Methylation of Lysine Residues in Yeast Ribosomal Protein Rpl42ab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC MEMBRANE-PROTEINS; HUMAN HISTONE H4; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; 80S RIBOSOME; SUBUNIT; METHYLTRANSFERASE; RPL23AB	We show that the Saccharomyces cerevisiae ribosomal protein Rpl42ab (the identical product of the RPL42A and RPL42B genes) is monomethylated at Lys-40 and Lys-55. The methylation of Lys-40 is dependent upon the Ybr030w gene product; the methylation of Lys-55 is dependent upon the Set7 gene product. Ybr030w and SET7 genes both encode SET domain containing proteins homologous to known protein lysine methyltransferases, suggesting that their products are the specific enzymes responsible for the monomethylation of the two sites in Rpl42ab. We thus designate Ybr030w as Rkm3 and Set7 as Rkm4. Yeast strains with deletions in both the Ybr030w and SET7 genes produce unmethylated Rpl42ab. A slow growth phenotype was seen for the SET7 deletion strain and the double knock-out when grown in low concentrations of the eukaryotic protein synthesis inhibitor, cycloheximide. These results suggest that modification of Rpl42ab at Lys-55 can fine-tune its structure to avoid inhibition. An intact mass fragmentation approach ("top down mass spectrometry") was used to quantitate the extent of methylation of Rpl42ab. In wild-type strains, it was found that 78% was monomethylated at both Lys-40 and Lys-55 and that 22% was a mixture of species with either Lys-40 or Lys-55 monomethylated. The top down approach was also used to reevaluate the methylation sites of Rpl12ab. We found that the yeast Rpl12ab protein is dimethylated at the N-terminal proline residue, trimethylated at Lys-3 by Rkm2, and monomethylated at Arg-66.	[Webb, Kristofor J.; Laganowsky, Arthur; Whitelegge, Julian P.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Webb, Kristofor J.; Laganowsky, Arthur; Whitelegge, Julian P.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.] Univ Calif Los Angeles, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu		Laganowsky, Arthur/0000-0001-5012-5547; Webb, Kristofor/0000-0001-8111-9756	National Institutes of Health [GM026020, S10 RR023045, 5T32GM008496]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM026020 and Grant S10 RR023045 purchase of the LTQ FT Ultra mass spectrometer). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by the National Institutes of Health Chemistry Biology Interface Training Program Grant 5T32GM008496.	Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Culhane JC, 2007, CURR OPIN CHEM BIOL, V11, P561, DOI 10.1016/j.cbpa.2007.07.014; Dirk LMA, 2006, ENZYMES, V24, P179, DOI 10.1016/S1874-6047(06)80009-0; ITOH T, 1978, FEBS LETT, V96, P399, DOI 10.1016/0014-5793(78)80447-5; KAWAI S, 1992, J BACTERIOL, V174, P254, DOI 10.1128/jb.174.1.254-262.1992; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Ng DWK, 2007, BBA-GENE STRUCT EXPR, V1769, P316, DOI 10.1016/j.bbaexp.2007.04.003; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pesavento JJ, 2006, ANAL CHEM, V78, P4271, DOI 10.1021/ac0600050; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2007, J BIOL CHEM, V282, P12368, DOI 10.1074/jbc.M611896200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Whitelegge JP, 1998, PROTEIN SCI, V7, P1423, DOI 10.1002/pro.5560070619; Whitelegge Julian P, 2004, Methods Mol Biol, V251, P323; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003	27	36	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35561	35568		10.1074/jbc.M806006200	http://dx.doi.org/10.1074/jbc.M806006200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18957409	Green Published, hybrid			2022-12-27	WOS:000261687900028
